archetype #,Feature Name,P value (Mann-Whitney),Median Difference,Mean Difference,Significant after Benjamini-Hochberg correction?,Is first bin maximal?
1,GO BLEB ASSEMBLY,3.9926e-07,1.6202,1.3957,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,8.1192e-05,1.5121,1.2888,1,1
1,GO MEMBRANE RAFT ASSEMBLY,7.0571e-06,1.4257,1.5231,1,1
1,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,2.5122e-07,1.3066,1.1603,1,1
1,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,2.8891e-07,1.2317,1.0926,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,0.00014418,1.1881,0.98381,1,1
1,GO NEGATIVE REGULATION OF HIPPO SIGNALING,1.9904e-06,1.1139,0.97689,1,1
1,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,1.2366e-07,1.1054,0.98596,1,1
1,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,3.3202e-07,1.0843,1.0301,1,1
1,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,0.0006154,1.0756,0.94856,1,1
1,GO T HELPER 2 CELL DIFFERENTIATION,1.6452e-07,1.0692,1.0508,1,1
1,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,1.5816e-05,1.0649,0.96077,1,1
1,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,6.2985e-07,1.054,0.91261,1,1
1,GO T HELPER 1 CELL DIFFERENTIATION,1.4963e-07,1.0301,0.86747,1,1
1,GO NEUTROPHIL HOMEOSTASIS,1.104e-05,1.0288,0.9251,1,1
1,GO HYALURONAN CATABOLIC PROCESS,1.4674e-06,1.0272,0.98847,1,1
1,GO REGULATION OF PLASMINOGEN ACTIVATION,9.389e-05,1.0145,0.87651,1,1
1,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,8.628e-07,1.0115,0.97766,1,1
1,GO RESPONSE TO INTERFERON ALPHA,2.8077e-06,1.0105,1.0672,1,1
1,GO GLYCOPROTEIN CATABOLIC PROCESS,8.3127e-06,0.98795,0.79839,1,1
1,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,7.889e-07,0.9695,0.92395,1,1
1,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00032948,0.96203,0.73375,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,3.0689e-05,0.9304,0.86227,1,1
1,GO REGULATION OF METANEPHROS DEVELOPMENT,1.6452e-07,0.92007,0.89428,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.00024286,0.90973,0.72951,1,1
1,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,6.2367e-06,0.90936,0.86293,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,1.0779e-06,0.892,0.7645,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,1.2454e-05,0.89181,0.75609,1,1
1,GO NEGATIVE REGULATION OF CELL KILLING,0.0001547,0.8802,0.69752,1,1
1,GO MEMBRANE RAFT ORGANIZATION,9.7801e-06,0.87229,0.93217,1,1
1,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,2.6902e-06,0.86993,0.78746,1,1
1,GO ENDODERMAL CELL DIFFERENTIATION,2.9301e-06,0.86597,0.86339,1,1
1,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,4.5813e-07,0.86061,0.75652,1,1
1,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,3.0264e-07,0.85499,0.84946,1,1
1,GO GLOMERULAR MESANGIUM DEVELOPMENT,3.1904e-06,0.8452,0.71879,1,1
1,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,1.2862e-06,0.83091,0.78294,1,1
1,GO INFLAMMATORY RESPONSE TO WOUNDING,1.5331e-06,0.82817,0.92754,1,1
1,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,1.4268e-07,0.82762,0.79249,1,1
1,GO CD40 SIGNALING PATHWAY,1.2971e-07,0.82693,0.77599,1,1
1,GO RESPONSE TO INTERFERON BETA,4.8612e-06,0.81918,0.92985,1,1
1,GO COLLAGEN BIOSYNTHETIC PROCESS,2.9301e-06,0.81777,0.75362,1,1
1,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,2.6307e-05,0.81615,0.76824,1,1
1,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,1.5201e-05,0.81582,0.93524,1,1
1,GO EXTRACELLULAR MATRIX CONSTITUENT SECRETION,0.00059588,0.81242,0.6316,1,1
1,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,1.2962e-05,0.80747,0.81432,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,5.0194e-07,0.80446,0.67474,1,1
1,GO HEMIDESMOSOME ASSEMBLY,1.8521e-05,0.80373,0.91387,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,8.628e-07,0.80137,0.69417,1,1
1,GO ZYMOGEN INHIBITION,1.1237e-07,0.79652,0.84926,1,1
1,GO BONE TRABECULA FORMATION,0.0019282,0.78694,0.66313,1,1
1,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.00057693,0.78408,0.67395,1,1
1,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,7.5427e-07,0.78406,0.6651,1,1
1,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,9.8628e-07,0.78229,0.68947,1,1
1,GO PLASMINOGEN ACTIVATION,0.00019753,0.77909,0.59725,1,1
1,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,2.1663e-05,0.77097,0.63158,1,1
1,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,1.3441e-06,0.77051,0.67479,1,1
1,GO DNA DEAMINATION,8.3127e-06,0.7672,0.6408,1,1
1,GO METANEPHRIC GLOMERULUS DEVELOPMENT,4.1617e-05,0.76685,0.62662,1,1
1,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,3.7145e-05,0.76678,0.68003,1,1
1,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.00013433,0.76551,0.6038,1,1
1,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,2.6902e-06,0.76101,0.71497,1,1
1,GO ENDODERM FORMATION,7.6603e-06,0.76072,0.73679,1,1
1,GO DENDRITIC CELL APOPTOTIC PROCESS,1.0184e-05,0.75393,0.60341,1,1
1,GO HIPPO SIGNALING,5.0683e-06,0.75227,0.62253,1,1
1,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,1.9904e-06,0.75166,0.72184,1,1
1,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,1.1776e-06,0.74902,0.82201,1,1
1,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,5.753e-07,0.74649,0.72725,1,1
1,GO CYTIDINE TO URIDINE EDITING,0.00019753,0.74461,0.67881,1,1
1,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,2.6307e-05,0.74383,0.65473,1,1
1,GO METANEPHRIC EPITHELIUM DEVELOPMENT,3.3287e-06,0.73881,0.64306,1,1
1,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,4.6623e-06,0.73765,0.78822,1,1
1,GO LATERAL MESODERM DEVELOPMENT,1.4044e-06,0.73685,0.64083,1,1
1,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,1.4039e-05,0.7297,0.64031,1,1
1,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,2.0829e-07,0.72952,0.64771,1,1
1,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,3.5759e-05,0.72759,0.6672,1,1
1,GO CELLULAR RESPONSE TO X RAY,0.00018427,0.72155,0.5304,1,1
1,GO INFLAMMATORY CELL APOPTOTIC PROCESS,4.3763e-07,0.72044,0.71725,1,1
1,GO RESPONSE TO MURAMYL DIPEPTIDE,1.7118e-05,0.71488,0.59951,1,1
1,GO EPIBOLY,4.6623e-06,0.71392,0.71857,1,1
1,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,2.7578e-07,0.71003,0.6839,1,1
1,GO NEGATIVE REGULATION OF VIRAL PROCESS,3.6228e-06,0.7086,0.59955,1,1
1,GO CHAPERONE MEDIATED AUTOPHAGY,0.00072223,0.70781,0.53161,1,1
1,GO TROPHOBLAST CELL MIGRATION,1.0604e-05,0.70407,0.77364,1,1
1,GO CHRONIC INFLAMMATORY RESPONSE,2.3654e-06,0.70342,0.66809,1,1
1,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,4.1802e-07,0.69716,0.66467,1,1
1,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,2.6902e-06,0.69595,0.67264,1,1
1,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,9.7801e-06,0.6933,0.62966,1,1
1,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,7.5427e-07,0.69195,0.64889,1,1
1,GO T HELPER 1 TYPE IMMUNE RESPONSE,2.0829e-07,0.69042,0.61433,1,1
1,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.00013917,0.67972,0.67995,1,1
1,GO MULTI ORGANISM CELLULAR PROCESS,7.0571e-06,0.67857,0.80367,1,1
1,GO RAP PROTEIN SIGNAL TRANSDUCTION,3.0576e-06,0.67808,0.59429,1,1
1,GO XENOBIOTIC CATABOLIC PROCESS,0.00074557,0.67234,0.57467,1,1
1,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,0.00016595,0.67201,0.6678,1,1
1,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,9.7346e-05,0.66933,0.62464,1,1
1,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,9.4334e-07,0.66879,0.67233,1,1
1,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,9.3916e-06,0.66835,0.61904,1,1
1,GO MUCUS SECRETION,0.00084609,0.66378,0.57868,1,1
1,GO RESPONSE TO INTERLEUKIN 18,0.0037331,0.66078,0.57346,1,1
1,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,4.6623e-06,0.66014,0.50538,1,1
1,GO T CELL EXTRAVASATION,0.00036427,0.65824,0.56867,1,1
1,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,9.389e-05,0.65756,0.56895,1,1
1,GO REGULATION OF PINOCYTOSIS,5.2837e-06,0.65699,0.6613,1,1
1,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,7.0571e-06,0.65376,0.62603,1,1
1,GO FIBRINOLYSIS,5.8301e-05,0.65363,0.73087,1,1
1,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,5.9841e-06,0.65247,0.67222,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,7.3528e-06,0.65032,0.67375,1,1
1,GO GLOMERULAR MESANGIAL CELL PROLIFERATION,1.5201e-05,0.64834,0.68777,1,1
1,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,2.5122e-07,0.6482,0.73208,1,1
1,GO T CELL MEDIATED CYTOTOXICITY,5.4121e-05,0.6478,0.55941,1,1
1,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.00010092,0.64701,0.51738,1,1
1,GO GAP JUNCTION ASSEMBLY,1.7118e-05,0.64462,0.58393,1,1
1,GO OLIGOSACCHARIDE CATABOLIC PROCESS,0.00013917,0.6445,0.51222,1,1
1,GO PIGMENT GRANULE MATURATION,6.2367e-06,0.64112,0.52246,1,1
1,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,3.3132e-05,0.63898,0.53633,1,1
1,GO NEGATIVE REGULATION OF CELL AGING,1.8084e-07,0.62907,0.60635,1,1
1,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,2.4692e-06,0.62853,0.60796,1,1
1,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,9.7801e-06,0.62743,0.50568,1,1
1,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,1.8521e-05,0.62346,0.52649,1,1
1,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,2.1702e-06,0.62295,0.58252,1,1
1,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,1.725e-07,0.62179,0.65187,1,1
1,GO ENDODERM DEVELOPMENT,6.2367e-06,0.61775,0.59546,1,1
1,GO ZYMOGEN ACTIVATION,6.7596e-05,0.6166,0.51418,1,1
1,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0045306,0.61651,0.66628,1,1
1,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0001165,0.61622,0.5013,1,1
1,GO REGULATION OF MACROPHAGE DIFFERENTIATION,4.2876e-06,0.61406,0.59821,1,1
1,GO REGULATION OF VIRAL GENOME REPLICATION,4.6623e-06,0.61323,0.51995,1,1
1,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.010245,0.61236,0.39839,1,1
1,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,2.7578e-07,0.61085,0.57039,1,1
1,GO CELLULAR RESPONSE TO SALT STRESS,2.6307e-05,0.60928,0.56943,1,1
1,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.0026572,0.60891,0.63123,1,1
1,GO LEUKOCYTE AGGREGATION,0.00081984,0.6074,0.5151,1,1
1,GO REGULATION OF ISOTYPE SWITCHING,5.2139e-05,0.60729,0.43299,1,1
1,GO CHEMOKINE BIOSYNTHETIC PROCESS,1.7806e-05,0.60628,0.65626,1,1
1,GO BIOLOGICAL PHASE,0.00028792,0.60413,0.59094,1,1
1,GO VASCULOGENESIS,3.4772e-07,0.60346,0.59267,1,1
1,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,2.5774e-06,0.60224,0.64401,1,1
1,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,3.9418e-06,0.60153,0.55727,1,1
1,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,8.6584e-06,0.59994,0.66284,1,1
1,GO BASEMENT MEMBRANE ORGANIZATION,3.3132e-05,0.59955,0.60472,1,1
1,GO APOPTOTIC CELL CLEARANCE,3.9418e-06,0.59943,0.64989,1,1
1,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,4.3218e-05,0.59921,0.49325,1,1
1,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,1.1776e-06,0.59784,0.73496,1,1
1,GO ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER,0.0030654,0.59725,0.39995,1,1
1,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,4.8612e-06,0.59637,0.59926,1,1
1,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,8.7323e-05,0.59606,0.44058,1,1
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,6.2367e-06,0.5958,0.4279,1,1
1,GO CYTOLYSIS,1.8521e-05,0.59555,0.47077,1,1
1,GO LIVER REGENERATION,3.0576e-06,0.59534,0.5415,1,1
1,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,1.2454e-05,0.59458,0.5184,1,1
1,GO COLLAGEN METABOLIC PROCESS,1.5201e-05,0.58733,0.54034,1,1
1,GO NUCLEOSIDE CATABOLIC PROCESS,0.00024286,0.58625,0.48282,1,1
1,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,4.1112e-06,0.58625,0.51379,1,1
1,GO CYSTEINE METABOLIC PROCESS,0.00063551,0.58608,0.45339,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS,5.2837e-06,0.58529,0.6175,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00044439,0.58453,0.52447,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,2.0784e-06,0.58278,0.55753,1,1
1,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,6.0198e-07,0.58243,0.56266,1,1
1,GO INTERLEUKIN 1 PRODUCTION,3.0689e-05,0.58224,0.46676,1,1
1,GO NOTOCHORD DEVELOPMENT,5.2837e-06,0.58159,0.63858,1,1
1,GO REGULATION OF VIRAL LIFE CYCLE,2.6902e-06,0.5807,0.51067,1,1
1,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,5.8301e-05,0.57926,0.56169,1,1
1,GO MODULATION BY HOST OF VIRAL PROCESS,6.8936e-07,0.57919,0.5867,1,1
1,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,5.9841e-06,0.57865,0.60491,1,1
1,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,9.7346e-05,0.57818,0.64059,1,1
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,6.7596e-05,0.57809,0.55326,1,1
1,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,6.0504e-05,0.57539,0.61964,1,1
1,GO POSITIVE REGULATION OF VASOCONSTRICTION,1.4044e-06,0.57534,0.47189,1,1
1,GO NEGATIVE REGULATION OF COAGULATION,0.00016023,0.57413,0.54662,1,1
1,GO RIBONUCLEOSIDE CATABOLIC PROCESS,1.104e-05,0.57348,0.62689,1,1
1,GO ENTRY INTO HOST,1.0311e-06,0.57198,0.56994,1,1
1,GO HEME METABOLIC PROCESS,1.4044e-06,0.57183,0.52812,1,1
1,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,2.4346e-05,0.57123,0.58818,1,1
1,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.00023468,0.57033,0.49294,1,1
1,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.00081984,0.56741,0.58885,1,1
1,GO GLYCOLIPID CATABOLIC PROCESS,8.4205e-05,0.56622,0.51697,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,3.4421e-05,0.56455,0.57084,1,1
1,GO AMYLOID BETA CLEARANCE,3.1888e-05,0.56355,0.44185,1,1
1,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,1.0184e-05,0.5619,0.6594,1,1
1,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,5.2837e-06,0.5601,0.54034,1,1
1,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,3.9418e-06,0.55959,0.50427,1,1
1,GO TOLERANCE INDUCTION,0.00049035,0.55878,0.45802,1,1
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.00026903,0.55702,0.48826,1,1
1,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,1.104e-05,0.55695,0.52321,1,1
1,GO RESPONSE TO NITROSATIVE STRESS,0.00018427,0.55531,0.43429,1,1
1,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,2.6307e-05,0.55454,0.49991,1,1
1,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,1.5201e-05,0.55442,0.52659,1,1
1,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.00022676,0.55338,0.52242,1,1
1,GO CELLULAR RESPONSE TO DSRNA,5.9841e-06,0.55324,0.53323,1,1
1,GO TYPE 2 IMMUNE RESPONSE,7.0571e-06,0.5506,0.556,1,1
1,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,7.547e-05,0.55056,0.42506,1,1
1,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,6.2786e-05,0.55054,0.45064,1,1
1,GO BRANCH ELONGATION OF AN EPITHELIUM,0.00072223,0.55036,0.50734,1,1
1,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,7.6603e-06,0.54924,0.50633,1,1
1,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,9.4334e-07,0.54697,0.49811,1,1
1,GO RESPONSE TO X RAY,1.725e-07,0.54625,0.58124,1,1
1,GO REGULATION OF T HELPER CELL DIFFERENTIATION,2.2658e-06,0.54577,0.46327,1,1
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,3.1888e-05,0.54548,0.40941,1,1
1,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,7.547e-05,0.54509,0.52131,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,2.1831e-07,0.54479,0.63326,1,1
1,GO SALIVARY GLAND DEVELOPMENT,0.00023468,0.54391,0.50192,1,1
1,GO ENTRY OF BACTERIUM INTO HOST CELL,0.00018427,0.54357,0.55042,1,1
1,GO REGULATION OF FIBRINOLYSIS,0.00038934,0.54138,0.54167,1,1
1,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,5.9841e-06,0.54087,0.50546,1,1
1,GO INTERLEUKIN 13 PRODUCTION,0.00065623,0.54042,0.47741,1,1
1,GO POSITIVE REGULATION OF STEROL TRANSPORT,2.6902e-06,0.5403,0.48195,1,1
1,GO VIRAL GENOME REPLICATION,3.9418e-06,0.53958,0.45233,1,1
1,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,1.0184e-05,0.53905,0.42778,1,1
1,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.00014418,0.53707,0.45003,1,1
1,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,6.5149e-05,0.53538,0.49976,1,1
1,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,7.2111e-07,0.53503,0.58393,1,1
1,GO CELLULAR RESPONSE TO IRON ION,0.00012074,0.53361,0.49443,1,1
1,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,4.5813e-07,0.53268,0.52649,1,1
1,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,3.7145e-05,0.53245,0.3957,1,1
1,GO COLLAGEN CATABOLIC PROCESS,2.3418e-05,0.53243,0.5421,1,1
1,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,7.8282e-05,0.5317,0.41552,1,1
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.00041602,0.53142,0.50595,1,1
1,GO REGULATION OF COLLAGEN METABOLIC PROCESS,3.4421e-05,0.53071,0.5597,1,1
1,GO REGULATION OF T CELL APOPTOTIC PROCESS,7.9801e-06,0.52978,0.42911,1,1
1,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,1.9904e-06,0.52924,0.48881,1,1
1,GO RESPONSE TO TYPE I INTERFERON,9.7346e-05,0.52911,0.6007,1,1
1,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,5.4121e-05,0.5289,0.59621,1,1
1,GO 3 UTR MEDIATED MRNA DESTABILIZATION,2.0829e-07,0.52793,0.52745,1,1
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,1.0184e-05,0.52768,0.52038,1,1
1,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.00034072,0.52752,0.40181,1,1
1,GO VAGINA DEVELOPMENT,2.7343e-05,0.5274,0.56462,1,1
1,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.00063551,0.52599,0.35635,1,1
1,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,3.3287e-06,0.5233,0.5873,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,2.0829e-07,0.52267,0.49372,1,1
1,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,2.9301e-06,0.52137,0.47675,1,1
1,GO REGULATION OF AMYLOID BETA CLEARANCE,0.0049174,0.52061,0.36033,1,1
1,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,3.3287e-06,0.51992,0.44348,1,1
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,3.4421e-05,0.51977,0.44153,1,1
1,GO STORE OPERATED CALCIUM ENTRY,6.7596e-05,0.51969,0.38597,1,1
1,GO EXTRACELLULAR MATRIX DISASSEMBLY,2.7343e-05,0.51904,0.51738,1,1
1,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.00027832,0.51714,0.40966,1,1
1,GO RESPONSE TO ANGIOTENSIN,3.17e-07,0.51612,0.49888,1,1
1,GO CELLULAR RESPONSE TO INTERFERON BETA,0.00017186,0.51528,0.4657,1,1
1,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.00010845,0.51455,0.4619,1,1
1,GO RECEPTOR CATABOLIC PROCESS,7.2111e-07,0.51135,0.46481,1,1
1,GO REGULATION OF SYMBIOTIC PROCESS,1.4674e-06,0.50967,0.42182,1,1
1,GO RESPONSE TO INTERFERON GAMMA,2.5308e-05,0.50958,0.48502,1,1
1,GO RESPONSE TO SALT STRESS,1.0184e-05,0.50893,0.38828,1,1
1,GO POSITIVE REGULATION OF PROTEIN IMPORT,1.6729e-06,0.50763,0.468,1,1
1,GO T CELL MEDIATED IMMUNITY,8.6584e-06,0.50749,0.46159,1,1
1,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.00074557,0.50574,0.45416,1,1
1,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.00023468,0.50552,0.48921,1,1
1,GO ELASTIC FIBER ASSEMBLY,0.0073363,0.50279,0.59679,1,1
1,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,7.547e-05,0.50077,0.49398,1,1
1,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00010092,0.50071,0.43046,1,1
1,GO NEGATIVE REGULATION OF PROTEIN MATURATION,9.0221e-07,0.5007,0.62714,1,1
1,GO SKIN MORPHOGENESIS,0.00045924,0.49996,0.63011,1,1
1,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.0021689,0.4997,0.38822,1,1
1,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,8.7323e-05,0.4983,0.45527,1,1
1,GO POSITIVE REGULATION OF ERAD PATHWAY,2.4692e-06,0.49818,0.42629,1,1
1,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,1.0779e-06,0.49805,0.45909,1,1
1,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.0021062,0.49603,0.40009,1,1
1,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,2.3418e-05,0.49586,0.40976,1,1
1,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.031748,0.49399,0.30596,1,1
1,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,7.013e-05,0.49354,0.36526,1,1
1,GO INTERLEUKIN 1 BETA PRODUCTION,4.4878e-05,0.49344,0.42107,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.00079435,0.49327,0.42378,1,1
1,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,4.3218e-05,0.49314,0.39942,1,1
1,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,7.0571e-06,0.49289,0.38754,1,1
1,GO MATURATION OF SSU RRNA,7.013e-05,0.4915,0.37101,1,1
1,GO CAVEOLIN MEDIATED ENDOCYTOSIS,2.1663e-05,0.48967,0.42667,1,1
1,GO RETINAL METABOLIC PROCESS,0.0053338,0.48923,0.35336,1,1
1,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.00014935,0.4887,0.42715,1,1
1,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,6.2985e-07,0.48604,0.54801,1,1
1,GO AORTIC VALVE DEVELOPMENT,0.00026003,0.48593,0.41418,1,1
1,GO PINOCYTOSIS,3.9926e-07,0.48579,0.61613,1,1
1,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00047456,0.48419,0.45417,1,1
1,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,1.0184e-05,0.48416,0.48318,1,1
1,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,5.0226e-05,0.48377,0.38988,1,1
1,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,9.389e-05,0.48321,0.66885,1,1
1,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,4.6597e-05,0.48284,0.35173,1,1
1,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.00059588,0.48233,0.34521,1,1
1,GO REGULATION OF MYOBLAST FUSION,1.7118e-05,0.48168,0.55024,1,1
1,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,3.3132e-05,0.48084,0.42081,1,1
1,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.018836,0.48066,0.35725,1,1
1,GO FORMATION OF PRIMARY GERM LAYER,1.8521e-05,0.48051,0.43902,1,1
1,GO PROGESTERONE METABOLIC PROCESS,0.007729,0.48008,0.2296,1,1
1,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,4.1802e-07,0.47881,0.41591,1,1
1,GO RRNA PSEUDOURIDINE SYNTHESIS,0.0036303,0.47825,0.30549,1,1
1,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.00081984,0.47813,0.4044,1,1
1,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.0018173,0.47791,0.42846,1,1
1,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.00027832,0.47718,0.41691,1,1
1,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.00014935,0.47666,0.37023,1,1
1,GO NIK NF KAPPAB SIGNALING,1.6452e-07,0.47654,0.43898,1,1
1,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.0016129,0.47626,0.3752,1,1
1,GO SKELETAL MUSCLE TISSUE REGENERATION,5.508e-06,0.47622,0.4329,1,1
1,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,4.4712e-06,0.47553,0.41563,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,8.7323e-05,0.47511,0.43263,1,1
1,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,2.1663e-05,0.47505,0.37104,1,1
1,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,4.4712e-06,0.47487,0.47393,1,1
1,GO HAIR FOLLICLE MATURATION,0.0010206,0.4746,0.3475,1,1
1,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.00047456,0.47433,0.39605,1,1
1,GO CYTOKINE METABOLIC PROCESS,4.1112e-06,0.47403,0.40011,1,1
1,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,1.5201e-05,0.47395,0.35869,1,1
1,GO VIRAL RNA GENOME REPLICATION,7.5427e-07,0.47388,0.44772,1,1
1,GO REGULATION OF TRANSPOSITION,0.0001165,0.47325,0.47218,1,1
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,2.8077e-06,0.47275,0.49483,1,1
1,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.00098941,0.4724,0.34228,1,1
1,GO SEQUESTERING OF EXTRACELLULAR LIGAND FROM RECEPTOR,0.00047456,0.4719,0.60275,1,1
1,GO BLOOD VESSEL REMODELING,0.00024286,0.47136,0.39561,1,1
1,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.0011199,0.4707,0.44371,1,1
1,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,9.0221e-07,0.46997,0.43709,1,1
1,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.00032948,0.46959,0.53804,1,1
1,GO RESPONSE TO INTERLEUKIN 12,5.4977e-07,0.46955,0.43261,1,1
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.00090094,0.46929,0.38858,1,1
1,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.00030804,0.46889,0.34737,1,1
1,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,2.6307e-05,0.46886,0.42364,1,1
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.00047456,0.46849,0.37585,1,1
1,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,3.4772e-07,0.46825,0.44514,1,1
1,GO MOVEMENT IN HOST ENVIRONMENT,7.889e-07,0.46814,0.49432,1,1
1,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,2.4692e-06,0.46744,0.48672,1,1
1,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,7.8282e-05,0.46682,0.40917,1,1
1,GO DEFENSE RESPONSE TO VIRUS,1.2962e-05,0.46678,0.42182,1,1
1,GO REGULATION OF HORMONE METABOLIC PROCESS,4.6597e-05,0.46674,0.42398,1,1
1,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,1.0779e-06,0.46666,0.49681,1,1
1,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.00035231,0.46661,0.37846,1,1
1,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,3.0689e-05,0.46654,0.40542,1,1
1,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,1.104e-05,0.4665,0.39772,1,1
1,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.0030654,0.46592,0.36541,1,1
1,GO REGULATION OF PROTEIN DEUBIQUITINATION,5.7413e-06,0.46552,0.49463,1,1
1,GO HYALURONAN METABOLIC PROCESS,0.00019079,0.4653,0.43524,1,1
1,GO MATURATION OF LSU RRNA,3.1888e-05,0.46526,0.44119,1,1
1,GO REGULATION OF GLOMERULAR FILTRATION,0.0026572,0.46469,0.41319,1,1
1,GO REGULATION OF T CELL CYTOKINE PRODUCTION,3.8583e-05,0.46466,0.45707,1,1
1,GO RESPONSE TO HYPEROXIA,0.00044439,0.4646,0.42674,1,1
1,GO GROWTH PLATE CARTILAGE DEVELOPMENT,6.0504e-05,0.46419,0.41183,1,1
1,GO INTERLEUKIN 8 PRODUCTION,6.7728e-06,0.46405,0.40663,1,1
1,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.0099891,0.46395,0.31686,1,1
1,GO RIG I SIGNALING PATHWAY,1.0779e-06,0.46367,0.43536,1,1
1,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.0010528,0.46351,0.40739,1,1
1,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,5.0226e-05,0.46346,0.48464,1,1
1,GO MUSCLE CELL FATE COMMITMENT,0.0001547,0.46339,0.47152,1,1
1,GO POSITIVE REGULATION OF VASCULOGENESIS,0.0018173,0.46336,0.38553,1,1
1,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,4.1112e-06,0.46315,0.3958,1,1
1,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,7.9801e-06,0.46301,0.65574,1,1
1,GO CELLULAR RESPONSE TO OSMOTIC STRESS,5.2837e-06,0.46233,0.39844,1,1
1,GO COLLAGEN FIBRIL ORGANIZATION,0.0001165,0.46159,0.64582,1,1
1,GO REGULATION OF TRANSLATIONAL TERMINATION,7.6603e-06,0.46056,0.42266,1,1
1,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.00026003,0.46034,0.45689,1,1
1,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,7.6379e-08,0.45798,0.57132,1,1
1,GO THYMOCYTE APOPTOTIC PROCESS,8.6584e-06,0.45741,0.43501,1,1
1,GO OSTEOBLAST DEVELOPMENT,0.0017641,0.45708,0.36804,1,1
1,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,5.0194e-07,0.45701,0.43243,1,1
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,5.6174e-05,0.45558,0.4119,1,1
1,GO HYPEROSMOTIC SALINITY RESPONSE,0.00084609,0.4554,0.33115,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,2.9301e-06,0.45535,0.38867,1,1
1,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.00037661,0.45525,0.36044,1,1
1,GO MEMBRANE PROTEIN PROTEOLYSIS,4.1617e-05,0.45501,0.41578,1,1
1,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,1.1788e-07,0.45439,0.40471,1,1
1,GO PROTEASOME ASSEMBLY,6.7728e-06,0.45437,0.37866,1,1
1,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,2.0784e-06,0.45382,0.43796,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.00012074,0.45343,0.34423,1,1
1,GO LYMPHANGIOGENESIS,2.3418e-05,0.45312,0.43636,1,1
1,GO MESODERMAL CELL DIFFERENTIATION,4.8379e-05,0.4525,0.38028,1,1
1,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.02268,0.45146,0.26751,1,1
1,GO INTERLEUKIN 2 PRODUCTION,4.1802e-07,0.45124,0.46555,1,1
1,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.00014935,0.45117,0.42249,1,1
1,GO REGULATION OF MEMBRANE INVAGINATION,0.00041602,0.45081,0.40696,1,1
1,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,3.9418e-06,0.45052,0.38864,1,1
1,GO BONE TRABECULA MORPHOGENESIS,0.017137,0.45033,0.37198,1,1
1,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,4.2876e-06,0.45007,0.38054,1,1
1,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.00025131,0.44966,0.35601,1,1
1,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,2.4346e-05,0.44959,0.42544,1,1
1,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,5.508e-06,0.44945,0.41512,1,1
1,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,0.00010845,0.44888,0.58664,1,1
1,GO PRIMARY MIRNA PROCESSING,2.9532e-05,0.44766,0.41171,1,1
1,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,1.6455e-05,0.44759,0.41263,1,1
1,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,1.3441e-06,0.44643,0.44348,1,1
1,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.00021167,0.44599,0.38546,1,1
1,GO MYELOID CELL APOPTOTIC PROCESS,5.0683e-06,0.44554,0.47882,1,1
1,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.00065623,0.44536,0.39654,1,1
1,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,1.8521e-05,0.44479,0.57695,1,1
1,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.0011549,0.44472,0.43802,1,1
1,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,2.3654e-06,0.44463,0.498,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION,2.8077e-06,0.44452,0.38166,1,1
1,GO MODULATION BY HOST OF SYMBIONT PROCESS,1.2308e-06,0.44449,0.40553,1,1
1,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.00038934,0.44432,0.54916,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.0012662,0.44414,0.34153,1,1
1,GO GERMINAL CENTER FORMATION,0.00072223,0.44344,0.39309,1,1
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,6.5149e-05,0.44268,0.40266,1,1
1,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,2.8418e-05,0.44164,0.42649,1,1
1,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,7.0571e-06,0.44108,0.5269,1,1
1,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,1.5201e-05,0.43934,0.40627,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,1.1237e-07,0.43909,0.41866,1,1
1,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.00042998,0.43773,0.4073,1,1
1,GO AMINOGLYCAN CATABOLIC PROCESS,5.2139e-05,0.43747,0.45107,1,1
1,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.0022992,0.4374,0.57632,1,1
1,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.00032948,0.4373,0.60872,1,1
1,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,5.8301e-05,0.43489,0.37605,1,1
1,GO TYPE I INTERFERON PRODUCTION,1.0604e-05,0.43431,0.34281,1,1
1,GO PROTEIN ACTIVATION CASCADE,7.013e-05,0.43358,0.33543,1,1
1,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.012508,0.43292,0.34523,1,1
1,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,1.7118e-05,0.43292,0.47604,1,1
1,GO MACROPHAGE PROLIFERATION,0.0057817,0.43278,0.36432,1,1
1,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.0057817,0.43269,0.46344,1,1
1,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,5.6174e-05,0.43259,0.41551,1,1
1,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,5.2837e-06,0.43174,0.44988,1,1
1,GO RESPONSE TO FLUID SHEAR STRESS,6.7596e-05,0.43172,0.40725,1,1
1,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,2.0784e-06,0.43063,0.41302,1,1
1,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,2.5308e-05,0.43051,0.47144,1,1
1,GO PLATELET AGGREGATION,1.4674e-06,0.42999,0.38679,1,1
1,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.030383,0.42824,0.33538,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,9.8628e-07,0.42778,0.49838,1,1
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,1.5816e-05,0.42744,0.35387,1,1
1,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,0.00067758,0.42727,0.58237,1,1
1,GO REGULATION OF NECROTIC CELL DEATH,3.6228e-06,0.42704,0.51238,1,1
1,GO RIBOSOME ASSEMBLY,0.00028792,0.42689,0.34493,1,1
1,GO SEMI LUNAR VALVE DEVELOPMENT,0.00072223,0.42641,0.38834,1,1
1,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.0057817,0.42612,0.34386,1,1
1,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.00014418,0.42516,0.40423,1,1
1,GO LYMPH VESSEL MORPHOGENESIS,0.00018427,0.42445,0.37107,1,1
1,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.00023468,0.42438,0.42738,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.00069957,0.4241,0.343,1,1
1,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.00047456,0.42338,0.38276,1,1
1,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,7.9801e-06,0.42291,0.39698,1,1
1,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,3.8583e-05,0.42226,0.31022,1,1
1,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.0053338,0.42218,0.30648,1,1
1,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,3.4421e-05,0.42213,0.36917,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,5.9841e-06,0.42121,0.43398,1,1
1,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.00040247,0.42118,0.48371,1,1
1,GO REGULATION OF HIPPO SIGNALING,0.001228,0.42085,0.33334,1,1
1,GO L ASCORBIC ACID METABOLIC PROCESS,0.0024367,0.42075,0.34423,1,1
1,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,1.0604e-05,0.42048,0.40325,1,1
1,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.00010845,0.42,0.44515,1,1
1,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,1.3441e-06,0.41965,0.37182,1,1
1,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,2.0033e-05,0.41936,0.33316,1,1
1,GO VIRAL LIFE CYCLE,4.3763e-07,0.41928,0.42213,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,1.104e-05,0.41924,0.42554,1,1
1,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,1.906e-06,0.41872,0.40747,1,1
1,GO EXTRACELLULAR STRUCTURE ORGANIZATION,7.013e-05,0.41838,0.43811,1,1
1,GO REGULATION OF RIBOSOME BIOGENESIS,1.1493e-05,0.41807,0.47632,1,1
1,GO ENAMEL MINERALIZATION,0.0022992,0.4175,0.39985,1,1
1,GO PEPTIDYL PROLINE MODIFICATION,5.0683e-06,0.41743,0.36083,1,1
1,GO MULTI ORGANISM LOCALIZATION,5.986e-08,0.41721,0.42011,1,1
1,GO TELOMERASE RNA LOCALIZATION,0.00017186,0.41699,0.33483,1,1
1,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,6.0504e-05,0.41699,0.35872,1,1
1,GO KERATAN SULFATE CATABOLIC PROCESS,0.00016595,0.41664,0.55918,1,1
1,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,5.7413e-06,0.4163,0.5081,1,1
1,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,9.3916e-06,0.41589,0.3775,1,1
1,GO ENDOTHELIAL CELL CHEMOTAXIS,0.0020453,0.41571,0.40457,1,1
1,GO ANIMAL ORGAN REGENERATION,1.7118e-05,0.41553,0.44192,1,1
1,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.00069957,0.41551,0.3804,1,1
1,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,2.8418e-05,0.41549,0.35012,1,1
1,GO REGULATION OF FIBROBLAST MIGRATION,0.0014299,0.41536,0.36168,1,1
1,GO DETECTION OF BIOTIC STIMULUS,7.013e-05,0.41491,0.419,1,1
1,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,2.2524e-05,0.41479,0.39294,1,1
1,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,3.1888e-05,0.41397,0.44134,1,1
1,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,2.3654e-06,0.41376,0.36529,1,1
1,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,4.4878e-05,0.41374,0.34508,1,1
1,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.0010859,0.41356,0.41647,1,1
1,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,4.1802e-07,0.4132,0.40584,1,1
1,GO REGULATION OF STEM CELL DIFFERENTIATION,1.1788e-07,0.41314,0.40165,1,1
1,GO REGULATION OF T CELL MEDIATED IMMUNITY,3.4421e-05,0.41302,0.39102,1,1
1,GO IMMATURE T CELL PROLIFERATION,5.4121e-05,0.41288,0.4502,1,1
1,GO VIRAL TRANSLATION,5.0683e-06,0.41209,0.41362,1,1
1,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,2.7343e-05,0.41157,0.32367,1,1
1,GO INTERFERON BETA PRODUCTION,0.00012074,0.41142,0.31503,1,1
1,GO VASCULAR TRANSPORT,0.029068,0.41092,0.44521,1,1
1,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.00017796,0.41075,0.33976,1,1
1,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.0028141,0.41022,0.30102,1,1
1,GO REGULATION OF MONONUCLEAR CELL MIGRATION,2.8418e-05,0.41019,0.36723,1,1
1,GO POSITIVE REGULATION OF PHAGOCYTOSIS,1.4039e-05,0.40945,0.43896,1,1
1,GO PEPTIDE CROSS LINKING,0.00010462,0.40915,0.46253,1,1
1,GO REGULATION OF MRNA BINDING,1.5201e-05,0.40814,0.36707,1,1
1,GO ERBB2 SIGNALING PATHWAY,1.349e-05,0.40799,0.35051,1,1
1,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.00025131,0.40715,0.41089,1,1
1,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.00023468,0.40708,0.41105,1,1
1,GO MONONUCLEAR CELL DIFFERENTIATION,5.2139e-05,0.40611,0.37476,1,1
1,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,3.4728e-06,0.4053,0.49367,1,1
1,GO CYCLOOXYGENASE PATHWAY,0.02068,0.40521,0.34214,1,1
1,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.00017796,0.40504,0.54318,1,1
1,GO REGULATION OF AUTOPHAGOSOME MATURATION,3.0576e-06,0.40446,0.39067,1,1
1,GO INTEGRIN MEDIATED SIGNALING PATHWAY,5.508e-06,0.4044,0.48429,1,1
1,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,9.7346e-05,0.40435,0.3833,1,1
1,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.0001547,0.40416,0.37624,1,1
1,GO I KAPPAB PHOSPHORYLATION,8.4205e-05,0.40407,0.29778,1,1
1,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,2.9532e-05,0.40402,0.44761,1,1
1,GO IRON ION TRANSMEMBRANE TRANSPORT,1.6729e-06,0.40384,0.34478,1,1
1,GO PROGRAMMED NECROTIC CELL DEATH,2.0784e-06,0.40325,0.50713,1,1
1,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.00016595,0.40267,0.42018,1,1
1,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,5.2837e-06,0.40259,0.36521,1,1
1,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.00010092,0.4013,0.3297,1,1
1,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.0051916,0.40126,0.37925,1,1
1,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,1.9904e-06,0.40039,0.39782,1,1
1,GO FIBROBLAST MIGRATION,0.00063551,0.40016,0.3504,1,1
1,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,6.2985e-07,0.40003,0.35742,1,1
1,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.012508,0.39904,0.30553,1,1
1,GO REGULATION OF STEROL TRANSPORT,3.0689e-05,0.39811,0.3285,1,1
1,GO BONE GROWTH,0.00037661,0.39804,0.38928,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,8.4205e-05,0.39785,0.36744,1,1
1,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.00028792,0.39779,0.47398,1,1
1,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.00020448,0.39778,0.38012,1,1
1,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.0021062,0.39708,0.38766,1,1
1,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.00012074,0.39707,0.45262,1,1
1,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.00036427,0.397,0.41675,1,1
1,GO EMBRYO IMPLANTATION,7.3528e-06,0.3963,0.47112,1,1
1,GO MODULATION OF PROCESS OF OTHER ORGANISM,5.6174e-05,0.39564,0.30342,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,1.6729e-06,0.39555,0.42084,1,1
1,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,1.2971e-07,0.39552,0.41704,1,1
1,GO ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.0017641,0.39525,0.37051,1,1
1,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,8.6584e-06,0.39421,0.39242,1,1
1,GO CELL ADHESION MEDIATED BY INTEGRIN,7.013e-05,0.39385,0.4388,1,1
1,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.0099891,0.39287,0.28247,1,1
1,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.00016023,0.39208,0.28524,1,1
1,GO HISTONE SERINE PHOSPHORYLATION,8.7323e-05,0.39174,0.39591,1,1
1,GO POSITIVE REGULATION OF MITOPHAGY,0.00067758,0.3914,0.32066,1,1
1,GO REGULATION OF STORE OPERATED CALCIUM ENTRY,0.00055855,0.39137,0.32459,1,1
1,GO T CELL APOPTOTIC PROCESS,2.1702e-06,0.39048,0.3671,1,1
1,GO CERAMIDE CATABOLIC PROCESS,0.00052342,0.38996,0.34096,1,1
1,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,2.1663e-05,0.38994,0.36368,1,1
1,GO INTERACTION WITH HOST,7.5427e-07,0.38851,0.43045,1,1
1,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,2.3654e-06,0.38821,0.39068,1,1
1,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.00084609,0.38813,0.31587,1,1
1,GO REGULATION OF PROTEIN IMPORT,1.4039e-05,0.38812,0.37197,1,1
1,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.00018427,0.38781,0.54037,1,1
1,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,1.7474e-06,0.38731,0.38453,1,1
1,GO RESPONSE TO ESTROGEN,8.628e-07,0.38605,0.38594,1,1
1,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,0.00029782,0.38585,0.3385,1,1
1,GO REGULATION OF NIK NF KAPPAB SIGNALING,1.7474e-06,0.38534,0.3687,1,1
1,GO MATURATION OF 5 8S RRNA,9.7346e-05,0.38425,0.33464,1,1
1,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00023468,0.38396,0.31966,1,1
1,GO REGULATION OF PROTEIN MATURATION,1.2308e-06,0.38382,0.38493,1,1
1,GO REGULATION OF GASTRULATION,5.9841e-06,0.38339,0.37265,1,1
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.0031536,0.38332,0.32484,1,1
1,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,1.4039e-05,0.38263,0.34371,1,1
1,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,1.0311e-06,0.38246,0.36179,1,1
1,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.00072223,0.38224,0.34491,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.0013872,0.38206,0.35524,1,1
1,GO SPROUTING ANGIOGENESIS,1.7806e-05,0.38202,0.34709,1,1
1,GO CYTOPLASMIC TRANSLATION,0.00055855,0.38197,0.30132,1,1
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,5.508e-06,0.38187,0.3241,1,1
1,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,1.1493e-05,0.38186,0.35393,1,1
1,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.0011199,0.3818,0.34614,1,1
1,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.00011241,0.38,0.47016,1,1
1,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.00023468,0.37959,0.31316,1,1
1,GO BEHAVIORAL RESPONSE TO PAIN,0.001191,0.37959,0.31552,1,1
1,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,6.0504e-05,0.3792,0.39861,1,1
1,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,1.8958e-07,0.3785,0.50019,1,1
1,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,1.6455e-05,0.37758,0.42092,1,1
1,GO MEMBRANE INVAGINATION,1.7118e-05,0.3772,0.33591,1,1
1,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.0001547,0.37719,0.33031,1,1
1,GO MAMMARY GLAND MORPHOGENESIS,9.7346e-05,0.37681,0.38165,1,1
1,GO PROTEIN TARGETING TO LYSOSOME,0.0014299,0.37643,0.2966,1,1
1,GO MUSCLE FILAMENT SLIDING,4.8379e-05,0.37605,0.33182,1,1
1,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0026572,0.37515,0.39304,1,1
1,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,1.1964e-05,0.37484,0.31804,1,1
1,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,2.8891e-07,0.37476,0.3705,1,1
1,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,2.3418e-05,0.37454,0.30615,1,1
1,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,2.2524e-05,0.37434,0.29584,1,1
1,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,2.8418e-05,0.37424,0.32633,1,1
1,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,8.7323e-05,0.37407,0.37158,1,1
1,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,6.0504e-05,0.37282,0.36811,1,1
1,GO REGULATION OF EXOSOMAL SECRETION,0.0054795,0.37219,0.23161,1,1
1,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,1.104e-05,0.37168,0.33127,1,1
1,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.0021062,0.3716,0.31152,1,1
1,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,6.4994e-06,0.3715,0.32597,1,1
1,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.00041602,0.37108,0.31465,1,1
1,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.0027346,0.37075,0.30499,1,1
1,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00016023,0.37024,0.32614,1,1
1,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,1.4039e-05,0.36936,0.32904,1,1
1,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.00074557,0.3692,0.31994,1,1
1,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,8.7323e-05,0.36906,0.35067,1,1
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,2.2658e-06,0.369,0.31609,1,1
1,GO MRNA TRANSCRIPTION,1.4039e-05,0.36896,0.36621,1,1
1,GO SNRNA PROCESSING,0.00084609,0.36826,0.5597,1,1
1,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,3.3287e-06,0.3678,0.34092,1,1
1,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.00019079,0.36758,0.29975,1,1
1,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.0001165,0.36751,0.30796,1,1
1,GO REGULATION OF VIRAL TRANSCRIPTION,4.1112e-06,0.36739,0.29188,1,1
1,GO INTERACTION WITH SYMBIONT,1.7806e-05,0.36728,0.31965,1,1
1,GO PULMONARY VALVE DEVELOPMENT,0.0050528,0.367,0.39712,1,1
1,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.00067758,0.36672,0.35964,1,1
1,GO INTERLEUKIN 17 PRODUCTION,9.7801e-06,0.36648,0.45344,1,1
1,GO GLIAL CELL ACTIVATION,0.001228,0.36566,0.31018,1,1
1,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,5.7413e-06,0.36556,0.32173,1,1
1,GO NCRNA PROCESSING,2.9532e-05,0.36512,0.28483,1,1
1,GO POSITIVE REGULATION OF T CELL PROLIFERATION,4.6597e-05,0.36482,0.33601,1,1
1,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.00025131,0.36469,0.31166,1,1
1,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,1.9263e-05,0.36452,0.32314,1,1
1,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.016339,0.36373,0.27931,1,1
1,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.00055855,0.36366,0.3943,1,1
1,GO REGULATION OF PHAGOCYTOSIS,1.2962e-05,0.36301,0.36829,1,1
1,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,1.1964e-05,0.36298,0.3799,1,1
1,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.00054072,0.36294,0.28092,1,1
1,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,5.7413e-06,0.36285,0.37553,1,1
1,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.0017641,0.36245,0.31144,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.0018173,0.36203,0.27611,1,1
1,GO NATURAL KILLER CELL PROLIFERATION,0.0027346,0.36187,0.36582,1,1
1,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.00022676,0.36154,0.51146,1,1
1,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.01282,0.36133,0.36756,1,1
1,GO NEGATIVE REGULATION OF WOUND HEALING,0.00014935,0.3613,0.38617,1,1
1,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.00087311,0.36122,0.45187,1,1
1,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.0012662,0.36108,0.30771,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,1.0604e-05,0.36099,0.33041,1,1
1,GO NECROTIC CELL DEATH,5.0683e-06,0.36079,0.44011,1,1
1,GO REGULATION OF COAGULATION,0.00025131,0.36015,0.38288,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00016595,0.35978,0.27059,1,1
1,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,8.3127e-06,0.35955,0.3486,1,1
1,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.0017123,0.35953,0.3139,1,1
1,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.0051916,0.35916,0.34041,1,1
1,GO LEUKOCYTE APOPTOTIC PROCESS,2.2658e-06,0.35891,0.35473,1,1
1,GO NEGATIVE REGULATION OF CELL SIZE,7.3528e-06,0.35848,0.31998,1,1
1,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,7.013e-05,0.35847,0.27599,1,1
1,GO TRANSLATIONAL TERMINATION,0.00024286,0.35841,0.26613,1,1
1,GO UBIQUITIN DEPENDENT ERAD PATHWAY,8.1192e-05,0.35821,0.27399,1,1
1,GO SKELETAL MUSCLE CELL PROLIFERATION,5.2139e-05,0.35803,0.3933,1,1
1,GO INNATE IMMUNE RESPONSE,2.5308e-05,0.35779,0.27797,1,1
1,GO RESPONSE TO VIRUS,1.0604e-05,0.35752,0.35775,1,1
1,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.0022992,0.35747,0.30616,1,1
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,1.5201e-05,0.35666,0.35833,1,1
1,GO RIBOSOME BIOGENESIS,0.00010462,0.35553,0.29718,1,1
1,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,2.6307e-05,0.35514,0.44642,1,1
1,GO EXTRACELLULAR MATRIX ASSEMBLY,0.014138,0.35505,0.37117,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,6.5149e-05,0.3549,0.26486,1,1
1,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.00014935,0.35415,0.30298,1,1
1,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.00018427,0.35402,0.28895,1,1
1,GO SERTOLI CELL DEVELOPMENT,0.001872,0.35364,0.31632,1,1
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.025994,0.35294,0.43775,1,1
1,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.00017186,0.35273,0.3849,1,1
1,GO CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.013465,0.35247,0.43162,1,1
1,GO CYTOKINETIC PROCESS,3.1904e-06,0.35233,0.32908,1,1
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00010845,0.35188,0.36767,1,1
1,GO FOCAL ADHESION ASSEMBLY,0.00063551,0.35161,0.35611,1,1
1,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.031748,0.35151,0.26121,1,1
1,GO PIGMENT ACCUMULATION,0.00013917,0.35138,0.32497,1,1
1,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,1.6729e-06,0.35119,0.35296,1,1
1,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.001872,0.35089,0.27353,1,1
1,GO HYPOTONIC RESPONSE,0.0012662,0.35069,0.29844,1,1
1,GO B CELL MEDIATED IMMUNITY,2.4346e-05,0.35039,0.3078,1,1
1,GO FOREGUT MORPHOGENESIS,0.00012512,0.35005,0.40004,1,1
1,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,9.0551e-05,0.34959,0.36623,1,1
1,GO ARGININE METABOLIC PROCESS,0.0015189,0.3494,0.32554,1,1
1,GO MONONUCLEAR CELL MIGRATION,0.00019079,0.34928,0.31581,1,1
1,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,4.4712e-06,0.34904,0.32098,1,1
1,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.00030804,0.34868,0.34281,1,1
1,GO ERAD PATHWAY,3.8583e-05,0.348,0.25827,1,1
1,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.00098941,0.34775,0.33818,1,1
1,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,2.8418e-05,0.34748,0.33912,1,1
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,3.5759e-05,0.34673,0.36637,1,1
1,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.0045306,0.34661,0.37792,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00055855,0.34661,0.29049,1,1
1,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.00016595,0.34579,0.33916,1,1
1,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00032948,0.34556,0.37092,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.00036427,0.34517,0.30326,1,1
1,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.00092958,0.34513,0.34231,1,1
1,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,3.0689e-05,0.34484,0.27188,1,1
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.00087311,0.34483,0.29017,1,1
1,GO FIBROBLAST PROLIFERATION,0.00025131,0.34444,0.29509,1,1
1,GO COPPER ION HOMEOSTASIS,7.9801e-06,0.34414,0.47265,1,1
1,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,5.4121e-05,0.34374,0.30771,1,1
1,GO NCRNA 3 END PROCESSING,0.0030654,0.34296,0.37691,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.00055855,0.34235,0.41425,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.00012074,0.34182,0.30785,1,1
1,GO LENS FIBER CELL DEVELOPMENT,0.0015653,0.34173,0.37575,1,1
1,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,1.349e-05,0.3417,0.36377,1,1
1,GO REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.0021062,0.34158,0.35089,1,1
1,GO RRNA METABOLIC PROCESS,0.00013433,0.34139,0.27879,1,1
1,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.02843,0.34117,0.28191,1,1
1,GO REGULATION OF PROTEIN FOLDING,2.2524e-05,0.34102,0.28965,1,1
1,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.00040247,0.34086,0.3235,1,1
1,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,1.9263e-05,0.34062,0.37353,1,1
1,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.02843,0.34037,0.238,1,1
1,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.016339,0.34035,0.37608,1,1
1,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.00037661,0.34004,0.31432,1,1
1,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.0028957,0.33988,0.31431,1,1
1,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.00092958,0.33977,0.26611,1,1
1,GO VIRAL GENE EXPRESSION,4.3218e-05,0.33947,0.33929,1,1
1,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.00052342,0.33911,0.3699,1,1
1,GO GASTRULATION,2.1663e-05,0.33885,0.32929,1,1
1,GO BASEMENT MEMBRANE ASSEMBLY,0.0019282,0.33884,0.44336,1,1
1,GO RESPONSE TO PROGESTERONE,0.0069616,0.33875,0.28058,1,1
1,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0025817,0.3385,0.32583,1,1
1,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.00020448,0.3383,0.35626,1,1
1,GO REGULATION OF LIPASE ACTIVITY,3.5759e-05,0.3378,0.26345,1,1
1,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.0017123,0.33766,0.33009,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,2.4692e-06,0.33746,0.30383,1,1
1,GO POSITIVE REGULATION OF TRANSLATION,2.2879e-07,0.33732,0.35442,1,1
1,GO LEFT RIGHT AXIS SPECIFICATION,0.0022992,0.33715,0.37587,1,1
1,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,9.0551e-05,0.33702,0.45177,1,1
1,GO RESPONSE TO INTERLEUKIN 1,2.5774e-06,0.33695,0.35649,1,1
1,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,7.3528e-06,0.33693,0.32782,1,1
1,GO NATURAL KILLER CELL ACTIVATION,2.4346e-05,0.33686,0.31571,1,1
1,GO SMAD PROTEIN COMPLEX ASSEMBLY,9.389e-05,0.33586,0.44759,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.0014299,0.3356,0.31629,1,1
1,GO ALPHA BETA T CELL ACTIVATION,0.00013917,0.33552,0.25301,1,1
1,GO REGULATION OF HISTONE PHOSPHORYLATION,0.00034072,0.33543,0.32746,1,1
1,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,6.0504e-05,0.33531,0.39129,1,1
1,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,3.0576e-06,0.33525,0.32394,1,1
1,GO ADAPTIVE IMMUNE RESPONSE,1.1964e-05,0.3351,0.30587,1,1
1,GO PLATELET DEGRANULATION,0.00034072,0.33497,0.37413,1,1
1,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,9.3916e-06,0.33454,0.3933,1,1
1,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.00017186,0.33454,0.27578,1,1
1,GO CORTICAL CYTOSKELETON ORGANIZATION,1.9904e-06,0.3344,0.338,1,1
1,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,5.7413e-06,0.33405,0.31729,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.0023671,0.33323,0.32407,1,1
1,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.016339,0.33282,0.34926,1,1
1,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,1.8958e-07,0.33248,0.35338,1,1
1,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,2.0833e-05,0.33242,0.27667,1,1
1,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.00032948,0.33193,0.24873,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.0016129,0.33184,0.22537,1,1
1,GO KERATAN SULFATE METABOLIC PROCESS,6.2786e-05,0.33159,0.35615,1,1
1,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.00012074,0.33137,0.38916,1,1
1,GO PROTEIN OXIDATION,0.052669,0.33122,0.29643,1,1
1,GO GOLGI TO VACUOLE TRANSPORT,6.2786e-05,0.33093,0.27386,1,1
1,GO CELL SUBSTRATE ADHESION,4.8379e-05,0.3306,0.35911,1,1
1,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.011612,0.33058,0.25663,1,1
1,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,3.8583e-05,0.33054,0.37677,1,1
1,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.017137,0.33037,0.23916,1,1
1,GO INTERFERON ALPHA PRODUCTION,0.0015189,0.33031,0.24798,1,1
1,GO TETRAPYRROLE METABOLIC PROCESS,6.0504e-05,0.33019,0.24692,1,1
1,GO PROTEIN TARGETING TO VACUOLE,0.00021909,0.33016,0.25491,1,1
1,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,5.2139e-05,0.32992,0.29985,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.00074557,0.32965,0.29383,1,1
1,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,2.1663e-05,0.32958,0.32372,1,1
1,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,3.1888e-05,0.32926,0.28349,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.00023468,0.32914,0.35243,1,1
1,GO RESPONSE TO MANGANESE ION,6.0504e-05,0.32904,0.31022,1,1
1,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.009256,0.32862,0.29419,1,1
1,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.0026572,0.32858,0.33947,1,1
1,GO CELLULAR COPPER ION HOMEOSTASIS,2.9532e-05,0.32852,0.51419,1,1
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.00065623,0.32793,0.30866,1,1
1,GO IMMUNE EFFECTOR PROCESS,1.6455e-05,0.3277,0.28404,1,1
1,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.0014299,0.32757,0.2605,1,1
1,GO PORE COMPLEX ASSEMBLY,0.00019753,0.32744,0.26788,1,1
1,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00042998,0.327,0.31046,1,1
1,GO LENS FIBER CELL DIFFERENTIATION,0.00055855,0.32695,0.33105,1,1
1,GO PLATELET MORPHOGENESIS,1.8521e-05,0.32641,0.29071,1,1
1,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.011047,0.32617,0.3625,1,1
1,GO CHONDROCYTE PROLIFERATION,0.0064317,0.32597,0.39307,1,1
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.00016023,0.32513,0.34986,1,1
1,GO OSTEOCLAST DEVELOPMENT,7.2754e-05,0.32501,0.37602,1,1
1,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.00012074,0.32438,0.22687,1,1
1,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.00092958,0.32436,0.28102,1,1
1,GO LYMPHOCYTE MEDIATED IMMUNITY,3.1888e-05,0.32429,0.29559,1,1
1,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.00069957,0.32418,0.29509,1,1
1,GO SNRNA METABOLIC PROCESS,0.00031859,0.32355,0.44802,1,1
1,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,3.7145e-05,0.32349,0.27818,1,1
1,GO RESPONSE TO HYDROGEN PEROXIDE,0.00016023,0.32328,0.25653,1,1
1,GO MESODERM MORPHOGENESIS,1.7118e-05,0.32325,0.3174,1,1
1,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.00026903,0.32317,0.25587,1,1
1,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.00098941,0.32292,0.31671,1,1
1,GO RNA 5 END PROCESSING,0.00024286,0.3228,0.28786,1,1
1,GO SPINDLE MIDZONE ASSEMBLY,0.00042998,0.32241,0.28994,1,1
1,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,7.013e-05,0.32222,0.32272,1,1
1,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,5.2139e-05,0.32215,0.44586,1,1
1,GO REGULATION OF CELL SUBSTRATE ADHESION,0.0001547,0.32183,0.34225,1,1
1,GO TRANSLATIONAL INITIATION,0.00052342,0.32166,0.28664,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,3.4421e-05,0.32138,0.29595,1,1
1,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.0053338,0.32102,0.27704,1,1
1,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.0015189,0.32077,0.23886,1,1
1,GO PEPTIDE CATABOLIC PROCESS,0.00050664,0.32074,0.23697,1,1
1,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.0030654,0.32056,0.21989,1,1
1,GO COPPER ION TRANSPORT,4.1617e-05,0.31969,0.32192,1,1
1,GO DEFENSE RESPONSE TO OTHER ORGANISM,3.4421e-05,0.31946,0.26436,1,1
1,GO MAMMARY GLAND DUCT MORPHOGENESIS,9.389e-05,0.3194,0.36691,1,1
1,GO REGULATION OF PODOSOME ASSEMBLY,0.00026003,0.31918,0.42276,1,1
1,GO MONOCYTE CHEMOTAXIS,0.00026003,0.31884,0.34891,1,1
1,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,9.0551e-05,0.31863,0.30954,1,1
1,GO EXOCRINE SYSTEM DEVELOPMENT,0.0030654,0.31854,0.33091,1,1
1,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,5.0226e-05,0.31847,0.29176,1,1
1,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.017549,0.31817,0.26501,1,1
1,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,3.3287e-06,0.31788,0.33556,1,1
1,GO REGULATION OF WOUND HEALING,0.00074557,0.31777,0.28617,1,1
1,GO VIRAL RELEASE FROM HOST CELL,3.8583e-05,0.31754,0.29322,1,1
1,GO REGENERATION,4.1617e-05,0.3173,0.26388,1,1
1,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.00025131,0.31714,0.38033,1,1
1,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.00054072,0.3157,0.28188,1,1
1,GO HISTONE PHOSPHORYLATION,4.6597e-05,0.31565,0.27407,1,1
1,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00024286,0.31539,0.29945,1,1
1,GO POSITIVE REGULATION OF ACTION POTENTIAL,0.0029794,0.31524,0.24854,1,1
1,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,2.9532e-05,0.31482,0.32162,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,5.8301e-05,0.31478,0.26329,1,1
1,GO RECEPTOR BIOSYNTHETIC PROCESS,2.4346e-05,0.31461,0.30158,1,1
1,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00013433,0.31443,0.30511,1,1
1,GO NCRNA METABOLIC PROCESS,5.8301e-05,0.31443,0.25174,1,1
1,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,2.0033e-05,0.31366,0.31044,1,1
1,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.0016129,0.31366,0.22848,1,1
1,GO VESICLE CARGO LOADING,2.1663e-05,0.31358,0.29633,1,1
1,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.00040247,0.31352,0.33689,1,1
1,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.0017641,0.31351,0.27097,1,1
1,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.0025817,0.31324,0.28177,1,1
1,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,2.0833e-05,0.31274,0.33104,1,1
1,GO SYMBIOTIC PROCESS,2.8891e-07,0.31248,0.28731,1,1
1,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.00047456,0.31232,0.2932,1,1
1,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.0012662,0.31214,0.27169,1,1
1,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0075304,0.31205,0.27038,1,1
1,GO SYNCYTIUM FORMATION,9.389e-05,0.31191,0.31342,1,1
1,GO INTRACELLULAR MRNA LOCALIZATION,2.9532e-05,0.31153,0.38896,1,1
1,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.001228,0.31114,0.25697,1,1
1,GO REGULATION OF IMMUNE EFFECTOR PROCESS,1.7118e-05,0.31034,0.29134,1,1
1,GO PROTEIN DEGLYCOSYLATION,0.00081984,0.31014,0.28114,1,1
1,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.0019282,0.30999,0.26357,1,1
1,GO CYTOKINE MEDIATED SIGNALING PATHWAY,2.2524e-05,0.30991,0.34417,1,1
1,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.015574,0.30976,0.30155,1,1
1,GO REGULATION OF RECEPTOR BINDING,0.024846,0.30968,0.29175,1,1
1,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.00059588,0.30968,0.27896,1,1
1,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.0025817,0.30964,0.24008,1,1
1,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,6.7728e-06,0.30961,0.34701,1,1
1,GO DENDRITIC CELL DIFFERENTIATION,0.019739,0.30939,0.25599,1,1
1,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.027188,0.30919,0.17863,1,1
1,GO POSITIVE REGULATION OF ORGAN GROWTH,2.7343e-05,0.30811,0.33454,1,1
1,GO CELL CELL JUNCTION MAINTENANCE,0.00353,0.30801,0.28563,1,1
1,GO CHONDROCYTE DIFFERENTIATION,0.00034072,0.30746,0.27932,1,1
1,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,1.6729e-06,0.30727,0.28153,1,1
1,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0017641,0.30708,0.29187,1,1
1,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.0028957,0.30683,0.30134,1,1
1,GO LIPOPROTEIN LOCALIZATION,0.0027346,0.30655,0.35307,1,1
1,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00067758,0.30639,0.28696,1,1
1,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,1.4039e-05,0.30576,0.27989,1,1
1,GO TISSUE REGENERATION,0.00037661,0.30523,0.27292,1,1
1,GO POSITIVE REGULATION OF LIPID STORAGE,2.5308e-05,0.30478,0.38181,1,1
1,GO ASTROCYTE ACTIVATION,0.0066042,0.30474,0.2739,1,1
1,GO REGULATION OF MRNA CATABOLIC PROCESS,6.2985e-07,0.3045,0.27665,1,1
1,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.015203,0.30418,0.39584,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.00098941,0.304,0.20245,1,1
1,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00035231,0.30395,0.25098,1,1
1,GO ACTIN FILAMENT SEVERING,0.0022332,0.30394,0.34924,1,1
1,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,4.0073e-05,0.30377,0.30623,1,1
1,GO NUCLEAR PORE ORGANIZATION,0.00011241,0.30376,0.33347,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.009256,0.30363,0.27188,1,1
1,GO VASCULATURE DEVELOPMENT,3.8583e-05,0.30356,0.28461,1,1
1,GO TRNA 5 LEADER REMOVAL,0.00019753,0.3035,0.33214,1,1
1,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,1.9904e-06,0.30344,0.23357,1,1
1,GO POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION,0.00069957,0.30326,0.34594,1,1
1,GO LEUKOCYTE MEDIATED IMMUNITY,2.4346e-05,0.30325,0.28835,1,1
1,GO CYTOKINE PRODUCTION,4.6597e-05,0.30307,0.25563,1,1
1,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.0026572,0.30294,0.35738,1,1
1,GO REPLICATIVE SENESCENCE,0.0073363,0.30279,0.36457,1,1
1,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,3.7791e-06,0.30251,0.43386,1,1
1,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,3.4421e-05,0.30227,0.25794,1,1
1,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,1.0311e-06,0.30217,0.31619,1,1
1,GO PIGMENT METABOLIC PROCESS,2.8418e-05,0.30198,0.25685,1,1
1,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.00069957,0.30179,0.2162,1,1
1,GO CARNITINE METABOLIC PROCESS,0.013465,0.30166,0.2488,1,1
1,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.0053338,0.3013,0.22965,1,1
1,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.00030804,0.30113,0.25674,1,1
1,GO ALPHA BETA T CELL DIFFERENTIATION,0.00035231,0.30084,0.24939,1,1
1,GO MACROPHAGE MIGRATION,4.8612e-06,0.30081,0.35775,1,1
1,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.0040578,0.30076,0.26845,1,1
1,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.004408,0.30062,0.23728,1,1
1,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.00024286,0.30006,0.20834,1,1
1,GO T CELL CYTOKINE PRODUCTION,2.9532e-05,0.29996,0.39267,1,1
1,GO MUSCLE CELL PROLIFERATION,1.2962e-05,0.29994,0.29921,1,1
1,GO URETER DEVELOPMENT,0.0036303,0.29983,0.29817,1,1
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00018427,0.29968,0.25199,1,1
1,GO RESPONSE TO CYTOKINE,1.9263e-05,0.29966,0.29208,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00065623,0.29954,0.24342,1,1
1,GO LEUKOCYTE CELL CELL ADHESION,0.00019079,0.29938,0.23359,1,1
1,GO RRNA MODIFICATION,0.0020453,0.2993,0.21211,1,1
1,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.00098941,0.29927,0.23932,1,1
1,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00012512,0.29918,0.29352,1,1
1,GO OLIGOPEPTIDE TRANSPORT,0.0029794,0.2991,0.3586,1,1
1,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.0010528,0.29907,0.33454,1,1
1,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.00095906,0.29838,0.25679,1,1
1,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.0027346,0.29833,0.26917,1,1
1,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,3.8583e-05,0.29831,0.30479,1,1
1,GO RIBONUCLEOSIDE METABOLIC PROCESS,2.8077e-06,0.29831,0.30926,1,1
1,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00065623,0.29829,0.25478,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00024286,0.29828,0.22959,1,1
1,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.0099891,0.29824,0.4015,1,1
1,GO POSITIVE REGULATION OF CELL ADHESION,0.00012074,0.29815,0.28293,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,1.0604e-05,0.29803,0.30704,1,1
1,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.00042998,0.29797,0.2276,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,3.5759e-05,0.29781,0.23693,1,1
1,GO NEGATIVE REGULATION OF GENE SILENCING,7.013e-05,0.29777,0.28742,1,1
1,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.0026572,0.29765,0.33247,1,1
1,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.0011549,0.29696,0.32403,1,1
1,GO NCRNA EXPORT FROM NUCLEUS,0.00079435,0.2969,0.23221,1,1
1,GO PODOSOME ASSEMBLY,7.013e-05,0.2969,0.38997,1,1
1,GO REGULATION OF KIDNEY DEVELOPMENT,4.1617e-05,0.29644,0.34107,1,1
1,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.00026903,0.29619,0.37838,1,1
1,GO ENDOTHELIAL CELL MIGRATION,7.2754e-05,0.29597,0.30658,1,1
1,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.02843,0.29537,0.3781,1,1
1,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.00052342,0.2953,0.27673,1,1
1,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,6.7596e-05,0.29489,0.23356,1,1
1,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.0047853,0.29484,0.27576,1,1
1,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,2.5774e-06,0.2948,0.28352,1,1
1,GO SELECTIVE AUTOPHAGY,1.1776e-06,0.29472,0.29955,1,1
1,GO CELLULAR RESPONSE TO VIRUS,8.6584e-06,0.29412,0.31565,1,1
1,GO REGULATION OF CELL AGING,2.4692e-06,0.29407,0.30357,1,1
1,GO SPERM EGG RECOGNITION,6.7596e-05,0.29394,0.24076,1,1
1,GO NEGATIVE REGULATION OF LIPID STORAGE,0.0016129,0.29345,0.31072,1,1
1,GO GLAND MORPHOGENESIS,0.00036427,0.29338,0.3438,1,1
1,GO MEMBRANE LIPID CATABOLIC PROCESS,0.0059384,0.29308,0.1831,1,1
1,GO BLOOD VESSEL MORPHOGENESIS,3.5759e-05,0.29304,0.2898,1,1
1,GO T CELL CHEMOTAXIS,5.4121e-05,0.29304,0.26329,1,1
1,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,3.8583e-05,0.29279,0.31531,1,1
1,GO ENDOTHELIAL CELL DEVELOPMENT,0.0073363,0.29263,0.21017,1,1
1,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.00030804,0.29181,0.31435,1,1
1,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.00055855,0.29178,0.30459,1,1
1,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.0001165,0.29172,0.24372,1,1
1,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.00074557,0.29105,0.29146,1,1
1,GO MITOCHONDRIAL TRANSLATION,0.00095906,0.29091,0.22177,1,1
1,GO KETONE BIOSYNTHETIC PROCESS,0.00012512,0.29066,0.25398,1,1
1,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.037747,0.29056,0.22054,1,1
1,GO LYMPH VESSEL DEVELOPMENT,0.0018173,0.29048,0.3143,1,1
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.00049035,0.29039,0.29211,1,1
1,GO MYOBLAST DIFFERENTIATION,7.6603e-06,0.29037,0.32118,1,1
1,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,1.2962e-05,0.29034,0.31038,1,1
1,GO IRON SULFUR CLUSTER ASSEMBLY,0.00026003,0.28993,0.28218,1,1
1,GO RESPONSE TO TUMOR NECROSIS FACTOR,2.6307e-05,0.28976,0.3087,1,1
1,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.00030804,0.28953,0.32322,1,1
1,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.00052342,0.2893,0.21285,1,1
1,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,1.5201e-05,0.28929,0.30646,1,1
1,GO MYOBLAST MIGRATION,0.0022992,0.28919,0.44014,1,1
1,GO TRACHEA MORPHOGENESIS,0.0010528,0.28909,0.27126,1,1
1,GO PARAXIAL MESODERM DEVELOPMENT,0.00038934,0.28899,0.38686,1,1
1,GO REGULATION OF INNATE IMMUNE RESPONSE,0.00013433,0.28896,0.22138,1,1
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.00045924,0.28892,0.23298,1,1
1,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.0012662,0.28884,0.21559,1,1
1,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,6.2786e-05,0.28882,0.26314,1,1
1,GO T CELL RECEPTOR SIGNALING PATHWAY,8.628e-07,0.28881,0.28488,1,1
1,GO REGULATION OF MIRNA METABOLIC PROCESS,0.0017641,0.28853,0.25921,1,1
1,GO RESPONSE TO DSRNA,6.5149e-05,0.28845,0.3282,1,1
1,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,7.8282e-05,0.28802,0.35232,1,1
1,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.0030654,0.28785,0.28414,1,1
1,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.00028792,0.28779,0.29925,1,1
1,GO MYOBLAST FUSION,0.00017186,0.28771,0.33429,1,1
1,GO SERTOLI CELL DIFFERENTIATION,0.0028957,0.28759,0.25987,1,1
1,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.0015653,0.28755,0.20048,1,1
1,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.001662,0.28736,0.26418,1,1
1,GO REGULATION OF RNA BINDING,9.7801e-06,0.28722,0.28969,1,1
1,GO WOUND HEALING,8.7323e-05,0.28717,0.30468,1,1
1,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,1.9904e-06,0.28707,0.27274,1,1
1,GO REGULATION OF CHOLESTEROL EFFLUX,0.00013433,0.28691,0.29564,1,1
1,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,4.1802e-07,0.28667,0.30169,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.00029782,0.28584,0.42322,1,1
1,GO CELLULAR RESPONSE TO CHEMICAL STRESS,1.8521e-05,0.28568,0.2464,1,1
1,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.00042998,0.28566,0.28653,1,1
1,GO MATERNAL PLACENTA DEVELOPMENT,0.00054072,0.28523,0.29039,1,1
1,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00044439,0.28517,0.24482,1,1
1,GO MACROPHAGE APOPTOTIC PROCESS,0.00014935,0.28445,0.41232,1,1
1,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.00030804,0.28441,0.29813,1,1
1,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.00013917,0.28439,0.30166,1,1
1,GO MYELOID LEUKOCYTE DIFFERENTIATION,2.9532e-05,0.28434,0.22491,1,1
1,GO RESPONSE TO PROTOZOAN,0.00042998,0.28426,0.29939,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,3.4728e-06,0.28424,0.3367,1,1
1,GO RNA CATABOLIC PROCESS,7.2111e-07,0.28421,0.26553,1,1
1,GO CELLULAR RESPONSE TO ETHANOL,0.0026572,0.2842,0.2881,1,1
1,GO CELL CELL RECOGNITION,3.9418e-06,0.28408,0.27963,1,1
1,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.016339,0.28406,0.20261,1,1
1,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.0032441,0.28369,0.23735,1,1
1,GO INTERLEUKIN 5 PRODUCTION,0.027803,0.28362,0.25541,1,1
1,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.0013054,0.28302,0.2956,1,1
1,GO RESPONSE TO PEPTIDOGLYCAN,0.00069957,0.28287,0.35184,1,1
1,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00012964,0.28275,0.32583,1,1
1,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.00019753,0.28262,0.25386,1,1
1,GO REGULATION OF CELL MATRIX ADHESION,0.00032948,0.28245,0.32339,1,1
1,GO MACROPHAGE DIFFERENTIATION,2.0033e-05,0.2823,0.35983,1,1
1,GO CARDIAC MUSCLE CELL PROLIFERATION,0.0014299,0.28217,0.26883,1,1
1,GO DECIDUALIZATION,0.017549,0.28206,0.27599,1,1
1,GO REGULATION OF SPROUTING ANGIOGENESIS,1.9263e-05,0.28176,0.34596,1,1
1,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.0017641,0.2817,0.24119,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,3.8583e-05,0.28105,0.24942,1,1
1,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.00049035,0.28092,0.28541,1,1
1,GO SEQUESTERING OF METAL ION,0.00026903,0.28084,0.2613,1,1
1,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.0079323,0.28079,0.21595,1,1
1,GO PRODUCTION OF SIRNA INVOLVED IN RNA INTERFERENCE,0.014841,0.28058,0.23468,1,1
1,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.033166,0.28057,0.18419,1,1
1,GO PHAGOCYTOSIS,5.508e-06,0.2804,0.32036,1,1
1,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.0060989,0.2804,0.33175,1,1
1,GO AMINO SUGAR METABOLIC PROCESS,0.00020448,0.27967,0.23936,1,1
1,GO POSITIVE REGULATION OF IMMUNE RESPONSE,4.3218e-05,0.27951,0.21718,1,1
1,GO TRABECULA FORMATION,0.0057817,0.27947,0.35518,1,1
1,GO CELLULAR RESPONSE TO RETINOIC ACID,0.001228,0.27944,0.25624,1,1
1,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,2.6307e-05,0.27927,0.377,1,1
1,GO ACUTE INFLAMMATORY RESPONSE,0.00036427,0.27906,0.30669,1,1
1,GO CARDIOBLAST DIFFERENTIATION,0.0064317,0.27899,0.31833,1,1
1,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.00063551,0.27887,0.31931,1,1
1,GO NUCLEOSIDE SALVAGE,0.00081984,0.27852,0.42899,1,1
1,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,9.0551e-05,0.27809,0.26738,1,1
1,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,8.4205e-05,0.27782,0.26966,1,1
1,GO CHEMOKINE PRODUCTION,0.0020453,0.27751,0.24934,1,1
1,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,1.5816e-05,0.27713,0.27484,1,1
1,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.00059588,0.27711,0.27779,1,1
1,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.013139,0.27702,0.22178,1,1
1,GO NEGATIVE REGULATION OF DNA REPAIR,7.6603e-06,0.27674,0.26988,1,1
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.00069957,0.27652,0.26404,1,1
1,GO ASYMMETRIC CELL DIVISION,0.0017641,0.27633,0.24158,1,1
1,GO T CELL ACTIVATION,0.0001547,0.27628,0.21391,1,1
1,GO IMMUNOGLOBULIN PRODUCTION,3.8583e-05,0.27595,0.23898,1,1
1,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.0067808,0.27563,0.21094,1,1
1,GO CARTILAGE DEVELOPMENT,0.0017123,0.27548,0.225,1,1
1,GO SMOOTH MUSCLE CELL PROLIFERATION,2.9532e-05,0.27544,0.3342,1,1
1,GO INTERLEUKIN 4 PRODUCTION,0.0067808,0.27542,0.17791,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.00052342,0.27517,0.24391,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.00024286,0.27467,0.24683,1,1
1,GO CELL REDOX HOMEOSTASIS,3.1888e-05,0.27441,0.27871,1,1
1,GO ASTROCYTE DEVELOPMENT,0.00042998,0.27406,0.29919,1,1
1,GO GLYCOSYL COMPOUND METABOLIC PROCESS,4.8379e-05,0.27378,0.21661,1,1
1,GO ACUTE PHASE RESPONSE,0.0060989,0.27373,0.25734,1,1
1,GO POSITIVE REGULATION OF CELL ACTIVATION,8.7323e-05,0.2735,0.23198,1,1
1,GO RESPONSE TO IONIZING RADIATION,3.3287e-06,0.2735,0.27005,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.00016595,0.273,0.26527,1,1
1,GO MITOCHONDRIAL PROTEIN PROCESSING,0.0010528,0.27299,0.23474,1,1
1,GO EXTRACELLULAR VESICLE BIOGENESIS,0.0025817,0.27293,0.2131,1,1
1,GO RESPONSE TO THYROID HORMONE,0.0015653,0.27259,0.27612,1,1
1,GO REGULATION OF PEPTIDASE ACTIVITY,0.0034322,0.27223,0.17982,1,1
1,GO DENDRITIC CELL CHEMOTAXIS,0.0030654,0.27181,0.28109,1,1
1,GO REGULATION OF RESPONSE TO WOUNDING,0.0010859,0.2718,0.23741,1,1
1,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.00072223,0.27165,0.24099,1,1
1,GO INNER CELL MASS CELL PROLIFERATION,0.0011199,0.27164,0.34143,1,1
1,GO SULFUR COMPOUND CATABOLIC PROCESS,0.00090094,0.27146,0.32009,1,1
1,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.00052342,0.27134,0.26153,1,1
1,GO RESPONSE TO BIOTIC STIMULUS,3.5759e-05,0.2712,0.2397,1,1
1,GO T CELL MIGRATION,0.00072223,0.27115,0.25813,1,1
1,GO MAINTENANCE OF PROTEIN LOCATION,1.2862e-06,0.27113,0.27174,1,1
1,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.016734,0.27104,0.22227,1,1
1,GO MITOTIC CYTOKINETIC PROCESS,3.1888e-05,0.27086,0.28127,1,1
1,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.00072223,0.2708,0.31769,1,1
1,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.0013054,0.27078,0.30401,1,1
1,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.00069957,0.27069,0.36586,1,1
1,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,3.4421e-05,0.27044,0.21743,1,1
1,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.001986,0.2703,0.3197,1,1
1,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.0049174,0.27001,0.2902,1,1
1,GO METANEPHRIC NEPHRON DEVELOPMENT,0.00024286,0.26994,0.27278,1,1
1,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.0083534,0.26958,0.20729,1,1
1,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.00032948,0.26924,0.20175,1,1
1,GO NEGATIVE REGULATION OF OSSIFICATION,0.0007696,0.26924,0.21979,1,1
1,GO HEMOGLOBIN METABOLIC PROCESS,0.0053338,0.26889,0.21193,1,1
1,GO LYMPHOCYTE CHEMOTAXIS,5.0226e-05,0.26849,0.28137,1,1
1,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.0013872,0.2681,0.20463,1,1
1,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.0019282,0.268,0.22054,1,1
1,GO NUCLEOBASE METABOLIC PROCESS,0.0018173,0.26754,0.21411,1,1
1,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.00098941,0.26751,0.25773,1,1
1,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.00011241,0.2674,0.39395,1,1
1,GO MYELOID LEUKOCYTE ACTIVATION,9.7346e-05,0.26735,0.28143,1,1
1,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0050528,0.2673,0.20584,1,1
1,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.0042883,0.26706,0.29047,1,1
1,GO I KAPPAB KINASE NF KAPPAB SIGNALING,1.1493e-05,0.26688,0.35378,1,1
1,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.0038387,0.26675,0.20169,1,1
1,GO CORONARY VASCULATURE DEVELOPMENT,0.0013457,0.26654,0.26252,1,1
1,GO MEMBRANE DISASSEMBLY,0.0050528,0.26613,0.24921,1,1
1,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.011326,0.26555,0.29292,1,1
1,GO RESPONSE TO OSMOTIC STRESS,0.00079435,0.26552,0.20392,1,1
1,GO KERATINOCYTE MIGRATION,0.001872,0.26548,0.25797,1,1
1,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.033166,0.26543,0.20304,1,1
1,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.00014935,0.26537,0.24704,1,1
1,GO CHONDROCYTE DEVELOPMENT,0.0057817,0.26522,0.30449,1,1
1,GO HISTONE H4 DEACETYLATION,0.0049174,0.26479,0.23153,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.00038934,0.26476,0.25895,1,1
1,GO TRANSLATIONAL ELONGATION,0.00092958,0.2646,0.21184,1,1
1,GO IRON ION HOMEOSTASIS,1.1493e-05,0.26454,0.26054,1,1
1,GO PLASMA MEMBRANE TUBULATION,0.00014418,0.26446,0.29141,1,1
1,GO VIRION ASSEMBLY,1.1964e-05,0.26433,0.22917,1,1
1,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.0045306,0.26425,0.2403,1,1
1,GO TRANSPOSITION,0.025994,0.26409,0.2092,1,1
1,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.00084609,0.26387,0.23958,1,1
1,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0038387,0.26372,0.29784,1,1
1,GO DETECTION OF OTHER ORGANISM,0.011904,0.2637,0.26818,1,1
1,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.0013457,0.26363,0.42808,1,1
1,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,1.7806e-05,0.26346,0.39003,1,1
1,GO POSITIVE REGULATION OF LIPID LOCALIZATION,2.2524e-05,0.26333,0.24661,1,1
1,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.00025131,0.2633,0.29067,1,1
1,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,1.5201e-05,0.26314,0.32581,1,1
1,GO RESPONSE TO DEXAMETHASONE,0.024846,0.26298,0.16793,1,1
1,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,3.1888e-05,0.26294,0.2682,1,1
1,GO CELLULAR KETONE METABOLIC PROCESS,4.0073e-05,0.26289,0.19758,1,1
1,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.0016129,0.26284,0.25948,1,1
1,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.0019282,0.26264,0.20873,1,1
1,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.00052342,0.26233,0.25426,1,1
1,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,2.6307e-05,0.26219,0.24067,1,1
1,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.00034072,0.26192,0.20871,1,1
1,GO NUCLEAR ENVELOPE ORGANIZATION,0.0012662,0.26154,0.21115,1,1
1,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.0010859,0.26151,0.22382,1,1
1,GO RESPONSE TO PARATHYROID HORMONE,0.0041716,0.26132,0.24233,1,1
1,GO NADP METABOLIC PROCESS,0.0099891,0.26127,0.20782,1,1
1,GO MITOCHONDRIAL GENE EXPRESSION,0.0015653,0.2612,0.20556,1,1
1,GO OSTEOBLAST DIFFERENTIATION,0.00059588,0.26112,0.24001,1,1
1,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.0031536,0.26106,0.20988,1,1
1,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.00072223,0.26101,0.22551,1,1
1,GO AUTOPHAGOSOME MATURATION,6.5149e-05,0.26096,0.26182,1,1
1,GO REGULATION OF CELLULAR EXTRAVASATION,0.0015189,0.26095,0.27211,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,4.8379e-05,0.2609,0.2612,1,1
1,GO STEROL TRANSPORT,0.0011549,0.26086,0.19787,1,1
1,GO POSITIVE REGULATION OF DNA RECOMBINATION,2.3418e-05,0.26079,0.26977,1,1
1,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,3.1904e-06,0.26056,0.33024,1,1
1,GO ACTIVATION OF MAPKK ACTIVITY,6.0504e-05,0.26053,0.29347,1,1
1,GO NEGATIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.025994,0.2605,0.14916,1,1
1,GO RESPONSE TO WOUNDING,0.00010845,0.26042,0.25377,1,1
1,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.0010528,0.25988,0.22792,1,1
1,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.00037661,0.25986,0.23348,1,1
1,GO BILE ACID AND BILE SALT TRANSPORT,0.049546,0.25951,0.11902,1,1
1,GO REGULATION OF GENE SILENCING,2.0784e-06,0.25947,0.25481,1,1
1,GO DNA DEALKYLATION,0.00092958,0.25913,0.24444,1,1
1,GO POSITIVE REGULATION OF VIRAL PROCESS,2.0784e-06,0.25877,0.25293,1,1
1,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.00074557,0.25865,0.21432,1,1
1,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.0069616,0.25832,0.23541,1,1
1,GO RNA DESTABILIZATION,2.5308e-05,0.25812,0.25818,1,1
1,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.00092958,0.2581,0.16276,1,1
1,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,8.7323e-05,0.25801,0.24964,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,2.4692e-06,0.25786,0.23826,1,1
1,GO POSITIVE REGULATION OF HEART GROWTH,0.00044439,0.25753,0.29185,1,1
1,GO REGULATION OF TOLERANCE INDUCTION,0.026586,0.25752,0.24451,1,1
1,GO GRANULOCYTE MIGRATION,0.00047456,0.2574,0.26925,1,1
1,GO CELL ACTIVATION,6.0504e-05,0.25723,0.22754,1,1
1,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,9.0551e-05,0.25674,0.33477,1,1
1,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.0031536,0.25649,0.20109,1,1
1,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.0010528,0.25644,0.26581,1,1
1,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.0010206,0.25642,0.22591,1,1
1,GO TRNA 5 END PROCESSING,0.00028792,0.25637,0.28881,1,1
1,GO CRISTAE FORMATION,0.015203,0.25634,0.20168,1,1
1,GO CHOLESTEROL EFFLUX,0.00030804,0.25607,0.24302,1,1
1,GO PROTEIN FOLDING,0.00036427,0.25591,0.2084,1,1
1,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,7.2754e-05,0.25568,0.24326,1,1
1,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.00019753,0.25564,0.23393,1,1
1,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,0.0017123,0.25553,0.24099,1,1
1,GO REGULATION OF NUCLEASE ACTIVITY,0.0011549,0.25552,0.26642,1,1
1,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.011047,0.25536,0.28861,1,1
1,GO HEPATOCYTE DIFFERENTIATION,0.044685,0.25513,0.24301,1,1
1,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.00037661,0.2551,0.27881,1,1
1,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.00016595,0.25502,0.25054,1,1
1,GO CELL MATRIX ADHESION,0.00032948,0.25483,0.30045,1,1
1,GO MYELOID DENDRITIC CELL ACTIVATION,0.023205,0.25482,0.32281,1,1
1,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.0013872,0.2546,0.20229,1,1
1,GO RRNA TRANSCRIPTION,0.0010859,0.25457,0.23091,1,1
1,GO PROSTATE GLAND DEVELOPMENT,0.00087311,0.25454,0.33258,1,1
1,GO REGULATION OF CELL KILLING,0.0094949,0.25435,0.18829,1,1
1,GO PIGMENT BIOSYNTHETIC PROCESS,4.6597e-05,0.25431,0.22745,1,1
1,GO REGULATION OF IMMUNE RESPONSE,4.8379e-05,0.25381,0.21346,1,1
1,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.001872,0.25378,0.31171,1,1
1,GO COAGULATION,7.8282e-05,0.25352,0.27348,1,1
1,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,6.2786e-05,0.25346,0.25657,1,1
1,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.02843,0.25341,0.19188,1,1
1,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,7.0571e-06,0.25329,0.27148,1,1
1,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.0027346,0.25316,0.237,1,1
1,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,4.2876e-06,0.253,0.24813,1,1
1,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.00041602,0.25296,0.26689,1,1
1,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.00012074,0.25286,0.20969,1,1
1,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,1.6015e-06,0.25279,0.22905,1,1
1,GO POSITIVE REGULATION OF CELL SIZE,0.041967,0.25229,0.22199,1,1
1,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.00047456,0.25186,0.21525,1,1
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,2.9532e-05,0.25167,0.24354,1,1
1,GO AUTOPHAGY OF NUCLEUS,0.00072223,0.2516,0.24453,1,1
1,GO DERMATAN SULFATE METABOLIC PROCESS,0.03939,0.25147,0.40019,1,1
1,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.0012662,0.25097,0.2745,1,1
1,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.00030804,0.25092,0.28924,1,1
1,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.046579,0.25089,0.15925,1,1
1,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.0017123,0.25079,0.24592,1,1
1,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.0020453,0.25077,0.20496,1,1
1,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.001986,0.2507,0.24499,1,1
1,GO REGULATION OF HEART GROWTH,0.00052342,0.25055,0.21439,1,1
1,GO ERK1 AND ERK2 CASCADE,4.0073e-05,0.25018,0.23143,1,1
1,GO REGULATION OF CELL ACTIVATION,0.00025131,0.25003,0.19607,1,1
1,GO PLATELET ACTIVATION,0.00028792,0.24983,0.23061,1,1
1,GO NUCLEAR ENVELOPE REASSEMBLY,2.0833e-05,0.24972,0.2529,1,1
1,GO LYMPHOCYTE MIGRATION,0.00098941,0.24937,0.20427,1,1
1,GO DETERMINATION OF DORSAL VENTRAL ASYMMETRY,0.020205,0.24926,0.23606,1,1
1,GO NUCLEOSIDE METABOLIC PROCESS,1.349e-05,0.24925,0.24856,1,1
1,GO TRNA METHYLATION,0.00021909,0.24895,0.23175,1,1
1,GO REGULATION OF ORGAN GROWTH,5.9841e-06,0.24884,0.28224,1,1
1,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0037331,0.24872,0.23319,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.014138,0.2485,0.25172,1,1
1,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00044439,0.24842,0.21623,1,1
1,GO FATTY ACID BETA OXIDATION,0.0016129,0.24817,0.22211,1,1
1,GO TOXIN TRANSPORT,0.0094949,0.2481,0.15797,1,1
1,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,5.6174e-05,0.24788,0.20396,1,1
1,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,3.3287e-06,0.24788,0.30815,1,1
1,GO REGULATION OF VASCULATURE DEVELOPMENT,3.5759e-05,0.24783,0.28613,1,1
1,GO LIPID OXIDATION,0.0083534,0.24758,0.16615,1,1
1,GO MITOPHAGY,0.00035231,0.24745,0.2355,1,1
1,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.00014935,0.24725,0.20774,1,1
1,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,2.8418e-05,0.24713,0.23511,1,1
1,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.00055855,0.24698,0.21654,1,1
1,GO TRNA PROCESSING,0.00042998,0.2469,0.18179,1,1
1,GO REGULATION OF LYSOSOMAL LUMEN PH,0.0013457,0.2468,0.25112,1,1
1,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.0097392,0.24667,0.24378,1,1
1,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,1.8521e-05,0.24665,0.34812,1,1
1,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.0060989,0.24659,0.33057,1,1
1,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,7.547e-05,0.24627,0.20785,1,1
1,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0001547,0.24621,0.44,1,1
1,GO LYMPHOCYTE APOPTOTIC PROCESS,0.00021167,0.24615,0.22616,1,1
1,GO REGULATION OF LEUKOCYTE MIGRATION,0.00021909,0.24613,0.24992,1,1
1,GO MIDBODY ABSCISSION,0.00095906,0.24608,0.26348,1,1
1,GO MACROPHAGE CYTOKINE PRODUCTION,0.027188,0.24603,0.35099,1,1
1,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.00069957,0.24586,0.26087,1,1
1,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,5.4121e-05,0.24585,0.22762,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.0011549,0.24579,0.17667,1,1
1,GO RESPONSE TO OXYGEN RADICAL,0.00047456,0.24559,0.17801,1,1
1,GO PEPTIDE BIOSYNTHETIC PROCESS,1.7118e-05,0.24559,0.21741,1,1
1,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.0099891,0.24555,0.21671,1,1
1,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.0071468,0.24553,0.21313,1,1
1,GO RESPONSE TO BACTERIUM,0.00010845,0.24518,0.24381,1,1
1,GO REGULATION OF HEMOPOIESIS,1.5201e-05,0.24503,0.21268,1,1
1,GO LIPID IMPORT INTO CELL,0.036164,0.24502,0.19441,1,1
1,GO ACTIVATION OF IMMUNE RESPONSE,3.8583e-05,0.24501,0.19682,1,1
1,GO METANEPHROS DEVELOPMENT,9.7346e-05,0.245,0.24616,1,1
1,GO REGULATION OF DEFENSE RESPONSE,0.00017186,0.24491,0.19959,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.00021909,0.24468,0.19316,1,1
1,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.00025131,0.24459,0.25013,1,1
1,GO LYMPHOCYTE ACTIVATION,0.00014418,0.24458,0.19315,1,1
1,GO RESPONSE TO INTERLEUKIN 7,0.011047,0.24439,0.20184,1,1
1,GO POLYAMINE BIOSYNTHETIC PROCESS,0.010506,0.24435,0.24159,1,1
1,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,7.8282e-05,0.24394,0.20963,1,1
1,GO AMEBOIDAL TYPE CELL MIGRATION,0.0001165,0.24384,0.24281,1,1
1,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.00353,0.24367,0.18904,1,1
1,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.00022676,0.24332,0.24714,1,1
1,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.0019282,0.24281,0.24966,1,1
1,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.0066042,0.24271,0.25654,1,1
1,GO TISSUE REMODELING,0.0022992,0.24263,0.22996,1,1
1,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.0011199,0.2426,0.25509,1,1
1,GO RESPONSE TO GAMMA RADIATION,3.7145e-05,0.24248,0.24556,1,1
1,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.018836,0.24242,0.1651,1,1
1,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.010245,0.24214,0.18581,1,1
1,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00052342,0.24174,0.19997,1,1
1,GO HOMOTYPIC CELL CELL ADHESION,0.00038934,0.2417,0.27589,1,1
1,GO RESPONSE TO TESTOSTERONE,8.4205e-05,0.24163,0.26615,1,1
1,GO POSITIVE REGULATION OF HEMOPOIESIS,0.00012512,0.24162,0.23695,1,1
1,GO REGULATION OF CALCIUM ION IMPORT,0.015953,0.24161,0.15445,1,1
1,GO L GLUTAMATE IMPORT,0.037747,0.24156,0.17912,1,1
1,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.00044439,0.24124,0.23592,1,1
1,GO TONGUE MORPHOGENESIS,0.029068,0.24098,0.27712,1,1
1,GO CELL KILLING,0.010773,0.24092,0.14573,1,1
1,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.0013457,0.2409,0.18284,1,1
1,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.0097392,0.24068,0.17891,1,1
1,GO NEGATIVE REGULATION OF DNA REPLICATION,0.053746,0.24064,0.17354,1,1
1,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.00020448,0.24023,0.20478,1,1
1,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.0010206,0.24011,0.3314,1,1
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.001872,0.23979,0.25432,1,1
1,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,1.7806e-05,0.23978,0.22171,1,1
1,GO RESPONSE TO CORTICOSTEROID,0.0010528,0.23978,0.21771,1,1
1,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00019079,0.23965,0.22347,1,1
1,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.0057817,0.23955,0.20924,1,1
1,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.0039469,0.23946,0.22762,1,1
1,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,2.7343e-05,0.23942,0.20357,1,1
1,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,4.8379e-05,0.2394,0.37154,1,1
1,GO HISTONE H2B UBIQUITINATION,0.00063551,0.23918,0.21001,1,1
1,GO MITRAL VALVE DEVELOPMENT,0.047551,0.23888,0.28063,1,1
1,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.00027832,0.23884,0.22603,1,1
1,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.0057817,0.23862,0.20385,1,1
1,GO PROTEIN LOCALIZATION TO VACUOLE,0.001986,0.23846,0.17115,1,1
1,GO POSITIVE REGULATION OF COAGULATION,0.007729,0.23845,0.25508,1,1
1,GO NEPHRON TUBULE FORMATION,0.026586,0.23827,0.24413,1,1
1,GO POSITIVE REGULATION OF AUTOPHAGY,1.104e-05,0.2382,0.23967,1,1
1,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.0025083,0.23797,0.20677,1,1
1,GO COMPLEMENT ACTIVATION,0.00092958,0.23792,0.2281,1,1
1,GO RNA 3 END PROCESSING,3.3132e-05,0.23766,0.2125,1,1
1,GO NUCLEAR EXPORT,4.4712e-06,0.23723,0.21894,1,1
1,GO NEURAL TUBE PATTERNING,0.010773,0.23708,0.19163,1,1
1,GO REGULATION OF T CELL ACTIVATION,0.00074557,0.23676,0.18703,1,1
1,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0007696,0.23619,0.32206,1,1
1,GO PROTEIN PROCESSING,0.0010206,0.23607,0.19102,1,1
1,GO TISSUE MIGRATION,9.0551e-05,0.23604,0.28409,1,1
1,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0057817,0.23515,0.2074,1,1
1,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.0016129,0.23508,0.31439,1,1
1,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,5.8301e-05,0.23496,0.22249,1,1
1,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.0083534,0.23477,0.15871,1,1
1,GO DEFENSE RESPONSE,0.00019079,0.23443,0.21186,1,1
1,GO ACTIN CYTOSKELETON REORGANIZATION,0.0020453,0.23433,0.21793,1,1
1,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.0060989,0.23395,0.28223,1,1
1,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.0045306,0.23387,0.23548,1,1
1,GO POSITIVE REGULATION OF HAIR CYCLE,0.012203,0.23377,0.32412,1,1
1,GO MESODERM DEVELOPMENT,6.0504e-05,0.23369,0.20219,1,1
1,GO LIPID STORAGE,0.00036427,0.23358,0.24103,1,1
1,GO AMINOGLYCAN METABOLIC PROCESS,0.0019282,0.23332,0.22847,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.0006154,0.23332,0.24446,1,1
1,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.031059,0.23255,0.18275,1,1
1,GO T CELL PROLIFERATION,0.0015189,0.23232,0.20009,1,1
1,GO RRNA METHYLATION,0.009256,0.23227,0.15734,1,1
1,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.0013872,0.23208,0.25568,1,1
1,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.0041716,0.23201,0.25414,1,1
1,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,2.6902e-06,0.232,0.20803,1,1
1,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.00057693,0.23168,0.29585,1,1
1,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.00012964,0.23146,0.34363,1,1
1,GO AXIS ELONGATION,0.009256,0.23132,0.25337,1,1
1,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,5.0226e-05,0.2312,0.23804,1,1
1,GO FC RECEPTOR SIGNALING PATHWAY,8.4205e-05,0.23097,0.20017,1,1
1,GO ACTIVATION OF INNATE IMMUNE RESPONSE,2.8418e-05,0.23091,0.23452,1,1
1,GO CELLULAR DEFENSE RESPONSE,0.010245,0.23087,0.25878,1,1
1,GO RNA MODIFICATION,8.4205e-05,0.23061,0.19649,1,1
1,GO REGULATION OF KERATINOCYTE MIGRATION,0.013798,0.23029,0.19251,1,1
1,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.0010528,0.23028,0.36092,1,1
1,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.00021909,0.23025,0.22024,1,1
1,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0050528,0.23023,0.15979,1,1
1,GO REGULATION OF MRNA 3 END PROCESSING,1.4039e-05,0.23022,0.23193,1,1
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.046579,0.23012,0.2835,1,1
1,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.0019282,0.22996,0.27294,1,1
1,GO REGULATION OF EPITHELIAL CELL MIGRATION,6.7596e-05,0.2298,0.28467,1,1
1,GO HYPEROSMOTIC RESPONSE,0.004408,0.22955,0.23424,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.029068,0.22915,0.1394,1,1
1,GO DE NOVO PROTEIN FOLDING,0.0039469,0.22912,0.17492,1,1
1,GO RESPONSE TO OXIDATIVE STRESS,2.4346e-05,0.22888,0.21948,1,1
1,GO BODY FLUID SECRETION,0.00022676,0.22887,0.21845,1,1
1,GO ENDODERMAL CELL FATE COMMITMENT,0.00031859,0.22824,0.25793,1,1
1,GO CELLULAR IRON ION HOMEOSTASIS,5.0226e-05,0.22821,0.20483,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,1.1964e-05,0.22814,0.2121,1,1
1,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.023741,0.22813,0.16212,1,1
1,GO OSTEOCLAST DIFFERENTIATION,7.013e-05,0.2281,0.20187,1,1
1,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00034072,0.22807,0.19955,1,1
1,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.00044439,0.22799,0.27463,1,1
1,GO PEPTIDE METABOLIC PROCESS,1.2454e-05,0.22794,0.19902,1,1
1,GO POST GOLGI VESICLE MEDIATED TRANSPORT,1.1493e-05,0.22789,0.23691,1,1
1,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.0050528,0.22766,0.23052,1,1
1,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.0075304,0.22756,0.23025,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0020453,0.22748,0.21291,1,1
1,GO POSITIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.0040578,0.22743,0.19344,1,1
1,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,7.2754e-05,0.22728,0.26424,1,1
1,GO REGULATION OF PROTEOLYSIS,0.00018427,0.22716,0.18204,1,1
1,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,1.0604e-05,0.227,0.24473,1,1
1,GO RNA POLYADENYLATION,0.00022676,0.22693,0.18156,1,1
1,GO FOAM CELL DIFFERENTIATION,0.0028957,0.22665,0.23289,1,1
1,GO TRNA MODIFICATION,0.00072223,0.22664,0.1792,1,1
1,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.00019079,0.22657,0.21338,1,1
1,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.013465,0.22654,0.1852,1,1
1,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.041093,0.22626,0.20424,1,1
1,GO RUFFLE ORGANIZATION,0.00028792,0.22615,0.18025,1,1
1,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.0015653,0.22612,0.24416,1,1
1,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.00021167,0.22599,0.2365,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.00065623,0.22575,0.20545,1,1
1,GO REGULATION OF MACROPHAGE MIGRATION,2.9532e-05,0.2257,0.27981,1,1
1,GO RESPONSE TO MISFOLDED PROTEIN,0.0021689,0.22541,0.20526,1,1
1,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.036948,0.2252,0.18425,1,1
1,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.00044439,0.22509,0.18472,1,1
1,GO STRIATED MUSCLE CELL PROLIFERATION,0.00019753,0.22464,0.27276,1,1
1,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.00072223,0.22453,0.30708,1,1
1,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.014841,0.22432,0.23505,1,1
1,GO CERAMIDE TRANSPORT,0.038561,0.2242,0.21445,1,1
1,GO REGULATION OF CENTRIOLE REPLICATION,0.0046564,0.22419,0.16833,1,1
1,GO MULTIVESICULAR BODY ORGANIZATION,0.00067758,0.22413,0.1829,1,1
1,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.001986,0.22398,0.21376,1,1
1,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.00010462,0.22367,0.24166,1,1
1,GO REGULATION OF MULTI ORGANISM PROCESS,0.0079323,0.22328,0.19698,1,1
1,GO LEUKOCYTE PROLIFERATION,0.0032441,0.22312,0.169,1,1
1,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.00022676,0.22286,0.23472,1,1
1,GO REGULATION OF VASCULOGENESIS,0.017137,0.22229,0.28856,1,1
1,GO BONE MORPHOGENESIS,0.0036303,0.22204,0.21887,1,1
1,GO CHYLOMICRON ASSEMBLY,0.0073363,0.22201,0.20547,1,1
1,GO PROTEIN KINASE B SIGNALING,0.00050664,0.22199,0.18497,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.0066042,0.2217,0.18764,1,1
1,GO SULFUR AMINO ACID METABOLIC PROCESS,0.0025083,0.22159,0.16038,1,1
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.0057817,0.22126,0.16742,1,1
1,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.010245,0.22105,0.26983,1,1
1,GO MACROPHAGE CHEMOTAXIS,6.2786e-05,0.22063,0.33288,1,1
1,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.00013917,0.22058,0.22416,1,1
1,GO MYELOID CELL HOMEOSTASIS,5.4121e-05,0.22051,0.20809,1,1
1,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.00042998,0.21998,0.18048,1,1
1,GO OVULATION,0.036164,0.21987,0.22594,1,1
1,GO POSITIVE REGULATION OF T CELL MIGRATION,0.0013457,0.21975,0.24573,1,1
1,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.0099891,0.21963,0.19169,1,1
1,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.015203,0.21936,0.16967,1,1
1,GO PLACENTA DEVELOPMENT,0.0013457,0.21915,0.19367,1,1
1,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.0050528,0.21909,0.19526,1,1
1,GO POLYAMINE METABOLIC PROCESS,0.0031536,0.21901,0.22766,1,1
1,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,5.4121e-05,0.21894,0.21876,1,1
1,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.0013872,0.21889,0.16791,1,1
1,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00036427,0.2188,0.23295,1,1
1,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0097392,0.21856,0.21621,1,1
1,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,1.3441e-06,0.21853,0.20715,1,1
1,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.00049035,0.21841,0.21952,1,1
1,GO TRANSITION METAL ION HOMEOSTASIS,7.013e-05,0.21821,0.21463,1,1
1,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.00017796,0.21813,0.18378,1,1
1,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.025414,0.2176,0.16326,1,1
1,GO TRNA METABOLIC PROCESS,0.00074557,0.21758,0.17607,1,1
1,GO ERBB SIGNALING PATHWAY,0.00026003,0.21744,0.23781,1,1
1,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.015574,0.21699,0.24982,1,1
1,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.00087311,0.21687,0.35208,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.0094949,0.2168,0.19654,1,1
1,GO INTERFERON GAMMA PRODUCTION,0.00019753,0.21654,0.24949,1,1
1,GO REGULATION OF LIPID LOCALIZATION,0.00044439,0.21649,0.17027,1,1
1,GO REGULATION OF URINE VOLUME,0.00098941,0.21647,0.22207,1,1
1,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.001662,0.2164,0.19404,1,1
1,GO PLASMA MEMBRANE FUSION,0.036164,0.21637,0.18681,1,1
1,GO RESPONSE TO RETINOIC ACID,0.0007696,0.21608,0.21074,1,1
1,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.0011199,0.21592,0.21247,1,1
1,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,9.7346e-05,0.2159,0.26585,1,1
1,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.0018173,0.21588,0.2003,1,1
1,GO REGULATION OF INFLAMMATORY RESPONSE,0.0029794,0.21587,0.17787,1,1
1,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.00057693,0.21583,0.19268,1,1
1,GO LEUKOCYTE MIGRATION,0.0075304,0.21566,0.17549,1,1
1,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.0069616,0.21544,0.17107,1,1
1,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.00050664,0.21527,0.20883,1,1
1,GO POSITIVE REGULATION OF PROTEOLYSIS,4.0073e-05,0.21526,0.17854,1,1
1,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.015574,0.21516,0.15113,1,1
1,GO VESICLE TARGETING,7.2754e-05,0.21491,0.22302,1,1
1,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.0006154,0.21472,0.20847,1,1
1,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.00030804,0.21456,0.19004,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.0033369,0.21425,0.24762,1,1
1,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.00032948,0.21412,0.1947,1,1
1,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,1.7118e-05,0.21408,0.19582,1,1
1,GO RNA PROCESSING,8.7323e-05,0.21369,0.16966,1,1
1,GO PEPTIDYL ASPARAGINE MODIFICATION,0.001228,0.21359,0.1608,1,1
1,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.050569,0.21355,0.23998,1,1
1,GO MRNA TRANSPORT,7.8282e-05,0.21354,0.1901,1,1
1,GO ORGANELLE INHERITANCE,0.00084609,0.21327,0.18272,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.0022332,0.21308,0.17067,1,1
1,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.00026003,0.21296,0.22886,1,1
1,GO PROTEIN K63 LINKED UBIQUITINATION,0.00020448,0.21268,0.16655,1,1
1,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.00353,0.21267,0.22414,1,1
1,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.0042883,0.21238,0.17149,1,1
1,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.011904,0.21229,0.21386,1,1
1,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.024846,0.2118,0.17286,1,1
1,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.042857,0.2118,0.11976,1,1
1,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0026572,0.21173,0.29046,1,1
1,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.0062634,0.21153,0.27922,1,1
1,GO REGULATION OF LYMPHOCYTE MIGRATION,0.0022992,0.2115,0.21223,1,1
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,5.508e-06,0.21117,0.19448,1,1
1,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.0011199,0.21109,0.16033,1,1
1,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.0013457,0.21098,0.14793,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.0013457,0.21078,0.20982,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.0032441,0.21033,0.20221,1,1
1,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,2.9301e-06,0.2098,0.22786,1,1
1,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.00020448,0.20918,0.22549,1,1
1,GO RNA METHYLATION,0.00027832,0.20916,0.19183,1,1
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0030654,0.2091,0.17716,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.0017641,0.20902,0.20132,1,1
1,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.052669,0.20883,0.19179,1,1
1,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.0020453,0.20854,0.176,1,1
1,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.013465,0.20852,0.16174,1,1
1,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.00081984,0.20827,0.19659,1,1
1,GO REGULATION OF HEART MORPHOGENESIS,0.030383,0.20823,0.24294,1,1
1,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,5.508e-06,0.20805,0.2105,1,1
1,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.0022332,0.20801,0.19775,1,1
1,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.00054072,0.20748,0.18107,1,1
1,GO FATTY ACID CATABOLIC PROCESS,0.013139,0.20736,0.14167,1,1
1,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.00012074,0.20696,0.19564,1,1
1,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.00029782,0.20683,0.1866,1,1
1,GO ENDOSOME ORGANIZATION,0.00038934,0.20655,0.17273,1,1
1,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00044439,0.20654,0.17895,1,1
1,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.0025083,0.20639,0.20065,1,1
1,GO MYELOID CELL DIFFERENTIATION,4.3218e-05,0.20609,0.17783,1,1
1,GO TOOTH MINERALIZATION,0.03245,0.2058,0.21843,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.0036303,0.2057,0.18639,1,1
1,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.0019282,0.20557,0.21352,1,1
1,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.047551,0.20552,0.17715,1,1
1,GO GRANULOCYTE CHEMOTAXIS,0.0081404,0.2054,0.23856,1,1
1,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.012203,0.20495,0.22614,1,1
1,GO RNA LOCALIZATION,8.4205e-05,0.20488,0.20366,1,1
1,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.00021909,0.2047,0.18128,1,1
1,GO POSITIVE REGULATION OF PROTEIN BINDING,0.00034072,0.20427,0.17861,1,1
1,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.0010206,0.20418,0.21379,1,1
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,3.5759e-05,0.20392,0.19086,1,1
1,GO NEGATIVE T CELL SELECTION,0.054842,0.20383,0.16179,1,1
1,GO TRNA TRANSPORT,0.0041716,0.20381,0.18781,1,1
1,GO VESICLE BUDDING FROM MEMBRANE,0.0001165,0.20346,0.22031,1,1
1,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.0007696,0.20337,0.18647,1,1
1,GO PROTEIN MATURATION,0.00054072,0.20272,0.14604,1,1
1,GO STRESS FIBER ASSEMBLY,0.0019282,0.20259,0.2182,1,1
1,GO CELLULAR RESPONSE TO ATP,0.0010859,0.20257,0.19442,1,1
1,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.0094949,0.20255,0.14998,1,1
1,GO REGULATION OF CELL CELL ADHESION,0.0031536,0.20235,0.15379,1,1
1,GO ESTABLISHMENT OF RNA LOCALIZATION,6.0504e-05,0.20228,0.20034,1,1
1,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00090094,0.20208,0.19098,1,1
1,GO PROTEIN AUTOPROCESSING,0.027803,0.20206,0.13198,1,1
1,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.0037331,0.20191,0.21281,1,1
1,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.0025083,0.20189,0.15971,1,1
1,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.0016129,0.20144,0.22573,1,1
1,GO REGULATION OF ERBB SIGNALING PATHWAY,0.00032948,0.20137,0.28109,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.0014738,0.20136,0.17577,1,1
1,GO REGULATION OF LIPID STORAGE,0.00098941,0.20122,0.23762,1,1
1,GO MITOTIC RECOMBINATION,0.0029794,0.20102,0.20263,1,1
1,GO REGULATION OF RECEPTOR RECYCLING,0.001986,0.2006,0.21529,1,1
1,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.00010462,0.2004,0.17371,1,1
1,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00025131,0.20037,0.22038,1,1
1,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.013139,0.20023,0.1707,1,1
1,GO TONGUE DEVELOPMENT,0.009256,0.2,0.24937,1,1
1,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.0010206,0.19982,0.14742,1,1
1,GO RESPONSE TO INTERLEUKIN 4,0.00079435,0.19955,0.18518,1,1
1,GO PEPTIDYL TYROSINE MODIFICATION,3.3132e-05,0.19935,0.22181,1,1
1,GO MITOTIC CYTOKINESIS,0.0011549,0.19935,0.20166,1,1
1,GO PROTEIN ADP RIBOSYLATION,0.0060989,0.19932,0.17847,1,1
1,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.0007696,0.19931,0.23034,1,1
1,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.0011199,0.19888,0.14247,1,1
1,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,1.0311e-06,0.19884,0.16361,1,1
1,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.00032948,0.19807,0.16933,1,1
1,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.0011549,0.19791,0.17478,1,1
1,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.054842,0.19781,0.1425,1,1
1,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.0099891,0.19748,0.16287,1,1
1,GO RESPONSE TO STEROID HORMONE,0.00353,0.19721,0.15238,1,1
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.0071468,0.19713,0.26421,1,1
1,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,4.8379e-05,0.19683,0.19881,1,1
1,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,1.8251e-06,0.19672,0.19143,1,1
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.0010206,0.19671,0.17792,1,1
1,GO LACTATION,0.0037331,0.1965,0.18953,1,1
1,GO REGULATION OF CELL ADHESION,0.0047853,0.19633,0.17584,1,1
1,GO CELL AGING,5.9841e-06,0.19624,0.21193,1,1
1,GO RESPONSE TO OXYGEN LEVELS,0.0023671,0.19603,0.17005,1,1
1,GO HISTONE MRNA METABOLIC PROCESS,0.0042883,0.19596,0.14517,1,1
1,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.0066042,0.19587,0.17961,1,1
1,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.0017641,0.19564,0.192,1,1
1,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.031748,0.19555,0.15768,1,1
1,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.00054072,0.1955,0.19151,1,1
1,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.00025131,0.19549,0.19861,1,1
1,GO AMIDE BIOSYNTHETIC PROCESS,9.389e-05,0.19521,0.16845,1,1
1,GO TUBE MORPHOGENESIS,0.00044439,0.19429,0.20007,1,1
1,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.018398,0.19429,0.14614,1,1
1,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.018398,0.19402,0.1216,1,1
1,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.02268,0.19387,0.14544,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,1.9263e-05,0.19381,0.17199,1,1
1,GO REGULATION OF BODY FLUID LEVELS,0.0010859,0.19356,0.17729,1,1
1,GO REGULATION OF RUFFLE ASSEMBLY,0.017969,0.1933,0.12135,1,1
1,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0060989,0.19309,0.21152,1,1
1,GO RNA INTERFERENCE,0.034637,0.19302,0.15537,1,1
1,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.04854,0.19202,0.27113,1,1
1,GO TRANSCRIPTION BY RNA POLYMERASE I,0.0060989,0.19191,0.16988,1,1
1,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,3.1888e-05,0.19162,0.19082,1,1
1,GO IMMUNE SYSTEM DEVELOPMENT,0.00011241,0.19137,0.15548,1,1
1,GO REGULATION OF MYELOID CELL DIFFERENTIATION,6.0504e-05,0.19026,0.18671,1,1
1,GO DNA TEMPLATED TRANSCRIPTION INITIATION,1.9904e-06,0.18985,0.18348,1,1
1,GO PROTEIN DENEDDYLATION,0.015203,0.18983,0.15017,1,1
1,GO NUCLEAR TRANSPORT,2.2524e-05,0.18981,0.162,1,1
1,GO CIRCULATORY SYSTEM DEVELOPMENT,0.00028792,0.18977,0.19585,1,1
1,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.027188,0.18975,0.18581,1,1
1,GO KERATINOCYTE PROLIFERATION,0.0062634,0.18975,0.33395,1,1
1,GO ORGANIC ACID CATABOLIC PROCESS,0.0099891,0.18956,0.14537,1,1
1,GO SULFUR COMPOUND METABOLIC PROCESS,0.00030804,0.18952,0.16505,1,1
1,GO B CELL ACTIVATION,0.0011549,0.1892,0.14484,1,1
1,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.00041602,0.1892,0.24035,1,1
1,GO VACUOLAR ACIDIFICATION,0.0050528,0.18904,0.16947,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.03245,0.18866,0.18126,1,1
1,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.011326,0.18863,0.17496,1,1
1,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,6.7596e-05,0.1883,0.20653,1,1
1,GO CONNECTIVE TISSUE DEVELOPMENT,0.0038387,0.18797,0.1835,1,1
1,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.004408,0.18779,0.16621,1,1
1,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.03245,0.18774,0.24951,1,1
1,GO KIDNEY MESENCHYME DEVELOPMENT,0.029719,0.18741,0.17628,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.00019753,0.1872,0.19555,1,1
1,GO MACROMOLECULE CATABOLIC PROCESS,1.1776e-06,0.18718,0.17151,1,1
1,GO REGULATION OF DNA RECOMBINATION,0.00027832,0.18711,0.19847,1,1
1,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.0083534,0.18702,0.15516,1,1
1,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00025131,0.18699,0.19125,1,1
1,GO REGULATION OF T CELL CHEMOTAXIS,0.0090226,0.18693,0.20305,1,1
1,GO REGULATION OF B CELL ACTIVATION,0.0087944,0.18691,0.12974,1,1
1,GO REGULATION OF T CELL DIFFERENTIATION,0.0036303,0.18681,0.16308,1,1
1,GO CELLULAR RESPONSE TO HEAT,0.00079435,0.18661,0.17683,1,1
1,GO SUPEROXIDE METABOLIC PROCESS,0.025414,0.18653,0.13034,1,1
1,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.011326,0.1863,0.15933,1,1
1,GO INFLAMMATORY RESPONSE,0.00057693,0.18622,0.22072,1,1
1,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,6.7728e-06,0.18588,0.22228,1,1
1,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.03939,0.18583,0.15983,1,1
1,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.012203,0.18558,0.19428,1,1
1,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.00021167,0.18551,0.1963,1,1
1,GO CENTRIOLE ASSEMBLY,0.0031536,0.1853,0.13807,1,1
1,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.00353,0.18519,0.2361,1,1
1,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,1.5201e-05,0.18498,0.14743,1,1
1,GO PROTEIN HOMOTETRAMERIZATION,0.00027832,0.18497,0.16631,1,1
1,GO CELLULAR AMIDE METABOLIC PROCESS,5.0226e-05,0.18486,0.16166,1,1
1,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.00063551,0.18428,0.17359,1,1
1,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.0010206,0.18421,0.19971,1,1
1,GO ESCRT COMPLEX DISASSEMBLY,0.044685,0.18403,0.15263,1,1
1,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.0046564,0.18378,0.14717,1,1
1,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.00059588,0.18356,0.33932,1,1
1,GO CELL CHEMOTAXIS,0.0064317,0.18333,0.18454,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.00065623,0.18319,0.15843,1,1
1,GO MESENCHYME DEVELOPMENT,0.0022332,0.183,0.18645,1,1
1,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,7.3528e-06,0.18256,0.169,1,1
1,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.025414,0.1824,0.21707,1,1
1,GO PROTEIN NEDDYLATION,0.0013457,0.18232,0.18801,1,1
1,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.012508,0.18231,0.24807,1,1
1,GO GOLGI VESICLE BUDDING,0.00049035,0.18208,0.18191,1,1
1,GO LEUKOCYTE DIFFERENTIATION,0.00040247,0.18194,0.16505,1,1
1,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.00098941,0.18194,0.16927,1,1
1,GO EMBRYONIC HEART TUBE DEVELOPMENT,1.4609e-05,0.18187,0.22785,1,1
1,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.0038387,0.18145,0.17872,1,1
1,GO PROTEIN N LINKED GLYCOSYLATION,0.0017123,0.18141,0.14984,1,1
1,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.00044439,0.18081,0.14485,1,1
1,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.0057817,0.18074,0.21567,1,1
1,GO NEGATIVE REGULATION OF CELL DEATH,0.00010845,0.18067,0.15969,1,1
1,GO NEGATIVE REGULATION OF CELL ADHESION,0.013465,0.18052,0.17049,1,1
1,GO APOPTOTIC SIGNALING PATHWAY,0.0016129,0.18031,0.15188,1,1
1,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.02843,0.18029,0.18242,1,1
1,GO ENDOTHELIAL CELL PROLIFERATION,0.0069616,0.18028,0.1636,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.0026572,0.18006,0.16975,1,1
1,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,3.7145e-05,0.18001,0.20687,1,1
1,GO RNA CAPPING,4.0073e-05,0.17984,0.17955,1,1
1,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.0030654,0.17981,0.15006,1,1
1,GO PROTEIN LOCALIZATION TO NUCLEUS,0.00024286,0.17966,0.15591,1,1
1,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,8.7323e-05,0.1795,0.21587,1,1
1,GO AGING,0.00036427,0.1789,0.16438,1,1
1,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.025994,0.17885,0.14248,1,1
1,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.0014738,0.17879,0.1828,1,1
1,GO LEUKOCYTE HOMEOSTASIS,0.00047456,0.1785,0.18476,1,1
1,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.0013457,0.17841,0.15427,1,1
1,GO FACE DEVELOPMENT,0.0013054,0.17832,0.23535,1,1
1,GO CELLULAR RESPONSE TO LIPID,0.00069957,0.17739,0.17653,1,1
1,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,7.547e-05,0.17718,0.24985,1,1
1,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.00054072,0.17688,0.13697,1,1
1,GO PROTEIN TARGETING TO MEMBRANE,0.022165,0.17619,0.14915,1,1
1,GO AUTOPHAGOSOME ORGANIZATION,0.00029782,0.17532,0.19285,1,1
1,GO VACUOLAR TRANSPORT,0.0010528,0.17499,0.14663,1,1
1,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.00018427,0.17497,0.14421,1,1
1,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.013798,0.17465,0.12585,1,1
1,GO HISTONE DEACETYLATION,0.00084609,0.17461,0.12594,1,1
1,GO EMBRYONIC HEART TUBE MORPHOGENESIS,2.9532e-05,0.17459,0.21057,1,1
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.00042998,0.17438,0.1474,1,1
1,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.0010206,0.17413,0.16944,1,1
1,GO GOLGI VESICLE TRANSPORT,6.0504e-05,0.17379,0.15938,1,1
1,GO T CELL DIFFERENTIATION IN THYMUS,0.00010092,0.17348,0.18511,1,1
1,GO PROTEIN TARGETING,0.00072223,0.17315,0.15369,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.00035231,0.17309,0.17913,1,1
1,GO ATP BIOSYNTHETIC PROCESS,0.012203,0.17266,0.17367,1,1
1,GO MODULATION BY VIRUS OF HOST PROCESS,0.0012662,0.17242,0.17485,1,1
1,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.050569,0.17239,0.12843,1,1
1,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,6.2786e-05,0.17205,0.16352,1,1
1,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.00020448,0.17203,0.17085,1,1
1,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.0013457,0.172,0.1457,1,1
1,GO PROTEIN IMPORT,4.6597e-05,0.1717,0.1673,1,1
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0050528,0.17154,0.13589,1,1
1,GO STEROL IMPORT,0.0017123,0.17151,0.39713,1,1
1,GO NEURAL TUBE DEVELOPMENT,0.013139,0.17146,0.16419,1,1
1,GO LYSOSOMAL TRANSPORT,0.0013457,0.17139,0.16093,1,1
1,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.0010528,0.1712,0.14963,1,1
1,GO LEFT RIGHT PATTERN FORMATION,0.021165,0.17109,0.2111,1,1
1,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.001662,0.17106,0.20749,1,1
1,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,2.6307e-05,0.17089,0.14946,1,1
1,GO DEFENSE RESPONSE TO BACTERIUM,0.0083534,0.17045,0.15005,1,1
1,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0056288,0.16934,0.1658,1,1
1,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.0031536,0.16916,0.14135,1,1
1,GO RRNA 3 END PROCESSING,0.0025817,0.16903,0.17091,1,1
1,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.0011549,0.16866,0.23149,1,1
1,GO EMBRYONIC EYE MORPHOGENESIS,0.050569,0.16865,0.18787,1,1
1,GO MRNA METABOLIC PROCESS,3.0689e-05,0.16862,0.16171,1,1
1,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.029068,0.16826,0.2146,1,1
1,GO REGULATION OF NUCLEAR DIVISION,0.001872,0.16809,0.11888,1,1
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.052669,0.16805,0.13802,1,1
1,GO IMPORT INTO NUCLEUS,0.00021909,0.16798,0.14618,1,1
1,GO DRUG METABOLIC PROCESS,0.045624,0.16779,0.091395,1,1
1,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.00025131,0.1677,0.22018,1,1
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.036948,0.16759,0.14268,1,1
1,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.00025131,0.16742,0.17059,1,1
1,GO SPINDLE LOCALIZATION,0.00057693,0.16731,0.15215,1,1
1,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.0046564,0.16718,0.15797,1,1
1,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.021165,0.16695,0.1581,1,1
1,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.00029782,0.16683,0.19198,1,1
1,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.0051916,0.16668,0.17152,1,1
1,GO NEUTROPHIL MIGRATION,0.019739,0.16634,0.20815,1,1
1,GO REGULATION OF RESPONSE TO STRESS,0.00021167,0.16626,0.15059,1,1
1,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.0034322,0.1658,0.13977,1,1
1,GO REGULATION OF SPINDLE ORGANIZATION,0.004408,0.1658,0.13995,1,1
1,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.0051916,0.16574,0.13916,1,1
1,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0021062,0.16567,0.18735,1,1
1,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.017969,0.16565,0.16147,1,1
1,GO COPII COATED VESICLE BUDDING,0.0011199,0.16531,0.18042,1,1
1,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.00047456,0.16525,0.19027,1,1
1,GO REGULATION OF VACUOLE ORGANIZATION,0.012508,0.16523,0.14233,1,1
1,GO PROTEIN KINASE A SIGNALING,0.00098941,0.16514,0.18856,1,1
1,GO POSITIVE REGULATION OF CATABOLIC PROCESS,3.5759e-05,0.16465,0.16368,1,1
1,GO REGULATION OF TRANSLATIONAL INITIATION,0.0029794,0.16464,0.13611,1,1
1,GO CANONICAL WNT SIGNALING PATHWAY,0.0045306,0.16417,0.15017,1,1
1,GO CELLULAR COMPONENT DISASSEMBLY,1.6455e-05,0.16397,0.14746,1,1
1,GO LYMPHOCYTE COSTIMULATION,0.0034322,0.16395,0.15024,1,1
1,GO GLOMERULUS DEVELOPMENT,0.00041602,0.16344,0.34836,1,1
1,GO TRANSLESION SYNTHESIS,0.0007696,0.16296,0.16062,1,1
1,GO OSSIFICATION,0.010245,0.16293,0.15834,1,1
1,GO RESPONSE TO HEAT,0.00020448,0.1628,0.18267,1,1
1,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.030383,0.16267,0.11329,1,1
1,GO POSITIVE REGULATION OF BINDING,0.0012662,0.16234,0.14102,1,1
1,GO TELOMERE ORGANIZATION,0.00047456,0.16219,0.14022,1,1
1,GO VACUOLE ORGANIZATION,0.0011199,0.16206,0.12945,1,1
1,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,4.1617e-05,0.16175,0.17398,1,1
1,GO MYELOID LEUKOCYTE MIGRATION,0.02843,0.16166,0.1762,1,1
1,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.00029782,0.16123,0.16036,1,1
1,GO RECEPTOR RECYCLING,0.020205,0.16122,0.12322,1,1
1,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.0038387,0.16114,0.13758,1,1
1,GO PROTEIN POLYUBIQUITINATION,1.0184e-05,0.161,0.16219,1,1
1,GO SULFUR COMPOUND TRANSPORT,0.0022992,0.16089,0.13313,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.00079435,0.1608,0.14446,1,1
1,GO THYROID HORMONE METABOLIC PROCESS,0.017137,0.16069,0.14923,1,1
1,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.018398,0.16049,0.12005,1,1
1,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.00081984,0.16045,0.16534,1,1
1,GO RESPONSE TO MINERALOCORTICOID,0.0050528,0.16028,0.24521,1,1
1,GO PLASMA MEMBRANE ORGANIZATION,0.02268,0.15957,0.11033,1,1
1,GO HORMONE BIOSYNTHETIC PROCESS,0.018836,0.15931,0.15302,1,1
1,GO REGULATION OF MRNA METABOLIC PROCESS,4.8379e-05,0.15897,0.15164,1,1
1,GO POSITIVE REGULATION OF MAPK CASCADE,0.0013872,0.15896,0.15697,1,1
1,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0029794,0.15896,0.1415,1,1
1,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.00042998,0.15834,0.17673,1,1
1,GO RNA STABILIZATION,0.015203,0.15833,0.13609,1,1
1,GO GLIAL CELL APOPTOTIC PROCESS,0.05161,0.15801,0.23768,1,1
1,GO REGULATION OF CELLULAR CATABOLIC PROCESS,4.6623e-06,0.15801,0.16315,1,1
1,GO REGULATION OF MITOPHAGY,0.024288,0.15751,0.17925,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,0.037747,0.15746,0.18903,1,1
1,GO REGULATION OF LIPID TRANSPORT,0.0019282,0.15735,0.1424,1,1
1,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.0045306,0.15703,0.11476,1,1
1,GO POSITIVE REGULATION OF MACROAUTOPHAGY,7.013e-05,0.15693,0.21631,1,1
1,GO PROTEOLYSIS,0.00017186,0.15686,0.13027,1,1
1,GO REGULATION OF TELOMERE MAINTENANCE,0.0075304,0.1565,0.11965,1,1
1,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.024846,0.1565,0.1148,1,1
1,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.012203,0.15616,0.1432,1,1
1,GO CELLULAR PROTEIN CATABOLIC PROCESS,2.8418e-05,0.15603,0.13904,1,1
1,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0046564,0.15523,0.17671,1,1
1,GO REGULATION OF VASOCONSTRICTION,0.0028957,0.15513,0.20814,1,1
1,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.00019079,0.15488,0.1393,1,1
1,GO ASTROCYTE DIFFERENTIATION,0.011612,0.15445,0.15974,1,1
1,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,4.0073e-05,0.154,0.14843,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.00012512,0.15364,0.1497,1,1
1,GO MAINTENANCE OF LOCATION,9.0551e-05,0.1534,0.16322,1,1
1,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,5.0226e-05,0.15305,0.17078,1,1
1,GO ERYTHROCYTE HOMEOSTASIS,0.00017796,0.15291,0.17667,1,1
1,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.00087311,0.15278,0.17229,1,1
1,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.013139,0.15267,0.12754,1,1
1,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.0039469,0.15242,0.13091,1,1
1,GO LYMPHOCYTE DIFFERENTIATION,0.00059588,0.15239,0.15364,1,1
1,GO BONE DEVELOPMENT,0.0029794,0.15235,0.17777,1,1
1,GO PROTEIN CATABOLIC PROCESS,4.3218e-05,0.15231,0.13385,1,1
1,GO REPLACEMENT OSSIFICATION,0.025994,0.15222,0.21449,1,1
1,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,1.5816e-05,0.15213,0.15624,1,1
1,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.0085714,0.15194,0.20737,1,1
1,GO ANIMAL ORGAN FORMATION,0.053746,0.15173,0.14129,1,1
1,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.0073363,0.15168,0.11887,1,1
1,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.023205,0.15153,0.29717,1,1
1,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.0010206,0.15136,0.1577,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.00098941,0.15101,0.13665,1,1
1,GO CELL CYCLE G2 M PHASE TRANSITION,0.0017123,0.15088,0.11461,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.02068,0.15085,0.17911,1,1
1,GO DNA BIOSYNTHETIC PROCESS,2.0784e-06,0.15081,0.16466,1,1
1,GO MEIOTIC SPINDLE ORGANIZATION,0.0051916,0.15039,0.16887,1,1
1,GO TUBE DEVELOPMENT,0.0038387,0.15007,0.15137,1,1
1,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0064317,0.14993,0.15936,1,1
1,GO T HELPER CELL LINEAGE COMMITMENT,0.017549,0.1498,0.17049,1,1
1,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.027188,0.14962,0.15942,1,1
1,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.001662,0.14949,0.274,1,1
1,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.023741,0.14916,0.13149,1,1
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0040578,0.14901,0.13855,1,1
1,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.030383,0.14878,0.1342,1,1
1,GO RNA EXPORT FROM NUCLEUS,0.0051916,0.14871,0.13627,1,1
1,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.0025083,0.14833,0.15994,1,1
1,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.043763,0.14784,0.10534,1,1
1,GO NON RECOMBINATIONAL REPAIR,0.00021167,0.14777,0.15679,1,1
1,GO REGULATION OF BIOMINERALIZATION,0.049546,0.14774,0.16738,1,1
1,GO REGULATION OF BINDING,0.0050528,0.14765,0.11736,1,1
1,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.00034072,0.14734,0.13433,1,1
1,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.00042998,0.14727,0.15282,1,1
1,GO PIGMENT GRANULE ORGANIZATION,0.026586,0.14705,0.19356,1,1
1,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.011612,0.14682,0.15816,1,1
1,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.00012074,0.14654,0.14448,1,1
1,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.00065623,0.14653,0.13666,1,1
1,GO REGULATION OF PROTEIN BINDING,0.0014299,0.14649,0.14025,1,1
1,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.0085714,0.14636,0.12619,1,1
1,GO REGULATION OF CATABOLIC PROCESS,8.3127e-06,0.14626,0.14718,1,1
1,GO REGULATION OF CELL DEATH,0.0007696,0.14611,0.12253,1,1
1,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.001228,0.14597,0.12798,1,1
1,GO CHROMOSOME LOCALIZATION,0.027803,0.14565,0.11549,1,1
1,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0069616,0.14544,0.11061,1,1
1,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.01282,0.1452,0.12295,1,1
1,GO NEURAL TUBE FORMATION,0.013798,0.14497,0.16372,1,1
1,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.00079435,0.14495,0.13429,1,1
1,GO NCRNA CATABOLIC PROCESS,0.044685,0.14454,0.1379,1,1
1,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.00087311,0.14452,0.12345,1,1
1,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.00025131,0.1445,0.17725,1,1
1,GO TRANSCYTOSIS,0.033894,0.14396,0.14216,1,1
1,GO CARDIAC SEPTUM DEVELOPMENT,0.0047853,0.14396,0.19645,1,1
1,GO BLASTOCYST GROWTH,0.0083534,0.14348,0.22245,1,1
1,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.024288,0.14317,0.15704,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.00057693,0.14298,0.11548,1,1
1,GO RESPONSE TO UV,0.0017641,0.14281,0.13692,1,1
1,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.00021909,0.14279,0.13806,1,1
1,GO REGULATION OF CENTROSOME DUPLICATION,0.00044439,0.14278,0.17324,1,1
1,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0075304,0.14268,0.14133,1,1
1,GO SCHWANN CELL DEVELOPMENT,0.024288,0.14254,0.13236,1,1
1,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.0023671,0.14251,0.10571,1,1
1,GO UV DAMAGE EXCISION REPAIR,0.052669,0.14225,0.097928,1,1
1,GO ESTABLISHMENT OF TISSUE POLARITY,0.00042998,0.1422,0.18317,1,1
1,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.0012662,0.14083,0.17403,1,1
1,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.054842,0.1408,0.083507,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.010773,0.14075,0.13709,1,1
1,GO ORGANIC ACID METABOLIC PROCESS,0.0022332,0.14047,0.11008,1,1
1,GO MITOTIC SPINDLE ORGANIZATION,0.014138,0.14036,0.13203,1,1
1,GO REGULATION OF PROTEIN CATABOLIC PROCESS,5.2139e-05,0.14031,0.13611,1,1
1,GO GENE SILENCING,6.5149e-05,0.14012,0.13875,1,1
1,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.0045306,0.13997,0.15474,1,1
1,GO SMALL MOLECULE CATABOLIC PROCESS,0.0025817,0.13995,0.12351,1,1
1,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.05161,0.13963,0.12189,1,1
1,GO POSTREPLICATION REPAIR,0.00063551,0.13961,0.14206,1,1
1,GO CELLULAR RESPONSE TO UV,0.0067808,0.13961,0.12866,1,1
1,GO TRABECULA MORPHOGENESIS,0.02843,0.13919,0.18404,1,1
1,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,4.0073e-05,0.13859,0.17591,1,1
1,GO INOSITOL LIPID MEDIATED SIGNALING,0.00074557,0.13806,0.17902,1,1
1,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.035393,0.13771,0.095157,1,1
1,GO CELLULAR RESPONSE TO RADIATION,0.0016129,0.13765,0.12558,1,1
1,GO RESPONSE TO CHEMOKINE,0.023205,0.13739,0.17569,1,1
1,GO REGULATION OF ENDOCYTOSIS,0.013139,0.13709,0.10573,1,1
1,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.0016129,0.13689,0.13978,1,1
1,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.010245,0.13688,0.19336,1,1
1,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.034637,0.13605,0.069149,1,1
1,GO RESPONSE TO LIPID,0.0041716,0.13589,0.14131,1,1
1,GO NUCLEUS ORGANIZATION,0.019739,0.13547,0.10785,1,1
1,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.007729,0.13541,0.19393,1,1
1,GO MITOTIC METAPHASE PLATE CONGRESSION,0.017137,0.13522,0.10809,1,1
1,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.0053338,0.13485,0.089591,1,1
1,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.0020453,0.1348,0.18059,1,1
1,GO CARDIAC SEPTUM MORPHOGENESIS,0.040234,0.13471,0.17964,1,1
1,GO BODY MORPHOGENESIS,0.038561,0.13442,0.13415,1,1
1,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.0045306,0.13415,0.20023,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,3.7145e-05,0.13404,0.14585,1,1
1,GO REGULATION OF MAPK CASCADE,0.0030654,0.13398,0.1297,1,1
1,GO EXOCYTOSIS,0.0057817,0.13386,0.11791,1,1
1,GO REGULATION OF MAP KINASE ACTIVITY,0.0087944,0.13381,0.10975,1,1
1,GO POSITIVE REGULATION OF CELL DEATH,0.0047853,0.13368,0.1155,1,1
1,GO STEM CELL DIFFERENTIATION,0.00014418,0.13358,0.16694,1,1
1,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.0090226,0.13328,0.16162,1,1
1,GO MESENCHYMAL CELL DIFFERENTIATION,0.021165,0.13301,0.15418,1,1
1,GO HOMEOSTASIS OF NUMBER OF CELLS,0.00052342,0.13283,0.13973,1,1
1,GO TRANSITION METAL ION TRANSPORT,0.0013872,0.13276,0.091691,1,1
1,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.0023671,0.13261,0.14533,1,1
1,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.001228,0.13258,0.14901,1,1
1,GO VIRAL BUDDING,0.0013872,0.13218,0.16172,1,1
1,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.015953,0.13196,0.097798,1,1
1,GO NUCLEOTIDE EXCISION REPAIR,0.00026003,0.13195,0.13512,1,1
1,GO CELLULAR HORMONE METABOLIC PROCESS,0.01282,0.13191,0.12295,1,1
1,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0011199,0.13146,0.14455,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE,0.0025083,0.13123,0.098971,1,1
1,GO BASE EXCISION REPAIR AP SITE FORMATION,0.055956,0.13099,0.13986,1,1
1,GO REGULATION OF CHEMOTAXIS,0.017969,0.13062,0.11933,1,1
1,GO GENITALIA DEVELOPMENT,0.025414,0.13028,0.098901,1,1
1,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.0037331,0.13023,0.14715,1,1
1,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.00074557,0.13002,0.1283,1,1
1,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.0036303,0.12977,0.10798,1,1
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.013798,0.1297,0.092286,1,1
1,GO MRNA 3 END PROCESSING,0.0030654,0.12957,0.13614,1,1
1,GO CELL CYCLE PHASE TRANSITION,0.00087311,0.12952,0.1097,1,1
1,GO RESPONSE TO LEPTIN,0.05161,0.12928,0.15102,1,1
1,GO MAINTENANCE OF LOCATION IN CELL,0.00031859,0.12923,0.15068,1,1
1,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.00087311,0.12876,0.12337,1,1
1,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.025994,0.12869,0.12267,1,1
1,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0046564,0.12865,0.13428,1,1
1,GO REGULATION OF SENSORY PERCEPTION,0.041093,0.12846,0.11738,1,1
1,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.012203,0.12816,0.097961,1,1
1,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0062634,0.12811,0.16599,1,1
1,GO RECEPTOR METABOLIC PROCESS,0.0038387,0.12743,0.12521,1,1
1,GO METAPHASE PLATE CONGRESSION,0.015203,0.1273,0.11905,1,1
1,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.013798,0.12646,0.11062,1,1
1,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0036303,0.12635,0.12276,1,1
1,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.00353,0.12631,0.13138,1,1
1,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.029719,0.1261,0.18239,1,1
1,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.011612,0.12584,0.11961,1,1
1,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.02068,0.12549,0.11746,1,1
1,GO ORGAN GROWTH,0.0031536,0.12521,0.16762,1,1
1,GO REGULATION OF WNT SIGNALING PATHWAY,0.019739,0.12488,0.12086,1,1
1,GO PROTEIN MONOUBIQUITINATION,0.0045306,0.12407,0.091485,1,1
1,GO REGULATION OF DNA CATABOLIC PROCESS,0.00052342,0.124,0.21988,1,1
1,GO REGULATION OF MITOTIC CELL CYCLE,0.001228,0.12391,0.11067,1,1
1,GO CYTOKINESIS,0.0090226,0.12373,0.10505,1,1
1,GO APOPTOTIC PROCESS,0.00079435,0.1235,0.11336,1,1
1,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.0060989,0.12251,0.11351,1,1
1,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0030654,0.12241,0.13441,1,1
1,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.00025131,0.12222,0.11303,1,1
1,GO REGULATION OF ERAD PATHWAY,0.0083534,0.12215,0.1213,1,1
1,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.018836,0.1221,0.13221,1,1
1,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.00022676,0.12208,0.11276,1,1
1,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0019282,0.12207,0.16077,1,1
1,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.016339,0.12191,0.12156,1,1
1,GO ACTIN FILAMENT ORGANIZATION,0.041093,0.12171,0.096139,1,1
1,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.029719,0.12141,0.12932,1,1
1,GO CELL CYCLE G1 S PHASE TRANSITION,0.0049174,0.12098,0.11163,1,1
1,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.0041716,0.12088,0.094183,1,1
1,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.0025817,0.12022,0.12142,1,1
1,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.0027346,0.11978,0.10976,1,1
1,GO CENTRIOLE CENTRIOLE COHESION,0.013465,0.11876,0.1654,1,1
1,GO REGULATION OF HISTONE UBIQUITINATION,0.0081404,0.11871,0.14013,1,1
1,GO CELL DIVISION,0.012508,0.11853,0.091467,1,1
1,GO REGULATION OF OSSIFICATION,0.022165,0.11837,0.15118,1,1
1,GO REGULATION OF HYDROLASE ACTIVITY,0.015574,0.11826,0.089286,1,1
1,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.042857,0.11822,0.12083,1,1
1,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.046579,0.11822,0.14724,1,1
1,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.00030804,0.11775,0.12763,1,1
1,GO GOLGI ORGANIZATION,0.0051916,0.11731,0.11124,1,1
1,GO HUMORAL IMMUNE RESPONSE,0.04854,0.11726,0.091386,1,1
1,GO CELLULAR SENESCENCE,0.0029794,0.11703,0.12509,1,1
1,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.0073363,0.11682,0.11664,1,1
1,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.0014299,0.11625,0.12088,1,1
1,GO TISSUE MORPHOGENESIS,0.001662,0.11597,0.15024,1,1
1,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0071468,0.11568,0.12432,1,1
1,GO REGULATION OF CHROMOSOME SEPARATION,0.0049174,0.11547,0.16403,1,1
1,GO AUTOPHAGY OF MITOCHONDRION,0.00084609,0.11502,0.1375,1,1
1,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0087944,0.1146,0.10431,1,1
1,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.0036303,0.11335,0.11658,1,1
1,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.0047853,0.11332,0.10566,1,1
1,GO REGULATION OF DNA REPLICATION,0.012508,0.11296,0.094317,1,1
1,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.0001165,0.11294,0.12809,1,1
1,GO REGULATION OF AUTOPHAGY,0.0010528,0.11277,0.11173,1,1
1,GO MEMBRANE ORGANIZATION,0.013139,0.11274,0.082158,1,1
1,GO REGULATION OF ACTIN FILAMENT LENGTH,0.017137,0.11223,0.097598,1,1
1,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.041093,0.11204,0.11507,1,1
1,GO ORGANELLE FISSION,0.02843,0.11178,0.076591,1,1
1,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.00054072,0.11155,0.103,1,1
1,GO FEMALE GAMETE GENERATION,0.01282,0.11153,0.081845,1,1
1,GO APOPTOTIC DNA FRAGMENTATION,0.0064317,0.11115,0.094958,1,1
1,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.00055855,0.1109,0.15421,1,1
1,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.043763,0.11009,0.13576,1,1
1,GO HEART GROWTH,0.043763,0.10984,0.1187,1,1
1,GO IN UTERO EMBRYONIC DEVELOPMENT,0.0020453,0.10974,0.10906,1,1
1,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.00011241,0.10894,0.118,1,1
1,GO INTRA S DNA DAMAGE CHECKPOINT,0.010506,0.10883,0.12597,1,1
1,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.0019282,0.10861,0.11321,1,1
1,GO MRNA EXPORT FROM NUCLEUS,0.010506,0.10851,0.11208,1,1
1,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.00353,0.10794,0.091252,1,1
1,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.00063551,0.1076,0.12054,1,1
1,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.00012074,0.10751,0.10516,1,1
1,GO MACROAUTOPHAGY,7.547e-05,0.10746,0.13176,1,1
1,GO REGULATION OF CELL CYCLE PROCESS,0.0018173,0.10742,0.096355,1,1
1,GO PROTEIN LOCALIZATION TO ORGANELLE,7.013e-05,0.10712,0.10474,1,1
1,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.013465,0.10624,0.14125,1,1
1,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.0011199,0.10561,0.10639,1,1
1,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.001228,0.10557,0.18316,1,1
1,GO MITOTIC CELL CYCLE CHECKPOINT,0.0021689,0.10542,0.11328,1,1
1,GO RESPONSE TO ABIOTIC STIMULUS,0.017549,0.1053,0.083644,1,1
1,GO B CELL DIFFERENTIATION,0.027188,0.10446,0.10894,1,1
1,GO SPINDLE ORGANIZATION,0.046579,0.10392,0.088331,1,1
1,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.016734,0.10354,0.13362,1,1
1,GO MULTIVESICULAR BODY SORTING PATHWAY,0.036948,0.10305,0.10625,1,1
1,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.0023671,0.10292,0.1301,1,1
1,GO REGULATION OF DNA REPAIR,0.011612,0.10232,0.091418,1,1
1,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.038561,0.10224,0.06092,1,1
1,GO NEGATIVE REGULATION OF BINDING,0.038561,0.10135,0.078448,1,1
1,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.014486,0.10134,0.12466,1,1
1,GO RNA SURVEILLANCE,0.00353,0.10112,0.16302,1,1
1,GO MITOTIC CELL CYCLE,0.00353,0.10003,0.098733,1,1
1,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.0018173,0.099729,0.072648,1,1
1,GO PEPTIDYL THREONINE MODIFICATION,0.027803,0.09936,0.087252,1,1
1,GO EMBRYONIC MORPHOGENESIS,0.034637,0.098714,0.094361,1,1
1,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.035393,0.098571,0.090304,1,1
1,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.035393,0.098241,0.086669,1,1
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.00045924,0.098195,0.091999,1,1
1,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.035393,0.09817,0.082267,1,1
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.00026903,0.098126,0.094432,1,1
1,GO RUFFLE ASSEMBLY,0.015203,0.096832,0.11848,1,1
1,GO REGULATION OF ATPASE ACTIVITY,0.0062634,0.096651,0.096257,1,1
1,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.0029794,0.096475,0.099852,1,1
1,GO REGULATION OF PHOSPHORYLATION,0.0073363,0.096333,0.094354,1,1
1,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.013798,0.096307,0.08611,1,1
1,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.0034322,0.096167,0.10662,1,1
1,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.029068,0.095725,0.084299,1,1
1,GO CHROMOSOME SEPARATION,0.017137,0.095352,0.12818,1,1
1,GO REGULATION OF TRANSFERASE ACTIVITY,0.00353,0.094944,0.089031,1,1
1,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.0053338,0.093448,0.089749,1,1
1,GO REGULATION OF DNA METABOLIC PROCESS,0.00035231,0.093265,0.10591,1,1
1,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.009256,0.093032,0.07966,1,1
1,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.0014299,0.092091,0.13185,1,1
1,GO CELL CYCLE PROCESS,0.011612,0.092088,0.07622,1,1
1,GO ORGANELLE DISASSEMBLY,0.0014738,0.091245,0.11025,1,1
1,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.031059,0.0906,0.085434,1,1
1,GO DNA METABOLIC PROCESS,0.00063551,0.090204,0.095756,1,1
1,GO NEGATIVE REGULATION OF SIGNALING,0.007729,0.089732,0.087781,1,1
1,GO IRON ION TRANSPORT,0.017137,0.08938,0.085667,1,1
1,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.042857,0.088474,0.11477,1,1
1,GO TUBE FORMATION,0.029719,0.08837,0.11836,1,1
1,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0046564,0.088307,0.11812,1,1
1,GO PEPTIDYL AMINO ACID MODIFICATION,0.0064317,0.08754,0.071453,1,1
1,GO RESPONSE TO PEPTIDE,0.026586,0.087436,0.072104,1,1
1,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.009256,0.086876,0.082554,1,1
1,GO REGULATION OF CELL CYCLE,0.015574,0.086329,0.066633,1,1
1,GO ENDOCYTOSIS,0.009256,0.086194,0.10299,1,1
1,GO INTRACELLULAR PROTEIN TRANSPORT,0.00047456,0.085755,0.085941,1,1
1,GO SNRNA TRANSCRIPTION,0.0042883,0.085252,0.099109,1,1
1,GO DNA INTEGRITY CHECKPOINT,0.050569,0.084952,0.079297,1,1
1,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.015574,0.084843,0.10019,1,1
1,GO CELL CELL SIGNALING BY WNT,0.047551,0.084622,0.094761,1,1
1,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.014486,0.083716,0.077738,1,1
1,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.017549,0.083705,0.053928,1,1
1,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.015953,0.083256,0.067405,1,1
1,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.00035231,0.082616,0.10252,1,1
1,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.025994,0.082129,0.090953,1,1
1,GO NON CANONICAL WNT SIGNALING PATHWAY,0.011904,0.081474,0.12437,1,1
1,GO HEART DEVELOPMENT,0.021165,0.080762,0.11303,1,1
1,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.034637,0.080452,0.059552,1,1
1,GO RESPONSE TO HORMONE,0.019283,0.080122,0.084885,1,1
1,GO MITOTIC NUCLEAR DIVISION,0.010245,0.078081,0.096371,1,1
1,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.050569,0.077702,0.080763,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.035393,0.077628,0.081701,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.031748,0.077543,0.066286,1,1
1,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.011047,0.077444,0.091997,1,1
1,GO SULFATE TRANSPORT,0.03939,0.077033,0.082838,1,1
1,GO CELL CYCLE,0.018398,0.077,0.063208,1,1
1,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.031748,0.076283,0.066856,1,1
1,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.018836,0.075809,0.094948,1,1
1,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.025994,0.075168,0.11064,1,1
1,GO CELL CYCLE CHECKPOINT,0.016339,0.075122,0.079891,1,1
1,GO CHROMOSOME SEGREGATION,0.038561,0.074881,0.082981,1,1
1,GO DOUBLE STRAND BREAK REPAIR,0.0069616,0.074853,0.10312,1,1
1,GO DNA MODIFICATION,0.017549,0.074223,0.088602,1,1
1,GO CHROMOSOME CONDENSATION,0.009256,0.074131,0.12035,1,1
1,GO RESPONSE TO PEPTIDE HORMONE,0.046579,0.073238,0.061459,1,1
1,GO CELLULAR RESPONSE TO PEPTIDE,0.031059,0.072369,0.064581,1,1
1,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.02843,0.070309,0.083239,1,1
1,GO TRANSCRIPTION BY RNA POLYMERASE III,0.016734,0.070249,0.083786,1,1
1,GO INTRACELLULAR TRANSPORT,0.0054795,0.069634,0.064029,1,1
1,GO NUCLEAR CHROMOSOME SEGREGATION,0.047551,0.067762,0.074774,1,1
1,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.013798,0.066613,0.075086,1,1
1,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.03939,0.064966,0.089485,1,1
1,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.036948,0.063781,0.065656,1,1
1,GO SKELETAL SYSTEM DEVELOPMENT,0.054842,0.062556,0.11441,1,1
1,GO MUSCLE STRUCTURE DEVELOPMENT,0.021165,0.061405,0.11174,1,1
1,GO DNA CATABOLIC PROCESS,0.052669,0.060456,0.054951,1,1
1,GO DNA RECOMBINATION,0.02268,0.059759,0.095868,1,1
1,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.027803,0.059605,0.059179,1,1
1,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.033894,0.059151,0.076623,1,1
1,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.036164,0.058854,0.098284,1,1
1,GO DNA REPAIR,0.0060989,0.058216,0.084605,1,1
1,GO ENDOSOMAL TRANSPORT,0.023205,0.055684,0.077908,1,1
1,GO MUSCLE ORGAN DEVELOPMENT,0.03939,0.039935,0.087105,1,1
1,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00028792,0.60764,0.52557,1,0
1,GO IMMUNE RESPONSE TO TUMOR CELL,9.0551e-05,0.50369,0.45026,1,0
1,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.00023468,0.47865,0.46716,1,0
1,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,3.7145e-05,0.46232,0.44502,1,0
1,GO PROSTANOID BIOSYNTHETIC PROCESS,0.0001165,0.44055,0.42483,1,0
1,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00087311,0.42166,0.4213,1,0
1,GO PROSTANOID METABOLIC PROCESS,2.2524e-05,0.39358,0.42935,1,0
1,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.0011199,0.39069,0.36276,1,0
1,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0046564,0.38707,0.2725,1,0
1,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.0017641,0.38153,0.48995,1,0
1,GO ETHER BIOSYNTHETIC PROCESS,0.001228,0.37053,0.39182,1,0
1,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.0049174,0.36404,0.32833,1,0
1,GO PROTEIN HYDROXYLATION,0.0056288,0.34105,0.36545,1,0
1,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.033894,0.32172,0.24435,1,0
1,GO PENTOSE METABOLIC PROCESS,0.0018173,0.31918,0.26189,1,0
1,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.035393,0.3181,0.31142,1,0
1,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.0054795,0.30866,0.33489,1,0
1,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.011904,0.30605,0.26357,1,0
1,GO GLYCINE METABOLIC PROCESS,0.01282,0.30223,0.22872,1,0
1,GO EOSINOPHIL MIGRATION,0.018398,0.30125,0.30609,1,0
1,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.0010528,0.29622,0.24838,1,0
1,GO BARBED END ACTIN FILAMENT CAPPING,0.03939,0.29088,0.23143,1,0
1,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0012662,0.29054,0.24495,1,0
1,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00024286,0.28927,0.28551,1,0
1,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.010773,0.28398,0.40778,1,0
1,GO GALACTOSE METABOLIC PROCESS,0.012203,0.28298,0.23709,1,0
1,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.001986,0.28221,0.31515,1,0
1,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,7.6603e-06,0.27825,0.25659,1,0
1,GO LUNG MORPHOGENESIS,0.0025817,0.27777,0.27184,1,0
1,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.016339,0.27725,0.20954,1,0
1,GO AMINO ACID BETAINE METABOLIC PROCESS,0.017549,0.27516,0.21625,1,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.010245,0.27338,0.28182,1,0
1,GO C21 STEROID HORMONE METABOLIC PROCESS,0.0011549,0.27133,0.24598,1,0
1,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.00065623,0.26938,0.25274,1,0
1,GO MUSCLE CELL MIGRATION,0.010506,0.26857,0.23628,1,0
1,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.001191,0.26799,0.23381,1,0
1,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.037747,0.26217,0.25219,1,0
1,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.00041602,0.26208,0.27368,1,0
1,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.022165,0.25521,0.20542,1,0
1,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.044685,0.2549,0.36553,1,0
1,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.0081404,0.25197,0.26374,1,0
1,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.0083534,0.25195,0.24709,1,0
1,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.036164,0.25134,0.18344,1,0
1,GO REGULATION OF LIGASE ACTIVITY,0.014841,0.24598,0.20738,1,0
1,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.0012662,0.24462,0.23566,1,0
1,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.038561,0.24318,0.18464,1,0
1,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.0071468,0.23926,0.18156,1,0
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.0066042,0.23778,0.2153,1,0
1,GO EPOXYGENASE P450 PATHWAY,0.017137,0.2366,0.19092,1,0
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0049174,0.23562,0.30945,1,0
1,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.00034072,0.23353,0.351,1,0
1,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0051916,0.23224,0.23801,1,0
1,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.0045306,0.23165,0.20724,1,0
1,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.00035231,0.23093,0.26745,1,0
1,GO GLUTATHIONE METABOLIC PROCESS,0.001872,0.23027,0.21936,1,0
1,GO PEPTIDYL PROLINE HYDROXYLATION,0.036948,0.22851,0.35282,1,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.0020453,0.22647,0.21528,1,0
1,GO MITOCHONDRIAL TRANSCRIPTION,0.0083534,0.22533,0.2029,1,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.031748,0.22395,0.22476,1,0
1,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.00042998,0.2233,0.32781,1,0
1,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.014138,0.22089,0.22033,1,0
1,GO SMOOTH MUSCLE CELL MIGRATION,0.047551,0.21744,0.19551,1,0
1,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.011047,0.21726,0.17123,1,0
1,GO ETHANOL METABOLIC PROCESS,0.0083534,0.21647,0.30706,1,0
1,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.020205,0.21025,0.20218,1,0
1,GO SUPEROXIDE ANION GENERATION,0.015203,0.21014,0.22618,1,0
1,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.0036303,0.20984,0.18965,1,0
1,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.014841,0.20909,0.23845,1,0
1,GO RESPONSE TO INTERLEUKIN 15,0.00063551,0.20794,0.33153,1,0
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.0059384,0.20773,0.22121,1,0
1,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.0025817,0.20513,0.14783,1,0
1,GO PHOSPHOLIPID CATABOLIC PROCESS,0.03939,0.20116,0.12839,1,0
1,GO POSITIVE REGULATION OF TISSUE REMODELING,0.0026572,0.20026,0.23064,1,0
1,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.0057817,0.19905,0.31457,1,0
1,GO GLYCEROL ETHER METABOLIC PROCESS,0.0039469,0.19825,0.24576,1,0
1,GO AMINO SUGAR CATABOLIC PROCESS,0.0069616,0.19748,0.13256,1,0
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.009256,0.19739,0.19422,1,0
1,GO REGULATION OF PLATELET ACTIVATION,0.035393,0.19693,0.16496,1,0
1,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.001228,0.19627,0.18522,1,0
1,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.045624,0.19475,0.17151,1,0
1,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.0028141,0.19318,0.1604,1,0
1,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,0.00098941,0.18892,0.20994,1,0
1,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.0022332,0.18853,0.28317,1,0
1,GO IMMUNOGLOBULIN SECRETION,0.02843,0.18785,0.21728,1,0
1,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.0071468,0.18616,0.17515,1,0
1,GO REGULATION OF BONE DEVELOPMENT,0.0021689,0.18233,0.23027,1,0
1,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.036164,0.1823,0.1644,1,0
1,GO TRNA WOBBLE BASE MODIFICATION,0.0054795,0.18043,0.17374,1,0
1,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0059384,0.17855,0.28304,1,0
1,GO POSITIVE REGULATION OF CELL AGING,0.038561,0.1785,0.21619,1,0
1,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,2.7343e-05,0.17738,0.20721,1,0
1,GO RESPONSE TO ISCHEMIA,0.00038934,0.17656,0.19071,1,0
1,GO RETINOL METABOLIC PROCESS,0.0067808,0.17599,0.18048,1,0
1,GO DETOXIFICATION,0.009256,0.17533,0.14541,1,0
1,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.050569,0.17464,0.11286,1,0
1,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.0059384,0.17431,0.26319,1,0
1,GO T CELL DIFFERENTIATION,0.0017641,0.17422,0.15391,1,0
1,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.016339,0.17354,0.16855,1,0
1,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.045624,0.17311,0.22504,1,0
1,GO CELLULAR EXTRAVASATION,0.0036303,0.17306,0.18129,1,0
1,GO RESPONSE TO KETONE,0.023205,0.17048,0.1118,1,0
1,GO REGULATION OF MACROPHAGE ACTIVATION,0.011612,0.16907,0.17183,1,0
1,GO AMELOGENESIS,0.055956,0.16861,0.19304,1,0
1,GO REGULATION OF TRANSLATIONAL ELONGATION,0.042857,0.16829,0.12508,1,0
1,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.011612,0.16827,0.31844,1,0
1,GO RESPONSE TO XENOBIOTIC STIMULUS,0.020205,0.16775,0.13378,1,0
1,GO UBIQUINONE METABOLIC PROCESS,0.043763,0.1675,0.11161,1,0
1,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.0056288,0.16745,0.1475,1,0
1,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.00057693,0.1671,0.1448,1,0
1,GO POSITIVE CHEMOTAXIS,0.029719,0.16606,0.18804,1,0
1,GO SEQUESTERING OF TRIGLYCERIDE,0.016734,0.16573,0.2713,1,0
1,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.03939,0.16382,0.12366,1,0
1,GO RESPONSE TO TUMOR CELL,0.05161,0.16372,0.17066,1,0
1,GO MATURE B CELL DIFFERENTIATION,0.011612,0.16176,0.21161,1,0
1,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.011904,0.16146,0.17001,1,0
1,GO ETHER METABOLIC PROCESS,0.04854,0.1593,0.16624,1,0
1,GO BONE REMODELING,0.013798,0.15253,0.15794,1,0
1,GO INTEGRIN ACTIVATION,0.017137,0.15167,0.16545,1,0
1,GO FATTY ACID METABOLIC PROCESS,0.007729,0.15153,0.11121,1,0
1,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.021165,0.14916,0.19596,1,0
1,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.036948,0.14451,0.14128,1,0
1,GO PEROXISOMAL TRANSPORT,0.0030654,0.14358,0.17847,1,0
1,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.034637,0.14249,0.096619,1,0
1,GO RESPONSE TO ANTIBIOTIC,0.0040578,0.142,0.16471,1,0
1,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.0075304,0.14188,0.2674,1,0
1,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.025414,0.13951,0.11745,1,0
1,GO AMINE METABOLIC PROCESS,0.013139,0.1394,0.11107,1,0
1,GO ELECTRON TRANSPORT CHAIN,0.0087944,0.139,0.11245,1,0
1,GO REGULATION OF RESPONSE TO TUMOR CELL,0.03245,0.13888,0.17807,1,0
1,GO PROTEIN TARGETING TO MITOCHONDRION,0.014841,0.13839,0.099012,1,0
1,GO ENDOCRINE PROCESS,0.0059384,0.13485,0.14979,1,0
1,GO EPITHELIAL CELL DEVELOPMENT,0.049546,0.13409,0.11281,1,0
1,GO CELLULAR LIPID CATABOLIC PROCESS,0.021165,0.1338,0.10271,1,0
1,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0013457,0.13369,0.16509,1,0
1,GO PEROXISOME ORGANIZATION,0.0032441,0.13308,0.16896,1,0
1,GO NEGATIVE REGULATION OF MAPK CASCADE,0.019283,0.13249,0.098535,1,0
1,GO TRNA WOBBLE URIDINE MODIFICATION,0.012203,0.13121,0.17033,1,0
1,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.024288,0.13034,0.16899,1,0
1,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.035393,0.1293,0.15624,1,0
1,GO AEROBIC RESPIRATION,0.03939,0.12857,0.09567,1,0
1,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.009256,0.12847,0.16078,1,0
1,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.029068,0.12799,0.10466,1,0
1,GO MUSCLE ATROPHY,0.036948,0.12787,0.24012,1,0
1,GO CELLULAR RESPIRATION,0.015574,0.12605,0.10996,1,0
1,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.02166,0.12605,0.17584,1,0
1,GO ALPHA AMINO ACID METABOLIC PROCESS,0.021165,0.12504,0.084751,1,0
1,GO GOLGI TO ENDOSOME TRANSPORT,0.019739,0.12362,0.14775,1,0
1,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.024846,0.12304,0.15005,1,0
1,GO REGULATION OF LIPID METABOLIC PROCESS,0.0049174,0.12205,0.098396,1,0
1,GO LIPID MODIFICATION,0.026586,0.12189,0.090843,1,0
1,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.052669,0.11895,0.096961,1,0
1,GO BASE EXCISION REPAIR,0.015574,0.11874,0.12906,1,0
1,GO OXIDATION REDUCTION PROCESS,0.011047,0.11854,0.09143,1,0
1,GO LIPID CATABOLIC PROCESS,0.026586,0.11815,0.073749,1,0
1,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.0057817,0.11813,0.14944,1,0
1,GO REGULATION OF PROTEIN STABILITY,0.0022992,0.11689,0.10339,1,0
1,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.025994,0.11516,0.099523,1,0
1,GO PROTEIN STABILIZATION,0.0011549,0.11335,0.12883,1,0
1,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.041967,0.11315,0.12266,1,0
1,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.011904,0.11241,0.11997,1,0
1,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.027188,0.11231,0.12392,1,0
1,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0062634,0.11225,0.076285,1,0
1,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.045624,0.11207,0.098939,1,0
1,GO LIPID LOCALIZATION,0.049546,0.11159,0.064809,1,0
1,GO ESTROGEN METABOLIC PROCESS,0.02166,0.11086,0.14754,1,0
1,GO FATTY ACID BIOSYNTHETIC PROCESS,0.036164,0.11018,0.08308,1,0
1,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.022165,0.10911,0.1106,1,0
1,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.034637,0.10888,0.18558,1,0
1,GO CARBOHYDRATE CATABOLIC PROCESS,0.026586,0.10623,0.083252,1,0
1,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.025414,0.10536,0.24058,1,0
1,GO BONE RESORPTION,0.050569,0.10516,0.10384,1,0
1,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.049546,0.10346,0.122,1,0
1,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.046579,0.10284,0.20771,1,0
1,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.036164,0.10237,0.080462,1,0
1,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.019283,0.10203,0.081995,1,0
1,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.04854,0.10099,0.14717,1,0
1,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.027803,0.10043,0.075846,1,0
1,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.001986,0.10026,0.10751,1,0
1,GO ALCOHOL METABOLIC PROCESS,0.054842,0.10003,0.066375,1,0
1,GO NEPHRON DEVELOPMENT,0.023741,0.097375,0.16202,1,0
1,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.049546,0.097245,0.074178,1,0
1,GO MYOTUBE DIFFERENTIATION,0.029068,0.094963,0.12466,1,0
1,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.011047,0.092602,0.084116,1,0
1,GO RESPONSE TO GROWTH FACTOR,0.009256,0.092111,0.12628,1,0
1,GO HORMONE METABOLIC PROCESS,0.029719,0.091664,0.089009,1,0
1,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.0094949,0.091334,0.081324,1,0
1,GO GLYCOPROTEIN METABOLIC PROCESS,0.038561,0.090494,0.065861,1,0
1,GO FLUID TRANSPORT,0.040234,0.08976,0.095969,1,0
1,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.017549,0.088975,0.14635,1,0
1,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.018836,0.088046,0.06461,1,0
1,GO VESICLE ORGANIZATION,0.042857,0.087253,0.068114,1,0
1,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.019283,0.087037,0.1365,1,0
1,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.015574,0.085725,0.064077,1,0
1,GO CELLULAR LIPID METABOLIC PROCESS,0.052669,0.084939,0.059204,1,0
1,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.0047853,0.083163,0.066217,1,0
1,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.018398,0.082912,0.069807,1,0
1,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.044685,0.082175,0.07741,1,0
1,GO LIPID METABOLIC PROCESS,0.03245,0.081536,0.060341,1,0
1,GO REGULATION OF CELL POPULATION PROLIFERATION,0.041093,0.080863,0.078759,1,0
1,GO CARBOHYDRATE METABOLIC PROCESS,0.02166,0.077008,0.058521,1,0
1,GO REGULATION OF INTRACELLULAR TRANSPORT,0.014841,0.076609,0.090709,1,0
1,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.055956,0.075937,0.098607,1,0
1,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.041967,0.074622,0.055568,1,0
1,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.02166,0.074288,0.13794,1,0
1,GO PROTEIN TETRAMERIZATION,0.046579,0.072655,0.069273,1,0
1,GO NCRNA TRANSCRIPTION,0.033894,0.072448,0.090498,1,0
1,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.052669,0.071319,0.055739,1,0
1,GO REGULATION OF FATTY ACID BETA OXIDATION,0.052669,0.069692,0.12357,1,0
1,GO MITOTIC SISTER CHROMATID SEGREGATION,0.045624,0.069617,0.083828,1,0
1,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.041967,0.066812,0.069104,1,0
1,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.045624,0.065757,0.054909,1,0
1,GO GLYCEROLIPID METABOLIC PROCESS,0.053746,0.063351,0.050091,1,0
1,GO ARTERY DEVELOPMENT,0.016734,0.062426,0.23014,1,0
1,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.015953,0.060064,0.15327,1,0
1,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.0053338,0.054857,0.074243,1,0
1,GO MITOCHONDRIAL TRANSPORT,0.05161,0.051881,0.055516,1,0
1,GO CELLULAR MACROMOLECULE LOCALIZATION,0.017969,0.043411,0.050848,1,0
1,GO ORGANIC ANION TRANSPORT,0.025994,-0.040582,-0.082876,1,0
1,GO ANION TRANSPORT,0.016734,-0.043842,-0.082026,1,0
1,GO INORGANIC ANION TRANSPORT,0.036164,-0.054397,-0.079942,1,0
1,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.04854,-0.059381,-0.086845,1,0
1,GO PROTEIN ACETYLATION,0.014841,-0.061301,-0.073042,1,0
1,GO RESPONSE TO MONOSACCHARIDE,0.010506,-0.066938,-0.090996,1,0
1,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.016734,-0.066963,-0.11004,1,0
1,GO OOCYTE DIFFERENTIATION,0.04854,-0.069951,-0.097286,1,0
1,GO REGULATION OF GLUCOSE IMPORT,0.018836,-0.070924,-0.13502,1,0
1,GO REGULATION OF RECEPTOR INTERNALIZATION,0.014486,-0.071158,-0.11991,1,0
1,GO RESPONSE TO CARBOHYDRATE,0.045624,-0.071733,-0.067973,1,0
1,GO ORGANIC ACID TRANSPORT,0.0011199,-0.073631,-0.11551,1,0
1,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.036164,-0.074074,-0.079667,1,0
1,GO CALCIUM MEDIATED SIGNALING,0.047551,-0.077167,-0.069136,1,0
1,GO REGULATION OF TRANSPORT,0.0045306,-0.078517,-0.081576,1,0
1,GO VESICLE LOCALIZATION,0.029068,-0.081321,-0.069145,1,0
1,GO STEROL BIOSYNTHETIC PROCESS,0.043763,-0.083027,-0.15368,1,0
1,GO POSITIVE REGULATION OF INSULIN SECRETION,0.023205,-0.083327,-0.14205,1,0
1,GO TRANSMEMBRANE TRANSPORT,0.0014738,-0.087343,-0.094297,1,0
1,GO NEGATIVE REGULATION OF ION TRANSPORT,0.010773,-0.088587,-0.096168,1,0
1,GO ANION TRANSMEMBRANE TRANSPORT,0.024288,-0.092056,-0.082235,1,0
1,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,0.00054072,-0.09381,-0.14145,1,0
1,GO SENSORY PERCEPTION OF SMELL,0.004408,-0.095358,-0.099112,1,0
1,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.01282,-0.096373,-0.13209,1,0
1,GO ADULT FEEDING BEHAVIOR,0.041093,-0.096581,-0.16847,1,0
1,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.027188,-0.098386,-0.091473,1,0
1,GO LEUKOCYTE TETHERING OR ROLLING,0.040234,-0.099015,-0.10854,1,0
1,GO REGULATION OF GLUCOSE METABOLIC PROCESS,0.0057817,-0.099647,-0.13035,1,0
1,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.0069616,-0.10149,-0.10445,1,0
1,GO MATING,0.0029794,-0.10194,-0.14789,1,0
1,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.019739,-0.10368,-0.14903,1,0
1,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.02843,-0.10385,-0.10401,1,0
1,GO POSITIVE REGULATION OF ANION TRANSPORT,0.0059384,-0.10466,-0.15612,1,0
1,GO REGULATION OF MEIOTIC CELL CYCLE,0.0036303,-0.10473,-0.14094,1,0
1,GO CELLULAR RESPONSE TO ALKALOID,0.041093,-0.1054,-0.12122,1,0
1,GO POSITIVE REGULATION OF SECRETION,0.00092958,-0.10706,-0.13128,1,0
1,GO ADIPOSE TISSUE DEVELOPMENT,0.04854,-0.10785,-0.15715,1,0
1,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.020205,-0.1126,-0.18837,1,0
1,GO CIRCULATORY SYSTEM PROCESS,0.023741,-0.11459,-0.085753,1,0
1,GO ORGANIC HYDROXY COMPOUND TRANSPORT,0.00014935,-0.11603,-0.17448,1,0
1,GO DETECTION OF STIMULUS,3.0689e-05,-0.11718,-0.12749,1,0
1,GO OLIGODENDROCYTE DEVELOPMENT,0.0051916,-0.11769,-0.2155,1,0
1,GO REGULATION OF HORMONE LEVELS,0.00063551,-0.11789,-0.15298,1,0
1,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.024846,-0.11968,-0.18011,1,0
1,GO REGULATION OF ANION TRANSPORT,0.0028957,-0.12005,-0.15125,1,0
1,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.046579,-0.1203,-0.12996,1,0
1,GO PROTON TRANSMEMBRANE TRANSPORT,0.015574,-0.12039,-0.091332,1,0
1,GO IMPORT ACROSS PLASMA MEMBRANE,0.0094949,-0.12062,-0.12317,1,0
1,GO ANATOMICAL STRUCTURE MATURATION,0.0042883,-0.12093,-0.11865,1,0
1,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.031748,-0.12097,-0.13319,1,0
1,GO AMINO ACID TRANSMEMBRANE TRANSPORT,0.038561,-0.12246,-0.11248,1,0
1,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.023741,-0.1231,-0.12014,1,0
1,GO PEPTIDE SECRETION,0.00021167,-0.12425,-0.1417,1,0
1,GO REGULATION OF FERTILIZATION,0.024846,-0.12461,-0.16347,1,0
1,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.054842,-0.12493,-0.15335,1,0
1,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.0026572,-0.12579,-0.118,1,0
1,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.044685,-0.12608,-0.16643,1,0
1,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.055956,-0.12609,-0.1569,1,0
1,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.0081404,-0.12875,-0.099262,1,0
1,GO ION TRANSPORT,5.6174e-05,-0.12881,-0.13302,1,0
1,GO MATING BEHAVIOR,0.041967,-0.1301,-0.14632,1,0
1,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.016734,-0.13127,-0.14205,1,0
1,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.018398,-0.13236,-0.2106,1,0
1,GO LAYER FORMATION IN CEREBRAL CORTEX,0.03939,-0.13259,-0.22796,1,0
1,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0060989,-0.1326,-0.14302,1,0
1,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.033894,-0.13403,-0.24897,1,0
1,GO REGULATION OF CILIUM ASSEMBLY,0.02166,-0.13477,-0.11342,1,0
1,GO METAL ION TRANSPORT,9.0551e-05,-0.13536,-0.13652,1,0
1,GO NEGATIVE REGULATION OF RNA SPLICING,0.014138,-0.13672,-0.12485,1,0
1,GO NEUTRAL AMINO ACID TRANSPORT,0.027188,-0.13771,-0.14688,1,0
1,GO WATER HOMEOSTASIS,0.036164,-0.13851,-0.12101,1,0
1,GO REGULATION OF PEPTIDE SECRETION,0.00052342,-0.13863,-0.13208,1,0
1,GO GLUTAMATE METABOLIC PROCESS,0.013139,-0.13948,-0.13065,1,0
1,GO GANGLIOSIDE METABOLIC PROCESS,0.044685,-0.13988,-0.12488,1,0
1,GO SOMITOGENESIS,0.019739,-0.14167,-0.089996,1,0
1,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,5.2139e-05,-0.14399,-0.12668,1,0
1,GO SECOND MESSENGER MEDIATED SIGNALING,0.00021167,-0.14479,-0.14813,1,0
1,GO CARBOHYDRATE HOMEOSTASIS,0.0010859,-0.14502,-0.13935,1,0
1,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.001986,-0.14553,-0.12828,1,0
1,GO SENSORY PERCEPTION OF TASTE,0.014841,-0.14698,-0.11489,1,0
1,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.0075304,-0.14739,-0.20076,1,0
1,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.00353,-0.14811,-0.16796,1,0
1,GO RESPONSE TO ELECTRICAL STIMULUS,0.044685,-0.14871,-0.14249,1,0
1,GO CELLULAR RESPONSE TO LITHIUM ION,0.024846,-0.14911,-0.24254,1,0
1,GO SYNAPTIC TRANSMISSION GABAERGIC,0.001872,-0.14971,-0.17617,1,0
1,GO REGULATION OF CARDIAC CONDUCTION,0.0011549,-0.15008,-0.1803,1,0
1,GO REGULATION OF APPETITE,0.0038387,-0.15028,-0.1489,1,0
1,GO NEUTRAL LIPID CATABOLIC PROCESS,0.0097392,-0.15065,-0.16725,1,0
1,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND,0.010773,-0.15186,-0.37975,1,0
1,GO PHAGOSOME ACIDIFICATION,0.040234,-0.15263,-0.14016,1,0
1,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.00095906,-0.15287,-0.15148,1,0
1,GO CELL MATURATION,0.00031859,-0.15376,-0.1504,1,0
1,GO POST ANAL TAIL MORPHOGENESIS,0.025994,-0.15461,-0.1783,1,0
1,GO RENAL WATER HOMEOSTASIS,0.0050528,-0.15511,-0.13888,1,0
1,GO POSITIVE REGULATION OF MRNA PROCESSING,0.00026903,-0.15542,-0.17214,1,0
1,GO ION TRANSMEMBRANE TRANSPORT,2.6307e-05,-0.15833,-0.15332,1,0
1,GO CATION TRANSPORT,7.0571e-06,-0.1589,-0.16515,1,0
1,GO REGULATION OF RESPIRATORY BURST,0.049546,-0.15911,-0.20048,1,0
1,GO CELLULAR GLUCOSE HOMEOSTASIS,0.00069957,-0.16081,-0.13754,1,0
1,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.043763,-0.16156,-0.1096,1,0
1,GO DEFENSE RESPONSE TO FUNGUS,0.00050664,-0.16216,-0.19538,1,0
1,GO HISTONE H4 K16 ACETYLATION,0.0026572,-0.16435,-0.21847,1,0
1,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.049546,-0.16517,-0.15965,1,0
1,GO HISTONE H4 ACETYLATION,0.0042883,-0.16577,-0.13572,1,0
1,GO TELENCEPHALON GLIAL CELL MIGRATION,0.017969,-0.16653,-0.24484,1,0
1,GO FEAR RESPONSE,0.0010528,-0.16714,-0.18994,1,0
1,GO SENSORY PERCEPTION,9.3916e-06,-0.16762,-0.15726,1,0
1,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,0.052669,-0.16838,-0.19391,1,0
1,GO LIPID DROPLET ORGANIZATION,0.019739,-0.16876,-0.13406,1,0
1,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.037747,-0.16881,-0.22372,1,0
1,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.014486,-0.16893,-0.168,1,0
1,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.0033369,-0.17065,-0.18721,1,0
1,GO DIGESTIVE SYSTEM PROCESS,0.046579,-0.17127,-0.1128,1,0
1,GO ACID SECRETION,0.00063551,-0.17314,-0.19049,1,0
1,GO HISTONE H3 K4 METHYLATION,0.047551,-0.1741,-0.16752,1,0
1,GO CALCIUM ION IMPORT,0.0029794,-0.17476,-0.17423,1,0
1,GO REGULATION OF SECRETION,2.3654e-06,-0.17623,-0.18163,1,0
1,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.031059,-0.1763,-0.15008,1,0
1,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.041967,-0.17662,-0.16543,1,0
1,GO MECHANORECEPTOR DIFFERENTIATION,0.0027346,-0.17686,-0.20973,1,0
1,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,2.4346e-05,-0.17715,-0.19181,1,0
1,GO RESPONSE TO INTERLEUKIN 2,0.022165,-0.17733,-0.16994,1,0
1,GO CATION TRANSMEMBRANE TRANSPORT,1.1964e-05,-0.17953,-0.16936,1,0
1,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,1.1964e-05,-0.17966,-0.1719,1,0
1,GO MEMBRANE FISSION,0.0056288,-0.17975,-0.22549,1,0
1,GO TRIGLYCERIDE CATABOLIC PROCESS,0.02268,-0.18123,-0.16299,1,0
1,GO CHLORIDE TRANSPORT,9.389e-05,-0.18174,-0.17291,1,0
1,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,0.010773,-0.18237,-0.21565,1,0
1,GO POSITIVE REGULATION OF HORMONE SECRETION,0.00014935,-0.18366,-0.19688,1,0
1,GO SODIUM ION TRANSPORT,1.1964e-05,-0.18378,-0.20478,1,0
1,GO POLYOL TRANSPORT,0.044685,-0.18584,-0.15047,1,0
1,GO HYPOTHALAMUS DEVELOPMENT,0.0032441,-0.18591,-0.24417,1,0
1,GO REGULATION OF TRANSMEMBRANE TRANSPORT,2.0033e-05,-0.1864,-0.17316,1,0
1,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,0.0014738,-0.18714,-0.21823,1,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.001872,-0.18822,-0.22987,1,0
1,GO REGULATION OF ION TRANSPORT,2.4692e-06,-0.19236,-0.19951,1,0
1,GO NEURON PROJECTION ORGANIZATION,0.00059588,-0.19277,-0.21993,1,0
1,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.031748,-0.19294,-0.19371,1,0
1,GO IMPORT INTO CELL,0.00016023,-0.19358,-0.18168,1,0
1,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.035393,-0.1946,-0.16257,1,0
1,GO DIGESTION,0.014486,-0.19629,-0.14627,1,0
1,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,3.0689e-05,-0.1966,-0.18694,1,0
1,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.0040578,-0.19728,-0.15019,1,0
1,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.00017796,-0.19857,-0.18892,1,0
1,GO DORSAL AORTA DEVELOPMENT,0.042857,-0.19866,-0.187,1,0
1,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.00087311,-0.20001,-0.18329,1,0
1,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.0021062,-0.20084,-0.23964,1,0
1,GO REGULATION OF BLOOD CIRCULATION,1.8521e-05,-0.20307,-0.20697,1,0
1,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0051916,-0.20348,-0.20104,1,0
1,GO PEPTIDYL CYSTEINE MODIFICATION,4.6597e-05,-0.20447,-0.21929,1,0
1,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.035393,-0.20565,-0.16514,1,0
1,GO ORGANIC CATION TRANSPORT,2.3418e-05,-0.20569,-0.26045,1,0
1,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.0087944,-0.2058,-0.21134,1,0
1,GO RESPONSE TO ALKALOID,6.4994e-06,-0.20821,-0.22535,1,0
1,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.00067758,-0.20834,-0.19728,1,0
1,GO HAIR CELL DIFFERENTIATION,0.0079323,-0.20932,-0.23895,1,0
1,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.054842,-0.21137,-0.20896,1,0
1,GO LIPID TRANSLOCATION,0.0054795,-0.2115,-0.18918,1,0
1,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.00026903,-0.21153,-0.20884,1,0
1,GO HISTONE H3 K9 DEMETHYLATION,0.0031536,-0.21191,-0.22514,1,0
1,GO TELENCEPHALON DEVELOPMENT,2.4346e-05,-0.21229,-0.21841,1,0
1,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,1.7118e-05,-0.21705,-0.21765,1,0
1,GO BILE ACID BIOSYNTHETIC PROCESS,0.01282,-0.2194,-0.17779,1,0
1,GO REGULATION OF CELL MATURATION,0.0090226,-0.22172,-0.18019,1,0
1,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.0021689,-0.22293,-0.31534,1,0
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.038561,-0.22383,-0.20343,1,0
1,GO REGULATION OF HORMONE SECRETION,4.1802e-07,-0.22532,-0.26146,1,0
1,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,2.5308e-05,-0.22545,-0.22653,1,0
1,GO GENETIC IMPRINTING,0.014486,-0.22579,-0.14843,1,0
1,GO REPRODUCTIVE BEHAVIOR,5.8301e-05,-0.22816,-0.28073,1,0
1,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.0017641,-0.22847,-0.21757,1,0
1,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.03245,-0.23055,-0.17408,1,0
1,GO RDNA HETEROCHROMATIN ASSEMBLY,6.7596e-05,-0.23119,-0.24781,1,0
1,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.00040247,-0.2351,-0.24371,1,0
1,GO ADHERENS JUNCTION ORGANIZATION,0.00087311,-0.23523,-0.24716,1,0
1,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.00052342,-0.23555,-0.24891,1,0
1,GO RESPONSE TO HYDROXYUREA,0.016339,-0.23848,-0.18229,1,0
1,GO BILE ACID METABOLIC PROCESS,0.023205,-0.2389,-0.15365,1,0
1,GO POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.029719,-0.2407,-0.30153,1,0
1,GO CORTICOSTEROID HORMONE SECRETION,0.031059,-0.24352,-0.22572,1,0
1,GO RESPONSE TO AMPHETAMINE,0.00018427,-0.24536,-0.28522,1,0
1,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00010092,-0.24561,-0.22705,1,0
1,GO REGULATION OF ACROSOME REACTION,0.0067808,-0.2458,-0.29116,1,0
1,GO SODIUM ION TRANSMEMBRANE TRANSPORT,4.2876e-06,-0.24618,-0.24331,1,0
1,GO HIPPOCAMPUS DEVELOPMENT,0.00019079,-0.24679,-0.27656,1,0
1,GO PROTEIN HETEROOLIGOMERIZATION,0.00010845,-0.2501,-0.23205,1,0
1,GO GASTRULATION WITH MOUTH FORMING SECOND,0.0039469,-0.2527,-0.24366,1,0
1,GO HORMONE TRANSPORT,1.4268e-07,-0.25276,-0.28245,1,0
1,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.00090094,-0.25334,-0.23575,1,0
1,GO LIMBIC SYSTEM DEVELOPMENT,4.1617e-05,-0.25359,-0.27316,1,0
1,GO REGULATION OF SODIUM ION TRANSPORT,0.0006154,-0.25383,-0.205,1,0
1,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.0039469,-0.25489,-0.28531,1,0
1,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.001986,-0.25632,-0.28192,1,0
1,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.0001165,-0.25794,-0.32731,1,0
1,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.016339,-0.25972,-0.20687,1,0
1,GO REGULATION OF ORGANIC ACID TRANSPORT,4.8612e-06,-0.25981,-0.2751,1,0
1,GO REGULATION OF ACTION POTENTIAL,0.0012662,-0.26057,-0.22087,1,0
1,GO PANCREAS DEVELOPMENT,0.00079435,-0.26139,-0.22534,1,0
1,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,1.1493e-05,-0.2622,-0.23767,1,0
1,GO GLYCOLIPID BIOSYNTHETIC PROCESS,2.0833e-05,-0.26228,-0.22844,1,0
1,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,4.7955e-07,-0.26497,-0.244,1,0
1,GO CAMP BIOSYNTHETIC PROCESS,0.0027346,-0.26581,-0.30416,1,0
1,GO STRIATUM DEVELOPMENT,0.00030804,-0.26605,-0.31609,1,0
1,GO ACROSOME REACTION,0.00081984,-0.26611,-0.23139,1,0
1,GO CELLULAR RESPONSE TO CALCIUM ION,1.7806e-05,-0.26626,-0.27217,1,0
1,GO FEEDING BEHAVIOR,2.5122e-07,-0.26638,-0.28119,1,0
1,GO AMINE BIOSYNTHETIC PROCESS,0.0053338,-0.26678,-0.20992,1,0
1,GO LUNG ALVEOLUS DEVELOPMENT,0.014138,-0.27042,-0.20312,1,0
1,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.0025817,-0.27259,-0.28018,1,0
1,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.021165,-0.27514,-0.25237,1,0
1,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,5.2139e-05,-0.27549,-0.37976,1,0
1,GO PHAGOLYSOSOME ASSEMBLY,0.013139,-0.27647,-0.23519,1,0
1,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.0075304,-0.278,-0.23492,1,0
1,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,0.00022676,-0.28125,-0.35601,1,0
1,GO LIPOXYGENASE PATHWAY,0.025994,-0.28313,-0.26469,1,0
1,GO HISTONE H4 K5 ACETYLATION,0.00065623,-0.2835,-0.24981,1,0
1,GO KILLING OF CELLS OF OTHER ORGANISM,0.00010845,-0.28481,-0.22192,1,0
1,GO ENDOCRINE PANCREAS DEVELOPMENT,0.0047853,-0.28526,-0.2116,1,0
1,GO EXPORT ACROSS PLASMA MEMBRANE,0.0011199,-0.28577,-0.23452,1,0
1,GO SODIUM ION HOMEOSTASIS,7.6603e-06,-0.28586,-0.31106,1,0
1,GO RESPONSE TO FORSKOLIN,0.010245,-0.28703,-0.29944,1,0
1,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.029719,-0.2881,-0.20957,1,0
1,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,2.7343e-05,-0.28826,-0.42023,1,0
1,GO RESPONSE TO MAGNESIUM ION,0.034637,-0.29008,-0.21917,1,0
1,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.00038934,-0.29029,-0.2649,1,0
1,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.010506,-0.29069,-0.336,1,0
1,GO EXCITATORY SYNAPSE ASSEMBLY,0.0057817,-0.29073,-0.32055,1,0
1,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0015189,-0.2928,-0.32046,1,0
1,GO NEGATIVE REGULATION OF LYASE ACTIVITY,0.0013054,-0.29299,-0.31501,1,0
1,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.030383,-0.29427,-0.18098,1,0
1,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.00014935,-0.29634,-0.29023,1,0
1,GO REGULATION OF NERVOUS SYSTEM PROCESS,2.2658e-06,-0.29656,-0.33004,1,0
1,GO REGULATION OF HEART RATE,4.6597e-05,-0.29709,-0.26306,1,0
1,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.00041602,-0.29721,-0.35709,1,0
1,GO AMINO ACID TRANSPORT,6.8936e-07,-0.29737,-0.28275,1,0
1,GO SIGNAL RELEASE,2.0038e-08,-0.29747,-0.31041,1,0
1,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.00065623,-0.29797,-0.28073,1,0
1,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.02166,-0.30082,-0.22259,1,0
1,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.016339,-0.30163,-0.25802,1,0
1,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.054842,-0.3025,-0.19271,1,0
1,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.024288,-0.30274,-0.24993,1,0
1,GO OPIOID RECEPTOR SIGNALING PATHWAY,0.0066042,-0.30929,-0.29046,1,0
1,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,1.2962e-05,-0.30994,-0.28925,1,0
1,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.0010206,-0.31081,-0.27148,1,0
1,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,5.753e-07,-0.31348,-0.32019,1,0
1,GO ACROSOME ASSEMBLY,0.00021167,-0.31559,-0.28014,1,0
1,GO REGULATION OF INSULIN SECRETION,2.8891e-07,-0.31633,-0.31576,1,0
1,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.00012074,-0.31635,-0.27792,1,0
1,GO MITOCHONDRION DISTRIBUTION,0.0011199,-0.32165,-0.28559,1,0
1,GO PROTEIN PALMITOYLATION,1.5331e-06,-0.32239,-0.3257,1,0
1,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.00018427,-0.32276,-0.30497,1,0
1,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,4.0073e-05,-0.32504,-0.30835,1,0
1,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.00017186,-0.32543,-0.26138,1,0
1,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,9.0179e-06,-0.32676,-0.29773,1,0
1,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.00020448,-0.32726,-0.25686,1,0
1,GO AROMATIC AMINO ACID TRANSPORT,5.6174e-05,-0.32957,-0.37771,1,0
1,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,7.3528e-06,-0.33155,-0.34934,1,0
1,GO POSITIVE REGULATION OF EXOCYTOSIS,2.0829e-07,-0.3316,-0.34936,1,0
1,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,1.9873e-07,-0.3317,-0.35088,1,0
1,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,0.0018173,-0.332,-0.32423,1,0
1,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.0029794,-0.33301,-0.29765,1,0
1,GO POTASSIUM ION HOMEOSTASIS,2.0833e-05,-0.33354,-0.30524,1,0
1,GO INSULIN SECRETION,9.7275e-08,-0.33443,-0.33808,1,0
1,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.00041602,-0.33498,-0.30858,1,0
1,GO PEPTIDE HORMONE SECRETION,3.6563e-08,-0.33809,-0.34609,1,0
1,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.017549,-0.33891,-0.24592,1,0
1,GO REGULATION OF PEPTIDE HORMONE SECRETION,4.6826e-08,-0.33966,-0.32875,1,0
1,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.011047,-0.33996,-0.31789,1,0
1,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.00022676,-0.3403,-0.30562,1,0
1,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,4.3218e-05,-0.34049,-0.30999,1,0
1,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,9.389e-05,-0.3414,-0.3665,1,0
1,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.0013872,-0.34193,-0.41668,1,0
1,GO LIPID DROPLET FORMATION,0.044685,-0.34251,-0.25589,1,0
1,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.0019282,-0.34283,-0.25177,1,0
1,GO EPITHELIAL STRUCTURE MAINTENANCE,0.00016595,-0.34458,-0.31742,1,0
1,GO ADRENAL GLAND DEVELOPMENT,7.547e-05,-0.34487,-0.38527,1,0
1,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.00037661,-0.34611,-0.36795,1,0
1,GO ASSOCIATIVE LEARNING,5.2533e-07,-0.35167,-0.33136,1,0
1,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.00055855,-0.35206,-0.30488,1,0
1,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,3.3132e-05,-0.35207,-0.38283,1,0
1,GO NEGATIVE REGULATION OF BEHAVIOR,0.00021167,-0.35241,-0.32352,1,0
1,GO TOXIN METABOLIC PROCESS,0.017137,-0.35272,-0.23766,1,0
1,GO GLYCINE TRANSPORT,0.0020453,-0.35375,-0.35312,1,0
1,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.029068,-0.35669,-0.20969,1,0
1,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.00013917,-0.36004,-0.30831,1,0
1,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0041716,-0.36031,-0.30992,1,0
1,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.0028141,-0.36127,-0.25298,1,0
1,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.00087311,-0.36521,-0.31392,1,0
1,GO LEARNING,1.2971e-07,-0.36695,-0.37451,1,0
1,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.0069616,-0.36716,-0.25423,1,0
1,GO N GLYCAN PROCESSING,0.00014418,-0.36795,-0.36797,1,0
1,GO NERVE DEVELOPMENT,1.8251e-06,-0.36885,-0.36665,1,0
1,GO REGULATION OF EXOCYTOSIS,3.479e-08,-0.37292,-0.38057,1,0
1,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.0085714,-0.38302,-0.27735,1,0
1,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.0010528,-0.38318,-0.32258,1,0
1,GO POTASSIUM ION TRANSPORT,2.0038e-08,-0.38401,-0.38145,1,0
1,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.00049035,-0.38459,-0.41904,1,0
1,GO RESPONSE TO DIETARY EXCESS,3.3132e-05,-0.38683,-0.44828,1,0
1,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.0079323,-0.39365,-0.32677,1,0
1,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,2.8077e-06,-0.39569,-0.62677,1,0
1,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,1.5331e-06,-0.39727,-0.45927,1,0
1,GO MRNA SPLICE SITE SELECTION,3.4421e-05,-0.39984,-0.35622,1,0
1,GO TUBULIN DEACETYLATION,0.00049035,-0.40213,-0.3567,1,0
1,GO NEUROTRANSMITTER METABOLIC PROCESS,4.4712e-06,-0.40284,-0.41962,1,0
1,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.0049174,-0.40463,-0.29189,1,0
1,GO FOREBRAIN REGIONALIZATION,0.00016023,-0.40746,-0.38766,1,0
1,GO CELL DIFFERENTIATION IN HINDBRAIN,7.9801e-06,-0.4079,-0.40067,1,0
1,GO CELLULAR SODIUM ION HOMEOSTASIS,2.9532e-05,-0.40927,-0.40706,1,0
1,GO REGULATION OF CELL PROJECTION SIZE,0.00012964,-0.40956,-0.41459,1,0
1,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,2.0033e-05,-0.41172,-0.38605,1,0
1,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,2.2879e-07,-0.41369,-0.40901,1,0
1,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,0.00010092,-0.41413,-0.37986,1,0
1,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,6.0504e-05,-0.41785,-0.4328,1,0
1,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.00081984,-0.41833,-0.45084,1,0
1,GO PHOTORECEPTOR CELL DIFFERENTIATION,3.1904e-06,-0.42006,-0.38689,1,0
1,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.001662,-0.42031,-0.36321,1,0
1,GO NOREPINEPHRINE TRANSPORT,3.5759e-05,-0.42833,-0.34283,1,0
1,GO LUNG EPITHELIUM DEVELOPMENT,0.0062634,-0.43096,-0.29085,1,0
1,GO PARENTAL BEHAVIOR,9.7346e-05,-0.43186,-0.40867,1,0
1,GO DENTATE GYRUS DEVELOPMENT,0.017137,-0.43236,-0.40414,1,0
1,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,3.3202e-07,-0.43391,-0.43702,1,0
1,GO RESPONSE TO INSECTICIDE,2.3418e-05,-0.43913,-0.44401,1,0
1,GO DENDRITIC TRANSPORT,0.0014738,-0.44296,-0.33387,1,0
1,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,5.753e-07,-0.45826,-0.4355,1,0
1,GO REGULATION OF CGMP MEDIATED SIGNALING,0.00016595,-0.46187,-0.47373,1,0
1,GO SUCKLING BEHAVIOR,1.8521e-05,-0.46444,-0.47116,1,0
1,GO OPTIC NERVE DEVELOPMENT,7.2754e-05,-0.46456,-0.43417,1,0
1,GO AMMONIUM ION METABOLIC PROCESS,7.013e-05,-0.46707,-0.4332,1,0
1,GO NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION,4.1112e-06,-0.47445,-0.52508,1,0
1,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,2.7104e-08,-0.47698,-0.58131,1,0
1,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,2.9532e-05,-0.47828,-0.39471,1,0
1,GO REGULATION OF REGULATED SECRETORY PATHWAY,3.1491e-08,-0.48127,-0.4894,1,0
1,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,9.389e-05,-0.48238,-0.5585,1,0
1,GO RELAXATION OF CARDIAC MUSCLE,0.00018427,-0.48574,-0.46279,1,0
1,GO CATECHOLAMINE UPTAKE,2.0833e-05,-0.4908,-0.42194,1,0
1,GO POSTSYNAPSE ASSEMBLY,8.7323e-05,-0.50538,-0.54342,1,0
1,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.0030654,-0.50549,-0.28861,1,0
1,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.0066042,-0.5202,-0.30485,1,0
1,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.0085714,-0.53639,-0.32771,1,0
1,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,4.6826e-08,-0.54163,-0.55565,1,0
1,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,4.5813e-07,-0.55245,-0.52567,1,0
1,GO REGULATION OF NEURON MATURATION,0.0033369,-0.55274,-0.44995,1,0
1,GO RESPONSE TO L GLUTAMATE,0.00010092,-0.55551,-0.5243,1,0
1,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,4.4572e-08,-0.5575,-0.55741,1,0
1,GO NETRIN ACTIVATED SIGNALING PATHWAY,9.389e-05,-0.56394,-0.48834,1,0
1,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,4.1802e-07,-0.56657,-0.52265,1,0
1,GO STABILIZATION OF MEMBRANE POTENTIAL,9.3916e-06,-0.56847,-0.56791,1,0
1,GO RAB PROTEIN SIGNAL TRANSDUCTION,3.6414e-07,-0.5719,-0.54472,1,0
1,GO DOPAMINE METABOLIC PROCESS,9.7275e-08,-0.57283,-0.60057,1,0
1,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.0033369,-0.57476,-0.35626,1,0
1,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,3.0689e-05,-0.57489,-0.4275,1,0
1,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.00087311,-0.57633,-0.48889,1,0
1,GO DETECTION OF CALCIUM ION,2.4346e-05,-0.57858,-0.50939,1,0
1,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.00012512,-0.58977,-0.48359,1,0
1,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,4.3763e-07,-0.59011,-0.54302,1,0
1,GO SECRETORY GRANULE LOCALIZATION,2.0033e-05,-0.59167,-0.69885,1,0
1,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,1.071e-07,-0.59386,-0.64776,1,0
1,GO CGMP METABOLIC PROCESS,5.2533e-07,-0.59435,-0.57822,1,0
1,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,4.5813e-07,-0.59485,-0.5945,1,0
1,GO SIALYLATION,7.889e-07,-0.59769,-0.56458,1,0
1,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.00029782,-0.60146,-0.63441,1,0
1,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,5.7413e-06,-0.60295,-0.58534,1,0
1,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,2.2167e-08,-0.60414,-0.59143,1,0
1,GO PYRAMIDAL NEURON DIFFERENTIATION,0.00023468,-0.60674,-0.61515,1,0
1,GO LUNG CELL DIFFERENTIATION,0.0062634,-0.6138,-0.40734,1,0
1,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,9.0221e-07,-0.61897,-0.65804,1,0
1,GO CATECHOLAMINE METABOLIC PROCESS,1.2366e-07,-0.62089,-0.57744,1,0
1,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.00095906,-0.62189,-0.55188,1,0
1,GO DOPAMINE BIOSYNTHETIC PROCESS,2.3418e-05,-0.62277,-0.74685,1,0
1,GO ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.00069957,-0.62549,-0.5061,1,0
1,GO CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION,3.1904e-06,-0.62931,-0.65034,1,0
1,GO REGULATION OF BILE ACID METABOLIC PROCESS,0.0006154,-0.64208,-0.49874,1,0
1,GO SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL COMMUNICATION,1.4674e-06,-0.65848,-0.58693,1,0
1,GO NEUROEPITHELIAL CELL DIFFERENTIATION,1.2862e-06,-0.66067,-0.58108,1,0
1,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,4.3218e-05,-0.66962,-0.55353,1,0
1,GO REGULATION OF SYNAPSE MATURATION,6.5896e-07,-0.67521,-0.72894,1,0
1,GO RESPONSE TO HISTAMINE,3.0264e-07,-0.69406,-0.73878,1,0
1,GO RESPONSE TO LITHIUM ION,6.4994e-06,-0.70196,-0.58744,1,0
1,GO INHIBITORY SYNAPSE ASSEMBLY,1.071e-07,-0.73148,-0.81,1,0
1,GO THALAMUS DEVELOPMENT,3.17e-07,-0.73371,-0.67937,1,0
1,GO BRANCHING MORPHOGENESIS OF A NERVE,2.1663e-05,-0.73726,-0.69458,1,0
1,GO GAMMA DELTA T CELL DIFFERENTIATION,0.011612,-0.73735,-0.54706,1,0
1,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,5.4977e-07,-0.76512,-0.82679,1,0
1,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,1.6729e-06,-0.78917,-0.74926,1,0
1,GO INNERVATION,2.1831e-07,-0.80254,-0.78225,1,0
1,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,7.889e-07,-0.82162,-0.91258,1,0
1,GO EPITHELIAL CELL FATE COMMITMENT,0.0020453,-0.8366,-0.61812,1,0
1,GO SYNAPSE MATURATION,6.2859e-08,-0.83824,-0.90636,1,0
1,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,9.2696e-08,-0.84741,-0.76864,1,0
1,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,9.3916e-06,-0.85528,-0.77755,1,0
1,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,2.1831e-07,-0.86294,-0.84743,1,0
1,GO SEROTONIN METABOLIC PROCESS,7.5427e-07,-0.88537,-0.73057,1,0
1,GO SYNAPTIC VESICLE PRIMING,2.0038e-08,-0.95648,-0.97903,1,0
1,GO REGULATION OF DENDRITE EXTENSION,6.93e-08,-0.97479,-0.91195,1,0
1,GO DOPAMINE TRANSPORT,4.2424e-08,-0.97561,-0.8942,1,0
1,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,2.7104e-08,-0.97855,-0.96062,1,0
1,GO PROTEIN LOCALIZATION TO AXON,8.8325e-08,-1.0259,-1.1025,1,0
1,GO VESICLE FUSION TO PLASMA MEMBRANE,2.7104e-08,-1.0634,-1.0593,1,0
1,GO SYNAPTIC VESICLE MATURATION,4.1112e-06,-1.1052,-0.92609,1,0
1,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,3.1491e-08,-1.2215,-1.143,1,0
1,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,4.2424e-08,-1.2811,-1.233,1,0
1,GO FOREBRAIN NEURON FATE COMMITMENT,3.9418e-06,-1.3246,-1.1753,1,0
1,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,2.2167e-08,-1.7372,-1.8138,1,0
1,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.060602,0.41193,0.25895,0,1
1,GO ENDOTHELIAL CELL MORPHOGENESIS,0.072231,0.40223,0.23612,0,1
1,GO LAMELLIPODIUM MORPHOGENESIS,0.079444,0.34915,0.22332,0,1
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.099158,0.33887,0.28611,0,1
1,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.059411,0.3342,0.16525,0,1
1,GO ALPHA BETA T CELL PROLIFERATION,0.063042,0.325,0.20443,0,1
1,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.11039,0.32195,0.2729,0,1
1,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.10465,0.3143,0.1514,0,1
1,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.12049,0.31136,0.21904,0,1
1,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.092194,0.31055,0.1567,0,1
1,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.19695,0.29652,0.21442,0,1
1,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.22235,0.29289,0.16052,0,1
1,GO AMYLOID FIBRIL FORMATION,0.093897,0.2873,0.19045,0,1
1,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.060602,0.28694,0.21936,0,1
1,GO FOREBRAIN MORPHOGENESIS,0.060602,0.27352,0.16286,0,1
1,GO PHOSPHOLIPID EFFLUX,0.39371,0.26987,0.16372,0,1
1,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.21905,0.26671,0.15157,0,1
1,GO POSITIVE REGULATION OF VESICLE FUSION,0.15264,0.25322,0.22276,0,1
1,GO PULMONARY VALVE MORPHOGENESIS,0.0695,0.25206,0.36274,0,1
1,GO RESPONSE TO CADMIUM ION,0.088862,0.24916,0.13805,0,1
1,GO REGULATION OF NEURON PROJECTION REGENERATION,0.095625,0.24419,0.12674,0,1
1,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.40843,0.24125,0.10961,0,1
1,GO DISTAL TUBULE DEVELOPMENT,0.10845,0.24006,0.24638,0,1
1,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.084046,0.23911,0.1073,0,1
1,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.076492,0.23573,0.18355,0,1
1,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.22568,0.23379,0.098739,0,1
1,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.097379,0.22947,0.17318,0,1
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.12049,0.22558,0.15651,0,1
1,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.26847,0.22485,0.1034,0,1
1,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.15517,0.22174,0.20303,0,1
1,GO CELLULAR RESPONSE TO CADMIUM ION,0.10845,0.2204,0.18716,0,1
1,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.13355,0.21965,0.12233,0,1
1,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.17099,0.2192,0.12151,0,1
1,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.11235,0.21883,0.13114,0,1
1,GO PROSTATIC BUD FORMATION,0.076492,0.20995,0.22851,0,1
1,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.10096,0.20656,0.11374,0,1
1,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.15517,0.20307,0.14964,0,1
1,GO DNA DEMETHYLATION,0.077957,0.20109,0.14921,0,1
1,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.084046,0.19484,0.28091,0,1
1,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.12473,0.19458,0.17589,0,1
1,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.12259,0.19401,0.19816,0,1
1,GO MEMBRANE BIOGENESIS,0.073629,0.19312,0.15348,0,1
1,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.060602,0.19308,0.1725,0,1
1,GO REGULATION OF MESODERM DEVELOPMENT,0.35607,0.19209,0.1375,0,1
1,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.085627,0.19152,0.18028,0,1
1,GO VITAMIN BIOSYNTHETIC PROCESS,0.13583,0.1911,0.1312,0,1
1,GO DENDRITIC CELL MIGRATION,0.093897,0.18871,0.20045,0,1
1,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.065563,0.18822,0.10552,0,1
1,GO RESPONSE TO REDOX STATE,0.059411,0.18743,0.18289,0,1
1,GO NEURAL CREST CELL MIGRATION,0.076492,0.18637,0.16051,0,1
1,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.061812,0.18596,0.16862,0,1
1,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.31653,0.18435,0.063709,0,1
1,GO POSITIVE REGULATION OF NEURON MIGRATION,0.12908,0.18151,0.11705,0,1
1,GO NEUROINFLAMMATORY RESPONSE,0.11434,0.17636,0.17567,0,1
1,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.060602,0.17607,0.13093,0,1
1,GO ANTIBACTERIAL HUMORAL RESPONSE,0.076492,0.17101,0.11027,0,1
1,GO POSITIVE REGULATION OF WOUND HEALING,0.05824,0.17027,0.19935,0,1
1,GO CYTOPLASM ORGANIZATION,0.21579,0.17008,0.13425,0,1
1,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.16294,0.16989,0.17029,0,1
1,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.14285,0.16919,0.14493,0,1
1,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.088862,0.16799,0.17056,0,1
1,GO GONADOTROPIN SECRETION,0.10465,0.16728,0.17901,0,1
1,GO HINDLIMB MORPHOGENESIS,0.17374,0.16595,0.11482,0,1
1,GO PROTEIN REFOLDING,0.064293,0.1656,0.14354,0,1
1,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.14048,0.16437,0.074453,0,1
1,GO SMOOTHENED SIGNALING PATHWAY,0.077957,0.1621,0.09196,0,1
1,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.059411,0.16131,0.14728,0,1
1,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.060602,0.15887,0.20944,0,1
1,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.064293,0.1575,0.068237,0,1
1,GO KINETOCHORE ASSEMBLY,0.068167,0.15728,0.15909,0,1
1,GO REGULATION OF T CELL MIGRATION,0.084046,0.15274,0.11409,0,1
1,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.15517,0.15187,0.16575,0,1
1,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.087232,0.15166,0.10555,0,1
1,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.05824,0.1501,0.12425,0,1
1,GO MAINTENANCE OF CELL NUMBER,0.092194,0.14971,0.1126,0,1
1,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.10465,0.14861,0.087914,0,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.13355,0.14852,0.13192,0,1
1,GO REGULATION OF STEM CELL PROLIFERATION,0.19393,0.14848,0.083358,0,1
1,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.093897,0.1479,0.08821,0,1
1,GO ENDOCARDIAL CUSHION FORMATION,0.30815,0.14752,0.10553,0,1
1,GO REGULATION OF GONAD DEVELOPMENT,0.8303,0.14709,-0.037448,0,1
1,GO DIOL BIOSYNTHETIC PROCESS,0.090515,0.14374,0.083526,0,1
1,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.077957,0.14359,0.18215,0,1
1,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.095625,0.1435,0.12557,0,1
1,GO EMBRYONIC DIGIT MORPHOGENESIS,0.12049,0.14331,0.10849,0,1
1,GO CORPUS CALLOSUM DEVELOPMENT,0.17099,0.14262,0.10542,0,1
1,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.25363,0.14206,0.097189,0,1
1,GO POSITIVE REGULATION OF CHEMOTAXIS,0.057089,0.142,0.12808,0,1
1,GO SKELETAL SYSTEM MORPHOGENESIS,0.093897,0.14097,0.092651,0,1
1,GO EXTRACELLULAR TRANSPORT,0.15015,0.14052,0.091719,0,1
1,GO TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE REMODELING,0.22905,0.14029,0.091658,0,1
1,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.10845,0.13982,0.1113,0,1
1,GO REGULATION OF MYELINATION,0.079444,0.1394,0.096224,0,1
1,GO RESPONSE TO DRUG,0.061812,0.13912,0.086229,0,1
1,GO ACTIVATED T CELL PROLIFERATION,0.17653,0.13829,0.084253,0,1
1,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.14769,0.13549,0.10545,0,1
1,GO MUSCLE ADAPTATION,0.087232,0.13341,0.08315,0,1
1,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.063042,0.13135,0.10463,0,1
1,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.084046,0.13083,0.084243,0,1
1,GO ENDOTHELIUM DEVELOPMENT,0.53742,0.13006,0.02136,0,1
1,GO GLYCOSIDE METABOLIC PROCESS,0.23245,0.1297,0.064439,0,1
1,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.085627,0.12937,0.089189,0,1
1,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.059411,0.12928,0.19746,0,1
1,GO PIRNA METABOLIC PROCESS,0.38408,0.12242,0.13568,0,1
1,GO SPHINGOID METABOLIC PROCESS,0.082489,0.12236,0.075626,0,1
1,GO POSITIVE REGULATION OF DNA BINDING,0.26471,0.12149,0.070471,0,1
1,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.061812,0.121,0.10523,0,1
1,GO REGULATION OF HISTONE DEACETYLATION,0.063042,0.12055,0.11265,0,1
1,GO REGULATION OF DNA BINDING,0.20309,0.12024,0.048234,0,1
1,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.15517,0.11858,0.089827,0,1
1,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.29184,0.11797,0.079827,0,1
1,GO OOCYTE MATURATION,0.12473,0.11701,0.047668,0,1
1,GO PROTEIN K11 LINKED UBIQUITINATION,0.05824,0.11443,0.098,0,1
1,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.12049,0.1137,0.067782,0,1
1,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.13814,0.11176,0.10607,0,1
1,GO OXIDATIVE PHOSPHORYLATION,0.070855,0.11113,0.10024,0,1
1,GO LEUKOCYTE CHEMOTAXIS,0.097379,0.1106,0.13635,0,1
1,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.097379,0.11036,0.1178,0,1
1,GO NEURAL CREST CELL DIFFERENTIATION,0.16559,0.11007,0.13138,0,1
1,GO POSITIVE REGULATION OF URINE VOLUME,0.16294,0.10891,0.1537,0,1
1,GO INTRACELLULAR LIPID TRANSPORT,0.16294,0.10765,0.082437,0,1
1,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.27227,0.10596,0.04775,0,1
1,GO MESENCHYME MORPHOGENESIS,0.076492,0.10471,0.22771,0,1
1,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.12908,0.10262,0.11172,0,1
1,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.30402,0.1025,0.11949,0,1
1,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.085627,0.10222,0.089957,0,1
1,GO REGULATION OF ATP METABOLIC PROCESS,0.097379,0.1012,0.060006,0,1
1,GO MITOCHONDRIAL DEPOLARIZATION,0.20621,0.10073,0.10856,0,1
1,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.33812,0.099716,0.049527,0,1
1,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.15015,0.0997,0.091903,0,1
1,GO OXALATE TRANSPORT,0.38888,0.099479,0.038065,0,1
1,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.16294,0.098951,0.092195,0,1
1,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.060602,0.098451,0.10374,0,1
1,GO VIRAL LATENCY,0.40843,0.098098,0.04893,0,1
1,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.079444,0.097892,0.060474,0,1
1,GO PROTEIN K48 LINKED UBIQUITINATION,0.072231,0.097866,0.080839,0,1
1,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.17374,0.097647,0.1469,0,1
1,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.090515,0.097376,0.048538,0,1
1,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.41842,0.096707,0.069239,0,1
1,GO ESTABLISHMENT OF CELL POLARITY,0.05824,0.096575,0.070964,0,1
1,GO REGULATION OF PROSTAGLANDIN SECRETION,0.11039,0.096224,0.11535,0,1
1,GO TUMOR NECROSIS FACTOR SECRETION,0.11636,0.095473,0.13829,0,1
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.43367,0.093966,0.049128,0,1
1,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.16294,0.093787,0.13103,0,1
1,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.066855,0.093447,0.088101,0,1
1,GO NEGATIVE REGULATION OF DNA BINDING,0.4598,0.092844,0.018005,0,1
1,GO G2 DNA DAMAGE CHECKPOINT,0.064293,0.092293,0.094872,0,1
1,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.085627,0.091779,0.13204,0,1
1,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.12049,0.090769,0.13267,0,1
1,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.05824,0.09053,0.096407,0,1
1,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.059411,0.089788,0.078112,0,1
1,GO EPITHELIAL TUBE FORMATION,0.073629,0.089452,0.10796,0,1
1,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.064293,0.088713,0.16383,0,1
1,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.27227,0.088084,0.12692,0,1
1,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.080955,0.088072,0.1242,0,1
1,GO ACTIVATION OF GTPASE ACTIVITY,0.090515,0.087618,0.086001,0,1
1,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.40843,0.087564,0.038645,0,1
1,GO REGULATION OF GLIAL CELL MIGRATION,0.085627,0.087243,0.12075,0,1
1,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.26847,0.086746,0.039843,0,1
1,GO REGULATION OF CYTOKINESIS,0.15773,0.086203,0.052527,0,1
1,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.0695,0.086015,0.062935,0,1
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.10465,0.085813,0.10052,0,1
1,GO ERYTHROCYTE DEVELOPMENT,0.060602,0.084779,0.11083,0,1
1,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.16559,0.083051,0.089985,0,1
1,GO KERATINOCYTE DIFFERENTIATION,0.20621,0.082897,0.12547,0,1
1,GO POSITIVE REGULATION OF DNA REPLICATION,0.22905,0.082826,0.060013,0,1
1,GO P BODY ASSEMBLY,0.36526,0.081734,0.040387,0,1
1,GO HISTONE EXCHANGE,0.18219,0.079686,0.072961,0,1
1,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.095625,0.079326,0.087593,0,1
1,GO MULTI ORGANISM PROCESS,0.05824,0.079298,0.03715,0,1
1,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.092194,0.076329,0.062715,0,1
1,GO MEIOTIC CHROMOSOME SEGREGATION,0.13583,0.075769,0.098304,0,1
1,GO NODAL SIGNALING PATHWAY,0.47049,0.075604,0.049171,0,1
1,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.075049,0.074679,0.068497,0,1
1,GO ACTIN FILAMENT BASED PROCESS,0.088862,0.073892,0.075325,0,1
1,GO MAINTENANCE OF ORGANELLE LOCATION,0.41341,0.073687,0.049005,0,1
1,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.22905,0.073294,0.053203,0,1
1,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.35153,0.073171,0.03946,0,1
1,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.17934,0.072883,0.10567,0,1
1,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.38888,0.072355,0.0085551,0,1
1,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.082489,0.072316,0.070803,0,1
1,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.11434,0.069717,0.082448,0,1
1,GO MACROMOLECULE DEACYLATION,0.082489,0.069533,0.056305,0,1
1,GO SPINDLE ASSEMBLY,0.085627,0.067873,0.065653,0,1
1,GO NEUTROPHIL CHEMOTAXIS,0.25001,0.067281,0.15818,0,1
1,GO MRNA PROCESSING,0.11434,0.065998,0.055544,0,1
1,GO RNA SPLICING,0.097379,0.065347,0.054364,0,1
1,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.20309,0.064721,0.074155,0,1
1,GO RESPONSE TO LEAD ION,0.19393,0.064649,0.079278,0,1
1,GO REGULATION OF CELL DIVISION,0.097379,0.064538,0.067459,0,1
1,GO PEPTIDYL LYSINE TRIMETHYLATION,0.19095,0.063454,0.056505,0,1
1,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.69061,0.062392,0.027247,0,1
1,GO PROTEIN LOCALIZATION TO MEMBRANE,0.095625,0.061591,0.039602,0,1
1,GO DNA CONFORMATION CHANGE,0.11434,0.06145,0.06017,0,1
1,GO CALCINEURIN MEDIATED SIGNALING,0.39371,0.060444,0.049805,0,1
1,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.13355,0.058099,0.063091,0,1
1,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.12908,0.056697,0.088366,0,1
1,GO ERROR FREE TRANSLESION SYNTHESIS,0.24643,0.054493,0.02887,0,1
1,GO MEGAKARYOCYTE DIFFERENTIATION,0.076492,0.05399,0.085456,0,1
1,GO POSITIVE REGULATION OF CELL DIVISION,0.48678,0.051367,0.066423,0,1
1,GO REGULATION OF ORGANELLE ORGANIZATION,0.11039,0.050787,0.036229,0,1
1,GO NEGATIVE REGULATION OF GROWTH,0.36526,0.050453,0.033829,0,1
1,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.12473,0.049102,0.058112,0,1
1,GO HISTONE H3 ACETYLATION,0.52025,0.044558,0.019188,0,1
1,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.25001,0.042814,0.026217,0,1
1,GO RESPONSE TO ZINC ION,0.63354,0.03988,0.028093,0,1
1,GO ORGANELLE ASSEMBLY,0.11636,0.038501,0.041617,0,1
1,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.36064,0.037533,0.014345,0,1
1,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.079444,0.036016,0.063086,0,1
1,GO POSITIVE REGULATION OF DNA REPAIR,0.53167,0.02608,0.023955,0,1
1,GO REGULATION OF CHROMOSOME ORGANIZATION,0.26847,0.022111,0.036289,0,1
1,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,3.4728e-06,0.68038,0.55859,0,0
1,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.00027832,0.47262,0.52067,0,0
1,GO ETHANOL OXIDATION,0.010773,0.46201,0.42618,0,0
1,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.036948,0.3731,0.26486,0,0
1,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.019739,0.34296,0.22206,0,0
1,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.00054072,0.34043,0.39602,0,0
1,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.16294,0.332,0.1965,0,0
1,GO NADPH REGENERATION,0.00023468,0.32921,0.32807,0,0
1,GO HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.012508,0.32783,0.18983,0,0
1,GO PSEUDOURIDINE SYNTHESIS,0.0029794,0.32629,0.27505,0,0
1,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.00098941,0.32141,0.27787,0,0
1,GO HOMOCYSTEINE METABOLIC PROCESS,0.0047853,0.3163,0.26792,0,0
1,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.060602,0.31133,0.25049,0,0
1,GO REGULATION OF ANOIKIS,0.014486,0.30642,0.25908,0,0
1,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.065563,0.30232,0.27884,0,0
1,GO DIVALENT INORGANIC ANION HOMEOSTASIS,0.0019282,0.29653,0.35974,0,0
1,GO PHAGOCYTOSIS RECOGNITION,0.0017641,0.28992,0.45696,0,0
1,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.022165,0.28801,0.27567,0,0
1,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.0031536,0.28535,0.26584,0,0
1,GO CELLULAR HYPEROSMOTIC RESPONSE,0.001872,0.28063,0.30361,0,0
1,GO FIBROBLAST ACTIVATION,0.00045924,0.27951,0.3285,0,0
1,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.0073363,0.27946,0.27424,0,0
1,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.11434,0.27628,0.17399,0,0
1,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.017137,0.27466,0.33889,0,0
1,GO HEPARIN METABOLIC PROCESS,0.027803,0.2716,0.29507,0,0
1,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.011612,0.27014,0.32429,0,0
1,GO RENAL VESICLE DEVELOPMENT,0.17374,0.2689,0.12103,0,0
1,GO INOSITOL TRISPHOSPHATE METABOLIC PROCESS,0.085627,0.26736,0.18773,0,0
1,GO GTP METABOLIC PROCESS,0.00016023,0.26495,0.30332,0,0
1,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.093897,0.26481,0.18409,0,0
1,GO POSITIVE REGULATION OF RESPONSE TO TUMOR CELL,0.0050528,0.25869,0.24961,0,0
1,GO TYPE B PANCREATIC CELL APOPTOTIC PROCESS,0.15015,0.25783,0.13008,0,0
1,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.29184,0.25468,0.17915,0,0
1,GO EOSINOPHIL CHEMOTAXIS,0.11235,0.25318,0.264,0,0
1,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.093897,0.25216,0.25893,0,0
1,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.0013457,0.24951,0.27919,0,0
1,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.0090226,0.24815,0.42178,0,0
1,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.055956,0.24698,0.20707,0,0
1,GO CARDIOLIPIN METABOLIC PROCESS,0.021165,0.24609,0.16619,0,0
1,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.4978,0.24453,0.18126,0,0
1,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0066042,0.24263,0.22718,0,0
1,GO OXYGEN TRANSPORT,0.54903,0.24068,0.061542,0,0
1,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.12259,0.23959,0.11511,0,0
1,GO NUCLEOTIDE SALVAGE,0.16032,0.23881,0.22153,0,0
1,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.0087944,0.23816,0.18695,0,0
1,GO DNA LIGATION,0.00052342,0.23713,0.27782,0,0
1,GO TETRAHYDROFOLATE INTERCONVERSION,0.001662,0.23605,0.27352,0,0
1,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,2.2524e-05,0.23516,0.23655,0,0
1,GO MITOCHONDRIAL DNA REPLICATION,0.00021167,0.23492,0.212,0,0
1,GO AMINE CATABOLIC PROCESS,0.0042883,0.23235,0.3154,0,0
1,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.0081404,0.23089,0.20731,0,0
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.036164,0.22958,0.1896,0,0
1,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.0695,0.22893,0.2468,0,0
1,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.065563,0.22858,0.15446,0,0
1,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.063042,0.22758,0.31901,0,0
1,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.10654,0.22268,0.23378,0,0
1,GO TRACHEA DEVELOPMENT,0.0060989,0.22186,0.25064,0,0
1,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.092194,0.22149,0.3215,0,0
1,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.027803,0.22001,0.28225,0,0
1,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.010506,0.21959,0.15011,0,0
1,GO PROTEIN LOCALIZATION TO LYSOSOME,0.02068,0.21887,0.13165,0,0
1,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.0075304,0.21479,0.31537,0,0
1,GO LYSINE METABOLIC PROCESS,0.23589,0.21475,0.14096,0,0
1,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.024288,0.21399,0.17266,0,0
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.00072223,0.21373,0.22192,0,0
1,GO P38MAPK CASCADE,0.00020448,0.21368,0.30899,0,0
1,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.0049174,0.21338,0.20503,0,0
1,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.15015,0.21298,0.20731,0,0
1,GO CYTOCHROME COMPLEX ASSEMBLY,0.0099891,0.21289,0.17529,0,0
1,GO REGULATION OF BMP SIGNALING PATHWAY,0.0099891,0.21284,0.2039,0,0
1,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.0053338,0.21259,0.15341,0,0
1,GO AMP METABOLIC PROCESS,0.084046,0.21059,0.21869,0,0
1,GO CELL JUNCTION DISASSEMBLY,0.11636,0.20878,0.11902,0,0
1,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.15015,0.20829,0.15969,0,0
1,GO CELLULAR OXIDANT DETOXIFICATION,0.0041716,0.20594,0.16376,0,0
1,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.24288,0.20562,0.17641,0,0
1,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.014841,0.2033,0.11387,0,0
1,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.001872,0.20253,0.17793,0,0
1,GO AMINO ACID ACTIVATION,0.010773,0.20154,0.18666,0,0
1,GO NEGATIVE REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS,0.099158,0.2003,0.23693,0,0
1,GO GENITALIA MORPHOGENESIS,0.02268,0.20029,0.25234,0,0
1,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.11039,0.19944,0.18953,0,0
1,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.14769,0.1983,0.21909,0,0
1,GO SCHWANN CELL DIFFERENTIATION,0.00095906,0.19785,0.18836,0,0
1,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.0094949,0.19532,0.15943,0,0
1,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.0695,0.19424,0.11775,0,0
1,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.0695,0.19389,0.1875,0,0
1,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.00079435,0.19376,0.21149,0,0
1,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.017137,0.19226,0.1634,0,0
1,GO PROTEIN LOCALIZATION TO EARLY ENDOSOME,0.092194,0.19145,0.24011,0,0
1,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.14526,0.1908,0.12496,0,0
1,GO FIBROBLAST APOPTOTIC PROCESS,0.036948,0.19003,0.19438,0,0
1,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.057089,0.18999,0.1689,0,0
1,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.014138,0.18903,0.25948,0,0
1,GO PEPTIDYL ARGININE MODIFICATION,0.0013457,0.18864,0.14099,0,0
1,GO ALDITOL PHOSPHATE METABOLIC PROCESS,0.061812,0.18793,0.16068,0,0
1,GO POSITIVE REGULATION OF CELL KILLING,0.080955,0.18737,0.11551,0,0
1,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.055956,0.18614,0.23124,0,0
1,GO REGULATION OF TRANSLATIONAL FIDELITY,0.12689,0.18382,0.079451,0,0
1,GO ALDITOL METABOLIC PROCESS,0.0016129,0.18344,0.22669,0,0
1,GO ANOIKIS,0.10096,0.18169,0.13985,0,0
1,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.34702,0.18147,0.075088,0,0
1,GO NUCLEUS LOCALIZATION,0.092194,0.17989,0.11181,0,0
1,GO GAS TRANSPORT,0.23589,0.17923,0.1148,0,0
1,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.077957,0.17813,0.19538,0,0
1,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.44924,0.17709,0.074124,0,0
1,GO ATRIAL SEPTUM MORPHOGENESIS,0.32506,0.17646,0.12862,0,0
1,GO NEGATIVE REGULATION OF ANOIKIS,0.070855,0.1764,0.22748,0,0
1,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.15264,0.17607,0.10952,0,0
1,GO BLASTOCYST FORMATION,0.0011199,0.17525,0.1667,0,0
1,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.0069616,0.17506,0.12361,0,0
1,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.073629,0.17493,0.24093,0,0
1,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.188,0.17386,0.13065,0,0
1,GO TRANSEPITHELIAL TRANSPORT,0.0025083,0.17223,0.1703,0,0
1,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.49227,0.17193,0.1325,0,0
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.0023671,0.17184,0.14995,0,0
1,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.40349,0.17131,0.11772,0,0
1,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.093897,0.17121,0.1818,0,0
1,GO PROTEIN DEMANNOSYLATION,0.064293,0.17118,0.13708,0,0
1,GO PEPTIDYL METHIONINE MODIFICATION,0.00353,0.17057,0.16036,0,0
1,GO ANION HOMEOSTASIS,0.068167,0.16967,0.10071,0,0
1,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.034637,0.16923,0.1531,0,0
1,GO INTERMEMBRANE LIPID TRANSFER,0.0028957,0.16847,0.15618,0,0
1,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.25001,0.16732,0.24378,0,0
1,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.10096,0.16699,0.092313,0,0
1,GO PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER,0.0069616,0.16669,0.20373,0,0
1,GO RESPONSE TO UV C,0.0059384,0.16649,0.24093,0,0
1,GO LAMELLIPODIUM ORGANIZATION,0.00059588,0.16612,0.21196,0,0
1,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.023205,0.16504,0.14342,0,0
1,GO IMP METABOLIC PROCESS,0.20937,0.16486,0.11547,0,0
1,GO PEPTIDYL ARGININE N METHYLATION,0.090515,0.16317,0.12134,0,0
1,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.21256,0.16317,0.08039,0,0
1,GO SYNAPTIC GROWTH AT NEUROMUSCULAR JUNCTION,0.41842,0.16258,0.072994,0,0
1,GO RNA DECAPPING,0.0022992,0.16082,0.17221,0,0
1,GO MYOBLAST PROLIFERATION,0.20309,0.16006,0.090993,0,0
1,GO TRICARBOXYLIC ACID CYCLE,0.28785,0.16002,0.047788,0,0
1,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.001662,0.15995,0.19005,0,0
1,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.16559,0.15927,0.092554,0,0
1,GO COPII COATED VESICLE CARGO LOADING,0.0016129,0.15842,0.17982,0,0
1,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.064293,0.15699,0.094083,0,0
1,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.20309,0.15627,0.067445,0,0
1,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.041967,0.15579,0.16047,0,0
1,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.013798,0.15539,0.15424,0,0
1,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.031059,0.15504,0.12782,0,0
1,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.020205,0.15472,0.2356,0,0
1,GO POLYSACCHARIDE CATABOLIC PROCESS,0.016734,0.15433,0.13174,0,0
1,GO HEART TRABECULA FORMATION,0.34702,0.15432,0.12699,0,0
1,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.079444,0.15422,0.1738,0,0
1,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.0029794,0.15414,0.13716,0,0
1,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.17099,0.15365,0.23814,0,0
1,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.049546,0.15161,0.13139,0,0
1,GO FUCOSE METABOLIC PROCESS,0.188,0.15131,0.078698,0,0
1,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.031748,0.15088,0.15772,0,0
1,GO ACTIVATION OF JNKK ACTIVITY,0.023205,0.1507,0.15431,0,0
1,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.31653,0.15012,0.066179,0,0
1,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.041093,0.15001,0.16727,0,0
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.011326,0.1499,0.17985,0,0
1,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.0023671,0.14963,0.1421,0,0
1,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.037747,0.14949,0.21522,0,0
1,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.22235,0.14927,0.036279,0,0
1,GO LAMELLIPODIUM ASSEMBLY,0.0025083,0.14892,0.16976,0,0
1,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.018398,0.1488,0.17522,0,0
1,GO NEPHRIC DUCT MORPHOGENESIS,0.98953,0.14849,0.023352,0,0
1,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.33812,0.14833,0.055103,0,0
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.013798,0.148,0.18279,0,0
1,GO MALE GENITALIA DEVELOPMENT,0.21905,0.14772,0.076335,0,0
1,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.055956,0.14725,0.15416,0,0
1,GO PROTEIN LOCALIZATION TO CELL CORTEX,0.036164,0.1464,0.20162,0,0
1,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.14048,0.14633,0.077204,0,0
1,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.04854,0.14566,0.14632,0,0
1,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.1313,0.14564,0.098494,0,0
1,GO GOLGI LOCALIZATION,0.30815,0.14502,0.10003,0,0
1,GO TRNA CATABOLIC PROCESS,0.12908,0.14498,0.20929,0,0
1,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.0054795,0.14453,0.13341,0,0
1,GO PEPTIDYL ARGININE METHYLATION,0.066855,0.14385,0.11717,0,0
1,GO MORPHOGENESIS OF AN EPITHELIUM,0.00084609,0.14297,0.159,0,0
1,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.19695,0.14292,0.080998,0,0
1,GO NAD BIOSYNTHETIC PROCESS,0.12689,0.14261,0.14757,0,0
1,GO AMYLOID BETA FORMATION,0.15015,0.1423,0.095318,0,0
1,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.188,0.14222,0.070896,0,0
1,GO HEART VALVE DEVELOPMENT,0.022165,0.14185,0.19389,0,0
1,GO RENAL FILTRATION,0.11039,0.14166,0.16041,0,0
1,GO LIVER MORPHOGENESIS,0.092194,0.1414,0.15212,0,0
1,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.11434,0.14132,0.16214,0,0
1,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.077957,0.14105,0.21142,0,0
1,GO REGULATION OF HAIR CYCLE,0.17653,0.14064,0.13672,0,0
1,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.31232,0.14003,0.20093,0,0
1,GO NEGATIVE REGULATION OF AUTOPHAGY,0.015953,0.13972,0.11435,0,0
1,GO ERYTHROCYTE MATURATION,0.011326,0.13963,0.2281,0,0
1,GO MIDGUT DEVELOPMENT,0.35607,0.13942,0.10059,0,0
1,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.22235,0.13941,0.073962,0,0
1,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.011326,0.13865,0.11991,0,0
1,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.070855,0.13864,0.13109,0,0
1,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.018836,0.13839,0.13773,0,0
1,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.0062634,0.13836,0.15839,0,0
1,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.78962,0.13815,0.12549,0,0
1,GO SECRETION BY TISSUE,0.05824,0.13811,0.16183,0,0
1,GO ISOPRENOID METABOLIC PROCESS,0.11841,0.13773,0.094797,0,0
1,GO GLUCOCORTICOID METABOLIC PROCESS,0.079444,0.13712,0.13276,0,0
1,GO REGULATION OF TISSUE REMODELING,0.090515,0.13683,0.079815,0,0
1,GO MONOSACCHARIDE CATABOLIC PROCESS,0.12908,0.13647,0.067541,0,0
1,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.25729,0.1363,0.035093,0,0
1,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.029719,0.13597,0.21114,0,0
1,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.3746,0.13591,0.0081117,0,0
1,GO STEROL HOMEOSTASIS,0.064293,0.1357,0.085561,0,0
1,GO XENOBIOTIC TRANSPORT,0.059411,0.13563,0.15667,0,0
1,GO REGULATION OF PROTON TRANSPORT,0.017137,0.13498,0.16853,0,0
1,GO STEROID ESTERIFICATION,0.20309,0.13444,0.11831,0,0
1,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.073629,0.1343,0.14386,0,0
1,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.03939,0.13373,0.15506,0,0
1,GO REGULATION OF CELLULAR RESPIRATION,0.23937,0.13316,0.076311,0,0
1,GO PURINE CONTAINING COMPOUND SALVAGE,0.29184,0.13289,0.071417,0,0
1,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.064293,0.13287,0.10055,0,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.029068,0.13238,0.20867,0,0
1,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.23245,0.13213,0.16109,0,0
1,GO EPITHELIAL CELL PROLIFERATION,0.0087944,0.13195,0.15454,0,0
1,GO SPHINGOMYELIN METABOLIC PROCESS,0.088862,0.13152,0.094712,0,0
1,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.12049,0.13118,0.079119,0,0
1,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.065563,0.13109,0.2054,0,0
1,GO RESPONSE TO VITAMIN A,0.16294,0.13041,0.093519,0,0
1,GO L PHENYLALANINE METABOLIC PROCESS,0.14769,0.13027,0.082352,0,0
1,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.00084609,0.13015,0.11845,0,0
1,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,0.31232,0.12957,0.1483,0,0
1,GO MIRNA METABOLIC PROCESS,0.0051916,0.12895,0.14777,0,0
1,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.39858,0.12882,0.044973,0,0
1,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.53742,0.12746,0.030575,0,0
1,GO CARBOHYDRATE DERIVATIVE TRANSPORT,0.22905,0.12745,0.057169,0,0
1,GO CORONARY VASCULATURE MORPHOGENESIS,0.24643,0.12696,0.17029,0,0
1,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.17934,0.1269,0.10192,0,0
1,GO LIPID DIGESTION,0.39858,0.12679,0.031475,0,0
1,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.44924,0.12665,0.12184,0,0
1,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.64605,0.12662,0.023771,0,0
1,GO RESPONSE TO INTERLEUKIN 6,0.11636,0.12644,0.094975,0,0
1,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.40349,0.12625,0.10492,0,0
1,GO REVERSE CHOLESTEROL TRANSPORT,0.42347,0.12519,0.051,0,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.22905,0.12493,0.12709,0,0
1,GO INTRACELLULAR STEROL TRANSPORT,0.4598,0.12487,0.037956,0,0
1,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.001662,0.12466,0.11995,0,0
1,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.31232,0.12441,0.1492,0,0
1,GO REGULATION OF TELOMERASE ACTIVITY,0.025414,0.1244,0.1242,0,0
1,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.12259,0.12407,0.049201,0,0
1,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.11039,0.12344,0.13265,0,0
1,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.073629,0.1229,0.10511,0,0
1,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.00353,0.12281,0.19913,0,0
1,GO AMYLOID BETA METABOLIC PROCESS,0.12908,0.12281,0.087512,0,0
1,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.89907,0.12192,-0.047936,0,0
1,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.8303,0.12161,-0.0078757,0,0
1,GO PROTEIN KINASE C SIGNALING,0.68418,0.12136,-0.024001,0,0
1,GO NEGATIVE REGULATION OF STEROL TRANSPORT,0.24643,0.12135,0.068799,0,0
1,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.13355,0.12126,0.099338,0,0
1,GO INACTIVATION OF MAPK ACTIVITY,0.40843,0.12098,0.10332,0,0
1,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.23589,0.12093,0.10753,0,0
1,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.13583,0.12067,0.092851,0,0
1,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.11841,0.12067,0.15325,0,0
1,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.19095,0.12055,0.038641,0,0
1,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.0030654,0.11959,0.16641,0,0
1,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.043763,0.11942,0.11195,0,0
1,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.11235,0.11942,0.17932,0,0
1,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.29586,0.11936,0.17549,0,0
1,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.36526,0.11901,0.12839,0,0
1,GO REGULATION OF AMYLOID BETA FORMATION,0.20937,0.11856,0.089796,0,0
1,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.035393,0.11851,0.075327,0,0
1,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.00052342,0.11811,0.13536,0,0
1,GO INTERMEDIATE FILAMENT ORGANIZATION,0.38408,0.11811,0.091267,0,0
1,GO B CELL PROLIFERATION,0.46512,0.11791,0.020309,0,0
1,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.099158,0.11742,0.13302,0,0
1,GO COLLECTING DUCT DEVELOPMENT,0.26471,0.1169,0.092997,0,0
1,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.0097392,0.11685,0.17775,0,0
1,GO REGULATION OF GASTRIC ACID SECRETION,0.12049,0.11669,0.18358,0,0
1,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.068167,0.11661,0.096902,0,0
1,GO MITOTIC CELL CYCLE ARREST,0.26471,0.11614,0.082862,0,0
1,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.53742,0.11587,0.10076,0,0
1,GO MRNA CLEAVAGE,0.00047456,0.11584,0.13511,0,0
1,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.026586,0.11536,0.11716,0,0
1,GO DORSAL VENTRAL AXIS SPECIFICATION,0.53742,0.11524,0.16097,0,0
1,GO MITOTIC DNA REPLICATION CHECKPOINT,0.092194,0.11476,0.1003,0,0
1,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.61497,0.1145,0.010297,0,0
1,GO NAD METABOLIC PROCESS,0.20621,0.11402,0.093738,0,0
1,GO HEXOSE CATABOLIC PROCESS,0.26471,0.11391,0.039846,0,0
1,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.62113,0.11386,0.0082855,0,0
1,GO RESPONSE TO ATP,0.05161,0.11372,0.091854,0,0
1,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.041093,0.11358,0.14163,0,0
1,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.087232,0.11304,0.12292,0,0
1,GO TRICARBOXYLIC ACID METABOLIC PROCESS,0.56075,0.11288,0.020452,0,0
1,GO REGULATION OF LIPID KINASE ACTIVITY,0.0031536,0.1128,0.14721,0,0
1,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.1028,0.11218,0.18515,0,0
1,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.23589,0.11182,0.072493,0,0
1,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.019283,0.1118,0.078868,0,0
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.0054795,0.11127,0.08802,0,0
1,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.0695,0.11125,0.085282,0,0
1,GO LIPOPROTEIN CATABOLIC PROCESS,0.32506,0.11109,0.064158,0,0
1,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.32077,0.11106,0.0385,0,0
1,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.41341,0.11101,0.045982,0,0
1,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.25363,0.11088,0.11656,0,0
1,GO FOLIC ACID METABOLIC PROCESS,0.21579,0.11081,0.05906,0,0
1,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.084046,0.10984,0.13103,0,0
1,GO CELLULAR PIGMENTATION,0.070855,0.10983,0.095223,0,0
1,GO RESPONSE TO HYDROPEROXIDE,0.43883,0.10974,0.10942,0,0
1,GO COENZYME A METABOLIC PROCESS,0.16828,0.10957,0.090251,0,0
1,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.91987,0.10919,-0.0026485,0,0
1,GO LIPID HOMEOSTASIS,0.072231,0.10914,0.053855,0,0
1,GO INTERLEUKIN 6 PRODUCTION,0.19393,0.10912,0.099911,0,0
1,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.30402,0.10896,0.094167,0,0
1,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.4545,0.10889,0.065975,0,0
1,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.14769,0.10865,0.069804,0,0
1,GO NEGATIVE REGULATION OF CELL DIVISION,0.43883,0.10827,0.043485,0,0
1,GO LATERAL VENTRICLE DEVELOPMENT,0.12908,0.10817,0.1568,0,0
1,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.55487,0.10794,0.016468,0,0
1,GO ENGULFMENT OF APOPTOTIC CELL,0.50896,0.10788,0.021627,0,0
1,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.26471,0.10762,0.11719,0,0
1,GO REGULATION OF MAST CELL ACTIVATION,0.075049,0.10746,0.14638,0,0
1,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.12689,0.10728,0.11014,0,0
1,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.040234,0.10721,0.20214,0,0
1,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.49227,0.1071,0.02541,0,0
1,GO ICOSANOID BIOSYNTHETIC PROCESS,0.26847,0.10708,0.085526,0,0
1,GO GLIAL CELL MIGRATION,0.11039,0.10696,0.11795,0,0
1,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.0021062,0.10688,0.12405,0,0
1,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.045624,0.10673,0.12143,0,0
1,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.068167,0.10664,0.084585,0,0
1,GO PROSTATE GLAND MORPHOGENESIS,0.44924,0.10644,0.14728,0,0
1,GO ER NUCLEUS SIGNALING PATHWAY,0.41341,0.10603,0.040547,0,0
1,GO PERICARDIUM DEVELOPMENT,0.018836,0.1051,0.18255,0,0
1,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.11235,0.10509,0.073363,0,0
1,GO VITAMIN D METABOLIC PROCESS,0.19393,0.10499,0.14436,0,0
1,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.27999,0.10419,0.086629,0,0
1,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.59664,0.104,0.038811,0,0
1,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.029068,0.10385,0.1607,0,0
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.40843,0.10379,0.093473,0,0
1,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.27227,0.10369,0.11517,0,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.040234,0.10344,0.09283,0,0
1,GO HISTONE ARGININE METHYLATION,0.23937,0.10344,0.063469,0,0
1,GO CARNITINE SHUTTLE,0.080955,0.10325,0.13615,0,0
1,GO HYALURONAN BIOSYNTHETIC PROCESS,0.076492,0.10318,0.18722,0,0
1,GO FAT CELL DIFFERENTIATION,0.061812,0.10288,0.074778,0,0
1,GO OVULATION CYCLE PROCESS,0.33812,0.10287,0.061378,0,0
1,GO MINERALOCORTICOID METABOLIC PROCESS,0.33812,0.10201,0.11771,0,0
1,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.055956,0.10177,0.1531,0,0
1,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.060602,0.1012,0.11275,0,0
1,GO LYTIC VACUOLE ORGANIZATION,0.33812,0.10115,0.023447,0,0
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.077957,0.10106,0.16581,0,0
1,GO PYRUVATE METABOLIC PROCESS,0.60883,0.10073,0.021272,0,0
1,GO REGULATION OF BONE MINERALIZATION,0.10465,0.10064,0.15114,0,0
1,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.4545,0.1004,0.084037,0,0
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.010506,0.10039,0.11162,0,0
1,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.30815,0.10012,0.053152,0,0
1,GO PROTEOGLYCAN METABOLIC PROCESS,0.18508,0.099761,0.12163,0,0
1,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.21579,0.099475,0.11772,0,0
1,GO NEGATIVE REGULATION OF JNK CASCADE,0.0695,0.099273,0.094612,0,0
1,GO THIOESTER METABOLIC PROCESS,0.14048,0.098845,0.084558,0,0
1,GO REGULATION OF FATTY ACID OXIDATION,0.41842,0.098392,0.05411,0,0
1,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.32506,0.098194,0.082305,0,0
1,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.13814,0.098172,0.13599,0,0
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.15517,0.098147,0.061917,0,0
1,GO CELLULAR RESPONSE TO CHOLESTEROL,0.11636,0.097964,0.16073,0,0
1,GO RESPONSE TO PH,0.11841,0.097757,0.12936,0,0
1,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.05161,0.09767,0.10372,0,0
1,GO HEAD MORPHOGENESIS,0.027803,0.09765,0.19853,0,0
1,GO PROTEIN SUMOYLATION,0.070855,0.097258,0.077201,0,0
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.30402,0.097206,0.066392,0,0
1,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.038561,0.096924,0.18568,0,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.38888,0.096612,0.08061,0,0
1,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.11841,0.096533,0.11077,0,0
1,GO HEART TRABECULA MORPHOGENESIS,0.19393,0.096442,0.092383,0,0
1,GO RESPONSE TO STEROL,0.16828,0.096247,0.090676,0,0
1,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.15773,0.095992,0.097088,0,0
1,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.24643,0.095923,0.035807,0,0
1,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.020205,0.095801,0.098729,0,0
1,GO GOLGI RIBBON FORMATION,0.14769,0.094949,0.13018,0,0
1,GO MANGANESE ION TRANSPORT,0.20621,0.094835,0.10797,0,0
1,GO RESPONSE TO GONADOTROPIN,0.073629,0.094305,0.17135,0,0
1,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.88523,0.094148,-0.020881,0,0
1,GO OUTFLOW TRACT MORPHOGENESIS,0.049546,0.093943,0.1875,0,0
1,GO B CELL APOPTOTIC PROCESS,0.61497,0.093761,0.010643,0,0
1,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.0075304,0.09351,0.16721,0,0
1,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.34702,0.093484,0.055968,0,0
1,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.28785,0.093319,0.096336,0,0
1,GO COCHLEA MORPHOGENESIS,0.81668,0.093287,-0.030358,0,0
1,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.22235,0.09226,0.051114,0,0
1,GO INTESTINAL LIPID ABSORPTION,0.29184,0.092128,0.058082,0,0
1,GO DNA REPLICATION INITIATION,0.20309,0.091601,0.050706,0,0
1,GO RESPONSE TO NUTRIENT,0.25729,0.091502,0.069098,0,0
1,GO REGULATION OF B CELL DIFFERENTIATION,0.63354,0.091295,0.070403,0,0
1,GO REGULATION OF WATER LOSS VIA SKIN,0.59059,0.091265,0.051567,0,0
1,GO PHOSPHOLIPID HOMEOSTASIS,0.16559,0.091144,0.13921,0,0
1,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.56666,0.091008,0.022032,0,0
1,GO REGULATION OF B CELL PROLIFERATION,0.66501,0.090847,-0.0054981,0,0
1,GO PIGMENT CELL DIFFERENTIATION,0.43883,0.090835,0.065249,0,0
1,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.20937,0.090624,0.099583,0,0
1,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.22905,0.090181,0.036125,0,0
1,GO POSITIVE REGULATION OF OSSIFICATION,0.21579,0.08995,0.1073,0,0
1,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.11039,0.089624,0.27644,0,0
1,GO REGULATION OF CENTROSOME CYCLE,0.0042883,0.089521,0.12041,0,0
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.0014738,0.089227,0.11481,0,0
1,GO FATTY ACID HOMEOSTASIS,0.35607,0.088891,0.054387,0,0
1,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.48678,0.088799,0.040277,0,0
1,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.12049,0.088764,0.069994,0,0
1,GO RETROGRADE AXONAL TRANSPORT,0.7495,0.08859,-0.019931,0,0
1,GO T CELL LINEAGE COMMITMENT,0.027188,0.088542,0.13023,0,0
1,GO MYELIN MAINTENANCE,0.56075,0.088396,0.046495,0,0
1,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.041967,0.088203,0.11796,0,0
1,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.057089,0.087934,0.37584,0,0
1,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.050569,0.087566,0.12632,0,0
1,GO RESPONSE TO VITAMIN,0.46512,0.087443,0.07684,0,0
1,GO GLIAL CELL DEVELOPMENT,0.43367,0.087071,0.026003,0,0
1,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.2,0.086947,0.057816,0,0
1,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.12689,0.086394,0.13536,0,0
1,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.00067758,0.086291,0.097239,0,0
1,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.59664,0.085861,0.0043753,0,0
1,GO MUSCLE CELL APOPTOTIC PROCESS,0.28785,0.085743,0.048292,0,0
1,GO RESPONSE TO IRON ION,0.10654,0.085685,0.10755,0,0
1,GO MICROVILLUS ASSEMBLY,0.31653,0.085634,0.076319,0,0
1,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.15773,0.084999,0.087373,0,0
1,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.093897,0.08495,0.13134,0,0
1,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.14526,0.084601,0.080711,0,0
1,GO POSITIVE REGULATION OF BONE RESORPTION,0.26847,0.084528,0.094102,0,0
1,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.98953,0.084386,-0.030681,0,0
1,GO NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.17934,0.084318,0.11322,0,0
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.052669,0.083992,0.1303,0,0
1,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.17653,0.083979,0.11681,0,0
1,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.23245,0.083955,0.090182,0,0
1,GO POLYOL BIOSYNTHETIC PROCESS,0.11434,0.083423,0.048864,0,0
1,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.63978,0.083294,0.037765,0,0
1,GO CENTROSOME DUPLICATION,0.064293,0.083025,0.090664,0,0
1,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.24643,0.083008,0.038332,0,0
1,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.65234,0.082681,0.018177,0,0
1,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.12049,0.082442,0.06987,0,0
1,GO DNA GEOMETRIC CHANGE,0.029719,0.08162,0.11552,0,0
1,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.24288,0.081471,0.20313,0,0
1,GO LACTATE METABOLIC PROCESS,0.11636,0.081435,0.11012,0,0
1,GO KINETOCHORE ORGANIZATION,0.26847,0.081344,0.085805,0,0
1,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.30402,0.081307,0.05072,0,0
1,GO NUCLEOTIDE PHOSPHORYLATION,0.4978,0.081222,0.023931,0,0
1,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.16559,0.081171,0.050428,0,0
1,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.25001,0.081128,0.073704,0,0
1,GO RESPONSE TO WATER,0.85082,0.080941,0.0079415,0,0
1,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.13583,0.08093,0.064689,0,0
1,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.12689,0.080749,0.10928,0,0
1,GO MONOSACCHARIDE METABOLIC PROCESS,0.057089,0.080502,0.054332,0,0
1,GO REGULATION OF INTEGRIN ACTIVATION,0.39858,0.080078,0.057757,0,0
1,GO MACROPHAGE ACTIVATION,0.12908,0.080018,0.12144,0,0
1,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.26847,0.080004,0.075762,0,0
1,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.11434,0.079923,0.12155,0,0
1,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.39371,0.079801,0.030766,0,0
1,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.1028,0.079793,0.082856,0,0
1,GO FATTY ACID TRANSPORT,0.10845,0.079145,0.063857,0,0
1,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.54903,0.079083,0.046533,0,0
1,GO EPITHELIAL CELL CELL ADHESION,0.46512,0.079034,0.16276,0,0
1,GO NATURAL KILLER CELL DIFFERENTIATION,0.15773,0.07869,0.088126,0,0
1,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.18219,0.078475,0.062443,0,0
1,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.81668,0.078468,0.15022,0,0
1,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.19095,0.078423,0.051249,0,0
1,GO TERPENOID METABOLIC PROCESS,0.28785,0.078365,0.073637,0,0
1,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.87144,0.078319,-0.01224,0,0
1,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.15773,0.077889,0.051711,0,0
1,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.27227,0.0778,0.073781,0,0
1,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.2,0.077582,0.14928,0,0
1,GO STEROID METABOLIC PROCESS,0.21256,0.077547,0.027803,0,0
1,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.62113,0.077484,0.048262,0,0
1,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.98255,0.077465,-0.027117,0,0
1,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.44924,0.077396,0.052701,0,0
1,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.13814,0.077115,0.094518,0,0
1,GO ACTIN FILAMENT NETWORK FORMATION,0.69061,0.077061,0.049127,0,0
1,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.53167,0.077045,0.040012,0,0
1,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.090515,0.077036,0.051311,0,0
1,GO REGULATION OF REPRODUCTIVE PROCESS,0.22568,0.077031,0.034561,0,0
1,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.39858,0.076941,0.056074,0,0
1,GO REGULATION OF STEROID METABOLIC PROCESS,0.27999,0.07679,0.02201,0,0
1,GO AORTA DEVELOPMENT,0.080955,0.07674,0.20083,0,0
1,GO CELLULAR RESPONSE TO KETONE,0.36991,0.076654,0.033053,0,0
1,GO MALE SEX DIFFERENTIATION,0.11434,0.076574,0.094716,0,0
1,GO VITAMIN D BIOSYNTHETIC PROCESS,0.98255,0.076434,0.060181,0,0
1,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.28785,0.076403,0.069207,0,0
1,GO CELL PROLIFERATION IN HINDBRAIN,0.23589,0.076345,0.098344,0,0
1,GO SULFATION,0.29992,0.076201,0.11401,0,0
1,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.42855,0.076133,0.070358,0,0
1,GO NEURAL CREST FORMATION,0.90599,0.075967,0.014521,0,0
1,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.065563,0.075955,0.068328,0,0
1,GO INTERLEUKIN 12 PRODUCTION,0.20309,0.075755,0.080696,0,0
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.057089,0.075747,0.075863,0,0
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.12259,0.075176,0.11191,0,0
1,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.14285,0.075172,0.10386,0,0
1,GO CHROMATIN DISASSEMBLY,0.56075,0.075013,0.010796,0,0
1,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.12049,0.074471,0.076817,0,0
1,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.25363,0.073851,0.064935,0,0
1,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.51459,0.073664,0.11888,0,0
1,GO REGULATION OF SKELETAL MUSCLE CONTRACTION,0.54903,0.073556,0.037575,0,0
1,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.74288,0.073541,0.024468,0,0
1,GO LYMPHOCYTE HOMEOSTASIS,0.32077,0.073471,0.029558,0,0
1,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.16294,0.073462,0.043133,0,0
1,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.2,0.073048,0.14806,0,0
1,GO BIOLOGICAL ADHESION,0.065563,0.073046,0.094376,0,0
1,GO RESPIRATORY BURST,0.53167,0.072495,0.03201,0,0
1,GO KETONE CATABOLIC PROCESS,0.60883,0.072333,0.07034,0,0
1,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.35153,0.072214,0.10648,0,0
1,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.14769,0.07217,0.10607,0,0
1,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.033166,0.072057,0.31159,0,0
1,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.33373,0.071557,0.062424,0,0
1,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.27227,0.071422,0.037374,0,0
1,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.090515,0.071315,0.059135,0,0
1,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.037747,0.071161,0.14139,0,0
1,GO CELL MOTILITY,0.060602,0.071126,0.079206,0,0
1,GO HISTONE DEUBIQUITINATION,0.26471,0.071015,0.054538,0,0
1,GO RESPONSE TO UV B,0.47588,0.07095,0.10715,0,0
1,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.092194,0.070765,0.16982,0,0
1,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.20937,0.070703,0.10125,0,0
1,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.85768,0.070652,0.029405,0,0
1,GO REGULATION OF MUSCLE ADAPTATION,0.35607,0.070652,0.039218,0,0
1,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.14769,0.070592,0.18783,0,0
1,GO SEQUESTERING OF CALCIUM ION,0.16559,0.070576,0.064988,0,0
1,GO MALE MEIOTIC NUCLEAR DIVISION,0.62732,0.070555,0.084057,0,0
1,GO STEROL METABOLIC PROCESS,0.46512,0.07038,0.018312,0,0
1,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.43367,0.070123,0.047388,0,0
1,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0090226,0.06994,0.10259,0,0
1,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.4978,0.069895,0.0031591,0,0
1,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.40349,0.06956,0.1209,0,0
1,GO RESPONSE TO NITRIC OXIDE,0.4598,0.069371,0.053359,0,0
1,GO EMBRYONIC PLACENTA DEVELOPMENT,0.39858,0.06936,0.068158,0,0
1,GO RESPONSE TO TOXIC SUBSTANCE,0.52594,0.069053,0.017294,0,0
1,GO OVULATION CYCLE,0.19695,0.068509,0.10108,0,0
1,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.14769,0.068394,0.042942,0,0
1,GO DETOXIFICATION OF INORGANIC COMPOUND,0.72969,0.067837,0.059112,0,0
1,GO PARAXIAL MESODERM MORPHOGENESIS,0.21905,0.067755,0.18454,0,0
1,GO MITOCHONDRION ORGANIZATION,0.0029794,0.067695,0.076056,0,0
1,GO ACTIVATION OF JUN KINASE ACTIVITY,0.064293,0.067277,0.078383,0,0
1,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.37932,0.066826,0.047873,0,0
1,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.12473,0.066541,0.067219,0,0
1,GO DIOL METABOLIC PROCESS,0.44402,0.066356,0.031762,0,0
1,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.11636,0.06631,0.061538,0,0
1,GO PROTEIN DESTABILIZATION,0.26471,0.065932,0.038651,0,0
1,GO REGULATION OF CHROMOSOME SEGREGATION,0.026586,0.065553,0.10756,0,0
1,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.34256,0.065368,0.058246,0,0
1,GO CELL CELL ADHESION,0.32506,0.065342,0.045124,0,0
1,GO CHOLESTEROL STORAGE,0.51459,0.065054,0.076313,0,0
1,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.17099,0.064972,0.091794,0,0
1,GO MYELOID CELL DEVELOPMENT,0.188,0.064467,0.07237,0,0
1,GO RESPONSE TO COPPER ION,0.44402,0.064379,0.084501,0,0
1,GO HISTONE H2A ACETYLATION,0.34256,0.064297,0.04135,0,0
1,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.50337,0.064293,0.037683,0,0
1,GO ATP METABOLIC PROCESS,0.066855,0.064126,0.06263,0,0
1,GO PROTEIN AUTOPHOSPHORYLATION,0.095625,0.063779,0.069646,0,0
1,GO MAMMARY GLAND DEVELOPMENT,0.14048,0.063394,0.092857,0,0
1,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.59664,0.063253,0.02999,0,0
1,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.17374,0.063244,0.082656,0,0
1,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.26471,0.063021,0.041119,0,0
1,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.05824,0.06294,0.12745,0,0
1,GO ACTIVATION OF MAPK ACTIVITY,0.1028,0.062924,0.058227,0,0
1,GO TISSUE HOMEOSTASIS,0.15264,0.062816,0.050694,0,0
1,GO ACETYL COA METABOLIC PROCESS,0.49227,0.062704,0.035264,0,0
1,GO REGULATION OF LIPID CATABOLIC PROCESS,0.1028,0.06264,0.074272,0,0
1,GO RESPIRATORY SYSTEM DEVELOPMENT,0.13583,0.062584,0.094363,0,0
1,GO APICAL JUNCTION ASSEMBLY,0.13583,0.062473,0.12661,0,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME,0.36064,0.062267,0.094205,0,0
1,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.69707,0.062245,0.0070007,0,0
1,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.26471,0.062168,0.092234,0,0
1,GO URONIC ACID METABOLIC PROCESS,0.36526,0.062151,0.041218,0,0
1,GO INTERMEDIATE FILAMENT BASED PROCESS,0.73628,0.062038,0.03915,0,0
1,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.8303,0.061814,0.1167,0,0
1,GO NADH METABOLIC PROCESS,0.38408,0.061784,0.059245,0,0
1,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.48678,0.06173,0.019736,0,0
1,GO CELL CYCLE ARREST,0.12259,0.06167,0.046515,0,0
1,GO DENDRITIC SPINE MAINTENANCE,0.19393,0.061495,0.1111,0,0
1,GO HISTONE H3 K9 ACETYLATION,0.41842,0.061328,0.050949,0,0
1,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.29586,0.061298,0.10917,0,0
1,GO BONE CELL DEVELOPMENT,0.53167,0.061201,0.0472,0,0
1,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.13355,0.061166,0.053634,0,0
1,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.36064,0.061156,0.044652,0,0
1,GO CHROMATIN REMODELING AT CENTROMERE,0.41842,0.061041,0.030221,0,0
1,GO ANTIMICROBIAL HUMORAL RESPONSE,0.064293,0.061034,0.10331,0,0
1,GO EPITHELIUM DEVELOPMENT,0.10096,0.060936,0.075215,0,0
1,GO HISTONE H3 K27 METHYLATION,0.4545,0.060859,0.039314,0,0
1,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.31653,0.060584,0.13635,0,0
1,GO PROTEIN AUTOUBIQUITINATION,0.12049,0.060198,0.049147,0,0
1,GO REGULATION OF TELOMERE CAPPING,0.48678,0.059732,0.022028,0,0
1,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.099158,0.059721,0.080286,0,0
1,GO UROGENITAL SYSTEM DEVELOPMENT,0.053746,0.059695,0.12353,0,0
1,GO GMP METABOLIC PROCESS,0.86455,0.059605,-0.0067701,0,0
1,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.29586,0.059543,0.060467,0,0
1,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.035393,0.059512,0.10784,0,0
1,GO RESPONSE TO SALT,0.72969,0.059492,-0.018369,0,0
1,GO REGULATION OF NEUTROPHIL MIGRATION,0.26098,0.059461,0.042588,0,0
1,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.063042,0.059341,0.075675,0,0
1,GO REGULATION OF TUBE SIZE,0.21579,0.059309,0.068478,0,0
1,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.35153,0.05929,0.097697,0,0
1,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.83713,0.05927,-0.0032433,0,0
1,GO REGULATION OF EXIT FROM MITOSIS,0.40349,0.058616,0.038568,0,0
1,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.19393,0.058594,0.15551,0,0
1,GO REGULATION OF FAT CELL DIFFERENTIATION,0.25001,0.058516,0.059578,0,0
1,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.053746,0.058396,0.079631,0,0
1,GO ACETYL COA BIOSYNTHETIC PROCESS,0.47049,0.058283,0.030519,0,0
1,GO DISACCHARIDE METABOLIC PROCESS,0.30402,0.057847,0.082309,0,0
1,GO ENDOSOME TO LYSOSOME TRANSPORT,0.2839,0.057784,0.050281,0,0
1,GO CARDIOCYTE DIFFERENTIATION,0.088862,0.057503,0.114,0,0
1,GO METHIONINE METABOLIC PROCESS,0.78289,0.057346,-0.032085,0,0
1,GO REGULATION OF CARTILAGE DEVELOPMENT,0.32938,0.056636,0.10472,0,0
1,GO NEURON PROJECTION REGENERATION,0.77618,0.056622,-0.0016787,0,0
1,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.71006,0.05661,0.0058673,0,0
1,GO PROSTAGLANDIN SECRETION,0.093897,0.056519,0.11858,0,0
1,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.059411,0.056398,0.064256,0,0
1,GO RESPONSE TO PROSTAGLANDIN E,0.67137,0.056255,0.024508,0,0
1,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.30402,0.056023,0.16652,0,0
1,GO ODONTOGENESIS,0.11841,0.055814,0.12202,0,0
1,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.33812,0.055813,0.075237,0,0
1,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.4978,0.055384,0.070555,0,0
1,GO RESPONSE TO TEMPERATURE STIMULUS,0.099158,0.055361,0.068771,0,0
1,GO AMMONIUM TRANSPORT,0.12049,0.055347,0.13319,0,0
1,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.12259,0.054847,0.046298,0,0
1,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.87833,0.054579,-0.03751,0,0
1,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.56666,0.054531,0.016069,0,0
1,GO CHLORIDE ION HOMEOSTASIS,0.64605,0.054489,0.022581,0,0
1,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.2839,0.054477,0.099757,0,0
1,GO MITOTIC CHROMOSOME CONDENSATION,0.96163,0.054236,0.0088377,0,0
1,GO RESPONSE TO ACIDIC PH,0.42855,0.0539,0.046906,0,0
1,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.98255,0.053589,0.019203,0,0
1,GO TRIGLYCERIDE METABOLIC PROCESS,0.24288,0.05348,0.033593,0,0
1,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.20309,0.053458,0.077304,0,0
1,GO RESPONSE TO RADIATION,0.088862,0.053309,0.038365,0,0
1,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.61497,0.053146,0.023957,0,0
1,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.15517,0.052936,0.036127,0,0
1,GO DNA METHYLATION,0.5726,0.052655,0.010499,0,0
1,GO REGULATION OF MUSCLE HYPERTROPHY,0.14285,0.052607,0.09456,0,0
1,GO PROSTAGLANDIN TRANSPORT,0.53167,0.052512,0.017057,0,0
1,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.39858,0.052035,0.069638,0,0
1,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.39858,0.051963,0.10403,0,0
1,GO REGULATION OF CELL SHAPE,0.050569,0.051665,0.135,0,0
1,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.35153,0.051594,0.093892,0,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.27999,0.051395,0.1004,0,0
1,GO POLYOL METABOLIC PROCESS,0.072231,0.051378,0.058704,0,0
1,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.14285,0.051363,0.041577,0,0
1,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.14048,0.051338,0.037686,0,0
1,GO EPITHELIAL TUBE MORPHOGENESIS,0.029719,0.051299,0.10637,0,0
1,GO HOMEOSTATIC PROCESS,0.49227,0.051231,0.0089713,0,0
1,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.35607,0.051039,0.031341,0,0
1,GO CYTOKINE SECRETION,0.59059,0.050984,0.051688,0,0
1,GO REGULATION OF PROTEIN DEACETYLATION,0.7495,0.05094,-0.03016,0,0
1,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.23589,0.050807,0.14468,0,0
1,GO NOTCH RECEPTOR PROCESSING,0.54321,0.050769,0.06133,0,0
1,GO HEART VALVE FORMATION,0.94073,0.050734,0.0097191,0,0
1,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.98953,0.050324,-0.015492,0,0
1,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.49227,0.050143,0.079475,0,0
1,GO TRIPARTITE REGIONAL SUBDIVISION,0.65866,0.05,0.036019,0,0
1,GO MODIFIED AMINO ACID TRANSPORT,0.17934,0.049563,0.063236,0,0
1,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.40349,0.04939,0.045776,0,0
1,GO JNK CASCADE,0.17099,0.049037,0.045658,0,0
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.73628,0.049035,0.014326,0,0
1,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.34256,0.048877,0.026175,0,0
1,GO REGULATION OF MACROAUTOPHAGY,0.017969,0.048796,0.098069,0,0
1,GO RESPONSE TO STEROL DEPLETION,0.91987,0.048757,-0.015523,0,0
1,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.15015,0.048735,0.049449,0,0
1,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.19095,0.048647,0.11698,0,0
1,GO ENSHEATHMENT OF NEURONS,0.8303,0.048526,-0.0069173,0,0
1,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.42347,0.048417,0.05863,0,0
1,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.23589,0.048339,0.085945,0,0
1,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.36526,0.048177,0.055707,0,0
1,GO VITAMIN METABOLIC PROCESS,0.099158,0.048156,0.060516,0,0
1,GO PHOSPHOLIPID METABOLIC PROCESS,0.0695,0.047968,0.049861,0,0
1,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.81668,0.047893,-0.048462,0,0
1,GO NEPHRON EPITHELIUM DEVELOPMENT,0.26847,0.047863,0.10268,0,0
1,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.18219,0.047779,0.049203,0,0
1,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.12689,0.04769,0.12028,0,0
1,GO PEPTIDYL SERINE MODIFICATION,0.23245,0.047639,0.038873,0,0
1,GO NUCLEAR MIGRATION,0.4978,0.047507,0.04609,0,0
1,GO MITOTIC SPINDLE ASSEMBLY,0.30815,0.047495,0.063392,0,0
1,GO HISTONE H3 DEACETYLATION,0.37932,0.047461,0.052151,0,0
1,GO DNA REPLICATION CHECKPOINT,0.43367,0.047366,0.03918,0,0
1,GO COENZYME A BIOSYNTHETIC PROCESS,0.92682,0.047259,-0.0001723,0,0
1,GO PROTEIN LOCALIZATION TO ENDOSOME,0.090515,0.047171,0.13613,0,0
1,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.67776,0.047169,0.028511,0,0
1,GO RESPONSE TO PROSTAGLANDIN,0.4545,0.047166,0.073366,0,0
1,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.43883,0.0471,0.021103,0,0
1,GO SKIN DEVELOPMENT,0.19393,0.047054,0.11464,0,0
1,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.63978,0.047019,0.04051,0,0
1,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.31653,0.046535,0.036426,0,0
1,GO TONIC SMOOTH MUSCLE CONTRACTION,0.4545,0.046432,0.1638,0,0
1,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.78289,0.046421,0.057684,0,0
1,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.25729,0.046397,0.096728,0,0
1,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.62732,0.046291,0.018928,0,0
1,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.53742,0.04623,0.036147,0,0
1,GO PRO B CELL DIFFERENTIATION,0.61497,0.045908,0.093526,0,0
1,GO SECRETION,0.15015,0.045892,0.040774,0,0
1,GO ARTERY MORPHOGENESIS,0.34256,0.045882,0.17602,0,0
1,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.35607,0.045873,0.047015,0,0
1,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.60272,0.045696,0.022539,0,0
1,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.20309,0.045684,0.033799,0,0
1,GO POSITIVE REGULATION OF NEURON DEATH,0.77618,0.045492,0.0089633,0,0
1,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.18219,0.045387,0.055793,0,0
1,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.74288,0.045369,-0.047348,0,0
1,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.36991,0.045363,0.10624,0,0
1,GO NEGATIVE REGULATION OF TRANSPORT,0.2,0.045285,0.044508,0,0
1,GO RESPONSE TO ENDOGENOUS STIMULUS,0.1028,0.045278,0.05488,0,0
1,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.96163,0.045176,-0.014863,0,0
1,GO TRANSFERRIN TRANSPORT,0.33373,0.045175,0.032601,0,0
1,GO CARDIAC CHAMBER DEVELOPMENT,0.1028,0.04488,0.10753,0,0
1,GO RESPONSE TO INSULIN,0.44402,0.04469,0.012701,0,0
1,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.33373,0.044629,0.05075,0,0
1,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.25001,0.044628,0.090108,0,0
1,GO EMBRYONIC ORGAN DEVELOPMENT,0.15773,0.044312,0.059116,0,0
1,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.99651,0.044161,-0.034906,0,0
1,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.36991,0.043989,0.038335,0,0
1,GO REGULATION OF MRNA POLYADENYLATION,0.22235,0.043379,0.059196,0,0
1,GO INOSITOL METABOLIC PROCESS,0.7495,0.043347,0.015797,0,0
1,GO CELLULAR RESPONSE TO COPPER ION,0.66501,0.04327,-0.0047461,0,0
1,GO MICROVILLUS ORGANIZATION,0.32938,0.042972,-0.11218,0,0
1,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.62113,0.042959,0.04004,0,0
1,GO PROTEIN POLYMERIZATION,0.24643,0.042929,0.031943,0,0
1,GO RESPONSE TO ACID CHEMICAL,0.32077,0.042789,0.047336,0,0
1,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.50896,0.042747,0.13334,0,0
1,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.72969,0.04231,0.018304,0,0
1,GO OSTEOBLAST PROLIFERATION,0.39858,0.042074,0.11625,0,0
1,GO PROTEIN O LINKED GLYCOSYLATION,0.5726,0.041933,-0.0051349,0,0
1,GO HISTONE H3 K14 ACETYLATION,0.74288,0.041848,0.00078313,0,0
1,GO NEGATIVE REGULATION OF BONE REMODELING,0.69061,0.041788,0.061742,0,0
1,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.27227,0.041623,0.042583,0,0
1,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.32077,0.041559,0.038691,0,0
1,GO CARDIAC CHAMBER MORPHOGENESIS,0.23245,0.041264,0.10123,0,0
1,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.18219,0.041224,0.048127,0,0
1,GO CENTROMERE COMPLEX ASSEMBLY,0.32506,0.041077,0.074986,0,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.72969,0.041054,0.01035,0,0
1,GO ANIMAL ORGAN MORPHOGENESIS,0.20309,0.040901,0.059334,0,0
1,GO NEUROBLAST DIVISION,0.49227,0.040898,0.067255,0,0
1,GO EMBRYONIC ORGAN MORPHOGENESIS,0.53167,0.040792,0.032773,0,0
1,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.85082,0.040695,0.035047,0,0
1,GO RECOMBINATIONAL REPAIR,0.42855,0.040644,0.057618,0,0
1,GO RESPONSE TO ALCOHOL,0.59664,0.04056,0.021719,0,0
1,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.48678,0.040437,0.024675,0,0
1,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.38408,0.040223,0.050141,0,0
1,GO SPECIFICATION OF SYMMETRY,0.2,0.040005,0.053161,0,0
1,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.67776,0.039896,0.052313,0,0
1,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.26471,0.039891,0.052471,0,0
1,GO MONOCARBOXYLIC ACID TRANSPORT,0.3746,0.039879,0.018128,0,0
1,GO POSITIVE REGULATION OF SIGNALING,0.12049,0.039844,0.045792,0,0
1,GO MRNA METHYLATION,0.4598,0.039841,0.059146,0,0
1,GO PHOTOPERIODISM,0.69707,0.039814,-0.0040856,0,0
1,GO NEUTRAL LIPID METABOLIC PROCESS,0.39371,0.03979,0.015923,0,0
1,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.62113,0.039577,0.0073409,0,0
1,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.28785,0.039512,0.049669,0,0
1,GO REPRODUCTION,0.25001,0.039184,0.024131,0,0
1,GO EXECUTION PHASE OF APOPTOSIS,0.15517,0.039071,0.045043,0,0
1,GO EMBRYONIC HEMOPOIESIS,0.60272,0.038977,-0.038811,0,0
1,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.42347,0.038862,0.041423,0,0
1,GO PRE MIRNA PROCESSING,0.59664,0.038828,0.030396,0,0
1,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.4978,0.038649,0.078726,0,0
1,GO ICOSANOID METABOLIC PROCESS,0.22235,0.03862,0.078402,0,0
1,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.4598,0.038584,0.034987,0,0
1,GO REGULATION OF SPINDLE ASSEMBLY,0.20309,0.037741,0.090311,0,0
1,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.099158,0.037379,0.055354,0,0
1,GO CERAMIDE METABOLIC PROCESS,0.21579,0.037319,0.019461,0,0
1,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.39371,0.036775,0.01723,0,0
1,GO EMBRYO DEVELOPMENT,0.20621,0.036722,0.052727,0,0
1,GO POSITIVE REGULATION OF MYELINATION,0.74288,0.036617,0.046634,0,0
1,GO REGULATION OF PROTEIN SUMOYLATION,0.29992,0.036592,0.089946,0,0
1,GO ACTIN NUCLEATION,0.40843,0.036577,0.0034616,0,0
1,GO STEM CELL DIVISION,0.3746,0.036463,0.11222,0,0
1,GO RECEPTOR INTERNALIZATION,0.35607,0.03642,0.045801,0,0
1,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.47588,0.035723,0.040417,0,0
1,GO ANDROGEN METABOLIC PROCESS,0.76948,0.035458,-0.01621,0,0
1,GO CELL VOLUME HOMEOSTASIS,0.39858,0.035431,0.03374,0,0
1,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.63978,0.03541,0.0019937,0,0
1,GO GLUCOSE CATABOLIC PROCESS,0.72313,0.035388,0.014749,0,0
1,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.85082,0.035096,-0.025969,0,0
1,GO REGULATION OF CELL SIZE,0.88523,0.034958,-0.02723,0,0
1,GO REGULATION OF GTPASE ACTIVITY,0.32077,0.034876,0.038614,0,0
1,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.18219,0.034862,0.06128,0,0
1,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.94073,0.034492,-0.023162,0,0
1,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.66501,0.034053,0.022242,0,0
1,GO REGULATION OF MICROVILLUS ORGANIZATION,0.69061,0.033958,-0.12534,0,0
1,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.92682,0.033795,-0.013774,0,0
1,GO REGULATION OF JUN KINASE ACTIVITY,0.32077,0.033773,0.04995,0,0
1,GO FEMALE GENITALIA DEVELOPMENT,0.53742,0.033742,0.058345,0,0
1,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.60272,0.033414,0.050778,0,0
1,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.44924,0.03341,0.029882,0,0
1,GO POSITIVE REGULATION OF JNK CASCADE,0.23245,0.033175,0.044757,0,0
1,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.20309,0.033088,0.095842,0,0
1,GO DNA REPLICATION,0.15015,0.032934,0.05159,0,0
1,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.61497,0.032916,0.0046625,0,0
1,GO ADAPTIVE THERMOGENESIS,0.76281,0.032685,0.0037292,0,0
1,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.32506,0.032605,0.042451,0,0
1,GO ENDOCRINE HORMONE SECRETION,0.8303,0.032526,0.018798,0,0
1,GO REGULATION OF PROTEIN LOCALIZATION,0.64605,0.032487,0.010775,0,0
1,GO REGULATION OF PLATELET AGGREGATION,0.69061,0.032442,-0.059617,0,0
1,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.21579,0.032325,0.038894,0,0
1,GO ADHERENS JUNCTION ASSEMBLY,0.55487,0.032125,0.013449,0,0
1,GO MEMBRANE FUSION,0.71658,0.031889,-0.00021207,0,0
1,GO SISTER CHROMATID SEGREGATION,0.17099,0.031846,0.058137,0,0
1,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.69707,0.031637,0.029906,0,0
1,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.5726,0.031357,0.037536,0,0
1,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.095625,0.031231,0.089758,0,0
1,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.72969,0.031228,-0.059392,0,0
1,GO MEIOTIC CELL CYCLE PROCESS,0.34256,0.030985,0.049518,0,0
1,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.56075,0.030814,0.01413,0,0
1,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.81668,0.030713,-0.00021495,0,0
1,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.80312,0.030669,-0.026205,0,0
1,GO PROTEIN TRIMERIZATION,0.98255,0.030527,0.0050115,0,0
1,GO REGULATION OF CELLULAR COMPONENT SIZE,0.50896,0.030508,0.016677,0,0
1,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.11039,0.030496,0.049734,0,0
1,GO ATRIAL SEPTUM DEVELOPMENT,0.86455,0.030331,-0.0093823,0,0
1,GO MUSCLE HYPERTROPHY,0.68418,0.030311,0.020426,0,0
1,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.27999,0.030118,0.13772,0,0
1,GO HISTONE UBIQUITINATION,0.44402,0.030082,0.042558,0,0
1,GO MISMATCH REPAIR,0.59059,0.030035,0.025693,0,0
1,GO REGULATION OF HELICASE ACTIVITY,0.53742,0.029976,0.065037,0,0
1,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.94073,0.029695,0.022323,0,0
1,GO FERTILIZATION,0.69061,0.029391,0.0073409,0,0
1,GO POSITIVE REGULATION OF B CELL PROLIFERATION,0.76281,0.029247,-0.058689,0,0
1,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.54903,0.029029,0.056336,0,0
1,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.77618,0.028968,0.018124,0,0
1,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.83713,0.028795,-0.01569,0,0
1,GO RESPONSE TO INORGANIC SUBSTANCE,0.4545,0.028782,0.032489,0,0
1,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.31653,0.028606,0.035834,0,0
1,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.4978,0.028579,0.046577,0,0
1,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.59664,0.028544,0.015527,0,0
1,GO NEGATIVE REGULATION OF SECRETION,0.27611,0.028455,0.040338,0,0
1,GO POLYSACCHARIDE METABOLIC PROCESS,0.73628,0.0284,-0.004563,0,0
1,GO THYROID GLAND DEVELOPMENT,0.65866,0.028396,0.05552,0,0
1,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.2839,0.028226,0.037515,0,0
1,GO REGULATION OF VASCULAR PERMEABILITY,0.56075,0.028199,0.030727,0,0
1,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.27999,0.02784,0.028685,0,0
1,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.62732,0.027818,0.021656,0,0
1,GO PROTEIN AUTO ADP RIBOSYLATION,0.59059,0.027811,0.052454,0,0
1,GO CELLULAR RESPONSE TO PH,0.8303,0.027798,0.026979,0,0
1,GO MRNA MODIFICATION,0.46512,0.027591,0.056272,0,0
1,GO HEART MORPHOGENESIS,0.092194,0.027577,0.10498,0,0
1,GO REGULATION OF SULFUR METABOLIC PROCESS,0.71658,0.027338,-0.068617,0,0
1,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.67776,0.027211,0.017328,0,0
1,GO MIDBRAIN DEVELOPMENT,0.3746,0.02721,0.070525,0,0
1,GO HOMOLOGOUS RECOMBINATION,0.5726,0.027192,0.048018,0,0
1,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.80989,0.02713,0.00093684,0,0
1,GO VITAMIN TRANSPORT,0.56666,0.027053,0.02038,0,0
1,GO RRNA CATABOLIC PROCESS,0.58456,0.027047,0.031638,0,0
1,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.27611,0.026993,0.050302,0,0
1,GO LONG CHAIN FATTY ACID TRANSPORT,0.36526,0.026987,0.035127,0,0
1,GO IRON COORDINATION ENTITY TRANSPORT,0.48678,0.026854,-0.09327,0,0
1,GO DEVELOPMENTAL PIGMENTATION,0.70355,0.026853,-0.022127,0,0
1,GO MACROMOLECULE DEPALMITOYLATION,0.58456,0.026733,0.032599,0,0
1,GO CELLULAR RESPONSE TO ALCOHOL,0.56666,0.026671,0.037918,0,0
1,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.38888,0.026207,0.05185,0,0
1,GO CALCIUM IMPORT INTO THE MITOCHONDRION,0.80312,0.026094,0.023314,0,0
1,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.5726,0.026005,0.028814,0,0
1,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.92682,0.02594,0.013129,0,0
1,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.19393,0.02593,0.092307,0,0
1,GO PEPTIDYL HISTIDINE MODIFICATION,0.64605,0.025876,0.032081,0,0
1,GO REGULATION OF ORGANELLE ASSEMBLY,0.29586,0.025838,0.037172,0,0
1,GO ETHANOL CATABOLIC PROCESS,0.46512,0.025688,0.14729,0,0
1,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.52594,0.025616,0.018828,0,0
1,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.13355,0.025572,0.072787,0,0
1,GO CELLULAR GLUCAN METABOLIC PROCESS,0.4978,0.025559,0.027506,0,0
1,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.22568,0.025524,0.051753,0,0
1,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.63354,0.025521,0.024087,0,0
1,GO RENAL ABSORPTION,0.59059,0.025513,0.050517,0,0
1,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.33373,0.025494,0.10165,0,0
1,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.53742,0.02545,0.058042,0,0
1,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.65866,0.025353,0.017786,0,0
1,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.82348,0.025082,-0.045609,0,0
1,GO LONG CHAIN FATTY ACID CATABOLIC PROCESS,0.73628,0.02478,0.0015331,0,0
1,GO NEPHRIC DUCT DEVELOPMENT,0.9686,0.02454,0.022746,0,0
1,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.50337,0.024374,0.030188,0,0
1,GO EPITHELIAL CELL DIFFERENTIATION,0.57857,0.024289,0.047943,0,0
1,GO REGULATION OF PROTEIN POLYMERIZATION,0.94769,0.02427,-0.0039735,0,0
1,GO RESPONSE TO ACTIVITY,0.56666,0.024097,0.011338,0,0
1,GO DIACYLGLYCEROL METABOLIC PROCESS,0.63978,0.023952,-0.06786,0,0
1,GO REGULATION OF SPINDLE CHECKPOINT,0.18219,0.023686,0.11199,0,0
1,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.86455,0.023596,0.049929,0,0
1,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.37932,0.02357,0.020338,0,0
1,GO CYTOSKELETON ORGANIZATION,0.34256,0.023468,0.034272,0,0
1,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.74288,0.023449,-0.034557,0,0
1,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.5726,0.023387,0.030496,0,0
1,GO PHOSPHOLIPID TRANSPORT,0.85082,0.023372,-0.0052723,0,0
1,GO MUSCLE FIBER DEVELOPMENT,0.88523,0.02335,-0.0063153,0,0
1,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.39858,0.023311,0.029007,0,0
1,GO HORMONE MEDIATED SIGNALING PATHWAY,0.2839,0.023224,0.032429,0,0
1,GO TELOMERE CAPPING,0.81668,0.022819,0.0060849,0,0
1,GO RESPONSE TO ESTRADIOL,0.17374,0.022799,0.067347,0,0
1,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.40349,0.022731,0.034596,0,0
1,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.16828,0.022572,0.039343,0,0
1,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.39371,0.022398,0.047471,0,0
1,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.52025,0.021749,0.057731,0,0
1,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.73628,0.021694,-0.04223,0,0
1,GO POSITIVE REGULATION OF CELL CYCLE,0.52025,0.021265,0.024685,0,0
1,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.24288,0.021237,0.042622,0,0
1,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.44402,0.021115,0.1239,0,0
1,GO AUTOPHAGIC CELL DEATH,0.84397,0.021031,0.01102,0,0
1,GO MITOCHONDRIAL FISSION,0.92682,0.021023,0.0060417,0,0
1,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.30815,0.020967,0.083827,0,0
1,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.54903,0.02088,0.0081283,0,0
1,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.54321,0.020563,-0.055545,0,0
1,GO METAL ION HOMEOSTASIS,0.80312,0.020519,0.0063634,0,0
1,GO CELLULAR RESPONSE TO AMYLOID BETA,0.89907,0.020338,0.021912,0,0
1,GO MULTICELLULAR ORGANISM REPRODUCTION,0.64605,0.020232,0.0001457,0,0
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.41842,0.019982,0.058534,0,0
1,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.72969,0.019827,-0.030713,0,0
1,GO CAMP METABOLIC PROCESS,0.51459,0.019544,0.099216,0,0
1,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.36991,0.01945,0.035285,0,0
1,GO HISTONE H3 K4 TRIMETHYLATION,0.8303,0.019439,0.026003,0,0
1,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.25729,0.019375,0.036839,0,0
1,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.35607,0.019199,0.031295,0,0
1,GO TEMPERATURE HOMEOSTASIS,0.8303,0.019152,-0.00223,0,0
1,GO HISTONE MONOUBIQUITINATION,0.55487,0.018931,0.029504,0,0
1,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.80312,0.018778,-0.027268,0,0
1,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.46512,0.018654,0.041783,0,0
1,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.58456,0.018625,0.012598,0,0
1,GO LIPOPROTEIN METABOLIC PROCESS,0.91293,0.01833,-0.034295,0,0
1,GO FATTY ACID DERIVATIVE TRANSPORT,0.56075,0.018029,-0.041681,0,0
1,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.55487,0.018,0.036525,0,0
1,GO CELL PROJECTION ASSEMBLY,0.60272,0.017796,0.026481,0,0
1,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.80989,0.017764,-0.0067835,0,0
1,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.47049,0.017668,0.07682,0,0
1,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.4598,0.017633,0.044261,0,0
1,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.98255,0.017615,-0.010614,0,0
1,GO CYTOSOLIC TRANSPORT,0.41341,0.017442,0.034231,0,0
1,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.96163,0.017366,0.015795,0,0
1,GO MEIOTIC CHROMOSOME SEPARATION,0.62732,0.017253,0.076934,0,0
1,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.15517,0.017127,0.077467,0,0
1,GO RESPONSE TO MUSCLE INACTIVITY,0.50896,0.016616,0.078244,0,0
1,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.68418,0.016481,0.0048723,0,0
1,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,0.29586,0.016351,0.10027,0,0
1,GO REGULATION OF NEUROMUSCULAR JUNCTION DEVELOPMENT,0.73628,0.016278,-0.056408,0,0
1,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.25729,0.016268,0.033589,0,0
1,GO LIPID BIOSYNTHETIC PROCESS,0.47588,0.016236,0.0075302,0,0
1,GO REGULATION OF HISTONE MODIFICATION,0.76281,0.016185,0.015256,0,0
1,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.50337,0.016166,0.099024,0,0
1,GO CELLULAR RESPONSE TO DRUG,0.12908,0.016115,0.081621,0,0
1,GO NEGATIVE REGULATION OF TISSUE REMODELING,0.89907,0.015719,0.014012,0,0
1,GO MOTILE CILIUM ASSEMBLY,0.82348,0.015654,-0.032603,0,0
1,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.77618,0.01549,0.0069854,0,0
1,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.59664,0.015403,0.028434,0,0
1,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.52594,0.014942,0.039244,0,0
1,GO LIPID PHOSPHORYLATION,0.60883,0.014905,0.019163,0,0
1,GO RESPONSE TO CORTICOSTERONE,0.32506,0.01459,0.15025,0,0
1,GO PROTEIN LOCALIZATION TO CILIUM,0.91987,0.014543,-0.0045786,0,0
1,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.84397,0.014275,-0.027901,0,0
1,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.94769,0.014254,-0.0025757,0,0
1,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.67137,0.01409,0.0038901,0,0
1,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.4598,0.014047,0.052742,0,0
1,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.52594,0.014033,0.074987,0,0
1,GO ION HOMEOSTASIS,0.98953,0.013989,-0.0026094,0,0
1,GO RESPONSE TO CAMP,0.84397,0.013967,0.025859,0,0
1,GO CENTROSOME SEPARATION,0.34256,0.013641,0.068924,0,0
1,GO GLYCOSYLATION,0.93377,0.013578,-0.031055,0,0
1,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.8303,0.013572,-0.020084,0,0
1,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.52594,0.013363,0.12105,0,0
1,GO ONE CARBON METABOLIC PROCESS,0.67776,0.013162,-0.039866,0,0
1,GO EPIDERMIS DEVELOPMENT,0.54321,0.013151,0.071515,0,0
1,GO GROWTH,0.32938,0.013043,0.02779,0,0
1,GO ENDOCYTIC RECYCLING,0.16559,0.012798,0.061629,0,0
1,GO CELLULAR ION HOMEOSTASIS,0.56666,0.012534,0.013916,0,0
1,GO REGULATION OF BLOOD PRESSURE,0.96163,0.012151,0.01089,0,0
1,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.55487,0.012116,0.057098,0,0
1,GO CHROMOSOME ORGANIZATION,0.47588,0.012067,0.030172,0,0
1,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.71006,0.011855,0.048049,0,0
1,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.82348,0.011485,0.0092754,0,0
1,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.50337,0.011369,0.02518,0,0
1,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.60883,0.011265,0.037808,0,0
1,GO DNA DEPENDENT DNA REPLICATION,0.41842,0.011242,0.034962,0,0
1,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.85082,0.011217,-0.0299,0,0
1,GO BLASTODERM SEGMENTATION,0.63978,0.011208,0.06585,0,0
1,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.52594,0.010836,0.040188,0,0
1,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.40843,0.010659,0.025265,0,0
1,GO MITOCHONDRIAL RNA PROCESSING,0.4545,0.010583,0.061587,0,0
1,GO POSITIVE REGULATION OF AXON EXTENSION,0.85082,0.010504,-0.015368,0,0
1,GO GLUCOSE IMPORT,0.36064,0.010433,-0.062394,0,0
1,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.80989,0.010168,0.032565,0,0
1,GO REGULATION OF MITOCHONDRIAL FISSION,0.84397,0.010089,0.014561,0,0
1,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.9686,0.010005,-0.03507,0,0
1,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.96163,0.0097933,-0.0035404,0,0
1,GO AORTA MORPHOGENESIS,0.84397,0.0096129,0.12662,0,0
1,GO RESPONSE TO NITROGEN COMPOUND,0.3746,0.0095524,0.024184,0,0
1,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.53167,0.0094272,-0.02078,0,0
1,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.80989,0.0090649,0.033848,0,0
1,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.69061,0.0089561,0.02858,0,0
1,GO DNA METHYLATION OR DEMETHYLATION,0.34256,0.0088834,0.053318,0,0
1,GO DNA DOUBLE STRAND BREAK PROCESSING,0.96163,0.0087368,0.0024594,0,0
1,GO STEROID BIOSYNTHETIC PROCESS,0.72969,0.0087181,-0.0484,0,0
1,GO PROTEIN COMPLEX OLIGOMERIZATION,0.79636,0.0087019,0.0062137,0,0
1,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.8303,0.0086359,-0.02384,0,0
1,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.5726,0.0084504,0.046314,0,0
1,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.80989,0.0083471,0.007477,0,0
1,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.80312,0.0083381,0.030997,0,0
1,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.33812,0.0083347,-0.06942,0,0
1,GO ZINC ION HOMEOSTASIS,0.84397,0.0082495,0.041887,0,0
1,GO SKIN EPIDERMIS DEVELOPMENT,0.94769,0.0081392,0.044278,0,0
1,GO REGULATION OF CALCIUM ION TRANSPORT,0.91987,0.0080072,0.00086796,0,0
1,GO REGULATION OF CHROMATIN ORGANIZATION,0.89907,0.0079758,0.0044391,0,0
1,GO PANCREATIC JUICE SECRETION,0.79636,0.0077407,0.036838,0,0
1,GO MICROTUBULE NUCLEATION,0.79636,0.0076721,-0.01065,0,0
1,GO MESENCHYMAL CELL PROLIFERATION,0.73628,0.0076571,0.053419,0,0
1,GO ORGAN INDUCTION,0.32938,0.0072145,0.078405,0,0
1,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.35607,0.0068661,0.082957,0,0
1,GO L SERINE METABOLIC PROCESS,0.60883,0.0067769,0.030511,0,0
1,GO POSITIVE REGULATION OF GROWTH,0.89907,0.0067018,0.004681,0,0
1,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.85082,0.0066901,0.0012188,0,0
1,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.99651,0.0066548,-0.022089,0,0
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.90599,0.0066194,0.031082,0,0
1,GO POSITIVE REGULATION OF CYTOKINESIS,0.98255,0.0064278,0.016281,0,0
1,GO RESPONSE TO ORGANOPHOSPHORUS,0.4545,0.0063467,0.056624,0,0
1,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.76281,0.0062774,-0.008204,0,0
1,GO PEPTIDYL LYSINE MODIFICATION,0.63978,0.0061204,-0.020469,0,0
1,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.96163,0.006109,-0.0089163,0,0
1,GO CELLULAR RESPONSE TO FATTY ACID,0.85082,0.0059997,-0.0012011,0,0
1,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.72969,0.0059004,-0.013907,0,0
1,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.94769,0.0058778,0.0059692,0,0
1,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.22905,0.0058593,0.052814,0,0
1,GO POSITIVE REGULATION OF GLIOGENESIS,0.66501,0.0057878,0.023971,0,0
1,GO HETEROTYPIC CELL CELL ADHESION,0.57857,0.00576,0.041739,0,0
1,GO SARCOMERE ORGANIZATION,0.75615,0.0057011,0.052285,0,0
1,GO STRESS GRANULE ASSEMBLY,0.56075,0.0056795,-0.035309,0,0
1,GO ORGANOPHOSPHATE ESTER TRANSPORT,0.71006,0.0056082,-0.032398,0,0
1,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.92682,0.0055483,-0.038498,0,0
1,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.58456,0.0052667,0.0067976,0,0
1,GO B CELL HOMEOSTASIS,0.59059,0.0051746,0.025432,0,0
1,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.9686,0.0051197,0.007677,0,0
1,GO TELOMERIC LOOP DISASSEMBLY,0.7495,0.0050277,0.01665,0,0
1,GO REGULATION OF GROWTH,0.48131,0.0047398,0.018365,0,0
1,GO RESPONSE TO GROWTH HORMONE,0.72969,0.004669,0.036892,0,0
1,GO SNORNA METABOLIC PROCESS,0.76948,0.0046267,-0.0065935,0,0
1,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.60272,0.0043921,0.096716,0,0
1,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.59059,0.0042596,0.044414,0,0
1,GO NEGATIVE REGULATION OF CELL GROWTH,0.76281,0.0041331,0.0040622,0,0
1,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.98953,0.0040743,-0.010897,0,0
1,GO MUSCLE CELL DIFFERENTIATION,0.40349,0.0035238,0.059692,0,0
1,GO ADHESION OF SYMBIONT TO HOST,0.18508,0.0034959,0.19211,0,0
1,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.82348,0.0033953,0.0086286,0,0
1,GO REGULATION OF CELLULAR PH,0.87833,0.0032145,-0.0041584,0,0
1,GO APPENDAGE DEVELOPMENT,0.99651,0.0030334,0.018715,0,0
1,GO PROTEIN HOMOOLIGOMERIZATION,0.77618,0.0029631,-0.010865,0,0
1,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.78289,0.002955,-0.013643,0,0
1,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.91987,0.0028732,0.029264,0,0
1,GO REGULATION OF GUANYLATE CYCLASE ACTIVITY,0.5726,0.0027906,-0.11448,0,0
1,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.76948,0.0025742,0.025937,0,0
1,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.99651,0.0024112,0.0035709,0,0
1,GO FUCOSYLATION,0.61497,0.0022545,-0.039425,0,0
1,GO RESPONSE TO MECHANICAL STIMULUS,0.94073,0.0018591,0.0071259,0,0
1,GO ALCOHOL BIOSYNTHETIC PROCESS,0.74288,0.001847,-0.028036,0,0
1,GO REGULATION OF GLUCONEOGENESIS,0.85768,0.0018253,-0.010074,0,0
1,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.44924,0.0016388,0.073991,0,0
1,GO REGULATION OF PROTEIN TARGETING,0.63978,0.0015472,0.019716,0,0
1,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.87833,0.0012256,0.026613,0,0
1,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.78962,0.0011268,-0.026614,0,0
1,GO CELLULAR RESPONSE TO ZINC ION,0.85768,0.00076696,-0.048713,0,0
1,GO POSITIVE REGULATION OF TRANSPORT,0.85768,0.00071729,0.00064048,0,0
1,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.58456,0.00068242,0.044617,0,0
1,GO NEGATIVE CHEMOTAXIS,0.68418,0.00059101,0.018138,0,0
1,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.74288,0.00057775,-0.030806,0,0
1,GO TAXIS,0.60272,0.00055706,0.0070367,0,0
1,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.89907,0.00043354,0.011249,0,0
1,GO 3 UTR MEDIATED MRNA STABILIZATION,0.4545,0.00023964,0.09011,0,0
1,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.74288,0.00011649,-0.020067,0,0
1,GO REGULATION OF GOLGI ORGANIZATION,0.78289,-0.00032872,0.027779,0,0
1,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.94769,-0.00074357,-0.0073125,0,0
1,GO GLAND DEVELOPMENT,0.40843,-0.00078003,0.041082,0,0
1,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.9686,-0.00081968,0.041751,0,0
1,GO UV PROTECTION,0.65234,-0.00089702,0.062269,0,0
1,GO REGULATION OF PH,0.98953,-0.00093359,-0.015561,0,0
1,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.96163,-0.00093799,-0.001738,0,0
1,GO DNA PACKAGING,0.81668,-0.0010755,0.00077447,0,0
1,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.63978,-0.0012403,0.071593,0,0
1,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.93377,-0.0013098,-0.0029942,0,0
1,GO MEIOTIC CELL CYCLE,0.91987,-0.0014108,0.01921,0,0
1,GO CARBOHYDRATE TRANSPORT,0.72969,-0.0015082,-0.033413,0,0
1,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.34256,-0.0016425,0.10425,0,0
1,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.30815,-0.0017501,0.072112,0,0
1,GO NEGATIVE REGULATION OF PROTEIN SUMOYLATION,0.40349,-0.0020833,0.14242,0,0
1,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.91293,-0.0021318,0.043442,0,0
1,GO REPLICATION FORK PROCESSING,0.67137,-0.0022801,0.063156,0,0
1,GO MOLTING CYCLE,0.96163,-0.0023157,0.048621,0,0
1,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,0.83713,-0.0023557,-0.0098257,0,0
1,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.79636,-0.002362,-0.024284,0,0
1,GO INTERSTRAND CROSS LINK REPAIR,0.63354,-0.0026689,0.01272,0,0
1,GO ATP TRANSPORT,0.95466,-0.0028,-0.0096792,0,0
1,GO RESPONSE TO BMP,0.46512,-0.0029235,0.054523,0,0
1,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.91987,-0.0029491,-0.002217,0,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.71658,-0.0030207,0.051497,0,0
1,GO METHYLATION,0.94073,-0.0031648,0.0040062,0,0
1,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.75615,-0.0032135,0.050454,0,0
1,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.7495,-0.003231,-0.016904,0,0
1,GO HISTONE H2A UBIQUITINATION,0.96163,-0.0033038,0.0085122,0,0
1,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.83713,-0.0034376,0.016348,0,0
1,GO TOR SIGNALING,0.54321,-0.0036529,-0.017432,0,0
1,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.64605,-0.0039513,0.041895,0,0
1,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,0.77618,-0.0039871,-0.017608,0,0
1,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.84397,-0.0040201,0.017502,0,0
1,GO RETINA HOMEOSTASIS,0.72969,-0.0040532,-0.030267,0,0
1,GO SIGNAL PEPTIDE PROCESSING,0.59664,-0.0040554,0.039991,0,0
1,GO METHIONINE BIOSYNTHETIC PROCESS,0.66501,-0.0040767,-0.070489,0,0
1,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.91987,-0.0040953,-0.0015516,0,0
1,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.87144,-0.0041661,0.012175,0,0
1,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.36991,-0.0042729,0.062516,0,0
1,GO NUCLEOSOME ORGANIZATION,0.86455,-0.0048712,-0.013902,0,0
1,GO RESPONSE TO AMYLOID BETA,0.89215,-0.0050477,0.013941,0,0
1,GO PROTEIN O LINKED MANNOSYLATION,0.74288,-0.005098,-0.031561,0,0
1,GO REGULATION OF ENDOCYTIC RECYCLING,0.56666,-0.0051576,-0.075083,0,0
1,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.93377,-0.0053929,-0.0073345,0,0
1,GO PROTEIN HETEROTETRAMERIZATION,0.49227,-0.0054378,-0.045079,0,0
1,GO DEFINITIVE HEMOPOIESIS,0.9686,-0.0054953,0.0083138,0,0
1,GO SINGLE STRAND BREAK REPAIR,0.88523,-0.0055247,0.0035831,0,0
1,GO POSITIVE REGULATION OF CELL GROWTH,0.53167,-0.0056576,-0.031963,0,0
1,GO HEPATOCYTE APOPTOTIC PROCESS,0.62113,-0.0057069,0.12535,0,0
1,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.62113,-0.0058327,0.03429,0,0
1,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.89907,-0.0059612,0.006032,0,0
1,GO MEIOSIS I CELL CYCLE PROCESS,0.74288,-0.005991,0.034788,0,0
1,GO SEQUESTERING OF ACTIN MONOMERS,0.68418,-0.0060184,0.017997,0,0
1,GO RESPONSE TO COLD,0.40843,-0.0061696,-0.08443,0,0
1,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.87144,-0.0062998,0.019003,0,0
1,GO MUSCLE CELL DEVELOPMENT,0.8303,-0.0063392,0.04095,0,0
1,GO SINGLE FERTILIZATION,0.46512,-0.0063968,-0.035726,0,0
1,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.95466,-0.0065943,-0.044158,0,0
1,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.44924,-0.0066986,-0.061737,0,0
1,GO SNORNA 3 END PROCESSING,0.81668,-0.0068445,-0.013432,0,0
1,GO CELLULAR HOMEOSTASIS,0.59059,-0.0071592,0.011974,0,0
1,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.79636,-0.0074709,0.00012411,0,0
1,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.72313,-0.0075936,-0.052614,0,0
1,GO REGULATION OF RNA SPLICING,0.88523,-0.0076035,-0.019755,0,0
1,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.84397,-0.0079973,-0.013254,0,0
1,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,0.92682,-0.008039,-0.00021337,0,0
1,GO CARDIAC CELL FATE COMMITMENT,0.67776,-0.0082448,-0.071876,0,0
1,GO PROTEIN LOCALIZATION TO CHROMATIN,0.84397,-0.0082558,0.038591,0,0
1,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.1313,-0.0084851,-0.070327,0,0
1,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.41842,-0.0084982,-0.10843,0,0
1,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.46512,-0.0085606,0.22596,0,0
1,GO LEYDIG CELL DIFFERENTIATION,0.85768,-0.0086654,-0.030752,0,0
1,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.44402,-0.0087254,-0.076764,0,0
1,GO REGULATION OF MRNA PROCESSING,0.97557,-0.0087996,-0.010473,0,0
1,GO NUCLEOTIDE TRANSPORT,0.4978,-0.0089596,-0.052874,0,0
1,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,0.47588,-0.0090263,-0.05762,0,0
1,GO ONE CARBON COMPOUND TRANSPORT,0.82348,-0.0092098,-0.022756,0,0
1,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.25363,-0.0092463,-0.086429,0,0
1,GO REGULATION OF RENAL SYSTEM PROCESS,0.73628,-0.0093563,0.030788,0,0
1,GO O GLYCAN PROCESSING,0.98953,-0.0093573,-0.024858,0,0
1,GO REGULATION OF CELL FATE SPECIFICATION,0.48678,-0.0097058,0.12571,0,0
1,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.54321,-0.0097587,-0.042735,0,0
1,GO CHEMICAL HOMEOSTASIS,0.29586,-0.010283,-0.041121,0,0
1,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.66501,-0.010521,-0.048294,0,0
1,GO PROSTATE GLAND GROWTH,0.70355,-0.010952,0.16183,0,0
1,GO MUSCLE ORGAN MORPHOGENESIS,0.59664,-0.01108,0.065416,0,0
1,GO ARACHIDONIC ACID SECRETION,0.41341,-0.011108,-0.092539,0,0
1,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.37932,-0.011143,-0.088567,0,0
1,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.42855,-0.011285,-0.046148,0,0
1,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.88523,-0.011315,0.026005,0,0
1,GO CELL PROLIFERATION IN FOREBRAIN,0.92682,-0.011327,-0.038959,0,0
1,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.55487,-0.01138,0.053145,0,0
1,GO COVALENT CHROMATIN MODIFICATION,0.4978,-0.011477,-0.017108,0,0
1,GO RETINOIC ACID METABOLIC PROCESS,0.74288,-0.011482,-0.018979,0,0
1,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.81668,-0.011534,-0.025965,0,0
1,GO ENERGY RESERVE METABOLIC PROCESS,0.90599,-0.011553,0.0018445,0,0
1,GO NUCLEOSOME ASSEMBLY,0.62732,-0.01162,-0.038456,0,0
1,GO DNA STRAND ELONGATION,0.40349,-0.011679,-0.065884,0,0
1,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.50337,-0.011775,-0.032484,0,0
1,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.89907,-0.011964,-0.009063,0,0
1,GO MICROTUBULE ANCHORING,0.91293,-0.012188,0.0039443,0,0
1,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.89215,-0.012236,1.9233e-05,0,0
1,GO HISTAMINE TRANSPORT,0.9686,-0.012581,-0.019464,0,0
1,GO RENAL TUBULE DEVELOPMENT,0.41341,-0.012776,0.093754,0,0
1,GO FRUCTOSE METABOLIC PROCESS,0.59059,-0.012915,-0.098626,0,0
1,GO REGULATION OF FATTY ACID TRANSPORT,0.94769,-0.013086,0.0061894,0,0
1,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.7495,-0.013147,-0.018265,0,0
1,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.42347,-0.013247,-0.049274,0,0
1,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.55487,-0.013291,-0.048858,0,0
1,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.89907,-0.013929,-0.023796,0,0
1,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.90599,-0.014131,0.0092627,0,0
1,GO BIOMINERALIZATION,0.54321,-0.014146,0.070986,0,0
1,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.99651,-0.014376,-0.014639,0,0
1,GO NEPHRON MORPHOGENESIS,0.59664,-0.014495,0.039367,0,0
1,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.54903,-0.014569,0.044957,0,0
1,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.2839,-0.014722,-0.047539,0,0
1,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.94073,-0.014805,0.010551,0,0
1,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.98255,-0.01509,0.016438,0,0
1,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.40349,-0.015167,-0.05661,0,0
1,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.12259,-0.015337,-0.10372,0,0
1,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.71658,-0.015874,-0.01393,0,0
1,GO RADIAL GLIAL CELL DIFFERENTIATION,0.75615,-0.015929,-0.040449,0,0
1,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.71658,-0.015995,-0.0098331,0,0
1,GO THYMIC T CELL SELECTION,0.88523,-0.016054,-0.0044366,0,0
1,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.98953,-0.016404,-0.0051629,0,0
1,GO REGULATION OF CELL DIFFERENTIATION,0.78289,-0.016473,-0.0069666,0,0
1,GO CELLULAR RESPONSE TO MANGANESE ION,0.80312,-0.016514,0.0054221,0,0
1,GO REGULATION OF CELLULAR LOCALIZATION,0.61497,-0.016531,-0.017448,0,0
1,GO REGULATION OF NEUROBLAST PROLIFERATION,0.87833,-0.01692,0.0038722,0,0
1,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.99651,-0.016949,0.024016,0,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.99651,-0.016959,0.0045993,0,0
1,GO CELL CELL JUNCTION ASSEMBLY,0.63354,-0.01728,0.023194,0,0
1,GO LYSOSOME LOCALIZATION,0.59059,-0.017471,-0.028317,0,0
1,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.7495,-0.017739,0.029653,0,0
1,GO QUINONE METABOLIC PROCESS,0.56666,-0.017886,-0.0019581,0,0
1,GO REGULATION OF LYASE ACTIVITY,0.48131,-0.018204,-0.058685,0,0
1,GO SEXUAL REPRODUCTION,0.72969,-0.018466,-0.018879,0,0
1,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.40349,-0.018488,-0.12184,0,0
1,GO GPI ANCHOR METABOLIC PROCESS,0.52025,-0.018857,-0.036806,0,0
1,GO VENTRICULAR SEPTUM DEVELOPMENT,0.36526,-0.018979,0.091834,0,0
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.75615,-0.018999,-0.023588,0,0
1,GO KIDNEY EPITHELIUM DEVELOPMENT,0.49227,-0.019194,0.076702,0,0
1,GO SEX DIFFERENTIATION,0.9686,-0.019303,0.0064538,0,0
1,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.56666,-0.019533,0.043829,0,0
1,GO CARBOHYDRATE PHOSPHORYLATION,0.83713,-0.019613,-0.0092295,0,0
1,GO MITOCHONDRIAL FUSION,0.79636,-0.019718,0.0057753,0,0
1,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.61497,-0.019855,-0.044875,0,0
1,GO PEROXISOMAL MEMBRANE TRANSPORT,0.59059,-0.01992,-0.038195,0,0
1,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.67137,-0.020313,-0.049147,0,0
1,GO LIPOSACCHARIDE METABOLIC PROCESS,0.17374,-0.020545,-0.068486,0,0
1,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.64605,-0.020551,-0.061718,0,0
1,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.87144,-0.020581,0.039521,0,0
1,GO RESPONSE TO LIGHT STIMULUS,0.24288,-0.020708,-0.038911,0,0
1,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.90599,-0.020838,0.024097,0,0
1,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.4598,-0.021056,-0.037228,0,0
1,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,0.96163,-0.021257,0.045952,0,0
1,GO SMOOTH MUSCLE CONTRACTION,0.78962,-0.021477,-0.0027645,0,0
1,GO PURINE NUCLEOTIDE TRANSPORT,0.53742,-0.02217,-0.042442,0,0
1,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.4978,-0.022224,-0.021692,0,0
1,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.72969,-0.022322,-0.0014214,0,0
1,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.50337,-0.022408,-0.025501,0,0
1,GO LYMPH NODE DEVELOPMENT,0.87144,-0.022506,0.062063,0,0
1,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.48131,-0.022777,-0.07196,0,0
1,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.93377,-0.023021,-0.035202,0,0
1,GO LIPID EXPORT FROM CELL,0.94073,-0.023226,-0.0064461,0,0
1,GO GLIAL CELL PROLIFERATION,0.70355,-0.023571,0.029826,0,0
1,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.92682,-0.023648,-0.015202,0,0
1,GO MANNOSYLATION,0.97557,-0.023953,-0.015156,0,0
1,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.71006,-0.024082,-0.0035622,0,0
1,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.26471,-0.024096,-0.073745,0,0
1,GO EXIT FROM MITOSIS,0.72969,-0.024208,-0.015241,0,0
1,GO GAMETE GENERATION,0.77618,-0.024593,-0.015862,0,0
1,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.98953,-0.024659,-0.00080513,0,0
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.85082,-0.024731,0.0066259,0,0
1,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.56666,-0.02477,-0.039299,0,0
1,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.53167,-0.025054,0.054771,0,0
1,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.8303,-0.025107,-0.037948,0,0
1,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.59664,-0.025166,-0.034732,0,0
1,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.31232,-0.025293,-0.057484,0,0
1,GO DRUG CATABOLIC PROCESS,0.93377,-0.025323,0.0055193,0,0
1,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.32077,-0.025348,-0.01873,0,0
1,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.79636,-0.025485,-0.013867,0,0
1,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.52025,-0.025614,-0.015252,0,0
1,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.54321,-0.025755,0.1136,0,0
1,GO REGULATION OF BONE REMODELING,0.92682,-0.025975,-0.011323,0,0
1,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.60272,-0.025982,-0.046086,0,0
1,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.73628,-0.02615,-0.025797,0,0
1,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.54903,-0.026187,0.00081858,0,0
1,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.98953,-0.026223,0.017938,0,0
1,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.3746,-0.026346,-0.033959,0,0
1,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.95466,-0.026367,0.026501,0,0
1,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.91293,-0.026431,0.011437,0,0
1,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.48131,-0.027128,0.079361,0,0
1,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.98953,-0.027145,0.027773,0,0
1,GO MUSCLE SYSTEM PROCESS,0.86455,-0.02745,-0.0044828,0,0
1,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.72313,-0.027555,-0.010789,0,0
1,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.74288,-0.027588,-0.022541,0,0
1,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,0.70355,-0.027607,-0.077766,0,0
1,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.73628,-0.027612,0.059451,0,0
1,GO C4 DICARBOXYLATE TRANSPORT,0.85768,-0.02777,0.0013544,0,0
1,GO DEVELOPMENTAL GROWTH,0.54903,-0.02788,-0.020537,0,0
1,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.56666,-0.028138,0.064585,0,0
1,GO ARACHIDONIC ACID METABOLIC PROCESS,0.76948,-0.028225,-0.0075701,0,0
1,GO SPLEEN DEVELOPMENT,0.87833,-0.028422,0.029875,0,0
1,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.87833,-0.028692,0.0095876,0,0
1,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.27227,-0.028757,-0.13619,0,0
1,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.52594,-0.028846,-0.013891,0,0
1,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.57857,-0.028854,-0.036574,0,0
1,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.8303,-0.029044,-0.015382,0,0
1,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.78289,-0.029495,0.016312,0,0
1,GO MALE GAMETE GENERATION,0.35153,-0.02985,-0.031417,0,0
1,GO REGULATION OF MITOCHONDRIAL FUSION,0.41842,-0.029866,-0.04726,0,0
1,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.88523,-0.030069,-0.0063389,0,0
1,GO HISTAMINE SECRETION,0.56666,-0.030177,0.053297,0,0
1,GO MUSCLE TISSUE DEVELOPMENT,0.9686,-0.030475,0.026135,0,0
1,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.92682,-0.03048,0.040317,0,0
1,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.61497,-0.030481,-0.038894,0,0
1,GO SKELETAL MUSCLE CONTRACTION,0.26847,-0.03063,-0.094783,0,0
1,GO SECONDARY METABOLIC PROCESS,0.83713,-0.030768,-0.035075,0,0
1,GO APPENDAGE MORPHOGENESIS,0.65234,-0.03115,-0.014079,0,0
1,GO REGULATION OF PHOSPHATASE ACTIVITY,0.25363,-0.031185,-0.043048,0,0
1,GO CELLULAR RESPONSE TO STEROL,0.46512,-0.031215,-0.043119,0,0
1,GO GLUCOSE METABOLIC PROCESS,0.54321,-0.031325,-0.030534,0,0
1,GO ZINC ION TRANSPORT,0.69061,-0.031351,0.03084,0,0
1,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,0.15015,-0.031516,-0.072049,0,0
1,GO REGULATION OF DEPHOSPHORYLATION,0.44924,-0.031685,-0.030241,0,0
1,GO EPIDERMAL CELL DIFFERENTIATION,0.93377,-0.031724,0.050432,0,0
1,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.41842,-0.031744,-0.094534,0,0
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.62732,-0.031754,-0.0024299,0,0
1,GO HISTONE H3 K9 TRIMETHYLATION,0.60883,-0.031783,-0.029398,0,0
1,GO THIOESTER BIOSYNTHETIC PROCESS,0.4978,-0.031894,-0.048239,0,0
1,GO GLIOGENESIS,0.5726,-0.031936,-0.025989,0,0
1,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.54903,-0.031958,-0.08133,0,0
1,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.91987,-0.032033,-0.004154,0,0
1,GO ORGANELLE LOCALIZATION,0.17099,-0.032192,-0.039524,0,0
1,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.5726,-0.032254,-0.014685,0,0
1,GO STEM CELL PROLIFERATION,0.56666,-0.032641,-0.038117,0,0
1,GO KERATINOCYTE DEVELOPMENT,0.85768,-0.032948,-0.023294,0,0
1,GO PLASMA MEMBRANE REPAIR,0.76281,-0.03299,-0.12649,0,0
1,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.64605,-0.033019,-0.0095901,0,0
1,GO VITAMIN CATABOLIC PROCESS,0.20309,-0.03311,-0.17325,0,0
1,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.61497,-0.033155,-0.068632,0,0
1,GO MULTICELLULAR ORGANISM GROWTH,0.18508,-0.033241,-0.048526,0,0
1,GO T CELL SELECTION,0.71006,-0.033423,0.032591,0,0
1,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.47588,-0.033614,-0.027646,0,0
1,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,0.91293,-0.033708,0.029289,0,0
1,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.7495,-0.033775,-0.030289,0,0
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.59059,-0.034107,-0.029444,0,0
1,GO BLASTOCYST DEVELOPMENT,0.62113,-0.034196,-0.014215,0,0
1,GO INTERLEUKIN 10 PRODUCTION,0.97557,-0.034244,0.038527,0,0
1,GO PIGMENTATION,0.58456,-0.034285,-0.0056531,0,0
1,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.76948,-0.034306,0.015578,0,0
1,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.39371,-0.034423,-0.036292,0,0
1,GO REGULATION OF MUSCLE CONTRACTION,0.41341,-0.034426,-0.030094,0,0
1,GO POSITIVE REGULATION OF PEPTIDE SECRETION,0.28785,-0.034585,-0.050773,0,0
1,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.59664,-0.034782,-0.059386,0,0
1,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.4545,-0.034795,-0.080988,0,0
1,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.98953,-0.034813,0.017396,0,0
1,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,0.62113,-0.035199,-0.051942,0,0
1,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.16032,-0.035355,-0.095753,0,0
1,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.82348,-0.035647,0.027651,0,0
1,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.65234,-0.035711,-0.013337,0,0
1,GO REGULATION OF ENDOCRINE PROCESS,0.98953,-0.035803,0.0018631,0,0
1,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.74288,-0.035901,-0.016595,0,0
1,GO MAINTENANCE OF BLOOD BRAIN BARRIER,0.89215,-0.035976,0.013676,0,0
1,GO HETEROCHROMATIN ORGANIZATION,0.67137,-0.036289,-0.011447,0,0
1,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.26471,-0.036502,-0.047439,0,0
1,GO CELL GROWTH,0.52594,-0.036691,-0.024388,0,0
1,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.42347,-0.036705,0.052057,0,0
1,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.48131,-0.036863,-0.040151,0,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.88523,-0.037109,0.013249,0,0
1,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.4598,-0.037109,-0.045889,0,0
1,GO RESPONSE TO FATTY ACID,0.54321,-0.037439,-0.013843,0,0
1,GO CARDIAC VENTRICLE DEVELOPMENT,0.90599,-0.037509,0.029365,0,0
1,GO CELL CYCLE DNA REPLICATION,0.4598,-0.037617,-0.049981,0,0
1,GO ORGANELLE MEMBRANE FUSION,0.27999,-0.037661,-0.073225,0,0
1,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.47049,-0.037777,-0.042485,0,0
1,GO REGULATION OF MICROTUBULE BASED PROCESS,0.11235,-0.037955,-0.070158,0,0
1,GO DIVALENT INORGANIC CATION TRANSPORT,0.23589,-0.038264,-0.043448,0,0
1,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.40843,-0.038433,-0.082668,0,0
1,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.49227,-0.038515,-0.013039,0,0
1,GO OOGENESIS,0.17099,-0.03852,-0.066732,0,0
1,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.37932,-0.038547,-0.10376,0,0
1,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.47049,-0.038618,-0.081402,0,0
1,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.67776,-0.038846,-0.02304,0,0
1,GO REGULATORY T CELL DIFFERENTIATION,0.88523,-0.038971,0.019296,0,0
1,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,0.12908,-0.03907,-0.076188,0,0
1,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.15773,-0.039076,-0.071493,0,0
1,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.34256,-0.039195,-0.070329,0,0
1,GO ACTIN FILAMENT BASED MOVEMENT,0.59059,-0.039337,-0.017442,0,0
1,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.17099,-0.039348,-0.061393,0,0
1,GO RESPONSE TO AXON INJURY,0.36526,-0.039354,-0.074348,0,0
1,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.23937,-0.039626,-0.16145,0,0
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.95466,-0.039647,0.009399,0,0
1,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.80989,-0.03999,0.0020358,0,0
1,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.44924,-0.040603,-0.070739,0,0
1,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.91293,-0.040686,0.00011589,0,0
1,GO SPERM MOTILITY,0.17099,-0.041421,-0.077212,0,0
1,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.43367,-0.041442,-0.10287,0,0
1,GO PROTEIN INSERTION INTO MEMBRANE,0.42855,-0.041512,-0.049879,0,0
1,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.079444,-0.041629,-0.080353,0,0
1,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.98953,-0.041707,-0.013062,0,0
1,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.77618,-0.041782,-0.020952,0,0
1,GO CHROMATIN ORGANIZATION,0.31232,-0.041857,-0.025016,0,0
1,GO PEPTIDYL LYSINE ACETYLATION,0.066855,-0.041878,-0.058965,0,0
1,GO MEMBRANE LIPID METABOLIC PROCESS,0.2,-0.042151,-0.057572,0,0
1,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.47049,-0.042322,-0.020479,0,0
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.80989,-0.042724,0.014492,0,0
1,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.1028,-0.042849,-0.068014,0,0
1,GO MITOCHONDRION MORPHOGENESIS,0.51459,-0.042896,-0.014019,0,0
1,GO PROTEIN DEPHOSPHORYLATION,0.2,-0.043288,-0.042859,0,0
1,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.72969,-0.043381,-0.0014679,0,0
1,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.71658,-0.043935,-0.022035,0,0
1,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.44924,-0.04416,-0.049671,0,0
1,GO SPHINGOLIPID METABOLIC PROCESS,0.23245,-0.044561,-0.054037,0,0
1,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.32938,-0.044603,-0.058648,0,0
1,GO DRINKING BEHAVIOR,0.37932,-0.044622,-0.098152,0,0
1,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.32077,-0.044781,-0.036809,0,0
1,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.50337,-0.044831,-0.038478,0,0
1,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.38888,-0.045175,-0.065896,0,0
1,GO MESONEPHROS DEVELOPMENT,0.98255,-0.04523,0.018467,0,0
1,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.16294,-0.04551,-0.077694,0,0
1,GO RESPONSE TO ETHANOL,0.19393,-0.045589,-0.058137,0,0
1,GO REGULATION OF CELL FATE COMMITMENT,0.79636,-0.045606,0.081314,0,0
1,GO REGULATION OF METAL ION TRANSPORT,0.11235,-0.045764,-0.04934,0,0
1,GO DEPHOSPHORYLATION,0.10096,-0.046054,-0.050617,0,0
1,GO MALE MEIOSIS I,0.76948,-0.046327,-0.01238,0,0
1,GO MEMBRANE HYPERPOLARIZATION,0.16294,-0.046467,-0.13087,0,0
1,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.56666,-0.046545,-0.0077278,0,0
1,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.13583,-0.046685,-0.088918,0,0
1,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.22235,-0.046698,-0.067526,0,0
1,GO SPERM CAPACITATION,0.39371,-0.046736,-0.065417,0,0
1,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.25363,-0.046973,-0.12365,0,0
1,GO SUBSTANTIA NIGRA DEVELOPMENT,0.2,-0.047028,-0.065862,0,0
1,GO ALCOHOL CATABOLIC PROCESS,0.53167,-0.047119,-0.003221,0,0
1,GO COBALAMIN METABOLIC PROCESS,0.48678,-0.047223,-0.080146,0,0
1,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.52594,-0.047361,-0.050239,0,0
1,GO REGULATION OF PEPTIDE TRANSPORT,0.15264,-0.047447,-0.044518,0,0
1,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.91987,-0.047624,0.060211,0,0
1,GO PEPTIDYL LYSINE DIMETHYLATION,0.94073,-0.047763,0.00031721,0,0
1,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.4598,-0.047826,-0.014164,0,0
1,GO RESPONSE TO MUSCLE ACTIVITY,0.50337,-0.047852,-0.050388,0,0
1,GO MICROTUBULE BASED PROCESS,0.18219,-0.048614,-0.054847,0,0
1,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.84397,-0.049044,0.0017566,0,0
1,GO BICARBONATE TRANSPORT,0.65866,-0.049155,-0.040564,0,0
1,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.090515,-0.049848,-0.087127,0,0
1,GO PHOSPHATE ION TRANSPORT,0.21905,-0.050037,-0.05793,0,0
1,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.94073,-0.050187,0.016526,0,0
1,GO REGULATION OF CELL MORPHOGENESIS,0.061812,-0.050393,-0.09171,0,0
1,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.35607,-0.050503,-0.082226,0,0
1,GO MUSCLE CONTRACTION,0.53742,-0.050507,-0.022286,0,0
1,GO POSITIVE T CELL SELECTION,0.83713,-0.050708,0.055587,0,0
1,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.27999,-0.050786,-0.057693,0,0
1,GO CONVERGENT EXTENSION,0.79636,-0.050948,-0.03083,0,0
1,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.86455,-0.051146,-0.0021926,0,0
1,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.42347,-0.051167,-0.069811,0,0
1,GO STEROID HORMONE SECRETION,0.53167,-0.051888,-0.069744,0,0
1,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.90599,-0.051899,0.023905,0,0
1,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.78289,-0.052154,-0.0050495,0,0
1,GO ECTODERM DEVELOPMENT,0.32077,-0.052218,-0.019717,0,0
1,GO ORGANELLE FUSION,0.17934,-0.05232,-0.067556,0,0
1,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.75615,-0.052617,-0.012731,0,0
1,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.94769,-0.052843,0.083349,0,0
1,GO REGULATION OF CHOLESTEROL ESTERIFICATION,0.44402,-0.052968,-0.09814,0,0
1,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.35153,-0.053055,-0.03963,0,0
1,GO MAGNESIUM ION HOMEOSTASIS,0.41341,-0.053061,-0.0072442,0,0
1,GO DEMETHYLATION,0.46512,-0.05315,-0.011394,0,0
1,GO NEURON DEATH,0.068167,-0.053484,-0.060936,0,0
1,GO STEROID CATABOLIC PROCESS,0.98255,-0.053569,-0.0089745,0,0
1,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.13583,-0.053809,-0.096477,0,0
1,GO REGULATION OF FEEDING BEHAVIOR,0.26847,-0.054139,-0.08356,0,0
1,GO RESPONSE TO STARVATION,0.16559,-0.054272,-0.066652,0,0
1,GO DOSAGE COMPENSATION,0.70355,-0.054625,-0.0066102,0,0
1,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.63354,-0.054872,-0.051138,0,0
1,GO ASTRAL MICROTUBULE ORGANIZATION,0.22568,-0.055176,-0.099633,0,0
1,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.3746,-0.055292,-0.045759,0,0
1,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.74288,-0.055385,0.010224,0,0
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.20937,-0.055394,-0.083713,0,0
1,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.064293,-0.05565,-0.10682,0,0
1,GO AXON EXTENSION,0.18219,-0.056545,-0.093474,0,0
1,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.62113,-0.05665,-0.0081538,0,0
1,GO REGULATION OF MEMBRANE REPOLARIZATION,0.13355,-0.057149,-0.1034,0,0
1,GO REGULATION OF PROTEIN ACETYLATION,0.15015,-0.057288,-0.065041,0,0
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.37932,-0.057778,-0.057939,0,0
1,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.85768,-0.057879,0.0072563,0,0
1,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.97557,-0.058272,0.015571,0,0
1,GO ALDEHYDE CATABOLIC PROCESS,0.31653,-0.058317,-0.047379,0,0
1,GO MEMBRANE DOCKING,0.15517,-0.058383,-0.060681,0,0
1,GO RESPIRATORY SYSTEM PROCESS,0.48131,-0.058404,-0.04375,0,0
1,GO T CELL HOMEOSTASIS,0.065563,-0.05849,-0.08136,0,0
1,GO GLIAL CELL DIFFERENTIATION,0.27999,-0.058692,-0.054532,0,0
1,GO REGULATION OF RESPONSE TO FOOD,0.036948,-0.059317,-0.13772,0,0
1,GO PROXIMAL DISTAL PATTERN FORMATION,0.56666,-0.059438,-0.072945,0,0
1,GO GRANULOCYTE DIFFERENTIATION,0.48131,-0.06037,-0.030487,0,0
1,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.75615,-0.060384,-0.0187,0,0
1,GO MAST CELL ACTIVATION,0.16294,-0.060463,-0.1087,0,0
1,GO METANEPHRIC COLLECTING DUCT DEVELOPMENT,0.49227,-0.060483,-0.065627,0,0
1,GO REGULATION OF CELL CYCLE CHECKPOINT,0.32077,-0.060579,-0.032685,0,0
1,GO OUTER DYNEIN ARM ASSEMBLY,0.47049,-0.060646,-0.032503,0,0
1,GO ACTIN MEDIATED CELL CONTRACTION,0.71658,-0.06067,-0.0053145,0,0
1,GO ATP DEPENDENT CHROMATIN REMODELING,0.21905,-0.060823,-0.059947,0,0
1,GO B CELL RECEPTOR SIGNALING PATHWAY,0.30402,-0.060884,-0.084416,0,0
1,GO MYELIN ASSEMBLY,0.65866,-0.060949,-0.029525,0,0
1,GO MYOFIBRIL ASSEMBLY,0.85768,-0.061116,0.036795,0,0
1,GO REGULATION OF CHROMATIN ASSEMBLY,0.23589,-0.061331,-0.091644,0,0
1,GO FEMALE SEX DIFFERENTIATION,0.33812,-0.061684,-0.047993,0,0
1,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,0.40349,-0.061807,-0.074192,0,0
1,GO ACYLGLYCEROL HOMEOSTASIS,0.35153,-0.061913,-0.073422,0,0
1,GO METANEPHROS MORPHOGENESIS,0.53742,-0.061992,-0.063289,0,0
1,GO ER OVERLOAD RESPONSE,0.76281,-0.062297,0.034489,0,0
1,GO CHROMATIN REMODELING,0.31653,-0.062473,-0.055633,0,0
1,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.33812,-0.062555,-0.018183,0,0
1,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.46512,-0.062748,-0.039691,0,0
1,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.076492,-0.063208,-0.10858,0,0
1,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.23589,-0.063247,-0.062097,0,0
1,GO REGULATION OF DEVELOPMENTAL GROWTH,0.035393,-0.063666,-0.081876,0,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.53167,-0.063911,-0.020471,0,0
1,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.72969,-0.063983,0.014331,0,0
1,GO REGULATION OF CELL CYCLE ARREST,0.092194,-0.063993,-0.057051,0,0
1,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.22905,-0.064089,-0.045932,0,0
1,GO REGULATION OF ODONTOGENESIS,0.54903,-0.064309,-0.034601,0,0
1,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.12908,-0.064401,-0.07282,0,0
1,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.87833,-0.06457,0.0060753,0,0
1,GO POST EMBRYONIC DEVELOPMENT,0.47049,-0.064867,-0.027016,0,0
1,GO REGULATION OF DEACETYLASE ACTIVITY,0.8303,-0.065663,-0.0069093,0,0
1,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.15015,-0.06573,-0.15371,0,0
1,GO LOCOMOTOR RHYTHM,0.73628,-0.06598,-0.015496,0,0
1,GO GLUTAMINE METABOLIC PROCESS,0.37932,-0.066035,-0.084339,0,0
1,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.44924,-0.066338,-0.026842,0,0
1,GO PHAGOSOME MATURATION,0.72313,-0.066357,-0.031644,0,0
1,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.52025,-0.066954,-0.075414,0,0
1,GO RESPONSE TO METAL ION,0.21579,-0.067214,-0.049395,0,0
1,GO PRENYLATION,0.49227,-0.068035,-0.078257,0,0
1,GO REGULATION OF DNA METHYLATION,0.95466,-0.068081,0.0027282,0,0
1,GO RESPONSE TO GLUCAGON,0.11841,-0.068504,-0.081729,0,0
1,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.21905,-0.068727,-0.08503,0,0
1,GO CERAMIDE BIOSYNTHETIC PROCESS,0.10465,-0.06878,-0.076003,0,0
1,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.19095,-0.069402,-0.13581,0,0
1,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.21256,-0.069427,-0.1154,0,0
1,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.16294,-0.069436,-0.066098,0,0
1,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.064293,-0.069843,-0.069126,0,0
1,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.080955,-0.06994,-0.10046,0,0
1,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.22235,-0.069959,-0.10023,0,0
1,GO POSITIVE REGULATION OF TOR SIGNALING,0.0695,-0.070242,-0.072422,0,0
1,GO REGULATION OF GLIAL CELL PROLIFERATION,0.52594,-0.070304,-0.0363,0,0
1,GO BONE MINERALIZATION,0.53742,-0.070731,0.020606,0,0
1,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.036948,-0.070934,-0.081666,0,0
1,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.64605,-0.071398,0.11975,0,0
1,GO REGULATION OF GTP BINDING,0.47588,-0.071547,0.088576,0,0
1,GO CARDIAC CHAMBER FORMATION,0.35607,-0.072027,-0.16617,0,0
1,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.86455,-0.072491,-0.028144,0,0
1,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.26471,-0.072584,-0.033639,0,0
1,GO SISTER CHROMATID COHESION,0.52594,-0.072679,-0.039919,0,0
1,GO NEGATIVE REGULATION OF TOR SIGNALING,0.10654,-0.073177,-0.094611,0,0
1,GO PROTEIN CONTAINING COMPLEX REMODELING,0.25363,-0.073261,-0.096021,0,0
1,GO MICROTUBULE ANCHORING AT CENTROSOME,0.29184,-0.073523,-0.059046,0,0
1,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.02268,-0.073927,-0.11829,0,0
1,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.23589,-0.07419,-0.10373,0,0
1,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.061812,-0.074292,-0.18241,0,0
1,GO DIET INDUCED THERMOGENESIS,0.12473,-0.074351,-0.12649,0,0
1,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.10845,-0.074515,-0.055951,0,0
1,GO CELLULAR RESPONSE TO STARVATION,0.10096,-0.074545,-0.077849,0,0
1,GO FATTY ACYL COA METABOLIC PROCESS,0.35607,-0.074548,-0.070217,0,0
1,GO REGULATION OF ACTIN NUCLEATION,0.095625,-0.074608,-0.11284,0,0
1,GO SEGMENTATION,0.21256,-0.074612,-0.047638,0,0
1,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.53167,-0.074911,-0.12858,0,0
1,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.59664,-0.074991,-0.023142,0,0
1,GO LOCALIZATION WITHIN MEMBRANE,0.10465,-0.07504,-0.086765,0,0
1,GO RETINAL CONE CELL DIFFERENTIATION,0.40843,-0.075704,-0.10026,0,0
1,GO ALANINE TRANSPORT,0.11235,-0.075709,-0.14604,0,0
1,GO DIGESTIVE TRACT MORPHOGENESIS,0.41842,-0.075979,-0.049682,0,0
1,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.99651,-0.076214,0.0072531,0,0
1,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.13814,-0.076343,-0.1323,0,0
1,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.53742,-0.076737,-0.071996,0,0
1,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.084046,-0.077175,-0.05176,0,0
1,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.21256,-0.077231,-0.10772,0,0
1,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.068167,-0.077237,-0.10284,0,0
1,GO MITOCHONDRIAL GENOME MAINTENANCE,0.67776,-0.077332,-0.054626,0,0
1,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.31653,-0.07768,-0.10849,0,0
1,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.23245,-0.077801,-0.068572,0,0
1,GO CELL RECOGNITION,0.093897,-0.077916,-0.077128,0,0
1,GO STRIATED MUSCLE ADAPTATION,0.25001,-0.077937,-0.078504,0,0
1,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.29992,-0.078382,-0.068015,0,0
1,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.13814,-0.07856,-0.059139,0,0
1,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.093897,-0.07863,-0.088526,0,0
1,GO REGULATION OF TOR SIGNALING,0.097379,-0.079197,-0.054324,0,0
1,GO VENTRICULAR SYSTEM DEVELOPMENT,0.61497,-0.079261,0.0019505,0,0
1,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.15517,-0.079561,-0.11536,0,0
1,GO MITOCHONDRIAL TRNA PROCESSING,0.73628,-0.079617,0.033569,0,0
1,GO DEVELOPMENTAL INDUCTION,0.090515,-0.079644,-0.11086,0,0
1,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.33812,-0.079805,-0.057132,0,0
1,GO PENILE ERECTION,0.1313,-0.079868,-0.12449,0,0
1,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.055956,-0.080374,-0.14036,0,0
1,GO WATER TRANSPORT,0.057089,-0.080515,-0.10473,0,0
1,GO POLYOL CATABOLIC PROCESS,0.15015,-0.080871,-0.089017,0,0
1,GO CELL MORPHOGENESIS,0.017969,-0.081443,-0.10547,0,0
1,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.37932,-0.081444,-0.065272,0,0
1,GO NON MOTILE CILIUM ASSEMBLY,0.51459,-0.081658,-0.034768,0,0
1,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.087232,-0.081699,-0.13784,0,0
1,GO HISTONE H3 K36 METHYLATION,0.29586,-0.082195,-0.077973,0,0
1,GO BONE MATURATION,0.36991,-0.082357,-0.089128,0,0
1,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.19695,-0.082909,-0.090634,0,0
1,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.66501,-0.082988,0.012334,0,0
1,GO SENSORY SYSTEM DEVELOPMENT,0.40843,-0.0831,-0.035209,0,0
1,GO PIGMENT GRANULE LOCALIZATION,0.20937,-0.083147,-0.06465,0,0
1,GO REGULATION OF AXON GUIDANCE,0.26098,-0.083353,-0.10053,0,0
1,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.54903,-0.083484,-0.025477,0,0
1,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.96163,-0.083488,-0.032115,0,0
1,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.68418,-0.083493,-0.028358,0,0
1,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.18508,-0.083547,-0.073276,0,0
1,GO SYNAPTIC VESICLE BUDDING,0.77618,-0.083567,-0.0073547,0,0
1,GO LINOLEIC ACID METABOLIC PROCESS,0.39371,-0.083642,-0.072735,0,0
1,GO CELL JUNCTION ASSEMBLY,0.21256,-0.083981,-0.047902,0,0
1,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.068167,-0.084012,-0.10216,0,0
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.39371,-0.084177,-0.035996,0,0
1,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.059411,-0.084312,-0.098395,0,0
1,GO NEGATIVE REGULATION OF NEURON DEATH,0.0066042,-0.084481,-0.094914,0,0
1,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.48678,-0.084859,-0.11356,0,0
1,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.54903,-0.085146,-0.0027039,0,0
1,GO DIGESTIVE SYSTEM DEVELOPMENT,0.21256,-0.085205,-0.059731,0,0
1,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.31232,-0.086054,-0.060517,0,0
1,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.85082,-0.08608,-0.01307,0,0
1,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.072231,-0.086441,-0.080493,0,0
1,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.02268,-0.086489,-0.090609,0,0
1,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.41341,-0.08665,-0.080206,0,0
1,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.043763,-0.086716,-0.084331,0,0
1,GO REGULATION OF CILIUM BEAT FREQUENCY,0.39858,-0.086837,-0.06751,0,0
1,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.31653,-0.086901,-0.066746,0,0
1,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.095625,-0.086931,-0.10318,0,0
1,GO MAST CELL MEDIATED IMMUNITY,0.25001,-0.087325,-0.077856,0,0
1,GO CAMERA TYPE EYE DEVELOPMENT,0.42347,-0.087372,-0.017405,0,0
1,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.25729,-0.087538,-0.072417,0,0
1,GO AMINO ACID IMPORT,0.3746,-0.087543,-0.061589,0,0
1,GO CELLULAR COMPONENT MAINTENANCE,0.061812,-0.087596,-0.11436,0,0
1,GO SENSORY ORGAN MORPHOGENESIS,0.21579,-0.087695,-0.057323,0,0
1,GO RHYTHMIC PROCESS,0.0049174,-0.087755,-0.082677,0,0
1,GO MAGNESIUM ION TRANSPORT,0.15773,-0.087865,-0.088412,0,0
1,GO CARDIAC MUSCLE FIBER DEVELOPMENT,0.095625,-0.087875,-0.12047,0,0
1,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.34702,-0.088169,-0.068941,0,0
1,GO EAR MORPHOGENESIS,0.090515,-0.089167,-0.098636,0,0
1,GO MITOTIC DNA REPLICATION,0.28785,-0.089262,-0.071005,0,0
1,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.32506,-0.089319,-0.08731,0,0
1,GO REGULATION OF CYCLASE ACTIVITY,0.092194,-0.089369,-0.11227,0,0
1,GO PH REDUCTION,0.12259,-0.089952,-0.072959,0,0
1,GO RENAL SYSTEM PROCESS,0.26098,-0.090364,-0.061049,0,0
1,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.60883,-0.090493,-0.026769,0,0
1,GO ADAPTATION OF SIGNALING PATHWAY,0.21579,-0.090784,-0.10098,0,0
1,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.188,-0.091016,-0.12173,0,0
1,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.075049,-0.091359,-0.10002,0,0
1,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.077957,-0.092114,-0.17431,0,0
1,GO GASTRIC ACID SECRETION,0.68418,-0.092486,-0.017981,0,0
1,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.20937,-0.092687,-0.082581,0,0
1,GO HORMONE CATABOLIC PROCESS,0.60272,-0.0929,-0.070039,0,0
1,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.11636,-0.093022,-0.11642,0,0
1,GO NEGATIVE REGULATION OF AXON EXTENSION,0.4978,-0.0932,-0.070298,0,0
1,GO PROTEIN NITROSYLATION,0.30402,-0.09324,-0.10278,0,0
1,GO CILIUM MOVEMENT,0.11841,-0.093383,-0.080416,0,0
1,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.19095,-0.093476,-0.087976,0,0
1,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.26847,-0.093553,-0.031328,0,0
1,GO KIDNEY MORPHOGENESIS,0.50896,-0.093772,-0.029185,0,0
1,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.53167,-0.094012,-0.0047233,0,0
1,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.32938,-0.094227,-0.074287,0,0
1,GO ESTROGEN BIOSYNTHETIC PROCESS,0.56075,-0.094286,-0.039923,0,0
1,GO EXPLORATION BEHAVIOR,0.064293,-0.094317,-0.24491,0,0
1,GO ANATOMICAL STRUCTURE REGRESSION,0.079444,-0.094371,-0.24239,0,0
1,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0040578,-0.094619,-0.15417,0,0
1,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.11039,-0.094739,-0.097606,0,0
1,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.73628,-0.094864,-0.022034,0,0
1,GO ACTIN FILAMENT DEPOLYMERIZATION,0.48131,-0.094892,-0.019256,0,0
1,GO PROTEIN ACYLATION,0.00084609,-0.095026,-0.099282,0,0
1,GO GLYCEROLIPID CATABOLIC PROCESS,0.17653,-0.095186,-0.066087,0,0
1,GO HISTONE H3 K9 MODIFICATION,0.046579,-0.095328,-0.10001,0,0
1,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.53742,-0.095706,-0.023756,0,0
1,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.2839,-0.095894,-0.042026,0,0
1,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.015953,-0.09704,-0.11686,0,0
1,GO ESTROUS CYCLE,0.65866,-0.098024,-0.038346,0,0
1,GO CHEMOSENSORY BEHAVIOR,0.084046,-0.098329,-0.15803,0,0
1,GO CILIUM ORGANIZATION,0.22905,-0.098534,-0.043919,0,0
1,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.39371,-0.09861,-0.0723,0,0
1,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.14048,-0.099156,-0.069704,0,0
1,GO MICROTUBULE BASED TRANSPORT,0.14048,-0.09929,-0.067136,0,0
1,GO REGULATION OF TRANSPORTER ACTIVITY,0.013798,-0.099382,-0.10639,0,0
1,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.15264,-0.099635,-0.073387,0,0
1,GO MESODERMAL CELL FATE COMMITMENT,0.53742,-0.099803,-0.084602,0,0
1,GO GERM CELL DEVELOPMENT,0.040234,-0.099856,-0.081635,0,0
1,GO EMBRYONIC BODY MORPHOGENESIS,0.53742,-0.10048,-0.045216,0,0
1,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.64605,-0.10114,-0.024495,0,0
1,GO PROTEIN MANNOSYLATION,0.25001,-0.10136,-0.066175,0,0
1,GO IMMUNOLOGICAL MEMORY PROCESS,0.84397,-0.10147,0.00029428,0,0
1,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.12689,-0.10181,-0.11448,0,0
1,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.17374,-0.102,-0.056275,0,0
1,GO WHITE FAT CELL DIFFERENTIATION,0.19695,-0.10328,-0.074944,0,0
1,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.56075,-0.10348,-0.056298,0,0
1,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.15773,-0.10398,-0.077468,0,0
1,GO REGULATION OF RECEPTOR CLUSTERING,0.075049,-0.10402,-0.19022,0,0
1,GO CORNIFICATION,0.56075,-0.10419,-0.02174,0,0
1,GO CELLULAR ANION HOMEOSTASIS,0.19695,-0.10425,-0.088382,0,0
1,GO REGULATION OF ICOSANOID SECRETION,0.15264,-0.10429,-0.096844,0,0
1,GO RESPONSE TO MUSCLE STRETCH,0.68418,-0.1043,0.00011863,0,0
1,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.030383,-0.10445,-0.091287,0,0
1,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.48678,-0.10459,-0.018793,0,0
1,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.15773,-0.10485,-0.018492,0,0
1,GO OLIGODENDROCYTE DIFFERENTIATION,0.065563,-0.1052,-0.14514,0,0
1,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.055956,-0.10528,-0.13802,0,0
1,GO PROTEIN DEMETHYLATION,0.092194,-0.10535,-0.12639,0,0
1,GO MIDDLE EAR MORPHOGENESIS,0.98255,-0.10572,0.048353,0,0
1,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.80312,-0.10622,0.026082,0,0
1,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.4598,-0.10669,-0.028792,0,0
1,GO L AMINO ACID TRANSPORT,0.085627,-0.10713,-0.10165,0,0
1,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.80312,-0.10747,0.01136,0,0
1,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.50337,-0.10774,-0.058374,0,0
1,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.0064317,-0.10791,-0.13407,0,0
1,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.30815,-0.10842,-0.10957,0,0
1,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.54321,-0.10865,-0.030058,0,0
1,GO CELL CELL JUNCTION ORGANIZATION,0.67776,-0.10866,-0.016032,0,0
1,GO ACTIVATION OF MAPKKK ACTIVITY,0.39371,-0.10913,-0.068309,0,0
1,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.41341,-0.10914,-0.052031,0,0
1,GO G0 TO G1 TRANSITION,0.1313,-0.10986,-0.061248,0,0
1,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,0.079444,-0.10988,-0.0964,0,0
1,GO CARDIAC CELL DEVELOPMENT,0.27999,-0.11032,-0.024073,0,0
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.2839,-0.1104,-0.12566,0,0
1,GO SENSORY ORGAN DEVELOPMENT,0.073629,-0.11053,-0.080666,0,0
1,GO POSITIVE REGULATION OF HEART RATE,0.5726,-0.11057,-0.023202,0,0
1,GO TORC1 SIGNALING,0.045624,-0.11076,-0.076978,0,0
1,GO PATTERN SPECIFICATION PROCESS,0.064293,-0.1109,-0.10729,0,0
1,GO BASIC AMINO ACID TRANSPORT,0.082489,-0.11105,-0.17752,0,0
1,GO SECRETORY GRANULE ORGANIZATION,0.014841,-0.11112,-0.15879,0,0
1,GO MICROTUBULE BASED MOVEMENT,0.05824,-0.11119,-0.085803,0,0
1,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.49227,-0.11124,-0.029177,0,0
1,GO EXCRETION,0.082489,-0.11128,-0.076503,0,0
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.50337,-0.11182,-0.053942,0,0
1,GO CIRCADIAN RHYTHM,2.8418e-05,-0.11194,-0.13785,0,0
1,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.75615,-0.11202,-0.0033343,0,0
1,GO REGULATION OF EXTENT OF CELL GROWTH,0.024846,-0.11207,-0.14183,0,0
1,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.11841,-0.11217,-0.036275,0,0
1,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.0094949,-0.11239,-0.10252,0,0
1,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.11841,-0.11239,-0.097132,0,0
1,GO NEURON APOPTOTIC PROCESS,0.0007696,-0.11297,-0.11891,0,0
1,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,0.073629,-0.11344,-0.11588,0,0
1,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.14526,-0.11388,-0.18479,0,0
1,GO CARDIAC ATRIUM MORPHOGENESIS,0.67137,-0.1139,-0.004211,0,0
1,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.065563,-0.11411,-0.13867,0,0
1,GO GDP METABOLIC PROCESS,0.093897,-0.1142,-0.198,0,0
1,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.0075304,-0.11433,-0.13429,0,0
1,GO TRANSPORT ALONG MICROTUBULE,0.097379,-0.11435,-0.095342,0,0
1,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.082489,-0.11437,-0.11024,0,0
1,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.53742,-0.11458,-0.0755,0,0
1,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.092194,-0.11504,-0.17201,0,0
1,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.2839,-0.11517,-0.060311,0,0
1,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.36991,-0.11543,-0.075666,0,0
1,GO RESPONSE TO CALCIUM ION,0.070855,-0.11583,-0.096779,0,0
1,GO ROOF OF MOUTH DEVELOPMENT,0.27611,-0.11615,-0.064884,0,0
1,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.2839,-0.11638,-0.06433,0,0
1,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.13355,-0.11652,-0.068114,0,0
1,GO AV NODE CELL TO BUNDLE OF HIS CELL COMMUNICATION,0.19095,-0.11683,-0.11786,0,0
1,GO REGULATION OF SISTER CHROMATID COHESION,0.17653,-0.11687,-0.066185,0,0
1,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.099158,-0.1171,-0.19645,0,0
1,GO SENSORY PERCEPTION OF BITTER TASTE,0.13814,-0.11725,-0.0085036,0,0
1,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.20309,-0.11753,-0.069836,0,0
1,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.017137,-0.11773,-0.15122,0,0
1,GO BROWN FAT CELL DIFFERENTIATION,0.43883,-0.11844,-0.053535,0,0
1,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.36991,-0.11869,-0.059949,0,0
1,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.29586,-0.1187,-0.060918,0,0
1,GO BRAIN MORPHOGENESIS,0.031748,-0.1193,-0.1413,0,0
1,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.2,-0.11979,-0.12021,0,0
1,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.28785,-0.11999,-0.11469,0,0
1,GO REGULATION OF NEURON MIGRATION,0.029068,-0.12009,-0.18165,0,0
1,GO SPERM AXONEME ASSEMBLY,0.21579,-0.12027,-0.12351,0,0
1,GO EYE MORPHOGENESIS,0.22235,-0.1203,-0.046845,0,0
1,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.063042,-0.12037,-0.10799,0,0
1,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.093897,-0.12162,-0.18129,0,0
1,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.1313,-0.12193,-0.11255,0,0
1,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.27999,-0.1221,-0.064232,0,0
1,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.0032441,-0.12251,-0.11569,0,0
1,GO LONG TERM MEMORY,0.025994,-0.12257,-0.16928,0,0
1,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.1028,-0.12268,-0.066554,0,0
1,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.4978,-0.12319,-0.067007,0,0
1,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.00353,-0.1233,-0.17511,0,0
1,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,0.47049,-0.1238,-0.13615,0,0
1,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.068167,-0.12382,-0.088952,0,0
1,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.55487,-0.12418,-0.089347,0,0
1,GO FACIAL NERVE MORPHOGENESIS,0.24643,-0.12434,-0.1636,0,0
1,GO POSITIVE REGULATION OF RNA SPLICING,0.00049035,-0.12446,-0.14158,0,0
1,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,0.12473,-0.12467,-0.1808,0,0
1,GO SOMITE DEVELOPMENT,0.010506,-0.12501,-0.11285,0,0
1,GO OXIDATIVE DEMETHYLATION,0.065563,-0.12586,-0.1031,0,0
1,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.00026003,-0.12588,-0.15038,0,0
1,GO REGULATION OF CELL DEVELOPMENT,0.0014299,-0.12597,-0.14513,0,0
1,GO KERATINIZATION,0.35153,-0.12627,-0.050749,0,0
1,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.72969,-0.12683,0.14187,0,0
1,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.075049,-0.12712,-0.12043,0,0
1,GO HISTONE METHYLATION,0.025994,-0.12712,-0.10724,0,0
1,GO INCLUSION BODY ASSEMBLY,0.30815,-0.12715,-0.12994,0,0
1,GO RESPONSE TO INACTIVITY,0.24643,-0.12786,-0.090575,0,0
1,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.099158,-0.12812,-0.09276,0,0
1,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.26098,-0.12813,-0.076144,0,0
1,GO REGULATION OF OOGENESIS,0.075049,-0.12817,-0.070795,0,0
1,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.013798,-0.12825,-0.15903,0,0
1,GO CARDIAC VENTRICLE MORPHOGENESIS,0.30402,-0.12851,-0.060403,0,0
1,GO RECEPTOR CLUSTERING,0.0036303,-0.12859,-0.20643,0,0
1,GO MOTOR NEURON AXON GUIDANCE,0.0051916,-0.12863,-0.18401,0,0
1,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.82348,-0.1287,-0.023353,0,0
1,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.12473,-0.12915,-0.21309,0,0
1,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.072231,-0.12977,-0.126,0,0
1,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0069616,-0.13001,-0.17738,0,0
1,GO LABYRINTHINE LAYER DEVELOPMENT,0.75615,-0.13048,-0.0075086,0,0
1,GO ANIMAL ORGAN MATURATION,0.30402,-0.13068,-0.065247,0,0
1,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.013465,-0.13103,-0.14041,0,0
1,GO NEUROTROPHIN SIGNALING PATHWAY,0.03939,-0.13106,-0.11129,0,0
1,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.077957,-0.13115,-0.11004,0,0
1,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.0030654,-0.13169,-0.17085,0,0
1,GO TERPENOID BIOSYNTHETIC PROCESS,0.21256,-0.13201,-0.1419,0,0
1,GO PHOTOTRANSDUCTION,0.0024367,-0.13223,-0.14488,0,0
1,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.1313,-0.13224,-0.096375,0,0
1,GO CHROMATIN SILENCING,0.17374,-0.13225,-0.038896,0,0
1,GO POSITIVE REGULATION OF ION TRANSPORT,0.001662,-0.1323,-0.11673,0,0
1,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.26098,-0.13254,-0.10233,0,0
1,GO SPERMATID DIFFERENTIATION,0.072231,-0.13256,-0.081116,0,0
1,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.25363,-0.13273,-0.080109,0,0
1,GO RESPONSE TO ETHER,0.14526,-0.13289,-0.11782,0,0
1,GO EATING BEHAVIOR,0.0060989,-0.13308,-0.13996,0,0
1,GO PEPTIDYL LYSINE METHYLATION,0.066855,-0.13319,-0.10259,0,0
1,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.0023671,-0.13326,-0.12913,0,0
1,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.088862,-0.13326,-0.11162,0,0
1,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.0010528,-0.13336,-0.12376,0,0
1,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.013465,-0.13336,-0.15107,0,0
1,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0023671,-0.13383,-0.14795,0,0
1,GO HEART INDUCTION,0.51459,-0.13451,-0.083438,0,0
1,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.065563,-0.13466,-0.087351,0,0
1,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.12259,-0.13482,-0.086194,0,0
1,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.21905,-0.13494,-0.10383,0,0
1,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.19393,-0.13555,-0.27709,0,0
1,GO REGULATION OF STEM CELL DIVISION,0.46512,-0.13606,-0.077046,0,0
1,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.00025131,-0.13633,-0.18039,0,0
1,GO RESPONSE TO FUNGUS,0.059411,-0.13641,-0.1213,0,0
1,GO FEVER GENERATION,0.43883,-0.13648,0.035229,0,0
1,GO RESPONSE TO PAIN,0.053746,-0.13655,-0.15577,0,0
1,GO CGMP MEDIATED SIGNALING,0.10096,-0.13657,-0.12589,0,0
1,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.11235,-0.13658,-0.093037,0,0
1,GO BRONCHUS DEVELOPMENT,0.94073,-0.13662,0.021868,0,0
1,GO THYMUS DEVELOPMENT,0.39858,-0.13733,-0.051332,0,0
1,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.057089,-0.1375,-0.18026,0,0
1,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.23937,-0.13761,-0.051424,0,0
1,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.080955,-0.13771,-0.12934,0,0
1,GO REGULATION OF GLIOGENESIS,0.022165,-0.13792,-0.10871,0,0
1,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.084046,-0.13824,-0.13163,0,0
1,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.0047853,-0.13832,-0.18411,0,0
1,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.15773,-0.13852,-0.14911,0,0
1,GO NOTCH SIGNALING PATHWAY,0.12473,-0.13861,-0.074433,0,0
1,GO VESICLE CYTOSKELETAL TRAFFICKING,0.0017641,-0.13883,-0.17801,0,0
1,GO CELL PROJECTION ORGANIZATION,0.0011549,-0.13918,-0.12983,0,0
1,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.15773,-0.13954,-0.053487,0,0
1,GO V D J RECOMBINATION,0.38408,-0.14019,-0.048939,0,0
1,GO HINDBRAIN MORPHOGENESIS,0.007729,-0.14021,-0.16393,0,0
1,GO REGULATION OF CHLORIDE TRANSPORT,0.26847,-0.14032,-0.092245,0,0
1,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.17374,-0.14054,-0.1512,0,0
1,GO CELL JUNCTION ORGANIZATION,0.0031536,-0.1408,-0.12681,0,0
1,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.21579,-0.14118,-0.11658,0,0
1,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.78962,-0.1414,0.047166,0,0
1,GO PARTURITION,0.14048,-0.14227,-0.13813,0,0
1,GO ERROR PRONE TRANSLESION SYNTHESIS,0.10465,-0.14237,-0.10805,0,0
1,GO POSITIVE REGULATION OF CELL MATURATION,0.5726,-0.1427,-0.052044,0,0
1,GO REGULATION OF EXCRETION,0.15015,-0.14276,-0.1067,0,0
1,GO NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.33373,-0.1429,-0.09819,0,0
1,GO REGULATION OF TORC1 SIGNALING,0.0015653,-0.14351,-0.15349,0,0
1,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.061812,-0.1438,-0.12547,0,0
1,GO REGULATION OF PROTEIN GLYCOSYLATION,0.064293,-0.14397,-0.16949,0,0
1,GO CELL CELL SIGNALING,2.3418e-05,-0.14429,-0.15226,0,0
1,GO CELLULAR RESPONSE TO CAMP,0.013798,-0.14476,-0.12795,0,0
1,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.004408,-0.14571,-0.17419,0,0
1,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.084046,-0.14651,-0.093699,0,0
1,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.017969,-0.14684,-0.12261,0,0
1,GO CELL FATE COMMITMENT,0.0062634,-0.14737,-0.14879,0,0
1,GO MEMBRANE REPOLARIZATION,0.0094949,-0.1479,-0.17745,0,0
1,GO EMBRYONIC PLACENTA MORPHOGENESIS,0.41341,-0.14804,-0.065537,0,0
1,GO VASCULAR WOUND HEALING,0.18508,-0.14816,-0.16783,0,0
1,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.17099,-0.14835,-0.1175,0,0
1,GO CELLULAR RESPONSE TO VITAMIN,0.10654,-0.14852,-0.092903,0,0
1,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.0062634,-0.14855,-0.17415,0,0
1,GO REGULATION OF CILIUM MOVEMENT,0.0029794,-0.14895,-0.15281,0,0
1,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.11841,-0.14905,-0.18992,0,0
1,GO INNER EAR MORPHOGENESIS,0.025414,-0.14937,-0.15247,0,0
1,GO CARDIAC MYOFIBRIL ASSEMBLY,0.087232,-0.15052,-0.1835,0,0
1,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.56075,-0.15057,-0.035199,0,0
1,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.059411,-0.15155,-0.11739,0,0
1,GO RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION,0.188,-0.1516,-0.15714,0,0
1,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.0036303,-0.15196,-0.17204,0,0
1,GO DIVALENT METAL ION EXPORT,0.36526,-0.15207,-0.079896,0,0
1,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.21256,-0.15215,-0.06267,0,0
1,GO DETERMINATION OF ADULT LIFESPAN,0.065563,-0.1522,-0.11872,0,0
1,GO REGULATION OF HISTONE METHYLATION,0.031059,-0.15287,-0.10845,0,0
1,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.010773,-0.15308,-0.21313,0,0
1,GO REGIONALIZATION,0.061812,-0.15342,-0.11902,0,0
1,GO MITOTIC SISTER CHROMATID COHESION,0.14285,-0.15359,-0.098617,0,0
1,GO MYOTUBE CELL DEVELOPMENT,0.085627,-0.15378,-0.14714,0,0
1,GO MICROTUBULE POLYMERIZATION,0.0018173,-0.15398,-0.18448,0,0
1,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.0053338,-0.15442,-0.12907,0,0
1,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.090515,-0.15522,-0.10912,0,0
1,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.19695,-0.15547,-0.01645,0,0
1,GO EMBRYONIC BRAIN DEVELOPMENT,0.19095,-0.156,-0.10775,0,0
1,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.0099891,-0.15702,-0.12522,0,0
1,GO RESPONSE TO VITAMIN D,0.32077,-0.15744,-0.10366,0,0
1,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.0075304,-0.15747,-0.13636,0,0
1,GO RESPONSE TO EPINEPHRINE,0.13814,-0.15785,-0.16997,0,0
1,GO HISTONE H2A MONOUBIQUITINATION,0.060602,-0.15787,-0.11166,0,0
1,GO CELLULAR RESPONSE TO FOLLICLE STIMULATING HORMONE STIMULUS,0.43367,-0.15797,-0.068074,0,0
1,GO CRANIAL NERVE MORPHOGENESIS,0.12908,-0.15816,-0.14616,0,0
1,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.2,-0.15819,-0.12808,0,0
1,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.10845,-0.15821,-0.09403,0,0
1,GO LABYRINTHINE LAYER MORPHOGENESIS,0.71006,-0.15821,-0.020029,0,0
1,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.011612,-0.15824,-0.12487,0,0
1,GO AXO DENDRITIC PROTEIN TRANSPORT,0.03939,-0.1583,-0.18877,0,0
1,GO RESPONSE TO IMMOBILIZATION STRESS,0.077957,-0.1585,-0.15364,0,0
1,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.052669,-0.15868,-0.13045,0,0
1,GO VASODILATION,0.14769,-0.15875,-0.14674,0,0
1,GO CARDIAC ATRIUM DEVELOPMENT,0.16559,-0.15979,-0.076143,0,0
1,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.17934,-0.15991,-0.081259,0,0
1,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.011326,-0.16026,-0.11372,0,0
1,GO DETECTION OF LIGHT STIMULUS,4.1617e-05,-0.16141,-0.19276,0,0
1,GO PROTEIN METHYLATION,0.023741,-0.16157,-0.11282,0,0
1,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.019739,-0.16187,-0.14189,0,0
1,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.035393,-0.1622,-0.10854,0,0
1,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.00031859,-0.1624,-0.28301,0,0
1,GO REGULATION OF CHROMATIN BINDING,0.076492,-0.16342,-0.10715,0,0
1,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.00012074,-0.16361,-0.16847,0,0
1,GO MULTICELLULAR ORGANISM AGING,0.0066042,-0.16362,-0.15169,0,0
1,GO MELANOCYTE DIFFERENTIATION,0.10654,-0.16397,-0.12525,0,0
1,GO OVARIAN FOLLICLE DEVELOPMENT,0.18219,-0.16482,-0.080744,0,0
1,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.011326,-0.16525,-0.14864,0,0
1,GO AXO DENDRITIC TRANSPORT,0.017137,-0.16596,-0.17393,0,0
1,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.52025,-0.16601,-0.042367,0,0
1,GO HISTONE H3 K9 METHYLATION,0.0057817,-0.16616,-0.14171,0,0
1,GO SPERMATID NUCLEUS DIFFERENTIATION,0.25001,-0.16628,-0.011584,0,0
1,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.064293,-0.1679,-0.22961,0,0
1,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.13583,-0.16812,-0.081739,0,0
1,GO RHYTHMIC BEHAVIOR,0.0069616,-0.16835,-0.18175,0,0
1,GO INTESTINAL ABSORPTION,0.1313,-0.16847,-0.11793,0,0
1,GO POSITIVE REGULATION OF BEHAVIOR,0.010506,-0.16998,-0.22078,0,0
1,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.22905,-0.17004,-0.14276,0,0
1,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.016339,-0.17156,-0.27229,0,0
1,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.11841,-0.17259,-0.086386,0,0
1,GO DENDRITE SELF AVOIDANCE,0.057089,-0.17348,-0.16539,0,0
1,GO REGULATION OF HISTONE H4 ACETYLATION,0.17099,-0.17361,-0.10308,0,0
1,GO REGULATION OF SYSTEM PROCESS,1.0604e-05,-0.17437,-0.18056,0,0
1,GO RENAL SODIUM EXCRETION,0.11434,-0.17472,-0.094394,0,0
1,GO AXIS SPECIFICATION,0.042857,-0.17495,-0.13276,0,0
1,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.015953,-0.17512,-0.18625,0,0
1,GO RESPONSE TO AMINO ACID STARVATION,0.0013457,-0.17568,-0.17519,0,0
1,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,0.19393,-0.17629,-0.15263,0,0
1,GO COLLATERAL SPROUTING,0.01282,-0.17792,-0.20274,0,0
1,GO CELLULAR RESPONSE TO NUTRIENT,0.02843,-0.17953,-0.14316,0,0
1,GO POSITIVE THYMIC T CELL SELECTION,0.13814,-0.17968,-0.078298,0,0
1,GO DORSAL VENTRAL PATTERN FORMATION,0.016734,-0.17974,-0.20436,0,0
1,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.12049,-0.17978,-0.12024,0,0
1,GO REGULATION OF POSITIVE CHEMOTAXIS,0.18508,-0.17993,-0.095218,0,0
1,GO DEVELOPMENTAL CELL GROWTH,0.00023468,-0.17997,-0.19571,0,0
1,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.10465,-0.18024,-0.15029,0,0
1,GO MICROTUBULE SEVERING,0.084046,-0.18038,-0.12788,0,0
1,GO REGULATION OF BEHAVIOR,0.001191,-0.18043,-0.18117,0,0
1,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.00014935,-0.18057,-0.17957,0,0
1,GO MODIFICATION OF SYNAPTIC STRUCTURE,0.068167,-0.18065,-0.15201,0,0
1,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.0017641,-0.18086,-0.16746,0,0
1,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,8.1192e-05,-0.18111,-0.18317,0,0
1,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.14048,-0.18186,-0.10106,0,0
1,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.014841,-0.1821,-0.13888,0,0
1,GO CARTILAGE MORPHOGENESIS,0.29586,-0.18255,-0.1338,0,0
1,GO REGULATION OF ANIMAL ORGAN FORMATION,0.54903,-0.18273,-0.029276,0,0
1,GO EPIDERMIS MORPHOGENESIS,0.19695,-0.18286,0.019511,0,0
1,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.015574,-0.18357,-0.18283,0,0
1,GO REGULATION OF CATION CHANNEL ACTIVITY,0.011612,-0.184,-0.13733,0,0
1,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00013433,-0.1843,-0.24936,0,0
1,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.13583,-0.18601,-0.1362,0,0
1,GO HEAD DEVELOPMENT,0.00028792,-0.18641,-0.17958,0,0
1,GO POSITIVE REGULATION OF AXONOGENESIS,0.0057817,-0.18673,-0.17138,0,0
1,GO NEUROBLAST PROLIFERATION,0.029068,-0.1877,-0.19065,0,0
1,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.0051916,-0.18788,-0.18212,0,0
1,GO RESPONSE TO AMINE,0.0056288,-0.18821,-0.18485,0,0
1,GO REGULATION OF CIRCADIAN RHYTHM,1.8251e-06,-0.18897,-0.20285,0,0
1,GO SLEEP,0.0001547,-0.18908,-0.21111,0,0
1,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.011904,-0.18925,-0.21584,0,0
1,GO RETINAL ROD CELL DIFFERENTIATION,0.17099,-0.18929,-0.1582,0,0
1,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.099158,-0.18933,-0.096151,0,0
1,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.00052342,-0.18972,-0.22957,0,0
1,GO CARDIAC VENTRICLE FORMATION,0.064293,-0.18991,-0.35578,0,0
1,GO RESPONSE TO CAFFEINE,0.11841,-0.19011,-0.11913,0,0
1,GO SNARE COMPLEX ASSEMBLY,0.085627,-0.19036,-0.118,0,0
1,GO INNATE IMMUNE RESPONSE IN MUCOSA,0.0019282,-0.19052,-0.21572,0,0
1,GO TYPE B PANCREATIC CELL PROLIFERATION,0.36991,-0.19086,-0.12215,0,0
1,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.082489,-0.19111,-0.15408,0,0
1,GO NEUROGENESIS,3.4421e-05,-0.19118,-0.19588,0,0
1,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.0067808,-0.19317,-0.27486,0,0
1,GO RESPONSE TO FOOD,4.3218e-05,-0.19346,-0.19647,0,0
1,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.001228,-0.1936,-0.22131,0,0
1,GO ANTEROGRADE AXONAL TRANSPORT,0.0059384,-0.19415,-0.21585,0,0
1,GO EAR DEVELOPMENT,0.0016129,-0.19449,-0.18767,0,0
1,GO APICAL PROTEIN LOCALIZATION,0.073629,-0.19502,-0.21188,0,0
1,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,5.2139e-05,-0.19582,-0.18164,0,0
1,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.0062634,-0.19798,-0.2366,0,0
1,GO PHOTORECEPTOR CELL MAINTENANCE,5.2139e-05,-0.19829,-0.25852,0,0
1,GO DETECTION OF VISIBLE LIGHT,3.3132e-05,-0.1987,-0.19571,0,0
1,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.16828,-0.199,-0.11487,0,0
1,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.0066042,-0.19941,-0.24769,0,0
1,GO KETONE BODY METABOLIC PROCESS,0.025414,-0.19948,-0.25548,0,0
1,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00016595,-0.19954,-0.21686,0,0
1,GO MAINTENANCE OF CELL POLARITY,0.0028957,-0.19986,-0.2292,0,0
1,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.00095906,-0.20024,-0.18418,0,0
1,GO TELENCEPHALON REGIONALIZATION,0.36526,-0.20162,-0.12502,0,0
1,GO DENDRITIC SPINE DEVELOPMENT,0.0019282,-0.20189,-0.18819,0,0
1,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.0031536,-0.20479,-0.19802,0,0
1,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00072223,-0.20493,-0.19031,0,0
1,GO REGULATION OF NEURON DIFFERENTIATION,1.8521e-05,-0.20545,-0.24644,0,0
1,GO PSEUDOPODIUM ORGANIZATION,0.76948,-0.20603,-0.0080412,0,0
1,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.027188,-0.20647,-0.11087,0,0
1,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.00052342,-0.20796,-0.19544,0,0
1,GO NEGATIVE REGULATION OF GLUCOSE IMPORT,0.079444,-0.20904,-0.11278,0,0
1,GO CARDIAC MUSCLE CONTRACTION,0.00074557,-0.20912,-0.17389,0,0
1,GO EMBRYONIC PATTERN SPECIFICATION,0.0073363,-0.20962,-0.19974,0,0
1,GO POSITIVE REGULATION OF HEART CONTRACTION,0.033166,-0.20981,-0.14577,0,0
1,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.041093,-0.20993,-0.25726,0,0
1,GO MESODERMAL CELL FATE SPECIFICATION,0.085627,-0.21025,-0.24312,0,0
1,GO NEURON REMODELING,0.22235,-0.21029,-0.10983,0,0
1,GO COPULATION,0.023205,-0.21131,-0.16463,0,0
1,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.18508,-0.21192,-0.12972,0,0
1,GO FORELIMB MORPHOGENESIS,0.046579,-0.21206,-0.156,0,0
1,GO NEGATIVE REGULATION OF GLIOGENESIS,0.0033369,-0.21321,-0.23439,0,0
1,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.28785,-0.21325,-0.13907,0,0
1,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.0022992,-0.21337,-0.33702,0,0
1,GO CELLULAR COMPONENT MORPHOGENESIS,2.9532e-05,-0.21356,-0.22313,0,0
1,GO LEUKOTRIENE METABOLIC PROCESS,0.087232,-0.21629,-0.11296,0,0
1,GO TRANS SYNAPTIC SIGNALING MODULATING SYNAPTIC TRANSMISSION,0.036948,-0.21712,-0.22387,0,0
1,GO CELLULAR RESPONSE TO VITAMIN D,0.076492,-0.21742,-0.1716,0,0
1,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,1.2962e-05,-0.21794,-0.24498,0,0
1,GO REGULATION OF AXONOGENESIS,2.6307e-05,-0.21854,-0.26248,0,0
1,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.14769,-0.21941,-0.12122,0,0
1,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,0.26471,-0.21958,-0.23447,0,0
1,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.00069957,-0.22018,-0.23839,0,0
1,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.0049174,-0.22075,-0.22213,0,0
1,GO VESICLE DOCKING,0.00012074,-0.22076,-0.23113,0,0
1,GO NEURON PROJECTION EXTENSION,0.00027832,-0.22084,-0.22531,0,0
1,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,4.1617e-05,-0.22097,-0.19389,0,0
1,GO REGULATION OF POTASSIUM ION TRANSPORT,1.104e-05,-0.22101,-0.23294,0,0
1,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.0032441,-0.22106,-0.26747,0,0
1,GO AXONAL TRANSPORT,0.0042883,-0.22117,-0.21992,0,0
1,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.14526,-0.22181,-0.20442,0,0
1,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.60883,-0.22214,-0.033297,0,0
1,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.00087311,-0.22227,-0.2921,0,0
1,GO NEURON PROJECTION GUIDANCE,0.0006154,-0.22262,-0.22936,0,0
1,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,7.547e-05,-0.22396,-0.24204,0,0
1,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.00032948,-0.22415,-0.23725,0,0
1,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,6.4994e-06,-0.22426,-0.20477,0,0
1,GO NEGATIVE REGULATION OF AXONOGENESIS,0.041967,-0.22449,-0.16558,0,0
1,GO POSITIVE REGULATION OF FERTILIZATION,0.095625,-0.22458,-0.18942,0,0
1,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.0023671,-0.22629,-0.19388,0,0
1,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.0050528,-0.22632,-0.15647,0,0
1,GO CARDIAC MUSCLE CELL CONTRACTION,0.0050528,-0.22637,-0.17925,0,0
1,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.0028957,-0.22656,-0.14964,0,0
1,GO SHORT TERM MEMORY,0.015953,-0.22714,-0.28965,0,0
1,GO ADULT HEART DEVELOPMENT,0.14769,-0.22772,-0.13548,0,0
1,GO POSTSYNAPSE ORGANIZATION,1.7118e-05,-0.22796,-0.27656,0,0
1,GO NEURON DIFFERENTIATION,3.6228e-06,-0.22853,-0.24197,0,0
1,GO HEART PROCESS,1.7118e-05,-0.22855,-0.21186,0,0
1,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.085627,-0.22934,-0.16283,0,0
1,GO STRIATED MUSCLE CONTRACTION,8.7323e-05,-0.22935,-0.19584,0,0
1,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.00021909,-0.22961,-0.3003,0,0
1,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.0032441,-0.2298,-0.16257,0,0
1,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.00014935,-0.23014,-0.22217,0,0
1,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.0046564,-0.23053,-0.30873,0,0
1,GO REGULATION OF MICROTUBULE BINDING,0.00011241,-0.2308,-0.28672,0,0
1,GO IMMATURE B CELL DIFFERENTIATION,0.054842,-0.23203,-0.1464,0,0
1,GO REGULATION OF MEMBRANE PERMEABILITY,0.0049174,-0.23206,-0.1425,0,0
1,GO AXON DEVELOPMENT,0.00010845,-0.23214,-0.2467,0,0
1,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,0.0033369,-0.23264,-0.28228,0,0
1,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.19095,-0.23265,-0.13683,0,0
1,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.52025,-0.23486,-0.0090589,0,0
1,GO FILOPODIUM ASSEMBLY,0.001986,-0.23507,-0.21868,0,0
1,GO COMMISSURAL NEURON AXON GUIDANCE,0.057089,-0.2356,-0.23972,0,0
1,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.011904,-0.23616,-0.24941,0,0
1,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.00050664,-0.23665,-0.27529,0,0
1,GO DEVELOPMENTAL MATURATION,4.1112e-06,-0.23684,-0.23612,0,0
1,GO RESPONSE TO NERVE GROWTH FACTOR,0.0013054,-0.23711,-0.19265,0,0
1,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.00016595,-0.23746,-0.2457,0,0
1,GO MEMORY,1.0779e-06,-0.23802,-0.27514,0,0
1,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.010245,-0.2393,-0.17244,0,0
1,GO CELL FATE DETERMINATION,0.0075304,-0.23949,-0.23798,0,0
1,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.36526,-0.23976,-0.039153,0,0
1,GO SECONDARY PALATE DEVELOPMENT,0.0042883,-0.24023,-0.23416,0,0
1,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.00010845,-0.24039,-0.23144,0,0
1,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.19095,-0.24043,-0.15836,0,0
1,GO NERVOUS SYSTEM PROCESS,9.2696e-08,-0.2424,-0.23003,0,0
1,GO ENDOCRINE SYSTEM DEVELOPMENT,0.00031859,-0.24266,-0.22588,0,0
1,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,1.9263e-05,-0.24351,-0.26203,0,0
1,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.0025083,-0.24364,-0.20433,0,0
1,GO NEURAL PRECURSOR CELL PROLIFERATION,0.00025131,-0.24428,-0.24119,0,0
1,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,1.104e-05,-0.24448,-0.31841,0,0
1,GO SPINAL CORD DEVELOPMENT,0.00012964,-0.24452,-0.27684,0,0
1,GO REGULATION OF FLAGELLATED SPERM MOTILITY,5.2139e-05,-0.24472,-0.21155,0,0
1,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.00081984,-0.24531,-0.25458,0,0
1,GO RESPONSE TO CATECHOLAMINE,5.508e-06,-0.2454,-0.27069,0,0
1,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.0017123,-0.24542,-0.21998,0,0
1,GO ACTIN FILAMENT BASED TRANSPORT,0.085627,-0.24596,-0.14598,0,0
1,GO PROTEIN DEPOLYMERIZATION,6.0504e-05,-0.24704,-0.23089,0,0
1,GO CRANIAL NERVE DEVELOPMENT,7.547e-05,-0.24715,-0.2938,0,0
1,GO MICROTUBULE BUNDLE FORMATION,0.0075304,-0.24739,-0.1757,0,0
1,GO INNER DYNEIN ARM ASSEMBLY,0.042857,-0.24745,-0.25242,0,0
1,GO REGULATION OF COLLATERAL SPROUTING,0.015574,-0.24881,-0.23557,0,0
1,GO HEART FORMATION,0.031748,-0.24922,-0.19035,0,0
1,GO PALLIUM DEVELOPMENT,5.4121e-05,-0.24965,-0.2349,0,0
1,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,1.6455e-05,-0.24972,-0.2175,0,0
1,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,4.2876e-06,-0.2498,-0.27428,0,0
1,GO HEAT GENERATION,0.22235,-0.25016,-0.11366,0,0
1,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.013465,-0.25018,-0.21863,0,0
1,GO CELL AGGREGATION,0.031748,-0.25135,-0.17246,0,0
1,GO CAMERA TYPE EYE MORPHOGENESIS,0.025994,-0.25202,-0.13639,0,0
1,GO INTRACILIARY TRANSPORT,0.093897,-0.25219,-0.13904,0,0
1,GO NEURON DEVELOPMENT,3.9418e-06,-0.25282,-0.24651,0,0
1,GO SEX DETERMINATION,0.0097392,-0.2537,-0.21935,0,0
1,GO CEREBRAL CORTEX CELL MIGRATION,0.0007696,-0.25376,-0.27967,0,0
1,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.0022992,-0.25393,-0.20474,0,0
1,GO COGNITION,3.3202e-07,-0.25542,-0.27577,0,0
1,GO FOREBRAIN DEVELOPMENT,2.1663e-05,-0.25594,-0.22859,0,0
1,GO CELL PART MORPHOGENESIS,1.1964e-05,-0.25606,-0.24945,0,0
1,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.17374,-0.25722,-0.14344,0,0
1,GO CEREBRAL CORTEX DEVELOPMENT,0.00010845,-0.258,-0.23276,0,0
1,GO BEHAVIOR,5.986e-08,-0.25855,-0.27507,0,0
1,GO MONOVALENT INORGANIC CATION TRANSPORT,6.6003e-08,-0.25879,-0.25393,0,0
1,GO CELL DIFFERENTIATION IN SPINAL CORD,0.001228,-0.25889,-0.27231,0,0
1,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.0056288,-0.26012,-0.45695,0,0
1,GO LONG TERM SYNAPTIC POTENTIATION,0.00010462,-0.2605,-0.2613,0,0
1,GO VISUAL BEHAVIOR,2.2524e-05,-0.26087,-0.24067,0,0
1,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.00049035,-0.26136,-0.26295,0,0
1,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.0001165,-0.26156,-0.297,0,0
1,GO UTERUS DEVELOPMENT,0.011612,-0.26168,-0.24732,0,0
1,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.023741,-0.26272,-0.22875,0,0
1,GO CELL FATE SPECIFICATION,0.00031859,-0.26372,-0.32534,0,0
1,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,3.6228e-06,-0.26427,-0.28094,0,0
1,GO INSEMINATION,0.068167,-0.26515,-0.16047,0,0
1,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.00016023,-0.26622,-0.30021,0,0
1,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.00074557,-0.26676,-0.28662,0,0
1,GO NEUROMUSCULAR PROCESS,1.349e-05,-0.26782,-0.26518,0,0
1,GO INTRACILIARY RETROGRADE TRANSPORT,0.16828,-0.26858,-0.15484,0,0
1,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,7.0571e-06,-0.26894,-0.32545,0,0
1,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.0006154,-0.26938,-0.31994,0,0
1,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.0033369,-0.27124,-0.2374,0,0
1,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.014486,-0.27315,-0.20623,0,0
1,GO COCHLEA DEVELOPMENT,0.0013872,-0.27336,-0.27755,0,0
1,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.05824,-0.27689,-0.27574,0,0
1,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.036164,-0.27787,-0.16217,0,0
1,GO REGULATION OF DENDRITE MORPHOGENESIS,1.5816e-05,-0.28011,-0.29739,0,0
1,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,6.4994e-06,-0.28062,-0.24247,0,0
1,GO CHROMATIN SILENCING AT TELOMERE,3.0689e-05,-0.2811,-0.25217,0,0
1,GO CEREBELLAR CORTEX MORPHOGENESIS,0.00017796,-0.28188,-0.30811,0,0
1,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.00027832,-0.28488,-0.32821,0,0
1,GO DENDRITIC SPINE MORPHOGENESIS,0.00017186,-0.28518,-0.31343,0,0
1,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.016339,-0.28539,-0.29829,0,0
1,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.11841,-0.28553,-0.17816,0,0
1,GO AXONEME ASSEMBLY,0.027803,-0.28703,-0.18921,0,0
1,GO DETECTION OF ABIOTIC STIMULUS,6.2859e-08,-0.28797,-0.3031,0,0
1,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,2.0033e-05,-0.2885,-0.3704,0,0
1,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,3.8583e-05,-0.28871,-0.2942,0,0
1,GO REGULATION OF SYNAPSE ASSEMBLY,0.00044439,-0.28919,-0.26232,0,0
1,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.0085714,-0.28999,-0.33395,0,0
1,GO CELL JUNCTION MAINTENANCE,0.001228,-0.29324,-0.2652,0,0
1,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.00011241,-0.29378,-0.29143,0,0
1,GO GAMMA DELTA T CELL ACTIVATION,0.3746,-0.2944,-0.083464,0,0
1,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,3.0576e-06,-0.29607,-0.31274,0,0
1,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.020205,-0.29725,-0.26098,0,0
1,GO EPITHELIAL CELL MORPHOGENESIS,0.35607,-0.29763,-0.085352,0,0
1,GO FOREBRAIN CELL MIGRATION,0.00036427,-0.29808,-0.26094,0,0
1,GO REGULATION OF CAMP MEDIATED SIGNALING,1.349e-05,-0.29886,-0.29442,0,0
1,GO RESPONSE TO DOPAMINE,5.0194e-07,-0.29898,-0.29493,0,0
1,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.00011241,-0.30059,-0.36037,0,0
1,GO ENERGY HOMEOSTASIS,0.0062634,-0.30075,-0.23771,0,0
1,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.0030654,-0.30125,-0.2131,0,0
1,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,9.7346e-05,-0.30144,-0.30203,0,0
1,GO REGULATION OF FILOPODIUM ASSEMBLY,0.001191,-0.30337,-0.26902,0,0
1,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.00017796,-0.3034,-0.28613,0,0
1,GO ECTODERMAL PLACODE DEVELOPMENT,0.15517,-0.30515,-0.16801,0,0
1,GO WALKING BEHAVIOR,6.2367e-06,-0.30634,-0.36594,0,0
1,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,1.0311e-06,-0.30689,-0.27086,0,0
1,GO PRESYNAPSE ORGANIZATION,0.00036427,-0.31259,-0.31012,0,0
1,GO MICROTUBULE DEPOLYMERIZATION,1.8251e-06,-0.31274,-0.41158,0,0
1,GO SENSORY PERCEPTION OF PAIN,2.5122e-07,-0.31375,-0.29677,0,0
1,GO NUCLEAR BODY ORGANIZATION,0.0011549,-0.31529,-0.3162,0,0
1,GO AXONAL TRANSPORT OF MITOCHONDRION,0.00098941,-0.31648,-0.3889,0,0
1,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,5.7413e-06,-0.31735,-0.35234,0,0
1,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.0069616,-0.31818,-0.28976,0,0
1,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,4.3218e-05,-0.31822,-0.30639,0,0
1,GO VENTRAL SPINAL CORD DEVELOPMENT,0.00084609,-0.31911,-0.29143,0,0
1,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.27227,-0.32028,-0.13339,0,0
1,GO CELL MIGRATION IN HINDBRAIN,6.7596e-05,-0.32032,-0.43093,0,0
1,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.0022332,-0.32077,-0.29994,0,0
1,GO REGULATION OF DENDRITE DEVELOPMENT,1.7474e-06,-0.32133,-0.31385,0,0
1,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0083534,-0.32343,-0.27818,0,0
1,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.14048,-0.32385,-0.26065,0,0
1,GO INDOLALKYLAMINE METABOLIC PROCESS,0.011612,-0.32425,-0.24547,0,0
1,GO HINDBRAIN DEVELOPMENT,9.0221e-07,-0.32556,-0.3293,0,0
1,GO POSITIVE REGULATION OF CILIUM MOVEMENT,6.2367e-06,-0.32619,-0.30997,0,0
1,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.00092958,-0.32759,-0.28353,0,0
1,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.00059588,-0.32789,-0.35111,0,0
1,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.0041716,-0.32864,-0.22239,0,0
1,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.00018427,-0.32921,-0.30985,0,0
1,GO POSITIVE REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.04854,-0.32982,-0.34462,0,0
1,GO CARDIAC CONDUCTION,2.4692e-06,-0.32988,-0.31423,0,0
1,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0028141,-0.33055,-0.27211,0,0
1,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.00013433,-0.33085,-0.30865,0,0
1,GO RESPONSE TO LIGHT INTENSITY,5.6174e-05,-0.33177,-0.34819,0,0
1,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,0.00010092,-0.33257,-0.30126,0,0
1,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.013465,-0.33295,-0.26889,0,0
1,GO CALCIUM ION IMPORT INTO CYTOSOL,0.00024286,-0.333,-0.37073,0,0
1,GO CLATHRIN COAT ASSEMBLY,0.0067808,-0.33586,-0.27933,0,0
1,GO ACIDIC AMINO ACID TRANSPORT,1.3605e-07,-0.33703,-0.38476,0,0
1,GO OTIC VESICLE MORPHOGENESIS,0.041093,-0.33821,-0.35345,0,0
1,GO NOREPINEPHRINE SECRETION,6.4994e-06,-0.33854,-0.3868,0,0
1,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.015953,-0.3396,-0.31924,0,0
1,GO NEURON PROJECTION ARBORIZATION,0.00032948,-0.3405,-0.31321,0,0
1,GO RELAXATION OF MUSCLE,0.00025131,-0.34134,-0.32365,0,0
1,GO DICARBOXYLIC ACID TRANSPORT,1.5691e-07,-0.34235,-0.32056,0,0
1,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.016339,-0.34292,-0.29162,0,0
1,GO PROTEIN POLYGLUTAMYLATION,3.7145e-05,-0.3432,-0.3416,0,0
1,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.03245,-0.34391,-0.24365,0,0
1,GO PROTEIN LOCALIZATION TO CELL JUNCTION,9.0179e-06,-0.34395,-0.34864,0,0
1,GO PHOTORECEPTOR CELL DEVELOPMENT,3.7791e-06,-0.34415,-0.35671,0,0
1,GO EMBRYONIC AXIS SPECIFICATION,0.00014418,-0.34486,-0.30221,0,0
1,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,1.8084e-07,-0.34677,-0.38894,0,0
1,GO MITOCHONDRION LOCALIZATION,0.00059588,-0.35054,-0.26735,0,0
1,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.00012074,-0.35085,-0.35463,0,0
1,GO MEGAKARYOCYTE DEVELOPMENT,0.0050528,-0.35164,-0.32272,0,0
1,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.05824,-0.35727,-0.19005,0,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.009256,-0.35817,-0.28033,0,0
1,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,7.547e-05,-0.35874,-0.30802,0,0
1,GO DENDRITE DEVELOPMENT,8.2505e-07,-0.35968,-0.32486,0,0
1,GO SYNAPTIC VESICLE TRANSPORT,4.8612e-06,-0.3597,-0.40917,0,0
1,GO REGULATION OF MEMBRANE POTENTIAL,1.6359e-08,-0.36042,-0.39192,0,0
1,GO DENDRITE MORPHOGENESIS,2.2658e-06,-0.36532,-0.34205,0,0
1,GO SYNAPSE ORGANIZATION,7.5427e-07,-0.36645,-0.33678,0,0
1,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,6.0504e-05,-0.36773,-0.36848,0,0
1,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,1.4674e-06,-0.36788,-0.3639,0,0
1,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,3.0576e-06,-0.36907,-0.35159,0,0
1,GO ACTIN CROSSLINK FORMATION,0.041967,-0.36966,-0.24074,0,0
1,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,1.8251e-06,-0.37112,-0.39334,0,0
1,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.0011549,-0.37193,-0.33202,0,0
1,GO ACTION POTENTIAL,2.6322e-07,-0.37252,-0.37664,0,0
1,GO REGULATION OF POSTSYNAPSE ORGANIZATION,3.4728e-06,-0.37261,-0.37143,0,0
1,GO HEART FIELD SPECIFICATION,0.04854,-0.37362,-0.26865,0,0
1,GO DETECTION OF MECHANICAL STIMULUS,8.6584e-06,-0.37388,-0.33032,0,0
1,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,2.1663e-05,-0.37617,-0.47485,0,0
1,GO SYNAPTIC SIGNALING,2.3313e-08,-0.37842,-0.39521,0,0
1,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.00074557,-0.37947,-0.38295,0,0
1,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,2.6902e-06,-0.38015,-0.42532,0,0
1,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,4.3218e-05,-0.38031,-0.35516,0,0
1,GO MALE SEX DETERMINATION,0.0069616,-0.3805,-0.3007,0,0
1,GO TYPE B PANCREATIC CELL DEVELOPMENT,7.8282e-05,-0.38107,-0.37956,0,0
1,GO SEGMENT SPECIFICATION,0.0001547,-0.38153,-0.4563,0,0
1,GO NEUROTRANSMITTER REUPTAKE,4.8612e-06,-0.38218,-0.39971,0,0
1,GO CEREBELLAR CORTEX DEVELOPMENT,8.628e-07,-0.3854,-0.41324,0,0
1,GO NEURON CELLULAR HOMEOSTASIS,7.3528e-06,-0.38713,-0.45449,0,0
1,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,8.1192e-05,-0.38838,-0.38036,0,0
1,GO MULTICELLULAR ORGANISMAL SIGNALING,8.4155e-08,-0.38843,-0.38635,0,0
1,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,5.4121e-05,-0.39084,-0.41266,0,0
1,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.39371,-0.39397,-0.13347,0,0
1,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,8.6584e-06,-0.39408,-0.41267,0,0
1,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,4.5813e-07,-0.39629,-0.37581,0,0
1,GO CIRCADIAN SLEEP WAKE CYCLE,8.628e-07,-0.39681,-0.41327,0,0
1,GO SKELETAL MUSCLE ADAPTATION,0.00045924,-0.40052,-0.29071,0,0
1,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,3.5759e-05,-0.40257,-0.38368,0,0
1,GO REGULATION OF SYNAPTIC PLASTICITY,6.2859e-08,-0.40279,-0.43421,0,0
1,GO SECONDARY HEART FIELD SPECIFICATION,0.0056288,-0.40304,-0.41464,0,0
1,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,8.1192e-05,-0.4045,-0.48612,0,0
1,GO MEMBRANE DEPOLARIZATION,3.6414e-07,-0.40477,-0.39438,0,0
1,GO FAT CELL PROLIFERATION,0.00021167,-0.40618,-0.37476,0,0
1,GO NEUROPEPTIDE SIGNALING PATHWAY,7.2756e-08,-0.40682,-0.39779,0,0
1,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,2.3654e-06,-0.40798,-0.44512,0,0
1,GO LONG TERM SYNAPTIC DEPRESSION,1.0184e-05,-0.40823,-0.38145,0,0
1,GO LOCOMOTORY BEHAVIOR,2.4515e-08,-0.40932,-0.44117,0,0
1,GO NEURON MIGRATION,1.2862e-06,-0.41124,-0.4215,0,0
1,GO SYNAPTIC VESICLE RECYCLING,5.0194e-07,-0.41209,-0.42115,0,0
1,GO SOMATIC STEM CELL DIVISION,0.068167,-0.4124,-0.20035,0,0
1,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,4.1802e-07,-0.4153,-0.46897,0,0
1,GO METENCEPHALON DEVELOPMENT,3.9926e-07,-0.41531,-0.40624,0,0
1,GO REGULATION OF HEAT GENERATION,0.036164,-0.41679,-0.29352,0,0
1,GO OTIC VESICLE DEVELOPMENT,0.1028,-0.42015,-0.23206,0,0
1,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,1.2454e-05,-0.42045,-0.47108,0,0
1,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.0021689,-0.42088,-0.43007,0,0
1,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,1.7118e-05,-0.42119,-0.39739,0,0
1,GO RESPONSE TO NICOTINE,9.0551e-05,-0.4214,-0.30138,0,0
1,GO OLFACTORY LOBE DEVELOPMENT,0.0050528,-0.42225,-0.30716,0,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.12473,-0.42276,-0.21681,0,0
1,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,3.1904e-06,-0.42301,-0.38769,0,0
1,GO PITUITARY GLAND DEVELOPMENT,1.4609e-05,-0.42356,-0.44635,0,0
1,GO REGULATION OF TUBULIN DEACETYLATION,0.00012964,-0.42368,-0.53163,0,0
1,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,3.8131e-07,-0.42472,-0.43084,0,0
1,GO RESPONSE TO POTASSIUM ION,0.0015189,-0.42646,-0.35153,0,0
1,GO FOREBRAIN GENERATION OF NEURONS,7.013e-05,-0.42705,-0.38413,0,0
1,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.00016595,-0.42905,-0.33748,0,0
1,GO REGULATION OF TRANS SYNAPTIC SIGNALING,3.479e-08,-0.42934,-0.42563,0,0
1,GO SEROTONIN TRANSPORT,1.8084e-07,-0.43436,-0.58646,0,0
1,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,4.4878e-05,-0.43467,-0.39529,0,0
1,GO RESPONSE TO COCAINE,1.8084e-07,-0.43526,-0.4526,0,0
1,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,1.0779e-06,-0.43697,-0.47606,0,0
1,GO FOREBRAIN NEURON DEVELOPMENT,0.0011549,-0.44136,-0.39073,0,0
1,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,7.9801e-06,-0.44173,-0.45387,0,0
1,GO RECEPTOR LOCALIZATION TO SYNAPSE,4.1112e-06,-0.44568,-0.46596,0,0
1,GO GROOMING BEHAVIOR,5.7413e-06,-0.44832,-0.44599,0,0
1,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,6.5896e-07,-0.45052,-0.45026,0,0
1,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,1.3441e-06,-0.45146,-0.44632,0,0
1,GO DIENCEPHALON DEVELOPMENT,1.1267e-06,-0.45163,-0.42553,0,0
1,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,3.5759e-05,-0.4518,-0.559,0,0
1,GO REGULATION OF AMINO ACID TRANSPORT,3.479e-08,-0.45381,-0.48088,0,0
1,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,6.2786e-05,-0.4568,-0.52978,0,0
1,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,3.8583e-05,-0.45788,-0.46786,0,0
1,GO SYNAPSE ASSEMBLY,1.8958e-07,-0.45912,-0.46599,0,0
1,GO LIMB BUD FORMATION,0.065563,-0.46115,-0.25822,0,0
1,GO RESPONSE TO LEUCINE,0.0010528,-0.46122,-0.43267,0,0
1,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0023671,-0.46264,-0.44933,0,0
1,GO ADULT BEHAVIOR,1.6359e-08,-0.46329,-0.53964,0,0
1,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,2.9301e-06,-0.4634,-0.47645,0,0
1,GO EPITHELIAL CELL MATURATION,8.1192e-05,-0.46371,-0.45929,0,0
1,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.014841,-0.46375,-0.43412,0,0
1,GO RESPONSE TO ACETYLCHOLINE,3.3287e-06,-0.46538,-0.45198,0,0
1,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.00084609,-0.46871,-0.39154,0,0
1,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,1.906e-06,-0.46983,-0.52905,0,0
1,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,6.2367e-06,-0.4705,-0.49226,0,0
1,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,1.8521e-05,-0.47285,-0.41321,0,0
1,GO PRESYNAPTIC ENDOCYTOSIS,3.0264e-07,-0.47523,-0.46463,0,0
1,GO NEUROTRANSMITTER UPTAKE,5.0194e-07,-0.47568,-0.42745,0,0
1,GO ENDOCARDIUM DEVELOPMENT,0.0050528,-0.47578,-0.30516,0,0
1,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,7.889e-07,-0.47722,-0.44381,0,0
1,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,5.0226e-05,-0.47914,-0.53926,0,0
1,GO EXOCYTIC PROCESS,2.5778e-08,-0.48015,-0.49094,0,0
1,GO ADULT LOCOMOTORY BEHAVIOR,2.1077e-08,-0.48264,-0.49378,0,0
1,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,2.9957e-08,-0.48538,-0.50633,0,0
1,GO PROTEIN LOCALIZATION TO SYNAPSE,1.906e-06,-0.48887,-0.46518,0,0
1,GO CARDIOBLAST PROLIFERATION,0.016734,-0.48986,-0.38316,0,0
1,GO SUBPALLIUM DEVELOPMENT,1.5201e-05,-0.49099,-0.49773,0,0
1,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,4.0073e-05,-0.4922,-0.45638,0,0
1,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.0028957,-0.49258,-0.35106,0,0
1,GO TRIGEMINAL NERVE DEVELOPMENT,0.00063551,-0.4958,-0.55742,0,0
1,GO SYNAPTIC VESICLE LOCALIZATION,6.2985e-07,-0.49637,-0.55609,0,0
1,GO NEURAL RETINA DEVELOPMENT,1.4674e-06,-0.49953,-0.46853,0,0
1,GO NEURON MATURATION,2.5122e-07,-0.50011,-0.49199,0,0
1,GO CELLULAR POTASSIUM ION HOMEOSTASIS,3.0576e-06,-0.50031,-0.46647,0,0
1,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.073629,-0.50173,-0.2526,0,0
1,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,1.5201e-05,-0.51031,-0.38088,0,0
1,GO NEURON RECOGNITION,5.4977e-07,-0.51074,-0.52935,0,0
1,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,7.013e-05,-0.51721,-0.4209,0,0
1,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,8.4155e-08,-0.51864,-0.49459,0,0
1,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,1.7806e-05,-0.51924,-0.48839,0,0
1,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,4.0375e-08,-0.52257,-0.52577,0,0
1,GO INHIBITORY POSTSYNAPTIC POTENTIAL,6.2367e-06,-0.52635,-0.63452,0,0
1,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,1.2308e-06,-0.52774,-0.54522,0,0
1,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.024288,-0.53523,-0.48005,0,0
1,GO RETROGRADE TRANS SYNAPTIC SIGNALING,1.0604e-05,-0.53557,-0.65071,0,0
1,GO CELL CELL ADHESION MEDIATED BY CADHERIN,4.1617e-05,-0.54267,-0.46132,0,0
1,GO POSITIVE REGULATION OF HEAT GENERATION,0.04854,-0.54359,-0.29407,0,0
1,GO TRANSMISSION OF NERVE IMPULSE,3.479e-08,-0.5451,-0.55215,0,0
1,GO REGULATION OF VESICLE FUSION,1.3441e-06,-0.54631,-0.552,0,0
1,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.0013054,-0.54752,-0.46953,0,0
1,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,2.5122e-07,-0.54788,-0.55342,0,0
1,GO SPINAL CORD PATTERNING,7.6603e-06,-0.54838,-0.56668,0,0
1,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,2.8496e-08,-0.55377,-0.54368,0,0
1,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,2.6322e-07,-0.55674,-0.55522,0,0
1,GO GLIAL CELL FATE COMMITMENT,0.00021167,-0.56253,-0.60226,0,0
1,GO AXONAL FASCICULATION,9.7346e-05,-0.56264,-0.53428,0,0
1,GO MAINTENANCE OF SYNAPSE STRUCTURE,4.6623e-06,-0.56407,-0.63633,0,0
1,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,2.5308e-05,-0.56456,-0.47515,0,0
1,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,6.5896e-07,-0.57163,-0.53572,0,0
1,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,1.9873e-07,-0.57457,-0.60754,0,0
1,GO MAST CELL MIGRATION,0.00013917,-0.58071,-0.51752,0,0
1,GO REFLEX,4.6623e-06,-0.58359,-0.60446,0,0
1,GO NOREPINEPHRINE METABOLIC PROCESS,4.1112e-06,-0.58637,-0.60817,0,0
1,GO CEREBELLAR CORTEX FORMATION,5.2533e-07,-0.58696,-0.52959,0,0
1,GO REGULATION OF NEUROTRANSMITTER LEVELS,2.0038e-08,-0.59829,-0.60208,0,0
1,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,1.5691e-07,-0.59978,-0.61697,0,0
1,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,2.3418e-05,-0.60134,-0.59424,0,0
1,GO NEURAL NUCLEUS DEVELOPMENT,7.2111e-07,-0.60658,-0.50162,0,0
1,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,3.8131e-07,-0.60951,-0.55285,0,0
1,GO ADENOHYPOPHYSIS DEVELOPMENT,3.4421e-05,-0.60985,-0.63421,0,0
1,GO GROWTH HORMONE SECRETION,3.4772e-07,-0.61447,-0.59732,0,0
1,GO FOREBRAIN NEURON DIFFERENTIATION,1.8521e-05,-0.61519,-0.4948,0,0
1,GO GLUTAMATE SECRETION,2.9957e-08,-0.61791,-0.60505,0,0
1,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,2.1077e-08,-0.61931,-0.63504,0,0
1,GO BEHAVIORAL RESPONSE TO COCAINE,1.7806e-05,-0.63023,-0.66855,0,0
1,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,6.2985e-07,-0.64138,-0.63718,0,0
1,GO DETECTION OF TEMPERATURE STIMULUS,3.1491e-08,-0.64582,-0.70606,0,0
1,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,1.8108e-08,-0.6502,-0.68241,0,0
1,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,2.2167e-08,-0.65364,-0.66001,0,0
1,GO REGULATION OF GLUTAMATE SECRETION,4.9191e-08,-0.65507,-0.66975,0,0
1,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,2.1077e-08,-0.65769,-0.70195,0,0
1,GO NEUROTRANSMITTER TRANSPORT,2.2167e-08,-0.65886,-0.65589,0,0
1,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.12473,-0.66317,-0.35136,0,0
1,GO NEURON FATE COMMITMENT,5.4977e-07,-0.66533,-0.70444,0,0
1,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,2.0784e-06,-0.66928,-0.59231,0,0
1,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,2.7578e-07,-0.6727,-0.66852,0,0
1,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,1.1267e-06,-0.67606,-0.6922,0,0
1,GO SYNAPTIC MEMBRANE ADHESION,5.508e-06,-0.67883,-0.61022,0,0
1,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,2.4692e-06,-0.68215,-0.63151,0,0
1,GO STARTLE RESPONSE,1.9873e-07,-0.68666,-0.63936,0,0
1,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,5.1671e-08,-0.71544,-0.69859,0,0
1,GO NEURONAL ACTION POTENTIAL,3.8423e-08,-0.7157,-0.73607,0,0
1,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,3.3202e-07,-0.71682,-0.60133,0,0
1,GO NEUROTRANSMITTER SECRETION,2.2167e-08,-0.71782,-0.72218,0,0
1,GO DORSAL SPINAL CORD DEVELOPMENT,2.7578e-07,-0.72341,-0.68816,0,0
1,GO SPONTANEOUS SYNAPTIC TRANSMISSION,8.3127e-06,-0.72507,-0.64723,0,0
1,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,3.1491e-08,-0.72657,-0.73845,0,0
1,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,5.986e-08,-0.73533,-0.7255,0,0
1,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,4.2424e-08,-0.74186,-0.68997,0,0
1,GO POSITIVE REGULATION OF AMINE TRANSPORT,4.2424e-08,-0.74481,-0.70642,0,0
1,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,7.0571e-06,-0.76293,-0.62062,0,0
1,GO SYNAPTIC VESICLE EXOCYTOSIS,1.905e-08,-0.76832,-0.77529,0,0
1,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,2.7578e-07,-0.77322,-0.70008,0,0
1,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.01282,-0.78379,-0.48709,0,0
1,GO AMINE TRANSPORT,2.1077e-08,-0.78766,-0.72775,0,0
1,GO SEROTONIN SECRETION,3.3202e-07,-0.79114,-0.68978,0,0
1,GO MONOAMINE TRANSPORT,2.4515e-08,-0.80517,-0.76822,0,0
1,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,4.2424e-08,-0.80591,-0.83599,0,0
1,GO NERVOUS SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,1.1788e-07,-0.80721,-0.83927,0,0
1,GO RESPONSE TO AUDITORY STIMULUS,8.0176e-08,-0.81447,-0.77858,0,0
1,GO SYNAPTIC VESICLE DOCKING,6.93e-08,-0.81637,-0.91308,0,0
1,GO CALCIUM ION REGULATED EXOCYTOSIS,4.0375e-08,-0.81644,-0.80316,0,0
1,GO REGULATION OF SYNAPTIC VESICLE CYCLE,2.3313e-08,-0.82188,-0.76774,0,0
1,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,2.0038e-08,-0.82572,-0.84319,0,0
1,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,3.3202e-07,-0.82744,-0.88116,0,0
1,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,3.6563e-08,-0.82798,-0.8554,0,0
1,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,1.4268e-07,-0.8381,-0.81263,0,0
1,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,1.4674e-06,-0.85251,-0.76395,0,0
1,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,3.479e-08,-0.85662,-0.87823,0,0
1,GO NEURON FATE SPECIFICATION,4.3763e-07,-0.86658,-0.95448,0,0
1,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,1.7474e-06,-0.86705,-0.78991,0,0
1,GO NEURON CELL CELL ADHESION,1.5691e-07,-0.87743,-1.0293,0,0
1,GO RETINAL GANGLION CELL AXON GUIDANCE,5.0683e-06,-0.87786,-0.79356,0,0
1,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,1.725e-07,-0.88779,-0.85889,0,0
1,GO REGULATION OF GROWTH HORMONE SECRETION,1.071e-07,-0.89905,-0.84146,0,0
1,GO DENDRITE EXTENSION,6.6003e-08,-0.9014,-0.80799,0,0
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,4.9191e-08,-0.92226,-0.88376,0,0
1,GO RETINA LAYER FORMATION,1.9904e-06,-0.92323,-0.74569,0,0
1,GO NEURONAL ION CHANNEL CLUSTERING,1.3441e-06,-0.94545,-0.88864,0,0
1,GO DENSE CORE GRANULE TRANSPORT,6.8936e-07,-0.96209,-1.0685,0,0
1,GO PREPULSE INHIBITION,4.6826e-08,-0.96905,-0.9126,0,0
1,GO VOCALIZATION BEHAVIOR,2.0829e-07,-0.99095,-0.93413,0,0
1,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,6.8936e-07,-1.0061,-0.85453,0,0
1,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,2.9957e-08,-1.0127,-1.1091,0,0
1,GO NOSE DEVELOPMENT,5.0683e-06,-1.0142,-0.84601,0,0
1,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,6.8936e-07,-1.0183,-0.98251,0,0
1,GO CATECHOLAMINE SECRETION,2.8496e-08,-1.0262,-0.94062,0,0
1,GO SYNAPTIC VESICLE CLUSTERING,1.2366e-07,-1.0683,-1.0728,0,0
1,GO NEGATIVE REGULATION OF AMINE TRANSPORT,6.6003e-08,-1.0728,-0.95793,0,0
1,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,2.9957e-08,-1.0969,-1.1579,0,0
1,GO GANGLION DEVELOPMENT,3.8423e-08,-1.1058,-1.0325,0,0
1,GO MECHANOSENSORY BEHAVIOR,4.4572e-08,-1.1358,-1.1728,0,0
1,GO GABAERGIC NEURON DIFFERENTIATION,8.2505e-07,-1.1388,-1.0104,0,0
1,GO REGULATION OF DOPAMINE SECRETION,4.2424e-08,-1.1705,-1.1059,0,0
1,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,4.0375e-08,-1.4227,-1.4025,0,0
1,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,1.8958e-07,-1.6358,-1.4989,0,0
2,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,3.6228e-06,0.94756,0.94014,1,1
2,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,2.9301e-06,0.91031,0.81499,1,1
2,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,1.071e-07,0.80365,0.80566,1,1
2,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,1.0311e-06,0.79422,0.73973,1,1
2,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,6.8936e-07,0.7916,0.92578,1,1
2,GO RESPONSE TO HISTAMINE,2.2658e-06,0.74477,0.72042,1,1
2,GO RESPONSE TO L GLUTAMATE,4.2876e-06,0.69465,0.60666,1,1
2,GO SYNAPSE MATURATION,1.4674e-06,0.68545,0.7436,1,1
2,GO SECRETORY GRANULE LOCALIZATION,2.0033e-05,0.65007,0.54422,1,1
2,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,2.8418e-05,0.62605,0.56859,1,1
2,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,1.2454e-05,0.61639,0.52145,1,1
2,GO PYRAMIDAL NEURON DIFFERENTIATION,3.3132e-05,0.60719,0.59391,1,1
2,GO TYPE B PANCREATIC CELL APOPTOTIC PROCESS,4.0073e-05,0.59411,0.55227,1,1
2,GO REGULATION OF SYNAPSE MATURATION,7.2754e-05,0.57877,0.59374,1,1
2,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,4.1112e-06,0.57691,0.53241,1,1
2,GO BRANCHING MORPHOGENESIS OF A NERVE,4.6623e-06,0.5716,0.67473,1,1
2,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,8.6584e-06,0.5636,0.52821,1,1
2,GO SYNAPTIC VESICLE MATURATION,1.5816e-05,0.56314,0.55209,1,1
2,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,2.2524e-05,0.55993,0.47787,1,1
2,GO OPIOID RECEPTOR SIGNALING PATHWAY,1.906e-06,0.54883,0.56841,1,1
2,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.013465,0.5278,0.27946,1,1
2,GO TELENCEPHALON GLIAL CELL MIGRATION,3.1888e-05,0.52089,0.44522,1,1
2,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.00026003,0.51822,0.43648,1,1
2,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,3.8583e-05,0.51426,0.60361,1,1
2,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.00029782,0.51233,0.39413,1,1
2,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,3.1904e-06,0.50604,0.55189,1,1
2,GO CORPUS CALLOSUM DEVELOPMENT,1.2366e-07,0.50581,0.55815,1,1
2,GO POSTSYNAPSE ASSEMBLY,2.2524e-05,0.50478,0.5522,1,1
2,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.001662,0.49835,0.41138,1,1
2,GO SUCKLING BEHAVIOR,2.6902e-06,0.49306,0.46816,1,1
2,GO PLASMA MEMBRANE REPAIR,6.0198e-07,0.49163,0.5509,1,1
2,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.00019753,0.4888,0.39291,1,1
2,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,5.2837e-06,0.48509,0.42077,1,1
2,GO UV PROTECTION,3.0576e-06,0.48315,0.47018,1,1
2,GO REGULATION OF GUANYLATE CYCLASE ACTIVITY,0.0026572,0.48243,0.39301,1,1
2,GO OXYGEN TRANSPORT,0.007729,0.48098,0.47859,1,1
2,GO ADULT HEART DEVELOPMENT,2.9532e-05,0.46765,0.43997,1,1
2,GO GLYCINE TRANSPORT,0.010245,0.46638,0.32803,1,1
2,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,1.1964e-05,0.46059,0.47156,1,1
2,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,7.547e-05,0.45958,0.48595,1,1
2,GO PROTEIN LOCALIZATION TO AXON,0.0037331,0.45649,0.45228,1,1
2,GO TELENCEPHALON REGIONALIZATION,0.0066042,0.45498,0.35935,1,1
2,GO MODIFICATION OF SYNAPTIC STRUCTURE,3.3287e-06,0.45296,0.44,1,1
2,GO MATURATION OF LSU RRNA,0.00014935,0.4519,0.37323,1,1
2,GO POSITIVE REGULATION OF NEURON MIGRATION,0.00072223,0.45108,0.37243,1,1
2,GO RIBOSOME ASSEMBLY,0.00032948,0.44701,0.35206,1,1
2,GO EXCITATORY SYNAPSE ASSEMBLY,3.3132e-05,0.44645,0.43335,1,1
2,GO NEGATIVE REGULATION OF LYASE ACTIVITY,2.3418e-05,0.44561,0.41876,1,1
2,GO PEPTIDYL SERINE DEPHOSPHORYLATION,1.5816e-05,0.44531,0.41464,1,1
2,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.00026003,0.44497,0.40363,1,1
2,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.00013433,0.44103,0.35656,1,1
2,GO TRICARBOXYLIC ACID METABOLIC PROCESS,7.8282e-05,0.44058,0.41204,1,1
2,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.0019282,0.43622,0.29455,1,1
2,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,3.7145e-05,0.43405,0.49431,1,1
2,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,5.2139e-05,0.43229,0.44291,1,1
2,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,0.02068,0.42852,0.26809,1,1
2,GO REGULATION OF GONAD DEVELOPMENT,0.00090094,0.42822,0.27321,1,1
2,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,1.4039e-05,0.42626,0.40752,1,1
2,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.00036427,0.41768,0.35519,1,1
2,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.00052342,0.41701,0.41583,1,1
2,GO IMP METABOLIC PROCESS,9.0551e-05,0.41481,0.41783,1,1
2,GO CGMP METABOLIC PROCESS,0.00045924,0.41082,0.36304,1,1
2,GO CARDIAC VENTRICLE FORMATION,0.00040247,0.41063,0.57213,1,1
2,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.00044439,0.40928,0.41246,1,1
2,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.00034072,0.40609,0.35238,1,1
2,GO RESPONSE TO ELECTRICAL STIMULUS,9.0551e-05,0.40382,0.32816,1,1
2,GO VITAMIN CATABOLIC PROCESS,0.01282,0.40346,0.31243,1,1
2,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,8.3127e-06,0.4005,0.35991,1,1
2,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.0062634,0.3971,0.36548,1,1
2,GO REGULATION OF CGMP MEDIATED SIGNALING,0.013139,0.39707,0.27753,1,1
2,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,2.3418e-05,0.39682,0.38372,1,1
2,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,6.5149e-05,0.39636,0.43113,1,1
2,GO ELASTIC FIBER ASSEMBLY,0.00045924,0.39581,0.47755,1,1
2,GO ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.0059384,0.39443,0.26069,1,1
2,GO MYOBLAST PROLIFERATION,4.6623e-06,0.39425,0.4101,1,1
2,GO SIALYLATION,0.0013457,0.39342,0.40768,1,1
2,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,2.2524e-05,0.3916,0.34173,1,1
2,GO CARDIAC CHAMBER FORMATION,0.00041602,0.39111,0.51814,1,1
2,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.0057817,0.38824,0.30976,1,1
2,GO INNERVATION,0.00052342,0.38703,0.39486,1,1
2,GO FACIAL NERVE MORPHOGENESIS,0.0066042,0.38467,0.35033,1,1
2,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.00031859,0.38363,0.34614,1,1
2,GO NEGATIVE CHEMOTAXIS,0.00012512,0.38309,0.34246,1,1
2,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.0057817,0.38233,0.2726,1,1
2,GO REGULATION OF COLLAGEN METABOLIC PROCESS,0.0027346,0.38146,0.25967,1,1
2,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.00019753,0.38097,0.35262,1,1
2,GO CYTOPLASMIC TRANSLATION,0.00049035,0.38017,0.35101,1,1
2,GO VESICLE FUSION TO PLASMA MEMBRANE,7.9801e-06,0.37741,0.47846,1,1
2,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.0069616,0.37522,0.29253,1,1
2,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.001228,0.37444,0.36944,1,1
2,GO HEART VALVE FORMATION,0.00037661,0.37386,0.39291,1,1
2,GO AV NODE CELL TO BUNDLE OF HIS CELL COMMUNICATION,0.00045924,0.36967,0.38396,1,1
2,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00018427,0.36937,0.37404,1,1
2,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00012964,0.36873,0.41623,1,1
2,GO CHEMOSENSORY BEHAVIOR,0.0020453,0.36777,0.26236,1,1
2,GO DENTATE GYRUS DEVELOPMENT,7.8282e-05,0.36694,0.51687,1,1
2,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.009256,0.36495,0.27525,1,1
2,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.0036303,0.35922,0.25656,1,1
2,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.033166,0.35692,0.22823,1,1
2,GO L GLUTAMATE IMPORT,0.00045924,0.35529,0.29567,1,1
2,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.00014418,0.3552,0.31646,1,1
2,GO ADAPTATION OF SIGNALING PATHWAY,0.0014299,0.35044,0.24031,1,1
2,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.0001547,0.34932,0.33442,1,1
2,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.00065623,0.34881,0.3587,1,1
2,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.00090094,0.34876,0.44965,1,1
2,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,2.5774e-06,0.34625,0.39766,1,1
2,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.00022676,0.34618,0.32216,1,1
2,GO ADULT FEEDING BEHAVIOR,0.00065623,0.34356,0.22249,1,1
2,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.021165,0.34351,0.2709,1,1
2,GO DORSAL VENTRAL AXIS SPECIFICATION,0.0022992,0.34218,0.3393,1,1
2,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.00067758,0.34121,0.27606,1,1
2,GO TRANSLATIONAL INITIATION,0.0010528,0.3411,0.3039,1,1
2,GO REGULATION OF CYTOPLASMIC TRANSLATION,1.7806e-05,0.34055,0.31045,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.0083534,0.33889,0.32249,1,1
2,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.03939,0.33738,0.25131,1,1
2,GO REGULATION OF TRANSLATIONAL FIDELITY,0.0010859,0.33694,0.25895,1,1
2,GO GAS TRANSPORT,0.0066042,0.33673,0.37192,1,1
2,GO LIMB BUD FORMATION,0.015203,0.33666,0.37697,1,1
2,GO LAYER FORMATION IN CEREBRAL CORTEX,0.0017641,0.33651,0.28969,1,1
2,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0015189,0.33579,0.29889,1,1
2,GO TELOMERASE RNA LOCALIZATION,0.00013917,0.32701,0.32189,1,1
2,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,1.0604e-05,0.32643,0.36839,1,1
2,GO SYNAPTIC TRANSMISSION GABAERGIC,2.6307e-05,0.32293,0.28974,1,1
2,GO SYNAPTIC VESICLE PRIMING,3.0689e-05,0.32128,0.41314,1,1
2,GO CELL PROLIFERATION IN FOREBRAIN,0.027803,0.32032,0.19312,1,1
2,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.00090094,0.31727,0.30085,1,1
2,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.027803,0.317,0.2786,1,1
2,GO PURINE CONTAINING COMPOUND SALVAGE,0.0023671,0.31699,0.27417,1,1
2,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,4.1617e-05,0.31621,0.33865,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.00016023,0.31598,0.29368,1,1
2,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.00079435,0.31522,0.36813,1,1
2,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00087311,0.31486,0.26049,1,1
2,GO AORTA DEVELOPMENT,0.0016129,0.31397,0.20113,1,1
2,GO MATURATION OF SSU RRNA,0.00045924,0.31375,0.29689,1,1
2,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,1.4609e-05,0.3125,0.37367,1,1
2,GO NEURON PROJECTION ORGANIZATION,3.1904e-06,0.31218,0.30704,1,1
2,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.00059588,0.31056,0.29615,1,1
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.0047853,0.31015,0.32372,1,1
2,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00047456,0.3101,0.30501,1,1
2,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.00081984,0.30788,0.31239,1,1
2,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.041967,0.30776,0.23304,1,1
2,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.00042998,0.30492,0.26796,1,1
2,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.0021689,0.30332,0.24321,1,1
2,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.0037331,0.30275,0.20971,1,1
2,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.00069957,0.30273,0.3116,1,1
2,GO GLYCINE METABOLIC PROCESS,0.054842,0.29931,0.20115,1,1
2,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.00019753,0.2983,0.34389,1,1
2,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.0047853,0.29787,0.27686,1,1
2,GO DIVALENT METAL ION EXPORT,0.00059588,0.29766,0.39797,1,1
2,GO REGULATION OF LYASE ACTIVITY,3.0689e-05,0.29634,0.26996,1,1
2,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.0021062,0.29468,0.22458,1,1
2,GO MATURATION OF 5 8S RRNA,0.0017641,0.29439,0.24399,1,1
2,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.041967,0.29417,0.18102,1,1
2,GO MATING BEHAVIOR,0.0025817,0.29386,0.21672,1,1
2,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.0010206,0.29365,0.4059,1,1
2,GO PENTOSE METABOLIC PROCESS,0.0037331,0.2933,0.23187,1,1
2,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.0079323,0.29304,0.18715,1,1
2,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.054842,0.29297,0.1712,1,1
2,GO MITOCHONDRIAL TRANSCRIPTION,0.0038387,0.29273,0.25142,1,1
2,GO PEPTIDYL ARGININE N METHYLATION,0.00010462,0.29234,0.31636,1,1
2,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.0075304,0.29187,0.24686,1,1
2,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.0026572,0.29084,0.22203,1,1
2,GO EMBRYONIC BRAIN DEVELOPMENT,8.1192e-05,0.29082,0.31637,1,1
2,GO SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL COMMUNICATION,0.0036303,0.29063,0.33102,1,1
2,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.0010528,0.29002,0.23738,1,1
2,GO NAD METABOLIC PROCESS,0.0028957,0.28961,0.2362,1,1
2,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.0025083,0.28931,0.23327,1,1
2,GO L SERINE METABOLIC PROCESS,0.011904,0.28863,0.29792,1,1
2,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.0071468,0.28737,0.21499,1,1
2,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,9.7346e-05,0.28657,0.21378,1,1
2,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00072223,0.28487,0.2813,1,1
2,GO TRNA WOBBLE BASE MODIFICATION,0.0010206,0.28381,0.22364,1,1
2,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.0057817,0.28372,0.27887,1,1
2,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.015203,0.2822,0.25272,1,1
2,GO RIBOSOME BIOGENESIS,0.00057693,0.27931,0.25228,1,1
2,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.00025131,0.27665,0.31857,1,1
2,GO REGULATION OF MRNA BINDING,0.00026003,0.27398,0.297,1,1
2,GO PEPTIDYL HISTIDINE MODIFICATION,0.00063551,0.27295,0.21766,1,1
2,GO MESODERMAL CELL FATE SPECIFICATION,0.041093,0.27198,0.18829,1,1
2,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.004408,0.27146,0.1994,1,1
2,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.0015653,0.27089,0.28208,1,1
2,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.00054072,0.27016,0.23454,1,1
2,GO STRESS GRANULE ASSEMBLY,1.1493e-05,0.2701,0.24164,1,1
2,GO PROTEIN TARGETING TO MEMBRANE,0.0021689,0.26871,0.22891,1,1
2,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.00353,0.26731,0.20427,1,1
2,GO EXTRACELLULAR MATRIX ASSEMBLY,0.0011199,0.26595,0.24764,1,1
2,GO BONE GROWTH,0.009256,0.2629,0.2313,1,1
2,GO NEURON REMODELING,0.0010528,0.2624,0.29998,1,1
2,GO HYPOTONIC RESPONSE,0.025994,0.26188,0.17492,1,1
2,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.013139,0.26177,0.20083,1,1
2,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,4.0073e-05,0.26171,0.23927,1,1
2,GO LEARNING,3.5759e-05,0.26107,0.2771,1,1
2,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.016734,0.26084,0.2363,1,1
2,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0042883,0.26079,0.20316,1,1
2,GO MITOCHONDRION DISTRIBUTION,0.00014935,0.26009,0.25265,1,1
2,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.00014935,0.25989,0.19652,1,1
2,GO TRANSLATIONAL ELONGATION,0.00038934,0.25826,0.22275,1,1
2,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.0039469,0.25823,0.2013,1,1
2,GO RRNA MODIFICATION,0.007729,0.2571,0.21839,1,1
2,GO RRNA METABOLIC PROCESS,0.00084609,0.25574,0.22872,1,1
2,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.00087311,0.25477,0.26261,1,1
2,GO REPRODUCTIVE BEHAVIOR,0.0018173,0.25446,0.24261,1,1
2,GO CELL JUNCTION DISASSEMBLY,0.0013054,0.25444,0.25289,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,9.0551e-05,0.25444,0.25267,1,1
2,GO VIRAL TRANSLATION,0.0013054,0.25369,0.28863,1,1
2,GO REGULATION OF NEUROBLAST PROLIFERATION,0.0053338,0.25352,0.22196,1,1
2,GO CELL PROLIFERATION IN HINDBRAIN,0.013798,0.25024,0.23231,1,1
2,GO CELL DIFFERENTIATION IN HINDBRAIN,0.0051916,0.24683,0.26074,1,1
2,GO POSITIVE REGULATION OF ORGAN GROWTH,0.0022332,0.24555,0.21421,1,1
2,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.0066042,0.24493,0.19261,1,1
2,GO ACTIVATION OF MAPKKK ACTIVITY,0.054842,0.24402,0.13174,1,1
2,GO NOREPINEPHRINE TRANSPORT,0.0021689,0.24248,0.20411,1,1
2,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.00079435,0.23776,0.19158,1,1
2,GO INHIBITORY SYNAPSE ASSEMBLY,0.001228,0.23725,0.42057,1,1
2,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.037747,0.23697,0.22179,1,1
2,GO ASSOCIATIVE LEARNING,5.2139e-05,0.23591,0.24356,1,1
2,GO ONE CARBON COMPOUND TRANSPORT,0.020205,0.23556,0.15196,1,1
2,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0060989,0.23513,0.18145,1,1
2,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00026903,0.23406,0.20807,1,1
2,GO FOREBRAIN REGIONALIZATION,0.016339,0.23337,0.24722,1,1
2,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.025994,0.23302,0.20211,1,1
2,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.00026903,0.23286,0.2258,1,1
2,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.037747,0.23278,0.22524,1,1
2,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.0094949,0.23246,0.20721,1,1
2,GO POLYOL TRANSPORT,0.0079323,0.23114,0.18719,1,1
2,GO TRNA WOBBLE URIDINE MODIFICATION,0.0039469,0.2296,0.2025,1,1
2,GO SNORNA 3 END PROCESSING,0.00098941,0.22817,0.34461,1,1
2,GO TRNA MODIFICATION,0.00019079,0.22811,0.22381,1,1
2,GO RRNA TRANSCRIPTION,0.00054072,0.22764,0.21113,1,1
2,GO REGULATION OF CYCLASE ACTIVITY,6.2786e-05,0.22515,0.25885,1,1
2,GO VIRAL GENE EXPRESSION,0.011904,0.22434,0.20572,1,1
2,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.0028141,0.22387,0.20694,1,1
2,GO TRNA METHYLATION,0.0022992,0.22314,0.17565,1,1
2,GO NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.0057817,0.22244,0.24928,1,1
2,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.0031536,0.22073,0.17238,1,1
2,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.0033369,0.22015,0.19904,1,1
2,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.0026572,0.21849,0.17044,1,1
2,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,8.7323e-05,0.21784,0.23145,1,1
2,GO AROMATIC AMINO ACID TRANSPORT,0.004408,0.21751,0.34059,1,1
2,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.0028141,0.21551,0.28893,1,1
2,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.00087311,0.21531,0.21643,1,1
2,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0073363,0.21512,0.19907,1,1
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.00024286,0.21398,0.23165,1,1
2,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.0083534,0.21394,0.15885,1,1
2,GO REGULATION OF STORE OPERATED CALCIUM ENTRY,0.011612,0.21373,0.23113,1,1
2,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.023205,0.21365,0.20936,1,1
2,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.0097392,0.21356,0.18451,1,1
2,GO REGULATION OF RNA BINDING,0.00035231,0.21323,0.24793,1,1
2,GO TUBULIN DEACETYLATION,0.014841,0.2129,0.1902,1,1
2,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,0.017969,0.21275,0.19516,1,1
2,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.00045924,0.21256,0.19071,1,1
2,GO PROTEIN TARGETING TO MITOCHONDRION,0.0006154,0.21208,0.1453,1,1
2,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.0045306,0.21,0.19261,1,1
2,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0015189,0.20967,0.16934,1,1
2,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.0075304,0.20888,0.1496,1,1
2,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.0024367,0.20799,0.17967,1,1
2,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.045624,0.20758,0.15517,1,1
2,GO OXIDATIVE PHOSPHORYLATION,0.0031536,0.20716,0.16271,1,1
2,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.010506,0.20713,0.17369,1,1
2,GO POSITIVE REGULATION OF HEART GROWTH,0.0071468,0.20653,0.178,1,1
2,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.00035231,0.20626,0.23644,1,1
2,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.00059588,0.20539,0.29311,1,1
2,GO URONIC ACID METABOLIC PROCESS,0.00055855,0.20522,0.1716,1,1
2,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.0046564,0.20437,0.16281,1,1
2,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.016734,0.20408,0.20365,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.0017641,0.20349,0.19653,1,1
2,GO TELOMERIC LOOP DISASSEMBLY,0.001191,0.20346,0.2066,1,1
2,GO AMINO ACID TRANSMEMBRANE TRANSPORT,6.0504e-05,0.2032,0.21928,1,1
2,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.00012074,0.20188,0.20711,1,1
2,GO CRANIAL NERVE MORPHOGENESIS,0.033894,0.20162,0.20302,1,1
2,GO TRANSLATIONAL TERMINATION,0.0039469,0.20079,0.19092,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.0034322,0.20069,0.15221,1,1
2,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.036948,0.19936,0.20169,1,1
2,GO FEAR RESPONSE,0.0097392,0.19857,0.16602,1,1
2,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.00050664,0.19822,0.19569,1,1
2,GO NCRNA PROCESSING,0.0012662,0.19782,0.18397,1,1
2,GO SNORNA METABOLIC PROCESS,0.0031536,0.1972,0.30796,1,1
2,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.047551,0.19713,0.17411,1,1
2,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.0049174,0.19691,0.19162,1,1
2,GO HISTONE ARGININE METHYLATION,0.00067758,0.1969,0.2115,1,1
2,GO IRON COORDINATION ENTITY TRANSPORT,0.0062634,0.19677,0.19911,1,1
2,GO AMINO ACID IMPORT,0.0041716,0.19661,0.18047,1,1
2,GO POSITIVE REGULATION OF MRNA PROCESSING,2.6902e-06,0.19536,0.20291,1,1
2,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.00028792,0.19524,0.23795,1,1
2,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.014841,0.19511,0.13259,1,1
2,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.0060989,0.19511,0.20831,1,1
2,GO RESPONSE TO PROSTAGLANDIN E,0.052669,0.1941,0.096069,1,1
2,GO AEROBIC RESPIRATION,0.0016129,0.1938,0.17211,1,1
2,GO RNA POLYADENYLATION,0.00042998,0.19367,0.14716,1,1
2,GO CELLULAR ANION HOMEOSTASIS,0.044685,0.19324,0.18555,1,1
2,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.017969,0.1928,0.15027,1,1
2,GO MRNA MODIFICATION,0.0007696,0.19273,0.23559,1,1
2,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.0018173,0.19214,0.17905,1,1
2,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.001191,0.19124,0.22808,1,1
2,GO PLASMA MEMBRANE TUBULATION,0.011326,0.19059,0.15792,1,1
2,GO PROTEIN NITROSYLATION,0.020205,0.18795,0.19961,1,1
2,GO MEMBRANE DISASSEMBLY,0.026586,0.1872,0.12351,1,1
2,GO REGULATION OF TRANSLATIONAL ELONGATION,0.0028141,0.18641,0.16102,1,1
2,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.0039469,0.18635,0.20534,1,1
2,GO CRISTAE FORMATION,0.010773,0.18633,0.19498,1,1
2,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.001228,0.18625,0.18231,1,1
2,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0069616,0.18464,0.14181,1,1
2,GO NEGATIVE REGULATION OF BEHAVIOR,0.0056288,0.18358,0.23025,1,1
2,GO PEPTIDYL ARGININE METHYLATION,0.00032948,0.18283,0.21665,1,1
2,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.013798,0.18278,0.18877,1,1
2,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.001191,0.18234,0.20343,1,1
2,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.0049174,0.18212,0.1579,1,1
2,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.007729,0.18164,0.17887,1,1
2,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.0007696,0.17987,0.13438,1,1
2,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.0022992,0.17916,0.17914,1,1
2,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.01282,0.17876,0.14442,1,1
2,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,7.547e-05,0.17796,0.2271,1,1
2,GO PYRUVATE METABOLIC PROCESS,0.0045306,0.17695,0.12067,1,1
2,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.0075304,0.17618,0.15109,1,1
2,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.0034322,0.17482,0.21853,1,1
2,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.0023671,0.17411,0.13803,1,1
2,GO CELLULAR RESPIRATION,0.0041716,0.17387,0.14646,1,1
2,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.0073363,0.17338,0.14406,1,1
2,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.010245,0.17319,0.13409,1,1
2,GO HISTONE MRNA METABOLIC PROCESS,0.00027832,0.17269,0.15609,1,1
2,GO EXCRETION,0.0056288,0.17257,0.13673,1,1
2,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.0010859,0.17212,0.20056,1,1
2,GO CELLULAR RESPONSE TO HEAT,0.0013457,0.17064,0.12044,1,1
2,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.043763,0.17035,0.16556,1,1
2,GO L AMINO ACID TRANSPORT,0.00063551,0.17017,0.19111,1,1
2,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.0067808,0.17,0.1241,1,1
2,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00023468,0.16976,0.15496,1,1
2,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.0013457,0.16916,0.2218,1,1
2,GO HISTONE H3 K9 DEMETHYLATION,0.0083534,0.16904,0.19259,1,1
2,GO TRNA PROCESSING,0.00090094,0.16875,0.17937,1,1
2,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.036948,0.16846,0.17184,1,1
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.010506,0.16785,0.18837,1,1
2,GO HIPPOCAMPUS DEVELOPMENT,0.0054795,0.16721,0.20077,1,1
2,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.0064317,0.16709,0.21801,1,1
2,GO REGULATION OF SPINDLE CHECKPOINT,0.00092958,0.1669,0.14928,1,1
2,GO CARBOHYDRATE PHOSPHORYLATION,0.012203,0.16623,0.14042,1,1
2,GO STRIATUM DEVELOPMENT,0.016339,0.16617,0.18751,1,1
2,GO MITOCHONDRIAL PROTEIN PROCESSING,0.01282,0.16366,0.17074,1,1
2,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.041093,0.16341,0.1333,1,1
2,GO MITOCHONDRIAL GENE EXPRESSION,0.0046564,0.16254,0.19159,1,1
2,GO REGULATION OF RECEPTOR INTERNALIZATION,0.014486,0.16219,0.099699,1,1
2,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.010506,0.16121,0.17084,1,1
2,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.0029794,0.15835,0.14723,1,1
2,GO MITOTIC DNA REPLICATION CHECKPOINT,0.010506,0.15666,0.14296,1,1
2,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.029068,0.15409,0.1588,1,1
2,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.012203,0.15294,0.16955,1,1
2,GO PROTEIN DEMETHYLATION,0.037747,0.15217,0.11321,1,1
2,GO MRNA METHYLATION,0.01282,0.15177,0.19339,1,1
2,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.011326,0.15121,0.21752,1,1
2,GO REGULATION OF CARDIAC CONDUCTION,0.024846,0.15042,0.12439,1,1
2,GO RNA SURVEILLANCE,0.033894,0.1503,0.12882,1,1
2,GO REGULATION OF ENDOCYTIC RECYCLING,0.02268,0.14991,0.1987,1,1
2,GO NCRNA METABOLIC PROCESS,0.0029794,0.14765,0.15371,1,1
2,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.041093,0.1475,0.12282,1,1
2,GO REGULATION OF TRANSLATIONAL INITIATION,0.00069957,0.1464,0.12066,1,1
2,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.015574,0.14537,0.10928,1,1
2,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.013798,0.14497,0.14402,1,1
2,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.007729,0.14423,0.10342,1,1
2,GO PROTEIN TARGETING,0.007729,0.14409,0.10904,1,1
2,GO TRICARBOXYLIC ACID CYCLE,0.0064317,0.14323,0.14307,1,1
2,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.00026003,0.14301,0.15939,1,1
2,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,7.013e-05,0.14268,0.18832,1,1
2,GO PEPTIDE BIOSYNTHETIC PROCESS,0.0054795,0.14261,0.13749,1,1
2,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.0053338,0.13936,0.16664,1,1
2,GO PROTEIN HETEROOLIGOMERIZATION,0.0020453,0.13918,0.15842,1,1
2,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.00047456,0.13806,0.24592,1,1
2,GO REPLICATION FORK PROCESSING,0.0040578,0.13801,0.13472,1,1
2,GO REGULATION OF MITOCHONDRIAL FISSION,0.03245,0.13664,0.1133,1,1
2,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0042883,0.13658,0.11355,1,1
2,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.0011549,0.13652,0.13207,1,1
2,GO REGULATION OF MRNA POLYADENYLATION,0.0014738,0.13645,0.12815,1,1
2,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.0026572,0.13383,0.1528,1,1
2,GO ARTERY DEVELOPMENT,0.049546,0.13343,0.062324,1,1
2,GO REGULATION OF CELL CYCLE ARREST,0.011047,0.13304,0.088991,1,1
2,GO DNA REPLICATION CHECKPOINT,0.0041716,0.13282,0.1289,1,1
2,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.01282,0.13277,0.23479,1,1
2,GO LIMBIC SYSTEM DEVELOPMENT,0.04854,0.13163,0.11612,1,1
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.0016129,0.1315,0.11326,1,1
2,GO AMINO ACID TRANSPORT,0.00016595,0.13054,0.1682,1,1
2,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.0010206,0.12938,0.11393,1,1
2,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.019739,0.12764,0.15135,1,1
2,GO RESPONSE TO AMPHETAMINE,0.045624,0.1275,0.13089,1,1
2,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.01282,0.12653,0.14995,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.0056288,0.12485,0.12084,1,1
2,GO NUCLEOTIDE PHOSPHORYLATION,0.0047853,0.12371,0.12014,1,1
2,GO ATP METABOLIC PROCESS,0.0024367,0.12365,0.10989,1,1
2,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.02268,0.12358,0.10602,1,1
2,GO REGULATION OF MRNA PROCESSING,0.001228,0.12321,0.10397,1,1
2,GO BASE EXCISION REPAIR,0.017549,0.12253,0.087776,1,1
2,GO MATING,0.033166,0.12237,0.091484,1,1
2,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.02843,0.12167,0.10248,1,1
2,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.0039469,0.12166,0.10347,1,1
2,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.029719,0.12095,0.11361,1,1
2,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.0075304,0.12071,0.11613,1,1
2,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.014138,0.11894,0.08456,1,1
2,GO REGULATION OF TELOMERE MAINTENANCE,0.0046564,0.1189,0.11692,1,1
2,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.03939,0.11847,0.11502,1,1
2,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0050528,0.11797,0.10938,1,1
2,GO NCRNA EXPORT FROM NUCLEUS,0.033166,0.11753,0.11239,1,1
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.024846,0.11601,0.12444,1,1
2,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.007729,0.11555,0.076652,1,1
2,GO PROTEIN TETRAMERIZATION,0.00059588,0.11506,0.13276,1,1
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0099891,0.11483,0.10236,1,1
2,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.0013054,0.1146,0.172,1,1
2,GO NCRNA 3 END PROCESSING,0.01282,0.11383,0.095253,1,1
2,GO IMPORT ACROSS PLASMA MEMBRANE,0.001986,0.11376,0.13349,1,1
2,GO CELLULAR GLUCOSE HOMEOSTASIS,0.0047853,0.11257,0.11194,1,1
2,GO MUSCLE ORGAN MORPHOGENESIS,0.031059,0.11238,0.095715,1,1
2,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.029068,0.11227,0.098242,1,1
2,GO CELLULAR RESPONSE TO DRUG,0.0085714,0.11156,0.12578,1,1
2,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.016734,0.11143,0.084827,1,1
2,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.033166,0.1105,0.076747,1,1
2,GO TELENCEPHALON DEVELOPMENT,0.0028141,0.11012,0.13391,1,1
2,GO RNA 3 END PROCESSING,0.0064317,0.10664,0.082163,1,1
2,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0050528,0.10659,0.091621,1,1
2,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.023741,0.10627,0.11456,1,1
2,GO MRNA 3 END PROCESSING,0.0075304,0.10424,0.078822,1,1
2,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.018398,0.10337,0.13184,1,1
2,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.016734,0.1032,0.091181,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.02843,0.10275,0.079815,1,1
2,GO MITOTIC RECOMBINATION,0.03939,0.10239,0.12336,1,1
2,GO REGULATION OF CELL CYCLE CHECKPOINT,0.0037331,0.10232,0.09644,1,1
2,GO LEUKOCYTE TETHERING OR ROLLING,0.009256,0.1022,0.12556,1,1
2,GO TELOMERE ORGANIZATION,0.0059384,0.1018,0.092471,1,1
2,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.047551,0.10107,0.0937,1,1
2,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.024288,0.099497,0.10904,1,1
2,GO MRNA METABOLIC PROCESS,0.0014299,0.099475,0.10604,1,1
2,GO METAL ION TRANSPORT,0.031059,0.098552,0.068972,1,1
2,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.024846,0.097809,0.086502,1,1
2,GO RNA PROCESSING,0.00044439,0.096204,0.11772,1,1
2,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.001986,0.096203,0.10604,1,1
2,GO INTERSTRAND CROSS LINK REPAIR,0.0028141,0.095757,0.09109,1,1
2,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.044685,0.095589,0.080866,1,1
2,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.011326,0.094873,0.17996,1,1
2,GO MITOCHONDRIAL GENOME MAINTENANCE,0.041967,0.09449,0.13653,1,1
2,GO NCRNA TRANSCRIPTION,0.0025083,0.093842,0.09324,1,1
2,GO TRANSCRIPTION BY RNA POLYMERASE III,0.0094949,0.090542,0.090551,1,1
2,GO SODIUM ION TRANSPORT,0.04854,0.090093,0.07834,1,1
2,GO PHOSPHATE ION TRANSPORT,0.02166,0.089491,0.090965,1,1
2,GO PROTEIN HOMOOLIGOMERIZATION,0.0022992,0.089404,0.10202,1,1
2,GO REGULATION OF CALCIUM ION TRANSPORT,0.029068,0.08883,0.090382,1,1
2,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.0012662,0.08686,0.10335,1,1
2,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.025994,0.082868,0.082697,1,1
2,GO PROTEIN HETEROTETRAMERIZATION,0.0050528,0.082708,0.13026,1,1
2,GO MRNA PROCESSING,0.0010859,0.07968,0.091229,1,1
2,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.016339,0.07527,0.067584,1,1
2,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.0056288,0.074586,0.08917,1,1
2,GO RNA SPLICING,0.0023671,0.072933,0.085108,1,1
2,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.037747,0.053063,0.05135,1,1
2,GO CARDIAC VENTRICLE MORPHOGENESIS,0.036164,0.048604,0.11244,1,1
2,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.038561,0.038589,0.066038,1,1
2,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,0.00081984,0.49751,0.48283,1,0
2,GO CHAPERONE MEDIATED AUTOPHAGY,0.0081404,0.35604,0.31425,1,0
2,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,0.013798,0.32666,0.44768,1,0
2,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.053746,0.31706,0.17246,1,0
2,GO RRNA PSEUDOURIDINE SYNTHESIS,0.011904,0.30728,0.28329,1,0
2,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.01282,0.30544,0.21362,1,0
2,GO REGULATION OF METANEPHROS DEVELOPMENT,0.037747,0.30237,0.18672,1,0
2,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.013465,0.29312,0.23126,1,0
2,GO BONE TRABECULA FORMATION,0.016339,0.29217,0.28867,1,0
2,GO ARGININE METABOLIC PROCESS,0.0079323,0.27497,0.29089,1,0
2,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.018398,0.27165,0.20893,1,0
2,GO COLLAGEN BIOSYNTHETIC PROCESS,0.03245,0.26305,0.1703,1,0
2,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.0022332,0.24364,0.23682,1,0
2,GO COLLAGEN METABOLIC PROCESS,0.020205,0.24009,0.14035,1,0
2,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.03939,0.22828,0.26749,1,0
2,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.0016129,0.22746,0.18799,1,0
2,GO RESPONSE TO INTERLEUKIN 7,0.00019753,0.22077,0.19118,1,0
2,GO HISTONE SERINE PHOSPHORYLATION,0.0037331,0.21351,0.17163,1,0
2,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.031059,0.20867,0.18668,1,0
2,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.019283,0.20829,0.13889,1,0
2,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.0079323,0.20082,0.20231,1,0
2,GO CELLULAR COPPER ION HOMEOSTASIS,0.014486,0.19694,0.17506,1,0
2,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.05161,0.1833,0.11631,1,0
2,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.0045306,0.18258,0.17858,1,0
2,GO CORONARY VASCULATURE DEVELOPMENT,0.013798,0.18198,0.12879,1,0
2,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,0.011904,0.18024,0.16927,1,0
2,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.045624,0.17967,0.12845,1,0
2,GO POSITIVE REGULATION OF ACTION POTENTIAL,0.055956,0.17964,0.1357,1,0
2,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0030654,0.17692,0.23384,1,0
2,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.02166,0.1762,0.13534,1,0
2,GO KIDNEY MESENCHYME DEVELOPMENT,0.027803,0.17038,0.1883,1,0
2,GO DENDRITIC TRANSPORT,0.010506,0.16695,0.24093,1,0
2,GO RRNA METHYLATION,0.0081404,0.16645,0.18496,1,0
2,GO REGULATION OF TRANSLATIONAL TERMINATION,0.010506,0.16562,0.19049,1,0
2,GO MITOCHONDRIAL TRANSLATION,0.0042883,0.16381,0.19525,1,0
2,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.0059384,0.16057,0.19391,1,0
2,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.011047,0.1597,0.20058,1,0
2,GO NUCLEAR PORE ORGANIZATION,0.041093,0.15717,0.11028,1,0
2,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.042857,0.15679,0.097057,1,0
2,GO COPPER ION HOMEOSTASIS,0.024846,0.15663,0.14424,1,0
2,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.046579,0.15659,0.12563,1,0
2,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.02068,0.15485,0.11071,1,0
2,GO IMPORT INTO CELL,0.00031859,0.15268,0.16949,1,0
2,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.042857,0.15178,0.12137,1,0
2,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.0069616,0.14894,0.15764,1,0
2,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.0087944,0.14827,0.14805,1,0
2,GO BASEMENT MEMBRANE ASSEMBLY,0.054842,0.14706,0.17956,1,0
2,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.035393,0.14524,0.11023,1,0
2,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.0026572,0.14459,0.15038,1,0
2,GO PROTEIN DENEDDYLATION,0.033166,0.14066,0.13452,1,0
2,GO RNA CATABOLIC PROCESS,0.012203,0.13892,0.11055,1,0
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.03939,0.13858,0.17548,1,0
2,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.036164,0.13815,0.12703,1,0
2,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.041093,0.13814,0.09988,1,0
2,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0094949,0.13631,0.16419,1,0
2,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.043763,0.13544,0.12947,1,0
2,GO LIVER REGENERATION,0.040234,0.13541,0.077176,1,0
2,GO RNA METHYLATION,0.0039469,0.1329,0.13947,1,0
2,GO MODULATION BY HOST OF VIRAL PROCESS,0.0087944,0.13195,0.11512,1,0
2,GO POSITIVE REGULATION OF TRANSLATION,0.0090226,0.13023,0.11092,1,0
2,GO TRNA TRANSPORT,0.007729,0.12413,0.1308,1,0
2,GO MRNA SPLICE SITE SELECTION,0.042857,0.123,0.13568,1,0
2,GO PEPTIDE METABOLIC PROCESS,0.024846,0.11942,0.091635,1,0
2,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.042857,0.11906,0.073813,1,0
2,GO AMIDE BIOSYNTHETIC PROCESS,0.0087944,0.11847,0.11837,1,0
2,GO MAINTENANCE OF PROTEIN LOCATION,0.015574,0.11796,0.081204,1,0
2,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.014486,0.11788,0.11892,1,0
2,GO RNA 5 END PROCESSING,0.035393,0.11506,0.12281,1,0
2,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.03245,0.11289,0.1031,1,0
2,GO NUCLEOBASE METABOLIC PROCESS,0.0037331,0.11212,0.17851,1,0
2,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.022165,0.11169,0.12288,1,0
2,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.036948,0.11156,0.096039,1,0
2,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.045624,0.11137,0.11873,1,0
2,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.0069616,0.11107,0.10628,1,0
2,GO TRNA METABOLIC PROCESS,0.0034322,0.10892,0.14407,1,0
2,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0094949,0.10875,0.096243,1,0
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.009256,0.1067,0.12313,1,0
2,GO CELLULAR IRON ION HOMEOSTASIS,0.015953,0.10552,0.11118,1,0
2,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.031059,0.10453,0.11387,1,0
2,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.034637,0.10317,0.086476,1,0
2,GO POTASSIUM ION TRANSPORT,0.035393,0.10273,0.1169,1,0
2,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.024846,0.099707,0.083464,1,0
2,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.031059,0.098422,0.099572,1,0
2,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.0060989,0.098297,0.099857,1,0
2,GO TRANSCRIPTION BY RNA POLYMERASE I,0.017969,0.098288,0.11512,1,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,0.015953,0.09826,0.081023,1,0
2,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.004408,0.096457,0.12148,1,0
2,GO CATION TRANSMEMBRANE TRANSPORT,0.020205,0.095754,0.083423,1,0
2,GO RNA MODIFICATION,0.0075304,0.09438,0.12402,1,0
2,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.024846,0.091317,0.082704,1,0
2,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.04854,0.089731,0.099952,1,0
2,GO RESPONSE TO CALCIUM ION,0.050569,0.088902,0.089481,1,0
2,GO RESPONSE TO HEAT,0.017969,0.088863,0.079789,1,0
2,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.010245,0.088589,0.06583,1,0
2,GO PIGMENT BIOSYNTHETIC PROCESS,0.033166,0.088546,0.11543,1,0
2,GO ORGANIC CATION TRANSPORT,0.02268,0.085963,0.1203,1,0
2,GO RNA LOCALIZATION,0.0079323,0.084538,0.089299,1,0
2,GO LACTATION,0.036948,0.081867,0.11724,1,0
2,GO CELL CYCLE DNA REPLICATION,0.044685,0.07298,0.079722,1,0
2,GO CELLULAR AMIDE METABOLIC PROCESS,0.054842,0.070652,0.070367,1,0
2,GO NUCLEAR EXPORT,0.024846,0.070434,0.06326,1,0
2,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.047551,0.068477,0.092842,1,0
2,GO FATTY ACYL COA METABOLIC PROCESS,0.054842,0.06832,0.13079,1,0
2,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.024846,0.067091,0.096255,1,0
2,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.016734,0.063443,0.10185,1,0
2,GO RNA EXPORT FROM NUCLEUS,0.041967,0.063385,0.083155,1,0
2,GO REGULATION OF MRNA METABOLIC PROCESS,0.02068,0.061768,0.062723,1,0
2,GO DIVALENT INORGANIC CATION TRANSPORT,0.044685,0.060003,0.063979,1,0
2,GO NUCLEOTIDE EXCISION REPAIR,0.05161,0.059969,0.059967,1,0
2,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.031059,0.056379,0.062983,1,0
2,GO NUCLEAR TRANSPORT,0.023741,0.052646,0.053247,1,0
2,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,0.035393,0.052448,0.055266,1,0
2,GO MITOTIC CELL CYCLE CHECKPOINT,0.049546,-0.031431,-0.054434,1,0
2,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.047551,-0.037358,-0.049977,1,0
2,GO VESICLE ORGANIZATION,0.053746,-0.037366,-0.070643,1,0
2,GO CYTOKINESIS,0.046579,-0.038365,-0.070188,1,0
2,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.049546,-0.03837,-0.055105,1,0
2,GO PEPTIDYL AMINO ACID MODIFICATION,0.049546,-0.04202,-0.041943,1,0
2,GO TISSUE MORPHOGENESIS,0.047551,-0.042047,-0.080539,1,0
2,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.004408,-0.042958,-0.071349,1,0
2,GO HETEROCHROMATIN ORGANIZATION,0.04854,-0.044763,-0.052471,1,0
2,GO PHOSPHOLIPID CATABOLIC PROCESS,0.054842,-0.045134,-0.14388,1,0
2,GO NEGATIVE REGULATION OF CELL DEATH,0.055956,-0.046016,-0.073182,1,0
2,GO REGULATION OF PROTEIN LOCALIZATION,0.027803,-0.046405,-0.057805,1,0
2,GO PROTEIN O LINKED GLYCOSYLATION,0.025414,-0.046584,-0.13269,1,0
2,GO METAPHASE PLATE CONGRESSION,0.014138,-0.047354,-0.09609,1,0
2,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.025994,-0.047781,-0.15593,1,0
2,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.042857,-0.048096,-0.056265,1,0
2,GO NON RECOMBINATIONAL REPAIR,0.029719,-0.049058,-0.070112,1,0
2,GO ACTIN FILAMENT BASED PROCESS,0.036948,-0.05139,-0.072544,1,0
2,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.047551,-0.052509,-0.059863,1,0
2,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.037747,-0.053669,-0.068959,1,0
2,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.014138,-0.053852,-0.15297,1,0
2,GO PHOSPHOLIPID METABOLIC PROCESS,0.037747,-0.055403,-0.066143,1,0
2,GO POSITIVE REGULATION OF SIGNALING,0.033166,-0.055813,-0.065149,1,0
2,GO MALE GAMETE GENERATION,0.0045306,-0.056225,-0.08556,1,0
2,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.009256,-0.056332,-0.085675,1,0
2,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.03245,-0.056358,-0.056157,1,0
2,GO MACROAUTOPHAGY,0.0054795,-0.057538,-0.080368,1,0
2,GO REGULATION OF CELL POPULATION PROLIFERATION,0.019283,-0.057979,-0.084699,1,0
2,GO ACTIN FILAMENT ORGANIZATION,0.017549,-0.058128,-0.094691,1,0
2,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.038561,-0.058545,-0.10222,1,0
2,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.019739,-0.058587,-0.081149,1,0
2,GO SEXUAL REPRODUCTION,0.0025817,-0.059443,-0.071044,1,0
2,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,0.024288,-0.059497,-0.077715,1,0
2,GO ORGANELLE FISSION,0.019283,-0.060777,-0.053453,1,0
2,GO PROTEIN AUTOUBIQUITINATION,0.027188,-0.061491,-0.065572,1,0
2,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.03939,-0.061936,-0.17826,1,0
2,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.045624,-0.0624,-0.12938,1,0
2,GO CELLULAR LIPID METABOLIC PROCESS,0.053746,-0.062759,-0.071512,1,0
2,GO REGULATION OF HYDROLASE ACTIVITY,0.012203,-0.062843,-0.080199,1,0
2,GO HUMORAL IMMUNE RESPONSE,0.0013872,-0.063414,-0.13611,1,0
2,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.042857,-0.06359,-0.11612,1,0
2,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.023741,-0.063699,-0.12651,1,0
2,GO VACUOLE ORGANIZATION,0.049546,-0.063873,-0.080909,1,0
2,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.0067808,-0.064341,-0.1042,1,0
2,GO CELL MOTILITY,0.036948,-0.064481,-0.079393,1,0
2,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.053746,-0.064966,-0.079914,1,0
2,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.024288,-0.065264,-0.08581,1,0
2,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.042857,-0.065369,-0.13007,1,0
2,GO TUBE MORPHOGENESIS,0.041093,-0.06564,-0.099175,1,0
2,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.033894,-0.065921,-0.067849,1,0
2,GO LEUKOCYTE DIFFERENTIATION,0.011047,-0.066015,-0.10214,1,0
2,GO TUMOR NECROSIS FACTOR SECRETION,0.05161,-0.067007,-0.10693,1,0
2,GO SECRETION,0.012508,-0.067035,-0.08332,1,0
2,GO REGULATION OF ACTIN FILAMENT LENGTH,0.03245,-0.067433,-0.079096,1,0
2,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.026586,-0.06747,-0.092176,1,0
2,GO GLYCEROLIPID METABOLIC PROCESS,0.024846,-0.067811,-0.070702,1,0
2,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.030383,-0.067849,-0.11162,1,0
2,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.055956,-0.069583,-0.079324,1,0
2,GO TUBE DEVELOPMENT,0.033894,-0.069626,-0.094207,1,0
2,GO MUSCLE ADAPTATION,0.05161,-0.070042,-0.090495,1,0
2,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0079323,-0.070156,-0.080998,1,0
2,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.04854,-0.07016,-0.070453,1,0
2,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.001872,-0.070793,-0.12646,1,0
2,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.02166,-0.071389,-0.099685,1,0
2,GO REGULATION OF MEIOTIC CELL CYCLE,0.025994,-0.071424,-0.085065,1,0
2,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.014138,-0.071536,-0.11367,1,0
2,GO MULTICELLULAR ORGANISM REPRODUCTION,0.0038387,-0.072065,-0.074907,1,0
2,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.03245,-0.072305,-0.11245,1,0
2,GO LYMPHOCYTE ACTIVATION,0.0075304,-0.072443,-0.11104,1,0
2,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.0085714,-0.072665,-0.087308,1,0
2,GO MULTI ORGANISM PROCESS,0.009256,-0.074202,-0.06881,1,0
2,GO PEPTIDE SECRETION,0.025414,-0.074792,-0.08505,1,0
2,GO NEGATIVE T CELL SELECTION,0.0027346,-0.075183,-0.16075,1,0
2,GO REGULATION OF RESPONSE TO STRESS,0.0064317,-0.075297,-0.092052,1,0
2,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.038561,-0.076032,-0.079738,1,0
2,GO DEPHOSPHORYLATION,0.021165,-0.077657,-0.058171,1,0
2,GO REGULATION OF PEPTIDE TRANSPORT,0.0097392,-0.07785,-0.076389,1,0
2,GO IN UTERO EMBRYONIC DEVELOPMENT,0.011326,-0.077982,-0.078376,1,0
2,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.041967,-0.078097,-0.11692,1,0
2,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.041967,-0.078222,-0.095114,1,0
2,GO POSITIVE REGULATION OF SECRETION,0.031748,-0.078364,-0.079138,1,0
2,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.03245,-0.078499,-0.10286,1,0
2,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.0039469,-0.078562,-0.08408,1,0
2,GO EXOCYTOSIS,0.011047,-0.078638,-0.10281,1,0
2,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.018836,-0.078865,-0.058864,1,0
2,GO MACROPHAGE DIFFERENTIATION,0.045624,-0.079261,-0.13395,1,0
2,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.017549,-0.079405,-0.10827,1,0
2,GO IMMUNE SYSTEM DEVELOPMENT,0.0015653,-0.079454,-0.10403,1,0
2,GO CHROMOSOME LOCALIZATION,0.0025817,-0.079572,-0.11324,1,0
2,GO DETECTION OF STIMULUS,0.0010859,-0.079666,-0.097326,1,0
2,GO PROTEIN MONOUBIQUITINATION,0.0049174,-0.079687,-0.077954,1,0
2,GO REGULATION OF ENDOCRINE PROCESS,0.049546,-0.08022,-0.12088,1,0
2,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.015574,-0.080753,-0.10773,1,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.037747,-0.080788,-0.11695,1,0
2,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.019739,-0.080956,-0.12703,1,0
2,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.042857,-0.081063,-0.10309,1,0
2,GO GAMETE GENERATION,0.0010206,-0.081244,-0.088169,1,0
2,GO TUBE FORMATION,0.023205,-0.081475,-0.096162,1,0
2,GO REGULATION OF HEMOPOIESIS,0.010773,-0.081738,-0.105,1,0
2,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.044685,-0.081822,-0.10828,1,0
2,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.0064317,-0.08192,-0.10728,1,0
2,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.016339,-0.081932,-0.096147,1,0
2,GO ENDOSOMAL TRANSPORT,0.00028792,-0.082157,-0.10138,1,0
2,GO REGULATION OF IMMUNE RESPONSE,0.010773,-0.082422,-0.11106,1,0
2,GO VACUOLAR TRANSPORT,0.0094949,-0.082562,-0.1011,1,0
2,GO FATTY ACID METABOLIC PROCESS,0.031059,-0.082955,-0.10209,1,0
2,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.038561,-0.083001,-0.11834,1,0
2,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.012508,-0.083325,-0.12337,1,0
2,GO FAT CELL DIFFERENTIATION,0.0067808,-0.083727,-0.12377,1,0
2,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.014486,-0.084075,-0.1136,1,0
2,GO MAST CELL MEDIATED IMMUNITY,0.019739,-0.084268,-0.18989,1,0
2,GO GLUCOSE METABOLIC PROCESS,0.044685,-0.084349,-0.067101,1,0
2,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.0075304,-0.084664,-0.10493,1,0
2,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.035393,-0.084752,-0.069618,1,0
2,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.010773,-0.085104,-0.11029,1,0
2,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.013139,-0.085154,-0.12442,1,0
2,GO POSITIVE REGULATION OF VIRAL PROCESS,0.0056288,-0.08531,-0.10888,1,0
2,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.011904,-0.08548,-0.080851,1,0
2,GO RESPONSE TO ANTIBIOTIC,0.037747,-0.085625,-0.11302,1,0
2,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.04854,-0.085844,-0.10889,1,0
2,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.011047,-0.085863,-0.17353,1,0
2,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.050569,-0.086101,-0.12924,1,0
2,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.0094949,-0.086271,-0.12897,1,0
2,GO REGULATION OF PROTEOLYSIS,0.0057817,-0.086679,-0.112,1,0
2,GO GOLGI TO VACUOLE TRANSPORT,0.014486,-0.086788,-0.13458,1,0
2,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.041967,-0.08685,-0.069253,1,0
2,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.009256,-0.087266,-0.095113,1,0
2,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.013798,-0.087488,-0.13861,1,0
2,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.036948,-0.08754,-0.090013,1,0
2,GO HOMEOSTASIS OF NUMBER OF CELLS,0.00081984,-0.087676,-0.10881,1,0
2,GO REGULATION OF ERBB SIGNALING PATHWAY,0.033166,-0.087948,-0.13159,1,0
2,GO EMBRYONIC MORPHOGENESIS,0.012203,-0.088139,-0.10272,1,0
2,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.047551,-0.088301,-0.081081,1,0
2,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.014841,-0.088522,-0.1165,1,0
2,GO LYMPHOCYTE DIFFERENTIATION,0.0021062,-0.088558,-0.11587,1,0
2,GO CELLULAR SENESCENCE,0.017549,-0.088653,-0.11054,1,0
2,GO RESPONSE TO HYDROGEN PEROXIDE,0.053746,-0.089326,-0.087658,1,0
2,GO PROTEOLYSIS,0.00044439,-0.089362,-0.10478,1,0
2,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.04854,-0.089702,-0.075698,1,0
2,GO NATURAL KILLER CELL ACTIVATION,0.011904,-0.089745,-0.13561,1,0
2,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.02268,-0.089912,-0.090142,1,0
2,GO REGULATION OF T CELL DIFFERENTIATION,0.018398,-0.090064,-0.10809,1,0
2,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.030383,-0.090119,-0.20065,1,0
2,GO ACTIVATION OF GTPASE ACTIVITY,0.0064317,-0.090415,-0.098557,1,0
2,GO REGULATION OF CELLULAR PH,0.0049174,-0.090578,-0.097889,1,0
2,GO CELL CELL ADHESION,0.004408,-0.09071,-0.12249,1,0
2,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.0069616,-0.09084,-0.1134,1,0
2,GO CELLULAR PIGMENTATION,0.0036303,-0.09092,-0.13554,1,0
2,GO REGULATION OF NUCLEAR DIVISION,0.0050528,-0.091131,-0.08089,1,0
2,GO CELL MATRIX ADHESION,0.038561,-0.091166,-0.1199,1,0
2,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.054842,-0.091353,-0.054921,1,0
2,GO REGULATION OF PH,0.0062634,-0.091444,-0.094954,1,0
2,GO POST GOLGI VESICLE MEDIATED TRANSPORT,0.02268,-0.091575,-0.10198,1,0
2,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,0.010245,-0.091642,-0.12579,1,0
2,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.030383,-0.091662,-0.14272,1,0
2,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.015953,-0.091744,-0.12223,1,0
2,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.016339,-0.092052,-0.097263,1,0
2,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.012508,-0.092218,-0.10432,1,0
2,GO RESPONSE TO GAMMA RADIATION,0.036948,-0.092257,-0.093986,1,0
2,GO GLAND DEVELOPMENT,0.013139,-0.092267,-0.099714,1,0
2,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.0099891,-0.092299,-0.10271,1,0
2,GO ERBB SIGNALING PATHWAY,0.02843,-0.092544,-0.11082,1,0
2,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.012203,-0.092747,-0.12479,1,0
2,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.0028957,-0.092966,-0.091004,1,0
2,GO PROTEIN MATURATION,0.015574,-0.092989,-0.10116,1,0
2,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.017137,-0.093242,-0.1859,1,0
2,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.019739,-0.093259,-0.14598,1,0
2,GO POSITIVE REGULATION OF PROTEIN IMPORT,0.018836,-0.093434,-0.18171,1,0
2,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.0024367,-0.093456,-0.1471,1,0
2,GO LIPID LOCALIZATION,0.0079323,-0.09371,-0.11778,1,0
2,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.017969,-0.093974,-0.093809,1,0
2,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.0042883,-0.09409,-0.12622,1,0
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.013798,-0.094359,-0.11699,1,0
2,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.04854,-0.094558,-0.099281,1,0
2,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.0025083,-0.094888,-0.15669,1,0
2,GO PEPTIDYL ASPARAGINE MODIFICATION,0.02268,-0.095105,-0.13525,1,0
2,GO RESPONSE TO ALCOHOL,0.044685,-0.095276,-0.077525,1,0
2,GO GOLGI VESICLE BUDDING,0.0081404,-0.095367,-0.11661,1,0
2,GO ACTIVATION OF IMMUNE RESPONSE,0.0097392,-0.095573,-0.10692,1,0
2,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.0013872,-0.095585,-0.121,1,0
2,GO POSTREPLICATION REPAIR,0.011904,-0.096376,-0.08894,1,0
2,GO COPII COATED VESICLE BUDDING,0.0053338,-0.096385,-0.11379,1,0
2,GO REGULATION OF SPROUTING ANGIOGENESIS,0.052669,-0.096441,-0.12145,1,0
2,GO REGULATION OF BODY FLUID LEVELS,0.0010859,-0.096588,-0.1364,1,0
2,GO POSITIVE REGULATION OF B CELL PROLIFERATION,0.038561,-0.09677,-0.13006,1,0
2,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.03939,-0.096774,-0.14335,1,0
2,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.041967,-0.097474,-0.17357,1,0
2,GO GENITALIA DEVELOPMENT,0.031748,-0.097801,-0.11878,1,0
2,GO GOLGI ORGANIZATION,0.0025083,-0.097875,-0.11643,1,0
2,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,0.015574,-0.098282,-0.13644,1,0
2,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.027803,-0.098302,-0.10269,1,0
2,GO LIPOSACCHARIDE METABOLIC PROCESS,0.050569,-0.098544,-0.10396,1,0
2,GO AUTOPHAGY OF NUCLEUS,0.054842,-0.098654,-0.13863,1,0
2,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.001986,-0.098769,-0.11462,1,0
2,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.017549,-0.098956,-0.093767,1,0
2,GO ORGANELLE DISASSEMBLY,0.0087944,-0.099028,-0.092583,1,0
2,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.023205,-0.099219,-0.1092,1,0
2,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.0069616,-0.099376,-0.12092,1,0
2,GO COAGULATION,0.0051916,-0.099857,-0.13878,1,0
2,GO REGULATION OF INNATE IMMUNE RESPONSE,0.009256,-0.099859,-0.13181,1,0
2,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.00044439,-0.099918,-0.12903,1,0
2,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.010773,-0.099989,-0.13459,1,0
2,GO APOPTOTIC SIGNALING PATHWAY,0.0041716,-0.10043,-0.1099,1,0
2,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.022165,-0.1009,-0.15697,1,0
2,GO ERAD PATHWAY,0.010506,-0.10131,-0.11486,1,0
2,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.011904,-0.10153,-0.12119,1,0
2,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.00054072,-0.10187,-0.1406,1,0
2,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.0060989,-0.10191,-0.14091,1,0
2,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.0013054,-0.10192,-0.14426,1,0
2,GO RESPONSE TO XENOBIOTIC STIMULUS,0.014486,-0.10213,-0.14414,1,0
2,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.034637,-0.10216,-0.10785,1,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.045624,-0.10218,-0.10611,1,0
2,GO REGULATION OF CELL ADHESION,0.0026572,-0.10247,-0.1538,1,0
2,GO REGULATION OF CELL ACTIVATION,0.0022992,-0.10248,-0.13089,1,0
2,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.0023671,-0.10265,-0.10487,1,0
2,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.015574,-0.10293,-0.1546,1,0
2,GO ENDOCYTIC RECYCLING,0.0020453,-0.10297,-0.1284,1,0
2,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.0053338,-0.10314,-0.1281,1,0
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.0085714,-0.10358,-0.137,1,0
2,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.00092958,-0.10358,-0.14937,1,0
2,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.0025083,-0.10375,-0.13773,1,0
2,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.00092958,-0.10393,-0.11064,1,0
2,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.026586,-0.10435,-0.085846,1,0
2,GO PH REDUCTION,0.0021689,-0.10437,-0.14997,1,0
2,GO CELL ACTIVATION,0.0027346,-0.10443,-0.13744,1,0
2,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.015574,-0.10467,-0.13052,1,0
2,GO REGULATION OF CELL SUBSTRATE ADHESION,0.03245,-0.10489,-0.13769,1,0
2,GO ADAPTIVE THERMOGENESIS,0.02268,-0.10497,-0.09286,1,0
2,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.043763,-0.10516,-0.10536,1,0
2,GO REGULATION OF CENTRIOLE REPLICATION,0.0060989,-0.10518,-0.13486,1,0
2,GO HISTONE MONOUBIQUITINATION,0.00026903,-0.10577,-0.13101,1,0
2,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.02166,-0.10578,-0.18634,1,0
2,GO DIGESTIVE SYSTEM PROCESS,0.033894,-0.10582,-0.12398,1,0
2,GO T CELL DIFFERENTIATION,0.0046564,-0.10597,-0.12217,1,0
2,GO PROTEIN POLYUBIQUITINATION,7.547e-05,-0.10635,-0.12601,1,0
2,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0022992,-0.10682,-0.21834,1,0
2,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.038561,-0.10693,-0.11031,1,0
2,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.011326,-0.10731,-0.18883,1,0
2,GO RESPONSE TO OSMOTIC STRESS,0.023205,-0.10739,-0.11405,1,0
2,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.0069616,-0.10748,-0.13913,1,0
2,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.040234,-0.10761,-0.18224,1,0
2,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.033894,-0.10795,-0.1079,1,0
2,GO IMMUNOGLOBULIN PRODUCTION,0.00049035,-0.10805,-0.13497,1,0
2,GO PROTEIN KINASE B SIGNALING,0.0042883,-0.10819,-0.13353,1,0
2,GO LIPID DIGESTION,0.012508,-0.10865,-0.28191,1,0
2,GO INTERLEUKIN 17 PRODUCTION,0.030383,-0.10907,-0.14524,1,0
2,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.026586,-0.10914,-0.17042,1,0
2,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.025414,-0.1093,-0.17811,1,0
2,GO PEPTIDYL TYROSINE MODIFICATION,0.0037331,-0.10936,-0.13087,1,0
2,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.042857,-0.10946,-0.09126,1,0
2,GO NUCLEOSIDE CATABOLIC PROCESS,0.053746,-0.10949,-0.15808,1,0
2,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,8.7323e-05,-0.10953,-0.14344,1,0
2,GO REPRODUCTION,0.0007696,-0.10999,-0.092536,1,0
2,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.016734,-0.11011,-0.10868,1,0
2,GO REGULATION OF PEPTIDE SECRETION,0.0083534,-0.11015,-0.099042,1,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.031748,-0.11072,-0.18395,1,0
2,GO VESICLE BUDDING FROM MEMBRANE,0.00087311,-0.11132,-0.14441,1,0
2,GO REPLACEMENT OSSIFICATION,0.035393,-0.11165,-0.16091,1,0
2,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.00095906,-0.11176,-0.15167,1,0
2,GO RESPONSE TO BIOTIC STIMULUS,0.0023671,-0.11176,-0.13851,1,0
2,GO LYMPHOCYTE CHEMOTAXIS,0.020205,-0.11203,-0.13579,1,0
2,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.00042998,-0.11209,-0.15393,1,0
2,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.041093,-0.1121,-0.089285,1,0
2,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0071468,-0.11215,-0.088894,1,0
2,GO POSITIVE REGULATION OF CELL ACTIVATION,0.00087311,-0.11217,-0.14572,1,0
2,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.00090094,-0.11244,-0.15274,1,0
2,GO HEMOGLOBIN METABOLIC PROCESS,0.010506,-0.11274,-0.16972,1,0
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.014486,-0.11296,-0.11908,1,0
2,GO INNATE IMMUNE RESPONSE,0.00092958,-0.11297,-0.16868,1,0
2,GO LEUKOCYTE CELL CELL ADHESION,0.001662,-0.11298,-0.15534,1,0
2,GO CARBOHYDRATE TRANSPORT,0.0067808,-0.11335,-0.10615,1,0
2,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00052342,-0.11337,-0.19464,1,0
2,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.014138,-0.11384,-0.10532,1,0
2,GO REGULATION OF MEMBRANE INVAGINATION,0.044685,-0.11432,-0.19369,1,0
2,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.0037331,-0.11433,-0.10729,1,0
2,GO MYELOID CELL DIFFERENTIATION,0.00025131,-0.11435,-0.12563,1,0
2,GO MITOTIC CYTOKINESIS,0.0030654,-0.11455,-0.12727,1,0
2,GO PLATELET MORPHOGENESIS,0.0051916,-0.11539,-0.20988,1,0
2,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,0.049546,-0.11558,-0.19466,1,0
2,GO REGULATION OF T CELL ACTIVATION,0.00087311,-0.11577,-0.14916,1,0
2,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.0019282,-0.11619,-0.11366,1,0
2,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.042857,-0.11675,-0.12906,1,0
2,GO ANTIMICROBIAL HUMORAL RESPONSE,0.017969,-0.11697,-0.13148,1,0
2,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.0064317,-0.11699,-0.1915,1,0
2,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.02268,-0.11734,-0.11495,1,0
2,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,0.0036303,-0.11734,-0.21546,1,0
2,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.02166,-0.11741,-0.21897,1,0
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.0021689,-0.11744,-0.21493,1,0
2,GO MYOBLAST DIFFERENTIATION,0.00353,-0.1177,-0.18566,1,0
2,GO DENDRITIC CELL MIGRATION,0.03939,-0.11815,-0.17082,1,0
2,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.0042883,-0.11821,-0.15809,1,0
2,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.020205,-0.11829,-0.15136,1,0
2,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.0030654,-0.1183,-0.175,1,0
2,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.0071468,-0.11846,-0.13149,1,0
2,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00079435,-0.11849,-0.1507,1,0
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0046564,-0.11865,-0.10903,1,0
2,GO REGULATION OF INFLAMMATORY RESPONSE,0.00037661,-0.11881,-0.14684,1,0
2,GO LYMPHOCYTE COSTIMULATION,0.016734,-0.1192,-0.12062,1,0
2,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00012074,-0.11925,-0.16242,1,0
2,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.014138,-0.11938,-0.17878,1,0
2,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.030383,-0.1196,-0.11207,1,0
2,GO REGULATION OF HISTONE DEACETYLATION,0.054842,-0.11977,-0.10854,1,0
2,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.00057693,-0.1198,-0.17694,1,0
2,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.0062634,-0.12015,-0.103,1,0
2,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.00065623,-0.12034,-0.1434,1,0
2,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.049546,-0.12065,-0.13147,1,0
2,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.036948,-0.12079,-0.19372,1,0
2,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.036948,-0.12122,-0.16682,1,0
2,GO DIGESTION,0.0037331,-0.12135,-0.15953,1,0
2,GO NOTCH SIGNALING PATHWAY,0.0041716,-0.12161,-0.12592,1,0
2,GO T CELL ACTIVATION,0.00084609,-0.1218,-0.15324,1,0
2,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.010245,-0.12181,-0.091078,1,0
2,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.027188,-0.12199,-0.11447,1,0
2,GO RESPONSE TO WOUNDING,0.0097392,-0.12206,-0.13851,1,0
2,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.043763,-0.12209,-0.13789,1,0
2,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.052669,-0.12216,-0.15298,1,0
2,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.036164,-0.12218,-0.12394,1,0
2,GO SPINDLE LOCALIZATION,0.001228,-0.12219,-0.14155,1,0
2,GO RESPONSE TO BACTERIUM,0.011612,-0.12235,-0.12854,1,0
2,GO PROTEIN DESTABILIZATION,0.0045306,-0.1224,-0.12012,1,0
2,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.036164,-0.12245,-0.17099,1,0
2,GO TISSUE MIGRATION,0.052669,-0.12264,-0.10693,1,0
2,GO CYTOKINE PRODUCTION,0.00021167,-0.12282,-0.17499,1,0
2,GO AUTOPHAGY OF MITOCHONDRION,0.0045306,-0.1229,-0.11055,1,0
2,GO TISSUE HOMEOSTASIS,5.508e-06,-0.12321,-0.18363,1,0
2,GO EPITHELIUM DEVELOPMENT,4.6597e-05,-0.12322,-0.15616,1,0
2,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.00014418,-0.12327,-0.15893,1,0
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0045306,-0.12336,-0.10713,1,0
2,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.012508,-0.12338,-0.14282,1,0
2,GO AUTOPHAGOSOME ORGANIZATION,0.00041602,-0.12341,-0.1536,1,0
2,GO BONE CELL DEVELOPMENT,0.021165,-0.12346,-0.13918,1,0
2,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.00010845,-0.12354,-0.12675,1,0
2,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.015203,-0.12356,-0.19931,1,0
2,GO REGULATION OF DEFENSE RESPONSE,0.00049035,-0.12387,-0.14928,1,0
2,GO VIRAL LATENCY,0.024288,-0.12407,-0.12119,1,0
2,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.038561,-0.12409,-0.20943,1,0
2,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.00013433,-0.12422,-0.14223,1,0
2,GO MYELOID LEUKOCYTE ACTIVATION,0.0026572,-0.12426,-0.16489,1,0
2,GO REGULATION OF ISOTYPE SWITCHING,0.0028141,-0.12432,-0.19311,1,0
2,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.0085714,-0.1248,-0.21404,1,0
2,GO TRANSLESION SYNTHESIS,0.004408,-0.12481,-0.11409,1,0
2,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,0.031748,-0.12484,-0.12044,1,0
2,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.04854,-0.12484,-0.15094,1,0
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0037331,-0.1252,-0.19543,1,0
2,GO ACUTE INFLAMMATORY RESPONSE,0.0064317,-0.12528,-0.19474,1,0
2,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.04854,-0.12536,-0.11375,1,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.042857,-0.12547,-0.24358,1,0
2,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.0014738,-0.12559,-0.16921,1,0
2,GO VESICLE TARGETING,0.0010859,-0.12596,-0.15258,1,0
2,GO DEFENSE RESPONSE,0.00067758,-0.12607,-0.14936,1,0
2,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.054842,-0.12653,-0.11945,1,0
2,GO POLYAMINE METABOLIC PROCESS,0.05161,-0.12688,-0.10507,1,0
2,GO DNA DEALKYLATION,0.021165,-0.12709,-0.13663,1,0
2,GO REGULATION OF MUSCLE ADAPTATION,0.0073363,-0.12709,-0.13064,1,0
2,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.0050528,-0.12729,-0.17163,1,0
2,GO REGULATION OF PEPTIDASE ACTIVITY,0.00024286,-0.12733,-0.1873,1,0
2,GO REGULATION OF PINOCYTOSIS,0.0049174,-0.12742,-0.21435,1,0
2,GO VIRAL LIFE CYCLE,0.0006154,-0.12754,-0.18525,1,0
2,GO INFLAMMATORY RESPONSE,0.0010528,-0.12767,-0.14813,1,0
2,GO GOLGI TO ENDOSOME TRANSPORT,0.029719,-0.1277,-0.13862,1,0
2,GO RESPONSE TO IRON ION,0.017969,-0.12784,-0.15696,1,0
2,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0014738,-0.12842,-0.14968,1,0
2,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.013465,-0.12854,-0.12884,1,0
2,GO KILLING OF CELLS OF OTHER ORGANISM,0.0046564,-0.12856,-0.12382,1,0
2,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.01282,-0.1286,-0.17838,1,0
2,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00023468,-0.12895,-0.16558,1,0
2,GO WOUND HEALING,0.0054795,-0.1293,-0.15726,1,0
2,GO FIBROBLAST MIGRATION,0.007729,-0.12942,-0.17907,1,0
2,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.014138,-0.12982,-0.14473,1,0
2,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.00084609,-0.12995,-0.18643,1,0
2,GO RESPONSE TO INTERLEUKIN 6,0.0012662,-0.13027,-0.18833,1,0
2,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00042998,-0.13033,-0.17338,1,0
2,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.024288,-0.13054,-0.14495,1,0
2,GO PHAGOSOME ACIDIFICATION,0.011047,-0.13061,-0.16997,1,0
2,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.004408,-0.13062,-0.18148,1,0
2,GO ACTIN FILAMENT DEPOLYMERIZATION,0.019739,-0.13104,-0.13652,1,0
2,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.042857,-0.13113,-0.13624,1,0
2,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.05161,-0.13174,-0.18714,1,0
2,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.00050664,-0.132,-0.16849,1,0
2,GO REGULATION OF CHEMOTAXIS,0.0025817,-0.13201,-0.13346,1,0
2,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.0083534,-0.13223,-0.22541,1,0
2,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.042857,-0.13227,-0.10183,1,0
2,GO NEURAL TUBE DEVELOPMENT,0.00079435,-0.13232,-0.14758,1,0
2,GO REGULATION OF LEUKOCYTE MIGRATION,0.013465,-0.13233,-0.11869,1,0
2,GO SENSORY PERCEPTION OF BITTER TASTE,0.00067758,-0.13237,-0.17463,1,0
2,GO HISTONE H2A UBIQUITINATION,0.0036303,-0.13238,-0.12349,1,0
2,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.052669,-0.13279,-0.10656,1,0
2,GO PEPTIDE CROSS LINKING,0.031059,-0.1329,-0.19153,1,0
2,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.0031536,-0.1334,-0.14323,1,0
2,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.0083534,-0.13365,-0.18128,1,0
2,GO ANTIGEN PROCESSING AND PRESENTATION,0.004408,-0.13383,-0.18717,1,0
2,GO REGULATION OF GLUCOSE METABOLIC PROCESS,0.00067758,-0.13394,-0.14216,1,0
2,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00079435,-0.13405,-0.18566,1,0
2,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.00037661,-0.1343,-0.18074,1,0
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.0071468,-0.13466,-0.25989,1,0
2,GO PEPTIDYL THREONINE MODIFICATION,0.0010206,-0.13467,-0.13057,1,0
2,GO LEUKOCYTE MEDIATED IMMUNITY,0.00045924,-0.13472,-0.18616,1,0
2,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.03245,-0.13487,-0.15042,1,0
2,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.010245,-0.13504,-0.138,1,0
2,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0073363,-0.13507,-0.13492,1,0
2,GO MYELOID DENDRITIC CELL ACTIVATION,0.0034322,-0.1352,-0.20747,1,0
2,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0010206,-0.13529,-0.18728,1,0
2,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.00012512,-0.13531,-0.11985,1,0
2,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0028957,-0.13533,-0.18301,1,0
2,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.017549,-0.1354,-0.11915,1,0
2,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.035393,-0.13556,-0.122,1,0
2,GO DIOL BIOSYNTHETIC PROCESS,0.018398,-0.13599,-0.16919,1,0
2,GO B CELL ACTIVATION,1.349e-05,-0.13627,-0.16989,1,0
2,GO DEFENSE RESPONSE TO OTHER ORGANISM,0.00034072,-0.13627,-0.17261,1,0
2,GO REGULATION OF MAST CELL ACTIVATION,0.025994,-0.13635,-0.1584,1,0
2,GO PIGMENT GRANULE LOCALIZATION,0.01282,-0.13658,-0.1564,1,0
2,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0057817,-0.13663,-0.16375,1,0
2,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.044685,-0.13707,-0.10245,1,0
2,GO RESPONSE TO CYTOKINE,0.0015653,-0.13722,-0.15304,1,0
2,GO LEUKOCYTE PROLIFERATION,5.2139e-05,-0.13752,-0.18262,1,0
2,GO CYTOKINE SECRETION,0.00036427,-0.13774,-0.16718,1,0
2,GO POSITIVE REGULATION OF PEPTIDE SECRETION,0.00059588,-0.13782,-0.13632,1,0
2,GO REGULATION OF T CELL CHEMOTAXIS,0.017969,-0.13784,-0.13105,1,0
2,GO ATP BIOSYNTHETIC PROCESS,0.017137,-0.13838,-0.12921,1,0
2,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.0015653,-0.13838,-0.16625,1,0
2,GO CELLULAR RESPONSE TO ALCOHOL,0.0036303,-0.13851,-0.13108,1,0
2,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0022992,-0.13857,-0.19007,1,0
2,GO B CELL PROLIFERATION,0.0047853,-0.13915,-0.14366,1,0
2,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.025414,-0.13941,-0.14385,1,0
2,GO POSITIVE REGULATION OF CELL ADHESION,0.0013457,-0.13943,-0.17667,1,0
2,GO RESPONSE TO PEPTIDOGLYCAN,0.0011199,-0.13949,-0.21885,1,0
2,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00029782,-0.13965,-0.1945,1,0
2,GO REGULATION OF SPINDLE ORGANIZATION,0.00026003,-0.13967,-0.1549,1,0
2,GO LEUKOCYTE APOPTOTIC PROCESS,0.019283,-0.14022,-0.1494,1,0
2,GO REGULATION OF NEUTROPHIL MIGRATION,0.0085714,-0.14029,-0.15571,1,0
2,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.0081404,-0.14034,-0.14479,1,0
2,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.0011549,-0.14036,-0.19254,1,0
2,GO AMINO SUGAR CATABOLIC PROCESS,0.019739,-0.14046,-0.16668,1,0
2,GO MEMBRANE FISSION,0.055956,-0.14069,-0.11701,1,0
2,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.0001547,-0.14116,-0.15776,1,0
2,GO T CELL PROLIFERATION,0.00047456,-0.14122,-0.17393,1,0
2,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.0028141,-0.14125,-0.16001,1,0
2,GO GRANULOCYTE MIGRATION,0.0039469,-0.14139,-0.1513,1,0
2,GO ARACHIDONIC ACID METABOLIC PROCESS,0.030383,-0.14149,-0.14655,1,0
2,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.016734,-0.14167,-0.18334,1,0
2,GO RESPONSE TO ETHER,0.024288,-0.14185,-0.11441,1,0
2,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.0057817,-0.14203,-0.15264,1,0
2,GO REGULATION OF T HELPER CELL DIFFERENTIATION,0.00035231,-0.14214,-0.22517,1,0
2,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.00012512,-0.14214,-0.20648,1,0
2,GO POSITIVE REGULATION OF HEMOPOIESIS,0.00029782,-0.14289,-0.16849,1,0
2,GO VIRAL RNA GENOME REPLICATION,0.0025083,-0.14291,-0.18684,1,0
2,GO V D J RECOMBINATION,0.011904,-0.14309,-0.19634,1,0
2,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.0047853,-0.14328,-0.23072,1,0
2,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.0024367,-0.14331,-0.18293,1,0
2,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.035393,-0.14355,-0.18871,1,0
2,GO BLOOD VESSEL REMODELING,0.0053338,-0.14366,-0.2213,1,0
2,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0011549,-0.14393,-0.18759,1,0
2,GO PROTEIN K48 LINKED UBIQUITINATION,0.00013917,-0.14424,-0.15291,1,0
2,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.02068,-0.14432,-0.21244,1,0
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.009256,-0.14442,-0.18871,1,0
2,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.042857,-0.14456,-0.15514,1,0
2,GO INTERLEUKIN 4 PRODUCTION,0.0014299,-0.14457,-0.20697,1,0
2,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.0037331,-0.14465,-0.17389,1,0
2,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.013465,-0.14492,-0.17924,1,0
2,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.017137,-0.14525,-0.11333,1,0
2,GO CHEMOKINE PRODUCTION,0.00035231,-0.14531,-0.21654,1,0
2,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.0018173,-0.14548,-0.14576,1,0
2,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.0014738,-0.14601,-0.16132,1,0
2,GO MAST CELL ACTIVATION,0.0090226,-0.14638,-0.18771,1,0
2,GO ER NUCLEUS SIGNALING PATHWAY,0.017549,-0.14655,-0.14279,1,0
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.0010528,-0.14678,-0.18093,1,0
2,GO MYELOID CELL DEVELOPMENT,0.00041602,-0.14679,-0.14912,1,0
2,GO SENSORY PERCEPTION OF TASTE,0.00087311,-0.14694,-0.17863,1,0
2,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00055855,-0.14704,-0.21074,1,0
2,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.00019079,-0.14753,-0.18056,1,0
2,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00027832,-0.14789,-0.19066,1,0
2,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.001872,-0.14792,-0.17967,1,0
2,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.033166,-0.14877,-0.19191,1,0
2,GO DISACCHARIDE METABOLIC PROCESS,0.05161,-0.1488,-0.1726,1,0
2,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,1.9904e-06,-0.14883,-0.18084,1,0
2,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0015653,-0.14894,-0.18765,1,0
2,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.011904,-0.14926,-0.19602,1,0
2,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,0.015574,-0.1494,-0.12683,1,0
2,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.009256,-0.14942,-0.17523,1,0
2,GO REGULATION OF VASCULATURE DEVELOPMENT,0.00353,-0.14945,-0.15172,1,0
2,GO ENDOTHELIAL CELL DEVELOPMENT,0.00057693,-0.14947,-0.2105,1,0
2,GO LYMPHOCYTE APOPTOTIC PROCESS,0.013465,-0.14956,-0.1439,1,0
2,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,5.6174e-05,-0.14956,-0.17964,1,0
2,GO RENAL TUBULE DEVELOPMENT,0.001191,-0.14991,-0.17985,1,0
2,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0025817,-0.14994,-0.20246,1,0
2,GO POSITIVE REGULATION OF NEURON DEATH,0.0075304,-0.14999,-0.11888,1,0
2,GO NUCLEOTIDE TRANSPORT,0.033166,-0.15011,-0.098094,1,0
2,GO I KAPPAB KINASE NF KAPPAB SIGNALING,0.00032948,-0.15014,-0.18851,1,0
2,GO SECRETION BY TISSUE,0.013465,-0.15017,-0.16291,1,0
2,GO SECONDARY METABOLIC PROCESS,0.0029794,-0.15038,-0.21197,1,0
2,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.02166,-0.15049,-0.19718,1,0
2,GO REGULATION OF B CELL ACTIVATION,0.00028792,-0.15059,-0.17344,1,0
2,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.0038387,-0.15116,-0.14668,1,0
2,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00027832,-0.15117,-0.17891,1,0
2,GO REGULATION OF FIBROBLAST MIGRATION,0.0075304,-0.1512,-0.1891,1,0
2,GO POSITIVE REGULATION OF HORMONE SECRETION,0.0032441,-0.15164,-0.14705,1,0
2,GO LEUKOCYTE MIGRATION,0.00052342,-0.15167,-0.16869,1,0
2,GO CYTOKINE METABOLIC PROCESS,0.0007696,-0.15171,-0.20216,1,0
2,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00013433,-0.15188,-0.18461,1,0
2,GO PINOCYTOSIS,0.017549,-0.15217,-0.18144,1,0
2,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.00037661,-0.15284,-0.21262,1,0
2,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00019079,-0.15285,-0.22724,1,0
2,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.007729,-0.15288,-0.25354,1,0
2,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.031748,-0.15312,-0.2892,1,0
2,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.045624,-0.15342,-0.1403,1,0
2,GO DETERMINATION OF ADULT LIFESPAN,0.03939,-0.15348,-0.13741,1,0
2,GO REGULATION OF T CELL CYTOKINE PRODUCTION,0.0039469,-0.15351,-0.21867,1,0
2,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.00012074,-0.15356,-0.20431,1,0
2,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.0049174,-0.15376,-0.16147,1,0
2,GO REGULATION OF CELL CELL ADHESION,0.00019753,-0.15387,-0.18583,1,0
2,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.00036427,-0.15402,-0.19018,1,0
2,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,5.8301e-05,-0.15411,-0.20674,1,0
2,GO INTESTINAL LIPID ABSORPTION,0.0057817,-0.15426,-0.30133,1,0
2,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.0066042,-0.15435,-0.18217,1,0
2,GO GRANULOCYTE CHEMOTAXIS,0.004408,-0.15444,-0.14176,1,0
2,GO DEFENSE RESPONSE TO BACTERIUM,5.0226e-05,-0.15451,-0.18967,1,0
2,GO IMMUNE EFFECTOR PROCESS,0.00027832,-0.15462,-0.18866,1,0
2,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.0010528,-0.15478,-0.19313,1,0
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.0032441,-0.15482,-0.23943,1,0
2,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.01282,-0.15482,-0.17457,1,0
2,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.00027832,-0.15485,-0.20869,1,0
2,GO ACTIN NUCLEATION,9.3916e-06,-0.15517,-0.17974,1,0
2,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0054795,-0.15535,-0.19323,1,0
2,GO INTRA S DNA DAMAGE CHECKPOINT,0.00084609,-0.15538,-0.14248,1,0
2,GO GENETIC IMPRINTING,0.001662,-0.1559,-0.18531,1,0
2,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.012508,-0.15608,-0.25662,1,0
2,GO T HELPER 1 CELL DIFFERENTIATION,0.020205,-0.15641,-0.32179,1,0
2,GO T HELPER 1 TYPE IMMUNE RESPONSE,0.001191,-0.15661,-0.24229,1,0
2,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,0.0056288,-0.15663,-0.43877,1,0
2,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.00021909,-0.15674,-0.17691,1,0
2,GO RESPONSE TO REDOX STATE,0.042857,-0.15686,-0.15179,1,0
2,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.00074557,-0.15704,-0.18448,1,0
2,GO INTERACTION WITH HOST,0.00019079,-0.15709,-0.20914,1,0
2,GO NEGATIVE REGULATION OF CELL ADHESION,0.00079435,-0.15766,-0.18699,1,0
2,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.0014299,-0.15773,-0.2157,1,0
2,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.00057693,-0.15783,-0.1292,1,0
2,GO LYMPHOCYTE MEDIATED IMMUNITY,0.00016023,-0.15786,-0.21085,1,0
2,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,0.00067758,-0.15788,-0.18079,1,0
2,GO PURINE NUCLEOTIDE TRANSPORT,0.035393,-0.15803,-0.10595,1,0
2,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.0026572,-0.15807,-0.2037,1,0
2,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.0087944,-0.15853,-0.16251,1,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0038387,-0.15858,-0.15479,1,0
2,GO LINOLEIC ACID METABOLIC PROCESS,0.041967,-0.15888,-0.19555,1,0
2,GO CARBOHYDRATE DERIVATIVE TRANSPORT,0.00034072,-0.1591,-0.19399,1,0
2,GO FOAM CELL DIFFERENTIATION,0.019283,-0.15919,-0.17345,1,0
2,GO RESPONSE TO DSRNA,0.0051916,-0.1593,-0.15298,1,0
2,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00016023,-0.15932,-0.20877,1,0
2,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.054842,-0.1597,-0.22913,1,0
2,GO HISTAMINE TRANSPORT,0.02843,-0.15977,-0.22185,1,0
2,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.0060989,-0.15995,-0.27992,1,0
2,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.00010092,-0.16008,-0.19963,1,0
2,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.00017796,-0.16016,-0.18245,1,0
2,GO REGULATION OF IMMUNE EFFECTOR PROCESS,4.8379e-05,-0.16017,-0.21337,1,0
2,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.020205,-0.16021,-0.17337,1,0
2,GO CELL KILLING,0.00074557,-0.16039,-0.18127,1,0
2,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.00023468,-0.16045,-0.19554,1,0
2,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,1.5816e-05,-0.16078,-0.24415,1,0
2,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,0.017549,-0.16089,-0.24785,1,0
2,GO POSITIVE REGULATION OF INSULIN SECRETION,0.0025083,-0.16094,-0.13679,1,0
2,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00026903,-0.16179,-0.2271,1,0
2,GO ENDOTHELIAL CELL MIGRATION,0.017137,-0.16179,-0.13681,1,0
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0036303,-0.16222,-0.20852,1,0
2,GO RESPONSE TO VIRUS,7.2754e-05,-0.16236,-0.22056,1,0
2,GO REPRODUCTIVE SYSTEM DEVELOPMENT,8.7323e-05,-0.16304,-0.15477,1,0
2,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.023205,-0.16307,-0.22829,1,0
2,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.0037331,-0.16314,-0.18802,1,0
2,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.00024286,-0.16323,-0.17159,1,0
2,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.0039469,-0.16341,-0.16958,1,0
2,GO LEUKOTRIENE METABOLIC PROCESS,0.017549,-0.16375,-0.15881,1,0
2,GO BONE RESORPTION,0.001662,-0.16393,-0.2021,1,0
2,GO EPITHELIAL CELL DEVELOPMENT,4.0073e-05,-0.16412,-0.20926,1,0
2,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,5.4121e-05,-0.16446,-0.21357,1,0
2,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.0033369,-0.16459,-0.23974,1,0
2,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.014138,-0.16466,-0.14851,1,0
2,GO PROTEIN K63 LINKED UBIQUITINATION,8.6584e-06,-0.16481,-0.16849,1,0
2,GO PROTEIN PROCESSING,0.00031859,-0.16503,-0.17643,1,0
2,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.016339,-0.16508,-0.20976,1,0
2,GO POSITIVE REGULATION OF BONE RESORPTION,0.030383,-0.16509,-0.17813,1,0
2,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0099891,-0.16521,-0.21723,1,0
2,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,0.00035231,-0.16611,-0.20067,1,0
2,GO PROTEIN DEMANNOSYLATION,0.016734,-0.16667,-0.1826,1,0
2,GO RESPONSE TO TUMOR NECROSIS FACTOR,0.00012512,-0.16682,-0.20585,1,0
2,GO REGULATION OF ICOSANOID SECRETION,0.043763,-0.16685,-0.13495,1,0
2,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.0053338,-0.16686,-0.18038,1,0
2,GO REGULATION OF LEUKOCYTE PROLIFERATION,5.4121e-05,-0.16691,-0.21403,1,0
2,GO MEGAKARYOCYTE DIFFERENTIATION,4.4712e-06,-0.1672,-0.18873,1,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.0090226,-0.16723,-0.18053,1,0
2,GO ALPHA BETA T CELL ACTIVATION,1.5816e-05,-0.16759,-0.22358,1,0
2,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.00072223,-0.16822,-0.19688,1,0
2,GO RESPONSE TO ISCHEMIA,0.001986,-0.16838,-0.16397,1,0
2,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0087944,-0.16857,-0.18176,1,0
2,GO T CELL CYTOKINE PRODUCTION,0.0037331,-0.16864,-0.19095,1,0
2,GO RESPONSE TO PROGESTERONE,0.0049174,-0.1687,-0.22083,1,0
2,GO MESONEPHROS DEVELOPMENT,0.012508,-0.16888,-0.15112,1,0
2,GO MYELOID LEUKOCYTE MIGRATION,0.0014299,-0.16935,-0.16125,1,0
2,GO ORGANOPHOSPHATE ESTER TRANSPORT,1.6455e-05,-0.16944,-0.1757,1,0
2,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.0033369,-0.16957,-0.33203,1,0
2,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.038561,-0.17029,-0.16591,1,0
2,GO ZYMOGEN ACTIVATION,0.0051916,-0.17036,-0.27421,1,0
2,GO RIG I SIGNALING PATHWAY,0.0025083,-0.17043,-0.18276,1,0
2,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.0010859,-0.17043,-0.23775,1,0
2,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.024846,-0.17045,-0.16178,1,0
2,GO EXECUTION PHASE OF APOPTOSIS,1.0184e-05,-0.17048,-0.1646,1,0
2,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.025414,-0.17053,-0.3756,1,0
2,GO ENTRY INTO HOST,0.00050664,-0.17066,-0.26205,1,0
2,GO ACUTE PHASE RESPONSE,0.0031536,-0.17081,-0.1885,1,0
2,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,0.013465,-0.17095,-0.14719,1,0
2,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.0022332,-0.17123,-0.19664,1,0
2,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.0028141,-0.17125,-0.20777,1,0
2,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,4.1617e-05,-0.17141,-0.24649,1,0
2,GO RESPONSE TO ANGIOTENSIN,0.0024367,-0.17178,-0.21932,1,0
2,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.00037661,-0.17193,-0.21364,1,0
2,GO DIOL METABOLIC PROCESS,0.019739,-0.17195,-0.17019,1,0
2,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.004408,-0.17196,-0.17018,1,0
2,GO CENTROSOME DUPLICATION,9.389e-05,-0.17204,-0.17864,1,0
2,GO REGULATION OF CHROMATIN ASSEMBLY,0.00055855,-0.17215,-0.159,1,0
2,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.0025817,-0.17218,-0.21653,1,0
2,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.00063551,-0.17254,-0.21976,1,0
2,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.033894,-0.17272,-0.17615,1,0
2,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.0029794,-0.17299,-0.21201,1,0
2,GO REGULATION OF B CELL PROLIFERATION,0.0017123,-0.17333,-0.18159,1,0
2,GO SKELETAL MUSCLE CELL PROLIFERATION,0.036164,-0.17361,-0.19823,1,0
2,GO ICOSANOID BIOSYNTHETIC PROCESS,0.012508,-0.17408,-0.20794,1,0
2,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.0051916,-0.1742,-0.17726,1,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.0014738,-0.17422,-0.17904,1,0
2,GO PROSTANOID BIOSYNTHETIC PROCESS,0.019283,-0.17445,-0.2578,1,0
2,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.0075304,-0.17471,-0.2284,1,0
2,GO CYTOLYSIS,0.0054795,-0.17473,-0.22888,1,0
2,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.0013872,-0.17476,-0.1755,1,0
2,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0045306,-0.17502,-0.19628,1,0
2,GO T HELPER 17 TYPE IMMUNE RESPONSE,6.7596e-05,-0.17559,-0.19025,1,0
2,GO ENDOCRINE HORMONE SECRETION,0.0056288,-0.17573,-0.15316,1,0
2,GO O GLYCAN PROCESSING,0.0031536,-0.17579,-0.2369,1,0
2,GO REGULATION OF RUFFLE ASSEMBLY,0.00079435,-0.17596,-0.1982,1,0
2,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.0025083,-0.17613,-0.17621,1,0
2,GO RETINA HOMEOSTASIS,0.00032948,-0.17619,-0.14676,1,0
2,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.001228,-0.17636,-0.17727,1,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,5.2139e-05,-0.17658,-0.2252,1,0
2,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.015574,-0.17694,-0.22061,1,0
2,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.0047853,-0.17737,-0.19456,1,0
2,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0001165,-0.17743,-0.194,1,0
2,GO EPOXYGENASE P450 PATHWAY,0.03939,-0.17744,-0.19399,1,0
2,GO PLATELET ACTIVATION,4.1617e-05,-0.17749,-0.21602,1,0
2,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.018836,-0.17791,-0.15795,1,0
2,GO CELL ADHESION MEDIATED BY INTEGRIN,0.013465,-0.17804,-0.23875,1,0
2,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00024286,-0.17827,-0.19891,1,0
2,GO B CELL DIFFERENTIATION,4.1112e-06,-0.17886,-0.20911,1,0
2,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,2.1663e-05,-0.1789,-0.24823,1,0
2,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0016129,-0.17895,-0.21136,1,0
2,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.00036427,-0.17899,-0.16736,1,0
2,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,1.7806e-05,-0.17912,-0.19717,1,0
2,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00017186,-0.17933,-0.24299,1,0
2,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.0036303,-0.17976,-0.23816,1,0
2,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0034322,-0.17994,-0.15644,1,0
2,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.0011549,-0.18011,-0.26679,1,0
2,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.0018173,-0.18039,-0.20622,1,0
2,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.0031536,-0.18041,-0.17537,1,0
2,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.0067808,-0.18146,-0.20684,1,0
2,GO PHOSPHOLIPID TRANSPORT,9.7346e-05,-0.18173,-0.18523,1,0
2,GO NEPHRON DEVELOPMENT,0.00034072,-0.18181,-0.18869,1,0
2,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.00052342,-0.18189,-0.2359,1,0
2,GO CELLULAR RESPONSE TO VIRUS,3.5759e-05,-0.18208,-0.22268,1,0
2,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0081404,-0.18208,-0.18681,1,0
2,GO DIGESTIVE SYSTEM DEVELOPMENT,0.00081984,-0.18246,-0.19194,1,0
2,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,5.8301e-05,-0.18284,-0.21292,1,0
2,GO CYTOKINE MEDIATED SIGNALING PATHWAY,0.00019753,-0.18286,-0.20857,1,0
2,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.00017796,-0.18323,-0.26212,1,0
2,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.0053338,-0.1835,-0.18746,1,0
2,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.00049035,-0.18353,-0.2607,1,0
2,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.0046564,-0.18402,-0.23911,1,0
2,GO MYELOID CELL HOMEOSTASIS,1.7806e-05,-0.18416,-0.19416,1,0
2,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.00090094,-0.18552,-0.17905,1,0
2,GO DEFENSE RESPONSE TO VIRUS,3.6228e-06,-0.18591,-0.29096,1,0
2,GO ENDOSOME ORGANIZATION,5.7413e-06,-0.18602,-0.1872,1,0
2,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.0027346,-0.18632,-0.20252,1,0
2,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,1.7118e-05,-0.18636,-0.21519,1,0
2,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.0046564,-0.18693,-0.22136,1,0
2,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0028957,-0.18694,-0.3128,1,0
2,GO REGULATION OF TISSUE REMODELING,0.00353,-0.18727,-0.18813,1,0
2,GO MITOTIC METAPHASE PLATE CONGRESSION,0.00017796,-0.18756,-0.15865,1,0
2,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00010845,-0.18759,-0.23729,1,0
2,GO HYPOTHALAMUS DEVELOPMENT,0.010245,-0.18772,-0.19643,1,0
2,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.0039469,-0.18868,-0.22033,1,0
2,GO ACTIN FILAMENT NETWORK FORMATION,0.029068,-0.18875,-0.28838,1,0
2,GO ALPHA BETA T CELL DIFFERENTIATION,3.6228e-06,-0.18876,-0.24018,1,0
2,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.0087944,-0.18891,-0.22537,1,0
2,GO IMMUNOGLOBULIN SECRETION,5.8301e-05,-0.18902,-0.32871,1,0
2,GO KERATINOCYTE PROLIFERATION,0.023741,-0.18905,-0.1901,1,0
2,GO MATERNAL PLACENTA DEVELOPMENT,0.020205,-0.18916,-0.18951,1,0
2,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.0053338,-0.18936,-0.20841,1,0
2,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.00026003,-0.18937,-0.20372,1,0
2,GO MULTIVESICULAR BODY SORTING PATHWAY,4.6597e-05,-0.18985,-0.20809,1,0
2,GO REGULATION OF SYMBIOTIC PROCESS,2.3418e-05,-0.19054,-0.23827,1,0
2,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.042857,-0.19116,-0.1446,1,0
2,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,4.1617e-05,-0.19125,-0.20666,1,0
2,GO MATURE B CELL DIFFERENTIATION,0.0079323,-0.19127,-0.24139,1,0
2,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00042998,-0.19132,-0.18364,1,0
2,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00045924,-0.19145,-0.25472,1,0
2,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.033166,-0.19155,-0.18675,1,0
2,GO MYELOID CELL APOPTOTIC PROCESS,0.0039469,-0.19155,-0.20908,1,0
2,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.009256,-0.1917,-0.21063,1,0
2,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.0014738,-0.19173,-0.19582,1,0
2,GO POSITIVE REGULATION OF TISSUE REMODELING,0.0007696,-0.19186,-0.24411,1,0
2,GO HISTONE H4 DEACETYLATION,0.0083534,-0.19221,-0.18168,1,0
2,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.019283,-0.19244,-0.19172,1,0
2,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.025994,-0.19261,-0.19316,1,0
2,GO MACROPHAGE MIGRATION,0.016734,-0.19285,-0.15018,1,0
2,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.014138,-0.19285,-0.19495,1,0
2,GO REGULATION OF GASTRULATION,0.0036303,-0.19303,-0.19391,1,0
2,GO TYPE I INTERFERON PRODUCTION,0.00012512,-0.19307,-0.22172,1,0
2,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,4.0073e-05,-0.19317,-0.20567,1,0
2,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,8.4205e-05,-0.19418,-0.24207,1,0
2,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.0053338,-0.1944,-0.18269,1,0
2,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.030383,-0.19452,-0.19046,1,0
2,GO RESPONSE TO INTERLEUKIN 2,0.0024367,-0.19464,-0.21173,1,0
2,GO LEUKOCYTE CHEMOTAXIS,0.00034072,-0.19467,-0.17473,1,0
2,GO RESPONSE TO INTERFERON GAMMA,0.0022992,-0.19468,-0.25638,1,0
2,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.00020448,-0.19474,-0.22513,1,0
2,GO LIPID DROPLET ORGANIZATION,0.00057693,-0.19506,-0.24384,1,0
2,GO INTERMEDIATE FILAMENT BASED PROCESS,0.00072223,-0.19512,-0.22377,1,0
2,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.00052342,-0.19534,-0.26544,1,0
2,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.0041716,-0.19545,-0.23709,1,0
2,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.013798,-0.19553,-0.16904,1,0
2,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.0028141,-0.19558,-0.17657,1,0
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.0011549,-0.19644,-0.24342,1,0
2,GO B CELL MEDIATED IMMUNITY,4.1617e-05,-0.19658,-0.25168,1,0
2,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.013465,-0.19668,-0.20185,1,0
2,GO ENDODERMAL CELL FATE COMMITMENT,0.0027346,-0.19669,-0.18498,1,0
2,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,0.0053338,-0.19672,-0.37465,1,0
2,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.0001165,-0.19674,-0.23763,1,0
2,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.0090226,-0.19698,-0.16844,1,0
2,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.0025817,-0.19709,-0.1548,1,0
2,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.0034322,-0.1971,-0.17857,1,0
2,GO RESPONSE TO OXYGEN RADICAL,0.00031859,-0.19742,-0.19113,1,0
2,GO MICROVILLUS ASSEMBLY,0.053746,-0.19753,-0.20991,1,0
2,GO ADAPTIVE IMMUNE RESPONSE,1.5201e-05,-0.19811,-0.24424,1,0
2,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.0024367,-0.19818,-0.25076,1,0
2,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.001228,-0.19822,-0.26604,1,0
2,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.021165,-0.19857,-0.19446,1,0
2,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.0031536,-0.19869,-0.15963,1,0
2,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.0034322,-0.19925,-0.25923,1,0
2,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.050569,-0.19937,-0.14583,1,0
2,GO VIRAL GENOME REPLICATION,0.00019079,-0.19966,-0.25058,1,0
2,GO IMMUNE RESPONSE TO TUMOR CELL,0.017549,-0.19969,-0.24726,1,0
2,GO CELL CHEMOTAXIS,0.00014935,-0.19992,-0.19702,1,0
2,GO MICROVILLUS ORGANIZATION,0.0040578,-0.20036,-0.24987,1,0
2,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.0047853,-0.20082,-0.23713,1,0
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.0038387,-0.20094,-0.21145,1,0
2,GO VASCULAR WOUND HEALING,0.047551,-0.20094,-0.1695,1,0
2,GO MOVEMENT IN HOST ENVIRONMENT,4.0073e-05,-0.20127,-0.26159,1,0
2,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.00010092,-0.20136,-0.21635,1,0
2,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,3.0689e-05,-0.20164,-0.24896,1,0
2,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.0027346,-0.20192,-0.23749,1,0
2,GO ERYTHROCYTE HOMEOSTASIS,3.1888e-05,-0.20196,-0.18645,1,0
2,GO ETHANOL METABOLIC PROCESS,0.018836,-0.20221,-0.22088,1,0
2,GO ENDOCRINE PROCESS,0.0021689,-0.20277,-0.19742,1,0
2,GO MONONUCLEAR CELL MIGRATION,0.0015189,-0.2029,-0.20107,1,0
2,GO VIRION ASSEMBLY,4.8612e-06,-0.20303,-0.20821,1,0
2,GO T CELL MEDIATED CYTOTOXICITY,0.019739,-0.20305,-0.31241,1,0
2,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.018836,-0.2032,-0.29272,1,0
2,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.0032441,-0.20377,-0.19792,1,0
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,2.1702e-06,-0.20405,-0.22395,1,0
2,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.00090094,-0.20412,-0.23801,1,0
2,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.035393,-0.20415,-0.19456,1,0
2,GO RESPONSE TO COPPER ION,0.0094949,-0.20454,-0.28372,1,0
2,GO MACROPHAGE CHEMOTAXIS,0.015574,-0.20459,-0.15958,1,0
2,GO POSITIVE REGULATION OF CELL KILLING,0.00027832,-0.20468,-0.24762,1,0
2,GO ACTIN CYTOSKELETON REORGANIZATION,8.3127e-06,-0.20517,-0.19981,1,0
2,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.00090094,-0.20534,-0.19398,1,0
2,GO BONE REMODELING,0.0067808,-0.20576,-0.18857,1,0
2,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.036948,-0.2058,-0.3584,1,0
2,GO CELLULAR DEFENSE RESPONSE,3.0576e-06,-0.20588,-0.28847,1,0
2,GO REGULATION OF RESPIRATORY BURST,0.0011549,-0.20635,-0.22913,1,0
2,GO CYTOKINETIC PROCESS,1.1493e-05,-0.20698,-0.2535,1,0
2,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.001872,-0.20732,-0.23,1,0
2,GO RESPONSE TO MECHANICAL STIMULUS,4.3218e-05,-0.20756,-0.21244,1,0
2,GO LIPID STORAGE,0.0019282,-0.20795,-0.18547,1,0
2,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.0006154,-0.20853,-0.23021,1,0
2,GO SUPEROXIDE METABOLIC PROCESS,0.00031859,-0.2086,-0.20416,1,0
2,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.00030804,-0.2088,-0.23571,1,0
2,GO REPLICATIVE SENESCENCE,0.037747,-0.2091,-0.18202,1,0
2,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.00072223,-0.20911,-0.22309,1,0
2,GO ANTIBACTERIAL HUMORAL RESPONSE,0.0015653,-0.20922,-0.2255,1,0
2,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.00010092,-0.20979,-0.26298,1,0
2,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.00030804,-0.21007,-0.19438,1,0
2,GO REGULATORY T CELL DIFFERENTIATION,0.0024367,-0.21051,-0.25494,1,0
2,GO REGULATION OF ACTIN NUCLEATION,7.013e-05,-0.21059,-0.23706,1,0
2,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,0.026586,-0.21085,-0.2233,1,0
2,GO MONOCYTE CHEMOTAXIS,0.00098941,-0.21086,-0.24741,1,0
2,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.001662,-0.21109,-0.17954,1,0
2,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.00022676,-0.21165,-0.21018,1,0
2,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.017969,-0.21172,-0.29752,1,0
2,GO B CELL APOPTOTIC PROCESS,0.00049035,-0.21179,-0.25333,1,0
2,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.00081984,-0.21195,-0.26482,1,0
2,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,5.9841e-06,-0.21209,-0.27498,1,0
2,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.0013054,-0.2125,-0.18284,1,0
2,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.024846,-0.21262,-0.19456,1,0
2,GO POSITIVE T CELL SELECTION,0.0020453,-0.21266,-0.17666,1,0
2,GO HORMONE CATABOLIC PROCESS,0.0040578,-0.21298,-0.268,1,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.00016595,-0.21323,-0.23457,1,0
2,GO ACTIVATED T CELL PROLIFERATION,0.00090094,-0.21349,-0.20102,1,0
2,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.0039469,-0.2135,-0.28308,1,0
2,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00030804,-0.21379,-0.2708,1,0
2,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,5.8301e-05,-0.21386,-0.22757,1,0
2,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,2.0033e-05,-0.21438,-0.24567,1,0
2,GO CELLULAR RESPONSE TO DSRNA,0.0015189,-0.21458,-0.24055,1,0
2,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0027346,-0.21505,-0.19654,1,0
2,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.0022332,-0.21511,-0.20742,1,0
2,GO DETERMINATION OF DORSAL VENTRAL ASYMMETRY,0.0073363,-0.21563,-0.22312,1,0
2,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.00023468,-0.21583,-0.2611,1,0
2,GO NEURAL TUBE FORMATION,5.508e-06,-0.21605,-0.21581,1,0
2,GO ERBB2 SIGNALING PATHWAY,2.0833e-05,-0.21644,-0.26576,1,0
2,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,7.547e-05,-0.21684,-0.28659,1,0
2,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,6.5149e-05,-0.21721,-0.20417,1,0
2,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.036948,-0.21748,-0.15889,1,0
2,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00024286,-0.21769,-0.26093,1,0
2,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.018836,-0.21834,-0.1872,1,0
2,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.0067808,-0.2186,-0.188,1,0
2,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,0.023741,-0.21892,-0.25559,1,0
2,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,0.044685,-0.21924,-0.23152,1,0
2,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.00024286,-0.21992,-0.23488,1,0
2,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.018836,-0.22005,-0.2922,1,0
2,GO CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.0085714,-0.22029,-0.24136,1,0
2,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.013139,-0.22034,-0.24011,1,0
2,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.0020453,-0.22041,-0.21338,1,0
2,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.00014935,-0.22042,-0.22091,1,0
2,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.00074557,-0.22052,-0.23118,1,0
2,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,6.7596e-05,-0.22062,-0.24206,1,0
2,GO RESPONSE TO IMMOBILIZATION STRESS,0.0014738,-0.22117,-0.26106,1,0
2,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.0042883,-0.22129,-0.15994,1,0
2,GO REGULATION OF MACROPHAGE MIGRATION,0.0050528,-0.22173,-0.1835,1,0
2,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,2.7343e-05,-0.22194,-0.24205,1,0
2,GO INTERLEUKIN 12 PRODUCTION,3.4728e-06,-0.22211,-0.29373,1,0
2,GO REGULATION OF CELL KILLING,4.8379e-05,-0.22214,-0.25679,1,0
2,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND,0.0032441,-0.22215,-0.3142,1,0
2,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.00063551,-0.22233,-0.19661,1,0
2,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,5.8301e-05,-0.22287,-0.2445,1,0
2,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.011326,-0.22309,-0.29545,1,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.046579,-0.2238,-0.16822,1,0
2,GO CELLULAR RESPONSE TO LITHIUM ION,0.017137,-0.22444,-0.21637,1,0
2,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,5.508e-06,-0.22459,-0.26358,1,0
2,GO MAMMARY GLAND MORPHOGENESIS,0.016734,-0.22463,-0.21877,1,0
2,GO METANEPHRIC EPITHELIUM DEVELOPMENT,0.012203,-0.2247,-0.24322,1,0
2,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.0038387,-0.2247,-0.22273,1,0
2,GO REGULATION OF CENTROSOME DUPLICATION,9.0179e-06,-0.22561,-0.22652,1,0
2,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.00084609,-0.22566,-0.24754,1,0
2,GO MEMBRANE RAFT ORGANIZATION,0.015203,-0.22589,-0.30842,1,0
2,GO AUTOPHAGOSOME MATURATION,8.3127e-06,-0.22632,-0.24604,1,0
2,GO AMYLOID BETA CLEARANCE,0.00098941,-0.22633,-0.22719,1,0
2,GO POSITIVE REGULATION OF CHEMOTAXIS,3.5759e-05,-0.22635,-0.21966,1,0
2,GO UNSATURATED FATTY ACID METABOLIC PROCESS,3.8583e-05,-0.22652,-0.25966,1,0
2,GO PANCREAS DEVELOPMENT,0.00079435,-0.22667,-0.21684,1,0
2,GO ICOSANOID METABOLIC PROCESS,4.8612e-06,-0.22668,-0.29497,1,0
2,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.011326,-0.2269,-0.28724,1,0
2,GO HAIR CELL DIFFERENTIATION,0.00067758,-0.22705,-0.30225,1,0
2,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.00018427,-0.22775,-0.31642,1,0
2,GO CELLULAR RESPONSE TO INTERFERON BETA,0.034637,-0.22817,-0.22697,1,0
2,GO EOSINOPHIL CHEMOTAXIS,0.015574,-0.22819,-0.32833,1,0
2,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.011047,-0.22869,-0.19893,1,0
2,GO EPITHELIAL CELL DIFFERENTIATION,1.349e-05,-0.22914,-0.21975,1,0
2,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.0025083,-0.22917,-0.21106,1,0
2,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.00019079,-0.22951,-0.28921,1,0
2,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.00013433,-0.22958,-0.24524,1,0
2,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.00018427,-0.22973,-0.26764,1,0
2,GO INTERFERON BETA PRODUCTION,7.8282e-05,-0.22975,-0.2223,1,0
2,GO REGULATION OF CELL MATRIX ADHESION,0.0011199,-0.23004,-0.21837,1,0
2,GO SPERM CAPACITATION,0.00035231,-0.23005,-0.20641,1,0
2,GO NEGATIVE REGULATION OF LIPID STORAGE,0.0014299,-0.23007,-0.22609,1,0
2,GO TISSUE REMODELING,0.00045924,-0.23097,-0.22321,1,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,7.8282e-05,-0.23157,-0.25202,1,0
2,GO T CELL MEDIATED IMMUNITY,0.00022676,-0.23181,-0.28114,1,0
2,GO LIVER MORPHOGENESIS,0.0060989,-0.23202,-0.26133,1,0
2,GO POLYAMINE BIOSYNTHETIC PROCESS,0.001872,-0.23253,-0.22796,1,0
2,GO SMOOTH MUSCLE CELL MIGRATION,6.5149e-05,-0.23294,-0.30385,1,0
2,GO PLACENTA DEVELOPMENT,5.2837e-06,-0.23308,-0.24538,1,0
2,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.011612,-0.23334,-0.22078,1,0
2,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,2.4346e-05,-0.23393,-0.25058,1,0
2,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.02268,-0.23406,-0.20338,1,0
2,GO REGULATION OF COAGULATION,0.00042998,-0.23454,-0.28661,1,0
2,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.0018173,-0.23487,-0.22772,1,0
2,GO GLOMERULUS DEVELOPMENT,0.00040247,-0.23508,-0.27223,1,0
2,GO PIGMENT ACCUMULATION,0.00069957,-0.23533,-0.24213,1,0
2,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.00011241,-0.23554,-0.26285,1,0
2,GO REGULATION OF RESPONSE TO WOUNDING,0.00016595,-0.2363,-0.24885,1,0
2,GO SPHINGOMYELIN METABOLIC PROCESS,0.0032441,-0.23642,-0.22832,1,0
2,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.011326,-0.23688,-0.29969,1,0
2,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.00084609,-0.23692,-0.31663,1,0
2,GO RESPONSE TO LEPTIN,0.014841,-0.23696,-0.21683,1,0
2,GO BILE ACID METABOLIC PROCESS,0.0001547,-0.23739,-0.24479,1,0
2,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.0040578,-0.23753,-0.29836,1,0
2,GO GASTRULATION WITH MOUTH FORMING SECOND,0.0099891,-0.23757,-0.19277,1,0
2,GO MULTIVESICULAR BODY ORGANIZATION,1.0311e-06,-0.23775,-0.24534,1,0
2,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,1.6455e-05,-0.23804,-0.24279,1,0
2,GO REGULATION OF BONE REMODELING,0.0059384,-0.23806,-0.20804,1,0
2,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.013798,-0.23846,-0.24683,1,0
2,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.0011549,-0.2385,-0.23034,1,0
2,GO REGULATION OF B CELL DIFFERENTIATION,0.0016129,-0.23864,-0.21939,1,0
2,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,8.6584e-06,-0.23954,-0.27036,1,0
2,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.0014738,-0.24015,-0.29273,1,0
2,GO REGULATION OF VIRAL LIFE CYCLE,9.3916e-06,-0.24069,-0.31282,1,0
2,GO RUFFLE ORGANIZATION,5.753e-07,-0.2416,-0.25942,1,0
2,GO B CELL RECEPTOR SIGNALING PATHWAY,0.00023468,-0.24255,-0.22243,1,0
2,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.007729,-0.24275,-0.27836,1,0
2,GO REGULATION OF VIRAL GENOME REPLICATION,5.2139e-05,-0.24295,-0.32085,1,0
2,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,3.4421e-05,-0.24328,-0.26399,1,0
2,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.00044439,-0.24388,-0.23842,1,0
2,GO REGULATION OF RECEPTOR BINDING,0.0051916,-0.24406,-0.24122,1,0
2,GO CELL CELL JUNCTION ORGANIZATION,3.4728e-06,-0.24465,-0.27055,1,0
2,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.00049035,-0.24546,-0.21638,1,0
2,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.017549,-0.24561,-0.25071,1,0
2,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.027188,-0.24568,-0.13963,1,0
2,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.00081984,-0.24588,-0.26629,1,0
2,GO LONG CHAIN FATTY ACID CATABOLIC PROCESS,0.0053338,-0.24622,-0.29305,1,0
2,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.0031536,-0.24657,-0.19922,1,0
2,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.00069957,-0.2476,-0.32612,1,0
2,GO RUFFLE ASSEMBLY,7.889e-07,-0.24772,-0.25036,1,0
2,GO MAGNESIUM ION TRANSPORT,5.7413e-06,-0.24806,-0.30052,1,0
2,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00032948,-0.24865,-0.22503,1,0
2,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.0013457,-0.24887,-0.22264,1,0
2,GO GLYCEROL ETHER METABOLIC PROCESS,0.00092958,-0.24896,-0.26571,1,0
2,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.00084609,-0.24956,-0.22203,1,0
2,GO NEGATIVE REGULATION OF CELL KILLING,0.016734,-0.24956,-0.38989,1,0
2,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.00018427,-0.24982,-0.23766,1,0
2,GO INTERLEUKIN 6 PRODUCTION,1.0311e-06,-0.24986,-0.25164,1,0
2,GO SKIN DEVELOPMENT,3.1888e-05,-0.25008,-0.24267,1,0
2,GO INTERLEUKIN 8 PRODUCTION,3.4421e-05,-0.25161,-0.26375,1,0
2,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.0067808,-0.25167,-0.24715,1,0
2,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.00050664,-0.25182,-0.21858,1,0
2,GO CELLULAR RESPONSE TO CADMIUM ION,0.040234,-0.25236,-0.22468,1,0
2,GO REGULATION OF EXOSOMAL SECRETION,5.7413e-06,-0.25266,-0.30234,1,0
2,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.00016023,-0.25312,-0.30547,1,0
2,GO EOSINOPHIL MIGRATION,0.0039469,-0.25314,-0.33673,1,0
2,GO GLYCOSIDE METABOLIC PROCESS,0.040234,-0.25318,-0.31809,1,0
2,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.031748,-0.2535,-0.21394,1,0
2,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,8.2505e-07,-0.25363,-0.32642,1,0
2,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.03245,-0.25371,-0.31817,1,0
2,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,4.8379e-05,-0.25406,-0.28955,1,0
2,GO EPIDERMIS DEVELOPMENT,2.2524e-05,-0.2541,-0.2431,1,0
2,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.00041602,-0.25555,-0.29162,1,0
2,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.0038387,-0.25562,-0.29218,1,0
2,GO BIOLOGICAL PHASE,0.033166,-0.2559,-0.32727,1,0
2,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.054842,-0.25594,-0.24168,1,0
2,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,0.0045306,-0.25629,-0.38517,1,0
2,GO GERMINAL CENTER FORMATION,0.017969,-0.25681,-0.28634,1,0
2,GO TRANSCYTOSIS,6.7596e-05,-0.25794,-0.24346,1,0
2,GO VIRAL RELEASE FROM HOST CELL,4.5813e-07,-0.25822,-0.27857,1,0
2,GO T CELL SELECTION,0.0025817,-0.25841,-0.17252,1,0
2,GO BROWN FAT CELL DIFFERENTIATION,5.0226e-05,-0.25842,-0.31036,1,0
2,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.0016129,-0.25925,-0.26186,1,0
2,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,1.5331e-06,-0.25932,-0.29812,1,0
2,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.016734,-0.26101,-0.26029,1,0
2,GO NECROTIC CELL DEATH,0.00069957,-0.26175,-0.24807,1,0
2,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.0007696,-0.2618,-0.30188,1,0
2,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.00013917,-0.26277,-0.25581,1,0
2,GO RDNA HETEROCHROMATIN ASSEMBLY,7.013e-05,-0.26277,-0.25226,1,0
2,GO EXTRACELLULAR VESICLE BIOGENESIS,4.4712e-06,-0.26339,-0.28481,1,0
2,GO ER OVERLOAD RESPONSE,0.033166,-0.26405,-0.20384,1,0
2,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.00042998,-0.26408,-0.32444,1,0
2,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.00012074,-0.26412,-0.24638,1,0
2,GO NEUROEPITHELIAL CELL DIFFERENTIATION,0.012203,-0.26518,-0.2249,1,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00029782,-0.26547,-0.32186,1,0
2,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.0010528,-0.26567,-0.28976,1,0
2,GO WATER HOMEOSTASIS,0.0010859,-0.2666,-0.24307,1,0
2,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.0030654,-0.26752,-0.26249,1,0
2,GO ACTIN FILAMENT BASED TRANSPORT,0.00087311,-0.26765,-0.27725,1,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.0099891,-0.26796,-0.43197,1,0
2,GO REGULATION OF WOUND HEALING,6.5149e-05,-0.26837,-0.28992,1,0
2,GO INTERLEUKIN 10 PRODUCTION,1.1964e-05,-0.26843,-0.2883,1,0
2,GO LEFT RIGHT AXIS SPECIFICATION,0.0006154,-0.26939,-0.31114,1,0
2,GO INTERLEUKIN 13 PRODUCTION,0.0059384,-0.26991,-0.26897,1,0
2,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,4.3218e-05,-0.27,-0.25704,1,0
2,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,0.0046564,-0.27219,-0.35907,1,0
2,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,0.0018173,-0.27289,-0.32491,1,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,3.0576e-06,-0.27331,-0.32003,1,0
2,GO PROGRAMMED NECROTIC CELL DEATH,0.00036427,-0.27386,-0.27448,1,0
2,GO SIGNAL PEPTIDE PROCESSING,6.2786e-05,-0.27455,-0.35918,1,0
2,GO CELL CELL JUNCTION ASSEMBLY,1.8251e-06,-0.2747,-0.28631,1,0
2,GO GDP METABOLIC PROCESS,0.0099891,-0.27545,-0.23466,1,0
2,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,5.2533e-07,-0.27599,-0.30411,1,0
2,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0060989,-0.27599,-0.27453,1,0
2,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,4.1112e-06,-0.27697,-0.2946,1,0
2,GO REGULATION OF BILE ACID METABOLIC PROCESS,0.019739,-0.27818,-0.22433,1,0
2,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,2.9532e-05,-0.27823,-0.2547,1,0
2,GO INTERLEUKIN 1 BETA PRODUCTION,6.2367e-06,-0.27843,-0.31747,1,0
2,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.02068,-0.2801,-0.36336,1,0
2,GO REGULATION OF PLATELET ACTIVATION,6.0504e-05,-0.28027,-0.3648,1,0
2,GO REGULATION OF MICROVILLUS ORGANIZATION,0.0010528,-0.28029,-0.33755,1,0
2,GO INTERLEUKIN 5 PRODUCTION,0.011047,-0.28092,-0.21074,1,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.00072223,-0.28173,-0.30843,1,0
2,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,3.7145e-05,-0.2822,-0.29097,1,0
2,GO ACTIN FILAMENT SEVERING,0.0047853,-0.2824,-0.31525,1,0
2,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,1.4674e-06,-0.28415,-0.31777,1,0
2,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,6.7596e-05,-0.28487,-0.29067,1,0
2,GO CELLULAR RESPONSE TO ALKALOID,0.00014418,-0.2852,-0.26135,1,0
2,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.00019079,-0.28537,-0.35242,1,0
2,GO DENDRITIC CELL DIFFERENTIATION,2.7343e-05,-0.28633,-0.34976,1,0
2,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.0075304,-0.28692,-0.30594,1,0
2,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.0081404,-0.28721,-0.20979,1,0
2,GO INTERLEUKIN 1 PRODUCTION,2.2658e-06,-0.2884,-0.34316,1,0
2,GO PLATELET AGGREGATION,2.6307e-05,-0.28918,-0.28722,1,0
2,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,2.1702e-06,-0.28972,-0.2868,1,0
2,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00019079,-0.28997,-0.36913,1,0
2,GO POSITIVE REGULATION OF CELL SIZE,0.00012512,-0.29019,-0.33138,1,0
2,GO MUSCLE CELL MIGRATION,5.0226e-05,-0.29145,-0.2889,1,0
2,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.00013433,-0.29179,-0.3439,1,0
2,GO INTESTINAL ABSORPTION,0.00014935,-0.29193,-0.32136,1,0
2,GO OLIGOPEPTIDE TRANSPORT,0.0013872,-0.29235,-0.36432,1,0
2,GO HETEROTYPIC CELL CELL ADHESION,3.0576e-06,-0.29252,-0.34378,1,0
2,GO REGULATION OF INTEGRIN ACTIVATION,0.00010462,-0.29321,-0.32558,1,0
2,GO HOMOTYPIC CELL CELL ADHESION,4.1617e-05,-0.29375,-0.31832,1,0
2,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.018836,-0.29395,-0.20767,1,0
2,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,0.027803,-0.29423,-0.30208,1,0
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.00067758,-0.29434,-0.31884,1,0
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,7.0571e-06,-0.29463,-0.30316,1,0
2,GO SPLEEN DEVELOPMENT,1.4044e-06,-0.29584,-0.28265,1,0
2,GO OSTEOBLAST PROLIFERATION,0.00010462,-0.29629,-0.3177,1,0
2,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,9.0179e-06,-0.29686,-0.29205,1,0
2,GO DECIDUALIZATION,0.0038387,-0.29723,-0.29606,1,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,1.9904e-06,-0.29804,-0.33319,1,0
2,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.00038934,-0.2983,-0.32016,1,0
2,GO ANOIKIS,1.104e-05,-0.29847,-0.32652,1,0
2,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,0.020205,-0.29852,-0.27063,1,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.00054072,-0.29897,-0.33388,1,0
2,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.023205,-0.29949,-0.23421,1,0
2,GO T HELPER CELL LINEAGE COMMITMENT,4.8379e-05,-0.30004,-0.27867,1,0
2,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.0075304,-0.30162,-0.26013,1,0
2,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.0028957,-0.3024,-0.25799,1,0
2,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.0054795,-0.30381,-0.29111,1,0
2,GO ALPHA BETA T CELL PROLIFERATION,1.7806e-05,-0.30409,-0.34839,1,0
2,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.0059384,-0.30429,-0.41633,1,0
2,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.00042998,-0.30511,-0.32144,1,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,3.9926e-07,-0.3054,-0.31235,1,0
2,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.017137,-0.30542,-0.47191,1,0
2,GO NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00037661,-0.30585,-0.29082,1,0
2,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.0079323,-0.30608,-0.25945,1,0
2,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,3.7145e-05,-0.30622,-0.36877,1,0
2,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,3.3132e-05,-0.30958,-0.33903,1,0
2,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.0087944,-0.31152,-0.43355,1,0
2,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,6.0504e-05,-0.31164,-0.4274,1,0
2,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,6.2367e-06,-0.31241,-0.29558,1,0
2,GO RESPONSE TO NITROSATIVE STRESS,0.00010092,-0.31387,-0.41922,1,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,9.7801e-06,-0.316,-0.30444,1,0
2,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.0010528,-0.31782,-0.3985,1,0
2,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,0.014138,-0.31831,-0.24614,1,0
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,7.2754e-05,-0.3189,-0.30745,1,0
2,GO NATURAL KILLER CELL PROLIFERATION,0.00022676,-0.31933,-0.35296,1,0
2,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.00012512,-0.31948,-0.27264,1,0
2,GO EMBRYONIC PLACENTA DEVELOPMENT,2.5774e-06,-0.32067,-0.35368,1,0
2,GO BARBED END ACTIN FILAMENT CAPPING,0.00013433,-0.32067,-0.4067,1,0
2,GO ETHER METABOLIC PROCESS,0.00024286,-0.32158,-0.3238,1,0
2,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.0081404,-0.32171,-0.29305,1,0
2,GO ESCRT COMPLEX DISASSEMBLY,0.00013433,-0.32177,-0.30842,1,0
2,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.00010092,-0.32231,-0.41032,1,0
2,GO REGULATION OF NECROTIC CELL DEATH,0.00022676,-0.32293,-0.31857,1,0
2,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00029782,-0.32306,-0.3267,1,0
2,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.0053338,-0.32368,-0.23044,1,0
2,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.00087311,-0.32478,-0.33323,1,0
2,GO NEGATIVE REGULATION OF VIRAL PROCESS,2.4346e-05,-0.32514,-0.37414,1,0
2,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,3.17e-07,-0.32574,-0.36739,1,0
2,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,1.906e-06,-0.32644,-0.35873,1,0
2,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,9.0551e-05,-0.32649,-0.49659,1,0
2,GO LIPOXYGENASE PATHWAY,0.0015653,-0.32839,-0.35137,1,0
2,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.0062634,-0.32858,-0.25416,1,0
2,GO LEFT RIGHT PATTERN FORMATION,0.00012964,-0.32909,-0.30426,1,0
2,GO KERATINOCYTE DEVELOPMENT,0.025414,-0.33042,-0.28399,1,0
2,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.031059,-0.33255,-0.23364,1,0
2,GO BILE ACID AND BILE SALT TRANSPORT,3.5759e-05,-0.33346,-0.36409,1,0
2,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,9.3916e-06,-0.33422,-0.36738,1,0
2,GO PROGESTERONE METABOLIC PROCESS,0.00044439,-0.3345,-0.46742,1,0
2,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00063551,-0.33785,-0.39231,1,0
2,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,5.8301e-05,-0.33818,-0.3144,1,0
2,GO HEMATOPOIETIC STEM CELL PROLIFERATION,1.4044e-06,-0.33845,-0.33214,1,0
2,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.0010206,-0.33953,-0.36921,1,0
2,GO SUPEROXIDE ANION GENERATION,0.00017186,-0.34021,-0.32774,1,0
2,GO TRANSPOSITION,1.7118e-05,-0.34022,-0.41665,1,0
2,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.0019282,-0.34024,-0.27362,1,0
2,GO ZYMOGEN INHIBITION,0.00018427,-0.34126,-0.40275,1,0
2,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.00054072,-0.3422,-0.34746,1,0
2,GO RESPONSE TO INTERFERON ALPHA,0.0024367,-0.34261,-0.46016,1,0
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,4.3218e-05,-0.34314,-0.35544,1,0
2,GO PROSTANOID METABOLIC PROCESS,2.3418e-05,-0.34391,-0.43093,1,0
2,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.017969,-0.34458,-0.29141,1,0
2,GO DETECTION OF OTHER ORGANISM,4.3218e-05,-0.34508,-0.39188,1,0
2,GO IMMUNOLOGICAL MEMORY PROCESS,8.1192e-05,-0.34512,-0.34359,1,0
2,GO GLOMERULAR MESANGIAL CELL PROLIFERATION,0.0069616,-0.34711,-0.41594,1,0
2,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,6.7596e-05,-0.34729,-0.42145,1,0
2,GO LIPID TRANSLOCATION,1.8251e-06,-0.34769,-0.32187,1,0
2,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,8.1192e-05,-0.34789,-0.33195,1,0
2,GO EPIDERMAL CELL DIFFERENTIATION,9.7801e-06,-0.34994,-0.32441,1,0
2,GO HISTAMINE SECRETION,0.004408,-0.35224,-0.34449,1,0
2,GO LATE ENDOSOME TO VACUOLE TRANSPORT,5.2533e-07,-0.35314,-0.34367,1,0
2,GO MITOTIC CYTOKINETIC PROCESS,5.1671e-08,-0.35462,-0.38135,1,0
2,GO KERATINOCYTE DIFFERENTIATION,1.104e-05,-0.35542,-0.33714,1,0
2,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.0021062,-0.35735,-0.34442,1,0
2,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,2.8891e-07,-0.35749,-0.37725,1,0
2,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.0016129,-0.35752,-0.4848,1,0
2,GO ENDOTHELIAL CELL CHEMOTAXIS,7.2754e-05,-0.35926,-0.38583,1,0
2,GO PROTEIN ADP RIBOSYLATION,1.1493e-05,-0.35936,-0.31088,1,0
2,GO POSITIVE REGULATION OF COAGULATION,2.8077e-06,-0.35968,-0.36426,1,0
2,GO AMINE BIOSYNTHETIC PROCESS,0.0039469,-0.35989,-0.27633,1,0
2,GO VIRAL BUDDING,4.1802e-07,-0.36018,-0.30959,1,0
2,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.0014299,-0.36235,-0.41913,1,0
2,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,0.00016595,-0.36442,-0.39438,1,0
2,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.0079323,-0.36585,-0.46838,1,0
2,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,5.4977e-07,-0.36655,-0.37184,1,0
2,GO HEPATOCYTE DIFFERENTIATION,0.00072223,-0.36744,-0.33667,1,0
2,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,4.0073e-05,-0.36865,-0.39858,1,0
2,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.0021062,-0.36881,-0.41526,1,0
2,GO RESPONSE TO INTERFERON BETA,0.0015189,-0.36925,-0.47942,1,0
2,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,5.2837e-06,-0.36938,-0.38245,1,0
2,GO ADRENAL GLAND DEVELOPMENT,0.00045924,-0.36996,-0.30908,1,0
2,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.00016595,-0.3702,-0.37092,1,0
2,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,7.3528e-06,-0.37291,-0.4365,1,0
2,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00027832,-0.37409,-0.36678,1,0
2,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,1.6455e-05,-0.37503,-0.39173,1,0
2,GO LUNG EPITHELIUM DEVELOPMENT,0.0010528,-0.37541,-0.29342,1,0
2,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,2.9532e-05,-0.37623,-0.38386,1,0
2,GO GAP JUNCTION ASSEMBLY,3.8583e-05,-0.37954,-0.47572,1,0
2,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,1.4039e-05,-0.37995,-0.37162,1,0
2,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,1.9263e-05,-0.3813,-0.36927,1,0
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,3.3132e-05,-0.38141,-0.47901,1,0
2,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.0014738,-0.38151,-0.48088,1,0
2,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,1.5201e-05,-0.3827,-0.38461,1,0
2,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.00017186,-0.38724,-0.38847,1,0
2,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,2.2879e-07,-0.38762,-0.46097,1,0
2,GO POSITIVE REGULATION OF CELL MATURATION,7.8282e-05,-0.38891,-0.42751,1,0
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,6.0504e-05,-0.38909,-0.49545,1,0
2,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.00092958,-0.39007,-0.34123,1,0
2,GO INTERFERON ALPHA PRODUCTION,9.4334e-07,-0.39028,-0.38184,1,0
2,GO TOXIN METABOLIC PROCESS,0.010506,-0.39189,-0.28136,1,0
2,GO DNA DEAMINATION,0.001191,-0.39408,-0.37956,1,0
2,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,1.5816e-05,-0.3966,-0.39359,1,0
2,GO RESPONSE TO TYPE I INTERFERON,1.5816e-05,-0.3972,-0.51811,1,0
2,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,5.0194e-07,-0.40082,-0.44143,1,0
2,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,3.0689e-05,-0.40384,-0.38688,1,0
2,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,2.5774e-06,-0.40399,-0.41128,1,0
2,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,3.3287e-06,-0.40454,-0.44126,1,0
2,GO INFLAMMATORY RESPONSE TO WOUNDING,0.038561,-0.40676,-0.32394,1,0
2,GO PARAXIAL MESODERM DEVELOPMENT,0.00040247,-0.4106,-0.35141,1,0
2,GO VASCULAR TRANSPORT,0.00032948,-0.41351,-0.43145,1,0
2,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,4.6623e-06,-0.41442,-0.5307,1,0
2,GO REGULATION OF PLATELET AGGREGATION,7.8282e-05,-0.41461,-0.4927,1,0
2,GO REGULATION OF TRANSPOSITION,7.9801e-06,-0.4174,-0.47822,1,0
2,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,3.1888e-05,-0.41765,-0.35528,1,0
2,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,2.2879e-07,-0.41917,-0.37594,1,0
2,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,0.0025817,-0.41948,-0.3296,1,0
2,GO TOLERANCE INDUCTION,0.00035231,-0.41976,-0.4532,1,0
2,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,6.4994e-06,-0.42159,-0.52534,1,0
2,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,6.2786e-05,-0.42252,-0.46546,1,0
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,1.6015e-06,-0.4252,-0.49017,1,0
2,GO KERATINIZATION,2.7343e-05,-0.42753,-0.36981,1,0
2,GO POSITIVE REGULATION OF WOUND HEALING,5.2533e-07,-0.42842,-0.47284,1,0
2,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,3.7145e-05,-0.4294,-0.39364,1,0
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,8.1192e-05,-0.4321,-0.41443,1,0
2,GO MAINTENANCE OF BLOOD BRAIN BARRIER,1.2366e-07,-0.43419,-0.49423,1,0
2,GO GLIAL CELL APOPTOTIC PROCESS,0.00017796,-0.43898,-0.42635,1,0
2,GO LEYDIG CELL DIFFERENTIATION,0.001986,-0.44113,-0.40441,1,0
2,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.00074557,-0.44239,-0.4068,1,0
2,GO REGULATION OF TOLERANCE INDUCTION,2.6902e-06,-0.44317,-0.50979,1,0
2,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,1.4268e-07,-0.44578,-0.45789,1,0
2,GO RESPONSE TO INTERLEUKIN 18,0.00017796,-0.44644,-0.5171,1,0
2,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,6.7728e-06,-0.44842,-0.39402,1,0
2,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,9.7801e-06,-0.45496,-0.55607,1,0
2,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.00042998,-0.45839,-0.45926,1,0
2,GO CORNIFICATION,3.5759e-05,-0.45883,-0.41776,1,0
2,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,5.0226e-05,-0.45926,-0.63387,1,0
2,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,7.2754e-05,-0.46042,-0.40321,1,0
2,GO CELLULAR RESPONSE TO NITROGEN STARVATION,5.7413e-06,-0.46129,-0.46877,1,0
2,GO LABYRINTHINE LAYER DEVELOPMENT,1.2962e-05,-0.46211,-0.39934,1,0
2,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.00017186,-0.46555,-0.43602,1,0
2,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.00065623,-0.46852,-0.37734,1,0
2,GO RESPONSE TO WATER,6.7596e-05,-0.46905,-0.42596,1,0
2,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.0013872,-0.4696,-0.39297,1,0
2,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,2.0833e-05,-0.47305,-0.4793,1,0
2,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,5.508e-06,-0.47602,-0.47528,1,0
2,GO CELL CELL JUNCTION MAINTENANCE,0.00036427,-0.48016,-0.39339,1,0
2,GO RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION,1.1964e-05,-0.48384,-0.45744,1,0
2,GO MIDBODY ABSCISSION,1.5691e-07,-0.48641,-0.48507,1,0
2,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,3.9418e-06,-0.49691,-0.52259,1,0
2,GO RESPONSE TO LITHIUM ION,3.7145e-05,-0.49709,-0.47986,1,0
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.00095906,-0.50367,-0.36502,1,0
2,GO RESPONSE TO FORSKOLIN,4.2876e-06,-0.50527,-0.46257,1,0
2,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,9.3916e-06,-0.50832,-0.45937,1,0
2,GO SEROTONIN METABOLIC PROCESS,0.011326,-0.50881,-0.31563,1,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,2.4692e-06,-0.51142,-0.47635,1,0
2,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.00050664,-0.52989,-0.49198,1,0
2,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,4.6597e-05,-0.5309,-0.47422,1,0
2,GO PROTEIN AUTO ADP RIBOSYLATION,5.6174e-05,-0.53712,-0.45348,1,0
2,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.0045306,-0.53873,-0.35833,1,0
2,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,5.2837e-06,-0.55036,-0.52776,1,0
2,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,2.2524e-05,-0.55124,-0.4387,1,0
2,GO EPITHELIAL CELL MORPHOGENESIS,4.1112e-06,-0.5572,-0.53601,1,0
2,GO APICAL JUNCTION ASSEMBLY,4.9191e-08,-0.56098,-0.52845,1,0
2,GO REGULATION OF WATER LOSS VIA SKIN,0.00032948,-0.57307,-0.47633,1,0
2,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,4.4712e-06,-0.57605,-0.58621,1,0
2,GO NEGATIVE REGULATION OF ANOIKIS,2.8077e-06,-0.57759,-0.60574,1,0
2,GO ENTRY OF BACTERIUM INTO HOST CELL,2.3418e-05,-0.57882,-0.57934,1,0
2,GO POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.00049035,-0.5793,-0.43966,1,0
2,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,9.389e-05,-0.58673,-0.52029,1,0
2,GO GAMMA DELTA T CELL ACTIVATION,1.4044e-06,-0.59862,-0.56138,1,0
2,GO MUCUS SECRETION,0.00084609,-0.60014,-0.52376,1,0
2,GO ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER,2.1702e-06,-0.61866,-0.60316,1,0
2,GO CYTIDINE TO URIDINE EDITING,0.0001165,-0.61921,-0.65655,1,0
2,GO PARAXIAL MESODERM MORPHOGENESIS,6.4994e-06,-0.63775,-0.59594,1,0
2,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,4.3218e-05,-0.64222,-0.63275,1,0
2,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,7.2754e-05,-0.64706,-0.7541,1,0
2,GO LUNG CELL DIFFERENTIATION,0.00012074,-0.65646,-0.51701,1,0
2,GO GAMMA DELTA T CELL DIFFERENTIATION,8.3127e-06,-0.66246,-0.65678,1,0
2,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,9.4334e-07,-0.67958,-0.63089,1,0
2,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,2.6322e-07,-0.74931,-0.65572,1,0
2,GO EPITHELIAL CELL CELL ADHESION,1.5691e-07,-0.7504,-0.79986,1,0
2,GO LIPID DROPLET FORMATION,7.3528e-06,-0.767,-0.68572,1,0
2,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,6.0504e-05,-0.8094,-0.88752,1,0
2,GO EMBRYONIC PLACENTA MORPHOGENESIS,2.8891e-07,-0.92382,-0.82664,1,0
2,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,5.0194e-07,-0.96787,-0.81736,1,0
2,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,7.8282e-05,-0.99536,-1.0952,1,0
2,GO HEPATOCYTE APOPTOTIC PROCESS,1.8084e-07,-0.99605,-1.0676,1,0
2,GO LABYRINTHINE LAYER MORPHOGENESIS,3.0264e-07,-1.0047,-0.89157,1,0
2,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,1.2308e-06,-1.1075,-0.9977,1,0
2,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.14048,0.3332,0.13527,0,1
2,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.060602,0.30348,0.18271,0,1
2,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.10465,0.27498,0.12566,0,1
2,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.077957,0.2721,0.20978,0,1
2,GO THALAMUS DEVELOPMENT,0.42347,0.211,0.095315,0,1
2,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.14285,0.19643,0.11303,0,1
2,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.10654,0.19335,0.18023,0,1
2,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.30402,0.18828,0.071766,0,1
2,GO RESPONSE TO MANGANESE ION,0.095625,0.18754,0.10711,0,1
2,GO NEURAL CREST CELL MIGRATION,0.064293,0.18719,0.12956,0,1
2,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.2839,0.18712,0.13208,0,1
2,GO COCHLEA MORPHOGENESIS,0.070855,0.185,0.11256,0,1
2,GO RESPONSE TO MUSCLE ACTIVITY,0.11434,0.18411,0.11316,0,1
2,GO RESPONSE TO VITAMIN A,0.15015,0.18388,0.10886,0,1
2,GO TETRAHYDROFOLATE INTERCONVERSION,0.12908,0.18381,0.11776,0,1
2,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.0695,0.18298,0.16604,0,1
2,GO DETECTION OF TEMPERATURE STIMULUS,0.15264,0.18144,0.16619,0,1
2,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.065563,0.17947,0.11335,0,1
2,GO MIDDLE EAR MORPHOGENESIS,0.41341,0.17478,0.035279,0,1
2,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.092194,0.1745,0.11047,0,1
2,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.20937,0.16977,0.091043,0,1
2,GO FIBROBLAST APOPTOTIC PROCESS,0.099158,0.1652,0.11653,0,1
2,GO POST ANAL TAIL MORPHOGENESIS,0.13583,0.16295,0.09286,0,1
2,GO ODONTOGENESIS,0.13814,0.16051,0.075846,0,1
2,GO ALDITOL PHOSPHATE METABOLIC PROCESS,0.12908,0.16023,0.13459,0,1
2,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.061812,0.15431,0.10314,0,1
2,GO NUCLEUS LOCALIZATION,0.082489,0.15271,0.095375,0,1
2,GO NERVE DEVELOPMENT,0.11841,0.15175,0.09633,0,1
2,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.15517,0.14983,0.13446,0,1
2,GO BONE MORPHOGENESIS,0.10654,0.1475,0.072442,0,1
2,GO CELLULAR HYPEROSMOTIC RESPONSE,0.26098,0.14593,0.088138,0,1
2,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.10096,0.13825,0.077172,0,1
2,GO MESODERMAL CELL FATE COMMITMENT,0.28785,0.13813,0.055579,0,1
2,GO CELLULAR RESPONSE TO MANGANESE ION,0.060602,0.13743,0.11847,0,1
2,GO T CELL HOMEOSTASIS,0.12689,0.13464,0.053061,0,1
2,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.075049,0.12975,0.11657,0,1
2,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.20937,0.12905,0.064557,0,1
2,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.52594,0.12846,0.04104,0,1
2,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.13583,0.12709,0.104,0,1
2,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.12908,0.1266,0.11207,0,1
2,GO INNATE IMMUNE RESPONSE IN MUCOSA,0.29184,0.12632,0.084081,0,1
2,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.057089,0.12452,0.17914,0,1
2,GO SMOOTH MUSCLE CONTRACTION,0.11636,0.12434,0.063471,0,1
2,GO NEUROBLAST PROLIFERATION,0.14048,0.12256,0.087126,0,1
2,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.093897,0.12094,0.068757,0,1
2,GO MONOSACCHARIDE CATABOLIC PROCESS,0.19695,0.12009,0.063184,0,1
2,GO LYMPH VESSEL DEVELOPMENT,0.14769,0.11937,0.073455,0,1
2,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,0.16294,0.11889,0.09017,0,1
2,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.30402,0.11099,0.064195,0,1
2,GO SLEEP,0.29184,0.10954,0.05629,0,1
2,GO HEART VALVE DEVELOPMENT,0.27227,0.10804,0.063939,0,1
2,GO ALDEHYDE CATABOLIC PROCESS,0.064293,0.10773,0.10406,0,1
2,GO SECRETORY GRANULE ORGANIZATION,0.22568,0.10553,0.055856,0,1
2,GO POSITIVE REGULATION OF ION TRANSPORT,0.076492,0.1043,0.078154,0,1
2,GO SKELETAL SYSTEM MORPHOGENESIS,0.36064,0.10427,0.032545,0,1
2,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.59059,0.10414,0.032692,0,1
2,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.075049,0.10372,0.095769,0,1
2,GO OUTFLOW TRACT MORPHOGENESIS,0.19095,0.10319,0.058589,0,1
2,GO SPINDLE MIDZONE ASSEMBLY,0.60272,0.1027,0.03177,0,1
2,GO RESPONSE TO LEAD ION,0.2,0.099167,0.066486,0,1
2,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.10654,0.096015,0.079689,0,1
2,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.070855,0.095187,0.082986,0,1
2,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.070855,0.093583,0.11512,0,1
2,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.072231,0.09215,0.069895,0,1
2,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.12908,0.091841,0.068493,0,1
2,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.27999,0.091737,0.027537,0,1
2,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.42855,0.090715,0.051687,0,1
2,GO RRNA 3 END PROCESSING,0.1313,0.090271,0.099363,0,1
2,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.72969,0.087255,0.00042408,0,1
2,GO CELLULAR RESPONSE TO UV,0.090515,0.086893,0.060283,0,1
2,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.30815,0.085366,0.044127,0,1
2,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.38408,0.084446,0.047501,0,1
2,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.29184,0.083715,0.0484,0,1
2,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.11434,0.082719,0.083548,0,1
2,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.25363,0.081677,0.04365,0,1
2,GO REGULATION OF PROTEIN TARGETING,0.059411,0.080954,0.067854,0,1
2,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.095625,0.080499,0.080015,0,1
2,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.082489,0.076793,0.056017,0,1
2,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.55487,0.076436,0.026264,0,1
2,GO CATION TRANSPORT,0.05824,0.075116,0.060237,0,1
2,GO 3 UTR MEDIATED MRNA STABILIZATION,0.77618,0.074206,-0.012709,0,1
2,GO HISTONE H3 K36 METHYLATION,0.51459,0.07244,0.031562,0,1
2,GO ESTROGEN BIOSYNTHETIC PROCESS,0.60272,0.070872,0.029586,0,1
2,GO MITOCHONDRIAL FISSION,0.17934,0.066962,0.067096,0,1
2,GO ATP DEPENDENT CHROMATIN REMODELING,0.060602,0.065935,0.06487,0,1
2,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.063042,0.064006,0.038941,0,1
2,GO CEREBRAL CORTEX DEVELOPMENT,0.082489,0.063571,0.083382,0,1
2,GO MISMATCH REPAIR,0.26098,0.061634,0.040266,0,1
2,GO PRENYLATION,0.43883,0.060469,0.026651,0,1
2,GO CHROMOSOME CONDENSATION,0.10465,0.056019,0.064779,0,1
2,GO PROTEIN LOCALIZATION TO MEMBRANE,0.11434,0.050566,0.041946,0,1
2,GO DEFENSE RESPONSE TO FUNGUS,0.69061,0.049532,0.0085766,0,1
2,GO REGULATION OF HISTONE UBIQUITINATION,0.33373,0.048465,0.043883,0,1
2,GO MRNA TRANSPORT,0.095625,0.047191,0.05429,0,1
2,GO MITOCHONDRION ORGANIZATION,0.17653,0.038028,0.029368,0,1
2,GO DNA REPAIR,0.077957,0.037393,0.035463,0,1
2,GO TORC1 SIGNALING,0.088862,0.033763,0.062223,0,1
2,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.96163,0.02307,-0.010031,0,1
2,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,2.3418e-05,0.58202,0.62154,0,0
2,GO DENSE CORE GRANULE TRANSPORT,0.00041602,0.57831,0.51559,0,0
2,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.00059588,0.56333,0.5821,0,0
2,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,4.1617e-05,0.52422,0.50849,0,0
2,GO NEURON CELLULAR HOMEOSTASIS,1.5331e-06,0.49745,0.49407,0,0
2,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,0.0047853,0.45378,0.36699,0,0
2,GO SYNAPTIC MEMBRANE ADHESION,0.00038934,0.44341,0.47686,0,0
2,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.020205,0.4197,0.32519,0,0
2,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.010773,0.38101,0.2694,0,0
2,GO ANATOMICAL STRUCTURE REGRESSION,0.0049174,0.37793,0.30971,0,0
2,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,9.0551e-05,0.37466,0.4369,0,0
2,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,0.00028792,0.37316,0.34224,0,0
2,GO REGULATION OF VESICLE FUSION,4.4878e-05,0.36279,0.4105,0,0
2,GO SYNAPTIC VESICLE CLUSTERING,0.00090094,0.36122,0.49279,0,0
2,GO PROTEIN TRIMERIZATION,0.00022676,0.3573,0.36141,0,0
2,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,7.013e-05,0.3558,0.41317,0,0
2,GO SHORT TERM MEMORY,0.0022332,0.35017,0.32134,0,0
2,GO DENDRITIC SPINE MORPHOGENESIS,2.1663e-05,0.32993,0.32988,0,0
2,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.079444,0.32819,0.20651,0,0
2,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.00031859,0.32762,0.38047,0,0
2,GO REGULATION OF NEURON MIGRATION,0.00036427,0.32467,0.28077,0,0
2,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.0067808,0.32231,0.3593,0,0
2,GO NEUROTRANSMITTER REUPTAKE,0.00029782,0.31881,0.30582,0,0
2,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.027188,0.31677,0.24137,0,0
2,GO PREPULSE INHIBITION,0.011047,0.31329,0.33627,0,0
2,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.0047853,0.3128,0.27844,0,0
2,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00042998,0.30979,0.37234,0,0
2,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.00017186,0.30909,0.303,0,0
2,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.0073363,0.30895,0.2251,0,0
2,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.0010528,0.30801,0.47087,0,0
2,GO REGULATION OF HIPPO SIGNALING,0.087232,0.30609,0.1616,0,0
2,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.21256,0.29727,0.11575,0,0
2,GO PHAGOCYTOSIS RECOGNITION,0.052669,0.29655,0.16095,0,0
2,GO TOOTH MINERALIZATION,0.075049,0.29597,0.14282,0,0
2,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,0.031748,0.29573,0.37958,0,0
2,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,4.4878e-05,0.2951,0.38378,0,0
2,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.00044439,0.29292,0.22038,0,0
2,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,4.2876e-06,0.28722,0.38318,0,0
2,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.0075304,0.28483,0.24571,0,0
2,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.0010859,0.28339,0.25764,0,0
2,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.015953,0.28339,0.195,0,0
2,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.0027346,0.28208,0.29485,0,0
2,GO REGULATION OF POSTSYNAPSE ORGANIZATION,1.9263e-05,0.2812,0.29651,0,0
2,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,9.389e-05,0.27784,0.31439,0,0
2,GO VOCALIZATION BEHAVIOR,0.030383,0.27735,0.35457,0,0
2,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.029068,0.27701,0.172,0,0
2,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.0064317,0.27528,0.21508,0,0
2,GO GLUTAMATE SECRETION,0.00029782,0.27482,0.30144,0,0
2,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00016023,0.27422,0.2883,0,0
2,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.0010859,0.27257,0.30115,0,0
2,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.012203,0.2705,0.32617,0,0
2,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,9.0551e-05,0.2694,0.31875,0,0
2,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.013465,0.26825,0.30375,0,0
2,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0031536,0.26779,0.27331,0,0
2,GO GTP METABOLIC PROCESS,0.0021689,0.26286,0.23585,0,0
2,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.019739,0.2609,0.27203,0,0
2,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.2,0.25982,0.18244,0,0
2,GO HOMOCYSTEINE METABOLIC PROCESS,0.0038387,0.25753,0.34078,0,0
2,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.00019753,0.25151,0.27618,0,0
2,GO MITOCHONDRION LOCALIZATION,3.4421e-05,0.24872,0.21481,0,0
2,GO POSITIVE REGULATION OF VESICLE FUSION,0.11235,0.2487,0.20634,0,0
2,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.029068,0.24711,0.20917,0,0
2,GO REGULATION OF SYNAPTIC PLASTICITY,0.00035231,0.24686,0.23419,0,0
2,GO PSEUDOURIDINE SYNTHESIS,0.015574,0.2463,0.21943,0,0
2,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.0047853,0.24321,0.20474,0,0
2,GO REGULATION OF DOPAMINE SECRETION,0.025414,0.24193,0.30834,0,0
2,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,0.0015653,0.2416,0.24139,0,0
2,GO REGULATION OF DENDRITE MORPHOGENESIS,2.0033e-05,0.2415,0.25324,0,0
2,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.0059384,0.24118,0.17636,0,0
2,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.079444,0.23858,0.17847,0,0
2,GO NEUROTRANSMITTER UPTAKE,0.0012662,0.23757,0.23734,0,0
2,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.0056288,0.23754,0.21434,0,0
2,GO RESPONSE TO HYPEROXIA,0.21905,0.23675,0.093777,0,0
2,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.033166,0.2364,0.23571,0,0
2,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.0026572,0.23251,0.2819,0,0
2,GO NEGATIVE REGULATION OF AXONOGENESIS,0.034637,0.2307,0.16896,0,0
2,GO EXPLORATION BEHAVIOR,0.0081404,0.22547,0.28578,0,0
2,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,6.7596e-05,0.22515,0.29582,0,0
2,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.00019753,0.22483,0.2524,0,0
2,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,0.097379,0.22447,0.14673,0,0
2,GO LATERAL VENTRICLE DEVELOPMENT,0.0083534,0.22406,0.22513,0,0
2,GO SYNAPTIC VESICLE EXOCYTOSIS,3.1888e-05,0.22368,0.30447,0,0
2,GO SYNAPTIC VESICLE DOCKING,0.023741,0.22255,0.26474,0,0
2,GO SYNAPSE ORGANIZATION,9.0551e-05,0.22201,0.22157,0,0
2,GO POSTSYNAPSE ORGANIZATION,7.8282e-05,0.22101,0.24513,0,0
2,GO LONG TERM SYNAPTIC DEPRESSION,0.0087944,0.2208,0.20689,0,0
2,GO ENAMEL MINERALIZATION,0.19393,0.22049,0.12673,0,0
2,GO CELLULAR RESPONSE TO PH,0.00013433,0.21743,0.2188,0,0
2,GO HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.05824,0.21712,0.14067,0,0
2,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.0027346,0.2165,0.26938,0,0
2,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,0.095625,0.21504,0.16926,0,0
2,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.033894,0.21116,0.18694,0,0
2,GO NEURON RECOGNITION,0.014841,0.21085,0.20202,0,0
2,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.097379,0.21014,0.1369,0,0
2,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.00021909,0.20953,0.26645,0,0
2,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.05824,0.2088,0.19463,0,0
2,GO REGULATION OF SYNAPSE ASSEMBLY,0.00087311,0.20663,0.2178,0,0
2,GO DENDRITIC SPINE DEVELOPMENT,0.00016023,0.20566,0.23771,0,0
2,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.1028,0.20502,0.1412,0,0
2,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.00044439,0.20471,0.21521,0,0
2,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.0056288,0.20426,0.24748,0,0
2,GO REGULATION OF TUBULIN DEACETYLATION,0.027188,0.20276,0.20538,0,0
2,GO AXO DENDRITIC PROTEIN TRANSPORT,0.036948,0.20256,0.14063,0,0
2,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.0062634,0.20156,0.21024,0,0
2,GO NEUROBLAST DIVISION,0.10465,0.20113,0.16202,0,0
2,GO NEPHRIC DUCT MORPHOGENESIS,0.0695,0.20112,0.27288,0,0
2,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,0.29586,0.20077,0.089066,0,0
2,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,0.3746,0.20026,0.1234,0,0
2,GO SEROTONIN TRANSPORT,0.092194,0.19987,0.13843,0,0
2,GO TRANS SYNAPTIC SIGNALING MODULATING SYNAPTIC TRANSMISSION,0.066855,0.19852,0.15497,0,0
2,GO SALIVARY GLAND DEVELOPMENT,0.12689,0.19843,0.1108,0,0
2,GO AMP METABOLIC PROCESS,0.14769,0.19832,0.097326,0,0
2,GO GLUCOSE CATABOLIC PROCESS,0.011612,0.19776,0.2154,0,0
2,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.0022332,0.1974,0.26312,0,0
2,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.064293,0.197,0.15482,0,0
2,GO CGMP MEDIATED SIGNALING,0.022165,0.19695,0.13884,0,0
2,GO CORONARY VASCULATURE MORPHOGENESIS,0.015203,0.19653,0.20902,0,0
2,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.014138,0.19562,0.16247,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS,0.15773,0.19313,0.1908,0,0
2,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.26471,0.19306,0.087065,0,0
2,GO DENDRITE SELF AVOIDANCE,0.041967,0.19194,0.1856,0,0
2,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.00024286,0.19188,0.24956,0,0
2,GO REGULATION OF DENDRITE DEVELOPMENT,0.00012074,0.19017,0.20882,0,0
2,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.0006154,0.18942,0.15551,0,0
2,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.01282,0.18917,0.28102,0,0
2,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.31232,0.18914,0.10494,0,0
2,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.0060989,0.1887,0.20607,0,0
2,GO AXONAL FASCICULATION,0.066855,0.18785,0.20241,0,0
2,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.18219,0.18645,0.15957,0,0
2,GO REGULATION OF NEUROTRANSMITTER LEVELS,0.0013054,0.18509,0.20822,0,0
2,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.011047,0.18468,0.17127,0,0
2,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.25001,0.18443,0.067083,0,0
2,GO FOREBRAIN CELL MIGRATION,0.00049035,0.18415,0.23235,0,0
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.0016129,0.18413,0.17665,0,0
2,GO CALCIUM ION IMPORT INTO CYTOSOL,0.024846,0.18345,0.22184,0,0
2,GO ONE CARBON METABOLIC PROCESS,0.013139,0.18303,0.13074,0,0
2,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.045624,0.18289,0.16825,0,0
2,GO REGULATION OF CATION CHANNEL ACTIVITY,0.00026003,0.18249,0.2041,0,0
2,GO NEURON PROJECTION GUIDANCE,0.0056288,0.18235,0.16389,0,0
2,GO PRESYNAPSE ORGANIZATION,0.007729,0.18186,0.20793,0,0
2,GO MICROTUBULE DEPOLYMERIZATION,0.030383,0.18146,0.16576,0,0
2,GO BEHAVIORAL RESPONSE TO PAIN,0.18508,0.18137,0.13887,0,0
2,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.049546,0.18136,0.15569,0,0
2,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.045624,0.18131,0.1476,0,0
2,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.0099891,0.18129,0.18737,0,0
2,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.12473,0.18122,0.10465,0,0
2,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.19095,0.1812,0.11729,0,0
2,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.014841,0.17909,0.14522,0,0
2,GO MOTOR NEURON AXON GUIDANCE,0.012203,0.17899,0.17322,0,0
2,GO NEUROTRANSMITTER TRANSPORT,0.00084609,0.17881,0.23235,0,0
2,GO NEURON PROJECTION EXTENSION,0.00065623,0.1778,0.17702,0,0
2,GO ALDITOL METABOLIC PROCESS,0.0056288,0.17726,0.17885,0,0
2,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.1313,0.17674,0.16827,0,0
2,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.00069957,0.17671,0.2571,0,0
2,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.0081404,0.17668,0.20275,0,0
2,GO ACIDIC AMINO ACID TRANSPORT,0.00014935,0.17661,0.21319,0,0
2,GO LONG TERM MEMORY,0.0041716,0.17645,0.19976,0,0
2,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.1313,0.17567,0.12315,0,0
2,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.092194,0.17496,0.12255,0,0
2,GO BASIC AMINO ACID TRANSPORT,0.13583,0.17471,0.16587,0,0
2,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.0028957,0.17417,0.18703,0,0
2,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.21256,0.17362,0.047425,0,0
2,GO CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION,0.20309,0.17338,0.15988,0,0
2,GO RELAXATION OF MUSCLE,0.082489,0.17281,0.12867,0,0
2,GO PROSTATE GLAND GROWTH,0.17099,0.17216,0.068806,0,0
2,GO LEUKOCYTE AGGREGATION,0.077957,0.17168,0.13519,0,0
2,GO STABILIZATION OF MEMBRANE POTENTIAL,0.51459,0.17098,0.078423,0,0
2,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.077957,0.17053,0.092339,0,0
2,GO MINERALOCORTICOID METABOLIC PROCESS,0.22905,0.17035,0.096224,0,0
2,GO REGULATION OF SYNAPTIC VESICLE CYCLE,0.0011549,0.17007,0.27365,0,0
2,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.00353,0.16997,0.15308,0,0
2,GO NEUROTRANSMITTER SECRETION,0.0013054,0.16961,0.24314,0,0
2,GO NADH METABOLIC PROCESS,0.0020453,0.16892,0.23118,0,0
2,GO HEME METABOLIC PROCESS,0.13814,0.16832,0.099533,0,0
2,GO POSITIVE REGULATION OF HEART RATE,0.040234,0.16813,0.18861,0,0
2,GO NEGATIVE REGULATION OF AXON EXTENSION,0.0073363,0.1681,0.19008,0,0
2,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.059411,0.16806,0.13846,0,0
2,GO TONIC SMOOTH MUSCLE CONTRACTION,0.092194,0.16715,0.09528,0,0
2,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.0041716,0.16648,0.13209,0,0
2,GO FATTY ACID HOMEOSTASIS,0.044685,0.16644,0.20355,0,0
2,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.0075304,0.16634,0.16894,0,0
2,GO FOLIC ACID METABOLIC PROCESS,0.041967,0.16632,0.17031,0,0
2,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.0079323,0.16511,0.13868,0,0
2,GO RESPONSE TO ACETYLCHOLINE,0.04854,0.16384,0.18446,0,0
2,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.10654,0.163,0.088909,0,0
2,GO DENDRITE MORPHOGENESIS,0.0014738,0.16149,0.18245,0,0
2,GO RESPONSE TO AMINE,0.0094949,0.16148,0.17707,0,0
2,GO CARDIAC CONDUCTION,0.010773,0.16145,0.15299,0,0
2,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.082489,0.16141,0.11853,0,0
2,GO RECEPTOR CLUSTERING,0.065563,0.16141,0.10745,0,0
2,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.041967,0.16069,0.13783,0,0
2,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.18508,0.16014,0.11315,0,0
2,GO RESPONSE TO PROTOZOAN,0.55487,0.15933,0.020455,0,0
2,GO FOREBRAIN NEURON DEVELOPMENT,0.11235,0.1591,0.15054,0,0
2,GO HEPARIN METABOLIC PROCESS,0.045624,0.15858,0.22973,0,0
2,GO REGULATION OF TRANS SYNAPTIC SIGNALING,0.00081984,0.15747,0.20098,0,0
2,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,0.015203,0.15686,0.17096,0,0
2,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.033894,0.15562,0.12154,0,0
2,GO NEURONAL ION CHANNEL CLUSTERING,0.1313,0.15494,0.20744,0,0
2,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.060602,0.15474,0.11877,0,0
2,GO NEPHRIC DUCT DEVELOPMENT,0.20937,0.15455,0.1298,0,0
2,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.30815,0.15376,0.0535,0,0
2,GO THYROID GLAND DEVELOPMENT,0.022165,0.15356,0.18117,0,0
2,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.13814,0.15332,0.096099,0,0
2,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.015203,0.15295,0.097831,0,0
2,GO VASCULOGENESIS,0.32077,0.15279,0.034338,0,0
2,GO RESPONSE TO CAFFEINE,0.10096,0.15263,0.1189,0,0
2,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.029068,0.15185,0.30318,0,0
2,GO DENDRITE DEVELOPMENT,0.00087311,0.15132,0.17742,0,0
2,GO RESPIRATORY SYSTEM PROCESS,0.010506,0.14997,0.14022,0,0
2,GO MEMBRANE REPOLARIZATION,0.014138,0.14965,0.13738,0,0
2,GO XENOBIOTIC TRANSPORT,0.23937,0.14962,0.036327,0,0
2,GO AXON EXTENSION,0.0028957,0.14933,0.15833,0,0
2,GO SYNAPSE ASSEMBLY,0.012203,0.1488,0.16867,0,0
2,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.043763,0.14864,0.13656,0,0
2,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.072231,0.14838,0.1029,0,0
2,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.014486,0.14824,0.12566,0,0
2,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.044685,0.1478,0.14767,0,0
2,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.12908,0.14773,0.09882,0,0
2,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.017137,0.14759,0.15602,0,0
2,GO CEREBELLAR CORTEX DEVELOPMENT,0.0046564,0.14683,0.19829,0,0
2,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.68418,0.14644,0.042439,0,0
2,GO COLLATERAL SPROUTING,0.02843,0.14592,0.15473,0,0
2,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.34702,0.14582,0.067119,0,0
2,GO BONE TRABECULA MORPHOGENESIS,0.12259,0.14555,0.1142,0,0
2,GO MUSCLE CELL FATE COMMITMENT,0.2839,0.14515,0.061047,0,0
2,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.047551,0.14515,0.10055,0,0
2,GO FIBRINOLYSIS,0.27227,0.14489,-0.014555,0,0
2,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.084046,0.14438,0.14979,0,0
2,GO DEVELOPMENTAL CELL GROWTH,0.00074557,0.14342,0.149,0,0
2,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.16294,0.14334,0.094518,0,0
2,GO BEHAVIORAL RESPONSE TO COCAINE,0.20621,0.14262,0.15547,0,0
2,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.47588,0.14236,-0.15827,0,0
2,GO PROTEIN ACTIVATION CASCADE,0.68418,0.14226,-0.019158,0,0
2,GO REGULATION OF AXON GUIDANCE,0.059411,0.14205,0.091043,0,0
2,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.18219,0.14187,0.077712,0,0
2,GO LIPID IMPORT INTO CELL,0.27999,0.14127,0.061506,0,0
2,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.24643,0.14089,0.051468,0,0
2,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.04854,0.13973,0.12553,0,0
2,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.031059,0.1397,0.13311,0,0
2,GO REGULATION OF AXONOGENESIS,0.012203,0.13962,0.14762,0,0
2,GO REGULATION OF RIBOSOME BIOGENESIS,0.11235,0.13913,0.10017,0,0
2,GO CELL AGGREGATION,0.073629,0.13892,0.10884,0,0
2,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0011549,0.13884,0.15637,0,0
2,GO ALANINE TRANSPORT,0.14048,0.13877,0.13747,0,0
2,GO RESPONSE TO UV B,0.89215,0.13872,-0.044541,0,0
2,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.26471,0.13871,0.055067,0,0
2,GO DNA REPLICATION INITIATION,0.0018173,0.13857,0.14311,0,0
2,GO SYNAPTIC VESICLE RECYCLING,0.029719,0.13856,0.14167,0,0
2,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.097379,0.13833,0.14589,0,0
2,GO REGULATION OF PLASMINOGEN ACTIVATION,0.47049,0.13733,-0.044057,0,0
2,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.033894,0.13709,0.18228,0,0
2,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,0.0033369,0.13635,0.21006,0,0
2,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.13583,0.13599,0.14502,0,0
2,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.009256,0.13573,0.11999,0,0
2,GO PARENTAL BEHAVIOR,0.27611,0.13494,0.093322,0,0
2,GO PROTEIN LOCALIZATION TO SYNAPSE,0.0090226,0.13417,0.19615,0,0
2,GO STARTLE RESPONSE,0.22235,0.13404,0.12204,0,0
2,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.092194,0.1338,0.0909,0,0
2,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0026572,0.13362,0.13974,0,0
2,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.18219,0.13362,0.096613,0,0
2,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.0038387,0.13277,0.1505,0,0
2,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.004408,0.13276,0.139,0,0
2,GO NEUROMUSCULAR PROCESS,0.0060989,0.13239,0.14602,0,0
2,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.15773,0.13179,0.072583,0,0
2,GO REGULATION OF EXTENT OF CELL GROWTH,0.0030654,0.13151,0.15901,0,0
2,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.064293,0.1315,0.14118,0,0
2,GO COLLAGEN FIBRIL ORGANIZATION,0.11841,0.13124,0.05568,0,0
2,GO PROTEIN OXIDATION,0.12049,0.13088,0.072808,0,0
2,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.17374,0.13022,0.10472,0,0
2,GO PRESYNAPTIC ENDOCYTOSIS,0.034637,0.13006,0.14386,0,0
2,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.20621,0.12996,0.08712,0,0
2,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.085627,0.12959,0.12237,0,0
2,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,0.054842,0.12954,0.15753,0,0
2,GO REGULATION OF STEROL TRANSPORT,0.49227,0.12951,0.027337,0,0
2,GO NEGATIVE REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS,0.27999,0.1293,0.10607,0,0
2,GO REGULATION OF MEMBRANE POTENTIAL,0.02166,0.12912,0.12848,0,0
2,GO AORTIC VALVE DEVELOPMENT,0.18508,0.12903,0.083409,0,0
2,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.54903,0.12856,0.062475,0,0
2,GO COCHLEA DEVELOPMENT,0.0085714,0.12808,0.14509,0,0
2,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.0695,0.1279,0.11656,0,0
2,GO CATECHOLAMINE UPTAKE,0.16828,0.12781,0.13783,0,0
2,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.0010528,0.12762,0.16732,0,0
2,GO SYNAPTIC SIGNALING,0.001986,0.12747,0.172,0,0
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.27611,0.12734,0.10221,0,0
2,GO REGULATION OF BMP SIGNALING PATHWAY,0.8303,0.1273,0.00708,0,0
2,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.0025083,0.12726,0.12677,0,0
2,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.077957,0.12711,0.08124,0,0
2,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.064293,0.12701,0.11209,0,0
2,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.077957,0.127,0.090624,0,0
2,GO CARDIOLIPIN METABOLIC PROCESS,0.23589,0.12658,0.067219,0,0
2,GO INHIBITORY POSTSYNAPTIC POTENTIAL,0.20937,0.1263,0.14382,0,0
2,GO ENDODERM DEVELOPMENT,0.2839,0.12617,0.025249,0,0
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.099158,0.12532,0.16393,0,0
2,GO MEMORY,0.0067808,0.12525,0.13818,0,0
2,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.13355,0.12514,0.23131,0,0
2,GO REGULATION OF ODONTOGENESIS,0.40843,0.12506,0.031587,0,0
2,GO METENCEPHALON DEVELOPMENT,0.0054795,0.12488,0.16011,0,0
2,GO REGULATION OF CELLULAR RESPIRATION,0.097379,0.12458,0.11837,0,0
2,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.070855,0.12428,0.11219,0,0
2,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.53167,0.12415,0.026669,0,0
2,GO ACETYL COA BIOSYNTHETIC PROCESS,0.10096,0.12406,0.11849,0,0
2,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.59059,0.12406,0.0070754,0,0
2,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.10654,0.12351,0.24502,0,0
2,GO REGULATION OF HEART RATE,0.10465,0.12348,0.095051,0,0
2,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.39858,0.12348,0.09055,0,0
2,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.11039,0.12311,0.08545,0,0
2,GO PROTEOGLYCAN METABOLIC PROCESS,0.041093,0.12291,0.091021,0,0
2,GO REGULATION OF CELLULAR EXTRAVASATION,0.11235,0.12275,0.11146,0,0
2,GO NEURAL CREST FORMATION,0.36991,0.12272,0.07721,0,0
2,GO CAMP METABOLIC PROCESS,0.31232,0.12264,0.054026,0,0
2,GO GLUTAMINE METABOLIC PROCESS,0.0031536,0.12242,0.15681,0,0
2,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.17099,0.12222,0.077015,0,0
2,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.34702,0.12148,0.1034,0,0
2,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.20937,0.12099,0.079371,0,0
2,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.070855,0.12077,0.10228,0,0
2,GO RESPONSE TO LIGHT INTENSITY,0.14769,0.12009,0.1245,0,0
2,GO SYNAPTIC VESICLE LOCALIZATION,0.014841,0.11988,0.19226,0,0
2,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.011904,0.11981,0.10207,0,0
2,GO RESPONSE TO NITRIC OXIDE,0.0060989,0.11975,0.1029,0,0
2,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.0075304,0.11938,0.12948,0,0
2,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.099158,0.11908,0.091544,0,0
2,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.12689,0.11897,0.11581,0,0
2,GO COMMISSURAL NEURON AXON GUIDANCE,0.20937,0.11875,0.13745,0,0
2,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.188,0.11867,0.089562,0,0
2,GO MECHANOSENSORY BEHAVIOR,0.36526,0.1182,0.17894,0,0
2,GO REGULATION OF POTASSIUM ION TRANSPORT,0.10096,0.11796,0.079862,0,0
2,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.026586,0.11785,0.1383,0,0
2,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.080955,0.1175,0.098141,0,0
2,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.23245,0.11711,0.078572,0,0
2,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.036164,0.11708,0.11111,0,0
2,GO CELLULAR RESPONSE TO RETINOIC ACID,0.11235,0.11693,0.064552,0,0
2,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.014138,0.1168,0.11783,0,0
2,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.14285,0.11668,0.19877,0,0
2,GO MITOCHONDRIAL RNA PROCESSING,0.070855,0.11661,0.15768,0,0
2,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.066855,0.11658,0.080127,0,0
2,GO STORE OPERATED CALCIUM ENTRY,0.44402,0.11647,0.034577,0,0
2,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.91987,0.11642,0.029245,0,0
2,GO LONG TERM SYNAPTIC POTENTIATION,0.14526,0.11641,0.08259,0,0
2,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.053746,0.11627,0.18126,0,0
2,GO AXON DEVELOPMENT,0.0050528,0.11594,0.15111,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.059411,0.11573,0.1537,0,0
2,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.041967,0.11561,0.11825,0,0
2,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.052669,0.11532,0.078129,0,0
2,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,0.022165,0.11502,0.13665,0,0
2,GO CELL PART MORPHOGENESIS,0.0024367,0.11485,0.1479,0,0
2,GO REGULATION OF TRANSPORTER ACTIVITY,0.010506,0.11484,0.11228,0,0
2,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.21256,0.11469,0.12975,0,0
2,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.066855,0.11431,0.13884,0,0
2,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.046579,0.1143,0.11196,0,0
2,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.1313,0.11422,0.1157,0,0
2,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.043763,0.1138,0.13072,0,0
2,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.015574,0.11325,0.13457,0,0
2,GO POSITIVE REGULATION OF AXONOGENESIS,0.017137,0.11306,0.15792,0,0
2,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.26098,0.11301,0.14473,0,0
2,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,0.12908,0.11274,0.14697,0,0
2,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.35607,0.11239,0.068419,0,0
2,GO GLIAL CELL MIGRATION,0.052669,0.11218,0.13199,0,0
2,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.033166,0.1119,0.10784,0,0
2,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.17653,0.11182,0.05138,0,0
2,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.018836,0.11181,0.17577,0,0
2,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.20621,0.11179,0.051553,0,0
2,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.25729,0.1117,0.072017,0,0
2,GO URETER DEVELOPMENT,0.41842,0.11161,0.072538,0,0
2,GO COGNITION,0.0031536,0.11159,0.15657,0,0
2,GO SEQUESTERING OF METAL ION,0.11841,0.11155,0.077539,0,0
2,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,0.34256,0.11099,0.048058,0,0
2,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,0.061812,0.11097,0.13005,0,0
2,GO RESPONSE TO PARATHYROID HORMONE,0.16828,0.11045,0.16887,0,0
2,GO NEURON MIGRATION,0.042857,0.11025,0.14875,0,0
2,GO UBIQUINONE METABOLIC PROCESS,0.2,0.11014,0.02765,0,0
2,GO TRIGLYCERIDE CATABOLIC PROCESS,0.25001,0.11002,0.084059,0,0
2,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.26471,0.10971,0.089985,0,0
2,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.088862,0.10951,0.10544,0,0
2,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.015203,0.10934,0.19385,0,0
2,GO SPERMATID NUCLEUS DIFFERENTIATION,0.036948,0.10884,0.10272,0,0
2,GO MYELIN MAINTENANCE,0.46512,0.10871,0.05417,0,0
2,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.10845,0.10842,0.17539,0,0
2,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.013139,0.10831,0.12606,0,0
2,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.066855,0.10823,0.083208,0,0
2,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.047551,0.1078,0.085432,0,0
2,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.30402,0.10773,0.091316,0,0
2,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.004408,0.10765,0.16898,0,0
2,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.079444,0.10761,0.13606,0,0
2,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.21905,0.1076,0.065025,0,0
2,GO DORSAL AORTA DEVELOPMENT,0.24288,0.10736,0.086646,0,0
2,GO ANION HOMEOSTASIS,0.17934,0.10723,0.076362,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.19393,0.10666,0.1672,0,0
2,GO DOPAMINE TRANSPORT,0.33812,0.10662,0.15678,0,0
2,GO ASYMMETRIC CELL DIVISION,0.39371,0.10648,0.0629,0,0
2,GO CEREBELLAR CORTEX MORPHOGENESIS,0.14526,0.10629,0.11146,0,0
2,GO PHOSPHOLIPID HOMEOSTASIS,0.39858,0.10609,0.041172,0,0
2,GO COENZYME A BIOSYNTHETIC PROCESS,0.26847,0.10608,0.07133,0,0
2,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.029068,0.10605,0.11104,0,0
2,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.15264,0.10543,0.064202,0,0
2,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,0.20621,0.10501,0.038164,0,0
2,GO CELLULAR RESPONSE TO ETHANOL,0.11434,0.105,0.12598,0,0
2,GO TOXIN TRANSPORT,0.10096,0.10474,0.067394,0,0
2,GO GROWTH HORMONE SECRETION,0.16294,0.10466,0.10545,0,0
2,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.27227,0.10464,0.079484,0,0
2,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.12908,0.10451,0.12432,0,0
2,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.34702,0.10387,0.057386,0,0
2,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.19695,0.10371,0.094687,0,0
2,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.016734,0.1037,0.11503,0,0
2,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.016734,0.10328,0.12458,0,0
2,GO RESPONSE TO AMYLOID BETA,0.0094949,0.10326,0.1324,0,0
2,GO TRNA 5 END PROCESSING,0.12473,0.10284,0.079239,0,0
2,GO REGULATION OF SYSTEM PROCESS,0.016734,0.10271,0.089714,0,0
2,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.084046,0.10254,0.11759,0,0
2,GO CELLULAR RESPONSE TO CALCIUM ION,0.097379,0.10248,0.094569,0,0
2,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.05824,0.10243,0.090781,0,0
2,GO PROTEIN COMPLEX OLIGOMERIZATION,0.0023671,0.10243,0.09872,0,0
2,GO WALKING BEHAVIOR,0.004408,0.10242,0.20944,0,0
2,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.26098,0.10238,0.15396,0,0
2,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.060602,0.10188,0.083724,0,0
2,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.38408,0.10184,0.054856,0,0
2,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.44924,0.1016,0.14169,0,0
2,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.32506,0.10158,0.057278,0,0
2,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.011047,0.10155,0.11642,0,0
2,GO REGULATION OF METAL ION TRANSPORT,0.082489,0.10141,0.067514,0,0
2,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,0.049546,0.10137,0.11162,0,0
2,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.17099,0.10112,0.059583,0,0
2,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.19393,0.10101,-0.010585,0,0
2,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.22235,0.10099,0.074943,0,0
2,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.14048,0.1007,0.081393,0,0
2,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.23589,0.10064,0.1404,0,0
2,GO AXO DENDRITIC TRANSPORT,0.043763,0.10041,0.10129,0,0
2,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.65866,0.10026,0.046327,0,0
2,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.024846,0.10018,0.11791,0,0
2,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.57857,0.10015,-0.021418,0,0
2,GO PROSTAGLANDIN SECRETION,0.17099,0.10012,0.085141,0,0
2,GO NAD BIOSYNTHETIC PROCESS,0.5726,0.099913,0.02916,0,0
2,GO PHAGOLYSOSOME ASSEMBLY,0.29992,0.099778,0.059685,0,0
2,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.63978,0.099585,0.039394,0,0
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.41341,0.099415,0.015277,0,0
2,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,0.17653,0.099388,0.090573,0,0
2,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.22235,0.099251,0.049878,0,0
2,GO ACROSOME ASSEMBLY,0.15773,0.098843,0.14126,0,0
2,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.14285,0.098716,0.046371,0,0
2,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.70355,0.098621,0.01751,0,0
2,GO REGULATION OF MIRNA METABOLIC PROCESS,0.4545,0.097984,0.073768,0,0
2,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.25363,0.097836,0.044028,0,0
2,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,0.16032,0.097756,0.10818,0,0
2,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.31653,0.097516,0.041001,0,0
2,GO REGULATION OF ATP METABOLIC PROCESS,0.065563,0.097368,0.064835,0,0
2,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.23245,0.097273,0.072781,0,0
2,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.044685,0.097259,0.12093,0,0
2,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.029068,0.097005,0.08091,0,0
2,GO RENAL VESICLE DEVELOPMENT,0.18219,0.09686,0.12136,0,0
2,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.17374,0.09671,0.085387,0,0
2,GO LATERAL MESODERM DEVELOPMENT,0.99651,0.096493,-0.042264,0,0
2,GO REVERSE CHOLESTEROL TRANSPORT,0.72969,0.096301,-0.0135,0,0
2,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.038561,0.096255,0.11449,0,0
2,GO RENAL SODIUM EXCRETION,0.095625,0.096118,0.077543,0,0
2,GO BICARBONATE TRANSPORT,0.16828,0.095931,0.057661,0,0
2,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.36526,0.095619,0.024502,0,0
2,GO AXONAL TRANSPORT OF MITOCHONDRION,0.18508,0.095579,0.15747,0,0
2,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.068167,0.09548,0.080124,0,0
2,GO ENDODERM FORMATION,0.25363,0.095455,0.025382,0,0
2,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.05824,0.095351,0.080819,0,0
2,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.0079323,0.09519,0.12173,0,0
2,GO TRANSEPITHELIAL TRANSPORT,0.060602,0.095126,0.071842,0,0
2,GO PIGMENT METABOLIC PROCESS,0.13355,0.094987,0.079327,0,0
2,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.18219,0.094937,0.063127,0,0
2,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.29586,0.094911,0.033694,0,0
2,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.4978,0.094615,0.011696,0,0
2,GO CELL RECOGNITION,0.057089,0.094592,0.072826,0,0
2,GO DENDRITIC SPINE MAINTENANCE,0.14048,0.094365,0.078247,0,0
2,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.02268,0.093868,0.12209,0,0
2,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.54903,0.09376,0.037638,0,0
2,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.2,0.093725,0.074412,0,0
2,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.32938,0.093651,0.17063,0,0
2,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.27227,0.0934,0.11352,0,0
2,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.44402,0.093148,0.037235,0,0
2,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.021165,0.093074,0.086229,0,0
2,GO CELLULAR COMPONENT MORPHOGENESIS,0.010773,0.092962,0.11854,0,0
2,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.0024367,0.092894,0.131,0,0
2,GO NOREPINEPHRINE METABOLIC PROCESS,0.44402,0.092883,0.11071,0,0
2,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.054842,0.092556,0.08351,0,0
2,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.092194,0.09236,0.080909,0,0
2,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.11636,0.092058,0.10672,0,0
2,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.095625,0.091975,0.14316,0,0
2,GO MODULATION BY HOST OF SYMBIONT PROCESS,0.0695,0.091905,0.040213,0,0
2,GO MEMBRANE DEPOLARIZATION,0.14769,0.091862,0.10733,0,0
2,GO SNARE COMPLEX ASSEMBLY,0.63354,0.09169,0.023899,0,0
2,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.85768,0.091628,-0.035297,0,0
2,GO AMELOGENESIS,0.72313,0.091497,0.017454,0,0
2,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.29992,0.091025,0.062368,0,0
2,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,0.079444,0.090943,0.089883,0,0
2,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.12908,0.090858,0.07639,0,0
2,GO REGULATION OF LIPID CATABOLIC PROCESS,0.19393,0.090771,0.067024,0,0
2,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.073629,0.090744,0.0655,0,0
2,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.36526,0.090547,0.066859,0,0
2,GO NUCLEOTIDE SALVAGE,0.16032,0.090474,0.12384,0,0
2,GO EXPORT ACROSS PLASMA MEMBRANE,0.14769,0.090338,0.086928,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.017137,0.089889,0.14576,0,0
2,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.15264,0.089392,0.1084,0,0
2,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.02843,0.089345,0.091656,0,0
2,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.045624,0.089295,0.096514,0,0
2,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.036164,0.089277,0.11426,0,0
2,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.079444,0.089231,0.081202,0,0
2,GO AMINO ACID ACTIVATION,0.17099,0.089177,0.096164,0,0
2,GO DNA DEPENDENT DNA REPLICATION,0.020205,0.089143,0.079149,0,0
2,GO REGULATION OF GLUTAMATE SECRETION,0.17653,0.089087,0.13757,0,0
2,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.2,0.088542,0.06317,0,0
2,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.064293,0.088449,0.097257,0,0
2,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.43367,0.088351,0.053667,0,0
2,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.15773,0.088278,0.063281,0,0
2,GO CATECHOLAMINE SECRETION,0.070855,0.088274,0.21533,0,0
2,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.94769,0.088241,-0.017123,0,0
2,GO RECEPTOR INTERNALIZATION,0.049546,0.088196,0.094469,0,0
2,GO RNA STABILIZATION,0.13583,0.088143,0.071223,0,0
2,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,0.060602,0.088074,0.064686,0,0
2,GO GROOMING BEHAVIOR,0.20621,0.088031,0.11623,0,0
2,GO COPPER ION TRANSPORT,0.19695,0.087859,0.074573,0,0
2,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.47588,0.087791,0.047237,0,0
2,GO DENDRITIC CELL APOPTOTIC PROCESS,0.39371,0.087635,0.037074,0,0
2,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.25363,0.087382,0.067867,0,0
2,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.037747,0.087362,0.086978,0,0
2,GO REGULATION OF STEM CELL DIFFERENTIATION,0.32938,0.087207,0.028107,0,0
2,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.39858,0.086961,0.037733,0,0
2,GO PALLIUM DEVELOPMENT,0.011612,0.086703,0.12236,0,0
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.047551,0.086679,0.097788,0,0
2,GO SKELETAL MUSCLE CONTRACTION,0.11039,0.086276,0.085481,0,0
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.033894,0.086043,0.089639,0,0
2,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.36526,0.085893,0.021861,0,0
2,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.13814,0.08582,0.079721,0,0
2,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.17099,0.085525,0.043005,0,0
2,GO REGULATION OF ION TRANSPORT,0.14285,0.085163,0.060629,0,0
2,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.0099891,0.085126,0.18506,0,0
2,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.28785,0.085014,0.067548,0,0
2,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.74288,0.084953,-0.011379,0,0
2,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.5726,0.084937,0.0074552,0,0
2,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.25729,0.084792,0.1637,0,0
2,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.075049,0.084777,0.056319,0,0
2,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.14526,0.084508,0.05929,0,0
2,GO HORMONE BIOSYNTHETIC PROCESS,0.10845,0.084391,0.088945,0,0
2,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.38408,0.084332,0.03121,0,0
2,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,0.34256,0.084212,0.065424,0,0
2,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.088862,0.084073,0.16487,0,0
2,GO BLASTOCYST FORMATION,0.10465,0.083901,0.07186,0,0
2,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.093897,0.083683,0.095142,0,0
2,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.67776,0.083643,-0.0021424,0,0
2,GO POSITIVE REGULATION OF LIPID STORAGE,0.3746,0.083425,0.053785,0,0
2,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.016734,0.083355,0.11394,0,0
2,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.013139,0.083289,0.099556,0,0
2,GO MESODERMAL CELL DIFFERENTIATION,0.31232,0.082899,0.010792,0,0
2,GO NEGATIVE REGULATION OF DNA BINDING,0.044685,0.082305,0.1067,0,0
2,GO PLASMINOGEN ACTIVATION,0.46512,0.082181,-0.039713,0,0
2,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.75615,0.082149,-0.074696,0,0
2,GO POSITIVE REGULATION OF RNA SPLICING,0.044685,0.081949,0.065575,0,0
2,GO PODOSOME ASSEMBLY,0.67137,0.081675,-0.064838,0,0
2,GO ZINC ION TRANSPORT,0.23937,0.081671,0.059316,0,0
2,GO RECEPTOR LOCALIZATION TO SYNAPSE,0.28785,0.081668,0.10687,0,0
2,GO PROSTATE GLAND MORPHOGENESIS,0.25001,0.081626,0.029616,0,0
2,GO ENDOTHELIAL CELL PROLIFERATION,0.74288,0.08162,0.0065297,0,0
2,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.23937,0.081615,0.073582,0,0
2,GO TONGUE MORPHOGENESIS,0.4598,0.081393,0.12758,0,0
2,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.17934,0.081261,0.082883,0,0
2,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.064293,0.081174,0.14722,0,0
2,GO REGULATION OF AMYLOID BETA FORMATION,0.60272,0.080998,0.035328,0,0
2,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.42347,0.080935,0.03634,0,0
2,GO OTIC VESICLE MORPHOGENESIS,0.22235,0.080834,0.17572,0,0
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.32077,0.080806,0.049153,0,0
2,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.32077,0.080729,0.029259,0,0
2,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.041093,0.080665,0.085237,0,0
2,GO PULMONARY VALVE MORPHOGENESIS,0.50896,0.080652,0.027984,0,0
2,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.31232,0.08065,0.072418,0,0
2,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.55487,0.080271,0.037342,0,0
2,GO CELLULAR RESPONSE TO FOLLICLE STIMULATING HORMONE STIMULUS,0.2,0.080203,0.10426,0,0
2,GO GLIAL CELL ACTIVATION,0.69707,0.080002,0.010975,0,0
2,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.14526,0.079913,0.088509,0,0
2,GO ENDOCARDIAL CUSHION FORMATION,0.52594,0.079881,0.033788,0,0
2,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.23245,0.079584,0.11512,0,0
2,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.36991,0.079189,0.044649,0,0
2,GO REGULATION OF DNA METHYLATION,0.55487,0.078676,0.022381,0,0
2,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.18508,0.078595,0.066106,0,0
2,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.12049,0.078554,0.08366,0,0
2,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.31653,0.078538,0.044265,0,0
2,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.5726,0.07847,0.015,0,0
2,GO CELL GROWTH,0.075049,0.078358,0.049189,0,0
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.0695,0.078322,0.089378,0,0
2,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.11039,0.078308,0.051503,0,0
2,GO SEQUESTERING OF CALCIUM ION,0.30402,0.078271,0.048713,0,0
2,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.10845,0.078262,0.069084,0,0
2,GO REGULATION OF NEURON PROJECTION REGENERATION,0.60272,0.078197,0.048157,0,0
2,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.3746,0.078174,0.024524,0,0
2,GO MITOTIC CHROMOSOME CONDENSATION,0.084046,0.078058,0.085615,0,0
2,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.21905,0.07805,0.047038,0,0
2,GO NUCLEAR MIGRATION,0.093897,0.077994,0.098162,0,0
2,GO TRABECULA FORMATION,0.22568,0.077658,0.066652,0,0
2,GO DICARBOXYLIC ACID TRANSPORT,0.043763,0.077645,0.10789,0,0
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.25729,0.077515,0.06121,0,0
2,GO AMINO SUGAR METABOLIC PROCESS,0.29184,0.077403,0.034278,0,0
2,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.87833,0.077391,-0.031794,0,0
2,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.4598,0.077289,0.012326,0,0
2,GO ADULT BEHAVIOR,0.055956,0.077249,0.14414,0,0
2,GO DRUG CATABOLIC PROCESS,0.085627,0.077231,0.084308,0,0
2,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.070855,0.077169,0.095196,0,0
2,GO AXONAL TRANSPORT,0.070855,0.077143,0.10062,0,0
2,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.26098,0.077094,0.10614,0,0
2,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.56075,0.077027,0.080368,0,0
2,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.4545,0.076803,0.039002,0,0
2,GO PROTEIN CONTAINING COMPLEX REMODELING,0.19095,0.076794,0.038257,0,0
2,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.47049,0.076733,0.087098,0,0
2,GO POSITIVE REGULATION OF HEART CONTRACTION,0.46512,0.076668,0.05701,0,0
2,GO MAINTENANCE OF CELL POLARITY,0.23937,0.076611,0.073465,0,0
2,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.61497,0.076578,0.019408,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,0.52594,0.076353,0.023953,0,0
2,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.67776,0.076184,0.045548,0,0
2,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.88523,0.076182,-0.051929,0,0
2,GO MONONUCLEAR CELL DIFFERENTIATION,0.31653,0.075882,0.091314,0,0
2,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.32938,0.075861,0.085015,0,0
2,GO REGULATION OF EXCRETION,0.12259,0.075844,0.11051,0,0
2,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.17653,0.075733,0.040967,0,0
2,GO CARDIAC MUSCLE FIBER DEVELOPMENT,0.3746,0.075674,0.0491,0,0
2,GO GANGLIOSIDE METABOLIC PROCESS,0.35607,0.075559,0.08742,0,0
2,GO ASTRAL MICROTUBULE ORGANIZATION,0.37932,0.075513,0.046886,0,0
2,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.082489,0.07523,0.11739,0,0
2,GO PLASMA MEMBRANE ORGANIZATION,0.30815,0.07504,0.048406,0,0
2,GO IRON ION HOMEOSTASIS,0.20309,0.074902,0.055373,0,0
2,GO PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER,0.14769,0.074629,0.10781,0,0
2,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.76281,0.074518,0.0086407,0,0
2,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.66501,0.074091,-0.012677,0,0
2,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.085627,0.074082,0.062271,0,0
2,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.11636,0.07407,0.079286,0,0
2,GO REGULATION OF SENSORY PERCEPTION,0.1313,0.073811,0.11994,0,0
2,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.068167,0.073734,0.06478,0,0
2,GO REGULATION OF NEURON DIFFERENTIATION,0.026586,0.073598,0.10531,0,0
2,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.21905,0.073492,0.093333,0,0
2,GO THIOESTER METABOLIC PROCESS,0.25729,0.073276,0.052488,0,0
2,GO PROTEIN KINASE A SIGNALING,0.2839,0.07278,0.047207,0,0
2,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.94073,0.072656,-0.016114,0,0
2,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.33812,0.072441,0.057914,0,0
2,GO LOCOMOTORY BEHAVIOR,0.036164,0.072435,0.13478,0,0
2,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.23245,0.072351,0.14897,0,0
2,GO MITOTIC SISTER CHROMATID COHESION,0.48131,0.072182,0.03863,0,0
2,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.085627,0.07167,0.091229,0,0
2,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.27999,0.071191,0.043413,0,0
2,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.12049,0.071179,0.052823,0,0
2,GO REGULATION OF BLOOD CIRCULATION,0.17099,0.07079,0.06219,0,0
2,GO RESPONSE TO COCAINE,0.47049,0.070694,0.053782,0,0
2,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.32506,0.070677,0.023749,0,0
2,GO CELL JUNCTION ORGANIZATION,0.188,0.07046,0.04718,0,0
2,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.17934,0.070351,0.051365,0,0
2,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.34702,0.070264,0.030359,0,0
2,GO NEGATIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.4545,0.070237,0.023566,0,0
2,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.14526,0.070001,0.11623,0,0
2,GO PROTEIN HOMOTETRAMERIZATION,0.075049,0.069941,0.066948,0,0
2,GO MESENCHYMAL CELL PROLIFERATION,0.090515,0.069754,0.13252,0,0
2,GO TRABECULA MORPHOGENESIS,0.68418,0.069601,0.00042882,0,0
2,GO REGULATION OF HISTONE PHOSPHORYLATION,0.37932,0.069578,0.054866,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.32506,0.069519,0.047766,0,0
2,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.037747,0.069404,0.071298,0,0
2,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.065563,0.069382,0.070423,0,0
2,GO NEGATIVE REGULATION OF CELL AGING,0.78962,0.069356,-0.046214,0,0
2,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.12908,0.069332,0.057547,0,0
2,GO RESPONSE TO ACIDIC PH,0.61497,0.069269,-0.0041426,0,0
2,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.33812,0.068977,0.040546,0,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.32506,0.068946,0.054595,0,0
2,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.05824,0.068821,0.071223,0,0
2,GO POSITIVE REGULATION OF FERTILIZATION,0.22905,0.068786,0.12685,0,0
2,GO REGULATION OF DNA BINDING,0.32506,0.068703,0.035944,0,0
2,GO MULTICELLULAR ORGANISMAL SIGNALING,0.092194,0.068576,0.10112,0,0
2,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.059411,0.068576,0.062462,0,0
2,GO RESPONSE TO INTERLEUKIN 12,0.40349,0.068368,0.034789,0,0
2,GO LENS FIBER CELL DEVELOPMENT,0.40349,0.067964,0.057793,0,0
2,GO INTRACELLULAR LIPID TRANSPORT,0.32506,0.067907,0.051331,0,0
2,GO TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE REMODELING,0.39371,0.067675,0.031582,0,0
2,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,0.16559,0.067378,0.083294,0,0
2,GO ACTION POTENTIAL,0.31653,0.066927,0.062919,0,0
2,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.03245,0.066848,0.090725,0,0
2,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.092194,0.066661,0.065468,0,0
2,GO NEURON DEVELOPMENT,0.015574,0.066648,0.10551,0,0
2,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.11039,0.066519,0.060207,0,0
2,GO RECOMBINATIONAL REPAIR,0.084046,0.066379,0.049275,0,0
2,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.4545,0.066267,0.05857,0,0
2,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.22235,0.066172,0.060251,0,0
2,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.63354,0.066041,-0.0040107,0,0
2,GO MULTICELLULAR ORGANISM GROWTH,0.14048,0.065507,0.039674,0,0
2,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.85768,0.065444,-0.0028137,0,0
2,GO HIPPO SIGNALING,0.68418,0.065365,-0.024942,0,0
2,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.024288,0.065336,0.096793,0,0
2,GO HEXOSE CATABOLIC PROCESS,0.4598,0.065182,0.035594,0,0
2,GO RESPONSE TO AMINO ACID STARVATION,0.17653,0.065071,0.077566,0,0
2,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.3746,0.064971,0.040328,0,0
2,GO CELLULAR RESPONSE TO X RAY,0.41842,0.064863,0.016317,0,0
2,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.073629,0.064843,0.15596,0,0
2,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.055956,0.064814,0.067937,0,0
2,GO HISTONE H3 K27 METHYLATION,0.40349,0.064767,0.041694,0,0
2,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.30402,0.064586,0.12124,0,0
2,GO CELLULAR RESPONSE TO AMYLOID BETA,0.12689,0.064443,0.07886,0,0
2,GO POSITIVE REGULATION OF AXON EXTENSION,0.21905,0.064149,0.10092,0,0
2,GO SYNAPTIC VESICLE TRANSPORT,0.11434,0.063924,0.11139,0,0
2,GO EMBRYONIC AXIS SPECIFICATION,0.42855,0.063734,0.056971,0,0
2,GO DERMATAN SULFATE METABOLIC PROCESS,0.93377,0.063732,-0.0072338,0,0
2,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.72969,0.063652,0.0051246,0,0
2,GO ION TRANSMEMBRANE TRANSPORT,0.05824,0.063493,0.061114,0,0
2,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.39371,0.063293,0.046665,0,0
2,GO MAINTENANCE OF SYNAPSE STRUCTURE,0.54903,0.063118,0.086518,0,0
2,GO METHIONINE BIOSYNTHETIC PROCESS,0.32938,0.062669,0.024869,0,0
2,GO RESPONSE TO SALT,0.92682,0.062643,0.00048644,0,0
2,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.22235,0.06263,0.0745,0,0
2,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.28785,0.062444,0.041102,0,0
2,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,0.58456,0.062265,0.054427,0,0
2,GO NEURON MATURATION,0.073629,0.062192,0.1618,0,0
2,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.50337,0.062074,0.015222,0,0
2,GO GLUCOCORTICOID METABOLIC PROCESS,0.90599,0.062055,-0.0055476,0,0
2,GO REGULATION OF CAMP MEDIATED SIGNALING,0.31232,0.062028,0.069046,0,0
2,GO COLLAGEN CATABOLIC PROCESS,0.52025,0.062015,0.00011165,0,0
2,GO BEHAVIOR,0.013139,0.062013,0.11244,0,0
2,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.3746,0.06199,0.028828,0,0
2,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.036164,0.061913,0.066182,0,0
2,GO MULTI ORGANISM LOCALIZATION,0.15264,0.061525,0.032862,0,0
2,GO SNRNA PROCESSING,0.15773,0.061408,-0.0063667,0,0
2,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.63978,0.061342,0.018724,0,0
2,GO MEMBRANE HYPERPOLARIZATION,0.44924,0.061284,0.069574,0,0
2,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.58456,0.061271,0.021532,0,0
2,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.76281,0.061217,0.038906,0,0
2,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.13355,0.061175,0.11112,0,0
2,GO NEURON DIFFERENTIATION,0.033166,0.061143,0.09311,0,0
2,GO RNA CAPPING,0.087232,0.061067,0.064207,0,0
2,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.40349,0.061015,0.054946,0,0
2,GO HEART PROCESS,0.12259,0.06089,0.068836,0,0
2,GO LOCALIZATION WITHIN MEMBRANE,0.2,0.060871,0.062917,0,0
2,GO CERAMIDE TRANSPORT,0.11434,0.060835,0.045107,0,0
2,GO OPTIC NERVE DEVELOPMENT,0.32938,0.060655,0.088409,0,0
2,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.10654,0.060355,0.045853,0,0
2,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.76281,0.060279,-0.055547,0,0
2,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.049546,0.060199,0.081212,0,0
2,GO POSITIVE REGULATION OF URINE VOLUME,0.5726,0.060194,0.011848,0,0
2,GO REGULATION OF CELL SIZE,0.027803,0.06009,0.078054,0,0
2,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.041093,0.060038,0.10921,0,0
2,GO REGULATION OF MRNA 3 END PROCESSING,0.12049,0.060029,0.062462,0,0
2,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.36526,0.059805,0.094879,0,0
2,GO NUCLEOSIDE METABOLIC PROCESS,0.12908,0.059782,0.047589,0,0
2,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.26098,0.059782,0.039865,0,0
2,GO NEURON PROJECTION ARBORIZATION,0.49227,0.059684,0.069472,0,0
2,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.87144,0.059626,-0.016596,0,0
2,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.12689,0.059588,0.062803,0,0
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.38888,0.059495,0.059975,0,0
2,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.96163,0.059474,0.0074326,0,0
2,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.1028,0.059414,0.067347,0,0
2,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.71006,0.059403,-0.061317,0,0
2,GO REGULATION OF EXOCYTOSIS,0.12908,0.059169,0.083328,0,0
2,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.69061,0.059045,0.016918,0,0
2,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.23245,0.058912,0.051956,0,0
2,GO PROTEIN FOLDING,0.19695,0.058895,0.037073,0,0
2,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.21905,0.05883,0.18293,0,0
2,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.39858,0.058732,0.057713,0,0
2,GO REGULATION OF SODIUM ION TRANSPORT,0.36991,0.058589,0.04793,0,0
2,GO NEUTRAL LIPID CATABOLIC PROCESS,0.48678,0.058587,0.043292,0,0
2,GO HISTONE DEUBIQUITINATION,0.22905,0.058474,0.029267,0,0
2,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.42855,0.058445,0.01996,0,0
2,GO PROTEIN O LINKED MANNOSYLATION,0.40349,0.058248,0.034762,0,0
2,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.17934,0.057919,0.052955,0,0
2,GO MRNA EXPORT FROM NUCLEUS,0.059411,0.057863,0.069993,0,0
2,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.188,0.057766,0.070135,0,0
2,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.67137,0.057761,-0.0024584,0,0
2,GO PEPTIDYL LYSINE DIMETHYLATION,0.088862,0.057756,0.05304,0,0
2,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.32938,0.057662,0.027942,0,0
2,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.41341,0.057564,0.03109,0,0
2,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.12908,0.057514,0.096921,0,0
2,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.83713,0.057268,-0.011995,0,0
2,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.045624,0.057252,0.082736,0,0
2,GO REGULATION OF FATTY ACID BETA OXIDATION,0.25001,0.057197,0.081448,0,0
2,GO APOPTOTIC DNA FRAGMENTATION,0.12689,0.056973,0.054069,0,0
2,GO FEEDING BEHAVIOR,0.088862,0.056843,0.084705,0,0
2,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.92682,0.056737,-0.0044084,0,0
2,GO MITOCHONDRIAL DNA REPLICATION,0.44924,0.056697,0.032179,0,0
2,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.56666,0.056407,0.022729,0,0
2,GO RESPONSE TO MISFOLDED PROTEIN,0.72969,0.05629,-0.0008014,0,0
2,GO MONOVALENT INORGANIC CATION TRANSPORT,0.11636,0.05621,0.064125,0,0
2,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.14526,0.056149,0.057714,0,0
2,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.85768,0.056012,-0.042994,0,0
2,GO ACTIN MEDIATED CELL CONTRACTION,0.47049,0.055942,0.047177,0,0
2,GO REGULATION OF MRNA CATABOLIC PROCESS,0.16032,0.055811,0.040261,0,0
2,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.48678,0.055774,-0.077812,0,0
2,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.88523,0.05573,0.0054114,0,0
2,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.23589,0.055727,0.111,0,0
2,GO NEPHRON TUBULE FORMATION,0.79636,0.055653,0.036197,0,0
2,GO ERROR FREE TRANSLESION SYNTHESIS,0.079444,0.055331,0.075593,0,0
2,GO NOREPINEPHRINE SECRETION,0.37932,0.055307,0.052206,0,0
2,GO REGULATION OF HEART GROWTH,0.23589,0.055286,0.066202,0,0
2,GO DNA GEOMETRIC CHANGE,0.054842,0.055228,0.060255,0,0
2,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.25729,0.055025,0.049114,0,0
2,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.065563,0.055002,0.04809,0,0
2,GO ANIMAL ORGAN REGENERATION,0.4978,0.054878,-0.0026538,0,0
2,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.81668,0.054837,-0.034905,0,0
2,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.71006,0.054812,0.0049911,0,0
2,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.68418,0.0548,0.015893,0,0
2,GO G0 TO G1 TRANSITION,0.43367,0.05475,0.036869,0,0
2,GO CYTOCHROME COMPLEX ASSEMBLY,0.24643,0.054744,0.073746,0,0
2,GO PROTEIN DEPOLYMERIZATION,0.40349,0.054687,0.035538,0,0
2,GO TRACHEA DEVELOPMENT,0.4598,0.054649,0.060868,0,0
2,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.34702,0.054639,0.074693,0,0
2,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.29992,0.054492,0.03947,0,0
2,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.56666,0.054206,0.020814,0,0
2,GO PROSTAGLANDIN TRANSPORT,0.58456,0.05399,0.016902,0,0
2,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.26471,0.053979,0.072737,0,0
2,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.71658,0.053975,0.017606,0,0
2,GO OSTEOBLAST DEVELOPMENT,0.71658,0.053807,-0.021909,0,0
2,GO PROTEASOME ASSEMBLY,0.2,0.053773,0.053468,0,0
2,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.76948,0.053703,0.016269,0,0
2,GO ANTEROGRADE AXONAL TRANSPORT,0.11841,0.053664,0.080307,0,0
2,GO STRIATED MUSCLE CONTRACTION,0.14526,0.053577,0.068468,0,0
2,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.42347,0.053419,0.04701,0,0
2,GO NEGATIVE REGULATION OF RNA SPLICING,0.14526,0.053381,0.070599,0,0
2,GO PROTEIN NEDDYLATION,0.12049,0.053309,0.067427,0,0
2,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,0.26098,0.053132,0.13369,0,0
2,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.14048,0.05306,0.053304,0,0
2,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.33373,0.052918,0.067288,0,0
2,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.1313,0.052863,0.075474,0,0
2,GO MAINTENANCE OF LOCATION IN CELL,0.29184,0.052824,0.043541,0,0
2,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.41842,0.05282,0.050627,0,0
2,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.84397,0.052755,-0.028331,0,0
2,GO NEURON CELL CELL ADHESION,0.61497,0.052642,0.10326,0,0
2,GO PROTEIN POLYGLUTAMYLATION,0.36064,0.052559,0.035699,0,0
2,GO MYELIN ASSEMBLY,0.49227,0.052436,0.042426,0,0
2,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,0.83713,0.05231,-0.055094,0,0
2,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.63354,0.052278,0.024987,0,0
2,GO NUCLEOSOME ORGANIZATION,0.14526,0.052174,0.050352,0,0
2,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.72969,0.052144,0.013265,0,0
2,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.32506,0.052067,0.043894,0,0
2,GO RESPONSE TO CATECHOLAMINE,0.47588,0.051724,0.0425,0,0
2,GO MUSCLE CONTRACTION,0.13814,0.051623,0.053266,0,0
2,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.63978,0.05139,0.023118,0,0
2,GO IRON SULFUR CLUSTER ASSEMBLY,0.14769,0.05134,0.11065,0,0
2,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.2839,0.051251,0.057719,0,0
2,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.59664,0.051103,-0.044502,0,0
2,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.71658,0.051083,0.0022241,0,0
2,GO MONOAMINE TRANSPORT,0.55487,0.051073,0.10533,0,0
2,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.16294,0.051029,0.064254,0,0
2,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.25363,0.050937,0.02684,0,0
2,GO RESPONSE TO POTASSIUM ION,0.59059,0.050913,0.052922,0,0
2,GO GRANULOCYTE DIFFERENTIATION,0.96163,0.050771,-0.026791,0,0
2,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.24288,0.050528,0.091945,0,0
2,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.38408,0.050521,0.079565,0,0
2,GO ADHESION OF SYMBIONT TO HOST,0.5726,0.050321,0.033531,0,0
2,GO PEPTIDYL METHIONINE MODIFICATION,0.15015,0.050316,0.06293,0,0
2,GO CIRCADIAN SLEEP WAKE CYCLE,0.33812,0.050176,0.083192,0,0
2,GO REGULATION OF CELL PROJECTION SIZE,0.94769,0.050105,-0.0076313,0,0
2,GO CARDIAC CHAMBER DEVELOPMENT,0.53167,0.050087,0.016322,0,0
2,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.40349,0.049989,0.026336,0,0
2,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.25363,0.049893,0.036914,0,0
2,GO RHYTHMIC BEHAVIOR,0.47049,0.049745,0.042894,0,0
2,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.11434,0.049733,0.11575,0,0
2,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.98953,0.049408,-0.006554,0,0
2,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.15015,0.049344,0.041168,0,0
2,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.70355,0.049297,-0.011863,0,0
2,GO TRANSMEMBRANE TRANSPORT,0.11841,0.049215,0.040787,0,0
2,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.98255,0.049192,-0.017618,0,0
2,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.16294,0.049185,0.099555,0,0
2,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.83713,0.049162,-0.0024512,0,0
2,GO RESPONSE TO CORTICOSTERONE,0.91987,0.049093,-0.019411,0,0
2,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.42347,0.049075,0.01986,0,0
2,GO SCHWANN CELL DEVELOPMENT,0.72313,0.048968,0.017815,0,0
2,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.86455,0.048931,0.016773,0,0
2,GO CHROMATIN DISASSEMBLY,0.22235,0.048408,0.125,0,0
2,GO ACYLGLYCEROL HOMEOSTASIS,0.42347,0.048374,0.038189,0,0
2,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,0.33812,0.048365,0.058467,0,0
2,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.43883,0.048133,0.06176,0,0
2,GO REGULATION OF CELL MORPHOGENESIS,0.087232,0.048035,0.062806,0,0
2,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.17099,0.048005,0.046503,0,0
2,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.81668,0.047761,0.0094245,0,0
2,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.38888,0.04765,0.031904,0,0
2,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.42855,0.047545,0.038869,0,0
2,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.58456,0.04754,0.013204,0,0
2,GO REGULATION OF ORGAN GROWTH,0.35607,0.04754,0.035379,0,0
2,GO INNER CELL MASS CELL PROLIFERATION,0.25729,0.047341,0.061132,0,0
2,GO CARBOHYDRATE CATABOLIC PROCESS,0.23937,0.047273,0.047214,0,0
2,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.62732,0.047146,0.030781,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME,0.62113,0.047105,0.047123,0,0
2,GO CARDIAC CHAMBER MORPHOGENESIS,0.69061,0.04698,0.0037934,0,0
2,GO POSITIVE REGULATION OF STEROL TRANSPORT,0.86455,0.046963,-0.036538,0,0
2,GO OSTEOCLAST DEVELOPMENT,0.22905,0.046955,0.076249,0,0
2,GO REGULATION OF SKELETAL MUSCLE CONTRACTION,0.62113,0.046823,0.028654,0,0
2,GO KERATAN SULFATE CATABOLIC PROCESS,0.9686,0.046602,-0.055373,0,0
2,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.43883,0.046447,0.052152,0,0
2,GO ACROSOME REACTION,0.54321,0.046437,0.028279,0,0
2,GO FORMATION OF PRIMARY GERM LAYER,0.65234,0.046422,-0.0089847,0,0
2,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.41842,0.046411,0.052284,0,0
2,GO NEUROGENESIS,0.075049,0.046395,0.071918,0,0
2,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.55487,0.046293,0.032767,0,0
2,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.15773,0.046282,0.068317,0,0
2,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.60883,0.046193,0.036286,0,0
2,GO PROTEIN LOCALIZATION TO CELL JUNCTION,0.35153,0.046032,0.060186,0,0
2,GO RESPONSE TO NERVE GROWTH FACTOR,0.082489,0.045935,0.10175,0,0
2,GO MITOTIC CELL CYCLE ARREST,0.60883,0.04592,0.03141,0,0
2,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.25729,0.045851,0.068885,0,0
2,GO MICROTUBULE POLYMERIZATION,0.044685,0.045838,0.11001,0,0
2,GO CEREBELLAR CORTEX FORMATION,0.63978,0.045735,0.048536,0,0
2,GO POSITIVE REGULATION OF DNA BINDING,0.10465,0.045604,0.064125,0,0
2,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.71006,0.045453,-0.0036157,0,0
2,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.33812,0.045402,0.066379,0,0
2,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,0.21905,0.045383,0.045223,0,0
2,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,0.95466,0.045349,-0.026062,0,0
2,GO MYOBLAST FUSION,0.89215,0.045198,-0.025843,0,0
2,GO REGULATION OF PROTEIN GLYCOSYLATION,0.69707,0.045174,0.0098476,0,0
2,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,0.31232,0.044919,0.059493,0,0
2,GO SULFUR COMPOUND CATABOLIC PROCESS,0.093897,0.044885,0.10197,0,0
2,GO RESPONSE TO DOPAMINE,0.61497,0.044837,0.033992,0,0
2,GO CHROMATIN SILENCING,0.46512,0.044804,0.026672,0,0
2,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.71006,0.044783,0.016251,0,0
2,GO ORGAN GROWTH,0.54903,0.044716,0.018631,0,0
2,GO BASEMENT MEMBRANE ORGANIZATION,0.86455,0.044645,-0.072866,0,0
2,GO RRNA CATABOLIC PROCESS,0.62732,0.044437,0.04833,0,0
2,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.78962,0.044324,0.0072863,0,0
2,GO HEART TRABECULA FORMATION,0.95466,0.044239,-0.0041626,0,0
2,GO HISTONE METHYLATION,0.1028,0.044139,0.047003,0,0
2,GO CORTICOSTEROID HORMONE SECRETION,0.81668,0.044039,-0.020328,0,0
2,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.16828,0.043899,0.12862,0,0
2,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.061812,0.043714,0.131,0,0
2,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.32077,0.043609,0.049395,0,0
2,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.95466,0.043547,-0.012278,0,0
2,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.42347,0.04348,0.037169,0,0
2,GO PHOTORECEPTOR CELL DEVELOPMENT,0.38888,0.043411,0.05894,0,0
2,GO MICROTUBULE NUCLEATION,0.67137,0.043043,0.030211,0,0
2,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.10654,0.042921,0.09844,0,0
2,GO REGULATION OF LIPID KINASE ACTIVITY,0.22905,0.042914,0.041127,0,0
2,GO EXOCRINE SYSTEM DEVELOPMENT,0.48678,0.042716,0.033185,0,0
2,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.88523,0.042581,0.023569,0,0
2,GO REGULATION OF PODOSOME ASSEMBLY,0.50896,0.042552,-0.11406,0,0
2,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.20621,0.042531,0.072654,0,0
2,GO PROTEIN HYDROXYLATION,0.78289,0.042499,0.014227,0,0
2,GO PROTEIN PALMITOYLATION,0.30815,0.042405,0.061275,0,0
2,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.21256,0.04236,0.096539,0,0
2,GO BONE DEVELOPMENT,0.3746,0.042278,0.014209,0,0
2,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.89907,0.042198,-0.021191,0,0
2,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.14285,0.041947,0.040574,0,0
2,GO TRNA 5 LEADER REMOVAL,0.63354,0.041775,0.01211,0,0
2,GO ESTABLISHMENT OF RNA LOCALIZATION,0.092194,0.041691,0.050936,0,0
2,GO PROTEIN STABILIZATION,0.52025,0.041628,0.017604,0,0
2,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.69707,0.041617,0.042231,0,0
2,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,1,0.041609,-0.013308,0,0
2,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.60272,0.04137,-0.015169,0,0
2,GO LYMPHANGIOGENESIS,0.26098,0.041195,0.057051,0,0
2,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.41341,0.041186,0.027773,0,0
2,GO NADP METABOLIC PROCESS,0.70355,0.041152,-0.016033,0,0
2,GO PROTEIN LOCALIZATION TO ORGANELLE,0.05824,0.041143,0.037228,0,0
2,GO ELECTRON TRANSPORT CHAIN,0.37932,0.040798,0.031763,0,0
2,GO REGULATION OF DEVELOPMENTAL GROWTH,0.10654,0.040787,0.053955,0,0
2,GO CARTILAGE MORPHOGENESIS,0.35153,0.04077,0.14204,0,0
2,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.4598,0.040627,0.046269,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.75615,0.040613,-0.040405,0,0
2,GO SNRNA METABOLIC PROCESS,0.25001,0.040524,-0.0053469,0,0
2,GO PROTEIN IMPORT,0.58456,0.040337,0.0071906,0,0
2,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.64605,0.039969,-0.042298,0,0
2,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.91987,0.039865,-0.0085776,0,0
2,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.86455,0.039813,-0.0023915,0,0
2,GO PROTON TRANSMEMBRANE TRANSPORT,0.78962,0.039672,-0.0087641,0,0
2,GO RESPONSE TO UV,0.12259,0.039584,0.042676,0,0
2,GO EMBRYONIC EYE MORPHOGENESIS,0.99651,0.039419,-0.019693,0,0
2,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.80989,0.03933,0.024745,0,0
2,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.84397,0.039168,-0.0045513,0,0
2,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.91293,0.039067,-0.013666,0,0
2,GO CELL MORPHOGENESIS,0.14526,0.038997,0.058199,0,0
2,GO REGULATION OF URINE VOLUME,0.65234,0.038963,0.011216,0,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.95466,0.038951,-0.010853,0,0
2,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.29184,0.038797,0.040875,0,0
2,GO POLYOL METABOLIC PROCESS,0.24288,0.038771,0.036067,0,0
2,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.96163,0.03877,-0.010743,0,0
2,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.42855,0.038761,0.046427,0,0
2,GO OXIDATIVE DEMETHYLATION,0.15517,0.038625,0.072435,0,0
2,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.20621,0.038547,0.030599,0,0
2,GO ION TRANSPORT,0.23937,0.038322,0.031685,0,0
2,GO CARDIAC MUSCLE CELL CONTRACTION,0.25729,0.038216,0.080229,0,0
2,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.76948,0.038215,0.0055821,0,0
2,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.78962,0.03819,-0.0078515,0,0
2,GO SECOND MESSENGER MEDIATED SIGNALING,0.33373,0.038161,0.031432,0,0
2,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.76948,0.038053,0.035254,0,0
2,GO IMMATURE T CELL PROLIFERATION,0.72969,0.038013,-0.01894,0,0
2,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.30402,0.037981,0.042514,0,0
2,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.9686,0.037969,-0.025374,0,0
2,GO VITAMIN BIOSYNTHETIC PROCESS,0.41842,0.03795,0.046741,0,0
2,GO CELL CELL SIGNALING,0.13355,0.037895,0.047582,0,0
2,GO NEUROPEPTIDE SIGNALING PATHWAY,0.17099,0.037849,0.099701,0,0
2,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.50896,0.037847,0.02657,0,0
2,GO REGULATION OF GENE SILENCING,0.28785,0.037828,0.031926,0,0
2,GO PROTEIN KINASE C SIGNALING,0.98953,0.037794,-0.0076044,0,0
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.090515,0.037701,0.056622,0,0
2,GO CEREBRAL CORTEX CELL MIGRATION,0.073629,0.037433,0.12602,0,0
2,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.68418,0.037332,0.015243,0,0
2,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.67137,0.037196,0.016443,0,0
2,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.49227,0.037067,0.057624,0,0
2,GO DEVELOPMENTAL GROWTH,0.14285,0.037026,0.047565,0,0
2,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.38888,0.037015,0.016176,0,0
2,GO NEGATIVE REGULATION OF DNA REPAIR,0.78289,0.036885,0.008726,0,0
2,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.71658,0.036778,-0.0092596,0,0
2,GO BLASTOCYST GROWTH,0.47049,0.036748,0.016377,0,0
2,GO COENZYME A METABOLIC PROCESS,0.80312,0.03672,0.013962,0,0
2,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.041093,0.036656,0.074008,0,0
2,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.56075,0.036493,0.040761,0,0
2,GO RESPONSE TO RETINOIC ACID,0.76948,0.036452,-0.016635,0,0
2,GO RESPONSE TO LEUCINE,0.4978,0.03628,0.078433,0,0
2,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.52025,0.036273,0.026461,0,0
2,GO GMP METABOLIC PROCESS,0.80989,0.03627,0.042603,0,0
2,GO REGULATION OF HISTONE METHYLATION,0.15773,0.036244,0.048961,0,0
2,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.8303,0.036212,0.032197,0,0
2,GO REGULATION OF DNA REPAIR,0.7495,0.036026,0.0030106,0,0
2,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.67776,0.036019,0.00746,0,0
2,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.031748,0.035939,0.067457,0,0
2,GO REGULATION OF ACROSOME REACTION,0.39371,0.035938,0.070154,0,0
2,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.13814,0.035896,0.10478,0,0
2,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.4598,0.035834,0.062649,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.89907,0.035827,-0.026239,0,0
2,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,0.21905,0.035753,0.10856,0,0
2,GO SKELETAL MUSCLE TISSUE REGENERATION,0.69707,0.035704,-0.011069,0,0
2,GO CRANIAL NERVE DEVELOPMENT,0.67137,0.035667,-0.061516,0,0
2,GO CHLORIDE TRANSPORT,0.49227,0.035636,0.025545,0,0
2,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.29184,0.035526,0.036014,0,0
2,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.47588,0.03537,0.020826,0,0
2,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.34702,0.035361,0.020919,0,0
2,GO VENTRICULAR SEPTUM DEVELOPMENT,0.47049,0.035198,0.041503,0,0
2,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.98953,0.035074,-0.014027,0,0
2,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.63354,0.035062,0.0040174,0,0
2,GO CHROMATIN REMODELING AT CENTROMERE,0.17099,0.034998,0.078447,0,0
2,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.61497,0.034779,-0.010887,0,0
2,GO RESPONSE TO ESTROGEN,0.48678,0.034711,0.0087973,0,0
2,GO I KAPPAB PHOSPHORYLATION,0.98953,0.034662,-0.030051,0,0
2,GO AMYLOID BETA FORMATION,0.84397,0.034629,0.0047639,0,0
2,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.16828,0.034385,0.030482,0,0
2,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.11434,0.034342,0.062309,0,0
2,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.71006,0.034128,0.023519,0,0
2,GO SULFUR COMPOUND METABOLIC PROCESS,0.36991,0.034056,0.024522,0,0
2,GO AORTA MORPHOGENESIS,0.89215,0.034007,-0.028269,0,0
2,GO GROWTH,0.51459,0.033947,0.014628,0,0
2,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.63978,0.033925,0.0085486,0,0
2,GO REGULATION OF FERTILIZATION,0.39371,0.033886,0.034041,0,0
2,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.50337,0.033874,-0.070401,0,0
2,GO INACTIVATION OF MAPK ACTIVITY,0.89907,0.033782,0.011946,0,0
2,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.26847,0.033624,0.05577,0,0
2,GO CELL CYCLE G2 M PHASE TRANSITION,0.17099,0.0333,0.029814,0,0
2,GO NEUROTROPHIN SIGNALING PATHWAY,0.48678,0.03326,0.034975,0,0
2,GO CHOLESTEROL EFFLUX,0.70355,0.033257,-0.045448,0,0
2,GO REGULATION OF CELL DEVELOPMENT,0.12473,0.033246,0.058581,0,0
2,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.43367,0.033047,0.036882,0,0
2,GO CELLULAR HOMEOSTASIS,0.23589,0.033012,0.031681,0,0
2,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,0.74288,0.032724,-0.042776,0,0
2,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.050569,0.032713,0.064769,0,0
2,GO CARTILAGE DEVELOPMENT,0.73628,0.032683,-0.0058453,0,0
2,GO PORE COMPLEX ASSEMBLY,0.80989,0.032664,-0.034393,0,0
2,GO LYTIC VACUOLE ORGANIZATION,0.85768,0.032642,-0.01039,0,0
2,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.56075,0.032546,0.027683,0,0
2,GO DNA CONFORMATION CHANGE,0.16032,0.032404,0.03942,0,0
2,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.70355,0.032357,-0.046804,0,0
2,GO RNA INTERFERENCE,0.20621,0.03234,0.069483,0,0
2,GO METHYLATION,0.033166,0.032322,0.058393,0,0
2,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.47588,0.032237,0.011778,0,0
2,GO LUNG ALVEOLUS DEVELOPMENT,0.4978,0.032095,0.0372,0,0
2,GO REGULATION OF PROTON TRANSPORT,0.55487,0.03197,0.044068,0,0
2,GO PROTEIN ACETYLATION,0.26847,0.031965,0.017669,0,0
2,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.52594,0.031952,0.059015,0,0
2,GO NEGATIVE REGULATION OF BINDING,0.3746,0.031909,0.033044,0,0
2,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.59664,0.031803,0.021365,0,0
2,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.71658,0.031783,0.0052435,0,0
2,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.24643,0.031667,0.018889,0,0
2,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,0.85082,0.031627,9.4196e-05,0,0
2,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.75615,0.031621,-0.0013877,0,0
2,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.097379,0.031562,0.062583,0,0
2,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.53167,0.031557,0.022321,0,0
2,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.2,0.031533,0.02891,0,0
2,GO NADPH REGENERATION,0.97557,0.03146,-0.014396,0,0
2,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.68418,0.031428,0.018659,0,0
2,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.86455,0.031386,0.010408,0,0
2,GO FOREBRAIN DEVELOPMENT,0.15773,0.031358,0.064155,0,0
2,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.25001,0.031311,0.038895,0,0
2,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.44402,0.031263,0.018939,0,0
2,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.67137,0.031137,0.014411,0,0
2,GO REGULATION OF TORC1 SIGNALING,0.26847,0.030901,0.038266,0,0
2,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.42855,0.030871,0.025901,0,0
2,GO MEIOTIC SPINDLE ORGANIZATION,0.92682,0.030773,0.0029153,0,0
2,GO SEMI LUNAR VALVE DEVELOPMENT,0.80989,0.030645,-0.0048553,0,0
2,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.78962,0.030489,0.0047626,0,0
2,GO CELLULAR RESPONSE TO VITAMIN,0.51459,0.030433,0.023195,0,0
2,GO MUSCLE SYSTEM PROCESS,0.23937,0.030397,0.038068,0,0
2,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.78962,0.030362,0.0039012,0,0
2,GO ION HOMEOSTASIS,0.53742,0.030339,0.017595,0,0
2,GO CARDIAC MUSCLE CONTRACTION,0.20937,0.030078,0.067402,0,0
2,GO OVULATION CYCLE PROCESS,0.40349,0.030026,0.040106,0,0
2,GO DNA PACKAGING,0.33373,0.029913,0.028574,0,0
2,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.81668,0.029894,-0.012265,0,0
2,GO ENERGY HOMEOSTASIS,0.55487,0.029863,0.050136,0,0
2,GO QUINONE METABOLIC PROCESS,0.32938,0.029856,-0.15592,0,0
2,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.50896,0.029631,0.028245,0,0
2,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.58456,0.029594,0.057225,0,0
2,GO NEGATIVE REGULATION OF CELL DIVISION,0.94769,0.029519,0.0078431,0,0
2,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.96163,0.029503,-0.013801,0,0
2,GO RESPONSE TO TEMPERATURE STIMULUS,0.14769,0.02944,0.043423,0,0
2,GO RESPONSE TO MAGNESIUM ION,0.9686,0.029394,-0.0081614,0,0
2,GO T CELL DIFFERENTIATION IN THYMUS,0.44924,0.029312,0.026918,0,0
2,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.91987,0.029294,-0.067343,0,0
2,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.71006,0.029261,-0.043304,0,0
2,GO SENSORY PERCEPTION OF PAIN,0.82348,0.029227,0.024267,0,0
2,GO RESPONSE TO GONADOTROPIN,0.92682,0.029167,-0.018143,0,0
2,GO MIRNA METABOLIC PROCESS,0.95466,0.029152,-0.00043178,0,0
2,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,0.66501,0.029119,0.0058449,0,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.94073,0.029071,-0.037658,0,0
2,GO DEVELOPMENTAL MATURATION,0.22905,0.028994,0.059102,0,0
2,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.96163,0.028993,0.013514,0,0
2,GO HISTONE EXCHANGE,0.31653,0.028887,0.039289,0,0
2,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,0.62113,0.028843,-0.063157,0,0
2,GO LYMPH NODE DEVELOPMENT,0.87144,0.028811,-0.013562,0,0
2,GO ACTIVATION OF MAPKK ACTIVITY,0.94769,0.028809,-0.0032546,0,0
2,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.67137,0.028734,0.051423,0,0
2,GO CONVERGENT EXTENSION,0.56666,0.028632,0.041216,0,0
2,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,0.4978,0.028512,0.02142,0,0
2,GO CHYLOMICRON ASSEMBLY,0.78962,0.028507,-0.019807,0,0
2,GO DNA REPLICATION,0.17653,0.028502,0.033985,0,0
2,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.29184,0.028124,0.017059,0,0
2,GO MIDBRAIN DEVELOPMENT,0.76281,0.028068,-0.035876,0,0
2,GO OXIDATION REDUCTION PROCESS,0.68418,0.028046,0.0095475,0,0
2,GO INORGANIC ANION TRANSPORT,0.42347,0.027832,0.015758,0,0
2,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.42855,0.027774,0.047455,0,0
2,GO METAL ION HOMEOSTASIS,0.84397,0.02774,0.0037628,0,0
2,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.23245,0.027726,0.10127,0,0
2,GO REGULATION OF LIGASE ACTIVITY,0.94073,0.027714,0.004058,0,0
2,GO CELL CYCLE ARREST,0.33373,0.027653,0.025913,0,0
2,GO PEROXISOMAL MEMBRANE TRANSPORT,0.42347,0.027639,0.031295,0,0
2,GO RESPONSE TO MONOSACCHARIDE,0.61497,0.027606,0.0067171,0,0
2,GO STRIATED MUSCLE CELL PROLIFERATION,0.89907,0.027545,-0.023932,0,0
2,GO CELLULAR RESPONSE TO CHOLESTEROL,0.56075,0.027486,0.042877,0,0
2,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.52594,0.027418,0.038913,0,0
2,GO IRON ION TRANSPORT,0.77618,0.027225,-0.0098631,0,0
2,GO CHONDROCYTE DEVELOPMENT,0.47049,0.027036,0.011729,0,0
2,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.46512,0.027007,0.03849,0,0
2,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.36526,0.026823,0.032309,0,0
2,GO NEGATIVE REGULATION OF AUTOPHAGY,0.5726,0.026772,0.026549,0,0
2,GO LAMELLIPODIUM MORPHOGENESIS,0.22568,0.026735,-0.14412,0,0
2,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.42347,0.026586,0.049709,0,0
2,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.25363,0.026583,0.047106,0,0
2,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.42347,0.026536,0.024151,0,0
2,GO PROTEIN ACYLATION,0.13583,0.026497,0.027667,0,0
2,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.80989,0.026417,0.0048714,0,0
2,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.88523,0.026403,-0.0021909,0,0
2,GO MRNA CLEAVAGE,0.22235,0.026381,0.051584,0,0
2,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.72969,0.026187,0.014482,0,0
2,GO CELLULAR RESPONSE TO RADIATION,0.72313,0.026019,-0.0023432,0,0
2,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.56075,0.026014,0.010009,0,0
2,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.12689,0.025895,0.046954,0,0
2,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.55487,0.025797,0.023933,0,0
2,GO NEURAL CREST CELL DIFFERENTIATION,0.55487,0.025671,0.027042,0,0
2,GO SEGMENTATION,0.48678,0.025492,0.021605,0,0
2,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.87833,0.025299,-0.040874,0,0
2,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.92682,0.025244,-0.012407,0,0
2,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.41842,0.025238,0.03403,0,0
2,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.87144,0.025062,-0.039824,0,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.58456,0.024944,-0.06273,0,0
2,GO NERVOUS SYSTEM PROCESS,0.34702,0.024861,0.038292,0,0
2,GO REGULATION OF GLIOGENESIS,0.78289,0.024815,0.012054,0,0
2,GO MUSCLE ORGAN DEVELOPMENT,0.38408,0.024716,0.01842,0,0
2,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.54321,0.02446,0.042752,0,0
2,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.82348,0.024273,0.004358,0,0
2,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.9686,0.02426,-0.035691,0,0
2,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.70355,0.02423,-0.006168,0,0
2,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.81668,0.024143,-0.031975,0,0
2,GO REGULATION OF FIBRINOLYSIS,0.68418,0.024101,-0.09294,0,0
2,GO FILOPODIUM ASSEMBLY,0.46512,0.023969,0.037676,0,0
2,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.88523,0.023937,-0.016667,0,0
2,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.63978,0.02391,0.020487,0,0
2,GO CHROMOSOME SEPARATION,0.42855,0.02386,0.025272,0,0
2,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.98255,0.023852,-0.025406,0,0
2,GO ALCOHOL BIOSYNTHETIC PROCESS,0.39371,0.023753,0.024745,0,0
2,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.72969,0.023648,0.032474,0,0
2,GO CHROMATIN SILENCING AT TELOMERE,0.34256,0.023635,0.060195,0,0
2,GO HISTONE H3 K4 METHYLATION,0.95466,0.023547,0.0012104,0,0
2,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.65234,0.023542,0.012827,0,0
2,GO REGULATION OF TELOMERASE ACTIVITY,0.83713,0.023357,-0.018905,0,0
2,GO REGULATION OF GROWTH,0.90599,0.023354,-0.00044268,0,0
2,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.96163,0.023258,-0.033939,0,0
2,GO THIOESTER BIOSYNTHETIC PROCESS,0.13814,0.023166,0.084946,0,0
2,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.86455,0.023017,-0.017188,0,0
2,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.13583,0.022928,0.060352,0,0
2,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.70355,0.022912,0.010331,0,0
2,GO INTERACTION WITH SYMBIONT,0.4545,0.022889,0.0019219,0,0
2,GO LYMPH VESSEL MORPHOGENESIS,0.72313,0.022857,-0.06373,0,0
2,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,0.62732,0.022769,0.022613,0,0
2,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.98953,0.022752,-0.017444,0,0
2,GO WATER TRANSPORT,0.91293,0.022676,-0.0035743,0,0
2,GO REGULATION OF RECEPTOR RECYCLING,0.61497,0.022614,-0.038741,0,0
2,GO REGULATION OF CHROMOSOME ORGANIZATION,0.16828,0.022592,0.024635,0,0
2,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.64605,0.022425,0.03981,0,0
2,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.61497,0.022396,0.049255,0,0
2,GO REGULATION OF RNA SPLICING,0.2,0.021959,0.036933,0,0
2,GO POSITIVE REGULATION OF AMINE TRANSPORT,0.61497,0.021905,0.09446,0,0
2,GO INTERMEMBRANE LIPID TRANSFER,0.95466,0.021783,-0.0027989,0,0
2,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.37932,0.02162,0.035968,0,0
2,GO DNA METABOLIC PROCESS,0.39858,0.021597,0.015568,0,0
2,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.60272,0.021583,0.044211,0,0
2,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.72313,0.021456,0.004522,0,0
2,GO RETINAL CONE CELL DIFFERENTIATION,0.60272,0.021411,-0.075543,0,0
2,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.79636,0.021405,-0.0081328,0,0
2,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.71006,0.021397,-0.059285,0,0
2,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.73628,0.021363,-0.015008,0,0
2,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,0.26471,0.021339,0.07162,0,0
2,GO PROTEIN METHYLATION,0.59059,0.021317,0.020162,0,0
2,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.39371,0.021265,0.10921,0,0
2,GO REGULATION OF BEHAVIOR,0.67137,0.021183,0.017133,0,0
2,GO PROTEIN LOCALIZATION TO CHROMATIN,0.98953,0.021103,0.002342,0,0
2,GO PEPTIDYL ARGININE MODIFICATION,0.13814,0.020855,0.082401,0,0
2,GO CARDIAC SEPTUM DEVELOPMENT,0.53167,0.020774,0.023525,0,0
2,GO PEPTIDYL CYSTEINE MODIFICATION,0.70355,0.020711,0.020402,0,0
2,GO NEGATIVE REGULATION OF STEROL TRANSPORT,0.36064,0.020512,0.024503,0,0
2,GO ORGANELLE MEMBRANE FUSION,0.70355,0.020481,0.0053225,0,0
2,GO DNA RECOMBINATION,0.50896,0.020447,0.011395,0,0
2,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.17653,0.020436,0.12032,0,0
2,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.32938,0.02037,-0.10796,0,0
2,GO SNRNA TRANSCRIPTION,0.23937,0.020297,0.025213,0,0
2,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.85082,0.02027,0.0037798,0,0
2,GO FOREGUT MORPHOGENESIS,0.8303,0.02027,-0.019063,0,0
2,GO RIBONUCLEOSIDE METABOLIC PROCESS,0.72313,0.020237,-0.00023766,0,0
2,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.39371,0.020216,0.097113,0,0
2,GO CHROMATIN REMODELING,0.23589,0.020082,0.036679,0,0
2,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.36991,0.020018,0.057893,0,0
2,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.57857,0.019838,0.017424,0,0
2,GO HEART TRABECULA MORPHOGENESIS,0.94769,0.019723,-0.004214,0,0
2,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.56666,0.01962,-0.096087,0,0
2,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.68418,0.019617,0.028103,0,0
2,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.66501,0.019419,0.0024772,0,0
2,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.27999,0.019343,0.048686,0,0
2,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.42347,0.019231,0.069953,0,0
2,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.31653,0.01916,0.034708,0,0
2,GO NEURAL TUBE PATTERNING,0.98953,0.019061,-0.0099716,0,0
2,GO REGULATION OF MYELINATION,0.51459,0.019049,0.051814,0,0
2,GO NEGATIVE REGULATION OF GLIOGENESIS,0.78962,0.018996,-0.01939,0,0
2,GO SECONDARY PALATE DEVELOPMENT,0.53167,0.018966,-0.057617,0,0
2,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.91293,0.018898,0.0007021,0,0
2,GO CALCIUM ION REGULATED EXOCYTOSIS,0.30402,0.018874,0.14205,0,0
2,GO CONNECTIVE TISSUE DEVELOPMENT,0.95466,0.018871,-0.019809,0,0
2,GO BRAIN MORPHOGENESIS,0.67776,0.018857,0.044687,0,0
2,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.67776,0.018855,0.01276,0,0
2,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.48678,0.018828,0.059431,0,0
2,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.50896,0.018781,0.026803,0,0
2,GO TRIGLYCERIDE METABOLIC PROCESS,0.92682,0.0187,0.014684,0,0
2,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,0.67776,0.018616,-0.066419,0,0
2,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.42855,0.018591,0.029812,0,0
2,GO DENDRITE EXTENSION,0.34702,0.018508,0.14333,0,0
2,GO CARDIAC MUSCLE CELL PROLIFERATION,0.43883,0.018494,0.025655,0,0
2,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.42347,0.018441,0.05027,0,0
2,GO CARBOHYDRATE HOMEOSTASIS,0.4598,0.018052,0.021581,0,0
2,GO REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.94073,0.018001,0.039363,0,0
2,GO HISTONE H3 K4 TRIMETHYLATION,0.87833,0.017889,-0.011816,0,0
2,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.24643,0.017792,0.042424,0,0
2,GO CELLULAR COMPONENT DISASSEMBLY,0.47588,0.017532,0.01762,0,0
2,GO DNA DOUBLE STRAND BREAK PROCESSING,0.86455,0.017507,-0.0079791,0,0
2,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.27611,0.017285,0.039654,0,0
2,GO PROSTATIC BUD FORMATION,0.83713,0.017271,-0.094231,0,0
2,GO ENDODERMAL CELL DIFFERENTIATION,0.63354,0.017071,-0.059135,0,0
2,GO CANONICAL WNT SIGNALING PATHWAY,0.80312,0.017066,-0.0033325,0,0
2,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,0.85768,0.017032,-0.022861,0,0
2,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.46512,0.016925,0.02599,0,0
2,GO TRANSITION METAL ION HOMEOSTASIS,0.56075,0.016895,0.015071,0,0
2,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.84397,0.016853,0.0044396,0,0
2,GO REGULATION OF CHROMOSOME SEGREGATION,0.26847,0.016798,0.038712,0,0
2,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.27611,0.016703,0.053101,0,0
2,GO REGULATION OF OOGENESIS,0.44924,0.01662,-0.056119,0,0
2,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.90599,0.01645,0.007407,0,0
2,GO EMBRYONIC PATTERN SPECIFICATION,0.71006,0.016362,0.020384,0,0
2,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.53167,0.016183,0.025218,0,0
2,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.63354,0.016057,0.035845,0,0
2,GO DETECTION OF VISIBLE LIGHT,0.48131,0.0159,0.044241,0,0
2,GO ORGANELLE FUSION,0.80989,0.015796,-0.0066239,0,0
2,GO CHONDROCYTE DIFFERENTIATION,0.89215,0.015664,-0.032996,0,0
2,GO NODAL SIGNALING PATHWAY,0.9686,0.015654,-0.016513,0,0
2,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.42347,0.015603,0.049487,0,0
2,GO VESICLE DOCKING,0.48678,0.015435,0.035588,0,0
2,GO HORMONE MEDIATED SIGNALING PATHWAY,0.85082,0.015429,-0.010858,0,0
2,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.35607,0.015387,0.027589,0,0
2,GO ENSHEATHMENT OF NEURONS,0.75615,0.015249,0.0062892,0,0
2,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.38888,0.015212,0.045411,0,0
2,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.38888,0.015163,0.026909,0,0
2,GO SOMATIC STEM CELL DIVISION,0.87144,0.015116,0.024833,0,0
2,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.95466,0.015107,-0.01713,0,0
2,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.69707,0.015035,-0.00017288,0,0
2,GO RESPONSE TO CAMP,0.29184,0.014955,0.047401,0,0
2,GO CARDIAC VENTRICLE DEVELOPMENT,0.64605,0.014931,0.018597,0,0
2,GO REGULATION OF PROTEIN MATURATION,0.78289,0.014886,-0.048514,0,0
2,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.99651,0.014794,-0.053607,0,0
2,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.82348,0.014788,0.015365,0,0
2,GO COMPLEMENT ACTIVATION,0.8303,0.014705,-0.056068,0,0
2,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.4598,0.014615,0.040127,0,0
2,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.94073,0.014529,-0.013746,0,0
2,GO LYSOSOME LOCALIZATION,0.43883,0.014507,-0.054235,0,0
2,GO RESPONSE TO PROSTAGLANDIN,0.54903,0.014507,0.016201,0,0
2,GO INTRACELLULAR MRNA LOCALIZATION,0.93377,0.014461,-0.018421,0,0
2,GO POSITIVE REGULATION OF ANION TRANSPORT,0.92682,0.014395,-0.020453,0,0
2,GO HISTONE DEACETYLATION,0.86455,0.014311,-0.0095593,0,0
2,GO RETINOIC ACID METABOLIC PROCESS,0.81668,0.014272,-0.058788,0,0
2,GO SYNCYTIUM FORMATION,0.91293,0.014208,-0.00773,0,0
2,GO CELLULAR ION HOMEOSTASIS,0.78962,0.014174,0.0070492,0,0
2,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.98953,0.014172,-0.014974,0,0
2,GO DIVALENT INORGANIC ANION HOMEOSTASIS,0.63354,0.014161,0.030027,0,0
2,GO REGULATION OF MICROTUBULE BINDING,0.36064,0.014122,0.06788,0,0
2,GO CELL CYCLE PHASE TRANSITION,0.91987,0.01403,-0.0022613,0,0
2,GO AMINOGLYCAN METABOLIC PROCESS,0.73628,0.014016,-0.00043295,0,0
2,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.78962,0.013994,-0.0028564,0,0
2,GO MEMBRANE BIOGENESIS,0.91293,0.013919,-0.016019,0,0
2,GO ALPHA AMINO ACID METABOLIC PROCESS,0.56075,0.013905,0.031828,0,0
2,GO REGULATION OF ENDOCYTOSIS,0.97557,0.013786,-0.000796,0,0
2,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.98953,0.013741,9.2521e-05,0,0
2,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.99651,0.013716,0.0016867,0,0
2,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.23937,0.013563,0.0867,0,0
2,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.63354,0.013491,0.030871,0,0
2,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.48131,0.013438,0.010475,0,0
2,GO OLIGODENDROCYTE DEVELOPMENT,0.49227,0.013319,-0.052704,0,0
2,GO REGULATION OF CELLULAR LOCALIZATION,0.41341,0.013302,0.020149,0,0
2,GO RESPONSE TO MUSCLE STRETCH,0.65234,0.012963,0.019026,0,0
2,GO TERPENOID METABOLIC PROCESS,0.53167,0.012959,-0.048455,0,0
2,GO CELL CELL SIGNALING BY WNT,0.67776,0.012924,0.0040329,0,0
2,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,1,0.012924,-0.010853,0,0
2,GO SOMITOGENESIS,0.75615,0.012884,-0.013891,0,0
2,GO NCRNA CATABOLIC PROCESS,0.92682,0.012874,-0.00061769,0,0
2,GO POST EMBRYONIC DEVELOPMENT,0.50337,0.012845,-0.03428,0,0
2,GO RESPONSE TO CARBOHYDRATE,0.8303,0.012791,-0.0018795,0,0
2,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.68418,0.012757,0.015022,0,0
2,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.93377,0.012426,-0.011165,0,0
2,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.5726,0.012155,-0.022016,0,0
2,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.22905,0.01208,0.023931,0,0
2,GO HINDBRAIN DEVELOPMENT,0.34702,0.012054,0.056454,0,0
2,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.97557,0.011896,-0.010103,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.85768,0.011887,0.0023157,0,0
2,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.82348,0.01186,0.010332,0,0
2,GO CELL CYCLE G1 S PHASE TRANSITION,0.79636,0.011832,-0.0006604,0,0
2,GO VASODILATION,0.30402,0.011816,0.058037,0,0
2,GO MITOCHONDRIAL TRNA PROCESSING,0.29184,0.011812,0.1047,0,0
2,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.68418,0.011693,0.037641,0,0
2,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.72313,0.011683,0.0096705,0,0
2,GO POSITIVE REGULATION OF T CELL MIGRATION,0.62732,0.011669,-0.044504,0,0
2,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.52025,0.011663,-0.060471,0,0
2,GO MANNOSYLATION,0.72313,0.01166,-0.041711,0,0
2,GO MITOCHONDRIAL TRANSPORT,0.57857,0.011623,0.0083721,0,0
2,GO MESENCHYME DEVELOPMENT,0.92682,0.011533,-0.017653,0,0
2,GO HEAD DEVELOPMENT,0.38888,0.011522,0.035896,0,0
2,GO NEGATIVE REGULATION OF CELL CYCLE,0.85768,0.011515,-0.0063422,0,0
2,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.97557,0.011501,-0.0084849,0,0
2,GO DOUBLE STRAND BREAK REPAIR,0.70355,0.011466,0.010564,0,0
2,GO PEPTIDYL PROLINE MODIFICATION,0.76948,0.011348,0.00081077,0,0
2,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.40843,0.011263,-0.051516,0,0
2,GO CIRCULATORY SYSTEM PROCESS,0.95466,0.011262,-0.0044998,0,0
2,GO RESPONSE TO ATP,0.54321,0.011184,0.023555,0,0
2,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,0.90599,0.011106,-0.077073,0,0
2,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.57857,0.011054,-0.021601,0,0
2,GO VISUAL BEHAVIOR,0.48678,0.011038,0.036199,0,0
2,GO REGULATION OF LIPASE ACTIVITY,0.76948,0.011037,-0.010956,0,0
2,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.9686,0.010961,-0.042987,0,0
2,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.92682,0.010889,-0.0036678,0,0
2,GO DNA LIGATION,0.97557,0.010881,-0.0011536,0,0
2,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.71006,0.010711,0.0058404,0,0
2,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.9686,0.0107,-0.01829,0,0
2,GO SOMITE DEVELOPMENT,0.72969,0.010665,0.01032,0,0
2,GO REGULATION OF FILOPODIUM ASSEMBLY,0.57857,0.010611,0.05109,0,0
2,GO RECEPTOR METABOLIC PROCESS,0.69707,0.010605,0.01992,0,0
2,GO CELL FATE COMMITMENT,0.77618,0.01056,-0.019383,0,0
2,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.56666,0.010495,0.017299,0,0
2,GO REGULATION OF CELL DIFFERENTIATION,0.98953,0.010484,-0.0071665,0,0
2,GO HINDBRAIN MORPHOGENESIS,0.5726,0.010333,0.045606,0,0
2,GO REGULATION OF FEEDING BEHAVIOR,0.19095,0.010159,0.10225,0,0
2,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.87833,0.010127,-0.010742,0,0
2,GO MITOTIC DNA REPLICATION,0.90599,0.010126,-0.013772,0,0
2,GO THYMUS DEVELOPMENT,0.93377,0.010049,-0.0022784,0,0
2,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.78289,0.010027,0.0062207,0,0
2,GO RHYTHMIC PROCESS,0.90599,0.0097994,0.002983,0,0
2,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.76281,0.0097513,0.011355,0,0
2,GO STEM CELL DIFFERENTIATION,0.76281,0.0096906,-0.018138,0,0
2,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.76948,0.0096897,-0.0073922,0,0
2,GO INTRACELLULAR PROTEIN TRANSPORT,0.65866,0.0095956,0.0069814,0,0
2,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,0.81668,0.0094596,0.0014535,0,0
2,GO GLIAL CELL PROLIFERATION,0.72969,0.0093701,-0.038691,0,0
2,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.59059,0.0093476,0.01958,0,0
2,GO RESPONSE TO DRUG,0.57857,0.0091927,0.020593,0,0
2,GO INTRACELLULAR TRANSPORT,0.9686,0.0091498,-0.0026833,0,0
2,GO LYMPHOCYTE HOMEOSTASIS,0.89907,0.0091333,-0.010242,0,0
2,GO ESTABLISHMENT OF TISSUE POLARITY,0.91987,0.0091104,0.0022079,0,0
2,GO HEAD MORPHOGENESIS,0.73628,0.0090675,-0.054164,0,0
2,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.82348,0.0090306,0.012044,0,0
2,GO INSEMINATION,0.56666,0.0090097,-0.071983,0,0
2,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.83713,0.0088583,-0.029768,0,0
2,GO RESPONSE TO IONIZING RADIATION,0.60272,0.0086388,-0.036803,0,0
2,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.78289,0.0085554,-0.042887,0,0
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.86455,0.0083696,-0.047653,0,0
2,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.71006,0.0083209,-0.041158,0,0
2,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.63978,0.0083131,-0.031907,0,0
2,GO NEGATIVE REGULATION OF NEURON DEATH,0.73628,0.0082851,0.011449,0,0
2,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.52594,0.0082561,0.044908,0,0
2,GO REGULATION OF ATPASE ACTIVITY,0.9686,0.0081832,-0.010798,0,0
2,GO REGULATION OF MACROAUTOPHAGY,0.87144,0.0081344,-0.0070383,0,0
2,GO FIBROBLAST ACTIVATION,0.80312,0.0081279,-0.041497,0,0
2,GO NUCLEOSOME ASSEMBLY,0.55487,0.0080678,0.024743,0,0
2,GO RESPONSE TO FATTY ACID,0.63354,0.007977,0.014849,0,0
2,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.32077,0.0079634,-0.06499,0,0
2,GO CALCIUM MEDIATED SIGNALING,0.5726,0.0078482,0.013017,0,0
2,GO CELLULAR LIPID CATABOLIC PROCESS,0.39858,0.0078203,-0.050042,0,0
2,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.96163,0.0078085,-0.0010393,0,0
2,GO REGULATION OF DENDRITE EXTENSION,0.5726,0.0077551,0.11384,0,0
2,GO REGULATION OF SULFUR METABOLIC PROCESS,0.62732,0.0077524,0.039512,0,0
2,GO REGULATION OF VACUOLE ORGANIZATION,0.61497,0.0077184,-0.037848,0,0
2,GO POSITIVE REGULATION OF BINDING,0.89215,0.0076239,0.005204,0,0
2,GO ANIMAL ORGAN MORPHOGENESIS,0.76948,0.0075946,-0.023653,0,0
2,GO CALCIUM IMPORT INTO THE MITOCHONDRION,0.59059,0.007441,-0.043833,0,0
2,GO ENDOCYTOSIS,0.73628,0.0073062,0.0071156,0,0
2,GO REGULATION OF CHROMOSOME SEPARATION,0.41341,0.0072445,0.032636,0,0
2,GO TETRAPYRROLE METABOLIC PROCESS,0.78289,0.0070853,0.00025501,0,0
2,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.91987,0.0070363,-0.024636,0,0
2,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.43883,0.0069035,0.021505,0,0
2,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.96163,0.0068807,-0.025694,0,0
2,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.91987,0.0068506,-0.020342,0,0
2,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.72969,0.0068365,0.021299,0,0
2,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.90599,0.0067852,-0.0039021,0,0
2,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.73628,0.0067294,-0.0023183,0,0
2,GO DNA STRAND ELONGATION,0.79636,0.0066817,0.033476,0,0
2,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.40349,0.006628,0.032395,0,0
2,GO SPINAL CORD DEVELOPMENT,0.56666,0.0065917,0.036106,0,0
2,GO REGULATION OF DEACETYLASE ACTIVITY,0.8303,0.0064893,-0.02342,0,0
2,GO ISOPRENOID METABOLIC PROCESS,0.41842,0.0064745,-0.050097,0,0
2,GO TRIPARTITE REGIONAL SUBDIVISION,0.39858,0.0064415,-0.082113,0,0
2,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.71006,0.0064107,-0.062065,0,0
2,GO PEPTIDYL LYSINE MODIFICATION,0.81668,0.0064007,-0.0014967,0,0
2,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.3746,0.0063876,0.036079,0,0
2,GO TRANSITION METAL ION TRANSPORT,0.9686,0.0062893,-0.012317,0,0
2,GO GLYCEROLIPID CATABOLIC PROCESS,0.69707,0.0062535,-0.03318,0,0
2,GO PEPTIDYL LYSINE METHYLATION,0.9686,0.0061402,0.0075368,0,0
2,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.85768,0.0060765,-0.0030939,0,0
2,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.71658,0.0059511,-0.039991,0,0
2,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.50337,0.0059337,-0.048614,0,0
2,GO CELLULAR SODIUM ION HOMEOSTASIS,0.96163,0.0058761,-0.011583,0,0
2,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.74288,0.005827,0.038529,0,0
2,GO AMINOGLYCAN CATABOLIC PROCESS,0.74288,0.005808,-0.056682,0,0
2,GO NEURAL PRECURSOR CELL PROLIFERATION,0.98953,0.0056344,0.0085193,0,0
2,GO VESICLE CARGO LOADING,0.96163,0.0055976,-0.034602,0,0
2,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.47049,0.0055959,-0.076542,0,0
2,GO STEROL TRANSPORT,0.5726,0.0055668,-0.042278,0,0
2,GO COVALENT CHROMATIN MODIFICATION,0.84397,0.0055293,0.0032237,0,0
2,GO ASTROCYTE DIFFERENTIATION,0.98953,0.0053946,0.0052026,0,0
2,GO MITOCHONDRION MORPHOGENESIS,0.85768,0.0053581,-0.0010191,0,0
2,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.79636,0.005149,-0.026913,0,0
2,GO MIDGUT DEVELOPMENT,0.96163,0.0051445,-0.015151,0,0
2,GO CHONDROCYTE PROLIFERATION,0.91987,0.0051153,0.0016201,0,0
2,GO CELLULAR RESPONSE TO ATP,0.3746,0.0050817,0.047175,0,0
2,GO ANION TRANSMEMBRANE TRANSPORT,0.41842,0.0050806,0.031823,0,0
2,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.72969,0.0050624,-0.043073,0,0
2,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.94073,0.0050359,-0.0048989,0,0
2,GO HEART GROWTH,0.2839,0.0050315,0.056927,0,0
2,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.30815,0.0050261,0.037477,0,0
2,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.63354,0.0049954,0.013793,0,0
2,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.61497,0.0049698,0.037935,0,0
2,GO REGULATION OF PROTEIN ACETYLATION,0.97557,0.0049425,-0.0017851,0,0
2,GO CHROMATIN ORGANIZATION,0.98255,0.004924,-0.0017387,0,0
2,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.85082,0.0049136,-0.061184,0,0
2,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.48131,0.0048492,0.023663,0,0
2,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.52025,0.0048344,0.01364,0,0
2,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.66501,0.0047222,-0.063692,0,0
2,GO MACROMOLECULE DEACYLATION,0.65866,0.0047171,0.015379,0,0
2,GO CELL CYCLE PROCESS,0.89215,0.0046228,-0.003076,0,0
2,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.74288,0.0046221,-0.027191,0,0
2,GO RECEPTOR RECYCLING,0.91293,0.004562,-0.012386,0,0
2,GO ADULT LOCOMOTORY BEHAVIOR,0.38408,0.0044266,0.080401,0,0
2,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.31653,0.0043766,0.044046,0,0
2,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,0.69061,0.0042673,-0.0027631,0,0
2,GO REGULATION OF BINDING,0.62732,0.0042594,-0.01871,0,0
2,GO HYPEROSMOTIC RESPONSE,0.78289,0.0042529,-0.031204,0,0
2,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.90599,0.004252,0.011128,0,0
2,GO PEPTIDYL SERINE MODIFICATION,0.33812,0.0041312,-0.028558,0,0
2,GO REGULATION OF PROTEIN STABILITY,0.62732,0.0041212,-0.016858,0,0
2,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.90599,0.0039969,-0.011779,0,0
2,GO VENTRICULAR SYSTEM DEVELOPMENT,0.52594,0.0038315,0.034647,0,0
2,GO ACTIN FILAMENT BASED MOVEMENT,0.85082,0.0037939,-0.0089701,0,0
2,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.7495,0.0037598,0.0014151,0,0
2,GO DRUG METABOLIC PROCESS,0.7495,0.0037539,-0.0068088,0,0
2,GO METHIONINE METABOLIC PROCESS,0.91293,0.0036902,-0.018883,0,0
2,GO ENGULFMENT OF APOPTOTIC CELL,0.73628,0.0036781,-0.043312,0,0
2,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.63978,0.0034803,-0.040616,0,0
2,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.63354,0.0034268,0.01767,0,0
2,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.72313,0.0033832,0.014453,0,0
2,GO REGULATION OF CELL CYCLE PROCESS,0.97557,0.0033497,-0.0034348,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.33812,0.0033183,0.048085,0,0
2,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.77618,0.0032772,-0.0396,0,0
2,GO POSITIVE REGULATION OF MYELINATION,0.53167,0.0032278,0.045445,0,0
2,GO SKELETAL SYSTEM DEVELOPMENT,0.91293,0.0032274,-0.017486,0,0
2,GO MAST CELL MIGRATION,0.79636,0.0030541,-0.057608,0,0
2,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.9686,0.0030387,-0.0057029,0,0
2,GO NEGATIVE REGULATION OF ION TRANSPORT,0.72969,0.0030025,0.01727,0,0
2,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.75615,0.0029931,0.03214,0,0
2,GO MITOTIC CELL CYCLE,0.87144,0.0029303,-0.009113,0,0
2,GO DOPAMINE METABOLIC PROCESS,0.96163,0.0028974,0.028137,0,0
2,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.93377,0.0028891,-0.0074689,0,0
2,GO ACTIVATION OF JNKK ACTIVITY,0.89215,0.0028527,-0.012984,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.59059,0.0027225,-0.033148,0,0
2,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.68418,0.0026018,0.0055043,0,0
2,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.75615,0.0024251,0.011794,0,0
2,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.56666,0.0021858,0.027748,0,0
2,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.66501,0.0021491,-0.012893,0,0
2,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.96163,0.0020983,-0.00019962,0,0
2,GO POSITIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.42855,0.0020975,0.092799,0,0
2,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.65234,0.0019754,0.060867,0,0
2,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.49227,0.0019008,-0.065546,0,0
2,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.76948,0.0018088,-0.0023158,0,0
2,GO ERROR PRONE TRANSLESION SYNTHESIS,0.91987,0.0017719,0.0062413,0,0
2,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.69061,0.001762,0.016804,0,0
2,GO CELL PROJECTION ORGANIZATION,0.66501,0.0017527,0.018766,0,0
2,GO VESICLE CYTOSKELETAL TRAFFICKING,0.71658,0.0017109,0.023363,0,0
2,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.75615,0.0015939,-0.042717,0,0
2,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.9686,0.0014908,-0.0014358,0,0
2,GO REGULATION OF WNT SIGNALING PATHWAY,0.9686,0.0014733,-0.0091945,0,0
2,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.85082,0.0014074,-0.034616,0,0
2,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.52025,0.0012349,0.026247,0,0
2,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.89907,0.0012121,-0.012278,0,0
2,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.31232,0.0011984,-0.059052,0,0
2,GO RESPONSE TO INTERLEUKIN 4,0.59059,0.0011784,-0.036901,0,0
2,GO IMPORT INTO NUCLEUS,0.93377,0.0011547,-0.0035695,0,0
2,GO HYPEROSMOTIC SALINITY RESPONSE,0.78289,0.0011132,-0.048874,0,0
2,GO LIPID PHOSPHORYLATION,0.50337,0.0010831,0.041144,0,0
2,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.53167,0.0010643,-0.039973,0,0
2,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.65866,0.0010595,0.033711,0,0
2,GO RESPONSE TO ORGANOPHOSPHORUS,0.44402,0.00094454,0.029056,0,0
2,GO ORGANIC HYDROXY COMPOUND TRANSPORT,0.78962,0.00092425,-0.029875,0,0
2,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.72969,0.00085306,-0.076354,0,0
2,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.87144,0.00066066,0.0056869,0,0
2,GO HOMOLOGOUS RECOMBINATION,0.97557,0.00061569,-0.001468,0,0
2,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.80312,0.00058415,0.013009,0,0
2,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.83713,0.00054748,-0.013983,0,0
2,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.85768,0.00049936,-0.030225,0,0
2,GO RESPONSE TO NICOTINE,0.69061,0.00045567,0.027831,0,0
2,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.54321,0.00034335,-0.014881,0,0
2,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.41341,0.00014907,0.021634,0,0
2,GO NON CANONICAL WNT SIGNALING PATHWAY,0.91293,0.00013118,0.00040004,0,0
2,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.75615,0.00011039,0.014211,0,0
2,GO IRON ION TRANSMEMBRANE TRANSPORT,0.83713,5.2757e-05,-0.039116,0,0
2,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.5726,-4.8057e-05,-0.016782,0,0
2,GO MAINTENANCE OF LOCATION,0.78289,-6.148e-05,0.0098354,0,0
2,GO PROTEIN AUTOPROCESSING,0.98953,-0.00016379,-0.022545,0,0
2,GO PIRNA METABOLIC PROCESS,0.48131,-0.0002303,-0.10914,0,0
2,GO REGULATION OF MUSCLE CONTRACTION,0.52025,-0.00023226,-0.028183,0,0
2,GO POSITIVE REGULATION OF AUTOPHAGY,0.77618,-0.00036335,0.0048093,0,0
2,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.63354,-0.000428,-0.044165,0,0
2,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.96163,-0.00048452,0.0017186,0,0
2,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.80312,-0.00049308,-0.05234,0,0
2,GO MUSCLE HYPERTROPHY,0.72969,-0.00058105,-0.028925,0,0
2,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.41842,-0.0007005,-0.034803,0,0
2,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,1,-0.00076563,-0.031239,0,0
2,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.76948,-0.00085104,-0.029858,0,0
2,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.62732,-0.00086836,0.019572,0,0
2,GO FEVER GENERATION,0.53742,-0.0010039,0.030955,0,0
2,GO REGULATION OF RESPONSE TO FOOD,0.69061,-0.001153,-0.019731,0,0
2,GO MITOTIC SISTER CHROMATID SEGREGATION,0.80989,-0.0011931,-0.0028538,0,0
2,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.50896,-0.0012676,-0.044833,0,0
2,GO THYROID HORMONE METABOLIC PROCESS,0.79636,-0.0012742,0.0056948,0,0
2,GO METANEPHRIC COLLECTING DUCT DEVELOPMENT,0.96163,-0.0012755,-0.0061296,0,0
2,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.52594,-0.0013027,0.025534,0,0
2,GO NUCLEAR BODY ORGANIZATION,0.78962,-0.001415,-0.014481,0,0
2,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.89215,-0.0014205,0.011426,0,0
2,GO BODY FLUID SECRETION,0.81668,-0.0014761,0.0029811,0,0
2,GO RESPONSE TO GLUCAGON,0.91987,-0.0015068,-0.014708,0,0
2,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.60883,-0.0015098,-0.030795,0,0
2,GO OVULATION CYCLE,0.4978,-0.0015213,0.032306,0,0
2,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.97557,-0.0016361,0.0037829,0,0
2,GO REGULATION OF REPRODUCTIVE PROCESS,0.63354,-0.0016612,-0.02543,0,0
2,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.85768,-0.0016885,-0.0014084,0,0
2,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.94769,-0.0017264,-0.012812,0,0
2,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.67137,-0.0017465,-0.066126,0,0
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.59664,-0.0019113,-0.030114,0,0
2,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.39858,-0.0019951,0.039776,0,0
2,GO C21 STEROID HORMONE METABOLIC PROCESS,0.85768,-0.0020953,-0.059625,0,0
2,GO REGULATION OF CARTILAGE DEVELOPMENT,0.78962,-0.0021106,-0.043574,0,0
2,GO REGULATION OF CYTOKINESIS,0.43883,-0.002141,-0.032988,0,0
2,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.78289,-0.0021447,0.0050345,0,0
2,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.97557,-0.0021541,-0.011407,0,0
2,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.7495,-0.0021752,-0.039342,0,0
2,GO NUCLEOSIDE SALVAGE,0.36991,-0.0022156,0.039444,0,0
2,GO EXOCYTIC PROCESS,0.56666,-0.002245,0.062948,0,0
2,GO PIGMENT GRANULE MATURATION,0.85768,-0.0023048,-0.054706,0,0
2,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.97557,-0.0023323,-0.0083782,0,0
2,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.84397,-0.0023651,-0.025005,0,0
2,GO TAXIS,0.7495,-0.0024014,-0.010814,0,0
2,GO NEURON DEATH,0.92682,-0.0025196,-0.0017035,0,0
2,GO POSITIVE REGULATION OF TOR SIGNALING,0.95466,-0.0026231,-0.013383,0,0
2,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.83713,-0.0030017,0.0066233,0,0
2,GO DOSAGE COMPENSATION,0.8303,-0.0030349,-0.013877,0,0
2,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.58456,-0.0030703,-0.15633,0,0
2,GO CHROMOSOME ORGANIZATION,0.87833,-0.0030851,0.0056816,0,0
2,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.37932,-0.0032129,-0.048803,0,0
2,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.40349,-0.003424,0.021385,0,0
2,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.93377,-0.0035655,-0.017228,0,0
2,GO RESPONSE TO LIGHT STIMULUS,0.60883,-0.0037699,0.020089,0,0
2,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.80989,-0.0038033,0.010839,0,0
2,GO PEPTIDYL LYSINE ACETYLATION,0.68418,-0.0038524,-0.013559,0,0
2,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.53742,-0.0038826,0.035653,0,0
2,GO CHEMICAL HOMEOSTASIS,0.95466,-0.003967,-0.0080533,0,0
2,GO HEART MORPHOGENESIS,0.99651,-0.0041449,-0.018148,0,0
2,GO HISTONE H4 K16 ACETYLATION,0.54903,-0.0041466,-0.019115,0,0
2,GO ORGANIC ACID TRANSPORT,0.55487,-0.0042215,0.017458,0,0
2,GO REGULATION OF CATABOLIC PROCESS,0.94073,-0.004325,-0.0048182,0,0
2,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.97557,-0.0043475,-0.013154,0,0
2,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.94769,-0.0043516,-0.016717,0,0
2,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.80312,-0.0043878,-0.024818,0,0
2,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.67776,-0.0045072,0.0046049,0,0
2,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.52025,-0.0047153,-0.030987,0,0
2,GO RESPONSE TO PH,0.76948,-0.004738,-0.027486,0,0
2,GO PROTEIN LOCALIZATION TO NUCLEUS,0.69707,-0.0047639,-0.021699,0,0
2,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.71658,-0.0048014,-0.013175,0,0
2,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.80312,-0.0048961,-0.015413,0,0
2,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.75615,-0.0049049,-0.025801,0,0
2,GO REGULATION OF DNA CATABOLIC PROCESS,0.97557,-0.005009,0.0067403,0,0
2,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.72313,-0.005061,-0.052126,0,0
2,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.55487,-0.0050735,0.08997,0,0
2,GO MACROMOLECULE CATABOLIC PROCESS,0.90599,-0.0050959,-0.0070516,0,0
2,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.61497,-0.0051145,-0.021377,0,0
2,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.87144,-0.0051889,0.013658,0,0
2,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.72313,-0.0052208,-0.050558,0,0
2,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.82348,-0.0052434,-0.0048747,0,0
2,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.65866,-0.0052449,-0.048825,0,0
2,GO CELLULAR RESPONSE TO OSMOTIC STRESS,0.66501,-0.005382,-0.043445,0,0
2,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.20621,-0.0057439,-0.059669,0,0
2,GO CELLULAR OXIDANT DETOXIFICATION,0.87144,-0.0061845,-0.014707,0,0
2,GO LIPID CATABOLIC PROCESS,0.47588,-0.0062484,-0.037588,0,0
2,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.65234,-0.0063962,-0.022471,0,0
2,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.56666,-0.0064213,-0.021922,0,0
2,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.3746,-0.0064736,0.045386,0,0
2,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.91293,-0.0065886,-0.010019,0,0
2,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.95466,-0.0066102,-0.030804,0,0
2,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.85768,-0.0067242,0.0015205,0,0
2,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.48131,-0.0067761,0.044148,0,0
2,GO HEAT GENERATION,0.62113,-0.0067979,-0.041792,0,0
2,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.76281,-0.0068298,-0.040138,0,0
2,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.49227,-0.0068596,-0.061985,0,0
2,GO BLASTODERM SEGMENTATION,0.4978,-0.0069007,0.08959,0,0
2,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.44402,-0.0069391,-0.061373,0,0
2,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.31232,-0.006964,-0.10786,0,0
2,GO MUSCLE STRUCTURE DEVELOPMENT,0.58456,-0.0069784,-0.030028,0,0
2,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.76948,-0.0071088,-0.0088894,0,0
2,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.86455,-0.0071364,0.018294,0,0
2,GO PROTEIN LOCALIZATION TO CELL CORTEX,0.87833,-0.007325,-0.045401,0,0
2,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.7495,-0.0073674,-0.011251,0,0
2,GO HINDLIMB MORPHOGENESIS,0.66501,-0.0074091,0.010561,0,0
2,GO POLYOL BIOSYNTHETIC PROCESS,0.86455,-0.0074578,-0.016199,0,0
2,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.84397,-0.0076558,-0.01464,0,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.76281,-0.0076769,-0.0092746,0,0
2,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,0.92682,-0.0077309,-0.018139,0,0
2,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.80989,-0.008001,-0.01596,0,0
2,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.89907,-0.0080193,-0.0045908,0,0
2,GO MICROTUBULE ANCHORING AT CENTROSOME,0.70355,-0.0080197,-0.011913,0,0
2,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.65234,-0.0080541,-0.025212,0,0
2,GO SERTOLI CELL DEVELOPMENT,0.89215,-0.0080773,0.020725,0,0
2,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.83713,-0.0081249,-0.022048,0,0
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.71006,-0.0081736,-0.041355,0,0
2,GO SULFUR AMINO ACID METABOLIC PROCESS,0.61497,-0.008546,0.029044,0,0
2,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.80989,-0.0085715,-0.015401,0,0
2,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.54321,-0.0086583,-0.029287,0,0
2,GO APOPTOTIC CELL CLEARANCE,0.82348,-0.0088617,-0.082832,0,0
2,GO ERK1 AND ERK2 CASCADE,0.51459,-0.0089105,-0.046951,0,0
2,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.85768,-0.0089968,-0.012245,0,0
2,GO TRACHEA MORPHOGENESIS,0.89907,-0.0091072,-0.018687,0,0
2,GO DRINKING BEHAVIOR,0.7495,-0.0093318,-0.0030326,0,0
2,GO PIGMENT GRANULE ORGANIZATION,0.97557,-0.0093498,0.0090277,0,0
2,GO REGULATION OF MICROTUBULE BASED PROCESS,0.69707,-0.009508,-0.004935,0,0
2,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.87144,-0.00953,-0.011361,0,0
2,GO RESPONSE TO X RAY,0.60272,-0.0096007,-0.065705,0,0
2,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.50896,-0.0096237,-0.068419,0,0
2,GO FIBROBLAST PROLIFERATION,0.54903,-0.0097005,0.024163,0,0
2,GO MITRAL VALVE DEVELOPMENT,0.59664,-0.00975,-0.0624,0,0
2,GO PERICARDIUM DEVELOPMENT,0.94073,-0.0097832,-0.011658,0,0
2,GO RESPONSE TO ETHANOL,0.99651,-0.0098929,-0.00047781,0,0
2,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.60883,-0.010035,-0.049841,0,0
2,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.65866,-0.01009,-0.037508,0,0
2,GO POSITIVE REGULATION OF GLIOGENESIS,0.62732,-0.010112,-0.030351,0,0
2,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.53167,-0.010163,-0.041355,0,0
2,GO PROSTATE GLAND DEVELOPMENT,0.69707,-0.010221,-0.027857,0,0
2,GO CENTROMERE COMPLEX ASSEMBLY,0.49227,-0.010278,0.037499,0,0
2,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.8303,-0.010279,-0.010079,0,0
2,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.73628,-0.010351,-0.018502,0,0
2,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.81668,-0.010369,0.0030049,0,0
2,GO REGULATION OF PROTEIN FOLDING,0.65234,-0.010619,-0.0232,0,0
2,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.97557,-0.010684,-0.013915,0,0
2,GO SEQUESTERING OF EXTRACELLULAR LIGAND FROM RECEPTOR,0.60272,-0.010713,-0.10836,0,0
2,GO HEART DEVELOPMENT,0.48678,-0.010727,-0.037599,0,0
2,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.36064,-0.010749,-0.084745,0,0
2,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.99651,-0.010795,-0.023231,0,0
2,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.31653,-0.010802,-0.029142,0,0
2,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.80989,-0.010999,-0.0041155,0,0
2,GO BASE EXCISION REPAIR AP SITE FORMATION,0.95466,-0.011084,0.01409,0,0
2,GO GENE SILENCING,0.40843,-0.011122,-0.021814,0,0
2,GO SENSORY PERCEPTION OF SMELL,0.44924,-0.011182,-0.034949,0,0
2,GO CELLULAR RESPONSE TO ZINC ION,0.67776,-0.011203,-0.1668,0,0
2,GO COLLECTING DUCT DEVELOPMENT,0.68418,-0.011264,-0.036411,0,0
2,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.64605,-0.011307,0.058723,0,0
2,GO BLOOD VESSEL MORPHOGENESIS,0.19095,-0.011431,-0.080238,0,0
2,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.4545,-0.011468,-0.032258,0,0
2,GO RESPONSE TO AXON INJURY,0.91293,-0.011778,-0.0012456,0,0
2,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.62113,-0.011837,-0.034786,0,0
2,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.44402,-0.011893,0.12852,0,0
2,GO VESICLE LOCALIZATION,0.26847,-0.012029,-0.033037,0,0
2,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.47049,-0.012085,-0.032097,0,0
2,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.69061,-0.012213,-0.018482,0,0
2,GO CELLULAR RESPONSE TO STARVATION,0.40843,-0.012282,-0.041562,0,0
2,GO MUSCLE TISSUE DEVELOPMENT,0.44924,-0.012391,-0.031789,0,0
2,GO MESODERM DEVELOPMENT,0.44924,-0.012459,-0.050142,0,0
2,GO FEMALE SEX DIFFERENTIATION,0.56075,-0.012515,-0.022809,0,0
2,GO NEUTRAL AMINO ACID TRANSPORT,0.62732,-0.012588,0.025694,0,0
2,GO PROTEIN SUMOYLATION,0.77618,-0.012736,-0.0075734,0,0
2,GO NEGATIVE REGULATION OF SIGNALING,0.50337,-0.012781,-0.022183,0,0
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.87833,-0.012867,-0.0079675,0,0
2,GO BIOMINERALIZATION,0.89215,-0.012871,-0.020201,0,0
2,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.34256,-0.012913,-0.031051,0,0
2,GO CELLULAR RESPONSE TO VITAMIN D,0.55487,-0.012973,0.085402,0,0
2,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.17934,-0.013086,-0.058279,0,0
2,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.21579,-0.013223,-0.045768,0,0
2,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.33812,-0.01325,-0.059833,0,0
2,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.93377,-0.013264,0.0035065,0,0
2,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.57857,-0.013331,-0.027579,0,0
2,GO DNA BIOSYNTHETIC PROCESS,0.65866,-0.013388,-0.013358,0,0
2,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.76948,-0.013403,0.024341,0,0
2,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.20309,-0.013471,-0.05008,0,0
2,GO PROTEIN TARGETING TO LYSOSOME,0.56666,-0.013499,-0.066469,0,0
2,GO POLYOL CATABOLIC PROCESS,0.78962,-0.013535,-0.024826,0,0
2,GO GASTRULATION,0.65866,-0.013544,-0.044904,0,0
2,GO MICROTUBULE ANCHORING,0.63978,-0.013549,-0.024947,0,0
2,GO GLYCOPROTEIN METABOLIC PROCESS,0.56666,-0.013641,-0.035936,0,0
2,GO PHOTOPERIODISM,0.88523,-0.013648,-0.015083,0,0
2,GO BLASTOCYST DEVELOPMENT,0.60272,-0.013652,-0.018421,0,0
2,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.98255,-0.013772,-0.0020253,0,0
2,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.36064,-0.013815,-0.055739,0,0
2,GO REGULATION OF GLIAL CELL PROLIFERATION,0.7495,-0.013861,-0.027981,0,0
2,GO SERTOLI CELL DIFFERENTIATION,0.96163,-0.013871,-5.346e-05,0,0
2,GO RETROGRADE AXONAL TRANSPORT,0.93377,-0.013925,0.012308,0,0
2,GO REGULATION OF FATTY ACID OXIDATION,0.65866,-0.013971,0.046057,0,0
2,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.8303,-0.013999,0.0024329,0,0
2,GO HISTONE H3 K9 MODIFICATION,0.36526,-0.014096,-0.039662,0,0
2,GO NEUROINFLAMMATORY RESPONSE,0.72969,-0.014098,-0.032344,0,0
2,GO REGULATION OF BIOMINERALIZATION,0.59664,-0.014158,-0.038722,0,0
2,GO MITOPHAGY,0.33812,-0.014368,-0.059769,0,0
2,GO VITAMIN TRANSPORT,0.78289,-0.01444,0.035671,0,0
2,GO EXTRACELLULAR STRUCTURE ORGANIZATION,0.96163,-0.014539,-0.053293,0,0
2,GO HISTONE PHOSPHORYLATION,0.5726,-0.014694,-0.040065,0,0
2,GO HISTONE H3 K9 METHYLATION,0.59664,-0.01473,-0.027067,0,0
2,GO CELL DIVISION,0.48131,-0.014868,-0.022416,0,0
2,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.80312,-0.015031,-0.031949,0,0
2,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.60272,-0.015053,-0.043052,0,0
2,GO CELLULAR MACROMOLECULE LOCALIZATION,0.60272,-0.015136,-0.0088106,0,0
2,GO REGULATION OF HISTONE MODIFICATION,0.89215,-0.015318,-0.0092663,0,0
2,GO REGULATION OF T CELL MIGRATION,0.42347,-0.015403,-0.054232,0,0
2,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.40843,-0.015546,-0.019983,0,0
2,GO G2 DNA DAMAGE CHECKPOINT,0.87144,-0.015547,-0.015575,0,0
2,GO OSTEOBLAST DIFFERENTIATION,0.81668,-0.015593,-0.0057824,0,0
2,GO POSITIVE REGULATION OF CELL GROWTH,0.15517,-0.015865,-0.045594,0,0
2,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.98255,-0.015901,-0.023011,0,0
2,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.39371,-0.015977,-0.05669,0,0
2,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.4545,-0.016055,-0.03357,0,0
2,GO SPINDLE ORGANIZATION,0.39858,-0.016137,-0.028088,0,0
2,GO GLIOGENESIS,0.74288,-0.016142,-0.017504,0,0
2,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.59664,-0.016208,-0.068997,0,0
2,GO PRODUCTION OF SIRNA INVOLVED IN RNA INTERFERENCE,0.61497,-0.016301,0.028317,0,0
2,GO RESPONSE TO STEROL,0.77618,-0.016342,-0.017548,0,0
2,GO POSITIVE REGULATION OF DNA REPAIR,0.56666,-0.016354,-0.024477,0,0
2,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.39371,-0.016433,-0.052615,0,0
2,GO ORGAN INDUCTION,0.4978,-0.016484,-0.074804,0,0
2,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.15264,-0.016519,-0.058883,0,0
2,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.24288,-0.016529,-0.032371,0,0
2,GO REGULATION OF ORGANELLE ORGANIZATION,0.50337,-0.016546,-0.015016,0,0
2,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.50896,-0.016593,-0.053644,0,0
2,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.20937,-0.016604,-0.065645,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.44924,-0.016703,-0.027995,0,0
2,GO SISTER CHROMATID COHESION,0.92682,-0.016719,0.0106,0,0
2,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,0.68418,-0.016808,-0.052488,0,0
2,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.72313,-0.016871,-0.073009,0,0
2,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.46512,-0.016947,-0.030799,0,0
2,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,0.80312,-0.01708,-0.062657,0,0
2,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.4545,-0.017094,-0.030825,0,0
2,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.83713,-0.017231,-0.034079,0,0
2,GO SMOOTHENED SIGNALING PATHWAY,0.33373,-0.017298,-0.048122,0,0
2,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.72969,-0.017307,-0.013092,0,0
2,GO AUTOPHAGIC CELL DEATH,0.52594,-0.017344,-0.05563,0,0
2,GO REGULATION OF VASCULAR PERMEABILITY,0.70355,-0.017345,-0.030833,0,0
2,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.76281,-0.017359,-0.012146,0,0
2,GO REGULATION OF TRANSPORT,0.61497,-0.017377,-0.014246,0,0
2,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.53742,-0.017379,-0.029342,0,0
2,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.5726,-0.01739,-0.0339,0,0
2,GO GLAND MORPHOGENESIS,0.46512,-0.017413,-0.092293,0,0
2,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.27611,-0.017446,-0.045449,0,0
2,GO CALCIUM ION IMPORT,0.65866,-0.017459,0.027533,0,0
2,GO TRANSPORT ALONG MICROTUBULE,0.89907,-0.01748,0.01167,0,0
2,GO REGULATION OF CHROMATIN ORGANIZATION,0.53167,-0.017485,-0.019121,0,0
2,GO KERATAN SULFATE METABOLIC PROCESS,0.77618,-0.017605,-0.041129,0,0
2,GO CARDIAC SEPTUM MORPHOGENESIS,0.86455,-0.017617,-0.029001,0,0
2,GO ACETYL COA METABOLIC PROCESS,0.74288,-0.017803,0.024424,0,0
2,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.58456,-0.017903,-0.012086,0,0
2,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.72313,-0.017932,-0.0043403,0,0
2,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.47049,-0.017987,-0.049102,0,0
2,GO AMMONIUM ION METABOLIC PROCESS,0.36991,-0.01823,-0.09678,0,0
2,GO SISTER CHROMATID SEGREGATION,0.60272,-0.018329,-0.011517,0,0
2,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.91293,-0.01838,-0.080202,0,0
2,GO ANION TRANSPORT,0.7495,-0.018423,-0.010151,0,0
2,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.94769,-0.018629,0.018076,0,0
2,GO SKIN EPIDERMIS DEVELOPMENT,0.88523,-0.018726,-0.024389,0,0
2,GO RESPONSE TO ZINC ION,0.62113,-0.018737,-0.069647,0,0
2,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.58456,-0.018831,0.020753,0,0
2,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.53742,-0.018839,-0.060528,0,0
2,GO REGULATION OF DNA METABOLIC PROCESS,0.71006,-0.018859,-0.010004,0,0
2,GO PROTEIN N LINKED GLYCOSYLATION,0.34702,-0.018873,-0.071356,0,0
2,GO DIACYLGLYCEROL METABOLIC PROCESS,0.32506,-0.018886,-0.078006,0,0
2,GO REGULATION OF STEM CELL PROLIFERATION,0.53167,-0.01915,-0.046456,0,0
2,GO REGULATION OF CELL CYCLE,0.30815,-0.019229,-0.020215,0,0
2,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.41341,-0.019283,-0.022807,0,0
2,GO ORGANELLE INHERITANCE,0.49227,-0.019439,-0.037226,0,0
2,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.48131,-0.019447,-0.032394,0,0
2,GO EPITHELIAL STRUCTURE MAINTENANCE,0.49227,-0.019517,-0.042666,0,0
2,GO VASCULATURE DEVELOPMENT,0.25363,-0.019522,-0.066452,0,0
2,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.48678,-0.019665,-0.050587,0,0
2,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.58456,-0.019705,0.028858,0,0
2,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.23589,-0.019711,-0.054555,0,0
2,GO REGULATION OF LYMPHOCYTE MIGRATION,0.39858,-0.019807,-0.060449,0,0
2,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.56666,-0.019892,-0.028081,0,0
2,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.2,-0.019967,-0.071375,0,0
2,GO REGULATION OF AUTOPHAGY,0.4978,-0.019997,-0.022612,0,0
2,GO REGULATION OF CELLULAR COMPONENT SIZE,0.68418,-0.020077,-0.014108,0,0
2,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.50896,-0.020125,0.067618,0,0
2,GO POSITIVE REGULATION OF GROWTH,0.67776,-0.020305,-0.012599,0,0
2,GO REGULATION OF PHOSPHORYLATION,0.20937,-0.020325,-0.042632,0,0
2,GO CELL VOLUME HOMEOSTASIS,0.15264,-0.020357,-0.080097,0,0
2,GO LAMELLIPODIUM ORGANIZATION,0.23245,-0.020431,-0.059592,0,0
2,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.77618,-0.02049,-0.033878,0,0
2,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.65234,-0.020664,-0.02965,0,0
2,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.24643,-0.020679,-0.10669,0,0
2,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.65866,-0.021099,-0.030584,0,0
2,GO MEMBRANE FUSION,0.27999,-0.021176,-0.048341,0,0
2,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.89907,-0.021317,0.071593,0,0
2,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.25363,-0.02133,-0.028237,0,0
2,GO MICROTUBULE BASED MOVEMENT,0.27227,-0.021344,-0.033256,0,0
2,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.89907,-0.021446,-0.0045247,0,0
2,GO MUSCLE FILAMENT SLIDING,0.91987,-0.021468,-0.016047,0,0
2,GO ORGANIC ACID METABOLIC PROCESS,0.81668,-0.021567,-0.016558,0,0
2,GO NUCLEAR ENVELOPE REASSEMBLY,0.4598,-0.021573,-0.051162,0,0
2,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.67776,-0.021645,-0.032571,0,0
2,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.51459,-0.021663,-0.03962,0,0
2,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.4545,-0.021732,-0.015393,0,0
2,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.53167,-0.021734,-0.026713,0,0
2,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.67776,-0.021846,-0.0047164,0,0
2,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.70355,-0.021862,-0.021587,0,0
2,GO REGULATION OF VASCULOGENESIS,0.33373,-0.021997,-0.093101,0,0
2,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.50337,-0.022015,-0.027923,0,0
2,GO REGULATION OF AUTOPHAGOSOME MATURATION,0.78289,-0.022044,-0.03604,0,0
2,GO VITAMIN D BIOSYNTHETIC PROCESS,0.67137,-0.022119,-0.031084,0,0
2,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.72313,-0.02213,-0.051099,0,0
2,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.59664,-0.022203,-0.017086,0,0
2,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.21905,-0.022287,-0.090021,0,0
2,GO PEPTIDYL LYSINE TRIMETHYLATION,0.47588,-0.022386,-0.021315,0,0
2,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.80312,-0.022407,-0.038593,0,0
2,GO RESPONSE TO OXYGEN LEVELS,0.93377,-0.022455,-0.013078,0,0
2,GO FERTILIZATION,0.26098,-0.022487,-0.028927,0,0
2,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.188,-0.022569,-0.04408,0,0
2,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.29586,-0.022607,-0.034894,0,0
2,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.18219,-0.02268,-0.13403,0,0
2,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.50337,-0.022701,-0.035619,0,0
2,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.89907,-0.022744,-0.020357,0,0
2,GO POLYSACCHARIDE CATABOLIC PROCESS,0.92682,-0.022747,-0.0033542,0,0
2,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.77618,-0.02277,-0.02659,0,0
2,GO GLIAL CELL DIFFERENTIATION,0.61497,-0.02287,-0.023392,0,0
2,GO CELLULAR RESPONSE TO KETONE,0.32938,-0.022926,-0.066363,0,0
2,GO BODY MORPHOGENESIS,0.31653,-0.022946,-0.081159,0,0
2,GO INTERLEUKIN 2 PRODUCTION,0.72313,-0.023015,-0.049528,0,0
2,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.59664,-0.023039,-0.081571,0,0
2,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.21579,-0.023048,-0.1047,0,0
2,GO P BODY ASSEMBLY,0.61497,-0.023064,-0.018746,0,0
2,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.95466,-0.023077,0.00022288,0,0
2,GO PROTEIN TARGETING TO VACUOLE,0.36991,-0.023133,-0.057583,0,0
2,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.32506,-0.023137,-0.056151,0,0
2,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.78962,-0.023186,-0.082528,0,0
2,GO DNA INTEGRITY CHECKPOINT,0.29586,-0.023214,-0.038719,0,0
2,GO RECEPTOR BIOSYNTHETIC PROCESS,0.36064,-0.02324,-0.063778,0,0
2,GO ORGANIC ACID CATABOLIC PROCESS,0.40349,-0.023243,-0.049346,0,0
2,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.17374,-0.023355,-0.046619,0,0
2,GO FATTY ACID TRANSPORT,0.72969,-0.023384,-0.024542,0,0
2,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.49227,-0.023425,-0.050692,0,0
2,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.49227,-0.023635,-0.021057,0,0
2,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.38408,-0.023652,-0.068116,0,0
2,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.15773,-0.024099,-0.049024,0,0
2,GO AMINE CATABOLIC PROCESS,0.44924,-0.024209,-0.093456,0,0
2,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.30402,-0.024269,-0.1025,0,0
2,GO POLYSACCHARIDE METABOLIC PROCESS,0.27611,-0.024315,-0.054826,0,0
2,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.32938,-0.024508,-0.030476,0,0
2,GO RESPONSE TO ABIOTIC STIMULUS,0.52025,-0.024594,-0.023625,0,0
2,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.35607,-0.024607,-0.033533,0,0
2,GO CARBOHYDRATE METABOLIC PROCESS,0.80989,-0.024674,-0.0090311,0,0
2,GO REGULATION OF DNA REPLICATION,0.92682,-0.02468,-0.0045385,0,0
2,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.65866,-0.024829,-0.01931,0,0
2,GO NEGATIVE REGULATION OF OSSIFICATION,0.36064,-0.024879,-0.07039,0,0
2,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.41341,-0.024891,-0.055045,0,0
2,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.67137,-0.024914,-0.030866,0,0
2,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.019739,-0.024923,-0.086715,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.30815,-0.024951,-0.031347,0,0
2,GO C4 DICARBOXYLATE TRANSPORT,0.98255,-0.024992,0.01505,0,0
2,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.35153,-0.025158,-0.071753,0,0
2,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.38888,-0.025203,-0.024403,0,0
2,GO REGULATION OF DEPHOSPHORYLATION,0.41842,-0.025215,-0.021795,0,0
2,GO MELANOCYTE DIFFERENTIATION,0.43367,-0.025222,-0.056351,0,0
2,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,0.78962,-0.025276,-0.01593,0,0
2,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.2839,-0.025285,-0.029132,0,0
2,GO PATTERN SPECIFICATION PROCESS,0.44924,-0.025338,-0.030402,0,0
2,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.60272,-0.025653,-0.045093,0,0
2,GO AMINE TRANSPORT,0.99651,-0.025839,0.064469,0,0
2,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.98953,-0.025852,0.045742,0,0
2,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.53742,-0.025889,-0.011043,0,0
2,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.99651,-0.025897,0.0025506,0,0
2,GO CELLULAR KETONE METABOLIC PROCESS,0.5726,-0.02593,-0.053479,0,0
2,GO REGULATION OF ORGANELLE ASSEMBLY,0.11841,-0.025953,-0.040729,0,0
2,GO CELL CYCLE,0.25001,-0.025977,-0.022523,0,0
2,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.27227,-0.026075,-0.049069,0,0
2,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.24288,-0.026102,-0.018355,0,0
2,GO POSITIVE REGULATION OF EXOCYTOSIS,0.72313,-0.02615,0.0020184,0,0
2,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.87144,-0.026156,-0.015939,0,0
2,GO MEMBRANE DOCKING,0.20309,-0.026247,-0.029645,0,0
2,GO MAMMARY GLAND DEVELOPMENT,0.20621,-0.026289,-0.071253,0,0
2,GO RESPONSE TO RADIATION,0.65866,-0.02629,-0.0067871,0,0
2,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.24643,-0.026311,-0.028875,0,0
2,GO MUSCLE CELL DIFFERENTIATION,0.40349,-0.026345,-0.042672,0,0
2,GO MACROPHAGE ACTIVATION,0.84397,-0.026365,-0.024553,0,0
2,GO MESENCHYMAL CELL DIFFERENTIATION,0.56075,-0.026375,-0.047339,0,0
2,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,1,-0.026387,-0.012159,0,0
2,GO T CELL MIGRATION,0.43367,-0.026446,-0.06959,0,0
2,GO TRANSMISSION OF NERVE IMPULSE,0.9686,-0.026471,0.027409,0,0
2,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.25363,-0.026567,-0.076366,0,0
2,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.36064,-0.026647,-0.055413,0,0
2,GO BLEB ASSEMBLY,0.33373,-0.026684,-0.25347,0,0
2,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.15773,-0.026729,-0.097364,0,0
2,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,0.43367,-0.026904,-0.028678,0,0
2,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.50337,-0.026967,-0.044751,0,0
2,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.36064,-0.027007,-0.033968,0,0
2,GO AXIS SPECIFICATION,0.69707,-0.027023,-0.00131,0,0
2,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.46512,-0.027051,-0.040504,0,0
2,GO COPII COATED VESICLE CARGO LOADING,0.62732,-0.027099,-0.023682,0,0
2,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.87144,-0.027157,-0.0027098,0,0
2,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.85082,-0.02721,-0.0089129,0,0
2,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.17934,-0.027252,-0.048935,0,0
2,GO HOMEOSTATIC PROCESS,0.26847,-0.02729,-0.030685,0,0
2,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.15264,-0.027331,-0.13456,0,0
2,GO MUSCLE ATROPHY,0.51459,-0.027353,-0.093716,0,0
2,GO FACE DEVELOPMENT,0.2,-0.027398,-0.098459,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.81668,-0.02754,-0.022786,0,0
2,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.34256,-0.027581,-0.03578,0,0
2,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.33373,-0.027635,-0.03034,0,0
2,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.67776,-0.027651,-0.017569,0,0
2,GO REGULATION OF ACTION POTENTIAL,0.78289,-0.027837,-0.022079,0,0
2,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.56075,-0.027854,-0.10173,0,0
2,GO RESPONSE TO INSULIN,0.23937,-0.027872,-0.040946,0,0
2,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.95466,-0.027884,0.0057815,0,0
2,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.7495,-0.027931,-0.0022154,0,0
2,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.96163,-0.028046,-0.020998,0,0
2,GO REGULATION OF INTRACELLULAR TRANSPORT,0.34256,-0.028056,-0.028641,0,0
2,GO SMOOTH MUSCLE CELL PROLIFERATION,0.61497,-0.028077,-0.044532,0,0
2,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.68418,-0.028218,-0.021905,0,0
2,GO RESPONSE TO STARVATION,0.69707,-0.028266,-0.019755,0,0
2,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.32077,-0.028559,-0.044567,0,0
2,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.32938,-0.028631,-0.061288,0,0
2,GO CHROMOSOME SEGREGATION,0.4598,-0.028657,-0.022158,0,0
2,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.12473,-0.028662,-0.054169,0,0
2,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.83713,-0.028844,-0.0091235,0,0
2,GO REGULATION OF MEMBRANE REPOLARIZATION,0.67776,-0.028846,0.028935,0,0
2,GO ORGANIC ANION TRANSPORT,0.52594,-0.028995,-0.022643,0,0
2,GO EPIDERMIS MORPHOGENESIS,0.87144,-0.029194,-0.039638,0,0
2,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.69707,-0.0292,-0.0099276,0,0
2,GO CELL SUBSTRATE ADHESION,0.56666,-0.029225,-0.050192,0,0
2,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.88523,-0.029295,-0.023462,0,0
2,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.5726,-0.029314,-0.027981,0,0
2,GO OSSIFICATION,0.33373,-0.029494,-0.057957,0,0
2,GO REGULATION OF CELL DIVISION,0.25729,-0.029523,-0.04194,0,0
2,GO MUSCLE CELL PROLIFERATION,0.61497,-0.029577,-0.039756,0,0
2,GO FOCAL ADHESION ASSEMBLY,0.43883,-0.029639,-0.064164,0,0
2,GO LEUKOCYTE HOMEOSTASIS,0.28785,-0.02964,-0.067543,0,0
2,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.20937,-0.029771,-0.10267,0,0
2,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.27227,-0.029816,-0.030102,0,0
2,GO CIRCULATORY SYSTEM DEVELOPMENT,0.25729,-0.029835,-0.058054,0,0
2,GO NUCLEAR ENVELOPE ORGANIZATION,0.25729,-0.029843,-0.056505,0,0
2,GO NIK NF KAPPAB SIGNALING,0.27227,-0.029898,-0.085049,0,0
2,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.059411,-0.02991,-0.065,0,0
2,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.070855,-0.030125,-0.036356,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.25001,-0.030207,-0.042938,0,0
2,GO MOLTING CYCLE,0.63354,-0.030221,-0.044955,0,0
2,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.31653,-0.03029,-0.057567,0,0
2,GO LONG CHAIN FATTY ACID TRANSPORT,0.62113,-0.030407,-0.03705,0,0
2,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.21256,-0.030434,-0.071756,0,0
2,GO CELL JUNCTION ASSEMBLY,0.31232,-0.030441,-0.050339,0,0
2,GO STEM CELL DIVISION,0.94769,-0.03047,-0.0068845,0,0
2,GO ALCOHOL CATABOLIC PROCESS,0.4978,-0.030495,-0.053634,0,0
2,GO ACID SECRETION,0.90599,-0.030511,-0.0013233,0,0
2,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.77618,-0.030557,-0.010788,0,0
2,GO CELLULAR EXTRAVASATION,0.56075,-0.030612,-0.031455,0,0
2,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.50896,-0.030648,-0.056695,0,0
2,GO GLUTATHIONE METABOLIC PROCESS,0.91987,-0.030648,-0.02002,0,0
2,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.40349,-0.030654,-0.052955,0,0
2,GO REGULATION OF CHOLESTEROL EFFLUX,0.30402,-0.030756,-0.068411,0,0
2,GO T CELL RECEPTOR SIGNALING PATHWAY,0.080955,-0.030783,-0.083591,0,0
2,GO REGULATION OF GLUCONEOGENESIS,0.76948,-0.030822,-0.021881,0,0
2,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.69707,-0.030851,-0.027205,0,0
2,GO RESPIRATORY SYSTEM DEVELOPMENT,0.14526,-0.03092,-0.079507,0,0
2,GO REGULATION OF CELL AGING,0.32506,-0.030984,-0.064828,0,0
2,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.14526,-0.031013,-0.041615,0,0
2,GO INOSITOL LIPID MEDIATED SIGNALING,0.20621,-0.031033,-0.058887,0,0
2,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.22568,-0.031154,-0.053133,0,0
2,GO AGING,0.1028,-0.031162,-0.074528,0,0
2,GO REGULATION OF CALCIUM ION IMPORT,0.54321,-0.031173,-0.040351,0,0
2,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.23589,-0.031365,-0.062076,0,0
2,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.69707,-0.031397,-0.026546,0,0
2,GO HAIR FOLLICLE MATURATION,0.27611,-0.031505,-0.10466,0,0
2,GO PROTEIN CATABOLIC PROCESS,0.095625,-0.031539,-0.052693,0,0
2,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.47588,-0.031565,-0.039208,0,0
2,GO SKIN MORPHOGENESIS,0.39371,-0.031647,-0.14764,0,0
2,GO SULFATE TRANSPORT,0.073629,-0.031684,-0.062673,0,0
2,GO POSITIVE REGULATION OF HEAT GENERATION,0.69061,-0.03171,-0.032563,0,0
2,GO CORTICAL CYTOSKELETON ORGANIZATION,0.38888,-0.031726,-0.06098,0,0
2,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.068167,-0.031776,-0.037793,0,0
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.4545,-0.031787,-0.045034,0,0
2,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.0695,-0.031794,-0.043171,0,0
2,GO LAMELLIPODIUM ASSEMBLY,0.44402,-0.031798,-0.036458,0,0
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.65234,-0.031911,-0.028526,0,0
2,GO DNA CATABOLIC PROCESS,0.15773,-0.032259,-0.067355,0,0
2,GO SMALL MOLECULE CATABOLIC PROCESS,0.23245,-0.032418,-0.05419,0,0
2,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.78962,-0.032572,-0.052148,0,0
2,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.15264,-0.03268,-0.16772,0,0
2,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.51459,-0.032754,-0.026166,0,0
2,GO REGULATION OF PHAGOCYTOSIS,0.22235,-0.032766,-0.090831,0,0
2,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.24643,-0.032795,-0.071503,0,0
2,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.90599,-0.032901,-0.019411,0,0
2,GO SODIUM ION HOMEOSTASIS,0.27999,-0.032947,-0.046438,0,0
2,GO REGULATION OF PROTEIN BINDING,0.36064,-0.03295,-0.037602,0,0
2,GO REGULATION OF GROWTH HORMONE SECRETION,0.89907,-0.033011,0.01014,0,0
2,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.22568,-0.033062,-0.068204,0,0
2,GO NEUTRAL LIPID METABOLIC PROCESS,0.61497,-0.033134,-0.010585,0,0
2,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.23245,-0.033202,-0.07845,0,0
2,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.11039,-0.033212,-0.03158,0,0
2,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.60272,-0.033233,-0.022539,0,0
2,GO HISTONE H2B UBIQUITINATION,0.19095,-0.033276,-0.077911,0,0
2,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.36064,-0.033339,-0.15957,0,0
2,GO REGULATION OF TRANSFERASE ACTIVITY,0.15517,-0.033368,-0.037576,0,0
2,GO DNA METHYLATION,0.59664,-0.033528,-0.014798,0,0
2,GO OLIGOSACCHARIDE CATABOLIC PROCESS,0.60883,-0.033558,-0.077682,0,0
2,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.85768,-0.03357,0.0008337,0,0
2,GO LYSOSOMAL TRANSPORT,0.32506,-0.033694,-0.053499,0,0
2,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.46512,-0.033767,-0.044268,0,0
2,GO HISTONE H3 K9 ACETYLATION,0.32938,-0.033798,-0.055461,0,0
2,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.5726,-0.033834,-0.029344,0,0
2,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.22905,-0.033836,-0.080209,0,0
2,GO RESPONSE TO METAL ION,0.29184,-0.033855,-0.042174,0,0
2,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.17099,-0.033886,-0.03698,0,0
2,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.89907,-0.033909,0.016014,0,0
2,GO ALCOHOL METABOLIC PROCESS,0.69707,-0.033941,-0.029167,0,0
2,GO DETOXIFICATION,0.53167,-0.033965,-0.044965,0,0
2,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.48678,-0.033968,-0.067663,0,0
2,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.35607,-0.034059,-0.10266,0,0
2,GO FLUID TRANSPORT,0.25363,-0.034061,-0.074638,0,0
2,GO SIGNAL RELEASE,0.65866,-0.034071,-0.0010474,0,0
2,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.20309,-0.034174,-0.10134,0,0
2,GO INTRACELLULAR STEROL TRANSPORT,0.57857,-0.034258,-0.055949,0,0
2,GO MICROTUBULE BASED PROCESS,0.38408,-0.034271,-0.014227,0,0
2,GO NUCLEAR CHROMOSOME SEGREGATION,0.12259,-0.034518,-0.043649,0,0
2,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.81668,-0.034534,0.0091153,0,0
2,GO SUBSTANTIA NIGRA DEVELOPMENT,0.62113,-0.03477,-0.047274,0,0
2,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.38408,-0.034804,-0.028389,0,0
2,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.99651,-0.034977,-0.0036248,0,0
2,GO CYTOSOLIC TRANSPORT,0.36526,-0.03502,-0.030797,0,0
2,GO ENERGY RESERVE METABOLIC PROCESS,0.51459,-0.035137,-0.030078,0,0
2,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.2,-0.035363,-0.031391,0,0
2,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.79636,-0.03559,-0.02196,0,0
2,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.39371,-0.035609,-0.026577,0,0
2,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.67776,-0.035659,-0.014561,0,0
2,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.43367,-0.035699,-0.042587,0,0
2,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.21256,-0.035736,-0.040174,0,0
2,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.093897,-0.035767,-0.054094,0,0
2,GO RESPONSE TO PEPTIDE,0.25729,-0.035808,-0.036664,0,0
2,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.22235,-0.035875,-0.065438,0,0
2,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.89215,-0.035892,0.015056,0,0
2,GO CIRCADIAN RHYTHM,0.24643,-0.035946,-0.029111,0,0
2,GO RESPONSE TO HYDROXYUREA,0.27999,-0.035971,-0.074191,0,0
2,GO REGULATION OF HEAT GENERATION,0.54903,-0.036122,-0.056632,0,0
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.031059,-0.036167,-0.13545,0,0
2,GO NEGATIVE REGULATION OF CELL GROWTH,0.58456,-0.036219,-0.018153,0,0
2,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.31653,-0.036249,-0.052113,0,0
2,GO CERAMIDE CATABOLIC PROCESS,0.55487,-0.03626,-0.098518,0,0
2,GO CELL REDOX HOMEOSTASIS,0.92682,-0.036266,-0.024957,0,0
2,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.54321,-0.03635,-0.019318,0,0
2,GO PIGMENT CELL DIFFERENTIATION,0.38408,-0.036384,-0.055867,0,0
2,GO RESPONSE TO HYDROPEROXIDE,0.95466,-0.03645,-0.0058813,0,0
2,GO NEURON APOPTOTIC PROCESS,0.63978,-0.036481,-0.0072482,0,0
2,GO RESPONSE TO THYROID HORMONE,0.82348,-0.036511,-0.029967,0,0
2,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.38408,-0.036559,-0.050379,0,0
2,GO SEQUESTERING OF TRIGLYCERIDE,0.72313,-0.036686,0.025592,0,0
2,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.13583,-0.036791,-0.10331,0,0
2,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.38408,-0.036805,-0.071526,0,0
2,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.26471,-0.036864,-0.060497,0,0
2,GO PEPTIDE CATABOLIC PROCESS,0.36991,-0.036872,-0.066441,0,0
2,GO RESPONSE TO ACID CHEMICAL,0.80989,-0.036963,-0.013388,0,0
2,GO CELLULAR RESPONSE TO PEPTIDE,0.14769,-0.037064,-0.045112,0,0
2,GO DENDRITIC CELL CHEMOTAXIS,0.27999,-0.037255,-0.097812,0,0
2,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.93377,-0.03729,-0.0008696,0,0
2,GO NEPHRON MORPHOGENESIS,0.20309,-0.037413,-0.073062,0,0
2,GO LIPID MODIFICATION,0.061812,-0.037429,-0.071872,0,0
2,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.28785,-0.037451,-0.044029,0,0
2,GO GLIAL CELL DEVELOPMENT,0.40349,-0.037506,-0.044883,0,0
2,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.73628,-0.037519,-0.033958,0,0
2,GO LOCOMOTOR RHYTHM,0.94073,-0.037552,0.010264,0,0
2,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.51459,-0.037629,-0.069764,0,0
2,GO POSITIVE REGULATION OF CELL CYCLE,0.12049,-0.037645,-0.032588,0,0
2,GO MACROMOLECULE DEPALMITOYLATION,0.29992,-0.03767,-0.062206,0,0
2,GO RENAL SYSTEM PROCESS,0.084046,-0.037818,-0.092098,0,0
2,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.84397,-0.038001,-0.039616,0,0
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.2,-0.038061,-0.10665,0,0
2,GO DE NOVO PROTEIN FOLDING,0.31653,-0.038069,-0.038373,0,0
2,GO REGULATION OF AMINO ACID TRANSPORT,0.59664,-0.038191,-0.018397,0,0
2,GO REGULATION OF MULTI ORGANISM PROCESS,0.53167,-0.038201,-0.051807,0,0
2,GO RESPONSE TO ACTIVITY,0.23937,-0.03821,-0.067827,0,0
2,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.54903,-0.038384,-0.041155,0,0
2,GO RESPONSE TO GROWTH FACTOR,0.20309,-0.03839,-0.059884,0,0
2,GO PROTEIN DEPHOSPHORYLATION,0.51459,-0.038394,-0.014103,0,0
2,GO N GLYCAN PROCESSING,0.39858,-0.038396,-0.10408,0,0
2,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.11841,-0.038424,-0.059097,0,0
2,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.49227,-0.038452,-0.11563,0,0
2,GO APPENDAGE DEVELOPMENT,0.12689,-0.038465,-0.09591,0,0
2,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.3746,-0.038467,-0.10747,0,0
2,GO CARNITINE SHUTTLE,0.91293,-0.038579,0.013771,0,0
2,GO ORGANELLE LOCALIZATION,0.05824,-0.038687,-0.039002,0,0
2,GO TRANSFERRIN TRANSPORT,0.2839,-0.038787,-0.062721,0,0
2,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.084046,-0.038791,-0.06953,0,0
2,GO REGULATION OF MITOTIC CELL CYCLE,0.073629,-0.038847,-0.04078,0,0
2,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.48678,-0.038902,-0.067253,0,0
2,GO DIET INDUCED THERMOGENESIS,0.73628,-0.038937,0.06081,0,0
2,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.29586,-0.039185,-0.04237,0,0
2,GO DNA MODIFICATION,0.17653,-0.039344,-0.043046,0,0
2,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.057089,-0.039424,-0.10535,0,0
2,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.12473,-0.039426,-0.062679,0,0
2,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.099158,-0.03947,-0.056999,0,0
2,GO CENTRIOLE CENTRIOLE COHESION,0.84397,-0.039504,0.013789,0,0
2,GO REGENERATION,0.44924,-0.039542,-0.050252,0,0
2,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.061812,-0.039547,-0.085658,0,0
2,GO PEROXISOMAL TRANSPORT,0.33812,-0.039597,-0.047467,0,0
2,GO REGULATION OF INSULIN SECRETION,0.91987,-0.039604,-0.00057665,0,0
2,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.22905,-0.039639,-0.047706,0,0
2,GO NEGATIVE REGULATION OF DNA REPLICATION,0.59664,-0.039711,-0.031453,0,0
2,GO ADIPOSE TISSUE DEVELOPMENT,0.86455,-0.03972,-0.00070276,0,0
2,GO NEURON PROJECTION REGENERATION,0.89215,-0.039762,0.010796,0,0
2,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.84397,-0.039803,-0.0012998,0,0
2,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.71658,-0.039815,-0.06205,0,0
2,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.11039,-0.0399,-0.060889,0,0
2,GO AXIS ELONGATION,0.43883,-0.039958,-0.092542,0,0
2,GO REGULATION OF BLOOD PRESSURE,0.27611,-0.039994,-0.057518,0,0
2,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.80312,-0.039999,-0.020449,0,0
2,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.26847,-0.04001,-0.029269,0,0
2,GO LIPID OXIDATION,0.39371,-0.040258,-0.057369,0,0
2,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.51459,-0.040537,-0.031294,0,0
2,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.20309,-0.040573,-0.078009,0,0
2,GO METANEPHROS DEVELOPMENT,0.18219,-0.040599,-0.08717,0,0
2,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.59664,-0.040689,-0.083843,0,0
2,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.9686,-0.040872,-0.0072722,0,0
2,GO VAGINA DEVELOPMENT,0.66501,-0.040942,-0.065526,0,0
2,GO NEGATIVE REGULATION OF TRANSPORT,0.30402,-0.040996,-0.030411,0,0
2,GO REGULATION OF GASTRIC ACID SECRETION,0.74288,-0.041092,-0.053444,0,0
2,GO ANIMAL ORGAN FORMATION,0.64605,-0.041307,-0.04753,0,0
2,GO REGULATION OF PROTEIN POLYMERIZATION,0.62113,-0.041312,-0.014243,0,0
2,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.070855,-0.041433,-0.062038,0,0
2,GO CHOLESTEROL STORAGE,0.55487,-0.041642,-0.043475,0,0
2,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.43367,-0.041695,-0.070172,0,0
2,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.31232,-0.041744,-0.037809,0,0
2,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.11841,-0.041768,-0.1354,0,0
2,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.41341,-0.041783,-0.041813,0,0
2,GO STEROID BIOSYNTHETIC PROCESS,0.5726,-0.041792,-0.0294,0,0
2,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.13355,-0.041859,-0.046722,0,0
2,GO PROTEIN AUTOPHOSPHORYLATION,0.47588,-0.04197,-0.025186,0,0
2,GO CHRONIC INFLAMMATORY RESPONSE,0.65234,-0.041986,-0.10079,0,0
2,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.98953,-0.042116,0.020262,0,0
2,GO CERAMIDE METABOLIC PROCESS,0.12049,-0.042272,-0.079071,0,0
2,GO PEROXISOME ORGANIZATION,0.22905,-0.04234,-0.053457,0,0
2,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.75615,-0.042351,-0.032161,0,0
2,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.26847,-0.042466,-0.059192,0,0
2,GO NEGATIVE REGULATION OF GENE SILENCING,0.71658,-0.042635,0.017626,0,0
2,GO ENDOSOME TO LYSOSOME TRANSPORT,0.19695,-0.042642,-0.054506,0,0
2,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.96163,-0.042652,-0.013778,0,0
2,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.21256,-0.042748,-0.068053,0,0
2,GO OOGENESIS,0.093897,-0.042759,-0.089788,0,0
2,GO VITAMIN D METABOLIC PROCESS,0.53167,-0.042766,-0.062195,0,0
2,GO REGULATION OF SISTER CHROMATID COHESION,0.53742,-0.042845,-0.027221,0,0
2,GO CD40 SIGNALING PATHWAY,0.34702,-0.042873,-0.12019,0,0
2,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.1313,-0.04288,-0.061497,0,0
2,GO REGULATION OF CILIUM MOVEMENT,0.061812,-0.042892,-0.10529,0,0
2,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.61497,-0.04295,-0.0063505,0,0
2,GO REGULATION OF APPETITE,0.31232,-0.042951,-0.063649,0,0
2,GO ZINC ION HOMEOSTASIS,0.52594,-0.042958,-0.094631,0,0
2,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.72969,-0.043058,-0.013679,0,0
2,GO ASTROCYTE ACTIVATION,0.30402,-0.043064,-0.078155,0,0
2,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.38408,-0.043199,-0.024521,0,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.29184,-0.043241,-0.051012,0,0
2,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.19095,-0.043286,-0.058209,0,0
2,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.064293,-0.04336,-0.054893,0,0
2,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.53167,-0.043416,-0.034598,0,0
2,GO MAINTENANCE OF CELL NUMBER,0.1028,-0.043477,-0.074725,0,0
2,GO MEMBRANE ORGANIZATION,0.33812,-0.043611,-0.030583,0,0
2,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.082489,-0.043676,-0.056599,0,0
2,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.79636,-0.043696,-0.0084209,0,0
2,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.78289,-0.043801,-0.027243,0,0
2,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.36991,-0.043886,-0.054294,0,0
2,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.16294,-0.044033,-0.045415,0,0
2,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.46512,-0.044044,-0.047773,0,0
2,GO REGULATION OF MITOPHAGY,0.25729,-0.044058,-0.068177,0,0
2,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.55487,-0.044097,-0.048412,0,0
2,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.56666,-0.04418,-0.033172,0,0
2,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.21256,-0.044222,-0.038824,0,0
2,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.14526,-0.044224,-0.094239,0,0
2,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.44924,-0.044239,-0.077296,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.05824,-0.044253,-0.04826,0,0
2,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.14769,-0.044285,-0.058075,0,0
2,GO PROTEIN POLYMERIZATION,0.42855,-0.044392,-0.022277,0,0
2,GO TOR SIGNALING,0.15517,-0.044434,-0.034649,0,0
2,GO RESPONSE TO HORMONE,0.29184,-0.044482,-0.03894,0,0
2,GO REGULATION OF SECRETION,0.17099,-0.044584,-0.046648,0,0
2,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.31232,-0.044735,-0.068603,0,0
2,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.52025,-0.044783,-0.023919,0,0
2,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.29586,-0.044801,-0.12579,0,0
2,GO POSITIVE REGULATION OF CILIUM MOVEMENT,0.78962,-0.044913,0.036864,0,0
2,GO SPINDLE ASSEMBLY,0.05824,-0.044964,-0.053659,0,0
2,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.41842,-0.04497,-0.073289,0,0
2,GO RESPONSE TO INTERLEUKIN 1,0.088862,-0.044973,-0.10864,0,0
2,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.85082,-0.045019,-0.013569,0,0
2,GO POSITIVE REGULATION OF CELL DEATH,0.21905,-0.045074,-0.044078,0,0
2,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.8303,-0.045257,-0.051683,0,0
2,GO ORGANELLE ASSEMBLY,0.0066042,-0.045259,-0.058024,0,0
2,GO CALCINEURIN MEDIATED SIGNALING,0.42347,-0.045265,-0.037511,0,0
2,GO POSITIVE REGULATION OF VASOCONSTRICTION,0.72969,-0.04527,-0.037436,0,0
2,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.17099,-0.045311,-0.073217,0,0
2,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.1313,-0.045372,-0.06962,0,0
2,GO POSITIVE REGULATION OF TRANSPORT,0.14769,-0.045383,-0.037579,0,0
2,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.83713,-0.045384,-0.031136,0,0
2,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.94769,-0.045392,-0.018674,0,0
2,GO RECEPTOR CATABOLIC PROCESS,0.44402,-0.045482,-0.055209,0,0
2,GO RESPONSE TO KETONE,0.17099,-0.045567,-0.077068,0,0
2,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.69061,-0.045643,-0.045265,0,0
2,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.079444,-0.045653,-0.065112,0,0
2,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.0695,-0.045681,-0.090317,0,0
2,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.20309,-0.045849,-0.066294,0,0
2,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,0.22568,-0.045864,-0.093317,0,0
2,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,0.62113,-0.046024,0.076036,0,0
2,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.48678,-0.046026,-0.060973,0,0
2,GO ASTROCYTE DEVELOPMENT,0.43883,-0.046047,-0.057739,0,0
2,GO CHLORIDE ION HOMEOSTASIS,0.73628,-0.046056,-0.023494,0,0
2,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.17653,-0.04608,-0.052696,0,0
2,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.23937,-0.046175,-0.13623,0,0
2,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.18219,-0.046193,-0.029822,0,0
2,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.24643,-0.046277,-0.050009,0,0
2,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.12259,-0.0464,-0.055246,0,0
2,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.60272,-0.046604,-0.025664,0,0
2,GO EXTRACELLULAR MATRIX CONSTITUENT SECRETION,0.27999,-0.046728,-0.2537,0,0
2,GO BONE MINERALIZATION,0.59664,-0.046734,-0.031952,0,0
2,GO RESPONSE TO NUTRIENT,0.32938,-0.046753,-0.060608,0,0
2,GO REGULATION OF GLUCOSE IMPORT,0.29586,-0.046767,-0.05418,0,0
2,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.44402,-0.046786,-0.032654,0,0
2,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.24643,-0.046825,-0.039587,0,0
2,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.22235,-0.046875,-0.044578,0,0
2,GO RESPONSE TO PAIN,0.65866,-0.047002,-0.062546,0,0
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.077957,-0.047005,-0.087691,0,0
2,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.13814,-0.047021,-0.037595,0,0
2,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.13583,-0.047041,-0.062751,0,0
2,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.25363,-0.047043,-0.053979,0,0
2,GO RESPONSE TO INORGANIC SUBSTANCE,0.085627,-0.047119,-0.056345,0,0
2,GO STEROL BIOSYNTHETIC PROCESS,0.7495,-0.047182,0.022279,0,0
2,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.11039,-0.047234,-0.072339,0,0
2,GO LIPID HOMEOSTASIS,0.18508,-0.047324,-0.072075,0,0
2,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.54903,-0.047375,-0.017306,0,0
2,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.030383,-0.047395,-0.0479,0,0
2,GO JNK CASCADE,0.17653,-0.047471,-0.046982,0,0
2,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.9686,-0.047642,0.0054404,0,0
2,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.092194,-0.047734,-0.074036,0,0
2,GO NUCLEUS ORGANIZATION,0.066855,-0.047765,-0.048761,0,0
2,GO REGULATION OF DNA RECOMBINATION,0.43367,-0.047786,-0.033608,0,0
2,GO OSTEOCLAST DIFFERENTIATION,0.59664,-0.047815,-0.013753,0,0
2,GO MEMBRANE LIPID METABOLIC PROCESS,0.077957,-0.048062,-0.084675,0,0
2,GO REGULATION OF LIPID LOCALIZATION,0.25729,-0.048159,-0.055455,0,0
2,GO CELLULAR RESPONSE TO STEROL,0.98255,-0.048185,0.0053542,0,0
2,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.29992,-0.048244,-0.041564,0,0
2,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,0.8303,-0.048266,-0.017858,0,0
2,GO MECHANORECEPTOR DIFFERENTIATION,0.15015,-0.048332,-0.12801,0,0
2,GO GLUCOSE IMPORT,0.25363,-0.048497,-0.047554,0,0
2,GO PENILE ERECTION,0.74288,-0.048522,-0.028242,0,0
2,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.12049,-0.048531,-0.082053,0,0
2,GO VACUOLAR ACIDIFICATION,0.16294,-0.048637,-0.11439,0,0
2,GO REGULATION OF PHOSPHATASE ACTIVITY,0.18219,-0.048821,-0.045107,0,0
2,GO MANGANESE ION TRANSPORT,0.72313,-0.048862,-0.010146,0,0
2,GO REGULATION OF MUSCLE HYPERTROPHY,0.21905,-0.048885,-0.066053,0,0
2,GO HISTONE H3 ACETYLATION,0.13583,-0.048885,-0.042872,0,0
2,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.092194,-0.049001,-0.069983,0,0
2,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.3746,-0.049032,-0.15971,0,0
2,GO RESPONSE TO TUMOR CELL,0.26098,-0.049036,-0.1034,0,0
2,GO KETONE BIOSYNTHETIC PROCESS,0.64605,-0.049193,-0.053361,0,0
2,GO RESPONSE TO ENDOGENOUS STIMULUS,0.11039,-0.049196,-0.049893,0,0
2,GO PEPTIDYL PROLINE HYDROXYLATION,0.82348,-0.049413,-0.061782,0,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.26847,-0.049473,-0.043069,0,0
2,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.060602,-0.049595,-0.054655,0,0
2,GO INOSITOL TRISPHOSPHATE METABOLIC PROCESS,0.22905,-0.049611,-0.14107,0,0
2,GO INTEGRIN ACTIVATION,0.35153,-0.049632,-0.079514,0,0
2,GO REGULATION OF FLAGELLATED SPERM MOTILITY,0.83713,-0.049665,0.00089528,0,0
2,GO MEMBRANE INVAGINATION,0.20937,-0.049668,-0.072821,0,0
2,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.15517,-0.049676,-0.13311,0,0
2,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.10096,-0.049693,-0.16087,0,0
2,GO SCHWANN CELL DIFFERENTIATION,0.43883,-0.04979,-0.039119,0,0
2,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.22568,-0.049796,-0.044982,0,0
2,GO SINGLE FERTILIZATION,0.090515,-0.049836,-0.05013,0,0
2,GO MITOTIC SPINDLE ORGANIZATION,0.1313,-0.04992,-0.059113,0,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.77618,-0.049942,-0.013333,0,0
2,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.075049,-0.049967,-0.085534,0,0
2,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.44402,-0.049996,-0.022489,0,0
2,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.7495,-0.050075,-0.022681,0,0
2,GO BIOLOGICAL ADHESION,0.13355,-0.050117,-0.073472,0,0
2,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.23589,-0.050222,-0.094412,0,0
2,GO LYMPHOCYTE MIGRATION,0.24288,-0.050246,-0.078135,0,0
2,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.21905,-0.050306,-0.091423,0,0
2,GO ARACHIDONIC ACID SECRETION,0.26847,-0.050416,-0.084436,0,0
2,GO REGIONALIZATION,0.29992,-0.050447,-0.039031,0,0
2,GO KINETOCHORE ORGANIZATION,0.41341,-0.050601,-0.055677,0,0
2,GO EPITHELIAL CELL PROLIFERATION,0.053746,-0.050618,-0.10607,0,0
2,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.20937,-0.050746,-0.1183,0,0
2,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.70355,-0.050754,-0.029724,0,0
2,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.93377,-0.050779,0.004387,0,0
2,GO RESPONSE TO ALKALOID,0.33373,-0.050782,-0.045193,0,0
2,GO CERAMIDE BIOSYNTHETIC PROCESS,0.17653,-0.050807,-0.069296,0,0
2,GO CAMERA TYPE EYE DEVELOPMENT,0.26471,-0.05083,-0.039678,0,0
2,GO MITOTIC NUCLEAR DIVISION,0.12689,-0.050997,-0.040191,0,0
2,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.99651,-0.051017,-0.015055,0,0
2,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.11434,-0.051027,-0.046379,0,0
2,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.91987,-0.051057,-0.0029276,0,0
2,GO STRESS FIBER ASSEMBLY,0.40349,-0.051068,-0.051594,0,0
2,GO REGULATION OF LIPID TRANSPORT,0.32077,-0.051105,-0.056605,0,0
2,GO REGULATION OF TUBE SIZE,0.19393,-0.051248,-0.067098,0,0
2,GO CELL CYCLE CHECKPOINT,0.082489,-0.05134,-0.045361,0,0
2,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.19393,-0.051372,-0.079947,0,0
2,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.28785,-0.051375,-0.076763,0,0
2,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.50337,-0.051386,-0.034784,0,0
2,GO SPHINGOLIPID METABOLIC PROCESS,0.14526,-0.051479,-0.072734,0,0
2,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.48678,-0.05157,-0.073262,0,0
2,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.25729,-0.051725,-0.090823,0,0
2,GO PIGMENTATION,0.12908,-0.051755,-0.068555,0,0
2,GO OVULATION,0.44402,-0.051842,-0.081234,0,0
2,GO LIPOPROTEIN CATABOLIC PROCESS,0.20309,-0.05186,-0.10054,0,0
2,GO RESPONSE TO CHEMOKINE,0.54903,-0.051865,-0.045098,0,0
2,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.093897,-0.051995,-0.11452,0,0
2,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.24643,-0.052098,-0.041733,0,0
2,GO REGULATION OF CELL DEATH,0.079444,-0.052102,-0.059277,0,0
2,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.15517,-0.052159,-0.046643,0,0
2,GO REGULATION OF ORGANIC ACID TRANSPORT,0.33373,-0.052205,-0.060209,0,0
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.35153,-0.052596,-0.088513,0,0
2,GO RESPONSE TO VITAMIN,0.55487,-0.052661,-0.045344,0,0
2,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.54321,-0.052702,-0.047104,0,0
2,GO REGULATION OF LIPID METABOLIC PROCESS,0.3746,-0.052811,-0.037548,0,0
2,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.71006,-0.052823,-0.083316,0,0
2,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.036948,-0.052873,-0.041961,0,0
2,GO RESPONSE TO PEPTIDE HORMONE,0.17374,-0.052919,-0.042604,0,0
2,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.75615,-0.053214,-0.024949,0,0
2,GO RESPONSE TO TOXIC SUBSTANCE,0.13583,-0.053266,-0.066299,0,0
2,GO REGULATION OF GTPASE ACTIVITY,0.38888,-0.0533,-0.023923,0,0
2,GO PHAGOCYTOSIS,0.2839,-0.053521,-0.068683,0,0
2,GO NEGATIVE REGULATION OF SECRETION,0.12473,-0.053615,-0.055788,0,0
2,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.46512,-0.053724,-0.024273,0,0
2,GO ATP TRANSPORT,0.89907,-0.053776,0.0065594,0,0
2,GO PROTEIN LOCALIZATION TO LYSOSOME,0.52594,-0.053879,-0.040107,0,0
2,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.10096,-0.053887,-0.04293,0,0
2,GO EMBRYO DEVELOPMENT,0.1028,-0.053924,-0.053059,0,0
2,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.22235,-0.053968,-0.061382,0,0
2,GO ESTROGEN METABOLIC PROCESS,0.27227,-0.054029,-0.073494,0,0
2,GO THYMIC T CELL SELECTION,0.20309,-0.054055,-0.050215,0,0
2,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,0.27999,-0.054061,-0.15296,0,0
2,GO AMINO ACID BETAINE METABOLIC PROCESS,0.5726,-0.05411,-0.066397,0,0
2,GO SYMBIOTIC PROCESS,0.087232,-0.054117,-0.079782,0,0
2,GO RESPONSE TO NITROGEN COMPOUND,0.20309,-0.054237,-0.035746,0,0
2,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.093897,-0.054293,-0.060521,0,0
2,GO STRIATED MUSCLE ADAPTATION,0.63354,-0.054364,-0.021443,0,0
2,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.43367,-0.054601,-0.011595,0,0
2,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.11039,-0.054657,-0.054942,0,0
2,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.25729,-0.054699,-0.077944,0,0
2,GO MESENCHYME MORPHOGENESIS,0.092194,-0.054741,-0.13341,0,0
2,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.48131,-0.054777,-0.025516,0,0
2,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.43367,-0.054815,-0.060493,0,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.32938,-0.054824,-0.034578,0,0
2,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.2,-0.05483,-0.098465,0,0
2,GO REGULATION OF PROTEIN DEACETYLATION,0.69061,-0.055013,-0.013454,0,0
2,GO ACTIVATION OF MAPK ACTIVITY,0.2,-0.055256,-0.055429,0,0
2,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.076492,-0.055397,-0.065251,0,0
2,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.39858,-0.055449,-0.042461,0,0
2,GO PRE MIRNA PROCESSING,0.51459,-0.055494,-0.034901,0,0
2,GO SELECTIVE AUTOPHAGY,0.19695,-0.055543,-0.07192,0,0
2,GO CYTOSKELETON ORGANIZATION,0.04854,-0.055548,-0.051262,0,0
2,GO APOPTOTIC PROCESS,0.1028,-0.055601,-0.054798,0,0
2,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.41842,-0.055681,-0.052568,0,0
2,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.25001,-0.055796,-0.043774,0,0
2,GO DEVELOPMENTAL PIGMENTATION,0.14769,-0.055822,-0.076351,0,0
2,GO DEMETHYLATION,0.088862,-0.055835,-0.051845,0,0
2,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.47588,-0.05587,-0.023843,0,0
2,GO PROTEIN LOCALIZATION TO VACUOLE,0.2839,-0.056102,-0.05852,0,0
2,GO REGULATION OF CILIUM ASSEMBLY,0.10654,-0.056109,-0.057024,0,0
2,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.13355,-0.056217,-0.044563,0,0
2,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.53742,-0.056224,0.12115,0,0
2,GO CELL CELL RECOGNITION,0.11841,-0.056289,-0.073026,0,0
2,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.93377,-0.056476,-0.015392,0,0
2,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.34702,-0.05653,-0.031693,0,0
2,GO MAINTENANCE OF ORGANELLE LOCATION,0.43367,-0.056572,-0.024253,0,0
2,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.14048,-0.056629,-0.12413,0,0
2,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.74288,-0.056701,-0.022079,0,0
2,GO SINGLE STRAND BREAK REPAIR,0.38408,-0.056713,-0.047228,0,0
2,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.22235,-0.056787,-0.051562,0,0
2,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.60272,-0.057025,-0.0053905,0,0
2,GO REGULATION OF FAT CELL DIFFERENTIATION,0.16032,-0.05722,-0.075605,0,0
2,GO POSITIVE REGULATION OF JNK CASCADE,0.12259,-0.057266,-0.061562,0,0
2,GO REGULATION OF BONE MINERALIZATION,0.32506,-0.057299,-0.06991,0,0
2,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.065563,-0.05744,-0.13976,0,0
2,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.43367,-0.057444,-0.057828,0,0
2,GO RESPONSE TO TESTOSTERONE,0.4598,-0.057452,-0.053363,0,0
2,GO REGULATION OF KIDNEY DEVELOPMENT,0.33812,-0.057477,-0.081057,0,0
2,GO MEMBRANE PROTEIN PROTEOLYSIS,0.11039,-0.057543,-0.13967,0,0
2,GO PROTEIN MANNOSYLATION,0.69707,-0.057564,-0.020375,0,0
2,GO MICROTUBULE BASED TRANSPORT,0.16828,-0.05759,-0.040918,0,0
2,GO HISTONE H4 ACETYLATION,0.087232,-0.057684,-0.047474,0,0
2,GO SENSORY PERCEPTION,0.11841,-0.057936,-0.04304,0,0
2,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.32077,-0.058163,-0.063558,0,0
2,GO POSITIVE REGULATION OF PROTEOLYSIS,0.12908,-0.058167,-0.06074,0,0
2,GO AMYLOID BETA METABOLIC PROCESS,0.30402,-0.058198,-0.055448,0,0
2,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.38408,-0.058241,-0.092118,0,0
2,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.042857,-0.058243,-0.13615,0,0
2,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.077957,-0.058284,-0.05069,0,0
2,GO RESPONSE TO DEXAMETHASONE,0.49227,-0.058314,-0.050802,0,0
2,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.18219,-0.058361,-0.082675,0,0
2,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.91987,-0.058464,0.0099453,0,0
2,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.15517,-0.058631,-0.077146,0,0
2,GO REGULATION OF T CELL APOPTOTIC PROCESS,0.31653,-0.05865,-0.095502,0,0
2,GO EMBRYONIC ORGAN MORPHOGENESIS,0.059411,-0.058702,-0.086829,0,0
2,GO REGULATION OF NUCLEASE ACTIVITY,0.11434,-0.058703,-0.11516,0,0
2,GO GLYCOSYLATION,0.15517,-0.058708,-0.07068,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.32077,-0.058723,-0.035755,0,0
2,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.16828,-0.058764,-0.069985,0,0
2,GO FATTY ACID BETA OXIDATION,0.32077,-0.058862,-0.064597,0,0
2,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.085627,-0.059026,-0.091971,0,0
2,GO CAMP BIOSYNTHETIC PROCESS,0.36064,-0.059118,-0.096058,0,0
2,GO NEURONAL ACTION POTENTIAL,0.25001,-0.059138,-0.076407,0,0
2,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.76948,-0.059148,-0.0038809,0,0
2,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.19095,-0.05917,-0.1236,0,0
2,GO POSITIVE REGULATION OF MAPK CASCADE,0.35607,-0.059229,-0.048949,0,0
2,GO TONGUE DEVELOPMENT,0.41341,-0.059263,-0.085089,0,0
2,GO GOLGI RIBBON FORMATION,0.38888,-0.059418,-0.062741,0,0
2,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.48678,-0.059444,-0.068701,0,0
2,GO GLYCOLIPID CATABOLIC PROCESS,0.24643,-0.059615,-0.15713,0,0
2,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.12049,-0.059713,-0.082747,0,0
2,GO RESPONSE TO FUNGUS,0.30815,-0.059877,-0.047315,0,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.18219,-0.05992,-0.097341,0,0
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.095625,-0.059945,-0.069165,0,0
2,GO T CELL CHEMOTAXIS,0.12049,-0.059949,-0.082357,0,0
2,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.98953,-0.059995,0.029895,0,0
2,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.23937,-0.060031,-0.081232,0,0
2,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.059411,-0.060173,-0.10032,0,0
2,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.26098,-0.06027,-0.040523,0,0
2,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.12473,-0.060364,-0.082909,0,0
2,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.13583,-0.06039,-0.067139,0,0
2,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.20309,-0.0604,-0.10067,0,0
2,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,0.12259,-0.060446,-0.085593,0,0
2,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.36991,-0.060454,-0.041694,0,0
2,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.92682,-0.060632,0.0018042,0,0
2,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.12908,-0.060711,-0.11151,0,0
2,GO NEGATIVE REGULATION OF GROWTH,0.14048,-0.060887,-0.052195,0,0
2,GO RESPONSE TO INTERLEUKIN 15,0.17653,-0.060934,-0.11468,0,0
2,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.44402,-0.061,-0.041059,0,0
2,GO APPENDAGE MORPHOGENESIS,0.15773,-0.061007,-0.10467,0,0
2,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.53742,-0.061014,-0.037754,0,0
2,GO SEX DIFFERENTIATION,0.11636,-0.061016,-0.050249,0,0
2,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.19095,-0.061072,-0.057507,0,0
2,GO CELLULAR HORMONE METABOLIC PROCESS,0.36991,-0.061221,-0.056979,0,0
2,GO HISTONE UBIQUITINATION,0.041093,-0.061309,-0.066636,0,0
2,GO FC RECEPTOR SIGNALING PATHWAY,0.082489,-0.061364,-0.077825,0,0
2,GO REGULATION OF HORMONE METABOLIC PROCESS,0.2,-0.061378,-0.1525,0,0
2,GO CELL DIFFERENTIATION IN SPINAL CORD,0.25729,-0.061488,-0.067297,0,0
2,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.63978,-0.061547,-0.025898,0,0
2,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.15517,-0.061581,-0.11519,0,0
2,GO REGULATION OF TOR SIGNALING,0.15015,-0.061624,-0.047396,0,0
2,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.11841,-0.0617,-0.068346,0,0
2,GO MORPHOGENESIS OF AN EPITHELIUM,0.013139,-0.061745,-0.099152,0,0
2,GO ESTABLISHMENT OF CELL POLARITY,0.05161,-0.061757,-0.075136,0,0
2,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.25001,-0.061778,-0.080982,0,0
2,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.24288,-0.061829,-0.1638,0,0
2,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.059411,-0.061852,-0.081493,0,0
2,GO RENAL FILTRATION,0.55487,-0.061867,-0.041388,0,0
2,GO HISTONE H3 K14 ACETYLATION,0.33812,-0.06193,-0.0471,0,0
2,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.51459,-0.062005,-0.030543,0,0
2,GO MODIFIED AMINO ACID TRANSPORT,0.16294,-0.062178,-0.10012,0,0
2,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.22235,-0.062194,-0.090051,0,0
2,GO ANATOMICAL STRUCTURE MATURATION,0.16559,-0.062198,-0.044743,0,0
2,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.80312,-0.062241,-0.021675,0,0
2,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.44402,-0.062587,-0.02347,0,0
2,GO PULMONARY VALVE DEVELOPMENT,0.33373,-0.062824,-0.10819,0,0
2,GO REGULATION OF VASOCONSTRICTION,0.19695,-0.062861,-0.070382,0,0
2,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.019739,-0.062998,-0.085776,0,0
2,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.32077,-0.063034,-0.033723,0,0
2,GO HYALURONAN METABOLIC PROCESS,0.35153,-0.063039,-0.069863,0,0
2,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.15015,-0.063307,-0.057595,0,0
2,GO POSITIVE REGULATION OF CELL AGING,0.1028,-0.063568,-0.11919,0,0
2,GO OOCYTE MATURATION,0.66501,-0.063675,-0.020409,0,0
2,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.065563,-0.063757,-0.063544,0,0
2,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.13583,-0.0638,-0.086583,0,0
2,GO POSITIVE THYMIC T CELL SELECTION,0.25001,-0.063803,-0.094649,0,0
2,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.85768,-0.063809,0.0040887,0,0
2,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.36064,-0.063845,-0.049305,0,0
2,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.23589,-0.063872,-0.10514,0,0
2,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.70355,-0.064012,-0.031214,0,0
2,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.14048,-0.06404,-0.070882,0,0
2,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.13583,-0.064134,-0.12509,0,0
2,GO REGULATION OF STEROID METABOLIC PROCESS,0.27611,-0.064153,-0.061548,0,0
2,GO REGULATION OF CELL MATURATION,0.087232,-0.064441,-0.072833,0,0
2,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,0.55487,-0.064485,0.094908,0,0
2,GO PROTEIN LOCALIZATION TO CILIUM,0.066855,-0.06483,-0.10504,0,0
2,GO GPI ANCHOR METABOLIC PROCESS,0.18219,-0.064888,-0.10029,0,0
2,GO MONOCARBOXYLIC ACID TRANSPORT,0.43367,-0.065007,-0.031353,0,0
2,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.18219,-0.065068,-0.11325,0,0
2,GO LIPID BIOSYNTHETIC PROCESS,0.060602,-0.065325,-0.070494,0,0
2,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.16294,-0.065333,-0.050958,0,0
2,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.21579,-0.065418,-0.049418,0,0
2,GO PRIMARY MIRNA PROCESSING,0.48131,-0.065474,-0.048068,0,0
2,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.52594,-0.065615,-0.050706,0,0
2,GO POSITIVE REGULATION OF PROTEIN BINDING,0.49227,-0.065623,-0.042442,0,0
2,GO REGULATION OF EXIT FROM MITOSIS,0.14048,-0.065695,-0.089292,0,0
2,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.76948,-0.065715,0.0055686,0,0
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.18219,-0.065767,-0.079642,0,0
2,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.11434,-0.065784,-0.15275,0,0
2,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.068167,-0.065843,-0.055671,0,0
2,GO FATTY ACID CATABOLIC PROCESS,0.088862,-0.066178,-0.098585,0,0
2,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.059411,-0.066245,-0.086528,0,0
2,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.12259,-0.066303,-0.10011,0,0
2,GO REGULATION OF ANION TRANSPORT,0.092194,-0.066316,-0.072435,0,0
2,GO RESPONSE TO MINERALOCORTICOID,0.24643,-0.066361,-0.08214,0,0
2,GO HYALURONAN BIOSYNTHETIC PROCESS,0.22568,-0.06646,-0.10443,0,0
2,GO MULTICELLULAR ORGANISM AGING,0.017549,-0.066565,-0.12547,0,0
2,GO EPIBOLY,0.29184,-0.066593,-0.129,0,0
2,GO EATING BEHAVIOR,0.21905,-0.066676,-0.069817,0,0
2,GO CELLULAR RESPONSE TO CAMP,0.69061,-0.06671,0.0053828,0,0
2,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.061812,-0.066742,-0.086157,0,0
2,GO DETECTION OF ABIOTIC STIMULUS,0.05824,-0.066789,-0.083841,0,0
2,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.65866,-0.066992,-0.020116,0,0
2,GO INTERFERON GAMMA PRODUCTION,0.12049,-0.06706,-0.076101,0,0
2,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.59664,-0.067076,-0.059338,0,0
2,GO VITAMIN METABOLIC PROCESS,0.98255,-0.067183,0.0024998,0,0
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.74288,-0.067271,-0.035863,0,0
2,GO NEURAL RETINA DEVELOPMENT,0.78289,-0.067299,-0.0081928,0,0
2,GO AMEBOIDAL TYPE CELL MIGRATION,0.082489,-0.067305,-0.089652,0,0
2,GO CELLULAR RESPONSE TO SALT STRESS,0.4598,-0.067345,-0.088499,0,0
2,GO RESPONSE TO OXIDATIVE STRESS,0.095625,-0.067411,-0.069622,0,0
2,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.095625,-0.067649,-0.063693,0,0
2,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.10845,-0.067715,-0.05579,0,0
2,GO REGULATION OF PROSTAGLANDIN SECRETION,0.4545,-0.06773,-0.059121,0,0
2,GO REGULATION OF JUN KINASE ACTIVITY,0.064293,-0.067756,-0.080653,0,0
2,GO HISTONE H2A ACETYLATION,0.22235,-0.067757,-0.061376,0,0
2,GO REGULATION OF BONE DEVELOPMENT,0.16559,-0.067791,-0.08264,0,0
2,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.81668,-0.067959,0.006514,0,0
2,GO REGULATION OF MAPK CASCADE,0.21256,-0.068029,-0.055321,0,0
2,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.097379,-0.068033,-0.14833,0,0
2,GO MEMBRANE RAFT ASSEMBLY,0.4598,-0.068115,-0.19913,0,0
2,GO STEROID HORMONE SECRETION,0.25001,-0.068121,-0.099478,0,0
2,GO NATURAL KILLER CELL DIFFERENTIATION,0.39858,-0.068122,-0.048999,0,0
2,GO FOREBRAIN NEURON DIFFERENTIATION,0.25363,-0.068167,-0.091611,0,0
2,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.27611,-0.068202,-0.070329,0,0
2,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.94769,-0.06822,0.063735,0,0
2,GO STEROID CATABOLIC PROCESS,0.4545,-0.068223,-0.067968,0,0
2,GO LIPID METABOLIC PROCESS,0.082489,-0.06838,-0.061218,0,0
2,GO BONE MATURATION,0.39371,-0.068413,-0.070685,0,0
2,GO FATTY ACID BIOSYNTHETIC PROCESS,0.10465,-0.068465,-0.090477,0,0
2,GO CELLULAR RESPONSE TO LIPID,0.17653,-0.068646,-0.067613,0,0
2,GO GLYCOPROTEIN CATABOLIC PROCESS,0.38888,-0.068737,-0.15186,0,0
2,GO TROPHOBLAST CELL MIGRATION,0.24643,-0.068763,-0.17683,0,0
2,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.11636,-0.068841,-0.13751,0,0
2,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.11039,-0.068864,-0.084924,0,0
2,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.15773,-0.068878,-0.087709,0,0
2,GO DETECTION OF BIOTIC STIMULUS,0.49227,-0.069196,-0.09461,0,0
2,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.25729,-0.069239,-0.044835,0,0
2,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.44924,-0.069307,-0.059768,0,0
2,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.32938,-0.069376,-0.083875,0,0
2,GO REGULATION OF PROTEIN IMPORT,0.14048,-0.069387,-0.10439,0,0
2,GO RESPONSE TO CORTICOSTEROID,0.10845,-0.069552,-0.097558,0,0
2,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.063042,-0.069572,-0.07148,0,0
2,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.14285,-0.06961,-0.12077,0,0
2,GO MAGNESIUM ION HOMEOSTASIS,0.52025,-0.069614,-0.072431,0,0
2,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.65866,-0.069665,-0.029161,0,0
2,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.42347,-0.069711,-0.12189,0,0
2,GO STEM CELL PROLIFERATION,0.085627,-0.069873,-0.088511,0,0
2,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.49227,-0.069902,-0.047194,0,0
2,GO MUSCLE CELL DEVELOPMENT,0.14048,-0.069984,-0.069522,0,0
2,GO RESPONSE TO EPINEPHRINE,1,-0.070059,0.0084342,0,0
2,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.36526,-0.070127,-0.11902,0,0
2,GO L PHENYLALANINE METABOLIC PROCESS,0.34256,-0.070147,-0.16427,0,0
2,GO RESPONSE TO SALT STRESS,0.17099,-0.070179,-0.097227,0,0
2,GO CELLULAR RESPONSE TO FATTY ACID,0.55487,-0.07019,-0.051358,0,0
2,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.32077,-0.070281,-0.075533,0,0
2,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.21579,-0.070396,-0.15765,0,0
2,GO OOCYTE DIFFERENTIATION,0.088862,-0.070457,-0.11075,0,0
2,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.23589,-0.070469,-0.048612,0,0
2,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.077957,-0.070546,-0.10172,0,0
2,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.076492,-0.070944,-0.075557,0,0
2,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.52025,-0.071008,-0.14249,0,0
2,GO POSITIVE REGULATION OF ERAD PATHWAY,0.18508,-0.071112,-0.073072,0,0
2,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.12473,-0.071121,-0.13684,0,0
2,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.088862,-0.07116,-0.081142,0,0
2,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.26471,-0.071183,-0.050459,0,0
2,GO UV DAMAGE EXCISION REPAIR,0.41842,-0.07124,-0.038872,0,0
2,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.34702,-0.071327,-0.081445,0,0
2,GO HISTONE H4 K5 ACETYLATION,0.66501,-0.071361,-0.014335,0,0
2,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.19393,-0.071443,-0.10888,0,0
2,GO POSITIVE REGULATION OF DNA REPLICATION,0.12908,-0.071506,-0.057411,0,0
2,GO REGULATION OF CHOLESTEROL ESTERIFICATION,0.16032,-0.071682,-0.19393,0,0
2,GO BRANCH ELONGATION OF AN EPITHELIUM,0.20309,-0.071726,-0.19148,0,0
2,GO RESPONSE TO STEROID HORMONE,0.090515,-0.071862,-0.082773,0,0
2,GO REGULATION OF ERAD PATHWAY,0.11039,-0.072218,-0.056497,0,0
2,GO NEUTROPHIL CHEMOTAXIS,0.088862,-0.072555,-0.076916,0,0
2,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.079444,-0.072652,-0.096508,0,0
2,GO CELL MATURATION,0.095625,-0.072739,-0.059033,0,0
2,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.26098,-0.072774,-0.040754,0,0
2,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.22905,-0.072841,-0.10171,0,0
2,GO FEMALE GAMETE GENERATION,0.05824,-0.072977,-0.071017,0,0
2,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.14526,-0.073112,-0.063294,0,0
2,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.11636,-0.073163,-0.12615,0,0
2,GO RESPONSE TO GROWTH HORMONE,0.38888,-0.073195,-0.069182,0,0
2,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.42855,-0.073636,-0.063622,0,0
2,GO LENS FIBER CELL DIFFERENTIATION,0.31232,-0.073693,-0.086789,0,0
2,GO REGULATION OF AMYLOID BETA CLEARANCE,0.19695,-0.073724,-0.14012,0,0
2,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.084046,-0.073751,-0.072273,0,0
2,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.059411,-0.073851,-0.076544,0,0
2,GO REGULATION OF HORMONE SECRETION,0.17653,-0.074032,-0.05161,0,0
2,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.013139,-0.074079,-0.11156,0,0
2,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.13583,-0.074207,-0.10346,0,0
2,GO POTASSIUM ION HOMEOSTASIS,0.19695,-0.074241,-0.085051,0,0
2,GO SPERM EGG RECOGNITION,0.14526,-0.07425,-0.060326,0,0
2,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.015203,-0.074726,-0.069842,0,0
2,GO EXTRACELLULAR MATRIX DISASSEMBLY,0.25729,-0.074747,-0.10372,0,0
2,GO FUCOSE METABOLIC PROCESS,0.33812,-0.074971,-0.086857,0,0
2,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.082489,-0.075002,-0.073294,0,0
2,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.27999,-0.075064,-0.074805,0,0
2,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.29586,-0.075212,-0.11366,0,0
2,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.10654,-0.075306,-0.11015,0,0
2,GO SPERM MOTILITY,0.012203,-0.075329,-0.091459,0,0
2,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.16559,-0.075576,-0.098151,0,0
2,GO REGULATION OF MAP KINASE ACTIVITY,0.077957,-0.075608,-0.077803,0,0
2,GO REGULATION OF PEPTIDE HORMONE SECRETION,0.42347,-0.075615,-0.030029,0,0
2,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.095625,-0.075639,-0.089565,0,0
2,GO CELLULAR RESPONSE TO IRON ION,0.076492,-0.075751,-0.2086,0,0
2,GO MODULATION BY VIRUS OF HOST PROCESS,0.10096,-0.075787,-0.081429,0,0
2,GO DIGESTIVE TRACT MORPHOGENESIS,0.34256,-0.075824,-0.063825,0,0
2,GO NEGATIVE REGULATION OF TOR SIGNALING,0.66501,-0.075893,-0.013919,0,0
2,GO HISTONE H3 DEACETYLATION,0.16294,-0.076023,-0.060796,0,0
2,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.017969,-0.07604,-0.099561,0,0
2,GO REGULATION OF VIRAL TRANSCRIPTION,0.068167,-0.07605,-0.079694,0,0
2,GO POSITIVE REGULATION OF HAIR CYCLE,0.27227,-0.076241,-0.12255,0,0
2,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.188,-0.076252,-0.099063,0,0
2,GO EAR DEVELOPMENT,0.035393,-0.0763,-0.099769,0,0
2,GO OXALATE TRANSPORT,0.18508,-0.076339,-0.070137,0,0
2,GO STEROL METABOLIC PROCESS,0.36991,-0.076559,-0.044179,0,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.28785,-0.076608,-0.048475,0,0
2,GO GOLGI VESICLE TRANSPORT,0.064293,-0.076635,-0.067156,0,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.12259,-0.076699,-0.13211,0,0
2,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.14285,-0.076791,-0.075534,0,0
2,GO DNA METHYLATION OR DEMETHYLATION,0.023205,-0.076905,-0.071375,0,0
2,GO PEPTIDE HORMONE SECRETION,0.53167,-0.077103,-0.0186,0,0
2,GO OLIGODENDROCYTE DIFFERENTIATION,0.25363,-0.077124,-0.059487,0,0
2,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.16032,-0.077268,-0.064251,0,0
2,GO SENSORY SYSTEM DEVELOPMENT,0.12049,-0.077274,-0.06012,0,0
2,GO KIDNEY MORPHOGENESIS,0.054842,-0.077294,-0.10155,0,0
2,GO RESPONSE TO LIPID,0.13355,-0.077308,-0.066226,0,0
2,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.070855,-0.077435,-0.099518,0,0
2,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.031059,-0.07751,-0.091504,0,0
2,GO RESPONSE TO VITAMIN D,0.80989,-0.077594,0.039877,0,0
2,GO CARDIAC ATRIUM MORPHOGENESIS,0.53167,-0.077645,-0.031668,0,0
2,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.40349,-0.077647,-0.11588,0,0
2,GO NEUROTRANSMITTER METABOLIC PROCESS,0.19095,-0.077662,-0.098862,0,0
2,GO SENSORY ORGAN DEVELOPMENT,0.084046,-0.077666,-0.067344,0,0
2,GO REGULATION OF MACROPHAGE ACTIVATION,0.16294,-0.077716,-0.099133,0,0
2,GO REGULATION OF LYSOSOMAL LUMEN PH,0.21905,-0.077791,-0.1154,0,0
2,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.63354,-0.07786,0.021852,0,0
2,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.16559,-0.077919,-0.073781,0,0
2,GO NEUTROPHIL MIGRATION,0.082489,-0.078095,-0.096768,0,0
2,GO CELL AGING,0.061812,-0.078269,-0.080006,0,0
2,GO ARTERY MORPHOGENESIS,0.11039,-0.078324,-0.10161,0,0
2,GO MONOSACCHARIDE METABOLIC PROCESS,0.1313,-0.078506,-0.057484,0,0
2,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.093897,-0.078605,-0.17566,0,0
2,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.21579,-0.078614,-0.08538,0,0
2,GO REGULATION OF HORMONE LEVELS,0.095625,-0.078628,-0.068587,0,0
2,GO DEVELOPMENTAL INDUCTION,0.17099,-0.078658,-0.1118,0,0
2,GO REGULATION OF OSSIFICATION,0.12049,-0.078785,-0.0924,0,0
2,GO RESPONSE TO FLUID SHEAR STRESS,0.10845,-0.07879,-0.13168,0,0
2,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.15517,-0.078833,-0.093369,0,0
2,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.077957,-0.078852,-0.08791,0,0
2,GO FOREBRAIN MORPHOGENESIS,0.82348,-0.078887,-0.0056324,0,0
2,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.17653,-0.078912,-0.081512,0,0
2,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.087232,-0.079113,-0.065285,0,0
2,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.13814,-0.079144,-0.091213,0,0
2,GO SULFUR COMPOUND TRANSPORT,0.072231,-0.079169,-0.082162,0,0
2,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.39858,-0.079174,-0.063072,0,0
2,GO INCLUSION BODY ASSEMBLY,0.89907,-0.079179,0.033338,0,0
2,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.082489,-0.079539,-0.095341,0,0
2,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,0.62732,-0.079689,-0.12377,0,0
2,GO POSITIVE REGULATION OF CYTOKINESIS,0.17653,-0.079723,-0.071325,0,0
2,GO STEROID ESTERIFICATION,0.11434,-0.079851,-0.19435,0,0
2,GO EMBRYO IMPLANTATION,0.24643,-0.079902,-0.10811,0,0
2,GO CENTRIOLE ASSEMBLY,0.13814,-0.079905,-0.068935,0,0
2,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.10096,-0.079933,-0.089764,0,0
2,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.15517,-0.079957,-0.097999,0,0
2,GO HEMIDESMOSOME ASSEMBLY,0.66501,-0.079977,-0.12878,0,0
2,GO PHOSPHOLIPID EFFLUX,0.21905,-0.080125,-0.1366,0,0
2,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.088862,-0.080256,-0.13641,0,0
2,GO HORMONE TRANSPORT,0.19695,-0.080339,-0.05185,0,0
2,GO REGULATION OF CIRCADIAN RHYTHM,0.027188,-0.080418,-0.06057,0,0
2,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.32938,-0.080418,-0.079,0,0
2,GO COBALAMIN METABOLIC PROCESS,0.21256,-0.08045,-0.092696,0,0
2,GO KERATINOCYTE MIGRATION,0.61497,-0.08049,-0.039674,0,0
2,GO AMINE METABOLIC PROCESS,0.12049,-0.080577,-0.079885,0,0
2,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.60883,-0.080587,-0.0053089,0,0
2,GO NEGATIVE REGULATION OF MAPK CASCADE,0.11434,-0.08078,-0.068347,0,0
2,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.14285,-0.08084,-0.24794,0,0
2,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.17934,-0.080883,-0.082861,0,0
2,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.38888,-0.081216,-0.039415,0,0
2,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.89907,-0.08135,0.012913,0,0
2,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.0021062,-0.081483,-0.10326,0,0
2,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.79636,-0.081497,-0.014733,0,0
2,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.36064,-0.081499,-0.088131,0,0
2,GO REGULATION OF GLIAL CELL MIGRATION,0.46512,-0.081511,-0.043248,0,0
2,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.21905,-0.081737,-0.10744,0,0
2,GO MALE MEIOSIS I,0.14526,-0.081746,-0.16335,0,0
2,GO MEIOTIC CELL CYCLE PROCESS,0.0018173,-0.081769,-0.08676,0,0
2,GO POSITIVE REGULATION OF RESPONSE TO TUMOR CELL,0.27999,-0.081823,-0.079765,0,0
2,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.045624,-0.081921,-0.088216,0,0
2,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.36991,-0.081949,-0.11858,0,0
2,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.11039,-0.081967,-0.073009,0,0
2,GO DETECTION OF LIGHT STIMULUS,0.17934,-0.082008,-0.068604,0,0
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.98953,-0.082031,0.0090464,0,0
2,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,0.057089,-0.082351,-0.1822,0,0
2,GO FOREBRAIN GENERATION OF NEURONS,0.12908,-0.082473,-0.10733,0,0
2,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.049546,-0.082713,-0.09224,0,0
2,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.11636,-0.082782,-0.07921,0,0
2,GO REGULATION OF LIPID STORAGE,0.087232,-0.082949,-0.091851,0,0
2,GO REGULATION OF KERATINOCYTE MIGRATION,0.14526,-0.082951,-0.092192,0,0
2,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.21579,-0.082956,-0.10327,0,0
2,GO ERYTHROCYTE MATURATION,0.12049,-0.08344,-0.088107,0,0
2,GO PROTEIN DEGLYCOSYLATION,0.11039,-0.08417,-0.14361,0,0
2,GO REGULATION OF HAIR CYCLE,0.20937,-0.084269,-0.10289,0,0
2,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.027803,-0.08431,-0.14589,0,0
2,GO POSITIVE REGULATION OF CELL DIVISION,0.20937,-0.084536,-0.056248,0,0
2,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.39858,-0.084864,-0.049769,0,0
2,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.12473,-0.0849,-0.10945,0,0
2,GO EXIT FROM MITOSIS,0.022165,-0.084988,-0.10847,0,0
2,GO GASTRIC ACID SECRETION,0.60883,-0.08499,-0.037888,0,0
2,GO CARDIAC CELL DEVELOPMENT,0.20309,-0.085085,-0.06729,0,0
2,GO CELLULAR RESPONSE TO NUTRIENT,0.55487,-0.085163,-0.041185,0,0
2,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.10654,-0.085236,-0.081822,0,0
2,GO B CELL HOMEOSTASIS,0.32506,-0.085482,-0.0654,0,0
2,GO P38MAPK CASCADE,0.095625,-0.085628,-0.11232,0,0
2,GO INNER EAR MORPHOGENESIS,0.055956,-0.085652,-0.10908,0,0
2,GO CILIUM MOVEMENT,0.0020453,-0.085741,-0.127,0,0
2,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,0.18508,-0.085753,-0.10198,0,0
2,GO LIPOPROTEIN METABOLIC PROCESS,0.076492,-0.086105,-0.076304,0,0
2,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.36064,-0.086299,-0.092187,0,0
2,GO SPHINGOID METABOLIC PROCESS,0.29586,-0.086473,-0.083811,0,0
2,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.082489,-0.086596,-0.067863,0,0
2,GO TEMPERATURE HOMEOSTASIS,0.087232,-0.086657,-0.064314,0,0
2,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.25363,-0.086693,-0.11179,0,0
2,GO INOSITOL METABOLIC PROCESS,0.060602,-0.086994,-0.11438,0,0
2,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.13814,-0.087059,-0.083389,0,0
2,GO CARDIAC MYOFIBRIL ASSEMBLY,0.059411,-0.0872,-0.13205,0,0
2,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,0.67776,-0.087223,-0.074606,0,0
2,GO MULTI ORGANISM CELLULAR PROCESS,0.092194,-0.087339,-0.18318,0,0
2,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.13814,-0.087407,-0.19943,0,0
2,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.057089,-0.087547,-0.16547,0,0
2,GO OTIC VESICLE DEVELOPMENT,0.68418,-0.087736,-0.044953,0,0
2,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.080955,-0.087739,-0.094854,0,0
2,GO ACTIN CROSSLINK FORMATION,0.87144,-0.087869,0.077755,0,0
2,GO STEROL HOMEOSTASIS,0.20621,-0.088167,-0.089323,0,0
2,GO TISSUE REGENERATION,0.1028,-0.088299,-0.11001,0,0
2,GO CELLULAR GLUCAN METABOLIC PROCESS,0.13814,-0.088552,-0.066869,0,0
2,GO POSITIVE REGULATION OF MITOPHAGY,0.13583,-0.088655,-0.096032,0,0
2,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.10096,-0.088765,-0.076278,0,0
2,GO WHITE FAT CELL DIFFERENTIATION,0.095625,-0.088786,-0.10801,0,0
2,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.13355,-0.088807,-0.1344,0,0
2,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.072231,-0.089101,-0.11879,0,0
2,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.16559,-0.089316,-0.093759,0,0
2,GO POSITIVE CHEMOTAXIS,0.068167,-0.089478,-0.12492,0,0
2,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.15015,-0.089579,-0.11969,0,0
2,GO DISTAL TUBULE DEVELOPMENT,0.28785,-0.089763,-0.11846,0,0
2,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.043763,-0.089812,-0.09272,0,0
2,GO RNA DESTABILIZATION,0.087232,-0.090047,-0.076442,0,0
2,GO REGULATION OF COLLATERAL SPROUTING,0.91987,-0.090175,-0.0011283,0,0
2,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,0.87144,-0.090279,-0.050626,0,0
2,GO FUCOSYLATION,0.42347,-0.090311,-0.05878,0,0
2,GO MUSCLE FIBER DEVELOPMENT,0.12473,-0.090507,-0.078158,0,0
2,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.31653,-0.090544,-0.089967,0,0
2,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.26098,-0.09056,-0.093363,0,0
2,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.084046,-0.09068,-0.10219,0,0
2,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.21256,-0.090789,-0.040896,0,0
2,GO CYCLOOXYGENASE PATHWAY,0.89907,-0.090943,-0.0083277,0,0
2,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.087232,-0.091064,-0.091989,0,0
2,GO MEIOSIS I CELL CYCLE PROCESS,0.0087944,-0.091301,-0.11058,0,0
2,GO GERM CELL DEVELOPMENT,0.0056288,-0.091316,-0.088962,0,0
2,GO INSULIN SECRETION,0.41842,-0.091501,-0.034162,0,0
2,GO MEIOTIC CELL CYCLE,0.00037661,-0.091734,-0.09741,0,0
2,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.072231,-0.091962,-0.18076,0,0
2,GO MACROPHAGE PROLIFERATION,0.43883,-0.091977,-0.11518,0,0
2,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.073629,-0.092056,-0.086216,0,0
2,GO MALE SEX DIFFERENTIATION,0.0069616,-0.092178,-0.10836,0,0
2,GO LUNG MORPHOGENESIS,0.072231,-0.092227,-0.14341,0,0
2,GO CELLULAR COMPONENT MAINTENANCE,0.015203,-0.092248,-0.10601,0,0
2,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.21256,-0.092277,-0.063994,0,0
2,GO PROTEIN INSERTION INTO MEMBRANE,0.095625,-0.092371,-0.060268,0,0
2,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.042857,-0.092571,-0.14696,0,0
2,GO VENTRAL SPINAL CORD DEVELOPMENT,0.12908,-0.092676,-0.074987,0,0
2,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.063042,-0.0929,-0.13949,0,0
2,GO RNA DECAPPING,0.063042,-0.093165,-0.084048,0,0
2,GO RESPONSE TO FOOD,0.064293,-0.093167,-0.092211,0,0
2,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.12689,-0.093304,-0.11504,0,0
2,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,0.38408,-0.093305,-0.080008,0,0
2,GO PHAGOSOME MATURATION,0.14526,-0.093437,-0.085654,0,0
2,GO GLUTAMATE METABOLIC PROCESS,0.14285,-0.093568,-0.094321,0,0
2,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.10096,-0.093605,-0.091261,0,0
2,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.48678,-0.093985,-0.065317,0,0
2,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.12049,-0.094103,-0.18566,0,0
2,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.75615,-0.09437,-0.026685,0,0
2,GO MEIOTIC CHROMOSOME SEPARATION,0.080955,-0.094409,-0.083872,0,0
2,GO SUBPALLIUM DEVELOPMENT,0.21905,-0.094589,-0.086714,0,0
2,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,0.063042,-0.094642,-0.11428,0,0
2,GO KINETOCHORE ASSEMBLY,0.57857,-0.094721,-0.053244,0,0
2,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.010245,-0.094843,-0.12706,0,0
2,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.15264,-0.095036,-0.13654,0,0
2,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.090515,-0.095162,-0.13351,0,0
2,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,0.44402,-0.095188,-0.03795,0,0
2,GO STEROID METABOLIC PROCESS,0.079444,-0.095191,-0.083801,0,0
2,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.099158,-0.095222,-0.11135,0,0
2,GO PROTEIN REFOLDING,0.29586,-0.09544,-0.053965,0,0
2,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.99651,-0.095512,-0.06923,0,0
2,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.18508,-0.095779,-0.12623,0,0
2,GO MITOCHONDRIAL FUSION,0.031748,-0.0959,-0.098395,0,0
2,GO DETOXIFICATION OF INORGANIC COMPOUND,0.30402,-0.096014,-0.34622,0,0
2,GO RESPONSE TO BMP,0.042857,-0.096422,-0.11419,0,0
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.16294,-0.096559,-0.099548,0,0
2,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.44402,-0.09674,-0.097956,0,0
2,GO REGULATION OF HISTONE H4 ACETYLATION,0.23937,-0.097144,-0.072208,0,0
2,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.20309,-0.097336,-0.073089,0,0
2,GO HISTONE H2A MONOUBIQUITINATION,0.070855,-0.097522,-0.078017,0,0
2,GO CYTOPLASM ORGANIZATION,0.084046,-0.097634,-0.12684,0,0
2,GO MITOTIC SPINDLE ASSEMBLY,0.0032441,-0.097681,-0.12134,0,0
2,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.64605,-0.097792,-0.053434,0,0
2,GO RENAL WATER HOMEOSTASIS,0.13355,-0.097948,-0.091902,0,0
2,GO ECTODERM DEVELOPMENT,0.015574,-0.09795,-0.11081,0,0
2,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.15264,-0.09813,-0.10051,0,0
2,GO CATECHOLAMINE METABOLIC PROCESS,0.81668,-0.098187,0.018086,0,0
2,GO SPROUTING ANGIOGENESIS,0.073629,-0.098418,-0.10615,0,0
2,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.19695,-0.098759,-0.10064,0,0
2,GO RETROGRADE TRANS SYNAPTIC SIGNALING,0.5726,-0.098813,-0.040628,0,0
2,GO PROTEIN LOCALIZATION TO ENDOSOME,0.12473,-0.098825,-0.1131,0,0
2,GO MESODERM MORPHOGENESIS,0.077957,-0.098903,-0.11643,0,0
2,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.060602,-0.099032,-0.18398,0,0
2,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.080955,-0.099088,-0.11472,0,0
2,GO ANDROGEN METABOLIC PROCESS,0.47588,-0.09924,-0.057015,0,0
2,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.23937,-0.099259,-0.062738,0,0
2,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.26098,-0.099356,-0.063304,0,0
2,GO RESPONSE TO STEROL DEPLETION,0.25363,-0.099511,-0.10718,0,0
2,GO T CELL APOPTOTIC PROCESS,0.084046,-0.099884,-0.11709,0,0
2,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.12259,-0.099893,-0.08762,0,0
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.022165,-0.099988,-0.15007,0,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,0.62732,-0.10003,-0.082911,0,0
2,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.085627,-0.10012,-0.096106,0,0
2,GO HEART INDUCTION,0.36064,-0.10018,-0.082211,0,0
2,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.0023671,-0.1002,-0.15959,0,0
2,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,0.4978,-0.10032,-0.068885,0,0
2,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.33812,-0.10033,-0.061251,0,0
2,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.072231,-0.10036,-0.1479,0,0
2,GO NEGATIVE REGULATION OF COAGULATION,0.32938,-0.10056,-0.14047,0,0
2,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.097379,-0.10059,-0.072517,0,0
2,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.64605,-0.10088,-0.066347,0,0
2,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.20309,-0.10109,-0.14733,0,0
2,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.092194,-0.10111,-0.078679,0,0
2,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.60883,-0.10114,-0.049575,0,0
2,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.34256,-0.10131,-0.11721,0,0
2,GO RELAXATION OF CARDIAC MUSCLE,0.46512,-0.10141,-0.083864,0,0
2,GO NOTOCHORD DEVELOPMENT,0.39371,-0.10143,-0.12899,0,0
2,GO MACROPHAGE APOPTOTIC PROCESS,0.11434,-0.10143,-0.12999,0,0
2,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.00050664,-0.1016,-0.097924,0,0
2,GO MALE MEIOTIC NUCLEAR DIVISION,0.11636,-0.1018,-0.11731,0,0
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.03939,-0.10185,-0.078305,0,0
2,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.0054795,-0.10192,-0.097993,0,0
2,GO POSITIVE REGULATION OF OSSIFICATION,0.047551,-0.10217,-0.13505,0,0
2,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.15773,-0.10298,-0.10393,0,0
2,GO GOLGI LOCALIZATION,0.095625,-0.10299,-0.088866,0,0
2,GO EPITHELIAL CELL FATE COMMITMENT,0.35607,-0.10336,-0.057254,0,0
2,GO RESPONSE TO COLD,0.090515,-0.10342,-0.13864,0,0
2,GO EAR MORPHOGENESIS,0.012203,-0.1035,-0.12465,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.20621,-0.10359,-0.083018,0,0
2,GO DEFINITIVE HEMOPOIESIS,0.34256,-0.10408,-0.054531,0,0
2,GO SULFATION,0.11235,-0.10413,-0.13199,0,0
2,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.16828,-0.10432,-0.20675,0,0
2,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.23937,-0.10438,-0.14381,0,0
2,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.023741,-0.10443,-0.11891,0,0
2,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.033166,-0.10445,-0.079391,0,0
2,GO MUSCLE CELL APOPTOTIC PROCESS,0.10845,-0.10455,-0.077879,0,0
2,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.041093,-0.10467,-0.12192,0,0
2,GO CARDIAC ATRIUM DEVELOPMENT,0.85768,-0.10474,-0.010847,0,0
2,GO XENOBIOTIC CATABOLIC PROCESS,0.7495,-0.10487,-0.049168,0,0
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.05824,-0.10505,-0.15867,0,0
2,GO KETONE BODY METABOLIC PROCESS,0.47049,-0.10567,-0.069096,0,0
2,GO PANCREATIC JUICE SECRETION,0.24288,-0.10591,-0.073648,0,0
2,GO RESPONSE TO ESTRADIOL,0.093897,-0.10593,-0.083027,0,0
2,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.55487,-0.10596,-0.081441,0,0
2,GO OLFACTORY LOBE DEVELOPMENT,0.40843,-0.10605,-0.070457,0,0
2,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.22235,-0.10614,-0.084726,0,0
2,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.12049,-0.1064,-0.078279,0,0
2,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.1313,-0.1066,-0.088014,0,0
2,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.7495,-0.10672,-0.023395,0,0
2,GO SPERMATID DIFFERENTIATION,0.0087944,-0.1071,-0.10775,0,0
2,GO SEX DETERMINATION,0.033894,-0.10741,-0.13898,0,0
2,GO DETECTION OF MECHANICAL STIMULUS,0.012508,-0.10772,-0.16527,0,0
2,GO DIENCEPHALON DEVELOPMENT,0.092194,-0.10818,-0.10951,0,0
2,GO FATTY ACID DERIVATIVE TRANSPORT,0.25363,-0.10856,-0.05197,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.0049174,-0.10864,-0.10882,0,0
2,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.38408,-0.10867,-0.090366,0,0
2,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.27227,-0.10892,-0.076187,0,0
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.097379,-0.10894,-0.1109,0,0
2,GO REGULATION OF FATTY ACID TRANSPORT,0.24643,-0.1092,-0.076207,0,0
2,GO MRNA TRANSCRIPTION,0.25363,-0.10935,-0.072209,0,0
2,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.41341,-0.10941,-0.042975,0,0
2,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.016734,-0.1097,-0.10881,0,0
2,GO NERVOUS SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.63978,-0.10983,-0.14513,0,0
2,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.082489,-0.11013,-0.081344,0,0
2,GO FAT CELL PROLIFERATION,0.26098,-0.11081,-0.081584,0,0
2,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.16828,-0.11097,-0.14394,0,0
2,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.041093,-0.1115,-0.082264,0,0
2,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.072231,-0.11222,-0.16981,0,0
2,GO EMBRYONIC ORGAN DEVELOPMENT,0.0023671,-0.11228,-0.11441,0,0
2,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.75615,-0.11251,-0.048589,0,0
2,GO KETONE CATABOLIC PROCESS,0.070855,-0.11282,-0.1894,0,0
2,GO RESPONSE TO INSECTICIDE,0.80989,-0.11311,-0.013078,0,0
2,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.079444,-0.11333,-0.084827,0,0
2,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.12049,-0.1136,-0.28901,0,0
2,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.068167,-0.11386,-0.18963,0,0
2,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.031748,-0.11388,-0.22195,0,0
2,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.47588,-0.11402,-0.045653,0,0
2,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.21579,-0.1141,-0.11565,0,0
2,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.099158,-0.11447,-0.17675,0,0
2,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.91293,-0.11454,0.022408,0,0
2,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,0.12259,-0.11456,-0.16197,0,0
2,GO MEIOTIC CHROMOSOME SEGREGATION,0.0085714,-0.1146,-0.11829,0,0
2,GO MEMBRANE LIPID CATABOLIC PROCESS,0.060602,-0.11507,-0.16772,0,0
2,GO LIPOPROTEIN LOCALIZATION,0.14285,-0.11514,-0.10287,0,0
2,GO RESPONSE TO UV C,0.030383,-0.11551,-0.1629,0,0
2,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.072231,-0.11557,-0.12803,0,0
2,GO MYOTUBE DIFFERENTIATION,0.10096,-0.11618,-0.088465,0,0
2,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.12049,-0.11621,-0.17828,0,0
2,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.23937,-0.11666,-0.12927,0,0
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,0.088862,-0.11691,-0.12826,0,0
2,GO GLOMERULAR MESANGIUM DEVELOPMENT,0.25001,-0.11722,-0.16384,0,0
2,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.2,-0.11725,-0.11246,0,0
2,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.092194,-0.11832,-0.1604,0,0
2,GO NEURON FATE COMMITMENT,0.41341,-0.11835,-0.040205,0,0
2,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.15015,-0.11851,-0.15717,0,0
2,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.095625,-0.11896,-0.12616,0,0
2,GO CARDIOCYTE DIFFERENTIATION,0.17934,-0.11901,-0.068565,0,0
2,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.090515,-0.11902,-0.13531,0,0
2,GO HORMONE METABOLIC PROCESS,0.11434,-0.1193,-0.098397,0,0
2,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.72313,-0.11935,-0.041044,0,0
2,GO STEROL IMPORT,0.34702,-0.11938,-0.055777,0,0
2,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.085627,-0.11962,-0.18799,0,0
2,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.25729,-0.11971,-0.079686,0,0
2,GO SYNAPTIC GROWTH AT NEUROMUSCULAR JUNCTION,0.27611,-0.12024,-0.076403,0,0
2,GO ROOF OF MOUTH DEVELOPMENT,0.016339,-0.12098,-0.13489,0,0
2,GO RESPONSE TO MURAMYL DIPEPTIDE,0.087232,-0.12111,-0.15455,0,0
2,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.038561,-0.12132,-0.16502,0,0
2,GO HISTONE H3 K9 TRIMETHYLATION,0.11434,-0.12172,-0.08329,0,0
2,GO HEART FORMATION,0.25001,-0.12187,-0.08206,0,0
2,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,0.41842,-0.12194,-0.056898,0,0
2,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.0073363,-0.1225,-0.12381,0,0
2,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.085627,-0.12254,-0.10509,0,0
2,GO T HELPER 2 CELL DIFFERENTIATION,0.33373,-0.12264,-0.19267,0,0
2,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.36064,-0.12265,-0.09638,0,0
2,GO INFLAMMATORY CELL APOPTOTIC PROCESS,0.16828,-0.12326,-0.14239,0,0
2,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.25001,-0.12327,-0.12467,0,0
2,GO NEGATIVE REGULATION OF CELL SIZE,0.082489,-0.12343,-0.094469,0,0
2,GO SYNAPTIC VESICLE BUDDING,0.15015,-0.12357,-0.10189,0,0
2,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.63354,-0.12361,-0.079345,0,0
2,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.22568,-0.12369,-0.10727,0,0
2,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.35153,-0.12382,-0.085274,0,0
2,GO NEGATIVE REGULATION OF TISSUE REMODELING,0.084046,-0.12411,-0.18517,0,0
2,GO REGULATION OF MESODERM DEVELOPMENT,0.14285,-0.12419,-0.11158,0,0
2,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.0036303,-0.12448,-0.13972,0,0
2,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.13583,-0.12451,-0.12157,0,0
2,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.21579,-0.12457,-0.073951,0,0
2,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.12908,-0.125,-0.10917,0,0
2,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.10096,-0.12573,-0.1186,0,0
2,GO EPITHELIAL TUBE MORPHOGENESIS,0.00017186,-0.12589,-0.15114,0,0
2,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.18219,-0.126,-0.11398,0,0
2,GO POSITIVE REGULATION OF BEHAVIOR,0.036948,-0.12609,-0.18719,0,0
2,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.05161,-0.12619,-0.18499,0,0
2,GO CYSTEINE METABOLIC PROCESS,0.56666,-0.12668,-0.065246,0,0
2,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.054842,-0.12674,-0.11463,0,0
2,GO RESPONSE TO DIETARY EXCESS,0.46512,-0.12681,-0.073083,0,0
2,GO RESPIRATORY BURST,0.0030654,-0.12709,-0.24633,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.15264,-0.12731,-0.085475,0,0
2,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.076492,-0.1274,-0.17121,0,0
2,GO RESPONSE TO CADMIUM ION,0.11039,-0.12778,-0.12653,0,0
2,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.075049,-0.12815,-0.11737,0,0
2,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.060602,-0.12853,-0.15283,0,0
2,GO NEUTROPHIL HOMEOSTASIS,0.29992,-0.12898,-0.14992,0,0
2,GO CILIUM ORGANIZATION,0.00052342,-0.12901,-0.13345,0,0
2,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.042857,-0.12913,-0.2315,0,0
2,GO REGULATION OF GTP BINDING,0.40843,-0.12916,-0.069615,0,0
2,GO REGULATION OF CELL SHAPE,0.007729,-0.12957,-0.13399,0,0
2,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.090515,-0.12965,-0.19235,0,0
2,GO ETHER BIOSYNTHETIC PROCESS,0.12689,-0.12983,-0.19409,0,0
2,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.076492,-0.1303,-0.10402,0,0
2,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.095625,-0.13039,-0.10267,0,0
2,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.017549,-0.13045,-0.11113,0,0
2,GO AMMONIUM TRANSPORT,0.10845,-0.13054,-0.19741,0,0
2,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.072231,-0.1308,-0.1429,0,0
2,GO LIPID EXPORT FROM CELL,0.076492,-0.1312,-0.11281,0,0
2,GO SPECIFICATION OF SYMMETRY,0.001986,-0.13171,-0.11453,0,0
2,GO BILE ACID BIOSYNTHETIC PROCESS,0.057089,-0.13195,-0.10423,0,0
2,GO REGULATION OF RESPONSE TO TUMOR CELL,0.077957,-0.13235,-0.13666,0,0
2,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.0032441,-0.13243,-0.12134,0,0
2,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.12908,-0.13297,-0.23336,0,0
2,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.12689,-0.13369,-0.12255,0,0
2,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.13355,-0.13395,-0.18851,0,0
2,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.099158,-0.13406,-0.087686,0,0
2,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.32938,-0.13435,-0.081308,0,0
2,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.01282,-0.1348,-0.14885,0,0
2,GO NEGATIVE REGULATION OF WOUND HEALING,0.066855,-0.1352,-0.15909,0,0
2,GO ADHERENS JUNCTION ORGANIZATION,0.072231,-0.13536,-0.10553,0,0
2,GO SENSORY ORGAN MORPHOGENESIS,0.00044439,-0.13553,-0.14304,0,0
2,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.00040247,-0.13585,-0.15198,0,0
2,GO METANEPHRIC NEPHRON DEVELOPMENT,0.1313,-0.13603,-0.097823,0,0
2,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.29992,-0.13626,-0.13545,0,0
2,GO REGULATION OF NEURON MATURATION,0.4598,-0.13662,-0.043819,0,0
2,GO RETINOL METABOLIC PROCESS,0.057089,-0.13684,-0.17424,0,0
2,GO PLASMA MEMBRANE FUSION,0.13814,-0.13697,-0.13578,0,0
2,GO FORELIMB MORPHOGENESIS,0.15264,-0.137,-0.11631,0,0
2,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.19695,-0.13708,-0.070767,0,0
2,GO ENDOCRINE PANCREAS DEVELOPMENT,0.2839,-0.13874,-0.069496,0,0
2,GO UTERUS DEVELOPMENT,0.27999,-0.14048,-0.068691,0,0
2,GO REGULATION OF RENAL SYSTEM PROCESS,0.12473,-0.14058,-0.11492,0,0
2,GO PROTEIN K11 LINKED UBIQUITINATION,0.0028957,-0.14073,-0.1457,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.24288,-0.14184,-0.10259,0,0
2,GO L ASCORBIC ACID METABOLIC PROCESS,0.37932,-0.1419,-0.095205,0,0
2,GO REGULATION OF MITOCHONDRIAL FUSION,0.05824,-0.14226,-0.10691,0,0
2,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.013465,-0.14252,-0.17536,0,0
2,GO PHOTORECEPTOR CELL MAINTENANCE,0.052669,-0.14262,-0.11501,0,0
2,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.097379,-0.14286,-0.1077,0,0
2,GO PHOTOTRANSDUCTION,0.0073363,-0.14296,-0.14348,0,0
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.0057817,-0.14298,-0.17715,0,0
2,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.21905,-0.14358,-0.11073,0,0
2,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.16294,-0.14358,-0.17508,0,0
2,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.0028957,-0.1439,-0.19045,0,0
2,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.082489,-0.14419,-0.11358,0,0
2,GO OVARIAN FOLLICLE DEVELOPMENT,0.014486,-0.14453,-0.12149,0,0
2,GO EPITHELIAL TUBE FORMATION,0.00022676,-0.14479,-0.15709,0,0
2,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.00022676,-0.14503,-0.1583,0,0
2,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.014841,-0.14516,-0.13223,0,0
2,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.035393,-0.14517,-0.18809,0,0
2,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.24288,-0.14552,-0.19843,0,0
2,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.15264,-0.14566,-0.16436,0,0
2,GO ANIMAL ORGAN MATURATION,0.13355,-0.14576,-0.10707,0,0
2,GO CARNITINE METABOLIC PROCESS,0.38888,-0.14588,-0.064017,0,0
2,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.26847,-0.14619,-0.090231,0,0
2,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,0.53742,-0.14649,-0.16679,0,0
2,GO NEGATIVE REGULATION OF BONE REMODELING,0.10845,-0.14707,-0.17964,0,0
2,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.35607,-0.1471,-0.082958,0,0
2,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.066855,-0.14727,-0.1549,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.19393,-0.14817,-0.10305,0,0
2,GO PLATELET DEGRANULATION,0.20621,-0.1483,-0.1132,0,0
2,GO PROTEIN LOCALIZATION TO EARLY ENDOSOME,0.21256,-0.14852,-0.17387,0,0
2,GO ENDOTHELIUM DEVELOPMENT,0.0013872,-0.14899,-0.16446,0,0
2,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.48131,-0.14951,-0.075744,0,0
2,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.00059588,-0.14964,-0.12514,0,0
2,GO NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.32506,-0.14965,-0.11279,0,0
2,GO MICROTUBULE BUNDLE FORMATION,0.00087311,-0.14969,-0.16357,0,0
2,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.093897,-0.14977,-0.11086,0,0
2,GO COPULATION,0.068167,-0.1504,-0.11843,0,0
2,GO REGULATION OF MYOBLAST FUSION,0.12049,-0.15075,-0.17769,0,0
2,GO MACROPHAGE CYTOKINE PRODUCTION,0.20309,-0.15141,-0.14563,0,0
2,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.26098,-0.15142,-0.14635,0,0
2,GO UROGENITAL SYSTEM DEVELOPMENT,0.0015653,-0.15155,-0.14694,0,0
2,GO CELL PROJECTION ASSEMBLY,5.4121e-05,-0.15189,-0.12875,0,0
2,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.21579,-0.15203,-0.12687,0,0
2,GO DETECTION OF CALCIUM ION,0.2,-0.15249,-0.13043,0,0
2,GO REGULATION OF HEART MORPHOGENESIS,0.22568,-0.15254,-0.10321,0,0
2,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.023205,-0.15258,-0.1816,0,0
2,GO MICROTUBULE SEVERING,0.024846,-0.15297,-0.14641,0,0
2,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.20309,-0.15304,-0.15205,0,0
2,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.12689,-0.15324,-0.15939,0,0
2,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.0028957,-0.15332,-0.18154,0,0
2,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.070855,-0.15402,-0.13608,0,0
2,GO MYOFIBRIL ASSEMBLY,0.0013054,-0.15403,-0.1654,0,0
2,GO POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION,0.15015,-0.15425,-0.13189,0,0
2,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.0049174,-0.1545,-0.18074,0,0
2,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.17099,-0.1547,-0.067165,0,0
2,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.29586,-0.15483,-0.054061,0,0
2,GO AMYLOID FIBRIL FORMATION,0.33373,-0.15512,-0.11336,0,0
2,GO SEROTONIN SECRETION,0.14526,-0.15553,-0.095884,0,0
2,GO EYE MORPHOGENESIS,0.0007696,-0.15573,-0.15378,0,0
2,GO GANGLION DEVELOPMENT,0.1313,-0.15648,-0.18093,0,0
2,GO HYALURONAN CATABOLIC PROCESS,0.20309,-0.15652,-0.16605,0,0
2,GO EPITHELIAL CELL MATURATION,0.070855,-0.1566,-0.13123,0,0
2,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.020205,-0.15667,-0.12284,0,0
2,GO T CELL EXTRAVASATION,0.13583,-0.15669,-0.23466,0,0
2,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.073629,-0.15673,-0.15122,0,0
2,GO TELOMERE CAPPING,0.0041716,-0.15682,-0.11467,0,0
2,GO ADHERENS JUNCTION ASSEMBLY,0.23589,-0.15705,-0.067929,0,0
2,GO NEURAL NUCLEUS DEVELOPMENT,0.019739,-0.1571,-0.15153,0,0
2,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.007729,-0.1573,-0.18045,0,0
2,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.0037331,-0.15743,-0.14227,0,0
2,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.18508,-0.15763,-0.13072,0,0
2,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.014486,-0.15774,-0.12947,0,0
2,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.0017641,-0.15846,-0.16745,0,0
2,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.12259,-0.15903,-0.20717,0,0
2,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.25363,-0.15953,-0.13287,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.070855,-0.16018,-0.14161,0,0
2,GO MALE GENITALIA DEVELOPMENT,0.036164,-0.16024,-0.16504,0,0
2,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.033894,-0.16114,-0.19282,0,0
2,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.25001,-0.16144,-0.11423,0,0
2,GO TYPE 2 IMMUNE RESPONSE,0.065563,-0.16191,-0.19482,0,0
2,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.42347,-0.1623,-0.10631,0,0
2,GO CELL FATE DETERMINATION,0.0094949,-0.16255,-0.18638,0,0
2,GO REGULATION OF HELICASE ACTIVITY,0.21256,-0.16348,-0.1121,0,0
2,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.0050528,-0.16395,-0.16202,0,0
2,GO LACTATE METABOLIC PROCESS,0.077957,-0.16484,-0.14518,0,0
2,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.019739,-0.16498,-0.16212,0,0
2,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.74288,-0.16555,-0.03071,0,0
2,GO NEGATIVE REGULATION OF JNK CASCADE,0.011904,-0.16609,-0.13149,0,0
2,GO LYSINE METABOLIC PROCESS,0.082489,-0.16717,-0.21034,0,0
2,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.20621,-0.16786,-0.12081,0,0
2,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.080955,-0.16839,-0.11155,0,0
2,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.0042883,-0.1685,-0.20823,0,0
2,GO TRNA CATABOLIC PROCESS,0.24643,-0.16872,-0.13514,0,0
2,GO REGULATION OF CHROMATIN BINDING,0.00095906,-0.16935,-0.21586,0,0
2,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.10465,-0.16995,-0.22625,0,0
2,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.049546,-0.17037,-0.23522,0,0
2,GO ACTIVATION OF JUN KINASE ACTIVITY,0.00035231,-0.17079,-0.15974,0,0
2,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.18219,-0.17115,-0.077585,0,0
2,GO NEPHRON EPITHELIUM DEVELOPMENT,0.0015653,-0.17192,-0.16732,0,0
2,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.53167,-0.17269,-0.038424,0,0
2,GO KIDNEY EPITHELIUM DEVELOPMENT,0.0028957,-0.17377,-0.17369,0,0
2,GO INTERMEDIATE FILAMENT ORGANIZATION,0.23245,-0.17407,-0.10281,0,0
2,GO ERYTHROCYTE DEVELOPMENT,0.0032441,-0.17411,-0.13457,0,0
2,GO REGULATION OF GOLGI ORGANIZATION,0.044685,-0.17453,-0.14119,0,0
2,GO DORSAL VENTRAL PATTERN FORMATION,0.0037331,-0.17487,-0.14148,0,0
2,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.0022992,-0.17542,-0.16577,0,0
2,GO MYOTUBE CELL DEVELOPMENT,0.016339,-0.17563,-0.15797,0,0
2,GO METANEPHROS MORPHOGENESIS,0.25001,-0.17581,-0.075415,0,0
2,GO DNA DEMETHYLATION,0.00029782,-0.17626,-0.19988,0,0
2,GO CAMERA TYPE EYE MORPHOGENESIS,0.00052342,-0.17744,-0.15958,0,0
2,GO SPERM AXONEME ASSEMBLY,0.018398,-0.17897,-0.14658,0,0
2,GO MITOCHONDRIAL DEPOLARIZATION,0.11039,-0.17905,-0.12555,0,0
2,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.14769,-0.17951,-0.12749,0,0
2,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.21256,-0.17955,-0.1377,0,0
2,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.036164,-0.17974,-0.1366,0,0
2,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.00067758,-0.1798,-0.18452,0,0
2,GO BRONCHUS DEVELOPMENT,0.20309,-0.18006,-0.13595,0,0
2,GO REGULATION OF CILIUM BEAT FREQUENCY,0.013139,-0.18018,-0.17527,0,0
2,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.0056288,-0.1806,-0.16351,0,0
2,GO ETHANOL CATABOLIC PROCESS,0.27999,-0.18063,-0.10727,0,0
2,GO CELL FATE SPECIFICATION,0.013798,-0.18077,-0.14292,0,0
2,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.12689,-0.18205,-0.097632,0,0
2,GO RAP PROTEIN SIGNAL TRANSDUCTION,0.10654,-0.18215,-0.1864,0,0
2,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.080955,-0.18238,-0.2116,0,0
2,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.00036427,-0.18249,-0.21438,0,0
2,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.0029794,-0.18274,-0.23216,0,0
2,GO RESPONSE TO INACTIVITY,0.02166,-0.18324,-0.15967,0,0
2,GO REGULATION OF TELOMERE CAPPING,0.0025083,-0.18534,-0.14784,0,0
2,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.0011549,-0.18602,-0.16315,0,0
2,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.12689,-0.18625,-0.15532,0,0
2,GO INTRACILIARY TRANSPORT,0.0025083,-0.18655,-0.20942,0,0
2,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.00032948,-0.18658,-0.16686,0,0
2,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.16032,-0.1866,-0.18686,0,0
2,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0056288,-0.18666,-0.16861,0,0
2,GO GENITALIA MORPHOGENESIS,0.1028,-0.18737,-0.14642,0,0
2,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,6.2786e-05,-0.18748,-0.24241,0,0
2,GO PRO B CELL DIFFERENTIATION,0.03939,-0.18773,-0.17599,0,0
2,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.0069616,-0.18822,-0.15997,0,0
2,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.072231,-0.18966,-0.20207,0,0
2,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.22235,-0.18976,-0.20246,0,0
2,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.080955,-0.18988,-0.14246,0,0
2,GO POSITIVE REGULATION OF VASCULOGENESIS,0.32938,-0.18998,-0.11467,0,0
2,GO RESPONSE TO AUDITORY STIMULUS,0.11235,-0.19042,-0.13911,0,0
2,GO RENAL ABSORPTION,0.082489,-0.19141,-0.23081,0,0
2,GO ETHANOL OXIDATION,0.15773,-0.19142,-0.23688,0,0
2,GO CELL MIGRATION IN HINDBRAIN,0.041093,-0.19215,-0.19747,0,0
2,GO REGULATION OF CHLORIDE TRANSPORT,0.05824,-0.19226,-0.1733,0,0
2,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0011549,-0.19228,-0.17259,0,0
2,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.0040578,-0.19241,-0.17525,0,0
2,GO GALACTOSE METABOLIC PROCESS,0.10465,-0.19284,-0.15601,0,0
2,GO SEGMENT SPECIFICATION,0.016734,-0.1934,-0.22752,0,0
2,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.17934,-0.19379,-0.14419,0,0
2,GO NON MOTILE CILIUM ASSEMBLY,0.0062634,-0.19384,-0.15592,0,0
2,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.0094949,-0.19414,-0.17633,0,0
2,GO FEMALE GENITALIA DEVELOPMENT,0.0030654,-0.19429,-0.21205,0,0
2,GO ENDOCRINE SYSTEM DEVELOPMENT,0.0083534,-0.19517,-0.14355,0,0
2,GO PROXIMAL DISTAL PATTERN FORMATION,0.18508,-0.19669,-0.13112,0,0
2,GO REGULATION OF MEMBRANE PERMEABILITY,2.8418e-05,-0.19715,-0.20872,0,0
2,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.17934,-0.19725,-0.1207,0,0
2,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.12473,-0.1974,-0.18682,0,0
2,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.073629,-0.19844,-0.1825,0,0
2,GO SARCOMERE ORGANIZATION,0.0040578,-0.19847,-0.18119,0,0
2,GO EMBRYONIC DIGIT MORPHOGENESIS,0.00035231,-0.1996,-0.20529,0,0
2,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.075049,-0.20108,-0.12896,0,0
2,GO CARDIOBLAST DIFFERENTIATION,0.10654,-0.20179,-0.12994,0,0
2,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.11636,-0.20224,-0.095155,0,0
2,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.1313,-0.20253,-0.1455,0,0
2,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.014486,-0.20301,-0.21454,0,0
2,GO PARTURITION,0.082489,-0.2036,-0.1589,0,0
2,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.0016129,-0.20414,-0.21579,0,0
2,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.070855,-0.20441,-0.18912,0,0
2,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.17374,-0.20468,-0.1526,0,0
2,GO SECONDARY HEART FIELD SPECIFICATION,0.017549,-0.20492,-0.26988,0,0
2,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.049546,-0.20493,-0.15013,0,0
2,GO REGULATION OF PROTEIN SUMOYLATION,0.043763,-0.20577,-0.115,0,0
2,GO PHOSPHOLIPID DEPHOSPHORYLATION,9.389e-05,-0.2064,-0.21255,0,0
2,GO CLATHRIN COAT ASSEMBLY,0.11039,-0.20747,-0.10216,0,0
2,GO SEQUESTERING OF ACTIN MONOMERS,0.25729,-0.20766,-0.15062,0,0
2,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.0016129,-0.20814,-0.22175,0,0
2,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.033166,-0.20879,-0.1891,0,0
2,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.00014935,-0.2089,-0.20287,0,0
2,GO CENTROSOME SEPARATION,0.0067808,-0.20902,-0.19563,0,0
2,GO REGULATION OF STEM CELL DIVISION,0.12259,-0.20926,-0.10614,0,0
2,GO FOREBRAIN NEURON FATE COMMITMENT,0.13583,-0.20935,-0.15585,0,0
2,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.0034322,-0.20965,-0.15386,0,0
2,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00010462,-0.21082,-0.26754,0,0
2,GO REGULATION OF CENTROSOME CYCLE,7.6603e-06,-0.21304,-0.1946,0,0
2,GO DORSAL SPINAL CORD DEVELOPMENT,0.40349,-0.21308,-0.034826,0,0
2,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,0.12473,-0.2133,-0.15283,0,0
2,GO REGULATION OF ANIMAL ORGAN FORMATION,0.16828,-0.21457,-0.11528,0,0
2,GO ATRIAL SEPTUM DEVELOPMENT,0.05161,-0.21646,-0.16836,0,0
2,GO APICAL PROTEIN LOCALIZATION,0.0049174,-0.21697,-0.17376,0,0
2,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.0028141,-0.21714,-0.20972,0,0
2,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.076492,-0.21747,-0.23213,0,0
2,GO EMBRYONIC BODY MORPHOGENESIS,0.00026903,-0.21769,-0.26574,0,0
2,GO TERPENOID BIOSYNTHETIC PROCESS,0.059411,-0.21796,-0.28744,0,0
2,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.040234,-0.21923,-0.20719,0,0
2,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.21579,-0.22055,-0.073047,0,0
2,GO NEGATIVE REGULATION OF GLUCOSE IMPORT,0.0083534,-0.22244,-0.24134,0,0
2,GO MALE SEX DETERMINATION,0.0038387,-0.22247,-0.24751,0,0
2,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.00021167,-0.22558,-0.22814,0,0
2,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.00011241,-0.22664,-0.19871,0,0
2,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.10845,-0.22751,-0.16087,0,0
2,GO TRIGEMINAL NERVE DEVELOPMENT,0.060602,-0.22914,-0.31862,0,0
2,GO INTRACILIARY RETROGRADE TRANSPORT,0.063042,-0.22994,-0.19183,0,0
2,GO ESTROUS CYCLE,0.0071468,-0.23163,-0.24358,0,0
2,GO CELL JUNCTION MAINTENANCE,0.0011549,-0.23176,-0.2268,0,0
2,GO THYMOCYTE APOPTOTIC PROCESS,0.079444,-0.23252,-0.16641,0,0
2,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.12689,-0.23289,-0.19345,0,0
2,GO RADIAL GLIAL CELL DIFFERENTIATION,0.05161,-0.23341,-0.20904,0,0
2,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.21905,-0.23403,-0.11081,0,0
2,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0013457,-0.23426,-0.22204,0,0
2,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.084046,-0.23463,-0.20178,0,0
2,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.0020453,-0.23597,-0.2163,0,0
2,GO REGULATION OF GLOMERULAR FILTRATION,0.076492,-0.23651,-0.24512,0,0
2,GO SKELETAL MUSCLE ADAPTATION,0.04854,-0.23652,-0.1312,0,0
2,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,0.17934,-0.23766,-0.081558,0,0
2,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.029068,-0.23779,-0.17505,0,0
2,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.0024367,-0.2387,-0.29907,0,0
2,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.23937,-0.23921,-0.13675,0,0
2,GO RETINAL ROD CELL DIFFERENTIATION,0.15264,-0.23973,-0.14753,0,0
2,GO ATRIAL SEPTUM MORPHOGENESIS,0.03245,-0.23999,-0.22587,0,0
2,GO OUTER DYNEIN ARM ASSEMBLY,0.001191,-0.24059,-0.28135,0,0
2,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.0066042,-0.24254,-0.23492,0,0
2,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,1.8521e-05,-0.24306,-0.24897,0,0
2,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.011904,-0.2446,-0.21774,0,0
2,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.0047853,-0.24528,-0.28865,0,0
2,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.00011241,-0.24842,-0.29403,0,0
2,GO RETINAL METABOLIC PROCESS,0.077957,-0.25064,-0.21635,0,0
2,GO REGULATION OF POSITIVE CHEMOTAXIS,0.014486,-0.25132,-0.20024,0,0
2,GO REGULATION OF SPINDLE ASSEMBLY,7.3528e-06,-0.25391,-0.26491,0,0
2,GO SPINAL CORD PATTERNING,0.0087944,-0.25563,-0.24283,0,0
2,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.0015189,-0.25565,-0.26237,0,0
2,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.0001165,-0.25592,-0.26039,0,0
2,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.00036427,-0.25617,-0.26599,0,0
2,GO EMBRYONIC HEMOPOIESIS,0.001228,-0.2566,-0.21903,0,0
2,GO PITUITARY GLAND DEVELOPMENT,0.001986,-0.25694,-0.27516,0,0
2,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,0.19393,-0.25813,-0.1016,0,0
2,GO MYOBLAST MIGRATION,0.082489,-0.2586,-0.2141,0,0
2,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.015574,-0.26558,-0.25503,0,0
2,GO HEART FIELD SPECIFICATION,0.060602,-0.26833,-0.17541,0,0
2,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.029719,-0.26862,-0.19443,0,0
2,GO ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.061812,-0.26905,-0.21526,0,0
2,GO ENDOCARDIUM DEVELOPMENT,0.018398,-0.2693,-0.2307,0,0
2,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.0017123,-0.26948,-0.25984,0,0
2,GO FRUCTOSE METABOLIC PROCESS,0.079444,-0.2717,-0.24901,0,0
2,GO REGULATION OF CELL FATE COMMITMENT,0.00050664,-0.2724,-0.26348,0,0
2,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.00055855,-0.27266,-0.22664,0,0
2,GO ECTODERMAL PLACODE DEVELOPMENT,0.036164,-0.2733,-0.22995,0,0
2,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.068167,-0.27576,-0.22095,0,0
2,GO TYPE B PANCREATIC CELL PROLIFERATION,0.043763,-0.2761,-0.25581,0,0
2,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.041967,-0.28645,-0.22356,0,0
2,GO EXTRACELLULAR TRANSPORT,1.104e-05,-0.28703,-0.35817,0,0
2,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.00026903,-0.28802,-0.26272,0,0
2,GO CELL CELL ADHESION MEDIATED BY CADHERIN,0.0024367,-0.28859,-0.21119,0,0
2,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.070855,-0.29173,-0.17678,0,0
2,GO CARDIOBLAST PROLIFERATION,0.43883,-0.2964,-0.11467,0,0
2,GO CELLULAR RESPONSE TO COPPER ION,0.019283,-0.29926,-0.345,0,0
2,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,1.0184e-05,-0.30264,-0.28678,0,0
2,GO INDOLALKYLAMINE METABOLIC PROCESS,0.02843,-0.30537,-0.18731,0,0
2,GO AXONEME ASSEMBLY,3.1888e-05,-0.30878,-0.31671,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.00052342,-0.31439,-0.28122,0,0
2,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,0.011612,-0.3153,-0.23936,0,0
2,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.057089,-0.31534,-0.16377,0,0
2,GO IMMATURE B CELL DIFFERENTIATION,0.0019282,-0.31535,-0.23545,0,0
2,GO T CELL LINEAGE COMMITMENT,3.7145e-05,-0.31675,-0.28651,0,0
2,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.00081984,-0.31857,-0.24577,0,0
2,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,9.7346e-05,-0.32053,-0.26301,0,0
2,GO GABAERGIC NEURON DIFFERENTIATION,0.095625,-0.32207,-0.1348,0,0
2,GO DOPAMINE BIOSYNTHETIC PROCESS,0.097379,-0.32331,-0.24581,0,0
2,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,7.3528e-06,-0.33772,-0.40042,0,0
2,GO REFLEX,0.00087311,-0.34684,-0.36676,0,0
2,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.0031536,-0.3503,-0.31511,0,0
2,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.00010462,-0.35389,-0.41795,0,0
2,GO GONADOTROPIN SECRETION,0.00055855,-0.35713,-0.35836,0,0
2,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,7.0571e-06,-0.35948,-0.3418,0,0
2,GO REGULATION OF ANOIKIS,3.5759e-05,-0.36079,-0.41494,0,0
2,GO ENDOTHELIAL CELL MORPHOGENESIS,0.0021062,-0.36436,-0.37608,0,0
2,GO MOTILE CILIUM ASSEMBLY,0.00059588,-0.36813,-0.30731,0,0
2,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.0025083,-0.36907,-0.34298,0,0
2,GO REGULATION OF NEUROMUSCULAR JUNCTION DEVELOPMENT,0.0099891,-0.37217,-0.32764,0,0
2,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.035393,-0.37892,-0.28382,0,0
2,GO RESPONSE TO MUSCLE INACTIVITY,2.9532e-05,-0.38095,-0.37791,0,0
2,GO MEGAKARYOCYTE DEVELOPMENT,0.00028792,-0.38116,-0.38153,0,0
2,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.0017641,-0.38506,-0.33924,0,0
2,GO NEGATIVE REGULATION OF PROTEIN SUMOYLATION,0.12689,-0.38618,-0.17745,0,0
2,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,0.0059384,-0.3883,-0.31908,0,0
2,GO GLIAL CELL FATE COMMITMENT,0.0079323,-0.41107,-0.33351,0,0
2,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.0085714,-0.42279,-0.3354,0,0
2,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00012512,-0.43125,-0.3942,0,0
2,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.00013917,-0.43491,-0.44366,0,0
2,GO NEURON FATE SPECIFICATION,0.0081404,-0.43561,-0.28917,0,0
2,GO ADENOHYPOPHYSIS DEVELOPMENT,0.04854,-0.43791,-0.27687,0,0
2,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.0019282,-0.43953,-0.34183,0,0
2,GO RETINAL GANGLION CELL AXON GUIDANCE,0.00016595,-0.44235,-0.4661,0,0
2,GO POSITIVE REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0012662,-0.45043,-0.52504,0,0
2,GO REGULATION OF CELL FATE SPECIFICATION,9.0551e-05,-0.45104,-0.41235,0,0
2,GO RETINA LAYER FORMATION,0.00010845,-0.48066,-0.42623,0,0
2,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.0050528,-0.48127,-0.48072,0,0
2,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,0.038561,-0.49499,-0.24544,0,0
2,GO CARDIAC CELL FATE COMMITMENT,0.0027346,-0.52433,-0.42865,0,0
2,GO NOTCH RECEPTOR PROCESSING,8.6584e-06,-0.52724,-0.48523,0,0
2,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.00020448,-0.53073,-0.48748,0,0
2,GO INNER DYNEIN ARM ASSEMBLY,5.7413e-06,-0.53986,-0.59671,0,0
2,GO REGULATION OF RECEPTOR CLUSTERING,0.00024286,-0.54336,-0.47666,0,0
2,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.00021909,-0.56212,-0.45463,0,0
2,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.00016595,-0.56502,-0.52614,0,0
2,GO PSEUDOPODIUM ORGANIZATION,0.00020448,-0.5905,-0.44339,0,0
2,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.0025817,-0.63422,-0.53362,0,0
2,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,7.6603e-06,-0.72682,-0.57253,0,0
2,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,3.1904e-06,-0.77652,-0.71411,0,0
2,GO NOSE DEVELOPMENT,0.0001547,-0.96706,-0.65925,0,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,6.0504e-05,1.8686,1.3798,1,1
3,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,5.4121e-05,1.4114,1.1209,1,1
3,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,1.2962e-05,1.2851,1.0997,1,1
3,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.00037661,1.0456,0.76649,1,1
3,GO CYTIDINE TO URIDINE EDITING,7.3528e-06,0.92319,0.82151,1,1
3,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0013457,0.88987,0.68725,1,1
3,GO TOLERANCE INDUCTION,5.0683e-06,0.85031,0.78415,1,1
3,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.00012964,0.84853,0.59727,1,1
3,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00020448,0.8432,0.60034,1,1
3,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,1.0184e-05,0.81403,0.63864,1,1
3,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,9.8628e-07,0.79225,0.8409,1,1
3,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,2.4346e-05,0.78029,0.89063,1,1
3,GO REGULATION OF PLASMINOGEN ACTIVATION,0.00069957,0.77947,0.5265,1,1
3,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,0.00026003,0.77062,0.4711,1,1
3,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,1.2454e-05,0.76213,0.67032,1,1
3,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,8.628e-07,0.76209,0.71371,1,1
3,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.00010845,0.75763,0.55319,1,1
3,GO RESPONSE TO TYPE I INTERFERON,2.2658e-06,0.7406,0.68925,1,1
3,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,6.2367e-06,0.73465,0.64924,1,1
3,GO HISTAMINE SECRETION,2.0829e-07,0.72977,0.77482,1,1
3,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,7.8282e-05,0.69776,0.56333,1,1
3,GO GERMINAL CENTER FORMATION,1.104e-05,0.6869,0.60506,1,1
3,GO REGULATION OF TOLERANCE INDUCTION,3.0689e-05,0.68331,0.63422,1,1
3,GO LIPID DROPLET FORMATION,1.4044e-06,0.68312,0.72508,1,1
3,GO MUCUS SECRETION,0.00034072,0.67366,0.60677,1,1
3,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,1.906e-06,0.66532,0.62767,1,1
3,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,3.7791e-06,0.66472,0.61696,1,1
3,GO EXTRACELLULAR MATRIX CONSTITUENT SECRETION,0.00013433,0.66314,0.61703,1,1
3,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,1.8251e-06,0.65948,0.71164,1,1
3,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,5.0226e-05,0.65947,0.52454,1,1
3,GO HISTAMINE TRANSPORT,2.2879e-07,0.65932,0.73168,1,1
3,GO DOPAMINE BIOSYNTHETIC PROCESS,7.547e-05,0.65554,0.64528,1,1
3,GO RENAL ABSORPTION,5.0683e-06,0.65533,0.7054,1,1
3,GO T CELL MEDIATED CYTOTOXICITY,7.547e-05,0.65499,0.54066,1,1
3,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,2.5308e-05,0.6532,0.54831,1,1
3,GO ACTIN FILAMENT NETWORK FORMATION,0.00010092,0.64983,0.54247,1,1
3,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,3.0576e-06,0.64432,0.57427,1,1
3,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.00021909,0.6403,0.53806,1,1
3,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.00098941,0.63482,0.56601,1,1
3,GO POSITIVE REGULATION OF CELL MATURATION,2.6902e-06,0.63467,0.59936,1,1
3,GO MATURE B CELL DIFFERENTIATION,1.6455e-05,0.63305,0.46588,1,1
3,GO RESPONSE TO IMMOBILIZATION STRESS,1.4044e-06,0.63177,0.51429,1,1
3,GO PROGESTERONE METABOLIC PROCESS,0.00042998,0.62954,0.73486,1,1
3,GO DENDRITIC CELL DIFFERENTIATION,1.4609e-05,0.62672,0.52261,1,1
3,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,1.0604e-05,0.62318,0.51056,1,1
3,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,3.4728e-06,0.62186,0.65109,1,1
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.00019079,0.62185,0.66257,1,1
3,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.00067758,0.61735,0.50929,1,1
3,GO EOSINOPHIL MIGRATION,7.547e-05,0.61631,0.4941,1,1
3,GO RESPONSE TO NITROSATIVE STRESS,7.3528e-06,0.61391,0.56222,1,1
3,GO EOSINOPHIL CHEMOTAXIS,7.8282e-05,0.61246,0.49708,1,1
3,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,2.8077e-06,0.60825,0.58468,1,1
3,GO INTESTINAL ABSORPTION,1.4268e-07,0.60799,0.67455,1,1
3,GO RESPONSE TO INTERFERON BETA,0.00084609,0.60465,0.45609,1,1
3,GO DETECTION OF OTHER ORGANISM,4.2876e-06,0.60366,0.6244,1,1
3,GO REGULATION OF SUPEROXIDE ANION GENERATION,1.6455e-05,0.59806,0.57766,1,1
3,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,1.104e-05,0.58873,0.46986,1,1
3,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,2.5774e-06,0.58747,0.57759,1,1
3,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,2.3418e-05,0.58705,0.64077,1,1
3,GO O GLYCAN PROCESSING,7.2756e-08,0.58593,0.58654,1,1
3,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,3.0689e-05,0.58386,0.47297,1,1
3,GO INTESTINAL LIPID ABSORPTION,7.3528e-06,0.58019,0.67119,1,1
3,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,4.6623e-06,0.58018,0.55528,1,1
3,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,4.4712e-06,0.57903,0.55582,1,1
3,GO GLYCOLIPID CATABOLIC PROCESS,1.349e-05,0.57833,0.57936,1,1
3,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,7.013e-05,0.57502,0.42532,1,1
3,GO SEROTONIN METABOLIC PROCESS,3.0689e-05,0.57342,0.56144,1,1
3,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.00031859,0.57229,0.44688,1,1
3,GO RESPONSE TO INTERLEUKIN 18,0.00012964,0.57202,0.58348,1,1
3,GO GLYCOSIDE METABOLIC PROCESS,0.0034322,0.56936,0.69358,1,1
3,GO ADHESION OF SYMBIONT TO HOST,1.7118e-05,0.56592,0.51976,1,1
3,GO LONG CHAIN FATTY ACID CATABOLIC PROCESS,0.0025083,0.56527,0.55152,1,1
3,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,2.0784e-06,0.56359,0.56959,1,1
3,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,5.508e-06,0.55362,0.56044,1,1
3,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,8.3127e-06,0.55253,0.52474,1,1
3,GO NEGATIVE REGULATION OF TISSUE REMODELING,8.628e-07,0.55026,0.55943,1,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00010845,0.54979,0.43297,1,1
3,GO REGULATION OF B CELL APOPTOTIC PROCESS,4.6623e-06,0.54905,0.49028,1,1
3,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00040247,0.54886,0.48798,1,1
3,GO REGULATION OF MICROVILLUS ORGANIZATION,0.00090094,0.54754,0.45803,1,1
3,GO NEGATIVE REGULATION OF RECEPTOR BINDING,1.0184e-05,0.54749,0.58948,1,1
3,GO RESPONSE TO COLD,9.7275e-08,0.54652,0.49797,1,1
3,GO LABYRINTHINE LAYER MORPHOGENESIS,8.7323e-05,0.54562,0.54202,1,1
3,GO SPHINGOMYELIN METABOLIC PROCESS,4.1802e-07,0.54197,0.53928,1,1
3,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.0007696,0.54111,0.39955,1,1
3,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,2.3418e-05,0.53818,0.4496,1,1
3,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.00049035,0.53498,0.51637,1,1
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.00027832,0.53288,0.55561,1,1
3,GO REGULATION OF WATER LOSS VIA SKIN,1.2962e-05,0.53073,0.50959,1,1
3,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.0073363,0.52689,0.35263,1,1
3,GO REGULATION OF PLATELET AGGREGATION,4.0073e-05,0.52634,0.47698,1,1
3,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.0006154,0.52603,0.41375,1,1
3,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,6.4994e-06,0.52584,0.45497,1,1
3,GO KETONE CATABOLIC PROCESS,0.00092958,0.52361,0.46842,1,1
3,GO CERAMIDE CATABOLIC PROCESS,0.00021909,0.522,0.46185,1,1
3,GO TOXIN METABOLIC PROCESS,6.8936e-07,0.51812,0.54734,1,1
3,GO LIPID DIGESTION,4.3218e-05,0.51795,0.58843,1,1
3,GO REGULATION OF PLATELET ACTIVATION,1.7474e-06,0.5161,0.4628,1,1
3,GO NEGATIVE REGULATION OF ANOIKIS,2.9532e-05,0.51559,0.63075,1,1
3,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.00045924,0.51347,0.46987,1,1
3,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.00038934,0.51166,0.46705,1,1
3,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,0.00012964,0.51147,0.50834,1,1
3,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,9.7346e-05,0.5114,0.43952,1,1
3,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,2.0784e-06,0.511,0.43294,1,1
3,GO RESPONSE TO EPINEPHRINE,0.0023671,0.51035,0.36265,1,1
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.00021167,0.50938,0.47195,1,1
3,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.00010845,0.50847,0.44271,1,1
3,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,3.4421e-05,0.50799,0.56102,1,1
3,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,7.9801e-06,0.50785,0.509,1,1
3,GO ALPHA BETA T CELL PROLIFERATION,5.0683e-06,0.5073,0.42884,1,1
3,GO MICROVILLUS ORGANIZATION,6.5149e-05,0.50571,0.42802,1,1
3,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,4.0073e-05,0.50529,0.5496,1,1
3,GO LEYDIG CELL DIFFERENTIATION,0.00017796,0.50503,0.52752,1,1
3,GO NEGATIVE REGULATION OF BONE REMODELING,5.0683e-06,0.50383,0.54091,1,1
3,GO ACTIVATION OF JANUS KINASE ACTIVITY,3.7145e-05,0.50187,0.44323,1,1
3,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,3.1904e-06,0.50107,0.60137,1,1
3,GO PHAGOLYSOSOME ASSEMBLY,1.5331e-06,0.49854,0.51077,1,1
3,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,6.5896e-07,0.49426,0.45239,1,1
3,GO SUPEROXIDE ANION GENERATION,9.7801e-06,0.49258,0.46357,1,1
3,GO ACTIN FILAMENT SEVERING,0.00072223,0.49226,0.41905,1,1
3,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,1.5201e-05,0.49102,0.41043,1,1
3,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,2.9532e-05,0.4905,0.55658,1,1
3,GO NEGATIVE REGULATION OF VIRAL PROCESS,7.8282e-05,0.49024,0.37533,1,1
3,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.0083534,0.48947,0.50379,1,1
3,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,7.8282e-05,0.48935,0.40951,1,1
3,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,4.6623e-06,0.48811,0.49115,1,1
3,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,6.2786e-05,0.48408,0.4135,1,1
3,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.0001165,0.48394,0.44288,1,1
3,GO REGULATION OF T CELL CYTOKINE PRODUCTION,0.0010528,0.48295,0.31272,1,1
3,GO REGULATION OF INTEGRIN ACTIVATION,1.1267e-06,0.48196,0.50931,1,1
3,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,7.547e-05,0.48186,0.4162,1,1
3,GO RESPONSE TO DIETARY EXCESS,1.1493e-05,0.48098,0.47393,1,1
3,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.00019079,0.47975,0.40714,1,1
3,GO BARBED END ACTIN FILAMENT CAPPING,0.00014935,0.47903,0.44768,1,1
3,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,2.7343e-05,0.47706,0.48913,1,1
3,GO REGULATION OF TISSUE REMODELING,7.2111e-07,0.47639,0.42627,1,1
3,GO REGULATION OF MYOBLAST FUSION,2.5308e-05,0.47453,0.40957,1,1
3,GO REGULATION OF BONE REMODELING,5.753e-07,0.4727,0.48385,1,1
3,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,3.5759e-05,0.47119,0.45868,1,1
3,GO GALACTOSE METABOLIC PROCESS,1.7806e-05,0.47058,0.57245,1,1
3,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,0.017969,0.47049,0.24748,1,1
3,GO PLASMINOGEN ACTIVATION,0.00028792,0.47035,0.46981,1,1
3,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.00027832,0.47028,0.39968,1,1
3,GO CELLULAR DEFENSE RESPONSE,5.4977e-07,0.46944,0.46523,1,1
3,GO REGULATION OF NEURON MATURATION,2.6902e-06,0.46918,0.44646,1,1
3,GO EPITHELIAL CELL MORPHOGENESIS,0.00018427,0.46676,0.40776,1,1
3,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.00014935,0.46528,0.4766,1,1
3,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,9.8628e-07,0.46449,0.47648,1,1
3,GO HEPATOCYTE APOPTOTIC PROCESS,0.0015653,0.46331,0.46288,1,1
3,GO ZYMOGEN ACTIVATION,4.8379e-05,0.46214,0.44305,1,1
3,GO IMMUNOGLOBULIN SECRETION,0.00013917,0.46006,0.37894,1,1
3,GO RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION,6.5149e-05,0.46,0.5031,1,1
3,GO CELL ADHESION MEDIATED BY INTEGRIN,1.2962e-05,0.4586,0.43176,1,1
3,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,4.4712e-06,0.45785,0.50089,1,1
3,GO SIGNAL PEPTIDE PROCESSING,7.9801e-06,0.45727,0.44568,1,1
3,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.0047853,0.45709,0.32171,1,1
3,GO FOAM CELL DIFFERENTIATION,1.0184e-05,0.45689,0.39678,1,1
3,GO FRUCTOSE METABOLIC PROCESS,0.0019282,0.4567,0.4931,1,1
3,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,7.3528e-06,0.45632,0.49088,1,1
3,GO BONE RESORPTION,3.17e-07,0.45599,0.4754,1,1
3,GO MITOCHONDRIAL DEPOLARIZATION,2.6902e-06,0.45468,0.42244,1,1
3,GO RESPONSE TO REDOX STATE,0.00059588,0.45409,0.32958,1,1
3,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,6.2786e-05,0.45333,0.40313,1,1
3,GO MEMBRANE LIPID CATABOLIC PROCESS,1.2454e-05,0.45268,0.47274,1,1
3,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,6.5149e-05,0.45244,0.41024,1,1
3,GO RESPONSE TO STEROL DEPLETION,1.6729e-06,0.44979,0.50642,1,1
3,GO REGULATION OF FIBRINOLYSIS,0.00036427,0.44959,0.40134,1,1
3,GO PROTEIN DEGLYCOSYLATION,9.7801e-06,0.44919,0.42669,1,1
3,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,1.1964e-05,0.44823,0.41247,1,1
3,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.00019753,0.44737,0.45263,1,1
3,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,2.7343e-05,0.44732,0.50567,1,1
3,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.00032948,0.44658,0.34564,1,1
3,GO REGULATION OF HORMONE METABOLIC PROCESS,0.00087311,0.44649,0.34484,1,1
3,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.00032948,0.44564,0.42341,1,1
3,GO BASE CONVERSION OR SUBSTITUTION EDITING,2.1663e-05,0.4452,0.44876,1,1
3,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,6.4994e-06,0.44454,0.48983,1,1
3,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.00067758,0.44375,0.30524,1,1
3,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,9.0551e-05,0.4425,0.38421,1,1
3,GO REGULATION OF CHOLESTEROL ESTERIFICATION,5.2139e-05,0.44208,0.58756,1,1
3,GO QUINONE METABOLIC PROCESS,0.00014418,0.44202,0.57893,1,1
3,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,1.7118e-05,0.44142,0.36999,1,1
3,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,5.7413e-06,0.44076,0.48663,1,1
3,GO T CELL MEDIATED IMMUNITY,0.00013433,0.44007,0.3395,1,1
3,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.00036427,0.43919,0.43403,1,1
3,GO REGULATORY T CELL DIFFERENTIATION,5.0226e-05,0.43866,0.39951,1,1
3,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,2.3418e-05,0.43865,0.39356,1,1
3,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,5.4121e-05,0.43846,0.36596,1,1
3,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,5.7413e-06,0.43836,0.3857,1,1
3,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.00069957,0.43706,0.37884,1,1
3,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,1.9904e-06,0.43605,0.48305,1,1
3,GO STEROID ESTERIFICATION,1.7806e-05,0.43604,0.57379,1,1
3,GO ENDOTHELIAL CELL CHEMOTAXIS,5.0226e-05,0.43481,0.38825,1,1
3,GO POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.00024286,0.4346,0.46187,1,1
3,GO REGULATION OF PROTEIN COMPLEX STABILITY,7.0571e-06,0.43454,0.41352,1,1
3,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,1.4039e-05,0.43359,0.45431,1,1
3,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.00090094,0.43308,0.34103,1,1
3,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,5.0683e-06,0.43215,0.40331,1,1
3,GO RESPONSE TO INTERLEUKIN 15,0.001191,0.43116,0.30786,1,1
3,GO ENTRY INTO HOST,0.00010845,0.43018,0.30049,1,1
3,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.00353,0.43008,0.40568,1,1
3,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.0085714,0.42937,0.29304,1,1
3,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.00092958,0.42905,0.39628,1,1
3,GO LIVER MORPHOGENESIS,9.7346e-05,0.42898,0.40792,1,1
3,GO RESPONSE TO INTERFERON GAMMA,2.6307e-05,0.42877,0.38362,1,1
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.00029782,0.42872,0.39608,1,1
3,GO NEUROTRANSMITTER METABOLIC PROCESS,1.1493e-05,0.42794,0.40012,1,1
3,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.041093,0.42757,0.22351,1,1
3,GO PROTEIN LOCALIZATION TO EARLY ENDOSOME,0.029068,0.42724,0.25083,1,1
3,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,3.1888e-05,0.42694,0.38713,1,1
3,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,4.4878e-05,0.42591,0.32745,1,1
3,GO RESPONSE TO THYROID HORMONE,6.0504e-05,0.42573,0.38198,1,1
3,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.00016023,0.42494,0.35251,1,1
3,GO REGULATION OF VIRAL GENOME REPLICATION,0.00010092,0.42415,0.3294,1,1
3,GO PROTEIN O LINKED GLYCOSYLATION,1.6452e-07,0.42401,0.39682,1,1
3,GO L PHENYLALANINE METABOLIC PROCESS,3.4421e-05,0.42376,0.63389,1,1
3,GO INTRACELLULAR STEROL TRANSPORT,3.1888e-05,0.42364,0.37517,1,1
3,GO ICOSANOID METABOLIC PROCESS,2.4692e-06,0.42324,0.39274,1,1
3,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.018836,0.42318,0.35364,1,1
3,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.00090094,0.42307,0.37313,1,1
3,GO IMMUNOLOGICAL MEMORY PROCESS,4.0073e-05,0.42166,0.39437,1,1
3,GO NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.00029782,0.42101,0.47855,1,1
3,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,2.3418e-05,0.42065,0.3965,1,1
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.0006154,0.42061,0.3421,1,1
3,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0001165,0.41995,0.30048,1,1
3,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,2.3654e-06,0.41966,0.36543,1,1
3,GO POSITIVE REGULATION OF WOUND HEALING,1.4044e-06,0.41941,0.4366,1,1
3,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,9.0179e-06,0.41919,0.38059,1,1
3,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,5.0194e-07,0.41896,0.49438,1,1
3,GO B CELL APOPTOTIC PROCESS,2.8077e-06,0.41876,0.45778,1,1
3,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,9.7346e-05,0.41855,0.60743,1,1
3,GO LIPOXYGENASE PATHWAY,0.0085714,0.41835,0.33795,1,1
3,GO AMINE BIOSYNTHETIC PROCESS,2.8891e-07,0.41833,0.4528,1,1
3,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,8.4205e-05,0.41645,0.35744,1,1
3,GO CORTICOSTEROID HORMONE SECRETION,0.00022676,0.41318,0.41936,1,1
3,GO LABYRINTHINE LAYER DEVELOPMENT,6.0504e-05,0.41242,0.3379,1,1
3,GO NEGATIVE REGULATION OF COAGULATION,0.00098941,0.41182,0.34694,1,1
3,GO FUCOSE METABOLIC PROCESS,0.0013054,0.41147,0.35741,1,1
3,GO PROTEIN DEMANNOSYLATION,9.3916e-06,0.41112,0.43729,1,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0013872,0.41092,0.35342,1,1
3,GO REGULATION OF PROTEIN GLYCOSYLATION,5.2139e-05,0.4108,0.49349,1,1
3,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,6.8936e-07,0.41057,0.3593,1,1
3,GO REGULATION OF VIRAL LIFE CYCLE,7.547e-05,0.40999,0.32035,1,1
3,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.00087311,0.40997,0.34065,1,1
3,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.00065623,0.4099,0.37519,1,1
3,GO CARBOHYDRATE DERIVATIVE TRANSPORT,2.0829e-07,0.40972,0.39856,1,1
3,GO VITAMIN D METABOLIC PROCESS,3.3132e-05,0.40885,0.38917,1,1
3,GO EPITHELIAL CELL CELL ADHESION,0.00022676,0.40761,0.48334,1,1
3,GO MYOBLAST FUSION,0.00012074,0.40729,0.30549,1,1
3,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,6.2786e-05,0.40699,0.41973,1,1
3,GO AMMONIUM ION METABOLIC PROCESS,2.2524e-05,0.4052,0.48952,1,1
3,GO LEUKOTRIENE METABOLIC PROCESS,5.4121e-05,0.40483,0.36861,1,1
3,GO REGULATION OF COAGULATION,0.00010092,0.40474,0.34072,1,1
3,GO SMOOTH MUSCLE CELL MIGRATION,0.00017796,0.40433,0.32474,1,1
3,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,8.6584e-06,0.40424,0.38974,1,1
3,GO NATURAL KILLER CELL MEDIATED IMMUNITY,1.349e-05,0.40421,0.36239,1,1
3,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.00023468,0.4042,0.36766,1,1
3,GO VASODILATION,5.8301e-05,0.40384,0.42929,1,1
3,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.0010206,0.40303,0.36804,1,1
3,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,2.8418e-05,0.40268,0.31898,1,1
3,GO EMBRYONIC PLACENTA MORPHOGENESIS,0.0025817,0.40246,0.3912,1,1
3,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,3.0689e-05,0.40243,0.3373,1,1
3,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,9.7801e-06,0.40206,0.36477,1,1
3,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.00020448,0.40182,0.39419,1,1
3,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.00072223,0.40165,0.31638,1,1
3,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,3.9418e-06,0.4014,0.38448,1,1
3,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.00095906,0.40108,0.27774,1,1
3,GO LUNG CELL DIFFERENTIATION,0.00013917,0.40107,0.48645,1,1
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,9.0221e-07,0.40096,0.44792,1,1
3,GO REGULATION OF LEUKOCYTE DEGRANULATION,3.8583e-05,0.40061,0.32549,1,1
3,GO BONE REMODELING,1.4674e-06,0.40058,0.40107,1,1
3,GO LIPID TRANSLOCATION,6.5896e-07,0.40012,0.36171,1,1
3,GO ENTRY OF BACTERIUM INTO HOST CELL,0.0032441,0.39989,0.36436,1,1
3,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,8.6584e-06,0.39923,0.38687,1,1
3,GO VITAMIN D BIOSYNTHETIC PROCESS,0.00038934,0.39883,0.35921,1,1
3,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00067758,0.3987,0.46127,1,1
3,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.0020453,0.39844,0.42912,1,1
3,GO REGULATION OF CELL PROJECTION SIZE,0.0011549,0.39826,0.32801,1,1
3,GO MAGNESIUM ION TRANSPORT,1.0604e-05,0.39815,0.34716,1,1
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.00037661,0.398,0.36637,1,1
3,GO POSITIVE REGULATION OF CELL KILLING,1.2962e-05,0.39772,0.36826,1,1
3,GO ACUTE INFLAMMATORY RESPONSE,1.5816e-05,0.39768,0.37473,1,1
3,GO DEFENSE RESPONSE TO VIRUS,2.3418e-05,0.39734,0.32273,1,1
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,5.8301e-05,0.39723,0.39533,1,1
3,GO DIGESTION,9.3916e-06,0.39593,0.34095,1,1
3,GO HYALURONAN BIOSYNTHETIC PROCESS,0.0001547,0.39588,0.28877,1,1
3,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,2.5774e-06,0.39454,0.40401,1,1
3,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.0013054,0.3941,0.36093,1,1
3,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.00027832,0.39403,0.41298,1,1
3,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.00038934,0.39349,0.33215,1,1
3,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,5.9841e-06,0.39289,0.36901,1,1
3,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.00042998,0.39216,0.34579,1,1
3,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.0025083,0.39213,0.32232,1,1
3,GO DIGESTIVE SYSTEM PROCESS,3.9418e-06,0.39141,0.32342,1,1
3,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,7.2754e-05,0.39093,0.37352,1,1
3,GO N GLYCAN PROCESSING,7.2754e-05,0.38964,0.38284,1,1
3,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.00013917,0.38903,0.37042,1,1
3,GO VASCULAR WOUND HEALING,0.00081984,0.38903,0.39035,1,1
3,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.00081984,0.38892,0.3485,1,1
3,GO MUSCLE ATROPHY,0.0059384,0.38846,0.27105,1,1
3,GO IMMUNE RESPONSE TO TUMOR CELL,0.001191,0.38792,0.38854,1,1
3,GO POSITIVE REGULATION OF FERTILIZATION,0.001872,0.38774,0.31308,1,1
3,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,2.0833e-05,0.38748,0.40334,1,1
3,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.0001165,0.38746,0.44124,1,1
3,GO PARENTAL BEHAVIOR,0.017137,0.38745,0.25434,1,1
3,GO NEGATIVE REGULATION OF B CELL ACTIVATION,1.4044e-06,0.38692,0.40209,1,1
3,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.0064317,0.3867,0.42602,1,1
3,GO REGULATION OF STEROID METABOLIC PROCESS,5.9841e-06,0.3861,0.33383,1,1
3,GO ARACHIDONIC ACID METABOLIC PROCESS,4.8612e-06,0.38584,0.3748,1,1
3,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.00032948,0.38535,0.30826,1,1
3,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.0010528,0.38531,0.31978,1,1
3,GO SECONDARY METABOLIC PROCESS,0.00030804,0.38505,0.38274,1,1
3,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,2.3418e-05,0.3847,0.46457,1,1
3,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.00092958,0.38385,0.28621,1,1
3,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,3.4421e-05,0.38382,0.27534,1,1
3,GO KERATAN SULFATE METABOLIC PROCESS,1.5201e-05,0.38333,0.32645,1,1
3,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,1.9263e-05,0.3829,0.38908,1,1
3,GO RESPONSE TO INTERLEUKIN 2,7.9801e-06,0.38261,0.33278,1,1
3,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.00024286,0.3825,0.32865,1,1
3,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.0001547,0.38238,0.32298,1,1
3,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0028141,0.38213,0.4577,1,1
3,GO POSITIVE REGULATION OF B CELL PROLIFERATION,1.1267e-06,0.38176,0.39592,1,1
3,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.046579,0.38037,0.27172,1,1
3,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.037747,0.38022,0.2508,1,1
3,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,8.4205e-05,0.38019,0.32383,1,1
3,GO BASEMENT MEMBRANE ORGANIZATION,0.0023671,0.38,0.29213,1,1
3,GO RETINAL METABOLIC PROCESS,0.0024367,0.37994,0.49678,1,1
3,GO RELAXATION OF CARDIAC MUSCLE,0.0011549,0.37867,0.31277,1,1
3,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,6.7728e-06,0.37814,0.35478,1,1
3,GO TISSUE REMODELING,3.4728e-06,0.37798,0.34121,1,1
3,GO UBIQUINONE METABOLIC PROCESS,3.6228e-06,0.37784,0.3534,1,1
3,GO ANOIKIS,8.6584e-06,0.37697,0.39455,1,1
3,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,4.6623e-06,0.37634,0.36878,1,1
3,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.0012662,0.37608,0.36359,1,1
3,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,3.3132e-05,0.37543,0.42632,1,1
3,GO ACUTE PHASE RESPONSE,8.7323e-05,0.37529,0.33849,1,1
3,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,3.0576e-06,0.37473,0.35023,1,1
3,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,1.9263e-05,0.37439,0.37699,1,1
3,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,1.5201e-05,0.37373,0.43415,1,1
3,GO REGULATION OF VASCULOGENESIS,0.0014738,0.37368,0.36539,1,1
3,GO LIPID DROPLET ORGANIZATION,6.7728e-06,0.37349,0.35242,1,1
3,GO EPOXYGENASE P450 PATHWAY,0.0046564,0.37348,0.30977,1,1
3,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.0007696,0.3729,0.32032,1,1
3,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,8.4205e-05,0.37159,0.39228,1,1
3,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00018427,0.37096,0.29684,1,1
3,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,1.1964e-05,0.37091,0.31683,1,1
3,GO LEUKOCYTE MEDIATED CYTOTOXICITY,1.4609e-05,0.37073,0.31841,1,1
3,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.00038934,0.37059,0.28008,1,1
3,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.0075304,0.37059,0.30797,1,1
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.00034072,0.37057,0.32582,1,1
3,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.016734,0.37056,0.19178,1,1
3,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,4.8379e-05,0.37053,0.26669,1,1
3,GO AMINO SUGAR CATABOLIC PROCESS,5.8301e-05,0.37022,0.35781,1,1
3,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.00092958,0.36963,0.27856,1,1
3,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,5.8301e-05,0.36959,0.31717,1,1
3,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,7.547e-05,0.36935,0.32374,1,1
3,GO REGULATION OF ACROSOME REACTION,0.0023671,0.36898,0.37765,1,1
3,GO RESPONSE TO LITHIUM ION,6.7728e-06,0.36896,0.48743,1,1
3,GO DORSAL AORTA DEVELOPMENT,0.0016129,0.36836,0.29542,1,1
3,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,3.5759e-05,0.36808,0.27286,1,1
3,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,4.2876e-06,0.36788,0.32366,1,1
3,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.0034322,0.36747,0.34232,1,1
3,GO MOVEMENT IN HOST ENVIRONMENT,9.7346e-05,0.36725,0.27213,1,1
3,GO B CELL MEDIATED IMMUNITY,2.3418e-05,0.36712,0.32084,1,1
3,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.0031536,0.36667,0.30131,1,1
3,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,4.5813e-07,0.36643,0.33571,1,1
3,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.035393,0.36631,0.25202,1,1
3,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.0034322,0.36613,0.36995,1,1
3,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.00034072,0.36542,0.2596,1,1
3,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00031859,0.365,0.24014,1,1
3,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.00095906,0.36447,0.33971,1,1
3,GO PHAGOSOME ACIDIFICATION,1.906e-06,0.36432,0.37574,1,1
3,GO REGULATION OF LIGASE ACTIVITY,0.0021689,0.36364,0.23832,1,1
3,GO PEPTIDYL PROLINE HYDROXYLATION,0.0012662,0.36364,0.34249,1,1
3,GO REGULATION OF ICOSANOID SECRETION,1.0311e-06,0.36362,0.41494,1,1
3,GO ETHER METABOLIC PROCESS,0.00010462,0.36357,0.30359,1,1
3,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.001662,0.3635,0.29859,1,1
3,GO PHOSPHOLIPID EFFLUX,0.00016023,0.36345,0.39608,1,1
3,GO ANTIBACTERIAL HUMORAL RESPONSE,1.5201e-05,0.36343,0.37041,1,1
3,GO LYMPHOCYTE MEDIATED IMMUNITY,1.5201e-05,0.3634,0.3046,1,1
3,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,6.5149e-05,0.36324,0.3014,1,1
3,GO RESPONSE TO COPPER ION,0.00084609,0.36221,0.42817,1,1
3,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,4.6623e-06,0.36183,0.28485,1,1
3,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.0028957,0.36125,0.32549,1,1
3,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.00027832,0.36119,0.25268,1,1
3,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.055956,0.36026,0.29091,1,1
3,GO BILE ACID AND BILE SALT TRANSPORT,0.00028792,0.35997,0.56635,1,1
3,GO STEROL HOMEOSTASIS,1.104e-05,0.35929,0.36391,1,1
3,GO REGULATION OF B CELL PROLIFERATION,1.0779e-06,0.35923,0.37653,1,1
3,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,6.7596e-05,0.35903,0.33,1,1
3,GO VIRAL GENOME REPLICATION,0.00010462,0.35831,0.27992,1,1
3,GO REGULATION OF EXOSOMAL SECRETION,2.6307e-05,0.35826,0.31762,1,1
3,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,2.7578e-07,0.35805,0.34784,1,1
3,GO LIPOPROTEIN CATABOLIC PROCESS,9.7346e-05,0.35792,0.30826,1,1
3,GO MAINTENANCE OF BLOOD BRAIN BARRIER,5.0683e-06,0.35767,0.38834,1,1
3,GO SNARE COMPLEX ASSEMBLY,0.0010528,0.35758,0.2525,1,1
3,GO INTEGRIN ACTIVATION,1.104e-05,0.35733,0.34102,1,1
3,GO RESPONSE TO XENOBIOTIC STIMULUS,6.5149e-05,0.35729,0.33272,1,1
3,GO REGULATION OF B CELL ACTIVATION,2.8077e-06,0.35688,0.29066,1,1
3,GO RESPONSE TO WATER,0.0034322,0.35662,0.30837,1,1
3,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,6.2786e-05,0.35645,0.26705,1,1
3,GO RESPONSE TO CAFFEINE,0.0015653,0.35556,0.25764,1,1
3,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,3.4421e-05,0.35547,0.30749,1,1
3,GO STEROL METABOLIC PROCESS,6.8936e-07,0.35516,0.3281,1,1
3,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.00026003,0.35467,0.31759,1,1
3,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.00057693,0.35436,0.27136,1,1
3,GO METHIONINE METABOLIC PROCESS,4.4878e-05,0.35395,0.33269,1,1
3,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.00030804,0.35378,0.36954,1,1
3,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,6.7596e-05,0.35352,0.26078,1,1
3,GO BILE ACID METABOLIC PROCESS,4.4712e-06,0.35349,0.38793,1,1
3,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,1.4674e-06,0.35319,0.3569,1,1
3,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,2.0033e-05,0.35265,0.31129,1,1
3,GO RESPONSE TO ACIDIC PH,0.0017123,0.35217,0.2895,1,1
3,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.00017186,0.35208,0.3657,1,1
3,GO REGULATION OF CELL KILLING,2.3418e-05,0.35203,0.32506,1,1
3,GO OSTEOBLAST PROLIFERATION,0.00013917,0.35186,0.32919,1,1
3,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.0011549,0.35146,0.32268,1,1
3,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,5.508e-06,0.35143,0.30196,1,1
3,GO NUCLEOSIDE CATABOLIC PROCESS,0.00026003,0.35127,0.26701,1,1
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.0027346,0.35118,0.35853,1,1
3,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,2.3418e-05,0.35073,0.317,1,1
3,GO REGULATION OF B CELL MEDIATED IMMUNITY,7.547e-05,0.35064,0.29353,1,1
3,GO SPHINGOLIPID METABOLIC PROCESS,2.8891e-07,0.35023,0.3153,1,1
3,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.0075304,0.35003,0.30806,1,1
3,GO GLYCOSYLATION,1.8084e-07,0.34993,0.33656,1,1
3,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,6.7596e-05,0.34964,0.28546,1,1
3,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.026586,0.34962,0.32893,1,1
3,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,5.6174e-05,0.34912,0.31284,1,1
3,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,3.5759e-05,0.34904,0.2831,1,1
3,GO STEROID HORMONE SECRETION,0.00013917,0.34878,0.343,1,1
3,GO LYTIC VACUOLE ORGANIZATION,3.31e-08,0.34874,0.38603,1,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,1.7118e-05,0.34824,0.30217,1,1
3,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,3.1888e-05,0.3479,0.33054,1,1
3,GO NATURAL KILLER CELL PROLIFERATION,0.0020453,0.34763,0.32407,1,1
3,GO APICAL JUNCTION ASSEMBLY,9.4334e-07,0.34712,0.4129,1,1
3,GO INNATE IMMUNE RESPONSE,4.4712e-06,0.34678,0.28134,1,1
3,GO INOSITOL TRISPHOSPHATE METABOLIC PROCESS,0.0037331,0.34628,0.35378,1,1
3,GO ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER,0.00010845,0.34614,0.43614,1,1
3,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.00050664,0.34613,0.4104,1,1
3,GO GASTRULATION WITH MOUTH FORMING SECOND,8.4205e-05,0.34567,0.32903,1,1
3,GO CELLULAR RESPONSE TO STEROL DEPLETION,1.2962e-05,0.34546,0.40105,1,1
3,GO CORNIFICATION,7.0571e-06,0.34542,0.35019,1,1
3,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.0085714,0.34497,0.19667,1,1
3,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,7.2754e-05,0.34468,0.4017,1,1
3,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,1.0604e-05,0.34444,0.30228,1,1
3,GO REGULATION OF WOUND HEALING,1.349e-05,0.34438,0.32955,1,1
3,GO DIOL METABOLIC PROCESS,3.3132e-05,0.34404,0.35962,1,1
3,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,8.6584e-06,0.34392,0.30334,1,1
3,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,7.3528e-06,0.34382,0.29859,1,1
3,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,4.4878e-05,0.34296,0.33147,1,1
3,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.00079435,0.34292,0.2597,1,1
3,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,2.4692e-06,0.34281,0.37615,1,1
3,GO PLATELET DEGRANULATION,0.00031859,0.34277,0.27102,1,1
3,GO MEMBRANE LIPID METABOLIC PROCESS,5.0194e-07,0.34267,0.31235,1,1
3,GO RESPONSE TO MINERALOCORTICOID,0.00013433,0.34266,0.29587,1,1
3,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,8.4205e-05,0.34262,0.24282,1,1
3,GO CATECHOLAMINE UPTAKE,0.0053338,0.34259,0.28612,1,1
3,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.0026572,0.34252,0.30929,1,1
3,GO RESPONSE TO TUMOR CELL,0.00069957,0.34233,0.34064,1,1
3,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.00059588,0.34231,0.37596,1,1
3,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.00031859,0.34216,0.27348,1,1
3,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.0010206,0.34162,0.22898,1,1
3,GO PARAXIAL MESODERM MORPHOGENESIS,0.013798,0.3415,0.30052,1,1
3,GO LINOLEIC ACID METABOLIC PROCESS,0.0022332,0.34138,0.35248,1,1
3,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,2.8418e-05,0.34135,0.39306,1,1
3,GO PROTEIN N LINKED GLYCOSYLATION,1.4039e-05,0.34125,0.28895,1,1
3,GO REGULATION OF ORGANIC ACID TRANSPORT,4.8379e-05,0.34114,0.3081,1,1
3,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.0011549,0.34105,0.22938,1,1
3,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0022332,0.34022,0.25433,1,1
3,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.0017123,0.34,0.39595,1,1
3,GO MAST CELL ACTIVATION,1.1493e-05,0.33985,0.30655,1,1
3,GO UNSATURATED FATTY ACID METABOLIC PROCESS,5.0683e-06,0.33966,0.35316,1,1
3,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,9.389e-05,0.33913,0.36791,1,1
3,GO REGULATION OF GLIAL CELL PROLIFERATION,0.00052342,0.33869,0.26912,1,1
3,GO B CELL PROLIFERATION,2.0784e-06,0.33854,0.2981,1,1
3,GO IMMUNE EFFECTOR PROCESS,7.6603e-06,0.3385,0.27707,1,1
3,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,2.3418e-05,0.33837,0.30857,1,1
3,GO OPTIC NERVE DEVELOPMENT,0.00023468,0.33825,0.40016,1,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.00035231,0.33809,0.23915,1,1
3,GO RESPONSE TO VIRUS,1.8521e-05,0.33806,0.27555,1,1
3,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,9.389e-05,0.33778,0.33114,1,1
3,GO INSEMINATION,0.0010859,0.33772,0.32376,1,1
3,GO TYPE I INTERFERON PRODUCTION,1.5816e-05,0.33707,0.28588,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,5.0226e-05,0.33685,0.27037,1,1
3,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,6.2786e-05,0.33674,0.36548,1,1
3,GO DNA DEAMINATION,0.0030654,0.3367,0.33984,1,1
3,GO MAST CELL MEDIATED IMMUNITY,2.6307e-05,0.3364,0.30225,1,1
3,GO STEROID METABOLIC PROCESS,7.889e-07,0.3363,0.33898,1,1
3,GO CELLULAR RESPONSE TO FATTY ACID,7.2754e-05,0.33626,0.32978,1,1
3,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.00012074,0.33612,0.37488,1,1
3,GO KERATINOCYTE DEVELOPMENT,0.0056288,0.33608,0.33256,1,1
3,GO STEROID BIOSYNTHETIC PROCESS,3.7791e-06,0.33602,0.30431,1,1
3,GO KERATINIZATION,4.4712e-06,0.33601,0.31005,1,1
3,GO POSITIVE REGULATION OF TISSUE REMODELING,8.4205e-05,0.33591,0.35595,1,1
3,GO LEUKOCYTE MEDIATED IMMUNITY,7.9801e-06,0.33584,0.28971,1,1
3,GO T CELL CYTOKINE PRODUCTION,0.0010206,0.33576,0.25369,1,1
3,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.00050664,0.33574,0.33194,1,1
3,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.0079323,0.33558,0.22245,1,1
3,GO REGULATION OF NEUTROPHIL MIGRATION,1.1267e-06,0.33545,0.37608,1,1
3,GO CELL CELL JUNCTION ORGANIZATION,1.4039e-05,0.3352,0.26847,1,1
3,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.0013054,0.33415,0.26703,1,1
3,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,6.5149e-05,0.33381,0.27345,1,1
3,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,3.4421e-05,0.33335,0.27029,1,1
3,GO ETHER BIOSYNTHETIC PROCESS,0.011612,0.33328,0.17397,1,1
3,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.010245,0.333,0.3082,1,1
3,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.014841,0.33289,0.28767,1,1
3,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,6.5149e-05,0.33279,0.25779,1,1
3,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,1.0604e-05,0.33257,0.28202,1,1
3,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,9.0179e-06,0.33241,0.29973,1,1
3,GO CYTOKINE MEDIATED SIGNALING PATHWAY,4.8612e-06,0.33211,0.28857,1,1
3,GO POSITIVE REGULATION OF BONE RESORPTION,6.5149e-05,0.33197,0.42539,1,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.00011241,0.33195,0.24343,1,1
3,GO REGULATION OF LEUKOCYTE PROLIFERATION,3.5759e-05,0.33175,0.27592,1,1
3,GO NEGATIVE REGULATION OF LIPID STORAGE,0.00017796,0.33142,0.2999,1,1
3,GO RESPONSE TO PEPTIDOGLYCAN,0.00032948,0.33138,0.26628,1,1
3,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,6.5149e-05,0.33136,0.28335,1,1
3,GO I KAPPAB KINASE NF KAPPAB SIGNALING,9.0179e-06,0.33093,0.26835,1,1
3,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.0054795,0.33078,0.23943,1,1
3,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.00042998,0.33054,0.32309,1,1
3,GO KETONE BIOSYNTHETIC PROCESS,0.0001547,0.33049,0.31016,1,1
3,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0029794,0.33037,0.18874,1,1
3,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.00010845,0.33036,0.36701,1,1
3,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.00040247,0.33031,0.29579,1,1
3,GO OLIGOPEPTIDE TRANSPORT,0.00055855,0.33028,0.37735,1,1
3,GO CELL KILLING,2.9301e-06,0.33,0.28597,1,1
3,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.00021909,0.3297,0.32451,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,3.4421e-05,0.32931,0.24815,1,1
3,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,4.1617e-05,0.32923,0.31969,1,1
3,GO CERAMIDE BIOSYNTHETIC PROCESS,7.889e-07,0.3288,0.28532,1,1
3,GO LIPID STORAGE,1.5201e-05,0.3285,0.29977,1,1
3,GO CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.00041602,0.32836,0.30987,1,1
3,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,5.0194e-07,0.32832,0.34363,1,1
3,GO REVERSE CHOLESTEROL TRANSPORT,0.00034072,0.32826,0.47496,1,1
3,GO STABILIZATION OF MEMBRANE POTENTIAL,0.0051916,0.32813,0.31268,1,1
3,GO DEFENSE RESPONSE TO OTHER ORGANISM,4.2876e-06,0.32811,0.27063,1,1
3,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00010462,0.32753,0.37958,1,1
3,GO NADP METABOLIC PROCESS,0.0011199,0.32703,0.2924,1,1
3,GO INTERLEUKIN 1 PRODUCTION,0.00028792,0.32689,0.24798,1,1
3,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.00067758,0.32681,0.21575,1,1
3,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.00079435,0.32666,0.34359,1,1
3,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.0018173,0.32599,0.29172,1,1
3,GO BLOOD VESSEL REMODELING,0.00012964,0.32594,0.28741,1,1
3,GO RESPONSE TO CORTICOSTERONE,0.00028792,0.32533,0.32841,1,1
3,GO PEPTIDYL ASPARAGINE MODIFICATION,0.00022676,0.32525,0.28281,1,1
3,GO CELLULAR RESPONSE TO CADMIUM ION,0.023741,0.32488,0.24287,1,1
3,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,4.4878e-05,0.32464,0.29502,1,1
3,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,3.1888e-05,0.32427,0.3314,1,1
3,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.00026903,0.32418,0.21961,1,1
3,GO RESPONSE TO MAGNESIUM ION,0.00016023,0.32408,0.42707,1,1
3,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,4.6597e-05,0.32404,0.3206,1,1
3,GO INTERLEUKIN 10 PRODUCTION,2.5308e-05,0.32401,0.28363,1,1
3,GO ADAPTIVE IMMUNE RESPONSE,1.7806e-05,0.32387,0.30169,1,1
3,GO REGULATION OF PROSTAGLANDIN SECRETION,4.6597e-05,0.32356,0.35877,1,1
3,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.00042998,0.32336,0.24823,1,1
3,GO LIPOPROTEIN METABOLIC PROCESS,4.1112e-06,0.32327,0.26151,1,1
3,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,3.1888e-05,0.32307,0.30101,1,1
3,GO REGULATION OF IMMUNE EFFECTOR PROCESS,4.1617e-05,0.32257,0.2553,1,1
3,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,3.5759e-05,0.32249,0.27894,1,1
3,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,3.3287e-06,0.32235,0.33087,1,1
3,GO CAMP BIOSYNTHETIC PROCESS,0.0066042,0.32216,0.26619,1,1
3,GO L ASCORBIC ACID METABOLIC PROCESS,0.0054795,0.32207,0.34755,1,1
3,GO B CELL HOMEOSTASIS,0.00011241,0.32174,0.28424,1,1
3,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,3.7791e-06,0.32159,0.2941,1,1
3,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.02843,0.32158,0.28133,1,1
3,GO PHOSPHOLIPID CATABOLIC PROCESS,1.0184e-05,0.32114,0.36253,1,1
3,GO AMINOGLYCAN CATABOLIC PROCESS,0.0018173,0.32059,0.23639,1,1
3,GO TRANSPOSITION,0.0017641,0.32051,0.30702,1,1
3,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.00050664,0.32016,0.36735,1,1
3,GO BILE ACID BIOSYNTHETIC PROCESS,2.7343e-05,0.31979,0.32408,1,1
3,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,1.7474e-06,0.3197,0.31653,1,1
3,GO CHEMOKINE PRODUCTION,8.1192e-05,0.31911,0.2607,1,1
3,GO GLYCEROL ETHER METABOLIC PROCESS,0.0015189,0.31905,0.21368,1,1
3,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,2.3418e-05,0.3187,0.3346,1,1
3,GO RESPONSE TO GROWTH HORMONE,7.0571e-06,0.31851,0.36818,1,1
3,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00030804,0.31845,0.26379,1,1
3,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,8.7323e-05,0.31834,0.3877,1,1
3,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,7.9801e-06,0.31807,0.29622,1,1
3,GO LIPOSACCHARIDE METABOLIC PROCESS,5.9841e-06,0.31756,0.30614,1,1
3,GO REGULATION OF GLUCOSE METABOLIC PROCESS,9.0221e-07,0.31752,0.28318,1,1
3,GO INTERLEUKIN 6 PRODUCTION,9.3916e-06,0.31744,0.25963,1,1
3,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.00011241,0.31701,0.24969,1,1
3,GO INTERLEUKIN 8 PRODUCTION,4.4878e-05,0.31695,0.29674,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,4.1617e-05,0.31686,0.34068,1,1
3,GO REGULATION OF SULFUR METABOLIC PROCESS,0.004408,0.31679,0.29436,1,1
3,GO PURINE NUCLEOTIDE TRANSPORT,4.4712e-06,0.31669,0.27674,1,1
3,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.00034072,0.31651,0.32959,1,1
3,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.00067758,0.31646,0.31052,1,1
3,GO BASIC AMINO ACID TRANSPORT,0.0073363,0.31643,0.32189,1,1
3,GO CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION,0.0054795,0.31641,0.39235,1,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,1.349e-05,0.3163,0.3163,1,1
3,GO NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00010845,0.31624,0.36248,1,1
3,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,2.0784e-06,0.3159,0.28673,1,1
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,2.3418e-05,0.31577,0.26517,1,1
3,GO RESPONSE TO ISCHEMIA,4.8379e-05,0.31559,0.26539,1,1
3,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,5.508e-06,0.31543,0.32208,1,1
3,GO ADRENAL GLAND DEVELOPMENT,0.0001165,0.31537,0.39887,1,1
3,GO EMBRYONIC PLACENTA DEVELOPMENT,0.00013433,0.31529,0.27726,1,1
3,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,2.2658e-06,0.3142,0.25916,1,1
3,GO RESPONSE TO TUMOR NECROSIS FACTOR,9.3916e-06,0.31382,0.27726,1,1
3,GO ALANINE TRANSPORT,0.0030654,0.31381,0.28908,1,1
3,GO PIRNA METABOLIC PROCESS,0.01282,0.31363,0.26008,1,1
3,GO MEMBRANE FISSION,0.0023671,0.31331,0.25396,1,1
3,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,3.7145e-05,0.31292,0.30628,1,1
3,GO LUNG ALVEOLUS DEVELOPMENT,5.2837e-06,0.31261,0.35074,1,1
3,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.0001547,0.3123,0.2789,1,1
3,GO REGULATION OF ENDOCRINE PROCESS,1.104e-05,0.31213,0.29231,1,1
3,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.0037331,0.31207,0.23476,1,1
3,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,2.5308e-05,0.312,0.28947,1,1
3,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.00047456,0.31164,0.22219,1,1
3,GO ICOSANOID BIOSYNTHETIC PROCESS,4.3218e-05,0.31126,0.31372,1,1
3,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.00087311,0.31115,0.40191,1,1
3,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.014486,0.31101,0.23888,1,1
3,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.0021062,0.31089,0.31197,1,1
3,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,1.2308e-06,0.31085,0.33175,1,1
3,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,6.2367e-06,0.31082,0.28156,1,1
3,GO OLIGODENDROCYTE DEVELOPMENT,2.0033e-05,0.31072,0.29567,1,1
3,GO RESPONSE TO PROTOZOAN,0.00014418,0.31066,0.2512,1,1
3,GO MACROPHAGE CYTOKINE PRODUCTION,0.0059384,0.31065,0.24937,1,1
3,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,1.4039e-05,0.31032,0.26907,1,1
3,GO RETINOL METABOLIC PROCESS,0.00035231,0.31004,0.398,1,1
3,GO REGULATION OF SYMBIOTIC PROCESS,0.00019753,0.30992,0.22411,1,1
3,GO HYPOTHALAMUS DEVELOPMENT,0.001191,0.30974,0.27921,1,1
3,GO PROTEIN CONTAINING COMPLEX REMODELING,0.00013433,0.30934,0.31717,1,1
3,GO LUNG EPITHELIUM DEVELOPMENT,0.00092958,0.30923,0.30469,1,1
3,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,6.0504e-05,0.3092,0.26189,1,1
3,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.00020448,0.30899,0.32299,1,1
3,GO ACETYL COA BIOSYNTHETIC PROCESS,0.00041602,0.30881,0.30211,1,1
3,GO CYCLOOXYGENASE PATHWAY,0.0083534,0.30874,0.39175,1,1
3,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.00012964,0.30865,0.27059,1,1
3,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND,0.033166,0.30841,0.26592,1,1
3,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,0.011047,0.30809,0.23365,1,1
3,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.00016023,0.30798,0.31246,1,1
3,GO REGULATION OF TRANSPOSITION,0.0036303,0.30778,0.31014,1,1
3,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,3.0576e-06,0.30749,0.27473,1,1
3,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.00016023,0.30741,0.30259,1,1
3,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0046564,0.30723,0.22232,1,1
3,GO CERAMIDE METABOLIC PROCESS,8.2505e-07,0.30702,0.30023,1,1
3,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.00028792,0.3069,0.31547,1,1
3,GO NUCLEOTIDE SALVAGE,0.0083534,0.30637,0.25957,1,1
3,GO NEGATIVE REGULATION OF WOUND HEALING,0.00038934,0.3061,0.29893,1,1
3,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,2.8418e-05,0.30589,0.28086,1,1
3,GO MYELOID LEUKOCYTE ACTIVATION,7.9801e-06,0.30572,0.27955,1,1
3,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.0015653,0.30552,0.19269,1,1
3,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,5.0683e-06,0.30545,0.32975,1,1
3,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00069957,0.30535,0.22505,1,1
3,GO WATER HOMEOSTASIS,6.2367e-06,0.30534,0.31725,1,1
3,GO LEUKOCYTE PROLIFERATION,2.1663e-05,0.30524,0.24713,1,1
3,GO LIPID LOCALIZATION,2.7578e-07,0.30521,0.30596,1,1
3,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.052669,0.30518,0.30622,1,1
3,GO PHAGOSOME MATURATION,1.0184e-05,0.30491,0.31694,1,1
3,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,2.9301e-06,0.30469,0.29973,1,1
3,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.0015189,0.30465,0.33442,1,1
3,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.0036303,0.30443,0.30689,1,1
3,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,2.1702e-06,0.3044,0.35833,1,1
3,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.0036303,0.30403,0.29923,1,1
3,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,3.1888e-05,0.30386,0.25922,1,1
3,GO AMELOGENESIS,0.00040247,0.30376,0.29111,1,1
3,GO VACUOLAR ACIDIFICATION,3.7791e-06,0.30365,0.36015,1,1
3,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.00028792,0.30333,0.36872,1,1
3,GO BEHAVIORAL RESPONSE TO PAIN,0.0028957,0.30323,0.28903,1,1
3,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0056288,0.30313,0.25492,1,1
3,GO SPHINGOID METABOLIC PROCESS,0.00044439,0.3031,0.30586,1,1
3,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00021909,0.30299,0.29161,1,1
3,GO INTERLEUKIN 12 PRODUCTION,2.2658e-06,0.30274,0.32427,1,1
3,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,1.5201e-05,0.30257,0.29396,1,1
3,GO FUCOSYLATION,0.00016595,0.30249,0.34571,1,1
3,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,6.0504e-05,0.30207,0.32945,1,1
3,GO CARBOHYDRATE TRANSPORT,1.4674e-06,0.30176,0.27867,1,1
3,GO TYPE 2 IMMUNE RESPONSE,0.0022992,0.30173,0.25993,1,1
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,3.4421e-05,0.30172,0.28774,1,1
3,GO REGULATION OF INNATE IMMUNE RESPONSE,3.1904e-06,0.30172,0.27413,1,1
3,GO POSITIVE REGULATION OF CELL SIZE,4.1617e-05,0.30155,0.35051,1,1
3,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,2.0784e-06,0.3014,0.36963,1,1
3,GO LYMPHOCYTE MIGRATION,2.0833e-05,0.30132,0.24112,1,1
3,GO HAIR CELL DIFFERENTIATION,3.8583e-05,0.30067,0.2758,1,1
3,GO ALPHA BETA T CELL ACTIVATION,2.9532e-05,0.30057,0.25571,1,1
3,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.0060989,0.30053,0.25063,1,1
3,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,3.6228e-06,0.3004,0.29238,1,1
3,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.00090094,0.30002,0.29571,1,1
3,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.00018427,0.29997,0.26529,1,1
3,GO SYNCYTIUM FORMATION,0.00022676,0.29948,0.2276,1,1
3,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,5.0226e-05,0.29909,0.24468,1,1
3,GO DIET INDUCED THERMOGENESIS,0.00092958,0.29902,0.25655,1,1
3,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.00026903,0.29896,0.27282,1,1
3,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.0013872,0.29881,0.23868,1,1
3,GO PROTEIN HYDROXYLATION,0.0037331,0.29878,0.23813,1,1
3,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.00098941,0.29871,0.27399,1,1
3,GO INTERLEUKIN 13 PRODUCTION,0.0037331,0.29871,0.2707,1,1
3,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0006154,0.29862,0.31515,1,1
3,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.00010845,0.29847,0.28807,1,1
3,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.00038934,0.29821,0.25853,1,1
3,GO MANNOSYLATION,1.6455e-05,0.29791,0.276,1,1
3,GO REGULATION OF RESPONSE TO WOUNDING,8.4205e-05,0.2977,0.25917,1,1
3,GO AMYLOID FIBRIL FORMATION,0.00069957,0.29752,0.2779,1,1
3,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,1.2962e-05,0.2975,0.25962,1,1
3,GO PROGRAMMED NECROTIC CELL DEATH,7.2754e-05,0.29729,0.30644,1,1
3,GO ARACHIDONIC ACID SECRETION,3.1888e-05,0.29699,0.28033,1,1
3,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,2.2658e-06,0.29637,0.27777,1,1
3,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00018427,0.29569,0.22613,1,1
3,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.00023468,0.29564,0.23175,1,1
3,GO POSITIVE REGULATION OF DEFENSE RESPONSE,4.6623e-06,0.29563,0.25892,1,1
3,GO GOLGI TO ENDOSOME TRANSPORT,0.00016595,0.29541,0.30137,1,1
3,GO FATTY ACID CATABOLIC PROCESS,1.349e-05,0.29541,0.28332,1,1
3,GO POSITIVE REGULATION OF ANION TRANSPORT,1.5816e-05,0.29534,0.33817,1,1
3,GO PROTEIN TARGETING TO LYSOSOME,0.001986,0.29493,0.29528,1,1
3,GO PHOSPHOLIPID TRANSPORT,9.0221e-07,0.29488,0.27245,1,1
3,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,5.7413e-06,0.29439,0.26169,1,1
3,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.004408,0.29429,0.22668,1,1
3,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,5.6174e-05,0.29423,0.24935,1,1
3,GO INTERFERON BETA PRODUCTION,0.00031859,0.29423,0.22375,1,1
3,GO DISACCHARIDE METABOLIC PROCESS,0.00022676,0.29419,0.40408,1,1
3,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.0010859,0.29385,0.28595,1,1
3,GO NEUTRAL LIPID CATABOLIC PROCESS,0.00055855,0.29381,0.25284,1,1
3,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.00067758,0.29352,0.30227,1,1
3,GO CELL CELL JUNCTION ASSEMBLY,3.4728e-06,0.29347,0.28994,1,1
3,GO POSITIVE REGULATION OF CELL ADHESION,0.00014418,0.29324,0.21579,1,1
3,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00026903,0.29318,0.28352,1,1
3,GO T CELL PROLIFERATION,8.7323e-05,0.29261,0.23196,1,1
3,GO DEFENSE RESPONSE,3.4728e-06,0.29261,0.25801,1,1
3,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0006154,0.29251,0.27372,1,1
3,GO GLYCEROLIPID CATABOLIC PROCESS,3.8583e-05,0.29242,0.27449,1,1
3,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.00019079,0.29199,0.22395,1,1
3,GO EPITHELIAL CELL FATE COMMITMENT,0.011326,0.29195,0.26528,1,1
3,GO INTERFERON ALPHA PRODUCTION,3.3132e-05,0.29175,0.28949,1,1
3,GO CARNITINE METABOLIC PROCESS,0.0049174,0.29162,0.2462,1,1
3,GO DEFENSE RESPONSE TO BACTERIUM,5.4977e-07,0.29159,0.28734,1,1
3,GO PROSTANOID METABOLIC PROCESS,0.00079435,0.29143,0.38009,1,1
3,GO POLYOL TRANSPORT,0.0021689,0.29143,0.30674,1,1
3,GO ORGANOPHOSPHATE ESTER TRANSPORT,1.0207e-07,0.29102,0.2888,1,1
3,GO REGULATION OF RESPIRATORY BURST,0.00019753,0.29029,0.34711,1,1
3,GO PROSTANOID BIOSYNTHETIC PROCESS,0.0012662,0.29,0.30112,1,1
3,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,2.4692e-06,0.28993,0.33388,1,1
3,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,1.104e-05,0.28973,0.32306,1,1
3,GO REGULATION OF NECROTIC CELL DEATH,0.00026903,0.28965,0.29109,1,1
3,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.0069616,0.28961,0.24887,1,1
3,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.01282,0.28938,0.20468,1,1
3,GO DOPAMINE METABOLIC PROCESS,0.00092958,0.28923,0.29326,1,1
3,GO INTERLEUKIN 1 BETA PRODUCTION,0.00031859,0.2892,0.24725,1,1
3,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,1.5816e-05,0.2892,0.26892,1,1
3,GO REGULATION OF ACTIN NUCLEATION,0.00036427,0.28914,0.3006,1,1
3,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,9.8628e-07,0.28913,0.2704,1,1
3,GO T CELL MIGRATION,0.00072223,0.28883,0.22003,1,1
3,GO FATTY ACID DERIVATIVE TRANSPORT,1.0184e-05,0.28864,0.30176,1,1
3,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0026572,0.28853,0.1982,1,1
3,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.0057817,0.28847,0.27732,1,1
3,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.0029794,0.28844,0.21292,1,1
3,GO POLYSACCHARIDE METABOLIC PROCESS,1.3441e-06,0.28844,0.26833,1,1
3,GO PROTEIN PROCESSING,7.0571e-06,0.28781,0.27388,1,1
3,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.0039469,0.28746,0.24733,1,1
3,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.014138,0.28729,0.19349,1,1
3,GO RESPONSE TO DEXAMETHASONE,0.00092958,0.287,0.2393,1,1
3,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.0025817,0.28689,0.234,1,1
3,GO REGULATION OF FERTILIZATION,0.00014935,0.28643,0.33253,1,1
3,GO PROTEIN AUTO ADP RIBOSYLATION,0.011612,0.28628,0.27108,1,1
3,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.0016129,0.28615,0.28166,1,1
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.0022992,0.28594,0.26115,1,1
3,GO TISSUE HOMEOSTASIS,1.6729e-06,0.28589,0.25097,1,1
3,GO EXTRACELLULAR VESICLE BIOGENESIS,2.0033e-05,0.28579,0.26966,1,1
3,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.009256,0.28578,0.13974,1,1
3,GO NEGATIVE REGULATION OF CELL ACTIVATION,2.3418e-05,0.28572,0.24667,1,1
3,GO HORMONE CATABOLIC PROCESS,0.009256,0.28539,0.35403,1,1
3,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,6.7728e-06,0.28536,0.27987,1,1
3,GO C21 STEROID HORMONE METABOLIC PROCESS,0.0041716,0.28528,0.3388,1,1
3,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00040247,0.28508,0.23155,1,1
3,GO INTERLEUKIN 5 PRODUCTION,0.024288,0.28505,0.21003,1,1
3,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.00052342,0.2849,0.21055,1,1
3,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.0064317,0.28462,0.23204,1,1
3,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.0022992,0.28406,0.24409,1,1
3,GO B CELL ACTIVATION,7.9801e-06,0.28406,0.23062,1,1
3,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.001986,0.28404,0.27099,1,1
3,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.00012512,0.2836,0.28055,1,1
3,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00029782,0.28357,0.2236,1,1
3,GO PROSTAGLANDIN TRANSPORT,0.00027832,0.28315,0.34485,1,1
3,GO GANGLIOSIDE METABOLIC PROCESS,0.010245,0.28309,0.19297,1,1
3,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.014138,0.28304,0.29293,1,1
3,GO PHOSPHOLIPID HOMEOSTASIS,0.0036303,0.28253,0.26064,1,1
3,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.0062634,0.28251,0.19755,1,1
3,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,2.0033e-05,0.28234,0.26237,1,1
3,GO HETEROTYPIC CELL CELL ADHESION,0.0028141,0.28226,0.21376,1,1
3,GO DIOL BIOSYNTHETIC PROCESS,0.00011241,0.28207,0.36689,1,1
3,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.0039469,0.28195,0.27379,1,1
3,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,3.1904e-06,0.28159,0.24497,1,1
3,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,0.00017186,0.28137,0.29083,1,1
3,GO CELLULAR RESPONSE TO ALCOHOL,0.0011199,0.28123,0.18058,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0016129,0.28112,0.24256,1,1
3,GO NEGATIVE REGULATION OF HEMOPOIESIS,8.7323e-05,0.28111,0.22749,1,1
3,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,2.8418e-05,0.28108,0.22238,1,1
3,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.00013433,0.28084,0.21015,1,1
3,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.00020448,0.28082,0.33045,1,1
3,GO LEUKOCYTE MIGRATION,1.2962e-05,0.28079,0.25177,1,1
3,GO STEROID CATABOLIC PROCESS,0.00353,0.28055,0.28135,1,1
3,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,1.4044e-06,0.28044,0.27278,1,1
3,GO PH REDUCTION,1.1493e-05,0.28021,0.26013,1,1
3,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.0007696,0.28002,0.22549,1,1
3,GO STEROL BIOSYNTHETIC PROCESS,3.1888e-05,0.27962,0.27916,1,1
3,GO POSITIVE REGULATION OF IMMUNE RESPONSE,5.8301e-05,0.27908,0.20362,1,1
3,GO REGULATION OF MYOTUBE DIFFERENTIATION,1.2454e-05,0.27888,0.27501,1,1
3,GO REGULATION OF RUFFLE ASSEMBLY,0.00095906,0.27883,0.22552,1,1
3,GO ER NUCLEUS SIGNALING PATHWAY,0.00025131,0.27868,0.28494,1,1
3,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,3.6228e-06,0.27852,0.26487,1,1
3,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.00017186,0.27827,0.29771,1,1
3,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.0067808,0.27804,0.19202,1,1
3,GO ORGANIC HYDROXY COMPOUND TRANSPORT,2.0784e-06,0.27786,0.2719,1,1
3,GO HOMOTYPIC CELL CELL ADHESION,2.8418e-05,0.27785,0.30646,1,1
3,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.0028957,0.27785,0.35417,1,1
3,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.0085714,0.27782,0.19123,1,1
3,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.013798,0.27776,0.24165,1,1
3,GO ANTIMICROBIAL HUMORAL RESPONSE,7.9801e-06,0.27772,0.27237,1,1
3,GO RESPONSE TO BIOTIC STIMULUS,8.6584e-06,0.27766,0.23251,1,1
3,GO CELLULAR RESPONSE TO STARVATION,3.7791e-06,0.2776,0.25964,1,1
3,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.012203,0.2775,0.138,1,1
3,GO LEUKOCYTE CELL CELL ADHESION,9.389e-05,0.27727,0.21696,1,1
3,GO ENDOCRINE PROCESS,2.8418e-05,0.27722,0.29202,1,1
3,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.0007696,0.27685,0.26042,1,1
3,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.00020448,0.27678,0.31525,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.00030804,0.27676,0.20152,1,1
3,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,2.8077e-06,0.27672,0.26193,1,1
3,GO RESPONSE TO CYTOKINE,1.7118e-05,0.2767,0.2278,1,1
3,GO STEROL TRANSPORT,1.4039e-05,0.27647,0.29349,1,1
3,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.00072223,0.27647,0.26228,1,1
3,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.0036303,0.27642,0.19243,1,1
3,GO AMYLOID BETA METABOLIC PROCESS,0.0001165,0.2764,0.26276,1,1
3,GO CYTOPLASM ORGANIZATION,0.00017186,0.27614,0.32069,1,1
3,GO RESPONSE TO FATTY ACID,0.00017186,0.27603,0.23993,1,1
3,GO INTERLEUKIN 4 PRODUCTION,0.0042883,0.27598,0.20857,1,1
3,GO NUCLEOTIDE TRANSPORT,3.6228e-06,0.27578,0.26896,1,1
3,GO TRANSCYTOSIS,0.00014418,0.2755,0.28752,1,1
3,GO NEGATIVE REGULATION OF PROTEOLYSIS,6.0504e-05,0.2752,0.21769,1,1
3,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,5.0226e-05,0.27519,0.28243,1,1
3,GO AMINE METABOLIC PROCESS,1.0311e-06,0.27516,0.29883,1,1
3,GO DRUG METABOLIC PROCESS,0.00036427,0.2751,0.32673,1,1
3,GO RESPONSE TO INTERLEUKIN 6,0.00026903,0.27506,0.28251,1,1
3,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,1.4039e-05,0.27488,0.27901,1,1
3,GO MYELOID LEUKOCYTE MIGRATION,9.7801e-06,0.2746,0.23812,1,1
3,GO REGULATION OF PEPTIDASE ACTIVITY,1.8521e-05,0.2746,0.25378,1,1
3,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,1.8251e-06,0.27458,0.22536,1,1
3,GO RESPONSE TO PROGESTERONE,0.00025131,0.27402,0.25588,1,1
3,GO CYTOKINE PRODUCTION,1.5816e-05,0.27399,0.24421,1,1
3,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.014486,0.27382,0.25491,1,1
3,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00036427,0.27371,0.21081,1,1
3,GO POLYAMINE BIOSYNTHETIC PROCESS,0.00090094,0.27366,0.27464,1,1
3,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.00059588,0.27341,0.21104,1,1
3,GO RESPONSE TO NUTRIENT,0.00050664,0.27331,0.19079,1,1
3,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.0032441,0.2729,0.18808,1,1
3,GO GAMMA DELTA T CELL DIFFERENTIATION,0.012203,0.27287,0.33877,1,1
3,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.00026003,0.27286,0.24896,1,1
3,GO DETERMINATION OF ADULT LIFESPAN,0.00027832,0.27282,0.28837,1,1
3,GO POSITIVE REGULATION OF COAGULATION,0.00038934,0.27263,0.26831,1,1
3,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,8.7323e-05,0.27227,0.22247,1,1
3,GO EXOCYTOSIS,6.7728e-06,0.27215,0.22476,1,1
3,GO POSITIVE REGULATION OF CELL CELL ADHESION,9.389e-05,0.27198,0.21512,1,1
3,GO PEPTIDE SECRETION,9.0221e-07,0.27186,0.23407,1,1
3,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.00095906,0.27126,0.26955,1,1
3,GO RESPONSE TO FORSKOLIN,0.031748,0.27115,0.23486,1,1
3,GO REGULATION OF B CELL DIFFERENTIATION,0.00045924,0.2711,0.25722,1,1
3,GO CYTOKINE METABOLIC PROCESS,0.00010092,0.271,0.23112,1,1
3,GO REGULATION OF IMMUNE RESPONSE,5.0226e-05,0.27098,0.19863,1,1
3,GO REGULATION OF CELL CELL ADHESION,4.6597e-05,0.27096,0.22934,1,1
3,GO GLYCOPROTEIN METABOLIC PROCESS,7.6603e-06,0.27071,0.24353,1,1
3,GO ACTIVATION OF IMMUNE RESPONSE,6.5149e-05,0.27056,0.20011,1,1
3,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,4.1617e-05,0.27047,0.21928,1,1
3,GO CYTOKINE SECRETION,1.104e-05,0.27029,0.26124,1,1
3,GO BONE CELL DEVELOPMENT,0.0083534,0.26952,0.18245,1,1
3,GO MUSCLE CELL MIGRATION,0.0017123,0.26911,0.21291,1,1
3,GO CELL ACTIVATION,1.9263e-05,0.26875,0.21553,1,1
3,GO PARTURITION,0.021165,0.26859,0.25203,1,1
3,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0013457,0.26858,0.19913,1,1
3,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.033166,0.26856,0.20831,1,1
3,GO POSITIVE REGULATION OF B CELL ACTIVATION,1.7118e-05,0.26853,0.24878,1,1
3,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.0011199,0.2685,0.27894,1,1
3,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,3.8583e-05,0.26844,0.23972,1,1
3,GO SODIUM ION HOMEOSTASIS,6.2786e-05,0.26807,0.24102,1,1
3,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,5.4121e-05,0.26794,0.21822,1,1
3,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.0039469,0.26793,0.29191,1,1
3,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.010245,0.26776,0.23324,1,1
3,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00098941,0.26765,0.28101,1,1
3,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.00092958,0.26738,0.21388,1,1
3,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,5.9841e-06,0.26733,0.29841,1,1
3,GO PANCREATIC JUICE SECRETION,0.022165,0.26725,0.17574,1,1
3,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.00034072,0.26689,0.2,1,1
3,GO INTRACELLULAR LIPID TRANSPORT,4.1617e-05,0.26678,0.26883,1,1
3,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.0011199,0.26671,0.25066,1,1
3,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.0020453,0.26663,0.28299,1,1
3,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.0017123,0.26609,0.23108,1,1
3,GO AUTOPHAGY OF NUCLEUS,0.00353,0.26607,0.23631,1,1
3,GO DOPAMINE TRANSPORT,0.0017641,0.26585,0.32252,1,1
3,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.00059588,0.26573,0.2347,1,1
3,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,1.6455e-05,0.26572,0.22115,1,1
3,GO REGULATION OF MUSCLE ADAPTATION,0.00052342,0.26558,0.19083,1,1
3,GO RESPONSE TO PH,0.0015653,0.26528,0.19796,1,1
3,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,3.6414e-07,0.26523,0.23941,1,1
3,GO EPIDERMAL CELL DIFFERENTIATION,7.9801e-06,0.26522,0.27486,1,1
3,GO VITAMIN TRANSPORT,0.0073363,0.26484,0.21699,1,1
3,GO NEGATIVE REGULATION OF CELL CELL ADHESION,3.4421e-05,0.26415,0.27801,1,1
3,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.00013433,0.26404,0.23643,1,1
3,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.0001547,0.26357,0.21062,1,1
3,GO REGULATION OF INFLAMMATORY RESPONSE,1.7118e-05,0.26347,0.2243,1,1
3,GO INFLAMMATORY RESPONSE,8.3127e-06,0.2634,0.24213,1,1
3,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,8.6584e-06,0.26335,0.24513,1,1
3,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,1.7118e-05,0.26334,0.23606,1,1
3,GO KERATINOCYTE DIFFERENTIATION,1.349e-05,0.26325,0.27629,1,1
3,GO HORMONE METABOLIC PROCESS,4.4878e-05,0.26322,0.28692,1,1
3,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,5.8301e-05,0.26315,0.21761,1,1
3,GO SEQUESTERING OF TRIGLYCERIDE,0.0067808,0.26302,0.23856,1,1
3,GO TRANSFERRIN TRANSPORT,1.8251e-06,0.26283,0.33931,1,1
3,GO REGULATION OF BODY FLUID LEVELS,4.6597e-05,0.26258,0.20443,1,1
3,GO CELLULAR RESPONSE TO STEROL,0.00063551,0.26248,0.28561,1,1
3,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.00052342,0.26229,0.23272,1,1
3,GO RENAL SYSTEM PROCESS,3.4421e-05,0.26221,0.23194,1,1
3,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,6.5149e-05,0.26213,0.21304,1,1
3,GO NECROTIC CELL DEATH,8.7323e-05,0.26201,0.2899,1,1
3,GO REGULATION OF FATTY ACID TRANSPORT,5.7413e-06,0.262,0.39294,1,1
3,GO RESPONSE TO BACTERIUM,1.6455e-05,0.26191,0.23038,1,1
3,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,1.7474e-06,0.26187,0.27482,1,1
3,GO ETHANOL METABOLIC PROCESS,0.04854,0.26127,0.19393,1,1
3,GO SECRETION BY TISSUE,0.00035231,0.26114,0.24522,1,1
3,GO PLASMA MEMBRANE FUSION,0.0041716,0.26113,0.23432,1,1
3,GO ANDROGEN METABOLIC PROCESS,5.0226e-05,0.26105,0.39653,1,1
3,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,9.0179e-06,0.26079,0.23904,1,1
3,GO REGULATION OF RENAL SYSTEM PROCESS,0.0047853,0.26075,0.22297,1,1
3,GO GRANULOCYTE MIGRATION,2.9532e-05,0.26065,0.22851,1,1
3,GO RESPONSE TO GONADOTROPIN,0.00014418,0.26059,0.26161,1,1
3,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.00052342,0.26033,0.26876,1,1
3,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.00092958,0.26005,0.2655,1,1
3,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.0027346,0.25995,0.21814,1,1
3,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,5.508e-06,0.25995,0.28823,1,1
3,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.023205,0.2597,0.18921,1,1
3,GO REGULATION OF RECEPTOR BINDING,0.0041716,0.25957,0.28154,1,1
3,GO DENDRITIC CELL MIGRATION,0.0050528,0.25954,0.18558,1,1
3,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,5.0194e-07,0.25946,0.26982,1,1
3,GO ORGANELLE MEMBRANE FUSION,0.00014418,0.25928,0.21431,1,1
3,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.031059,0.25891,0.17968,1,1
3,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.0010528,0.25882,0.17671,1,1
3,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.00069957,0.25878,0.21734,1,1
3,GO CELLULAR KETONE METABOLIC PROCESS,0.00012964,0.25878,0.24141,1,1
3,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,2.3418e-05,0.25855,0.26057,1,1
3,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.0037331,0.2585,0.21433,1,1
3,GO ER OVERLOAD RESPONSE,0.00042998,0.25824,0.28159,1,1
3,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.00041602,0.25815,0.28122,1,1
3,GO MYELIN MAINTENANCE,0.0075304,0.25807,0.28513,1,1
3,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,6.7596e-05,0.25799,0.2633,1,1
3,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.0041716,0.25795,0.28369,1,1
3,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,4.7955e-07,0.25784,0.25215,1,1
3,GO AMINO ACID BETAINE METABOLIC PROCESS,0.00057693,0.25775,0.32896,1,1
3,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.00074557,0.25766,0.17988,1,1
3,GO AMMONIUM TRANSPORT,0.00052342,0.25748,0.27184,1,1
3,GO DETECTION OF CALCIUM ION,0.0059384,0.25734,0.3143,1,1
3,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00052342,0.25695,0.21488,1,1
3,GO GPI ANCHOR METABOLIC PROCESS,6.0504e-05,0.25689,0.26564,1,1
3,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0079323,0.25687,0.17674,1,1
3,GO REGULATION OF LIPID STORAGE,0.00016023,0.25619,0.22796,1,1
3,GO CELLULAR RESPONSE TO LITHIUM ION,0.00098941,0.25617,0.28244,1,1
3,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.011904,0.25605,0.26168,1,1
3,GO REGULATION OF DEFENSE RESPONSE,8.3127e-06,0.25594,0.22935,1,1
3,GO ALPHA BETA T CELL DIFFERENTIATION,0.0001547,0.25572,0.22104,1,1
3,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,5.0683e-06,0.25558,0.26623,1,1
3,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.00024286,0.25523,0.21275,1,1
3,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.0017123,0.25501,0.22613,1,1
3,GO PRIMARY ALCOHOL METABOLIC PROCESS,7.2754e-05,0.25487,0.33449,1,1
3,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.00017186,0.25483,0.19082,1,1
3,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.027803,0.25476,0.14861,1,1
3,GO COAGULATION,0.00020448,0.25418,0.19545,1,1
3,GO OXALATE TRANSPORT,0.004408,0.25365,0.19589,1,1
3,GO XENOBIOTIC TRANSPORT,0.00013917,0.25356,0.3249,1,1
3,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,5.4121e-05,0.25353,0.27034,1,1
3,GO CELLULAR RESPONSE TO CHOLESTEROL,0.0073363,0.2532,0.25128,1,1
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.0024367,0.25317,0.23436,1,1
3,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.00011241,0.25267,0.23378,1,1
3,GO REGULATION OF PEPTIDE SECRETION,3.8131e-07,0.2524,0.23559,1,1
3,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,2.3418e-05,0.25239,0.24779,1,1
3,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,3.8583e-05,0.25224,0.20546,1,1
3,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.0099891,0.25218,0.20359,1,1
3,GO SKIN DEVELOPMENT,6.2786e-05,0.25193,0.21586,1,1
3,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.014138,0.2518,0.16833,1,1
3,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.053746,0.25124,0.17756,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.00026003,0.25124,0.18006,1,1
3,GO MUSCLE HYPERTROPHY,0.0001165,0.25109,0.21702,1,1
3,GO REGULATION OF T CELL ACTIVATION,0.00013917,0.25071,0.19542,1,1
3,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,9.7346e-05,0.2507,0.22596,1,1
3,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.00029782,0.2503,0.21742,1,1
3,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,1.6455e-05,0.25027,0.19218,1,1
3,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.00029782,0.2502,0.32889,1,1
3,GO VESICLE BUDDING FROM MEMBRANE,0.00047456,0.25014,0.2051,1,1
3,GO CELLULAR GLUCAN METABOLIC PROCESS,3.5759e-05,0.25004,0.22284,1,1
3,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.0025083,0.24994,0.23272,1,1
3,GO RESPONSE TO INSECTICIDE,0.0054795,0.24989,0.29192,1,1
3,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00027832,0.24976,0.21171,1,1
3,GO REGULATION OF T CELL MIGRATION,0.0013054,0.24961,0.21828,1,1
3,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.00027832,0.24941,0.25232,1,1
3,GO MEMBRANE FUSION,3.0689e-05,0.24936,0.21774,1,1
3,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,1.4039e-05,0.24898,0.23913,1,1
3,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,5.0226e-05,0.24889,0.29822,1,1
3,GO ISOPRENOID METABOLIC PROCESS,0.00018427,0.24883,0.24664,1,1
3,GO RESPONSE TO CADMIUM ION,0.0097392,0.24882,0.20501,1,1
3,GO T CELL ACTIVATION,4.8379e-05,0.24824,0.20955,1,1
3,GO LEUKOCYTE CHEMOTAXIS,1.5201e-05,0.24804,0.22826,1,1
3,GO ADIPOSE TISSUE DEVELOPMENT,0.00057693,0.24803,0.21003,1,1
3,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,4.6597e-05,0.24799,0.19592,1,1
3,GO CELLULAR RESPONSE TO FOLLICLE STIMULATING HORMONE STIMULUS,0.0024367,0.24792,0.27582,1,1
3,GO ACYLGLYCEROL HOMEOSTASIS,0.0071468,0.24786,0.19848,1,1
3,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.0071468,0.24781,0.18307,1,1
3,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.0010859,0.24766,0.24935,1,1
3,GO EPIDERMIS DEVELOPMENT,3.4421e-05,0.24753,0.22298,1,1
3,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,3.6228e-06,0.24728,0.22168,1,1
3,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.00016595,0.24725,0.24165,1,1
3,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0013872,0.24708,0.23918,1,1
3,GO CHLORIDE ION HOMEOSTASIS,0.00059588,0.24704,0.23787,1,1
3,GO REGULATION OF RESPONSE TO TUMOR CELL,0.0040578,0.24682,0.23974,1,1
3,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,3.5759e-05,0.2468,0.2384,1,1
3,GO REGULATION OF CELL ADHESION,0.00022676,0.24672,0.19137,1,1
3,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.00084609,0.24659,0.2785,1,1
3,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.0016129,0.24656,0.20939,1,1
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00014418,0.24626,0.2099,1,1
3,GO ALCOHOL METABOLIC PROCESS,3.4728e-06,0.24611,0.26483,1,1
3,GO REGULATION OF ACTION POTENTIAL,0.0010206,0.24569,0.2269,1,1
3,GO PLATELET ACTIVATION,0.00010845,0.24558,0.21191,1,1
3,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,1.1493e-05,0.24557,0.25825,1,1
3,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.034637,0.24535,0.1515,1,1
3,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.0054795,0.24508,0.22432,1,1
3,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.0014738,0.24475,0.21444,1,1
3,GO B CELL RECEPTOR SIGNALING PATHWAY,9.0551e-05,0.24473,0.30898,1,1
3,GO DETERMINATION OF DORSAL VENTRAL ASYMMETRY,0.0094949,0.24465,0.19363,1,1
3,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00010462,0.24448,0.24237,1,1
3,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0037331,0.244,0.32707,1,1
3,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.00037661,0.24362,0.18619,1,1
3,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00090094,0.24351,0.22974,1,1
3,GO VITAMIN CATABOLIC PROCESS,0.045624,0.24347,0.25092,1,1
3,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.018836,0.24331,0.22273,1,1
3,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.0060989,0.24327,0.21672,1,1
3,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.023205,0.24321,0.15108,1,1
3,GO LYMPHOCYTE APOPTOTIC PROCESS,0.00034072,0.24288,0.23521,1,1
3,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.043763,0.24256,0.13254,1,1
3,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.00055855,0.24216,0.20687,1,1
3,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.0018173,0.24171,0.19542,1,1
3,GO INSULIN SECRETION,5.2837e-06,0.2417,0.23213,1,1
3,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.0014299,0.24167,0.20573,1,1
3,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.00055855,0.24154,0.23351,1,1
3,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.013465,0.24149,0.28337,1,1
3,GO REGULATION OF MUSCLE HYPERTROPHY,0.0010528,0.2414,0.20021,1,1
3,GO CELL CHEMOTAXIS,1.104e-05,0.24114,0.24088,1,1
3,GO REGULATION OF CHLORIDE TRANSPORT,0.007729,0.24099,0.30993,1,1
3,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.00052342,0.24089,0.22338,1,1
3,GO POSITIVE CHEMOTAXIS,0.0010206,0.24075,0.18441,1,1
3,GO GLIAL CELL PROLIFERATION,0.0023671,0.24051,0.2238,1,1
3,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.0060989,0.24047,0.21665,1,1
3,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00017796,0.24011,0.2586,1,1
3,GO AMINOGLYCAN METABOLIC PROCESS,0.00019079,0.23992,0.2231,1,1
3,GO CELLULAR METABOLIC COMPOUND SALVAGE,5.0226e-05,0.2398,0.27413,1,1
3,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.016734,0.23977,0.24263,1,1
3,GO CARBOHYDRATE HOMEOSTASIS,8.6584e-06,0.23976,0.21825,1,1
3,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,4.8379e-05,0.23952,0.19828,1,1
3,GO EPITHELIAL STRUCTURE MAINTENANCE,0.0062634,0.23935,0.18769,1,1
3,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.014841,0.23932,0.23785,1,1
3,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.00012074,0.23891,0.24987,1,1
3,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.00021909,0.23879,0.22526,1,1
3,GO POSITIVE REGULATION OF PEPTIDE SECRETION,4.8612e-06,0.23864,0.22582,1,1
3,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.038561,0.23863,0.16368,1,1
3,GO MUSCLE ADAPTATION,0.00036427,0.2386,0.18736,1,1
3,GO LOCOMOTOR RHYTHM,0.0075304,0.23835,0.18849,1,1
3,GO TERPENOID BIOSYNTHETIC PROCESS,0.043763,0.23822,0.2764,1,1
3,GO CELLULAR RESPONSE TO KETONE,0.0015653,0.23782,0.19902,1,1
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.0085714,0.23775,0.1795,1,1
3,GO RECEPTOR SIGNALING PATHWAY VIA STAT,5.8301e-05,0.23773,0.20459,1,1
3,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,9.0551e-05,0.23753,0.2592,1,1
3,GO VESICLE TARGETING,0.00063551,0.23752,0.21004,1,1
3,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.036948,0.23745,0.18114,1,1
3,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.018398,0.23744,0.17241,1,1
3,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.0028141,0.23733,0.28321,1,1
3,GO METHIONINE BIOSYNTHETIC PROCESS,0.0020453,0.23723,0.35055,1,1
3,GO CELLULAR RESPONSE TO CALCIUM ION,0.00098941,0.23708,0.22324,1,1
3,GO REGULATION OF ERBB SIGNALING PATHWAY,0.00074557,0.237,0.20441,1,1
3,GO ALCOHOL BIOSYNTHETIC PROCESS,3.7145e-05,0.23674,0.23389,1,1
3,GO I KAPPAB PHOSPHORYLATION,0.013798,0.23671,0.16757,1,1
3,GO THIOESTER BIOSYNTHETIC PROCESS,0.00034072,0.23671,0.23887,1,1
3,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.00087311,0.23657,0.28248,1,1
3,GO MONOCYTE CHEMOTAXIS,0.0012662,0.23629,0.21282,1,1
3,GO POSITIVE REGULATION OF CELL ACTIVATION,0.00026903,0.23622,0.17805,1,1
3,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.0059384,0.23616,0.15196,1,1
3,GO PIGMENTATION,0.00014935,0.23614,0.17595,1,1
3,GO RESPONSE TO STARVATION,1.2962e-05,0.23612,0.23688,1,1
3,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.019739,0.23609,0.12842,1,1
3,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,5.8301e-05,0.23583,0.22721,1,1
3,GO RESPONSE TO CALCIUM ION,0.00034072,0.23565,0.198,1,1
3,GO LIPID BIOSYNTHETIC PROCESS,2.6902e-06,0.23557,0.22925,1,1
3,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,2.8418e-05,0.23536,0.19535,1,1
3,GO GRANULOCYTE CHEMOTAXIS,0.00010462,0.23526,0.18768,1,1
3,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.00036427,0.23525,0.24977,1,1
3,GO NEGATIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.020205,0.23525,0.22512,1,1
3,GO REGULATION OF INSULIN SECRETION,2.0033e-05,0.23525,0.20683,1,1
3,GO SECRETION,4.4712e-06,0.23506,0.20048,1,1
3,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,2.9532e-05,0.23494,0.19229,1,1
3,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.0064317,0.23477,0.19568,1,1
3,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.00012512,0.23444,0.25336,1,1
3,GO RESPONSE TO STEROL,0.0014738,0.23429,0.21918,1,1
3,GO MUSCLE CELL APOPTOTIC PROCESS,0.00040247,0.23421,0.19188,1,1
3,GO PROTEIN MATURATION,1.5201e-05,0.2342,0.22042,1,1
3,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.0057817,0.23417,0.25458,1,1
3,GO CELLULAR LIPID CATABOLIC PROCESS,4.2876e-06,0.23406,0.28294,1,1
3,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.00010462,0.23389,0.19156,1,1
3,GO LIPID HOMEOSTASIS,3.0689e-05,0.2337,0.25657,1,1
3,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.00030804,0.23365,0.23344,1,1
3,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.052669,0.23317,0.13958,1,1
3,GO INOSITOL METABOLIC PROCESS,0.00025131,0.23308,0.26677,1,1
3,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.00067758,0.23291,0.30722,1,1
3,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,1.2454e-05,0.23285,0.23295,1,1
3,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,4.4878e-05,0.23282,0.19776,1,1
3,GO GLUCOSE METABOLIC PROCESS,9.4334e-07,0.23255,0.24922,1,1
3,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,5.8301e-05,0.23254,0.2605,1,1
3,GO CHOLESTEROL STORAGE,0.00023468,0.23245,0.29255,1,1
3,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.0042883,0.23224,0.2238,1,1
3,GO RESPONSE TO CORTICOSTEROID,0.00059588,0.23213,0.19489,1,1
3,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,6.2786e-05,0.23206,0.23262,1,1
3,GO PROTEIN AUTOPROCESSING,0.00019079,0.232,0.34266,1,1
3,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00010845,0.23196,0.20153,1,1
3,GO REGULATION OF LIPID TRANSPORT,3.7145e-05,0.23182,0.25531,1,1
3,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.0066042,0.23174,0.21943,1,1
3,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,2.0033e-05,0.23162,0.20048,1,1
3,GO PROTEIN KINASE C SIGNALING,0.027803,0.23145,0.21089,1,1
3,GO GDP METABOLIC PROCESS,0.041093,0.23138,0.19319,1,1
3,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00065623,0.23113,0.23583,1,1
3,GO VITAMIN METABOLIC PROCESS,0.0041716,0.2309,0.20524,1,1
3,GO PANCREAS DEVELOPMENT,0.011904,0.2308,0.16446,1,1
3,GO B CELL DIFFERENTIATION,6.4994e-06,0.23078,0.2296,1,1
3,GO MACROMOLECULE DEPALMITOYLATION,0.00055855,0.23068,0.23755,1,1
3,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,2.0033e-05,0.23066,0.21044,1,1
3,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.00022676,0.23046,0.18007,1,1
3,GO NEUTROPHIL MIGRATION,1.0604e-05,0.23035,0.22176,1,1
3,GO REGULATION OF PH,1.6015e-06,0.22996,0.23875,1,1
3,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.00084609,0.22994,0.18461,1,1
3,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.015574,0.22994,0.14522,1,1
3,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00055855,0.22965,0.17594,1,1
3,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.0001547,0.22963,0.26304,1,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.0053338,0.22947,0.24757,1,1
3,GO GOLGI VESICLE BUDDING,8.4205e-05,0.22943,0.21741,1,1
3,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00012964,0.22927,0.1941,1,1
3,GO REGULATION OF CELL ACTIVATION,0.00014935,0.22927,0.18166,1,1
3,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.00065623,0.22923,0.22058,1,1
3,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.029068,0.22891,0.2031,1,1
3,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,7.013e-05,0.22875,0.1792,1,1
3,GO SPLEEN DEVELOPMENT,0.0011199,0.22848,0.20862,1,1
3,GO POSITIVE REGULATION OF T CELL MIGRATION,0.0056288,0.22847,0.16629,1,1
3,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.0022992,0.22838,0.22091,1,1
3,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.011326,0.2282,0.14017,1,1
3,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.031748,0.22807,0.18858,1,1
3,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.010773,0.22805,0.23208,1,1
3,GO RESPONSE TO METAL ION,7.3528e-06,0.22801,0.22765,1,1
3,GO REGULATION OF LYMPHOCYTE MIGRATION,0.0028141,0.22793,0.17938,1,1
3,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,7.9801e-06,0.22785,0.23266,1,1
3,GO LIPID OXIDATION,8.7323e-05,0.22778,0.23328,1,1
3,GO REGULATION OF HEART RATE,0.00047456,0.22759,0.21851,1,1
3,GO LYMPHOCYTE HOMEOSTASIS,5.4121e-05,0.2275,0.22044,1,1
3,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.00069957,0.2274,0.19742,1,1
3,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.00092958,0.22723,0.19859,1,1
3,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.0031536,0.22712,0.321,1,1
3,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.018398,0.22705,0.26321,1,1
3,GO PHAGOCYTOSIS,0.00052342,0.227,0.1694,1,1
3,GO REGULATION OF PEPTIDE HORMONE SECRETION,1.2454e-05,0.22693,0.22233,1,1
3,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.0027346,0.22674,0.19541,1,1
3,GO CELLULAR RESPONSE TO ALKALOID,1.349e-05,0.22674,0.26003,1,1
3,GO FLUID TRANSPORT,0.00013433,0.22652,0.21945,1,1
3,GO REGULATION OF BLOOD PRESSURE,2.7343e-05,0.22652,0.19815,1,1
3,GO WOUND HEALING,0.00045924,0.22651,0.18737,1,1
3,GO LYMPHOCYTE COSTIMULATION,0.00067758,0.22641,0.19658,1,1
3,GO RESPONSE TO KETONE,0.00032948,0.22634,0.18013,1,1
3,GO REGULATION OF CELLULAR PH,1.906e-06,0.22619,0.23942,1,1
3,GO RESPONSE TO ALCOHOL,0.00013433,0.22566,0.17209,1,1
3,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.0036303,0.22561,0.19439,1,1
3,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.0067808,0.22543,0.17529,1,1
3,GO POSITIVE REGULATION OF SECRETION,5.508e-06,0.22526,0.21575,1,1
3,GO LIPID EXPORT FROM CELL,0.00028792,0.22499,0.28709,1,1
3,GO MECHANORECEPTOR DIFFERENTIATION,0.0001547,0.22487,0.20349,1,1
3,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.013798,0.22483,0.24855,1,1
3,GO SEQUESTERING OF CALCIUM ION,0.00036427,0.22475,0.17852,1,1
3,GO EPITHELIAL CELL DIFFERENTIATION,4.4878e-05,0.22469,0.20538,1,1
3,GO ACROSOME REACTION,0.02166,0.2246,0.17534,1,1
3,GO REGULATION OF ANION TRANSPORT,6.7596e-05,0.22459,0.24872,1,1
3,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.00030804,0.22459,0.3128,1,1
3,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.012508,0.22453,0.2713,1,1
3,GO REGULATION OF T CELL DIFFERENTIATION,0.00029782,0.22452,0.16142,1,1
3,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.00044439,0.22452,0.2261,1,1
3,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.00069957,0.22442,0.16461,1,1
3,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,4.4878e-05,0.22395,0.33943,1,1
3,GO GLOMERULUS DEVELOPMENT,0.0040578,0.22393,0.1947,1,1
3,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.00019079,0.22379,0.20183,1,1
3,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.0010859,0.22346,0.24892,1,1
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.001986,0.22331,0.18745,1,1
3,GO FATTY ACID BIOSYNTHETIC PROCESS,2.3418e-05,0.22329,0.2583,1,1
3,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.00035231,0.22325,0.18293,1,1
3,GO AMYLOID BETA FORMATION,0.001872,0.22318,0.23329,1,1
3,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,7.6603e-06,0.22315,0.24073,1,1
3,GO PROTEIN DESTABILIZATION,3.7145e-05,0.22308,0.20274,1,1
3,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.00052342,0.22307,0.23797,1,1
3,GO RESPONSE TO INSULIN,1.4609e-05,0.22279,0.19157,1,1
3,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.00067758,0.22274,0.17912,1,1
3,GO POSITIVE REGULATION OF CYTOKINE SECRETION,3.0689e-05,0.22265,0.22926,1,1
3,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.00054072,0.22232,0.26721,1,1
3,GO CIRCADIAN REGULATION OF GENE EXPRESSION,7.8282e-05,0.22226,0.2311,1,1
3,GO NEUTRAL AMINO ACID TRANSPORT,0.01282,0.22224,0.24287,1,1
3,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00038934,0.22212,0.16104,1,1
3,GO REGULATION OF LYSOSOMAL LUMEN PH,0.00016023,0.22206,0.32755,1,1
3,GO REGULATION OF LIPID LOCALIZATION,5.4121e-05,0.22164,0.23412,1,1
3,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.00013433,0.22157,0.21227,1,1
3,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.00059588,0.22141,0.19729,1,1
3,GO CELLULAR HORMONE METABOLIC PROCESS,0.0010206,0.22109,0.25307,1,1
3,GO REGULATION OF GLUCONEOGENESIS,2.4692e-06,0.221,0.28863,1,1
3,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.001228,0.22083,0.19672,1,1
3,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.0007696,0.2208,0.24993,1,1
3,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00010092,0.22077,0.18561,1,1
3,GO REGULATION OF NUCLEASE ACTIVITY,0.0037331,0.22077,0.17742,1,1
3,GO T CELL DIFFERENTIATION,3.4421e-05,0.22074,0.1844,1,1
3,GO REGULATION OF FATTY ACID OXIDATION,0.0037331,0.22053,0.20753,1,1
3,GO APOPTOTIC SIGNALING PATHWAY,3.3132e-05,0.22052,0.19038,1,1
3,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.00353,0.22041,0.20405,1,1
3,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.00010462,0.22017,0.19692,1,1
3,GO REGULATION OF AMYLOID BETA FORMATION,0.0026572,0.22008,0.25152,1,1
3,GO T HELPER CELL LINEAGE COMMITMENT,0.0057817,0.22008,0.17561,1,1
3,GO REGULATION OF CELL MATRIX ADHESION,0.0013872,0.21975,0.20653,1,1
3,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.00050664,0.21965,0.21634,1,1
3,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,4.8379e-05,0.2196,0.19146,1,1
3,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.00032948,0.21944,0.25145,1,1
3,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.0025817,0.21933,0.17742,1,1
3,GO SUPEROXIDE METABOLIC PROCESS,0.0001165,0.2192,0.24403,1,1
3,GO REGULATION OF IMMUNE SYSTEM PROCESS,5.6174e-05,0.2191,0.17709,1,1
3,GO REGULATION OF MAST CELL ACTIVATION,0.0014299,0.21908,0.21524,1,1
3,GO ENGULFMENT OF APOPTOTIC CELL,0.0016129,0.21906,0.20982,1,1
3,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.052669,0.21897,0.1884,1,1
3,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.00092958,0.21844,0.1579,1,1
3,GO FIBROBLAST PROLIFERATION,0.0031536,0.21808,0.18484,1,1
3,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.0021689,0.21805,0.15451,1,1
3,GO LEUKOCYTE DIFFERENTIATION,2.6307e-05,0.218,0.18465,1,1
3,GO PRODUCTION OF SIRNA INVOLVED IN RNA INTERFERENCE,0.050569,0.21797,0.17892,1,1
3,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,9.0551e-05,0.21796,0.25019,1,1
3,GO TERPENOID METABOLIC PROCESS,0.00049035,0.21795,0.22904,1,1
3,GO PROTEIN KINASE B SIGNALING,0.00087311,0.21771,0.15659,1,1
3,GO REGULATION OF HORMONE LEVELS,1.8251e-06,0.21767,0.24697,1,1
3,GO AUTOPHAGIC CELL DEATH,0.0037331,0.21734,0.19619,1,1
3,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.00019079,0.21732,0.23053,1,1
3,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,1.349e-05,0.21715,0.1972,1,1
3,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.02166,0.21713,0.2003,1,1
3,GO NATURAL KILLER CELL ACTIVATION,6.0504e-05,0.21707,0.21579,1,1
3,GO LEUKOCYTE APOPTOTIC PROCESS,0.0018173,0.21705,0.18624,1,1
3,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.0050528,0.21704,0.20557,1,1
3,GO LIPID METABOLIC PROCESS,3.1904e-06,0.21694,0.22268,1,1
3,GO REGULATION OF PROTEOLYSIS,7.8282e-05,0.21692,0.18068,1,1
3,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.0017641,0.21663,0.17544,1,1
3,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.011326,0.21661,0.14523,1,1
3,GO PEROXISOMAL TRANSPORT,0.0006154,0.21644,0.21202,1,1
3,GO CELLULAR LIPID METABOLIC PROCESS,3.4728e-06,0.21625,0.22606,1,1
3,GO CELL CELL ADHESION,0.00019753,0.21607,0.17692,1,1
3,GO RESPONSE TO IRON ION,0.0011199,0.21596,0.22411,1,1
3,GO RESPONSE TO OSMOTIC STRESS,0.00054072,0.21561,0.21783,1,1
3,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,9.3916e-06,0.21548,0.20056,1,1
3,GO PLACENTA DEVELOPMENT,0.014486,0.21533,0.13437,1,1
3,GO PROTEIN ADP RIBOSYLATION,0.0097392,0.21523,0.16914,1,1
3,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.0025817,0.21521,0.30492,1,1
3,GO ORGANELLE FUSION,0.00026003,0.21503,0.1741,1,1
3,GO RESPONSE TO INORGANIC SUBSTANCE,6.4994e-06,0.21503,0.18731,1,1
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,4.2876e-06,0.21501,0.2084,1,1
3,GO RESPONSE TO DSRNA,0.00044439,0.21471,0.1758,1,1
3,GO ERK1 AND ERK2 CASCADE,0.0011549,0.21467,0.17326,1,1
3,GO POSITIVE REGULATION OF HORMONE SECRETION,4.1617e-05,0.21453,0.23499,1,1
3,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.00063551,0.21432,0.14927,1,1
3,GO POSITIVE REGULATION OF HEMOPOIESIS,0.00010092,0.21402,0.19074,1,1
3,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.0033369,0.2139,0.16286,1,1
3,GO TRIGLYCERIDE METABOLIC PROCESS,0.0013457,0.21374,0.17946,1,1
3,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.00040247,0.21342,0.19172,1,1
3,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,9.389e-05,0.21328,0.17781,1,1
3,GO REGULATION OF HORMONE SECRETION,9.7801e-06,0.21326,0.21644,1,1
3,GO CATECHOLAMINE METABOLIC PROCESS,0.001872,0.2132,0.25671,1,1
3,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,1.1964e-05,0.21319,0.19121,1,1
3,GO LONG CHAIN FATTY ACID TRANSPORT,3.7791e-06,0.21281,0.24415,1,1
3,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,2.3418e-05,0.21267,0.19264,1,1
3,GO GAMMA DELTA T CELL ACTIVATION,0.010506,0.21265,0.25463,1,1
3,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.00034072,0.21258,0.18971,1,1
3,GO CELLULAR RESPONSE TO INSULIN STIMULUS,5.0226e-05,0.21245,0.17402,1,1
3,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,1.0604e-05,0.21204,0.26219,1,1
3,GO REGULATION OF LEUKOCYTE MIGRATION,0.00027832,0.21182,0.18005,1,1
3,GO SULFUR COMPOUND TRANSPORT,9.7346e-05,0.21176,0.21851,1,1
3,GO FATTY ACID TRANSPORT,1.1493e-05,0.21164,0.24296,1,1
3,GO DIGESTIVE SYSTEM DEVELOPMENT,0.0007696,0.21145,0.17157,1,1
3,GO LYMPHOCYTE ACTIVATION,7.013e-05,0.21124,0.17938,1,1
3,GO PROTEIN LOCALIZATION TO ENDOSOME,0.011612,0.21121,0.19135,1,1
3,GO PHOSPHOLIPID METABOLIC PROCESS,2.9301e-06,0.21067,0.19355,1,1
3,GO RESPONSE TO MECHANICAL STIMULUS,2.7343e-05,0.21065,0.21746,1,1
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,5.2837e-06,0.21008,0.2144,1,1
3,GO CHEMICAL HOMEOSTASIS,4.1112e-06,0.20983,0.18823,1,1
3,GO REGULATION OF BILE ACID METABOLIC PROCESS,0.0075304,0.20977,0.33233,1,1
3,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.00092958,0.20966,0.18941,1,1
3,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.00036427,0.20958,0.20866,1,1
3,GO REGULATION OF MACROPHAGE ACTIVATION,0.0059384,0.20957,0.16725,1,1
3,GO MANGANESE ION TRANSPORT,0.00090094,0.20935,0.2214,1,1
3,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.00031859,0.20933,0.17985,1,1
3,GO WHITE FAT CELL DIFFERENTIATION,0.0051916,0.20931,0.18895,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.0026572,0.20929,0.14642,1,1
3,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.011612,0.20918,0.17861,1,1
3,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.00042998,0.20905,0.1779,1,1
3,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.00017186,0.20902,0.23365,1,1
3,GO GLUTAMATE METABOLIC PROCESS,0.0007696,0.20895,0.20073,1,1
3,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,2.1663e-05,0.2088,0.23356,1,1
3,GO ADAPTIVE THERMOGENESIS,2.2658e-06,0.20858,0.22659,1,1
3,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.004408,0.20837,0.23222,1,1
3,GO NOTCH SIGNALING PATHWAY,0.00017796,0.20821,0.20025,1,1
3,GO PROSTAGLANDIN SECRETION,0.0021062,0.2082,0.25095,1,1
3,GO VITAMIN BIOSYNTHETIC PROCESS,0.013465,0.20813,0.19607,1,1
3,GO REGULATION OF TUBE SIZE,0.00019079,0.20798,0.19555,1,1
3,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.033894,0.20796,0.18765,1,1
3,GO VACUOLE ORGANIZATION,9.4334e-07,0.20791,0.24743,1,1
3,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0036303,0.20784,0.17928,1,1
3,GO NEUTRAL LIPID METABOLIC PROCESS,0.00090094,0.2076,0.1866,1,1
3,GO NEUROEPITHELIAL CELL DIFFERENTIATION,0.001191,0.20748,0.27589,1,1
3,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,3.9418e-06,0.20669,0.22032,1,1
3,GO RESPONSE TO HYDROGEN PEROXIDE,0.00014418,0.20664,0.18331,1,1
3,GO INORGANIC ANION TRANSPORT,1.1964e-05,0.20651,0.18273,1,1
3,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.018398,0.20628,0.19753,1,1
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,0.0040578,0.20622,0.17382,1,1
3,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,3.1888e-05,0.20608,0.21185,1,1
3,GO SENSORY PERCEPTION OF TASTE,0.00049035,0.20608,0.17253,1,1
3,GO FC RECEPTOR SIGNALING PATHWAY,0.00050664,0.20603,0.15166,1,1
3,GO ACTIN FILAMENT BASED TRANSPORT,0.011047,0.20593,0.21709,1,1
3,GO ACTIN FILAMENT DEPOLYMERIZATION,0.0001165,0.20591,0.20908,1,1
3,GO LYMPHOCYTE CHEMOTAXIS,0.0023671,0.20582,0.15056,1,1
3,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.0075304,0.20579,0.16674,1,1
3,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,1.4044e-06,0.20578,0.2308,1,1
3,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.0081404,0.20554,0.15178,1,1
3,GO HORMONE TRANSPORT,4.8612e-06,0.20545,0.23347,1,1
3,GO ACTIN NUCLEATION,0.00047456,0.20544,0.19608,1,1
3,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.041093,0.20531,0.17216,1,1
3,GO IRON ION TRANSPORT,3.3132e-05,0.20503,0.25203,1,1
3,GO ENDOCYTIC RECYCLING,0.00050664,0.20491,0.17031,1,1
3,GO REGULATION OF BONE DEVELOPMENT,0.017969,0.20475,0.13937,1,1
3,GO CHYLOMICRON ASSEMBLY,0.014841,0.20472,0.24087,1,1
3,GO EPITHELIAL CELL DEVELOPMENT,0.0010859,0.20414,0.16619,1,1
3,GO PEPTIDE HORMONE SECRETION,7.3528e-06,0.20402,0.22407,1,1
3,GO SYNAPTIC VESICLE BUDDING,0.025994,0.20362,0.20151,1,1
3,GO ENDOTHELIAL CELL MIGRATION,0.0013054,0.20338,0.17717,1,1
3,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,1.4039e-05,0.20293,0.21236,1,1
3,GO REGULATION OF HEMOPOIESIS,0.00010462,0.20276,0.16111,1,1
3,GO DETOXIFICATION,0.05161,0.20253,0.166,1,1
3,GO MONOSACCHARIDE METABOLIC PROCESS,3.0576e-06,0.20248,0.25926,1,1
3,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.016339,0.20246,0.12815,1,1
3,GO GLUCOSE IMPORT,0.00087311,0.20225,0.18555,1,1
3,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.0066042,0.20222,0.17753,1,1
3,GO FATTY ACID METABOLIC PROCESS,1.1493e-05,0.20153,0.25707,1,1
3,GO NEGATIVE REGULATION OF MAPK CASCADE,0.0013054,0.20148,0.1667,1,1
3,GO EPITHELIUM DEVELOPMENT,0.0001165,0.20116,0.1558,1,1
3,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.01282,0.20107,0.28733,1,1
3,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.0087944,0.20091,0.23831,1,1
3,GO CHLORIDE TRANSPORT,2.4346e-05,0.20085,0.1849,1,1
3,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0019282,0.20083,0.17365,1,1
3,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.0020453,0.2007,0.19327,1,1
3,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.019283,0.20063,0.18222,1,1
3,GO HEXOSE CATABOLIC PROCESS,0.029719,0.20063,0.18481,1,1
3,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.055956,0.20061,0.12719,1,1
3,GO COPII COATED VESICLE BUDDING,0.00026903,0.20059,0.19962,1,1
3,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.027188,0.20017,0.18865,1,1
3,GO T CELL RECEPTOR SIGNALING PATHWAY,0.00057693,0.20015,0.16197,1,1
3,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.014486,0.20011,0.1377,1,1
3,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.001662,0.2001,0.20438,1,1
3,GO REGULATION OF APPETITE,0.0069616,0.19986,0.13148,1,1
3,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.037747,0.19983,0.098114,1,1
3,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00052342,0.19981,0.16106,1,1
3,GO PROTEOLYSIS,2.8418e-05,0.19977,0.15797,1,1
3,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.022165,0.19973,0.17426,1,1
3,GO ACTIVATION OF INNATE IMMUNE RESPONSE,1.7806e-05,0.19959,0.23688,1,1
3,GO POSITIVE REGULATION OF EXOCYTOSIS,0.00012074,0.19945,0.21094,1,1
3,GO REGULATION OF LIPID METABOLIC PROCESS,3.5759e-05,0.19923,0.19551,1,1
3,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.00014935,0.19911,0.22104,1,1
3,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.0094949,0.19894,0.14323,1,1
3,GO ORGANIC ANION TRANSPORT,2.3654e-06,0.19881,0.22081,1,1
3,GO ANION TRANSPORT,2.5774e-06,0.19818,0.20301,1,1
3,GO RESPONSE TO WOUNDING,0.00069957,0.19816,0.16908,1,1
3,GO POSITIVE REGULATION OF INSULIN SECRETION,0.00022676,0.19806,0.19638,1,1
3,GO REGULATION OF SECRETION,1.1493e-05,0.19762,0.17953,1,1
3,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.0015653,0.19752,0.20194,1,1
3,GO BROWN FAT CELL DIFFERENTIATION,0.0010859,0.1973,0.22874,1,1
3,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.0010528,0.19676,0.19737,1,1
3,GO REGULATION OF MAP KINASE ACTIVITY,0.00024286,0.19597,0.17222,1,1
3,GO PLASMA MEMBRANE ORGANIZATION,0.00032948,0.19582,0.18828,1,1
3,GO VESICLE ORGANIZATION,8.4205e-05,0.1957,0.18013,1,1
3,GO CIRCULATORY SYSTEM PROCESS,6.0504e-05,0.19567,0.15659,1,1
3,GO CAMP METABOLIC PROCESS,0.036164,0.19558,0.15622,1,1
3,GO SPERM CAPACITATION,0.0047853,0.19546,0.20572,1,1
3,GO BICARBONATE TRANSPORT,0.011047,0.195,0.17465,1,1
3,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.0099891,0.19483,0.17096,1,1
3,GO INTERFERON GAMMA PRODUCTION,0.0017641,0.1948,0.15645,1,1
3,GO PEROXISOME ORGANIZATION,0.00072223,0.19471,0.20022,1,1
3,GO POSITIVE REGULATION OF PROTEIN BINDING,0.001872,0.19433,0.17584,1,1
3,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.03245,0.1943,0.16219,1,1
3,GO HUMORAL IMMUNE RESPONSE,7.3528e-06,0.19426,0.2446,1,1
3,GO REGULATION OF MEIOTIC CELL CYCLE,0.00041602,0.19414,0.15039,1,1
3,GO ANION TRANSMEMBRANE TRANSPORT,2.9532e-05,0.19403,0.18627,1,1
3,GO RESPONSE TO STEROID HORMONE,0.00028792,0.19384,0.17076,1,1
3,GO RESPONSE TO CHEMOKINE,0.0001165,0.19381,0.18449,1,1
3,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.0025083,0.19374,0.23014,1,1
3,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.0038387,0.19372,0.15186,1,1
3,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.0029794,0.19346,0.20298,1,1
3,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.0023671,0.19332,0.15646,1,1
3,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.0010206,0.19327,0.14832,1,1
3,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.00095906,0.19296,0.13677,1,1
3,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.00021909,0.19295,0.18974,1,1
3,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0011549,0.19294,0.17609,1,1
3,GO ENERGY RESERVE METABOLIC PROCESS,0.00054072,0.19291,0.18042,1,1
3,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,9.389e-05,0.19283,0.19156,1,1
3,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,7.6603e-06,0.19274,0.18481,1,1
3,GO LYMPHOCYTE DIFFERENTIATION,6.0504e-05,0.19269,0.16277,1,1
3,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.00010462,0.19246,0.14877,1,1
3,GO TISSUE MIGRATION,0.0010528,0.19242,0.17169,1,1
3,GO RESPONSE TO FUNGUS,0.00013917,0.19235,0.1826,1,1
3,GO MONOCARBOXYLIC ACID TRANSPORT,2.4346e-05,0.19227,0.23577,1,1
3,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.00019753,0.19225,0.18945,1,1
3,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.030383,0.19201,0.181,1,1
3,GO RENAL TUBULE DEVELOPMENT,0.0050528,0.19198,0.14491,1,1
3,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.0028141,0.19196,0.21005,1,1
3,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.00010462,0.19164,0.24419,1,1
3,GO POSITIVE REGULATION OF CHEMOTAXIS,0.0010528,0.19146,0.17612,1,1
3,GO CARBOHYDRATE METABOLIC PROCESS,5.2837e-06,0.19129,0.21817,1,1
3,GO POSITIVE REGULATION OF CELL AGING,0.012203,0.19121,0.19476,1,1
3,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.0010206,0.19089,0.24146,1,1
3,GO RESPONSE TO DRUG,0.00012964,0.19079,0.17705,1,1
3,GO LYSOSOME LOCALIZATION,0.00028792,0.19079,0.17435,1,1
3,GO OXIDATION REDUCTION PROCESS,3.4421e-05,0.19069,0.20816,1,1
3,GO REGULATION OF VASCULAR PERMEABILITY,0.00028792,0.19066,0.24347,1,1
3,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.00032948,0.19043,0.16859,1,1
3,GO ION TRANSPORT,2.0833e-05,0.19039,0.16879,1,1
3,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.0038387,0.1902,0.17711,1,1
3,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.02843,0.18986,0.15361,1,1
3,GO REGULATION OF DENDRITE EXTENSION,0.014138,0.18959,0.30451,1,1
3,GO IMPORT ACROSS PLASMA MEMBRANE,0.0040578,0.18957,0.15717,1,1
3,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.0031536,0.18952,0.13838,1,1
3,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.0010859,0.18926,0.16756,1,1
3,GO RESPONSE TO TOXIC SUBSTANCE,0.00065623,0.18924,0.19692,1,1
3,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.00011241,0.18912,0.16217,1,1
3,GO GOLGI ORGANIZATION,3.8583e-05,0.18899,0.1808,1,1
3,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,3.7145e-05,0.18854,0.1765,1,1
3,GO GLYCEROLIPID METABOLIC PROCESS,9.0179e-06,0.18833,0.18288,1,1
3,GO MYOTUBE DIFFERENTIATION,0.0001547,0.1883,0.19426,1,1
3,GO LIPID CATABOLIC PROCESS,4.1112e-06,0.1881,0.24463,1,1
3,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.0016129,0.18774,0.1759,1,1
3,GO NERVE DEVELOPMENT,0.038561,0.18758,0.1518,1,1
3,GO ANION HOMEOSTASIS,0.0075304,0.18742,0.17637,1,1
3,GO DEVELOPMENTAL PIGMENTATION,0.0027346,0.18706,0.1452,1,1
3,GO NEUTROPHIL CHEMOTAXIS,4.4878e-05,0.18691,0.16837,1,1
3,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.0045306,0.18681,0.15561,1,1
3,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.00040247,0.18679,0.16847,1,1
3,GO LEUKOCYTE HOMEOSTASIS,0.0020453,0.18671,0.15727,1,1
3,GO MYELOID CELL DIFFERENTIATION,9.389e-05,0.1867,0.1615,1,1
3,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.038561,0.18636,0.1905,1,1
3,GO POLYOL BIOSYNTHETIC PROCESS,7.2754e-05,0.18625,0.23862,1,1
3,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.0014299,0.18596,0.2188,1,1
3,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.016339,0.18584,0.14863,1,1
3,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.0029794,0.18575,0.12665,1,1
3,GO ESTROGEN METABOLIC PROCESS,0.013465,0.1857,0.18595,1,1
3,GO ION HOMEOSTASIS,2.4346e-05,0.18564,0.16581,1,1
3,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.009256,0.18559,0.17925,1,1
3,GO ENDOCRINE HORMONE SECRETION,0.00047456,0.18533,0.20043,1,1
3,GO AGING,4.3218e-05,0.18482,0.15792,1,1
3,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.012508,0.18471,0.14071,1,1
3,GO FATTY ACID BETA OXIDATION,0.00084609,0.18471,0.20724,1,1
3,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.011326,0.1845,0.14131,1,1
3,GO PLATELET MORPHOGENESIS,0.010773,0.18441,0.17076,1,1
3,GO MYELIN ASSEMBLY,0.02068,0.1842,0.17544,1,1
3,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.00026903,0.18418,0.21332,1,1
3,GO CELLULAR RESPONSE TO LIPID,0.0013054,0.18414,0.1413,1,1
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.00063551,0.18392,0.17405,1,1
3,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,1.5201e-05,0.1837,0.23744,1,1
3,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.013465,0.18361,0.28149,1,1
3,GO AMEBOIDAL TYPE CELL MIGRATION,0.0059384,0.1836,0.11945,1,1
3,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,5.0226e-05,0.18353,0.16412,1,1
3,GO REGULATION OF HISTONE H4 ACETYLATION,0.019739,0.18349,0.13836,1,1
3,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.0017641,0.18346,0.20553,1,1
3,GO MYELOID DENDRITIC CELL ACTIVATION,0.020205,0.18345,0.16864,1,1
3,GO HOMEOSTATIC PROCESS,5.7413e-06,0.18272,0.15553,1,1
3,GO BIOLOGICAL ADHESION,0.0011199,0.18266,0.14391,1,1
3,GO NEGATIVE REGULATION OF CELL ADHESION,0.00084609,0.18257,0.18142,1,1
3,GO RESPONSE TO EXTRACELLULAR STIMULUS,1.7118e-05,0.1823,0.18813,1,1
3,GO PROTON TRANSMEMBRANE TRANSPORT,1.4039e-05,0.18201,0.21477,1,1
3,GO ZINC ION TRANSPORT,0.022165,0.18178,0.16068,1,1
3,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0039469,0.18171,0.15233,1,1
3,GO LUNG MORPHOGENESIS,0.020205,0.18157,0.13727,1,1
3,GO TEMPERATURE HOMEOSTASIS,2.6307e-05,0.18151,0.18984,1,1
3,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.0071468,0.18147,0.18587,1,1
3,GO ACTIVATED T CELL PROLIFERATION,0.001872,0.18145,0.18695,1,1
3,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,2.1663e-05,0.18116,0.1678,1,1
3,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.0034322,0.18111,0.12741,1,1
3,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.0006154,0.181,0.18465,1,1
3,GO RESPONSE TO LIPID,0.00031859,0.18096,0.15577,1,1
3,GO REGULATION OF BLOOD CIRCULATION,0.0010859,0.18061,0.15187,1,1
3,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.00017186,0.18046,0.14184,1,1
3,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.0001165,0.18046,0.18098,1,1
3,GO BIOMINERALIZATION,0.0014299,0.18031,0.16447,1,1
3,GO SENSORY PERCEPTION OF SMELL,4.8379e-05,0.18001,0.19401,1,1
3,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.027803,0.17994,0.11559,1,1
3,GO REGULATION OF RESPONSE TO STRESS,0.00010845,0.17981,0.14488,1,1
3,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00010092,0.17943,0.17118,1,1
3,GO DENDRITIC CELL CHEMOTAXIS,0.046579,0.17938,0.13054,1,1
3,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.0025817,0.17932,0.16751,1,1
3,GO GLAND DEVELOPMENT,0.00035231,0.17929,0.1459,1,1
3,GO KERATINOCYTE MIGRATION,0.0099891,0.1792,0.15487,1,1
3,GO RENAL WATER HOMEOSTASIS,0.036948,0.1787,0.097893,1,1
3,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0028141,0.17868,0.1855,1,1
3,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.018398,0.17859,0.13973,1,1
3,GO METAL ION HOMEOSTASIS,3.1888e-05,0.17809,0.15868,1,1
3,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.013465,0.17803,0.18603,1,1
3,GO RESPONSE TO ETHER,0.00353,0.17797,0.1799,1,1
3,GO TRANSITION METAL ION HOMEOSTASIS,0.0067808,0.17789,0.14958,1,1
3,GO NEGATIVE REGULATION OF OSSIFICATION,0.0049174,0.17784,0.1657,1,1
3,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.0030654,0.17777,0.16052,1,1
3,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.00353,0.17755,0.12585,1,1
3,GO ENDOSOME ORGANIZATION,0.00040247,0.17737,0.17672,1,1
3,GO INTERMEDIATE FILAMENT BASED PROCESS,0.019283,0.17734,0.15461,1,1
3,GO REGULATION OF SODIUM ION TRANSPORT,0.011047,0.17722,0.1553,1,1
3,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.0019282,0.17702,0.1797,1,1
3,GO RESPONSE TO REACTIVE OXYGEN SPECIES,4.3218e-05,0.1768,0.16498,1,1
3,GO CELLULAR PIGMENTATION,0.00028792,0.17671,0.18971,1,1
3,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,4.6597e-05,0.17661,0.16518,1,1
3,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.00021909,0.17636,0.22639,1,1
3,GO IMMUNE SYSTEM DEVELOPMENT,5.6174e-05,0.17636,0.14701,1,1
3,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.018398,0.176,0.11782,1,1
3,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.00037661,0.17581,0.15255,1,1
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.0014738,0.17563,0.17594,1,1
3,GO METAL ION TRANSPORT,0.00030804,0.17549,0.13733,1,1
3,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.016734,0.17534,0.16246,1,1
3,GO MONOSACCHARIDE CATABOLIC PROCESS,0.02068,0.17501,0.16858,1,1
3,GO LIPID MODIFICATION,5.4121e-05,0.17469,0.18377,1,1
3,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.0099891,0.17456,0.27831,1,1
3,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.0010206,0.1745,0.15282,1,1
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.00021167,0.1744,0.18281,1,1
3,GO REGULATION OF HYDROLASE ACTIVITY,0.00037661,0.17435,0.12754,1,1
3,GO MONONUCLEAR CELL MIGRATION,0.0036303,0.17378,0.15132,1,1
3,GO MACROPHAGE ACTIVATION,0.00020448,0.17371,0.19441,1,1
3,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.0039469,0.17339,0.20947,1,1
3,GO REGULATION OF CELL POPULATION PROLIFERATION,0.00028792,0.17297,0.13916,1,1
3,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.00090094,0.1729,0.15743,1,1
3,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,5.8301e-05,0.17265,0.15371,1,1
3,GO RETINA HOMEOSTASIS,0.00045924,0.17223,0.12693,1,1
3,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.00044439,0.17219,0.17382,1,1
3,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0001165,0.17203,0.18966,1,1
3,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.017549,0.17175,0.13784,1,1
3,GO REGULATION OF ATP METABOLIC PROCESS,0.0053338,0.17161,0.1204,1,1
3,GO OOCYTE DIFFERENTIATION,0.00063551,0.1715,0.16102,1,1
3,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,8.1192e-05,0.17148,0.20713,1,1
3,GO ENDOCRINE PANCREAS DEVELOPMENT,0.018398,0.17147,0.15661,1,1
3,GO NEUROINFLAMMATORY RESPONSE,0.01282,0.17107,0.13365,1,1
3,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.001191,0.17095,0.13588,1,1
3,GO DETECTION OF STIMULUS,2.1663e-05,0.17072,0.14615,1,1
3,GO CATION TRANSPORT,0.00021167,0.17072,0.14279,1,1
3,GO RESPONSE TO OXIDATIVE STRESS,9.389e-05,0.17055,0.16306,1,1
3,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.00045924,0.17026,0.13928,1,1
3,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.031748,0.17025,0.14802,1,1
3,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.007729,0.17024,0.16881,1,1
3,GO T CELL HOMEOSTASIS,0.014841,0.16996,0.13463,1,1
3,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,7.2754e-05,0.16996,0.15282,1,1
3,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.0013872,0.16984,0.21514,1,1
3,GO GLIAL CELL DEVELOPMENT,0.0071468,0.1697,0.14547,1,1
3,GO TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE REMODELING,0.011047,0.1695,0.24792,1,1
3,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.0049174,0.16943,0.1869,1,1
3,GO ACID SECRETION,0.001662,0.1694,0.16324,1,1
3,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.0042883,0.16937,0.15883,1,1
3,GO MICROVILLUS ASSEMBLY,0.052669,0.16937,0.20803,1,1
3,GO REGULATION OF LIPID CATABOLIC PROCESS,0.00084609,0.16914,0.15459,1,1
3,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.0007696,0.16913,0.18636,1,1
3,GO MYELOID CELL HOMEOSTASIS,0.0037331,0.16885,0.12517,1,1
3,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.00012964,0.16874,0.14713,1,1
3,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.050569,0.16864,0.1272,1,1
3,GO ACETYL COA METABOLIC PROCESS,0.019739,0.16857,0.14695,1,1
3,GO REGULATION OF GLUCOSE IMPORT,0.00072223,0.16834,0.18386,1,1
3,GO REGULATION OF PEPTIDE TRANSPORT,1.9904e-06,0.16833,0.16827,1,1
3,GO REGULATION OF CELLULAR RESPIRATION,0.03245,0.1683,0.19601,1,1
3,GO REGULATION OF TRANSPORT,0.00016023,0.16822,0.11906,1,1
3,GO ORGANIC ACID CATABOLIC PROCESS,0.00050664,0.16802,0.20004,1,1
3,GO ORGANIC ACID BIOSYNTHETIC PROCESS,9.7346e-05,0.16777,0.20913,1,1
3,GO REGULATION OF CHEMOTAXIS,0.00090094,0.16764,0.1408,1,1
3,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.00069957,0.16743,0.23478,1,1
3,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.00021909,0.16711,0.14384,1,1
3,GO NEPHRON DEVELOPMENT,0.0090226,0.16695,0.1166,1,1
3,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.04854,0.16692,0.15145,1,1
3,GO SULFUR AMINO ACID METABOLIC PROCESS,0.011904,0.16688,0.18741,1,1
3,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,3.1888e-05,0.16681,0.15086,1,1
3,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.0006154,0.1664,0.14916,1,1
3,GO CHOLESTEROL EFFLUX,0.0021689,0.16632,0.1952,1,1
3,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.0016129,0.16616,0.1847,1,1
3,GO THYMIC T CELL SELECTION,0.017969,0.16612,0.096415,1,1
3,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.00047456,0.16596,0.17814,1,1
3,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.0026572,0.16588,0.13814,1,1
3,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.02068,0.16558,0.13488,1,1
3,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,2.2524e-05,0.1655,0.18615,1,1
3,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,5.4121e-05,0.16545,0.175,1,1
3,GO PEPTIDYL TYROSINE MODIFICATION,0.0010859,0.16514,0.14848,1,1
3,GO DEFENSE RESPONSE TO FUNGUS,0.0025817,0.16494,0.15522,1,1
3,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.00067758,0.16454,0.15968,1,1
3,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.037747,0.16432,0.14608,1,1
3,GO ION TRANSMEMBRANE TRANSPORT,9.0551e-05,0.16424,0.14865,1,1
3,GO MULTIVESICULAR BODY SORTING PATHWAY,0.001228,0.16416,0.15814,1,1
3,GO RESPONSE TO NITROGEN COMPOUND,5.4121e-05,0.16407,0.13294,1,1
3,GO ERBB SIGNALING PATHWAY,0.0062634,0.16384,0.14521,1,1
3,GO TRANSMEMBRANE TRANSPORT,2.2524e-05,0.16382,0.16443,1,1
3,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.0099891,0.16351,0.13314,1,1
3,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.00012074,0.16342,0.14513,1,1
3,GO ORGANELLE DISASSEMBLY,0.00049035,0.1634,0.16004,1,1
3,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.013798,0.16324,0.10991,1,1
3,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.00013433,0.16282,0.13028,1,1
3,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.0031536,0.16265,0.13248,1,1
3,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.013465,0.16251,0.15664,1,1
3,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,5.508e-06,0.16247,0.19693,1,1
3,GO PROTEIN K48 LINKED UBIQUITINATION,0.0013872,0.16228,0.12783,1,1
3,GO TUMOR NECROSIS FACTOR SECRETION,0.016339,0.16214,0.10583,1,1
3,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.00019079,0.16187,0.15225,1,1
3,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.0025817,0.16186,0.16348,1,1
3,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,9.389e-05,0.1618,0.1775,1,1
3,GO RUFFLE ORGANIZATION,0.00050664,0.1617,0.19804,1,1
3,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.0006154,0.16168,0.22662,1,1
3,GO EXECUTION PHASE OF APOPTOSIS,3.1904e-06,0.16131,0.19998,1,1
3,GO REGULATION OF ION TRANSPORT,0.0017123,0.16105,0.12816,1,1
3,GO TRANSLESION SYNTHESIS,0.0028141,0.161,0.12925,1,1
3,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.00044439,0.16069,0.1702,1,1
3,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.010245,0.16061,0.15865,1,1
3,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.00016595,0.16038,0.13709,1,1
3,GO ATP TRANSPORT,0.024288,0.16036,0.1111,1,1
3,GO CELLULAR EXTRAVASATION,0.013139,0.16019,0.11958,1,1
3,GO CELLULAR ION HOMEOSTASIS,9.7346e-05,0.15987,0.14383,1,1
3,GO REGULATION OF CELL MATURATION,0.0028957,0.15932,0.16774,1,1
3,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.0036303,0.15903,0.16437,1,1
3,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.00047456,0.15875,0.25812,1,1
3,GO NEGATIVE T CELL SELECTION,0.015953,0.15874,0.1139,1,1
3,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.0039469,0.15803,0.1704,1,1
3,GO RENAL SODIUM EXCRETION,0.0034322,0.15795,0.19629,1,1
3,GO ACTIVATION OF MAPK ACTIVITY,7.2754e-05,0.15778,0.17178,1,1
3,GO RDNA HETEROCHROMATIN ASSEMBLY,0.0034322,0.15757,0.17234,1,1
3,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.02068,0.15736,0.13307,1,1
3,GO ORGANIC ACID METABOLIC PROCESS,0.00019079,0.15718,0.18488,1,1
3,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.055956,0.1568,0.097864,1,1
3,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.024846,0.1567,0.17051,1,1
3,GO RESPONSE TO ENDOGENOUS STIMULUS,0.00014418,0.15633,0.1309,1,1
3,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.0071468,0.15632,0.11098,1,1
3,GO RESPONSE TO CARBOHYDRATE,0.00031859,0.1563,0.15139,1,1
3,GO MULTIVESICULAR BODY ORGANIZATION,0.004408,0.15615,0.13167,1,1
3,GO ENDOCYTOSIS,0.0069616,0.15612,0.10475,1,1
3,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.012508,0.15599,0.10483,1,1
3,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.037747,0.15567,0.25185,1,1
3,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.0073363,0.15558,0.12328,1,1
3,GO RESPONSE TO ACID CHEMICAL,0.0023671,0.15556,0.12605,1,1
3,GO REGULATION OF MAPK CASCADE,0.00042998,0.15537,0.14883,1,1
3,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.009256,0.1553,0.13237,1,1
3,GO POSITIVE REGULATION OF TRANSPORT,0.00019079,0.15525,0.12696,1,1
3,GO CALCIUM ION IMPORT,0.0057817,0.15516,0.12082,1,1
3,GO HOMEOSTASIS OF NUMBER OF CELLS,0.0025817,0.15503,0.11308,1,1
3,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.0045306,0.15494,0.16594,1,1
3,GO RESPONSE TO HORMONE,9.7346e-05,0.15492,0.15735,1,1
3,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.00023468,0.15447,0.14129,1,1
3,GO PROTEIN PALMITOYLATION,0.0097392,0.15434,0.15485,1,1
3,GO NEGATIVE REGULATION OF STEROL TRANSPORT,0.0067808,0.1543,0.37216,1,1
3,GO CELL MOTILITY,0.001872,0.15416,0.12104,1,1
3,GO POSITIVE REGULATION OF SIGNALING,5.8301e-05,0.15407,0.13813,1,1
3,GO POSITIVE REGULATION OF MAPK CASCADE,0.00022676,0.15406,0.15672,1,1
3,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.0069616,0.15401,0.11666,1,1
3,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.00028792,0.154,0.14481,1,1
3,GO REGULATION OF HISTONE DEACETYLATION,0.0023671,0.15395,0.1934,1,1
3,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.00020448,0.15375,0.15083,1,1
3,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.00052342,0.15347,0.12587,1,1
3,GO RESPONSE TO ALKALOID,0.0026572,0.15332,0.15028,1,1
3,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.00013917,0.1533,0.13442,1,1
3,GO SENSORY PERCEPTION OF BITTER TASTE,0.00054072,0.15287,0.14784,1,1
3,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.019283,0.15278,0.11422,1,1
3,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.050569,0.15265,0.16645,1,1
3,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.017969,0.15256,0.19675,1,1
3,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.036948,0.15227,0.13246,1,1
3,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.00025131,0.15198,0.14121,1,1
3,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,7.8282e-05,0.15195,0.19759,1,1
3,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.001191,0.15191,0.1851,1,1
3,GO T CELL SELECTION,0.00069957,0.15176,0.14205,1,1
3,GO ESTROGEN BIOSYNTHETIC PROCESS,0.020205,0.15155,0.22875,1,1
3,GO RESPONSE TO ANTIBIOTIC,0.0010528,0.15138,0.17327,1,1
3,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.029068,0.15134,0.10715,1,1
3,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.001191,0.1511,0.13713,1,1
3,GO POSITIVE REGULATION OF CELL DEATH,0.0011199,0.15098,0.11963,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0024367,0.15079,0.14721,1,1
3,GO POSITIVE REGULATION OF GLIOGENESIS,0.011326,0.15076,0.13634,1,1
3,GO CELLULAR SODIUM ION HOMEOSTASIS,0.029068,0.15073,0.20623,1,1
3,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.001191,0.15068,0.15272,1,1
3,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.0019282,0.15067,0.12269,1,1
3,GO CATION TRANSMEMBRANE TRANSPORT,0.00081984,0.15044,0.12961,1,1
3,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.0039469,0.15033,0.16328,1,1
3,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0013054,0.15029,0.13099,1,1
3,GO SMALL MOLECULE CATABOLIC PROCESS,0.00010462,0.15017,0.19864,1,1
3,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.03245,0.15015,0.16211,1,1
3,GO ORGANIC ACID TRANSPORT,1.2454e-05,0.15007,0.21103,1,1
3,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.0015189,0.14996,0.12046,1,1
3,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.040234,0.14987,0.09488,1,1
3,GO CELLULAR RESPONSE TO PEPTIDE,0.00010092,0.14985,0.14129,1,1
3,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.00014418,0.14905,0.21783,1,1
3,GO REGULATION OF CHROMATIN ASSEMBLY,0.0023671,0.14827,0.14352,1,1
3,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.00055855,0.14772,0.17452,1,1
3,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.0028141,0.14753,0.22896,1,1
3,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.00042998,0.14752,0.12064,1,1
3,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.001872,0.14746,0.13587,1,1
3,GO RESPONSE TO MONOSACCHARIDE,0.00036427,0.14737,0.15241,1,1
3,GO SINGLE FERTILIZATION,0.0027346,0.14678,0.10627,1,1
3,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.00030804,0.14675,0.13732,1,1
3,GO FAT CELL DIFFERENTIATION,0.00092958,0.14672,0.16446,1,1
3,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.00050664,0.14663,0.13613,1,1
3,GO ERYTHROCYTE HOMEOSTASIS,0.0010206,0.14634,0.13907,1,1
3,GO ORGANOPHOSPHATE CATABOLIC PROCESS,1.0604e-05,0.14623,0.17943,1,1
3,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.0037331,0.14616,0.16773,1,1
3,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,8.7323e-05,0.14582,0.14376,1,1
3,GO RESPONSE TO ACTIVITY,0.0028957,0.14581,0.16088,1,1
3,GO ALPHA AMINO ACID METABOLIC PROCESS,0.027803,0.1458,0.15544,1,1
3,GO EXCRETION,0.00050664,0.14572,0.17482,1,1
3,GO CELL MATURATION,8.1192e-05,0.14547,0.15816,1,1
3,GO AUTOPHAGY OF MITOCHONDRION,0.00095906,0.14545,0.16722,1,1
3,GO MEMBRANE ORGANIZATION,0.00074557,0.14523,0.11594,1,1
3,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.00040247,0.14519,0.12695,1,1
3,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.0025083,0.14498,0.12117,1,1
3,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.00014418,0.14453,0.17815,1,1
3,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.0015653,0.14443,0.10966,1,1
3,GO POSITIVE REGULATION OF PROTEOLYSIS,0.00054072,0.14437,0.15268,1,1
3,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.0069616,0.14436,0.15741,1,1
3,GO ALCOHOL CATABOLIC PROCESS,0.001228,0.14355,0.17336,1,1
3,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.04854,0.14339,0.12468,1,1
3,GO CELLULAR GLUCOSE HOMEOSTASIS,0.0007696,0.1433,0.14759,1,1
3,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.0037331,0.14329,0.11522,1,1
3,GO TRANSITION METAL ION TRANSPORT,2.9532e-05,0.14326,0.22689,1,1
3,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.00074557,0.14323,0.11038,1,1
3,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.016734,0.1431,0.093453,1,1
3,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.015574,0.14307,0.13265,1,1
3,GO PIGMENT GRANULE LOCALIZATION,0.0081404,0.14301,0.14299,1,1
3,GO PROTEIN AUTOUBIQUITINATION,4.3218e-05,0.14297,0.14358,1,1
3,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.0017123,0.14297,0.12286,1,1
3,GO RUFFLE ASSEMBLY,0.027188,0.14294,0.12112,1,1
3,GO REGULATION OF MACROPHAGE MIGRATION,0.0031536,0.14284,0.15907,1,1
3,GO FATTY ACYL COA METABOLIC PROCESS,0.0029794,0.14277,0.21509,1,1
3,GO SODIUM ION TRANSPORT,0.0011549,0.14268,0.16491,1,1
3,GO RESPONSE TO ETHANOL,0.0028957,0.1426,0.13463,1,1
3,GO POTASSIUM ION HOMEOSTASIS,0.017549,0.14254,0.14344,1,1
3,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.0013054,0.14244,0.1325,1,1
3,GO RESPONSE TO PEPTIDE HORMONE,4.6597e-05,0.14208,0.15029,1,1
3,GO CELL JUNCTION ASSEMBLY,0.013139,0.1413,0.10827,1,1
3,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.00010462,0.1413,0.20081,1,1
3,GO POSITIVE T CELL SELECTION,0.0050528,0.14109,0.12115,1,1
3,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.001986,0.14098,0.1829,1,1
3,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.00095906,0.14095,0.13929,1,1
3,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,4.1617e-05,0.1407,0.14437,1,1
3,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.01282,0.14066,0.14427,1,1
3,GO RESPONSE TO ESTRADIOL,0.0081404,0.14039,0.10006,1,1
3,GO CELLULAR HOMEOSTASIS,0.00014418,0.14024,0.13347,1,1
3,GO DRUG CATABOLIC PROCESS,0.0049174,0.14022,0.24113,1,1
3,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.0037331,0.14016,0.1111,1,1
3,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.00034072,0.13994,0.12169,1,1
3,GO EXPORT ACROSS PLASMA MEMBRANE,0.0067808,0.13966,0.2079,1,1
3,GO REGULATION OF PROTEIN BINDING,0.0013054,0.13966,0.1398,1,1
3,GO MEGAKARYOCYTE DIFFERENTIATION,0.0029794,0.13956,0.11504,1,1
3,GO THIOESTER METABOLIC PROCESS,0.00055855,0.13944,0.19297,1,1
3,GO CALCIUM MEDIATED SIGNALING,9.389e-05,0.13937,0.12187,1,1
3,GO SIGNAL RELEASE,0.00021909,0.13895,0.15515,1,1
3,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,1.5201e-05,0.1389,0.17196,1,1
3,GO GOLGI RIBBON FORMATION,0.021165,0.13862,0.16506,1,1
3,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.0001547,0.13839,0.14074,1,1
3,GO RESPONSE TO PEPTIDE,0.00012512,0.13838,0.13591,1,1
3,GO GOLGI TO VACUOLE TRANSPORT,0.022165,0.13824,0.14224,1,1
3,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0071468,0.13808,0.1313,1,1
3,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.010506,0.13791,0.10022,1,1
3,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,2.1663e-05,0.1376,0.1445,1,1
3,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.00055855,0.13754,0.11763,1,1
3,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0064317,0.1375,0.099987,1,1
3,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.020205,0.13733,0.15826,1,1
3,GO ORGANELLE INHERITANCE,0.023741,0.13722,0.11737,1,1
3,GO SULFATE TRANSPORT,0.050569,0.13709,0.10378,1,1
3,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.00069957,0.13703,0.13053,1,1
3,GO RESPONSE TO OXYGEN LEVELS,0.0014738,0.13702,0.1328,1,1
3,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.02166,0.13693,0.15517,1,1
3,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.036948,0.13678,0.085035,1,1
3,GO ACTIVATION OF GTPASE ACTIVITY,0.00090094,0.13641,0.12,1,1
3,GO WATER TRANSPORT,0.026586,0.1364,0.094761,1,1
3,GO REGULATION OF TOR SIGNALING,0.00036427,0.13629,0.12312,1,1
3,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.024846,0.13597,0.16334,1,1
3,GO COENZYME A BIOSYNTHETIC PROCESS,0.00047456,0.13582,0.2303,1,1
3,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.00026903,0.13581,0.11865,1,1
3,GO REGULATION OF REPRODUCTIVE PROCESS,0.004408,0.13579,0.10726,1,1
3,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.00098941,0.13501,0.12831,1,1
3,GO INTRA S DNA DAMAGE CHECKPOINT,0.0021062,0.135,0.13512,1,1
3,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.0022992,0.13489,0.17093,1,1
3,GO REGULATION OF PROTEIN LOCALIZATION,5.6174e-05,0.13487,0.12616,1,1
3,GO DNA CATABOLIC PROCESS,0.00057693,0.13416,0.12943,1,1
3,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.0016129,0.13406,0.11041,1,1
3,GO REGULATION OF CELL DEATH,0.00029782,0.134,0.12204,1,1
3,GO CARNITINE SHUTTLE,0.0028957,0.13391,0.22747,1,1
3,GO REGULATION OF PROTEIN DEACETYLATION,0.029719,0.13361,0.12753,1,1
3,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0017641,0.13353,0.1243,1,1
3,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.00030804,0.13347,0.16692,1,1
3,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.00013917,0.13326,0.14468,1,1
3,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.011326,0.13283,0.094365,1,1
3,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.017549,0.13279,0.077676,1,1
3,GO GLUTATHIONE METABOLIC PROCESS,0.012203,0.13244,0.24449,1,1
3,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.011047,0.13238,0.11705,1,1
3,GO FEEDING BEHAVIOR,0.0079323,0.13201,0.13285,1,1
3,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.00024286,0.13193,0.1267,1,1
3,GO RESPONSE TO ABIOTIC STIMULUS,0.00050664,0.13177,0.11086,1,1
3,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.00047456,0.13141,0.15431,1,1
3,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.0015189,0.13123,0.11802,1,1
3,GO NEGATIVE REGULATION OF SECRETION,0.0011549,0.13109,0.11943,1,1
3,GO REGULATION OF PROTEIN STABILITY,0.00036427,0.12998,0.12468,1,1
3,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.011326,0.12997,0.14206,1,1
3,GO IN UTERO EMBRYONIC DEVELOPMENT,0.013798,0.1297,0.075315,1,1
3,GO SECOND MESSENGER MEDIATED SIGNALING,0.00018427,0.12961,0.13645,1,1
3,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.00098941,0.12911,0.11845,1,1
3,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.0028141,0.12892,0.14213,1,1
3,GO HORMONE MEDIATED SIGNALING PATHWAY,0.0073363,0.12868,0.094897,1,1
3,GO POLYOL METABOLIC PROCESS,0.0010206,0.12844,0.14343,1,1
3,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.0025817,0.12836,0.16079,1,1
3,GO APOPTOTIC PROCESS,0.00019753,0.12818,0.12567,1,1
3,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.030383,0.12802,0.16605,1,1
3,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.0066042,0.12758,0.15272,1,1
3,GO ENDOSOME TO LYSOSOME TRANSPORT,0.00057693,0.12743,0.17123,1,1
3,GO REGULATION OF MUSCLE CONTRACTION,0.017137,0.12679,0.094778,1,1
3,GO RESPONSE TO ORGANOPHOSPHORUS,0.0027346,0.12654,0.12164,1,1
3,GO MAINTENANCE OF LOCATION IN CELL,0.00059588,0.12617,0.12532,1,1
3,GO PIGMENT CELL DIFFERENTIATION,0.049546,0.1261,0.084858,1,1
3,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.023741,0.12603,0.093448,1,1
3,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.0049174,0.1259,0.11326,1,1
3,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.0042883,0.12519,0.15714,1,1
3,GO RESPONSE TO GROWTH FACTOR,0.024846,0.12497,0.078586,1,1
3,GO MYELOID CELL DEVELOPMENT,0.012508,0.12477,0.11354,1,1
3,GO MESONEPHROS DEVELOPMENT,0.0083534,0.12443,0.13644,1,1
3,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.016339,0.12439,0.091701,1,1
3,GO REGULATION OF AUTOPHAGY,0.00014935,0.12429,0.13329,1,1
3,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.011326,0.12406,0.15294,1,1
3,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.03939,0.12385,0.136,1,1
3,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.023205,0.12372,0.11322,1,1
3,GO REGULATION OF VACUOLE ORGANIZATION,0.0067808,0.12371,0.13621,1,1
3,GO DIVALENT INORGANIC CATION TRANSPORT,0.0019282,0.12339,0.11468,1,1
3,GO IMPORT INTO CELL,0.024288,0.12322,0.11372,1,1
3,GO SOMITOGENESIS,0.0037331,0.12298,0.13168,1,1
3,GO MITOPHAGY,0.036948,0.12296,0.12414,1,1
3,GO ORGANIC CATION TRANSPORT,0.0049174,0.12273,0.20437,1,1
3,GO REGULATION OF FATTY ACID BETA OXIDATION,0.04854,0.12267,0.13398,1,1
3,GO RESPONSE TO INTERLEUKIN 4,0.0060989,0.12263,0.13894,1,1
3,GO POSITIVE REGULATION OF MYELINATION,0.02166,0.12259,0.11637,1,1
3,GO REGULATION OF PHOSPHORYLATION,0.0006154,0.12219,0.114,1,1
3,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.036164,0.12207,0.10394,1,1
3,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.054842,0.12176,0.090207,1,1
3,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.0030654,0.12172,0.11667,1,1
3,GO CERAMIDE TRANSPORT,0.053746,0.12154,0.21531,1,1
3,GO RESPONSE TO OXYGEN RADICAL,0.0053338,0.12127,0.17081,1,1
3,GO KILLING OF CELLS OF OTHER ORGANISM,0.00054072,0.12109,0.17824,1,1
3,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.0051916,0.121,0.10426,1,1
3,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.03939,0.12098,0.12658,1,1
3,GO LEUKOCYTE TETHERING OR ROLLING,0.0073363,0.12093,0.11049,1,1
3,GO ADHERENS JUNCTION ORGANIZATION,0.029068,0.12089,0.12716,1,1
3,GO CARBOHYDRATE CATABOLIC PROCESS,0.0010206,0.12075,0.16753,1,1
3,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.00098941,0.12047,0.12075,1,1
3,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.0075304,0.11992,0.11329,1,1
3,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.0013872,0.11985,0.16654,1,1
3,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.0059384,0.11959,0.1456,1,1
3,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.00026903,0.11943,0.16237,1,1
3,GO NEGATIVE REGULATION OF CELL DEATH,0.0011549,0.11936,0.11635,1,1
3,GO TOR SIGNALING,7.547e-05,0.11887,0.10888,1,1
3,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.0083534,0.11867,0.10382,1,1
3,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.00353,0.11847,0.12674,1,1
3,GO REGULATION OF CARTILAGE DEVELOPMENT,0.023205,0.11835,0.13381,1,1
3,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.041967,0.11828,0.16323,1,1
3,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.0029794,0.11771,0.11603,1,1
3,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.007729,0.11766,0.10212,1,1
3,GO PROTEIN AUTOPHOSPHORYLATION,0.0028141,0.11763,0.10048,1,1
3,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.0016129,0.11681,0.1026,1,1
3,GO POSITIVE REGULATION OF CELL GROWTH,0.0097392,0.11633,0.086744,1,1
3,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.00040247,0.1163,0.10852,1,1
3,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.0022992,0.11591,0.11806,1,1
3,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.0081404,0.11561,0.13309,1,1
3,GO LYMPH NODE DEVELOPMENT,0.019739,0.11534,0.15762,1,1
3,GO RESPONSE TO SALT,0.023741,0.1153,0.11223,1,1
3,GO ANATOMICAL STRUCTURE MATURATION,0.001228,0.11518,0.11527,1,1
3,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.02166,0.11503,0.092311,1,1
3,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.001228,0.11491,0.1113,1,1
3,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.00092958,0.11476,0.10293,1,1
3,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.0057817,0.11467,0.13684,1,1
3,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.00052342,0.11464,0.10958,1,1
3,GO REGULATION OF MULTI ORGANISM PROCESS,0.03939,0.11443,0.10894,1,1
3,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.012203,0.11428,0.11285,1,1
3,GO REGULATION OF METAL ION TRANSPORT,0.026586,0.11417,0.079715,1,1
3,GO SENSORY PERCEPTION,0.0017641,0.11367,0.092897,1,1
3,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.0024367,0.11358,0.10608,1,1
3,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.014841,0.11344,0.16623,1,1
3,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.00049035,0.11343,0.11131,1,1
3,GO BLASTOCYST DEVELOPMENT,0.0010206,0.11307,0.11333,1,1
3,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.0081404,0.11165,0.17253,1,1
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.035393,0.11159,0.15423,1,1
3,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.02166,0.1111,0.071085,1,1
3,GO PEPTIDYL CYSTEINE MODIFICATION,0.029719,0.11102,0.1039,1,1
3,GO TRIGLYCERIDE CATABOLIC PROCESS,0.037747,0.11075,0.1397,1,1
3,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.047551,0.11068,0.10652,1,1
3,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.0081404,0.11012,0.18066,1,1
3,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.0071468,0.10996,0.14214,1,1
3,GO RESPONSE TO TEMPERATURE STIMULUS,0.00050664,0.10995,0.13154,1,1
3,GO MUSCLE CELL DIFFERENTIATION,0.024846,0.10845,0.085869,1,1
3,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.0025817,0.10822,0.15187,1,1
3,GO POSITIVE REGULATION OF NEURON DEATH,0.0085714,0.10753,0.12753,1,1
3,GO POLYOL CATABOLIC PROCESS,0.011326,0.10744,0.13538,1,1
3,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.0038387,0.10721,0.090593,1,1
3,GO ELECTRON TRANSPORT CHAIN,0.0046564,0.10666,0.18691,1,1
3,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.0099891,0.1066,0.071774,1,1
3,GO BODY FLUID SECRETION,0.012508,0.10641,0.099181,1,1
3,GO ENDOSOMAL TRANSPORT,0.00072223,0.10628,0.096939,1,1
3,GO FERTILIZATION,0.0051916,0.10607,0.088828,1,1
3,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.025414,0.10547,0.088727,1,1
3,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.024288,0.10529,0.11032,1,1
3,GO REPRODUCTION,0.0025083,0.10525,0.089921,1,1
3,GO MULTI ORGANISM PROCESS,0.0060989,0.10516,0.076833,1,1
3,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.02166,0.10376,0.088254,1,1
3,GO OOGENESIS,0.031059,0.1032,0.080946,1,1
3,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.0025083,0.10292,0.088741,1,1
3,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.0081404,0.10234,0.11803,1,1
3,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.0054795,0.1008,0.10076,1,1
3,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.0019282,0.10037,0.1049,1,1
3,GO DEPHOSPHORYLATION,0.0031536,0.098729,0.079848,1,1
3,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.02068,0.098559,0.15302,1,1
3,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.0017641,0.098318,0.10308,1,1
3,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.030383,0.098234,0.076076,1,1
3,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.0057817,0.09707,0.13163,1,1
3,GO NEGATIVE REGULATION OF ION TRANSPORT,0.046579,0.096891,0.064257,1,1
3,GO NEGATIVE REGULATION OF SIGNALING,0.0085714,0.09689,0.084201,1,1
3,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.0087944,0.096829,0.11139,1,1
3,GO NEURON DEATH,0.023741,0.096396,0.062775,1,1
3,GO PROTEIN STABILIZATION,0.018836,0.096232,0.083834,1,1
3,GO PEPTIDYL SERINE MODIFICATION,0.023205,0.096006,0.063863,1,1
3,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.040234,0.09592,0.091336,1,1
3,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.019283,0.095849,0.069404,1,1
3,GO REGULATION OF TRANSFERASE ACTIVITY,0.0025817,0.094984,0.09485,1,1
3,GO REGULATION OF GROWTH,0.042857,0.093759,0.063435,1,1
3,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.024288,0.093507,0.080662,1,1
3,GO CYTOSOLIC TRANSPORT,0.0032441,0.093116,0.09783,1,1
3,GO VESICLE LOCALIZATION,0.0099891,0.092571,0.10122,1,1
3,GO JNK CASCADE,0.0030654,0.092536,0.11521,1,1
3,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.00353,0.092302,0.088702,1,1
3,GO POSITIVE REGULATION OF GROWTH,0.050569,0.09122,0.060543,1,1
3,GO REGULATION OF CELLULAR LOCALIZATION,0.010773,0.091084,0.064696,1,1
3,GO REGULATION OF JUN KINASE ACTIVITY,0.02843,0.090975,0.09425,1,1
3,GO POTASSIUM ION TRANSPORT,0.031059,0.090727,0.1234,1,1
3,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.0045306,0.090648,0.093154,1,1
3,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.015953,0.090492,0.14968,1,1
3,GO ACTIN FILAMENT BASED PROCESS,0.047551,0.09046,0.060824,1,1
3,GO ACTIN FILAMENT ORGANIZATION,0.022165,0.089571,0.076619,1,1
3,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.03939,0.089488,0.084978,1,1
3,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.0069616,0.089457,0.084674,1,1
3,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.0073363,0.088701,0.11793,1,1
3,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.02166,0.087581,0.063673,1,1
3,GO NEGATIVE REGULATION OF TRANSPORT,0.0087944,0.087406,0.088532,1,1
3,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.03939,0.087039,0.054701,1,1
3,GO PIGMENT GRANULE ORGANIZATION,0.026586,0.086564,0.098272,1,1
3,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.045624,0.086024,0.19985,1,1
3,GO REGULATION OF INTRACELLULAR TRANSPORT,0.054842,0.085639,0.045393,1,1
3,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.011612,0.085515,0.10204,1,1
3,GO RESPONSE TO CAMP,0.031059,0.085101,0.10399,1,1
3,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.041967,0.085082,0.074056,1,1
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.015953,0.08426,0.11682,1,1
3,GO MITOCHONDRIAL TRANSPORT,0.012508,0.084216,0.079493,1,1
3,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.055956,0.082437,0.065975,1,1
3,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.011326,0.081128,0.077332,1,1
3,GO REGULATION OF EXOCYTOSIS,0.015203,0.081075,0.11755,1,1
3,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.0041716,0.079987,0.074886,1,1
3,GO ENSHEATHMENT OF NEURONS,0.052669,0.077014,0.093996,1,1
3,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.020205,0.076296,0.063424,1,1
3,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.042857,0.075989,0.063899,1,1
3,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.024846,0.071007,0.04986,1,1
3,GO INTRACELLULAR TRANSPORT,0.0036303,0.069899,0.07034,1,1
3,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.050569,0.069697,0.060611,1,1
3,GO MULTICELLULAR ORGANISM REPRODUCTION,0.014138,0.069433,0.06277,1,1
3,GO PEPTIDYL AMINO ACID MODIFICATION,0.029719,0.069368,0.054717,1,1
3,GO REGULATION OF CALCIUM ION TRANSPORT,0.024846,0.068846,0.09338,1,1
3,GO MALE GAMETE GENERATION,0.038561,0.06868,0.056067,1,1
3,GO CELLULAR MACROMOLECULE LOCALIZATION,0.009256,0.067731,0.058529,1,1
3,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.050569,0.067584,0.07392,1,1
3,GO POSITIVE REGULATION OF CELL CYCLE,0.042857,0.065903,0.054056,1,1
3,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.022165,0.065756,0.086851,1,1
3,GO SEXUAL REPRODUCTION,0.017549,0.064668,0.060896,1,1
3,GO REGULATION OF GTPASE ACTIVITY,0.016734,0.064284,0.07873,1,1
3,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.018398,0.06318,0.07845,1,1
3,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.0057817,0.06215,0.064575,1,1
3,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.030383,0.061281,0.083602,1,1
3,GO REGULATION OF PHOSPHATASE ACTIVITY,0.037747,0.06094,0.064436,1,1
3,GO GAMETE GENERATION,0.03939,0.058099,0.053382,1,1
3,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.0036303,0.057519,0.087337,1,1
3,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.049546,0.056497,0.051487,1,1
3,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.037747,0.050038,0.049854,1,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.0032441,0.71315,0.56302,1,0
3,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,0.00042998,0.7052,0.42963,1,0
3,GO RESPONSE TO INTERFERON ALPHA,0.0012662,0.66825,0.41621,1,0
3,GO NEGATIVE REGULATION OF CELL KILLING,0.0053338,0.62818,0.47507,1,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,7.547e-05,0.59684,0.5199,1,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,5.8301e-05,0.59457,0.51148,1,0
3,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.0017641,0.59019,0.44112,1,0
3,GO OLIGOSACCHARIDE CATABOLIC PROCESS,0.00017796,0.51381,0.50396,1,0
3,GO GAP JUNCTION ASSEMBLY,0.001872,0.4991,0.35828,1,0
3,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,0.00063551,0.49013,0.39916,1,0
3,GO DENDRITIC CELL APOPTOTIC PROCESS,0.00012512,0.47769,0.46,1,0
3,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,0.033166,0.44361,0.27098,1,0
3,GO T CELL EXTRAVASATION,0.0007696,0.43889,0.513,1,0
3,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.00017796,0.42166,0.32848,1,0
3,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.0001547,0.4141,0.38517,1,0
3,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,5.4121e-05,0.39031,0.31565,1,0
3,GO CELLULAR RESPONSE TO INTERFERON BETA,0.00072223,0.38964,0.34772,1,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,0.019739,0.38942,0.23644,1,0
3,GO RESPONSE TO HISTAMINE,0.019283,0.37057,0.35965,1,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,9.389e-05,0.36538,0.3112,1,0
3,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.0034322,0.36184,0.45918,1,0
3,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.00055855,0.35769,0.27417,1,0
3,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,0.00069957,0.35635,0.3278,1,0
3,GO ANTIGEN PROCESSING AND PRESENTATION,7.8282e-05,0.35544,0.29374,1,0
3,GO KERATAN SULFATE CATABOLIC PROCESS,0.00069957,0.3543,0.32917,1,0
3,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.001986,0.35422,0.23699,1,0
3,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00042998,0.34882,0.31973,1,0
3,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00018427,0.34774,0.28243,1,0
3,GO ZYMOGEN INHIBITION,0.00063551,0.342,0.27711,1,0
3,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.0010206,0.34141,0.2276,1,0
3,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00063551,0.34116,0.2688,1,0
3,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.001986,0.33983,0.29034,1,0
3,GO GLOMERULAR MESANGIAL CELL PROLIFERATION,0.047551,0.33606,0.25261,1,0
3,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.015203,0.33533,0.27165,1,0
3,GO MEMBRANE RAFT ORGANIZATION,0.011326,0.33516,0.25824,1,0
3,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.0022992,0.33407,0.27656,1,0
3,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,0.0007696,0.3334,0.26839,1,0
3,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.00027832,0.33297,0.24062,1,0
3,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.00025131,0.33278,0.28453,1,0
3,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,0.00031859,0.33215,0.33101,1,0
3,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00017186,0.32997,0.28524,1,0
3,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.013798,0.3265,0.34273,1,0
3,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,0.00353,0.32649,0.31938,1,0
3,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,4.0073e-05,0.31512,0.25193,1,0
3,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.027803,0.31311,0.24388,1,0
3,GO TYPE B PANCREATIC CELL APOPTOTIC PROCESS,0.014138,0.31044,0.3228,1,0
3,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.0034322,0.30974,0.28492,1,0
3,GO AMYLOID BETA CLEARANCE,0.00067758,0.29516,0.23302,1,0
3,GO DETECTION OF BIOTIC STIMULUS,0.00022676,0.29344,0.34842,1,0
3,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,0.0079323,0.29334,0.27249,1,0
3,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.021165,0.29062,0.25004,1,0
3,GO REGULATION OF AMYLOID BETA CLEARANCE,0.0075304,0.28997,0.25603,1,0
3,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.041093,0.28863,0.27201,1,0
3,GO INTERACTION WITH HOST,0.00012964,0.28556,0.21939,1,0
3,GO VIRAL LIFE CYCLE,0.0001547,0.28548,0.20313,1,0
3,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,0.0042883,0.28473,0.2252,1,0
3,GO MEMBRANE PROTEIN PROTEOLYSIS,0.00026903,0.28416,0.2489,1,0
3,GO THYMOCYTE APOPTOTIC PROCESS,0.025994,0.28349,0.18808,1,0
3,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.0015653,0.28088,0.26465,1,0
3,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.0062634,0.27864,0.22025,1,0
3,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.024846,0.27664,0.20355,1,0
3,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.0073363,0.2733,0.18769,1,0
3,GO REGULATION OF CELLULAR EXTRAVASATION,0.011612,0.27058,0.21694,1,0
3,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,0.015953,0.26751,0.13548,1,0
3,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.001228,0.26654,0.23649,1,0
3,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.00092958,0.26567,0.22264,1,0
3,GO ENAMEL MINERALIZATION,0.009256,0.26166,0.25464,1,0
3,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0025083,0.26149,0.21865,1,0
3,GO CELLULAR RESPONSE TO DSRNA,0.001228,0.2582,0.21608,1,0
3,GO REGULATION OF ISOTYPE SWITCHING,0.0022992,0.25715,0.18229,1,0
3,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.0085714,0.25628,0.23599,1,0
3,GO ANIMAL ORGAN REGENERATION,0.0022332,0.25043,0.1712,1,0
3,GO VASCULAR TRANSPORT,0.03939,0.25008,0.22842,1,0
3,GO CD40 SIGNALING PATHWAY,0.0024367,0.25,0.19444,1,0
3,GO MACROPHAGE PROLIFERATION,0.05161,0.2488,0.2274,1,0
3,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.0039469,0.24794,0.27813,1,0
3,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.0010528,0.24675,0.18957,1,0
3,GO POSITIVE REGULATION OF HAIR CYCLE,0.050569,0.24634,0.23217,1,0
3,GO POSITIVE REGULATION OF LIPID STORAGE,0.0017641,0.24605,0.22084,1,0
3,GO PURINE CONTAINING COMPOUND SALVAGE,0.029719,0.24469,0.18652,1,0
3,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.0025817,0.24424,0.23837,1,0
3,GO PROTEIN TARGETING TO VACUOLE,0.0007696,0.24268,0.19813,1,0
3,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.0057817,0.2414,0.20653,1,0
3,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0022992,0.24027,0.17829,1,0
3,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.019283,0.23992,0.19824,1,0
3,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,0.001986,0.23942,0.17078,1,0
3,GO HYALURONAN CATABOLIC PROCESS,0.022165,0.23927,0.12656,1,0
3,GO PLATELET AGGREGATION,0.00090094,0.23927,0.21468,1,0
3,GO HYALURONAN METABOLIC PROCESS,0.00063551,0.23783,0.18591,1,0
3,GO RIG I SIGNALING PATHWAY,0.0017123,0.23753,0.16754,1,0
3,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.001986,0.23698,0.25404,1,0
3,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,0.00022676,0.23451,0.21297,1,0
3,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,0.00055855,0.23324,0.22565,1,0
3,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.0013872,0.23255,0.18011,1,0
3,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.0031536,0.23016,0.18222,1,0
3,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.0028141,0.22954,0.16529,1,0
3,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,0.031059,0.2281,0.17471,1,0
3,GO REGULATION OF T CELL APOPTOTIC PROCESS,0.015953,0.22734,0.19184,1,0
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.001986,0.2257,0.19659,1,0
3,GO RESPONSE TO INTERLEUKIN 1,0.00013433,0.22566,0.18758,1,0
3,GO RECEPTOR BIOSYNTHETIC PROCESS,0.0023671,0.22529,0.17216,1,0
3,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.014486,0.22515,0.1881,1,0
3,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.02843,0.22387,0.23346,1,0
3,GO PIGMENT ACCUMULATION,0.054842,0.22045,0.12377,1,0
3,GO KERATINOCYTE PROLIFERATION,0.010506,0.21488,0.17458,1,0
3,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.001986,0.21482,0.2578,1,0
3,GO RECEPTOR CATABOLIC PROCESS,0.0032441,0.21386,0.1525,1,0
3,GO CELL REDOX HOMEOSTASIS,0.0011199,0.21253,0.23863,1,0
3,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0079323,0.21165,0.15774,1,0
3,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.0026572,0.21152,0.21288,1,0
3,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.01282,0.21141,0.33167,1,0
3,GO PROTEIN LOCALIZATION TO VACUOLE,0.0046564,0.21139,0.15486,1,0
3,GO RESPONSE TO TESTOSTERONE,0.0062634,0.21102,0.16333,1,0
3,GO CELLULAR RESPONSE TO VIRUS,3.7145e-05,0.21029,0.23654,1,0
3,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.00019079,0.20761,0.2028,1,0
3,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.012508,0.20745,0.19095,1,0
3,GO CELLULAR RESPONSE TO IRON ION,0.025414,0.20742,0.18774,1,0
3,GO RESPONSE TO FLUID SHEAR STRESS,0.016734,0.20584,0.1699,1,0
3,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.013139,0.20554,0.2145,1,0
3,GO REGULATION OF CARDIAC CONDUCTION,0.00041602,0.20365,0.1922,1,0
3,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.040234,0.20352,0.1925,1,0
3,GO CYTOLYSIS,0.014138,0.20341,0.20072,1,0
3,GO CELL MATRIX ADHESION,0.0034322,0.20252,0.14732,1,0
3,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.0016129,0.20221,0.18639,1,0
3,GO HEPATOCYTE DIFFERENTIATION,0.0054795,0.20187,0.25005,1,0
3,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.030383,0.20146,0.14335,1,0
3,GO PROTEIN ACTIVATION CASCADE,0.05161,0.20135,0.20214,1,0
3,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.00084609,0.19943,0.18448,1,0
3,GO IMMUNOGLOBULIN PRODUCTION,4.3218e-05,0.19929,0.18766,1,0
3,GO REPLICATIVE SENESCENCE,0.0062634,0.19644,0.23184,1,0
3,GO NIK NF KAPPAB SIGNALING,0.00044439,0.19602,0.16763,1,0
3,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.04854,0.1936,0.15471,1,0
3,GO REGULATION OF CELL SUBSTRATE ADHESION,0.014841,0.19328,0.11805,1,0
3,GO MAMMARY GLAND MORPHOGENESIS,0.012203,0.19239,0.17666,1,0
3,GO SMOOTH MUSCLE CELL PROLIFERATION,0.0029794,0.19235,0.16791,1,0
3,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.015203,0.19234,0.21466,1,0
3,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.00065623,0.19187,0.19407,1,0
3,GO EXTRACELLULAR MATRIX DISASSEMBLY,0.0032441,0.19145,0.18726,1,0
3,GO REGULATION OF PHAGOCYTOSIS,0.02068,0.19136,0.12328,1,0
3,GO T HELPER 1 TYPE IMMUNE RESPONSE,0.03939,0.19112,0.11607,1,0
3,GO COLLAGEN CATABOLIC PROCESS,0.053746,0.19054,0.10088,1,0
3,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.0017123,0.18983,0.14094,1,0
3,GO REGULATION OF STEROL TRANSPORT,0.0028957,0.18847,0.17771,1,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.043763,0.18841,0.14394,1,0
3,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.014486,0.18837,0.14442,1,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.02268,0.18834,0.1304,1,0
3,GO CELLULAR RESPONSE TO OSMOTIC STRESS,0.053746,0.18834,0.12588,1,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.0053338,0.18828,0.18177,1,0
3,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.00079435,0.18817,0.15163,1,0
3,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.017969,0.18739,0.17236,1,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0037331,0.18703,0.15408,1,0
3,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.0040578,0.18645,0.16518,1,0
3,GO SELECTIVE AUTOPHAGY,0.00050664,0.18574,0.1976,1,0
3,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.00353,0.18559,0.1602,1,0
3,GO RESPONSE TO HYPEROXIA,0.049546,0.18383,0.11083,1,0
3,GO AUTOPHAGOSOME MATURATION,0.0042883,0.18376,0.19322,1,0
3,GO EXTRACELLULAR STRUCTURE ORGANIZATION,0.030383,0.18222,0.098687,1,0
3,GO GLAND MORPHOGENESIS,0.020205,0.18083,0.15011,1,0
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0047853,0.18019,0.1564,1,0
3,GO VIRION ASSEMBLY,0.0021689,0.1799,0.13905,1,0
3,GO MACROPHAGE MIGRATION,0.012508,0.17974,0.13257,1,0
3,GO ENDOTHELIAL CELL DEVELOPMENT,0.025414,0.17956,0.1254,1,0
3,GO HORMONE BIOSYNTHETIC PROCESS,0.016339,0.17923,0.17299,1,0
3,GO REGULATION OF PROTEIN MATURATION,0.0090226,0.17867,0.13379,1,0
3,GO POLYAMINE METABOLIC PROCESS,0.015953,0.17624,0.1674,1,0
3,GO REGULATION OF KERATINOCYTE MIGRATION,0.0073363,0.17553,0.16991,1,0
3,GO VIRAL RELEASE FROM HOST CELL,0.0064317,0.17511,0.16419,1,0
3,GO T CELL APOPTOTIC PROCESS,0.018836,0.17493,0.14811,1,0
3,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.012203,0.17326,0.19665,1,0
3,GO TETRAPYRROLE METABOLIC PROCESS,0.0047853,0.17226,0.22729,1,0
3,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.010245,0.1717,0.18406,1,0
3,GO SYMBIOTIC PROCESS,0.0017641,0.17154,0.12029,1,0
3,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.033166,0.17006,0.10224,1,0
3,GO VIRAL RNA GENOME REPLICATION,0.0087944,0.16953,0.1314,1,0
3,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.0079323,0.16834,0.12449,1,0
3,GO PEPTIDE CATABOLIC PROCESS,0.0039469,0.16732,0.21576,1,0
3,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,0.011612,0.16722,0.1292,1,0
3,GO ARGININE METABOLIC PROCESS,0.052669,0.1671,0.28254,1,0
3,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,0.0013872,0.16648,0.16498,1,0
3,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.029719,0.16635,0.14283,1,0
3,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.00038934,0.16622,0.1988,1,0
3,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.0042883,0.16439,0.14315,1,0
3,GO COPPER ION TRANSPORT,0.0073363,0.16378,0.2217,1,0
3,GO ERAD PATHWAY,0.0021062,0.16374,0.15269,1,0
3,GO ENDOTHELIAL CELL PROLIFERATION,0.0081404,0.16373,0.12513,1,0
3,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.050569,0.1606,0.15142,1,0
3,GO REGULATION OF VASCULATURE DEVELOPMENT,0.0034322,0.16038,0.13687,1,0
3,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.0069616,0.15989,0.19337,1,0
3,GO AMINO ACID IMPORT,0.03939,0.15979,0.14366,1,0
3,GO POSITIVE REGULATION OF AUTOPHAGY,0.00013433,0.1591,0.17806,1,0
3,GO COMPLEMENT ACTIVATION,0.013465,0.15901,0.19224,1,0
3,GO MACROPHAGE CHEMOTAXIS,0.016734,0.15884,0.12302,1,0
3,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,0.053746,0.15864,0.10334,1,0
3,GO GLIAL CELL ACTIVATION,0.015574,0.15848,0.135,1,0
3,GO IRON ION TRANSMEMBRANE TRANSPORT,0.024846,0.15668,0.18904,1,0
3,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,0.013798,0.15659,0.22807,1,0
3,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.029068,0.15615,0.17161,1,0
3,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.03939,0.15552,0.096092,1,0
3,GO TISSUE REGENERATION,0.012203,0.15543,0.15812,1,0
3,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.00049035,0.1552,0.18955,1,0
3,GO MAINTENANCE OF LOCATION,0.00034072,0.15472,0.13863,1,0
3,GO RESPONSE TO ANGIOTENSIN,0.016339,0.15411,0.19232,1,0
3,GO MACROPHAGE DIFFERENTIATION,0.021165,0.15378,0.14779,1,0
3,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.02068,0.15264,0.13535,1,0
3,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.054842,0.15231,0.18086,1,0
3,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.0013054,0.15086,0.27055,1,0
3,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.0015189,0.15064,0.22295,1,0
3,GO CELL SUBSTRATE ADHESION,0.040234,0.149,0.081656,1,0
3,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.0006154,0.14888,0.15125,1,0
3,GO AUTOPHAGOSOME ORGANIZATION,0.00023468,0.14844,0.19584,1,0
3,GO OSTEOCLAST DIFFERENTIATION,0.014138,0.14808,0.11204,1,0
3,GO IRON ION HOMEOSTASIS,0.014486,0.14802,0.14879,1,0
3,GO PEPTIDYL PROLINE MODIFICATION,0.036164,0.14765,0.11902,1,0
3,GO REGULATION OF KIDNEY DEVELOPMENT,0.016734,0.14676,0.13712,1,0
3,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.009256,0.14643,0.1049,1,0
3,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.0094949,0.14566,0.083076,1,0
3,GO DE NOVO PROTEIN FOLDING,0.0097392,0.14542,0.15314,1,0
3,GO POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION,0.041967,0.14492,0.20143,1,0
3,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.0033369,0.14464,0.1709,1,0
3,GO GLIAL CELL APOPTOTIC PROCESS,0.055956,0.1445,0.20082,1,0
3,GO SULFUR COMPOUND METABOLIC PROCESS,0.0017641,0.14401,0.16585,1,0
3,GO MIDBODY ABSCISSION,0.0039469,0.14386,0.21051,1,0
3,GO CELL CELL RECOGNITION,0.0036303,0.14375,0.17014,1,0
3,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.016734,0.14216,0.14093,1,0
3,GO REGULATION OF VASOCONSTRICTION,0.00081984,0.14172,0.18382,1,0
3,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.04854,0.14166,0.092515,1,0
3,GO REGENERATION,0.021165,0.14159,0.094409,1,0
3,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.041967,0.14154,0.088683,1,0
3,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.014486,0.14126,0.14561,1,0
3,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.0021689,0.1401,0.26122,1,0
3,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.0062634,0.13996,0.12823,1,0
3,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.049546,0.13865,0.087624,1,0
3,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.04854,0.13841,0.11294,1,0
3,GO MEMBRANE INVAGINATION,0.029068,0.13798,0.11153,1,0
3,GO LIPID IMPORT INTO CELL,0.031748,0.13702,0.19018,1,0
3,GO RIBONUCLEOSIDE METABOLIC PROCESS,0.029068,0.13584,0.083762,1,0
3,GO REGULATION OF CHOLESTEROL EFFLUX,0.031748,0.135,0.1065,1,0
3,GO CYTOKINETIC PROCESS,0.013465,0.13497,0.12072,1,0
3,GO VASCULATURE DEVELOPMENT,0.049546,0.13486,0.068852,1,0
3,GO AMINO SUGAR METABOLIC PROCESS,0.035393,0.13449,0.13839,1,0
3,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.001872,0.1342,0.19015,1,0
3,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.050569,0.13402,0.13495,1,0
3,GO BASE EXCISION REPAIR AP SITE FORMATION,0.02843,0.13342,0.13934,1,0
3,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.014841,0.13257,0.097162,1,0
3,GO STRESS FIBER ASSEMBLY,0.045624,0.1317,0.087824,1,0
3,GO METANEPHRIC NEPHRON DEVELOPMENT,0.024288,0.13075,0.14749,1,0
3,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.0081404,0.13073,0.095095,1,0
3,GO MUSCLE CELL PROLIFERATION,0.0099891,0.13072,0.1056,1,0
3,GO BLOOD VESSEL MORPHOGENESIS,0.023205,0.12918,0.090634,1,0
3,GO SPERM EGG RECOGNITION,0.01282,0.1281,0.11942,1,0
3,GO POSITIVE REGULATION OF MITOPHAGY,0.010773,0.12712,0.18599,1,0
3,GO VACUOLAR TRANSPORT,0.00027832,0.12598,0.16641,1,0
3,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.023741,0.12581,0.12816,1,0
3,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.0099891,0.12567,0.097874,1,0
3,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.012508,0.12567,0.10253,1,0
3,GO TUBE MORPHOGENESIS,0.017137,0.12507,0.089064,1,0
3,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.00013433,0.12452,0.13413,1,0
3,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.0028957,0.12443,0.12881,1,0
3,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.025994,0.12414,0.18565,1,0
3,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.041967,0.1224,0.13408,1,0
3,GO RESPONSE TO RETINOIC ACID,0.043763,0.1223,0.089667,1,0
3,GO PROTEIN K63 LINKED UBIQUITINATION,0.0019282,0.12178,0.12839,1,0
3,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.029068,0.12127,0.12393,1,0
3,GO PROTEIN CATABOLIC PROCESS,0.00023468,0.12059,0.11561,1,0
3,GO TUBE DEVELOPMENT,0.0090226,0.11973,0.098418,1,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.035393,0.1187,0.11474,1,0
3,GO STEROL IMPORT,0.029719,0.11846,0.20338,1,0
3,GO OSSIFICATION,0.019283,0.11707,0.10163,1,0
3,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.025414,0.11592,0.22989,1,0
3,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.031748,0.11556,0.1629,1,0
3,GO VIRAL BUDDING,0.0039469,0.11537,0.14873,1,0
3,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.052669,0.11512,0.14292,1,0
3,GO RESPONSE TO LEPTIN,0.027803,0.11497,0.17627,1,0
3,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.015203,0.11458,0.10206,1,0
3,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.013465,0.11318,0.074302,1,0
3,GO REGULATION OF ENDOCYTOSIS,0.045624,0.11211,0.07577,1,0
3,GO POSITIVE REGULATION OF VASOCONSTRICTION,0.045624,0.11142,0.094924,1,0
3,GO RESPONSE TO MISFOLDED PROTEIN,0.017549,0.1114,0.15555,1,0
3,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.05161,0.11047,0.082298,1,0
3,GO ATP METABOLIC PROCESS,0.015574,0.11023,0.10362,1,0
3,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.025414,0.11002,0.11925,1,0
3,GO POSTREPLICATION REPAIR,0.010773,0.10978,0.084653,1,0
3,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.034637,0.10831,0.079905,1,0
3,GO T CELL DIFFERENTIATION IN THYMUS,0.011612,0.10816,0.10902,1,0
3,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.0030654,0.10769,0.1058,1,0
3,GO TOXIN TRANSPORT,0.015953,0.10584,0.14405,1,0
3,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.041093,0.105,0.10748,1,0
3,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.00024286,0.10224,0.11274,1,0
3,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.018836,0.10081,0.1196,1,0
3,GO LYSOSOMAL TRANSPORT,0.0023671,0.099215,0.16025,1,0
3,GO TISSUE MORPHOGENESIS,0.02843,0.098721,0.067591,1,0
3,GO NUCLEAR ENVELOPE ORGANIZATION,0.036164,0.098515,0.061781,1,0
3,GO POSITIVE REGULATION OF VIRAL PROCESS,0.0075304,0.096918,0.099443,1,0
3,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.038561,0.096718,0.086365,1,0
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.0099891,0.095766,0.10903,1,0
3,GO PYRUVATE METABOLIC PROCESS,0.040234,0.095364,0.097045,1,0
3,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.034637,0.094807,0.068669,1,0
3,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.0032441,0.093877,0.11045,1,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.053746,0.093834,0.15424,1,0
3,GO MACROMOLECULE CATABOLIC PROCESS,0.0085714,0.092565,0.073283,1,0
3,GO POST GOLGI VESICLE MEDIATED TRANSPORT,0.023741,0.092107,0.11438,1,0
3,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.010245,0.091927,0.10799,1,0
3,GO GOLGI VESICLE TRANSPORT,0.0045306,0.091747,0.10847,1,0
3,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.015953,0.091491,0.075779,1,0
3,GO PROTEIN FOLDING,0.023741,0.091416,0.10257,1,0
3,GO PROTEIN POLYUBIQUITINATION,0.00028792,0.090871,0.11551,1,0
3,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.031059,0.090848,0.096899,1,0
3,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.036948,0.09079,0.085228,1,0
3,GO CELLULAR RESPIRATION,0.038561,0.090219,0.12651,1,0
3,GO REGULATION OF OSSIFICATION,0.009256,0.088222,0.13162,1,0
3,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.029719,0.087083,0.17424,1,0
3,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.029719,0.086976,0.060318,1,0
3,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.017549,0.084728,0.1406,1,0
3,GO CELLULAR COMPONENT DISASSEMBLY,0.033894,0.081593,0.068473,1,0
3,GO REGULATION OF CATABOLIC PROCESS,0.0057817,0.08146,0.079544,1,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.047551,0.081042,0.091602,1,0
3,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,0.04854,0.079135,0.087046,1,0
3,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.049546,0.078415,0.079124,1,0
3,GO RESPONSE TO INTERLEUKIN 7,0.055956,0.077957,0.098665,1,0
3,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.007729,0.074901,0.082788,1,0
3,GO MACROAUTOPHAGY,0.0010528,0.069962,0.12354,1,0
3,GO PROTEIN HOMOOLIGOMERIZATION,0.036164,0.069406,0.061426,1,0
3,GO TRICARBOXYLIC ACID CYCLE,0.054842,0.06933,0.16507,1,0
3,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.02843,0.068698,0.058175,1,0
3,GO INTRACELLULAR PROTEIN TRANSPORT,0.022165,0.06719,0.052456,1,0
3,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.04854,0.065384,0.085743,1,0
3,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.0085714,0.06535,0.073647,1,0
3,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.0026572,0.062414,0.081917,1,0
3,GO AEROBIC RESPIRATION,0.02268,0.059116,0.14974,1,0
3,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.0075304,0.057643,0.07742,1,0
3,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.047551,0.054798,0.06718,1,0
3,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.024846,0.050772,0.060119,1,0
3,GO REGULATION OF BINDING,0.031059,0.050037,0.073272,1,0
3,GO NON CANONICAL WNT SIGNALING PATHWAY,0.035393,0.048201,0.087726,1,0
3,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.016734,0.047865,0.054203,1,0
3,GO NUCLEOTIDE EXCISION REPAIR,0.055956,-0.036541,-0.060645,1,0
3,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.023205,-0.036923,-0.08642,1,0
3,GO REGULATION OF DNA METABOLIC PROCESS,0.025994,-0.046536,-0.057134,1,0
3,GO REGULATION OF RNA SPLICING,0.025414,-0.048226,-0.058554,1,0
3,GO PEPTIDYL LYSINE TRIMETHYLATION,0.018836,-0.050485,-0.087027,1,0
3,GO MRNA METABOLIC PROCESS,0.053746,-0.05158,-0.073477,1,0
3,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.031748,-0.054535,-0.07753,1,0
3,GO MRNA 3 END PROCESSING,0.031748,-0.055661,-0.083233,1,0
3,GO REGULATION OF LYASE ACTIVITY,0.038561,-0.05613,-0.13,1,0
3,GO TRANSCRIPTION BY RNA POLYMERASE III,0.05161,-0.058003,-0.062252,1,0
3,GO CHROMOSOME SEPARATION,0.055956,-0.059125,-0.07612,1,0
3,GO RNA EXPORT FROM NUCLEUS,0.031748,-0.060592,-0.08951,1,0
3,GO CELLULAR RESPONSE TO X RAY,0.019283,-0.06297,-0.19705,1,0
3,GO HISTONE MRNA METABOLIC PROCESS,0.040234,-0.065865,-0.099867,1,0
3,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.015203,-0.066038,-0.086172,1,0
3,GO MRNA EXPORT FROM NUCLEUS,0.012203,-0.067734,-0.095668,1,0
3,GO BASE EXCISION REPAIR,0.054842,-0.070621,-0.082045,1,0
3,GO REPLICATION FORK PROCESSING,0.024288,-0.071029,-0.13921,1,0
3,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.0090226,-0.071767,-0.10229,1,0
3,GO RECOMBINATIONAL REPAIR,0.014841,-0.072603,-0.087589,1,0
3,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.029068,-0.074251,-0.075561,1,0
3,GO REGULATION OF MRNA POLYADENYLATION,0.025414,-0.074873,-0.10966,1,0
3,GO MRNA PROCESSING,0.0030654,-0.07522,-0.085774,1,0
3,GO DNA CONFORMATION CHANGE,0.013465,-0.077659,-0.071276,1,0
3,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0039469,-0.079417,-0.10677,1,0
3,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.017549,-0.083589,-0.11362,1,0
3,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.03245,-0.083659,-0.066009,1,0
3,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.055956,-0.084493,-0.090572,1,0
3,GO RNA CAPPING,0.027803,-0.084524,-0.086429,1,0
3,GO MITOTIC SPINDLE ORGANIZATION,0.017549,-0.085532,-0.080358,1,0
3,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.029068,-0.085731,-0.16302,1,0
3,GO HISTONE H2A MONOUBIQUITINATION,0.03939,-0.085767,-0.10694,1,0
3,GO MUSCLE FILAMENT SLIDING,0.015574,-0.087364,-0.20599,1,0
3,GO POSITIVE REGULATION OF DNA REPAIR,0.0026572,-0.087724,-0.10898,1,0
3,GO NEGATIVE REGULATION OF DNA REPAIR,0.029719,-0.089141,-0.10817,1,0
3,GO RNA SPLICING,0.00057693,-0.089446,-0.10276,1,0
3,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0056288,-0.090372,-0.12287,1,0
3,GO MITOTIC DNA REPLICATION CHECKPOINT,0.047551,-0.090494,-0.16252,1,0
3,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.01282,-0.091774,-0.096996,1,0
3,GO SPINDLE ORGANIZATION,0.0090226,-0.09231,-0.075106,1,0
3,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0051916,-0.092447,-0.10385,1,0
3,GO INTERSTRAND CROSS LINK REPAIR,0.023741,-0.092761,-0.069844,1,0
3,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.0097392,-0.09388,-0.085039,1,0
3,GO CHROMOSOME CONDENSATION,0.035393,-0.096135,-0.086708,1,0
3,GO NEURAL TUBE PATTERNING,0.025414,-0.098615,-0.15146,1,0
3,GO REGULATION OF TELOMERE MAINTENANCE,0.0020453,-0.09894,-0.12029,1,0
3,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.05161,-0.10048,-0.12707,1,0
3,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.02268,-0.10128,-0.17425,1,0
3,GO REGULATION OF CYCLASE ACTIVITY,0.0066042,-0.10446,-0.18263,1,0
3,GO DNA PACKAGING,0.0057817,-0.10672,-0.078775,1,0
3,GO NUCLEOSOME ORGANIZATION,0.0022332,-0.10702,-0.11316,1,0
3,GO REGULATION OF DNA REPAIR,0.00026903,-0.10976,-0.11621,1,0
3,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.007729,-0.11014,-0.10534,1,0
3,GO CARDIAC MUSCLE CELL PROLIFERATION,0.021165,-0.11077,-0.15879,1,0
3,GO REGULATION OF CILIUM ASSEMBLY,0.001191,-0.11168,-0.12906,1,0
3,GO HISTONE EXCHANGE,0.045624,-0.11322,-0.080511,1,0
3,GO G0 TO G1 TRANSITION,0.050569,-0.11477,-0.081845,1,0
3,GO MITOTIC CHROMOSOME CONDENSATION,0.033894,-0.11583,-0.12519,1,0
3,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.00016595,-0.11734,-0.13816,1,0
3,GO REGULATION OF CELL CYCLE CHECKPOINT,0.021165,-0.11898,-0.074882,1,0
3,GO NEGATIVE REGULATION OF RNA SPLICING,0.0023671,-0.12046,-0.13803,1,0
3,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.018836,-0.1206,-0.13245,1,0
3,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.041967,-0.12061,-0.1409,1,0
3,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.0087944,-0.12134,-0.096556,1,0
3,GO TRNA WOBBLE BASE MODIFICATION,0.014486,-0.12172,-0.15695,1,0
3,GO POSITIVE REGULATION OF ORGAN GROWTH,0.043763,-0.1219,-0.13241,1,0
3,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.00012074,-0.12205,-0.13297,1,0
3,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.00047456,-0.12444,-0.12029,1,0
3,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.00029782,-0.12514,-0.11973,1,0
3,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.037747,-0.12567,-0.1161,1,0
3,GO CENTRIOLE ASSEMBLY,0.029719,-0.126,-0.090877,1,0
3,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.013798,-0.12629,-0.14263,1,0
3,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.036164,-0.12762,-0.11448,1,0
3,GO LYMPHANGIOGENESIS,0.0090226,-0.12803,-0.21219,1,0
3,GO NUCLEOSOME ASSEMBLY,0.025414,-0.12965,-0.10168,1,0
3,GO RRNA TRANSCRIPTION,0.05161,-0.12988,-0.13038,1,0
3,GO STRESS GRANULE ASSEMBLY,0.0060989,-0.13227,-0.14818,1,0
3,GO REGULATION OF MRNA PROCESSING,0.00067758,-0.13263,-0.1159,1,0
3,GO HISTONE H3 K9 DEMETHYLATION,0.014138,-0.13312,-0.17466,1,0
3,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.036164,-0.13575,-0.13003,1,0
3,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,5.8301e-05,-0.13577,-0.14851,1,0
3,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.00074557,-0.13725,-0.12599,1,0
3,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.01282,-0.14024,-0.10344,1,0
3,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.0083534,-0.14164,-0.15721,1,0
3,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.0039469,-0.14375,-0.15322,1,0
3,GO NEURON PROJECTION ORGANIZATION,0.01282,-0.14429,-0.16197,1,0
3,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.00012074,-0.14584,-0.13451,1,0
3,GO HIPPO SIGNALING,0.011904,-0.14586,-0.22976,1,0
3,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.03939,-0.14595,-0.15547,1,0
3,GO TRNA WOBBLE URIDINE MODIFICATION,0.0037331,-0.1463,-0.17881,1,0
3,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.05161,-0.14681,-0.17057,1,0
3,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.055956,-0.14706,-0.23321,1,0
3,GO REGULATION OF SENSORY PERCEPTION,0.036164,-0.14732,-0.1202,1,0
3,GO TELENCEPHALON DEVELOPMENT,0.012508,-0.14736,-0.11228,1,0
3,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.0079323,-0.14898,-0.22791,1,0
3,GO RESPONSE TO PARATHYROID HORMONE,0.026586,-0.14964,-0.18692,1,0
3,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.0079323,-0.15281,-0.19991,1,0
3,GO LATERAL MESODERM DEVELOPMENT,0.0085714,-0.15339,-0.30651,1,0
3,GO ATP DEPENDENT CHROMATIN REMODELING,0.0085714,-0.15369,-0.12129,1,0
3,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.0073363,-0.15526,-0.17443,1,0
3,GO COLLAGEN FIBRIL ORGANIZATION,0.02068,-0.15559,-0.22484,1,0
3,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.0085714,-0.15627,-0.14131,1,0
3,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.0025817,-0.15816,-0.14098,1,0
3,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.00013917,-0.15905,-0.14897,1,0
3,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.037747,-0.15943,-0.11065,1,0
3,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.0013054,-0.15976,-0.14457,1,0
3,GO NEPHRON TUBULE FORMATION,0.042857,-0.16087,-0.22487,1,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.025414,-0.16201,-0.2083,1,0
3,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.00016023,-0.16383,-0.15578,1,0
3,GO TELOMERIC LOOP DISASSEMBLY,0.0024367,-0.16627,-0.18344,1,0
3,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.00011241,-0.16866,-0.18089,1,0
3,GO NEGATIVE REGULATION OF MRNA PROCESSING,4.3218e-05,-0.16874,-0.16658,1,0
3,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.00014418,-0.16881,-0.16086,1,0
3,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.004408,-0.17024,-0.28118,1,0
3,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.054842,-0.17188,-0.18774,1,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.011326,-0.17473,-0.16015,1,0
3,GO MATURATION OF LSU RRNA,0.049546,-0.17621,-0.19905,1,0
3,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.05161,-0.1767,-0.20432,1,0
3,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.0060989,-0.17799,-0.2175,1,0
3,GO MESODERMAL CELL FATE SPECIFICATION,0.025994,-0.17937,-0.19001,1,0
3,GO PROTEIN DEMETHYLATION,0.0087944,-0.1803,-0.15228,1,0
3,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.014138,-0.18068,-0.1289,1,0
3,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.027803,-0.18179,-0.13734,1,0
3,GO SNORNA METABOLIC PROCESS,0.007729,-0.1826,-0.21006,1,0
3,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.029719,-0.1829,-0.28726,1,0
3,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.031748,-0.18397,-0.20707,1,0
3,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,0.02166,-0.1843,-0.1856,1,0
3,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.0022992,-0.18479,-0.23082,1,0
3,GO MITOCHONDRION DISTRIBUTION,0.0049174,-0.18529,-0.16265,1,0
3,GO ADULT HEART DEVELOPMENT,0.023205,-0.18598,-0.20671,1,0
3,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.010773,-0.18625,-0.14206,1,0
3,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,1.5201e-05,-0.18632,-0.1628,1,0
3,GO REPLACEMENT OSSIFICATION,0.016734,-0.1865,-0.18445,1,0
3,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.0022332,-0.18837,-0.2025,1,0
3,GO KIDNEY MESENCHYME DEVELOPMENT,0.031748,-0.1887,-0.18011,1,0
3,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.0022992,-0.18989,-0.14562,1,0
3,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.015953,-0.19049,-0.20137,1,0
3,GO REGULATION OF HIPPO SIGNALING,0.03939,-0.19294,-0.18819,1,0
3,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.00012964,-0.19488,-0.20324,1,0
3,GO CENTROMERE COMPLEX ASSEMBLY,0.0094949,-0.19602,-0.15727,1,0
3,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.023205,-0.19836,-0.1359,1,0
3,GO HIPPOCAMPUS DEVELOPMENT,0.0022992,-0.20012,-0.17592,1,0
3,GO SNORNA 3 END PROCESSING,0.001662,-0.2005,-0.25816,1,0
3,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.0027346,-0.20107,-0.19667,1,0
3,GO MUSCLE CELL FATE COMMITMENT,0.0094949,-0.20567,-0.24598,1,0
3,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,0.021165,-0.20903,-0.17558,1,0
3,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.00010092,-0.21034,-0.21746,1,0
3,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.0041716,-0.21201,-0.20332,1,0
3,GO TELENCEPHALON GLIAL CELL MIGRATION,0.0022332,-0.21296,-0.24121,1,0
3,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.0064317,-0.21458,-0.26553,1,0
3,GO MRNA SPLICE SITE SELECTION,0.00069957,-0.2166,-0.20933,1,0
3,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,1.1964e-05,-0.21776,-0.3131,1,0
3,GO LAYER FORMATION IN CEREBRAL CORTEX,0.0032441,-0.22009,-0.27204,1,0
3,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.0011549,-0.22034,-0.17481,1,0
3,GO FOREBRAIN REGIONALIZATION,0.031748,-0.22108,-0.20501,1,0
3,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.044685,-0.22217,-0.26237,1,0
3,GO TELOMERASE RNA LOCALIZATION,0.0097392,-0.22261,-0.22447,1,0
3,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.00074557,-0.22581,-0.23583,1,0
3,GO BONE GROWTH,0.0045306,-0.2264,-0.25267,1,0
3,GO CHROMATIN REMODELING AT CENTROMERE,0.0081404,-0.22907,-0.16024,1,0
3,GO EMBRYONIC EYE MORPHOGENESIS,0.0013457,-0.23042,-0.25719,1,0
3,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.0015189,-0.23207,-0.32468,1,0
3,GO LEUKOCYTE AGGREGATION,0.024846,-0.23309,-0.31022,1,0
3,GO RESPONSE TO ELECTRICAL STIMULUS,0.0075304,-0.235,-0.18739,1,0
3,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.02068,-0.23659,-0.1773,1,0
3,GO CELL PROLIFERATION IN FOREBRAIN,0.00032948,-0.23841,-0.25646,1,0
3,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.0073363,-0.24078,-0.17028,1,0
3,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.02166,-0.2417,-0.14386,1,0
3,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.016734,-0.24175,-0.2816,1,0
3,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.0027346,-0.24602,-0.32531,1,0
3,GO CARDIOBLAST DIFFERENTIATION,0.0015189,-0.24757,-0.29878,1,0
3,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.00010092,-0.24762,-0.45484,1,0
3,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,1.4039e-05,-0.2496,-0.23993,1,0
3,GO BONE TRABECULA FORMATION,0.037747,-0.2517,-0.3321,1,0
3,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.0017641,-0.25335,-0.33122,1,0
3,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,1.0604e-05,-0.25447,-0.23169,1,0
3,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.010773,-0.25453,-0.25917,1,0
3,GO ELASTIC FIBER ASSEMBLY,0.031748,-0.25485,-0.29687,1,0
3,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,0.00087311,-0.25975,-0.29535,1,0
3,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,1.349e-05,-0.26129,-0.28661,1,0
3,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0064317,-0.26772,-0.23022,1,0
3,GO REGULATION OF PROTEIN KINASE A SIGNALING,9.0551e-05,-0.26845,-0.2183,1,0
3,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,1.4044e-06,-0.2783,-0.28734,1,0
3,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.0049174,-0.28519,-0.20168,1,0
3,GO RESPONSE TO L GLUTAMATE,0.02166,-0.28703,-0.24622,1,0
3,GO EMBRYONIC BRAIN DEVELOPMENT,2.5308e-05,-0.29542,-0.31061,1,0
3,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.0041716,-0.29605,-0.23061,1,0
3,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.011326,-0.29731,-0.26024,1,0
3,GO SYNAPTIC VESICLE MATURATION,0.018836,-0.29895,-0.23938,1,0
3,GO NEGATIVE REGULATION OF LYASE ACTIVITY,0.0007696,-0.30176,-0.33839,1,0
3,GO MYOBLAST MIGRATION,0.0099891,-0.30351,-0.34623,1,0
3,GO REGULATION OF NEUROBLAST PROLIFERATION,0.00022676,-0.3046,-0.30673,1,0
3,GO DORSAL VENTRAL AXIS SPECIFICATION,0.001986,-0.30857,-0.34358,1,0
3,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.0011549,-0.30873,-0.30746,1,0
3,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.0006154,-0.31888,-0.32696,1,0
3,GO MODIFICATION OF SYNAPTIC STRUCTURE,4.3218e-05,-0.32485,-0.37398,1,0
3,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0018173,-0.32888,-0.23553,1,0
3,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.010773,-0.33216,-0.24389,1,0
3,GO POSITIVE REGULATION OF NEURON MIGRATION,0.0011199,-0.34032,-0.30213,1,0
3,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.0017123,-0.34189,-0.32305,1,0
3,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.00031859,-0.34582,-0.34618,1,0
3,GO DENDRITIC TRANSPORT,0.00028792,-0.34787,-0.33273,1,0
3,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.00090094,-0.36639,-0.39132,1,0
3,GO EXCITATORY SYNAPSE ASSEMBLY,0.00044439,-0.36749,-0.45215,1,0
3,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,9.3916e-06,-0.37129,-0.50933,1,0
3,GO CENTRIOLE CENTRIOLE COHESION,2.8418e-05,-0.37242,-0.34035,1,0
3,GO LIMB BUD FORMATION,0.010245,-0.41046,-0.33366,1,0
3,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.001191,-0.42044,-0.31044,1,0
3,GO POSTSYNAPSE ASSEMBLY,0.0026572,-0.42952,-0.44813,1,0
3,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.0010528,-0.43093,-0.43175,1,0
3,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.00022676,-0.44907,-0.52768,1,0
3,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,0.0041716,-0.46211,-0.32209,1,0
3,GO CORPUS CALLOSUM DEVELOPMENT,0.0013872,-0.46685,-0.33798,1,0
3,GO TELENCEPHALON REGIONALIZATION,0.016339,-0.48622,-0.35378,1,0
3,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.0007696,-0.50456,-0.42424,1,0
3,GO ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.001986,-0.51041,-0.36396,1,0
3,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.00019753,-0.52234,-0.45449,1,0
3,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,4.3218e-05,-0.5251,-0.5257,1,0
3,GO CARDIAC CHAMBER FORMATION,0.00030804,-0.55702,-0.5259,1,0
3,GO CARDIAC VENTRICLE FORMATION,0.0006154,-0.59463,-0.54356,1,0
3,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,3.5759e-05,-0.61647,-0.59664,1,0
3,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.00014935,-0.62103,-0.71615,1,0
3,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.00012964,-0.64563,-0.70349,1,0
3,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.060602,0.33427,0.25094,0,1
3,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.12049,0.30108,0.15281,0,1
3,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.10845,0.2898,0.16534,0,1
3,GO XENOBIOTIC CATABOLIC PROCESS,0.12049,0.28,0.24294,0,1
3,GO EPITHELIAL CELL MATURATION,0.066855,0.27348,0.18192,0,1
3,GO NEGATIVE REGULATION OF GLUCOSE IMPORT,0.063042,0.25782,0.17607,0,1
3,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.088862,0.24822,0.14182,0,1
3,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.070855,0.24691,0.32749,0,1
3,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.11434,0.24085,0.14376,0,1
3,GO REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME,0.084046,0.23813,0.16317,0,1
3,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.059411,0.2367,0.15385,0,1
3,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.50337,0.23536,0.0011828,0,1
3,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.085627,0.23518,0.22327,0,1
3,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.064293,0.22644,0.24539,0,1
3,GO NADPH REGENERATION,0.12689,0.22094,0.14895,0,1
3,GO RESPONSE TO UV B,0.14769,0.21592,0.08727,0,1
3,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.085627,0.21543,0.12022,0,1
3,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.085627,0.20992,0.178,0,1
3,GO REGULATION OF SYNAPSE MATURATION,0.59059,0.20688,0.012242,0,1
3,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.23245,0.20415,0.17105,0,1
3,GO CELLULAR OXIDANT DETOXIFICATION,0.075049,0.19844,0.12677,0,1
3,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.066855,0.19777,0.11385,0,1
3,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,0.36526,0.19621,0.1149,0,1
3,GO MAINTENANCE OF CELL POLARITY,0.10654,0.19188,0.12611,0,1
3,GO DRINKING BEHAVIOR,0.061812,0.19107,0.19331,0,1
3,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.10654,0.19099,0.15456,0,1
3,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.068167,0.18964,0.12955,0,1
3,GO RESPONSE TO LIGHT INTENSITY,0.085627,0.18778,0.11041,0,1
3,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.060602,0.18734,0.14749,0,1
3,GO REGULATION OF T HELPER CELL DIFFERENTIATION,0.061812,0.18659,0.089203,0,1
3,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.21905,0.18283,0.10342,0,1
3,GO REGULATION OF RESPONSE TO FOOD,0.31232,0.18237,0.055403,0,1
3,GO RESPONSE TO MUSCLE ACTIVITY,0.18219,0.18057,0.11836,0,1
3,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.10096,0.18055,0.13242,0,1
3,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.092194,0.17968,0.17413,0,1
3,GO RESPONSE TO AMINE,0.14048,0.17958,0.08951,0,1
3,GO NOREPINEPHRINE TRANSPORT,0.057089,0.17638,0.15429,0,1
3,GO RESPONSE TO VITAMIN,0.059411,0.17547,0.09532,0,1
3,GO MITOCHONDRIAL RNA PROCESSING,0.22568,0.17538,0.107,0,1
3,GO DNA DEMETHYLATION,0.11235,0.17458,0.11046,0,1
3,GO MACROPHAGE APOPTOTIC PROCESS,0.13355,0.17231,0.12814,0,1
3,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.073629,0.1718,0.12602,0,1
3,GO RESPONSE TO PROSTAGLANDIN,0.070855,0.17172,0.16487,0,1
3,GO CELLULAR ANION HOMEOSTASIS,0.066855,0.1684,0.11328,0,1
3,GO TRNA CATABOLIC PROCESS,0.064293,0.16784,0.23258,0,1
3,GO LYSINE METABOLIC PROCESS,0.23589,0.15816,0.12896,0,1
3,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.080955,0.15792,0.076961,0,1
3,GO REGULATION OF EXIT FROM MITOSIS,0.084046,0.15715,0.093684,0,1
3,GO DEVELOPMENTAL INDUCTION,0.073629,0.15674,0.10025,0,1
3,GO MEMBRANE HYPERPOLARIZATION,0.063042,0.15605,0.11981,0,1
3,GO SECRETORY GRANULE ORGANIZATION,0.093897,0.15242,0.097484,0,1
3,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.10654,0.15072,0.14098,0,1
3,GO HEART TRABECULA FORMATION,0.087232,0.1507,0.20678,0,1
3,GO NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.20937,0.15027,0.14238,0,1
3,GO POSITIVE THYMIC T CELL SELECTION,0.11039,0.14891,0.088921,0,1
3,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.068167,0.14822,0.08602,0,1
3,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.11636,0.14775,0.090757,0,1
3,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.066855,0.14765,0.14237,0,1
3,GO DIENCEPHALON DEVELOPMENT,0.15773,0.1471,0.096371,0,1
3,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.16828,0.14707,0.081385,0,1
3,GO MYELOID CELL APOPTOTIC PROCESS,0.12049,0.14697,0.09423,0,1
3,GO GLUCOCORTICOID METABOLIC PROCESS,0.36991,0.14406,0.059426,0,1
3,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.084046,0.14393,0.083991,0,1
3,GO CRANIAL NERVE DEVELOPMENT,0.080955,0.14285,0.12706,0,1
3,GO REGULATION OF EXCRETION,0.14526,0.14224,0.091505,0,1
3,GO REGULATION OF SPROUTING ANGIOGENESIS,0.11636,0.1386,0.071162,0,1
3,GO SEX DETERMINATION,0.21256,0.1386,0.081266,0,1
3,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.11841,0.13783,0.10648,0,1
3,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.05824,0.13737,0.11164,0,1
3,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,0.090515,0.13733,0.1503,0,1
3,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.20309,0.13654,0.10654,0,1
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.075049,0.13613,0.14125,0,1
3,GO NOREPINEPHRINE SECRETION,0.13814,0.13524,0.14634,0,1
3,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.13814,0.13477,0.10721,0,1
3,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.099158,0.13367,0.10737,0,1
3,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.17653,0.13348,0.080442,0,1
3,GO NEGATIVE REGULATION OF TOR SIGNALING,0.065563,0.13345,0.085639,0,1
3,GO METANEPHROS MORPHOGENESIS,0.14769,0.13054,0.10669,0,1
3,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.075049,0.12889,0.1271,0,1
3,GO HEMOGLOBIN METABOLIC PROCESS,0.21256,0.12791,0.053024,0,1
3,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.070855,0.12778,0.13467,0,1
3,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.057089,0.12486,0.054175,0,1
3,GO HYPEROSMOTIC RESPONSE,0.20621,0.12325,0.095022,0,1
3,GO MODULATION BY VIRUS OF HOST PROCESS,0.11235,0.122,0.091757,0,1
3,GO RESPONSE TO LEUCINE,0.2839,0.12191,0.094858,0,1
3,GO PHOSPHATE ION TRANSPORT,0.068167,0.12169,0.091813,0,1
3,GO RESPONSE TO UV C,0.11039,0.12114,0.088433,0,1
3,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.1028,0.12018,0.12115,0,1
3,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.070855,0.11682,0.10626,0,1
3,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.068167,0.11631,0.074042,0,1
3,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.12473,0.11627,0.080538,0,1
3,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.12689,0.1156,0.078288,0,1
3,GO REGULATION OF MITOPHAGY,0.063042,0.11272,0.10581,0,1
3,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.11235,0.11174,0.08544,0,1
3,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.23937,0.11162,0.071986,0,1
3,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.51459,0.11141,0.035015,0,1
3,GO INTERMEDIATE FILAMENT ORGANIZATION,0.2,0.11086,0.070676,0,1
3,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.22905,0.11067,0.11697,0,1
3,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.24288,0.10742,0.093937,0,1
3,GO POSITIVE REGULATION OF DNA REPLICATION,0.15015,0.10706,0.054828,0,1
3,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.068167,0.10618,0.12458,0,1
3,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.47049,0.10555,0.028333,0,1
3,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.22905,0.1036,0.095134,0,1
3,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.52025,0.10356,0.00061751,0,1
3,GO LAMELLIPODIUM ORGANIZATION,0.19393,0.10328,0.04961,0,1
3,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.066855,0.10299,0.054624,0,1
3,GO PRESYNAPTIC ENDOCYTOSIS,0.16559,0.10139,0.08927,0,1
3,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.36991,0.10082,0.035911,0,1
3,GO DNA DEALKYLATION,0.30402,0.10072,0.052745,0,1
3,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.29992,0.10034,0.083634,0,1
3,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.059411,0.10018,0.13104,0,1
3,GO REGULATION OF MITOCHONDRIAL FUSION,0.26471,0.099858,0.092515,0,1
3,GO RRNA CATABOLIC PROCESS,0.19695,0.098336,0.080959,0,1
3,GO FACE DEVELOPMENT,0.34256,0.097458,0.037208,0,1
3,GO PROTEIN K11 LINKED UBIQUITINATION,0.11841,0.097191,0.10489,0,1
3,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.31653,0.095269,0.037299,0,1
3,GO RETINOIC ACID METABOLIC PROCESS,0.23245,0.095184,0.075941,0,1
3,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.27999,0.092869,0.06029,0,1
3,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.33373,0.092843,0.051855,0,1
3,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.72313,0.092632,0.031646,0,1
3,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.20621,0.092225,0.060524,0,1
3,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.36526,0.090785,0.018264,0,1
3,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.17653,0.090177,0.056601,0,1
3,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.12259,0.088456,0.067777,0,1
3,GO MODIFIED AMINO ACID TRANSPORT,0.097379,0.086783,0.10636,0,1
3,GO REGULATION OF DNA CATABOLIC PROCESS,0.059411,0.084748,0.098977,0,1
3,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.23937,0.083941,0.032738,0,1
3,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.33373,0.082913,0.081474,0,1
3,GO MITOTIC DNA REPLICATION,0.23589,0.082198,0.074961,0,1
3,GO REGULATION OF CHROMATIN BINDING,0.20621,0.081901,0.073698,0,1
3,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.30815,0.079702,0.066759,0,1
3,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.60272,0.079193,0.027632,0,1
3,GO CELLULAR RESPONSE TO CAMP,0.15517,0.076421,0.065262,0,1
3,GO PHOTOTRANSDUCTION,0.061812,0.075914,0.053648,0,1
3,GO REGULATION OF ERAD PATHWAY,0.35607,0.07538,0.033216,0,1
3,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.11636,0.072744,0.070868,0,1
3,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.27611,0.070284,0.036046,0,1
3,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.076492,0.069025,0.047388,0,1
3,GO GERM CELL DEVELOPMENT,0.068167,0.068285,0.054953,0,1
3,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.063042,0.065689,0.070772,0,1
3,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.26471,0.064384,0.018111,0,1
3,GO DNA MODIFICATION,0.1028,0.061251,0.048709,0,1
3,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.076492,0.060373,0.043011,0,1
3,GO MACROMOLECULE DEACYLATION,0.065563,0.059613,0.049912,0,1
3,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.16559,0.057898,0.049351,0,1
3,GO MULTICELLULAR ORGANISM GROWTH,0.35607,0.056303,0.029735,0,1
3,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.21579,0.055962,0.041427,0,1
3,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.41842,0.054914,0.025694,0,1
3,GO REGULATION OF DEPHOSPHORYLATION,0.095625,0.053647,0.042465,0,1
3,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.17934,0.052792,0.033481,0,1
3,GO REGULATION OF ACTIN FILAMENT LENGTH,0.092194,0.051982,0.053949,0,1
3,GO RNA DECAPPING,0.83713,0.050027,0.026034,0,1
3,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.32938,0.047217,0.017798,0,1
3,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.22235,0.046575,0.048993,0,1
3,GO TORC1 SIGNALING,0.15517,0.040835,0.04149,0,1
3,GO METHYLATION,0.49227,0.037749,0.0010942,0,1
3,GO NEGATIVE REGULATION OF NEURON DEATH,0.20621,0.037107,0.036241,0,1
3,GO ORGANELLE LOCALIZATION,0.17099,0.027762,0.032317,0,1
3,GO NERVOUS SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,1.104e-05,0.8974,0.81791,0,0
3,GO RESPONSE TO PAIN,4.4712e-06,0.47426,0.46814,0,0
3,GO REGULATION OF ANOIKIS,4.1617e-05,0.44121,0.49942,0,0
3,GO TYPE B PANCREATIC CELL PROLIFERATION,0.00019753,0.44028,0.4545,0,0
3,GO RETROGRADE TRANS SYNAPTIC SIGNALING,0.013139,0.4232,0.31657,0,0
3,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.0001165,0.41635,0.50342,0,0
3,GO REFLEX,0.00050664,0.41425,0.44354,0,0
3,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.00081984,0.36739,0.41128,0,0
3,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.0031536,0.36449,0.3525,0,0
3,GO HEMIDESMOSOME ASSEMBLY,0.19393,0.33757,0.17145,0,0
3,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.0016129,0.33554,0.30397,0,0
3,GO CYSTEINE METABOLIC PROCESS,0.15015,0.33359,0.20111,0,0
3,GO NEURONAL ACTION POTENTIAL,0.00044439,0.32443,0.41263,0,0
3,GO RESPONSE TO MUSCLE STRETCH,0.00095906,0.30153,0.35821,0,0
3,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.049546,0.3002,0.19597,0,0
3,GO ETHANOL OXIDATION,0.016339,0.2954,0.41473,0,0
3,GO RADIAL GLIAL CELL DIFFERENTIATION,0.0053338,0.29013,0.31914,0,0
3,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.00038934,0.28143,0.23707,0,0
3,GO INDOLALKYLAMINE METABOLIC PROCESS,0.00013433,0.2813,0.36032,0,0
3,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,1.104e-05,0.28012,0.27912,0,0
3,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.0016129,0.27219,0.24313,0,0
3,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.054842,0.26894,0.20815,0,0
3,GO RESPIRATORY BURST,0.0017123,0.26769,0.2474,0,0
3,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.41341,0.26422,0.10039,0,0
3,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.02843,0.26232,0.28406,0,0
3,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.0025817,0.26161,0.35908,0,0
3,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,0.0016129,0.25981,0.2269,0,0
3,GO SEGMENT SPECIFICATION,0.188,0.25892,0.13844,0,0
3,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.015953,0.25883,0.1976,0,0
3,GO DETOXIFICATION OF INORGANIC COMPOUND,0.30402,0.25738,0.24929,0,0
3,GO CELLULAR RESPONSE TO COPPER ION,0.029068,0.25678,0.38384,0,0
3,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.0030654,0.25648,0.34698,0,0
3,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.031748,0.25562,0.21761,0,0
3,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.022165,0.25044,0.2189,0,0
3,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.001228,0.25033,0.22946,0,0
3,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.015574,0.2501,0.27505,0,0
3,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,0.090515,0.24595,0.12681,0,0
3,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.013798,0.24532,0.26482,0,0
3,GO REGULATION OF CGMP MEDIATED SIGNALING,0.17374,0.24405,0.11644,0,0
3,GO SKIN MORPHOGENESIS,0.40843,0.24295,0.021093,0,0
3,GO REGULATION OF METANEPHROS DEVELOPMENT,0.057089,0.24191,0.13535,0,0
3,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.00035231,0.24029,0.28522,0,0
3,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.11235,0.23852,0.072772,0,0
3,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,8.4205e-05,0.2379,0.32244,0,0
3,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.041967,0.2377,0.22398,0,0
3,GO POSITIVE REGULATION OF ACTION POTENTIAL,0.077957,0.23725,0.13041,0,0
3,GO REGULATION OF POSITIVE CHEMOTAXIS,0.00084609,0.23667,0.25188,0,0
3,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.017969,0.23403,0.21075,0,0
3,GO METANEPHRIC EPITHELIUM DEVELOPMENT,0.057089,0.23377,0.12912,0,0
3,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.018398,0.23328,0.20257,0,0
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.54903,0.23319,0.025929,0,0
3,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,9.389e-05,0.23295,0.2279,0,0
3,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.084046,0.2291,0.092677,0,0
3,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.011326,0.22879,0.18785,0,0
3,GO REGULATION OF DOPAMINE SECRETION,0.036164,0.22708,0.29775,0,0
3,GO POSITIVE REGULATION OF STEROL TRANSPORT,0.11841,0.22566,0.09774,0,0
3,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.00049035,0.22479,0.20241,0,0
3,GO POSITIVE REGULATION OF HEART RATE,0.004408,0.2238,0.26646,0,0
3,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,6.0504e-05,0.22325,0.21034,0,0
3,GO POSITIVE REGULATION OF AMINE TRANSPORT,0.0006154,0.22282,0.31299,0,0
3,GO REGULATION OF AMINO ACID TRANSPORT,0.0090226,0.22225,0.20324,0,0
3,GO T HELPER 2 CELL DIFFERENTIATION,0.090515,0.2189,0.096237,0,0
3,GO FIBRINOLYSIS,0.12049,0.21771,0.17064,0,0
3,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.057089,0.21746,0.09504,0,0
3,GO MEMBRANE RAFT ASSEMBLY,0.13355,0.21741,0.20055,0,0
3,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.0011199,0.2166,0.20686,0,0
3,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.0022992,0.21565,0.17291,0,0
3,GO HEPARIN METABOLIC PROCESS,0.15264,0.21443,0.13456,0,0
3,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.11841,0.21233,0.17136,0,0
3,GO NEPHRIC DUCT MORPHOGENESIS,0.38408,0.21076,0.050186,0,0
3,GO ENERGY HOMEOSTASIS,0.00353,0.21066,0.20854,0,0
3,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.093897,0.21037,0.081055,0,0
3,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.32938,0.2095,0.064859,0,0
3,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,0.29992,0.20798,0.064242,0,0
3,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.00021909,0.20739,0.20504,0,0
3,GO PSEUDOPODIUM ORGANIZATION,0.016734,0.20726,0.26781,0,0
3,GO ENDOCARDIUM DEVELOPMENT,0.041093,0.20675,0.2204,0,0
3,GO LAMELLIPODIUM MORPHOGENESIS,0.030383,0.20619,0.19964,0,0
3,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.020205,0.20528,0.2135,0,0
3,GO MEMBRANE DEPOLARIZATION,0.00079435,0.20491,0.231,0,0
3,GO INCLUSION BODY ASSEMBLY,0.019739,0.2047,0.23001,0,0
3,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.11235,0.20428,0.16327,0,0
3,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.0041716,0.20362,0.19879,0,0
3,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.16294,0.20341,0.14011,0,0
3,GO POSITIVE REGULATION OF HEART CONTRACTION,0.0017123,0.20106,0.23265,0,0
3,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,0.025994,0.19984,0.21364,0,0
3,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.036948,0.19814,0.28324,0,0
3,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.02843,0.19784,0.18986,0,0
3,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.16559,0.19739,0.17468,0,0
3,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.015953,0.19677,0.19367,0,0
3,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0034322,0.19612,0.19471,0,0
3,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,0.095625,0.19605,0.12676,0,0
3,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.18219,0.19604,0.13069,0,0
3,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.18508,0.19481,0.038522,0,0
3,GO MIDGUT DEVELOPMENT,0.092194,0.19446,0.18884,0,0
3,GO T HELPER 1 CELL DIFFERENTIATION,0.40349,0.19143,0.06552,0,0
3,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.20937,0.19138,0.062903,0,0
3,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.013465,0.19004,0.15703,0,0
3,GO GLIAL CELL FATE COMMITMENT,0.11235,0.18946,0.2311,0,0
3,GO PARAXIAL MESODERM DEVELOPMENT,0.16828,0.18744,0.12009,0,0
3,GO STORE OPERATED CALCIUM ENTRY,0.065563,0.18687,0.1577,0,0
3,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.14285,0.18661,0.080263,0,0
3,GO PODOSOME ASSEMBLY,0.38408,0.18575,0.035575,0,0
3,GO PITUITARY GLAND DEVELOPMENT,0.087232,0.18463,0.16024,0,0
3,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.14048,0.18443,0.036474,0,0
3,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.010245,0.18426,0.26344,0,0
3,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.0021062,0.18404,0.15714,0,0
3,GO PROTEIN O LINKED MANNOSYLATION,0.023205,0.18338,0.17466,0,0
3,GO HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.04854,0.18335,0.25014,0,0
3,GO ENDODERM DEVELOPMENT,0.084046,0.18223,0.087516,0,0
3,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.0050528,0.18223,0.1522,0,0
3,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.024288,0.18205,0.27681,0,0
3,GO ADENOHYPOPHYSIS DEVELOPMENT,0.14048,0.18112,0.20672,0,0
3,GO MULTICELLULAR ORGANISMAL SIGNALING,0.0033369,0.18111,0.17168,0,0
3,GO CARDIOLIPIN METABOLIC PROCESS,0.060602,0.18088,0.091715,0,0
3,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,0.18508,0.1807,0.12766,0,0
3,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.0075304,0.18053,0.20493,0,0
3,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0033369,0.18031,0.26168,0,0
3,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.02068,0.17929,0.1757,0,0
3,GO REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.34702,0.17897,0.0655,0,0
3,GO POSITIVE REGULATION OF VASCULOGENESIS,0.15773,0.17894,0.19312,0,0
3,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.16294,0.17776,0.20654,0,0
3,GO CALCIUM IMPORT INTO THE MITOCHONDRION,0.013465,0.17771,0.17091,0,0
3,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.076492,0.1767,0.12062,0,0
3,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.024288,0.1754,0.19688,0,0
3,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.14285,0.17518,0.15017,0,0
3,GO MEGAKARYOCYTE DEVELOPMENT,0.0090226,0.17513,0.26443,0,0
3,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.38408,0.17506,0.057954,0,0
3,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.16828,0.17406,0.15674,0,0
3,GO TRANSMISSION OF NERVE IMPULSE,0.0060989,0.17357,0.22937,0,0
3,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.64605,0.17295,0.023092,0,0
3,GO GLYCOPROTEIN CATABOLIC PROCESS,0.12473,0.17229,0.12781,0,0
3,GO AMINE TRANSPORT,0.0050528,0.17131,0.22876,0,0
3,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,0.23245,0.17106,0.096437,0,0
3,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.033894,0.17087,0.16186,0,0
3,GO PRO B CELL DIFFERENTIATION,0.042857,0.17071,0.18058,0,0
3,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.099158,0.17056,0.15988,0,0
3,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.27611,0.17014,0.092367,0,0
3,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.19393,0.17012,0.14182,0,0
3,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.014138,0.17005,0.19719,0,0
3,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.023205,0.17,0.25336,0,0
3,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.14048,0.16999,0.072641,0,0
3,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.085627,0.16923,0.11899,0,0
3,GO AMINE CATABOLIC PROCESS,0.0049174,0.16895,0.2848,0,0
3,GO P38MAPK CASCADE,0.0097392,0.16887,0.15462,0,0
3,GO PERICARDIUM DEVELOPMENT,0.36064,0.16877,0.029244,0,0
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.11434,0.1687,0.13402,0,0
3,GO INFLAMMATORY RESPONSE TO WOUNDING,0.29586,0.16749,0.12709,0,0
3,GO MAMMARY GLAND DEVELOPMENT,0.0029794,0.16713,0.13651,0,0
3,GO EPITHELIAL CELL PROLIFERATION,0.0013457,0.16648,0.14685,0,0
3,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.054842,0.16617,0.20232,0,0
3,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.087232,0.16504,0.1146,0,0
3,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.43367,0.16398,0.07251,0,0
3,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.21256,0.1637,0.17259,0,0
3,GO EATING BEHAVIOR,0.0015189,0.16324,0.19297,0,0
3,GO MONOAMINE TRANSPORT,0.012203,0.163,0.2268,0,0
3,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.025414,0.16264,0.2032,0,0
3,GO IMMATURE T CELL PROLIFERATION,0.17934,0.16255,0.13822,0,0
3,GO PROTEIN OXIDATION,0.30815,0.16153,0.039023,0,0
3,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.0017123,0.16015,0.20484,0,0
3,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.084046,0.15937,0.13457,0,0
3,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.011047,0.15935,0.22898,0,0
3,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.085627,0.15785,0.15062,0,0
3,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.085627,0.1574,0.16742,0,0
3,GO SKELETAL MUSCLE TISSUE REGENERATION,0.30815,0.15723,0.03819,0,0
3,GO STRIATED MUSCLE ADAPTATION,0.010245,0.15676,0.16894,0,0
3,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.38888,0.15667,0.16832,0,0
3,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.027188,0.15593,0.23059,0,0
3,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.16828,0.15587,0.11574,0,0
3,GO INACTIVATION OF MAPK ACTIVITY,0.04854,0.15546,0.16209,0,0
3,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.033166,0.15531,0.19608,0,0
3,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.0017123,0.15523,0.12415,0,0
3,GO OSTEOCLAST DEVELOPMENT,0.11841,0.15522,0.10958,0,0
3,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.075049,0.15517,0.10634,0,0
3,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.61497,0.15516,0.0052861,0,0
3,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.36064,0.15498,0.051378,0,0
3,GO CARDIAC CELL DEVELOPMENT,0.0083534,0.15449,0.13005,0,0
3,GO PROTEIN LOCALIZATION TO LYSOSOME,0.024288,0.15432,0.1686,0,0
3,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.22568,0.15398,0.069307,0,0
3,GO TRNA 5 LEADER REMOVAL,0.088862,0.15379,0.11718,0,0
3,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.0064317,0.1536,0.18554,0,0
3,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.27999,0.15343,0.08235,0,0
3,GO KETONE BODY METABOLIC PROCESS,0.082489,0.15342,0.21535,0,0
3,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.26098,0.15326,0.10402,0,0
3,GO ESTROUS CYCLE,0.26098,0.15281,0.098149,0,0
3,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.010245,0.15269,0.1591,0,0
3,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.89907,0.1522,-0.0010796,0,0
3,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.031059,0.15187,0.12085,0,0
3,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.059411,0.15169,0.079176,0,0
3,GO REGULATION OF DEACETYLASE ACTIVITY,0.060602,0.15104,0.14057,0,0
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.11434,0.15025,0.10452,0,0
3,GO MALE MEIOSIS I,0.35153,0.14996,0.14441,0,0
3,GO HEART PROCESS,0.0062634,0.14979,0.12299,0,0
3,GO CELLULAR RESPONSE TO ATP,0.0695,0.14965,0.11593,0,0
3,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.0053338,0.14874,0.13473,0,0
3,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.23589,0.14842,0.13549,0,0
3,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.20937,0.14841,0.18111,0,0
3,GO PEROXISOMAL MEMBRANE TRANSPORT,0.0090226,0.14839,0.15547,0,0
3,GO EMBRYONIC BODY MORPHOGENESIS,0.23245,0.14791,0.059445,0,0
3,GO GLOMERULAR MESANGIUM DEVELOPMENT,0.31232,0.14742,0.054023,0,0
3,GO PROTEIN MANNOSYLATION,0.010773,0.14726,0.16497,0,0
3,GO CELL CELL ADHESION MEDIATED BY CADHERIN,0.0038387,0.14706,0.25087,0,0
3,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.079444,0.14689,0.12038,0,0
3,GO NEUROPEPTIDE SIGNALING PATHWAY,0.009256,0.14573,0.16472,0,0
3,GO OXYGEN TRANSPORT,0.92682,0.14567,-0.030909,0,0
3,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.097379,0.14554,0.10452,0,0
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.01282,0.14548,0.14759,0,0
3,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.0064317,0.14521,0.15737,0,0
3,GO ZINC ION HOMEOSTASIS,0.065563,0.14509,0.18578,0,0
3,GO PIGMENT GRANULE MATURATION,0.27227,0.14507,0.060839,0,0
3,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.29184,0.14416,0.13246,0,0
3,GO ENDOTHELIUM DEVELOPMENT,0.0099891,0.14366,0.13991,0,0
3,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.025994,0.14362,0.15499,0,0
3,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.010506,0.1434,0.14901,0,0
3,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.027803,0.1434,0.13911,0,0
3,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.097379,0.14335,0.1415,0,0
3,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.0056288,0.14306,0.13934,0,0
3,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.097379,0.1429,0.17485,0,0
3,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.05824,0.14226,0.11027,0,0
3,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.049546,0.14212,0.15235,0,0
3,GO BRONCHUS DEVELOPMENT,0.35607,0.14201,0.11033,0,0
3,GO CALCIUM ION REGULATED EXOCYTOSIS,0.0034322,0.1418,0.25497,0,0
3,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.17099,0.14084,0.10594,0,0
3,GO ACTION POTENTIAL,0.0056288,0.14005,0.17085,0,0
3,GO OVARIAN FOLLICLE DEVELOPMENT,0.016339,0.13966,0.12183,0,0
3,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.34702,0.13956,0.057691,0,0
3,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.070855,0.13931,0.14348,0,0
3,GO ASTROCYTE ACTIVATION,0.12689,0.13904,0.08122,0,0
3,GO GLYCINE TRANSPORT,0.29992,0.13864,0.10653,0,0
3,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.077957,0.13861,0.10276,0,0
3,GO MONOVALENT INORGANIC CATION TRANSPORT,0.00023468,0.1382,0.16597,0,0
3,GO RESPIRATORY SYSTEM DEVELOPMENT,0.012508,0.13797,0.11515,0,0
3,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.48678,0.13731,0.0615,0,0
3,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,0.44402,0.13724,0.22943,0,0
3,GO NEGATIVE REGULATION OF AUTOPHAGY,0.014841,0.13655,0.10706,0,0
3,GO RESPONSE TO ESTROGEN,0.10465,0.13653,0.0826,0,0
3,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.029068,0.13613,0.11181,0,0
3,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.0030654,0.1357,0.17406,0,0
3,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.0695,0.13547,0.15249,0,0
3,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.079444,0.13516,0.12742,0,0
3,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.093897,0.13498,0.072314,0,0
3,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.090515,0.13471,0.088222,0,0
3,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.41341,0.13453,-0.021135,0,0
3,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.0085714,0.13449,0.14466,0,0
3,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.23245,0.13448,0.073276,0,0
3,GO ADULT FEEDING BEHAVIOR,0.98953,0.13436,-0.024706,0,0
3,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.007729,0.13422,0.18455,0,0
3,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.48678,0.13411,0.048391,0,0
3,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.33812,0.13409,0.10056,0,0
3,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.11841,0.13377,0.13336,0,0
3,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.10096,0.13324,0.089659,0,0
3,GO MORPHOGENESIS OF AN EPITHELIUM,0.014486,0.13309,0.079046,0,0
3,GO UROGENITAL SYSTEM DEVELOPMENT,0.012508,0.13302,0.10336,0,0
3,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.24643,0.13294,0.07274,0,0
3,GO INFLAMMATORY CELL APOPTOTIC PROCESS,0.10654,0.13282,0.071799,0,0
3,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.087232,0.13281,0.11446,0,0
3,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.12689,0.13276,0.28285,0,0
3,GO NEURON MATURATION,0.030383,0.13274,0.15977,0,0
3,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.079444,0.13267,0.11064,0,0
3,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.21256,0.13265,0.076404,0,0
3,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.54321,0.13233,0.057555,0,0
3,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.27999,0.13184,0.042393,0,0
3,GO RESPONSE TO MUSCLE INACTIVITY,0.11841,0.13177,0.15409,0,0
3,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.019283,0.13173,0.12955,0,0
3,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.14526,0.13167,0.10886,0,0
3,GO ACTIVATION OF MAPKKK ACTIVITY,0.43883,0.13159,0.083137,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.39371,0.1314,0.062377,0,0
3,GO FORMATION OF PRIMARY GERM LAYER,0.088862,0.13126,0.082646,0,0
3,GO MITOTIC CYTOKINETIC PROCESS,0.21905,0.13123,0.073356,0,0
3,GO REGULATION OF PODOSOME ASSEMBLY,0.47588,0.13108,0.025483,0,0
3,GO REGULATION OF VESICLE FUSION,0.17934,0.13086,0.13706,0,0
3,GO POSITIVE REGULATION OF RESPONSE TO TUMOR CELL,0.049546,0.13035,0.1579,0,0
3,GO CARDIAC CONDUCTION,0.024846,0.13035,0.12722,0,0
3,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.011612,0.13,0.1334,0,0
3,GO PROTEIN REFOLDING,0.05824,0.12978,0.15698,0,0
3,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.064293,0.12965,0.13456,0,0
3,GO REGULATION OF HAIR CYCLE,0.027803,0.12943,0.14277,0,0
3,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.084046,0.12898,0.1232,0,0
3,GO SERTOLI CELL DIFFERENTIATION,0.059411,0.12891,0.15451,0,0
3,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.60272,0.12879,0.011491,0,0
3,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.32077,0.12876,0.069147,0,0
3,GO MALE SEX DETERMINATION,0.070855,0.12861,0.16846,0,0
3,GO MYOBLAST DIFFERENTIATION,0.34256,0.12851,0.033266,0,0
3,GO ALDITOL METABOLIC PROCESS,0.27227,0.12838,0.066201,0,0
3,GO OUTER DYNEIN ARM ASSEMBLY,0.10654,0.12829,0.098522,0,0
3,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.0085714,0.12829,0.11307,0,0
3,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.32938,0.12786,0.054288,0,0
3,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.17374,0.12746,0.14352,0,0
3,GO HEME METABOLIC PROCESS,0.080955,0.12742,0.16572,0,0
3,GO FATTY ACID HOMEOSTASIS,0.13583,0.1272,0.15958,0,0
3,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.32938,0.12687,-0.0044477,0,0
3,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.087232,0.12685,0.12488,0,0
3,GO CATECHOLAMINE SECRETION,0.023205,0.1268,0.24712,0,0
3,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.080955,0.12657,0.094145,0,0
3,GO MECHANOSENSORY BEHAVIOR,0.83713,0.12632,0.028712,0,0
3,GO REPRODUCTIVE BEHAVIOR,0.05824,0.12582,0.1147,0,0
3,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.0087944,0.12493,0.11013,0,0
3,GO PENILE ERECTION,0.60883,0.12476,0.035057,0,0
3,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.082489,0.12451,0.099882,0,0
3,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.20621,0.1245,0.1595,0,0
3,GO VAGINA DEVELOPMENT,0.61497,0.12427,0.0049766,0,0
3,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.10654,0.12416,0.1122,0,0
3,GO GRANULOCYTE DIFFERENTIATION,0.26098,0.12336,0.091738,0,0
3,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.0047853,0.12331,0.12672,0,0
3,GO DIVALENT INORGANIC ANION HOMEOSTASIS,0.12908,0.12327,0.12347,0,0
3,GO RESPONSE TO INACTIVITY,0.052669,0.12319,0.1613,0,0
3,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.076492,0.12308,0.10862,0,0
3,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.024288,0.12285,0.1138,0,0
3,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.34702,0.1223,0.049907,0,0
3,GO NOREPINEPHRINE METABOLIC PROCESS,0.31232,0.12229,0.12866,0,0
3,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.52025,0.12189,0.03116,0,0
3,GO BEHAVIORAL RESPONSE TO COCAINE,0.82348,0.12169,0.012127,0,0
3,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.061812,0.12168,0.089102,0,0
3,GO REGULATION OF FAT CELL DIFFERENTIATION,0.013139,0.12157,0.14868,0,0
3,GO T CELL LINEAGE COMMITMENT,0.0034322,0.12133,0.14921,0,0
3,GO STARTLE RESPONSE,0.35607,0.12069,0.062694,0,0
3,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.070855,0.12066,0.093363,0,0
3,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.076492,0.12044,0.11195,0,0
3,GO SEQUESTERING OF ACTIN MONOMERS,0.63978,0.12035,-0.061826,0,0
3,GO CELLULAR RESPONSE TO ZINC ION,0.25001,0.12013,0.21288,0,0
3,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.073629,0.11938,0.10086,0,0
3,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.05161,0.11933,0.27424,0,0
3,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,0.43883,0.11921,0.044096,0,0
3,GO EXOCYTIC PROCESS,0.0062634,0.11885,0.16735,0,0
3,GO REGULATION OF MEMBRANE PERMEABILITY,0.0056288,0.11866,0.14349,0,0
3,GO SULFUR COMPOUND CATABOLIC PROCESS,0.12259,0.11832,0.062122,0,0
3,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.0007696,0.11831,0.19896,0,0
3,GO KIDNEY EPITHELIUM DEVELOPMENT,0.0085714,0.11822,0.12379,0,0
3,GO MITOCHONDRIAL TRNA PROCESSING,0.26098,0.11814,0.090311,0,0
3,GO NEPHRON EPITHELIUM DEVELOPMENT,0.023741,0.1175,0.10238,0,0
3,GO EPIDERMIS MORPHOGENESIS,0.095625,0.11732,0.08941,0,0
3,GO REGULATION OF FLAGELLATED SPERM MOTILITY,0.26471,0.117,0.05709,0,0
3,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.0040578,0.11697,0.14796,0,0
3,GO NEGATIVE REGULATION OF PROTEIN SUMOYLATION,0.40843,0.11667,0.091115,0,0
3,GO REGULATION OF CALCIUM ION IMPORT,0.10845,0.11603,0.11435,0,0
3,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.007729,0.11568,0.11295,0,0
3,GO NAD BIOSYNTHETIC PROCESS,0.087232,0.11557,0.12929,0,0
3,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.090515,0.11541,0.087536,0,0
3,GO OSTEOBLAST DIFFERENTIATION,0.20937,0.11523,0.054891,0,0
3,GO COLLAGEN METABOLIC PROCESS,0.53742,0.11514,0.0082159,0,0
3,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.22568,0.11502,0.057147,0,0
3,GO GASTRULATION,0.077957,0.11499,0.076202,0,0
3,GO MULTI ORGANISM CELLULAR PROCESS,0.085627,0.11497,0.081293,0,0
3,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.27999,0.11463,0.055813,0,0
3,GO POSITIVE REGULATION OF JNK CASCADE,0.00047456,0.11455,0.15183,0,0
3,GO PINOCYTOSIS,0.33812,0.11432,0.03286,0,0
3,GO EPITHELIAL TUBE MORPHOGENESIS,0.017549,0.1143,0.080279,0,0
3,GO CIRCADIAN RHYTHM,0.00041602,0.11423,0.11727,0,0
3,GO REGULATION OF MEMBRANE REPOLARIZATION,0.033894,0.11405,0.12864,0,0
3,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,0.26098,0.11402,0.11894,0,0
3,GO GABAERGIC NEURON DIFFERENTIATION,0.4598,0.11401,0.14089,0,0
3,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.087232,0.11398,0.091669,0,0
3,GO RESPONSE TO HYDROPEROXIDE,0.40349,0.11396,0.066915,0,0
3,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.0015653,0.1138,0.11533,0,0
3,GO LEFT RIGHT PATTERN FORMATION,0.54903,0.11378,0.04251,0,0
3,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.31232,0.11349,0.067146,0,0
3,GO MOLTING CYCLE,0.05824,0.11341,0.080479,0,0
3,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.070855,0.11335,0.060299,0,0
3,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.15015,0.11335,0.099827,0,0
3,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.03939,0.11322,0.11875,0,0
3,GO MITOCHONDRIAL TRANSCRIPTION,0.16828,0.11277,0.11143,0,0
3,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.03939,0.11268,0.12651,0,0
3,GO COENZYME A METABOLIC PROCESS,0.025414,0.11265,0.14801,0,0
3,GO VASCULOGENESIS,0.62732,0.11233,0.0055802,0,0
3,GO CYTOCHROME COMPLEX ASSEMBLY,0.076492,0.11197,0.12067,0,0
3,GO COLLAGEN BIOSYNTHETIC PROCESS,0.87833,0.1117,-0.036542,0,0
3,GO POSITIVE REGULATION OF ION TRANSPORT,0.0030654,0.11151,0.11315,0,0
3,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.012508,0.11148,0.1063,0,0
3,GO MONONUCLEAR CELL DIFFERENTIATION,0.05824,0.11139,0.1485,0,0
3,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.15264,0.1111,0.15907,0,0
3,GO MULTICELLULAR ORGANISM AGING,0.0031536,0.11083,0.14908,0,0
3,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.27611,0.11059,0.16423,0,0
3,GO MALE SEX DIFFERENTIATION,0.021165,0.11057,0.097577,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.040234,0.1103,0.088895,0,0
3,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.11039,0.11028,0.14205,0,0
3,GO EXOCRINE SYSTEM DEVELOPMENT,0.12259,0.11002,0.1112,0,0
3,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.077957,0.10992,0.075812,0,0
3,GO MEMBRANE REPOLARIZATION,0.080955,0.10991,0.10976,0,0
3,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.020205,0.10976,0.10847,0,0
3,GO OPIOID RECEPTOR SIGNALING PATHWAY,0.12908,0.10962,0.14891,0,0
3,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.073629,0.10962,0.1023,0,0
3,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.020205,0.1095,0.17649,0,0
3,GO BLEB ASSEMBLY,0.53742,0.10913,0.0033467,0,0
3,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.19695,0.10901,0.049633,0,0
3,GO FIBROBLAST ACTIVATION,0.27999,0.10891,0.073071,0,0
3,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.011904,0.10883,0.16415,0,0
3,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.025994,0.10835,0.17408,0,0
3,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.19393,0.1083,0.10306,0,0
3,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.025994,0.10796,0.11247,0,0
3,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.030383,0.10788,0.13243,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.13355,0.10783,0.10161,0,0
3,GO PLASMA MEMBRANE TUBULATION,0.22568,0.10781,0.059231,0,0
3,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.036948,0.10757,0.11884,0,0
3,GO HEAD MORPHOGENESIS,0.26847,0.10733,0.040487,0,0
3,GO COPPER ION HOMEOSTASIS,0.064293,0.10731,0.13898,0,0
3,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.035393,0.10727,0.11176,0,0
3,GO AXONEME ASSEMBLY,0.29992,0.10667,0.06727,0,0
3,GO NUCLEOSIDE SALVAGE,0.17934,0.10634,0.055287,0,0
3,GO MUSCLE SYSTEM PROCESS,0.0075304,0.10619,0.090279,0,0
3,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.33812,0.10616,0.022462,0,0
3,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.11235,0.106,0.096947,0,0
3,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.16559,0.10573,0.1262,0,0
3,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,0.36064,0.10564,0.018432,0,0
3,GO AMINO ACID TRANSMEMBRANE TRANSPORT,0.063042,0.10563,0.12163,0,0
3,GO COPULATION,0.050569,0.10553,0.14363,0,0
3,GO POSITIVE REGULATION OF TOR SIGNALING,0.0073363,0.10553,0.10944,0,0
3,GO PIGMENT METABOLIC PROCESS,0.085627,0.1054,0.10718,0,0
3,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.072231,0.10533,0.074595,0,0
3,GO SALIVARY GLAND DEVELOPMENT,0.34702,0.10504,0.056506,0,0
3,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.10654,0.10502,0.06594,0,0
3,GO RESPONSE TO NITRIC OXIDE,0.4545,0.1047,0.031247,0,0
3,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.17653,0.10468,0.12206,0,0
3,GO NEPHRIC DUCT DEVELOPMENT,0.15517,0.10448,0.11537,0,0
3,GO SPROUTING ANGIOGENESIS,0.19695,0.10431,0.043144,0,0
3,GO NEUROTRANSMITTER REUPTAKE,0.19095,0.10431,0.11317,0,0
3,GO EAR DEVELOPMENT,0.21579,0.1042,0.053576,0,0
3,GO PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER,0.16559,0.10417,0.087613,0,0
3,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.67137,0.10386,0.034014,0,0
3,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.93377,0.1037,0.00034562,0,0
3,GO MUSCLE CELL DEVELOPMENT,0.012203,0.10356,0.10829,0,0
3,GO RESPONSE TO AMPHETAMINE,0.20621,0.10345,0.1048,0,0
3,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.16559,0.10344,0.1379,0,0
3,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.57857,0.10325,0.035267,0,0
3,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.11039,0.10243,0.068804,0,0
3,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.035393,0.10243,0.10741,0,0
3,GO ENDODERMAL CELL FATE COMMITMENT,0.16559,0.10237,0.074809,0,0
3,GO VESICLE DOCKING,0.12689,0.10231,0.078868,0,0
3,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.27611,0.10215,0.031886,0,0
3,GO RNA INTERFERENCE,0.35153,0.102,0.065416,0,0
3,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.0056288,0.102,0.095137,0,0
3,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.13355,0.10194,0.10927,0,0
3,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.14285,0.10188,0.061014,0,0
3,GO NEURON REMODELING,0.36526,0.10174,0.045525,0,0
3,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.0031536,0.10095,0.11754,0,0
3,GO DETECTION OF MECHANICAL STIMULUS,0.23245,0.10087,0.065194,0,0
3,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.28785,0.10073,0.045585,0,0
3,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.2839,0.10061,0.063414,0,0
3,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.25363,0.10002,0.043698,0,0
3,GO IMMATURE B CELL DIFFERENTIATION,0.19393,0.09979,0.10758,0,0
3,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.055956,0.099738,0.10223,0,0
3,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.13583,0.099714,0.11418,0,0
3,GO SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL COMMUNICATION,0.30402,0.099607,0.079725,0,0
3,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.42855,0.09941,-0.018086,0,0
3,GO L AMINO ACID TRANSPORT,0.12689,0.099398,0.10571,0,0
3,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.02843,0.099383,0.07807,0,0
3,GO DENDRITIC SPINE MAINTENANCE,0.59059,0.099107,0.029252,0,0
3,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.11636,0.099106,0.095248,0,0
3,GO GLIAL CELL MIGRATION,0.26098,0.098874,0.043816,0,0
3,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.026586,0.098803,0.092432,0,0
3,GO PRE MIRNA PROCESSING,1,0.098802,-0.004958,0,0
3,GO FEMALE SEX DIFFERENTIATION,0.092194,0.098801,0.059032,0,0
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.0060989,0.098721,0.10907,0,0
3,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.045624,0.0985,0.093912,0,0
3,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.10654,0.098397,0.057235,0,0
3,GO CELLULAR COPPER ION HOMEOSTASIS,0.087232,0.098339,0.13686,0,0
3,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.12908,0.098289,0.064185,0,0
3,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.0695,0.098249,0.10452,0,0
3,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.16032,0.098168,0.057718,0,0
3,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,0.50896,0.098063,0.037568,0,0
3,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.32938,0.098051,0.093727,0,0
3,GO REGULATION OF AUTOPHAGOSOME MATURATION,0.5726,0.097994,0.052418,0,0
3,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.20309,0.097911,0.0933,0,0
3,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.11434,0.097774,0.12068,0,0
3,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.24643,0.097655,0.070585,0,0
3,GO REGULATION OF GLOMERULAR FILTRATION,0.65234,0.097462,0.062476,0,0
3,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,0.14769,0.097411,0.14382,0,0
3,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.84397,0.097091,-0.0033403,0,0
3,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.010506,0.097043,0.11804,0,0
3,GO CELLULAR IRON ION HOMEOSTASIS,0.072231,0.0969,0.12234,0,0
3,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.41842,0.096642,0.04892,0,0
3,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.0087944,0.096616,0.11093,0,0
3,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.21905,0.096605,0.061558,0,0
3,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.40349,0.096346,0.074923,0,0
3,GO DEFINITIVE HEMOPOIESIS,0.11434,0.096256,0.06761,0,0
3,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.53742,0.096226,-0.0090607,0,0
3,GO INNER DYNEIN ARM ASSEMBLY,0.55487,0.096201,0.032444,0,0
3,GO REGULATION OF STORE OPERATED CALCIUM ENTRY,0.36526,0.096188,0.092651,0,0
3,GO METANEPHROS DEVELOPMENT,0.16294,0.096005,0.07273,0,0
3,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.35607,0.095994,-0.022874,0,0
3,GO SKIN EPIDERMIS DEVELOPMENT,0.17099,0.095924,0.067628,0,0
3,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.3746,0.095676,0.077559,0,0
3,GO STRIATED MUSCLE CONTRACTION,0.05824,0.095657,0.084676,0,0
3,GO REGULATION OF MEMBRANE INVAGINATION,0.48131,0.095648,0.084902,0,0
3,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.1313,0.095576,0.056476,0,0
3,GO ASTROCYTE DEVELOPMENT,0.33812,0.095451,0.068013,0,0
3,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.14048,0.095321,0.060178,0,0
3,GO BONE MINERALIZATION,0.018398,0.09532,0.13059,0,0
3,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.25363,0.095077,0.10219,0,0
3,GO ACTIN FILAMENT BASED MOVEMENT,0.10465,0.095015,0.066913,0,0
3,GO LACTATE METABOLIC PROCESS,0.26471,0.09489,0.08113,0,0
3,GO RESPONSE TO NICOTINE,0.11636,0.094836,0.099406,0,0
3,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.059411,0.094747,0.12467,0,0
3,GO SECONDARY PALATE DEVELOPMENT,0.2839,0.094628,0.081221,0,0
3,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.28785,0.094588,0.083692,0,0
3,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.30815,0.094181,0.069607,0,0
3,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.0090226,0.093954,0.10995,0,0
3,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.17374,0.093789,0.088391,0,0
3,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.10845,0.093226,0.082962,0,0
3,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.099158,0.093141,0.070059,0,0
3,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.16559,0.093001,0.076543,0,0
3,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.1028,0.092897,0.095827,0,0
3,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.31653,0.092493,0.070291,0,0
3,GO ENDODERM FORMATION,0.25363,0.092242,0.041666,0,0
3,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.29184,0.092151,0.092223,0,0
3,GO THYROID HORMONE METABOLIC PROCESS,0.065563,0.09192,0.097349,0,0
3,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.12689,0.091813,0.11334,0,0
3,GO PROTEIN LOCALIZATION TO AXON,0.30402,0.091773,0.1525,0,0
3,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.16828,0.091766,0.050174,0,0
3,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.47049,0.091259,0.055372,0,0
3,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.43367,0.091171,0.040352,0,0
3,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,0.17653,0.091005,0.045314,0,0
3,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.51459,0.090963,0.030359,0,0
3,GO RESPONSE TO ATP,0.093897,0.090646,0.099222,0,0
3,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.25001,0.090533,0.12131,0,0
3,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.080955,0.090416,0.11146,0,0
3,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.014486,0.090164,0.1196,0,0
3,GO CIRCULATORY SYSTEM DEVELOPMENT,0.085627,0.090132,0.055376,0,0
3,GO MESENCHYMAL CELL PROLIFERATION,0.31232,0.089977,0.032869,0,0
3,GO POSITIVE REGULATION OF PROTEIN IMPORT,0.15015,0.089814,0.084321,0,0
3,GO OXIDATIVE PHOSPHORYLATION,0.061812,0.089634,0.12167,0,0
3,GO AMINO ACID ACTIVATION,0.41341,0.089589,0.05929,0,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.64605,0.089442,0.013774,0,0
3,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.11235,0.089362,0.086264,0,0
3,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.031059,0.089358,0.14167,0,0
3,GO REGULATION OF ODONTOGENESIS,0.29184,0.089323,0.046626,0,0
3,GO MALE MEIOTIC NUCLEAR DIVISION,0.23589,0.089167,0.11116,0,0
3,GO DECIDUALIZATION,0.75615,0.089107,0.0069898,0,0
3,GO COBALAMIN METABOLIC PROCESS,0.015203,0.088844,0.22578,0,0
3,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.054842,0.088771,0.20801,0,0
3,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.44924,0.088699,0.05023,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.11434,0.088393,0.081335,0,0
3,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.29992,0.088363,0.030866,0,0
3,GO SEGMENTATION,0.2,0.08823,0.069849,0,0
3,GO NEGATIVE REGULATION OF GENE SILENCING,0.40349,0.088132,0.032976,0,0
3,GO ADAPTATION OF SIGNALING PATHWAY,0.33812,0.08808,0.047335,0,0
3,GO INTERMEMBRANE LIPID TRANSFER,0.049546,0.087917,0.08362,0,0
3,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.17653,0.087864,0.053091,0,0
3,GO MELANOCYTE DIFFERENTIATION,0.076492,0.087842,0.094866,0,0
3,GO REGULATION OF SYSTEM PROCESS,0.010506,0.0877,0.097332,0,0
3,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.36526,0.087553,0.070229,0,0
3,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.16294,0.087543,0.090362,0,0
3,GO REGULATION OF PROTON TRANSPORT,0.25363,0.087534,0.093441,0,0
3,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.27227,0.087378,0.063791,0,0
3,GO REGULATION OF MIRNA METABOLIC PROCESS,0.63978,0.087347,-0.0024454,0,0
3,GO OSTEOBLAST DEVELOPMENT,0.30815,0.087337,0.024695,0,0
3,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.059411,0.087321,0.10266,0,0
3,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.090515,0.087192,0.05854,0,0
3,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.21579,0.087143,0.054804,0,0
3,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,0.63978,0.087063,0.060404,0,0
3,GO CELLULAR SENESCENCE,0.18508,0.087024,0.045517,0,0
3,GO HEART TRABECULA MORPHOGENESIS,0.23245,0.086939,0.0761,0,0
3,GO APOPTOTIC CELL CLEARANCE,0.12689,0.086734,0.05595,0,0
3,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.83713,0.086649,0.0036561,0,0
3,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.043763,0.086449,0.074338,0,0
3,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.19695,0.086308,0.059935,0,0
3,GO EAR MORPHOGENESIS,0.73628,0.086304,0.00048176,0,0
3,GO VISUAL BEHAVIOR,0.11434,0.086297,0.096315,0,0
3,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.040234,0.086049,0.11952,0,0
3,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.027188,0.086006,0.094757,0,0
3,GO ANIMAL ORGAN MATURATION,0.12259,0.085967,0.10134,0,0
3,GO ENDODERMAL CELL DIFFERENTIATION,0.26847,0.085812,0.023684,0,0
3,GO ALDEHYDE CATABOLIC PROCESS,0.66501,0.085597,0.024883,0,0
3,GO ACTIN CYTOSKELETON REORGANIZATION,0.17934,0.085552,0.038225,0,0
3,GO ERBB2 SIGNALING PATHWAY,0.36991,0.085196,0.074283,0,0
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.013798,0.085034,0.12399,0,0
3,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.072231,0.084504,0.093921,0,0
3,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.16828,0.084393,0.062946,0,0
3,GO OLIGODENDROCYTE DIFFERENTIATION,0.1028,0.08434,0.1024,0,0
3,GO RESPONSE TO INTERLEUKIN 12,0.20309,0.084215,0.072165,0,0
3,GO SEMI LUNAR VALVE DEVELOPMENT,0.60883,0.084099,-0.0091893,0,0
3,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.49227,0.084073,0.063656,0,0
3,GO RESPONSE TO VITAMIN A,0.40349,0.084021,0.040701,0,0
3,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.015203,0.083958,0.099601,0,0
3,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.057089,0.083806,0.08704,0,0
3,GO POSITIVE REGULATION OF OSSIFICATION,0.092194,0.083783,0.11755,0,0
3,GO CARBOHYDRATE PHOSPHORYLATION,0.3746,0.083731,0.056931,0,0
3,GO REGULATION OF PROTEIN FOLDING,0.11636,0.083703,0.072539,0,0
3,GO CELL AGING,0.087232,0.083612,0.057266,0,0
3,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,0.47049,0.083206,0.067221,0,0
3,GO ORGAN INDUCTION,0.36991,0.083051,0.029548,0,0
3,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.084046,0.083047,0.051706,0,0
3,GO POSITIVE REGULATION OF CYTOKINESIS,0.092194,0.082923,0.080432,0,0
3,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.27227,0.082901,0.042672,0,0
3,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.69061,0.082899,0.015562,0,0
3,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.43367,0.082671,0.017528,0,0
3,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.033166,0.082419,0.12636,0,0
3,GO TAXIS,0.31232,0.082279,0.028982,0,0
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.20621,0.082224,0.052422,0,0
3,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.32506,0.082193,0.045701,0,0
3,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.22905,0.082193,0.082619,0,0
3,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.4978,0.082006,0.031071,0,0
3,GO TRNA 5 END PROCESSING,0.51459,0.081992,0.037613,0,0
3,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.29586,0.081854,0.087937,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.063042,0.081837,0.061683,0,0
3,GO RELAXATION OF MUSCLE,0.21579,0.081705,0.079875,0,0
3,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.58456,0.081631,-0.0043759,0,0
3,GO MESODERM MORPHOGENESIS,0.25001,0.08162,0.037084,0,0
3,GO REGULATION OF CELL SHAPE,0.046579,0.081333,0.072151,0,0
3,GO OOCYTE MATURATION,0.42855,0.081327,0.039335,0,0
3,GO PORE COMPLEX ASSEMBLY,0.29586,0.081289,0.060585,0,0
3,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.13814,0.081023,0.1103,0,0
3,GO NATURAL KILLER CELL DIFFERENTIATION,0.23245,0.080885,0.06561,0,0
3,GO ASSOCIATIVE LEARNING,0.21579,0.080732,0.061914,0,0
3,GO GOLGI LOCALIZATION,0.16294,0.080424,0.078471,0,0
3,GO REGULATION OF MRNA CATABOLIC PROCESS,0.67776,0.080304,0.0032341,0,0
3,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.10654,0.080243,0.1003,0,0
3,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.17099,0.080196,0.084925,0,0
3,GO PROTEIN LOCALIZATION TO CELL CORTEX,0.43367,0.080147,0.065026,0,0
3,GO REGULATION OF RECEPTOR RECYCLING,0.13355,0.080115,0.089379,0,0
3,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.12259,0.080052,0.052194,0,0
3,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.76281,0.080049,-0.030881,0,0
3,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.014138,0.079748,0.14229,0,0
3,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.4545,0.079694,-0.034457,0,0
3,GO SYNAPTIC GROWTH AT NEUROMUSCULAR JUNCTION,0.56075,0.079502,0.010937,0,0
3,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.17653,0.079135,0.041999,0,0
3,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.10096,0.078905,0.11387,0,0
3,GO POSITIVE REGULATION OF BINDING,0.068167,0.07883,0.064412,0,0
3,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.076492,0.078711,0.068481,0,0
3,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.66501,0.078646,-0.0092667,0,0
3,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.095625,0.078645,0.04936,0,0
3,GO CARDIAC ATRIUM DEVELOPMENT,0.47049,0.078554,0.048704,0,0
3,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.029719,0.078501,0.09194,0,0
3,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.3746,0.078466,0.042271,0,0
3,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.33812,0.078412,0.037438,0,0
3,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.029068,0.078386,0.085193,0,0
3,GO NEGATIVE REGULATION OF DNA REPLICATION,0.43883,0.078369,0.05533,0,0
3,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.12689,0.078076,0.052235,0,0
3,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.1313,0.078047,0.060387,0,0
3,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.31653,0.078007,0.039504,0,0
3,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.38408,0.077739,0.085871,0,0
3,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.62113,0.077578,-0.0078958,0,0
3,GO KIDNEY MORPHOGENESIS,0.11039,0.077492,0.078141,0,0
3,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.50896,0.077484,0.0088968,0,0
3,GO NCRNA CATABOLIC PROCESS,0.084046,0.077404,0.090495,0,0
3,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.23245,0.076977,0.077604,0,0
3,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.42855,0.076641,0.033579,0,0
3,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.35607,0.076541,0.11536,0,0
3,GO ACTIVATION OF JUN KINASE ACTIVITY,0.034637,0.076033,0.11453,0,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.12689,0.076015,0.07537,0,0
3,GO POLYSACCHARIDE CATABOLIC PROCESS,0.027188,0.075812,0.14086,0,0
3,GO REGULATION OF COLLAGEN METABOLIC PROCESS,0.76948,0.075782,-0.0074538,0,0
3,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.42855,0.075752,0.038156,0,0
3,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.82348,0.075734,-0.0057252,0,0
3,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.035393,0.075328,0.089458,0,0
3,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.4545,0.075112,0.043369,0,0
3,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,0.10845,0.074735,0.13227,0,0
3,GO PROTEIN HOMOTETRAMERIZATION,0.19393,0.074526,0.046931,0,0
3,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.61497,0.074451,0.027052,0,0
3,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.0695,0.074283,0.032854,0,0
3,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.50896,0.074208,0.015193,0,0
3,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.085627,0.074102,0.074198,0,0
3,GO INTERACTION WITH SYMBIONT,0.188,0.073905,0.033449,0,0
3,GO FEAR RESPONSE,0.11039,0.073599,0.083762,0,0
3,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.32506,0.073517,0.10678,0,0
3,GO MUSCLE CONTRACTION,0.026586,0.073422,0.072178,0,0
3,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.95466,0.073409,-0.055241,0,0
3,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.15773,0.073346,0.16217,0,0
3,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.080955,0.073304,0.078487,0,0
3,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.23589,0.073179,0.11029,0,0
3,GO HYPOTONIC RESPONSE,0.72969,0.073158,-0.020131,0,0
3,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.085627,0.073092,0.10744,0,0
3,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.20621,0.073086,0.061027,0,0
3,GO PROTEOGLYCAN METABOLIC PROCESS,0.54321,0.072807,0.014211,0,0
3,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.53167,0.072519,0.031079,0,0
3,GO RECEPTOR METABOLIC PROCESS,0.12908,0.072447,0.0593,0,0
3,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.66501,0.072369,0.056697,0,0
3,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.47049,0.072327,0.0091225,0,0
3,GO DIACYLGLYCEROL METABOLIC PROCESS,0.088862,0.072161,0.17509,0,0
3,GO REGULATION OF BIOMINERALIZATION,0.093897,0.072078,0.087831,0,0
3,GO RHYTHMIC PROCESS,0.02166,0.071908,0.070563,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.52594,0.071897,0.021567,0,0
3,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.030383,0.071895,0.063155,0,0
3,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.33812,0.071874,0.070722,0,0
3,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.16828,0.071858,0.16777,0,0
3,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.15015,0.071805,0.044934,0,0
3,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,0.98953,0.07174,-0.044096,0,0
3,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.072231,0.071636,0.12803,0,0
3,GO RECEPTOR RECYCLING,0.077957,0.071385,0.093364,0,0
3,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.044685,0.071124,0.094626,0,0
3,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.17653,0.070988,0.075201,0,0
3,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.30402,0.070966,0.046962,0,0
3,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.21905,0.070731,0.07224,0,0
3,GO SMOOTH MUSCLE CONTRACTION,0.14048,0.07072,0.051746,0,0
3,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.049546,0.070592,0.07021,0,0
3,GO CELLULAR RESPONSE TO DRUG,0.42855,0.070495,0.035847,0,0
3,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.12689,0.070403,0.1262,0,0
3,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.22905,0.070295,0.10487,0,0
3,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.21579,0.070159,0.057853,0,0
3,GO GLIAL CELL DIFFERENTIATION,0.23589,0.069983,0.068071,0,0
3,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.011612,0.069942,0.085144,0,0
3,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.21579,0.069055,0.042799,0,0
3,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.10465,0.068882,0.10599,0,0
3,GO REGIONALIZATION,0.4545,0.068851,0.037085,0,0
3,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.72313,0.068788,0.031097,0,0
3,GO CELLULAR AMIDE METABOLIC PROCESS,0.093897,0.068631,0.068755,0,0
3,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.12473,0.06828,0.071041,0,0
3,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.12908,0.068275,0.063343,0,0
3,GO INOSITOL LIPID MEDIATED SIGNALING,0.095625,0.068212,0.063652,0,0
3,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.51459,0.068201,0.039798,0,0
3,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,0.61497,0.068077,-0.014656,0,0
3,GO EPITHELIAL TUBE FORMATION,0.44924,0.067992,0.011566,0,0
3,GO CHRONIC INFLAMMATORY RESPONSE,0.41842,0.067664,0.024957,0,0
3,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.14526,0.067443,0.093242,0,0
3,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.35607,0.067441,0.027705,0,0
3,GO PROTEIN COMPLEX OLIGOMERIZATION,0.029068,0.067413,0.074101,0,0
3,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.19393,0.067243,0.073095,0,0
3,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.17653,0.067163,0.055427,0,0
3,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.21256,0.067078,0.09353,0,0
3,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.22235,0.067057,0.05395,0,0
3,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.23245,0.067045,0.085536,0,0
3,GO RESPONSE TO PROSTAGLANDIN E,0.23589,0.066776,0.066118,0,0
3,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,0.36526,0.066657,0.079755,0,0
3,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.093897,0.066577,0.037537,0,0
3,GO RENAL FILTRATION,0.58456,0.066519,0.075008,0,0
3,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.073629,0.066341,0.067573,0,0
3,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.042857,0.066147,0.095043,0,0
3,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.4978,0.065974,0.019837,0,0
3,GO MALE GENITALIA DEVELOPMENT,0.19095,0.065946,0.10174,0,0
3,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.15517,0.06561,0.076533,0,0
3,GO ATP BIOSYNTHETIC PROCESS,0.084046,0.065576,0.1271,0,0
3,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.49227,0.065336,0.019563,0,0
3,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.082489,0.065302,0.079547,0,0
3,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.05824,0.065288,0.093043,0,0
3,GO ARTERY MORPHOGENESIS,0.17653,0.065233,0.034169,0,0
3,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.80989,0.065151,0.012739,0,0
3,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.56666,0.065029,0.0085923,0,0
3,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.38408,0.064984,0.036682,0,0
3,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.061812,0.06495,0.073632,0,0
3,GO GROWTH,0.21579,0.064911,0.035629,0,0
3,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.12689,0.064903,0.084862,0,0
3,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.073629,0.064877,0.052161,0,0
3,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.38408,0.06485,0.030927,0,0
3,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.068167,0.064501,0.068156,0,0
3,GO BODY MORPHOGENESIS,0.23937,0.064498,0.060058,0,0
3,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.42855,0.064425,0.027939,0,0
3,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.095625,0.064362,0.079591,0,0
3,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.20937,0.064185,0.073053,0,0
3,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.63978,0.064167,0.011593,0,0
3,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.036164,0.064146,0.11428,0,0
3,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.25729,0.064037,0.05519,0,0
3,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.42855,0.063868,0.066464,0,0
3,GO OVULATION CYCLE,0.36064,0.063787,0.038622,0,0
3,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.35153,0.063784,0.091551,0,0
3,GO CARDIAC MUSCLE FIBER DEVELOPMENT,0.7495,0.063778,-0.0047469,0,0
3,GO CARDIAC MUSCLE CONTRACTION,0.070855,0.063777,0.086045,0,0
3,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.12473,0.063696,0.060887,0,0
3,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.24643,0.063486,0.06099,0,0
3,GO REGULATION OF URINE VOLUME,0.75615,0.063409,0.0086955,0,0
3,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.11636,0.063131,0.028913,0,0
3,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.16032,0.063116,0.034295,0,0
3,GO MITOTIC CELL CYCLE ARREST,0.25729,0.063056,0.088301,0,0
3,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.27227,0.063032,0.1145,0,0
3,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.25363,0.062982,0.033478,0,0
3,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.21579,0.062931,0.067592,0,0
3,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.49227,0.062815,0.0093288,0,0
3,GO RESPONSE TO BMP,0.059411,0.062751,0.076458,0,0
3,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.62113,0.062441,0.082282,0,0
3,GO AMP METABOLIC PROCESS,0.27999,0.062436,0.11593,0,0
3,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.69061,0.062403,0.003736,0,0
3,GO NOTOCHORD DEVELOPMENT,0.63978,0.062261,-0.026511,0,0
3,GO MITOCHONDRIAL FUSION,0.46512,0.062162,0.056852,0,0
3,GO MITOCHONDRIAL FISSION,0.093897,0.06209,0.10925,0,0
3,GO FEMALE GAMETE GENERATION,0.11235,0.061977,0.058137,0,0
3,GO IRON COORDINATION ENTITY TRANSPORT,0.59059,0.061957,0.091589,0,0
3,GO RESPONSE TO GLUCAGON,0.27999,0.061949,0.077686,0,0
3,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.67137,0.061948,0.010058,0,0
3,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.7495,0.061943,0.018064,0,0
3,GO NUCLEOTIDE PHOSPHORYLATION,0.12473,0.061895,0.067921,0,0
3,GO ANATOMICAL STRUCTURE REGRESSION,0.56075,0.061819,0.050294,0,0
3,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.041967,0.061722,0.13821,0,0
3,GO DEVELOPMENTAL MATURATION,0.03939,0.061688,0.091356,0,0
3,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.85768,0.061522,0.0062243,0,0
3,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.012203,0.06149,0.12123,0,0
3,GO TRABECULA MORPHOGENESIS,0.68418,0.061486,-0.0027062,0,0
3,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,0.31232,0.061458,0.035742,0,0
3,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,0.18508,0.061446,0.087817,0,0
3,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.064293,0.061182,0.071249,0,0
3,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.34702,0.061094,0.024257,0,0
3,GO TOOTH MINERALIZATION,0.25001,0.061016,0.085311,0,0
3,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.36991,0.061011,0.027313,0,0
3,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.090515,0.06082,0.17517,0,0
3,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.17653,0.060628,0.17544,0,0
3,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.56075,0.060556,0.010158,0,0
3,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.76281,0.060103,0.022635,0,0
3,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.17934,0.060049,0.06342,0,0
3,GO PULMONARY VALVE MORPHOGENESIS,0.38888,0.060036,0.079813,0,0
3,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.85768,0.060009,0.019768,0,0
3,GO ESTABLISHMENT OF CELL POLARITY,0.55487,0.059966,0.032471,0,0
3,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,0.61497,0.059856,-0.029397,0,0
3,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.21256,0.05972,0.040414,0,0
3,GO CHAPERONE MEDIATED AUTOPHAGY,0.59664,0.059679,0.036605,0,0
3,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.52594,0.059654,0.14559,0,0
3,GO NEGATIVE REGULATION OF CELL SIZE,0.65866,0.059545,-0.0056144,0,0
3,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.32077,0.059384,0.051808,0,0
3,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.26098,0.059364,0.040879,0,0
3,GO REGULATION OF RECEPTOR CLUSTERING,0.38408,0.059231,0.13518,0,0
3,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.67137,0.059196,-0.022648,0,0
3,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.34256,0.058963,0.076163,0,0
3,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.27227,0.058858,0.064491,0,0
3,GO SEX DIFFERENTIATION,0.068167,0.058835,0.062389,0,0
3,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.51459,0.058752,0.027686,0,0
3,GO LOCOMOTORY BEHAVIOR,0.42347,0.058707,0.062651,0,0
3,GO EXTRACELLULAR MATRIX ASSEMBLY,0.77618,0.058698,0.0060998,0,0
3,GO PHOTOPERIODISM,0.23245,0.058655,0.090981,0,0
3,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.26847,0.058497,0.093029,0,0
3,GO VESICLE CARGO LOADING,0.4545,0.058334,0.067296,0,0
3,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.19393,0.058196,0.11232,0,0
3,GO FOCAL ADHESION ASSEMBLY,0.27999,0.058149,0.034694,0,0
3,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.36991,0.058135,0.070529,0,0
3,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.097379,0.058051,0.065066,0,0
3,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.48678,0.057857,0.047846,0,0
3,GO PROTEASOME ASSEMBLY,0.29184,0.057724,0.079137,0,0
3,GO POSITIVE REGULATION OF ERAD PATHWAY,0.26471,0.057471,0.050584,0,0
3,GO PEPTIDE METABOLIC PROCESS,0.56075,0.057339,0.02397,0,0
3,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,0.65234,0.057249,-0.02434,0,0
3,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.42855,0.057226,0.054451,0,0
3,GO CELL GROWTH,0.20621,0.05709,0.04241,0,0
3,GO TUBE FORMATION,0.53742,0.056972,0.0046051,0,0
3,GO MYOFIBRIL ASSEMBLY,0.057089,0.056969,0.079203,0,0
3,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.37932,0.056963,0.046604,0,0
3,GO EMBRYONIC DIGIT MORPHOGENESIS,0.46512,0.056918,0.038633,0,0
3,GO REGULATION OF CAMP MEDIATED SIGNALING,0.16294,0.056879,0.076124,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.015953,0.056639,0.060391,0,0
3,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.10465,0.056546,0.057929,0,0
3,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.42855,0.056541,0.03802,0,0
3,GO NUCLEAR ENVELOPE REASSEMBLY,0.53167,0.056362,0.022063,0,0
3,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.62732,0.056191,0.011191,0,0
3,GO AMINO ACID TRANSPORT,0.060602,0.056082,0.11599,0,0
3,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.18219,0.055954,0.072937,0,0
3,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.53167,0.055894,0.013049,0,0
3,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.32506,0.05585,0.052677,0,0
3,GO ADULT LOCOMOTORY BEHAVIOR,0.26098,0.055825,0.091084,0,0
3,GO INTERLEUKIN 17 PRODUCTION,0.13355,0.055718,0.1071,0,0
3,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.043763,0.055664,0.058337,0,0
3,GO ANIMAL ORGAN MORPHOGENESIS,0.15015,0.055541,0.043302,0,0
3,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.31232,0.055511,0.10613,0,0
3,GO ECTODERMAL PLACODE DEVELOPMENT,0.58456,0.055412,0.038449,0,0
3,GO LEFT RIGHT AXIS SPECIFICATION,0.67137,0.055322,0.023901,0,0
3,GO REGULATION OF BONE MINERALIZATION,0.29992,0.055238,0.064196,0,0
3,GO REGULATION OF LIPASE ACTIVITY,0.11039,0.055133,0.057972,0,0
3,GO CHONDROCYTE DIFFERENTIATION,0.39858,0.055065,0.043908,0,0
3,GO FEVER GENERATION,0.98255,0.0549,-0.022478,0,0
3,GO REGULATION OF CELL FATE SPECIFICATION,0.41842,0.054843,0.038156,0,0
3,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.063042,0.054803,0.059866,0,0
3,GO FACIAL NERVE MORPHOGENESIS,0.98255,0.05443,-0.050158,0,0
3,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.95466,0.054382,-0.018159,0,0
3,GO URONIC ACID METABOLIC PROCESS,0.079444,0.054346,0.1114,0,0
3,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.37932,0.054245,0.087162,0,0
3,GO POSITIVE REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.8303,0.054123,0.01283,0,0
3,GO INTRACELLULAR MRNA LOCALIZATION,0.69707,0.054071,0.0074812,0,0
3,GO CELL JUNCTION ORGANIZATION,0.2,0.05402,0.048795,0,0
3,GO PIGMENT BIOSYNTHETIC PROCESS,0.58456,0.054001,0.017518,0,0
3,GO NEGATIVE REGULATION OF GROWTH,0.070855,0.053957,0.074336,0,0
3,GO RNA DESTABILIZATION,0.75615,0.053911,-0.007529,0,0
3,GO PROTEIN TETRAMERIZATION,0.38888,0.0539,0.02671,0,0
3,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.94073,0.053628,-0.02763,0,0
3,GO PENTOSE METABOLIC PROCESS,0.65866,0.053617,0.056338,0,0
3,GO NUCLEOSIDE METABOLIC PROCESS,0.23589,0.053128,0.036902,0,0
3,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.33812,0.053,0.020647,0,0
3,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.0099891,0.052841,0.055355,0,0
3,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.29586,0.052765,0.046961,0,0
3,GO RESPONSE TO LIGHT STIMULUS,0.33812,0.05274,0.016312,0,0
3,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.52594,0.052687,0.037446,0,0
3,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.27611,0.052655,0.079664,0,0
3,GO REGULATION OF GLIOGENESIS,0.19393,0.052586,0.077766,0,0
3,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.63978,0.052452,-0.037997,0,0
3,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.65234,0.052341,-0.039327,0,0
3,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.065563,0.052339,0.088517,0,0
3,GO GLIOGENESIS,0.12259,0.052205,0.077302,0,0
3,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,0.30815,0.052178,0.056875,0,0
3,GO PROTEIN DEPHOSPHORYLATION,0.17099,0.052069,0.03707,0,0
3,GO EXTRACELLULAR TRANSPORT,0.42347,0.052048,0.045242,0,0
3,GO CANONICAL WNT SIGNALING PATHWAY,0.52594,0.051921,0.010457,0,0
3,GO EMBRYONIC ORGAN DEVELOPMENT,0.42855,0.051725,0.019944,0,0
3,GO ONE CARBON COMPOUND TRANSPORT,0.20621,0.051649,0.095809,0,0
3,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.57857,0.051569,0.013267,0,0
3,GO HISTONE DEACETYLATION,0.17653,0.05154,0.039627,0,0
3,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,0.29184,0.051385,0.068442,0,0
3,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.50337,0.051342,0.034466,0,0
3,GO REGULATION OF CELL AGING,0.9686,0.050901,-0.012059,0,0
3,GO NEGATIVE REGULATION OF JNK CASCADE,0.3746,0.050852,0.048264,0,0
3,GO RESPONSE TO HYDROXYUREA,0.14048,0.05079,0.09287,0,0
3,GO REGULATION OF PROTEIN IMPORT,0.26471,0.050703,0.053081,0,0
3,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.78962,0.050675,-0.012931,0,0
3,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.79636,0.050572,-0.020343,0,0
3,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.73628,0.050568,0.020235,0,0
3,GO REGULATION OF NUCLEAR DIVISION,0.22905,0.050497,0.033719,0,0
3,GO UV DAMAGE EXCISION REPAIR,0.88523,0.050378,0.0065068,0,0
3,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.90599,0.05034,-0.012954,0,0
3,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.13355,0.050201,0.041869,0,0
3,GO SOMITE DEVELOPMENT,0.090515,0.050049,0.072092,0,0
3,GO EMBRYO DEVELOPMENT,0.21905,0.050045,0.027706,0,0
3,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.32506,0.049998,0.081292,0,0
3,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.19695,0.049935,0.046748,0,0
3,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,0.78289,0.049787,0.045451,0,0
3,GO MODULATION BY HOST OF SYMBIONT PROCESS,0.54903,0.049719,-0.00087817,0,0
3,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.21905,0.049708,0.097942,0,0
3,GO REGULATION OF CELL FATE COMMITMENT,0.44402,0.049694,0.035116,0,0
3,GO PROTEIN IMPORT,0.28785,0.049567,0.044889,0,0
3,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.53742,0.049483,0.042198,0,0
3,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.5726,0.049238,0.016916,0,0
3,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.024288,0.048958,0.076226,0,0
3,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.34702,0.04878,0.03824,0,0
3,GO IRON SULFUR CLUSTER ASSEMBLY,0.18508,0.048723,0.084935,0,0
3,GO DETECTION OF TEMPERATURE STIMULUS,0.34702,0.048576,0.12497,0,0
3,GO CELL AGGREGATION,0.78289,0.048568,-0.043109,0,0
3,GO PROTEIN LOCALIZATION TO NUCLEUS,0.057089,0.048554,0.052307,0,0
3,GO CILIUM MOVEMENT,0.25001,0.048502,0.028161,0,0
3,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.94073,0.048334,-0.0044125,0,0
3,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.34702,0.048048,0.021478,0,0
3,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.39858,0.047898,0.075759,0,0
3,GO MESENCHYME DEVELOPMENT,0.87833,0.047856,-0.024902,0,0
3,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.32077,0.047772,0.074792,0,0
3,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.11636,0.047724,0.047329,0,0
3,GO REGULATION OF PROTEIN SUMOYLATION,0.49227,0.047555,0.023801,0,0
3,GO MUSCLE STRUCTURE DEVELOPMENT,0.082489,0.047539,0.052951,0,0
3,GO NUCLEUS LOCALIZATION,0.98255,0.047429,-0.012129,0,0
3,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.17099,0.047294,0.10379,0,0
3,GO RECEPTOR INTERNALIZATION,0.54321,0.047244,0.012912,0,0
3,GO RESPONSE TO IONIZING RADIATION,0.14048,0.046872,0.034834,0,0
3,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.91987,0.04679,-0.024078,0,0
3,GO NERVOUS SYSTEM PROCESS,0.13583,0.046775,0.048972,0,0
3,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.52025,0.04666,0.019073,0,0
3,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.16828,0.04659,0.08824,0,0
3,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.40843,0.046548,0.045897,0,0
3,GO CHEMOSENSORY BEHAVIOR,0.37932,0.046481,0.06971,0,0
3,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.095625,0.046466,0.15946,0,0
3,GO CALCIUM ION IMPORT INTO CYTOSOL,0.78962,0.046463,-0.053223,0,0
3,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.50896,0.046389,0.077418,0,0
3,GO P BODY ASSEMBLY,0.23937,0.046369,0.038109,0,0
3,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,0.56666,0.046358,0.075385,0,0
3,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.20309,0.046332,0.13447,0,0
3,GO RESPONSE TO MANGANESE ION,0.23245,0.046312,0.096111,0,0
3,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.36526,0.046187,0.054735,0,0
3,GO SENSORY ORGAN MORPHOGENESIS,0.65866,0.045913,0.0032287,0,0
3,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.29992,0.045872,0.050089,0,0
3,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.47588,0.045843,0.020252,0,0
3,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.12473,0.04579,0.046865,0,0
3,GO CRISTAE FORMATION,0.48131,0.045743,0.056539,0,0
3,GO ACTIN CROSSLINK FORMATION,0.89215,0.045711,-0.014886,0,0
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.3746,0.04562,0.05084,0,0
3,GO REGULATION OF GLIAL CELL MIGRATION,0.095625,0.045568,0.089811,0,0
3,GO BRANCH ELONGATION OF AN EPITHELIUM,0.95466,0.045559,-0.017918,0,0
3,GO PROTEIN TARGETING,0.62113,0.045449,0.015466,0,0
3,GO SCHWANN CELL DEVELOPMENT,0.74288,0.045396,0.018154,0,0
3,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.14285,0.045284,0.085782,0,0
3,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.087232,0.045048,0.089322,0,0
3,GO EMBRYO IMPLANTATION,0.60883,0.044889,0.007485,0,0
3,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.50337,0.044881,0.01762,0,0
3,GO RESPONSE TO COCAINE,0.37932,0.044825,0.055115,0,0
3,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.98953,0.044796,-0.0084771,0,0
3,GO AMIDE BIOSYNTHETIC PROCESS,0.74288,0.044713,0.010615,0,0
3,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,0.29184,0.044643,0.033515,0,0
3,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.21579,0.044642,0.051072,0,0
3,GO REGULATION OF WNT SIGNALING PATHWAY,0.66501,0.044577,0.0040417,0,0
3,GO NEURONAL ION CHANNEL CLUSTERING,0.32506,0.044559,0.12645,0,0
3,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.38888,0.044526,0.058174,0,0
3,GO ENDOCRINE SYSTEM DEVELOPMENT,0.095625,0.04444,0.10485,0,0
3,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.46512,0.044402,0.044775,0,0
3,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.019739,0.044368,0.052998,0,0
3,GO MODULATION BY HOST OF VIRAL PROCESS,0.36526,0.044077,0.010018,0,0
3,GO NEGATIVE REGULATION OF CELL CYCLE,0.093897,0.043904,0.036025,0,0
3,GO REGULATION OF GLUTAMATE SECRETION,0.60883,0.043882,0.058652,0,0
3,GO BLASTOCYST FORMATION,0.16032,0.043822,0.09391,0,0
3,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.78289,0.043615,0.0046231,0,0
3,GO REGULATION OF GASTRULATION,0.86455,0.043568,-0.01454,0,0
3,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.66501,0.043435,0.023407,0,0
3,GO ACTIVATION OF JNKK ACTIVITY,0.47049,0.043421,0.063295,0,0
3,GO PHOTORECEPTOR CELL MAINTENANCE,0.54321,0.043282,0.017454,0,0
3,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.43367,0.043214,0.044014,0,0
3,GO CONNECTIVE TISSUE DEVELOPMENT,0.23937,0.043051,0.036818,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,0.27227,0.043008,0.076643,0,0
3,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.11841,0.042982,0.19131,0,0
3,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.8303,0.042896,-0.027599,0,0
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.35607,0.042823,0.048039,0,0
3,GO ONE CARBON METABOLIC PROCESS,0.42347,0.042816,0.02511,0,0
3,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.52594,0.042646,0.046605,0,0
3,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.80989,0.042305,0.010008,0,0
3,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.029068,0.04229,0.044249,0,0
3,GO REGULATION OF VIRAL TRANSCRIPTION,0.26098,0.04229,0.021769,0,0
3,GO RESPONSE TO GAMMA RADIATION,0.26471,0.042283,0.056224,0,0
3,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.53742,0.042168,0.011615,0,0
3,GO EMBRYONIC MORPHOGENESIS,0.22905,0.042161,0.032293,0,0
3,GO POSITIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.31232,0.042074,0.057159,0,0
3,GO CELL CYCLE ARREST,0.16294,0.042035,0.039697,0,0
3,GO POSITIVE REGULATION OF CELL DIVISION,0.099158,0.041936,0.064437,0,0
3,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.066855,0.04187,0.13993,0,0
3,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.23589,0.041819,0.025696,0,0
3,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.20621,0.04176,0.032992,0,0
3,GO SYNAPTIC VESICLE RECYCLING,0.4978,0.041733,0.057795,0,0
3,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.69061,0.041596,0.0066916,0,0
3,GO DETECTION OF ABIOTIC STIMULUS,0.15773,0.041456,0.056178,0,0
3,GO AXIS SPECIFICATION,0.25363,0.041449,0.057028,0,0
3,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.46512,0.041337,0.062684,0,0
3,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.70355,0.04128,0.026005,0,0
3,GO REGULATION OF CELL DIFFERENTIATION,0.13355,0.041239,0.047863,0,0
3,GO RESPONSE TO RADIATION,0.11841,0.041161,0.032154,0,0
3,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.93377,0.041121,0.0058915,0,0
3,GO HEART INDUCTION,0.52025,0.041036,0.10633,0,0
3,GO ASTROCYTE DIFFERENTIATION,0.43367,0.04098,0.06926,0,0
3,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.22568,0.040884,0.051202,0,0
3,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.14769,0.040851,0.04398,0,0
3,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.88523,0.040838,0.0056364,0,0
3,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.21905,0.040792,0.052256,0,0
3,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.23937,0.040554,0.034269,0,0
3,GO MESENCHYMAL CELL DIFFERENTIATION,0.40349,0.04051,0.025162,0,0
3,GO CELLULAR RESPONSE TO RETINOIC ACID,0.50896,0.04039,0.015946,0,0
3,GO MITOCHONDRIAL GENE EXPRESSION,0.50337,0.040335,0.033682,0,0
3,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.65234,0.040236,0.0090227,0,0
3,GO INNERVATION,0.61497,0.040206,0.097203,0,0
3,GO INNER EAR MORPHOGENESIS,0.91987,0.040206,0.0017738,0,0
3,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.86455,0.040161,-0.021146,0,0
3,GO MAST CELL MIGRATION,0.95466,0.040077,-0.021272,0,0
3,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.13355,0.040033,0.03187,0,0
3,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.69061,0.039649,0.047027,0,0
3,GO NEURAL TUBE DEVELOPMENT,0.72313,0.039554,-0.0032661,0,0
3,GO NON RECOMBINATIONAL REPAIR,0.42855,0.039547,0.012108,0,0
3,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.23245,0.039209,0.09747,0,0
3,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.20621,0.03918,0.045262,0,0
3,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.22235,0.03917,0.030833,0,0
3,GO DEMETHYLATION,0.25001,0.039089,0.037449,0,0
3,GO REGULATION OF PROTEIN TARGETING,0.41842,0.039031,0.035171,0,0
3,GO ACTIVATION OF MAPKK ACTIVITY,0.39858,0.038878,0.044954,0,0
3,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.84397,0.038697,0.00077981,0,0
3,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.51459,0.038663,0.05321,0,0
3,GO RESPONSE TO FOOD,0.65234,0.038661,0.013935,0,0
3,GO AORTA MORPHOGENESIS,0.67776,0.038486,0.019141,0,0
3,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.62113,0.038378,0.0062195,0,0
3,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.66501,0.038343,0.017038,0,0
3,GO ESTABLISHMENT OF TISSUE POLARITY,0.17099,0.038318,0.052115,0,0
3,GO REGULATION OF DNA METHYLATION,0.60883,0.038087,0.024935,0,0
3,GO CRANIAL NERVE MORPHOGENESIS,0.98953,0.037694,-0.010139,0,0
3,GO CELL CELL SIGNALING BY WNT,0.50896,0.037668,0.016765,0,0
3,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,0.62113,0.037168,-0.00082158,0,0
3,GO LAMELLIPODIUM ASSEMBLY,0.67776,0.03673,0.01356,0,0
3,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.61497,0.036548,0.026751,0,0
3,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.7495,0.036527,-0.0060596,0,0
3,GO NOTCH RECEPTOR PROCESSING,0.17934,0.036393,0.20076,0,0
3,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.095625,0.036357,0.084528,0,0
3,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.76281,0.036288,0.013687,0,0
3,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.60272,0.036027,0.028554,0,0
3,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.31232,0.035896,0.093368,0,0
3,GO MAINTENANCE OF PROTEIN LOCATION,0.85082,0.035786,-0.0059435,0,0
3,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.72313,0.035768,0.020491,0,0
3,GO REGULATION OF STEM CELL DIFFERENTIATION,0.71658,0.035714,0.002747,0,0
3,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.59664,0.035495,0.030037,0,0
3,GO DNA METHYLATION OR DEMETHYLATION,0.21256,0.035473,0.048821,0,0
3,GO NEPHRON MORPHOGENESIS,0.26847,0.035462,0.055412,0,0
3,GO NEGATIVE REGULATION OF CELL DIVISION,0.87144,0.03545,0.017669,0,0
3,GO SPERM MOTILITY,0.58456,0.035378,0.016818,0,0
3,GO MIDDLE EAR MORPHOGENESIS,0.83713,0.035375,-0.041824,0,0
3,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,0.1028,0.034873,0.12571,0,0
3,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.25363,0.034791,0.032155,0,0
3,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.52594,0.034776,0.019598,0,0
3,GO CELL CELL SIGNALING,0.18508,0.034724,0.046973,0,0
3,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.20309,0.03472,0.037004,0,0
3,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.92682,0.034688,-0.0097378,0,0
3,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.21905,0.034688,0.052754,0,0
3,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,0.58456,0.034476,-0.011015,0,0
3,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.69707,0.034331,-0.053794,0,0
3,GO CARDIOCYTE DIFFERENTIATION,0.53742,0.034295,0.017724,0,0
3,GO HINDBRAIN MORPHOGENESIS,0.87144,0.03429,-0.011317,0,0
3,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.63978,0.034231,0.029636,0,0
3,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.78962,0.034106,-0.038409,0,0
3,GO FEMALE GENITALIA DEVELOPMENT,0.76948,0.033974,0.011245,0,0
3,GO NEUROTRANSMITTER UPTAKE,0.33373,0.033922,0.076767,0,0
3,GO CARDIAC MUSCLE CELL CONTRACTION,0.188,0.033881,0.082199,0,0
3,GO MAINTENANCE OF CELL NUMBER,0.52594,0.033876,-0.047037,0,0
3,GO NEUTROPHIL HOMEOSTASIS,0.89215,0.033818,-0.05783,0,0
3,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.95466,0.033783,-0.018418,0,0
3,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.72969,0.033591,0.038976,0,0
3,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.29992,0.033487,0.10367,0,0
3,GO HETEROCHROMATIN ORGANIZATION,0.78289,0.033398,-0.0081706,0,0
3,GO GENITALIA DEVELOPMENT,0.3746,0.033369,0.04214,0,0
3,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,0.38408,0.033288,0.031323,0,0
3,GO HISTONE SERINE PHOSPHORYLATION,0.61497,0.033273,0.066255,0,0
3,GO CELLULAR COMPONENT MAINTENANCE,0.60272,0.032966,0.031371,0,0
3,GO RESPONSE TO MURAMYL DIPEPTIDE,0.77618,0.032961,-0.017983,0,0
3,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.27227,0.032682,0.042895,0,0
3,GO PROTEIN LOCALIZATION TO ORGANELLE,0.31653,0.032657,0.021492,0,0
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.14526,0.032368,0.077539,0,0
3,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.27611,0.032312,0.05625,0,0
3,GO CELLULAR RESPONSE TO AMYLOID BETA,0.188,0.032257,0.089203,0,0
3,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.90599,0.032236,3.1671e-05,0,0
3,GO DETECTION OF LIGHT STIMULUS,0.41842,0.031867,0.0029024,0,0
3,GO REGULATION OF ORGANELLE ORGANIZATION,0.23245,0.031845,0.024856,0,0
3,GO CELLULAR RESPONSE TO MANGANESE ION,0.98953,0.031841,0.012655,0,0
3,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.56666,0.031803,0.019934,0,0
3,GO REGULATION OF PINOCYTOSIS,0.75615,0.031751,-0.071713,0,0
3,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.14048,0.031319,0.035736,0,0
3,GO CELL CELL JUNCTION MAINTENANCE,0.78962,0.031201,0.010735,0,0
3,GO MEMORY,0.75615,0.031107,0.018439,0,0
3,GO DENDRITE EXTENSION,0.31653,0.031001,0.13701,0,0
3,GO RESPONSE TO HEAT,0.27999,0.030897,0.058005,0,0
3,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.90599,0.030862,-0.0091785,0,0
3,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.10465,0.030787,0.039093,0,0
3,GO MEIOTIC CELL CYCLE PROCESS,0.21579,0.03062,0.039038,0,0
3,GO NEURON APOPTOTIC PROCESS,0.62732,0.030602,0.015878,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS,0.99651,0.030439,0.0053379,0,0
3,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.62113,0.030352,0.020389,0,0
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.22905,0.030282,0.093015,0,0
3,GO MESODERM DEVELOPMENT,0.9686,0.03026,-0.025098,0,0
3,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.42347,0.030211,0.015076,0,0
3,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.51459,0.030137,0.011891,0,0
3,GO MEIOTIC CELL CYCLE,0.076492,0.030082,0.054515,0,0
3,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.79636,0.030063,-0.0030847,0,0
3,GO REGULATION OF MACROAUTOPHAGY,0.024846,0.030058,0.088116,0,0
3,GO RESPONSE TO AUDITORY STIMULUS,0.62113,0.030046,0.070369,0,0
3,GO RAP PROTEIN SIGNAL TRANSDUCTION,0.77618,0.029943,-0.0017849,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,0.46512,0.029812,0.025807,0,0
3,GO CYTOSKELETON ORGANIZATION,0.54321,0.029734,0.013577,0,0
3,GO ORGANELLE FISSION,0.63354,0.02926,0.015023,0,0
3,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.54903,0.02925,0.019691,0,0
3,GO EMBRYONIC ORGAN MORPHOGENESIS,0.87144,0.029206,-0.018431,0,0
3,GO NEGATIVE REGULATION OF GLIOGENESIS,0.55487,0.029126,0.070655,0,0
3,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.89907,0.028734,-0.010588,0,0
3,GO PEPTIDYL THREONINE MODIFICATION,0.097379,0.028506,0.063989,0,0
3,GO HISTONE H2B UBIQUITINATION,0.42347,0.028447,0.030871,0,0
3,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.11434,0.028412,0.041724,0,0
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.35607,0.028241,0.045926,0,0
3,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,0.73628,0.02809,-0.027679,0,0
3,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.9686,0.028082,-0.010954,0,0
3,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.42347,0.028053,0.14391,0,0
3,GO MITOCHONDRION ORGANIZATION,0.015953,0.028023,0.086002,0,0
3,GO LACTATION,0.63978,0.027991,0.034412,0,0
3,GO CORTICAL CYTOSKELETON ORGANIZATION,0.71006,0.027868,0.019554,0,0
3,GO POSITIVE REGULATION OF RNA SPLICING,0.57857,0.027614,0.04404,0,0
3,GO VESICLE CYTOSKELETAL TRAFFICKING,0.54321,0.027405,0.037724,0,0
3,GO PEPTIDE CROSS LINKING,0.39858,0.027351,0.025012,0,0
3,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,0.17099,0.027215,0.041093,0,0
3,GO SPERM AXONEME ASSEMBLY,0.98953,0.027162,0.018262,0,0
3,GO SCHWANN CELL DIFFERENTIATION,0.73628,0.027138,0.0088882,0,0
3,GO CELLULAR RESPONSE TO NUTRIENT,0.27227,0.027079,0.06634,0,0
3,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.8303,0.026971,-0.017106,0,0
3,GO SARCOMERE ORGANIZATION,0.15773,0.026711,0.086404,0,0
3,GO ACTIN MEDIATED CELL CONTRACTION,0.31653,0.026652,0.047765,0,0
3,GO ODONTOGENESIS,0.83713,0.026651,-0.011361,0,0
3,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.35153,0.02652,0.020493,0,0
3,GO SPERMATID DIFFERENTIATION,0.36991,0.026227,0.029517,0,0
3,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.11434,0.026201,0.060385,0,0
3,GO THYMUS DEVELOPMENT,0.61497,0.02619,0.020784,0,0
3,GO EMBRYONIC AXIS SPECIFICATION,0.60272,0.026127,0.053295,0,0
3,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.53742,0.026108,0.0081611,0,0
3,GO REGULATION OF CHROMATIN ORGANIZATION,0.17934,0.026092,0.028451,0,0
3,GO TRABECULA FORMATION,0.89215,0.026012,-0.012114,0,0
3,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.88523,0.025932,-0.0064676,0,0
3,GO REGULATION OF CIRCADIAN RHYTHM,0.16294,0.025895,0.06891,0,0
3,GO PULMONARY VALVE DEVELOPMENT,0.31653,0.025895,0.092235,0,0
3,GO REGULATION OF GOLGI ORGANIZATION,0.55487,0.025854,0.050206,0,0
3,GO PREPULSE INHIBITION,0.81668,0.025845,0.028049,0,0
3,GO STEM CELL DIFFERENTIATION,0.96163,0.025825,-0.0093098,0,0
3,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.47049,0.025704,0.021988,0,0
3,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.41842,0.025528,0.10606,0,0
3,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.18508,0.025503,0.082666,0,0
3,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.94769,0.025471,-0.008592,0,0
3,GO REGULATION OF NEUROMUSCULAR JUNCTION DEVELOPMENT,0.75615,0.025463,-0.084545,0,0
3,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.51459,0.02543,0.019006,0,0
3,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.4978,0.025324,0.017556,0,0
3,GO SKELETAL SYSTEM DEVELOPMENT,0.47049,0.025248,0.0097946,0,0
3,GO PROTEIN TRIMERIZATION,0.62113,0.025029,0.018804,0,0
3,GO REGULATION OF MITOTIC CELL CYCLE,0.22568,0.025025,0.029264,0,0
3,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.63978,0.024911,0.015552,0,0
3,GO PROTEIN NITROSYLATION,0.65866,0.024743,-0.10542,0,0
3,GO TETRAHYDROFOLATE INTERCONVERSION,0.93377,0.024707,-0.039749,0,0
3,GO NEGATIVE REGULATION OF CELL GROWTH,0.18508,0.024691,0.044286,0,0
3,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.98953,0.024522,0.0043738,0,0
3,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.47049,0.024482,0.018338,0,0
3,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.85768,0.024415,-0.015151,0,0
3,GO BEHAVIOR,0.58456,0.024406,0.026024,0,0
3,GO NAD METABOLIC PROCESS,0.49227,0.024308,0.050882,0,0
3,GO PROTEIN TARGETING TO MEMBRANE,0.3746,0.024114,-0.084086,0,0
3,GO INTERLEUKIN 2 PRODUCTION,0.59664,0.024049,-0.015875,0,0
3,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.65234,0.024004,0.049562,0,0
3,GO REGULATION OF DEVELOPMENTAL GROWTH,0.97557,0.023984,-0.011405,0,0
3,GO TRANSEPITHELIAL TRANSPORT,0.31232,0.023844,0.081651,0,0
3,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.55487,0.023795,-0.074549,0,0
3,GO GONADOTROPIN SECRETION,0.49227,0.023791,0.052507,0,0
3,GO CARTILAGE DEVELOPMENT,0.81668,0.023637,-0.0086189,0,0
3,GO NEURAL PRECURSOR CELL PROLIFERATION,0.85768,0.023633,0.015408,0,0
3,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.76948,0.023442,-0.036681,0,0
3,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,0.76281,0.023381,0.035916,0,0
3,GO REGULATION OF CELLULAR COMPONENT SIZE,0.58456,0.02338,0.01324,0,0
3,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.38888,0.023294,0.029234,0,0
3,GO NOSE DEVELOPMENT,0.76281,0.023162,0.12717,0,0
3,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.63978,0.023112,0.048793,0,0
3,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.67776,0.02292,0.055159,0,0
3,GO MATING,0.13355,0.022884,0.080614,0,0
3,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.24288,0.02287,0.033336,0,0
3,GO FIBROBLAST MIGRATION,0.29184,0.022815,0.041707,0,0
3,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.37932,0.022632,0.023373,0,0
3,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.79636,0.02249,-0.01182,0,0
3,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.64605,0.02248,0.0088129,0,0
3,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.92682,0.022411,-0.021291,0,0
3,GO GAS TRANSPORT,0.87144,0.022044,-0.062267,0,0
3,GO PROTEIN LOCALIZATION TO MEMBRANE,0.44924,0.021976,0.016585,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.41341,0.021956,0.033382,0,0
3,GO MUSCLE TISSUE DEVELOPMENT,0.40349,0.021927,0.019648,0,0
3,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.4545,0.021813,0.031315,0,0
3,GO NEGATIVE REGULATION OF BINDING,0.19393,0.021519,0.05382,0,0
3,GO POST EMBRYONIC DEVELOPMENT,0.89215,0.021335,-0.0067532,0,0
3,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.74288,0.0213,0.01034,0,0
3,GO MEIOSIS I CELL CYCLE PROCESS,0.38888,0.021269,0.030204,0,0
3,GO EPIBOLY,0.75615,0.021246,-0.034192,0,0
3,GO REGULATION OF HISTONE MODIFICATION,0.14769,0.021225,0.035604,0,0
3,GO DEVELOPMENTAL GROWTH,1,0.021126,-0.0081999,0,0
3,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.62732,0.021121,0.010915,0,0
3,GO LENS FIBER CELL DEVELOPMENT,0.86455,0.02108,-0.03892,0,0
3,GO STEM CELL PROLIFERATION,0.9686,0.021075,-0.0044063,0,0
3,GO IMPORT INTO NUCLEUS,0.63978,0.020955,0.020848,0,0
3,GO CARDIAC ATRIUM MORPHOGENESIS,0.76281,0.020929,-0.026821,0,0
3,GO CGMP MEDIATED SIGNALING,0.93377,0.020828,-0.0067005,0,0
3,GO DNA BIOSYNTHETIC PROCESS,0.98255,0.020656,-0.0097086,0,0
3,GO OVULATION,0.62113,0.020487,0.04514,0,0
3,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.25001,0.020467,0.079161,0,0
3,GO CAMERA TYPE EYE MORPHOGENESIS,0.4978,0.020352,0.031063,0,0
3,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.25729,0.020244,0.16011,0,0
3,GO MULTI ORGANISM LOCALIZATION,0.80989,0.020111,-0.038431,0,0
3,GO BONE DEVELOPMENT,0.61497,0.019888,-0.04669,0,0
3,GO PRIMARY MIRNA PROCESSING,0.80989,0.019718,-0.0032944,0,0
3,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.48131,0.01965,0.050798,0,0
3,GO PROTEIN INSERTION INTO MEMBRANE,0.29586,0.019542,0.040817,0,0
3,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.3746,0.019479,0.071884,0,0
3,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.43883,0.019268,0.011277,0,0
3,GO REGULATION OF BMP SIGNALING PATHWAY,0.86455,0.01924,-0.027435,0,0
3,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.54903,0.019237,0.036026,0,0
3,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.99651,0.019191,-0.01557,0,0
3,GO GROOMING BEHAVIOR,0.50337,0.019189,0.077944,0,0
3,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.4598,0.019168,0.031089,0,0
3,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.24643,0.019002,0.12213,0,0
3,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.65234,0.018939,-0.029615,0,0
3,GO SENSORY PERCEPTION OF PAIN,0.35607,0.018849,0.05649,0,0
3,GO NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.94073,0.018829,-0.0041949,0,0
3,GO REGULATION OF TORC1 SIGNALING,0.49227,0.018711,0.024526,0,0
3,GO NEURAL TUBE FORMATION,0.59664,0.018698,0.011271,0,0
3,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.94073,0.018538,-0.01199,0,0
3,GO PROSTATE GLAND GROWTH,0.40349,0.018361,-0.10166,0,0
3,GO REGULATION OF CELL DIVISION,0.52025,0.018301,0.015435,0,0
3,GO CELL FATE DETERMINATION,0.4545,0.018261,0.059586,0,0
3,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.88523,0.018213,-0.020088,0,0
3,GO REGULATION OF CELL CYCLE,0.26847,0.018136,0.022745,0,0
3,GO REGULATION OF SPINDLE ASSEMBLY,0.2839,0.018044,0.053325,0,0
3,GO NUCLEOBASE METABOLIC PROCESS,0.72969,0.01745,0.016849,0,0
3,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.98255,0.017339,-0.030954,0,0
3,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.30402,0.017337,0.049662,0,0
3,GO LIPID PHOSPHORYLATION,0.36064,0.017276,0.056485,0,0
3,GO CARDIAC VENTRICLE MORPHOGENESIS,0.8303,0.017271,0.0020989,0,0
3,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.59059,0.017141,0.044297,0,0
3,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.4978,0.01689,0.076821,0,0
3,GO CLATHRIN COAT ASSEMBLY,0.71006,0.016886,0.030761,0,0
3,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.26847,0.016872,0.049862,0,0
3,GO COPII COATED VESICLE CARGO LOADING,0.7495,0.016838,-0.0028083,0,0
3,GO AXONAL FASCICULATION,0.27611,0.016757,-0.14903,0,0
3,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.59664,0.016195,0.016979,0,0
3,GO REGULATION OF GTP BINDING,0.71658,0.016185,0.016075,0,0
3,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.78962,0.01614,-0.03024,0,0
3,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.66501,0.016127,0.017335,0,0
3,GO MIRNA METABOLIC PROCESS,0.72969,0.0161,-0.031214,0,0
3,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.63978,0.016087,0.016904,0,0
3,GO FOLIC ACID METABOLIC PROCESS,0.69707,0.016065,-0.076157,0,0
3,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.78289,0.016048,0.022729,0,0
3,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.41341,0.016019,0.026363,0,0
3,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.14526,0.015792,0.040633,0,0
3,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,0.5726,0.015701,0.18886,0,0
3,GO REGULATION OF MITOCHONDRIAL FISSION,0.59664,0.015312,0.063305,0,0
3,GO T CELL CHEMOTAXIS,0.54321,0.015228,0.029947,0,0
3,GO ERYTHROCYTE DEVELOPMENT,0.79636,0.015212,0.0063515,0,0
3,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.98255,0.015161,-0.0013809,0,0
3,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.14769,0.014969,0.084416,0,0
3,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.72313,0.014966,-0.034289,0,0
3,GO EXIT FROM MITOSIS,0.29586,0.014795,0.043032,0,0
3,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.94769,0.014766,-0.014946,0,0
3,GO PROSTATE GLAND DEVELOPMENT,0.92682,0.014729,-0.045331,0,0
3,GO REGULATION OF MEMBRANE POTENTIAL,0.36991,0.014652,0.056592,0,0
3,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,0.85768,0.014628,-0.044145,0,0
3,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.50896,0.014571,0.065866,0,0
3,GO SKELETAL MUSCLE CONTRACTION,0.89907,0.014412,-0.0089159,0,0
3,GO REGULATION OF GASTRIC ACID SECRETION,0.31653,0.014218,0.09118,0,0
3,GO CELL JUNCTION DISASSEMBLY,0.74288,0.014058,0.009727,0,0
3,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.98255,0.013813,-0.0095307,0,0
3,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.67776,0.013799,0.056447,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.48678,0.013789,-0.04268,0,0
3,GO SENSORY ORGAN DEVELOPMENT,0.76281,0.013713,0.0037211,0,0
3,GO GLUCOSE CATABOLIC PROCESS,0.61497,0.013537,0.043141,0,0
3,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.89907,0.013499,0.027259,0,0
3,GO SKELETAL MUSCLE ADAPTATION,0.19095,0.013475,0.1123,0,0
3,GO SEQUESTERING OF EXTRACELLULAR LIGAND FROM RECEPTOR,0.69707,0.01347,0.0047271,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.76281,0.013316,0.0026569,0,0
3,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.28785,0.013238,0.043547,0,0
3,GO RESPONSE TO AXON INJURY,0.91987,0.012986,0.023324,0,0
3,GO GMP METABOLIC PROCESS,0.7495,0.012972,0.020027,0,0
3,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.63978,0.01297,0.023587,0,0
3,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.43367,0.012773,0.066346,0,0
3,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.63978,0.012737,0.11942,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.56075,0.012651,0.017759,0,0
3,GO POSITIVE REGULATION OF URINE VOLUME,0.82348,0.012631,-0.032104,0,0
3,GO STEM CELL DIVISION,0.94769,0.012459,-0.013368,0,0
3,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.30815,0.012357,0.096762,0,0
3,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.76948,0.012318,0.0017036,0,0
3,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.85768,0.012316,0.0011812,0,0
3,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.98953,0.012239,-0.019114,0,0
3,GO HEART DEVELOPMENT,0.62732,0.012161,0.0057915,0,0
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.90599,0.012153,-0.016608,0,0
3,GO ASYMMETRIC CELL DIVISION,0.59664,0.012129,0.049008,0,0
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.47588,0.012071,0.077536,0,0
3,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.56075,0.011817,0.025317,0,0
3,GO PATTERN SPECIFICATION PROCESS,1,0.011787,0.0029713,0,0
3,GO SNRNA METABOLIC PROCESS,0.69061,0.011723,0.00048124,0,0
3,GO C4 DICARBOXYLATE TRANSPORT,0.43883,0.011682,0.034575,0,0
3,GO CELL VOLUME HOMEOSTASIS,0.36526,0.011393,0.060473,0,0
3,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.37932,0.011361,0.01369,0,0
3,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.58456,0.011244,0.031785,0,0
3,GO VENTRICULAR SEPTUM DEVELOPMENT,0.75615,0.010976,-0.025398,0,0
3,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,0.88523,0.010754,-0.0083325,0,0
3,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.62732,0.010689,0.027507,0,0
3,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.91987,0.010521,-0.013754,0,0
3,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.4598,0.010342,0.019015,0,0
3,GO MEIOTIC CHROMOSOME SEGREGATION,0.96163,0.010182,-0.006151,0,0
3,GO RESPONSE TO ZINC ION,0.31653,0.010175,0.091626,0,0
3,GO RESPONSE TO CATECHOLAMINE,0.2,0.010136,0.071143,0,0
3,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,0.83713,0.010117,0.014589,0,0
3,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.51459,0.010003,0.02836,0,0
3,GO REGULATION OF CENTROSOME DUPLICATION,0.39371,0.0099619,0.045195,0,0
3,GO BLASTODERM SEGMENTATION,0.84397,0.0098449,0.010104,0,0
3,GO MATING BEHAVIOR,0.31232,0.0097485,0.059523,0,0
3,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.73628,0.0095508,-0.032428,0,0
3,GO MINERALOCORTICOID METABOLIC PROCESS,0.70355,0.0093804,0.026158,0,0
3,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.36991,0.0092685,0.13654,0,0
3,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.69061,0.009234,-0.059395,0,0
3,GO RESPONSE TO SALT STRESS,0.90599,0.0092217,-0.042308,0,0
3,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.76281,0.0091165,-0.0050107,0,0
3,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.96163,0.0090925,-0.0057177,0,0
3,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.73628,0.0090643,-0.021024,0,0
3,GO REGULATION OF TRANSPORTER ACTIVITY,0.54903,0.0090588,0.023583,0,0
3,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.53742,0.0090282,-0.039955,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.50896,0.008992,0.011987,0,0
3,GO POSITIVE REGULATION OF TRANSLATION,0.67137,0.008959,-0.04329,0,0
3,GO URETER DEVELOPMENT,0.88523,0.0088026,-0.018765,0,0
3,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.63978,0.0085937,0.018115,0,0
3,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,0.78289,0.0085769,-0.016371,0,0
3,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.72969,0.0085082,-0.020926,0,0
3,GO RNA CATABOLIC PROCESS,0.66501,0.0084772,-0.038041,0,0
3,GO CELL CYCLE,0.56666,0.0084447,0.010456,0,0
3,GO DOSAGE COMPENSATION,0.47588,0.0084009,0.035544,0,0
3,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.65234,0.0080867,0.038,0,0
3,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.29184,0.0080775,0.083199,0,0
3,GO NUCLEUS ORGANIZATION,0.52025,0.008064,0.02936,0,0
3,GO NEUROTROPHIN SIGNALING PATHWAY,0.91293,0.0075867,0.014314,0,0
3,GO PEPTIDE BIOSYNTHETIC PROCESS,0.70355,0.0075789,-0.034708,0,0
3,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.3746,0.0075068,0.021479,0,0
3,GO REGULATION OF TUBULIN DEACETYLATION,0.96163,0.0074931,0.038441,0,0
3,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.86455,0.0074216,-0.025918,0,0
3,GO HISTONE PHOSPHORYLATION,0.89215,0.007421,0.0015828,0,0
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.77618,0.0069705,-0.00045353,0,0
3,GO REGULATION OF T CELL CHEMOTAXIS,0.32077,0.0068155,0.072315,0,0
3,GO HEART VALVE DEVELOPMENT,0.79636,0.0066038,-0.046335,0,0
3,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.4598,0.0065511,-0.095486,0,0
3,GO MITOTIC CELL CYCLE CHECKPOINT,0.98255,0.0065002,0.0020607,0,0
3,GO REGULATION OF CELL SIZE,0.34702,0.006397,-0.06008,0,0
3,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.80989,0.0063649,0.014609,0,0
3,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.63978,0.006228,-0.035415,0,0
3,GO APOPTOTIC DNA FRAGMENTATION,0.78289,0.0061784,-0.010814,0,0
3,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.69061,0.006102,-0.026409,0,0
3,GO THALAMUS DEVELOPMENT,0.87144,0.0060879,0.0036378,0,0
3,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.62732,0.006015,0.022171,0,0
3,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.71658,0.0060114,-0.060158,0,0
3,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.85082,0.0060098,-0.00029438,0,0
3,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.58456,0.0059773,-0.071655,0,0
3,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.33373,0.0057673,0.091193,0,0
3,GO VIRAL LATENCY,0.38888,0.0052867,-0.074654,0,0
3,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.53167,0.0052433,-0.080266,0,0
3,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.99651,0.0052401,-0.0026309,0,0
3,GO PROTEIN POLYMERIZATION,0.54321,0.0047163,0.01262,0,0
3,GO CELL CYCLE G1 S PHASE TRANSITION,0.65866,0.0042493,0.0057702,0,0
3,GO REGULATION OF MRNA 3 END PROCESSING,0.65866,0.0042074,-0.042499,0,0
3,GO GASTRIC ACID SECRETION,0.27611,0.0040789,0.085376,0,0
3,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.63354,0.0039649,0.023311,0,0
3,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.88523,0.0039346,0.018381,0,0
3,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.29184,0.0039155,-0.067295,0,0
3,GO SYNAPTIC TRANSMISSION GABAERGIC,0.32938,0.0038577,-0.080622,0,0
3,GO GENE SILENCING,0.84397,0.0038318,-0.0074708,0,0
3,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.87833,0.0035935,-0.027271,0,0
3,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.78289,0.0035646,-0.010131,0,0
3,GO COLLATERAL SPROUTING,0.54321,0.0034704,-0.060792,0,0
3,GO PROTEIN HETEROOLIGOMERIZATION,0.94769,0.0033489,-0.014553,0,0
3,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.80312,0.003258,-0.029354,0,0
3,GO RESPONSE TO POTASSIUM ION,0.99651,0.0032238,0.014537,0,0
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.84397,0.0031868,0.00159,0,0
3,GO MICROTUBULE BUNDLE FORMATION,0.65866,0.0031868,0.022507,0,0
3,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.44402,0.0030704,-0.1007,0,0
3,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.97557,0.0027072,-0.0081611,0,0
3,GO EYE MORPHOGENESIS,0.87833,0.0024693,-0.0024072,0,0
3,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.63978,0.0023917,0.026217,0,0
3,GO REGULATION OF LIPID KINASE ACTIVITY,0.72313,0.0023163,-0.016565,0,0
3,GO CYTOKINESIS,0.60272,0.0021484,-0.019632,0,0
3,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.56075,0.0020618,0.10632,0,0
3,GO MITOTIC CYTOKINESIS,0.63978,0.0020523,-0.023103,0,0
3,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.95466,0.0020182,-0.011244,0,0
3,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.42855,0.0019623,-0.085427,0,0
3,GO SLEEP,0.67137,0.0014995,0.031883,0,0
3,GO CARDIAC CHAMBER MORPHOGENESIS,0.90599,0.0013498,-0.0087565,0,0
3,GO LIVER REGENERATION,0.58456,0.0012106,0.020699,0,0
3,GO REGULATION OF CELL CYCLE ARREST,0.94769,0.0011459,0.0066865,0,0
3,GO DORSAL SPINAL CORD DEVELOPMENT,0.92682,0.00099671,0.059918,0,0
3,GO CELLULAR RESPONSE TO SALT STRESS,0.25363,0.00087035,-0.1736,0,0
3,GO SERTOLI CELL DEVELOPMENT,0.91293,0.00084762,-0.037136,0,0
3,GO HISTONE H4 ACETYLATION,0.71006,0.00069771,-0.0089618,0,0
3,GO RENAL VESICLE DEVELOPMENT,0.87833,0.00064562,-0.039808,0,0
3,GO FAT CELL PROLIFERATION,0.77618,0.0005883,0.061886,0,0
3,GO SNRNA PROCESSING,0.71658,0.00055464,-0.01551,0,0
3,GO ORGAN GROWTH,0.65234,0.00048808,-0.030809,0,0
3,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.88523,0.00047488,0.027247,0,0
3,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.66501,0.00034271,-0.019393,0,0
3,GO MITOCHONDRIAL TRANSLATION,0.73628,0.00022451,0.019912,0,0
3,GO RHYTHMIC BEHAVIOR,0.56666,0.0001069,0.035352,0,0
3,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.99651,3.143e-05,0.001107,0,0
3,GO PROTEIN ACYLATION,0.85768,-0.00024996,-0.0028709,0,0
3,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.98953,-0.00038887,-0.00036282,0,0
3,GO DEVELOPMENTAL CELL GROWTH,0.35607,-0.00049897,-0.056187,0,0
3,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.93377,-0.00050837,-0.010659,0,0
3,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.69707,-0.00081348,-0.01521,0,0
3,GO HOMOCYSTEINE METABOLIC PROCESS,0.67137,-0.00086761,0.060961,0,0
3,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.93377,-0.00088807,-0.011489,0,0
3,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.76948,-0.00093506,0.057206,0,0
3,GO REGULATION OF MRNA METABOLIC PROCESS,0.38888,-0.00097242,-0.035599,0,0
3,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.97557,-0.0012966,-0.008831,0,0
3,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.9686,-0.0013502,0.012903,0,0
3,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.35607,-0.0014883,-0.068288,0,0
3,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.9686,-0.0015716,-0.0095622,0,0
3,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.69707,-0.0016769,0.0079229,0,0
3,GO PROTEIN SUMOYLATION,0.71658,-0.0017536,-0.014062,0,0
3,GO CELL CYCLE CHECKPOINT,0.98953,-0.0017607,0.00071649,0,0
3,GO REGULATION OF CILIUM MOVEMENT,0.67776,-0.0018792,0.013659,0,0
3,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.78962,-0.0019009,-0.0094556,0,0
3,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.63978,-0.0019052,-0.046582,0,0
3,GO TRNA METABOLIC PROCESS,0.75615,-0.0021242,-0.017922,0,0
3,GO FOREGUT MORPHOGENESIS,0.85768,-0.0021372,-0.042638,0,0
3,GO TRICARBOXYLIC ACID METABOLIC PROCESS,0.42347,-0.0022656,0.135,0,0
3,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.83713,-0.0023913,-0.037724,0,0
3,GO CAMERA TYPE EYE DEVELOPMENT,0.9686,-0.0024189,-0.01563,0,0
3,GO EMBRYONIC PATTERN SPECIFICATION,0.79636,-0.002492,0.024513,0,0
3,GO AROMATIC AMINO ACID TRANSPORT,0.60883,-0.0025105,0.061525,0,0
3,GO SHORT TERM MEMORY,0.92682,-0.0028841,0.00053802,0,0
3,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,1,-0.0030308,0.017755,0,0
3,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.42855,-0.0030575,-0.034355,0,0
3,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.54321,-0.0031276,-0.019459,0,0
3,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.82348,-0.0031422,-0.013797,0,0
3,GO NEURAL NUCLEUS DEVELOPMENT,0.52025,-0.0031778,0.075657,0,0
3,GO HISTONE H3 ACETYLATION,0.80312,-0.0035999,-0.011776,0,0
3,GO CELL PROJECTION ASSEMBLY,0.76281,-0.0036031,-0.0052728,0,0
3,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.40843,-0.0037107,-0.083102,0,0
3,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.7495,-0.0040149,0.027933,0,0
3,GO OVULATION CYCLE PROCESS,0.63354,-0.0042615,0.035674,0,0
3,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.38888,-0.0042751,0.054749,0,0
3,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.63354,-0.0043654,0.017407,0,0
3,GO CELL RECOGNITION,0.88523,-0.0044357,-0.023453,0,0
3,GO MIDBRAIN DEVELOPMENT,0.98255,-0.0045843,-0.010593,0,0
3,GO MISMATCH REPAIR,0.89907,-0.0048811,-0.013421,0,0
3,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.48678,-0.0048972,-0.076549,0,0
3,GO ECTODERM DEVELOPMENT,0.73628,-0.0051001,0.015658,0,0
3,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.71658,-0.0051557,-0.017538,0,0
3,GO DNA METHYLATION,0.76948,-0.0052058,0.014379,0,0
3,GO PROTEIN KINASE A SIGNALING,0.58456,-0.0053306,-0.040961,0,0
3,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.98255,-0.0054491,-0.0075691,0,0
3,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.97557,-0.0055743,0.0050539,0,0
3,GO RNA MODIFICATION,0.95466,-0.0055853,0.0038147,0,0
3,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.84397,-0.0056127,-0.011958,0,0
3,GO REGULATION OF ORGANELLE ASSEMBLY,0.36064,-0.0056131,-0.024288,0,0
3,GO CALCINEURIN MEDIATED SIGNALING,0.50337,-0.0056448,0.031438,0,0
3,GO NEUROMUSCULAR PROCESS,0.73628,-0.0057154,-0.015909,0,0
3,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.58456,-0.0057303,-0.091276,0,0
3,GO REGULATION OF GROWTH HORMONE SECRETION,0.86455,-0.0058936,0.051424,0,0
3,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.97557,-0.0061566,0.0059058,0,0
3,GO HISTONE MONOUBIQUITINATION,0.71006,-0.0062517,-0.02165,0,0
3,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.31653,-0.0064352,-0.035951,0,0
3,GO 3 UTR MEDIATED MRNA STABILIZATION,0.54903,-0.0064846,-0.061611,0,0
3,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.72313,-0.006763,-0.02112,0,0
3,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.97557,-0.0068262,0.010858,0,0
3,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.97557,-0.006845,0.00078776,0,0
3,GO ORGANELLE ASSEMBLY,0.75615,-0.006988,-0.005642,0,0
3,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.71658,-0.0070064,-0.039795,0,0
3,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,0.77618,-0.0070098,0.038608,0,0
3,GO SENSORY SYSTEM DEVELOPMENT,0.76281,-0.0070389,-0.016891,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.39858,-0.0070777,-0.067484,0,0
3,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.51459,-0.0071088,0.015935,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.76948,-0.0074392,0.022019,0,0
3,GO PROSTATE GLAND MORPHOGENESIS,0.91293,-0.0074641,-0.067676,0,0
3,GO DICARBOXYLIC ACID TRANSPORT,0.78962,-0.0075573,0.02817,0,0
3,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.64605,-0.007575,0.10613,0,0
3,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.85082,-0.0076437,0.016566,0,0
3,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.58456,-0.0077049,-0.040708,0,0
3,GO CHROMATIN ORGANIZATION,0.15773,-0.0077785,-0.037228,0,0
3,GO PROTEIN DEPOLYMERIZATION,0.48678,-0.0081449,0.034864,0,0
3,GO DNA METABOLIC PROCESS,0.54903,-0.0082761,-0.01732,0,0
3,GO MESENCHYME MORPHOGENESIS,0.66501,-0.008537,-0.059339,0,0
3,GO CELL MORPHOGENESIS,0.4598,-0.008646,-0.038784,0,0
3,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.69061,-0.0088006,-0.033882,0,0
3,GO DNA INTEGRITY CHECKPOINT,0.87833,-0.0090552,-0.0056212,0,0
3,GO MATERNAL PLACENTA DEVELOPMENT,0.50337,-0.009062,-0.071338,0,0
3,GO CELL FATE COMMITMENT,0.94769,-0.0091725,-0.0034617,0,0
3,GO SPECIFICATION OF SYMMETRY,0.56666,-0.0091866,-0.037284,0,0
3,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.36991,-0.0096037,-0.045483,0,0
3,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.23937,-0.009606,-0.098452,0,0
3,GO MITOTIC NUCLEAR DIVISION,0.54903,-0.0099063,-0.016816,0,0
3,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,0.67137,-0.010001,0.069817,0,0
3,GO RESPONSE TO AMINO ACID STARVATION,0.43367,-0.010028,0.044379,0,0
3,GO NADH METABOLIC PROCESS,0.9686,-0.01004,0.01605,0,0
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.71006,-0.010061,-0.0094545,0,0
3,GO INNATE IMMUNE RESPONSE IN MUCOSA,0.85768,-0.010197,-0.019854,0,0
3,GO MITOCHONDRIAL DNA REPLICATION,0.91293,-0.010331,-0.0076282,0,0
3,GO SKELETAL SYSTEM MORPHOGENESIS,0.35153,-0.010377,-0.058368,0,0
3,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.96163,-0.010398,0.022065,0,0
3,GO REGULATION OF ATPASE ACTIVITY,0.32938,-0.010415,-0.035674,0,0
3,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.24643,-0.010478,0.073993,0,0
3,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.82348,-0.010551,-0.034006,0,0
3,GO REGULATION OF PROTEIN POLYMERIZATION,0.9686,-0.010885,-0.0054614,0,0
3,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.36064,-0.010969,-0.069405,0,0
3,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.59664,-0.010973,-0.059297,0,0
3,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.94073,-0.011012,-0.02526,0,0
3,GO NUCLEAR TRANSPORT,0.83713,-0.011158,-0.013088,0,0
3,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.50337,-0.011252,0.044104,0,0
3,GO MAINTENANCE OF ORGANELLE LOCATION,0.82348,-0.011263,-0.025714,0,0
3,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.80312,-0.011466,0.0089978,0,0
3,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.64605,-0.011524,-0.019612,0,0
3,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.89907,-0.011682,0.00085986,0,0
3,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.80989,-0.011938,0.01246,0,0
3,GO REGULATION OF TRANSLATIONAL INITIATION,0.39371,-0.012524,-0.044384,0,0
3,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.83713,-0.012742,0.017303,0,0
3,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.44402,-0.012743,-0.044168,0,0
3,GO EXPLORATION BEHAVIOR,0.34702,-0.012843,-0.12663,0,0
3,GO METAPHASE PLATE CONGRESSION,0.64605,-0.012878,-0.0083785,0,0
3,GO TRANSLATIONAL TERMINATION,0.95466,-0.012956,-0.0030393,0,0
3,GO REGULATION OF POTASSIUM ION TRANSPORT,0.84397,-0.013051,0.012517,0,0
3,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.68418,-0.013471,-0.0069939,0,0
3,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.23589,-0.013886,-0.054542,0,0
3,GO NEURON CELL CELL ADHESION,0.56666,-0.013907,0.13344,0,0
3,GO CELL CYCLE PROCESS,0.60883,-0.013946,-0.0082385,0,0
3,GO HISTONE H2A UBIQUITINATION,0.55487,-0.01426,-0.034206,0,0
3,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.47588,-0.014529,-0.021754,0,0
3,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.99651,-0.014639,0.0047365,0,0
3,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.41842,-0.014843,-0.040254,0,0
3,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.59059,-0.014982,-0.037388,0,0
3,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.47049,-0.015098,-0.050701,0,0
3,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.99651,-0.01521,-0.0047032,0,0
3,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.49227,-0.015257,-0.12041,0,0
3,GO GROWTH HORMONE SECRETION,0.75615,-0.015544,0.053312,0,0
3,GO REGULATION OF SKELETAL MUSCLE CONTRACTION,0.69707,-0.015611,0.087341,0,0
3,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,1,-0.015625,0.0088442,0,0
3,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.53167,-0.015629,-0.1075,0,0
3,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,1,-0.015669,-0.02248,0,0
3,GO RESPONSE TO UV,0.36064,-0.015797,-0.034688,0,0
3,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,1,-0.015821,0.00029287,0,0
3,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.69061,-0.015872,-0.039852,0,0
3,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.55487,-0.015887,-0.019774,0,0
3,GO POSITIVE REGULATION OF TORC1 SIGNALING,1,-0.015969,0.022446,0,0
3,GO POSITIVE REGULATION OF VESICLE FUSION,0.86455,-0.016172,0.0012504,0,0
3,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.60272,-0.016178,0.033559,0,0
3,GO TONIC SMOOTH MUSCLE CONTRACTION,0.56075,-0.016252,0.08987,0,0
3,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.78289,-0.016387,0.007264,0,0
3,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.40349,-0.016685,-0.096856,0,0
3,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.83713,-0.01681,-0.011352,0,0
3,GO NCRNA 3 END PROCESSING,0.85768,-0.01681,-0.046326,0,0
3,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.93377,-0.016926,-0.012596,0,0
3,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.79636,-0.016988,0.029703,0,0
3,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.16559,-0.016996,-0.059848,0,0
3,GO MUSCLE ORGAN MORPHOGENESIS,0.89907,-0.017062,-0.022323,0,0
3,GO PROTEIN TARGETING TO MITOCHONDRION,0.72313,-0.017077,0.0040782,0,0
3,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.75615,-0.017118,-0.072343,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.66501,-0.017424,0.036304,0,0
3,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.78289,-0.017621,0.051411,0,0
3,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.32938,-0.01782,-0.075313,0,0
3,GO FIBROBLAST APOPTOTIC PROCESS,0.97557,-0.017859,-0.017759,0,0
3,GO REGULATION OF CELL MORPHOGENESIS,0.36991,-0.017897,-0.042517,0,0
3,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.29586,-0.017918,-0.068776,0,0
3,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.38888,-0.017988,-0.063842,0,0
3,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.64605,-0.018003,-0.014869,0,0
3,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.68418,-0.018162,-0.050112,0,0
3,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,0.76948,-0.018169,-0.039575,0,0
3,GO DNA DOUBLE STRAND BREAK PROCESSING,0.67776,-0.018189,-0.013073,0,0
3,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.87144,-0.018252,0.01536,0,0
3,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.46512,-0.018275,-0.036512,0,0
3,GO ESCRT COMPLEX DISASSEMBLY,0.87833,-0.018478,-0.0023342,0,0
3,GO COVALENT CHROMATIN MODIFICATION,0.22235,-0.018604,-0.034954,0,0
3,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.99651,-0.018739,-0.010346,0,0
3,GO HOMOLOGOUS RECOMBINATION,0.90599,-0.018759,-0.006775,0,0
3,GO APICAL PROTEIN LOCALIZATION,0.85768,-0.018834,0.012016,0,0
3,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.63354,-0.018862,-0.011884,0,0
3,GO GENITALIA MORPHOGENESIS,0.92682,-0.01887,-0.011814,0,0
3,GO MITOTIC METAPHASE PLATE CONGRESSION,0.72313,-0.018888,0.022297,0,0
3,GO CELL JUNCTION MAINTENANCE,0.75615,-0.019102,-0.0035952,0,0
3,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.4598,-0.019171,-0.088647,0,0
3,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.12473,-0.019252,-0.08514,0,0
3,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.61497,-0.019617,-0.026358,0,0
3,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.69707,-0.01965,0.0095855,0,0
3,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.29184,-0.020162,0.17742,0,0
3,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.87833,-0.020215,-0.017973,0,0
3,GO REGULATION OF HISTONE UBIQUITINATION,0.4545,-0.02061,-0.033159,0,0
3,GO REGULATION OF GONAD DEVELOPMENT,0.77618,-0.020674,-0.022841,0,0
3,GO REGULATION OF PROTEIN ACETYLATION,0.7495,-0.020789,-0.0037496,0,0
3,GO NUCLEAR EXPORT,0.40349,-0.020947,-0.044678,0,0
3,GO SKELETAL MUSCLE CELL PROLIFERATION,0.71658,-0.020975,-0.042594,0,0
3,GO MITOTIC CELL CYCLE,0.74288,-0.021035,-0.0048467,0,0
3,GO PEPTIDYL LYSINE MODIFICATION,0.12908,-0.021459,-0.029435,0,0
3,GO LENS FIBER CELL DIFFERENTIATION,0.90599,-0.021707,0.010636,0,0
3,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.57857,-0.021921,-0.0405,0,0
3,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.86455,-0.022055,0.026317,0,0
3,GO MEIOTIC CHROMOSOME SEPARATION,0.21905,-0.022341,-0.083313,0,0
3,GO CARDIAC VENTRICLE DEVELOPMENT,0.73628,-0.022437,-0.016642,0,0
3,GO HISTONE ARGININE METHYLATION,0.53167,-0.022489,-0.036456,0,0
3,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.19695,-0.022566,-0.038606,0,0
3,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.78289,-0.022575,-0.022652,0,0
3,GO CELL CYCLE PHASE TRANSITION,0.71006,-0.022622,-0.0069463,0,0
3,GO RNA METHYLATION,0.59664,-0.022639,-0.02466,0,0
3,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.35607,-0.022648,-0.044624,0,0
3,GO G2 DNA DAMAGE CHECKPOINT,0.53167,-0.022669,-0.045009,0,0
3,GO HEART MORPHOGENESIS,0.51459,-0.022696,-0.044093,0,0
3,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.98255,-0.022882,-0.00035379,0,0
3,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.50896,-0.023377,-0.07117,0,0
3,GO RESPONSE TO AMYLOID BETA,0.91293,-0.02338,0.018491,0,0
3,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.57857,-0.023552,-0.11074,0,0
3,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.75615,-0.023832,0.018154,0,0
3,GO REGULATION OF MRNA BINDING,0.50337,-0.02397,-0.078393,0,0
3,GO CELLULAR RESPONSE TO HEAT,0.69707,-0.024105,-0.020706,0,0
3,GO DIGESTIVE TRACT MORPHOGENESIS,0.9686,-0.024944,-0.0051794,0,0
3,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.37932,-0.024982,-0.075947,0,0
3,GO REGULATION OF ENDOCYTIC RECYCLING,0.42855,-0.025181,-0.072946,0,0
3,GO REGULATION OF CELL CYCLE PROCESS,0.55487,-0.02531,-0.012414,0,0
3,GO MRNA TRANSCRIPTION,0.63354,-0.025321,-0.03538,0,0
3,GO CENTROSOME DUPLICATION,0.59059,-0.025433,-0.017343,0,0
3,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.79636,-0.025606,-0.00096759,0,0
3,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,0.48678,-0.025711,-0.062688,0,0
3,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.97557,-0.025727,0.0012505,0,0
3,GO CEREBELLAR CORTEX FORMATION,0.76281,-0.025747,-0.0069536,0,0
3,GO CARDIAC MYOFIBRIL ASSEMBLY,0.59059,-0.025789,-0.03823,0,0
3,GO NCRNA EXPORT FROM NUCLEUS,0.44924,-0.025926,-0.055057,0,0
3,GO REGULATION OF CENTROSOME CYCLE,0.49227,-0.025936,-0.009549,0,0
3,GO CELL DIVISION,0.21579,-0.025965,-0.03303,0,0
3,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.68418,-0.026226,-0.017521,0,0
3,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.48678,-0.026327,-0.044314,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.98953,-0.026392,-0.013372,0,0
3,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.36991,-0.026579,-0.052064,0,0
3,GO CHROMOSOME LOCALIZATION,0.30815,-0.026631,-0.028685,0,0
3,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.59664,-0.026756,-0.067775,0,0
3,GO RETINA LAYER FORMATION,0.74288,-0.027094,0.083181,0,0
3,GO SNRNA TRANSCRIPTION,0.17099,-0.027128,-0.049012,0,0
3,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,0.36991,-0.027206,-0.052366,0,0
3,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.48131,-0.027391,-0.013454,0,0
3,GO REGULATION OF ORGAN GROWTH,0.35607,-0.027411,-0.058997,0,0
3,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.33812,-0.027483,-0.062271,0,0
3,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.48678,-0.02758,-0.01564,0,0
3,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.87144,-0.027583,0.03631,0,0
3,GO MITOTIC SPINDLE ASSEMBLY,0.52594,-0.027674,-0.020697,0,0
3,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.77618,-0.027827,-0.008157,0,0
3,GO TROPHOBLAST CELL MIGRATION,0.67776,-0.027919,-0.082361,0,0
3,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.89215,-0.028076,-0.016867,0,0
3,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.80312,-0.028149,-0.019137,0,0
3,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.82348,-0.028184,-0.022667,0,0
3,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.31232,-0.028214,-0.061327,0,0
3,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.12908,-0.028263,-0.092717,0,0
3,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.86455,-0.028342,0.0026729,0,0
3,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,0.53167,-0.028375,0.017653,0,0
3,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.30402,-0.028439,-0.090551,0,0
3,GO ESTABLISHMENT OF RNA LOCALIZATION,0.20937,-0.02848,-0.05852,0,0
3,GO DNA REPAIR,0.084046,-0.028518,-0.04233,0,0
3,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.80312,-0.028615,-0.013609,0,0
3,GO GANGLION DEVELOPMENT,0.87833,-0.028822,0.087987,0,0
3,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,0.60272,-0.028968,-0.052322,0,0
3,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.68418,-0.029655,0.029141,0,0
3,GO REGULATION OF GENE SILENCING,0.58456,-0.02983,-0.035427,0,0
3,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.57857,-0.030053,0.018513,0,0
3,GO CHROMATIN SILENCING AT TELOMERE,0.50337,-0.030054,-0.038355,0,0
3,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.4545,-0.030079,-0.050712,0,0
3,GO NCRNA METABOLIC PROCESS,0.54903,-0.03015,-0.044692,0,0
3,GO HISTONE H3 K36 METHYLATION,0.31232,-0.030342,-0.071674,0,0
3,GO AORTIC VALVE DEVELOPMENT,0.68418,-0.030357,-0.066702,0,0
3,GO SEQUESTERING OF METAL ION,0.59059,-0.030489,-0.075976,0,0
3,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.83713,-0.030935,-0.024167,0,0
3,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.40843,-0.031055,-0.046399,0,0
3,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.76948,-0.031067,-0.0056368,0,0
3,GO ADULT BEHAVIOR,0.83713,-0.031205,0.024984,0,0
3,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.57857,-0.031264,-0.038492,0,0
3,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.53742,-0.031285,-0.041953,0,0
3,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.62113,-0.031384,-0.049077,0,0
3,GO PEPTIDYL LYSINE ACETYLATION,0.17934,-0.031417,-0.036961,0,0
3,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.26847,-0.031428,-0.058735,0,0
3,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.5726,-0.031543,-0.040804,0,0
3,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.32077,-0.031609,-0.099853,0,0
3,GO REGULATION OF TRANSLATIONAL FIDELITY,0.77618,-0.031665,-0.033371,0,0
3,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.40349,-0.031714,-0.031258,0,0
3,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.93377,-0.031719,0.0013517,0,0
3,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.54903,-0.031778,-0.032364,0,0
3,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.75615,-0.031787,0.040144,0,0
3,GO REGULATION OF CHROMOSOME ORGANIZATION,0.21579,-0.031872,-0.028788,0,0
3,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.55487,-0.031966,0.02073,0,0
3,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.26847,-0.031982,-0.036872,0,0
3,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.92682,-0.032024,-0.023037,0,0
3,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.40843,-0.032232,-0.012306,0,0
3,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.91987,-0.032318,-0.0066512,0,0
3,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.59059,-0.032356,-0.022482,0,0
3,GO CELLULAR RESPONSE TO ETHANOL,0.54903,-0.032536,0.052742,0,0
3,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.49227,-0.032719,-0.13902,0,0
3,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.68418,-0.032742,-0.021592,0,0
3,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.32506,-0.033064,-0.060411,0,0
3,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.81668,-0.033094,-0.012032,0,0
3,GO SULFATION,0.85768,-0.033342,-0.011329,0,0
3,GO RESPONSE TO DOPAMINE,0.71006,-0.033581,0.023965,0,0
3,GO CELL PROJECTION ORGANIZATION,0.40349,-0.033903,-0.027694,0,0
3,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.82348,-0.034009,-0.014217,0,0
3,GO THYROID GLAND DEVELOPMENT,0.27227,-0.034281,-0.12155,0,0
3,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.34256,-0.034562,-0.074132,0,0
3,GO HEART GROWTH,0.63978,-0.034562,-0.021517,0,0
3,GO ERROR FREE TRANSLESION SYNTHESIS,0.71658,-0.034744,-0.0091381,0,0
3,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.78289,-0.034803,0.024652,0,0
3,GO MRNA METHYLATION,0.12689,-0.034825,-0.1075,0,0
3,GO RNA POLYADENYLATION,0.099158,-0.035341,-0.071831,0,0
3,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.23589,-0.035397,-0.11432,0,0
3,GO NUCLEAR MIGRATION,0.43367,-0.035397,-0.070288,0,0
3,GO CHONDROCYTE PROLIFERATION,0.34702,-0.035419,-0.12086,0,0
3,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,0.90599,-0.035476,-0.013447,0,0
3,GO SUBPALLIUM DEVELOPMENT,0.80989,-0.035632,0.057278,0,0
3,GO REGULATION OF NEUROTRANSMITTER LEVELS,0.76948,-0.035895,0.023213,0,0
3,GO HISTONE H3 K14 ACETYLATION,0.78289,-0.036107,0.0028491,0,0
3,GO REGULATION OF DNA RECOMBINATION,0.26847,-0.036329,-0.055113,0,0
3,GO TELOMERE ORGANIZATION,0.12908,-0.036663,-0.060144,0,0
3,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.76281,-0.036835,-0.041161,0,0
3,GO HISTONE UBIQUITINATION,0.14526,-0.036884,-0.050729,0,0
3,GO LIPOPROTEIN LOCALIZATION,0.26471,-0.036904,-0.090757,0,0
3,GO STRIATUM DEVELOPMENT,0.88523,-0.037281,0.019563,0,0
3,GO ENDOTHELIAL CELL MORPHOGENESIS,0.59059,-0.037544,-0.088617,0,0
3,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.51459,-0.037804,-0.039749,0,0
3,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.94769,-0.03801,0.005409,0,0
3,GO PROTEIN MONOUBIQUITINATION,0.42347,-0.038185,-0.024332,0,0
3,GO TRACHEA MORPHOGENESIS,0.64605,-0.038338,-0.032472,0,0
3,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.39858,-0.038456,-0.025411,0,0
3,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.72969,-0.038477,-0.012219,0,0
3,GO ALDITOL PHOSPHATE METABOLIC PROCESS,0.63978,-0.038482,0.11544,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.44402,-0.03857,-0.031078,0,0
3,GO CHROMOSOME ORGANIZATION,0.11434,-0.038659,-0.035176,0,0
3,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.51459,-0.03879,-0.043704,0,0
3,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.60883,-0.038889,-0.022125,0,0
3,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.5726,-0.039017,-0.054448,0,0
3,GO NEUROGENESIS,0.43883,-0.039095,-0.032343,0,0
3,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.25729,-0.03923,-0.065548,0,0
3,GO MITOTIC SISTER CHROMATID SEGREGATION,0.12049,-0.039469,-0.048,0,0
3,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.29992,-0.039489,-0.064487,0,0
3,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.43367,-0.039808,-0.04796,0,0
3,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.80989,-0.039961,-0.023339,0,0
3,GO SEROTONIN SECRETION,0.78289,-0.040092,-0.00022033,0,0
3,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,0.49227,-0.040665,-0.11744,0,0
3,GO CELLULAR RESPONSE TO RADIATION,0.41842,-0.040757,-0.029288,0,0
3,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.14285,-0.040959,-0.090665,0,0
3,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.53742,-0.041069,-0.020772,0,0
3,GO ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.50337,-0.041129,-0.083604,0,0
3,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.56075,-0.041197,-0.048258,0,0
3,GO METENCEPHALON DEVELOPMENT,0.65866,-0.04129,0.0014937,0,0
3,GO PROTEIN HETEROTETRAMERIZATION,0.68418,-0.041296,-0.021409,0,0
3,GO DNA REPLICATION,0.11841,-0.041301,-0.048872,0,0
3,GO NEURAL CREST CELL DIFFERENTIATION,0.33812,-0.041507,-0.077635,0,0
3,GO REGULATION OF CELL DEVELOPMENT,0.56666,-0.041611,-0.022206,0,0
3,GO DNA RECOMBINATION,0.17653,-0.041642,-0.039732,0,0
3,GO MUSCLE ORGAN DEVELOPMENT,0.4545,-0.041662,-0.02681,0,0
3,GO SPINDLE ASSEMBLY,0.1313,-0.042132,-0.043874,0,0
3,GO TRANSLATIONAL ELONGATION,0.61497,-0.042146,-0.041841,0,0
3,GO ADHERENS JUNCTION ASSEMBLY,0.57857,-0.042586,0.056031,0,0
3,GO GLUTAMINE METABOLIC PROCESS,0.31653,-0.042704,-0.075855,0,0
3,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.16032,-0.042963,-0.064931,0,0
3,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.33373,-0.043048,-0.11891,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.30815,-0.043086,-0.072168,0,0
3,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.62732,-0.043106,-0.025203,0,0
3,GO MEMBRANE DOCKING,0.35153,-0.043243,-0.022496,0,0
3,GO NCRNA TRANSCRIPTION,0.082489,-0.043513,-0.068913,0,0
3,GO REGULATION OF RECEPTOR INTERNALIZATION,0.19393,-0.04356,-0.067102,0,0
3,GO RNA 5 END PROCESSING,0.93377,-0.04376,0.010233,0,0
3,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.33812,-0.043858,-0.072888,0,0
3,GO CENTROSOME SEPARATION,0.94073,-0.044191,0.017433,0,0
3,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.50337,-0.044241,-0.035903,0,0
3,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.39371,-0.044474,-0.12077,0,0
3,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.10654,-0.044487,-0.065999,0,0
3,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.22568,-0.045082,-0.085046,0,0
3,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.59059,-0.045523,-0.028095,0,0
3,GO DOUBLE STRAND BREAK REPAIR,0.0695,-0.045553,-0.061955,0,0
3,GO REGULATION OF SISTER CHROMATID COHESION,0.10654,-0.045558,-0.099917,0,0
3,GO ARTERY DEVELOPMENT,0.34256,-0.045565,-0.073251,0,0
3,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.54903,-0.046057,-0.03423,0,0
3,GO HISTONE H3 K9 METHYLATION,0.33373,-0.046169,-0.046064,0,0
3,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.22905,-0.046318,-0.079828,0,0
3,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.98953,-0.04662,0.022385,0,0
3,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.22568,-0.046641,-0.10308,0,0
3,GO MRNA CLEAVAGE,0.15517,-0.04703,-0.05637,0,0
3,GO HISTONE H3 DEACETYLATION,0.75615,-0.047219,-0.019022,0,0
3,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.26098,-0.047343,-0.045151,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.21256,-0.047417,-0.061132,0,0
3,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.67776,-0.047461,-0.048004,0,0
3,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.15773,-0.047518,-0.077229,0,0
3,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.73628,-0.047661,-0.052351,0,0
3,GO MITOCHONDRION MORPHOGENESIS,0.50337,-0.047671,-0.043037,0,0
3,GO PROTEIN ACETYLATION,0.099158,-0.048143,-0.031573,0,0
3,GO ANIMAL ORGAN FORMATION,0.16828,-0.048199,-0.093955,0,0
3,GO PEPTIDYL HISTIDINE MODIFICATION,0.31232,-0.048319,-0.074626,0,0
3,GO HISTONE H3 K9 MODIFICATION,0.30402,-0.048897,-0.042878,0,0
3,GO CARDIAC CHAMBER DEVELOPMENT,0.56666,-0.048916,-0.033306,0,0
3,GO REGULATION OF SPINDLE ORGANIZATION,0.17653,-0.049046,-0.052447,0,0
3,GO PEPTIDYL ARGININE MODIFICATION,0.30815,-0.049465,-0.044163,0,0
3,GO RNA 3 END PROCESSING,0.084046,-0.049772,-0.075494,0,0
3,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.39371,-0.049899,-0.041963,0,0
3,GO MUSCLE FIBER DEVELOPMENT,0.53167,-0.050038,-0.022923,0,0
3,GO REGULATION OF CHROMOSOME SEPARATION,0.11235,-0.050446,-0.070003,0,0
3,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,0.32077,-0.050679,-0.12061,0,0
3,GO REGULATION OF CILIUM BEAT FREQUENCY,0.4545,-0.050713,-0.051895,0,0
3,GO CORONARY VASCULATURE DEVELOPMENT,0.23245,-0.050918,-0.096559,0,0
3,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.19695,-0.051036,-0.076172,0,0
3,GO OTIC VESICLE MORPHOGENESIS,0.31232,-0.051218,-0.11225,0,0
3,GO REGULATION OF FIBROBLAST MIGRATION,0.64605,-0.051267,-0.04748,0,0
3,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.80989,-0.051322,-0.021014,0,0
3,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.24643,-0.05137,-0.055588,0,0
3,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.47049,-0.051557,-0.036482,0,0
3,GO HISTONE METHYLATION,0.088862,-0.051889,-0.048741,0,0
3,GO MICROTUBULE BASED MOVEMENT,0.080955,-0.051951,-0.05177,0,0
3,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.29184,-0.052126,-0.058375,0,0
3,GO RNA PROCESSING,0.068167,-0.052135,-0.072769,0,0
3,GO PROTEIN METHYLATION,0.25729,-0.052217,-0.025082,0,0
3,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.072231,-0.052289,-0.10541,0,0
3,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.092194,-0.052321,-0.088399,0,0
3,GO LYMPH VESSEL DEVELOPMENT,0.16559,-0.052362,-0.1185,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.59059,-0.05242,-0.045351,0,0
3,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,0.36064,-0.052468,-0.073899,0,0
3,GO AORTA DEVELOPMENT,0.15517,-0.052513,-0.11606,0,0
3,GO RNA LOCALIZATION,0.057089,-0.052566,-0.085182,0,0
3,GO REGULATION OF BEHAVIOR,0.31653,-0.052722,-0.064972,0,0
3,GO RESPONSE TO VITAMIN D,0.47588,-0.052868,-0.08136,0,0
3,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.38888,-0.053056,-0.081646,0,0
3,GO TRANSLATIONAL INITIATION,0.15015,-0.053223,-0.14943,0,0
3,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.44402,-0.053224,-0.027455,0,0
3,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.36991,-0.053316,-0.072057,0,0
3,GO REGULATION OF FILOPODIUM ASSEMBLY,0.31232,-0.05332,-0.073336,0,0
3,GO COGNITION,0.4598,-0.053471,-0.034849,0,0
3,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,0.22905,-0.053537,-0.10263,0,0
3,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.26847,-0.053618,-0.095001,0,0
3,GO MOTILE CILIUM ASSEMBLY,0.59059,-0.053752,-0.049292,0,0
3,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.55487,-0.054044,-0.062128,0,0
3,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.36064,-0.054234,-0.044822,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.16559,-0.054311,-0.094404,0,0
3,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.087232,-0.054586,-0.053986,0,0
3,GO ACIDIC AMINO ACID TRANSPORT,0.39371,-0.054764,-0.02839,0,0
3,GO POST ANAL TAIL MORPHOGENESIS,0.20309,-0.054885,-0.087196,0,0
3,GO CELLULAR RESPONSE TO UV,0.16294,-0.055033,-0.061264,0,0
3,GO PEPTIDYL LYSINE DIMETHYLATION,0.10845,-0.055331,-0.071822,0,0
3,GO REGULATION OF FEEDING BEHAVIOR,0.15517,-0.055438,-0.12381,0,0
3,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.12689,-0.05547,-0.073433,0,0
3,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.51459,-0.055536,-0.10996,0,0
3,GO CELL PROLIFERATION IN HINDBRAIN,0.28785,-0.055552,-0.099955,0,0
3,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.23589,-0.055584,-0.053978,0,0
3,GO CARDIAC SEPTUM MORPHOGENESIS,0.53742,-0.055587,-0.068148,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.4545,-0.05564,-0.13323,0,0
3,GO RESPONSE TO X RAY,0.21905,-0.055659,-0.11267,0,0
3,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.070855,-0.05569,-0.072388,0,0
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.44402,-0.056073,-0.063354,0,0
3,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.78289,-0.056237,-0.031698,0,0
3,GO LONG TERM SYNAPTIC POTENTIATION,0.77618,-0.056266,-0.015493,0,0
3,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.066855,-0.056316,-0.076155,0,0
3,GO REGULATION OF HISTONE METHYLATION,0.44924,-0.056321,-0.019804,0,0
3,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.21579,-0.056346,-0.045884,0,0
3,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,0.34702,-0.056765,-0.042969,0,0
3,GO MITOCHONDRIAL GENOME MAINTENANCE,0.59664,-0.056868,-0.027096,0,0
3,GO MYOTUBE CELL DEVELOPMENT,0.56666,-0.056968,-0.03423,0,0
3,GO ERYTHROCYTE MATURATION,0.36991,-0.057178,-0.083835,0,0
3,GO SISTER CHROMATID SEGREGATION,0.11039,-0.057279,-0.044713,0,0
3,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.092194,-0.057708,-0.10406,0,0
3,GO CELL CYCLE DNA REPLICATION,0.068167,-0.057888,-0.076348,0,0
3,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,0.80989,-0.058161,-0.011377,0,0
3,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.73628,-0.058189,-0.022014,0,0
3,GO TRNA METHYLATION,0.50337,-0.058446,-0.038876,0,0
3,GO PEPTIDYL LYSINE METHYLATION,0.1028,-0.058479,-0.045571,0,0
3,GO REGULATION OF OOGENESIS,0.25363,-0.058528,-0.04219,0,0
3,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.71658,-0.058724,-0.045765,0,0
3,GO OXIDATIVE DEMETHYLATION,0.37932,-0.058862,-0.032491,0,0
3,GO REGULATION OF CHROMOSOME SEGREGATION,0.14526,-0.05906,-0.059346,0,0
3,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.97557,-0.059102,0.00626,0,0
3,GO MRNA MODIFICATION,0.37932,-0.059267,-0.066604,0,0
3,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.34256,-0.059445,-0.15942,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.43883,-0.059489,-0.04101,0,0
3,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.26471,-0.059519,-0.099377,0,0
3,GO VIRAL GENE EXPRESSION,0.27227,-0.059708,-0.11432,0,0
3,GO PROTEIN NEDDYLATION,0.15264,-0.059826,-0.073205,0,0
3,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.25729,-0.0599,-0.066876,0,0
3,GO RRNA METABOLIC PROCESS,0.21579,-0.059954,-0.092774,0,0
3,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.3746,-0.060058,-0.042835,0,0
3,GO REGULATION OF CYTOKINESIS,0.30402,-0.060073,-0.02513,0,0
3,GO ETHANOL CATABOLIC PROCESS,0.69061,-0.060088,-0.040365,0,0
3,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.67776,-0.060304,0.010834,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.19695,-0.060334,-0.081044,0,0
3,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.49227,-0.060447,-0.088162,0,0
3,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.023741,-0.060619,-0.075484,0,0
3,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.17374,-0.060654,-0.21266,0,0
3,GO REGULATION OF DNA BINDING,0.32506,-0.061013,-0.023052,0,0
3,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.33812,-0.061034,-0.038206,0,0
3,GO NUCLEAR CHROMOSOME SEGREGATION,0.12049,-0.061653,-0.036393,0,0
3,GO SPINDLE LOCALIZATION,0.12473,-0.061732,-0.067518,0,0
3,GO PEPTIDYL ARGININE METHYLATION,0.18508,-0.062006,-0.063771,0,0
3,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.50337,-0.062051,-0.063217,0,0
3,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.16559,-0.062098,-0.048481,0,0
3,GO SEROTONIN TRANSPORT,0.8303,-0.062114,-0.002465,0,0
3,GO HINDBRAIN DEVELOPMENT,0.74288,-0.062292,0.027306,0,0
3,GO HISTONE H2A ACETYLATION,0.40843,-0.062311,-0.053283,0,0
3,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.38888,-0.062412,-0.062364,0,0
3,GO ACROSOME ASSEMBLY,0.17653,-0.062858,-0.099484,0,0
3,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.1313,-0.062908,-0.095206,0,0
3,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.18219,-0.06291,-0.13289,0,0
3,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.087232,-0.063071,-0.058936,0,0
3,GO BIOLOGICAL PHASE,0.96163,-0.063073,0.020538,0,0
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.44924,-0.063154,-0.035897,0,0
3,GO DETECTION OF VISIBLE LIGHT,0.11039,-0.063436,-0.08899,0,0
3,GO BASEMENT MEMBRANE ASSEMBLY,0.98255,-0.063443,-0.0047894,0,0
3,GO NCRNA PROCESSING,0.24288,-0.063591,-0.080879,0,0
3,GO DNA GEOMETRIC CHANGE,0.022165,-0.06364,-0.091437,0,0
3,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.48678,-0.064016,-0.032138,0,0
3,GO STRIATED MUSCLE CELL PROLIFERATION,0.087232,-0.064019,-0.11555,0,0
3,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.090515,-0.064291,-0.088435,0,0
3,GO LYMPH VESSEL MORPHOGENESIS,0.32506,-0.064302,-0.089577,0,0
3,GO LONG TERM MEMORY,0.35607,-0.064305,-0.074072,0,0
3,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.044685,-0.064328,-0.10864,0,0
3,GO REGULATION OF CENTRIOLE REPLICATION,0.18508,-0.064484,-0.05084,0,0
3,GO POSITIVE REGULATION OF DNA BINDING,0.12908,-0.064649,-0.066323,0,0
3,GO REGULATION OF TELOMERASE ACTIVITY,0.35153,-0.064901,-0.059254,0,0
3,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.75615,-0.06492,-0.041817,0,0
3,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.14526,-0.064994,-0.060292,0,0
3,GO REGULATION OF HISTONE PHOSPHORYLATION,0.20621,-0.065163,-0.089307,0,0
3,GO MICROTUBULE BASED PROCESS,0.014138,-0.065387,-0.057428,0,0
3,GO SYNAPTIC VESICLE DOCKING,0.92682,-0.065433,0.061412,0,0
3,GO ERROR PRONE TRANSLESION SYNTHESIS,0.36991,-0.065708,-0.028191,0,0
3,GO CHROMATIN SILENCING,0.066855,-0.065776,-0.078656,0,0
3,GO REGULATION OF DNA REPLICATION,0.80989,-0.065818,-0.011417,0,0
3,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.061812,-0.06582,-0.10692,0,0
3,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.52594,-0.066156,-0.069956,0,0
3,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.9686,-0.066248,-0.004251,0,0
3,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.40843,-0.066283,-0.069409,0,0
3,GO REGULATION OF COLLATERAL SPROUTING,0.35607,-0.066741,-0.10147,0,0
3,GO HYPEROSMOTIC SALINITY RESPONSE,0.065563,-0.067058,-0.20039,0,0
3,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.33373,-0.067249,-0.051969,0,0
3,GO PROSTATIC BUD FORMATION,0.21256,-0.067595,-0.20156,0,0
3,GO EMBRYONIC HEMOPOIESIS,0.29586,-0.067807,-0.078412,0,0
3,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.33812,-0.06784,-0.065311,0,0
3,GO PEPTIDYL METHIONINE MODIFICATION,0.89907,-0.067979,0.070703,0,0
3,GO REGULATION OF MICROTUBULE BASED PROCESS,0.0094949,-0.068087,-0.0739,0,0
3,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.011904,-0.068278,-0.061168,0,0
3,GO CELLULAR RESPONSE TO VITAMIN D,0.50896,-0.068374,-0.062333,0,0
3,GO BONE MATURATION,0.29992,-0.068455,-0.079444,0,0
3,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.031748,-0.068558,-0.11185,0,0
3,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,1,-0.068633,0.0051617,0,0
3,GO HISTONE H3 K4 METHYLATION,0.13583,-0.068644,-0.047226,0,0
3,GO TRNA TRANSPORT,0.26471,-0.068698,-0.074635,0,0
3,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,0.12049,-0.068941,-0.10945,0,0
3,GO MESODERMAL CELL FATE COMMITMENT,0.27611,-0.069235,-0.090891,0,0
3,GO LEARNING,0.20309,-0.069247,-0.078891,0,0
3,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.077957,-0.069373,-0.20088,0,0
3,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.21905,-0.069426,-0.052758,0,0
3,GO AXIS ELONGATION,0.36526,-0.069577,-0.089923,0,0
3,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.044685,-0.069598,-0.13833,0,0
3,GO TRACHEA DEVELOPMENT,0.29184,-0.069898,-0.099549,0,0
3,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.070855,-0.069962,-0.1167,0,0
3,GO VESICLE FUSION TO PLASMA MEMBRANE,0.71658,-0.070064,0.050728,0,0
3,GO HEAD DEVELOPMENT,0.38888,-0.070248,-0.026041,0,0
3,GO APPENDAGE DEVELOPMENT,0.2839,-0.070636,-0.059587,0,0
3,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.17934,-0.070705,-0.045954,0,0
3,GO MICROTUBULE ANCHORING,0.10845,-0.070942,-0.065739,0,0
3,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.1028,-0.070982,-0.073803,0,0
3,GO REGULATION OF NEURON DIFFERENTIATION,0.29992,-0.0711,-0.050309,0,0
3,GO HEAT GENERATION,0.66501,-0.071157,-0.027266,0,0
3,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.073629,-0.071204,-0.063172,0,0
3,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.43883,-0.071228,-0.078448,0,0
3,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.94769,-0.071551,0.0024387,0,0
3,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.17653,-0.071696,-0.11103,0,0
3,GO CELL CYCLE G2 M PHASE TRANSITION,0.11434,-0.072043,-0.044925,0,0
3,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.54321,-0.072063,-0.061802,0,0
3,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.19695,-0.072198,-0.057153,0,0
3,GO MYOBLAST PROLIFERATION,0.27999,-0.072386,-0.097362,0,0
3,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.48678,-0.072403,-0.05077,0,0
3,GO SPINAL CORD PATTERNING,0.89907,-0.072526,0.0092846,0,0
3,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.17653,-0.072691,-0.064466,0,0
3,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.17099,-0.072738,-0.072284,0,0
3,GO MITOTIC RECOMBINATION,0.1313,-0.072836,-0.094104,0,0
3,GO REGULATION OF MICROTUBULE BINDING,0.11841,-0.073077,-0.12988,0,0
3,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.80312,-0.073205,-0.021455,0,0
3,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.40349,-0.073293,-0.038621,0,0
3,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.58456,-0.073314,-0.031023,0,0
3,GO WALKING BEHAVIOR,0.1313,-0.073368,-0.096441,0,0
3,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.31653,-0.073963,-0.12844,0,0
3,GO REGULATION OF RNA BINDING,0.0695,-0.074074,-0.12049,0,0
3,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.12049,-0.074203,-0.15564,0,0
3,GO POSITIVE REGULATION OF HEART GROWTH,0.13355,-0.074422,-0.11124,0,0
3,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.27227,-0.074547,-0.056617,0,0
3,GO TRNA MODIFICATION,0.25363,-0.074577,-0.070818,0,0
3,GO MOTOR NEURON AXON GUIDANCE,0.05161,-0.074804,-0.15626,0,0
3,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.26098,-0.074949,-0.076507,0,0
3,GO SUCKLING BEHAVIOR,0.35607,-0.07509,-0.094086,0,0
3,GO REGULATION OF STEM CELL DIVISION,0.65866,-0.07511,-0.028076,0,0
3,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.46512,-0.07525,-0.053798,0,0
3,GO NUCLEAR BODY ORGANIZATION,0.78962,-0.075263,0.03001,0,0
3,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.34256,-0.076133,-0.044128,0,0
3,GO PROXIMAL DISTAL PATTERN FORMATION,0.22905,-0.076144,-0.13846,0,0
3,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.30815,-0.076216,-0.084732,0,0
3,GO MEIOTIC SPINDLE ORGANIZATION,0.090515,-0.07622,-0.1061,0,0
3,GO CHROMOSOME SEGREGATION,0.059411,-0.076263,-0.048176,0,0
3,GO POSITIVE REGULATION OF HEAT GENERATION,0.62732,-0.076672,-0.049616,0,0
3,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.079444,-0.076741,-0.069799,0,0
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.18219,-0.076823,-0.11619,0,0
3,GO DISTAL TUBULE DEVELOPMENT,0.46512,-0.07687,-0.056693,0,0
3,GO MICROTUBULE POLYMERIZATION,0.018398,-0.0769,-0.12159,0,0
3,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.39858,-0.076943,-0.046394,0,0
3,GO CARDIAC SEPTUM DEVELOPMENT,0.24643,-0.076998,-0.079458,0,0
3,GO HISTONE H4 K5 ACETYLATION,0.4598,-0.076999,-0.028929,0,0
3,GO CYTOPLASMIC TRANSLATION,0.1028,-0.077125,-0.17792,0,0
3,GO POSITIVE REGULATION OF MRNA PROCESSING,0.11841,-0.077229,-0.06512,0,0
3,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.045624,-0.07724,-0.061676,0,0
3,GO REGULATION OF EXTENT OF CELL GROWTH,0.02843,-0.077295,-0.16547,0,0
3,GO SYNAPSE MATURATION,0.65234,-0.077346,-0.055313,0,0
3,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.81668,-0.077352,0.08908,0,0
3,GO NODAL SIGNALING PATHWAY,0.32506,-0.077438,-0.054758,0,0
3,GO POSITIVE REGULATION OF AXON EXTENSION,0.023205,-0.077466,-0.16886,0,0
3,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.42855,-0.077932,-0.078351,0,0
3,GO CELLULAR RESPONSE TO PH,0.22568,-0.078242,-0.07516,0,0
3,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.26847,-0.078457,-0.11665,0,0
3,GO SINGLE STRAND BREAK REPAIR,0.188,-0.078606,-0.087,0,0
3,GO NEUROTRANSMITTER TRANSPORT,0.39858,-0.078704,-0.0085724,0,0
3,GO TRNA PROCESSING,0.23937,-0.078714,-0.064171,0,0
3,GO MRNA TRANSPORT,0.072231,-0.078848,-0.073728,0,0
3,GO CEREBELLAR CORTEX MORPHOGENESIS,0.21579,-0.078915,-0.090002,0,0
3,GO MESODERMAL CELL DIFFERENTIATION,0.13583,-0.07939,-0.11619,0,0
3,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.9686,-0.079537,-0.0056515,0,0
3,GO DORSAL VENTRAL PATTERN FORMATION,0.4545,-0.079841,-0.007233,0,0
3,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.29586,-0.079927,-0.072287,0,0
3,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,0.62732,-0.079999,-0.033636,0,0
3,GO MEMBRANE DISASSEMBLY,0.188,-0.080071,-0.090682,0,0
3,GO CELL FATE SPECIFICATION,0.27999,-0.080405,-0.054002,0,0
3,GO REGULATION OF RIBOSOME BIOGENESIS,0.15264,-0.080443,-0.12427,0,0
3,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.11434,-0.080594,-0.18203,0,0
3,GO MEMBRANE BIOGENESIS,0.57857,-0.081007,-0.050121,0,0
3,GO DNA STRAND ELONGATION,0.14285,-0.081395,-0.067198,0,0
3,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.69061,-0.081566,-0.0096203,0,0
3,GO REGULATION OF HEAT GENERATION,0.5726,-0.081576,-0.041595,0,0
3,GO LIMBIC SYSTEM DEVELOPMENT,0.14526,-0.081594,-0.067069,0,0
3,GO RESPONSE TO NERVE GROWTH FACTOR,0.52594,-0.081653,-0.017626,0,0
3,GO CILIUM ORGANIZATION,0.16032,-0.081664,-0.049389,0,0
3,GO REGULATION OF TRANSLATIONAL ELONGATION,0.29586,-0.081994,-0.064559,0,0
3,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.46512,-0.08215,-0.034819,0,0
3,GO TRANS SYNAPTIC SIGNALING MODULATING SYNAPTIC TRANSMISSION,0.2,-0.082311,-0.14144,0,0
3,GO CHONDROCYTE DEVELOPMENT,0.40843,-0.08243,-0.085322,0,0
3,GO HAIR FOLLICLE MATURATION,0.40349,-0.082467,-0.077483,0,0
3,GO CIRCADIAN SLEEP WAKE CYCLE,0.3746,-0.082595,-0.034008,0,0
3,GO TRIPARTITE REGIONAL SUBDIVISION,0.95466,-0.082954,-0.0014294,0,0
3,GO L GLUTAMATE IMPORT,0.20309,-0.083352,-0.10506,0,0
3,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.0030654,-0.083374,-0.092165,0,0
3,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,0.27999,-0.083466,-0.095568,0,0
3,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.65866,-0.083494,-0.023284,0,0
3,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.11636,-0.083715,-0.067924,0,0
3,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.29586,-0.083743,-0.11115,0,0
3,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,0.23245,-0.083796,-0.10398,0,0
3,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.092194,-0.08393,-0.09298,0,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.26471,-0.084697,-0.086221,0,0
3,GO NEURON DEVELOPMENT,0.24288,-0.084739,-0.051456,0,0
3,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.42855,-0.084746,-0.02908,0,0
3,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.065563,-0.084943,-0.10345,0,0
3,GO SYNAPTIC SIGNALING,0.35607,-0.085036,-0.046757,0,0
3,GO NEURON DIFFERENTIATION,0.25729,-0.085056,-0.051773,0,0
3,GO POSITIVE REGULATION OF CILIUM MOVEMENT,0.91987,-0.085306,-0.013388,0,0
3,GO REGULATION OF TRANSLATIONAL TERMINATION,0.36064,-0.085405,-0.077345,0,0
3,GO SYNAPTIC VESICLE TRANSPORT,0.36064,-0.085682,-0.036991,0,0
3,GO CELLULAR COMPONENT MORPHOGENESIS,0.087232,-0.085696,-0.088498,0,0
3,GO SPINDLE MIDZONE ASSEMBLY,0.15517,-0.085836,-0.098512,0,0
3,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.29586,-0.085847,-0.10136,0,0
3,GO HISTONE H3 K4 TRIMETHYLATION,0.035393,-0.086026,-0.089752,0,0
3,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.011612,-0.08619,-0.14006,0,0
3,GO CHROMATIN REMODELING,0.007729,-0.086211,-0.077477,0,0
3,GO ASTRAL MICROTUBULE ORGANIZATION,0.62732,-0.086622,-0.032264,0,0
3,GO BONE MORPHOGENESIS,0.075049,-0.086677,-0.12656,0,0
3,GO MICROTUBULE NUCLEATION,0.052669,-0.086772,-0.08117,0,0
3,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.18508,-0.086802,-0.096225,0,0
3,GO ANTEROGRADE AXONAL TRANSPORT,0.014486,-0.087182,-0.1104,0,0
3,GO TUBULIN DEACETYLATION,0.4978,-0.087581,-0.031442,0,0
3,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.60883,-0.08781,-0.016605,0,0
3,GO PRENYLATION,0.42347,-0.087823,-0.060223,0,0
3,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.085627,-0.087849,-0.11828,0,0
3,GO RNA STABILIZATION,0.064293,-0.087937,-0.096524,0,0
3,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.13355,-0.088,-0.097442,0,0
3,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.20621,-0.088047,-0.14896,0,0
3,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.059411,-0.088163,-0.15347,0,0
3,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,0.41341,-0.08828,-0.086425,0,0
3,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.063042,-0.088667,-0.18241,0,0
3,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.095625,-0.088805,-0.10365,0,0
3,GO CELL MIGRATION IN HINDBRAIN,0.75615,-0.089303,-0.022109,0,0
3,GO ROOF OF MOUTH DEVELOPMENT,0.25001,-0.089396,-0.089324,0,0
3,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.27227,-0.089417,-0.085664,0,0
3,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.30815,-0.089585,-0.077981,0,0
3,GO CELLULAR RESPONSE TO VITAMIN,0.61497,-0.089976,-0.041584,0,0
3,GO REGULATION OF GUANYLATE CYCLASE ACTIVITY,0.10654,-0.090214,-0.18505,0,0
3,GO RETINAL GANGLION CELL AXON GUIDANCE,0.52025,-0.090284,-0.046293,0,0
3,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.34256,-0.090307,-0.17593,0,0
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.16294,-0.090826,-0.078326,0,0
3,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.023741,-0.090892,-0.093765,0,0
3,GO RNA SURVEILLANCE,0.10654,-0.091,-0.098371,0,0
3,GO HISTONE H3 K9 ACETYLATION,0.04854,-0.091044,-0.097257,0,0
3,GO MICROTUBULE BASED TRANSPORT,0.017137,-0.091049,-0.097245,0,0
3,GO DNA REPLICATION CHECKPOINT,0.061812,-0.091126,-0.11669,0,0
3,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.03245,-0.091372,-0.13453,0,0
3,GO REGULATION OF MYELINATION,0.035393,-0.091455,-0.096855,0,0
3,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.085627,-0.092198,-0.16837,0,0
3,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.13583,-0.092259,-0.083376,0,0
3,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.0028141,-0.092326,-0.091974,0,0
3,GO RIBOSOME ASSEMBLY,0.27999,-0.092326,-0.12607,0,0
3,GO TRANSCRIPTION BY RNA POLYMERASE I,0.21905,-0.092473,-0.067099,0,0
3,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.27999,-0.092602,-0.11213,0,0
3,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.29586,-0.092676,-0.062944,0,0
3,GO RETINAL CONE CELL DIFFERENTIATION,0.64605,-0.092777,-0.057549,0,0
3,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.0042883,-0.09295,-0.11912,0,0
3,GO TRANSPORT ALONG MICROTUBULE,0.0017123,-0.0936,-0.1135,0,0
3,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.31653,-0.093878,-0.058353,0,0
3,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.43883,-0.093971,-0.064826,0,0
3,GO NEGATIVE REGULATION OF DNA BINDING,0.043763,-0.093972,-0.10616,0,0
3,GO REGULATION OF SYNAPSE ASSEMBLY,0.39371,-0.094147,-0.071945,0,0
3,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.11039,-0.0944,-0.15503,0,0
3,GO SYNAPTIC VESICLE EXOCYTOSIS,0.18508,-0.094453,-0.015939,0,0
3,GO PSEUDOURIDINE SYNTHESIS,0.32077,-0.096468,-0.079834,0,0
3,GO SMOOTHENED SIGNALING PATHWAY,0.15015,-0.096773,-0.066505,0,0
3,GO NEURON PROJECTION ARBORIZATION,0.19695,-0.096998,-0.10969,0,0
3,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.099158,-0.097286,-0.15864,0,0
3,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,0.17099,-0.097959,-0.039585,0,0
3,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.17653,-0.098108,-0.11444,0,0
3,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.043763,-0.098341,-0.1459,0,0
3,GO NEURON PROJECTION EXTENSION,0.13583,-0.098386,-0.10506,0,0
3,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.40349,-0.098749,-0.073106,0,0
3,GO REGULATION OF SPINDLE CHECKPOINT,0.079444,-0.099196,-0.099092,0,0
3,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.53742,-0.099704,-0.054324,0,0
3,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.025414,-0.099733,-0.12666,0,0
3,GO FILOPODIUM ASSEMBLY,0.188,-0.099964,-0.085046,0,0
3,GO CONVERGENT EXTENSION,0.31653,-0.10004,-0.076145,0,0
3,GO PHOTORECEPTOR CELL DEVELOPMENT,0.22905,-0.1002,-0.067552,0,0
3,GO CORONARY VASCULATURE MORPHOGENESIS,0.2,-0.10024,-0.10699,0,0
3,GO GENETIC IMPRINTING,0.17099,-0.10077,-0.083407,0,0
3,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.26471,-0.1009,-0.07054,0,0
3,GO BLASTOCYST GROWTH,0.29992,-0.10154,-0.041329,0,0
3,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.41842,-0.10216,-0.075595,0,0
3,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.13583,-0.10221,-0.12987,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.2,-0.10224,-0.089814,0,0
3,GO AXON DEVELOPMENT,0.024846,-0.10235,-0.15153,0,0
3,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.59059,-0.10255,-0.032571,0,0
3,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.05824,-0.10289,-0.11292,0,0
3,GO ATRIAL SEPTUM DEVELOPMENT,0.68418,-0.1029,-0.028574,0,0
3,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.32506,-0.10293,-0.051746,0,0
3,GO REGULATION OF STEM CELL PROLIFERATION,0.054842,-0.10307,-0.11377,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.0695,-0.10361,-0.093158,0,0
3,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.099158,-0.10387,-0.113,0,0
3,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.035393,-0.10426,-0.15554,0,0
3,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.082489,-0.10446,-0.094746,0,0
3,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.0034322,-0.10461,-0.15684,0,0
3,GO RIBOSOME BIOGENESIS,0.188,-0.10509,-0.10983,0,0
3,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.24643,-0.1051,-0.088421,0,0
3,GO BRANCHING MORPHOGENESIS OF A NERVE,0.23937,-0.10513,-0.14065,0,0
3,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.0023671,-0.1053,-0.098933,0,0
3,GO MATURATION OF 5 8S RRNA,0.16294,-0.10531,-0.11292,0,0
3,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.079444,-0.10535,-0.15963,0,0
3,GO DNA DEPENDENT DNA REPLICATION,0.0083534,-0.10547,-0.096203,0,0
3,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.22568,-0.10563,-0.12852,0,0
3,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.54903,-0.10566,-0.029422,0,0
3,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.085627,-0.1057,-0.091532,0,0
3,GO HISTONE H4 DEACETYLATION,0.14769,-0.10583,-0.11275,0,0
3,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.21256,-0.10599,-0.06512,0,0
3,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.80312,-0.10637,0.010311,0,0
3,GO PROTEIN LOCALIZATION TO CELL JUNCTION,0.17099,-0.10649,-0.083176,0,0
3,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.78289,-0.10653,-0.02606,0,0
3,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.17653,-0.10658,-0.073155,0,0
3,GO AXO DENDRITIC TRANSPORT,0.0022992,-0.10699,-0.13897,0,0
3,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.085627,-0.1075,-0.16322,0,0
3,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,0.48678,-0.1076,-0.030555,0,0
3,GO CELL PART MORPHOGENESIS,0.025994,-0.10769,-0.11441,0,0
3,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.15773,-0.10783,-0.10806,0,0
3,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.016734,-0.10786,-0.10079,0,0
3,GO NEGATIVE REGULATION OF AXONOGENESIS,0.0085714,-0.10826,-0.22964,0,0
3,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.10465,-0.10854,-0.1166,0,0
3,GO NEURON PROJECTION GUIDANCE,0.0059384,-0.10855,-0.18546,0,0
3,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.05161,-0.10861,-0.074815,0,0
3,GO NEURAL CREST FORMATION,0.10845,-0.10885,-0.15557,0,0
3,GO SISTER CHROMATID COHESION,0.065563,-0.10936,-0.06391,0,0
3,GO PRESYNAPSE ORGANIZATION,0.38888,-0.10967,-0.080216,0,0
3,GO PROTEIN LOCALIZATION TO CHROMATIN,0.0020453,-0.11018,-0.13789,0,0
3,GO BONE TRABECULA MORPHOGENESIS,0.24288,-0.11024,-0.17699,0,0
3,GO PROTEIN POLYGLUTAMYLATION,0.079444,-0.11044,-0.092756,0,0
3,GO MITOCHONDRION LOCALIZATION,0.0051916,-0.11062,-0.11778,0,0
3,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,0.11434,-0.11078,-0.053873,0,0
3,GO REGULATION OF HELICASE ACTIVITY,0.14048,-0.11107,-0.096574,0,0
3,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.066855,-0.11111,-0.12,0,0
3,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.21905,-0.11128,-0.099944,0,0
3,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.22905,-0.11143,-0.10477,0,0
3,GO MAGNESIUM ION HOMEOSTASIS,0.44924,-0.11153,-0.044413,0,0
3,GO SYNAPSE ASSEMBLY,0.67137,-0.11191,-0.027053,0,0
3,GO NEGATIVE CHEMOTAXIS,0.19095,-0.11228,-0.13646,0,0
3,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.15517,-0.1131,-0.084938,0,0
3,GO TELOMERE CAPPING,0.016734,-0.11321,-0.076109,0,0
3,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,1,-0.11333,0.052822,0,0
3,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.14526,-0.1137,-0.058496,0,0
3,GO MICROTUBULE ANCHORING AT CENTROSOME,0.060602,-0.11419,-0.1207,0,0
3,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.23937,-0.11423,-0.062217,0,0
3,GO REGULATION OF AXONOGENESIS,0.037747,-0.11425,-0.15881,0,0
3,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.1313,-0.11494,-0.127,0,0
3,GO NEURAL RETINA DEVELOPMENT,0.29184,-0.11498,-0.045177,0,0
3,GO GLYCINE METABOLIC PROCESS,0.32077,-0.115,-0.055376,0,0
3,GO DIVALENT METAL ION EXPORT,0.38888,-0.11508,-0.11622,0,0
3,GO NEUROBLAST PROLIFERATION,0.073629,-0.11531,-0.11707,0,0
3,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.30815,-0.11585,-0.052451,0,0
3,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.20621,-0.11607,-0.25994,0,0
3,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.12049,-0.11626,-0.075676,0,0
3,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.25729,-0.11628,-0.099096,0,0
3,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.46512,-0.11633,-0.075363,0,0
3,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.070855,-0.11666,-0.10257,0,0
3,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.0085714,-0.11687,-0.14095,0,0
3,GO NEURAL CREST CELL MIGRATION,0.03939,-0.11726,-0.17354,0,0
3,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.18508,-0.11783,-0.072805,0,0
3,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.18219,-0.11798,-0.10884,0,0
3,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.0060989,-0.118,-0.17522,0,0
3,GO RRNA MODIFICATION,0.16032,-0.11806,-0.10338,0,0
3,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.10465,-0.11824,-0.09914,0,0
3,GO SYNAPTIC VESICLE PRIMING,0.47588,-0.11842,0.0097208,0,0
3,GO FOREBRAIN CELL MIGRATION,0.049546,-0.11842,-0.13399,0,0
3,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.088862,-0.11863,-0.11147,0,0
3,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.20937,-0.11869,-0.082046,0,0
3,GO DERMATAN SULFATE METABOLIC PROCESS,0.18508,-0.11953,-0.16927,0,0
3,GO REGULATION OF TRANS SYNAPTIC SIGNALING,0.17099,-0.12004,-0.075241,0,0
3,GO FOREBRAIN DEVELOPMENT,0.054842,-0.1202,-0.07406,0,0
3,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.068167,-0.12025,-0.10496,0,0
3,GO RESPONSE TO LEAD ION,0.047551,-0.12149,-0.10153,0,0
3,GO SUBSTANTIA NIGRA DEVELOPMENT,0.050569,-0.12166,-0.082795,0,0
3,GO UTERUS DEVELOPMENT,0.41341,-0.12215,-0.086303,0,0
3,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.10654,-0.12231,-0.14429,0,0
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.14048,-0.12273,-0.20108,0,0
3,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.12259,-0.12311,-0.14665,0,0
3,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.0011199,-0.12313,-0.10746,0,0
3,GO DNA REPLICATION INITIATION,0.00024286,-0.12315,-0.17803,0,0
3,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.39858,-0.1234,-0.082963,0,0
3,GO REGULATION OF TELOMERE CAPPING,0.019739,-0.12374,-0.097496,0,0
3,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,0.049546,-0.124,-0.15292,0,0
3,GO PEPTIDYL ARGININE N METHYLATION,0.10654,-0.12418,-0.11128,0,0
3,GO REGULATION OF CATION CHANNEL ACTIVITY,0.46512,-0.12438,-0.049716,0,0
3,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.057089,-0.12445,-0.12522,0,0
3,GO SPINAL CORD DEVELOPMENT,0.033166,-0.12449,-0.13598,0,0
3,GO NEUROTRANSMITTER SECRETION,0.12259,-0.12467,-0.041344,0,0
3,GO REGULATION OF AXON GUIDANCE,0.047551,-0.12473,-0.13865,0,0
3,GO COCHLEA DEVELOPMENT,0.15015,-0.12479,-0.12256,0,0
3,GO NEGATIVE REGULATION OF BEHAVIOR,0.21905,-0.12492,-0.10205,0,0
3,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.075049,-0.12543,-0.096636,0,0
3,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.40349,-0.12547,-0.072516,0,0
3,GO SYNAPSE ORGANIZATION,0.16828,-0.12555,-0.083251,0,0
3,GO HISTONE H3 K9 TRIMETHYLATION,0.075049,-0.12563,-0.085544,0,0
3,GO CEREBRAL CORTEX DEVELOPMENT,0.03939,-0.12563,-0.072828,0,0
3,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.009256,-0.12564,-0.14819,0,0
3,GO NEURON PROJECTION REGENERATION,0.27999,-0.1262,-0.075834,0,0
3,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.16032,-0.12699,-0.12787,0,0
3,GO MITOCHONDRIAL PROTEIN PROCESSING,0.17653,-0.12752,-0.068646,0,0
3,GO L SERINE METABOLIC PROCESS,0.40843,-0.12759,-0.099591,0,0
3,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.04854,-0.1278,-0.13641,0,0
3,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.52025,-0.12786,-0.053634,0,0
3,GO REGULATION OF HEART GROWTH,0.080955,-0.12822,-0.098609,0,0
3,GO POSITIVE REGULATION OF BEHAVIOR,0.066855,-0.12871,-0.18247,0,0
3,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.16294,-0.12875,-0.22562,0,0
3,GO RRNA METHYLATION,0.2839,-0.12887,-0.058499,0,0
3,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.28785,-0.12898,-0.069785,0,0
3,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.047551,-0.12905,-0.12879,0,0
3,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.022165,-0.12909,-0.14259,0,0
3,GO REGULATION OF SYNAPTIC PLASTICITY,0.13583,-0.12934,-0.083472,0,0
3,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.16559,-0.13006,-0.10934,0,0
3,GO CEREBELLAR CORTEX DEVELOPMENT,0.27611,-0.13034,-0.05784,0,0
3,GO PROTEIN LOCALIZATION TO CILIUM,0.0025083,-0.13137,-0.17116,0,0
3,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.041093,-0.13254,-0.089125,0,0
3,GO NEUROBLAST DIVISION,0.61497,-0.13274,-0.038372,0,0
3,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.12049,-0.13368,-0.12352,0,0
3,GO INHIBITORY POSTSYNAPTIC POTENTIAL,0.042857,-0.13372,-0.17366,0,0
3,GO REGULATION OF MESODERM DEVELOPMENT,0.041967,-0.13461,-0.1704,0,0
3,GO APPENDAGE MORPHOGENESIS,0.15264,-0.1347,-0.086297,0,0
3,GO PROTEIN DENEDDYLATION,0.27611,-0.13479,-0.066833,0,0
3,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.34256,-0.13491,-0.086418,0,0
3,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.090515,-0.13501,-0.082461,0,0
3,GO GLUTAMATE SECRETION,0.13583,-0.1361,-0.089396,0,0
3,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.0017123,-0.13657,-0.14069,0,0
3,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.11235,-0.13804,-0.1703,0,0
3,GO HISTONE H3 K27 METHYLATION,0.029719,-0.1383,-0.12641,0,0
3,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.059411,-0.13843,-0.079572,0,0
3,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.063042,-0.13929,-0.16876,0,0
3,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.34702,-0.13953,-0.12945,0,0
3,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.36526,-0.14033,-0.055037,0,0
3,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.12049,-0.14034,-0.14633,0,0
3,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.099158,-0.14056,-0.091182,0,0
3,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.87833,-0.14074,0.029896,0,0
3,GO VIRAL TRANSLATION,0.061812,-0.14076,-0.1726,0,0
3,GO COLLECTING DUCT DEVELOPMENT,0.13355,-0.14086,-0.14172,0,0
3,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.02068,-0.14137,-0.1514,0,0
3,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.024846,-0.1416,-0.087648,0,0
3,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.40843,-0.14164,-0.16983,0,0
3,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.21579,-0.14177,-0.084173,0,0
3,GO MATURATION OF SSU RRNA,0.059411,-0.14179,-0.17261,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.23937,-0.14203,-0.078824,0,0
3,GO NEGATIVE REGULATION OF CELL AGING,0.20309,-0.14235,-0.12452,0,0
3,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.23245,-0.1433,-0.11878,0,0
3,GO AXONAL TRANSPORT,0.0024367,-0.14344,-0.14911,0,0
3,GO REGULATION OF HEART MORPHOGENESIS,0.061812,-0.14345,-0.16015,0,0
3,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.082489,-0.1437,-0.18939,0,0
3,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.85082,-0.14382,0.0054751,0,0
3,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.0067808,-0.14391,-0.1898,0,0
3,GO REGULATION OF ANIMAL ORGAN FORMATION,0.4598,-0.144,-0.082699,0,0
3,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.1313,-0.14403,-0.12664,0,0
3,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.061812,-0.14451,-0.1533,0,0
3,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.014486,-0.14509,-0.11745,0,0
3,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.15015,-0.14557,-0.11962,0,0
3,GO SIALYLATION,0.91293,-0.14559,0.0028317,0,0
3,GO HISTONE DEUBIQUITINATION,0.026586,-0.14606,-0.085075,0,0
3,GO V D J RECOMBINATION,0.20309,-0.14669,-0.10317,0,0
3,GO RESPIRATORY SYSTEM PROCESS,0.0013872,-0.14697,-0.20324,0,0
3,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.073629,-0.147,-0.093658,0,0
3,GO RESPONSE TO ACETYLCHOLINE,0.095625,-0.14707,-0.18718,0,0
3,GO VENTRICULAR SYSTEM DEVELOPMENT,0.014138,-0.14714,-0.14036,0,0
3,GO CELLULAR HYPEROSMOTIC RESPONSE,0.17934,-0.14726,-0.15407,0,0
3,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.064293,-0.14738,-0.15817,0,0
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.12049,-0.1474,-0.11871,0,0
3,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.17934,-0.14752,-0.12586,0,0
3,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.13583,-0.148,-0.11381,0,0
3,GO PALLIUM DEVELOPMENT,0.0069616,-0.14823,-0.10994,0,0
3,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.21579,-0.149,-0.14887,0,0
3,GO NEURON FATE COMMITMENT,0.18508,-0.15001,-0.088576,0,0
3,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.029068,-0.15059,-0.13704,0,0
3,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.2839,-0.15073,-0.12677,0,0
3,GO OTIC VESICLE DEVELOPMENT,0.21256,-0.15116,-0.15139,0,0
3,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.21905,-0.15126,-0.14274,0,0
3,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.063042,-0.15176,-0.15668,0,0
3,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.090515,-0.15242,-0.13428,0,0
3,GO INNER CELL MASS CELL PROLIFERATION,0.2,-0.15266,-0.078376,0,0
3,GO FOREBRAIN GENERATION OF NEURONS,0.50337,-0.15279,-0.020189,0,0
3,GO METANEPHRIC COLLECTING DUCT DEVELOPMENT,0.090515,-0.15426,-0.18087,0,0
3,GO AXON EXTENSION,0.0053338,-0.15447,-0.19232,0,0
3,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,0.32077,-0.15481,-0.069866,0,0
3,GO POSITIVE REGULATION OF AXONOGENESIS,0.02068,-0.15485,-0.17205,0,0
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.0013457,-0.15491,-0.15072,0,0
3,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.016734,-0.15493,-0.18828,0,0
3,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.017549,-0.15494,-0.14342,0,0
3,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.17653,-0.15611,-0.112,0,0
3,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.36991,-0.15628,-0.052214,0,0
3,GO ENDOCARDIAL CUSHION FORMATION,0.12473,-0.1565,-0.12536,0,0
3,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,0.087232,-0.15678,-0.11884,0,0
3,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.4598,-0.15707,-0.051042,0,0
3,GO REGULATION OF DENDRITE DEVELOPMENT,0.036164,-0.15709,-0.10319,0,0
3,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.17374,-0.15745,-0.13193,0,0
3,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.02268,-0.1578,-0.16363,0,0
3,GO PYRAMIDAL NEURON DIFFERENTIATION,0.059411,-0.15864,-0.2051,0,0
3,GO HISTONE H4 K16 ACETYLATION,0.070855,-0.15896,-0.090193,0,0
3,GO NEURON CELLULAR HOMEOSTASIS,0.046579,-0.15905,-0.1914,0,0
3,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.0036303,-0.15911,-0.16811,0,0
3,GO SOMATIC STEM CELL DIVISION,0.12473,-0.15953,-0.19645,0,0
3,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,0.20937,-0.15996,-0.1495,0,0
3,GO COCHLEA MORPHOGENESIS,0.045624,-0.15997,-0.15441,0,0
3,GO HINDLIMB MORPHOGENESIS,0.087232,-0.16155,-0.13783,0,0
3,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0056288,-0.1617,-0.19252,0,0
3,GO RETROGRADE AXONAL TRANSPORT,0.0010859,-0.16171,-0.25629,0,0
3,GO INTRACILIARY RETROGRADE TRANSPORT,0.052669,-0.16281,-0.17883,0,0
3,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.27227,-0.16304,-0.049234,0,0
3,GO MITOTIC SISTER CHROMATID COHESION,0.02166,-0.16419,-0.13593,0,0
3,GO OUTFLOW TRACT MORPHOGENESIS,0.084046,-0.16422,-0.12573,0,0
3,GO RECEPTOR CLUSTERING,0.025414,-0.16577,-0.14721,0,0
3,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0016129,-0.16586,-0.2029,0,0
3,GO SYNAPTIC VESICLE LOCALIZATION,0.0046564,-0.16625,-0.16328,0,0
3,GO MITRAL VALVE DEVELOPMENT,0.066855,-0.16748,-0.20961,0,0
3,GO FORELIMB MORPHOGENESIS,0.057089,-0.16794,-0.17324,0,0
3,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.040234,-0.16933,-0.15548,0,0
3,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.0695,-0.16952,-0.13301,0,0
3,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.36526,-0.16967,-0.064821,0,0
3,GO FOREBRAIN NEURON FATE COMMITMENT,0.34702,-0.17056,-0.1082,0,0
3,GO DENDRITE SELF AVOIDANCE,0.080955,-0.17056,-0.16998,0,0
3,GO CARDIOBLAST PROLIFERATION,0.10465,-0.17289,-0.27634,0,0
3,GO INTRACILIARY TRANSPORT,0.023205,-0.17341,-0.14887,0,0
3,GO RRNA 3 END PROCESSING,0.27227,-0.17367,-0.058367,0,0
3,GO AXONAL TRANSPORT OF MITOCHONDRION,0.012203,-0.17461,-0.21288,0,0
3,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.070855,-0.17482,-0.16963,0,0
3,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.0079323,-0.17524,-0.14998,0,0
3,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.0071468,-0.17538,-0.15989,0,0
3,GO KINETOCHORE ORGANIZATION,0.0695,-0.17638,-0.12067,0,0
3,GO NEURON FATE SPECIFICATION,0.47588,-0.17732,-0.036099,0,0
3,GO POSTSYNAPSE ORGANIZATION,0.015574,-0.17741,-0.16033,0,0
3,GO CELL DIFFERENTIATION IN HINDBRAIN,0.085627,-0.17899,-0.15219,0,0
3,GO INHIBITORY SYNAPSE ASSEMBLY,0.29184,-0.17966,-0.096495,0,0
3,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.0695,-0.17992,-0.24946,0,0
3,GO REGULATION OF DENDRITE MORPHOGENESIS,0.0036303,-0.17999,-0.1651,0,0
3,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.84397,-0.18005,-0.024698,0,0
3,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.00079435,-0.18008,-0.20815,0,0
3,GO NEURON RECOGNITION,0.070855,-0.18282,-0.19081,0,0
3,GO FOREBRAIN NEURON DEVELOPMENT,0.075049,-0.18289,-0.17378,0,0
3,GO NUCLEAR PORE ORGANIZATION,0.068167,-0.18296,-0.13142,0,0
3,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.066855,-0.18342,-0.14309,0,0
3,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.00092958,-0.18372,-0.20676,0,0
3,GO REGULATION OF SYNAPTIC VESICLE CYCLE,0.029068,-0.18432,-0.10175,0,0
3,GO DENDRITE DEVELOPMENT,0.03245,-0.18444,-0.10745,0,0
3,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.017137,-0.18468,-0.16275,0,0
3,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.43883,-0.185,-0.025455,0,0
3,GO HEART FORMATION,0.16032,-0.18524,-0.10341,0,0
3,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.014841,-0.18531,-0.16548,0,0
3,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.11235,-0.18545,-0.20632,0,0
3,GO FOREBRAIN NEURON DIFFERENTIATION,0.54321,-0.18549,-0.028369,0,0
3,GO TONGUE MORPHOGENESIS,0.097379,-0.18577,-0.22121,0,0
3,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.25001,-0.18628,-0.12988,0,0
3,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.10096,-0.18678,-0.22457,0,0
3,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.012203,-0.18682,-0.13658,0,0
3,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.019283,-0.18827,-0.27985,0,0
3,GO NEURON MIGRATION,0.020205,-0.18907,-0.16345,0,0
3,GO IMP METABOLIC PROCESS,0.28785,-0.18914,-0.12931,0,0
3,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.066855,-0.18986,-0.16668,0,0
3,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.087232,-0.19009,-0.1116,0,0
3,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,0.065563,-0.19058,-0.126,0,0
3,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.1028,-0.19099,-0.15023,0,0
3,GO KINETOCHORE ASSEMBLY,0.076492,-0.192,-0.1262,0,0
3,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.084046,-0.19245,-0.15562,0,0
3,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.079444,-0.19391,-0.27867,0,0
3,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.019283,-0.19418,-0.21968,0,0
3,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.025994,-0.19425,-0.19023,0,0
3,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.14048,-0.1947,-0.15499,0,0
3,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.026586,-0.19515,-0.17766,0,0
3,GO PROTEIN LOCALIZATION TO SYNAPSE,0.019283,-0.19592,-0.17279,0,0
3,GO CELL DIFFERENTIATION IN SPINAL CORD,0.017549,-0.19676,-0.14817,0,0
3,GO CEREBRAL CORTEX CELL MIGRATION,0.031059,-0.19704,-0.13356,0,0
3,GO DENDRITIC SPINE DEVELOPMENT,0.023205,-0.19813,-0.14851,0,0
3,GO RRNA PSEUDOURIDINE SYNTHESIS,0.082489,-0.19919,-0.18711,0,0
3,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.014138,-0.20012,-0.16371,0,0
3,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.00087311,-0.20044,-0.26334,0,0
3,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.11235,-0.20064,-0.18491,0,0
3,GO DENDRITE MORPHOGENESIS,0.010773,-0.20094,-0.14905,0,0
3,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,0.11039,-0.2022,-0.19006,0,0
3,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.040234,-0.20222,-0.23417,0,0
3,GO MICROTUBULE SEVERING,0.092194,-0.2026,-0.12788,0,0
3,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.024846,-0.2032,-0.21232,0,0
3,GO LOCALIZATION WITHIN MEMBRANE,0.010245,-0.20354,-0.14881,0,0
3,GO DENSE CORE GRANULE TRANSPORT,0.33373,-0.20383,-0.082945,0,0
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.036164,-0.20441,-0.19979,0,0
3,GO SECONDARY HEART FIELD SPECIFICATION,0.32506,-0.20476,-0.098344,0,0
3,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.87144,-0.20548,-0.021219,0,0
3,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.019283,-0.2058,-0.28216,0,0
3,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.22905,-0.20628,-0.12789,0,0
3,GO NON MOTILE CILIUM ASSEMBLY,0.0015653,-0.20758,-0.17512,0,0
3,GO AV NODE CELL TO BUNDLE OF HIS CELL COMMUNICATION,0.12689,-0.20946,-0.19133,0,0
3,GO GTP METABOLIC PROCESS,0.014841,-0.20964,-0.20239,0,0
3,GO REGULATION OF NEURON MIGRATION,0.0014299,-0.21335,-0.24988,0,0
3,GO NEGATIVE REGULATION OF AXON EXTENSION,0.014841,-0.21388,-0.20327,0,0
3,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.0013457,-0.21399,-0.23414,0,0
3,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.00069957,-0.21482,-0.22305,0,0
3,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.17653,-0.21877,-0.11669,0,0
3,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.10845,-0.22001,-0.12855,0,0
3,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.047551,-0.22058,-0.20552,0,0
3,GO CGMP METABOLIC PROCESS,0.32938,-0.22097,-0.093709,0,0
3,GO HEART FIELD SPECIFICATION,0.26098,-0.22134,-0.10296,0,0
3,GO SPERMATID NUCLEUS DIFFERENTIATION,0.00052342,-0.22309,-0.24176,0,0
3,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.14048,-0.22464,-0.19959,0,0
3,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.065563,-0.22626,-0.20654,0,0
3,GO DENDRITIC SPINE MORPHOGENESIS,0.0021062,-0.22653,-0.23571,0,0
3,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.0036303,-0.22975,-0.24338,0,0
3,GO BRAIN MORPHOGENESIS,0.0031536,-0.22975,-0.16511,0,0
3,GO RETINAL ROD CELL DIFFERENTIATION,0.13355,-0.22977,-0.16539,0,0
3,GO COMMISSURAL NEURON AXON GUIDANCE,0.0081404,-0.22983,-0.33871,0,0
3,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.17374,-0.23067,-0.12451,0,0
3,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.0094949,-0.23219,-0.2629,0,0
3,GO MICROTUBULE DEPOLYMERIZATION,0.0067808,-0.23265,-0.20577,0,0
3,GO REGULATION OF NEURON PROJECTION REGENERATION,0.0032441,-0.23281,-0.22731,0,0
3,GO OLFACTORY LOBE DEVELOPMENT,0.024288,-0.23281,-0.22491,0,0
3,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.0027346,-0.23495,-0.23367,0,0
3,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.019283,-0.23553,-0.27672,0,0
3,GO TONGUE DEVELOPMENT,0.10096,-0.23629,-0.17956,0,0
3,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.11636,-0.23687,-0.16365,0,0
3,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,0.5726,-0.23693,-0.034725,0,0
3,GO RECEPTOR LOCALIZATION TO SYNAPSE,0.027188,-0.23827,-0.18996,0,0
3,GO SECRETORY GRANULE LOCALIZATION,0.076492,-0.23884,-0.18094,0,0
3,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.0050528,-0.23912,-0.25925,0,0
3,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,0.02268,-0.23977,-0.1563,0,0
3,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.011047,-0.24052,-0.19117,0,0
3,GO SYNAPTIC MEMBRANE ADHESION,0.14769,-0.24299,-0.18607,0,0
3,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.014138,-0.24388,-0.25753,0,0
3,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.027188,-0.24476,-0.29127,0,0
3,GO VENTRAL SPINAL CORD DEVELOPMENT,0.024846,-0.24505,-0.15844,0,0
3,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.14526,-0.25176,-0.2072,0,0
3,GO DENTATE GYRUS DEVELOPMENT,0.13583,-0.25311,-0.14692,0,0
3,GO DNA LIGATION,0.0057817,-0.25595,-0.1983,0,0
3,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.02843,-0.25606,-0.16562,0,0
3,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.031748,-0.25692,-0.16606,0,0
3,GO ATRIAL SEPTUM MORPHOGENESIS,0.023205,-0.25701,-0.23558,0,0
3,GO FOREBRAIN MORPHOGENESIS,0.0049174,-0.25917,-0.21333,0,0
3,GO NEGATIVE REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS,0.0015653,-0.26038,-0.3777,0,0
3,GO CARDIAC CELL FATE COMMITMENT,0.030383,-0.26131,-0.26725,0,0
3,GO UV PROTECTION,0.0695,-0.26304,-0.18076,0,0
3,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.017969,-0.27025,-0.24549,0,0
3,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.0099891,-0.2731,-0.27177,0,0
3,GO REGULATION OF POSTSYNAPSE ORGANIZATION,0.0073363,-0.27411,-0.20152,0,0
3,GO PLASMA MEMBRANE REPAIR,0.15773,-0.27773,-0.14674,0,0
3,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.39858,-0.27989,-0.053781,0,0
3,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.004408,-0.28205,-0.22066,0,0
3,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.00040247,-0.28635,-0.25966,0,0
3,GO AXO DENDRITIC PROTEIN TRANSPORT,0.0021062,-0.28678,-0.25828,0,0
3,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,4.1617e-05,-0.28792,-0.29869,0,0
3,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.0028957,-0.28961,-0.24978,0,0
3,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,3.0689e-05,-0.28988,-0.35261,0,0
3,GO HEART VALVE FORMATION,0.13355,-0.29469,-0.19902,0,0
3,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.017969,-0.29758,-0.24615,0,0
3,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.027803,-0.30604,-0.25054,0,0
3,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.014138,-0.30828,-0.30029,0,0
3,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,0.00044439,-0.31325,-0.25312,0,0
3,GO PHAGOCYTOSIS RECOGNITION,0.0087944,-0.31522,-0.26868,0,0
3,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.035393,-0.31644,-0.30501,0,0
3,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.070855,-0.31938,-0.26645,0,0
3,GO TRIGEMINAL NERVE DEVELOPMENT,0.036948,-0.32174,-0.32394,0,0
3,GO CARTILAGE MORPHOGENESIS,0.0090226,-0.32188,-0.32674,0,0
3,GO CHROMATIN DISASSEMBLY,3.0689e-05,-0.32549,-0.29539,0,0
3,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0099891,-0.33005,-0.23804,0,0
3,GO LATERAL VENTRICLE DEVELOPMENT,0.0057817,-0.33128,-0.31808,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.036948,-0.33666,-0.18205,0,0
3,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.0010206,-0.33915,-0.31011,0,0
3,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.00067758,-0.35641,-0.30682,0,0
3,GO MAINTENANCE OF SYNAPSE STRUCTURE,0.030383,-0.35836,-0.22266,0,0
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.004408,-0.36625,-0.32486,0,0
3,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0030654,-0.40009,-0.45476,0,0
3,GO LONG TERM SYNAPTIC DEPRESSION,0.00055855,-0.40846,-0.30782,0,0
3,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.010245,-0.41239,-0.34285,0,0
3,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.0016129,-0.43052,-0.39041,0,0
3,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.00037661,-0.43489,-0.42583,0,0
3,GO VOCALIZATION BEHAVIOR,0.046579,-0.44735,-0.30345,0,0
3,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,0.11434,-0.48089,-0.24229,0,0
3,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,3.8583e-05,-0.51494,-0.59494,0,0
3,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,0.00042998,-0.57796,-0.52826,0,0
3,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,0.00084609,-0.58462,-0.52459,0,0
3,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.0013054,-0.612,-0.44291,0,0
3,GO SYNAPTIC VESICLE CLUSTERING,0.00044439,-0.66147,-0.56029,0,0
4,GO FOREBRAIN NEURON FATE COMMITMENT,2.0033e-05,0.73192,0.87575,1,1
4,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,0.0023671,0.56017,0.44578,1,1
4,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,7.9801e-06,0.55173,0.50333,1,1
4,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.001986,0.51584,0.40296,1,1
4,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,9.7801e-06,0.42961,0.42688,1,1
4,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.00035231,0.37051,0.36539,1,1
4,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,0.0062634,0.34268,0.38577,1,1
4,GO THALAMUS DEVELOPMENT,0.010773,0.32591,0.2592,1,1
4,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.0057817,0.31895,0.27221,1,1
4,GO ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT,5.6174e-05,0.30278,0.46527,1,1
4,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.014138,0.27628,0.26023,1,1
4,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.009256,0.26035,0.22544,1,1
4,GO KINETOCHORE ORGANIZATION,0.0010859,0.25256,0.21653,1,1
4,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.0015653,0.247,0.21634,1,1
4,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.0010859,0.23977,0.22439,1,1
4,GO MRNA SPLICE SITE SELECTION,6.2786e-05,0.23498,0.26471,1,1
4,GO V D J RECOMBINATION,0.0025083,0.22829,0.2371,1,1
4,GO VIRAL LATENCY,0.0057817,0.2272,0.18246,1,1
4,GO KINETOCHORE ASSEMBLY,0.0036303,0.21244,0.1824,1,1
4,GO HISTONE H4 K16 ACETYLATION,7.013e-05,0.20893,0.21446,1,1
4,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.015574,0.20253,0.21156,1,1
4,GO CHROMATIN REMODELING AT CENTROMERE,0.00081984,0.20199,0.19604,1,1
4,GO HISTONE H2A MONOUBIQUITINATION,3.5759e-05,0.19936,0.22881,1,1
4,GO DENDRITIC TRANSPORT,0.015953,0.19529,0.1869,1,1
4,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.0056288,0.19042,0.15185,1,1
4,GO MITOTIC DNA REPLICATION CHECKPOINT,0.011047,0.18921,0.13824,1,1
4,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.0094949,0.18427,0.13809,1,1
4,GO CENTROMERE COMPLEX ASSEMBLY,0.0010859,0.1826,0.18466,1,1
4,GO SINGLE STRAND BREAK REPAIR,0.011612,0.18037,0.14414,1,1
4,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.035393,0.17925,0.14575,1,1
4,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.00012512,0.17735,0.19558,1,1
4,GO HISTONE H4 K5 ACETYLATION,0.00019753,0.17219,0.22065,1,1
4,GO REGULATION OF SISTER CHROMATID COHESION,0.0027346,0.17143,0.16066,1,1
4,GO GENETIC IMPRINTING,0.0028141,0.17101,0.1877,1,1
4,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.02268,0.16964,0.14731,1,1
4,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.00065623,0.16926,0.16169,1,1
4,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.0021689,0.16217,0.1571,1,1
4,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.00090094,0.16197,0.16195,1,1
4,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.0042883,0.16081,0.18134,1,1
4,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.02068,0.15991,0.14099,1,1
4,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.00081984,0.15959,0.151,1,1
4,GO RESPONSE TO HYDROXYUREA,0.010245,0.15834,0.184,1,1
4,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.0049174,0.15646,0.17189,1,1
4,GO ACROSOME ASSEMBLY,0.052669,0.1562,0.11135,1,1
4,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.02843,0.1525,0.13344,1,1
4,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.0094949,0.15239,0.1655,1,1
4,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.011904,0.15061,0.12489,1,1
4,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.010773,0.1449,0.13328,1,1
4,GO MAINTENANCE OF ORGANELLE LOCATION,0.02166,0.14457,0.092113,1,1
4,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.0028141,0.1445,0.18799,1,1
4,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.0083534,0.14327,0.11782,1,1
4,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.019739,0.14304,0.13259,1,1
4,GO DNA REPLICATION CHECKPOINT,0.02068,0.14289,0.11185,1,1
4,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.0007696,0.14262,0.15124,1,1
4,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.0040578,0.14194,0.116,1,1
4,GO HISTONE H2A UBIQUITINATION,0.0017123,0.14189,0.14466,1,1
4,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.0079323,0.14171,0.13958,1,1
4,GO CENTROSOME DUPLICATION,0.001986,0.14114,0.13301,1,1
4,GO MITOTIC CHROMOSOME CONDENSATION,0.001872,0.1411,0.17772,1,1
4,GO CENTRIOLE ASSEMBLY,0.00353,0.13945,0.11742,1,1
4,GO POSITIVE REGULATION OF DNA REPAIR,0.0019282,0.13856,0.11389,1,1
4,GO DOSAGE COMPENSATION,0.0031536,0.13802,0.12128,1,1
4,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.00020448,0.13743,0.1466,1,1
4,GO HISTONE H2A ACETYLATION,0.0022992,0.13688,0.15963,1,1
4,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.023741,0.13621,0.15554,1,1
4,GO REGULATION OF CILIUM ASSEMBLY,0.0057817,0.13062,0.11455,1,1
4,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.0019282,0.12899,0.11682,1,1
4,GO POST ANAL TAIL MORPHOGENESIS,0.03245,0.12724,0.11595,1,1
4,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.009256,0.12664,0.1551,1,1
4,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.0079323,0.12632,0.23323,1,1
4,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.0037331,0.12422,0.12922,1,1
4,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.017969,0.12062,0.145,1,1
4,GO ATP DEPENDENT CHROMATIN REMODELING,0.00098941,0.11954,0.133,1,1
4,GO HISTONE H4 ACETYLATION,0.00044439,0.11655,0.12092,1,1
4,GO DNA STRAND ELONGATION,0.0081404,0.11409,0.12012,1,1
4,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.0060989,0.11323,0.10197,1,1
4,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.013798,0.11285,0.12274,1,1
4,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.0024367,0.11267,0.13829,1,1
4,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.04854,0.11256,0.073081,1,1
4,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.019739,0.11248,0.14007,1,1
4,GO HISTONE MONOUBIQUITINATION,0.00047456,0.11174,0.12935,1,1
4,GO NUCLEOSOME ASSEMBLY,0.0049174,0.11165,0.13647,1,1
4,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.0073363,0.11063,0.13981,1,1
4,GO NEGATIVE REGULATION OF RNA SPLICING,0.0047853,0.10959,0.11747,1,1
4,GO G0 TO G1 TRANSITION,0.0033369,0.1072,0.13291,1,1
4,GO PEPTIDYL LYSINE ACETYLATION,0.0012662,0.10704,0.08635,1,1
4,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.041967,0.10456,0.13158,1,1
4,GO REGULATION OF CELL CYCLE CHECKPOINT,0.0057817,0.10436,0.086338,1,1
4,GO PEPTIDYL LYSINE TRIMETHYLATION,0.017137,0.10403,0.088365,1,1
4,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.055956,0.099741,0.10261,1,1
4,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.0014299,0.098336,0.114,1,1
4,GO CELL CYCLE DNA REPLICATION,0.03245,0.094995,0.078337,1,1
4,GO HISTONE H3 K4 METHYLATION,0.0069616,0.092819,0.13187,1,1
4,GO PROTEIN ACETYLATION,0.004408,0.091896,0.06502,1,1
4,GO NUCLEOSOME ORGANIZATION,0.0090226,0.09049,0.096242,1,1
4,GO PEPTIDYL LYSINE METHYLATION,0.0085714,0.085453,0.088612,1,1
4,GO RECOMBINATIONAL REPAIR,0.017549,0.081364,0.065194,1,1
4,GO INTERSTRAND CROSS LINK REPAIR,0.0059384,0.080915,0.089999,1,1
4,GO REGULATION OF MRNA PROCESSING,0.042857,0.080296,0.068197,1,1
4,GO HISTONE EXCHANGE,0.012203,0.079558,0.10728,1,1
4,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.017969,0.076051,0.11087,1,1
4,GO CHROMOSOME SEGREGATION,0.025994,0.073111,0.055105,1,1
4,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.01282,0.07068,0.08865,1,1
4,GO CELL CYCLE CHECKPOINT,0.011326,0.066261,0.058079,1,1
4,GO PEPTIDYL LYSINE MODIFICATION,0.033166,0.066025,0.043682,1,1
4,GO HETEROCHROMATIN ORGANIZATION,0.0067808,0.065941,0.093481,1,1
4,GO REGULATION OF DNA REPAIR,0.036164,0.065502,0.056553,1,1
4,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.035393,0.059419,0.049952,1,1
4,GO MITOTIC SISTER CHROMATID SEGREGATION,0.033894,0.058823,0.070184,1,1
4,GO SISTER CHROMATID SEGREGATION,0.014841,0.057264,0.071304,1,1
4,GO DNA PACKAGING,0.0042883,0.057153,0.091516,1,1
4,GO DNA INTEGRITY CHECKPOINT,0.031059,0.055933,0.048829,1,1
4,GO PROTEIN MONOUBIQUITINATION,0.041093,0.055354,0.056463,1,1
4,GO DNA CONFORMATION CHANGE,0.041093,0.053238,0.05452,1,1
4,GO NUCLEAR CHROMOSOME SEGREGATION,0.030383,0.05044,0.050679,1,1
4,GO CHROMATIN ORGANIZATION,0.013139,0.049741,0.051725,1,1
4,GO REGULATION OF RNA SPLICING,0.042857,0.048391,0.051909,1,1
4,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.026586,0.30182,0.20854,1,0
4,GO FOREBRAIN REGIONALIZATION,0.0046564,0.19132,0.234,1,0
4,GO GAMMA DELTA T CELL DIFFERENTIATION,0.052669,0.1806,0.28223,1,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.0047853,0.15751,0.16183,1,0
4,GO RDNA HETEROCHROMATIN ASSEMBLY,0.011612,0.11048,0.151,1,0
4,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.018398,0.10519,0.092984,1,0
4,GO REGULATION OF CENTRIOLE REPLICATION,0.052669,0.095996,0.078279,1,0
4,GO CHROMOSOME LOCALIZATION,0.014486,0.092369,0.074626,1,0
4,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.054842,0.089405,0.066205,1,0
4,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.031059,0.070226,0.08843,1,0
4,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.031059,0.065334,0.073184,1,0
4,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.05161,0.056303,0.065631,1,0
4,GO MITOTIC CELL CYCLE CHECKPOINT,0.023741,0.056015,0.051668,1,0
4,GO PROTEIN LOCALIZATION TO NUCLEUS,0.043763,-0.032646,-0.061591,1,0
4,GO NUCLEAR TRANSPORT,0.045624,-0.033821,-0.05783,1,0
4,GO REGULATION OF GENE SILENCING,0.049546,-0.0413,-0.080894,1,0
4,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.007729,-0.048538,-0.080815,1,0
4,GO ACTIVATION OF GTPASE ACTIVITY,0.02268,-0.049566,-0.098181,1,0
4,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.0062634,-0.049911,-0.056966,1,0
4,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.036164,-0.049938,-0.062268,1,0
4,GO SULFATE TRANSPORT,0.036164,-0.051374,-0.13315,1,0
4,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.014486,-0.052056,-0.069113,1,0
4,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.022165,-0.052565,-0.065153,1,0
4,GO PEPTIDYL THREONINE MODIFICATION,0.033166,-0.052656,-0.071396,1,0
4,GO MULTI ORGANISM PROCESS,0.014841,-0.05313,-0.061495,1,0
4,GO REGULATION OF PH,0.034637,-0.053309,-0.073746,1,0
4,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.0025083,-0.053954,-0.071439,1,0
4,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.038561,-0.053961,-0.072807,1,0
4,GO GPI ANCHOR METABOLIC PROCESS,0.040234,-0.054554,-0.11914,1,0
4,GO HOMEOSTASIS OF NUMBER OF CELLS,0.0099891,-0.056509,-0.084438,1,0
4,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.0028957,-0.057647,-0.061601,1,0
4,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.0059384,-0.058373,-0.069524,1,0
4,GO LYMPHOCYTE DIFFERENTIATION,0.031059,-0.058843,-0.085493,1,0
4,GO MESODERM DEVELOPMENT,0.011326,-0.058874,-0.11569,1,0
4,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.0015189,-0.059642,-0.064023,1,0
4,GO IMPORT INTO NUCLEUS,0.011612,-0.059684,-0.082369,1,0
4,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,0.052669,-0.060308,-0.10509,1,0
4,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.023741,-0.060314,-0.0961,1,0
4,GO STEM CELL DIFFERENTIATION,0.043763,-0.061096,-0.070577,1,0
4,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.053746,-0.061828,-0.094173,1,0
4,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.029719,-0.062043,-0.08145,1,0
4,GO REPRODUCTION,0.025414,-0.062979,-0.061288,1,0
4,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.0073363,-0.063017,-0.12848,1,0
4,GO IN UTERO EMBRYONIC DEVELOPMENT,0.046579,-0.063483,-0.064153,1,0
4,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.041093,-0.063708,-0.11109,1,0
4,GO CELL CELL SIGNALING BY WNT,0.026586,-0.064063,-0.076505,1,0
4,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.0017123,-0.06472,-0.087787,1,0
4,GO MRNA METABOLIC PROCESS,0.047551,-0.064764,-0.064523,1,0
4,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.027803,-0.065251,-0.10461,1,0
4,GO DETECTION OF STIMULUS,0.0085714,-0.065475,-0.070488,1,0
4,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.0083534,-0.065818,-0.094074,1,0
4,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.037747,-0.06737,-0.067277,1,0
4,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.029719,-0.068736,-0.073284,1,0
4,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.033894,-0.069232,-0.13645,1,0
4,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,0.011612,-0.06998,-0.09013,1,0
4,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.011047,-0.070811,-0.099172,1,0
4,GO DNA BIOSYNTHETIC PROCESS,0.02068,-0.070952,-0.061629,1,0
4,GO ENDOSOMAL TRANSPORT,0.011326,-0.071172,-0.06786,1,0
4,GO REGULATION OF SECRETION,0.02068,-0.071236,-0.081229,1,0
4,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.054842,-0.071245,-0.10693,1,0
4,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.022165,-0.071275,-0.111,1,0
4,GO METHIONINE METABOLIC PROCESS,0.017549,-0.071631,-0.13264,1,0
4,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.001662,-0.071722,-0.070912,1,0
4,GO PEPTIDYL AMINO ACID MODIFICATION,0.00034072,-0.071733,-0.0797,1,0
4,GO PROTEIN O LINKED GLYCOSYLATION,0.024288,-0.072213,-0.13826,1,0
4,GO POSITIVE REGULATION OF SECRETION,0.018836,-0.072427,-0.084393,1,0
4,GO HISTONE DEACETYLATION,0.027803,-0.073637,-0.074009,1,0
4,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.017137,-0.07366,-0.12594,1,0
4,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.012203,-0.073773,-0.11397,1,0
4,GO REGULATION OF INTRACELLULAR TRANSPORT,0.021165,-0.074196,-0.062501,1,0
4,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.037747,-0.074461,-0.10264,1,0
4,GO REGULATION OF URINE VOLUME,0.019283,-0.074572,-0.12378,1,0
4,GO CELLULAR RESPONSE TO ALCOHOL,0.037747,-0.074874,-0.098091,1,0
4,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.052669,-0.074908,-0.072414,1,0
4,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.036164,-0.075357,-0.11333,1,0
4,GO RESPONSE TO IONIZING RADIATION,0.011326,-0.076217,-0.088855,1,0
4,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.0013457,-0.07643,-0.086884,1,0
4,GO ALPHA BETA T CELL ACTIVATION,0.029719,-0.076883,-0.11904,1,0
4,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.024288,-0.077092,-0.082588,1,0
4,GO CANONICAL WNT SIGNALING PATHWAY,0.015574,-0.077196,-0.092977,1,0
4,GO DEPHOSPHORYLATION,0.0015653,-0.077504,-0.085134,1,0
4,GO REGULATION OF VIRAL TRANSCRIPTION,0.0051916,-0.077525,-0.12081,1,0
4,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0037331,-0.077532,-0.088442,1,0
4,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,0.05161,-0.078116,-0.10274,1,0
4,GO ARACHIDONIC ACID SECRETION,0.027188,-0.078312,-0.12435,1,0
4,GO SENSORY PERCEPTION OF SMELL,0.001228,-0.078635,-0.13292,1,0
4,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.00353,-0.078668,-0.099786,1,0
4,GO NUCLEAR ENVELOPE ORGANIZATION,0.019283,-0.078932,-0.0804,1,0
4,GO BLASTOCYST DEVELOPMENT,0.014486,-0.078993,-0.073136,1,0
4,GO IMMUNOGLOBULIN PRODUCTION,0.019283,-0.07902,-0.10448,1,0
4,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.00036427,-0.079077,-0.083662,1,0
4,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.021165,-0.079202,-0.066989,1,0
4,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.0085714,-0.079212,-0.10139,1,0
4,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.00063551,-0.07925,-0.11238,1,0
4,GO PROTON TRANSMEMBRANE TRANSPORT,0.0060989,-0.079251,-0.10403,1,0
4,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.050569,-0.079333,-0.13978,1,0
4,GO POSITIVE REGULATION OF CELL ACTIVATION,0.015574,-0.079632,-0.11606,1,0
4,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.049546,-0.079824,-0.185,1,0
4,GO TRANSCRIPTION BY RNA POLYMERASE III,0.017969,-0.079989,-0.082645,1,0
4,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.054842,-0.080432,-0.14074,1,0
4,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.010245,-0.080503,-0.11655,1,0
4,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.055956,-0.080556,-0.056422,1,0
4,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.0032441,-0.080659,-0.090366,1,0
4,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.022165,-0.080923,-0.06844,1,0
4,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.0031536,-0.080938,-0.099534,1,0
4,GO REGULATION OF GASTRULATION,0.055956,-0.080965,-0.12923,1,0
4,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.0031536,-0.081175,-0.099682,1,0
4,GO REGULATION OF PROTEIN LOCALIZATION,0.0022992,-0.081225,-0.083814,1,0
4,GO REGULATION OF CELLULAR LOCALIZATION,0.0023671,-0.08129,-0.079172,1,0
4,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.031059,-0.081335,-0.084008,1,0
4,GO LIPID DROPLET ORGANIZATION,0.036164,-0.081755,-0.13037,1,0
4,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.044685,-0.082097,-0.1352,1,0
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.042857,-0.082297,-0.11298,1,0
4,GO CELLULAR PIGMENTATION,0.026586,-0.082299,-0.09967,1,0
4,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.017137,-0.082539,-0.16063,1,0
4,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.014841,-0.082603,-0.069644,1,0
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.018836,-0.083115,-0.11573,1,0
4,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.018836,-0.083532,-0.13777,1,0
4,GO RESPONSE TO ALKALOID,0.047551,-0.083536,-0.086897,1,0
4,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.00021909,-0.083819,-0.11157,1,0
4,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.023205,-0.083986,-0.08672,1,0
4,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.0041716,-0.084226,-0.10788,1,0
4,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.05161,-0.084357,-0.12491,1,0
4,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.0045306,-0.084772,-0.11192,1,0
4,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.040234,-0.084834,-0.11359,1,0
4,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.0013457,-0.084951,-0.083473,1,0
4,GO REGULATION OF MRNA CATABOLIC PROCESS,0.0037331,-0.085453,-0.12285,1,0
4,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.04854,-0.085457,-0.15083,1,0
4,GO EPITHELIUM DEVELOPMENT,0.012203,-0.085571,-0.10226,1,0
4,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.047551,-0.085741,-0.090863,1,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.020205,-0.085859,-0.088167,1,0
4,GO HISTONE PHOSPHORYLATION,0.0067808,-0.085921,-0.12821,1,0
4,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.034637,-0.086321,-0.11604,1,0
4,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.033894,-0.086328,-0.12327,1,0
4,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.00028792,-0.086862,-0.098924,1,0
4,GO CELLULAR MACROMOLECULE LOCALIZATION,2.5308e-05,-0.087129,-0.088575,1,0
4,GO IMMUNE SYSTEM DEVELOPMENT,0.0029794,-0.087463,-0.097167,1,0
4,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.0039469,-0.087644,-0.082921,1,0
4,GO DEFENSE RESPONSE TO FUNGUS,0.040234,-0.087739,-0.10751,1,0
4,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.0033369,-0.087749,-0.10726,1,0
4,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.041967,-0.087848,-0.094203,1,0
4,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.012203,-0.087958,-0.06727,1,0
4,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.015953,-0.088003,-0.13212,1,0
4,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.00092958,-0.088029,-0.1362,1,0
4,GO POSITIVE REGULATION OF GROWTH,0.025414,-0.088223,-0.071712,1,0
4,GO OLIGODENDROCYTE DEVELOPMENT,0.052669,-0.088271,-0.10917,1,0
4,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.035393,-0.088596,-0.068999,1,0
4,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.031748,-0.088738,-0.11114,1,0
4,GO REGULATION OF GROWTH,0.00081984,-0.088786,-0.10497,1,0
4,GO MUSCLE ORGAN DEVELOPMENT,0.0010206,-0.088941,-0.11014,1,0
4,GO CELL AGING,0.0064317,-0.089129,-0.10069,1,0
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0025817,-0.089153,-0.10994,1,0
4,GO REGULATION OF PROTEIN FOLDING,0.0075304,-0.089427,-0.13242,1,0
4,GO REGULATION OF CELL POPULATION PROLIFERATION,0.00034072,-0.089538,-0.12171,1,0
4,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.0006154,-0.089676,-0.13141,1,0
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.053746,-0.089861,-0.11234,1,0
4,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.001662,-0.089883,-0.11582,1,0
4,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.001662,-0.090326,-0.10196,1,0
4,GO REGULATION OF PEPTIDE TRANSPORT,0.0028141,-0.090331,-0.086979,1,0
4,GO ENDOSOME ORGANIZATION,0.013465,-0.090734,-0.1011,1,0
4,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.031748,-0.090759,-0.14147,1,0
4,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,1.104e-05,-0.090923,-0.095508,1,0
4,GO TISSUE MORPHOGENESIS,0.00069957,-0.090985,-0.13212,1,0
4,GO ORGANELLE DISASSEMBLY,0.0021062,-0.09109,-0.11051,1,0
4,GO CELL CELL ADHESION,0.00059588,-0.091147,-0.14735,1,0
4,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.050569,-0.091599,-0.095901,1,0
4,GO SENSORY PERCEPTION,0.0026572,-0.091788,-0.090179,1,0
4,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.016339,-0.091878,-0.1349,1,0
4,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.00037661,-0.09193,-0.094916,1,0
4,GO REGULATION OF FERTILIZATION,0.035393,-0.092165,-0.15111,1,0
4,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.045624,-0.092582,-0.079274,1,0
4,GO REGULATION OF TRANSLATIONAL INITIATION,0.0016129,-0.092948,-0.12719,1,0
4,GO REGULATION OF PHOSPHATASE ACTIVITY,0.010773,-0.092975,-0.069518,1,0
4,GO INTERLEUKIN 4 PRODUCTION,0.019283,-0.09299,-0.14221,1,0
4,GO B CELL DIFFERENTIATION,0.024288,-0.092999,-0.10393,1,0
4,GO SKIN DEVELOPMENT,0.04854,-0.093099,-0.12322,1,0
4,GO POSITIVE REGULATION OF TRANSPORT,0.00045924,-0.093234,-0.11189,1,0
4,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.021165,-0.093263,-0.14304,1,0
4,GO NEGATIVE REGULATION OF ION TRANSPORT,0.0045306,-0.093335,-0.096758,1,0
4,GO MESENCHYME DEVELOPMENT,0.0041716,-0.093538,-0.1309,1,0
4,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.049546,-0.093615,-0.068786,1,0
4,GO MUSCLE CELL DIFFERENTIATION,0.0019282,-0.093722,-0.11364,1,0
4,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.021165,-0.093734,-0.089317,1,0
4,GO PROTEOLYSIS,5.8301e-05,-0.093768,-0.11633,1,0
4,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.00021909,-0.093857,-0.12113,1,0
4,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.011326,-0.093895,-0.123,1,0
4,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.0066042,-0.09431,-0.11128,1,0
4,GO PROTEIN IMPORT,0.00044439,-0.094415,-0.1196,1,0
4,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.00067758,-0.094758,-0.11119,1,0
4,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.010245,-0.09478,-0.14239,1,0
4,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.016339,-0.094836,-0.088252,1,0
4,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.00018427,-0.094938,-0.11047,1,0
4,GO GOLGI ORGANIZATION,0.00034072,-0.094994,-0.12431,1,0
4,GO POSITIVE REGULATION OF SIGNALING,0.00026003,-0.095121,-0.11095,1,0
4,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.00018427,-0.095141,-0.099674,1,0
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.004408,-0.095183,-0.10961,1,0
4,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.046579,-0.095272,-0.13255,1,0
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.0090226,-0.095767,-0.11164,1,0
4,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.030383,-0.095878,-0.12146,1,0
4,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.044685,-0.095955,-0.10053,1,0
4,GO LEUKOCYTE TETHERING OR ROLLING,0.011326,-0.096018,-0.10397,1,0
4,GO INTERLEUKIN 12 PRODUCTION,0.054842,-0.096306,-0.091594,1,0
4,GO SMOOTH MUSCLE CELL MIGRATION,0.038561,-0.09634,-0.16828,1,0
4,GO AMINO ACID TRANSPORT,0.013465,-0.096417,-0.095658,1,0
4,GO HORMONE MEDIATED SIGNALING PATHWAY,0.00055855,-0.096523,-0.10289,1,0
4,GO LEUKOCYTE DIFFERENTIATION,0.0006154,-0.096696,-0.1302,1,0
4,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.010773,-0.096997,-0.13163,1,0
4,GO CALCIUM MEDIATED SIGNALING,0.0079323,-0.097149,-0.087039,1,0
4,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.010773,-0.097159,-0.11303,1,0
4,GO LUNG MORPHOGENESIS,0.055956,-0.097503,-0.14177,1,0
4,GO RNA INTERFERENCE,0.045624,-0.097587,-0.12161,1,0
4,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0094949,-0.097617,-0.15696,1,0
4,GO AMINO ACID TRANSMEMBRANE TRANSPORT,0.00353,-0.097636,-0.15767,1,0
4,GO REGULATION OF TRANSPORT,0.00034072,-0.097796,-0.10843,1,0
4,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,0.00037661,-0.097894,-0.11567,1,0
4,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.012203,-0.097956,-0.12975,1,0
4,GO NEUTROPHIL MIGRATION,0.011326,-0.098032,-0.12927,1,0
4,GO PEPTIDYL SERINE MODIFICATION,0.011326,-0.098289,-0.071975,1,0
4,GO LIPOPROTEIN METABOLIC PROCESS,0.0039469,-0.098306,-0.12443,1,0
4,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.0083534,-0.098444,-0.11211,1,0
4,GO SKELETAL SYSTEM DEVELOPMENT,0.0032441,-0.098635,-0.1101,1,0
4,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.007729,-0.098837,-0.14286,1,0
4,GO REGULATION OF HYDROLASE ACTIVITY,7.013e-05,-0.098874,-0.13093,1,0
4,GO BASIC AMINO ACID TRANSPORT,0.050569,-0.098911,-0.18971,1,0
4,GO CELLULAR RESPONSE TO KETONE,0.0021689,-0.099089,-0.1497,1,0
4,GO MANGANESE ION TRANSPORT,0.03245,-0.099167,-0.13064,1,0
4,GO EMBRYONIC MORPHOGENESIS,0.027188,-0.099183,-0.09336,1,0
4,GO RESPONSE TO ESTRADIOL,0.00084609,-0.099389,-0.13291,1,0
4,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.02843,-0.099496,-0.21139,1,0
4,GO ENDOTHELIAL CELL DEVELOPMENT,0.0090226,-0.099559,-0.17021,1,0
4,GO AMINE METABOLIC PROCESS,0.0013872,-0.099826,-0.14354,1,0
4,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.0026572,-0.099926,-0.13285,1,0
4,GO ACTIN FILAMENT BASED PROCESS,0.00063551,-0.099942,-0.12548,1,0
4,GO AUTOPHAGY OF MITOCHONDRION,0.00087311,-0.10001,-0.12973,1,0
4,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.019739,-0.10006,-0.14093,1,0
4,GO CALCIUM ION IMPORT,0.014841,-0.10016,-0.10729,1,0
4,GO PROTEIN KINASE A SIGNALING,0.0099891,-0.10019,-0.11989,1,0
4,GO REGULATION OF HORMONE LEVELS,0.0062634,-0.10019,-0.11221,1,0
4,GO SINGLE FERTILIZATION,0.0090226,-0.10021,-0.10169,1,0
4,GO METHIONINE BIOSYNTHETIC PROCESS,0.02166,-0.10068,-0.16702,1,0
4,GO MACROAUTOPHAGY,4.3218e-05,-0.10075,-0.12292,1,0
4,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.021165,-0.10078,-0.086743,1,0
4,GO DEVELOPMENTAL PIGMENTATION,0.02166,-0.10078,-0.10839,1,0
4,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.0073363,-0.1008,-0.091553,1,0
4,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,9.389e-05,-0.10097,-0.10387,1,0
4,GO ORGAN GROWTH,0.0073363,-0.10101,-0.11097,1,0
4,GO POSITIVE REGULATION OF PEPTIDE SECRETION,0.036948,-0.10104,-0.078009,1,0
4,GO LEUKOCYTE HOMEOSTASIS,0.0028957,-0.10106,-0.12632,1,0
4,GO MODULATION BY VIRUS OF HOST PROCESS,0.030383,-0.10124,-0.11316,1,0
4,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.017969,-0.10128,-0.12368,1,0
4,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.044685,-0.1014,-0.084587,1,0
4,GO BONE DEVELOPMENT,0.0047853,-0.10143,-0.11817,1,0
4,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.05161,-0.10152,-0.11746,1,0
4,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.0085714,-0.10167,-0.13229,1,0
4,GO POSITIVE REGULATION OF B CELL PROLIFERATION,0.016734,-0.10174,-0.1708,1,0
4,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.021165,-0.10189,-0.14026,1,0
4,GO RENAL SYSTEM PROCESS,0.041093,-0.10191,-0.11291,1,0
4,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.007729,-0.10195,-0.16196,1,0
4,GO LYMPHOCYTE HOMEOSTASIS,0.0081404,-0.10196,-0.10305,1,0
4,GO CELL CELL JUNCTION ORGANIZATION,0.043763,-0.10202,-0.11707,1,0
4,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.021165,-0.10211,-0.1457,1,0
4,GO MYELOID CELL DIFFERENTIATION,0.00045924,-0.10211,-0.12835,1,0
4,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.00065623,-0.1022,-0.12055,1,0
4,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.0041716,-0.10227,-0.14162,1,0
4,GO PROTEIN KINASE B SIGNALING,0.0075304,-0.10229,-0.12036,1,0
4,GO BONE MORPHOGENESIS,0.055956,-0.10231,-0.12521,1,0
4,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.0024367,-0.10235,-0.10502,1,0
4,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.02068,-0.10245,-0.15309,1,0
4,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.017137,-0.10255,-0.11203,1,0
4,GO REGULATION OF PROTEIN MODIFICATION PROCESS,4.8379e-05,-0.10256,-0.11538,1,0
4,GO REGULATION OF GUANYLATE CYCLASE ACTIVITY,0.049546,-0.10297,-0.21589,1,0
4,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.00059588,-0.10299,-0.12287,1,0
4,GO REGULATION OF ACTIN FILAMENT LENGTH,0.0021689,-0.10301,-0.10767,1,0
4,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.02068,-0.10305,-0.13344,1,0
4,GO APOPTOTIC PROCESS,2.5308e-05,-0.10309,-0.12322,1,0
4,GO BILE ACID BIOSYNTHETIC PROCESS,0.012203,-0.10326,-0.15881,1,0
4,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.019283,-0.10338,-0.14255,1,0
4,GO REGULATION OF TOR SIGNALING,0.0066042,-0.10355,-0.085948,1,0
4,GO CHEMOKINE PRODUCTION,0.020205,-0.10355,-0.16241,1,0
4,GO TOR SIGNALING,0.00052342,-0.10356,-0.089798,1,0
4,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.0015653,-0.1037,-0.093174,1,0
4,GO POSITIVE REGULATION OF HEMOPOIESIS,0.0099891,-0.10374,-0.1288,1,0
4,GO LIVER REGENERATION,0.0030654,-0.1038,-0.21543,1,0
4,GO RESPONSE TO ACTIVITY,0.007729,-0.10391,-0.1088,1,0
4,GO REGULATION OF T CELL ACTIVATION,0.0050528,-0.10426,-0.12962,1,0
4,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.00040247,-0.10462,-0.12988,1,0
4,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.00014418,-0.10466,-0.11251,1,0
4,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0014738,-0.10467,-0.12102,1,0
4,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.050569,-0.10486,-0.13815,1,0
4,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.031748,-0.10491,-0.09905,1,0
4,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.04854,-0.10494,-0.13844,1,0
4,GO ENDOCYTIC RECYCLING,0.017549,-0.10496,-0.10366,1,0
4,GO REGULATION OF JUN KINASE ACTIVITY,0.023741,-0.10508,-0.10422,1,0
4,GO MULTI ORGANISM LOCALIZATION,0.0028957,-0.1051,-0.14162,1,0
4,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.041093,-0.10512,-0.059195,1,0
4,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.00028792,-0.10512,-0.11819,1,0
4,GO PROTEIN CATABOLIC PROCESS,2.6307e-05,-0.1053,-0.10514,1,0
4,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.031748,-0.10544,-0.11936,1,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.029719,-0.10585,-0.17354,1,0
4,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,0.023741,-0.10605,-0.13492,1,0
4,GO REGULATION OF CELL DEATH,3.1888e-05,-0.10613,-0.12294,1,0
4,GO POSITIVE REGULATION OF CELL DEATH,7.8282e-05,-0.10614,-0.1292,1,0
4,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,3.7145e-05,-0.10625,-0.10783,1,0
4,GO CELL MOTILITY,0.00054072,-0.10628,-0.13303,1,0
4,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0020453,-0.10629,-0.12337,1,0
4,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.03939,-0.10636,-0.14105,1,0
4,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.023205,-0.10642,-0.11402,1,0
4,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.040234,-0.10642,-0.14184,1,0
4,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.049546,-0.10659,-0.12362,1,0
4,GO NEGATIVE REGULATION OF BINDING,0.0027346,-0.10667,-0.10454,1,0
4,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0046564,-0.10673,-0.16605,1,0
4,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.019283,-0.10682,-0.13937,1,0
4,GO AGING,8.1192e-05,-0.10708,-0.1466,1,0
4,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.00013433,-0.10717,-0.1322,1,0
4,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.0015653,-0.10726,-0.11925,1,0
4,GO CYTOKINE SECRETION,0.033894,-0.10726,-0.10305,1,0
4,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.00054072,-0.10732,-0.12683,1,0
4,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,8.7323e-05,-0.10736,-0.12465,1,0
4,GO RESPONSE TO ABIOTIC STIMULUS,1.1493e-05,-0.10736,-0.13008,1,0
4,GO INTERLEUKIN 2 PRODUCTION,0.0049174,-0.10757,-0.15366,1,0
4,GO GOLGI TO VACUOLE TRANSPORT,0.012508,-0.10778,-0.14892,1,0
4,GO REGULATION OF BINDING,0.00032948,-0.10778,-0.11598,1,0
4,GO COAGULATION,0.00028792,-0.10795,-0.17531,1,0
4,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.019283,-0.10795,-0.12786,1,0
4,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.00028792,-0.10796,-0.10875,1,0
4,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.0051916,-0.10809,-0.14969,1,0
4,GO ALCOHOL BIOSYNTHETIC PROCESS,0.0017123,-0.1081,-0.13933,1,0
4,GO INTRACELLULAR TRANSPORT,6.4994e-06,-0.10811,-0.10151,1,0
4,GO POSITIVE REGULATION OF CELL AGING,0.014486,-0.10815,-0.14708,1,0
4,GO REGULATION OF TRANSLATIONAL TERMINATION,0.041967,-0.10818,-0.15823,1,0
4,GO ACID SECRETION,0.0079323,-0.1082,-0.14501,1,0
4,GO T CELL RECEPTOR SIGNALING PATHWAY,0.00074557,-0.10823,-0.15524,1,0
4,GO LEUKOTRIENE METABOLIC PROCESS,0.018836,-0.10833,-0.17573,1,0
4,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.00069957,-0.10834,-0.13891,1,0
4,GO PEPTIDE SECRETION,0.0030654,-0.10851,-0.11343,1,0
4,GO EPITHELIAL CELL DEVELOPMENT,0.02843,-0.10868,-0.11722,1,0
4,GO CELLULAR PROTEIN CATABOLIC PROCESS,1.7118e-05,-0.10873,-0.10422,1,0
4,GO RESPONSE TO GROWTH FACTOR,0.00038934,-0.10908,-0.12965,1,0
4,GO REGULATION OF CELL AGING,0.0094949,-0.10911,-0.12668,1,0
4,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.0025817,-0.10923,-0.11878,1,0
4,GO NEGATIVE REGULATION OF CELL DEATH,0.00010462,-0.10924,-0.12563,1,0
4,GO GOLGI VESICLE TRANSPORT,0.00010462,-0.10928,-0.11977,1,0
4,GO T CELL ACTIVATION,0.0039469,-0.1093,-0.13593,1,0
4,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.043763,-0.10933,-0.16969,1,0
4,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.017137,-0.10933,-0.087157,1,0
4,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0032441,-0.10934,-0.17136,1,0
4,GO TUBE DEVELOPMENT,0.00098941,-0.10942,-0.13724,1,0
4,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,7.2754e-05,-0.10946,-0.12319,1,0
4,GO RESPONSE TO IRON ION,0.02268,-0.10946,-0.12171,1,0
4,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.0025817,-0.10952,-0.11997,1,0
4,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.02068,-0.10964,-0.13499,1,0
4,GO CYTOSOLIC TRANSPORT,0.0025817,-0.10972,-0.1015,1,0
4,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.0034322,-0.10998,-0.12379,1,0
4,GO VACUOLAR TRANSPORT,0.0032441,-0.11004,-0.11691,1,0
4,GO RECEPTOR RECYCLING,0.0040578,-0.11015,-0.1321,1,0
4,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0040578,-0.11016,-0.10813,1,0
4,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.010773,-0.1102,-0.11705,1,0
4,GO REGULATION OF CELL ACTIVATION,0.0016129,-0.11034,-0.13908,1,0
4,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.026586,-0.11039,-0.1402,1,0
4,GO VIRAL RELEASE FROM HOST CELL,0.016734,-0.11061,-0.12399,1,0
4,GO GOLGI RIBBON FORMATION,0.040234,-0.11065,-0.11341,1,0
4,GO NUCLEOBASE METABOLIC PROCESS,0.014841,-0.11082,-0.17226,1,0
4,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.049546,-0.11111,-0.1449,1,0
4,GO RNA MODIFICATION,0.0016129,-0.11117,-0.13476,1,0
4,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.0049174,-0.1112,-0.11126,1,0
4,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.0094949,-0.11133,-0.13597,1,0
4,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.0025083,-0.11139,-0.12422,1,0
4,GO NEUROINFLAMMATORY RESPONSE,0.015574,-0.11164,-0.14178,1,0
4,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,0.015953,-0.11169,-0.13536,1,0
4,GO POSITIVE REGULATION OF VIRAL PROCESS,4.6597e-05,-0.11181,-0.14185,1,0
4,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.00010845,-0.11184,-0.13887,1,0
4,GO REGULATION OF B CELL ACTIVATION,0.0032441,-0.11184,-0.14736,1,0
4,GO PROTEIN N LINKED GLYCOSYLATION,0.00063551,-0.11194,-0.16506,1,0
4,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.040234,-0.11206,-0.12287,1,0
4,GO CARTILAGE DEVELOPMENT,0.0081404,-0.11214,-0.13478,1,0
4,GO PIGMENTATION,0.00045924,-0.11219,-0.14181,1,0
4,GO OSTEOCLAST DIFFERENTIATION,0.011612,-0.11232,-0.10964,1,0
4,GO APOPTOTIC SIGNALING PATHWAY,0.00010092,-0.11236,-0.13963,1,0
4,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,3.0576e-06,-0.11237,-0.12226,1,0
4,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0099891,-0.1127,-0.14549,1,0
4,GO GLYCOSYLATION,0.0007696,-0.11272,-0.14737,1,0
4,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.022165,-0.11273,-0.15565,1,0
4,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,1.1493e-05,-0.11296,-0.13841,1,0
4,GO RNA METHYLATION,0.0025817,-0.1133,-0.13463,1,0
4,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.044685,-0.11352,-0.1517,1,0
4,GO LIPOSACCHARIDE METABOLIC PROCESS,0.010245,-0.11359,-0.13254,1,0
4,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.00014418,-0.1136,-0.13997,1,0
4,GO PLATELET ACTIVATION,0.0023671,-0.11374,-0.15545,1,0
4,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.0016129,-0.11376,-0.13059,1,0
4,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.013465,-0.11385,-0.10103,1,0
4,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,0.025414,-0.11385,-0.2097,1,0
4,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.025994,-0.11392,-0.13983,1,0
4,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.02268,-0.11397,-0.13154,1,0
4,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0097392,-0.11402,-0.1384,1,0
4,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.0017641,-0.11421,-0.11313,1,0
4,GO PEPTIDYL CYSTEINE MODIFICATION,0.014841,-0.11425,-0.098921,1,0
4,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.053746,-0.1144,-0.22323,1,0
4,GO REGULATION OF PROTEIN MATURATION,0.0060989,-0.11446,-0.16017,1,0
4,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.035393,-0.11449,-0.11556,1,0
4,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.00069957,-0.11453,-0.17664,1,0
4,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.053746,-0.11459,-0.11554,1,0
4,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.0039469,-0.11472,-0.14168,1,0
4,GO ACTIN FILAMENT ORGANIZATION,0.00090094,-0.1148,-0.12666,1,0
4,GO PROTEIN LOCALIZATION TO VACUOLE,0.0030654,-0.11481,-0.13975,1,0
4,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.00018427,-0.11496,-0.16397,1,0
4,GO MESODERMAL CELL DIFFERENTIATION,0.02843,-0.11499,-0.1697,1,0
4,GO REGULATION OF CARTILAGE DEVELOPMENT,0.0034322,-0.11507,-0.1614,1,0
4,GO MAINTENANCE OF PROTEIN LOCATION,0.001872,-0.11517,-0.12704,1,0
4,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.011047,-0.11519,-0.10406,1,0
4,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.017549,-0.11526,-0.16986,1,0
4,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.047551,-0.11526,-0.14192,1,0
4,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,2.0033e-05,-0.11528,-0.13014,1,0
4,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.0045306,-0.11529,-0.15494,1,0
4,GO CELLULAR RESPONSE TO INSULIN STIMULUS,1.5816e-05,-0.11546,-0.14171,1,0
4,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.00067758,-0.11547,-0.15404,1,0
4,GO LYMPHOCYTE ACTIVATION,0.00081984,-0.11562,-0.13228,1,0
4,GO EPITHELIAL CELL DIFFERENTIATION,0.043763,-0.11566,-0.095436,1,0
4,GO CYTOLYSIS,0.043763,-0.11569,-0.18197,1,0
4,GO NUCLEOTIDE TRANSPORT,0.025994,-0.11571,-0.10891,1,0
4,GO VESICLE CARGO LOADING,0.0014299,-0.11574,-0.18537,1,0
4,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.010245,-0.11583,-0.10372,1,0
4,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.050569,-0.11584,-0.12163,1,0
4,GO REGULATION OF TRANSFERASE ACTIVITY,6.2786e-05,-0.1159,-0.12366,1,0
4,GO PURINE NUCLEOTIDE TRANSPORT,0.030383,-0.11594,-0.11566,1,0
4,GO PROTEIN LOCALIZATION TO ORGANELLE,3.3132e-05,-0.11596,-0.09837,1,0
4,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.0051916,-0.11598,-0.14314,1,0
4,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.00049035,-0.116,-0.12358,1,0
4,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.00031859,-0.11608,-0.12585,1,0
4,GO B CELL RECEPTOR SIGNALING PATHWAY,0.04854,-0.11616,-0.11846,1,0
4,GO REGULATION OF CHOLESTEROL EFFLUX,0.015574,-0.11625,-0.13591,1,0
4,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.0064317,-0.11648,-0.1891,1,0
4,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0041716,-0.1165,-0.13299,1,0
4,GO POST TRANSLATIONAL PROTEIN MODIFICATION,3.5759e-05,-0.11658,-0.15625,1,0
4,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0057817,-0.11674,-0.13156,1,0
4,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.031059,-0.11692,-0.13944,1,0
4,GO STEROID BIOSYNTHETIC PROCESS,0.00021909,-0.11696,-0.17855,1,0
4,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.0020453,-0.11697,-0.12354,1,0
4,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.00044439,-0.11702,-0.12995,1,0
4,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.02068,-0.11703,-0.12226,1,0
4,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,6.0504e-05,-0.11712,-0.13383,1,0
4,GO INTRACELLULAR PROTEIN TRANSPORT,6.7728e-06,-0.11723,-0.10746,1,0
4,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.020205,-0.11724,-0.15008,1,0
4,GO MESENCHYMAL CELL DIFFERENTIATION,0.0023671,-0.11726,-0.15547,1,0
4,GO REGULATION OF BODY FLUID LEVELS,0.00017186,-0.11726,-0.16248,1,0
4,GO INOSITOL LIPID MEDIATED SIGNALING,0.00069957,-0.11727,-0.1325,1,0
4,GO MACROMOLECULE CATABOLIC PROCESS,1.0779e-06,-0.1175,-0.13123,1,0
4,GO PHOSPHOLIPID TRANSPORT,0.00047456,-0.11763,-0.16528,1,0
4,GO RESPONSE TO PROGESTERONE,0.04854,-0.11772,-0.14588,1,0
4,GO NEGATIVE REGULATION OF SIGNALING,0.00020448,-0.11772,-0.11408,1,0
4,GO CONNECTIVE TISSUE DEVELOPMENT,0.00353,-0.11786,-0.1313,1,0
4,GO HEART DEVELOPMENT,0.00069957,-0.11788,-0.12497,1,0
4,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.020205,-0.11788,-0.16375,1,0
4,GO GLAND DEVELOPMENT,0.0012662,-0.11809,-0.1235,1,0
4,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.027803,-0.11837,-0.15655,1,0
4,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.00012074,-0.11857,-0.13986,1,0
4,GO REGULATION OF MUSCLE ADAPTATION,0.0030654,-0.11862,-0.14979,1,0
4,GO REGULATION OF HEMOPOIESIS,0.00081984,-0.11888,-0.13124,1,0
4,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.0050528,-0.1189,-0.15654,1,0
4,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.0012662,-0.11899,-0.18358,1,0
4,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.027188,-0.11901,-0.11952,1,0
4,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.014841,-0.1192,-0.10012,1,0
4,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.00029782,-0.11927,-0.13488,1,0
4,GO REGULATION OF EXOSOMAL SECRETION,0.033894,-0.11927,-0.16216,1,0
4,GO FC RECEPTOR SIGNALING PATHWAY,0.0056288,-0.11927,-0.11089,1,0
4,GO REGULATION OF T CELL MIGRATION,0.014138,-0.11928,-0.14317,1,0
4,GO ALANINE TRANSPORT,0.052669,-0.11933,-0.15533,1,0
4,GO PHAGOSOME MATURATION,0.017137,-0.11937,-0.12504,1,0
4,GO RRNA TRANSCRIPTION,0.049546,-0.1194,-0.11893,1,0
4,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.009256,-0.11941,-0.14415,1,0
4,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.052669,-0.11959,-0.092081,1,0
4,GO PINOCYTOSIS,0.0071468,-0.11963,-0.18752,1,0
4,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.004408,-0.11963,-0.12553,1,0
4,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.0028141,-0.11977,-0.19948,1,0
4,GO MEMBRANE ORGANIZATION,2.0033e-05,-0.11977,-0.13798,1,0
4,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.011612,-0.11979,-0.1945,1,0
4,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.0050528,-0.1201,-0.1234,1,0
4,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.014486,-0.12021,-0.1641,1,0
4,GO LIPID BIOSYNTHETIC PROCESS,1.1493e-05,-0.12024,-0.15842,1,0
4,GO REGULATION OF RESPONSE TO STRESS,7.547e-05,-0.12026,-0.12738,1,0
4,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,4.8379e-05,-0.12027,-0.13275,1,0
4,GO ENDOSOME TO LYSOSOME TRANSPORT,0.007729,-0.12034,-0.11157,1,0
4,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.001662,-0.12035,-0.13871,1,0
4,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.0025817,-0.12041,-0.15329,1,0
4,GO FERTILIZATION,0.0010859,-0.12051,-0.11525,1,0
4,GO NEGATIVE REGULATION OF CELL SIZE,0.017549,-0.12052,-0.15872,1,0
4,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,2.2524e-05,-0.12061,-0.12955,1,0
4,GO REGULATION OF PHOSPHORYLATION,2.4346e-05,-0.12062,-0.13596,1,0
4,GO MUSCLE STRUCTURE DEVELOPMENT,0.00054072,-0.12074,-0.12618,1,0
4,GO ANIMAL ORGAN FORMATION,0.012203,-0.12082,-0.14455,1,0
4,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.0059384,-0.12095,-0.15454,1,0
4,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.001872,-0.12102,-0.15266,1,0
4,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.013798,-0.12109,-0.12062,1,0
4,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.00035231,-0.12109,-0.12858,1,0
4,GO PHOSPHATE ION TRANSPORT,0.0085714,-0.12125,-0.11601,1,0
4,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.00063551,-0.12125,-0.14723,1,0
4,GO I KAPPAB PHOSPHORYLATION,0.0060989,-0.12127,-0.17578,1,0
4,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.036164,-0.12135,-0.14164,1,0
4,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.013465,-0.12139,-0.20955,1,0
4,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.0094949,-0.12146,-0.11926,1,0
4,GO CARBOHYDRATE TRANSPORT,0.00045924,-0.12156,-0.13148,1,0
4,GO REGULATION OF PROTEIN STABILITY,7.6603e-06,-0.12173,-0.13161,1,0
4,GO REGULATION OF PEPTIDE SECRETION,0.0053338,-0.12194,-0.10549,1,0
4,GO REGULATION OF PROTEIN IMPORT,0.011326,-0.12195,-0.15883,1,0
4,GO RESPONSE TO RETINOIC ACID,0.00027832,-0.12209,-0.18928,1,0
4,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.00057693,-0.1221,-0.13936,1,0
4,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.023205,-0.12216,-0.13355,1,0
4,GO ORGANOPHOSPHATE ESTER TRANSPORT,0.00057693,-0.12219,-0.13768,1,0
4,GO HOMEOSTATIC PROCESS,6.7728e-06,-0.12228,-0.12345,1,0
4,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.00084609,-0.12235,-0.19635,1,0
4,GO NEGATIVE REGULATION OF CELL ADHESION,0.0081404,-0.12236,-0.14915,1,0
4,GO HUMORAL IMMUNE RESPONSE,8.4205e-05,-0.1224,-0.1684,1,0
4,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.031748,-0.12257,-0.10257,1,0
4,GO ENSHEATHMENT OF NEURONS,0.0030654,-0.12265,-0.12296,1,0
4,GO RESPONSE TO MECHANICAL STIMULUS,0.0097392,-0.12267,-0.12309,1,0
4,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0029794,-0.12269,-0.10482,1,0
4,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,3.8583e-05,-0.12278,-0.12831,1,0
4,GO REGULATION OF MITOCHONDRIAL FISSION,0.019739,-0.12279,-0.11393,1,0
4,GO RRNA METHYLATION,0.022165,-0.12288,-0.15677,1,0
4,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,3.3132e-05,-0.12292,-0.13094,1,0
4,GO CATION TRANSPORT,0.00044439,-0.12309,-0.12799,1,0
4,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.0037331,-0.12323,-0.16398,1,0
4,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.015953,-0.12332,-0.16351,1,0
4,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.036948,-0.12336,-0.18478,1,0
4,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.05161,-0.1235,-0.15612,1,0
4,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0012662,-0.12356,-0.11859,1,0
4,GO RESPONSE TO MONOSACCHARIDE,0.0001165,-0.12357,-0.1342,1,0
4,GO MECHANORECEPTOR DIFFERENTIATION,0.031059,-0.12361,-0.13656,1,0
4,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.010773,-0.12368,-0.15054,1,0
4,GO SECRETION,2.1663e-05,-0.12384,-0.15268,1,0
4,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,6.2786e-05,-0.12384,-0.13306,1,0
4,GO PEPTIDYL ASPARAGINE MODIFICATION,0.0054795,-0.12393,-0.1535,1,0
4,GO TUBE MORPHOGENESIS,0.00035231,-0.12395,-0.15569,1,0
4,GO ERAD PATHWAY,0.00019753,-0.12397,-0.1557,1,0
4,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.016734,-0.12403,-0.2282,1,0
4,GO TYPE I INTERFERON PRODUCTION,0.013465,-0.12413,-0.15215,1,0
4,GO AORTA DEVELOPMENT,0.0059384,-0.12417,-0.17829,1,0
4,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.0015189,-0.12429,-0.13569,1,0
4,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.0028957,-0.1243,-0.14672,1,0
4,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.00092958,-0.12434,-0.10754,1,0
4,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.011904,-0.12436,-0.18853,1,0
4,GO OSSIFICATION,0.00016023,-0.1244,-0.165,1,0
4,GO FATTY ACID DERIVATIVE TRANSPORT,0.0067808,-0.12457,-0.1351,1,0
4,GO MYELOID CELL HOMEOSTASIS,0.0021689,-0.12469,-0.1309,1,0
4,GO CHONDROCYTE DIFFERENTIATION,0.034637,-0.12476,-0.12366,1,0
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.052669,-0.12491,-0.13467,1,0
4,GO AUTOPHAGOSOME ORGANIZATION,0.00055855,-0.12512,-0.16838,1,0
4,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.042857,-0.12512,-0.27934,1,0
4,GO RESPONSE TO ENDOGENOUS STIMULUS,4.0073e-05,-0.12534,-0.1277,1,0
4,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.016734,-0.12535,-0.095241,1,0
4,GO CELLULAR RESPONSE TO HEAT,0.0027346,-0.12568,-0.1184,1,0
4,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.00042998,-0.12599,-0.10951,1,0
4,GO REGULATION OF MIRNA METABOLIC PROCESS,0.0040578,-0.12617,-0.17768,1,0
4,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,9.0179e-06,-0.12621,-0.14993,1,0
4,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.025994,-0.12626,-0.13325,1,0
4,GO ENDOCRINE HORMONE SECRETION,0.013465,-0.12629,-0.14567,1,0
4,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.0090226,-0.12634,-0.15026,1,0
4,GO METAL ION TRANSPORT,0.00016023,-0.12646,-0.13548,1,0
4,GO CRISTAE FORMATION,0.004408,-0.12647,-0.20487,1,0
4,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.00034072,-0.12649,-0.19333,1,0
4,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.0015189,-0.12652,-0.13882,1,0
4,GO RIG I SIGNALING PATHWAY,0.011047,-0.12661,-0.16034,1,0
4,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.014841,-0.12664,-0.13747,1,0
4,GO CELLULAR ION HOMEOSTASIS,3.9418e-06,-0.12667,-0.14923,1,0
4,GO TRICARBOXYLIC ACID METABOLIC PROCESS,0.01282,-0.12701,-0.24083,1,0
4,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.018398,-0.12717,-0.14824,1,0
4,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.0099891,-0.12725,-0.15257,1,0
4,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,2.3654e-06,-0.12736,-0.13486,1,0
4,GO PROTEIN HETEROOLIGOMERIZATION,0.0051916,-0.12738,-0.13448,1,0
4,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.0030654,-0.12765,-0.14047,1,0
4,GO PROTEIN STABILIZATION,6.0504e-05,-0.12781,-0.13235,1,0
4,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.045624,-0.12784,-0.1736,1,0
4,GO INSULIN SECRETION,0.030383,-0.12787,-0.096731,1,0
4,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,0.0012662,-0.12787,-0.17746,1,0
4,GO LIPOPROTEIN LOCALIZATION,0.0021062,-0.12787,-0.18471,1,0
4,GO NIK NF KAPPAB SIGNALING,0.0023671,-0.12796,-0.16667,1,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.0013054,-0.128,-0.13909,1,0
4,GO REGULATION OF INSULIN SECRETION,0.014486,-0.12826,-0.10036,1,0
4,GO LIPOPROTEIN CATABOLIC PROCESS,0.014138,-0.12836,-0.19873,1,0
4,GO RESPONSE TO NITROGEN COMPOUND,9.3916e-06,-0.12852,-0.13444,1,0
4,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.025994,-0.12856,-0.18231,1,0
4,GO POSITIVE REGULATION OF CHEMOTAXIS,0.0049174,-0.12858,-0.14775,1,0
4,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,2.8077e-06,-0.12877,-0.14902,1,0
4,GO NEGATIVE REGULATION OF SECRETION,0.00035231,-0.12877,-0.12751,1,0
4,GO REGULATION OF REPRODUCTIVE PROCESS,0.00026903,-0.12885,-0.11454,1,0
4,GO REGULATION OF RUFFLE ASSEMBLY,0.03939,-0.12888,-0.1216,1,0
4,GO REGULATION OF INNATE IMMUNE RESPONSE,0.0022332,-0.12888,-0.14461,1,0
4,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.00016023,-0.12889,-0.15305,1,0
4,GO PROTEIN HETEROTETRAMERIZATION,0.0069616,-0.12894,-0.13424,1,0
4,GO HISTONE ARGININE METHYLATION,0.0097392,-0.12913,-0.1211,1,0
4,GO ATP TRANSPORT,0.030383,-0.12929,-0.11012,1,0
4,GO TEMPERATURE HOMEOSTASIS,0.0014299,-0.12938,-0.131,1,0
4,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.03245,-0.12938,-0.152,1,0
4,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.022165,-0.12943,-0.18456,1,0
4,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.0045306,-0.12962,-0.14258,1,0
4,GO JNK CASCADE,8.1192e-05,-0.12974,-0.1379,1,0
4,GO TRANSFERRIN TRANSPORT,0.00353,-0.12978,-0.15984,1,0
4,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.001872,-0.12983,-0.1726,1,0
4,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.027188,-0.12989,-0.23153,1,0
4,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.001986,-0.1299,-0.15246,1,0
4,GO REGULATION OF GTPASE ACTIVITY,0.00016023,-0.12993,-0.12795,1,0
4,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.0018173,-0.12999,-0.13291,1,0
4,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.01282,-0.13,-0.17176,1,0
4,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.00013917,-0.13015,-0.12525,1,0
4,GO NEGATIVE REGULATION OF TRANSPORT,7.013e-05,-0.13018,-0.12897,1,0
4,GO CELL CELL JUNCTION ASSEMBLY,0.020205,-0.13024,-0.12419,1,0
4,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.0090226,-0.13024,-0.17974,1,0
4,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.00072223,-0.13038,-0.14049,1,0
4,GO PHOSPHOLIPID METABOLIC PROCESS,3.6228e-06,-0.13047,-0.14931,1,0
4,GO REGULATION OF PROTEIN CATABOLIC PROCESS,1.8521e-05,-0.13055,-0.11845,1,0
4,GO RESPONSE TO PEPTIDE,2.5774e-06,-0.13056,-0.15139,1,0
4,GO TRNA WOBBLE BASE MODIFICATION,0.011326,-0.13058,-0.15691,1,0
4,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.00084609,-0.13059,-0.11857,1,0
4,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.00042998,-0.13068,-0.19129,1,0
4,GO COLLAGEN FIBRIL ORGANIZATION,0.015203,-0.13076,-0.237,1,0
4,GO IRON ION TRANSPORT,0.00022676,-0.13092,-0.14775,1,0
4,GO BIOLOGICAL ADHESION,6.0504e-05,-0.13099,-0.17025,1,0
4,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.0010206,-0.131,-0.12677,1,0
4,GO RESPONSE TO CARBOHYDRATE,1.6455e-05,-0.1311,-0.14528,1,0
4,GO RESPONSE TO LEPTIN,0.0081404,-0.13111,-0.16376,1,0
4,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.00069957,-0.13119,-0.15838,1,0
4,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,2.9532e-05,-0.13121,-0.13493,1,0
4,GO GLUTAMATE METABOLIC PROCESS,0.029719,-0.13136,-0.10918,1,0
4,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.0011549,-0.13146,-0.17281,1,0
4,GO REGULATION OF CELL CELL ADHESION,0.00031859,-0.13151,-0.18179,1,0
4,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.017137,-0.13159,-0.17718,1,0
4,GO URONIC ACID METABOLIC PROCESS,0.0085714,-0.1316,-0.14223,1,0
4,GO VESICLE ORGANIZATION,4.1617e-05,-0.13166,-0.14285,1,0
4,GO NEGATIVE REGULATION OF OSSIFICATION,0.0067808,-0.13167,-0.15745,1,0
4,GO ERBB SIGNALING PATHWAY,0.001986,-0.13176,-0.14394,1,0
4,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.026586,-0.13188,-0.17176,1,0
4,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.015574,-0.13197,-0.13417,1,0
4,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.001662,-0.13211,-0.15885,1,0
4,GO STRESS FIBER ASSEMBLY,0.0010528,-0.13211,-0.17939,1,0
4,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0021689,-0.13213,-0.16054,1,0
4,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,5.6174e-05,-0.1322,-0.15685,1,0
4,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,2.8418e-05,-0.13223,-0.14606,1,0
4,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.027188,-0.13233,-0.15257,1,0
4,GO RENAL TUBULE DEVELOPMENT,0.016339,-0.13237,-0.13197,1,0
4,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.00054072,-0.13245,-0.12802,1,0
4,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.053746,-0.13251,-0.078976,1,0
4,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.0025083,-0.13267,-0.14368,1,0
4,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.0045306,-0.13283,-0.21079,1,0
4,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,9.7346e-05,-0.13283,-0.16233,1,0
4,GO FEEDING BEHAVIOR,0.023205,-0.1329,-0.095868,1,0
4,GO RESPONSE TO IMMOBILIZATION STRESS,0.025414,-0.13292,-0.19755,1,0
4,GO POSITIVE REGULATION OF HEART GROWTH,0.004408,-0.13295,-0.18231,1,0
4,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.009256,-0.13305,-0.16438,1,0
4,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.036164,-0.13318,-0.13157,1,0
4,GO CELLULAR RESPONSE TO HORMONE STIMULUS,1.5201e-05,-0.1332,-0.14018,1,0
4,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.00081984,-0.13325,-0.1681,1,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.0085714,-0.13329,-0.10841,1,0
4,GO RESPONSE TO VIRUS,0.01282,-0.13339,-0.15337,1,0
4,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,4.0073e-05,-0.13341,-0.16268,1,0
4,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,4.1112e-06,-0.13343,-0.11809,1,0
4,GO CELLULAR DEFENSE RESPONSE,0.0030654,-0.13356,-0.20564,1,0
4,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.00016595,-0.13358,-0.1514,1,0
4,GO REGULATION OF PROTEOLYSIS,3.1888e-05,-0.13367,-0.15688,1,0
4,GO MACROPHAGE DIFFERENTIATION,0.0025817,-0.1337,-0.18292,1,0
4,GO RESPONSE TO OSMOTIC STRESS,0.00098941,-0.13374,-0.16582,1,0
4,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.00012512,-0.13378,-0.13196,1,0
4,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.001662,-0.13382,-0.15498,1,0
4,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0013054,-0.13384,-0.16048,1,0
4,GO MEMBRANE LIPID METABOLIC PROCESS,0.00044439,-0.13395,-0.16555,1,0
4,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.0001165,-0.13397,-0.23038,1,0
4,GO CERAMIDE METABOLIC PROCESS,0.00019079,-0.13434,-0.16388,1,0
4,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.0039469,-0.13437,-0.14747,1,0
4,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.00022676,-0.13442,-0.12368,1,0
4,GO VIRAL LIFE CYCLE,0.0015189,-0.13449,-0.17172,1,0
4,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.03245,-0.1345,-0.21841,1,0
4,GO SECOND MESSENGER MEDIATED SIGNALING,0.0023671,-0.13453,-0.10949,1,0
4,GO LEUKOCYTE CELL CELL ADHESION,0.00034072,-0.13457,-0.17439,1,0
4,GO MACROMOLECULE DEPALMITOYLATION,0.015203,-0.13457,-0.17677,1,0
4,GO REGULATION OF CATABOLIC PROCESS,1.2862e-06,-0.13464,-0.13727,1,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.0034322,-0.13465,-0.14761,1,0
4,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.025414,-0.13507,-0.16935,1,0
4,GO CATION TRANSMEMBRANE TRANSPORT,0.00050664,-0.13507,-0.13008,1,0
4,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.00050664,-0.13508,-0.15013,1,0
4,GO BONE GROWTH,0.055956,-0.13534,-0.17963,1,0
4,GO ION TRANSMEMBRANE TRANSPORT,0.00012074,-0.13535,-0.13609,1,0
4,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.0049174,-0.13539,-0.17085,1,0
4,GO NEGATIVE REGULATION OF LIPID STORAGE,0.01282,-0.13544,-0.18505,1,0
4,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,6.5149e-05,-0.13545,-0.1671,1,0
4,GO DENDRITIC CELL MIGRATION,0.017137,-0.13546,-0.18967,1,0
4,GO REGULATION OF MULTI ORGANISM PROCESS,0.00059588,-0.13552,-0.16352,1,0
4,GO RESPONSE TO PROSTAGLANDIN E,0.012508,-0.13561,-0.13631,1,0
4,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.0016129,-0.1358,-0.14691,1,0
4,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.00030804,-0.13588,-0.13097,1,0
4,GO POSITIVE REGULATION OF TRANSLATION,3.1888e-05,-0.13606,-0.19328,1,0
4,GO PROTEIN TARGETING TO VACUOLE,0.0022992,-0.13608,-0.15899,1,0
4,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0013872,-0.13609,-0.15202,1,0
4,GO CELL JUNCTION ASSEMBLY,0.00353,-0.13614,-0.12164,1,0
4,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.0081404,-0.13625,-0.19796,1,0
4,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.00012512,-0.13627,-0.13599,1,0
4,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0053338,-0.13629,-0.14488,1,0
4,GO PROTEIN HOMOOLIGOMERIZATION,4.8379e-05,-0.13633,-0.13757,1,0
4,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0013872,-0.13634,-0.16103,1,0
4,GO REGULATION OF ION TRANSPORT,0.0014299,-0.13637,-0.13644,1,0
4,GO RESPONSE TO ALCOHOL,0.00010462,-0.13643,-0.15702,1,0
4,GO CIRCULATORY SYSTEM DEVELOPMENT,0.00026003,-0.13645,-0.15085,1,0
4,GO TRANSMEMBRANE TRANSPORT,1.1964e-05,-0.13654,-0.14369,1,0
4,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.013798,-0.13656,-0.1523,1,0
4,GO NEGATIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.038561,-0.13663,-0.1451,1,0
4,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.0023671,-0.13668,-0.16332,1,0
4,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.027803,-0.13675,-0.14383,1,0
4,GO GOLGI TO ENDOSOME TRANSPORT,0.014138,-0.13678,-0.15271,1,0
4,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.025414,-0.13686,-0.15597,1,0
4,GO PROTEIN CONTAINING COMPLEX REMODELING,0.019283,-0.13693,-0.14154,1,0
4,GO SYMBIOTIC PROCESS,2.0033e-05,-0.13696,-0.16041,1,0
4,GO TRNA MODIFICATION,0.0029794,-0.13698,-0.15574,1,0
4,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,1.5201e-05,-0.13699,-0.14465,1,0
4,GO RECEPTOR BIOSYNTHETIC PROCESS,0.0046564,-0.13712,-0.16932,1,0
4,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.00014418,-0.13722,-0.19546,1,0
4,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.00019079,-0.13729,-0.14915,1,0
4,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.0056288,-0.1375,-0.17619,1,0
4,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.0030654,-0.13757,-0.15048,1,0
4,GO ORGANIC HYDROXY COMPOUND TRANSPORT,0.00050664,-0.13759,-0.16516,1,0
4,GO AUTOPHAGOSOME MATURATION,0.0031536,-0.1376,-0.16721,1,0
4,GO IMMUNOGLOBULIN SECRETION,0.0021689,-0.13772,-0.23069,1,0
4,GO RESPONSE TO FATTY ACID,0.0022332,-0.13779,-0.17153,1,0
4,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,5.2139e-05,-0.13789,-0.16635,1,0
4,GO KERATINOCYTE PROLIFERATION,0.044685,-0.13802,-0.16243,1,0
4,GO CELLULAR RESPONSE TO DSRNA,0.024288,-0.13804,-0.1693,1,0
4,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0099891,-0.13805,-0.13381,1,0
4,GO MITOCHONDRIAL TRANSPORT,3.7145e-05,-0.1381,-0.12573,1,0
4,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.01282,-0.13813,-0.15562,1,0
4,GO GRANULOCYTE CHEMOTAXIS,0.0019282,-0.13823,-0.16576,1,0
4,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.00031859,-0.13827,-0.14037,1,0
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.019739,-0.13829,-0.1977,1,0
4,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.0015189,-0.13834,-0.12929,1,0
4,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.015574,-0.13837,-0.14676,1,0
4,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.019283,-0.13849,-0.1448,1,0
4,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.0034322,-0.1385,-0.12988,1,0
4,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00052342,-0.13854,-0.14108,1,0
4,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.00020448,-0.13856,-0.1558,1,0
4,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.010245,-0.13859,-0.17868,1,0
4,GO PRIMARY MIRNA PROCESSING,0.0023671,-0.13861,-0.19582,1,0
4,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.00019079,-0.13866,-0.15892,1,0
4,GO METAL ION HOMEOSTASIS,3.6228e-06,-0.13874,-0.15671,1,0
4,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.0053338,-0.13882,-0.16754,1,0
4,GO MYELIN MAINTENANCE,0.014841,-0.13893,-0.24794,1,0
4,GO RECEPTOR METABOLIC PROCESS,0.0010206,-0.13893,-0.12893,1,0
4,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.00013917,-0.13895,-0.16255,1,0
4,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,4.4878e-05,-0.13895,-0.13685,1,0
4,GO INTRACELLULAR STEROL TRANSPORT,0.037747,-0.13898,-0.14974,1,0
4,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.001191,-0.13906,-0.154,1,0
4,GO REGULATION OF LYASE ACTIVITY,0.023741,-0.13909,-0.13541,1,0
4,GO B CELL ACTIVATION,0.0010528,-0.13915,-0.13922,1,0
4,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.00067758,-0.13926,-0.14721,1,0
4,GO SYNAPTIC TRANSMISSION GABAERGIC,0.0073363,-0.13929,-0.14779,1,0
4,GO RESPONSE TO INTERLEUKIN 1,2.0833e-05,-0.13931,-0.19495,1,0
4,GO CELLULAR RESPONSE TO PEPTIDE,2.3418e-05,-0.13931,-0.13783,1,0
4,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.0087944,-0.13946,-0.13428,1,0
4,GO RESPONSE TO STEROL,0.0033369,-0.13956,-0.19346,1,0
4,GO CELL ACTIVATION,7.2754e-05,-0.13957,-0.17161,1,0
4,GO GRANULOCYTE MIGRATION,0.00031859,-0.1397,-0.1857,1,0
4,GO OSTEOBLAST DIFFERENTIATION,0.00010092,-0.13985,-0.18752,1,0
4,GO LUNG ALVEOLUS DEVELOPMENT,0.023205,-0.13993,-0.13782,1,0
4,GO CORTICAL CYTOSKELETON ORGANIZATION,0.015203,-0.13995,-0.14156,1,0
4,GO CHEMICAL HOMEOSTASIS,3.7791e-06,-0.14003,-0.15049,1,0
4,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,2.6902e-06,-0.14008,-0.15839,1,0
4,GO CIRCULATORY SYSTEM PROCESS,0.0001165,-0.14023,-0.15051,1,0
4,GO TOXIN TRANSPORT,0.016734,-0.14037,-0.11713,1,0
4,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.0073363,-0.1405,-0.145,1,0
4,GO ORGANIC ACID TRANSPORT,7.9801e-06,-0.1405,-0.15674,1,0
4,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0024367,-0.14052,-0.13522,1,0
4,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.0041716,-0.14055,-0.1367,1,0
4,GO PROSTATE GLAND DEVELOPMENT,0.046579,-0.14065,-0.17277,1,0
4,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.047551,-0.14074,-0.14944,1,0
4,GO DIGESTION,0.02843,-0.14095,-0.11006,1,0
4,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,5.9841e-06,-0.14109,-0.14702,1,0
4,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.00010462,-0.14122,-0.14126,1,0
4,GO ARTERY DEVELOPMENT,0.0020453,-0.14136,-0.16029,1,0
4,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.0099891,-0.14144,-0.14947,1,0
4,GO DRUG CATABOLIC PROCESS,4.6597e-05,-0.1415,-0.22418,1,0
4,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,0.00090094,-0.14152,-0.15301,1,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.014138,-0.14154,-0.14145,1,0
4,GO MODULATION OF PROCESS OF OTHER ORGANISM,5.4121e-05,-0.14178,-0.1715,1,0
4,GO INORGANIC ANION TRANSPORT,6.7728e-06,-0.1418,-0.16268,1,0
4,GO ION TRANSPORT,5.2139e-05,-0.14193,-0.14269,1,0
4,GO LIPID MODIFICATION,1.0604e-05,-0.14201,-0.16445,1,0
4,GO MUSCLE CELL PROLIFERATION,0.00074557,-0.14209,-0.16962,1,0
4,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,3.8583e-05,-0.14212,-0.14665,1,0
4,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0023671,-0.1422,-0.18269,1,0
4,GO PROTEIN TRANSMEMBRANE TRANSPORT,3.1904e-06,-0.14225,-0.17679,1,0
4,GO VASCULATURE DEVELOPMENT,0.00016595,-0.14236,-0.18177,1,0
4,GO MUSCLE CELL FATE COMMITMENT,0.011326,-0.14254,-0.23281,1,0
4,GO MITOCHONDRIAL PROTEIN PROCESSING,0.012508,-0.14273,-0.18761,1,0
4,GO POTASSIUM ION TRANSPORT,0.033894,-0.1431,-0.09504,1,0
4,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,0.013798,-0.14317,-0.15325,1,0
4,GO LYSOSOMAL TRANSPORT,0.00067758,-0.14317,-0.14416,1,0
4,GO CELLULAR COMPONENT DISASSEMBLY,1.6729e-06,-0.14324,-0.15269,1,0
4,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.00011241,-0.14335,-0.14074,1,0
4,GO REGULATION OF TUBE SIZE,0.0031536,-0.14341,-0.13509,1,0
4,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.00055855,-0.14368,-0.15054,1,0
4,GO DIGESTIVE SYSTEM PROCESS,0.029068,-0.14373,-0.10502,1,0
4,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.052669,-0.14416,-0.22889,1,0
4,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,2.8418e-05,-0.14416,-0.14781,1,0
4,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,2.0033e-05,-0.14425,-0.18953,1,0
4,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.0075304,-0.14426,-0.15125,1,0
4,GO REGULATION OF DEFENSE RESPONSE,0.00011241,-0.14449,-0.15261,1,0
4,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,7.547e-05,-0.1445,-0.1585,1,0
4,GO REGULATION OF NUCLEASE ACTIVITY,0.0053338,-0.14452,-0.16698,1,0
4,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.00081984,-0.14484,-0.14548,1,0
4,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.00023468,-0.14486,-0.15421,1,0
4,GO METANEPHROS DEVELOPMENT,0.015574,-0.14488,-0.13006,1,0
4,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.0021689,-0.14488,-0.22241,1,0
4,GO PIGMENT CELL DIFFERENTIATION,0.027803,-0.14492,-0.11925,1,0
4,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.00034072,-0.14499,-0.17853,1,0
4,GO SPHINGOLIPID METABOLIC PROCESS,0.00011241,-0.14501,-0.18426,1,0
4,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.007729,-0.14502,-0.17835,1,0
4,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.021165,-0.14508,-0.18021,1,0
4,GO RESPONSE TO PEPTIDE HORMONE,2.6902e-06,-0.14508,-0.15269,1,0
4,GO REGULATION OF CALCIUM ION IMPORT,0.0028141,-0.14512,-0.16599,1,0
4,GO CELLULAR EXTRAVASATION,0.0031536,-0.14516,-0.15088,1,0
4,GO ER NUCLEUS SIGNALING PATHWAY,0.015203,-0.1452,-0.13326,1,0
4,GO RESPONSE TO KETONE,8.7323e-05,-0.1453,-0.17286,1,0
4,GO L GLUTAMATE IMPORT,0.021165,-0.14531,-0.17017,1,0
4,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.0021062,-0.14534,-0.14851,1,0
4,GO POSITIVE REGULATION OF CELL KILLING,0.011612,-0.14542,-0.17511,1,0
4,GO POSITIVE REGULATION OF CATABOLIC PROCESS,9.7801e-06,-0.14542,-0.15121,1,0
4,GO ANION TRANSPORT,2.6902e-06,-0.14548,-0.15633,1,0
4,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.0013872,-0.14557,-0.16503,1,0
4,GO REGULATION OF ERBB SIGNALING PATHWAY,0.00090094,-0.14557,-0.17325,1,0
4,GO REGULATION OF INFLAMMATORY RESPONSE,6.5149e-05,-0.14591,-0.18206,1,0
4,GO ENDOCYTOSIS,4.1617e-05,-0.14593,-0.15501,1,0
4,GO FAT CELL DIFFERENTIATION,0.00087311,-0.14597,-0.15693,1,0
4,GO ERYTHROCYTE HOMEOSTASIS,0.0017641,-0.14601,-0.1303,1,0
4,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.012203,-0.14609,-0.11088,1,0
4,GO CHYLOMICRON ASSEMBLY,0.00065623,-0.14611,-0.20608,1,0
4,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,1.9904e-06,-0.14632,-0.15973,1,0
4,GO TRNA METHYLATION,0.0030654,-0.14637,-0.16232,1,0
4,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.010506,-0.14638,-0.16103,1,0
4,GO ICOSANOID BIOSYNTHETIC PROCESS,0.0054795,-0.14639,-0.18842,1,0
4,GO URETER DEVELOPMENT,0.017969,-0.14641,-0.20306,1,0
4,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.042857,-0.14646,-0.1514,1,0
4,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,4.6597e-05,-0.14649,-0.13751,1,0
4,GO ORGANIC ANION TRANSPORT,4.4712e-06,-0.1465,-0.16158,1,0
4,GO SODIUM ION TRANSPORT,0.00098941,-0.14658,-0.14454,1,0
4,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,0.044685,-0.1468,-0.1438,1,0
4,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,1.3441e-06,-0.14685,-0.1411,1,0
4,GO ACROSOME REACTION,0.031748,-0.14685,-0.14383,1,0
4,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,0.027803,-0.14687,-0.12802,1,0
4,GO REGULATION OF SYMBIOTIC PROCESS,0.010245,-0.14693,-0.16232,1,0
4,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.0001165,-0.14698,-0.1485,1,0
4,GO PROTEIN TARGETING TO MITOCHONDRION,9.7346e-05,-0.14699,-0.16239,1,0
4,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.0014738,-0.14709,-0.18095,1,0
4,GO CELLULAR RESPONSE TO STEROL,0.025414,-0.14709,-0.17347,1,0
4,GO INTEGRIN ACTIVATION,0.010245,-0.14711,-0.1847,1,0
4,GO ALCOHOL CATABOLIC PROCESS,0.001872,-0.14711,-0.14711,1,0
4,GO ASTROCYTE DEVELOPMENT,0.024846,-0.14713,-0.1728,1,0
4,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,8.1192e-05,-0.14732,-0.14844,1,0
4,GO PROSTAGLANDIN TRANSPORT,0.0099891,-0.14736,-0.15763,1,0
4,GO GLUCOSE METABOLIC PROCESS,7.6603e-06,-0.14747,-0.16754,1,0
4,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.0015653,-0.14755,-0.19928,1,0
4,GO T CELL CHEMOTAXIS,0.014486,-0.14756,-0.13828,1,0
4,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.027803,-0.14758,-0.20165,1,0
4,GO RESPONSE TO INSULIN,1.8251e-06,-0.1477,-0.16164,1,0
4,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,3.7791e-06,-0.14798,-0.16733,1,0
4,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00084609,-0.14802,-0.16297,1,0
4,GO BLOOD VESSEL MORPHOGENESIS,0.00017186,-0.14806,-0.19487,1,0
4,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.014138,-0.14807,-0.16358,1,0
4,GO REGULATION OF B CELL PROLIFERATION,0.0017123,-0.14814,-0.18852,1,0
4,GO VESICLE BUDDING FROM MEMBRANE,2.0833e-05,-0.14821,-0.17877,1,0
4,GO CARBOHYDRATE HOMEOSTASIS,5.6174e-05,-0.14821,-0.16297,1,0
4,GO GLIAL CELL ACTIVATION,0.0011549,-0.14845,-0.19894,1,0
4,GO REGULATION OF CELLULAR CATABOLIC PROCESS,4.7955e-07,-0.1485,-0.15681,1,0
4,GO NEUTRAL AMINO ACID TRANSPORT,0.0026572,-0.14865,-0.19366,1,0
4,GO GLYCOPROTEIN METABOLIC PROCESS,0.00010462,-0.14867,-0.16026,1,0
4,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.011904,-0.14868,-0.12953,1,0
4,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.012203,-0.14879,-0.17272,1,0
4,GO RESPONSE TO TEMPERATURE STIMULUS,5.8301e-05,-0.1488,-0.14605,1,0
4,GO ACTIVATION OF IMMUNE RESPONSE,0.00030804,-0.14884,-0.15088,1,0
4,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.02268,-0.14886,-0.14929,1,0
4,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.0014299,-0.14886,-0.14806,1,0
4,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,8.1192e-05,-0.14891,-0.14195,1,0
4,GO PROTEIN NITROSYLATION,0.018836,-0.14897,-0.1829,1,0
4,GO REGULATION OF CELL KILLING,0.0051916,-0.1491,-0.17875,1,0
4,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00074557,-0.14922,-0.15547,1,0
4,GO ADIPOSE TISSUE DEVELOPMENT,0.02268,-0.14934,-0.11431,1,0
4,GO REGULATION OF HEART GROWTH,0.017137,-0.14953,-0.12193,1,0
4,GO REGULATION OF CELL ADHESION,0.00023468,-0.14958,-0.18328,1,0
4,GO ALPHA AMINO ACID CATABOLIC PROCESS,5.2139e-05,-0.14974,-0.20417,1,0
4,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.0014299,-0.14976,-0.17148,1,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.001986,-0.14981,-0.20734,1,0
4,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.0017641,-0.14998,-0.17209,1,0
4,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,0.023741,-0.15002,-0.17595,1,0
4,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.00020448,-0.15002,-0.24034,1,0
4,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.033894,-0.15008,-0.11886,1,0
4,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.00010092,-0.15012,-0.15932,1,0
4,GO EXOCYTOSIS,1.4609e-05,-0.15021,-0.18532,1,0
4,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.0028957,-0.15023,-0.21488,1,0
4,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,0.00022676,-0.15027,-0.14711,1,0
4,GO TRNA PROCESSING,0.0041716,-0.15027,-0.13558,1,0
4,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.00028792,-0.15036,-0.15507,1,0
4,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.0013872,-0.15036,-0.15588,1,0
4,GO MUSCLE ADAPTATION,0.00017186,-0.15037,-0.19283,1,0
4,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.0012662,-0.15038,-0.1837,1,0
4,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.0017641,-0.15041,-0.16179,1,0
4,GO WOUND HEALING,0.00034072,-0.15044,-0.20158,1,0
4,GO TRANSITION METAL ION TRANSPORT,4.6597e-05,-0.15045,-0.13761,1,0
4,GO ALPHA BETA T CELL PROLIFERATION,0.025994,-0.15046,-0.16572,1,0
4,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.010245,-0.15055,-0.15115,1,0
4,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.00057693,-0.15057,-0.17214,1,0
4,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.010245,-0.15064,-0.16031,1,0
4,GO LIPID HOMEOSTASIS,0.00014935,-0.15074,-0.16524,1,0
4,GO CORONARY VASCULATURE DEVELOPMENT,0.001228,-0.15087,-0.19858,1,0
4,GO FACE DEVELOPMENT,0.019739,-0.15105,-0.13357,1,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.00057693,-0.15106,-0.15528,1,0
4,GO RESPONSE TO ISCHEMIA,0.0045306,-0.15118,-0.15114,1,0
4,GO HYALURONAN BIOSYNTHETIC PROCESS,0.0019282,-0.15118,-0.20171,1,0
4,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,4.6597e-05,-0.15137,-0.15088,1,0
4,GO REGULATION OF GLUCONEOGENESIS,0.0016129,-0.15159,-0.13456,1,0
4,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.0023671,-0.15174,-0.12947,1,0
4,GO VACUOLAR ACIDIFICATION,0.0019282,-0.15178,-0.18395,1,0
4,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.0001547,-0.15179,-0.15438,1,0
4,GO FEAR RESPONSE,0.0013054,-0.1518,-0.16625,1,0
4,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.012203,-0.15182,-0.12015,1,0
4,GO RESPONSE TO WOUNDING,0.00038934,-0.15196,-0.18954,1,0
4,GO RESPONSE TO HEAT,0.00021167,-0.15196,-0.14812,1,0
4,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.00059588,-0.15197,-0.17095,1,0
4,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.00050664,-0.15212,-0.18074,1,0
4,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0025083,-0.15213,-0.16639,1,0
4,GO PHOSPHATIDIC ACID METABOLIC PROCESS,5.2139e-05,-0.15215,-0.17929,1,0
4,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.0016129,-0.15237,-0.21362,1,0
4,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.022165,-0.15246,-0.13784,1,0
4,GO RESPONSE TO EXTRACELLULAR STIMULUS,8.6584e-06,-0.15248,-0.1619,1,0
4,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.0049174,-0.15259,-0.18917,1,0
4,GO PEPTIDYL ARGININE METHYLATION,0.0025817,-0.15273,-0.15943,1,0
4,GO CELLULAR HOMEOSTASIS,1.7474e-06,-0.15301,-0.15311,1,0
4,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.00023468,-0.15318,-0.12373,1,0
4,GO NEPHRON DEVELOPMENT,0.0051916,-0.15333,-0.14311,1,0
4,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,7.0571e-06,-0.15343,-0.17137,1,0
4,GO REGULATION OF AUTOPHAGY,3.3287e-06,-0.15343,-0.16452,1,0
4,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00057693,-0.1535,-0.19725,1,0
4,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.00012074,-0.15352,-0.16285,1,0
4,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,0.02268,-0.15353,-0.14983,1,0
4,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,0.00016595,-0.15353,-0.18383,1,0
4,GO ESTABLISHMENT OF TISSUE POLARITY,0.00041602,-0.15355,-0.14222,1,0
4,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.00038934,-0.15358,-0.13459,1,0
4,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.024288,-0.15369,-0.25981,1,0
4,GO SENSORY PERCEPTION OF TASTE,0.011612,-0.15371,-0.12867,1,0
4,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,2.0033e-05,-0.15393,-0.15233,1,0
4,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.00010092,-0.15396,-0.22032,1,0
4,GO REGULATION OF ORGAN GROWTH,0.004408,-0.15398,-0.14066,1,0
4,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.00353,-0.15398,-0.18848,1,0
4,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.00017186,-0.15398,-0.19712,1,0
4,GO MESODERM MORPHOGENESIS,0.0018173,-0.15403,-0.19995,1,0
4,GO CELLULAR RESPONSE TO RETINOIC ACID,0.0021689,-0.15408,-0.20242,1,0
4,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0037331,-0.15414,-0.20113,1,0
4,GO ACUTE PHASE RESPONSE,0.0028957,-0.1542,-0.19042,1,0
4,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.0099891,-0.15446,-0.21553,1,0
4,GO CELL KILLING,0.00035231,-0.15454,-0.17717,1,0
4,GO PEPTIDYL TYROSINE MODIFICATION,0.00012964,-0.15454,-0.16742,1,0
4,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.0027346,-0.15477,-0.13099,1,0
4,GO PIGMENT ACCUMULATION,0.030383,-0.15479,-0.15652,1,0
4,GO ADAPTIVE THERMOGENESIS,0.0010859,-0.15479,-0.13934,1,0
4,GO LENS FIBER CELL DIFFERENTIATION,0.02166,-0.1548,-0.16353,1,0
4,GO ORGANELLE FUSION,0.00045924,-0.15481,-0.13928,1,0
4,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.0037331,-0.15492,-0.16576,1,0
4,GO GLIAL CELL DEVELOPMENT,0.0050528,-0.15506,-0.13911,1,0
4,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.036948,-0.15512,-0.14981,1,0
4,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.00020448,-0.15513,-0.1766,1,0
4,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.03939,-0.15528,-0.17478,1,0
4,GO DIVALENT INORGANIC CATION HOMEOSTASIS,1.0184e-05,-0.15537,-0.15998,1,0
4,GO LEUKOCYTE CHEMOTAXIS,0.0010859,-0.15542,-0.16672,1,0
4,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00054072,-0.15554,-0.15166,1,0
4,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0081404,-0.15571,-0.14404,1,0
4,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.0057817,-0.15575,-0.1564,1,0
4,GO SECONDARY METABOLIC PROCESS,0.023741,-0.15583,-0.16005,1,0
4,GO TRABECULA MORPHOGENESIS,0.0032441,-0.15584,-0.18778,1,0
4,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,3.8583e-05,-0.15584,-0.16814,1,0
4,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.0017641,-0.15614,-0.14222,1,0
4,GO LIPID EXPORT FROM CELL,0.0013054,-0.15617,-0.17769,1,0
4,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.00014935,-0.15618,-0.17549,1,0
4,GO CELLULAR KETONE METABOLIC PROCESS,0.00026003,-0.1562,-0.17405,1,0
4,GO CELLULAR LIPID METABOLIC PROCESS,1.9904e-06,-0.15625,-0.17926,1,0
4,GO ANION TRANSMEMBRANE TRANSPORT,2.5774e-06,-0.1564,-0.17076,1,0
4,GO VESICLE TARGETING,1.9263e-05,-0.15641,-0.19699,1,0
4,GO ION HOMEOSTASIS,2.5774e-06,-0.15649,-0.16191,1,0
4,GO RESPONSE TO INTERLEUKIN 4,0.0028141,-0.15657,-0.15544,1,0
4,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,5.9841e-06,-0.15658,-0.14771,1,0
4,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.00024286,-0.15662,-0.24078,1,0
4,GO HYALURONAN METABOLIC PROCESS,0.00010462,-0.15694,-0.23472,1,0
4,GO RESPONSE TO INORGANIC SUBSTANCE,1.0604e-05,-0.15696,-0.17612,1,0
4,GO NOTCH SIGNALING PATHWAY,0.0036303,-0.15699,-0.13512,1,0
4,GO NON CANONICAL WNT SIGNALING PATHWAY,0.00017186,-0.15714,-0.1539,1,0
4,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.0031536,-0.15718,-0.13064,1,0
4,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.00026903,-0.15742,-0.14552,1,0
4,GO REGULATION OF STEROL TRANSPORT,0.00095906,-0.15744,-0.20911,1,0
4,GO GLYCEROLIPID METABOLIC PROCESS,5.7413e-06,-0.15749,-0.15666,1,0
4,GO CELLULAR RESPONSE TO OXYGEN LEVELS,1.7118e-05,-0.15753,-0.16865,1,0
4,GO ACTIVATION OF MAPK ACTIVITY,0.00010092,-0.15768,-0.15095,1,0
4,GO RESPONSE TO TOXIC SUBSTANCE,6.0504e-05,-0.1578,-0.18022,1,0
4,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.02166,-0.15781,-0.14312,1,0
4,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,1.0604e-05,-0.15786,-0.16655,1,0
4,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.00024286,-0.15793,-0.18385,1,0
4,GO RESPONSE TO ACID CHEMICAL,7.2754e-05,-0.15802,-0.16943,1,0
4,GO REGULATION OF LIPASE ACTIVITY,6.2367e-06,-0.15822,-0.20036,1,0
4,GO DIVALENT INORGANIC CATION TRANSPORT,5.2139e-05,-0.15823,-0.15083,1,0
4,GO INNATE IMMUNE RESPONSE,0.00027832,-0.15826,-0.18508,1,0
4,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,1.1493e-05,-0.15833,-0.16313,1,0
4,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,1.8521e-05,-0.15836,-0.15384,1,0
4,GO ORGANELLE MEMBRANE FUSION,0.00036427,-0.15839,-0.16924,1,0
4,GO LYMPHOCYTE MEDIATED IMMUNITY,0.0010206,-0.15843,-0.19465,1,0
4,GO CELLULAR RESPONSE TO CHOLESTEROL,0.015203,-0.15843,-0.2074,1,0
4,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.018398,-0.15846,-0.12991,1,0
4,GO REGULATION OF IMMUNE EFFECTOR PROCESS,0.00049035,-0.15853,-0.18102,1,0
4,GO NEUTRAL LIPID METABOLIC PROCESS,1.0184e-05,-0.15856,-0.19811,1,0
4,GO ANTIMICROBIAL HUMORAL RESPONSE,5.0226e-05,-0.15865,-0.19306,1,0
4,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.035393,-0.15868,-0.12521,1,0
4,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.0027346,-0.15877,-0.16406,1,0
4,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,1.5816e-05,-0.15896,-0.16413,1,0
4,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00013917,-0.15901,-0.22368,1,0
4,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.035393,-0.15908,-0.11281,1,0
4,GO ISOPRENOID METABOLIC PROCESS,0.0032441,-0.15913,-0.16703,1,0
4,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,1.2454e-05,-0.15914,-0.15859,1,0
4,GO POSITIVE REGULATION OF ORGAN GROWTH,0.0024367,-0.15916,-0.20068,1,0
4,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.0011549,-0.15922,-0.17949,1,0
4,GO RNA CATABOLIC PROCESS,0.00021167,-0.1593,-0.17598,1,0
4,GO RESPONSE TO HORMONE,3.0576e-06,-0.15934,-0.16658,1,0
4,GO TERPENOID METABOLIC PROCESS,0.0037331,-0.15941,-0.1723,1,0
4,GO SEQUESTERING OF METAL ION,0.038561,-0.15955,-0.15132,1,0
4,GO NUCLEAR ENVELOPE REASSEMBLY,0.053746,-0.15957,-0.097643,1,0
4,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.0041716,-0.15957,-0.17645,1,0
4,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.0011549,-0.15961,-0.15084,1,0
4,GO RESPONSE TO REACTIVE OXYGEN SPECIES,4.6597e-05,-0.15968,-0.17549,1,0
4,GO T CELL PROLIFERATION,0.00017796,-0.15971,-0.19329,1,0
4,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.00012074,-0.15978,-0.1559,1,0
4,GO L AMINO ACID TRANSPORT,0.00054072,-0.15987,-0.18102,1,0
4,GO GLIAL CELL PROLIFERATION,0.0090226,-0.1599,-0.15527,1,0
4,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.029719,-0.15994,-0.13076,1,0
4,GO MACROPHAGE ACTIVATION,0.00019753,-0.16003,-0.19747,1,0
4,GO ANTIBACTERIAL HUMORAL RESPONSE,0.0022332,-0.16012,-0.2181,1,0
4,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.00081984,-0.16012,-0.19363,1,0
4,GO RESPONSE TO INTERLEUKIN 7,0.00095906,-0.16014,-0.17958,1,0
4,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.004408,-0.16021,-0.16105,1,0
4,GO COPII COATED VESICLE BUDDING,4.8612e-06,-0.16023,-0.18842,1,0
4,GO CERAMIDE BIOSYNTHETIC PROCESS,0.0010528,-0.16039,-0.1664,1,0
4,GO CELLULAR RESPONSE TO CALCIUM ION,0.0042883,-0.16043,-0.19858,1,0
4,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,2.6307e-05,-0.16063,-0.15474,1,0
4,GO RESPONSE TO INTERLEUKIN 15,0.00044439,-0.16067,-0.29701,1,0
4,GO CARDIAC SEPTUM DEVELOPMENT,0.0064317,-0.16069,-0.16676,1,0
4,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.00026903,-0.16072,-0.15186,1,0
4,GO MONOCARBOXYLIC ACID TRANSPORT,1.349e-05,-0.16075,-0.17041,1,0
4,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.00016595,-0.16075,-0.14891,1,0
4,GO REGULATION OF SODIUM ION TRANSPORT,0.00353,-0.16085,-0.16809,1,0
4,GO PROTEIN TARGETING TO LYSOSOME,0.0060989,-0.16093,-0.21122,1,0
4,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.0014738,-0.16094,-0.16975,1,0
4,GO LIPID METABOLIC PROCESS,1.906e-06,-0.16101,-0.17529,1,0
4,GO RIBONUCLEOSIDE METABOLIC PROCESS,0.00026003,-0.16101,-0.16721,1,0
4,GO LYMPHOCYTE MIGRATION,0.00027832,-0.16136,-0.17969,1,0
4,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,7.8282e-05,-0.16162,-0.17208,1,0
4,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.00079435,-0.16164,-0.20485,1,0
4,GO MEMBRANE FUSION,0.0001547,-0.16166,-0.16109,1,0
4,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.007729,-0.16167,-0.16423,1,0
4,GO RESPONSE TO OXIDATIVE STRESS,1.104e-05,-0.16168,-0.1805,1,0
4,GO REGULATION OF VIRAL LIFE CYCLE,0.035393,-0.1617,-0.18167,1,0
4,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.001872,-0.16176,-0.1726,1,0
4,GO PROTEIN AUTOPHOSPHORYLATION,6.7596e-05,-0.16178,-0.14747,1,0
4,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.00036427,-0.16181,-0.1979,1,0
4,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.0028141,-0.16188,-0.18213,1,0
4,GO CYTOKINE METABOLIC PROCESS,0.00047456,-0.16195,-0.2136,1,0
4,GO RESPONSE TO STEROID HORMONE,1.7118e-05,-0.16204,-0.18918,1,0
4,GO ACYLGLYCEROL HOMEOSTASIS,0.00072223,-0.1621,-0.19364,1,0
4,GO RESPONSE TO METAL ION,6.0504e-05,-0.1621,-0.17494,1,0
4,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.0067808,-0.16234,-0.18002,1,0
4,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00011241,-0.16251,-0.1926,1,0
4,GO REGULATION OF PEPTIDASE ACTIVITY,0.00063551,-0.16251,-0.16799,1,0
4,GO CHLORIDE TRANSPORT,0.00019753,-0.16273,-0.15862,1,0
4,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00026003,-0.16274,-0.15499,1,0
4,GO PLASMA MEMBRANE TUBULATION,0.03939,-0.16276,-0.14408,1,0
4,GO METANEPHRIC NEPHRON DEVELOPMENT,0.02268,-0.16297,-0.15267,1,0
4,GO CELLULAR RESPONSE TO STARVATION,0.00045924,-0.16301,-0.14845,1,0
4,GO CELLULAR RESPONSE TO ATP,0.0059384,-0.16332,-0.15226,1,0
4,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.025414,-0.16332,-0.15376,1,0
4,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.0015653,-0.16351,-0.18203,1,0
4,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.0094949,-0.16365,-0.20197,1,0
4,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00063551,-0.16366,-0.20274,1,0
4,GO POSITIVE REGULATION OF MYELINATION,0.010773,-0.16375,-0.14491,1,0
4,GO INTRACELLULAR LIPID TRANSPORT,0.0071468,-0.16377,-0.1571,1,0
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0007696,-0.16401,-0.17134,1,0
4,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,7.8282e-05,-0.16403,-0.16356,1,0
4,GO FATTY ACID TRANSPORT,2.9532e-05,-0.16407,-0.17965,1,0
4,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.033166,-0.16429,-0.2056,1,0
4,GO REGULATION OF BLOOD PRESSURE,0.0001165,-0.16429,-0.16585,1,0
4,GO PROTEIN FOLDING,1.9263e-05,-0.16431,-0.17639,1,0
4,GO REGULATION OF MACROPHAGE MIGRATION,0.00049035,-0.16431,-0.1871,1,0
4,GO HEART GROWTH,0.0037331,-0.16431,-0.13268,1,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0066042,-0.16433,-0.14167,1,0
4,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.0010528,-0.16447,-0.13569,1,0
4,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.0025817,-0.16452,-0.21223,1,0
4,GO GOLGI VESICLE BUDDING,1.906e-06,-0.16456,-0.19532,1,0
4,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.024288,-0.16458,-0.2172,1,0
4,GO B CELL PROLIFERATION,0.00028792,-0.16476,-0.18892,1,0
4,GO TRIGLYCERIDE METABOLIC PROCESS,1.104e-05,-0.16476,-0.21569,1,0
4,GO PROTEIN KINASE C SIGNALING,0.023205,-0.16477,-0.14657,1,0
4,GO REGULATION OF CHEMOTAXIS,0.00052342,-0.16486,-0.16382,1,0
4,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.0038387,-0.16487,-0.17237,1,0
4,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.0001547,-0.16496,-0.19473,1,0
4,GO AMMONIUM ION METABOLIC PROCESS,0.041967,-0.16502,-0.1756,1,0
4,GO TRNA 5 LEADER REMOVAL,0.0022332,-0.16529,-0.20511,1,0
4,GO MYOTUBE DIFFERENTIATION,0.001191,-0.16537,-0.15992,1,0
4,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,8.6584e-06,-0.16539,-0.18363,1,0
4,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.0046564,-0.16548,-0.23228,1,0
4,GO COMPLEMENT ACTIVATION,0.00020448,-0.16551,-0.2297,1,0
4,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.021165,-0.16556,-0.13521,1,0
4,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.00050664,-0.16568,-0.16803,1,0
4,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,3.1888e-05,-0.16578,-0.21365,1,0
4,GO RRNA MODIFICATION,0.0079323,-0.16605,-0.18643,1,0
4,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0016129,-0.16612,-0.23282,1,0
4,GO REGULATION OF VASCULATURE DEVELOPMENT,0.00019079,-0.16612,-0.1984,1,0
4,GO POST GOLGI VESICLE MEDIATED TRANSPORT,8.1192e-05,-0.16623,-0.17271,1,0
4,GO CHOLESTEROL EFFLUX,0.00041602,-0.16627,-0.19196,1,0
4,GO CELLULAR RESPONSE TO LIPID,9.7801e-06,-0.16638,-0.17506,1,0
4,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.0013457,-0.16652,-0.17452,1,0
4,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.00020448,-0.16656,-0.17748,1,0
4,GO OXALATE TRANSPORT,0.0021689,-0.16684,-0.22385,1,0
4,GO BLOOD VESSEL REMODELING,0.001228,-0.16684,-0.24449,1,0
4,GO ENERGY RESERVE METABOLIC PROCESS,6.2786e-05,-0.16685,-0.18585,1,0
4,GO LYMPHOCYTE CHEMOTAXIS,0.00052342,-0.16699,-0.17843,1,0
4,GO DIOL BIOSYNTHETIC PROCESS,0.0069616,-0.16704,-0.18241,1,0
4,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.0022332,-0.16709,-0.19228,1,0
4,GO PROTEIN MATURATION,1.8521e-05,-0.16716,-0.17218,1,0
4,GO NCRNA PROCESSING,0.0022332,-0.16732,-0.17817,1,0
4,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.0051916,-0.16733,-0.25037,1,0
4,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,2.1702e-06,-0.16734,-0.17475,1,0
4,GO REGULATION OF BLOOD CIRCULATION,0.0014738,-0.16735,-0.15283,1,0
4,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.0041716,-0.16737,-0.25464,1,0
4,GO REGULATION OF IMMUNE RESPONSE,0.00010845,-0.16753,-0.16221,1,0
4,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.0015653,-0.1676,-0.21276,1,0
4,GO BONE REMODELING,0.0012662,-0.16794,-0.21423,1,0
4,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,0.00010845,-0.168,-0.20766,1,0
4,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,0.030383,-0.16801,-0.1713,1,0
4,GO MYELOID LEUKOCYTE MIGRATION,9.389e-05,-0.16816,-0.20123,1,0
4,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,4.1617e-05,-0.16818,-0.20727,1,0
4,GO DEFENSE RESPONSE TO BACTERIUM,0.00035231,-0.16826,-0.16852,1,0
4,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,0.015203,-0.16828,-0.19457,1,0
4,GO ICOSANOID METABOLIC PROCESS,0.0010206,-0.16834,-0.20609,1,0
4,GO LIPID LOCALIZATION,5.0683e-06,-0.16845,-0.19543,1,0
4,GO DEFENSE RESPONSE TO OTHER ORGANISM,0.00010845,-0.16846,-0.18412,1,0
4,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.017137,-0.1685,-0.16973,1,0
4,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.00049035,-0.16853,-0.2098,1,0
4,GO FLUID TRANSPORT,0.0071468,-0.16877,-0.15194,1,0
4,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0019282,-0.16881,-0.15573,1,0
4,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.024288,-0.16884,-0.14872,1,0
4,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.00063551,-0.16908,-0.17112,1,0
4,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,1.1964e-05,-0.16917,-0.17029,1,0
4,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,1.349e-05,-0.1692,-0.16633,1,0
4,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,0.00063551,-0.16924,-0.17146,1,0
4,GO POSITIVE REGULATION OF BINDING,9.0551e-05,-0.16929,-0.14476,1,0
4,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,0.00016595,-0.16932,-0.19486,1,0
4,GO CARBOHYDRATE METABOLIC PROCESS,5.2533e-07,-0.16936,-0.19241,1,0
4,GO RESPONSE TO OXYGEN LEVELS,7.2111e-07,-0.16939,-0.2091,1,0
4,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.00028792,-0.16942,-0.20945,1,0
4,GO CELLULAR RESPONSE TO FATTY ACID,0.019739,-0.16945,-0.16902,1,0
4,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.00037661,-0.1695,-0.22068,1,0
4,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.0011549,-0.1696,-0.16995,1,0
4,GO CYTOKINE PRODUCTION,0.00010092,-0.16982,-0.17812,1,0
4,GO REGULATION OF ATP METABOLIC PROCESS,6.5149e-05,-0.16985,-0.15524,1,0
4,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.01282,-0.16993,-0.18748,1,0
4,GO B CELL MEDIATED IMMUNITY,0.0059384,-0.17015,-0.1766,1,0
4,GO ORGANIC CATION TRANSPORT,0.0051916,-0.17017,-0.16391,1,0
4,GO REGULATION OF VASCULAR PERMEABILITY,0.0046564,-0.17028,-0.17116,1,0
4,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0010859,-0.17031,-0.22061,1,0
4,GO TRNA METABOLIC PROCESS,0.00069957,-0.17033,-0.16517,1,0
4,GO SUPEROXIDE METABOLIC PROCESS,0.0081404,-0.17038,-0.15306,1,0
4,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,0.02068,-0.1704,-0.13925,1,0
4,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.0025817,-0.17047,-0.26119,1,0
4,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00050664,-0.17053,-0.2241,1,0
4,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.00017186,-0.17067,-0.21304,1,0
4,GO REGULATION OF MUSCLE HYPERTROPHY,0.001191,-0.17085,-0.18242,1,0
4,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.00067758,-0.1709,-0.23793,1,0
4,GO PIGMENT GRANULE MATURATION,0.0034322,-0.17101,-0.25089,1,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.013465,-0.17108,-0.16927,1,0
4,GO NCRNA METABOLIC PROCESS,0.00057693,-0.17115,-0.17775,1,0
4,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,1.349e-05,-0.17116,-0.18253,1,0
4,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,6.7596e-05,-0.17118,-0.21121,1,0
4,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,3.8583e-05,-0.17123,-0.19864,1,0
4,GO PROTEIN DEMANNOSYLATION,0.0011199,-0.1715,-0.26546,1,0
4,GO POSITIVE REGULATION OF PROTEOLYSIS,1.4039e-05,-0.17156,-0.1707,1,0
4,GO RESPONSE TO ORGANOPHOSPHORUS,4.0073e-05,-0.17179,-0.18735,1,0
4,GO REGULATION OF ENDOCRINE PROCESS,0.0010206,-0.17183,-0.17825,1,0
4,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,0.010245,-0.17187,-0.26613,1,0
4,GO LEUKOCYTE PROLIFERATION,8.7323e-05,-0.17195,-0.19241,1,0
4,GO T HELPER 1 TYPE IMMUNE RESPONSE,0.0016129,-0.17198,-0.24343,1,0
4,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.02068,-0.17198,-0.18357,1,0
4,GO INTERACTION WITH SYMBIONT,1.0604e-05,-0.17214,-0.19478,1,0
4,GO AMELOGENESIS,0.024288,-0.17218,-0.18008,1,0
4,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,1.0184e-05,-0.17226,-0.16808,1,0
4,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.00063551,-0.1723,-0.1707,1,0
4,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.0014299,-0.17231,-0.18872,1,0
4,GO GAP JUNCTION ASSEMBLY,0.04854,-0.17241,-0.21698,1,0
4,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.011047,-0.1725,-0.17841,1,0
4,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.04854,-0.17272,-0.15212,1,0
4,GO PROTEIN LOCALIZATION TO CELL SURFACE,5.8301e-05,-0.17273,-0.18467,1,0
4,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.0097392,-0.17276,-0.17784,1,0
4,GO DENDRITIC CELL CHEMOTAXIS,0.0090226,-0.17298,-0.18683,1,0
4,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.0053338,-0.17305,-0.17227,1,0
4,GO MESONEPHROS DEVELOPMENT,0.015574,-0.17306,-0.1514,1,0
4,GO ELECTRON TRANSPORT CHAIN,0.00025131,-0.17315,-0.1839,1,0
4,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.00010462,-0.17318,-0.16548,1,0
4,GO LIVER MORPHOGENESIS,0.044685,-0.17334,-0.20137,1,0
4,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.0042883,-0.17348,-0.18808,1,0
4,GO REGULATION OF FATTY ACID BETA OXIDATION,0.023205,-0.17361,-0.14145,1,0
4,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,7.2754e-05,-0.17372,-0.18827,1,0
4,GO OXIDATIVE PHOSPHORYLATION,0.00049035,-0.17376,-0.20847,1,0
4,GO LENS FIBER CELL DEVELOPMENT,0.009256,-0.17376,-0.2433,1,0
4,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,3.8583e-05,-0.1738,-0.15893,1,0
4,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.00027832,-0.17386,-0.19911,1,0
4,GO CELLULAR RESPIRATION,0.00037661,-0.17401,-0.20022,1,0
4,GO NUCLEOSIDE METABOLIC PROCESS,0.00036427,-0.17409,-0.1433,1,0
4,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.00065623,-0.17422,-0.1816,1,0
4,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,0.047551,-0.1743,-0.20869,1,0
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.0059384,-0.17436,-0.18636,1,0
4,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.00090094,-0.17437,-0.15914,1,0
4,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.0010206,-0.17439,-0.24362,1,0
4,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,5.2139e-05,-0.1744,-0.18248,1,0
4,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,2.9532e-05,-0.17444,-0.21942,1,0
4,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.00027832,-0.17452,-0.2004,1,0
4,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,2.3654e-06,-0.17455,-0.17556,1,0
4,GO RESPONSE TO CAMP,7.8282e-05,-0.17474,-0.20003,1,0
4,GO REGULATION OF LIPID METABOLIC PROCESS,5.9841e-06,-0.17474,-0.18166,1,0
4,GO GASTRULATION,0.00034072,-0.17474,-0.20661,1,0
4,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.00072223,-0.17474,-0.18519,1,0
4,GO INTERLEUKIN 1 BETA PRODUCTION,0.0062634,-0.17477,-0.20248,1,0
4,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.0090226,-0.17484,-0.25997,1,0
4,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.0015653,-0.17486,-0.17705,1,0
4,GO INFLAMMATORY RESPONSE,5.0226e-05,-0.17513,-0.18921,1,0
4,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.016734,-0.17525,-0.16641,1,0
4,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.00038934,-0.17525,-0.21438,1,0
4,GO MODIFICATION OF SYNAPTIC STRUCTURE,0.055956,-0.17544,-0.14744,1,0
4,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.0010859,-0.17544,-0.17533,1,0
4,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.0042883,-0.17551,-0.16851,1,0
4,GO BONE RESORPTION,0.0021689,-0.17558,-0.19028,1,0
4,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.0013872,-0.17568,-0.17161,1,0
4,GO PYRUVATE METABOLIC PROCESS,1.1964e-05,-0.17569,-0.19599,1,0
4,GO REGULATION OF MUSCLE CONTRACTION,3.8583e-05,-0.17584,-0.18986,1,0
4,GO LEUKOCYTE MEDIATED IMMUNITY,4.3218e-05,-0.17585,-0.21073,1,0
4,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.0012662,-0.17594,-0.1817,1,0
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.00021167,-0.17595,-0.21012,1,0
4,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,0.00090094,-0.17598,-0.19449,1,0
4,GO PROTEIN PROCESSING,0.00013433,-0.17604,-0.18031,1,0
4,GO GLAND MORPHOGENESIS,0.0071468,-0.17605,-0.21335,1,0
4,GO REGULATION OF MAPK CASCADE,1.2962e-05,-0.17608,-0.18389,1,0
4,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,1.8521e-05,-0.17621,-0.1791,1,0
4,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.00023468,-0.17621,-0.15646,1,0
4,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.0007696,-0.17627,-0.2015,1,0
4,GO PROTEIN HOMOTETRAMERIZATION,0.00017796,-0.1763,-0.14398,1,0
4,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00014935,-0.17634,-0.18508,1,0
4,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.02068,-0.17641,-0.16926,1,0
4,GO REGULATION OF LIPID TRANSPORT,0.00013433,-0.17658,-0.18288,1,0
4,GO MONOSACCHARIDE METABOLIC PROCESS,6.2985e-07,-0.17662,-0.21256,1,0
4,GO REGULATION OF CHLORIDE TRANSPORT,0.03939,-0.1769,-0.18338,1,0
4,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.00069957,-0.17691,-0.16539,1,0
4,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.0034322,-0.17702,-0.20218,1,0
4,GO RESPONSE TO CADMIUM ION,0.011326,-0.17705,-0.20069,1,0
4,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.0033369,-0.17711,-0.15465,1,0
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.0010859,-0.17719,-0.22523,1,0
4,GO TRNA 5 END PROCESSING,0.0056288,-0.17729,-0.17193,1,0
4,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.015953,-0.17736,-0.28664,1,0
4,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.00038934,-0.17744,-0.17179,1,0
4,GO RESPONSE TO TUMOR NECROSIS FACTOR,0.00040247,-0.1775,-0.19395,1,0
4,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.00026903,-0.17775,-0.19577,1,0
4,GO INTERLEUKIN 17 PRODUCTION,0.00021167,-0.17787,-0.23058,1,0
4,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,1.8251e-06,-0.17801,-0.20447,1,0
4,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.0011549,-0.17802,-0.22581,1,0
4,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.00054072,-0.17806,-0.1845,1,0
4,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.0045306,-0.17808,-0.19328,1,0
4,GO DEFENSE RESPONSE,4.1617e-05,-0.17832,-0.17888,1,0
4,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.00032948,-0.17842,-0.21606,1,0
4,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.00036427,-0.17842,-0.21139,1,0
4,GO GLYCINE METABOLIC PROCESS,0.012203,-0.17843,-0.25453,1,0
4,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.0020453,-0.17844,-0.22056,1,0
4,GO RESPONSE TO BIOTIC STIMULUS,2.6307e-05,-0.17853,-0.18304,1,0
4,GO CYTOSOLIC CALCIUM ION TRANSPORT,2.5308e-05,-0.17855,-0.18592,1,0
4,GO IMMATURE T CELL PROLIFERATION,0.0020453,-0.17856,-0.23371,1,0
4,GO MATURATION OF 5 8S RRNA,0.0042883,-0.17862,-0.21906,1,0
4,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.00032948,-0.17882,-0.25825,1,0
4,GO ENDODERMAL CELL DIFFERENTIATION,0.00028792,-0.17885,-0.33758,1,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,5.6174e-05,-0.17887,-0.21795,1,0
4,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.0067808,-0.17888,-0.15313,1,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0037331,-0.17888,-0.18929,1,0
4,GO PROTEIN TARGETING,6.7728e-06,-0.17898,-0.20015,1,0
4,GO RHO PROTEIN SIGNAL TRANSDUCTION,4.4878e-05,-0.179,-0.20977,1,0
4,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.0097392,-0.17901,-0.17847,1,0
4,GO REGULATION OF METAL ION TRANSPORT,2.0833e-05,-0.17902,-0.1673,1,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,4.8612e-06,-0.17915,-0.16843,1,0
4,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.0010859,-0.17918,-0.20965,1,0
4,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.0012662,-0.17925,-0.24169,1,0
4,GO T CELL MIGRATION,0.0006154,-0.17938,-0.21586,1,0
4,GO NEGATIVE REGULATION OF CELL ACTIVATION,7.2754e-05,-0.17942,-0.20662,1,0
4,GO PIGMENT GRANULE ORGANIZATION,0.0064317,-0.17942,-0.15805,1,0
4,GO REGULATION OF LYMPHOCYTE MIGRATION,0.0025817,-0.17957,-0.1769,1,0
4,GO STEROID CATABOLIC PROCESS,0.0025817,-0.17958,-0.19292,1,0
4,GO RESPONSE TO LIPID,3.7791e-06,-0.17964,-0.18492,1,0
4,GO EXTRACELLULAR MATRIX CONSTITUENT SECRETION,0.0071468,-0.17975,-0.36307,1,0
4,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.0081404,-0.17996,-0.22962,1,0
4,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.016339,-0.17998,-0.20125,1,0
4,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.010773,-0.18007,-0.18048,1,0
4,GO CELLULAR IRON ION HOMEOSTASIS,0.00023468,-0.1801,-0.16942,1,0
4,GO AMINO SUGAR METABOLIC PROCESS,0.00035231,-0.18027,-0.19887,1,0
4,GO REGULATION OF LEUKOCYTE MIGRATION,7.013e-05,-0.1803,-0.19755,1,0
4,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,2.8418e-05,-0.18033,-0.19363,1,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.0007696,-0.18041,-0.19095,1,0
4,GO POLYSACCHARIDE METABOLIC PROCESS,4.0073e-05,-0.18051,-0.18254,1,0
4,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,4.4712e-06,-0.18059,-0.18323,1,0
4,GO IMMUNE EFFECTOR PROCESS,5.6174e-05,-0.18061,-0.196,1,0
4,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.0029794,-0.18062,-0.21987,1,0
4,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.035393,-0.18063,-0.16593,1,0
4,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.00095906,-0.18077,-0.26608,1,0
4,GO TRANSLATIONAL TERMINATION,0.0010528,-0.18089,-0.21862,1,0
4,GO FOCAL ADHESION ASSEMBLY,0.00054072,-0.18113,-0.21623,1,0
4,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0014738,-0.18113,-0.23573,1,0
4,GO POSITIVE REGULATION OF T CELL MIGRATION,0.00016595,-0.18137,-0.21482,1,0
4,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.0066042,-0.18139,-0.17163,1,0
4,GO PRODUCTION OF SIRNA INVOLVED IN RNA INTERFERENCE,0.043763,-0.18144,-0.19046,1,0
4,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.0069616,-0.18147,-0.22493,1,0
4,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.00054072,-0.18163,-0.19571,1,0
4,GO REGULATION OF ENDOCYTOSIS,3.5759e-05,-0.18163,-0.16972,1,0
4,GO MYOBLAST PROLIFERATION,0.012508,-0.18163,-0.16838,1,0
4,GO ACETYL COA METABOLIC PROCESS,0.0034322,-0.18172,-0.17146,1,0
4,GO ANTIGEN PROCESSING AND PRESENTATION,0.00045924,-0.18178,-0.21268,1,0
4,GO RESPONSE TO DSRNA,0.00021167,-0.18179,-0.19845,1,0
4,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.001228,-0.18182,-0.16783,1,0
4,GO CELLULAR AMINO ACID CATABOLIC PROCESS,2.0833e-05,-0.18183,-0.21603,1,0
4,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.0041716,-0.18189,-0.19519,1,0
4,GO VACUOLE ORGANIZATION,1.9904e-06,-0.18195,-0.18711,1,0
4,GO RESPONSE TO ETHANOL,3.7145e-05,-0.18195,-0.18304,1,0
4,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.0017641,-0.18195,-0.23753,1,0
4,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.0038387,-0.18199,-0.20327,1,0
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.0001547,-0.18206,-0.17161,1,0
4,GO SMOOTH MUSCLE CELL PROLIFERATION,0.00026903,-0.18213,-0.21324,1,0
4,GO MACROPHAGE MIGRATION,0.00014418,-0.18215,-0.22405,1,0
4,GO REGENERATION,5.4121e-05,-0.18215,-0.20156,1,0
4,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.00052342,-0.18218,-0.23519,1,0
4,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.029068,-0.1822,-0.22948,1,0
4,GO ESTROGEN METABOLIC PROCESS,7.2754e-05,-0.18222,-0.23174,1,0
4,GO ASYMMETRIC CELL DIVISION,0.009256,-0.18231,-0.19754,1,0
4,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,5.508e-06,-0.18236,-0.16173,1,0
4,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,0.017549,-0.18244,-0.23828,1,0
4,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,1.4039e-05,-0.18245,-0.23463,1,0
4,GO ATP METABOLIC PROCESS,7.3528e-06,-0.18248,-0.17785,1,0
4,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,5.4121e-05,-0.18249,-0.19,1,0
4,GO REGULATION OF STORE OPERATED CALCIUM ENTRY,0.036164,-0.1825,-0.16689,1,0
4,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,7.6603e-06,-0.18251,-0.21364,1,0
4,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.013465,-0.18261,-0.1612,1,0
4,GO REGULATION OF MACROPHAGE ACTIVATION,0.00026903,-0.18261,-0.20292,1,0
4,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.00026903,-0.18267,-0.18211,1,0
4,GO PLATELET MORPHOGENESIS,0.00038934,-0.18269,-0.1985,1,0
4,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,7.9801e-06,-0.18279,-0.20097,1,0
4,GO FATTY ACID BETA OXIDATION,0.0001165,-0.18279,-0.2067,1,0
4,GO ALPHA AMINO ACID METABOLIC PROCESS,2.0833e-05,-0.1828,-0.20384,1,0
4,GO PROTEIN ACTIVATION CASCADE,0.00042998,-0.18285,-0.25289,1,0
4,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.0034322,-0.18289,-0.19213,1,0
4,GO POSITIVE REGULATION OF COAGULATION,0.0054795,-0.18289,-0.19567,1,0
4,GO TRANSLATIONAL ELONGATION,0.00040247,-0.1829,-0.21708,1,0
4,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.0037331,-0.18294,-0.24494,1,0
4,GO MODULATION BY HOST OF SYMBIONT PROCESS,2.6307e-05,-0.18304,-0.20414,1,0
4,GO OSTEOCLAST DEVELOPMENT,0.02166,-0.18311,-0.16451,1,0
4,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,1.4609e-05,-0.18313,-0.21279,1,0
4,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.0022332,-0.18314,-0.21486,1,0
4,GO PROTEIN TARGETING TO MEMBRANE,0.00084609,-0.18314,-0.22615,1,0
4,GO LEUKOCYTE MIGRATION,0.00022676,-0.18319,-0.18471,1,0
4,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,2.1702e-06,-0.18323,-0.19643,1,0
4,GO LIPID OXIDATION,2.9532e-05,-0.18329,-0.21236,1,0
4,GO NUCLEOTIDE PHOSPHORYLATION,2.6307e-05,-0.18337,-0.19104,1,0
4,GO ORGANIC ACID BIOSYNTHETIC PROCESS,8.3127e-06,-0.18341,-0.18575,1,0
4,GO REGULATION OF TISSUE REMODELING,0.00042998,-0.18346,-0.21205,1,0
4,GO PROTEIN AUTOPROCESSING,0.00084609,-0.18361,-0.23167,1,0
4,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,2.3418e-05,-0.1837,-0.20383,1,0
4,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.017137,-0.1837,-0.2043,1,0
4,GO CARNITINE SHUTTLE,0.035393,-0.18386,-0.16562,1,0
4,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,8.7323e-05,-0.1839,-0.23052,1,0
4,GO REGULATION OF OSSIFICATION,0.00013917,-0.18398,-0.19213,1,0
4,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,2.8418e-05,-0.18409,-0.23771,1,0
4,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.00022676,-0.18412,-0.27183,1,0
4,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.016734,-0.18416,-0.22686,1,0
4,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.00047456,-0.18427,-0.20324,1,0
4,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.0007696,-0.18445,-0.17589,1,0
4,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,2.6307e-05,-0.18449,-0.20804,1,0
4,GO ENDODERM DEVELOPMENT,0.00098941,-0.1845,-0.26762,1,0
4,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.00037661,-0.18451,-0.21736,1,0
4,GO LONG CHAIN FATTY ACID TRANSPORT,3.3132e-05,-0.18463,-0.18145,1,0
4,GO POSITIVE REGULATION OF CELL ADHESION,9.0551e-05,-0.18472,-0.21172,1,0
4,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,5.508e-06,-0.18474,-0.17521,1,0
4,GO CELLULAR RESPONSE TO SALT STRESS,0.0090226,-0.18477,-0.24041,1,0
4,GO NEGATIVE REGULATION OF GENE SILENCING,0.00021909,-0.18493,-0.22511,1,0
4,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.011047,-0.18506,-0.17976,1,0
4,GO STEROID METABOLIC PROCESS,2.7343e-05,-0.18518,-0.19636,1,0
4,GO REGULATION OF PROTEIN BINDING,5.2837e-06,-0.18519,-0.18937,1,0
4,GO MYELOID LEUKOCYTE ACTIVATION,1.4609e-05,-0.18527,-0.22499,1,0
4,GO RESPONSE TO STARVATION,6.7596e-05,-0.18528,-0.17294,1,0
4,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.033894,-0.18549,-0.2056,1,0
4,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.0010206,-0.18551,-0.21334,1,0
4,GO RESPONSE TO CYTOKINE,4.3218e-05,-0.18564,-0.19266,1,0
4,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.00081984,-0.18565,-0.24516,1,0
4,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,5.2533e-07,-0.18565,-0.18097,1,0
4,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.013798,-0.18573,-0.31492,1,0
4,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.0019282,-0.1858,-0.2048,1,0
4,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.00031859,-0.18582,-0.23043,1,0
4,GO INTERLEUKIN 1 PRODUCTION,0.0062634,-0.18594,-0.20526,1,0
4,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,7.2754e-05,-0.18605,-0.16557,1,0
4,GO SELECTIVE AUTOPHAGY,2.9532e-05,-0.1861,-0.20001,1,0
4,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.0011549,-0.18613,-0.18188,1,0
4,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.0054795,-0.18619,-0.20439,1,0
4,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,0.0025817,-0.18627,-0.19689,1,0
4,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.0017123,-0.18628,-0.22155,1,0
4,GO NEGATIVE REGULATION OF PROTEIN BINDING,7.2754e-05,-0.18642,-0.18609,1,0
4,GO ETHER BIOSYNTHETIC PROCESS,0.0056288,-0.1865,-0.31902,1,0
4,GO REGULATION OF PHAGOCYTOSIS,0.00017796,-0.18666,-0.21331,1,0
4,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.012508,-0.1867,-0.19395,1,0
4,GO SPROUTING ANGIOGENESIS,0.00010462,-0.18672,-0.21458,1,0
4,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.00024286,-0.18676,-0.17354,1,0
4,GO PEPTIDE BIOSYNTHETIC PROCESS,9.7346e-05,-0.18685,-0.19493,1,0
4,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.009256,-0.18697,-0.15639,1,0
4,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.0030654,-0.18712,-0.19041,1,0
4,GO POSITIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.0067808,-0.18712,-0.21507,1,0
4,GO TISSUE REMODELING,0.0013054,-0.18713,-0.20278,1,0
4,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0021062,-0.18713,-0.21344,1,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.00081984,-0.18729,-0.20242,1,0
4,GO CELL CHEMOTAXIS,0.00025131,-0.18762,-0.19478,1,0
4,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00016023,-0.18772,-0.20804,1,0
4,GO ORGANOPHOSPHATE METABOLIC PROCESS,9.4334e-07,-0.18774,-0.16583,1,0
4,GO CYTOKINE MEDIATED SIGNALING PATHWAY,0.00017796,-0.18776,-0.20505,1,0
4,GO RNA 5 END PROCESSING,0.0014299,-0.18791,-0.19913,1,0
4,GO BROWN FAT CELL DIFFERENTIATION,0.0064317,-0.18792,-0.17245,1,0
4,GO EXCRETION,0.00069957,-0.18799,-0.1688,1,0
4,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,9.7346e-05,-0.18807,-0.21584,1,0
4,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,1.2862e-06,-0.18809,-0.19061,1,0
4,GO REGULATION OF RIBOSOME BIOGENESIS,0.001191,-0.18809,-0.26668,1,0
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.00072223,-0.18826,-0.21131,1,0
4,GO TRICARBOXYLIC ACID CYCLE,0.00057693,-0.18831,-0.21463,1,0
4,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.00017796,-0.18833,-0.1751,1,0
4,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.00010462,-0.18833,-0.19007,1,0
4,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.0006154,-0.18834,-0.26459,1,0
4,GO PROTEASOME ASSEMBLY,0.012508,-0.1885,-0.16371,1,0
4,GO NEGATIVE REGULATION OF STEROL TRANSPORT,0.0027346,-0.18851,-0.22707,1,0
4,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.00074557,-0.18862,-0.16448,1,0
4,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.0046564,-0.18885,-0.23485,1,0
4,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.013139,-0.18888,-0.24178,1,0
4,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.046579,-0.18895,-0.25678,1,0
4,GO CELLULAR RESPONSE TO CHEMICAL STRESS,1.1493e-05,-0.189,-0.2007,1,0
4,GO MUSCLE HYPERTROPHY,9.389e-05,-0.18901,-0.20111,1,0
4,GO REGULATION OF RECEPTOR BINDING,0.045624,-0.18919,-0.20502,1,0
4,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,4.4878e-05,-0.18922,-0.18808,1,0
4,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.0028957,-0.18926,-0.19977,1,0
4,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.00050664,-0.1893,-0.26096,1,0
4,GO NEGATIVE REGULATION OF MAPK CASCADE,2.6307e-05,-0.18931,-0.1927,1,0
4,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,3.4421e-05,-0.18934,-0.21272,1,0
4,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.017137,-0.18938,-0.25434,1,0
4,GO STEROL TRANSPORT,8.7323e-05,-0.18943,-0.22274,1,0
4,GO REGULATION OF CALCIUM ION TRANSPORT,5.0683e-06,-0.18945,-0.19956,1,0
4,GO IMPORT INTO CELL,0.00018427,-0.18955,-0.17972,1,0
4,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.0018173,-0.1896,-0.20672,1,0
4,GO PROTEIN TETRAMERIZATION,5.4121e-05,-0.18973,-0.1587,1,0
4,GO AEROBIC RESPIRATION,2.5308e-05,-0.18981,-0.2422,1,0
4,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.019739,-0.18984,-0.19784,1,0
4,GO REVERSE CHOLESTEROL TRANSPORT,0.004408,-0.18986,-0.25246,1,0
4,GO HYPOTONIC RESPONSE,0.0011199,-0.19,-0.25573,1,0
4,GO SULFUR COMPOUND TRANSPORT,7.013e-05,-0.19004,-0.18865,1,0
4,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.00090094,-0.19012,-0.23034,1,0
4,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.00069957,-0.19056,-0.15744,1,0
4,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.00072223,-0.19062,-0.15662,1,0
4,GO RESPONSE TO COLD,0.0025817,-0.19063,-0.25286,1,0
4,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.043763,-0.19066,-0.13833,1,0
4,GO RESPONSE TO NUTRIENT,0.00035231,-0.19072,-0.18353,1,0
4,GO POSITIVE REGULATION OF MAPK CASCADE,9.0179e-06,-0.19088,-0.19373,1,0
4,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.0059384,-0.19094,-0.29694,1,0
4,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.00054072,-0.19103,-0.3001,1,0
4,GO PROSTANOID METABOLIC PROCESS,0.011047,-0.19114,-0.25435,1,0
4,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,1.9904e-06,-0.19122,-0.23186,1,0
4,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.00023468,-0.19125,-0.24572,1,0
4,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.0060989,-0.19143,-0.18866,1,0
4,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.0028141,-0.19146,-0.30918,1,0
4,GO REGULATION OF HIPPO SIGNALING,0.025414,-0.19153,-0.22392,1,0
4,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,7.547e-05,-0.19155,-0.17802,1,0
4,GO GENITALIA DEVELOPMENT,0.00037661,-0.19168,-0.17532,1,0
4,GO RESPONSE TO ANGIOTENSIN,0.001191,-0.19178,-0.23313,1,0
4,GO REGULATION OF RESPONSE TO WOUNDING,0.0031536,-0.19198,-0.19389,1,0
4,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,3.7791e-06,-0.19198,-0.17575,1,0
4,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,2.1663e-05,-0.192,-0.23165,1,0
4,GO ADAPTIVE IMMUNE RESPONSE,0.00025131,-0.19221,-0.20829,1,0
4,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,8.3127e-06,-0.19223,-0.2137,1,0
4,GO ZINC ION TRANSPORT,0.0011549,-0.19229,-0.18504,1,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.0079323,-0.19262,-0.19582,1,0
4,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,7.013e-05,-0.19267,-0.20512,1,0
4,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.00072223,-0.1928,-0.20787,1,0
4,GO ENGULFMENT OF APOPTOTIC CELL,0.00090094,-0.19285,-0.22234,1,0
4,GO MUSCLE ORGAN MORPHOGENESIS,0.0014299,-0.19287,-0.16175,1,0
4,GO PENTOSE METABOLIC PROCESS,0.0010859,-0.19287,-0.27466,1,0
4,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.0050528,-0.19288,-0.26872,1,0
4,GO CELLULAR GLUCOSE HOMEOSTASIS,7.547e-05,-0.19294,-0.16618,1,0
4,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.019283,-0.19307,-0.14745,1,0
4,GO REGULATION OF T CELL CHEMOTAXIS,0.0064317,-0.19335,-0.16946,1,0
4,GO STEROL HOMEOSTASIS,0.00059588,-0.19377,-0.19744,1,0
4,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,2.5774e-06,-0.19392,-0.18866,1,0
4,GO MACROPHAGE CHEMOTAXIS,0.00024286,-0.19414,-0.23402,1,0
4,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.052669,-0.19426,-0.17987,1,0
4,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.011326,-0.1944,-0.19658,1,0
4,GO RESPONSE TO PURINE CONTAINING COMPOUND,7.0571e-06,-0.19444,-0.19609,1,0
4,GO MYELIN ASSEMBLY,0.001986,-0.19448,-0.21863,1,0
4,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,6.0504e-05,-0.19459,-0.19235,1,0
4,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.00063551,-0.19474,-0.18797,1,0
4,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.00026903,-0.19478,-0.26418,1,0
4,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,1.8521e-05,-0.19488,-0.18438,1,0
4,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.0036303,-0.19494,-0.28591,1,0
4,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.011904,-0.19515,-0.13578,1,0
4,GO INTERACTION WITH HOST,9.7346e-05,-0.1952,-0.21326,1,0
4,GO VITAMIN METABOLIC PROCESS,3.7145e-05,-0.19532,-0.19678,1,0
4,GO REGULATION OF SULFUR METABOLIC PROCESS,0.02268,-0.19533,-0.18065,1,0
4,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,1.8521e-05,-0.19545,-0.25678,1,0
4,GO MAINTENANCE OF LOCATION,2.5774e-06,-0.19558,-0.19174,1,0
4,GO PEPTIDYL PROLINE MODIFICATION,4.1617e-05,-0.19558,-0.27969,1,0
4,GO RESPONSE TO DRUG,2.2658e-06,-0.19559,-0.22164,1,0
4,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.00054072,-0.19571,-0.2585,1,0
4,GO RESPONSE TO ESTROGEN,2.3418e-05,-0.19578,-0.24417,1,0
4,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.00037661,-0.19581,-0.22118,1,0
4,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0013872,-0.19595,-0.25813,1,0
4,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,1.1964e-05,-0.19595,-0.1952,1,0
4,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.03939,-0.19604,-0.16952,1,0
4,GO AMYLOID BETA CLEARANCE,0.00072223,-0.19611,-0.24476,1,0
4,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,7.547e-05,-0.19618,-0.18418,1,0
4,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.0039469,-0.19632,-0.21672,1,0
4,GO RESPONSE TO CHEMOKINE,5.508e-06,-0.19646,-0.20414,1,0
4,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.009256,-0.19652,-0.31178,1,0
4,GO ORGANOPHOSPHATE CATABOLIC PROCESS,1.4039e-05,-0.1966,-0.17644,1,0
4,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.0001165,-0.19671,-0.23163,1,0
4,GO T CELL CYTOKINE PRODUCTION,0.00063551,-0.19683,-0.21694,1,0
4,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.021165,-0.19688,-0.28164,1,0
4,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.0027346,-0.19704,-0.2383,1,0
4,GO RESPONSE TO PEPTIDOGLYCAN,0.00016595,-0.1972,-0.26762,1,0
4,GO POLYOL BIOSYNTHETIC PROCESS,1.9263e-05,-0.19729,-0.197,1,0
4,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.030383,-0.19743,-0.19253,1,0
4,GO REGULATION OF BONE REMODELING,0.0069616,-0.19747,-0.19563,1,0
4,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,7.889e-07,-0.19749,-0.25264,1,0
4,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.0022992,-0.19763,-0.21488,1,0
4,GO REGULATION OF PLATELET ACTIVATION,0.0026572,-0.1979,-0.26608,1,0
4,GO KIDNEY MESENCHYME DEVELOPMENT,0.055956,-0.19797,-0.1672,1,0
4,GO SCHWANN CELL DEVELOPMENT,5.2139e-05,-0.19804,-0.2048,1,0
4,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.00013917,-0.19824,-0.20781,1,0
4,GO SERTOLI CELL DIFFERENTIATION,0.010506,-0.19828,-0.20056,1,0
4,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,1.1493e-05,-0.19833,-0.20435,1,0
4,GO IRON SULFUR CLUSTER ASSEMBLY,0.00065623,-0.19839,-0.24929,1,0
4,GO PLATELET AGGREGATION,0.00072223,-0.19861,-0.24016,1,0
4,GO NEGATIVE CHEMOTAXIS,0.00081984,-0.1987,-0.26601,1,0
4,GO EXTRACELLULAR MATRIX ASSEMBLY,0.0031536,-0.19881,-0.26248,1,0
4,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.0017641,-0.19887,-0.24562,1,0
4,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.0030654,-0.19899,-0.1703,1,0
4,GO ORGANIC ACID METABOLIC PROCESS,6.2985e-07,-0.1991,-0.19682,1,0
4,GO MYELOID CELL APOPTOTIC PROCESS,0.0064317,-0.19911,-0.20622,1,0
4,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.0050528,-0.19917,-0.20653,1,0
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.0028141,-0.19935,-0.17386,1,0
4,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.0064317,-0.19946,-0.34116,1,0
4,GO REGULATION OF PROSTAGLANDIN SECRETION,0.029068,-0.19974,-0.16632,1,0
4,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,3.3132e-05,-0.19984,-0.20243,1,0
4,GO SPERM EGG RECOGNITION,1.4609e-05,-0.19997,-0.21868,1,0
4,GO ERK1 AND ERK2 CASCADE,4.1617e-05,-0.2001,-0.21187,1,0
4,GO REGULATION OF LIPID LOCALIZATION,1.2962e-05,-0.20025,-0.20771,1,0
4,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.023205,-0.20051,-0.2277,1,0
4,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.001228,-0.20053,-0.27589,1,0
4,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,0.014138,-0.20066,-0.37921,1,0
4,GO RESPONSE TO AMPHETAMINE,0.0083534,-0.20067,-0.22818,1,0
4,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.00017186,-0.20078,-0.19875,1,0
4,GO ANDROGEN METABOLIC PROCESS,0.0041716,-0.20113,-0.21159,1,0
4,GO REGULATION OF BIOMINERALIZATION,3.8583e-05,-0.20129,-0.23017,1,0
4,GO PEPTIDYL HISTIDINE MODIFICATION,0.0010859,-0.2014,-0.21727,1,0
4,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.027803,-0.20141,-0.19782,1,0
4,GO PRIMARY ALCOHOL METABOLIC PROCESS,5.2139e-05,-0.20157,-0.2604,1,0
4,GO MUSCLE FILAMENT SLIDING,0.0019282,-0.20162,-0.23298,1,0
4,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.0049174,-0.20163,-0.20822,1,0
4,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.0034322,-0.20168,-0.20842,1,0
4,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,1.104e-05,-0.20192,-0.23023,1,0
4,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.0040578,-0.20194,-0.17699,1,0
4,GO ENDOTHELIAL CELL PROLIFERATION,2.0033e-05,-0.20203,-0.23025,1,0
4,GO DIET INDUCED THERMOGENESIS,0.0015189,-0.20207,-0.22296,1,0
4,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.0011199,-0.20208,-0.20577,1,0
4,GO STEROL METABOLIC PROCESS,0.00026003,-0.20218,-0.18209,1,0
4,GO INTERFERON GAMMA PRODUCTION,0.00012964,-0.20241,-0.18815,1,0
4,GO RESPONSE TO SALT,0.0012662,-0.2025,-0.15519,1,0
4,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.0041716,-0.20264,-0.23812,1,0
4,GO LONG CHAIN FATTY ACID CATABOLIC PROCESS,0.014486,-0.20277,-0.28898,1,0
4,GO INTERLEUKIN 8 PRODUCTION,0.00072223,-0.2028,-0.22568,1,0
4,GO RESPONSE TO CORTICOSTERONE,0.0057817,-0.20287,-0.24251,1,0
4,GO REGULATION OF ACTION POTENTIAL,0.0011549,-0.20298,-0.20729,1,0
4,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.00019079,-0.20303,-0.27005,1,0
4,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.0033369,-0.20309,-0.22403,1,0
4,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.0051916,-0.20309,-0.21504,1,0
4,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.0013054,-0.20309,-0.28709,1,0
4,GO CYTOPLASMIC TRANSLATION,0.0025083,-0.20315,-0.27975,1,0
4,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.0006154,-0.20327,-0.27409,1,0
4,GO STEROID HORMONE SECRETION,0.0049174,-0.20342,-0.22823,1,0
4,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.0038387,-0.20357,-0.20074,1,0
4,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.03245,-0.20365,-0.3004,1,0
4,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.0041716,-0.20393,-0.22222,1,0
4,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,6.2985e-07,-0.20394,-0.19912,1,0
4,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.00026903,-0.20395,-0.24625,1,0
4,GO PEPTIDYL ARGININE N METHYLATION,0.0029794,-0.20406,-0.20546,1,0
4,GO MOVEMENT IN HOST ENVIRONMENT,8.7323e-05,-0.2042,-0.24893,1,0
4,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.00028792,-0.20464,-0.35388,1,0
4,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.00031859,-0.20465,-0.22319,1,0
4,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.0014299,-0.20475,-0.21207,1,0
4,GO TRANSITION METAL ION HOMEOSTASIS,1.5201e-05,-0.20477,-0.20887,1,0
4,GO LIPID CATABOLIC PROCESS,4.1802e-07,-0.20478,-0.22112,1,0
4,GO FATTY ACID CATABOLIC PROCESS,5.2837e-06,-0.20505,-0.23082,1,0
4,GO CELL SUBSTRATE JUNCTION ORGANIZATION,4.1617e-05,-0.20516,-0.27176,1,0
4,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.0045306,-0.20522,-0.23369,1,0
4,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,3.1888e-05,-0.20526,-0.24444,1,0
4,GO HEPATOCYTE DIFFERENTIATION,0.02166,-0.20531,-0.23198,1,0
4,GO RESPONSE TO CALCIUM ION,0.00014935,-0.20537,-0.2054,1,0
4,GO OSTEOBLAST PROLIFERATION,0.0050528,-0.20546,-0.25173,1,0
4,GO RESPONSE TO DEXAMETHASONE,0.00012964,-0.20563,-0.26129,1,0
4,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.0007696,-0.20567,-0.25555,1,0
4,GO HORMONE METABOLIC PROCESS,9.7346e-05,-0.20573,-0.1998,1,0
4,GO REGULATION OF SPROUTING ANGIOGENESIS,0.00020448,-0.20576,-0.21418,1,0
4,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,0.0010528,-0.20578,-0.22179,1,0
4,GO MEMBRANE INVAGINATION,5.0226e-05,-0.20579,-0.23238,1,0
4,GO IRON ION HOMEOSTASIS,4.8379e-05,-0.20591,-0.20389,1,0
4,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.0016129,-0.20593,-0.32231,1,0
4,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.00019079,-0.20607,-0.26052,1,0
4,GO VASCULOGENESIS,0.0030654,-0.20615,-0.26322,1,0
4,GO RESPONSE TO BACTERIUM,4.8612e-06,-0.20621,-0.21547,1,0
4,GO CARBOHYDRATE PHOSPHORYLATION,0.0047853,-0.20653,-0.19027,1,0
4,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,6.2367e-06,-0.20655,-0.21842,1,0
4,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.0097392,-0.20681,-0.19195,1,0
4,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.007729,-0.20684,-0.19083,1,0
4,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,0.0051916,-0.20712,-0.20472,1,0
4,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.00079435,-0.20723,-0.22888,1,0
4,GO ENDOCRINE PROCESS,0.00024286,-0.20724,-0.21322,1,0
4,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,1.1964e-05,-0.20733,-0.18459,1,0
4,GO PHOSPHOLIPID CATABOLIC PROCESS,5.2139e-05,-0.20745,-0.2438,1,0
4,GO REGULATION OF WATER LOSS VIA SKIN,0.033166,-0.20749,-0.22032,1,0
4,GO PEPTIDE CATABOLIC PROCESS,0.0016129,-0.20752,-0.20046,1,0
4,GO DETOXIFICATION,8.1192e-05,-0.20754,-0.22717,1,0
4,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,8.4205e-05,-0.20763,-0.22553,1,0
4,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,7.9801e-06,-0.20795,-0.22796,1,0
4,GO REGULATION OF TRANSLATIONAL ELONGATION,0.00084609,-0.20833,-0.1975,1,0
4,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.0037331,-0.20835,-0.20617,1,0
4,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.0015653,-0.20836,-0.19052,1,0
4,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.037747,-0.20844,-0.26716,1,0
4,GO AMINO SUGAR CATABOLIC PROCESS,0.00090094,-0.20844,-0.23484,1,0
4,GO PEPTIDE CROSS LINKING,0.00037661,-0.20845,-0.32164,1,0
4,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.0015189,-0.20848,-0.23648,1,0
4,GO CELLULAR GLUCAN METABOLIC PROCESS,9.7346e-05,-0.20848,-0.19688,1,0
4,GO CATECHOLAMINE UPTAKE,0.010773,-0.2086,-0.22119,1,0
4,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,1.0604e-05,-0.20871,-0.20821,1,0
4,GO ALCOHOL METABOLIC PROCESS,6.7728e-06,-0.20877,-0.20288,1,0
4,GO ETHER METABOLIC PROCESS,0.00087311,-0.20885,-0.25163,1,0
4,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,0.02843,-0.2089,-0.41367,1,0
4,GO FATTY ACID BIOSYNTHETIC PROCESS,7.0571e-06,-0.20891,-0.2292,1,0
4,GO MUSCLE CELL APOPTOTIC PROCESS,2.1663e-05,-0.20906,-0.22338,1,0
4,GO REGULATION OF AUTOPHAGOSOME MATURATION,0.0001165,-0.20914,-0.25081,1,0
4,GO GLUTATHIONE METABOLIC PROCESS,7.2754e-05,-0.2093,-0.32222,1,0
4,GO REGULATION OF MAP KINASE ACTIVITY,2.3418e-05,-0.20934,-0.17849,1,0
4,GO CELLULAR AMIDE METABOLIC PROCESS,5.4977e-07,-0.20942,-0.20412,1,0
4,GO ORGANIC ACID CATABOLIC PROCESS,1.2862e-06,-0.20951,-0.22955,1,0
4,GO SMALL MOLECULE CATABOLIC PROCESS,1.3441e-06,-0.20961,-0.2064,1,0
4,GO AMINO ACID IMPORT,0.00011241,-0.20963,-0.2453,1,0
4,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.014486,-0.20968,-0.22127,1,0
4,GO CARBOHYDRATE CATABOLIC PROCESS,5.753e-07,-0.20989,-0.22239,1,0
4,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,1.4039e-05,-0.21022,-0.24097,1,0
4,GO LOCOMOTOR RHYTHM,0.031748,-0.21034,-0.16433,1,0
4,GO CD40 SIGNALING PATHWAY,0.00023468,-0.21064,-0.29301,1,0
4,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.00072223,-0.2107,-0.22861,1,0
4,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.0038387,-0.21103,-0.25636,1,0
4,GO OXIDATION REDUCTION PROCESS,4.5813e-07,-0.21128,-0.21293,1,0
4,GO DIOL METABOLIC PROCESS,0.001872,-0.2113,-0.21969,1,0
4,GO GLYCEROL ETHER METABOLIC PROCESS,0.0025817,-0.21149,-0.22062,1,0
4,GO IRON ION TRANSMEMBRANE TRANSPORT,0.00095906,-0.21151,-0.21365,1,0
4,GO TISSUE REGENERATION,0.00017186,-0.21159,-0.24506,1,0
4,GO FATTY ACID METABOLIC PROCESS,2.2658e-06,-0.21166,-0.21872,1,0
4,GO RESPONSE TO MINERALOCORTICOID,0.00045924,-0.2117,-0.24258,1,0
4,GO SPHINGOID METABOLIC PROCESS,7.8282e-05,-0.21186,-0.27543,1,0
4,GO RRNA METABOLIC PROCESS,0.0013872,-0.21188,-0.21094,1,0
4,GO PEPTIDE METABOLIC PROCESS,2.4692e-06,-0.21195,-0.2077,1,0
4,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.046579,-0.21198,-0.16692,1,0
4,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.00041602,-0.21201,-0.22834,1,0
4,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.00065623,-0.21212,-0.2005,1,0
4,GO T HELPER 1 CELL DIFFERENTIATION,0.010773,-0.21221,-0.2984,1,0
4,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.0041716,-0.21242,-0.25148,1,0
4,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.00092958,-0.21243,-0.2613,1,0
4,GO AMINO ACID BETAINE METABOLIC PROCESS,0.0012662,-0.21254,-0.26454,1,0
4,GO AMEBOIDAL TYPE CELL MIGRATION,3.1888e-05,-0.2126,-0.21511,1,0
4,GO CERAMIDE TRANSPORT,0.0034322,-0.21275,-0.22608,1,0
4,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,8.7323e-05,-0.21294,-0.25302,1,0
4,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.00063551,-0.21324,-0.23653,1,0
4,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.0017641,-0.21332,-0.27689,1,0
4,GO REGULATION OF LIPID CATABOLIC PROCESS,3.1888e-05,-0.21334,-0.20422,1,0
4,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,6.7728e-06,-0.21338,-0.24969,1,0
4,GO CELLULAR AMINO ACID METABOLIC PROCESS,1.7806e-05,-0.2134,-0.20145,1,0
4,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.033894,-0.21342,-0.18748,1,0
4,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,5.0226e-05,-0.21357,-0.25767,1,0
4,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.00017796,-0.21365,-0.2064,1,0
4,GO NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.0033369,-0.21368,-0.28658,1,0
4,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,8.7323e-05,-0.21377,-0.28978,1,0
4,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.00019753,-0.21389,-0.2823,1,0
4,GO CELL CELL RECOGNITION,2.8077e-06,-0.21391,-0.25374,1,0
4,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.00032948,-0.21405,-0.22286,1,0
4,GO CELLULAR HORMONE METABOLIC PROCESS,0.00014418,-0.21412,-0.23523,1,0
4,GO AUTOPHAGY OF NUCLEUS,0.00022676,-0.21415,-0.23897,1,0
4,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,0.0017641,-0.21425,-0.27766,1,0
4,GO T CELL APOPTOTIC PROCESS,6.0504e-05,-0.21431,-0.23863,1,0
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.0001165,-0.21459,-0.23039,1,0
4,GO REGULATION OF ACROSOME REACTION,0.055956,-0.2149,-0.19537,1,0
4,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,0.00021909,-0.21506,-0.19721,1,0
4,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,7.547e-05,-0.21514,-0.27968,1,0
4,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.0010528,-0.21524,-0.23137,1,0
4,GO MITOCHONDRIAL TRANSLATION,0.00024286,-0.21531,-0.23503,1,0
4,GO CARNITINE METABOLIC PROCESS,0.025994,-0.21535,-0.16096,1,0
4,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.00087311,-0.21541,-0.2369,1,0
4,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.029719,-0.21541,-0.2377,1,0
4,GO REGULATION OF CELL SUBSTRATE ADHESION,0.00016595,-0.21544,-0.23488,1,0
4,GO MEMBRANE PROTEIN PROTEOLYSIS,0.00018427,-0.21546,-0.24767,1,0
4,GO IMPORT ACROSS PLASMA MEMBRANE,3.7145e-05,-0.21558,-0.19412,1,0
4,GO CELL SUBSTRATE ADHESION,4.0073e-05,-0.21561,-0.23892,1,0
4,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.0010206,-0.21562,-0.22783,1,0
4,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.014841,-0.21587,-0.17639,1,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.00036427,-0.21601,-0.21957,1,0
4,GO B CELL HOMEOSTASIS,0.00035231,-0.21612,-0.20317,1,0
4,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0031536,-0.21622,-0.20748,1,0
4,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.0083534,-0.21631,-0.21062,1,0
4,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.014138,-0.21633,-0.23297,1,0
4,GO HAIR FOLLICLE MATURATION,0.00095906,-0.21649,-0.29944,1,0
4,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,0.00035231,-0.21667,-0.2273,1,0
4,GO POLYOL METABOLIC PROCESS,4.3763e-07,-0.21669,-0.2155,1,0
4,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.04854,-0.21672,-0.2351,1,0
4,GO MAINTENANCE OF LOCATION IN CELL,5.9841e-06,-0.21674,-0.19768,1,0
4,GO HISTONE SERINE PHOSPHORYLATION,0.00045924,-0.21675,-0.25262,1,0
4,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,6.2985e-07,-0.21697,-0.27188,1,0
4,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.0064317,-0.21699,-0.22645,1,0
4,GO FIBROBLAST PROLIFERATION,0.00032948,-0.21727,-0.24725,1,0
4,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.012203,-0.21732,-0.19805,1,0
4,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,2.3418e-05,-0.2174,-0.20453,1,0
4,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.00090094,-0.21767,-0.24286,1,0
4,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.0042883,-0.21768,-0.21108,1,0
4,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.00023468,-0.21774,-0.22383,1,0
4,GO CELL MATRIX ADHESION,6.0504e-05,-0.21783,-0.24109,1,0
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.0059384,-0.21796,-0.19449,1,0
4,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,0.00055855,-0.21806,-0.2805,1,0
4,GO CELLULAR RESPONSE TO DRUG,1.104e-05,-0.21827,-0.20578,1,0
4,GO AMIDE BIOSYNTHETIC PROCESS,9.7801e-06,-0.21834,-0.19827,1,0
4,GO ANION HOMEOSTASIS,0.0013872,-0.21841,-0.19598,1,0
4,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.019283,-0.21841,-0.20775,1,0
4,GO REGULATION OF LIPID STORAGE,7.2754e-05,-0.2186,-0.23987,1,0
4,GO VITAMIN CATABOLIC PROCESS,0.016339,-0.2186,-0.23686,1,0
4,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.00010845,-0.21872,-0.16392,1,0
4,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.0085714,-0.21874,-0.2184,1,0
4,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.00037661,-0.21886,-0.27652,1,0
4,GO PULMONARY VALVE DEVELOPMENT,0.00092958,-0.21893,-0.38786,1,0
4,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.0075304,-0.21902,-0.1843,1,0
4,GO DE NOVO PROTEIN FOLDING,0.0010528,-0.21929,-0.1806,1,0
4,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.0066042,-0.21941,-0.1701,1,0
4,GO REGULATION OF STEROID METABOLIC PROCESS,0.00010092,-0.21974,-0.23604,1,0
4,GO LYTIC VACUOLE ORGANIZATION,2.8418e-05,-0.2199,-0.22241,1,0
4,GO T CELL MEDIATED IMMUNITY,9.389e-05,-0.22003,-0.29227,1,0
4,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.00067758,-0.22016,-0.23519,1,0
4,GO FOAM CELL DIFFERENTIATION,0.0017123,-0.22035,-0.22728,1,0
4,GO I KAPPAB KINASE NF KAPPAB SIGNALING,7.2754e-05,-0.22065,-0.21828,1,0
4,GO PHAGOCYTOSIS,1.0184e-05,-0.22093,-0.23234,1,0
4,GO REGULATION OF T CELL CYTOKINE PRODUCTION,0.00052342,-0.22121,-0.26525,1,0
4,GO BIOMINERALIZATION,1.104e-05,-0.22123,-0.22695,1,0
4,GO VITAMIN D METABOLIC PROCESS,0.0056288,-0.22134,-0.21786,1,0
4,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.0023671,-0.22153,-0.30344,1,0
4,GO ELASTIC FIBER ASSEMBLY,0.015574,-0.22168,-0.33719,1,0
4,GO STORE OPERATED CALCIUM ENTRY,0.0016129,-0.22172,-0.23827,1,0
4,GO SULFUR COMPOUND METABOLIC PROCESS,6.0198e-07,-0.22176,-0.23162,1,0
4,GO FORMATION OF PRIMARY GERM LAYER,0.00011241,-0.22177,-0.26452,1,0
4,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.001662,-0.22208,-0.20966,1,0
4,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.00012512,-0.22214,-0.25248,1,0
4,GO SYNCYTIUM FORMATION,9.0551e-05,-0.22227,-0.25681,1,0
4,GO GLYCEROLIPID CATABOLIC PROCESS,9.0551e-05,-0.22281,-0.21199,1,0
4,GO RIBOSOME BIOGENESIS,0.0020453,-0.22294,-0.21655,1,0
4,GO FUCOSYLATION,0.00014935,-0.22339,-0.26793,1,0
4,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.00025131,-0.2234,-0.24307,1,0
4,GO REGULATION OF CARDIAC CONDUCTION,7.8282e-05,-0.22346,-0.22638,1,0
4,GO CARDIAC VENTRICLE MORPHOGENESIS,0.010245,-0.22349,-0.14976,1,0
4,GO REGULATION OF COAGULATION,0.00050664,-0.2236,-0.2789,1,0
4,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.0036303,-0.2241,-0.19939,1,0
4,GO PROSTAGLANDIN SECRETION,0.0007696,-0.22427,-0.22892,1,0
4,GO PLASMA MEMBRANE ORGANIZATION,3.8583e-05,-0.22442,-0.22498,1,0
4,GO INTERMEDIATE FILAMENT BASED PROCESS,0.001228,-0.22447,-0.215,1,0
4,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.0039469,-0.22452,-0.25202,1,0
4,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.001986,-0.22452,-0.25774,1,0
4,GO ENTRY INTO HOST,2.9532e-05,-0.22464,-0.29522,1,0
4,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.010245,-0.22526,-0.2519,1,0
4,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.00057693,-0.2254,-0.22875,1,0
4,GO MITOCHONDRIAL GENE EXPRESSION,0.00017796,-0.2255,-0.23836,1,0
4,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.0057817,-0.22556,-0.3644,1,0
4,GO DENDRITIC CELL DIFFERENTIATION,0.00098941,-0.22559,-0.28237,1,0
4,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.00013433,-0.22568,-0.28303,1,0
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.001228,-0.22615,-0.20289,1,0
4,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.0045306,-0.22626,-0.23715,1,0
4,GO RESPONSE TO INTERLEUKIN 12,0.00042998,-0.22628,-0.2371,1,0
4,GO MUSCLE ATROPHY,0.054842,-0.22633,-0.16922,1,0
4,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,0.0010206,-0.22643,-0.27727,1,0
4,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.0032441,-0.2269,-0.21048,1,0
4,GO REGULATION OF RESPONSE TO TUMOR CELL,0.0013872,-0.22692,-0.233,1,0
4,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.00087311,-0.22721,-0.23766,1,0
4,GO DISACCHARIDE METABOLIC PROCESS,0.0038387,-0.22736,-0.24883,1,0
4,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,7.013e-05,-0.22746,-0.24427,1,0
4,GO VITAMIN BIOSYNTHETIC PROCESS,0.019283,-0.22777,-0.16878,1,0
4,GO CHOLESTEROL STORAGE,0.0036303,-0.22781,-0.21039,1,0
4,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.0075304,-0.22824,-0.20352,1,0
4,GO B CELL APOPTOTIC PROCESS,0.0015189,-0.22825,-0.22349,1,0
4,GO CELLULAR RESPONSE TO CADMIUM ION,0.029068,-0.22832,-0.25136,1,0
4,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.00057693,-0.22837,-0.21065,1,0
4,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00038934,-0.22846,-0.19777,1,0
4,GO ACUTE INFLAMMATORY RESPONSE,2.1663e-05,-0.22859,-0.29463,1,0
4,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.013798,-0.22873,-0.24633,1,0
4,GO POSITIVE CHEMOTAXIS,4.8379e-05,-0.22902,-0.24698,1,0
4,GO BONE TRABECULA FORMATION,0.021165,-0.22904,-0.39165,1,0
4,GO MULTI ORGANISM CELLULAR PROCESS,0.0022332,-0.22908,-0.31635,1,0
4,GO REGULATION OF FATTY ACID OXIDATION,0.0013054,-0.22916,-0.20497,1,0
4,GO SUPEROXIDE ANION GENERATION,0.014841,-0.22974,-0.23687,1,0
4,GO POSITIVE REGULATION OF LIPID LOCALIZATION,2.9532e-05,-0.22987,-0.22414,1,0
4,GO REGULATION OF FIBRINOLYSIS,2.1702e-06,-0.23011,-0.40206,1,0
4,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,4.2876e-06,-0.23067,-0.22969,1,0
4,GO POSITIVE REGULATION OF AUTOPHAGY,3.7791e-06,-0.23122,-0.21478,1,0
4,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.00084609,-0.23151,-0.2254,1,0
4,GO LIPID STORAGE,0.00012964,-0.23157,-0.23603,1,0
4,GO REGULATION OF MICROVILLUS ORGANIZATION,0.004408,-0.23193,-0.3144,1,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.010245,-0.23205,-0.20704,1,0
4,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.02268,-0.23205,-0.16555,1,0
4,GO BODY FLUID SECRETION,2.3654e-06,-0.23208,-0.24143,1,0
4,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,3.8583e-05,-0.23238,-0.2949,1,0
4,GO INOSITOL TRISPHOSPHATE METABOLIC PROCESS,0.00042998,-0.23265,-0.28014,1,0
4,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.0099891,-0.23283,-0.31123,1,0
4,GO RESPONSE TO HYDROGEN PEROXIDE,3.1888e-05,-0.23286,-0.24055,1,0
4,GO SEMI LUNAR VALVE DEVELOPMENT,0.0013054,-0.23298,-0.30658,1,0
4,GO COLLAGEN CATABOLIC PROCESS,1.349e-05,-0.23362,-0.32341,1,0
4,GO RESPONSE TO CORTICOSTEROID,1.4609e-05,-0.23363,-0.24713,1,0
4,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.00022676,-0.23367,-0.28611,1,0
4,GO RESPONSE TO TESTOSTERONE,0.0015653,-0.23373,-0.20706,1,0
4,GO RESPONSE TO XENOBIOTIC STIMULUS,9.7346e-05,-0.23378,-0.23067,1,0
4,GO RESPONSE TO DIETARY EXCESS,0.040234,-0.23381,-0.18826,1,0
4,GO CAMP METABOLIC PROCESS,0.001872,-0.23389,-0.22875,1,0
4,GO RESPONSE TO REDOX STATE,0.0025817,-0.23389,-0.21896,1,0
4,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00021167,-0.23393,-0.26685,1,0
4,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,8.3127e-06,-0.23424,-0.29731,1,0
4,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.013139,-0.23435,-0.1843,1,0
4,GO POSITIVE REGULATION OF WOUND HEALING,0.0075304,-0.23463,-0.20117,1,0
4,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.0022992,-0.23467,-0.20914,1,0
4,GO RRNA PSEUDOURIDINE SYNTHESIS,0.0081404,-0.23474,-0.25895,1,0
4,GO FIBRINOLYSIS,0.00019753,-0.23477,-0.36455,1,0
4,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,0.0010528,-0.23479,-0.35511,1,0
4,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.015953,-0.23507,-0.25728,1,0
4,GO REGULATION OF CELL MATRIX ADHESION,0.00027832,-0.23518,-0.25563,1,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0057817,-0.23519,-0.29183,1,0
4,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.00012964,-0.2352,-0.29049,1,0
4,GO RESPONSE TO FLUID SHEAR STRESS,0.00017796,-0.23563,-0.26633,1,0
4,GO NEUTRAL LIPID CATABOLIC PROCESS,0.0083534,-0.23586,-0.15868,1,0
4,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.0062634,-0.23593,-0.24415,1,0
4,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.047551,-0.23636,-0.14914,1,0
4,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,3.9418e-06,-0.23643,-0.24804,1,0
4,GO POSITIVE REGULATION OF P38MAPK CASCADE,8.1192e-05,-0.23648,-0.25893,1,0
4,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,1.6455e-05,-0.23649,-0.24628,1,0
4,GO EXPORT ACROSS PLASMA MEMBRANE,0.0011549,-0.23653,-0.20894,1,0
4,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,1.2454e-05,-0.23655,-0.27017,1,0
4,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.00059588,-0.23691,-0.21406,1,0
4,GO PIGMENT BIOSYNTHETIC PROCESS,7.013e-05,-0.23705,-0.23616,1,0
4,GO CELLULAR LIPID CATABOLIC PROCESS,3.6414e-07,-0.23731,-0.2423,1,0
4,GO CARBOHYDRATE DERIVATIVE TRANSPORT,8.3127e-06,-0.23779,-0.24429,1,0
4,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,4.0073e-05,-0.23783,-0.29535,1,0
4,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,1.9263e-05,-0.23821,-0.32417,1,0
4,GO MACROPHAGE APOPTOTIC PROCESS,0.0099891,-0.23822,-0.21769,1,0
4,GO TROPHOBLAST CELL MIGRATION,0.00098941,-0.23861,-0.34655,1,0
4,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00036427,-0.23877,-0.23746,1,0
4,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.0033369,-0.23894,-0.21756,1,0
4,GO MODULATION BY HOST OF VIRAL PROCESS,2.5774e-06,-0.23894,-0.29352,1,0
4,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,6.0504e-05,-0.23914,-0.2519,1,0
4,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.01282,-0.23918,-0.27595,1,0
4,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.010245,-0.23945,-0.1911,1,0
4,GO ETHANOL METABOLIC PROCESS,0.0033369,-0.23964,-0.26183,1,0
4,GO REGULATION OF WOUND HEALING,0.00074557,-0.23987,-0.2398,1,0
4,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,2.0833e-05,-0.23993,-0.24365,1,0
4,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.00047456,-0.24013,-0.35686,1,0
4,GO REGULATION OF TRANSLATIONAL FIDELITY,0.00012074,-0.24016,-0.2662,1,0
4,GO DRUG METABOLIC PROCESS,5.6174e-05,-0.24017,-0.27639,1,0
4,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.026586,-0.24027,-0.15681,1,0
4,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.0053338,-0.24034,-0.24886,1,0
4,GO VIRAL GENE EXPRESSION,0.0010206,-0.2404,-0.26434,1,0
4,GO REGULATION OF LYSOSOMAL LUMEN PH,0.0037331,-0.24042,-0.20492,1,0
4,GO SIGNAL PEPTIDE PROCESSING,0.0079323,-0.24121,-0.21523,1,0
4,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,8.4205e-05,-0.24186,-0.2658,1,0
4,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.017137,-0.24191,-0.17307,1,0
4,GO EXTRACELLULAR STRUCTURE ORGANIZATION,8.6584e-06,-0.24226,-0.28459,1,0
4,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0007696,-0.24231,-0.26594,1,0
4,GO MAMMARY GLAND MORPHOGENESIS,0.004408,-0.24231,-0.23262,1,0
4,GO RESPONSE TO PROTOZOAN,0.00026903,-0.24274,-0.24455,1,0
4,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.0011199,-0.24275,-0.2614,1,0
4,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.012508,-0.24291,-0.21286,1,0
4,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.00027832,-0.24293,-0.24308,1,0
4,GO SULFUR AMINO ACID METABOLIC PROCESS,4.1617e-05,-0.24303,-0.25658,1,0
4,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.00037661,-0.24306,-0.24419,1,0
4,GO REGULATION OF KERATINOCYTE MIGRATION,0.00084609,-0.24306,-0.22294,1,0
4,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.02166,-0.24318,-0.25322,1,0
4,GO CELLULAR RESPONSE TO OSMOTIC STRESS,4.8379e-05,-0.24413,-0.28301,1,0
4,GO VIRAL TRANSLATION,0.0028141,-0.24416,-0.25755,1,0
4,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,2.0033e-05,-0.2442,-0.30502,1,0
4,GO SPHINGOMYELIN METABOLIC PROCESS,0.00012512,-0.24441,-0.30351,1,0
4,GO VITAMIN TRANSPORT,1.9263e-05,-0.24464,-0.26383,1,0
4,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.0079323,-0.24483,-0.19051,1,0
4,GO PEROXISOME ORGANIZATION,5.0194e-07,-0.24494,-0.2728,1,0
4,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.00050664,-0.24496,-0.29608,1,0
4,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.0031536,-0.24502,-0.24225,1,0
4,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,2.9532e-05,-0.24503,-0.2555,1,0
4,GO EMBRYO IMPLANTATION,0.0037331,-0.24505,-0.20923,1,0
4,GO ACTIVATION OF MAPKKK ACTIVITY,0.019283,-0.24505,-0.20144,1,0
4,GO TRIGLYCERIDE CATABOLIC PROCESS,0.044685,-0.24525,-0.12604,1,0
4,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.0041716,-0.24527,-0.33853,1,0
4,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,1.0184e-05,-0.24547,-0.2826,1,0
4,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.0071468,-0.24549,-0.27126,1,0
4,GO ADAPTATION OF SIGNALING PATHWAY,0.0073363,-0.2455,-0.20117,1,0
4,GO XENOBIOTIC TRANSPORT,5.0226e-05,-0.24561,-0.25712,1,0
4,GO LEUKOCYTE APOPTOTIC PROCESS,0.00011241,-0.24581,-0.22642,1,0
4,GO LYMPHOCYTE APOPTOTIC PROCESS,2.2524e-05,-0.24601,-0.23026,1,0
4,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,3.3132e-05,-0.24604,-0.24891,1,0
4,GO SEQUESTERING OF TRIGLYCERIDE,0.00092958,-0.24658,-0.34234,1,0
4,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0040578,-0.24676,-0.27349,1,0
4,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.00026903,-0.24676,-0.26471,1,0
4,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.00036427,-0.24683,-0.31883,1,0
4,GO REGULATION OF VACUOLE ORGANIZATION,2.6902e-06,-0.2471,-0.25486,1,0
4,GO PROSTANOID BIOSYNTHETIC PROCESS,0.0041716,-0.24712,-0.27547,1,0
4,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0083534,-0.24721,-0.23639,1,0
4,GO ANIMAL ORGAN REGENERATION,2.0833e-05,-0.24725,-0.27231,1,0
4,GO THIOESTER METABOLIC PROCESS,1.0604e-05,-0.24734,-0.23406,1,0
4,GO TETRAPYRROLE METABOLIC PROCESS,4.8612e-06,-0.24759,-0.27753,1,0
4,GO AMINOGLYCAN METABOLIC PROCESS,9.0551e-05,-0.24794,-0.22542,1,0
4,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.0015653,-0.24823,-0.27327,1,0
4,GO REGULATION OF PROTEIN GLYCOSYLATION,0.0028141,-0.24826,-0.23658,1,0
4,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.00026003,-0.2487,-0.27381,1,0
4,GO AMINOGLYCAN CATABOLIC PROCESS,0.00049035,-0.24871,-0.29561,1,0
4,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.001191,-0.24899,-0.26404,1,0
4,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,1.8521e-05,-0.24938,-0.28527,1,0
4,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.00026003,-0.24943,-0.29135,1,0
4,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.00010845,-0.2495,-0.26532,1,0
4,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,6.2367e-06,-0.24956,-0.24913,1,0
4,GO PROGRAMMED NECROTIC CELL DEATH,0.00016595,-0.24959,-0.28813,1,0
4,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.013465,-0.24993,-0.22022,1,0
4,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,6.4994e-06,-0.25002,-0.26456,1,0
4,GO RESPONSE TO HYPEROXIA,0.00034072,-0.25063,-0.32454,1,0
4,GO LACTATION,5.8301e-05,-0.25071,-0.24312,1,0
4,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.0032441,-0.25087,-0.26795,1,0
4,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.00019079,-0.25148,-0.25717,1,0
4,GO MYOBLAST FUSION,3.3132e-05,-0.25161,-0.3029,1,0
4,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,5.2139e-05,-0.25164,-0.27517,1,0
4,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.0045306,-0.25182,-0.31076,1,0
4,GO DOPAMINE TRANSPORT,0.037747,-0.25205,-0.1458,1,0
4,GO ENAMEL MINERALIZATION,0.053746,-0.2521,-0.20661,1,0
4,GO BLOOD COAGULATION INTRINSIC PATHWAY,5.9841e-06,-0.25248,-0.27875,1,0
4,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,1.9904e-06,-0.2527,-0.27802,1,0
4,GO RETINAL METABOLIC PROCESS,0.037747,-0.25334,-0.27054,1,0
4,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.00059588,-0.25356,-0.35464,1,0
4,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.001228,-0.25364,-0.31692,1,0
4,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.00036427,-0.25365,-0.29855,1,0
4,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.0036303,-0.25412,-0.36701,1,0
4,GO BICARBONATE TRANSPORT,0.00016595,-0.25414,-0.21811,1,0
4,GO EXOCRINE SYSTEM DEVELOPMENT,0.0013872,-0.25421,-0.26665,1,0
4,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.00040247,-0.25458,-0.25936,1,0
4,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.0001547,-0.2547,-0.28199,1,0
4,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,1.0604e-05,-0.25485,-0.23748,1,0
4,GO EPIBOLY,0.0010206,-0.25508,-0.31766,1,0
4,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.00027832,-0.25551,-0.2867,1,0
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.004408,-0.25581,-0.30462,1,0
4,GO ENDODERM FORMATION,0.00019079,-0.25606,-0.33087,1,0
4,GO CHEMOSENSORY BEHAVIOR,7.0571e-06,-0.25649,-0.2754,1,0
4,GO REGULATION OF MYOBLAST FUSION,0.001228,-0.2566,-0.3102,1,0
4,GO TRANSLATIONAL INITIATION,0.00067758,-0.25661,-0.29268,1,0
4,GO RESPONSE TO GONADOTROPIN,5.0226e-05,-0.25665,-0.29862,1,0
4,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.00012512,-0.25669,-0.25382,1,0
4,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.00026903,-0.25682,-0.23901,1,0
4,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.0087944,-0.25695,-0.25094,1,0
4,GO ACETYL COA BIOSYNTHETIC PROCESS,2.9532e-05,-0.25698,-0.30845,1,0
4,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.00072223,-0.25709,-0.25248,1,0
4,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.053746,-0.25751,-0.15108,1,0
4,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.00012512,-0.25761,-0.33652,1,0
4,GO NECROTIC CELL DEATH,9.0551e-05,-0.2578,-0.29446,1,0
4,GO SEQUESTERING OF CALCIUM ION,7.0571e-06,-0.25787,-0.24094,1,0
4,GO RESPONSE TO MISFOLDED PROTEIN,8.7323e-05,-0.25805,-0.24632,1,0
4,GO CELLULAR ALDEHYDE METABOLIC PROCESS,5.0226e-05,-0.25811,-0.27508,1,0
4,GO NCRNA CATABOLIC PROCESS,0.00050664,-0.25819,-0.20085,1,0
4,GO RESPONSE TO TYPE I INTERFERON,0.014138,-0.25838,-0.3121,1,0
4,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.0006154,-0.25895,-0.25496,1,0
4,GO REGULATION OF KIDNEY DEVELOPMENT,0.00016023,-0.25943,-0.24367,1,0
4,GO HYPEROSMOTIC RESPONSE,0.014841,-0.25967,-0.17333,1,0
4,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.00063551,-0.25986,-0.26778,1,0
4,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,1.104e-05,-0.25988,-0.31585,1,0
4,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,7.547e-05,-0.25996,-0.2718,1,0
4,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.00012512,-0.25997,-0.26121,1,0
4,GO BILE ACID AND BILE SALT TRANSPORT,0.02166,-0.26017,-0.21851,1,0
4,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.012508,-0.26018,-0.31945,1,0
4,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,3.5759e-05,-0.2602,-0.28369,1,0
4,GO MITOCHONDRIAL DEPOLARIZATION,0.0015189,-0.26022,-0.25247,1,0
4,GO MICROVILLUS ASSEMBLY,0.0049174,-0.2604,-0.26393,1,0
4,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,5.2837e-06,-0.26044,-0.2914,1,0
4,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.00052342,-0.26054,-0.21518,1,0
4,GO POSITIVE REGULATION OF PROTEIN BINDING,1.2454e-05,-0.261,-0.21855,1,0
4,GO ENTRY OF BACTERIUM INTO HOST CELL,0.0050528,-0.26143,-0.34302,1,0
4,GO GERMINAL CENTER FORMATION,0.0010859,-0.26166,-0.38139,1,0
4,GO PROTEIN DEGLYCOSYLATION,2.5308e-05,-0.2619,-0.33855,1,0
4,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.00010462,-0.26224,-0.27108,1,0
4,GO PLATELET DEGRANULATION,1.8521e-05,-0.2626,-0.30164,1,0
4,GO MEMBRANE LIPID CATABOLIC PROCESS,3.0689e-05,-0.26277,-0.31909,1,0
4,GO RESPONSE TO PH,3.4421e-05,-0.26295,-0.27058,1,0
4,GO GLOMERULUS DEVELOPMENT,0.00021909,-0.26297,-0.27873,1,0
4,GO ACTIN FILAMENT SEVERING,0.015574,-0.26303,-0.27297,1,0
4,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,2.3418e-05,-0.26304,-0.25632,1,0
4,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.0028957,-0.26331,-0.25175,1,0
4,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.00041602,-0.26351,-0.25351,1,0
4,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,1.5816e-05,-0.26384,-0.30714,1,0
4,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.00016023,-0.26392,-0.29746,1,0
4,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,5.4977e-07,-0.26393,-0.27461,1,0
4,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.0011199,-0.26498,-0.27928,1,0
4,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.00047456,-0.26503,-0.24977,1,0
4,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,1.5201e-05,-0.26506,-0.31164,1,0
4,GO COPPER ION TRANSPORT,0.00014935,-0.26524,-0.27907,1,0
4,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.0067808,-0.26555,-0.26222,1,0
4,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.00044439,-0.26584,-0.35699,1,0
4,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.00059588,-0.26595,-0.32242,1,0
4,GO RECEPTOR CATABOLIC PROCESS,0.00045924,-0.26638,-0.22572,1,0
4,GO OVULATION,0.0026572,-0.26644,-0.25459,1,0
4,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,7.2754e-05,-0.2666,-0.28939,1,0
4,GO NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00098941,-0.26664,-0.27073,1,0
4,GO DETECTION OF OTHER ORGANISM,0.0025817,-0.2667,-0.30138,1,0
4,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,0.0019282,-0.26684,-0.3391,1,0
4,GO AORTIC VALVE DEVELOPMENT,0.0013054,-0.26685,-0.30134,1,0
4,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,2.3418e-05,-0.26692,-0.3457,1,0
4,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.00026903,-0.26696,-0.25843,1,0
4,GO FUCOSE METABOLIC PROCESS,0.0010206,-0.26697,-0.27203,1,0
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,1.6455e-05,-0.26709,-0.31466,1,0
4,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.00012074,-0.26744,-0.27524,1,0
4,GO T CELL EXTRAVASATION,0.0036303,-0.26755,-0.36367,1,0
4,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.00012964,-0.26799,-0.26514,1,0
4,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,0.0013054,-0.26802,-0.32938,1,0
4,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.00030804,-0.26845,-0.24806,1,0
4,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.0014738,-0.26888,-0.22999,1,0
4,GO ENDOTHELIAL CELL MIGRATION,9.0179e-06,-0.26895,-0.28166,1,0
4,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.00037661,-0.26903,-0.25445,1,0
4,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.022165,-0.2694,-0.29073,1,0
4,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.0019282,-0.26959,-0.28568,1,0
4,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,0.0021062,-0.26972,-0.31097,1,0
4,GO HYALURONAN CATABOLIC PROCESS,0.00057693,-0.26974,-0.37796,1,0
4,GO SULFUR COMPOUND CATABOLIC PROCESS,2.4692e-06,-0.26996,-0.28958,1,0
4,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.0010206,-0.27028,-0.26433,1,0
4,GO NADP METABOLIC PROCESS,8.7323e-05,-0.27059,-0.27292,1,0
4,GO APOPTOTIC CELL CLEARANCE,2.6307e-05,-0.27075,-0.33218,1,0
4,GO SKELETAL MUSCLE TISSUE REGENERATION,1.3441e-06,-0.27085,-0.34507,1,0
4,GO RESPONSE TO ACIDIC PH,0.00020448,-0.27102,-0.3298,1,0
4,GO AMYLOID BETA FORMATION,5.4121e-05,-0.27123,-0.2809,1,0
4,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.00065623,-0.27128,-0.25173,1,0
4,GO TYPE 2 IMMUNE RESPONSE,0.00013917,-0.2713,-0.32209,1,0
4,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,5.0226e-05,-0.27155,-0.25678,1,0
4,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.02166,-0.2722,-0.28041,1,0
4,GO C21 STEROID HORMONE METABOLIC PROCESS,0.00092958,-0.27257,-0.31302,1,0
4,GO TISSUE MIGRATION,1.0604e-05,-0.27285,-0.26157,1,0
4,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,8.3127e-06,-0.27294,-0.27398,1,0
4,GO RIBOSOME ASSEMBLY,0.00098941,-0.27296,-0.29987,1,0
4,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.0017123,-0.27303,-0.29411,1,0
4,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,3.4421e-05,-0.27304,-0.30501,1,0
4,GO REGULATION OF AMYLOID BETA CLEARANCE,0.00065623,-0.27324,-0.31304,1,0
4,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,0.020205,-0.27329,-0.3466,1,0
4,GO PEROXISOMAL TRANSPORT,4.3763e-07,-0.27336,-0.29178,1,0
4,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.00013917,-0.27342,-0.37197,1,0
4,GO REGULATION OF MONONUCLEAR CELL MIGRATION,8.3127e-06,-0.27371,-0.28537,1,0
4,GO REGULATION OF BONE DEVELOPMENT,0.00021167,-0.27388,-0.23299,1,0
4,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,1.104e-05,-0.27397,-0.30622,1,0
4,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.00098941,-0.27408,-0.2695,1,0
4,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,6.2367e-06,-0.27408,-0.3154,1,0
4,GO CELL REDOX HOMEOSTASIS,3.1888e-05,-0.27414,-0.27139,1,0
4,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,1.7806e-05,-0.27415,-0.38072,1,0
4,GO GLOMERULAR MESANGIUM DEVELOPMENT,0.0023671,-0.27421,-0.33814,1,0
4,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.0012662,-0.275,-0.25695,1,0
4,GO KETONE BIOSYNTHETIC PROCESS,9.7346e-05,-0.27517,-0.27385,1,0
4,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00026003,-0.27565,-0.29147,1,0
4,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.00044439,-0.27574,-0.28088,1,0
4,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.00072223,-0.2759,-0.24293,1,0
4,GO ARACHIDONIC ACID METABOLIC PROCESS,1.9904e-06,-0.27594,-0.31892,1,0
4,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.031748,-0.27595,-0.22238,1,0
4,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.0032441,-0.27621,-0.26131,1,0
4,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,2.2524e-05,-0.27651,-0.31313,1,0
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.0083534,-0.2768,-0.30445,1,0
4,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,2.4346e-05,-0.27724,-0.26765,1,0
4,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.00063551,-0.27732,-0.25028,1,0
4,GO KERATINOCYTE MIGRATION,2.9532e-05,-0.27741,-0.27081,1,0
4,GO RETINOL METABOLIC PROCESS,2.5308e-05,-0.27744,-0.32557,1,0
4,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.0022992,-0.27747,-0.2734,1,0
4,GO THIOESTER BIOSYNTHETIC PROCESS,2.0033e-05,-0.27779,-0.26937,1,0
4,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,0.013798,-0.27824,-0.26405,1,0
4,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.0013457,-0.2785,-0.42325,1,0
4,GO PODOSOME ASSEMBLY,0.0024367,-0.2786,-0.2455,1,0
4,GO PHOSPHOLIPID EFFLUX,0.00057693,-0.27868,-0.30411,1,0
4,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.00017186,-0.27868,-0.27527,1,0
4,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,1.0184e-05,-0.27908,-0.27378,1,0
4,GO MATURATION OF SSU RRNA,0.00057693,-0.27912,-0.27972,1,0
4,GO MACROPHAGE CYTOKINE PRODUCTION,0.0010206,-0.27947,-0.30482,1,0
4,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.0027346,-0.27948,-0.30932,1,0
4,GO MATURATION OF LSU RRNA,0.0081404,-0.27982,-0.25159,1,0
4,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.054842,-0.27985,-0.25649,1,0
4,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.0042883,-0.2804,-0.26731,1,0
4,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,9.389e-05,-0.28106,-0.2764,1,0
4,GO MONOSACCHARIDE CATABOLIC PROCESS,9.0179e-06,-0.28174,-0.28288,1,0
4,GO METANEPHRIC EPITHELIUM DEVELOPMENT,0.0056288,-0.2818,-0.25411,1,0
4,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.024846,-0.28212,-0.29079,1,0
4,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.00019753,-0.28224,-0.3516,1,0
4,GO PIGMENT METABOLIC PROCESS,3.0689e-05,-0.28241,-0.26273,1,0
4,GO RESPONSE TO MANGANESE ION,0.00010845,-0.28273,-0.2734,1,0
4,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.00022676,-0.28275,-0.22763,1,0
4,GO MONONUCLEAR CELL MIGRATION,3.3287e-06,-0.28296,-0.30084,1,0
4,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.010773,-0.28324,-0.35196,1,0
4,GO REGULATION OF CHOLESTEROL ESTERIFICATION,0.0018173,-0.2834,-0.33875,1,0
4,GO HEXOSE CATABOLIC PROCESS,1.7118e-05,-0.28341,-0.30527,1,0
4,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.0025083,-0.28342,-0.31874,1,0
4,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,1.4609e-05,-0.28349,-0.27779,1,0
4,GO ZYMOGEN INHIBITION,0.0094949,-0.2835,-0.26773,1,0
4,GO COLLAGEN METABOLIC PROCESS,0.00011241,-0.28377,-0.30584,1,0
4,GO OLIGOPEPTIDE TRANSPORT,0.0022332,-0.28378,-0.33295,1,0
4,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.00055855,-0.28395,-0.27264,1,0
4,GO VASCULAR TRANSPORT,0.012508,-0.284,-0.30179,1,0
4,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.00012964,-0.28444,-0.35075,1,0
4,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.00010092,-0.28496,-0.28281,1,0
4,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.0060989,-0.28513,-0.26376,1,0
4,GO REGULATION OF HEART RATE,0.00021909,-0.28525,-0.23508,1,0
4,GO NEUTROPHIL HOMEOSTASIS,0.001986,-0.28529,-0.34546,1,0
4,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,5.4121e-05,-0.2855,-0.33708,1,0
4,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,1.9263e-05,-0.28586,-0.32358,1,0
4,GO CORTICOSTEROID HORMONE SECRETION,0.00092958,-0.28588,-0.31097,1,0
4,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.0051916,-0.2861,-0.28049,1,0
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.013465,-0.28617,-0.29211,1,0
4,GO TRABECULA FORMATION,0.00026903,-0.28618,-0.32463,1,0
4,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.00049035,-0.28625,-0.27471,1,0
4,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,0.007729,-0.28649,-0.22883,1,0
4,GO REGULATION OF NECROTIC CELL DEATH,0.00028792,-0.28721,-0.3228,1,0
4,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,1.0184e-05,-0.28736,-0.32268,1,0
4,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,9.0551e-05,-0.28767,-0.25658,1,0
4,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.0037331,-0.28769,-0.3777,1,0
4,GO NEGATIVE REGULATION OF WOUND HEALING,0.00010462,-0.28771,-0.30369,1,0
4,GO REGULATION OF TOLERANCE INDUCTION,0.00095906,-0.28824,-0.36956,1,0
4,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.0012662,-0.28839,-0.30723,1,0
4,GO RESPONSE TO GROWTH HORMONE,0.00010092,-0.2887,-0.2877,1,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00010092,-0.28904,-0.35776,1,0
4,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.022165,-0.28924,-0.21646,1,0
4,GO RESPONSE TO INTERFERON GAMMA,2.0833e-05,-0.28941,-0.3562,1,0
4,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,8.1192e-05,-0.28964,-0.30667,1,0
4,GO DETECTION OF BIOTIC STIMULUS,6.0504e-05,-0.28975,-0.34131,1,0
4,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,1.4039e-05,-0.29021,-0.30534,1,0
4,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.00037661,-0.29032,-0.29885,1,0
4,GO AMYLOID BETA METABOLIC PROCESS,5.0226e-05,-0.29064,-0.26066,1,0
4,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,7.0571e-06,-0.29084,-0.29531,1,0
4,GO T HELPER 2 CELL DIFFERENTIATION,0.0028141,-0.29092,-0.39064,1,0
4,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,1.2962e-05,-0.29171,-0.34423,1,0
4,GO ENDOTHELIAL CELL CHEMOTAXIS,0.0019282,-0.29175,-0.27298,1,0
4,GO MITOCHONDRIAL RNA METABOLIC PROCESS,8.1192e-05,-0.29192,-0.28876,1,0
4,GO HORMONE BIOSYNTHETIC PROCESS,8.6584e-06,-0.29237,-0.28571,1,0
4,GO POSITIVE REGULATION OF HAIR CYCLE,0.0028141,-0.29248,-0.29791,1,0
4,GO CHRONIC INFLAMMATORY RESPONSE,0.00010462,-0.2931,-0.34927,1,0
4,GO SKIN MORPHOGENESIS,0.0054795,-0.29356,-0.35717,1,0
4,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.00019753,-0.29359,-0.27784,1,0
4,GO BEHAVIORAL RESPONSE TO PAIN,9.389e-05,-0.29397,-0.44445,1,0
4,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,4.8379e-05,-0.29446,-0.28729,1,0
4,GO PROTEIN OXIDATION,8.4205e-05,-0.29468,-0.35027,1,0
4,GO FATTY ACYL COA METABOLIC PROCESS,0.00052342,-0.29468,-0.23697,1,0
4,GO KERATAN SULFATE METABOLIC PROCESS,1.8251e-06,-0.29489,-0.35266,1,0
4,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,8.7323e-05,-0.2958,-0.30945,1,0
4,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.0022992,-0.29608,-0.23062,1,0
4,GO REGULATION OF EPITHELIAL CELL MIGRATION,7.0571e-06,-0.29615,-0.27499,1,0
4,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00013917,-0.2962,-0.33347,1,0
4,GO BASEMENT MEMBRANE ASSEMBLY,0.0057817,-0.29633,-0.32897,1,0
4,GO CELL JUNCTION DISASSEMBLY,0.00011241,-0.29644,-0.28823,1,0
4,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,6.0504e-05,-0.29685,-0.31696,1,0
4,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,6.4994e-06,-0.29688,-0.35622,1,0
4,GO NEGATIVE REGULATION OF COAGULATION,7.013e-05,-0.2969,-0.36782,1,0
4,GO REGULATION OF T CELL APOPTOTIC PROCESS,1.0184e-05,-0.29704,-0.31956,1,0
4,GO PLASMA MEMBRANE FUSION,0.00026003,-0.29707,-0.3318,1,0
4,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,1.349e-05,-0.29717,-0.38177,1,0
4,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.010245,-0.29783,-0.25098,1,0
4,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.00054072,-0.29805,-0.39625,1,0
4,GO KERATAN SULFATE CATABOLIC PROCESS,2.8418e-05,-0.29807,-0.35001,1,0
4,GO RESPONSE TO TUMOR CELL,2.1663e-05,-0.29812,-0.35378,1,0
4,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.03939,-0.29848,-0.29406,1,0
4,GO STEROID ESTERIFICATION,0.00029782,-0.29851,-0.35731,1,0
4,GO STEROL IMPORT,0.00037661,-0.29867,-0.30666,1,0
4,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,7.8282e-05,-0.29895,-0.31865,1,0
4,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,4.8379e-05,-0.29951,-0.34272,1,0
4,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.0067808,-0.29991,-0.28247,1,0
4,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,1.2454e-05,-0.30051,-0.311,1,0
4,GO SECRETION BY TISSUE,0.00026903,-0.30105,-0.26341,1,0
4,GO LIPID IMPORT INTO CELL,4.4878e-05,-0.30114,-0.29635,1,0
4,GO NEGATIVE REGULATION OF ANOIKIS,0.020205,-0.30268,-0.29188,1,0
4,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.00013917,-0.30289,-0.32596,1,0
4,GO INFLAMMATORY CELL APOPTOTIC PROCESS,0.00038934,-0.30404,-0.3226,1,0
4,GO RESPONSE TO STEROL DEPLETION,0.0015653,-0.30422,-0.25062,1,0
4,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,0.0014738,-0.30446,-0.29266,1,0
4,GO MICROVILLUS ORGANIZATION,0.0017641,-0.30566,-0.27336,1,0
4,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,0.00065623,-0.30602,-0.37342,1,0
4,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,3.5759e-05,-0.30604,-0.47092,1,0
4,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.0013872,-0.30719,-0.3264,1,0
4,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,4.3218e-05,-0.30959,-0.28239,1,0
4,GO COPPER ION HOMEOSTASIS,0.00014418,-0.30992,-0.28204,1,0
4,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.00036427,-0.31072,-0.26539,1,0
4,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.0001547,-0.31081,-0.266,1,0
4,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.00019753,-0.31096,-0.41795,1,0
4,GO SNARE COMPLEX ASSEMBLY,0.001872,-0.31104,-0.24431,1,0
4,GO CELL ADHESION MEDIATED BY INTEGRIN,3.3287e-06,-0.31187,-0.40346,1,0
4,GO PURINE CONTAINING COMPOUND SALVAGE,0.00054072,-0.31205,-0.30257,1,0
4,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.0017641,-0.31273,-0.33197,1,0
4,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,0.025994,-0.31298,-0.23833,1,0
4,GO IMP METABOLIC PROCESS,0.0056288,-0.31327,-0.2881,1,0
4,GO POSITIVE REGULATION OF LIPID STORAGE,3.9418e-06,-0.31377,-0.37647,1,0
4,GO REGULATION OF CELLULAR RESPIRATION,8.6584e-06,-0.31389,-0.3291,1,0
4,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.00065623,-0.31409,-0.37531,1,0
4,GO T CELL MEDIATED CYTOTOXICITY,0.00037661,-0.31557,-0.41482,1,0
4,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.0014299,-0.31585,-0.27436,1,0
4,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.0018173,-0.31589,-0.35658,1,0
4,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.0042883,-0.31627,-0.31835,1,0
4,GO HOMOTYPIC CELL CELL ADHESION,0.00032948,-0.31638,-0.2728,1,0
4,GO CELLULAR COPPER ION HOMEOSTASIS,0.00021909,-0.31643,-0.30482,1,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.0010528,-0.31689,-0.37117,1,0
4,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,9.8628e-07,-0.31744,-0.36298,1,0
4,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.0032441,-0.31761,-0.33638,1,0
4,GO MATURE B CELL DIFFERENTIATION,0.00047456,-0.31795,-0.31894,1,0
4,GO REGULATION OF MEMBRANE INVAGINATION,0.0042883,-0.31813,-0.2631,1,0
4,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.0075304,-0.31869,-0.26055,1,0
4,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.00029782,-0.31904,-0.34812,1,0
4,GO REGULATION OF MEMBRANE DEPOLARIZATION,4.4712e-06,-0.31917,-0.3195,1,0
4,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.00059588,-0.31953,-0.34484,1,0
4,GO RESPONSE TO MAGNESIUM ION,0.00069957,-0.31969,-0.3459,1,0
4,GO ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00025131,-0.31981,-0.34932,1,0
4,GO REGULATION OF CELLULAR EXTRAVASATION,9.7346e-05,-0.32076,-0.30651,1,0
4,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.00029782,-0.32104,-0.35394,1,0
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.00010845,-0.32113,-0.32595,1,0
4,GO PROTEIN HYDROXYLATION,4.4878e-05,-0.32225,-0.3975,1,0
4,GO NAD METABOLIC PROCESS,5.2139e-05,-0.32355,-0.32537,1,0
4,GO ZYMOGEN ACTIVATION,2.5308e-05,-0.32364,-0.40114,1,0
4,GO MONOCYTE CHEMOTAXIS,9.0179e-06,-0.32382,-0.32935,1,0
4,GO VAGINA DEVELOPMENT,0.0022332,-0.32389,-0.26492,1,0
4,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,9.0551e-05,-0.32411,-0.37729,1,0
4,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.0012662,-0.32455,-0.36169,1,0
4,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.00037661,-0.32455,-0.35853,1,0
4,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,0.0017641,-0.32486,-0.37371,1,0
4,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.0022992,-0.32521,-0.34351,1,0
4,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.00072223,-0.32585,-0.33381,1,0
4,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.00023468,-0.32586,-0.32992,1,0
4,GO RESPONSE TO CAFFEINE,0.00017186,-0.32608,-0.28664,1,0
4,GO MACROPHAGE PROLIFERATION,0.0011199,-0.32636,-0.36229,1,0
4,GO RELAXATION OF CARDIAC MUSCLE,0.0010859,-0.32745,-0.32059,1,0
4,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.00040247,-0.32771,-0.31631,1,0
4,GO L ASCORBIC ACID METABOLIC PROCESS,0.0013872,-0.32852,-0.35757,1,0
4,GO NEURON REMODELING,0.00040247,-0.32913,-0.34825,1,0
4,GO BLEB ASSEMBLY,0.0017123,-0.32982,-0.5535,1,0
4,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.00040247,-0.33096,-0.27692,1,0
4,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,3.0689e-05,-0.33207,-0.34561,1,0
4,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,2.1663e-05,-0.33271,-0.38393,1,0
4,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.0018173,-0.33285,-0.30146,1,0
4,GO COLLAGEN BIOSYNTHETIC PROCESS,0.001228,-0.33518,-0.35785,1,0
4,GO RESPONSE TO COPPER ION,0.00042998,-0.33545,-0.37977,1,0
4,GO CELLULAR RESPONSE TO FOLLICLE STIMULATING HORMONE STIMULUS,0.00037661,-0.33572,-0.36084,1,0
4,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,1.349e-05,-0.33583,-0.35835,1,0
4,GO REGULATION OF COLLAGEN METABOLIC PROCESS,6.7596e-05,-0.33612,-0.36465,1,0
4,GO OPIOID RECEPTOR SIGNALING PATHWAY,0.00036427,-0.33683,-0.36369,1,0
4,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.00034072,-0.33738,-0.35298,1,0
4,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,7.0571e-06,-0.33761,-0.3298,1,0
4,GO RESPONSE TO THYROID HORMONE,0.00013433,-0.33768,-0.3252,1,0
4,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,9.7801e-06,-0.33848,-0.34258,1,0
4,GO THYMOCYTE APOPTOTIC PROCESS,0.00022676,-0.33989,-0.3287,1,0
4,GO CELLULAR RESPONSE TO ETHANOL,0.00079435,-0.34162,-0.27989,1,0
4,GO CERAMIDE CATABOLIC PROCESS,5.0226e-05,-0.34263,-0.38321,1,0
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.0034322,-0.34295,-0.31841,1,0
4,GO STEROID HORMONE BIOSYNTHETIC PROCESS,5.0683e-06,-0.34333,-0.36019,1,0
4,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,6.5149e-05,-0.34442,-0.37795,1,0
4,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.00011241,-0.34449,-0.31436,1,0
4,GO SALIVARY GLAND DEVELOPMENT,0.00021909,-0.34502,-0.33183,1,0
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,1.4044e-06,-0.34513,-0.35199,1,0
4,GO CELLULAR RESPONSE TO INTERFERON BETA,0.00095906,-0.34551,-0.33384,1,0
4,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0018173,-0.34602,-0.32871,1,0
4,GO GLYCOPROTEIN CATABOLIC PROCESS,2.0833e-05,-0.34644,-0.50807,1,0
4,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.0014738,-0.34651,-0.3719,1,0
4,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.00012512,-0.3469,-0.39563,1,0
4,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.00014418,-0.34724,-0.36628,1,0
4,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,9.0179e-06,-0.34749,-0.36935,1,0
4,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.0011199,-0.34774,-0.34791,1,0
4,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,2.3654e-06,-0.35144,-0.3153,1,0
4,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,2.8077e-06,-0.35211,-0.41999,1,0
4,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.00072223,-0.35327,-0.33598,1,0
4,GO VASODILATION,7.8282e-05,-0.35365,-0.34211,1,0
4,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.0021062,-0.35397,-0.39975,1,0
4,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,1.8521e-05,-0.35566,-0.30967,1,0
4,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.00012512,-0.35577,-0.35497,1,0
4,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.0013872,-0.35705,-0.32685,1,0
4,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.018836,-0.35879,-0.24775,1,0
4,GO EXTRACELLULAR MATRIX DISASSEMBLY,6.8936e-07,-0.35885,-0.38576,1,0
4,GO POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION,0.00042998,-0.35915,-0.30211,1,0
4,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,3.5759e-05,-0.35975,-0.4197,1,0
4,GO REGULATION OF AMYLOID BETA FORMATION,8.6584e-06,-0.36001,-0.34833,1,0
4,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.0066042,-0.36102,-0.29688,1,0
4,GO NUCLEOTIDE SALVAGE,4.0073e-05,-0.36107,-0.42349,1,0
4,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.00055855,-0.36181,-0.44227,1,0
4,GO NEGATIVE REGULATION OF BONE REMODELING,0.00025131,-0.36229,-0.35447,1,0
4,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.0021062,-0.36262,-0.39424,1,0
4,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,7.0571e-06,-0.36269,-0.35556,1,0
4,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,5.7413e-06,-0.3634,-0.31914,1,0
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.00037661,-0.36348,-0.3986,1,0
4,GO POLYOL TRANSPORT,3.4421e-05,-0.36404,-0.33947,1,0
4,GO HISTAMINE SECRETION,0.0041716,-0.36516,-0.33949,1,0
4,GO NEGATIVE REGULATION OF TISSUE REMODELING,3.0689e-05,-0.36554,-0.39094,1,0
4,GO RESPONSE TO INTERFERON BETA,0.0024367,-0.36555,-0.43914,1,0
4,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.00026003,-0.36616,-0.32074,1,0
4,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0022332,-0.3667,-0.3771,1,0
4,GO HEME METABOLIC PROCESS,2.6307e-05,-0.36725,-0.3898,1,0
4,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.041967,-0.36775,-0.22188,1,0
4,GO CYSTEINE METABOLIC PROCESS,9.0551e-05,-0.36804,-0.46493,1,0
4,GO GAS TRANSPORT,0.001662,-0.36837,-0.35349,1,0
4,GO HISTAMINE TRANSPORT,0.0012662,-0.37047,-0.35423,1,0
4,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00025131,-0.37112,-0.36009,1,0
4,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.00010092,-0.37309,-0.38728,1,0
4,GO PLASMINOGEN ACTIVATION,1.104e-05,-0.37491,-0.43201,1,0
4,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.00032948,-0.37562,-0.41947,1,0
4,GO REGULATION OF HORMONE METABOLIC PROCESS,7.9801e-06,-0.37836,-0.41669,1,0
4,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.0046564,-0.37855,-0.387,1,0
4,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.0028957,-0.37865,-0.32526,1,0
4,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,5.4121e-05,-0.3791,-0.33292,1,0
4,GO REGULATION OF PODOSOME ASSEMBLY,0.0053338,-0.37911,-0.27166,1,0
4,GO MEMBRANE RAFT ORGANIZATION,9.0551e-05,-0.37924,-0.49199,1,0
4,GO BASEMENT MEMBRANE ORGANIZATION,2.3418e-05,-0.38012,-0.4235,1,0
4,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.00065623,-0.38028,-0.35918,1,0
4,GO POSITIVE REGULATION OF VASCULOGENESIS,0.0017123,-0.38069,-0.40137,1,0
4,GO EOSINOPHIL MIGRATION,5.8301e-05,-0.38211,-0.4327,1,0
4,GO FRUCTOSE METABOLIC PROCESS,0.0099891,-0.38333,-0.35051,1,0
4,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.00035231,-0.38397,-0.46003,1,0
4,GO ESTROGEN BIOSYNTHETIC PROCESS,2.9532e-05,-0.38406,-0.36815,1,0
4,GO INTERLEUKIN 5 PRODUCTION,0.00029782,-0.38438,-0.34846,1,0
4,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,8.3127e-06,-0.38538,-0.4371,1,0
4,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,1.7118e-05,-0.38587,-0.49918,1,0
4,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.00095906,-0.38714,-0.29818,1,0
4,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.00027832,-0.38943,-0.35695,1,0
4,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.00019079,-0.39044,-0.43028,1,0
4,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.00074557,-0.39104,-0.38276,1,0
4,GO MITOCHONDRIAL TRANSCRIPTION,4.2876e-06,-0.39117,-0.39029,1,0
4,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.00067758,-0.39131,-0.32532,1,0
4,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,1.1493e-05,-0.39229,-0.45656,1,0
4,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,8.4205e-05,-0.39241,-0.37082,1,0
4,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.00031859,-0.39274,-0.3963,1,0
4,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,0.00072223,-0.39437,-0.35689,1,0
4,GO NOTOCHORD DEVELOPMENT,0.0017123,-0.39474,-0.3202,1,0
4,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,8.7323e-05,-0.39677,-0.4495,1,0
4,GO CHAPERONE MEDIATED AUTOPHAGY,5.2139e-05,-0.39713,-0.49338,1,0
4,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,5.2139e-05,-0.39772,-0.36793,1,0
4,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,8.2505e-07,-0.3984,-0.39024,1,0
4,GO GLYCINE TRANSPORT,0.00079435,-0.39898,-0.38514,1,0
4,GO ARGININE METABOLIC PROCESS,7.547e-05,-0.39968,-0.41271,1,0
4,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,6.2786e-05,-0.40016,-0.37081,1,0
4,GO EPOXYGENASE P450 PATHWAY,1.4039e-05,-0.40128,-0.39493,1,0
4,GO GLYCOLIPID CATABOLIC PROCESS,2.3418e-05,-0.40441,-0.44417,1,0
4,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,8.7323e-05,-0.40514,-0.40056,1,0
4,GO DENDRITIC CELL APOPTOTIC PROCESS,4.6623e-06,-0.40526,-0.46736,1,0
4,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.0051916,-0.40616,-0.36908,1,0
4,GO REGULATION OF METANEPHROS DEVELOPMENT,2.2524e-05,-0.40952,-0.50263,1,0
4,GO RESPONSE TO INTERLEUKIN 18,0.0020453,-0.41206,-0.44041,1,0
4,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,4.6623e-06,-0.41304,-0.45313,1,0
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.00047456,-0.41314,-0.41289,1,0
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,5.2837e-06,-0.41397,-0.4377,1,0
4,GO IMMUNE RESPONSE TO TUMOR CELL,3.3132e-05,-0.41412,-0.43692,1,0
4,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.00065623,-0.41563,-0.33833,1,0
4,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.00031859,-0.41617,-0.30142,1,0
4,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,0.00067758,-0.41707,-0.37972,1,0
4,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,2.0833e-05,-0.41751,-0.43923,1,0
4,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,0.00025131,-0.41831,-0.58448,1,0
4,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.00012074,-0.41947,-0.45819,1,0
4,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.00055855,-0.42097,-0.3367,1,0
4,GO L PHENYLALANINE METABOLIC PROCESS,0.00026003,-0.42256,-0.36082,1,0
4,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.0025083,-0.42438,-0.49942,1,0
4,GO MONOACYLGLYCEROL METABOLIC PROCESS,9.3916e-06,-0.42558,-0.43579,1,0
4,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.00010462,-0.42951,-0.35324,1,0
4,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,7.0571e-06,-0.43015,-0.51129,1,0
4,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,7.547e-05,-0.43335,-0.42148,1,0
4,GO MUSCLE CELL CELLULAR HOMEOSTASIS,1.0779e-06,-0.43406,-0.476,1,0
4,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.00050664,-0.43419,-0.35604,1,0
4,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.0001547,-0.43467,-0.41801,1,0
4,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,5.0683e-06,-0.43525,-0.40817,1,0
4,GO BIOLOGICAL PHASE,0.00029782,-0.43575,-0.4865,1,0
4,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,0.00032948,-0.43839,-0.52748,1,0
4,GO INTERLEUKIN 13 PRODUCTION,8.7323e-05,-0.43931,-0.37219,1,0
4,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,5.0226e-05,-0.44032,-0.46494,1,0
4,GO REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS,0.00027832,-0.44253,-0.49837,1,0
4,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.00028792,-0.44325,-0.45567,1,0
4,GO TYPE B PANCREATIC CELL APOPTOTIC PROCESS,2.4346e-05,-0.44338,-0.51048,1,0
4,GO EOSINOPHIL CHEMOTAXIS,0.00010092,-0.44532,-0.46696,1,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.00074557,-0.44562,-0.5124,1,0
4,GO ACTIN FILAMENT NETWORK FORMATION,0.00026003,-0.44645,-0.41003,1,0
4,GO POSITIVE REGULATION OF ACTION POTENTIAL,3.0576e-06,-0.4514,-0.46195,1,0
4,GO XENOBIOTIC CATABOLIC PROCESS,0.00353,-0.45321,-0.44768,1,0
4,GO NEGATIVE REGULATION OF CELL KILLING,0.00022676,-0.45409,-0.51012,1,0
4,GO HEMIDESMOSOME ASSEMBLY,0.00014935,-0.4574,-0.56978,1,0
4,GO TOLERANCE INDUCTION,9.7801e-06,-0.45819,-0.54874,1,0
4,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,0.0001547,-0.46101,-0.4981,1,0
4,GO CYCLOOXYGENASE PATHWAY,1.1493e-05,-0.46481,-0.58866,1,0
4,GO ADHESION OF SYMBIONT TO HOST,4.4878e-05,-0.46558,-0.41552,1,0
4,GO MONONUCLEAR CELL DIFFERENTIATION,2.8891e-07,-0.46939,-0.48698,1,0
4,GO GALACTOSE METABOLIC PROCESS,1.1964e-05,-0.47797,-0.47939,1,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,9.7801e-06,-0.4807,-0.5043,1,0
4,GO INFLAMMATORY RESPONSE TO WOUNDING,0.0097392,-0.48254,-0.37536,1,0
4,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,2.5774e-06,-0.48787,-0.4472,1,0
4,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,0.0085714,-0.48978,-0.61016,1,0
4,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,0.0066042,-0.48998,-0.5443,1,0
4,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00069957,-0.49775,-0.56958,1,0
4,GO REGULATION OF MONOCYTE DIFFERENTIATION,9.3916e-06,-0.49783,-0.49851,1,0
4,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,3.4728e-06,-0.49791,-0.58543,1,0
4,GO PEPTIDYL PROLINE HYDROXYLATION,5.0226e-05,-0.49813,-0.48948,1,0
4,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.00010092,-0.50509,-0.42203,1,0
4,GO RESPONSE TO EPINEPHRINE,0.0018173,-0.51065,-0.39555,1,0
4,GO REGULATION OF VASCULOGENESIS,0.0029794,-0.51239,-0.4147,1,0
4,GO OXYGEN TRANSPORT,0.0039469,-0.51252,-0.43814,1,0
4,GO REGULATION OF GLOMERULUS DEVELOPMENT,7.8282e-05,-0.51717,-0.50306,1,0
4,GO REGULATION OF PLASMINOGEN ACTIVATION,1.104e-05,-0.51961,-0.6093,1,0
4,GO GLOMERULAR MESANGIAL CELL PROLIFERATION,0.00079435,-0.52213,-0.43976,1,0
4,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,3.1904e-06,-0.52902,-0.49998,1,0
4,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,2.5774e-06,-0.52907,-0.6119,1,0
4,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,1.2308e-06,-0.53299,-0.5992,1,0
4,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.0017123,-0.55171,-0.3902,1,0
4,GO OLIGOSACCHARIDE CATABOLIC PROCESS,1.5201e-05,-0.56005,-0.52865,1,0
4,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,5.8301e-05,-0.56225,-0.59371,1,0
4,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,6.8936e-07,-0.56341,-0.5849,1,0
4,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,1.2308e-06,-0.59273,-0.50226,1,0
4,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,1.1964e-05,-0.59302,-0.59767,1,0
4,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,4.6597e-05,-0.60369,-0.64643,1,0
4,GO MUCUS SECRETION,0.00035231,-0.60481,-0.58573,1,0
4,GO MEMBRANE RAFT ASSEMBLY,0.00024286,-0.66245,-0.73204,1,0
4,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,0.0067808,-0.70253,-0.78396,1,0
4,GO RESPONSE TO FORSKOLIN,0.072231,0.29552,0.19085,0,1
4,GO ESTROUS CYCLE,0.0695,0.22779,0.16113,0,1
4,GO GDP METABOLIC PROCESS,0.073629,0.20235,0.15454,0,1
4,GO EMBRYONIC BRAIN DEVELOPMENT,0.10654,0.1972,0.1047,0,1
4,GO NEURON PROJECTION ARBORIZATION,0.0695,0.19427,0.14142,0,1
4,GO PARENTAL BEHAVIOR,0.075049,0.18781,0.26442,0,1
4,GO CELL PROLIFERATION IN HINDBRAIN,0.26847,0.17912,0.090547,0,1
4,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.093897,0.15398,0.12092,0,1
4,GO NEGATIVE REGULATION OF GLUCOSE IMPORT,0.13355,0.14072,0.12573,0,1
4,GO PROTEIN DEMETHYLATION,0.1313,0.13138,0.077167,0,1
4,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.077957,0.12329,0.060932,0,1
4,GO RESPONSE TO FOOD,0.092194,0.11771,0.074382,0,1
4,GO HISTONE H3 K9 ACETYLATION,0.064293,0.1158,0.074271,0,1
4,GO INSEMINATION,0.2,0.11246,0.071446,0,1
4,GO CELLULAR RESPONSE TO LITHIUM ION,0.32506,0.11215,0.07306,0,1
4,GO REGULATION OF HISTONE H4 ACETYLATION,0.13583,0.10726,0.08764,0,1
4,GO PHOTORECEPTOR CELL DEVELOPMENT,0.10845,0.10645,0.090096,0,1
4,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.19695,0.099623,0.09436,0,1
4,GO MITOTIC DNA REPLICATION,0.23937,0.095759,0.066073,0,1
4,GO REPLICATION FORK PROCESSING,0.060602,0.084098,0.0728,0,1
4,GO CENTRIOLE CENTRIOLE COHESION,0.099158,0.083544,0.10944,0,1
4,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.25001,0.083273,0.093579,0,1
4,GO REGULATION OF PROTEIN ACETYLATION,0.090515,0.078311,0.052351,0,1
4,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.23937,0.071364,0.047048,0,1
4,GO MICROTUBULE NUCLEATION,0.57857,0.065722,0.026709,0,1
4,GO SPINDLE ORGANIZATION,0.12689,0.058772,0.034243,0,1
4,GO REGULATION OF EXIT FROM MITOSIS,0.83713,0.054974,-0.013361,0,1
4,GO DOUBLE STRAND BREAK REPAIR,0.090515,0.047388,0.03815,0,1
4,GO DNA REPLICATION,0.10654,0.046082,0.038267,0,1
4,GO PROTEIN ACYLATION,0.099158,0.042355,0.036402,0,1
4,GO TRIGEMINAL NERVE DEVELOPMENT,0.0023671,0.53409,0.37773,0,0
4,GO CARDIOBLAST PROLIFERATION,0.0085714,0.46234,0.40123,0,0
4,GO NEURON FATE SPECIFICATION,0.001191,0.43467,0.44081,0,0
4,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,0.00020448,0.37703,0.49548,0,0
4,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.027188,0.37014,0.27067,0,0
4,GO NEURON FATE COMMITMENT,6.5149e-05,0.36666,0.40196,0,0
4,GO POSITIVE REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.012203,0.35612,0.40195,0,0
4,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.0047853,0.35171,0.39236,0,0
4,GO GANGLION DEVELOPMENT,0.0083534,0.33641,0.34598,0,0
4,GO NOSE DEVELOPMENT,0.00057693,0.31685,0.50451,0,0
4,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.0054795,0.31556,0.38773,0,0
4,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.018398,0.3022,0.27623,0,0
4,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,0.001872,0.29852,0.34903,0,0
4,GO REGULATION OF NEUROMUSCULAR JUNCTION DEVELOPMENT,0.13583,0.28197,0.18747,0,0
4,GO MYOBLAST MIGRATION,0.066855,0.27438,0.1542,0,0
4,GO ATRIAL SEPTUM MORPHOGENESIS,0.025414,0.26794,0.23826,0,0
4,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.00016023,0.26719,0.36603,0,0
4,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,0.014486,0.25476,0.28146,0,0
4,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.017137,0.25208,0.29862,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.0037331,0.24639,0.33838,0,0
4,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.0073363,0.24513,0.21014,0,0
4,GO SPINAL CORD PATTERNING,0.0010859,0.24401,0.34323,0,0
4,GO MICROTUBULE DEPOLYMERIZATION,0.017969,0.23805,0.17407,0,0
4,GO COMMISSURAL NEURON AXON GUIDANCE,0.031748,0.23318,0.22076,0,0
4,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.0053338,0.23116,0.21554,0,0
4,GO CELL DIFFERENTIATION IN SPINAL CORD,0.00016595,0.23056,0.22481,0,0
4,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.10654,0.22924,0.22254,0,0
4,GO ECTODERMAL PLACODE DEVELOPMENT,0.068167,0.22198,0.19674,0,0
4,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.019283,0.21738,0.19187,0,0
4,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.12689,0.21555,0.18937,0,0
4,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.080955,0.21254,0.12988,0,0
4,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.020205,0.20669,0.16188,0,0
4,GO RETINAL ROD CELL DIFFERENTIATION,0.021165,0.20156,0.23989,0,0
4,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.1028,0.19702,0.11624,0,0
4,GO NEPHRON TUBULE FORMATION,0.25001,0.19595,0.10066,0,0
4,GO DENDRITE SELF AVOIDANCE,0.03939,0.19426,0.15784,0,0
4,GO SYNAPTIC VESICLE CLUSTERING,0.073629,0.19285,0.31119,0,0
4,GO CARDIAC VENTRICLE FORMATION,0.073629,0.19146,0.27904,0,0
4,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.48131,0.18846,0.029446,0,0
4,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.099158,0.18652,0.18107,0,0
4,GO LONG TERM SYNAPTIC DEPRESSION,0.044685,0.18521,0.14906,0,0
4,GO REGULATION OF GROWTH HORMONE SECRETION,0.036164,0.18392,0.24363,0,0
4,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.031748,0.18326,0.1414,0,0
4,GO POSITIVE REGULATION OF BEHAVIOR,0.11235,0.18125,0.12408,0,0
4,GO LATERAL MESODERM DEVELOPMENT,0.33812,0.17847,0.043991,0,0
4,GO CELL FATE SPECIFICATION,0.0067808,0.17662,0.16024,0,0
4,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.10654,0.17631,0.15906,0,0
4,GO HISTONE H3 K9 TRIMETHYLATION,0.0024367,0.17624,0.15486,0,0
4,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.19095,0.17573,0.11614,0,0
4,GO LIMB BUD FORMATION,0.099158,0.17518,0.14931,0,0
4,GO CARDIAC CHAMBER FORMATION,0.14769,0.1749,0.21491,0,0
4,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.4598,0.17357,0.089687,0,0
4,GO MEGAKARYOCYTE DEVELOPMENT,0.05161,0.17078,0.18379,0,0
4,GO ADENOHYPOPHYSIS DEVELOPMENT,0.4978,0.16916,0.084275,0,0
4,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.077957,0.16901,0.12348,0,0
4,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.0064317,0.16873,0.14721,0,0
4,GO TONGUE DEVELOPMENT,0.17934,0.16841,0.084213,0,0
4,GO REGULATION OF STEM CELL DIVISION,0.05161,0.16735,0.13405,0,0
4,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.17653,0.16693,0.13535,0,0
4,GO APICAL PROTEIN LOCALIZATION,0.013139,0.16646,0.15219,0,0
4,GO VENTRAL SPINAL CORD DEVELOPMENT,0.036948,0.16625,0.13687,0,0
4,GO CARDIAC CELL FATE COMMITMENT,0.0054795,0.16616,0.34511,0,0
4,GO FOREBRAIN NEURON DIFFERENTIATION,0.05824,0.16525,0.1934,0,0
4,GO THYROID GLAND DEVELOPMENT,0.83713,0.16435,0.017037,0,0
4,GO MALE SEX DETERMINATION,0.093897,0.16099,0.15709,0,0
4,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.025994,0.15998,0.13809,0,0
4,GO MAINTENANCE OF SYNAPSE STRUCTURE,0.088862,0.15962,0.18483,0,0
4,GO INTRACILIARY TRANSPORT,0.0075304,0.15857,0.18673,0,0
4,GO PYRAMIDAL NEURON DIFFERENTIATION,0.29184,0.1585,0.096214,0,0
4,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,0.012203,0.15604,0.26415,0,0
4,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.036948,0.15485,0.15567,0,0
4,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,0.052669,0.15342,0.20057,0,0
4,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.013798,0.15289,0.16794,0,0
4,GO CELL MIGRATION IN HINDBRAIN,0.14285,0.15287,0.11853,0,0
4,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.10096,0.15044,0.17302,0,0
4,GO GLIAL CELL FATE COMMITMENT,0.077957,0.15009,0.24774,0,0
4,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,0.076492,0.14967,0.16857,0,0
4,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.016339,0.14957,0.17037,0,0
4,GO FORELIMB MORPHOGENESIS,0.03939,0.14932,0.13901,0,0
4,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,0.14526,0.14929,0.25784,0,0
4,GO HISTONE H3 K9 METHYLATION,0.0024367,0.14882,0.14563,0,0
4,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,0.072231,0.14793,0.19324,0,0
4,GO OLFACTORY LOBE DEVELOPMENT,0.065563,0.14694,0.16833,0,0
4,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.0090226,0.14669,0.13634,0,0
4,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.088862,0.14253,0.19887,0,0
4,GO FOREBRAIN MORPHOGENESIS,0.69707,0.14249,0.010194,0,0
4,GO MICROTUBULE SEVERING,0.12259,0.14175,0.10797,0,0
4,GO REGULATION OF TRANSPOSITION,0.4598,0.14137,0.0443,0,0
4,GO MITOTIC SISTER CHROMATID COHESION,0.0031536,0.14086,0.17772,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.040234,0.13882,0.16213,0,0
4,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,0.0067808,0.13846,0.2658,0,0
4,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.19095,0.13793,0.12232,0,0
4,GO SUBPALLIUM DEVELOPMENT,0.17934,0.13736,0.14189,0,0
4,GO NEURAL TUBE PATTERNING,0.099158,0.13694,0.084862,0,0
4,GO CEREBELLAR CORTEX FORMATION,0.030383,0.13685,0.18732,0,0
4,GO EMBRYONIC HEMOPOIESIS,0.14769,0.13588,0.10677,0,0
4,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.26847,0.13534,0.11425,0,0
4,GO DNA LIGATION,0.20937,0.13475,0.084844,0,0
4,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.093897,0.13473,0.14322,0,0
4,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,0.025414,0.13405,0.32779,0,0
4,GO CEREBELLAR CORTEX MORPHOGENESIS,0.021165,0.13371,0.1537,0,0
4,GO GABAERGIC NEURON DIFFERENTIATION,0.20937,0.1326,0.26889,0,0
4,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.29992,0.13213,0.073394,0,0
4,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.031059,0.13198,0.10592,0,0
4,GO TRANSPOSITION,0.36064,0.13139,0.072425,0,0
4,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.19095,0.12989,0.16466,0,0
4,GO DNA DEMETHYLATION,0.057089,0.12979,0.0947,0,0
4,GO RESPONSE TO ACETYLCHOLINE,0.16828,0.12871,0.12648,0,0
4,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.31232,0.1285,0.065061,0,0
4,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.090515,0.12846,0.093376,0,0
4,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.68418,0.12802,0.019964,0,0
4,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.39371,0.12786,0.061443,0,0
4,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,0.095625,0.12779,0.44815,0,0
4,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.085627,0.12768,0.15518,0,0
4,GO RETINA LAYER FORMATION,0.077957,0.12572,0.19124,0,0
4,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.17934,0.12571,0.079799,0,0
4,GO FOREBRAIN GENERATION OF NEURONS,0.077957,0.12496,0.1438,0,0
4,GO NOREPINEPHRINE METABOLIC PROCESS,0.12049,0.12479,0.16758,0,0
4,GO SECONDARY HEART FIELD SPECIFICATION,0.20309,0.12476,0.14348,0,0
4,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,0.049546,0.12466,0.16838,0,0
4,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.049546,0.12401,0.23962,0,0
4,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,0.43883,0.12377,0.052901,0,0
4,GO DNA DEAMINATION,0.50337,0.12293,0.027098,0,0
4,GO DORSAL VENTRAL PATTERN FORMATION,0.0041716,0.1228,0.14944,0,0
4,GO DNA DOUBLE STRAND BREAK PROCESSING,0.1028,0.12278,0.075256,0,0
4,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.52594,0.12256,0.051309,0,0
4,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.86455,0.12217,0.011336,0,0
4,GO REGULATION OF CHROMATIN BINDING,0.068167,0.12206,0.095477,0,0
4,GO SPINAL CORD DEVELOPMENT,0.011904,0.12175,0.12741,0,0
4,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.65866,0.12057,0.031903,0,0
4,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.018398,0.11997,0.1372,0,0
4,GO ESCRT COMPLEX DISASSEMBLY,0.10654,0.11921,0.10321,0,0
4,GO SEGMENT SPECIFICATION,0.23245,0.11849,0.13178,0,0
4,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.082489,0.11832,0.13823,0,0
4,GO KERATINOCYTE DEVELOPMENT,0.28785,0.11798,0.13157,0,0
4,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.040234,0.11785,0.092792,0,0
4,GO RECEPTOR LOCALIZATION TO SYNAPSE,0.03939,0.11744,0.15996,0,0
4,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.066855,0.11706,0.087141,0,0
4,GO NATURAL KILLER CELL PROLIFERATION,0.27611,0.11555,0.083049,0,0
4,GO NEURAL NUCLEUS DEVELOPMENT,0.12689,0.11523,0.13055,0,0
4,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.19393,0.11467,0.13898,0,0
4,GO NEURAL RETINA DEVELOPMENT,0.095625,0.11433,0.10203,0,0
4,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.59664,0.11366,0.061731,0,0
4,GO CEREBELLAR CORTEX DEVELOPMENT,0.05161,0.11365,0.1304,0,0
4,GO TELENCEPHALON REGIONALIZATION,0.22905,0.11288,0.15264,0,0
4,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.11235,0.11156,0.12276,0,0
4,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.62732,0.11061,-0.10611,0,0
4,GO REGULATION OF HELICASE ACTIVITY,0.068167,0.10959,0.14539,0,0
4,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.9686,0.10938,0.0037625,0,0
4,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.038561,0.10932,0.15314,0,0
4,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.27999,0.10913,0.091867,0,0
4,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.36064,0.10784,0.060753,0,0
4,GO SEROTONIN SECRETION,0.11636,0.10708,0.14752,0,0
4,GO HISTONE H3 K4 TRIMETHYLATION,0.065563,0.10704,0.10151,0,0
4,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.02843,0.10679,0.12859,0,0
4,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.79636,0.10674,-0.00324,0,0
4,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,0.080955,0.10665,0.12093,0,0
4,GO HISTONE H3 K9 MODIFICATION,0.0021689,0.10648,0.12692,0,0
4,GO REGULATION OF MICROTUBULE BINDING,0.017969,0.10645,0.16918,0,0
4,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.21905,0.10618,0.20797,0,0
4,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.02268,0.1057,0.12981,0,0
4,GO SPERM AXONEME ASSEMBLY,0.188,0.10554,0.11112,0,0
4,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.085627,0.10543,0.1439,0,0
4,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.188,0.1051,0.067588,0,0
4,GO NEGATIVE REGULATION OF DNA BINDING,0.17653,0.10505,0.066607,0,0
4,GO HISTONE H3 K27 METHYLATION,0.027803,0.10495,0.097208,0,0
4,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.084046,0.1042,0.2582,0,0
4,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.60272,0.10367,0.043409,0,0
4,GO CARDIOBLAST DIFFERENTIATION,0.063042,0.1034,0.14218,0,0
4,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.33812,0.10332,0.050727,0,0
4,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,0.079444,0.10289,0.12791,0,0
4,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.064293,0.10268,0.10799,0,0
4,GO ERROR PRONE TRANSLESION SYNTHESIS,0.013465,0.10143,0.10647,0,0
4,GO RESPONSE TO DOPAMINE,0.39371,0.10126,0.04154,0,0
4,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.96163,0.10067,0.007395,0,0
4,GO SYNAPTIC VESICLE LOCALIZATION,0.026586,0.10062,0.18021,0,0
4,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.60272,0.099696,0.011101,0,0
4,GO CARDIAC ATRIUM MORPHOGENESIS,0.27611,0.097989,0.077195,0,0
4,GO SPERMATID NUCLEUS DIFFERENTIATION,0.055956,0.097048,0.10093,0,0
4,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.21579,0.096543,0.091217,0,0
4,GO TONGUE MORPHOGENESIS,0.46512,0.096008,0.10263,0,0
4,GO SISTER CHROMATID COHESION,0.0081404,0.093519,0.11555,0,0
4,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,0.27227,0.093125,0.11989,0,0
4,GO DNA REPLICATION INITIATION,0.072231,0.092783,0.07593,0,0
4,GO OTIC VESICLE DEVELOPMENT,0.21256,0.092368,0.124,0,0
4,GO INTRACILIARY RETROGRADE TRANSPORT,0.8303,0.091808,0.063336,0,0
4,GO PROTEIN AUTO ADP RIBOSYLATION,0.21256,0.091804,0.13657,0,0
4,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.40349,0.09037,0.14933,0,0
4,GO NON RECOMBINATIONAL REPAIR,0.13583,0.090314,0.046461,0,0
4,GO REGULATION OF STEM CELL PROLIFERATION,0.076492,0.090087,0.057954,0,0
4,GO AXO DENDRITIC PROTEIN TRANSPORT,0.43367,0.089269,0.079784,0,0
4,GO SEQUESTERING OF ACTIN MONOMERS,0.37932,0.088747,0.17037,0,0
4,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.13814,0.088643,0.087354,0,0
4,GO HISTONE UBIQUITINATION,0.011326,0.087846,0.080674,0,0
4,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.17374,0.087337,0.074636,0,0
4,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.28785,0.087151,0.12789,0,0
4,GO SIALYLATION,0.68418,0.086864,0.042026,0,0
4,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,0.48131,0.086756,0.041881,0,0
4,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.21579,0.086345,0.066352,0,0
4,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.30402,0.085858,0.087494,0,0
4,GO COPULATION,0.12049,0.085702,0.10646,0,0
4,GO PROTEIN LOCALIZATION TO CHROMATIN,0.060602,0.085689,0.068579,0,0
4,GO PITUITARY GLAND DEVELOPMENT,0.43367,0.085494,0.073424,0,0
4,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.13583,0.085095,0.074128,0,0
4,GO CENTROSOME SEPARATION,0.027803,0.084959,0.14412,0,0
4,GO VOCALIZATION BEHAVIOR,0.36064,0.084827,0.15489,0,0
4,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.53167,0.084472,0.12169,0,0
4,GO REGULATION OF PROTON TRANSPORT,0.72313,0.08427,0.025749,0,0
4,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.37932,0.084096,0.031285,0,0
4,GO DENSE CORE GRANULE TRANSPORT,0.4978,0.083989,0.1357,0,0
4,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.18508,0.083747,0.074703,0,0
4,GO MEIOTIC CHROMOSOME SEPARATION,0.61497,0.081915,0.014704,0,0
4,GO MITOTIC SPINDLE ASSEMBLY,0.040234,0.081179,0.071153,0,0
4,GO MICROTUBULE ANCHORING AT CENTROSOME,0.046579,0.081118,0.11829,0,0
4,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,0.64605,0.081041,0.066476,0,0
4,GO NON MOTILE CILIUM ASSEMBLY,0.027188,0.080543,0.12468,0,0
4,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.30402,0.080007,0.1254,0,0
4,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.11841,0.080005,0.061568,0,0
4,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.060602,0.079315,0.069025,0,0
4,GO DNA DEALKYLATION,0.16828,0.079103,0.060207,0,0
4,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.15517,0.078494,0.11285,0,0
4,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.52025,0.078315,0.032984,0,0
4,GO REGULATION OF NEUROBLAST PROLIFERATION,0.16559,0.078,0.090665,0,0
4,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.59664,0.077839,0.089451,0,0
4,GO T HELPER CELL LINEAGE COMMITMENT,0.30815,0.076901,0.046862,0,0
4,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.42347,0.076892,0.085697,0,0
4,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.65866,0.076691,0.038258,0,0
4,GO METAPHASE PLATE CONGRESSION,0.063042,0.076649,0.055005,0,0
4,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.0030654,0.076405,0.10209,0,0
4,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.69707,0.076336,0.025128,0,0
4,GO NEURAL PRECURSOR CELL PROLIFERATION,0.059411,0.076257,0.075167,0,0
4,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.027188,0.075977,0.12761,0,0
4,GO ERYTHROCYTE DEVELOPMENT,0.17099,0.07597,0.047993,0,0
4,GO NATURAL KILLER CELL DIFFERENTIATION,0.055956,0.075786,0.10294,0,0
4,GO MAGNESIUM ION HOMEOSTASIS,0.79636,0.075417,-0.034353,0,0
4,GO NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.27611,0.075401,0.1004,0,0
4,GO REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.79636,0.074839,-0.097443,0,0
4,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.34256,0.074835,0.036705,0,0
4,GO DETECTION OF TEMPERATURE STIMULUS,0.59059,0.074644,0.062922,0,0
4,GO SECRETORY GRANULE LOCALIZATION,0.75615,0.074619,0.032012,0,0
4,GO GAMMA DELTA T CELL ACTIVATION,0.19095,0.074426,0.13621,0,0
4,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.059411,0.074252,0.054803,0,0
4,GO POSITIVE T CELL SELECTION,0.23589,0.074163,0.045555,0,0
4,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.093897,0.074141,0.16021,0,0
4,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND,0.57857,0.074084,0.017165,0,0
4,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.44924,0.073995,0.049156,0,0
4,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.7495,0.073782,0.029495,0,0
4,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.018398,0.073482,0.098699,0,0
4,GO RESPIRATORY SYSTEM PROCESS,0.46512,0.07324,0.055374,0,0
4,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.74288,0.073217,-0.10133,0,0
4,GO IMMATURE B CELL DIFFERENTIATION,0.31232,0.072611,0.071288,0,0
4,GO CHROMATIN REMODELING,0.0075304,0.072561,0.081531,0,0
4,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.12049,0.072556,0.083697,0,0
4,GO SUBSTANTIA NIGRA DEVELOPMENT,0.40349,0.072411,0.041863,0,0
4,GO MITOTIC SPINDLE ORGANIZATION,0.13355,0.072265,0.038852,0,0
4,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.041093,0.072175,0.13224,0,0
4,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.097379,0.071962,0.087398,0,0
4,GO MIDDLE EAR MORPHOGENESIS,0.96163,0.071801,-0.031558,0,0
4,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.44924,0.071718,0.036173,0,0
4,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.2839,0.07166,0.067994,0,0
4,GO RETROGRADE AXONAL TRANSPORT,0.10654,0.071422,0.12468,0,0
4,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.15015,0.070741,0.062854,0,0
4,GO RESPONSE TO ETHER,0.093897,0.069289,0.076905,0,0
4,GO REGULATION OF CENTROSOME CYCLE,0.044685,0.069246,0.081692,0,0
4,GO CHROMATIN SILENCING,0.036948,0.068948,0.081581,0,0
4,GO SEX DETERMINATION,0.41341,0.067835,0.064705,0,0
4,GO T CELL SELECTION,0.17099,0.067414,0.053515,0,0
4,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.33373,0.067203,0.093255,0,0
4,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.5726,0.067167,0.028797,0,0
4,GO DNA DEPENDENT DNA REPLICATION,0.15517,0.066839,0.049756,0,0
4,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.2839,0.06638,0.051832,0,0
4,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.52594,0.066258,-0.0077185,0,0
4,GO RETINAL CONE CELL DIFFERENTIATION,0.36991,0.066093,0.060748,0,0
4,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.71006,0.06604,0.026839,0,0
4,GO CELL DIFFERENTIATION IN HINDBRAIN,0.16828,0.06596,0.10705,0,0
4,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.33812,0.065762,0.049502,0,0
4,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.26847,0.065434,0.061154,0,0
4,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.48131,0.065346,0.053928,0,0
4,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.89907,0.065168,-0.022503,0,0
4,GO MRNA EXPORT FROM NUCLEUS,0.20937,0.065146,0.042856,0,0
4,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.91987,0.064908,-0.020193,0,0
4,GO REGULATION OF GLUTAMATE SECRETION,0.077957,0.064673,0.22055,0,0
4,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.17374,0.064642,0.08984,0,0
4,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.36064,0.064366,0.068004,0,0
4,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.014138,0.064359,0.087238,0,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.38408,0.063327,0.035121,0,0
4,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.13583,0.06283,0.056822,0,0
4,GO RESPONSE TO LITHIUM ION,0.28785,0.062811,0.16006,0,0
4,GO SYNAPTIC VESICLE TRANSPORT,0.097379,0.062598,0.12398,0,0
4,GO REGULATION OF CHROMATIN ASSEMBLY,0.40843,0.062475,0.040546,0,0
4,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.17653,0.062394,0.032285,0,0
4,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.13814,0.062352,0.039048,0,0
4,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.36991,0.062306,0.079327,0,0
4,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.24643,0.062201,0.10348,0,0
4,GO CAMP BIOSYNTHETIC PROCESS,0.65234,0.061846,0.043808,0,0
4,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.085627,0.061534,0.089454,0,0
4,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.188,0.061228,0.06268,0,0
4,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.0097392,0.061193,0.088795,0,0
4,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.32077,0.060296,0.039088,0,0
4,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.26098,0.06016,0.036944,0,0
4,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.23937,0.05978,0.058129,0,0
4,GO REGULATION OF RECEPTOR CLUSTERING,0.62113,0.059704,0.069499,0,0
4,GO IMMUNOLOGICAL MEMORY PROCESS,0.29184,0.059666,0.090021,0,0
4,GO MICROTUBULE BUNDLE FORMATION,0.2839,0.059574,0.073819,0,0
4,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.54903,0.059548,0.023415,0,0
4,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.70355,0.059136,0.047478,0,0
4,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.2,0.058896,0.063199,0,0
4,GO NOTCH RECEPTOR PROCESSING,0.43883,0.058592,0.06194,0,0
4,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.42347,0.058206,0.035269,0,0
4,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.96163,0.058182,-0.0082987,0,0
4,GO CELL JUNCTION MAINTENANCE,0.2,0.058126,0.1012,0,0
4,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.89215,0.057855,0.010074,0,0
4,GO DORSAL SPINAL CORD DEVELOPMENT,0.28785,0.057786,0.14264,0,0
4,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.17934,0.057144,0.045453,0,0
4,GO REGULATION OF MICROTUBULE BASED PROCESS,0.19095,0.057092,0.036503,0,0
4,GO POSITIVE REGULATION OF MRNA PROCESSING,0.20937,0.056908,0.049147,0,0
4,GO RESPONSE TO UV B,0.89907,0.056899,0.019844,0,0
4,GO REGULATION OF CIRCADIAN RHYTHM,0.047551,0.056651,0.054576,0,0
4,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.44402,0.056536,0.014057,0,0
4,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.36991,0.055348,0.1195,0,0
4,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.58456,0.055247,0.013484,0,0
4,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.80989,0.054703,-0.054421,0,0
4,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.15264,0.054666,0.16761,0,0
4,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.061812,0.054556,0.081158,0,0
4,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.59059,0.054214,0.016172,0,0
4,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.015203,0.054112,0.067822,0,0
4,GO LUNG CELL DIFFERENTIATION,0.66501,0.053863,0.10945,0,0
4,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.28785,0.053778,0.05325,0,0
4,GO CELL FATE DETERMINATION,0.65866,0.053667,0.028507,0,0
4,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.76948,0.053525,-0.022669,0,0
4,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,0.19095,0.053219,0.10248,0,0
4,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.39858,0.05241,0.077324,0,0
4,GO NOREPINEPHRINE SECRETION,0.42347,0.052232,0.058149,0,0
4,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.14526,0.051951,0.082953,0,0
4,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.43883,0.051918,0.048763,0,0
4,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.12473,0.051825,0.03615,0,0
4,GO SULFATION,0.93377,0.051798,-0.014089,0,0
4,GO EPITHELIAL STRUCTURE MAINTENANCE,0.4978,0.051535,-0.045192,0,0
4,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.94769,0.051505,0.013948,0,0
4,GO CHROMATIN DISASSEMBLY,0.64605,0.051484,0.025592,0,0
4,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.72313,0.051473,0.023197,0,0
4,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,0.73628,0.051019,0.028947,0,0
4,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.71006,0.050807,0.018659,0,0
4,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.19095,0.05064,0.06959,0,0
4,GO NEGATIVE REGULATION OF LYASE ACTIVITY,0.76948,0.05059,0.022987,0,0
4,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,0.30402,0.050323,0.060691,0,0
4,GO ATRIAL SEPTUM DEVELOPMENT,0.36064,0.050201,0.091164,0,0
4,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.44924,0.050011,0.042706,0,0
4,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.38408,0.049823,0.043996,0,0
4,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.39371,0.049538,0.032955,0,0
4,GO COLLECTING DUCT DEVELOPMENT,0.29586,0.049527,0.06212,0,0
4,GO CHROMATIN SILENCING AT TELOMERE,0.39371,0.049236,0.03659,0,0
4,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,0.5726,0.049218,0.068159,0,0
4,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.10096,0.048465,0.082505,0,0
4,GO SKELETAL MUSCLE CELL PROLIFERATION,0.86455,0.04809,-0.038893,0,0
4,GO REGULATION OF HISTONE METHYLATION,0.066855,0.047941,0.073708,0,0
4,GO DIENCEPHALON DEVELOPMENT,0.47049,0.047926,0.055622,0,0
4,GO EPITHELIAL CELL MATURATION,0.51459,0.047501,0.06365,0,0
4,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.54903,0.047459,0.069091,0,0
4,GO PHOTORECEPTOR CELL MAINTENANCE,0.21905,0.047448,0.051022,0,0
4,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.055956,0.047414,0.059535,0,0
4,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.38408,0.047362,0.10349,0,0
4,GO HISTONE METHYLATION,0.088862,0.047251,0.05576,0,0
4,GO ASTRAL MICROTUBULE ORGANIZATION,0.035393,0.046897,0.13601,0,0
4,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.93377,0.046844,-0.017975,0,0
4,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.29184,0.046766,0.067676,0,0
4,GO CILIUM ORGANIZATION,0.05824,0.046748,0.07815,0,0
4,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.83713,0.046527,0.024264,0,0
4,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.14526,0.046497,0.043404,0,0
4,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.57857,0.046443,0.043439,0,0
4,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.96163,0.046433,-0.0059334,0,0
4,GO SPINDLE ASSEMBLY,0.18219,0.046098,0.032271,0,0
4,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.11841,0.04586,0.068606,0,0
4,GO PALLIUM DEVELOPMENT,0.64605,0.045839,0.022511,0,0
4,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.50896,0.04563,0.026356,0,0
4,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.67776,0.045458,0.026063,0,0
4,GO REGULATION OF CILIUM BEAT FREQUENCY,0.4978,0.045242,0.039735,0,0
4,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.39858,0.045195,0.014809,0,0
4,GO SMOOTHENED SIGNALING PATHWAY,0.35607,0.045121,0.030195,0,0
4,GO INHIBITORY POSTSYNAPTIC POTENTIAL,0.47049,0.045092,0.086136,0,0
4,GO MICROTUBULE BASED PROCESS,0.20621,0.044096,0.032471,0,0
4,GO MITOTIC METAPHASE PLATE CONGRESSION,0.084046,0.04403,0.069538,0,0
4,GO CELL PROLIFERATION IN FOREBRAIN,0.74288,0.043303,-0.0072902,0,0
4,GO RETINAL GANGLION CELL AXON GUIDANCE,0.32506,0.043247,0.1581,0,0
4,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.60272,0.043128,0.033354,0,0
4,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.033166,0.043105,0.13395,0,0
4,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.05824,0.043042,0.062956,0,0
4,GO DEMETHYLATION,0.059411,0.042949,0.054714,0,0
4,GO ERYTHROCYTE MATURATION,0.87144,0.042496,0.0047497,0,0
4,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.73628,0.042272,0.020162,0,0
4,GO ACTIN FILAMENT BASED TRANSPORT,0.43883,0.041975,0.064797,0,0
4,GO CEREBRAL CORTEX DEVELOPMENT,0.49227,0.041823,0.033057,0,0
4,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.56666,0.041745,0.030017,0,0
4,GO REGULATION OF SPINDLE ASSEMBLY,0.60883,0.041741,0.015718,0,0
4,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,0.53167,0.041509,0.035538,0,0
4,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.59664,0.041173,0.0034543,0,0
4,GO ER OVERLOAD RESPONSE,0.87144,0.040911,-0.00654,0,0
4,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.51459,0.040862,0.030417,0,0
4,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.97557,0.040858,-0.024352,0,0
4,GO FAT CELL PROLIFERATION,0.33812,0.040638,0.086514,0,0
4,GO DNA REPAIR,0.14048,0.040397,0.025343,0,0
4,GO PROTEIN METHYLATION,0.097379,0.040234,0.045445,0,0
4,GO MATERNAL PLACENTA DEVELOPMENT,0.90599,0.040184,-0.0063939,0,0
4,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.36526,0.039932,0.032513,0,0
4,GO REGULATION OF SPINDLE ORGANIZATION,0.57857,0.039891,0.011604,0,0
4,GO AXONAL TRANSPORT,0.21579,0.039824,0.070832,0,0
4,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.26471,0.03982,0.061976,0,0
4,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.51459,0.039358,0.035068,0,0
4,GO CGMP METABOLIC PROCESS,0.64605,0.039323,0.038434,0,0
4,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.4545,0.03926,0.077634,0,0
4,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.78289,0.03888,-0.043565,0,0
4,GO 3 UTR MEDIATED MRNA STABILIZATION,0.79636,0.038712,-0.017144,0,0
4,GO STEM CELL PROLIFERATION,0.22235,0.038483,0.039255,0,0
4,GO POSITIVE REGULATION OF DNA REPLICATION,0.49227,0.03844,0.026327,0,0
4,GO METENCEPHALON DEVELOPMENT,0.27227,0.038354,0.070031,0,0
4,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.18508,0.037828,0.033449,0,0
4,GO ANTEROGRADE AXONAL TRANSPORT,0.25729,0.037819,0.054017,0,0
4,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.34256,0.037515,0.028995,0,0
4,GO CELLULAR SODIUM ION HOMEOSTASIS,0.89215,0.037379,-0.0045063,0,0
4,GO UTERUS DEVELOPMENT,0.69707,0.037289,0.031636,0,0
4,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.67137,0.037127,-0.075806,0,0
4,GO AXO DENDRITIC TRANSPORT,0.34702,0.037031,0.057305,0,0
4,GO DNA GEOMETRIC CHANGE,0.36064,0.037031,0.027374,0,0
4,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.24643,0.036987,0.044797,0,0
4,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.36526,0.036957,0.046431,0,0
4,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.15015,0.036612,0.034591,0,0
4,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.78289,0.036589,0.027722,0,0
4,GO HISTONE H3 K36 METHYLATION,0.34702,0.036455,0.055732,0,0
4,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.30815,0.03616,0.07269,0,0
4,GO NEUROEPITHELIAL CELL DIFFERENTIATION,0.67776,0.036095,0.078036,0,0
4,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.28785,0.035651,0.032191,0,0
4,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.94769,0.03563,-0.01065,0,0
4,GO REGULATION OF FLAGELLATED SPERM MOTILITY,0.95466,0.03545,-0.01038,0,0
4,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.50337,0.034988,0.063164,0,0
4,GO POSITIVE REGULATION OF BONE RESORPTION,0.65234,0.034953,-0.042491,0,0
4,GO RENAL WATER HOMEOSTASIS,0.38888,0.034951,0.053059,0,0
4,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.40349,0.034784,0.025497,0,0
4,GO CLATHRIN COAT ASSEMBLY,0.79636,0.03476,0.018975,0,0
4,GO DETERMINATION OF ADULT LIFESPAN,0.94769,0.034511,-0.018865,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.36064,0.033942,0.043141,0,0
4,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.5726,0.033897,-0.08086,0,0
4,GO HISTONE H3 ACETYLATION,0.62113,0.033821,0.0099563,0,0
4,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.80989,0.033071,0.0074329,0,0
4,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.54903,0.03303,0.016728,0,0
4,GO MEGAKARYOCYTE DIFFERENTIATION,0.19095,0.032522,0.041166,0,0
4,GO REGULATION OF RECEPTOR INTERNALIZATION,0.89215,0.032428,-0.026782,0,0
4,GO PENILE ERECTION,0.24643,0.03236,0.13777,0,0
4,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.99651,0.032328,-0.0040422,0,0
4,GO DIGESTIVE TRACT MORPHOGENESIS,0.87144,0.032301,-0.011173,0,0
4,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.75615,0.032166,-0.057894,0,0
4,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.71658,0.032097,0.030761,0,0
4,GO LYMPHANGIOGENESIS,0.67776,0.0318,-0.072113,0,0
4,GO CAMERA TYPE EYE MORPHOGENESIS,0.36526,0.031762,0.030119,0,0
4,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.12908,0.031622,0.059775,0,0
4,GO CARDIAC ATRIUM DEVELOPMENT,0.69707,0.03157,0.033593,0,0
4,GO MAINTENANCE OF BLOOD BRAIN BARRIER,0.80312,0.031424,0.024337,0,0
4,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.78289,0.031342,-0.0032902,0,0
4,GO REGULATION OF BILE ACID METABOLIC PROCESS,0.76948,0.030788,0.032983,0,0
4,GO CHROMOSOME ORGANIZATION,0.079444,0.030765,0.029328,0,0
4,GO REGULATION OF CELL FATE COMMITMENT,0.52025,0.03049,0.033381,0,0
4,GO REGULATION OF SPINDLE CHECKPOINT,0.42347,0.030368,0.045359,0,0
4,GO P BODY ASSEMBLY,0.2,0.03026,0.047318,0,0
4,GO CELLULAR COMPONENT MAINTENANCE,0.54903,0.030218,0.038588,0,0
4,GO NEGATIVE REGULATION OF GLIOGENESIS,0.41842,0.030148,0.04954,0,0
4,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.47049,0.030137,0.021602,0,0
4,GO REGULATION OF MESODERM DEVELOPMENT,0.91293,0.030057,0.0022912,0,0
4,GO TRANSPORT ALONG MICROTUBULE,0.088862,0.029955,0.06024,0,0
4,GO REGULATION OF CENTROSOME DUPLICATION,0.34256,0.02995,0.045648,0,0
4,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.50337,0.029932,0.028984,0,0
4,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.78289,0.029831,-0.047276,0,0
4,GO NEURAL CREST FORMATION,0.32938,0.029727,0.079986,0,0
4,GO OOGENESIS,0.5726,0.029657,0.021822,0,0
4,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.32506,0.02957,0.032418,0,0
4,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.33812,0.029568,0.069719,0,0
4,GO POSITIVE REGULATION OF CILIUM MOVEMENT,0.53742,0.029566,0.038461,0,0
4,GO POSITIVE REGULATION OF RNA SPLICING,0.53167,0.029516,0.020925,0,0
4,GO MICROTUBULE BASED MOVEMENT,0.31653,0.029399,0.033764,0,0
4,GO SPINDLE LOCALIZATION,0.60883,0.029315,0.018585,0,0
4,GO MEIOTIC SPINDLE ORGANIZATION,0.53742,0.029189,0.023399,0,0
4,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.35153,0.029155,0.053926,0,0
4,GO MITRAL VALVE DEVELOPMENT,0.98255,0.029128,-0.043344,0,0
4,GO RESPONSE TO NERVE GROWTH FACTOR,0.16828,0.02907,0.072351,0,0
4,GO OLIGODENDROCYTE DIFFERENTIATION,0.90599,0.029046,0.010602,0,0
4,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.42855,0.028956,0.024899,0,0
4,GO POSITIVE REGULATION OF AXONOGENESIS,0.51459,0.028943,0.036928,0,0
4,GO MICROTUBULE POLYMERIZATION,0.70355,0.028934,0.01309,0,0
4,GO REGULATION OF AXONOGENESIS,0.88523,0.028882,0.0015944,0,0
4,GO PROTEIN K11 LINKED UBIQUITINATION,0.80989,0.028831,-0.0012246,0,0
4,GO MYELOID CELL DEVELOPMENT,0.40843,0.028823,0.030089,0,0
4,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.65234,0.028615,-0.021912,0,0
4,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.88523,0.028395,-0.00049682,0,0
4,GO DORSAL AORTA DEVELOPMENT,0.91987,0.028346,-0.0092445,0,0
4,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.91987,0.028278,-0.019928,0,0
4,GO DENDRITE MORPHOGENESIS,0.48678,0.028164,0.057615,0,0
4,GO REGULATION OF CHROMOSOME SEGREGATION,0.29586,0.028154,0.043196,0,0
4,GO CELLULAR RESPONSE TO VITAMIN D,0.59059,0.028064,-0.083499,0,0
4,GO RNA SPLICING,0.16294,0.027982,0.041161,0,0
4,GO VIRAL RNA GENOME REPLICATION,0.80312,0.027894,-0.034594,0,0
4,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,0.44924,0.027729,0.043639,0,0
4,GO PROTEIN DEPOLYMERIZATION,0.5726,0.027729,0.022404,0,0
4,GO PANCREAS DEVELOPMENT,0.8303,0.027726,0.0095828,0,0
4,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.79636,0.027465,0.0084299,0,0
4,GO TELENCEPHALON DEVELOPMENT,0.65234,0.027434,0.013885,0,0
4,GO OXIDATIVE DEMETHYLATION,0.54321,0.027334,0.028767,0,0
4,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.98953,0.027305,-0.010862,0,0
4,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.56075,0.027173,0.0189,0,0
4,GO CELL FATE COMMITMENT,0.44924,0.027172,0.017146,0,0
4,GO PHAGOSOME ACIDIFICATION,0.85082,0.02716,-0.034508,0,0
4,GO PROTEIN LOCALIZATION TO CELL JUNCTION,0.4598,0.026817,0.049523,0,0
4,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.22568,0.0266,0.047329,0,0
4,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.70355,0.026445,0.023553,0,0
4,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.82348,0.026081,-0.043173,0,0
4,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.75615,0.026034,-0.081305,0,0
4,GO GROWTH HORMONE SECRETION,0.42347,0.02591,0.091227,0,0
4,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.65234,0.025848,0.024468,0,0
4,GO BRAIN MORPHOGENESIS,0.57857,0.025813,0.019838,0,0
4,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,0.53167,0.025772,0.20704,0,0
4,GO PROTEIN LOCALIZATION TO CILIUM,0.40349,0.025628,0.060084,0,0
4,GO PROTEIN LOCALIZATION TO SYNAPSE,0.48678,0.025528,0.06056,0,0
4,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.87833,0.025511,-0.040788,0,0
4,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.72313,0.025443,0.011864,0,0
4,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.43883,0.025437,0.073984,0,0
4,GO COVALENT CHROMATIN MODIFICATION,0.11235,0.0254,0.034088,0,0
4,GO SECRETORY GRANULE ORGANIZATION,0.71006,0.025367,0.013931,0,0
4,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.046579,0.025185,0.057448,0,0
4,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.70355,0.025158,0.015101,0,0
4,GO MICROTUBULE BASED TRANSPORT,0.26471,0.025017,0.038767,0,0
4,GO DNA CATABOLIC PROCESS,0.52025,0.024831,0.021294,0,0
4,GO MITOCHONDRION LOCALIZATION,0.89215,0.024322,0.012759,0,0
4,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.95466,0.024164,-0.012105,0,0
4,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.82348,0.024065,-0.062694,0,0
4,GO T CELL LINEAGE COMMITMENT,0.66501,0.023941,0.025203,0,0
4,GO REPRODUCTIVE BEHAVIOR,0.79636,0.023641,-0.025058,0,0
4,GO FOREBRAIN DEVELOPMENT,0.36991,0.023591,0.035374,0,0
4,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.72313,0.023409,-0.062844,0,0
4,GO CELL PROJECTION ASSEMBLY,0.62732,0.023332,-0.012527,0,0
4,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.65866,0.02328,0.029957,0,0
4,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.70355,0.023202,0.013754,0,0
4,GO SNRNA TRANSCRIPTION,0.72313,0.023199,0.0031637,0,0
4,GO CHROMOSOME CONDENSATION,0.092194,0.023056,0.072776,0,0
4,GO MEIOTIC CHROMOSOME SEGREGATION,0.57857,0.023011,0.01116,0,0
4,GO PROTEIN INSERTION INTO MEMBRANE,0.32506,0.02281,0.03804,0,0
4,GO MRNA TRANSPORT,0.97557,0.022601,-0.0042985,0,0
4,GO REGULATION OF PROTEIN SUMOYLATION,0.9686,0.02255,0.0095447,0,0
4,GO CYTOKINESIS,0.94769,0.022359,-0.011451,0,0
4,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.5726,0.02233,0.011939,0,0
4,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.81668,0.0221,0.0016017,0,0
4,GO DNA METHYLATION OR DEMETHYLATION,0.42855,0.021946,0.021343,0,0
4,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.56666,0.02172,-0.063919,0,0
4,GO RESPONSE TO CATECHOLAMINE,0.62732,0.021578,-0.029521,0,0
4,GO AMINE BIOSYNTHETIC PROCESS,0.91987,0.021508,0.011103,0,0
4,GO DENDRITE DEVELOPMENT,0.78962,0.021492,0.022133,0,0
4,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.3746,0.021403,-0.084611,0,0
4,GO APPENDAGE MORPHOGENESIS,0.51459,0.02121,0.011076,0,0
4,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.52594,0.020995,0.025802,0,0
4,GO DNA RECOMBINATION,0.15773,0.020915,0.029746,0,0
4,GO REGULATION OF CYTOKINESIS,0.57857,0.020645,0.0060382,0,0
4,GO EXIT FROM MITOSIS,0.97557,0.020559,-0.0042917,0,0
4,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.44402,0.020489,-0.080656,0,0
4,GO MITOTIC NUCLEAR DIVISION,0.27999,0.020453,0.031004,0,0
4,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.69707,0.020328,0.0079602,0,0
4,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.67137,0.020271,0.01139,0,0
4,GO ECTODERM DEVELOPMENT,0.4545,0.020182,0.01425,0,0
4,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.8303,0.020157,0.026825,0,0
4,GO CELLULAR RESPONSE TO X RAY,0.86455,0.019887,-0.059571,0,0
4,GO MITOCHONDRIAL GENOME MAINTENANCE,0.47588,0.019838,0.037046,0,0
4,GO APOPTOTIC DNA FRAGMENTATION,0.78289,0.019646,0.009016,0,0
4,GO MRNA PROCESSING,0.22905,0.01958,0.03165,0,0
4,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.80312,0.01958,-0.035541,0,0
4,GO NEURON PROJECTION REGENERATION,0.4598,0.019567,-0.048111,0,0
4,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.71658,0.019499,0.016751,0,0
4,GO MULTICELLULAR ORGANISM AGING,0.94769,0.01945,-0.0047472,0,0
4,GO AXONEME ASSEMBLY,0.42347,0.019376,0.081158,0,0
4,GO EMBRYONIC AXIS SPECIFICATION,0.69707,0.019068,-0.033406,0,0
4,GO VENTRICULAR SYSTEM DEVELOPMENT,0.59664,0.019018,0.025758,0,0
4,GO PROTEIN K48 LINKED UBIQUITINATION,0.62732,0.018964,0.0057167,0,0
4,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.92682,0.018671,-0.020135,0,0
4,GO REGULATION OF NEURON PROJECTION REGENERATION,0.92682,0.018542,-0.0081026,0,0
4,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.54903,0.018383,0.088541,0,0
4,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.7495,0.01833,-0.056106,0,0
4,GO HINDBRAIN DEVELOPMENT,0.51459,0.018137,0.042506,0,0
4,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.92682,0.018071,-0.024888,0,0
4,GO ADRENAL GLAND DEVELOPMENT,0.85082,0.018036,-0.040265,0,0
4,GO MITOCHONDRIAL FUSION,0.66501,0.017904,-0.01891,0,0
4,GO SOMITE DEVELOPMENT,0.80312,0.017763,-0.013903,0,0
4,GO REGULATION OF TORC1 SIGNALING,0.82348,0.017717,-0.012628,0,0
4,GO REGULATION OF FIBROBLAST MIGRATION,0.96163,0.017676,-0.027417,0,0
4,GO GRANULOCYTE DIFFERENTIATION,0.33812,0.017587,-0.08674,0,0
4,GO TELOMERE CAPPING,0.44924,0.017522,0.024579,0,0
4,GO REGULATION OF NEURON MIGRATION,0.67137,0.017133,0.022965,0,0
4,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.91987,0.017059,0.029697,0,0
4,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,1,0.01695,0.00087319,0,0
4,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.72969,0.016843,0.0061665,0,0
4,GO NEGATIVE REGULATION OF DNA REPAIR,0.80989,0.016663,-0.029754,0,0
4,GO GERM CELL DEVELOPMENT,0.39371,0.016596,0.024186,0,0
4,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.79636,0.016445,-0.0098545,0,0
4,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.69707,0.016434,0.039144,0,0
4,GO REGULATION OF SYNAPTIC VESICLE CYCLE,0.69061,0.016395,0.093721,0,0
4,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.44924,0.016379,0.037453,0,0
4,GO CARTILAGE MORPHOGENESIS,0.57857,0.016352,0.050785,0,0
4,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.85768,0.016343,-0.0089182,0,0
4,GO REGULATION OF DNA RECOMBINATION,0.48131,0.016271,0.010191,0,0
4,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.50896,0.016256,0.021553,0,0
4,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.47588,0.016216,0.062399,0,0
4,GO MRNA METHYLATION,0.85082,0.016013,-0.014685,0,0
4,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.72969,0.015741,-0.0017233,0,0
4,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.87144,0.015469,0.016724,0,0
4,GO REGULATION OF CHROMOSOME SEPARATION,0.74288,0.015097,0.014513,0,0
4,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.53742,0.015077,0.018524,0,0
4,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.99651,0.015053,-0.021051,0,0
4,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.85082,0.014988,0.0031487,0,0
4,GO RUFFLE ASSEMBLY,0.74288,0.014956,-0.024888,0,0
4,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.72969,0.014526,-0.048459,0,0
4,GO TRANSCYTOSIS,0.98953,0.014329,-0.017912,0,0
4,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.85082,0.014295,-0.053809,0,0
4,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.68418,0.014291,0.0094249,0,0
4,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.9686,0.013903,0.0035376,0,0
4,GO REGULATION OF EXTENT OF CELL GROWTH,0.92682,0.013833,-0.017269,0,0
4,GO NEURON MIGRATION,0.43367,0.013753,0.080655,0,0
4,GO SPERMATID DIFFERENTIATION,0.65866,0.013746,0.025618,0,0
4,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.60883,0.013667,0.0046918,0,0
4,GO GAMETE GENERATION,0.96163,0.013617,-0.005191,0,0
4,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.98953,0.013528,0.003849,0,0
4,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.8303,0.013527,-0.0034294,0,0
4,GO RESPONSE TO UV,0.79636,0.013462,0.0010085,0,0
4,GO CELL DIVISION,0.54903,0.013214,0.011205,0,0
4,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.50337,0.013177,0.0083973,0,0
4,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.53742,0.013166,0.10264,0,0
4,GO ERROR FREE TRANSLESION SYNTHESIS,0.67776,0.013126,0.0071916,0,0
4,GO REGULATION OF HISTONE PHOSPHORYLATION,0.4598,0.01294,-0.073106,0,0
4,GO AROMATIC AMINO ACID TRANSPORT,0.77618,0.012473,-0.079928,0,0
4,GO HISTONE DEUBIQUITINATION,0.98255,0.012057,-0.011793,0,0
4,GO REGULATION OF DNA METABOLIC PROCESS,0.7495,0.011911,0.0018104,0,0
4,GO CYTIDINE TO URIDINE EDITING,0.54903,0.011816,-0.13045,0,0
4,GO CELLULAR RESPONSE TO VITAMIN,0.68418,0.011808,-0.086406,0,0
4,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.86455,0.011724,-0.044756,0,0
4,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.79636,0.011432,0.040034,0,0
4,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.4978,0.011358,0.037218,0,0
4,GO DETECTION OF ABIOTIC STIMULUS,0.94769,0.011151,0.0039751,0,0
4,GO DNA METABOLIC PROCESS,0.89215,0.011018,-0.0020169,0,0
4,GO HISTONE H3 K9 DEMETHYLATION,0.68418,0.010992,0.037697,0,0
4,GO NEURON CELL CELL ADHESION,0.33373,0.010863,0.18351,0,0
4,GO HINDBRAIN MORPHOGENESIS,0.19095,0.01069,0.058191,0,0
4,GO MEMBRANE DOCKING,0.9686,0.010537,-0.0010493,0,0
4,GO CRANIAL NERVE DEVELOPMENT,0.51459,0.010503,-0.057141,0,0
4,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.90599,0.010475,0.0082338,0,0
4,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.42347,0.010474,0.017232,0,0
4,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.98953,0.01043,-0.014936,0,0
4,GO REGULATION OF DENDRITE MORPHOGENESIS,0.90599,0.010087,0.016107,0,0
4,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.59059,0.010073,-0.011308,0,0
4,GO EMBRYONIC BODY MORPHOGENESIS,0.80312,0.01005,-0.022315,0,0
4,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.71006,0.010025,-0.030352,0,0
4,GO NUCLEAR BODY ORGANIZATION,0.50337,0.0099016,0.037525,0,0
4,GO CEREBRAL CORTEX CELL MIGRATION,1,0.0097536,-0.002699,0,0
4,GO REGULATORY T CELL DIFFERENTIATION,1,0.0097463,-0.032972,0,0
4,GO REGULATION OF MITOTIC CELL CYCLE,0.68418,0.0095393,-0.018926,0,0
4,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.42855,0.0095074,-0.041989,0,0
4,GO BONE CELL DEVELOPMENT,0.85082,0.009479,-0.00060631,0,0
4,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.80989,0.0093312,0.020697,0,0
4,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.84397,0.009331,-0.012248,0,0
4,GO REGULATION OF CELL FATE SPECIFICATION,0.90599,0.0092142,0.010498,0,0
4,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.59664,0.0091192,0.020539,0,0
4,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.92682,0.0090325,-0.019954,0,0
4,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,1,0.0087371,0.0039562,0,0
4,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.39371,0.0087137,-0.14909,0,0
4,GO MICROTUBULE ANCHORING,0.59664,0.0086105,0.018716,0,0
4,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.78289,0.0081275,0.041296,0,0
4,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.78962,0.0079747,-0.01781,0,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.71006,0.0079009,-0.030844,0,0
4,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.69061,0.0078345,-0.027555,0,0
4,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.34702,0.0073777,0.072898,0,0
4,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.82348,0.007194,-0.012434,0,0
4,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.84397,0.0071605,-0.018348,0,0
4,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.84397,0.0070768,0.065812,0,0
4,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.78289,0.006948,-0.049197,0,0
4,GO ORGANELLE LOCALIZATION,0.73628,0.0069022,-0.0081935,0,0
4,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.8303,0.0067211,-0.033837,0,0
4,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.87833,0.0067067,-7.3308e-05,0,0
4,GO NEGATIVE REGULATION OF CELL DIVISION,1,0.0065372,-0.0092216,0,0
4,GO RESPONSE TO NITROSATIVE STRESS,0.5726,0.0065015,-0.12102,0,0
4,GO REGULATION OF NEURON DIFFERENTIATION,0.64605,0.0064745,-0.015055,0,0
4,GO HIPPOCAMPUS DEVELOPMENT,0.73628,0.0064656,0.016516,0,0
4,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.78289,0.0063509,0.0070944,0,0
4,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.87833,0.0063437,-0.004103,0,0
4,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.63354,0.0061985,-0.038383,0,0
4,GO VESICLE CYTOSKELETAL TRAFFICKING,0.27999,0.0061658,0.04632,0,0
4,GO NEUROTROPHIN SIGNALING PATHWAY,0.89215,0.00607,-0.010917,0,0
4,GO MRNA 3 END PROCESSING,0.41341,0.0060647,0.025982,0,0
4,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.87833,0.0059327,-0.0098673,0,0
4,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.99651,0.0059208,-0.037702,0,0
4,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.86455,0.0059142,-0.051799,0,0
4,GO CELLULAR RESPONSE TO UV,0.97557,0.0058525,-0.0050484,0,0
4,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.95466,0.0055803,-0.018909,0,0
4,GO EYE MORPHOGENESIS,0.75615,0.0054502,0.0039868,0,0
4,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.53167,0.0054382,0.033847,0,0
4,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.85768,0.0053719,0.013336,0,0
4,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.62732,0.0050901,0.018376,0,0
4,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.8303,0.00498,0.0065332,0,0
4,GO RNA EXPORT FROM NUCLEUS,0.85768,0.004941,0.0021447,0,0
4,GO PROTEIN SUMOYLATION,0.70355,0.0047598,0.011778,0,0
4,GO HYPOTHALAMUS DEVELOPMENT,0.60883,0.0047549,-0.048571,0,0
4,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,0.37932,0.0043286,0.078489,0,0
4,GO REGULATION OF CILIUM MOVEMENT,0.92682,0.0042263,0.010729,0,0
4,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.88523,0.00414,0.0010156,0,0
4,GO REGULATION OF DNA REPLICATION,0.89215,0.0041086,-0.00032094,0,0
4,GO UV DAMAGE EXCISION REPAIR,0.88523,0.0040999,0.006363,0,0
4,GO RRNA 3 END PROCESSING,0.31653,0.0040998,-0.068649,0,0
4,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.95466,0.0040119,0.022038,0,0
4,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.9686,0.0038861,-0.0090863,0,0
4,GO POSITIVE REGULATION OF GLIOGENESIS,0.93377,0.0038707,0.0074134,0,0
4,GO POST EMBRYONIC DEVELOPMENT,1,0.0037792,0.0098211,0,0
4,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.48131,0.0037309,0.020266,0,0
4,GO SPERM MOTILITY,0.80989,0.0037028,0.010466,0,0
4,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.93377,0.0036014,-0.010244,0,0
4,GO SYNAPTIC MEMBRANE ADHESION,0.99651,0.0035647,-0.0073605,0,0
4,GO MITOTIC RECOMBINATION,0.56075,0.0035116,0.037409,0,0
4,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.87144,0.00344,-0.0066625,0,0
4,GO G2 DNA DAMAGE CHECKPOINT,0.52594,0.0033472,0.036875,0,0
4,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.65234,0.0032315,-0.031316,0,0
4,GO REGULATION OF ORGANIC ACID TRANSPORT,0.62113,0.0032236,-0.049673,0,0
4,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.91293,0.0030704,0.0085922,0,0
4,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.38408,0.003059,0.023817,0,0
4,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.90599,0.0025874,0.0076224,0,0
4,GO ROOF OF MOUTH DEVELOPMENT,0.77618,0.0025864,0.0083229,0,0
4,GO PROXIMAL DISTAL PATTERN FORMATION,0.77618,0.0024344,0.026931,0,0
4,GO NEUROBLAST PROLIFERATION,0.52025,0.002288,0.038223,0,0
4,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.80312,0.0020487,-0.0059764,0,0
4,GO MESODERMAL CELL FATE SPECIFICATION,0.95466,0.0020064,0.012995,0,0
4,GO REGULATION OF GLUCOSE IMPORT,0.56666,0.0018641,-0.026554,0,0
4,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.69061,0.0018214,-1.6067e-05,0,0
4,GO CELLULAR RESPONSE TO RADIATION,0.39371,0.001505,-0.036282,0,0
4,GO POSITIVE REGULATION OF VASOCONSTRICTION,0.56075,0.0013001,-0.071669,0,0
4,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.7495,0.0011804,-0.015714,0,0
4,GO SYNAPTIC VESICLE MATURATION,0.95466,0.0010208,0.042802,0,0
4,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.89215,0.0010114,-0.034088,0,0
4,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.74288,0.0010035,0.00014867,0,0
4,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.66501,0.00080925,-0.054525,0,0
4,GO CELL CYCLE G2 M PHASE TRANSITION,0.50896,0.00055945,0.015185,0,0
4,GO POSITIVE REGULATION OF CELL CYCLE,0.26471,0.00052982,-0.023993,0,0
4,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.50337,0.00045416,0.018252,0,0
4,GO REGULATION OF CELL DIVISION,0.94073,0.00040656,-0.0089177,0,0
4,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.85768,0.0003753,0.0093473,0,0
4,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.8303,0.00015033,0.02363,0,0
4,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.91293,9.8223e-05,0.00547,0,0
4,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.83713,-0.00010702,-0.0065078,0,0
4,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.59664,-0.000205,-0.021507,0,0
4,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.74288,-0.00036798,0.015348,0,0
4,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.53167,-0.00046375,-0.030595,0,0
4,GO MALE GAMETE GENERATION,0.70355,-0.00050404,-0.014092,0,0
4,GO REGULATION OF T HELPER CELL DIFFERENTIATION,0.55487,-0.0005193,-0.098586,0,0
4,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.31653,-0.00062496,-0.095536,0,0
4,GO CELL CELL JUNCTION MAINTENANCE,0.65866,-0.00084819,0.060103,0,0
4,GO DENDRITIC SPINE MAINTENANCE,0.43367,-0.0010464,-0.063176,0,0
4,GO REGULATION OF CELL MATURATION,0.63978,-0.0013623,-0.024222,0,0
4,GO REGULATION OF MRNA POLYADENYLATION,0.70355,-0.0013866,-0.024957,0,0
4,GO LEFT RIGHT AXIS SPECIFICATION,0.7495,-0.00151,-0.053126,0,0
4,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,0.40349,-0.0016558,0.069243,0,0
4,GO NUCLEOTIDE EXCISION REPAIR,0.76948,-0.0016958,-0.010678,0,0
4,GO ENDOCRINE SYSTEM DEVELOPMENT,0.79636,-0.0016996,0.013818,0,0
4,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.60272,-0.0019108,0.045833,0,0
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.4978,-0.0019213,0.029122,0,0
4,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.41842,-0.0021179,0.04533,0,0
4,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,0.71658,-0.0024814,0.090041,0,0
4,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.69707,-0.0025188,-0.02199,0,0
4,GO NEURON PROJECTION GUIDANCE,0.90599,-0.0025662,0.003905,0,0
4,GO POSITIVE REGULATION OF AXON EXTENSION,0.68418,-0.0025841,-0.025564,0,0
4,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.80989,-0.0026328,-0.014159,0,0
4,GO REGULATION OF CHROMOSOME ORGANIZATION,0.69061,-0.0027835,0.010502,0,0
4,GO MITOTIC CELL CYCLE,0.82348,-0.0028162,-0.014535,0,0
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.71006,-0.0028213,-0.026703,0,0
4,GO INNER CELL MASS CELL PROLIFERATION,0.85082,-0.002853,-0.018336,0,0
4,GO RESPONSE TO ELECTRICAL STIMULUS,0.9686,-0.0028549,-0.0045854,0,0
4,GO INTRACELLULAR MRNA LOCALIZATION,0.78962,-0.0029797,-0.027611,0,0
4,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.80989,-0.0030302,-0.0047083,0,0
4,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,0.91987,-0.0031439,0.015804,0,0
4,GO HISTONE H3 K14 ACETYLATION,0.87833,-0.0031469,0.012689,0,0
4,GO CHROMOSOME SEPARATION,0.70355,-0.0031588,0.018226,0,0
4,GO METANEPHRIC COLLECTING DUCT DEVELOPMENT,0.56075,-0.0032213,0.039897,0,0
4,GO REGULATION OF SENSORY PERCEPTION,0.36526,-0.0033416,-0.071516,0,0
4,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.64605,-0.0033467,0.12483,0,0
4,GO GENE SILENCING,0.47049,-0.0035073,-0.020602,0,0
4,GO REGULATION OF SYNAPTIC PLASTICITY,0.8303,-0.0037874,-0.0029854,0,0
4,GO REGULATION OF CELL CYCLE PROCESS,0.77618,-0.0039861,-0.011145,0,0
4,GO REGULATION OF CELL CYCLE,0.37932,-0.004061,-0.024894,0,0
4,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.46512,-0.0041137,0.063067,0,0
4,GO SKELETAL MUSCLE ADAPTATION,0.46512,-0.0043664,-0.057381,0,0
4,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.5726,-0.0044925,-0.06054,0,0
4,GO MALE SEX DIFFERENTIATION,0.12689,-0.0045385,-0.077995,0,0
4,GO DENDRITIC SPINE MORPHOGENESIS,0.89215,-0.0046797,-0.013929,0,0
4,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.72969,-0.0047439,-0.010725,0,0
4,GO POSTREPLICATION REPAIR,0.91293,-0.0047454,-0.0033254,0,0
4,GO LACTATE METABOLIC PROCESS,0.98255,-0.0049646,0.015309,0,0
4,GO NCRNA TRANSCRIPTION,0.51459,-0.0050332,-0.021102,0,0
4,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.65866,-0.0051623,-0.054777,0,0
4,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.85082,-0.0052616,-0.026194,0,0
4,GO ENDOCARDIUM DEVELOPMENT,0.43367,-0.0054394,0.10352,0,0
4,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.51459,-0.0054591,-0.040034,0,0
4,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.56666,-0.0055769,-0.032685,0,0
4,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.36526,-0.0056215,-0.043552,0,0
4,GO SEXUAL REPRODUCTION,0.38888,-0.005766,-0.026313,0,0
4,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.91293,-0.0059332,-0.029348,0,0
4,GO PHOTOTRANSDUCTION,0.71006,-0.0060551,-0.031802,0,0
4,GO PROGESTERONE METABOLIC PROCESS,0.60883,-0.0062676,-0.1607,0,0
4,GO BASE EXCISION REPAIR,0.85768,-0.006307,-0.01081,0,0
4,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.55487,-0.0063246,-0.018008,0,0
4,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.7495,-0.0063535,0.019118,0,0
4,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.78962,-0.0064124,-0.010513,0,0
4,GO REGULATION OF TRANS SYNAPTIC SIGNALING,0.9686,-0.0064214,0.033046,0,0
4,GO MEIOSIS I CELL CYCLE PROCESS,0.75615,-0.006435,-0.015772,0,0
4,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.88523,-0.006481,-0.00021012,0,0
4,GO CELL CYCLE PHASE TRANSITION,0.8303,-0.0066149,-0.014293,0,0
4,GO AXON EXTENSION,0.76281,-0.0066289,-0.025185,0,0
4,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.97557,-0.006706,-0.012954,0,0
4,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.69707,-0.0068222,-0.033957,0,0
4,GO HEAD DEVELOPMENT,0.89907,-0.0068585,0.0015471,0,0
4,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.91987,-0.0068813,0.00053226,0,0
4,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.44924,-0.0069424,0.042954,0,0
4,GO MAINTENANCE OF CELL NUMBER,0.55487,-0.0070085,-0.043346,0,0
4,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.22905,-0.0070122,-0.057158,0,0
4,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,0.80989,-0.0071062,-0.0082216,0,0
4,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,0.96163,-0.0072036,0.03667,0,0
4,GO RNA CAPPING,0.48131,-0.0072324,-0.032652,0,0
4,GO REGULATION OF CHROMATIN ORGANIZATION,0.80989,-0.0076054,0.0049277,0,0
4,GO SOMATIC STEM CELL DIVISION,0.31653,-0.0076638,0.16578,0,0
4,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.91293,-0.0077453,-0.0079756,0,0
4,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.43883,-0.0079065,-0.058253,0,0
4,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.50896,-0.0079377,-0.033373,0,0
4,GO CELL CYCLE,0.4598,-0.0079831,-0.018649,0,0
4,GO ENDOCRINE PANCREAS DEVELOPMENT,0.52594,-0.0083506,-0.037385,0,0
4,GO LYMPHOCYTE COSTIMULATION,0.43367,-0.0084207,-0.048076,0,0
4,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.92682,-0.0085422,-0.010198,0,0
4,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.44924,-0.008576,-0.067687,0,0
4,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.21905,-0.0087399,-0.11084,0,0
4,GO DETECTION OF LIGHT STIMULUS,0.79636,-0.0088382,-0.026966,0,0
4,GO DETECTION OF MECHANICAL STIMULUS,0.89907,-0.0088652,0.021054,0,0
4,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.89907,-0.0088724,-0.01169,0,0
4,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.56075,-0.00894,-0.043285,0,0
4,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.91293,-0.0089548,0.019092,0,0
4,GO ACTIN CROSSLINK FORMATION,0.80312,-0.0090008,-0.034218,0,0
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.79636,-0.0090566,0.0096868,0,0
4,GO DENDRITIC SPINE DEVELOPMENT,0.51459,-0.0091383,-0.048045,0,0
4,GO PROTEIN MANNOSYLATION,0.64605,-0.0091695,-0.024864,0,0
4,GO SPLEEN DEVELOPMENT,0.91987,-0.0091888,-0.0047495,0,0
4,GO DNA MODIFICATION,0.76281,-0.0092481,-0.0081365,0,0
4,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.94073,-0.0092746,0.0084755,0,0
4,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.52025,-0.0093491,-0.03563,0,0
4,GO MEIOTIC CELL CYCLE,1,-0.0093658,-0.0050866,0,0
4,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.32077,-0.0093817,-0.031041,0,0
4,GO HISTONE H4 DEACETYLATION,0.62113,-0.0094035,-0.037766,0,0
4,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.48131,-0.0094165,-0.029685,0,0
4,GO REGULATION OF HISTONE MODIFICATION,0.87144,-0.0094308,0.001347,0,0
4,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.95466,-0.0095142,-0.02705,0,0
4,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.90599,-0.01006,0.0098452,0,0
4,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.93377,-0.010072,-0.0068215,0,0
4,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.93377,-0.010279,-0.010017,0,0
4,GO ORGANELLE FISSION,0.91987,-0.010533,-0.0028891,0,0
4,GO AXON DEVELOPMENT,0.72313,-0.010602,-0.0073996,0,0
4,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.74288,-0.010732,0.009576,0,0
4,GO POSITIVE REGULATION OF CELL DIVISION,0.99651,-0.010746,-0.017565,0,0
4,GO MISMATCH REPAIR,0.66501,-0.010919,-0.021497,0,0
4,GO RNA DECAPPING,0.39371,-0.01093,-0.057477,0,0
4,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.98255,-0.010936,0.0053763,0,0
4,GO REGULATION OF AMINO ACID TRANSPORT,0.89215,-0.011052,0.015315,0,0
4,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.84397,-0.011117,-0.029823,0,0
4,GO MEIOTIC CELL CYCLE PROCESS,0.5726,-0.011126,-0.0186,0,0
4,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.31653,-0.011249,-0.065312,0,0
4,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.96163,-0.011266,-0.013115,0,0
4,GO DETECTION OF VISIBLE LIGHT,0.62113,-0.011298,0.00051088,0,0
4,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.99651,-0.011375,-0.02136,0,0
4,GO TRACHEA MORPHOGENESIS,0.84397,-0.011517,-0.018143,0,0
4,GO TELENCEPHALON GLIAL CELL MIGRATION,0.62113,-0.011605,-0.057439,0,0
4,GO POLYAMINE BIOSYNTHETIC PROCESS,0.92682,-0.011644,-0.017444,0,0
4,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.41341,-0.011694,-0.037049,0,0
4,GO REGULATION OF CELL CYCLE ARREST,0.75615,-0.011862,-0.0076443,0,0
4,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.90599,-0.011891,-0.0031275,0,0
4,GO REGULATION OF APPETITE,0.97557,-0.011937,-0.013188,0,0
4,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.30815,-0.011997,-0.089056,0,0
4,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.76281,-0.012101,-0.094859,0,0
4,GO RESPONSE TO POTASSIUM ION,0.60883,-0.012139,0.074885,0,0
4,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.79636,-0.012276,-0.0015471,0,0
4,GO CELL PART MORPHOGENESIS,0.93377,-0.012319,0.0019201,0,0
4,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.95466,-0.012359,0.00012736,0,0
4,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.19393,-0.012701,-0.11798,0,0
4,GO MYOTUBE CELL DEVELOPMENT,0.97557,-0.012723,-0.0052676,0,0
4,GO REGULATION OF TELOMERE CAPPING,0.87144,-0.012736,-0.011818,0,0
4,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.57857,-0.012804,-0.032834,0,0
4,GO SNORNA 3 END PROCESSING,0.73628,-0.012858,0.040102,0,0
4,GO MITOTIC CYTOKINESIS,0.78289,-0.012934,-0.018606,0,0
4,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.85082,-0.013138,0.0052515,0,0
4,GO REGULATION OF TELOMERE MAINTENANCE,0.53742,-0.013176,-0.031788,0,0
4,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.84397,-0.01334,0.013934,0,0
4,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.73628,-0.01352,-0.04007,0,0
4,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.60883,-0.013539,-0.023511,0,0
4,GO REGULATION OF DENDRITE DEVELOPMENT,0.77618,-0.013761,-0.0085756,0,0
4,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.75615,-0.01381,-0.02685,0,0
4,GO REGULATION OF DNA BINDING,0.76281,-0.014065,0.0087079,0,0
4,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.87833,-0.014067,0.0067462,0,0
4,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.91293,-0.014102,0.0099831,0,0
4,GO OOCYTE MATURATION,0.54321,-0.014106,-0.022699,0,0
4,GO LIPID DROPLET FORMATION,0.4598,-0.014298,-0.10563,0,0
4,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,0.66501,-0.014409,-0.079697,0,0
4,GO BLASTOCYST GROWTH,0.67776,-0.014461,-0.038508,0,0
4,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.97557,-0.014497,-0.029413,0,0
4,GO C4 DICARBOXYLATE TRANSPORT,0.38888,-0.01452,-0.054159,0,0
4,GO NEGATIVE REGULATION OF AXON EXTENSION,0.60272,-0.014576,-0.043655,0,0
4,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.74288,-0.014577,-0.02334,0,0
4,GO STRIATUM DEVELOPMENT,0.50896,-0.014649,-0.063595,0,0
4,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.82348,-0.014655,-0.0095323,0,0
4,GO SPERM CAPACITATION,0.78289,-0.014678,0.0078103,0,0
4,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.19393,-0.014867,-0.030298,0,0
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.76948,-0.014922,-0.020505,0,0
4,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.57857,-0.014926,-0.04331,0,0
4,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.46512,-0.014932,-0.021921,0,0
4,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.40349,-0.014983,-0.027053,0,0
4,GO POSITIVE REGULATION OF CYTOKINESIS,0.58456,-0.015324,-0.015094,0,0
4,GO REGULATION OF MRNA METABOLIC PROCESS,0.19095,-0.015345,-0.044581,0,0
4,GO FOREBRAIN CELL MIGRATION,0.60272,-0.015409,-0.020443,0,0
4,GO AMMONIUM TRANSPORT,0.85082,-0.01548,0.0020312,0,0
4,GO MITOTIC CYTOKINETIC PROCESS,0.8303,-0.015542,-0.0074376,0,0
4,GO REGULATION OF CELL DEVELOPMENT,0.34256,-0.015578,-0.033666,0,0
4,GO HISTONE MRNA METABOLIC PROCESS,0.64605,-0.015739,-0.02656,0,0
4,GO ALDEHYDE CATABOLIC PROCESS,0.81668,-0.015747,-0.03573,0,0
4,GO SODIUM ION HOMEOSTASIS,0.96163,-0.016101,0.0083545,0,0
4,GO NUCLEUS LOCALIZATION,0.63978,-0.016617,-0.026514,0,0
4,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.56075,-0.016842,-0.046715,0,0
4,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.85082,-0.016883,-0.045031,0,0
4,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.67776,-0.01689,-0.02045,0,0
4,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.98255,-0.016913,0.0068462,0,0
4,GO CELL CYCLE PROCESS,0.44402,-0.01697,-0.023181,0,0
4,GO REGULATION OF BEHAVIOR,0.74288,-0.017139,-0.028859,0,0
4,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.99651,-0.017219,-0.011965,0,0
4,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.74288,-0.017612,-0.013916,0,0
4,GO REGULATION OF GOLGI ORGANIZATION,0.62113,-0.017653,-0.016246,0,0
4,GO MALE MEIOSIS I,0.27999,-0.017709,-0.11137,0,0
4,GO REGULATION OF ACTIN NUCLEATION,0.29992,-0.017732,-0.073416,0,0
4,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.8303,-0.017773,-0.056373,0,0
4,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.69707,-0.017777,-0.047272,0,0
4,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.43367,-0.017779,-0.064472,0,0
4,GO POSITIVE REGULATION OF TISSUE REMODELING,0.66501,-0.017912,-0.036221,0,0
4,GO WATER TRANSPORT,0.72969,-0.018018,0.0012447,0,0
4,GO CELL CYCLE G1 S PHASE TRANSITION,0.22568,-0.018231,-0.039423,0,0
4,GO CYTOPLASM ORGANIZATION,0.89907,-0.018234,-0.014601,0,0
4,GO SPINDLE MIDZONE ASSEMBLY,0.67776,-0.018285,-0.030497,0,0
4,GO THYMIC T CELL SELECTION,0.71006,-0.018365,-0.020074,0,0
4,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.83713,-0.018434,0.0077249,0,0
4,GO SENSORY ORGAN MORPHOGENESIS,0.56075,-0.018456,-0.028987,0,0
4,GO COLLATERAL SPROUTING,0.32938,-0.018473,-0.05802,0,0
4,GO CIRCADIAN RHYTHM,0.36064,-0.01848,-0.032617,0,0
4,GO NEUROGENESIS,0.48678,-0.018515,-0.017475,0,0
4,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.23589,-0.018517,-0.091378,0,0
4,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.62732,-0.01859,-0.019441,0,0
4,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.81668,-0.018689,0.036523,0,0
4,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.25729,-0.018888,-0.051381,0,0
4,GO POSITIVE REGULATION OF CELL GROWTH,0.35607,-0.01907,-0.036605,0,0
4,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,0.82348,-0.019083,0.005376,0,0
4,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.7495,-0.019244,-0.013877,0,0
4,GO RNA LOCALIZATION,0.23937,-0.019256,-0.050929,0,0
4,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,0.85768,-0.019258,0.018381,0,0
4,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.59059,-0.019336,-0.093004,0,0
4,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.38408,-0.019343,-0.036133,0,0
4,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.83713,-0.019362,0.013346,0,0
4,GO CELL PROJECTION ORGANIZATION,0.36991,-0.01943,-0.025626,0,0
4,GO STEROL BIOSYNTHETIC PROCESS,0.23589,-0.019487,-0.084751,0,0
4,GO LEFT RIGHT PATTERN FORMATION,0.65866,-0.019493,-0.028565,0,0
4,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.7495,-0.019821,-0.015147,0,0
4,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.73628,-0.020007,-0.048001,0,0
4,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.59664,-0.020033,-0.030687,0,0
4,GO POSITIVE REGULATION OF DNA BINDING,0.66501,-0.020037,-0.017304,0,0
4,GO POSITIVE REGULATION OF HORMONE SECRETION,0.4545,-0.020084,-0.028803,0,0
4,GO LUNG EPITHELIUM DEVELOPMENT,0.99651,-0.020107,0.023251,0,0
4,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.91293,-0.020139,-0.01182,0,0
4,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,0.65866,-0.020172,-0.068126,0,0
4,GO PH REDUCTION,0.98255,-0.020183,-0.012041,0,0
4,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,1,-0.02019,-0.0014853,0,0
4,GO NEGATIVE REGULATION OF BEHAVIOR,0.54321,-0.020414,-0.042135,0,0
4,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.44402,-0.020442,-0.048473,0,0
4,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.29184,-0.020467,-0.047284,0,0
4,GO DECIDUALIZATION,0.94769,-0.020552,-0.020694,0,0
4,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.031059,-0.020577,-0.04899,0,0
4,GO REGULATION OF ODONTOGENESIS,0.44402,-0.020684,-0.089323,0,0
4,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.40843,-0.020723,-0.096503,0,0
4,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.19695,-0.020765,-0.13205,0,0
4,GO RESPONSE TO LIGHT STIMULUS,0.36064,-0.020806,-0.026754,0,0
4,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.14285,-0.020819,-0.034268,0,0
4,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.87144,-0.021021,-0.063521,0,0
4,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.27999,-0.021051,-0.12256,0,0
4,GO REGULATION OF SKELETAL MUSCLE CONTRACTION,0.24643,-0.021122,-0.13159,0,0
4,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.21579,-0.021176,-0.081541,0,0
4,GO NEURON DIFFERENTIATION,0.72969,-0.021237,-0.0037606,0,0
4,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.42855,-0.021367,-0.061197,0,0
4,GO VASCULAR WOUND HEALING,0.17934,-0.021446,-0.12414,0,0
4,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.29992,-0.021475,-0.036493,0,0
4,GO REGULATION OF COLLATERAL SPROUTING,0.81668,-0.021509,-0.021091,0,0
4,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.48678,-0.021531,-0.018055,0,0
4,GO REGULATION OF LIGASE ACTIVITY,0.44924,-0.021545,-0.066469,0,0
4,GO NUCLEAR EXPORT,0.28785,-0.021613,-0.040152,0,0
4,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.66501,-0.021727,-0.054994,0,0
4,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.60272,-0.021783,-0.061081,0,0
4,GO MULTIVESICULAR BODY ORGANIZATION,0.63978,-0.02183,-0.017679,0,0
4,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.69061,-0.022058,-0.011647,0,0
4,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.65866,-0.02219,-0.029594,0,0
4,GO NEGATIVE REGULATION OF CELL CYCLE,0.085627,-0.022315,-0.042666,0,0
4,GO QUINONE METABOLIC PROCESS,0.39858,-0.022333,-0.1221,0,0
4,GO MEMBRANE FISSION,0.48131,-0.022511,0.066865,0,0
4,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.99651,-0.022548,-0.0078347,0,0
4,GO CARDIAC MUSCLE FIBER DEVELOPMENT,0.51459,-0.022592,-0.074479,0,0
4,GO NEURON PROJECTION ORGANIZATION,0.63978,-0.022615,-0.039885,0,0
4,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.91987,-0.022696,0.059521,0,0
4,GO DNA METHYLATION,0.76281,-0.02282,-0.0042515,0,0
4,GO PATTERN SPECIFICATION PROCESS,0.7495,-0.022824,-0.01981,0,0
4,GO CALCINEURIN MEDIATED SIGNALING,0.41842,-0.022829,-0.046978,0,0
4,GO NEURON APOPTOTIC PROCESS,0.8303,-0.022866,-0.0026933,0,0
4,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.92682,-0.022988,-0.0022601,0,0
4,GO HIPPO SIGNALING,0.49227,-0.023011,-0.10363,0,0
4,GO N GLYCAN PROCESSING,0.63354,-0.023022,-0.039495,0,0
4,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.89907,-0.023044,-0.0036262,0,0
4,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,0.59664,-0.023113,-0.019108,0,0
4,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.80312,-0.023129,-0.017053,0,0
4,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.65234,-0.023214,-0.018566,0,0
4,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.60272,-0.023311,-0.019278,0,0
4,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.60272,-0.023381,0.033672,0,0
4,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.93377,-0.023398,0.0074388,0,0
4,GO MESODERMAL CELL FATE COMMITMENT,0.56075,-0.02354,-0.039153,0,0
4,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.89907,-0.023629,0.010668,0,0
4,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.36526,-0.023699,-0.053277,0,0
4,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.68418,-0.023844,-0.086395,0,0
4,GO MULTICELLULAR ORGANISM REPRODUCTION,0.24288,-0.023847,-0.02911,0,0
4,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.88523,-0.023949,-0.056837,0,0
4,GO REGULATION OF MYELINATION,0.62113,-0.023982,-0.023218,0,0
4,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.79636,-0.02405,-0.040776,0,0
4,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.31653,-0.024066,-0.028819,0,0
4,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.36991,-0.024144,-0.032492,0,0
4,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.15264,-0.024184,-0.031661,0,0
4,GO CELL CELL ADHESION MEDIATED BY CADHERIN,0.91293,-0.024238,0.013713,0,0
4,GO AXONAL TRANSPORT OF MITOCHONDRION,0.79636,-0.024252,-0.039489,0,0
4,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.40349,-0.024264,-0.063612,0,0
4,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.50337,-0.024436,-0.042067,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.7495,-0.024702,-0.012061,0,0
4,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.4978,-0.024917,-0.02867,0,0
4,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.44924,-0.024991,-0.046199,0,0
4,GO CHONDROCYTE DEVELOPMENT,0.76948,-0.025057,-0.050179,0,0
4,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.31653,-0.025109,-0.0070839,0,0
4,GO STRESS GRANULE ASSEMBLY,0.23589,-0.025223,-0.068587,0,0
4,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.56075,-0.025295,-0.039793,0,0
4,GO REGULATION OF NUCLEAR DIVISION,0.57857,-0.025338,-0.017431,0,0
4,GO INNATE IMMUNE RESPONSE IN MUCOSA,0.72313,-0.025489,-0.075279,0,0
4,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.42347,-0.025652,-0.066326,0,0
4,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.78289,-0.025779,-0.014993,0,0
4,GO NUCLEAR MIGRATION,0.92682,-0.026036,-0.019418,0,0
4,GO AXIS SPECIFICATION,0.16294,-0.026095,-0.075911,0,0
4,GO ORGANELLE ASSEMBLY,0.14048,-0.026101,-0.033989,0,0
4,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.52025,-0.026307,-0.046116,0,0
4,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.52025,-0.026445,-0.028762,0,0
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.48678,-0.026534,-0.019287,0,0
4,GO RESPONSE TO COCAINE,0.76948,-0.026617,0.0013761,0,0
4,GO POSITIVE REGULATION OF NEURON MIGRATION,0.38408,-0.026778,-0.099219,0,0
4,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.56666,-0.026781,-0.068267,0,0
4,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.33812,-0.026819,-0.053967,0,0
4,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.095625,-0.026882,-0.1358,0,0
4,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.27227,-0.027109,-0.063504,0,0
4,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.39371,-0.027112,-0.046502,0,0
4,GO FEMALE GAMETE GENERATION,0.30815,-0.027115,-0.034936,0,0
4,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.44924,-0.02712,-0.045849,0,0
4,GO PRO B CELL DIFFERENTIATION,0.9686,-0.027166,-0.0085232,0,0
4,GO NEURAL TUBE DEVELOPMENT,0.38888,-0.027235,-0.053033,0,0
4,GO REGULATION OF ANIMAL ORGAN FORMATION,0.69707,-0.027237,-0.056017,0,0
4,GO NEURON DEVELOPMENT,0.54903,-0.027276,-0.019192,0,0
4,GO APPENDAGE DEVELOPMENT,0.49227,-0.027356,-0.041663,0,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.38888,-0.027358,-0.054728,0,0
4,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.49227,-0.027372,0.064455,0,0
4,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.5726,-0.027447,-0.027618,0,0
4,GO ASTROCYTE ACTIVATION,0.66501,-0.027489,-0.039217,0,0
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.39371,-0.027493,-0.074763,0,0
4,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.87144,-0.027669,-0.024125,0,0
4,GO FOREBRAIN NEURON DEVELOPMENT,0.97557,-0.027736,0.030951,0,0
4,GO VESICLE LOCALIZATION,0.070855,-0.027779,-0.051459,0,0
4,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.36064,-0.027879,-0.031479,0,0
4,GO NEGATIVE T CELL SELECTION,0.23245,-0.027922,-0.0985,0,0
4,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.34702,-0.027926,-0.07526,0,0
4,GO LONG TERM SYNAPTIC POTENTIATION,0.5726,-0.027976,-0.042952,0,0
4,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.71658,-0.027995,-0.049066,0,0
4,GO PROTEIN NEDDYLATION,0.42855,-0.028266,-0.050479,0,0
4,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.22568,-0.028399,-0.19456,0,0
4,GO CELLULAR RESPONSE TO NUTRIENT,0.26471,-0.028429,-0.10313,0,0
4,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.20937,-0.028456,-0.064174,0,0
4,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.23589,-0.028489,-0.026924,0,0
4,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.88523,-0.028494,0.041893,0,0
4,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.53167,-0.028508,-0.027009,0,0
4,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.42855,-0.028521,-0.030692,0,0
4,GO NUCLEUS ORGANIZATION,0.34702,-0.028732,-0.032862,0,0
4,GO MAST CELL MIGRATION,0.8303,-0.02876,0.045762,0,0
4,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.49227,-0.028957,-0.054759,0,0
4,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.32506,-0.029002,-0.077951,0,0
4,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.87833,-0.029005,-0.0099823,0,0
4,GO SPECIFICATION OF SYMMETRY,0.42347,-0.02912,-0.01722,0,0
4,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.27999,-0.029211,-0.14526,0,0
4,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.71658,-0.029283,-0.046991,0,0
4,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.81668,-0.029358,-0.01128,0,0
4,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.31653,-0.029379,-0.037216,0,0
4,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.31232,-0.029423,-0.067146,0,0
4,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.50896,-0.029431,-0.094458,0,0
4,GO POSTSYNAPSE ASSEMBLY,0.97557,-0.029456,0.0092965,0,0
4,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.53742,-0.029749,-0.032721,0,0
4,GO SYNAPTIC VESICLE PRIMING,0.83713,-0.029843,0.05556,0,0
4,GO METHYLATION,0.085627,-0.029856,-0.037496,0,0
4,GO POSITIVE THYMIC T CELL SELECTION,0.71658,-0.029857,-0.017146,0,0
4,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.62113,-0.029859,-0.055907,0,0
4,GO CELLULAR COMPONENT MORPHOGENESIS,0.54321,-0.029951,-0.013299,0,0
4,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.20309,-0.030082,-0.048337,0,0
4,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.2,-0.030177,-0.082373,0,0
4,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.19393,-0.030272,-0.076582,0,0
4,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.71658,-0.030275,-0.011005,0,0
4,GO NEURON RECOGNITION,0.67776,-0.030365,0.038208,0,0
4,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.85768,-0.030371,-0.022753,0,0
4,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.11434,-0.030428,-0.060959,0,0
4,GO T CELL HOMEOSTASIS,0.69061,-0.030473,-0.01597,0,0
4,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.56075,-0.030497,-0.022409,0,0
4,GO NATURAL KILLER CELL ACTIVATION,0.54321,-0.030521,-0.050492,0,0
4,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.33812,-0.030564,-0.047511,0,0
4,GO REGULATION OF GLIOGENESIS,0.65234,-0.030609,0.011837,0,0
4,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.27611,-0.030636,-0.067965,0,0
4,GO ACTIVATION OF MAPKK ACTIVITY,0.39371,-0.030671,-0.063832,0,0
4,GO EAR DEVELOPMENT,0.21256,-0.030677,-0.062282,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.10096,-0.030774,-0.041513,0,0
4,GO NEURON PROJECTION EXTENSION,0.56666,-0.030893,-0.028751,0,0
4,GO CALCIUM ION IMPORT INTO CYTOSOL,0.67137,-0.031011,-0.027566,0,0
4,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.40349,-0.031262,-0.073149,0,0
4,GO EMBRYONIC EYE MORPHOGENESIS,0.87833,-0.031291,0.011394,0,0
4,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.20937,-0.031303,-0.092739,0,0
4,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.32938,-0.031428,-0.038823,0,0
4,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.71658,-0.031509,-0.0012528,0,0
4,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.35153,-0.031608,-0.030648,0,0
4,GO RECEPTOR CLUSTERING,0.71006,-0.031769,-0.026766,0,0
4,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.14285,-0.031769,-0.054239,0,0
4,GO MIDBODY ABSCISSION,0.79636,-0.03195,0.016097,0,0
4,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.65866,-0.03207,-0.040947,0,0
4,GO FOREGUT MORPHOGENESIS,0.48131,-0.032265,-0.076886,0,0
4,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.46512,-0.032413,-0.046554,0,0
4,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.15264,-0.03264,-0.10105,0,0
4,GO SNORNA METABOLIC PROCESS,0.80989,-0.032691,-0.010869,0,0
4,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.47588,-0.032811,-0.046056,0,0
4,GO HEPATOCYTE APOPTOTIC PROCESS,0.86455,-0.032849,0.10586,0,0
4,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.29586,-0.032874,-0.08634,0,0
4,GO COBALAMIN METABOLIC PROCESS,0.23937,-0.033012,-0.098996,0,0
4,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.18219,-0.033034,-0.046249,0,0
4,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.36526,-0.03316,-0.097328,0,0
4,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.76948,-0.033161,0.083646,0,0
4,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.42855,-0.033214,-0.11074,0,0
4,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.4598,-0.033256,-0.030137,0,0
4,GO LIMBIC SYSTEM DEVELOPMENT,0.62732,-0.033318,-0.022215,0,0
4,GO ESTABLISHMENT OF RNA LOCALIZATION,0.22905,-0.033436,-0.048885,0,0
4,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.53167,-0.033447,-0.030183,0,0
4,GO MRNA CLEAVAGE,0.28785,-0.033464,-0.037761,0,0
4,GO TRANSLESION SYNTHESIS,0.53742,-0.033478,-0.024556,0,0
4,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.4598,-0.033522,-0.054747,0,0
4,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.21905,-0.033587,-0.059252,0,0
4,GO RESPONSE TO RADIATION,0.066855,-0.033593,-0.043216,0,0
4,GO BRANCHING MORPHOGENESIS OF A NERVE,0.61497,-0.033651,-0.05697,0,0
4,GO POTASSIUM ION HOMEOSTASIS,0.69707,-0.033702,-0.02055,0,0
4,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.32077,-0.033822,-0.05298,0,0
4,GO SENSORY ORGAN DEVELOPMENT,0.25001,-0.033824,-0.041722,0,0
4,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.79636,-0.033831,0.001921,0,0
4,GO REGULATION OF OOGENESIS,0.90599,-0.033887,0.018626,0,0
4,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.46512,-0.033962,-0.089201,0,0
4,GO CIRCADIAN SLEEP WAKE CYCLE,0.66501,-0.034029,-0.03171,0,0
4,GO SLEEP,0.29586,-0.034113,-0.064867,0,0
4,GO REGULATION OF PINOCYTOSIS,0.080955,-0.034153,-0.16674,0,0
4,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.82348,-0.034285,-0.017898,0,0
4,GO SYNAPTIC SIGNALING,0.62732,-0.034301,-0.0022303,0,0
4,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.41842,-0.034599,-0.079851,0,0
4,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.097379,-0.034665,-0.049157,0,0
4,GO MULTICELLULAR ORGANISM GROWTH,0.17653,-0.034748,-0.044065,0,0
4,GO REGULATION OF INTEGRIN ACTIVATION,0.44924,-0.034768,-0.082721,0,0
4,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.66501,-0.034852,-0.028357,0,0
4,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.68418,-0.034881,-0.017924,0,0
4,GO COGNITION,0.68418,-0.034938,-0.017034,0,0
4,GO CELL MATURATION,0.33373,-0.034974,-0.036045,0,0
4,GO POSITIVE REGULATION OF MITOPHAGY,0.65866,-0.035022,-0.028846,0,0
4,GO NUCLEAR PORE ORGANIZATION,0.80312,-0.035132,-0.03189,0,0
4,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.29992,-0.035224,-0.074091,0,0
4,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.54321,-0.035325,-0.0097818,0,0
4,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.30402,-0.035502,-0.057071,0,0
4,GO CYTOSKELETON ORGANIZATION,0.055956,-0.035532,-0.058142,0,0
4,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.62732,-0.035651,-0.040368,0,0
4,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.9686,-0.03589,-0.0021617,0,0
4,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.60272,-0.036057,-0.053308,0,0
4,GO RNA POLYADENYLATION,0.097379,-0.036394,-0.074928,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.60883,-0.036479,-0.043886,0,0
4,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.36991,-0.03665,-0.036076,0,0
4,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.15517,-0.036782,-0.048697,0,0
4,GO MIDGUT DEVELOPMENT,0.35607,-0.036834,-0.10329,0,0
4,GO MEMBRANE HYPERPOLARIZATION,0.43367,-0.037198,-0.070754,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.34256,-0.037214,-0.069008,0,0
4,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.22905,-0.037255,-0.085928,0,0
4,GO TORC1 SIGNALING,0.37932,-0.037373,-0.049502,0,0
4,GO HAIR CELL DIFFERENTIATION,0.35607,-0.037424,-0.070532,0,0
4,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.188,-0.037425,-0.047905,0,0
4,GO PROTEIN K63 LINKED UBIQUITINATION,0.065563,-0.037439,-0.065048,0,0
4,GO DISTAL TUBULE DEVELOPMENT,0.7495,-0.037566,-0.06766,0,0
4,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,0.084046,-0.037622,-0.062857,0,0
4,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,0.54903,-0.037695,0.071376,0,0
4,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.67776,-0.03796,-0.035415,0,0
4,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.14769,-0.038056,-0.054115,0,0
4,GO INHIBITORY SYNAPSE ASSEMBLY,0.85082,-0.038481,0.01534,0,0
4,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.29992,-0.0385,-0.032679,0,0
4,GO SEROTONIN TRANSPORT,0.63978,-0.038506,-0.060907,0,0
4,GO PHOTOPERIODISM,0.43883,-0.038558,-0.038611,0,0
4,GO PROTEIN ADP RIBOSYLATION,0.63354,-0.038605,-0.0097631,0,0
4,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.13814,-0.038711,-0.058239,0,0
4,GO DEVELOPMENTAL CELL GROWTH,0.15015,-0.039008,-0.061867,0,0
4,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.27611,-0.039101,-0.09433,0,0
4,GO CELLULAR RESPONSE TO ALKALOID,0.39371,-0.039113,-0.039895,0,0
4,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.16828,-0.039172,-0.11635,0,0
4,GO LIPID PHOSPHORYLATION,0.15264,-0.039483,-0.049187,0,0
4,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.59059,-0.039485,-0.024332,0,0
4,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.69707,-0.039532,-0.08147,0,0
4,GO POSTSYNAPSE ORGANIZATION,0.62732,-0.039553,-0.025922,0,0
4,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,0.05824,-0.039574,-0.061389,0,0
4,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.39371,-0.039872,-0.070571,0,0
4,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.49227,-0.03994,-0.02438,0,0
4,GO HOMOLOGOUS RECOMBINATION,0.41341,-0.039946,-0.042093,0,0
4,GO GANGLIOSIDE METABOLIC PROCESS,0.38888,-0.040175,-0.073817,0,0
4,GO GMP METABOLIC PROCESS,0.78962,-0.040223,-0.018196,0,0
4,GO LYMPH VESSEL DEVELOPMENT,0.31232,-0.04023,-0.10165,0,0
4,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.44924,-0.04029,-0.078689,0,0
4,GO ERBB2 SIGNALING PATHWAY,0.21905,-0.040478,-0.082118,0,0
4,GO RETINOIC ACID METABOLIC PROCESS,0.49227,-0.040485,-0.056641,0,0
4,GO SENSORY SYSTEM DEVELOPMENT,0.2839,-0.040706,-0.037673,0,0
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.36991,-0.040709,-0.040311,0,0
4,GO REGULATION OF DNA CATABOLIC PROCESS,0.44402,-0.04074,-0.029299,0,0
4,GO HINDLIMB MORPHOGENESIS,0.63354,-0.040823,-0.047101,0,0
4,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.32506,-0.040995,-0.045757,0,0
4,GO CELLULAR SENESCENCE,0.10465,-0.04108,-0.061004,0,0
4,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.72313,-0.041125,-0.018837,0,0
4,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.188,-0.041162,-0.065502,0,0
4,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.17934,-0.041229,-0.027635,0,0
4,GO ADHERENS JUNCTION ORGANIZATION,0.21579,-0.041233,-0.063056,0,0
4,GO NEGATIVE REGULATION OF NEURON DEATH,0.188,-0.04133,-0.037971,0,0
4,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.75615,-0.04144,-0.029192,0,0
4,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.38408,-0.041515,-0.042162,0,0
4,GO REGULATION OF MEIOTIC CELL CYCLE,0.36064,-0.041551,-0.035404,0,0
4,GO LEARNING,0.7495,-0.041558,-0.011088,0,0
4,GO TUMOR NECROSIS FACTOR SECRETION,0.48131,-0.041694,-0.039761,0,0
4,GO MEMORY,0.31232,-0.041726,-0.049271,0,0
4,GO ACTIN NUCLEATION,0.11636,-0.041791,-0.073047,0,0
4,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.48678,-0.041841,-0.049553,0,0
4,GO PEPTIDYL LYSINE DIMETHYLATION,0.98255,-0.041872,0.0093348,0,0
4,GO CAMERA TYPE EYE DEVELOPMENT,0.32938,-0.041885,-0.036715,0,0
4,GO REGULATION OF MRNA 3 END PROCESSING,0.33812,-0.041886,-0.048997,0,0
4,GO RESPONSE TO INSECTICIDE,0.66501,-0.042031,-0.013682,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.53167,-0.042114,-0.04907,0,0
4,GO INTRA S DNA DAMAGE CHECKPOINT,0.30815,-0.042154,-0.04622,0,0
4,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.16559,-0.042208,-0.053005,0,0
4,GO SYNAPTIC VESICLE EXOCYTOSIS,0.42347,-0.042251,0.015697,0,0
4,GO FIBROBLAST ACTIVATION,0.2839,-0.042354,-0.099385,0,0
4,GO REGULATION OF CELLULAR PH,0.061812,-0.042585,-0.070705,0,0
4,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.62113,-0.042692,-0.038155,0,0
4,GO COCHLEA DEVELOPMENT,0.56075,-0.042707,-0.022091,0,0
4,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.80989,-0.042926,0.016414,0,0
4,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.25363,-0.04301,-0.06694,0,0
4,GO RESPONSE TO GLUCAGON,0.35153,-0.04323,-0.04254,0,0
4,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.41341,-0.043242,-0.021595,0,0
4,GO WATER HOMEOSTASIS,0.33812,-0.043294,-0.057123,0,0
4,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.4978,-0.04343,0.06486,0,0
4,GO REGULATION OF ERAD PATHWAY,0.14048,-0.043439,-0.062669,0,0
4,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.35607,-0.043494,-0.060176,0,0
4,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.12473,-0.043558,-0.066715,0,0
4,GO SYNAPSE MATURATION,0.54321,-0.043566,-0.071561,0,0
4,GO REGULATION OF ATPASE ACTIVITY,0.16559,-0.043664,-0.047064,0,0
4,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.30815,-0.043688,-0.046407,0,0
4,GO REGULATION OF MITOPHAGY,0.59664,-0.043721,-0.02255,0,0
4,GO RESPONSE TO AUDITORY STIMULUS,0.67776,-0.04376,0.093716,0,0
4,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.66501,-0.043799,-0.028624,0,0
4,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.55487,-0.043869,-0.050354,0,0
4,GO REGULATION OF PROTEIN POLYMERIZATION,0.15015,-0.044041,-0.049743,0,0
4,GO POSITIVE REGULATION OF INSULIN SECRETION,0.31653,-0.044186,-0.043028,0,0
4,GO REGULATION OF CELL DIFFERENTIATION,0.014138,-0.044254,-0.072287,0,0
4,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.57857,-0.044332,-0.021201,0,0
4,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.18508,-0.044463,-0.080982,0,0
4,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.14285,-0.044464,-0.17453,0,0
4,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.41842,-0.044541,-0.064436,0,0
4,GO STRIATED MUSCLE CELL PROLIFERATION,0.21905,-0.044553,-0.0728,0,0
4,GO REGULATION OF RNA BINDING,0.2839,-0.044934,-0.078337,0,0
4,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.41842,-0.044997,-0.042393,0,0
4,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.38888,-0.045075,-0.050026,0,0
4,GO ACTIN CYTOSKELETON REORGANIZATION,0.20621,-0.045105,-0.06938,0,0
4,GO RNA 3 END PROCESSING,0.69707,-0.045115,-0.024973,0,0
4,GO THYMUS DEVELOPMENT,0.8303,-0.045177,0.019387,0,0
4,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,0.62732,-0.045314,0.015865,0,0
4,GO REGIONALIZATION,0.59664,-0.045354,-0.029575,0,0
4,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.26471,-0.045435,-0.035968,0,0
4,GO REGULATION OF B CELL DIFFERENTIATION,0.39371,-0.04545,-0.070214,0,0
4,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.26098,-0.045501,-0.057668,0,0
4,GO CARDIAC MUSCLE CELL PROLIFERATION,0.23589,-0.045584,-0.079121,0,0
4,GO REGULATION OF ORGANELLE ORGANIZATION,0.0041716,-0.045773,-0.058869,0,0
4,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.12908,-0.045824,-0.11633,0,0
4,GO REGULATION OF ENDOCYTIC RECYCLING,0.48131,-0.045862,-0.053999,0,0
4,GO ENDODERMAL CELL FATE COMMITMENT,0.34702,-0.045978,-0.059979,0,0
4,GO PROTEIN POLYUBIQUITINATION,0.10654,-0.046034,-0.04889,0,0
4,GO AXONAL FASCICULATION,0.4545,-0.046072,-0.068206,0,0
4,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.53742,-0.046082,-0.056099,0,0
4,GO RESPONSE TO ANTIBIOTIC,0.188,-0.046212,-0.064518,0,0
4,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.27227,-0.04627,-0.067114,0,0
4,GO REGULATION OF WNT SIGNALING PATHWAY,0.076492,-0.046339,-0.067758,0,0
4,GO SKIN EPIDERMIS DEVELOPMENT,0.15773,-0.046656,-0.10493,0,0
4,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.013798,-0.046738,-0.083159,0,0
4,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.35153,-0.046741,-0.10166,0,0
4,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.80989,-0.046796,0.02401,0,0
4,GO ARTERY MORPHOGENESIS,0.12049,-0.046871,-0.094801,0,0
4,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.76281,-0.046917,0.023217,0,0
4,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.48131,-0.047078,-0.041993,0,0
4,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.22235,-0.047245,-0.061564,0,0
4,GO VIRAL BUDDING,0.59059,-0.047408,-0.0059537,0,0
4,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,0.64605,-0.047424,-0.037622,0,0
4,GO SEGMENTATION,0.090515,-0.047559,-0.085272,0,0
4,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.80989,-0.047837,-0.048436,0,0
4,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.22235,-0.047999,-0.04901,0,0
4,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.15015,-0.048003,-0.087295,0,0
4,GO REGULATION OF EXOCYTOSIS,0.095625,-0.048188,-0.051783,0,0
4,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.088862,-0.048438,-0.11024,0,0
4,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.087232,-0.048506,-0.059423,0,0
4,GO PROTEIN AUTOUBIQUITINATION,0.11039,-0.048508,-0.046258,0,0
4,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.64605,-0.048541,-0.030864,0,0
4,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.20937,-0.048725,-0.063558,0,0
4,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.16828,-0.048773,-0.097524,0,0
4,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.23589,-0.048794,-0.046984,0,0
4,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.099158,-0.048846,-0.076523,0,0
4,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.27227,-0.048966,-0.12233,0,0
4,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.4598,-0.048966,-0.13452,0,0
4,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.44402,-0.048972,-0.054129,0,0
4,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.56075,-0.048974,-0.02626,0,0
4,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.21905,-0.049037,-0.12941,0,0
4,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.36064,-0.049073,-0.099139,0,0
4,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.15264,-0.049073,-0.073081,0,0
4,GO REGULATION OF ICOSANOID SECRETION,0.59664,-0.049124,-0.033786,0,0
4,GO RESPONSE TO LEAD ION,0.40349,-0.049526,-0.054559,0,0
4,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,0.47588,-0.049538,-0.017986,0,0
4,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.44402,-0.049539,-0.035828,0,0
4,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.39858,-0.04969,-0.069906,0,0
4,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.34256,-0.049721,-0.064878,0,0
4,GO SOMITOGENESIS,0.095625,-0.049792,-0.076932,0,0
4,GO PROTEIN O LINKED MANNOSYLATION,0.33373,-0.049856,-0.052304,0,0
4,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.12689,-0.049895,-0.09051,0,0
4,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.35153,-0.04991,-0.043418,0,0
4,GO RUFFLE ORGANIZATION,0.39371,-0.050046,-0.041921,0,0
4,GO REGULATION OF CELL MORPHOGENESIS,0.18508,-0.050133,-0.054302,0,0
4,GO EATING BEHAVIOR,0.33373,-0.050168,-0.047433,0,0
4,GO REGULATION OF VASOCONSTRICTION,0.17374,-0.050236,-0.081644,0,0
4,GO SYNAPTIC VESICLE DOCKING,0.30402,-0.05026,-0.016454,0,0
4,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.16559,-0.050461,-0.079668,0,0
4,GO RNA DESTABILIZATION,0.29586,-0.05052,-0.057187,0,0
4,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.29992,-0.05054,-0.05061,0,0
4,GO RESPIRATORY SYSTEM DEVELOPMENT,0.1028,-0.050578,-0.076664,0,0
4,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.17374,-0.050609,-0.030641,0,0
4,GO POLYAMINE METABOLIC PROCESS,0.53167,-0.050854,-0.032021,0,0
4,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.22905,-0.050945,-0.050833,0,0
4,GO INOSITOL METABOLIC PROCESS,0.93377,-0.050972,-0.0070766,0,0
4,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.21579,-0.051032,-0.060855,0,0
4,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.37932,-0.051112,-0.11512,0,0
4,GO ACTIVATED T CELL PROLIFERATION,0.43883,-0.051368,-0.047513,0,0
4,GO VESICLE FUSION TO PLASMA MEMBRANE,0.32938,-0.051441,-0.0090706,0,0
4,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.50337,-0.051863,-0.041957,0,0
4,GO EPIDERMIS MORPHOGENESIS,0.58456,-0.051867,-0.066219,0,0
4,GO HEART FORMATION,0.81668,-0.051956,-0.014958,0,0
4,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.18508,-0.052186,-0.039723,0,0
4,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.14526,-0.052348,-0.1203,0,0
4,GO DEVELOPMENTAL INDUCTION,0.25363,-0.052488,-0.069575,0,0
4,GO DENTATE GYRUS DEVELOPMENT,0.4598,-0.052554,-0.076404,0,0
4,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.070855,-0.05257,-0.18302,0,0
4,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.082489,-0.052571,-0.061392,0,0
4,GO POSITIVE REGULATION OF ERAD PATHWAY,0.18508,-0.052575,-0.10739,0,0
4,GO ADULT BEHAVIOR,0.55487,-0.05259,-0.0035197,0,0
4,GO RESPONSE TO INTERLEUKIN 6,0.38888,-0.052609,-0.058369,0,0
4,GO DEVELOPMENTAL MATURATION,0.13814,-0.052667,-0.056549,0,0
4,GO CILIUM MOVEMENT,0.72969,-0.052753,-0.0038248,0,0
4,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.19393,-0.052841,-0.051806,0,0
4,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.71006,-0.053274,-0.0099878,0,0
4,GO CYTOKINETIC PROCESS,0.23589,-0.053306,-0.074491,0,0
4,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.26098,-0.053369,-0.065567,0,0
4,GO NEUROTRANSMITTER SECRETION,0.60272,-0.053573,0.01875,0,0
4,GO SNRNA METABOLIC PROCESS,0.19695,-0.053583,-0.095241,0,0
4,GO MIDBRAIN DEVELOPMENT,0.18219,-0.053772,-0.051282,0,0
4,GO REGULATION OF RENAL SYSTEM PROCESS,0.36064,-0.053859,-0.078612,0,0
4,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.4978,-0.053897,-0.014538,0,0
4,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.033166,-0.05408,-0.070686,0,0
4,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.17934,-0.054142,-0.06186,0,0
4,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.63354,-0.054474,-0.0067044,0,0
4,GO TELOMERE ORGANIZATION,0.20937,-0.054596,-0.046365,0,0
4,GO MOTOR NEURON AXON GUIDANCE,0.36526,-0.054661,-0.044303,0,0
4,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.11841,-0.054673,-0.077617,0,0
4,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.2,-0.054804,-0.071761,0,0
4,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.0062634,-0.055117,-0.057055,0,0
4,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.63354,-0.055134,-0.038613,0,0
4,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.22568,-0.055194,-0.090008,0,0
4,GO SYNAPTIC VESICLE RECYCLING,0.47588,-0.055229,-0.027561,0,0
4,GO EPITHELIAL TUBE FORMATION,0.2,-0.055243,-0.064074,0,0
4,GO LAYER FORMATION IN CEREBRAL CORTEX,0.36526,-0.055342,-0.065464,0,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.23589,-0.055477,-0.053984,0,0
4,GO RESPONSE TO UV C,0.62113,-0.055518,-0.031727,0,0
4,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.7495,-0.055537,0.033971,0,0
4,GO TISSUE HOMEOSTASIS,0.088862,-0.055792,-0.076654,0,0
4,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.80312,-0.055813,0.030191,0,0
4,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.19095,-0.055854,-0.090348,0,0
4,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.71006,-0.055924,-0.0093725,0,0
4,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.088862,-0.055991,-0.09527,0,0
4,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,0.43367,-0.05602,-0.057592,0,0
4,GO MYELOID DENDRITIC CELL ACTIVATION,0.19393,-0.056033,-0.0835,0,0
4,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.19095,-0.056138,-0.065178,0,0
4,GO SECONDARY PALATE DEVELOPMENT,0.25001,-0.056172,-0.085656,0,0
4,GO PROTEIN POLYMERIZATION,0.036948,-0.056189,-0.065367,0,0
4,GO REGULATION OF STEM CELL DIFFERENTIATION,0.14048,-0.056222,-0.097797,0,0
4,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.20937,-0.056289,-0.10967,0,0
4,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.082489,-0.056353,-0.11474,0,0
4,GO REGULATION OF GLIAL CELL MIGRATION,0.92682,-0.056358,-0.010982,0,0
4,GO EMBRYONIC DIGIT MORPHOGENESIS,0.33373,-0.056362,-0.063816,0,0
4,GO ADULT FEEDING BEHAVIOR,0.4598,-0.05637,-0.073627,0,0
4,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.47588,-0.056435,-0.048932,0,0
4,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.13583,-0.05646,-0.084352,0,0
4,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.21579,-0.056515,-0.14943,0,0
4,GO LOCALIZATION WITHIN MEMBRANE,0.50337,-0.056658,-0.035804,0,0
4,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.043763,-0.056841,-0.079306,0,0
4,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.10465,-0.056893,-0.087201,0,0
4,GO SENSORY PERCEPTION OF BITTER TASTE,0.10096,-0.056903,-0.090331,0,0
4,GO PIGMENT GRANULE LOCALIZATION,0.54903,-0.05692,-0.033884,0,0
4,GO KERATINIZATION,0.43883,-0.056947,-0.051566,0,0
4,GO CELL MORPHOGENESIS,0.18219,-0.056969,-0.046876,0,0
4,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.93377,-0.056995,-0.011018,0,0
4,GO NEGATIVE REGULATION OF JNK CASCADE,0.14048,-0.057076,-0.070192,0,0
4,GO VIRION ASSEMBLY,0.12049,-0.057083,-0.0663,0,0
4,GO REGULATION OF GLUCOSE METABOLIC PROCESS,0.076492,-0.057165,-0.084014,0,0
4,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.37932,-0.057182,-0.11373,0,0
4,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.38888,-0.057191,-0.039653,0,0
4,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.22568,-0.057246,-0.11016,0,0
4,GO TELOMERASE RNA LOCALIZATION,0.19695,-0.057348,-0.12681,0,0
4,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.13355,-0.057357,-0.062225,0,0
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.27611,-0.057437,-0.10092,0,0
4,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.36526,-0.057508,-0.071819,0,0
4,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.088862,-0.057577,-0.056875,0,0
4,GO UBIQUINONE METABOLIC PROCESS,0.076492,-0.057596,-0.10189,0,0
4,GO CELL CELL SIGNALING,0.064293,-0.057666,-0.056804,0,0
4,GO MAST CELL MEDIATED IMMUNITY,0.48131,-0.057811,-0.033628,0,0
4,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.21256,-0.057826,-0.12462,0,0
4,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.21256,-0.057852,-0.074065,0,0
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.32506,-0.058001,-0.087036,0,0
4,GO POSITIVE REGULATION OF NEURON DEATH,0.18508,-0.058289,-0.048926,0,0
4,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.26471,-0.058315,-0.052769,0,0
4,GO ALPHA BETA T CELL DIFFERENTIATION,0.20309,-0.058319,-0.086781,0,0
4,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.16559,-0.058328,-0.080305,0,0
4,GO MIRNA METABOLIC PROCESS,0.052669,-0.058515,-0.083928,0,0
4,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.31232,-0.058523,-0.04126,0,0
4,GO LYSINE METABOLIC PROCESS,0.27999,-0.058528,-0.13496,0,0
4,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.36526,-0.058566,-0.050099,0,0
4,GO RHYTHMIC PROCESS,0.065563,-0.058602,-0.053608,0,0
4,GO VISUAL BEHAVIOR,0.33812,-0.058606,-0.039102,0,0
4,GO MOTILE CILIUM ASSEMBLY,0.85082,-0.058842,0.0080382,0,0
4,GO EPITHELIAL CELL MORPHOGENESIS,0.58456,-0.058898,-0.042443,0,0
4,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.11235,-0.059145,-0.058601,0,0
4,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.12049,-0.059173,-0.12402,0,0
4,GO RESPONSE TO VITAMIN D,0.30815,-0.059198,-0.11468,0,0
4,GO REGULATION OF HISTONE UBIQUITINATION,0.10096,-0.059505,-0.061146,0,0
4,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.17374,-0.059521,-0.061485,0,0
4,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.17374,-0.059577,-0.093332,0,0
4,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.057089,-0.059608,-0.064341,0,0
4,GO TERPENOID BIOSYNTHETIC PROCESS,0.63354,-0.059651,-0.047348,0,0
4,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.4978,-0.059844,-0.049351,0,0
4,GO REGULATION OF POSTSYNAPSE ORGANIZATION,0.88523,-0.060029,-0.0096185,0,0
4,GO EXCITATORY SYNAPSE ASSEMBLY,0.62732,-0.060069,-0.041009,0,0
4,GO EAR MORPHOGENESIS,0.17374,-0.060091,-0.069496,0,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.32077,-0.060118,-0.097717,0,0
4,GO RNA SURVEILLANCE,0.68418,-0.060132,-0.010155,0,0
4,GO LIPID DIGESTION,0.16828,-0.06018,-0.1433,0,0
4,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.17934,-0.060202,-0.064272,0,0
4,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.19393,-0.060246,-0.10085,0,0
4,GO SYNAPTIC GROWTH AT NEUROMUSCULAR JUNCTION,0.93377,-0.060334,0.0008105,0,0
4,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.52025,-0.060461,-0.048552,0,0
4,GO BRONCHUS DEVELOPMENT,0.89215,-0.060641,-0.031854,0,0
4,GO HYPEROSMOTIC SALINITY RESPONSE,0.46512,-0.060752,-0.019237,0,0
4,GO SEX DIFFERENTIATION,0.015574,-0.060867,-0.081966,0,0
4,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.86455,-0.061215,-0.071575,0,0
4,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.92682,-0.061398,-0.0079419,0,0
4,GO PREPULSE INHIBITION,0.60883,-0.06143,-0.056279,0,0
4,GO SKELETAL SYSTEM MORPHOGENESIS,0.068167,-0.061598,-0.095598,0,0
4,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.54321,-0.061669,-0.045046,0,0
4,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.29184,-0.061703,-0.038997,0,0
4,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.35153,-0.061819,-0.067611,0,0
4,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.085627,-0.061832,-0.16904,0,0
4,GO RNA PROCESSING,0.082489,-0.061834,-0.062511,0,0
4,GO GLUTAMATE SECRETION,0.9686,-0.061852,0.021273,0,0
4,GO ANATOMICAL STRUCTURE MATURATION,0.12908,-0.061907,-0.057607,0,0
4,GO CELL VOLUME HOMEOSTASIS,0.049546,-0.061983,-0.079448,0,0
4,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.11434,-0.062013,-0.10418,0,0
4,GO RESPONSE TO BMP,0.047551,-0.062145,-0.096365,0,0
4,GO ACIDIC AMINO ACID TRANSPORT,0.47049,-0.062146,-0.021844,0,0
4,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.71006,-0.062202,-0.025112,0,0
4,GO RETINA HOMEOSTASIS,0.29184,-0.062357,-0.045425,0,0
4,GO PROTEIN POLYGLUTAMYLATION,0.68418,-0.062358,-0.01723,0,0
4,GO NEGATIVE REGULATION OF DNA REPLICATION,0.47049,-0.062378,-0.061325,0,0
4,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.15264,-0.062391,-0.10333,0,0
4,GO ORGANELLE INHERITANCE,0.070855,-0.062437,-0.074171,0,0
4,GO PHOSPHOLIPID HOMEOSTASIS,0.31653,-0.06246,-0.096213,0,0
4,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.2839,-0.062487,-0.13479,0,0
4,GO REGULATION OF DNA METHYLATION,0.12908,-0.062595,-0.091872,0,0
4,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.090515,-0.062612,-0.072201,0,0
4,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.16032,-0.062632,-0.062403,0,0
4,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.52025,-0.062647,-0.068469,0,0
4,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.33373,-0.062652,-0.061872,0,0
4,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.36991,-0.06286,-0.045166,0,0
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.4545,-0.062896,-0.083791,0,0
4,GO ATP BIOSYNTHETIC PROCESS,0.23937,-0.063149,-0.084598,0,0
4,GO CELL GROWTH,0.0038387,-0.063301,-0.097385,0,0
4,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.10465,-0.063412,-0.071936,0,0
4,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.26098,-0.06356,-0.11226,0,0
4,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.52025,-0.063575,-0.081812,0,0
4,GO MULTIVESICULAR BODY SORTING PATHWAY,0.21256,-0.063603,-0.051739,0,0
4,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.33373,-0.063632,-0.039383,0,0
4,GO INTERLEUKIN 10 PRODUCTION,0.16828,-0.063644,-0.081667,0,0
4,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.42855,-0.063691,-0.084936,0,0
4,GO PROTEIN DESTABILIZATION,0.070855,-0.063698,-0.072349,0,0
4,GO BASE EXCISION REPAIR AP SITE FORMATION,0.31653,-0.063721,-0.07311,0,0
4,GO HISTONE H3 DEACETYLATION,0.34702,-0.063741,-0.037648,0,0
4,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.024846,-0.064298,-0.087005,0,0
4,GO SYNAPSE ASSEMBLY,0.34256,-0.064505,-0.026421,0,0
4,GO POSITIVE REGULATION OF EXOCYTOSIS,0.15517,-0.064514,-0.070056,0,0
4,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.27999,-0.064545,-0.074429,0,0
4,GO FIBROBLAST MIGRATION,0.2839,-0.064611,-0.058769,0,0
4,GO POSITIVE REGULATION OF URINE VOLUME,0.075049,-0.064822,-0.11519,0,0
4,GO PROTEIN DENEDDYLATION,0.29992,-0.064845,-0.061255,0,0
4,GO RNA STABILIZATION,0.22568,-0.064963,-0.060723,0,0
4,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.43367,-0.06501,-0.094973,0,0
4,GO TELOMERIC LOOP DISASSEMBLY,0.77618,-0.065034,-0.020971,0,0
4,GO NERVOUS SYSTEM PROCESS,0.070855,-0.06504,-0.057377,0,0
4,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.32938,-0.065085,-0.067623,0,0
4,GO WALKING BEHAVIOR,0.29992,-0.065265,-0.053929,0,0
4,GO REGULATION OF MITOCHONDRIAL FUSION,0.2,-0.065296,-0.076749,0,0
4,GO NEURON MATURATION,0.19393,-0.065364,-0.065685,0,0
4,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.02268,-0.06538,-0.072373,0,0
4,GO TRANSMISSION OF NERVE IMPULSE,0.15264,-0.065472,-0.089662,0,0
4,GO COENZYME A BIOSYNTHETIC PROCESS,0.057089,-0.06561,-0.13806,0,0
4,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.13583,-0.06564,-0.13531,0,0
4,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.41842,-0.065706,-0.046034,0,0
4,GO MAGNESIUM ION TRANSPORT,0.47588,-0.065816,-0.035395,0,0
4,GO REGULATION OF ISOTYPE SWITCHING,0.77618,-0.065927,-0.069702,0,0
4,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.057089,-0.065933,-0.07691,0,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.38408,-0.066087,-0.09774,0,0
4,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.0019282,-0.066111,-0.082081,0,0
4,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.080955,-0.066153,-0.078296,0,0
4,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.22235,-0.06617,-0.067512,0,0
4,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.60883,-0.06618,-0.045192,0,0
4,GO BEHAVIOR,0.22568,-0.066258,-0.047404,0,0
4,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.79636,-0.066264,-0.014083,0,0
4,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.11039,-0.066422,-0.049492,0,0
4,GO EXTRACELLULAR VESICLE BIOGENESIS,0.38888,-0.066568,-0.055518,0,0
4,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,0.063042,-0.06684,-0.11373,0,0
4,GO REGULATION OF EXCRETION,0.69061,-0.066882,-0.022249,0,0
4,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.065563,-0.066966,-0.072396,0,0
4,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.35607,-0.067014,-0.042092,0,0
4,GO T CELL DIFFERENTIATION,0.12689,-0.067239,-0.077676,0,0
4,GO GLUCOSE IMPORT,0.1028,-0.067313,-0.062016,0,0
4,GO REGULATION OF T CELL DIFFERENTIATION,0.068167,-0.067314,-0.087344,0,0
4,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.15264,-0.067503,-0.12028,0,0
4,GO NEGATIVE REGULATION OF TOR SIGNALING,0.2,-0.067506,-0.056324,0,0
4,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.077957,-0.067774,-0.1033,0,0
4,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.33373,-0.067945,-0.078269,0,0
4,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.60883,-0.067957,-0.034499,0,0
4,GO INTERFERON ALPHA PRODUCTION,0.3746,-0.068061,-0.069194,0,0
4,GO WHITE FAT CELL DIFFERENTIATION,0.085627,-0.068184,-0.12108,0,0
4,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.079444,-0.068395,-0.16407,0,0
4,GO NEURON DEATH,0.072231,-0.068472,-0.051115,0,0
4,GO INNER EAR MORPHOGENESIS,0.27999,-0.068488,-0.058722,0,0
4,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.055956,-0.068631,-0.10333,0,0
4,GO REGULATION OF NEUTROPHIL MIGRATION,0.20309,-0.068696,-0.089154,0,0
4,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.24643,-0.068942,-0.10416,0,0
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.072231,-0.06896,-0.08552,0,0
4,GO PARTURITION,0.8303,-0.069158,-0.045807,0,0
4,GO RESPONSE TO FUNGUS,0.1313,-0.069447,-0.061828,0,0
4,GO EMBRYO DEVELOPMENT,0.035393,-0.069507,-0.068905,0,0
4,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.26847,-0.06964,-0.073425,0,0
4,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.65866,-0.069783,-0.015793,0,0
4,GO HEART VALVE FORMATION,0.3746,-0.069809,-0.1146,0,0
4,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.072231,-0.069855,-0.083161,0,0
4,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.16032,-0.069951,-0.10944,0,0
4,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.0013457,-0.069951,-0.090152,0,0
4,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.097379,-0.069999,-0.066151,0,0
4,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.047551,-0.070016,-0.091499,0,0
4,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.088862,-0.07007,-0.091281,0,0
4,GO THYROID HORMONE METABOLIC PROCESS,0.50337,-0.070103,-0.02538,0,0
4,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.046579,-0.070324,-0.10259,0,0
4,GO LOCOMOTORY BEHAVIOR,0.27227,-0.070347,-0.041714,0,0
4,GO SYNAPTIC VESICLE BUDDING,0.22235,-0.070402,-0.10657,0,0
4,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.0066042,-0.070411,-0.095307,0,0
4,GO EPIDERMIS DEVELOPMENT,0.082489,-0.070423,-0.10328,0,0
4,GO MITOCHONDRION DISTRIBUTION,0.64605,-0.070444,-0.0082525,0,0
4,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.070855,-0.070619,-0.10235,0,0
4,GO OOCYTE DIFFERENTIATION,0.14285,-0.070647,-0.073187,0,0
4,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.055956,-0.070652,-0.07279,0,0
4,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.061812,-0.070723,-0.059419,0,0
4,GO PROTEIN LOCALIZATION TO ENDOSOME,0.31232,-0.070796,-0.073708,0,0
4,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.14769,-0.070899,-0.091098,0,0
4,GO GLIAL CELL DIFFERENTIATION,0.13814,-0.071276,-0.070328,0,0
4,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.188,-0.071414,-0.080138,0,0
4,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.15773,-0.071478,-0.16465,0,0
4,GO PRENYLATION,0.52594,-0.071491,-0.026583,0,0
4,GO PORE COMPLEX ASSEMBLY,0.22568,-0.071626,-0.066383,0,0
4,GO EMBRYONIC ORGAN DEVELOPMENT,0.064293,-0.071707,-0.072514,0,0
4,GO REGULATION OF FATTY ACID TRANSPORT,0.11235,-0.071839,-0.10485,0,0
4,GO REGULATION OF MEMBRANE PERMEABILITY,0.29992,-0.071848,-0.041423,0,0
4,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.087232,-0.071941,-0.10129,0,0
4,GO MRNA MODIFICATION,0.19393,-0.072007,-0.084899,0,0
4,GO HISTONE H2B UBIQUITINATION,0.60272,-0.072015,-0.027641,0,0
4,GO TAXIS,0.0029794,-0.072031,-0.10497,0,0
4,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.22568,-0.072035,-0.19318,0,0
4,GO KILLING OF CELLS OF OTHER ORGANISM,0.188,-0.072203,-0.047563,0,0
4,GO SHORT TERM MEMORY,0.57857,-0.072223,-0.074118,0,0
4,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.0051916,-0.072233,-0.070818,0,0
4,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.025414,-0.072234,-0.11693,0,0
4,GO LYSOSOME LOCALIZATION,0.2839,-0.072288,-0.033286,0,0
4,GO EPITHELIAL CELL CELL ADHESION,0.75615,-0.072381,-0.017895,0,0
4,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.0097392,-0.072535,-0.076178,0,0
4,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.44924,-0.072645,-0.05264,0,0
4,GO MAST CELL ACTIVATION,0.22235,-0.072711,-0.068386,0,0
4,GO BONE MATURATION,0.2,-0.072809,-0.087964,0,0
4,GO REGULATION OF ANION TRANSPORT,0.087232,-0.072853,-0.082186,0,0
4,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.066855,-0.072886,-0.054178,0,0
4,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.26471,-0.072933,-0.05312,0,0
4,GO CELLULAR RESPONSE TO MANGANESE ION,0.47049,-0.072992,-0.045901,0,0
4,GO REGULATION OF MRNA BINDING,0.05824,-0.073133,-0.15636,0,0
4,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,0.38408,-0.073136,-0.029148,0,0
4,GO COPII COATED VESICLE CARGO LOADING,0.026586,-0.073354,-0.12589,0,0
4,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.26471,-0.07342,-0.094821,0,0
4,GO MANNOSYLATION,0.092194,-0.073458,-0.090281,0,0
4,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.045624,-0.073609,-0.053614,0,0
4,GO RESPONSE TO LEUCINE,0.4978,-0.07368,-0.030399,0,0
4,GO RESPONSE TO GAMMA RADIATION,0.093897,-0.073741,-0.073615,0,0
4,GO NEUTROPHIL CHEMOTAXIS,0.084046,-0.073742,-0.093845,0,0
4,GO PROSTATE GLAND MORPHOGENESIS,0.70355,-0.07381,-0.08456,0,0
4,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.39371,-0.073815,-0.054936,0,0
4,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.14526,-0.073967,-0.067136,0,0
4,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.18508,-0.07403,-0.13243,0,0
4,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.11039,-0.074183,-0.098615,0,0
4,GO REGULATION OF FEEDING BEHAVIOR,0.24288,-0.074497,-0.08728,0,0
4,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.29184,-0.074497,-0.11381,0,0
4,GO NCRNA EXPORT FROM NUCLEUS,0.22235,-0.074586,-0.066031,0,0
4,GO REGULATION OF ORGANELLE ASSEMBLY,0.033166,-0.074709,-0.054296,0,0
4,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.47588,-0.074756,-0.072729,0,0
4,GO ETHANOL CATABOLIC PROCESS,0.13583,-0.074999,-0.11892,0,0
4,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.12908,-0.075135,-0.14084,0,0
4,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.12259,-0.075279,-0.11061,0,0
4,GO NODAL SIGNALING PATHWAY,0.38888,-0.075354,-0.060312,0,0
4,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.046579,-0.075373,-0.063774,0,0
4,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.30402,-0.075374,-0.066184,0,0
4,GO REGULATION OF CYCLASE ACTIVITY,0.10845,-0.075401,-0.094466,0,0
4,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.050569,-0.075519,-0.074347,0,0
4,GO REGULATION OF CELL PROJECTION SIZE,0.50896,-0.07553,-0.076347,0,0
4,GO TUBE FORMATION,0.11636,-0.075621,-0.07454,0,0
4,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.31653,-0.075935,-0.043842,0,0
4,GO REGULATION OF CGMP MEDIATED SIGNALING,0.10096,-0.076259,-0.18366,0,0
4,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.54321,-0.076311,-0.042197,0,0
4,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.090515,-0.076492,-0.074941,0,0
4,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.31232,-0.076588,-0.0306,0,0
4,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.69707,-0.076607,0.0029319,0,0
4,GO REGULATION OF HEAT GENERATION,0.71006,-0.076608,0.012422,0,0
4,GO EPIDERMAL CELL DIFFERENTIATION,0.13583,-0.076685,-0.086183,0,0
4,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.28785,-0.076687,-0.047304,0,0
4,GO REGULATION OF CELLULAR COMPONENT SIZE,0.014841,-0.076688,-0.081096,0,0
4,GO SIGNAL RELEASE,0.1028,-0.076835,-0.047634,0,0
4,GO REGULATION OF DEVELOPMENTAL GROWTH,0.036948,-0.076885,-0.074273,0,0
4,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.87833,-0.07732,0.00445,0,0
4,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.066855,-0.077512,-0.10444,0,0
4,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.24288,-0.07763,-0.097028,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.33812,-0.077863,-0.074335,0,0
4,GO REGULATION OF HAIR CYCLE,0.022165,-0.077984,-0.15692,0,0
4,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.30402,-0.078118,-0.047563,0,0
4,GO NAD BIOSYNTHETIC PROCESS,0.21579,-0.078145,-0.084603,0,0
4,GO CONVERGENT EXTENSION,0.21905,-0.078202,-0.085917,0,0
4,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.24643,-0.07824,-0.071881,0,0
4,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.070855,-0.078477,-0.14076,0,0
4,GO MATING BEHAVIOR,0.20309,-0.078492,-0.089726,0,0
4,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.012203,-0.078608,-0.078399,0,0
4,GO INNER DYNEIN ARM ASSEMBLY,0.94073,-0.078938,0.038956,0,0
4,GO EXECUTION PHASE OF APOPTOSIS,0.070855,-0.078957,-0.059263,0,0
4,GO NEURAL TUBE FORMATION,0.15773,-0.079176,-0.070647,0,0
4,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.21579,-0.079262,-0.10163,0,0
4,GO EMBRYONIC PLACENTA DEVELOPMENT,0.27611,-0.079298,-0.076816,0,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.3746,-0.079654,-0.050554,0,0
4,GO MITOCHONDRION MORPHOGENESIS,0.20621,-0.079748,-0.058244,0,0
4,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.046579,-0.079952,-0.17357,0,0
4,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,0.12689,-0.079964,-0.1515,0,0
4,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.26098,-0.080131,-0.10146,0,0
4,GO EPITHELIAL CELL FATE COMMITMENT,0.34256,-0.080187,-0.07993,0,0
4,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.00353,-0.080253,-0.09459,0,0
4,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.54903,-0.080291,-0.06861,0,0
4,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.39858,-0.080314,-0.06961,0,0
4,GO NEURONAL ION CHANNEL CLUSTERING,0.34702,-0.080342,-0.11281,0,0
4,GO TONIC SMOOTH MUSCLE CONTRACTION,0.24288,-0.080431,-0.12756,0,0
4,GO RHYTHMIC BEHAVIOR,0.012203,-0.080475,-0.10527,0,0
4,GO BILE ACID METABOLIC PROCESS,0.084046,-0.080525,-0.12603,0,0
4,GO TRNA TRANSPORT,0.22905,-0.080529,-0.053919,0,0
4,GO LEUKOCYTE AGGREGATION,0.26098,-0.080687,-0.15881,0,0
4,GO PRESYNAPSE ORGANIZATION,0.38888,-0.080822,-0.0409,0,0
4,GO ASTROCYTE DIFFERENTIATION,0.079444,-0.080822,-0.11126,0,0
4,GO DEVELOPMENTAL GROWTH,0.0073363,-0.081113,-0.083703,0,0
4,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.17653,-0.08127,-0.12795,0,0
4,GO KETONE CATABOLIC PROCESS,0.34702,-0.081457,-0.12844,0,0
4,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.24643,-0.081666,-0.084811,0,0
4,GO T CELL DIFFERENTIATION IN THYMUS,0.1313,-0.081994,-0.076042,0,0
4,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.10096,-0.082047,-0.086217,0,0
4,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.20937,-0.082051,-0.21423,0,0
4,GO DENDRITE EXTENSION,0.83713,-0.082066,0.078861,0,0
4,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.32077,-0.082248,-0.066635,0,0
4,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.17374,-0.08252,-0.10282,0,0
4,GO DIGESTIVE SYSTEM DEVELOPMENT,0.18508,-0.082604,-0.067917,0,0
4,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.16828,-0.083085,-0.076399,0,0
4,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.12259,-0.083135,-0.11025,0,0
4,GO TRACHEA DEVELOPMENT,0.23937,-0.083145,-0.1251,0,0
4,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.47588,-0.083283,-0.077484,0,0
4,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.27227,-0.0833,-0.090389,0,0
4,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.19393,-0.083367,-0.11467,0,0
4,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.03245,-0.083419,-0.1248,0,0
4,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.079444,-0.083694,-0.08855,0,0
4,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.3746,-0.083697,-0.05432,0,0
4,GO REGULATION OF POTASSIUM ION TRANSPORT,0.14285,-0.083755,-0.078837,0,0
4,GO HORMONE TRANSPORT,0.077957,-0.083839,-0.072491,0,0
4,GO INTERLEUKIN 6 PRODUCTION,0.057089,-0.08395,-0.090351,0,0
4,GO CELL CYCLE ARREST,0.0038387,-0.083956,-0.081782,0,0
4,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.0695,-0.084033,-0.12647,0,0
4,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.02843,-0.084047,-0.1078,0,0
4,GO REGULATION OF NEUROTRANSMITTER LEVELS,0.20937,-0.084079,-0.029854,0,0
4,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.36526,-0.084117,-0.16514,0,0
4,GO GROWTH,0.0010206,-0.08414,-0.094969,0,0
4,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.33812,-0.084184,-0.077613,0,0
4,GO PIRNA METABOLIC PROCESS,0.072231,-0.08422,-0.15354,0,0
4,GO NEUROTRANSMITTER TRANSPORT,0.29992,-0.084239,-0.019517,0,0
4,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.011047,-0.084256,-0.11599,0,0
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.053746,-0.084394,-0.095684,0,0
4,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.2,-0.084394,-0.048631,0,0
4,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.63354,-0.084448,-0.11977,0,0
4,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.095625,-0.084777,-0.11325,0,0
4,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.23245,-0.084807,-0.086532,0,0
4,GO ESTABLISHMENT OF CELL POLARITY,0.064293,-0.084855,-0.063066,0,0
4,GO REGULATION OF PEPTIDE HORMONE SECRETION,0.12689,-0.08489,-0.065602,0,0
4,GO BODY MORPHOGENESIS,0.092194,-0.084966,-0.0956,0,0
4,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.11636,-0.084969,-0.10885,0,0
4,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.11434,-0.085043,-0.090819,0,0
4,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.12689,-0.085124,-0.091131,0,0
4,GO REGULATION OF AXON GUIDANCE,0.17374,-0.085231,-0.078325,0,0
4,GO PLACENTA DEVELOPMENT,0.099158,-0.085247,-0.096985,0,0
4,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.10845,-0.085419,-0.10231,0,0
4,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.10465,-0.08553,-0.086541,0,0
4,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.26847,-0.085759,-0.063369,0,0
4,GO HETEROTYPIC CELL CELL ADHESION,0.13583,-0.085899,-0.098542,0,0
4,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.092194,-0.086374,-0.181,0,0
4,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.05161,-0.086528,-0.06878,0,0
4,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.18219,-0.086546,-0.073574,0,0
4,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.50896,-0.086691,-0.07212,0,0
4,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.27611,-0.086791,-0.0076935,0,0
4,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.0695,-0.087026,-0.18382,0,0
4,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.14048,-0.087145,-0.12352,0,0
4,GO EPITHELIAL TUBE MORPHOGENESIS,0.013139,-0.087387,-0.10492,0,0
4,GO REGULATION OF HORMONE SECRETION,0.082489,-0.08742,-0.072565,0,0
4,GO ENDOTHELIAL CELL MORPHOGENESIS,0.39371,-0.087534,-0.12194,0,0
4,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.080955,-0.087549,-0.086432,0,0
4,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.063042,-0.087592,-0.16472,0,0
4,GO REGULATION OF CELL SIZE,0.041093,-0.087742,-0.073901,0,0
4,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.18219,-0.087786,-0.12317,0,0
4,GO NEUROTRANSMITTER METABOLIC PROCESS,0.25729,-0.08788,-0.087885,0,0
4,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.0017123,-0.087912,-0.088468,0,0
4,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.076492,-0.08808,-0.12625,0,0
4,GO REGULATION OF DEPHOSPHORYLATION,0.0062634,-0.0881,-0.068467,0,0
4,GO MOLTING CYCLE,0.024288,-0.08828,-0.11566,0,0
4,GO SNRNA PROCESSING,0.12049,-0.088314,-0.13065,0,0
4,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.56075,-0.088438,-0.030184,0,0
4,GO AORTA MORPHOGENESIS,0.41842,-0.088526,-0.062764,0,0
4,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.059411,-0.088766,-0.10558,0,0
4,GO EMBRYONIC ORGAN MORPHOGENESIS,0.080955,-0.088831,-0.078943,0,0
4,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.093897,-0.088849,-0.10343,0,0
4,GO NEGATIVE REGULATION OF AXONOGENESIS,0.25363,-0.088979,-0.073037,0,0
4,GO RESPONSE TO L GLUTAMATE,0.82348,-0.08901,0.025907,0,0
4,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.15517,-0.089016,-0.11832,0,0
4,GO BRANCH ELONGATION OF AN EPITHELIUM,0.073629,-0.089137,-0.23274,0,0
4,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.090515,-0.089152,-0.074571,0,0
4,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.18508,-0.089356,-0.07906,0,0
4,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.40843,-0.089379,-0.068605,0,0
4,GO MUSCLE CELL MIGRATION,0.14526,-0.089421,-0.11453,0,0
4,GO SENSORY PERCEPTION OF PAIN,0.049546,-0.089441,-0.077689,0,0
4,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.11039,-0.089452,-0.083658,0,0
4,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.077957,-0.089553,-0.16581,0,0
4,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.69707,-0.089608,-0.00057569,0,0
4,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.40349,-0.089664,-0.045544,0,0
4,GO REGULATION OF RESPONSE TO FOOD,0.2839,-0.089714,-0.065624,0,0
4,GO VESICLE DOCKING,0.010245,-0.0899,-0.12102,0,0
4,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.43367,-0.089906,-0.048629,0,0
4,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.19095,-0.090001,-0.067106,0,0
4,GO MUSCLE TISSUE DEVELOPMENT,0.0019282,-0.090062,-0.10333,0,0
4,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.087232,-0.09029,-0.057396,0,0
4,GO POLYOL CATABOLIC PROCESS,0.11434,-0.090329,-0.05876,0,0
4,GO CELL AGGREGATION,0.30402,-0.090402,-0.071736,0,0
4,GO MORPHOGENESIS OF AN EPITHELIUM,0.0020453,-0.090496,-0.12416,0,0
4,GO OVARIAN FOLLICLE DEVELOPMENT,0.21905,-0.09061,-0.055225,0,0
4,GO TUBULIN DEACETYLATION,0.30815,-0.090682,-0.057977,0,0
4,GO OTIC VESICLE MORPHOGENESIS,0.69707,-0.09083,-0.030556,0,0
4,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,0.18508,-0.090861,-0.089669,0,0
4,GO SARCOMERE ORGANIZATION,0.073629,-0.09104,-0.094783,0,0
4,GO MYOBLAST DIFFERENTIATION,0.10096,-0.091288,-0.10726,0,0
4,GO BONE TRABECULA MORPHOGENESIS,0.15517,-0.091304,-0.20338,0,0
4,GO CATECHOLAMINE METABOLIC PROCESS,0.51459,-0.091317,-0.019847,0,0
4,GO SYNAPSE ORGANIZATION,0.17374,-0.091392,-0.059115,0,0
4,GO PROTEIN DEPHOSPHORYLATION,0.0042883,-0.091457,-0.077046,0,0
4,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.27999,-0.091568,-0.071824,0,0
4,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.25729,-0.09163,-0.08807,0,0
4,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.095625,-0.091947,-0.091121,0,0
4,GO EMBRYONIC PATTERN SPECIFICATION,0.15517,-0.091949,-0.078744,0,0
4,GO TRNA WOBBLE URIDINE MODIFICATION,0.065563,-0.092034,-0.11749,0,0
4,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.10096,-0.092136,-0.13013,0,0
4,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.072231,-0.092283,-0.081683,0,0
4,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.39371,-0.092424,-0.047256,0,0
4,GO REPLICATIVE SENESCENCE,0.10654,-0.09248,-0.16311,0,0
4,GO INTESTINAL LIPID ABSORPTION,0.21579,-0.092691,-0.14801,0,0
4,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.11039,-0.092739,-0.11016,0,0
4,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.26098,-0.092971,-0.09637,0,0
4,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.16559,-0.093149,-0.084457,0,0
4,GO FACIAL NERVE MORPHOGENESIS,0.53167,-0.093199,-0.052685,0,0
4,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.0049174,-0.09321,-0.17627,0,0
4,GO GLIOGENESIS,0.036164,-0.093349,-0.090221,0,0
4,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.16294,-0.093402,-0.089166,0,0
4,GO ADULT HEART DEVELOPMENT,0.54321,-0.093579,-0.064172,0,0
4,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.007729,-0.09361,-0.099817,0,0
4,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.16294,-0.093683,-0.091245,0,0
4,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.001662,-0.093883,-0.11342,0,0
4,GO HEAD MORPHOGENESIS,0.13583,-0.093978,-0.087693,0,0
4,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.25729,-0.094009,-0.09426,0,0
4,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.76281,-0.094059,4.166e-05,0,0
4,GO POSITIVE REGULATION OF PROTEIN IMPORT,0.065563,-0.094084,-0.14054,0,0
4,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.36526,-0.094151,-0.077274,0,0
4,GO TRANSCRIPTION BY RNA POLYMERASE I,0.093897,-0.094153,-0.078178,0,0
4,GO DORSAL VENTRAL AXIS SPECIFICATION,0.41842,-0.094185,-0.076493,0,0
4,GO STABILIZATION OF MEMBRANE POTENTIAL,0.23937,-0.094241,-0.14441,0,0
4,GO MITOPHAGY,0.060602,-0.09431,-0.085217,0,0
4,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.22905,-0.094368,-0.076642,0,0
4,GO POSITIVE REGULATION OF TOR SIGNALING,0.0021062,-0.094428,-0.11739,0,0
4,GO REGULATION OF HEART MORPHOGENESIS,0.32938,-0.094501,-0.10254,0,0
4,GO GOLGI LOCALIZATION,0.21579,-0.09456,-0.072436,0,0
4,GO OUTER DYNEIN ARM ASSEMBLY,0.54903,-0.094731,-0.024647,0,0
4,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,0.0094949,-0.094939,-0.10719,0,0
4,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.36064,-0.095058,-0.12584,0,0
4,GO NEGATIVE REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS,0.57857,-0.095088,-0.10537,0,0
4,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.31653,-0.095127,-0.11399,0,0
4,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.02068,-0.09532,-0.11322,0,0
4,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.0025817,-0.095392,-0.10677,0,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.34256,-0.095728,-0.075803,0,0
4,GO PROTEIN PALMITOYLATION,0.19095,-0.095804,-0.050913,0,0
4,GO DOPAMINE METABOLIC PROCESS,0.51459,-0.095936,-0.016801,0,0
4,GO CRANIAL NERVE MORPHOGENESIS,0.188,-0.096158,-0.13302,0,0
4,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.097379,-0.096198,-0.097189,0,0
4,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.016734,-0.09637,-0.14401,0,0
4,GO RESPONSE TO AMINO ACID STARVATION,0.073629,-0.096506,-0.093426,0,0
4,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.27999,-0.096509,-0.084688,0,0
4,GO PRESYNAPTIC ENDOCYTOSIS,0.30815,-0.096563,-0.043271,0,0
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.031059,-0.096667,-0.082386,0,0
4,GO NCRNA 3 END PROCESSING,0.12689,-0.097004,-0.10534,0,0
4,GO REGULATION OF PROTEIN TARGETING,0.0040578,-0.097191,-0.10341,0,0
4,GO REGULATION OF PLATELET AGGREGATION,0.13583,-0.097233,-0.17679,0,0
4,GO DEFINITIVE HEMOPOIESIS,0.25363,-0.097271,-0.090753,0,0
4,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.22568,-0.097765,-0.058477,0,0
4,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.14048,-0.097799,-0.15393,0,0
4,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.62732,-0.09782,-0.031875,0,0
4,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.0097392,-0.097891,-0.15992,0,0
4,GO CELLULAR RESPONSE TO VIRUS,0.060602,-0.097974,-0.10689,0,0
4,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,0.27999,-0.098183,-0.08316,0,0
4,GO DETERMINATION OF DORSAL VENTRAL ASYMMETRY,0.097379,-0.098295,-0.16923,0,0
4,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.076492,-0.09834,-0.095308,0,0
4,GO ADHERENS JUNCTION ASSEMBLY,0.25001,-0.098367,-0.067957,0,0
4,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.085627,-0.09858,-0.1679,0,0
4,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.080955,-0.098667,-0.14739,0,0
4,GO NEGATIVE REGULATION OF CELL GROWTH,0.0021062,-0.098722,-0.11683,0,0
4,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.13583,-0.098729,-0.095938,0,0
4,GO HEMOGLOBIN METABOLIC PROCESS,0.060602,-0.09883,-0.13429,0,0
4,GO UROGENITAL SYSTEM DEVELOPMENT,0.0097392,-0.098831,-0.12444,0,0
4,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.13355,-0.099017,-0.11581,0,0
4,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.087232,-0.099055,-0.10492,0,0
4,GO AUTOPHAGIC CELL DEATH,0.21905,-0.099068,-0.081427,0,0
4,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.12473,-0.099254,-0.1015,0,0
4,GO MATING,0.092194,-0.09953,-0.071659,0,0
4,GO POSITIVE REGULATION OF CELL MATURATION,0.36526,-0.099585,-0.14843,0,0
4,GO CALCIUM ION REGULATED EXOCYTOSIS,0.19393,-0.09974,-0.051662,0,0
4,GO RESPONSE TO PARATHYROID HORMONE,0.090515,-0.099992,-0.15357,0,0
4,GO REGULATION OF TELOMERASE ACTIVITY,0.019739,-0.10007,-0.11302,0,0
4,GO POSITIVE REGULATION OF ANION TRANSPORT,0.076492,-0.10024,-0.1089,0,0
4,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.11434,-0.10056,-0.11334,0,0
4,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.10845,-0.10062,-0.1277,0,0
4,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,0.13814,-0.10073,-0.087271,0,0
4,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.20937,-0.10082,-0.11916,0,0
4,GO OVULATION CYCLE,0.042857,-0.10086,-0.10699,0,0
4,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.24288,-0.10099,-0.086009,0,0
4,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.01282,-0.10137,-0.11738,0,0
4,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.43883,-0.10161,-0.069353,0,0
4,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.58456,-0.10163,-0.074488,0,0
4,GO ENERGY HOMEOSTASIS,0.13814,-0.10172,-0.099585,0,0
4,GO PEPTIDE HORMONE SECRETION,0.084046,-0.10193,-0.0685,0,0
4,GO MACROMOLECULE DEACYLATION,0.0026572,-0.10197,-0.083751,0,0
4,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.0695,-0.10212,-0.09203,0,0
4,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.092194,-0.10234,-0.12688,0,0
4,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.12689,-0.10252,-0.12869,0,0
4,GO DICARBOXYLIC ACID TRANSPORT,0.11039,-0.10286,-0.057312,0,0
4,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.00353,-0.10308,-0.11016,0,0
4,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.15517,-0.10312,-0.12624,0,0
4,GO FILOPODIUM ASSEMBLY,0.25363,-0.10315,-0.06291,0,0
4,GO RESPONSE TO NITRIC OXIDE,0.061812,-0.10316,-0.073149,0,0
4,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.0019282,-0.10338,-0.13277,0,0
4,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.038561,-0.10343,-0.095817,0,0
4,GO CGMP MEDIATED SIGNALING,0.018398,-0.10345,-0.14235,0,0
4,GO KERATINOCYTE DIFFERENTIATION,0.082489,-0.10351,-0.11206,0,0
4,GO ENDOTHELIUM DEVELOPMENT,0.087232,-0.1039,-0.095858,0,0
4,GO ANIMAL ORGAN MORPHOGENESIS,0.0016129,-0.10408,-0.11379,0,0
4,GO ADULT LOCOMOTORY BEHAVIOR,0.21579,-0.10411,-0.058538,0,0
4,GO INTERFERON BETA PRODUCTION,0.068167,-0.10441,-0.11293,0,0
4,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.26847,-0.10453,-0.048713,0,0
4,GO PROSTATE GLAND GROWTH,0.12049,-0.10461,-0.17003,0,0
4,GO CELLULAR RESPONSE TO CAMP,0.023205,-0.10464,-0.1259,0,0
4,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.015574,-0.10477,-0.20754,0,0
4,GO ACTIVATION OF JNKK ACTIVITY,0.097379,-0.10514,-0.094998,0,0
4,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.0041716,-0.10517,-0.17581,0,0
4,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.34702,-0.10518,-0.056789,0,0
4,GO HEART VALVE DEVELOPMENT,0.031059,-0.1052,-0.16377,0,0
4,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.36991,-0.10529,-0.050397,0,0
4,GO ASSOCIATIVE LEARNING,0.11039,-0.1054,-0.077073,0,0
4,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.15773,-0.10544,-0.16712,0,0
4,GO HEAT GENERATION,0.2839,-0.10571,-0.043841,0,0
4,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.11434,-0.10586,-0.13469,0,0
4,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.16032,-0.10597,-0.09234,0,0
4,GO POSITIVE REGULATION OF AMINE TRANSPORT,0.94769,-0.10599,0.037687,0,0
4,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.030383,-0.10601,-0.089543,0,0
4,GO NEGATIVE REGULATION OF PROTEIN SUMOYLATION,0.17374,-0.10606,-0.077051,0,0
4,GO AMINE TRANSPORT,0.39858,-0.10616,-0.028969,0,0
4,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.49227,-0.10635,-0.08225,0,0
4,GO IRON COORDINATION ENTITY TRANSPORT,0.25363,-0.10644,-0.079726,0,0
4,GO PRE MIRNA PROCESSING,0.12473,-0.10655,-0.10904,0,0
4,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.56666,-0.10657,0.042134,0,0
4,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.38408,-0.10661,-0.029456,0,0
4,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.13355,-0.10672,-0.10743,0,0
4,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.188,-0.10679,-0.097378,0,0
4,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.21905,-0.10692,-0.10862,0,0
4,GO LYMPH VESSEL MORPHOGENESIS,0.076492,-0.10716,-0.14128,0,0
4,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.11039,-0.10717,-0.12928,0,0
4,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.065563,-0.10745,-0.11237,0,0
4,GO EXOCYTIC PROCESS,0.15015,-0.10761,-0.053,0,0
4,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.00044439,-0.10763,-0.12778,0,0
4,GO MITOCHONDRIAL DNA REPLICATION,0.05161,-0.10768,-0.10432,0,0
4,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.04854,-0.10772,-0.085886,0,0
4,GO LIPOXYGENASE PATHWAY,0.15015,-0.10804,-0.17409,0,0
4,GO REGULATION OF HISTONE DEACETYLATION,0.10654,-0.10811,-0.089012,0,0
4,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.035393,-0.10837,-0.093015,0,0
4,GO MEMBRANE DISASSEMBLY,0.10845,-0.10838,-0.10654,0,0
4,GO RESPONSE TO WATER,0.20309,-0.10851,-0.11747,0,0
4,GO REGULATION OF POSITIVE CHEMOTAXIS,0.12259,-0.10868,-0.11361,0,0
4,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.91987,-0.1088,-0.031751,0,0
4,GO CHONDROCYTE PROLIFERATION,0.42855,-0.10886,-0.10704,0,0
4,GO RENAL ABSORPTION,0.10465,-0.10892,-0.24248,0,0
4,GO POSITIVE REGULATION OF FERTILIZATION,0.16032,-0.10893,-0.14531,0,0
4,GO AMYLOID FIBRIL FORMATION,0.099158,-0.10909,-0.14269,0,0
4,GO REGULATION OF PROTEIN DEACETYLATION,0.070855,-0.10935,-0.076679,0,0
4,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.0050528,-0.10938,-0.089826,0,0
4,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.014841,-0.1094,-0.12674,0,0
4,GO VIRAL GENOME REPLICATION,0.064293,-0.10948,-0.1513,0,0
4,GO REGULATION OF MACROAUTOPHAGY,5.0226e-05,-0.10978,-0.12789,0,0
4,GO MESENCHYMAL CELL PROLIFERATION,0.34256,-0.1098,-0.10426,0,0
4,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.16294,-0.10989,-0.083915,0,0
4,GO PROTEIN LOCALIZATION TO LYSOSOME,0.010245,-0.10995,-0.15047,0,0
4,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.031748,-0.11001,-0.12541,0,0
4,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.14526,-0.1101,-0.15485,0,0
4,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.033166,-0.11013,-0.12799,0,0
4,GO FEMALE SEX DIFFERENTIATION,0.010245,-0.11016,-0.11649,0,0
4,GO TOXIN METABOLIC PROCESS,0.21256,-0.11024,-0.12572,0,0
4,GO REGULATION OF LIPID KINASE ACTIVITY,0.0014299,-0.11064,-0.14231,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.035393,-0.11068,-0.15989,0,0
4,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.188,-0.11083,-0.14731,0,0
4,GO TOOTH MINERALIZATION,0.090515,-0.11132,-0.14774,0,0
4,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,0.24288,-0.11133,-0.059132,0,0
4,GO NUCLEOSIDE CATABOLIC PROCESS,0.14769,-0.11153,-0.12135,0,0
4,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.0695,-0.11196,-0.11125,0,0
4,GO REGULATION OF GTP BINDING,0.043763,-0.11198,-0.18111,0,0
4,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.00072223,-0.11205,-0.12722,0,0
4,GO MELANOCYTE DIFFERENTIATION,0.25729,-0.11254,-0.064405,0,0
4,GO ACTIN FILAMENT DEPOLYMERIZATION,0.077957,-0.11285,-0.095485,0,0
4,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.015203,-0.11323,-0.165,0,0
4,GO NERVE DEVELOPMENT,0.12259,-0.11327,-0.10123,0,0
4,GO LATERAL VENTRICLE DEVELOPMENT,0.25363,-0.1135,-0.09099,0,0
4,GO MESENCHYME MORPHOGENESIS,0.014841,-0.11352,-0.17212,0,0
4,GO REGULATION OF BMP SIGNALING PATHWAY,0.037747,-0.11367,-0.12835,0,0
4,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.00098941,-0.11367,-0.13412,0,0
4,GO NEURAL CREST CELL DIFFERENTIATION,0.029068,-0.11383,-0.13097,0,0
4,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.099158,-0.11388,-0.22561,0,0
4,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.011047,-0.11417,-0.09783,0,0
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.057089,-0.11446,-0.11085,0,0
4,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.43367,-0.11449,-0.062555,0,0
4,GO BEHAVIORAL RESPONSE TO COCAINE,0.46512,-0.11541,-0.047171,0,0
4,GO MALE MEIOTIC NUCLEAR DIVISION,0.11434,-0.11546,-0.1067,0,0
4,GO REGULATION OF GASTRIC ACID SECRETION,0.21905,-0.11564,-0.12092,0,0
4,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.14769,-0.11565,-0.11844,0,0
4,GO CHLORIDE ION HOMEOSTASIS,0.11235,-0.11569,-0.1059,0,0
4,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.12049,-0.11576,-0.077846,0,0
4,GO DEFENSE RESPONSE TO VIRUS,0.05824,-0.11581,-0.14811,0,0
4,GO REGULATION OF SYSTEM PROCESS,0.0030654,-0.116,-0.11963,0,0
4,GO O GLYCAN PROCESSING,0.076492,-0.11617,-0.15868,0,0
4,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.29184,-0.11641,-0.1022,0,0
4,GO MUSCLE FIBER DEVELOPMENT,0.0094949,-0.11645,-0.11632,0,0
4,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.057089,-0.11667,-0.12278,0,0
4,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.011612,-0.117,-0.17757,0,0
4,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.055956,-0.1171,-0.096665,0,0
4,GO RESPONSE TO INTERLEUKIN 2,0.33373,-0.11721,-0.068485,0,0
4,GO POSITIVE REGULATION OF HEAT GENERATION,0.33812,-0.11733,-0.033483,0,0
4,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.10845,-0.11744,-0.067412,0,0
4,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.0020453,-0.11753,-0.11048,0,0
4,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.045624,-0.11755,-0.14484,0,0
4,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.15015,-0.11764,-0.099288,0,0
4,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.013798,-0.11766,-0.13557,0,0
4,GO DETECTION OF CALCIUM ION,0.61497,-0.11781,-0.051104,0,0
4,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.72969,-0.11795,-0.017226,0,0
4,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.073629,-0.1182,-0.12003,0,0
4,GO MAINTENANCE OF CELL POLARITY,0.12473,-0.1183,-0.095264,0,0
4,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.15015,-0.11837,-0.090264,0,0
4,GO TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE REMODELING,0.063042,-0.11839,-0.13469,0,0
4,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.10654,-0.11873,-0.11477,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.21256,-0.11875,-0.11373,0,0
4,GO MITOCHONDRIAL TRNA PROCESSING,0.10845,-0.11884,-0.13224,0,0
4,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.23245,-0.11892,-0.04231,0,0
4,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.53742,-0.11895,-0.056281,0,0
4,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.060602,-0.11919,-0.11451,0,0
4,GO METANEPHROS MORPHOGENESIS,0.36526,-0.11928,-0.051006,0,0
4,GO EMBRYONIC PLACENTA MORPHOGENESIS,0.67137,-0.11929,-0.013654,0,0
4,GO REGULATION OF MEMBRANE POTENTIAL,0.040234,-0.1193,-0.091322,0,0
4,GO REGULATION OF FILOPODIUM ASSEMBLY,0.12689,-0.11999,-0.09258,0,0
4,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.21256,-0.12005,-0.075896,0,0
4,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.0011549,-0.12031,-0.097219,0,0
4,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.14769,-0.12033,-0.097306,0,0
4,GO NOREPINEPHRINE TRANSPORT,0.2839,-0.12033,-0.070203,0,0
4,GO BARBED END ACTIN FILAMENT CAPPING,0.25729,-0.12038,-0.12526,0,0
4,GO NEPHRON MORPHOGENESIS,0.035393,-0.1208,-0.10372,0,0
4,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.92682,-0.12089,0.023221,0,0
4,GO REGULATION OF RECEPTOR RECYCLING,0.0695,-0.1212,-0.1072,0,0
4,GO REGULATION OF VIRAL GENOME REPLICATION,0.10654,-0.12131,-0.15602,0,0
4,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.21905,-0.12138,-0.069112,0,0
4,GO PROTEIN LOCALIZATION TO EARLY ENDOSOME,0.15264,-0.1214,-0.18276,0,0
4,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.072231,-0.12143,-0.11989,0,0
4,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.0034322,-0.12149,-0.12395,0,0
4,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.11039,-0.12154,-0.12106,0,0
4,GO INTESTINAL ABSORPTION,0.19393,-0.12175,-0.11863,0,0
4,GO ONE CARBON COMPOUND TRANSPORT,0.063042,-0.12195,-0.14615,0,0
4,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.25729,-0.12198,-0.17708,0,0
4,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.40843,-0.12223,-0.10251,0,0
4,GO DERMATAN SULFATE METABOLIC PROCESS,0.23937,-0.12231,-0.17459,0,0
4,GO HORMONE CATABOLIC PROCESS,0.5726,-0.12235,-0.027943,0,0
4,GO RESPONSE TO SALT STRESS,0.068167,-0.12247,-0.12294,0,0
4,GO REGULATION OF SYNAPSE MATURATION,0.38408,-0.12286,-0.11857,0,0
4,GO REGULATION OF GLIAL CELL PROLIFERATION,0.18219,-0.12295,-0.086178,0,0
4,GO MITOCHONDRIAL FISSION,0.011904,-0.12298,-0.11743,0,0
4,GO LYMPH NODE DEVELOPMENT,0.14526,-0.12317,-0.087268,0,0
4,GO LABYRINTHINE LAYER DEVELOPMENT,0.25363,-0.12324,-0.079533,0,0
4,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.188,-0.12325,-0.13478,0,0
4,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.21256,-0.12336,-0.087765,0,0
4,GO RENAL SODIUM EXCRETION,0.15517,-0.12351,-0.086451,0,0
4,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.0013872,-0.12411,-0.14229,0,0
4,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,0.29184,-0.12412,-0.10463,0,0
4,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.58456,-0.12414,-0.048833,0,0
4,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.12049,-0.12429,-0.18951,0,0
4,GO CELL RECOGNITION,0.0030654,-0.12432,-0.13198,0,0
4,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.10465,-0.12444,-0.11,0,0
4,GO GASTRULATION WITH MOUTH FORMING SECOND,0.17653,-0.12447,-0.0939,0,0
4,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.12908,-0.12467,-0.10843,0,0
4,GO RAP PROTEIN SIGNAL TRANSDUCTION,0.46512,-0.1247,-0.074282,0,0
4,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,0.11434,-0.12473,-0.17382,0,0
4,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.20309,-0.12481,-0.080353,0,0
4,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.05824,-0.12524,-0.12062,0,0
4,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.068167,-0.12534,-0.17773,0,0
4,GO PHAGOLYSOSOME ASSEMBLY,0.1028,-0.12551,-0.15921,0,0
4,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.0017123,-0.12559,-0.1537,0,0
4,GO ORGAN INDUCTION,0.0067808,-0.12596,-0.17946,0,0
4,GO ANIMAL ORGAN MATURATION,0.041967,-0.12616,-0.13323,0,0
4,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.23245,-0.12633,-0.11945,0,0
4,GO PARAXIAL MESODERM DEVELOPMENT,0.25363,-0.12641,-0.11186,0,0
4,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.053746,-0.12646,-0.12784,0,0
4,GO PANCREATIC JUICE SECRETION,0.060602,-0.1265,-0.118,0,0
4,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.2,-0.12679,-0.1004,0,0
4,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.65234,-0.127,0.11627,0,0
4,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.00012074,-0.12701,-0.12305,0,0
4,GO CORPUS CALLOSUM DEVELOPMENT,0.077957,-0.12702,-0.15023,0,0
4,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.059411,-0.1272,-0.11025,0,0
4,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.13583,-0.12726,-0.13215,0,0
4,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.0045306,-0.12807,-0.17341,0,0
4,GO REGULATION OF MEMBRANE REPOLARIZATION,0.013465,-0.12829,-0.15724,0,0
4,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,0.58456,-0.12855,-0.024032,0,0
4,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.02268,-0.12863,-0.14645,0,0
4,GO TRIPARTITE REGIONAL SUBDIVISION,0.2,-0.12869,-0.16489,0,0
4,GO CELL JUNCTION ORGANIZATION,0.0054795,-0.12875,-0.11685,0,0
4,GO NEGATIVE REGULATION OF GROWTH,6.2786e-05,-0.12881,-0.16485,0,0
4,GO NUCLEOSIDE SALVAGE,0.097379,-0.12881,-0.1343,0,0
4,GO RENAL VESICLE DEVELOPMENT,0.11434,-0.12895,-0.13243,0,0
4,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.0071468,-0.12897,-0.14966,0,0
4,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.21256,-0.12913,-0.21773,0,0
4,GO RESPONSE TO MURAMYL DIPEPTIDE,0.097379,-0.12914,-0.18642,0,0
4,GO OVULATION CYCLE PROCESS,0.0051916,-0.12919,-0.16161,0,0
4,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.057089,-0.12922,-0.2647,0,0
4,GO NEURON CELLULAR HOMEOSTASIS,0.29586,-0.1293,-0.10315,0,0
4,GO RESPONSE TO NICOTINE,0.52594,-0.12951,-0.01098,0,0
4,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.043763,-0.12956,-0.099827,0,0
4,GO RESPONSE TO X RAY,0.088862,-0.12957,-0.13263,0,0
4,GO MITOCHONDRION ORGANIZATION,2.6307e-05,-0.12962,-0.12376,0,0
4,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0014299,-0.12974,-0.14916,0,0
4,GO NEPHRON EPITHELIUM DEVELOPMENT,0.024288,-0.13,-0.12151,0,0
4,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.20309,-0.13008,-0.097585,0,0
4,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.10845,-0.13015,-0.20772,0,0
4,GO RESPONSE TO VITAMIN,0.013465,-0.13044,-0.15421,0,0
4,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.088862,-0.13052,-0.14487,0,0
4,GO LABYRINTHINE LAYER MORPHOGENESIS,0.36526,-0.13062,-0.082846,0,0
4,GO RESPONSE TO OXYGEN RADICAL,0.064293,-0.13063,-0.10204,0,0
4,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.0038387,-0.13067,-0.15961,0,0
4,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.092194,-0.13072,-0.13848,0,0
4,GO CARDIAC MYOFIBRIL ASSEMBLY,0.21579,-0.13104,-0.089332,0,0
4,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.082489,-0.13114,-0.10732,0,0
4,GO DIVALENT METAL ION EXPORT,0.20937,-0.13116,-0.11042,0,0
4,GO LINOLEIC ACID METABOLIC PROCESS,0.072231,-0.13178,-0.18946,0,0
4,GO STEM CELL DIVISION,0.052669,-0.13187,-0.11893,0,0
4,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.11636,-0.13201,-0.18437,0,0
4,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.009256,-0.13222,-0.12202,0,0
4,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.037747,-0.13248,-0.11072,0,0
4,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.0001165,-0.13266,-0.1375,0,0
4,GO PEPTIDYL METHIONINE MODIFICATION,0.0087944,-0.13287,-0.17177,0,0
4,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.0019282,-0.13306,-0.14595,0,0
4,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.012508,-0.13325,-0.12026,0,0
4,GO GLUTAMINE METABOLIC PROCESS,0.010245,-0.13326,-0.14532,0,0
4,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.027803,-0.13351,-0.21006,0,0
4,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.0695,-0.13361,-0.10843,0,0
4,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.059411,-0.13362,-0.097947,0,0
4,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.064293,-0.13366,-0.11234,0,0
4,GO APICAL JUNCTION ASSEMBLY,0.073629,-0.13368,-0.10436,0,0
4,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.00090094,-0.13377,-0.16852,0,0
4,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.13583,-0.13391,-0.13309,0,0
4,GO SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL COMMUNICATION,0.088862,-0.1345,-0.17145,0,0
4,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.17934,-0.13458,-0.086747,0,0
4,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.084046,-0.13478,-0.10538,0,0
4,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.25363,-0.13507,-0.11383,0,0
4,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.26471,-0.13507,-0.089888,0,0
4,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.092194,-0.13565,-0.13441,0,0
4,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.065563,-0.13566,-0.16112,0,0
4,GO REGULATION OF CELL SHAPE,0.046579,-0.13568,-0.10015,0,0
4,GO UV PROTECTION,0.075049,-0.13568,-0.1578,0,0
4,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.026586,-0.13612,-0.15675,0,0
4,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.20309,-0.13638,-0.15306,0,0
4,GO RESPONSE TO AXON INJURY,0.014138,-0.13649,-0.1265,0,0
4,GO KIDNEY MORPHOGENESIS,0.16294,-0.13668,-0.068634,0,0
4,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.065563,-0.13683,-0.10742,0,0
4,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,6.2786e-05,-0.13687,-0.16305,0,0
4,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.13814,-0.13749,-0.106,0,0
4,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.22235,-0.13758,-0.12881,0,0
4,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.059411,-0.13759,-0.16508,0,0
4,GO RESPONSE TO AMYLOID BETA,0.0036303,-0.13761,-0.16476,0,0
4,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.0066042,-0.1378,-0.14874,0,0
4,GO MONOAMINE TRANSPORT,0.11841,-0.13782,-0.057687,0,0
4,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.0021689,-0.13789,-0.12533,0,0
4,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.082489,-0.13789,-0.10128,0,0
4,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,0.15264,-0.13792,-0.13808,0,0
4,GO HEART FIELD SPECIFICATION,0.71658,-0.13802,-0.02389,0,0
4,GO RESPONSE TO INACTIVITY,0.050569,-0.13831,-0.17052,0,0
4,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.079444,-0.13884,-0.14063,0,0
4,GO RECEPTOR INTERNALIZATION,0.0042883,-0.13885,-0.11916,0,0
4,GO FEVER GENERATION,0.013139,-0.13915,-0.18404,0,0
4,GO DRINKING BEHAVIOR,0.18508,-0.13926,-0.13291,0,0
4,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.00027832,-0.13927,-0.15095,0,0
4,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.0046564,-0.13953,-0.29241,0,0
4,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.12689,-0.13959,-0.094217,0,0
4,GO INTERMEMBRANE LIPID TRANSFER,0.0023671,-0.13968,-0.13998,0,0
4,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.017969,-0.13974,-0.16716,0,0
4,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.17934,-0.13978,-0.21222,0,0
4,GO POSITIVE REGULATION OF STEROL TRANSPORT,0.090515,-0.14003,-0.13571,0,0
4,GO STRIATED MUSCLE ADAPTATION,0.010773,-0.14023,-0.16185,0,0
4,GO DIACYLGLYCEROL METABOLIC PROCESS,0.04854,-0.14031,-0.1201,0,0
4,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.093897,-0.14032,-0.23015,0,0
4,GO AXIS ELONGATION,0.11039,-0.14039,-0.14036,0,0
4,GO REGULATION OF DENDRITE EXTENSION,0.2,-0.14056,-0.034755,0,0
4,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.013139,-0.14064,-0.14825,0,0
4,GO HEART TRABECULA MORPHOGENESIS,0.0049174,-0.14069,-0.19758,0,0
4,GO CARDIOCYTE DIFFERENTIATION,0.0019282,-0.14113,-0.14801,0,0
4,GO MYOFIBRIL ASSEMBLY,0.015953,-0.1412,-0.12268,0,0
4,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.076492,-0.1415,-0.16103,0,0
4,GO SEQUESTERING OF EXTRACELLULAR LIGAND FROM RECEPTOR,0.061812,-0.1416,-0.24106,0,0
4,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.00028792,-0.14173,-0.15386,0,0
4,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.00092958,-0.14223,-0.15518,0,0
4,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.12259,-0.14304,-0.17846,0,0
4,GO NEURONAL ACTION POTENTIAL,0.36064,-0.14316,-0.067823,0,0
4,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.38408,-0.14379,-0.09993,0,0
4,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.00045924,-0.14383,-0.15396,0,0
4,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.072231,-0.14396,-0.15965,0,0
4,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.088862,-0.14396,-0.11339,0,0
4,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.25363,-0.14425,-0.19383,0,0
4,GO PERICARDIUM DEVELOPMENT,0.16032,-0.14496,-0.11832,0,0
4,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.097379,-0.14507,-0.11096,0,0
4,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.00059588,-0.14544,-0.18115,0,0
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.063042,-0.14557,-0.1178,0,0
4,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.090515,-0.14578,-0.11052,0,0
4,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.033166,-0.14606,-0.11807,0,0
4,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.57857,-0.14649,-0.017457,0,0
4,GO OSTEOBLAST DEVELOPMENT,0.066855,-0.14653,-0.14495,0,0
4,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.11235,-0.14707,-0.088538,0,0
4,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.25001,-0.14712,-0.087321,0,0
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.10845,-0.14744,-0.12217,0,0
4,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.31232,-0.14796,-0.099022,0,0
4,GO REGULATION OF DEACETYLASE ACTIVITY,0.053746,-0.14815,-0.11362,0,0
4,GO REPLACEMENT OSSIFICATION,0.082489,-0.14825,-0.14892,0,0
4,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.017969,-0.14882,-0.17512,0,0
4,GO CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.11235,-0.14896,-0.14928,0,0
4,GO MRNA TRANSCRIPTION,0.11235,-0.1493,-0.10425,0,0
4,GO REGULATION OF NEURON MATURATION,0.17374,-0.14937,-0.099886,0,0
4,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.0013054,-0.14991,-0.17797,0,0
4,GO LIPID TRANSLOCATION,0.082489,-0.14997,-0.12105,0,0
4,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.0047853,-0.15004,-0.14454,0,0
4,GO CORNIFICATION,0.16294,-0.15005,-0.11799,0,0
4,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.01282,-0.1502,-0.11729,0,0
4,GO NEPHRIC DUCT MORPHOGENESIS,0.030383,-0.15033,-0.26329,0,0
4,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.10096,-0.15035,-0.14609,0,0
4,GO PROTEOGLYCAN METABOLIC PROCESS,0.02068,-0.15043,-0.12686,0,0
4,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.12049,-0.15052,-0.12321,0,0
4,GO ODONTOGENESIS,0.0062634,-0.15057,-0.16368,0,0
4,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.015574,-0.15073,-0.13294,0,0
4,GO PROTEIN COMPLEX OLIGOMERIZATION,1.0604e-05,-0.15087,-0.15661,0,0
4,GO CELLULAR RESPONSE TO AMYLOID BETA,0.0025817,-0.15094,-0.17963,0,0
4,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.0695,-0.15155,-0.26177,0,0
4,GO PROTEIN LOCALIZATION TO MEMBRANE,2.8418e-05,-0.15174,-0.12856,0,0
4,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.0015653,-0.15196,-0.16871,0,0
4,GO SKELETAL MUSCLE CONTRACTION,0.013798,-0.1525,-0.17235,0,0
4,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.0097392,-0.15274,-0.1322,0,0
4,GO RETROGRADE TRANS SYNAPTIC SIGNALING,0.092194,-0.15275,-0.19805,0,0
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.39858,-0.15296,-0.065225,0,0
4,GO EPITHELIAL CELL PROLIFERATION,0.00029782,-0.15305,-0.17023,0,0
4,GO GROOMING BEHAVIOR,0.76948,-0.15313,0.0095132,0,0
4,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.0010528,-0.1532,-0.1651,0,0
4,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.14769,-0.15399,-0.081909,0,0
4,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.022165,-0.15419,-0.15388,0,0
4,GO SERTOLI CELL DEVELOPMENT,0.095625,-0.15444,-0.15005,0,0
4,GO POSITIVE REGULATION OF ION TRANSPORT,0.00017796,-0.15463,-0.15713,0,0
4,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.36526,-0.15468,-0.096272,0,0
4,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.090515,-0.15498,-0.15403,0,0
4,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.23245,-0.15501,-0.097813,0,0
4,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.0010206,-0.15511,-0.13267,0,0
4,GO ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER,0.11235,-0.15522,-0.16229,0,0
4,GO ANATOMICAL STRUCTURE REGRESSION,0.019739,-0.15524,-0.2182,0,0
4,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.00012512,-0.15525,-0.1629,0,0
4,GO HEART MORPHOGENESIS,0.0069616,-0.1553,-0.12394,0,0
4,GO TETRAHYDROFOLATE INTERCONVERSION,0.0097392,-0.15549,-0.19515,0,0
4,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.0014738,-0.1555,-0.15643,0,0
4,GO CELLULAR RESPONSE TO IRON ION,0.085627,-0.15573,-0.14191,0,0
4,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.0090226,-0.15576,-0.15516,0,0
4,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.080955,-0.15578,-0.17557,0,0
4,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.015574,-0.15591,-0.14402,0,0
4,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.079444,-0.15603,-0.16524,0,0
4,GO LONG TERM MEMORY,0.05824,-0.15621,-0.13039,0,0
4,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.070855,-0.15655,-0.19061,0,0
4,GO MITOCHONDRIAL RNA PROCESSING,0.026586,-0.15663,-0.17672,0,0
4,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.022165,-0.15681,-0.14411,0,0
4,GO SMOOTH MUSCLE CONTRACTION,9.0551e-05,-0.15684,-0.1796,0,0
4,GO MONOVALENT INORGANIC CATION TRANSPORT,0.0042883,-0.15747,-0.11693,0,0
4,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.057089,-0.15758,-0.16691,0,0
4,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.12689,-0.15761,-0.13576,0,0
4,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,1.6729e-06,-0.15778,-0.14647,0,0
4,GO REGULATION OF MAST CELL ACTIVATION,0.064293,-0.15789,-0.11016,0,0
4,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.018836,-0.15797,-0.14394,0,0
4,GO CARDIAC SEPTUM MORPHOGENESIS,0.11039,-0.15821,-0.13897,0,0
4,GO PEPTIDYL ARGININE MODIFICATION,0.00035231,-0.1583,-0.161,0,0
4,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.12049,-0.15874,-0.19345,0,0
4,GO LEYDIG CELL DIFFERENTIATION,0.29184,-0.15884,-0.11853,0,0
4,GO CORONARY VASCULATURE MORPHOGENESIS,0.066855,-0.15902,-0.15217,0,0
4,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.0069616,-0.15917,-0.19204,0,0
4,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.013139,-0.15933,-0.15531,0,0
4,GO RESPONSE TO ATP,0.00055855,-0.15939,-0.16027,0,0
4,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.00034072,-0.1594,-0.16641,0,0
4,GO RESPIRATORY BURST,0.0041716,-0.15959,-0.2239,0,0
4,GO PEROXISOMAL MEMBRANE TRANSPORT,0.0037331,-0.15989,-0.14027,0,0
4,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.095625,-0.15992,-0.16824,0,0
4,GO MAMMARY GLAND DEVELOPMENT,0.00026003,-0.15999,-0.17079,0,0
4,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.027803,-0.16008,-0.22932,0,0
4,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.057089,-0.16014,-0.16275,0,0
4,GO RESPONSE TO HISTAMINE,0.064293,-0.1604,-0.23565,0,0
4,GO CELLULAR ANION HOMEOSTASIS,0.085627,-0.16077,-0.13284,0,0
4,GO KIDNEY EPITHELIUM DEVELOPMENT,0.0099891,-0.1611,-0.14722,0,0
4,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.14526,-0.16124,-0.088991,0,0
4,GO REGULATION OF SYNAPSE ASSEMBLY,0.03939,-0.1618,-0.1279,0,0
4,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,0.17653,-0.16196,-0.14857,0,0
4,GO RESPONSE TO MUSCLE INACTIVITY,0.2,-0.16222,-0.084735,0,0
4,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.064293,-0.16233,-0.12064,0,0
4,GO MEMBRANE REPOLARIZATION,0.0030654,-0.16237,-0.18997,0,0
4,GO TRANSEPITHELIAL TRANSPORT,0.00042998,-0.16256,-0.18614,0,0
4,GO RESPONSE TO PROSTAGLANDIN,0.042857,-0.16299,-0.15443,0,0
4,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.079444,-0.163,-0.16009,0,0
4,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.025414,-0.16327,-0.14485,0,0
4,GO NEURAL CREST CELL MIGRATION,0.017969,-0.16334,-0.17441,0,0
4,GO P38MAPK CASCADE,0.00021909,-0.16339,-0.22249,0,0
4,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.12259,-0.16365,-0.14594,0,0
4,GO GASTRIC ACID SECRETION,0.084046,-0.16388,-0.13449,0,0
4,GO REGULATION OF CAMP MEDIATED SIGNALING,0.0057817,-0.16389,-0.15194,0,0
4,GO REGULATION OF TUBULIN DEACETYLATION,0.21579,-0.16405,-0.091154,0,0
4,GO SCHWANN CELL DIFFERENTIATION,0.0030654,-0.16415,-0.14441,0,0
4,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.0007696,-0.16439,-0.2248,0,0
4,GO RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION,0.23245,-0.16451,-0.14012,0,0
4,GO PARAXIAL MESODERM MORPHOGENESIS,0.16559,-0.16456,-0.14431,0,0
4,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.29992,-0.16468,-0.055684,0,0
4,GO RESPONSE TO VITAMIN A,0.075049,-0.16494,-0.12974,0,0
4,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.059411,-0.16507,-0.1477,0,0
4,GO NEUROMUSCULAR PROCESS,0.0051916,-0.16564,-0.13337,0,0
4,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.19393,-0.16569,-0.16211,0,0
4,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.021165,-0.1657,-0.16132,0,0
4,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.023205,-0.16579,-0.14364,0,0
4,GO SEROTONIN METABOLIC PROCESS,0.38408,-0.16586,-0.084655,0,0
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,5.2837e-06,-0.16594,-0.16048,0,0
4,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,5.2139e-05,-0.16608,-0.22734,0,0
4,GO PURINE NUCLEOSIDE METABOLIC PROCESS,2.0833e-05,-0.16633,-0.18105,0,0
4,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.00057693,-0.16671,-0.15022,0,0
4,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.17099,-0.1669,-0.18198,0,0
4,GO REGULATION OF MUSCLE SYSTEM PROCESS,2.4346e-05,-0.16696,-0.17383,0,0
4,GO NEUROPEPTIDE SIGNALING PATHWAY,0.010506,-0.16732,-0.1559,0,0
4,GO ACTIVATION OF JUN KINASE ACTIVITY,0.14285,-0.1674,-0.076066,0,0
4,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.14285,-0.1674,-0.11338,0,0
4,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.0033369,-0.16742,-0.17642,0,0
4,GO NEGATIVE REGULATION OF VIRAL PROCESS,0.075049,-0.16753,-0.18998,0,0
4,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.00012074,-0.16774,-0.17024,0,0
4,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.0007696,-0.16777,-0.20364,0,0
4,GO MUSCLE CELL DEVELOPMENT,0.00019753,-0.16798,-0.16739,0,0
4,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,0.25001,-0.16867,-0.17716,0,0
4,GO COCHLEA MORPHOGENESIS,0.043763,-0.169,-0.17546,0,0
4,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.082489,-0.16909,-0.20451,0,0
4,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.042857,-0.16925,-0.16168,0,0
4,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.00028792,-0.16973,-0.19063,0,0
4,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.023741,-0.17043,-0.13479,0,0
4,GO RIBOSE PHOSPHATE METABOLIC PROCESS,2.0784e-06,-0.17084,-0.18236,0,0
4,GO AV NODE CELL TO BUNDLE OF HIS CELL COMMUNICATION,0.21905,-0.17092,-0.1006,0,0
4,GO REFLEX,0.17374,-0.17102,-0.14481,0,0
4,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.02166,-0.17122,-0.23073,0,0
4,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.00035231,-0.17142,-0.1722,0,0
4,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.1313,-0.1715,-0.10328,0,0
4,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.05824,-0.17156,-0.1636,0,0
4,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.30402,-0.17208,-0.078697,0,0
4,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.060602,-0.17209,-0.18176,0,0
4,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.11235,-0.17217,-0.21407,0,0
4,GO POSITIVE REGULATION OF CELL SIZE,0.077957,-0.1723,-0.13631,0,0
4,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.047551,-0.17248,-0.14911,0,0
4,GO REGULATION OF TRANSPORTER ACTIVITY,0.0013457,-0.17252,-0.15363,0,0
4,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.00041602,-0.17258,-0.19447,0,0
4,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.02268,-0.17296,-0.17782,0,0
4,GO HEART PROCESS,0.00072223,-0.17321,-0.16853,0,0
4,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.02068,-0.17396,-0.14957,0,0
4,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.11636,-0.17438,-0.12957,0,0
4,GO EXTRACELLULAR TRANSPORT,0.18508,-0.17447,-0.078315,0,0
4,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.072231,-0.17471,-0.13676,0,0
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.17374,-0.17484,-0.11568,0,0
4,GO ANOIKIS,0.064293,-0.17503,-0.14324,0,0
4,GO REGULATION OF RESPIRATORY BURST,0.060602,-0.17515,-0.16988,0,0
4,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.00037661,-0.17515,-0.19694,0,0
4,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.001191,-0.1756,-0.22409,0,0
4,GO MEMBRANE BIOGENESIS,0.012508,-0.1758,-0.18261,0,0
4,GO LAMELLIPODIUM ORGANIZATION,0.00010462,-0.1759,-0.19132,0,0
4,GO NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.0021062,-0.1766,-0.26038,0,0
4,GO LAMELLIPODIUM ASSEMBLY,0.00069957,-0.17692,-0.16366,0,0
4,GO GONADOTROPIN SECRETION,0.1313,-0.17719,-0.11634,0,0
4,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.021165,-0.17736,-0.18146,0,0
4,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.0071468,-0.1777,-0.26032,0,0
4,GO ONE CARBON METABOLIC PROCESS,0.0013054,-0.17795,-0.18445,0,0
4,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.093897,-0.17807,-0.10066,0,0
4,GO RENAL FILTRATION,0.35153,-0.17878,-0.10075,0,0
4,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.0046564,-0.17899,-0.15017,0,0
4,GO MUSCLE SYSTEM PROCESS,1.2862e-06,-0.17901,-0.19319,0,0
4,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0016129,-0.17905,-0.1611,0,0
4,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,0.090515,-0.17915,-0.14686,0,0
4,GO TRANS SYNAPTIC SIGNALING MODULATING SYNAPTIC TRANSMISSION,0.15264,-0.17915,-0.15728,0,0
4,GO RADIAL GLIAL CELL DIFFERENTIATION,0.038561,-0.17918,-0.22639,0,0
4,GO COENZYME A METABOLIC PROCESS,0.0056288,-0.1793,-0.17287,0,0
4,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,0.15015,-0.17969,-0.17113,0,0
4,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,5.2139e-05,-0.18039,-0.16791,0,0
4,GO MODIFIED AMINO ACID TRANSPORT,0.0001547,-0.18041,-0.22286,0,0
4,GO POSITIVE REGULATION OF OSSIFICATION,0.00063551,-0.18052,-0.21902,0,0
4,GO REGULATION OF GONAD DEVELOPMENT,0.085627,-0.18142,-0.13408,0,0
4,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,0.19095,-0.18165,-0.080366,0,0
4,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.0094949,-0.18175,-0.20243,0,0
4,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.00065623,-0.18268,-0.14621,0,0
4,GO MUSCLE CONTRACTION,2.3654e-06,-0.18273,-0.19481,0,0
4,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.1028,-0.1829,-0.12838,0,0
4,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.0695,-0.18325,-0.19889,0,0
4,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.085627,-0.18334,-0.15695,0,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME,0.075049,-0.18359,-0.17472,0,0
4,GO GLIAL CELL MIGRATION,0.0020453,-0.18366,-0.19964,0,0
4,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.0045306,-0.18453,-0.194,0,0
4,GO PROSTATIC BUD FORMATION,0.10465,-0.18455,-0.23407,0,0
4,GO REGULATION OF CATION CHANNEL ACTIVITY,0.0050528,-0.18455,-0.15819,0,0
4,GO MECHANOSENSORY BEHAVIOR,0.47588,-0.18483,-0.047597,0,0
4,GO CATECHOLAMINE SECRETION,0.11841,-0.18517,-0.057224,0,0
4,GO CARDIAC CHAMBER DEVELOPMENT,0.00095906,-0.18532,-0.16435,0,0
4,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.0038387,-0.18564,-0.17798,0,0
4,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.013798,-0.18621,-0.19634,0,0
4,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.18508,-0.1867,-0.12904,0,0
4,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.0085714,-0.18673,-0.19728,0,0
4,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.43367,-0.18754,-0.069086,0,0
4,GO MITOTIC CELL CYCLE ARREST,0.1313,-0.18769,-0.097671,0,0
4,GO CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION,0.097379,-0.18798,-0.18695,0,0
4,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.017137,-0.18803,-0.12848,0,0
4,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.0073363,-0.18826,-0.22152,0,0
4,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.0064317,-0.18838,-0.1888,0,0
4,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.04854,-0.18838,-0.1727,0,0
4,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.050569,-0.18868,-0.099342,0,0
4,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.076492,-0.18907,-0.11691,0,0
4,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.0056288,-0.18961,-0.274,0,0
4,GO AMINE CATABOLIC PROCESS,0.0050528,-0.18981,-0.23906,0,0
4,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.031059,-0.19026,-0.17069,0,0
4,GO REGULATION OF FAT CELL DIFFERENTIATION,0.00087311,-0.19035,-0.17316,0,0
4,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.00044439,-0.19096,-0.21235,0,0
4,GO BONE MINERALIZATION,2.2524e-05,-0.19099,-0.23695,0,0
4,GO CARDIOLIPIN METABOLIC PROCESS,0.00026903,-0.19123,-0.23323,0,0
4,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.22905,-0.1916,-0.11542,0,0
4,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0062634,-0.19207,-0.19641,0,0
4,GO POSITIVE REGULATION OF JNK CASCADE,6.0504e-05,-0.19214,-0.16773,0,0
4,GO MULTICELLULAR ORGANISMAL SIGNALING,0.0069616,-0.19255,-0.15196,0,0
4,GO CARDIAC CHAMBER MORPHOGENESIS,0.0042883,-0.1933,-0.16785,0,0
4,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,5.4121e-05,-0.1936,-0.24197,0,0
4,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.00041602,-0.19372,-0.17725,0,0
4,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.00025131,-0.19435,-0.17558,0,0
4,GO OUTFLOW TRACT MORPHOGENESIS,0.0057817,-0.19439,-0.18749,0,0
4,GO CARDIAC VENTRICLE DEVELOPMENT,0.0039469,-0.19481,-0.15968,0,0
4,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.00087311,-0.19537,-0.15181,0,0
4,GO PSEUDOPODIUM ORGANIZATION,0.16828,-0.19641,-0.1586,0,0
4,GO CELLULAR RESPONSE TO PH,0.00057693,-0.19677,-0.20117,0,0
4,GO POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.2,-0.19752,-0.1595,0,0
4,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.097379,-0.19761,-0.15652,0,0
4,GO CALCIUM IMPORT INTO THE MITOCHONDRION,0.0025817,-0.19784,-0.19746,0,0
4,GO EXPLORATION BEHAVIOR,0.029719,-0.19787,-0.17684,0,0
4,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,0.060602,-0.19859,-0.22811,0,0
4,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.072231,-0.19861,-0.15019,0,0
4,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0071468,-0.19866,-0.16732,0,0
4,GO LAMELLIPODIUM MORPHOGENESIS,0.007729,-0.19876,-0.22242,0,0
4,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.0066042,-0.19892,-0.20092,0,0
4,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.0026572,-0.19896,-0.15636,0,0
4,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.1313,-0.19899,-0.13337,0,0
4,GO VENTRICULAR SEPTUM DEVELOPMENT,0.012203,-0.19931,-0.17253,0,0
4,GO INDOLALKYLAMINE METABOLIC PROCESS,0.16294,-0.19954,-0.12413,0,0
4,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.00012512,-0.20024,-0.1833,0,0
4,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.001228,-0.2004,-0.20005,0,0
4,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.0064317,-0.20107,-0.18289,0,0
4,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.05824,-0.20142,-0.11935,0,0
4,GO BLASTODERM SEGMENTATION,0.036948,-0.20148,-0.23918,0,0
4,GO RESPONSE TO INTERFERON ALPHA,0.22905,-0.20153,-0.27573,0,0
4,GO MEMBRANE DEPOLARIZATION,0.015574,-0.20167,-0.16261,0,0
4,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.022165,-0.20195,-0.14007,0,0
4,GO INOSITOL PHOSPHATE METABOLIC PROCESS,4.2876e-06,-0.20246,-0.19708,0,0
4,GO DICARBOXYLIC ACID METABOLIC PROCESS,3.4421e-05,-0.20268,-0.21078,0,0
4,GO OPTIC NERVE DEVELOPMENT,0.17934,-0.20292,-0.1363,0,0
4,GO PROTEIN LOCALIZATION TO CELL CORTEX,0.10654,-0.20417,-0.13317,0,0
4,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.024288,-0.20437,-0.23199,0,0
4,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,4.8612e-06,-0.20495,-0.20135,0,0
4,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.00012512,-0.20519,-0.18732,0,0
4,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.00034072,-0.20547,-0.19694,0,0
4,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,1.0184e-05,-0.20551,-0.21183,0,0
4,GO PSEUDOURIDINE SYNTHESIS,0.0025083,-0.20598,-0.25461,0,0
4,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.050569,-0.20622,-0.11003,0,0
4,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.001872,-0.20695,-0.18882,0,0
4,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.00031859,-0.207,-0.19843,0,0
4,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,0.31232,-0.20743,-0.065334,0,0
4,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.012203,-0.20745,-0.14741,0,0
4,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,2.0033e-05,-0.20752,-0.20161,0,0
4,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.00035231,-0.20793,-0.26305,0,0
4,GO GLYCOSIDE METABOLIC PROCESS,0.17099,-0.20863,-0.20641,0,0
4,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.0013457,-0.20891,-0.15224,0,0
4,GO SUCKLING BEHAVIOR,0.097379,-0.20899,-0.12694,0,0
4,GO ENDOCARDIAL CUSHION FORMATION,0.02068,-0.20906,-0.21473,0,0
4,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,1.104e-05,-0.20962,-0.20395,0,0
4,GO RESPONSE TO LIGHT INTENSITY,0.011904,-0.20966,-0.1987,0,0
4,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.00021909,-0.20974,-0.18089,0,0
4,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.2,-0.20975,-0.13339,0,0
4,GO REGULATION OF GLOMERULAR FILTRATION,0.32938,-0.21044,-0.10917,0,0
4,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,2.0833e-05,-0.21045,-0.20824,0,0
4,GO RESPONSE TO MUSCLE ACTIVITY,0.010506,-0.21079,-0.20846,0,0
4,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0695,-0.2108,-0.14651,0,0
4,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.019739,-0.21085,-0.21498,0,0
4,GO FOLIC ACID METABOLIC PROCESS,0.0011199,-0.21141,-0.2101,0,0
4,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.040234,-0.2117,-0.19189,0,0
4,GO TYPE B PANCREATIC CELL PROLIFERATION,0.025994,-0.21206,-0.27613,0,0
4,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.00098941,-0.21247,-0.2204,0,0
4,GO REGULATION OF BONE MINERALIZATION,2.8418e-05,-0.2146,-0.25084,0,0
4,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.064293,-0.21481,-0.11879,0,0
4,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.0037331,-0.21509,-0.27202,0,0
4,GO ACTIN FILAMENT BASED MOVEMENT,0.00012964,-0.21763,-0.20653,0,0
4,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.070855,-0.21815,-0.17205,0,0
4,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.061812,-0.21872,-0.14935,0,0
4,GO NEGATIVE REGULATION OF CELL AGING,0.079444,-0.21943,-0.15745,0,0
4,GO NEGATIVE REGULATION OF AUTOPHAGY,1.1964e-05,-0.21967,-0.21868,0,0
4,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.00031859,-0.21999,-0.19946,0,0
4,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.0001165,-0.22012,-0.21319,0,0
4,GO REGULATION OF STRIATED MUSCLE CONTRACTION,5.6174e-05,-0.2208,-0.22868,0,0
4,GO FIBROBLAST APOPTOTIC PROCESS,0.0062634,-0.2211,-0.20975,0,0
4,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.014486,-0.22154,-0.26362,0,0
4,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.00019753,-0.22158,-0.17209,0,0
4,GO CELLULAR OXIDANT DETOXIFICATION,0.0013054,-0.22248,-0.17827,0,0
4,GO POSITIVE REGULATION OF RESPONSE TO TUMOR CELL,0.0031536,-0.22284,-0.2256,0,0
4,GO FEMALE GENITALIA DEVELOPMENT,0.018836,-0.22328,-0.15204,0,0
4,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.0010528,-0.22332,-0.24825,0,0
4,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.001191,-0.22338,-0.18034,0,0
4,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.27227,-0.22377,-0.1299,0,0
4,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.0019282,-0.22377,-0.20019,0,0
4,GO CARDIAC CONDUCTION,0.0017641,-0.22383,-0.18859,0,0
4,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.00027832,-0.22581,-0.27523,0,0
4,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.0025817,-0.22591,-0.23364,0,0
4,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.0083534,-0.22681,-0.20345,0,0
4,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.12689,-0.22719,-0.12591,0,0
4,GO HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.00047456,-0.2272,-0.28634,0,0
4,GO PLASMA MEMBRANE REPAIR,0.057089,-0.22723,-0.15814,0,0
4,GO INACTIVATION OF MAPK ACTIVITY,0.0090226,-0.2275,-0.22009,0,0
4,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.00090094,-0.22815,-0.18967,0,0
4,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.075049,-0.22935,-0.17532,0,0
4,GO STRIATED MUSCLE CONTRACTION,0.00010462,-0.22942,-0.20653,0,0
4,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.0047853,-0.23043,-0.25676,0,0
4,GO PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER,0.00092958,-0.23069,-0.24318,0,0
4,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.0021062,-0.23172,-0.20202,0,0
4,GO ZINC ION HOMEOSTASIS,0.01282,-0.23429,-0.24296,0,0
4,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.00028792,-0.2361,-0.25049,0,0
4,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.00031859,-0.23612,-0.29613,0,0
4,GO PROTEIN LOCALIZATION TO AXON,0.32077,-0.23665,-0.099442,0,0
4,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.00027832,-0.23712,-0.29086,0,0
4,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.034637,-0.23762,-0.25192,0,0
4,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.05824,-0.23819,-0.17747,0,0
4,GO KETONE BODY METABOLIC PROCESS,0.0081404,-0.23876,-0.23681,0,0
4,GO CARDIAC CELL DEVELOPMENT,1.349e-05,-0.23939,-0.22515,0,0
4,GO VITAMIN D BIOSYNTHETIC PROCESS,0.10465,-0.24173,-0.15863,0,0
4,GO STARTLE RESPONSE,0.15015,-0.24296,-0.14242,0,0
4,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0017641,-0.24309,-0.2265,0,0
4,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.56666,-0.24337,-0.048857,0,0
4,GO HOMOCYSTEINE METABOLIC PROCESS,0.0011549,-0.245,-0.34565,0,0
4,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.02268,-0.24512,-0.2381,0,0
4,GO REGULATION OF DOPAMINE SECRETION,0.084046,-0.24528,-0.13953,0,0
4,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,0.11039,-0.24581,-0.11885,0,0
4,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.10465,-0.24596,-0.14769,0,0
4,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,7.2754e-05,-0.24664,-0.24746,0,0
4,GO POLYSACCHARIDE CATABOLIC PROCESS,1.0779e-06,-0.24906,-0.28797,0,0
4,GO REGULATION OF VESICLE FUSION,0.0081404,-0.24961,-0.26769,0,0
4,GO RRNA CATABOLIC PROCESS,0.060602,-0.25,-0.10968,0,0
4,GO ACTION POTENTIAL,0.0021062,-0.25044,-0.17841,0,0
4,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.0014738,-0.25076,-0.35747,0,0
4,GO INNERVATION,0.16559,-0.2521,-0.10258,0,0
4,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,2.7343e-05,-0.25211,-0.23062,0,0
4,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,6.2367e-06,-0.25288,-0.25208,0,0
4,GO RESPONSE TO AMINE,8.7323e-05,-0.25391,-0.27591,0,0
4,GO DIVALENT INORGANIC ANION HOMEOSTASIS,0.0056288,-0.25411,-0.24715,0,0
4,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.02068,-0.25485,-0.18789,0,0
4,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.00030804,-0.25583,-0.28328,0,0
4,GO BLASTOCYST FORMATION,3.1888e-05,-0.25592,-0.22113,0,0
4,GO ALDITOL PHOSPHATE METABOLIC PROCESS,9.389e-05,-0.25636,-0.32504,0,0
4,GO RESPONSE TO ZINC ION,0.0026572,-0.25696,-0.25023,0,0
4,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.055956,-0.25795,-0.25861,0,0
4,GO CARDIAC MUSCLE CONTRACTION,0.00010845,-0.25847,-0.21441,0,0
4,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.00074557,-0.25914,-0.24949,0,0
4,GO GLIAL CELL APOPTOTIC PROCESS,0.33373,-0.25915,-0.099294,0,0
4,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.00049035,-0.26024,-0.23906,0,0
4,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,7.5427e-07,-0.26163,-0.25938,0,0
4,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.0057817,-0.26277,-0.25494,0,0
4,GO REGULATION OF ANOIKIS,0.010245,-0.26311,-0.26565,0,0
4,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,6.0504e-05,-0.26405,-0.24374,0,0
4,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.00042998,-0.26434,-0.23711,0,0
4,GO CELLULAR RESPONSE TO ZINC ION,0.0059384,-0.26447,-0.41186,0,0
4,GO GLUCOCORTICOID METABOLIC PROCESS,0.00016023,-0.26558,-0.27917,0,0
4,GO ALDITOL METABOLIC PROCESS,1.9263e-05,-0.26579,-0.29228,0,0
4,GO MALE GENITALIA DEVELOPMENT,0.0011199,-0.26624,-0.23422,0,0
4,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.00016595,-0.2665,-0.35219,0,0
4,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,0.15015,-0.26678,-0.16059,0,0
4,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,0.041093,-0.26768,-0.19492,0,0
4,GO NEUROBLAST DIVISION,0.00059588,-0.26822,-0.31758,0,0
4,GO NEUROTRANSMITTER UPTAKE,0.0067808,-0.2689,-0.19414,0,0
4,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.0069616,-0.26939,-0.22547,0,0
4,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.077957,-0.27007,-0.26728,0,0
4,GO RESPONSE TO HYDROPEROXIDE,0.014138,-0.27121,-0.24318,0,0
4,GO PROTEIN REFOLDING,0.0023671,-0.27384,-0.21793,0,0
4,GO RESPONSE TO PAIN,0.0007696,-0.27504,-0.3049,0,0
4,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,3.0689e-05,-0.27509,-0.28902,0,0
4,GO GENITALIA MORPHOGENESIS,0.012203,-0.27548,-0.24088,0,0
4,GO ETHANOL OXIDATION,0.00353,-0.27573,-0.40826,0,0
4,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.017549,-0.27592,-0.28647,0,0
4,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.010245,-0.27712,-0.28786,0,0
4,GO CELLULAR RESPONSE TO COPPER ION,0.0064317,-0.27873,-0.36989,0,0
4,GO NADPH REGENERATION,0.0033369,-0.27928,-0.23746,0,0
4,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.0025083,-0.28012,-0.25409,0,0
4,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.030383,-0.28071,-0.20683,0,0
4,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,1.4044e-06,-0.28133,-0.30948,0,0
4,GO NEPHRIC DUCT DEVELOPMENT,0.0017123,-0.28432,-0.29832,0,0
4,GO HEART TRABECULA FORMATION,0.0015653,-0.28685,-0.32086,0,0
4,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.0015189,-0.2883,-0.21322,0,0
4,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.00052342,-0.28955,-0.2705,0,0
4,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.014138,-0.29039,-0.21657,0,0
4,GO RESPONSE TO MUSCLE STRETCH,0.0015189,-0.29116,-0.31913,0,0
4,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.00010092,-0.29274,-0.32833,0,0
4,GO CYTOCHROME COMPLEX ASSEMBLY,0.00087311,-0.29275,-0.23094,0,0
4,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.00035231,-0.29416,-0.25181,0,0
4,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.0049174,-0.29526,-0.2504,0,0
4,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.0020453,-0.29594,-0.30908,0,0
4,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.029068,-0.29683,-0.20053,0,0
4,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.057089,-0.29751,-0.21395,0,0
4,GO GLUCOSE CATABOLIC PROCESS,0.0001165,-0.30148,-0.3043,0,0
4,GO INTERMEDIATE FILAMENT ORGANIZATION,0.00022676,-0.30191,-0.28945,0,0
4,GO POSITIVE REGULATION OF HEART CONTRACTION,0.00020448,-0.30267,-0.26507,0,0
4,GO L SERINE METABOLIC PROCESS,0.085627,-0.30278,-0.17839,0,0
4,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.00025131,-0.30418,-0.28648,0,0
4,GO PHAGOCYTOSIS RECOGNITION,0.0036303,-0.30645,-0.28985,0,0
4,GO NEUROTRANSMITTER REUPTAKE,0.0040578,-0.30679,-0.24694,0,0
4,GO AMP METABOLIC PROCESS,4.0073e-05,-0.30708,-0.36656,0,0
4,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.0021689,-0.30801,-0.33528,0,0
4,GO DOPAMINE BIOSYNTHETIC PROCESS,0.53167,-0.3086,-0.088868,0,0
4,GO PROTEIN TRIMERIZATION,6.0504e-05,-0.30884,-0.36673,0,0
4,GO DETOXIFICATION OF INORGANIC COMPOUND,0.080955,-0.30947,-0.44931,0,0
4,GO CARDIAC MUSCLE CELL CONTRACTION,0.00020448,-0.31008,-0.24777,0,0
4,GO PULMONARY VALVE MORPHOGENESIS,0.00034072,-0.31039,-0.49723,0,0
4,GO ACTIN MEDIATED CELL CONTRACTION,1.7806e-05,-0.31117,-0.27186,0,0
4,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.0034322,-0.31354,-0.27495,0,0
4,GO RELAXATION OF MUSCLE,0.00025131,-0.31476,-0.29208,0,0
4,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.0032441,-0.31694,-0.26909,0,0
4,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.00090094,-0.32413,-0.38042,0,0
4,GO AMINO ACID ACTIVATION,0.00013917,-0.3282,-0.26893,0,0
4,GO INCLUSION BODY ASSEMBLY,0.0011199,-0.33098,-0.2666,0,0
4,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.00065623,-0.33401,-0.30874,0,0
4,GO POSITIVE REGULATION OF HEART RATE,0.00025131,-0.33801,-0.33681,0,0
4,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.00092958,-0.34028,-0.3276,0,0
4,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,7.547e-05,-0.34301,-0.26643,0,0
4,GO CELLULAR HYPEROSMOTIC RESPONSE,0.0030654,-0.34833,-0.30173,0,0
4,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,0.016339,-0.34879,-0.27514,0,0
4,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.001228,-0.35284,-0.25073,0,0
4,GO GTP METABOLIC PROCESS,6.0504e-05,-0.35759,-0.32973,0,0
4,GO FATTY ACID HOMEOSTASIS,0.0001547,-0.36386,-0.34769,0,0
4,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.00017186,-0.36885,-0.34551,0,0
4,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.0022992,-0.37109,-0.35731,0,0
4,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.024846,-0.37115,-0.29589,0,0
4,GO MINERALOCORTICOID METABOLIC PROCESS,0.00023468,-0.37383,-0.39956,0,0
4,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.010506,-0.37407,-0.30286,0,0
4,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,5.8301e-05,-0.37612,-0.29475,0,0
4,GO NERVOUS SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.01282,-0.37646,-0.39507,0,0
4,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.012508,-0.37784,-0.26057,0,0
4,GO POSITIVE REGULATION OF VESICLE FUSION,0.00092958,-0.37865,-0.4588,0,0
4,GO NADH METABOLIC PROCESS,3.8583e-05,-0.38417,-0.32219,0,0
4,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,6.0504e-05,-0.38471,-0.46816,0,0
4,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,6.2786e-05,-0.38536,-0.35827,0,0
4,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.00017186,-0.38538,-0.34985,0,0
4,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.0022332,-0.39899,-0.33206,0,0
4,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.00067758,-0.40209,-0.35777,0,0
4,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.00020448,-0.4123,-0.39933,0,0
4,GO HEPARIN METABOLIC PROCESS,3.4421e-05,-0.42313,-0.44112,0,0
4,GO HEART INDUCTION,0.0069616,-0.45443,-0.31454,0,0
4,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.00019753,-0.45655,-0.4453,0,0
4,GO ALDEHYDE BIOSYNTHETIC PROCESS,7.0571e-06,-0.47052,-0.49765,0,0
4,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.00050664,-0.48708,-0.42573,0,0
4,GO TRNA CATABOLIC PROCESS,0.010773,-0.48916,-0.29616,0,0
4,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,4.3218e-05,-0.49969,-0.45546,0,0
4,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.0017123,-0.50341,-0.4469,0,0
4,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,5.6174e-05,-0.54096,-0.5039,0,0
4,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,5.0226e-05,-0.54951,-0.46719,0,0
